data_2ls5_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ls5 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.553 ' HH ' ' HB2' ' A' ' 117' ' ' ARG . 47.7 m-85 . . . . . 0 N--CA 1.455 -0.186 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.417 HG13 HG22 ' A' ' 7' ' ' VAL . 46.1 pt -96.78 -14.03 7.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.418 0.627 . . . . 0.0 109.42 173.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.58 HG11 HD11 ' A' ' 127' ' ' ILE . 20.5 t -110.36 151.78 12.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.181 177.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.421 ' CD ' ' HB2' ' A' ' 11' ' ' GLU . 5.0 ppt_? -126.25 168.74 13.68 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.699 0.285 . . . . 0.0 111.55 -173.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.731 HG12 HD13 ' A' ' 130' ' ' LEU . 72.7 mt -65.92 128.26 28.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 120.955 0.407 . . . . 0.0 110.509 178.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.06 -4.35 65.2 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.79 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.421 ' HB2' ' CD ' ' A' ' 8' ' ' ARG . 7.3 tp10 -89.25 151.63 22.03 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.538 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 41.7 mtp -80.29 143.89 33.28 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.126 0.489 . . . . 0.0 110.657 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.22 132.24 56.77 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.646 -175.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -63.24 156.44 55.54 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.058 2.505 . . . . 0.0 112.071 176.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -97.9 165.6 11.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.818 -177.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.509 ' HE2' ' HH ' ' A' ' 108' ' ' TYR . 47.9 p90 -177.41 166.0 2.24 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.64 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 45.7 m -131.17 106.29 8.24 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 174.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.3 tt -107.97 143.27 18.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.008 -171.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.0 m -85.39 125.32 32.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.282 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.403 HD23 ' HB2' ' A' ' 95' ' ' PRO . 97.6 mt -83.45 173.74 11.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.33 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.449 HG23 ' O ' ' A' ' 96' ' ' LEU . 3.5 p -58.69 -31.19 67.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.696 -175.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -100.69 18.37 19.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.234 0.54 . . . . 0.0 110.355 -176.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.52 39.07 23.0 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.783 173.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -108.45 136.48 48.0 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.736 0.303 . . . . 0.0 111.064 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -99.45 116.07 30.74 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 17' ' ' THR . 3.1 p -120.23 126.12 74.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.382 0.61 . . . . 0.0 111.158 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.7 m -93.44 143.3 26.42 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.115 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.46 HD22 ' HA ' ' A' ' 28' ' ' LEU . 0.7 OUTLIER -66.59 -30.69 71.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.721 0.296 . . . . 0.0 110.295 -176.312 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.9 m -53.2 -43.01 66.85 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.191 176.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.9 m -67.54 -24.75 65.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.561 -175.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.1 mt -88.45 -22.06 23.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.787 -176.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 83.5 mtm-85 -60.2 159.41 9.81 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.894 0.378 . . . . 0.0 111.585 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.544 ' O ' ' HG3' ' A' ' 123' ' ' ARG . . . 85.25 -23.42 8.26 Favored Glycine 0 N--CA 1.452 -0.265 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -172.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.44 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 31.4 mtmm -109.21 167.93 9.75 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 176.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.414 HG22 HD21 ' A' ' 150' ' ' LEU . 26.1 m -81.87 114.19 22.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 121.208 0.528 . . . . 0.0 110.233 177.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.558 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 29.9 t -110.25 115.32 49.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.137 -173.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.475 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 27.6 ttt -101.16 114.73 28.96 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.119 175.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 69.7 mt -110.11 108.58 18.81 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.891 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.403 ' CG ' ' HA2' ' A' ' 73' ' ' GLY . 9.9 pt20 -94.7 130.01 41.37 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.463 ' HB2' ' HG2' ' A' ' 117' ' ' ARG . 77.2 m-85 -101.45 107.14 18.37 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 12.6 t -130.83 -174.92 3.51 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.252 -171.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.523 ' HB2' ' SG ' ' A' ' 45' ' ' CYS . . . -164.75 143.85 6.99 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.578 177.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 57.1 p -58.64 -25.3 62.59 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -177.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 36.4 p-90 -90.83 7.85 37.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.782 0.325 . . . . 0.0 111.741 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.523 ' SG ' ' HB2' ' A' ' 42' ' ' ALA . 71.8 m -93.25 127.03 38.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.053 0.454 . . . . 0.0 110.905 177.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -85.02 -33.06 19.18 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.457 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.63 HG13 ' HB2' ' A' ' 133' ' ' LEU . 40.3 t -65.11 -34.15 68.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 121.143 0.497 . . . . 0.0 110.629 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.679 ' SG ' HG21 ' A' ' 116' ' ' THR . 92.3 m -66.26 -15.89 63.57 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.461 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -78.33 -3.32 42.43 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.478 0.656 . . . . 0.0 110.298 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.407 ' O ' ' HD1' ' A' ' 54' ' ' PHE . 18.8 mtpp -101.77 -45.54 5.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.908 163.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.601 ' HB3' ' HA ' ' A' ' 48' ' ' CYS . 37.4 tt0 -54.87 -63.32 1.19 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.178 -1.374 . . . . 0.0 111.719 -176.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.64 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 79.8 mtp -59.33 -52.19 76.15 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.994 -173.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.64 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 50.5 Cg_exo -56.4 -40.8 82.21 Favored 'Trans proline' 0 C--N 1.358 1.034 0 C-N-CA 122.165 1.91 . . . . 0.0 112.752 179.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.407 ' HD1' ' O ' ' A' ' 50' ' ' LYS . 17.0 m-85 -67.21 -44.81 78.64 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.443 177.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.567 ' O ' ' HB ' ' A' ' 59' ' ' ILE . 81.8 mt -56.44 -45.34 81.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.531 176.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.571 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 38.6 tt0 -62.55 -48.69 78.4 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.415 178.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.496 ' HA ' HD22 ' A' ' 61' ' ' LEU . 29.1 ttpp -63.4 -54.07 42.54 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -173.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -104.29 -13.0 16.31 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -170.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.567 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 71.6 mt -105.16 -63.67 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.725 177.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.573 ' CD2' ' HB3' ' A' ' 94' ' ' TYR . 74.0 t-105 -59.89 -62.09 2.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.548 -175.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.496 HD22 ' HA ' ' A' ' 57' ' ' LYS . 2.6 mp -53.47 -23.06 9.08 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -175.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -89.75 -53.15 4.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.816 0.341 . . . . 0.0 111.418 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -113.18 2.63 15.68 Favored 'General case' 0 C--O 1.221 -0.437 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -167.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.476 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 12.0 pttp -39.07 -44.07 1.09 Allowed 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -172.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -96.8 -75.99 0.52 Allowed 'General case' 0 C--O 1.251 1.146 0 CA-C-O 121.334 0.588 . . . . 0.0 109.855 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.412 ' O ' ' HB1' ' A' ' 67' ' ' ALA . 24.8 t-20 66.56 -72.19 0.09 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 114.449 -1.251 . . . . 0.0 110.667 -177.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 66' ' ' ASN . . . 155.32 -26.17 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.323 0 O-C-N 125.044 1.465 . . . . 0.0 107.704 -175.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.44 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 14.9 t70 -140.04 22.38 2.43 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.991 -172.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.536 ' CE2' ' HB2' ' A' ' 71' ' ' LEU . 68.6 t80 -113.4 139.35 48.97 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.328 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.07 128.94 29.08 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.773 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.536 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 3.6 tt -134.23 117.36 16.39 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.449 HD11 ' C ' ' A' ' 71' ' ' LEU . 3.1 mp -128.66 130.72 68.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.788 0.327 . . . . 0.0 110.141 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.403 ' HA2' ' CG ' ' A' ' 39' ' ' GLN . . . -99.23 133.73 11.41 Favored Glycine 0 C--O 1.219 -0.797 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.526 176.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.0 mt -116.52 127.76 74.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 117.29 0.545 . . . . 0.0 110.905 -176.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.471 ' OD2' ' HA ' ' A' ' 42' ' ' ALA . 10.2 t70 -90.91 135.09 33.96 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 174.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.499 ' HB2' HD11 ' A' ' 115' ' ' ILE . 58.9 ttt-85 -68.69 -28.57 66.97 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -170.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -160.1 -26.87 0.06 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -170.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -74.49 130.83 81.14 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-O 121.292 0.568 . . . . 0.0 111.314 -176.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.522 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 25.4 Cg_endo -68.75 -166.64 0.16 Allowed 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 123.337 2.692 . . . . 0.0 114.831 -176.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -58.98 -55.27 37.25 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 114.315 -1.312 . . . . 0.0 112.248 -169.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.522 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -64.16 -36.29 83.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.542 -173.813 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.461 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 33.9 mmtp -59.79 -54.26 48.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.156 0.503 . . . . 0.0 110.885 177.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.0 t -61.92 -41.87 92.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.294 -177.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.1 mp -62.91 -44.27 96.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.648 0.261 . . . . 0.0 111.254 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.529 ' HA ' ' HE3' ' A' ' 88' ' ' LYS . . . -68.42 -27.62 66.36 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.317 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.438 ' HE2' ' SD ' ' A' ' 52' ' ' MET . 93.3 t80 -80.43 -53.26 6.76 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.911 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.69 -44.35 77.28 Favored 'General case' 0 C--O 1.226 -0.163 0 O-C-N 123.39 0.431 . . . . 0.0 111.787 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.529 ' HE3' ' HA ' ' A' ' 85' ' ' ALA . 18.4 pttp -62.92 -26.46 68.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.026 0.441 . . . . 0.0 111.352 -177.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.9 m -88.73 -22.56 23.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.885 -175.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.0 p -97.08 -13.88 21.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.13 0.491 . . . . 0.0 110.631 177.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 106.54 -74.99 0.22 Allowed Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -177.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.509 HG21 ' HE1' ' A' ' 52' ' ' MET . 51.0 t 28.66 85.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.056 1.343 . . . . 0.0 114.07 175.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.1 p -83.53 -0.95 52.54 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.697 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.573 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 50.6 p90 -96.59 139.48 21.67 Favored Pre-proline 0 C--N 1.332 -0.194 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.755 176.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.403 ' HB2' HD23 ' A' ' 20' ' ' LEU . 19.6 Cg_endo -60.47 133.82 51.21 Favored 'Trans proline' 0 C--O 1.238 0.508 0 C-N-CA 122.935 2.423 . . . . 0.0 113.333 -175.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.449 ' O ' HG23 ' A' ' 21' ' ' THR . 91.3 mt -109.31 139.19 44.58 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.435 176.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -105.55 148.55 16.53 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.75 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.444 HD23 ' H ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -92.1 127.09 37.44 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.282 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.427 ' HB3' ' O ' ' A' ' 75' ' ' ASP . 21.6 t0 -120.18 74.35 21.37 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 121.135 0.493 . . . . 0.0 109.881 173.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.98 98.4 0.71 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.419 2.08 . . . . 0.0 112.534 -175.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 123.94 -5.18 9.05 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.045 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 62.66 45.17 6.17 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 122.645 0.378 . . . . 0.0 111.127 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -84.04 -50.18 8.22 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.048 0.451 . . . . 0.0 110.398 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 34.2 mm -66.0 -34.01 67.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -64.22 -41.05 97.19 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.276 173.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.599 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -69.94 -18.37 63.36 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.623 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -77.15 -7.82 56.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.486 178.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.509 ' HH ' ' HE2' ' A' ' 16' ' ' PHE . 56.0 m-85 -125.34 -32.05 2.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.836 0.35 . . . . 0.0 111.365 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.599 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -149.6 169.3 21.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.736 0.303 . . . . 0.0 111.155 -177.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.461 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . 96.6 mt -72.61 133.94 44.92 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 177.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.71 -31.71 68.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.421 0.629 . . . . 0.0 110.48 -178.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -99.43 19.53 15.43 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.121 -176.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.461 ' CB ' ' HB2' ' A' ' 110' ' ' LEU . . . -119.57 56.9 0.92 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.426 -177.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 81.35 -157.68 38.87 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.409 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.499 HD11 ' HB2' ' A' ' 76' ' ' ARG . 2.5 tp -152.54 -60.48 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.679 HG21 ' SG ' ' A' ' 48' ' ' CYS . 16.5 p -56.65 111.86 1.12 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -172.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.553 ' HB2' ' HH ' ' A' ' 5' ' ' TYR . 13.5 ptp180 -169.72 154.2 5.31 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.665 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.488 ' HB2' HG21 ' A' ' 131' ' ' THR . 34.4 m-80 -124.8 131.08 53.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.457 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.7 t -108.83 109.63 29.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.981 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 30.6 tp -96.57 111.64 23.69 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.491 -0.483 . . . . 0.0 110.271 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.558 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 54.0 mt -93.21 137.49 22.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.996 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.521 ' HA ' ' HE1' ' A' ' 149' ' ' MET . 0.0 OUTLIER -90.02 179.27 5.99 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.008 0.433 . . . . 0.0 111.104 -177.259 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 32.5 ttm180 -62.95 -28.67 70.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.128 -175.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.473 ' CD ' ' HZ3' ' A' ' 126' ' ' LYS . 44.8 mt-10 -76.61 -30.37 56.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.119 0.485 . . . . 0.0 110.515 177.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.16 17.38 7.27 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.584 -176.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 80.4 mttt -103.1 148.26 25.96 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.887 0.375 . . . . 0.0 110.484 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.58 HD11 HG11 ' A' ' 7' ' ' VAL . 60.8 mt -84.7 112.43 21.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.149 178.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 28.5 m -102.3 -29.2 3.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -175.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -124.95 112.94 17.18 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.156 -173.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.731 HD13 HG12 ' A' ' 9' ' ' ILE . 11.1 mp -100.93 121.79 42.36 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.434 -0.803 . . . . 0.0 108.868 169.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.527 ' OG1' ' HB3' ' A' ' 138' ' ' GLU . 0.4 OUTLIER -122.43 145.16 48.55 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 177.565 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.416 ' N ' ' HD2' ' A' ' 132' ' ' ARG . 3.6 mpt_? -105.23 124.15 49.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.313 -177.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.675 ' HA ' ' HB ' ' A' ' 116' ' ' THR . 1.7 pp 39.86 50.07 2.29 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 124.091 0.869 . . . . 0.0 112.983 175.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.529 ' HB2' ' HG3' ' A' ' 51' ' ' GLU . 9.1 t80 68.97 -74.17 0.08 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.151 -177.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 41.6 t30 59.39 120.15 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.421 0.688 . . . . 0.0 111.814 -177.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -47.56 -62.54 1.39 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.984 -173.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -61.81 -41.66 98.04 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.833 -175.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.527 ' HB3' ' OG1' ' A' ' 131' ' ' THR . 17.7 mt-10 -64.85 -36.26 83.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.108 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.467 ' O ' HG21 ' A' ' 143' ' ' VAL . 82.1 t80 -64.42 -44.99 89.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.365 176.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.66 -50.19 70.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.906 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.2 m -66.18 -37.23 85.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.835 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.481 ' O ' HG13 ' A' ' 146' ' ' ILE . 2.6 tt -60.73 -49.16 78.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.813 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.467 HG21 ' O ' ' A' ' 139' ' ' PHE . 90.8 t -59.7 -46.56 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.258 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -58.42 -45.73 87.85 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.176 0.512 . . . . 0.0 110.266 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -61.4 -39.74 91.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.314 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.647 ' O ' HD22 ' A' ' 150' ' ' LEU . 66.6 mt -55.25 -47.95 77.08 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.196 0 CA-C-N 116.738 -0.21 . . . . 0.0 110.702 177.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -51.25 -43.64 61.56 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.72 -0.218 . . . . 0.0 110.543 176.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -67.61 -42.83 81.75 Favored 'General case' 0 C--O 1.217 -0.652 0 C-N-CA 120.646 -0.421 . . . . 0.0 111.12 175.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.521 ' HE1' ' HA ' ' A' ' 122' ' ' ASP . 38.6 mmm -57.31 -35.64 70.1 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 122.98 0.512 . . . . 0.0 111.136 -172.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.647 HD22 ' O ' ' A' ' 146' ' ' ILE . 4.4 mm? . . . . . 0 C--N 1.322 -0.592 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.796 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 . . . . . 0 CA--C 1.519 -0.215 0 CA-C-O 120.913 0.387 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.563 HG12 ' HA ' ' A' ' 109' ' ' ALA . 21.5 pt -109.58 -11.97 11.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.781 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.425 HG11 HD11 ' A' ' 127' ' ' ILE . 20.0 t -101.44 156.32 4.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.508 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 37.3 mtt85 -121.85 162.88 20.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.097 0.475 . . . . 0.0 111.342 -173.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.48 HG23 ' HA ' ' A' ' 128' ' ' VAL . 80.1 mt -75.93 126.36 36.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.153 177.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.59 -24.92 12.7 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.839 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -75.03 156.66 35.95 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.639 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 59.2 mtp -84.32 138.54 32.84 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.649 -178.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.492 ' HB2' HD12 ' A' ' 121' ' ' ILE . . . -62.65 123.01 77.62 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.432 -178.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 24.7 Cg_exo -62.44 114.62 2.44 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.615 2.21 . . . . 0.0 111.299 177.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.53 ' HA ' HD11 ' A' ' 28' ' ' LEU . 1.0 OUTLIER -63.4 151.9 39.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.418 -171.823 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.962 ' HB3' ' HE2' ' A' ' 107' ' ' LYS . 37.0 p90 -159.23 166.52 31.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.511 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 56.0 m -129.35 108.26 10.16 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.273 175.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.5 tt -106.7 145.02 14.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.991 0.424 . . . . 0.0 110.831 -174.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 24' ' ' LYS . 9.6 m -85.33 131.84 34.34 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.299 178.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.432 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 86.3 mt -87.15 172.52 9.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.311 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.451 HG21 ' O ' ' A' ' 96' ' ' LEU . 33.2 p -55.85 -34.01 65.05 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.889 -176.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -101.84 18.38 20.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.104 0.478 . . . . 0.0 110.772 -173.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.5 37.0 25.01 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.626 174.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 19' ' ' THR . 41.0 mmtm -108.16 167.04 10.29 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.1 -0.334 . . . . 0.0 110.1 176.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.33 120.37 24.23 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 -177.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 17' ' ' THR . 11.7 m -113.98 144.2 22.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.939 0.399 . . . . 0.0 110.017 175.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 18.0 m -122.61 143.42 49.77 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.645 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.53 HD11 ' HA ' ' A' ' 15' ' ' ASP . 17.5 mt -62.67 -35.98 81.41 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.715 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.481 ' HA ' ' HG2' ' A' ' 32' ' ' ARG . 59.2 m -55.83 -34.62 65.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.987 0.422 . . . . 0.0 110.937 175.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.0 t -75.25 -26.24 58.69 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.101 0.477 . . . . 0.0 110.227 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 85.8 mt -96.27 0.2 50.6 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.481 ' HG2' ' HA ' ' A' ' 29' ' ' SER . 37.8 mmt180 -60.3 138.24 57.99 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 102.99 -20.79 42.27 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -178.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.564 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 3.5 mppt? -109.72 157.79 18.76 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.203 -0.499 . . . . 0.0 110.432 178.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 p -82.2 116.52 26.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.355 0.598 . . . . 0.0 109.839 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 25.8 t -106.26 131.2 56.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.213 -173.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.529 ' SD ' HG23 ' A' ' 59' ' ' ILE . 27.7 ttt -111.64 123.6 50.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.392 175.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.432 ' HB2' ' HB ' ' A' ' 119' ' ' VAL . 3.3 mm? -103.78 116.87 33.1 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.642 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.06 114.94 29.21 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.67 176.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.494 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 92.3 m-85 -99.7 111.85 24.15 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.1 t -127.52 -174.62 3.23 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.193 -174.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -168.03 160.55 12.1 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.327 0.651 . . . . 0.0 109.736 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.45 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 78.3 p -75.91 -18.56 59.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.051 0.453 . . . . 0.0 111.353 -176.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 21.1 p-90 -103.35 12.08 35.84 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -175.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.402 ' HB3' HG22 ' A' ' 115' ' ' ILE . 23.0 p -110.12 114.58 28.2 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.074 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.93 -26.56 68.71 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.916 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.428 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 28.3 t -63.21 -36.82 77.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.959 0.409 . . . . 0.0 110.638 -178.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 52.1 m -68.32 -16.15 63.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.724 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -75.56 -7.96 55.53 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.154 0.502 . . . . 0.0 110.287 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.507 ' HD3' ' CD2' ' A' ' 134' ' ' TYR . 57.6 mttt -88.54 -54.26 4.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 122.488 1.137 . . . . 0.0 108.494 162.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.467 ' O ' HG13 ' A' ' 55' ' ' ILE . 24.3 tt0 -57.03 -62.75 1.53 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 113.001 -1.909 . . . . 0.0 112.55 -171.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.588 ' SD ' ' HE2' ' A' ' 86' ' ' PHE . 83.1 mtp -53.93 -54.77 43.14 Favored Pre-proline 0 CA--C 1.538 0.481 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -172.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.409 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 25.5 Cg_endo -62.61 -35.61 69.12 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 121.961 1.774 . . . . 0.0 112.591 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -67.04 -42.58 84.61 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.389 175.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 51' ' ' GLU . 70.4 mt -60.06 -52.93 55.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.985 178.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.57 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 16.4 pt-20 -64.75 -31.11 72.19 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.312 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -71.85 -56.03 6.47 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -176.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -108.15 -18.35 13.8 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -171.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.529 HG23 ' SD ' ' A' ' 37' ' ' MET . 48.4 mm -93.57 -53.95 7.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.721 176.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.57 ' HB3' ' HA ' ' A' ' 56' ' ' GLU . 74.9 t-105 -69.86 -73.06 0.17 Allowed 'General case' 0 C--O 1.215 -0.744 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.894 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -48.13 -29.17 3.4 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -174.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -91.38 -33.2 15.37 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.305 0.484 . . . . 0.0 112.305 -175.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -124.84 -4.55 7.57 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -171.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 17.4 pttp -43.71 -51.79 6.93 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -170.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.18 -81.18 0.18 Allowed 'General case' 0 C--O 1.247 0.959 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.499 ' CG ' HD12 ' A' ' 150' ' ' LEU . 12.1 t30 61.41 -71.7 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.347 -177.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 173.06 -26.88 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 123.573 0.749 . . . . 0.0 109.423 -177.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.496 ' HB2' ' HG3' ' A' ' 34' ' ' LYS . 6.3 p-10 -154.62 28.29 0.44 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.416 -172.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.577 ' HB2' HD11 ' A' ' 150' ' ' LEU . 79.4 t80 -100.5 125.55 46.84 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 118.548 -1.261 . . . . 0.0 110.422 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 36' ' ' VAL . . . -124.97 105.62 9.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.811 -176.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.49 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 3.9 tt -110.77 119.36 38.84 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.8 mm -124.34 126.11 71.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.444 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.469 ' HA3' HD23 ' A' ' 96' ' ' LEU . . . -89.17 133.83 12.04 Favored Glycine 0 C--O 1.221 -0.696 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.204 175.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 68.0 mt -120.8 114.74 44.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.867 0.334 . . . . 0.0 110.733 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -78.32 129.53 35.12 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 172.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.435 HH21 ' HA ' ' A' ' 112' ' ' ASP . 49.5 ttt-85 -45.67 -67.05 0.32 Allowed 'General case' 0 N--CA 1.469 0.478 0 O-C-N 123.97 0.794 . . . . 0.0 112.828 -170.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.639 ' HA ' ' O ' ' A' ' 99' ' ' ASP . 12.0 p-10 -145.61 21.05 1.5 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.58 0.705 . . . . 0.0 109.7 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -69.9 129.74 90.7 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.848 -177.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.552 ' HG2' ' HG2' ' A' ' 82' ' ' LYS . 16.5 Cg_endo -63.58 168.19 11.99 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 122.404 2.07 . . . . 0.0 112.204 173.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -52.55 -52.77 53.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.071 -172.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.542 ' OE2' ' HG2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -67.61 -28.08 67.44 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -173.602 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.552 ' HG2' ' HG2' ' A' ' 79' ' ' PRO . 44.0 mmtm -64.45 -51.07 64.97 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.831 0.348 . . . . 0.0 110.468 175.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.432 HG22 ' HB3' ' A' ' 98' ' ' LEU . 61.1 t -53.81 -52.2 37.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.106 -178.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.23 -39.22 92.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.577 -177.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.451 ' HA ' ' HE3' ' A' ' 88' ' ' LYS . . . -73.05 -26.59 61.35 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.787 -177.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.588 ' HE2' ' SD ' ' A' ' 52' ' ' MET . 71.8 t80 -84.85 -47.42 10.37 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.886 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.456 ' HB1' HD11 ' A' ' 96' ' ' LEU . . . -53.08 -47.48 68.49 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.289 0.368 . . . . 0.0 111.455 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.451 ' HE3' ' HA ' ' A' ' 85' ' ' ALA . 18.4 pttp -62.31 -23.98 67.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.033 0.444 . . . . 0.0 111.241 -178.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.9 m -92.62 -0.62 57.28 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.048 -175.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.1 p -122.97 -20.97 5.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.602 175.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 114.64 -76.29 0.25 Allowed Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -177.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.472 HG23 ' HE1' ' A' ' 52' ' ' MET . 86.7 t 43.93 87.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 124.494 1.118 . . . . 0.0 113.344 178.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.4 m -78.67 -5.4 52.94 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.493 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.447 ' CE1' ' HB3' ' A' ' 56' ' ' GLU . 49.0 p90 -107.29 145.58 31.49 Favored Pre-proline 0 C--N 1.33 -0.254 0 O-C-N 122.127 -0.358 . . . . 0.0 110.451 179.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -63.05 136.45 56.57 Favored 'Trans proline' 0 C--O 1.238 0.485 0 C-N-CA 122.371 2.047 . . . . 0.0 113.222 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.469 HD23 ' HA3' ' A' ' 73' ' ' GLY . 92.8 mt -105.14 151.51 23.94 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.871 175.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.432 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -125.13 145.51 15.73 Favored Glycine 0 N--CA 1.437 -1.297 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 175.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.729 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.2 pt? -100.09 132.71 45.3 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 120.744 0.306 . . . . 0.0 110.68 -176.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.639 ' O ' ' HA ' ' A' ' 77' ' ' ASP . 22.2 t0 -109.84 82.54 2.42 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.71 176.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.24 87.07 0.49 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.138 1.892 . . . . 0.0 112.264 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.04 -21.65 1.59 Allowed Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.131 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' A' ' 77' ' ' ASP . . . 70.15 24.25 5.0 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 122.866 0.466 . . . . 0.0 110.714 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -91.08 -29.08 17.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.583 -176.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.573 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 32.4 mm -70.04 -35.85 65.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 171.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -60.8 -40.14 91.54 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.741 172.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.665 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -68.28 -25.53 65.2 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.951 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.962 ' HE2' ' HB3' ' A' ' 16' ' ' PHE . 26.8 mtpp -70.72 -3.99 21.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.393 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.696 ' HB3' HH22 ' A' ' 117' ' ' ARG . 65.1 m-85 -129.37 -11.82 4.53 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.91 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.665 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -176.36 176.4 1.65 Allowed 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.861 ' HB2' ' HB1' ' A' ' 113' ' ' ALA . 95.4 mt -60.34 136.05 57.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.634 0.254 . . . . 0.0 110.505 177.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.56 ' HG2' ' HB1' ' A' ' 106' ' ' ALA . 53.8 mtp85 -49.57 -51.85 34.11 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.988 -177.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.435 ' HA ' HH21 ' A' ' 76' ' ' ARG . 6.8 m-20 -105.08 34.38 3.24 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.654 -173.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.861 ' HB1' ' HB2' ' A' ' 110' ' ' LEU . . . -85.02 9.88 13.44 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.1 178.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 118.1 -151.94 17.73 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.348 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.404 HG13 ' H ' ' A' ' 116' ' ' THR . 8.6 tp -151.1 170.74 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -177.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.576 HG23 ' HA ' ' A' ' 133' ' ' LEU . 30.7 m 71.77 93.97 0.08 Allowed 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.532 0.52 . . . . 0.0 110.314 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.696 HH22 ' HB3' ' A' ' 108' ' ' TYR . 54.8 mtp180 -146.58 149.13 32.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.66 -174.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.553 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 33.0 m-80 -127.6 119.83 26.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.75 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.432 ' HB ' ' HB2' ' A' ' 38' ' ' LEU . 73.1 t -124.58 122.91 64.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.619 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 34.5 tp -108.88 130.72 55.43 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.898 0.38 . . . . 0.0 110.917 -178.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.509 ' CD1' HG12 ' A' ' 127' ' ' ILE . 27.8 mm -111.07 139.11 36.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.695 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.511 ' OD2' ' HB2' ' A' ' 126' ' ' LYS . 3.4 p30 -84.47 171.82 12.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.808 0.337 . . . . 0.0 110.844 177.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -60.7 -25.52 66.46 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.427 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -82.13 -12.57 58.12 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.777 -174.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 103.86 3.92 45.61 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.607 176.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.639 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 9.0 mtmp? -96.72 160.26 14.47 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.142 0.496 . . . . 0.0 111.64 -177.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.509 HG12 ' CD1' ' A' ' 121' ' ' ILE . 43.5 mt -95.37 127.79 47.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.399 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.48 ' HA ' HG23 ' A' ' 9' ' ' ILE . 29.4 m -117.74 -23.19 3.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -176.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.619 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 50.1 tptt -128.66 115.98 18.88 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.558 -174.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.424 HD12 HG12 ' A' ' 9' ' ' ILE . 11.0 mp -110.74 109.77 20.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.975 175.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.553 ' HB ' ' HB2' ' A' ' 118' ' ' ASN . 89.3 m -135.71 141.8 44.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.878 0.371 . . . . 0.0 111.278 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 132' ' ' ARG . 1.3 ptp180 -124.42 150.61 45.43 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 171.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.576 ' HA ' HG23 ' A' ' 116' ' ' THR . 0.8 OUTLIER 46.32 104.95 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 O-C-N 124.703 1.252 . . . . 0.0 113.992 179.503 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.507 ' CD2' ' HD3' ' A' ' 50' ' ' LYS . 39.9 t80 -39.26 112.61 0.26 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.944 -1.026 . . . . 0.0 112.205 176.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -110.84 141.03 44.76 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 173.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.62 -58.45 6.75 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -173.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.405 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.7 mp0 -60.33 -32.19 71.02 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.893 0.378 . . . . 0.0 111.238 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -65.42 -47.5 76.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.571 -177.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.535 ' O ' HG22 ' A' ' 143' ' ' VAL . 88.8 t80 -61.77 -39.46 91.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.736 -178.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -59.96 -46.39 89.56 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.109 0.48 . . . . 0.0 110.375 176.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.3 m -62.69 -38.97 92.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.227 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.596 ' O ' HG12 ' A' ' 146' ' ' ILE . 1.1 mt -61.57 -46.62 89.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.953 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 139' ' ' PHE . 97.6 t -55.96 -49.19 76.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-O 120.688 0.28 . . . . 0.0 111.16 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.43 ' HA ' ' OE1' ' A' ' 144' ' ' GLN . 6.7 tp60 -66.46 -40.96 89.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.955 0.407 . . . . 0.0 110.48 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -57.96 -46.12 85.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.065 176.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.637 ' O ' HD21 ' A' ' 150' ' ' LEU . 38.4 mm -56.48 -44.69 81.08 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.279 177.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -53.68 -52.0 61.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.848 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -76.29 -20.82 56.97 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.932 -177.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.467 ' HE2' ' HA ' ' A' ' 122' ' ' ASP . 56.1 mmm -73.0 -28.52 62.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.131 0.491 . . . . 0.0 110.608 175.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.637 HD21 ' O ' ' A' ' 146' ' ' ILE . 4.3 mm? . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.234 175.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.565 ' CE1' HD21 ' A' ' 130' ' ' LEU . 61.2 m-85 . . . . . 0 CA--C 1.519 -0.229 0 CA-C-O 120.994 0.426 . . . . 0.0 112.101 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.9 pt -101.46 -11.64 8.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.317 169.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.8 m -110.95 150.33 13.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.005 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.434 ' HE ' ' CD ' ' A' ' 11' ' ' GLU . 77.6 mtm180 -118.82 163.78 16.37 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.339 0.59 . . . . 0.0 111.638 -175.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 77.3 mt -70.42 131.37 34.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.443 -0.798 . . . . 0.0 109.531 174.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.63 -27.27 15.5 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -176.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.434 ' CD ' ' HE ' ' A' ' 8' ' ' ARG . 14.3 mt-10 -80.19 174.94 11.1 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.65 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 55.6 mtp -98.8 146.43 25.94 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.875 0.369 . . . . 0.0 110.417 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.426 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -79.92 135.91 54.94 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.842 -177.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 21.2 Cg_exo -64.89 117.28 4.39 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.759 2.306 . . . . 0.0 111.915 177.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.41 ' CG ' ' HG ' ' A' ' 29' ' ' SER . 0.6 OUTLIER -68.21 141.85 55.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.949 -179.325 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.482 ' HB2' HD11 ' A' ' 104' ' ' ILE . 52.4 p90 -154.28 161.18 41.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.847 0.356 . . . . 0.0 111.224 -174.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.2 m -110.35 116.28 31.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.448 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.5 tt -114.64 142.14 28.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.936 0.398 . . . . 0.0 110.829 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.457 ' O ' HD22 ' A' ' 98' ' ' LEU . 14.8 m -93.41 123.03 36.42 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.126 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.428 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 92.7 mt -79.52 173.96 12.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.919 0.39 . . . . 0.0 111.393 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.456 HG21 ' O ' ' A' ' 96' ' ' LEU . 19.5 p -57.15 -34.63 68.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.283 -0.871 . . . . 0.0 113.159 -175.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -100.56 19.35 17.06 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.177 0.513 . . . . 0.0 110.535 -174.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.09 36.1 25.53 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.601 174.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -108.4 109.42 20.71 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.09 0.472 . . . . 0.0 110.337 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -89.7 113.94 25.52 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.275 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.7 m -119.12 153.94 21.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.049 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.2 m -112.88 150.96 31.02 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.529 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 0.5 OUTLIER -59.96 -38.46 82.55 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.166 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.503 ' HA ' ' CG ' ' A' ' 32' ' ' ARG . 64.9 m -54.59 -26.88 35.24 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.106 176.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.6 m -72.75 -20.2 61.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.045 0.45 . . . . 0.0 110.97 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.484 HD13 ' HB1' ' A' ' 70' ' ' ALA . 96.3 mt -114.87 3.04 14.49 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.305 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.529 ' HG2' ' O ' ' A' ' 28' ' ' LEU . 47.9 mmm-85 -66.25 139.13 58.06 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.09 -20.48 28.54 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -172.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.503 ' HB3' ' O ' ' A' ' 68' ' ' ASP . 42.5 mtmt -116.14 165.13 13.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.263 -0.468 . . . . 0.0 110.15 177.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 p -79.59 120.03 30.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.178 0.513 . . . . 0.0 110.031 174.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.496 HG23 ' HB3' ' A' ' 70' ' ' ALA . 43.5 t -115.37 125.18 72.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.863 -175.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.453 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 25.6 ttt -103.13 124.76 49.17 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.854 177.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.3 mt -117.57 141.19 48.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.183 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.447 ' N ' HE21 ' A' ' 39' ' ' GLN . 0.0 OUTLIER -139.05 136.67 35.51 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 174.791 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.422 ' HD2' ' HG3' ' A' ' 117' ' ' ARG . 98.0 m-85 -97.56 119.53 36.3 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.063 0.458 . . . . 0.0 110.675 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.4 t -127.82 -177.08 3.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.342 -175.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.632 ' HB1' ' SG ' ' A' ' 45' ' ' CYS . . . -165.77 155.52 12.45 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 176.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.475 ' H ' ' HG3' ' A' ' 78' ' ' GLU . 99.5 p -63.26 -24.28 67.8 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.93 0.395 . . . . 0.0 112.025 -175.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.5 p-90 -100.92 7.59 43.53 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.751 0.31 . . . . 0.0 111.786 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.632 ' SG ' ' HB1' ' A' ' 42' ' ' ALA . 88.8 m -88.41 99.79 12.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.037 0.446 . . . . 0.0 111.078 178.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.84 -20.44 77.59 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.203 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 34.6 t -76.29 -41.31 36.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.836 0.351 . . . . 0.0 110.197 177.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.755 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 72.2 m -68.72 -16.61 63.87 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.475 0.655 . . . . 0.0 110.376 177.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.485 HH21 ' HE1' ' A' ' 86' ' ' PHE . 25.3 ttm180 -71.19 -11.13 60.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.7 176.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.559 ' HD3' ' CD2' ' A' ' 134' ' ' TYR . 80.1 mttt -87.15 -57.66 2.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.609 0.719 . . . . 0.0 110.046 169.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.929 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 12.4 pt-20 -63.76 -44.84 92.26 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-N 115.065 -0.971 . . . . 0.0 112.495 -168.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.542 ' HE1' ' CE2' ' A' ' 86' ' ' PHE . 15.3 mtm -57.41 -55.51 43.67 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.045 -174.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.56 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 19.7 Cg_endo -60.73 -33.22 93.38 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 121.771 1.647 . . . . 0.0 112.481 177.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.418 ' HD1' ' O ' ' A' ' 50' ' ' LYS . 12.3 m-85 -70.35 -46.24 64.52 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.499 176.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 51' ' ' GLU . 96.9 mt -58.03 -51.43 70.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.612 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.61 ' HB3' ' CD1' ' A' ' 94' ' ' TYR . 0.4 OUTLIER -65.47 -34.93 79.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.403 -177.289 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.56 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 10.4 ttmm -68.5 -43.35 77.04 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.564 -174.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -106.12 -65.18 1.09 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.473 178.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 65.7 mt -55.7 -39.9 57.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.843 0.354 . . . . 0.0 110.966 -170.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.56 ' HB3' ' O ' ' A' ' 56' ' ' GLU . 75.5 t-105 -75.33 -71.32 0.37 Allowed 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.552 177.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.489 HD22 ' HD1' ' A' ' 60' ' ' TRP . 1.8 mm? -50.45 -34.91 26.43 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -173.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -84.01 -30.46 26.14 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -175.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.503 ' HB3' ' HG ' ' A' ' 150' ' ' LEU . 72.9 m-70 -129.56 -8.51 4.6 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -168.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -38.79 -48.73 1.55 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -171.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.47 -84.19 0.28 Allowed 'General case' 0 C--O 1.253 1.258 0 CA-C-O 121.246 0.546 . . . . 0.0 110.492 -175.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.427 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 44.5 t-20 59.24 -77.6 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.939 -169.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 66' ' ' ASN . . . 156.31 -23.01 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 125.327 1.451 . . . . 0.0 107.154 -173.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 34' ' ' LYS . 9.7 t70 -119.93 1.25 10.94 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.197 -173.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.507 ' HB2' HD11 ' A' ' 150' ' ' LEU . 84.9 t80 -110.67 151.04 28.17 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 119.09 -1.044 . . . . 0.0 112.297 -176.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.496 ' HB3' HG23 ' A' ' 36' ' ' VAL . . . -148.5 141.51 24.85 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.221 173.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.473 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 3.6 tt -139.02 127.25 22.66 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -177.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.404 ' N ' HD22 ' A' ' 71' ' ' LEU . 63.4 mt -135.79 130.91 49.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 120.73 0.3 . . . . 0.0 110.562 178.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.441 ' HA3' HD23 ' A' ' 96' ' ' LEU . . . -95.12 138.88 14.21 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.291 -0.956 . . . . 0.0 111.01 173.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 55.3 mt -119.66 118.21 56.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 117.395 0.598 . . . . 0.0 110.686 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.526 ' OD1' ' HA ' ' A' ' 42' ' ' ALA . 6.7 t0 -95.41 132.32 40.59 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.495 ' HD2' HD12 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -97.22 121.02 38.65 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.968 0.413 . . . . 0.0 111.942 -170.577 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 73.08 -35.81 0.34 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.347 1.059 . . . . 0.0 113.044 175.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.475 ' HG3' ' H ' ' A' ' 43' ' ' SER . 60.0 mm-40 -62.54 140.31 96.79 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-O 121.147 0.499 . . . . 0.0 111.241 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.525 ' O ' HG21 ' A' ' 83' ' ' VAL . 18.3 Cg_endo -84.25 -168.42 0.54 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.043 2.495 . . . . 0.0 113.64 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.52 HD23 HD13 ' A' ' 84' ' ' LEU . 1.7 tt -56.25 -57.49 12.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.801 -1.091 . . . . 0.0 112.138 -170.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -37.53 87.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.864 -173.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.493 ' CG ' ' HD2' ' A' ' 79' ' ' PRO . 27.1 mmtp -58.86 -50.43 74.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.585 0.231 . . . . 0.0 111.336 178.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.525 HG21 ' O ' ' A' ' 79' ' ' PRO . 46.9 t -58.4 -46.04 89.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.754 -178.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.52 HD13 HD23 ' A' ' 80' ' ' LEU . 10.9 mp -64.2 -47.63 79.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.335 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.02 -32.95 74.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.687 -176.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.542 ' CE2' ' HE1' ' A' ' 52' ' ' MET . 72.0 t80 -77.8 -43.72 29.71 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.502 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.464 ' HB3' HD12 ' A' ' 96' ' ' LEU . . . -59.22 -54.38 47.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.447 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.9 ptmm? -57.12 -26.59 60.74 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.971 -175.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 27.3 m -85.74 -4.06 59.06 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.382 -174.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 19.1 p -128.14 6.12 5.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.313 0.578 . . . . 0.0 110.321 175.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.55 -73.27 1.23 Allowed Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.294 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.449 HG13 ' O ' ' A' ' 94' ' ' TYR . 42.9 t 40.95 83.91 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.963 0.905 . . . . 0.0 112.695 -177.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.8 m -75.76 -3.8 36.91 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.541 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.61 ' CD1' ' HB3' ' A' ' 56' ' ' GLU . 50.0 p90 -107.72 153.07 41.71 Favored Pre-proline 0 C--N 1.33 -0.273 0 O-C-N 121.813 -0.554 . . . . 0.0 110.621 178.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.5 137.0 32.38 Favored 'Trans proline' 0 C--O 1.239 0.561 0 C-N-CA 122.253 1.969 . . . . 0.0 113.38 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.464 HD12 ' HB3' ' A' ' 87' ' ' ALA . 97.6 mt -104.84 153.67 21.04 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.342 173.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -121.6 147.37 17.29 Favored Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 174.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.701 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.7 pt? -100.27 131.8 46.01 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.88 0.371 . . . . 0.0 110.617 -177.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.419 ' OD2' ' HA ' ' A' ' 102' ' ' ALA . 14.8 t0 -119.35 75.46 16.6 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.491 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.439 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 15.7 Cg_exo -68.01 120.57 7.56 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.895 2.396 . . . . 0.0 111.766 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 102.42 -8.75 55.38 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -175.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.739 ' HB1' ' HE ' ' A' ' 111' ' ' ARG . . . 54.6 45.88 25.95 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 123.09 0.556 . . . . 0.0 111.547 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -76.09 -49.71 16.69 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.253 0.549 . . . . 0.0 110.062 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.482 HD11 ' HB2' ' A' ' 16' ' ' PHE . 27.9 mm -65.83 -36.28 77.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.276 178.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.445 ' HB3' ' HB2' ' A' ' 102' ' ' ALA . 71.5 t80 -62.56 -45.28 93.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.289 174.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.595 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -65.74 -21.01 66.48 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.769 -178.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -73.48 -12.06 60.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.824 0.345 . . . . 0.0 111.245 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.422 ' CZ ' ' HD2' ' A' ' 14' ' ' PRO . 65.8 m-85 -119.93 -34.57 3.69 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.351 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.595 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -154.72 160.37 41.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.783 0.325 . . . . 0.0 111.004 -177.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.454 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . 90.3 mt -67.09 136.29 54.94 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.739 ' HE ' ' HB1' ' A' ' 102' ' ' ALA . 67.5 mtp180 -49.46 -40.05 35.65 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -171.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -98.76 -8.98 25.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.12 0.486 . . . . 0.0 111.475 -175.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.454 ' CB ' ' HB2' ' A' ' 110' ' ' LEU . . . -81.45 40.88 0.59 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -171.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 97.79 114.62 3.31 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.262 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.495 HD12 ' HD2' ' A' ' 76' ' ' ARG . 2.6 tp -76.19 -49.77 24.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.642 0.258 . . . . 0.0 111.531 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.949 ' HB ' ' HB3' ' A' ' 133' ' ' LEU . 22.2 p -66.3 114.2 5.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.17 -173.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.422 ' HG3' ' HD2' ' A' ' 40' ' ' PHE . 10.8 ptp180 -169.33 145.52 3.31 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.952 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.625 ' HB2' ' OG1' ' A' ' 131' ' ' THR . 6.6 m120 -122.98 142.69 50.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.526 -177.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 29.1 t -128.51 120.7 53.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.301 -177.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.656 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 41.9 tp -105.17 116.83 32.62 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.964 174.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 57.0 mt -98.6 134.33 37.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.132 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.38 177.58 8.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.047 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.415 ' HD3' ' OD1' ' A' ' 68' ' ' ASP . 70.9 mtm180 -66.64 -27.26 67.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.967 -174.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -75.17 -29.67 60.48 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.082 0.468 . . . . 0.0 110.419 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.45 15.73 8.06 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.777 -176.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.65 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 82.4 mttt -97.62 157.62 15.94 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.827 0.346 . . . . 0.0 110.583 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.473 HG23 HD23 ' A' ' 130' ' ' LEU . 53.9 mt -91.04 120.67 40.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.576 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.6 m -114.97 1.77 8.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.83 ' HD2' HG22 ' A' ' 131' ' ' THR . 0.3 OUTLIER -163.71 124.61 2.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.779 0.323 . . . . 0.0 111.582 -178.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.565 HD21 ' CE1' ' A' ' 5' ' ' TYR . 96.5 mt -127.58 106.73 9.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.615 174.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.83 HG22 ' HD2' ' A' ' 129' ' ' LYS . 16.6 p -107.39 148.89 28.51 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.925 0.393 . . . . 0.0 111.062 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.503 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 23.5 mtm180 -92.84 107.8 19.5 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 174.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.949 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 4.0 pp 49.28 -172.18 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 O-C-N 124.239 0.962 . . . . 0.0 112.979 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.929 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 87.6 t80 -73.65 85.64 1.61 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.321 175.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.534 ' HB3' ' HB2' ' A' ' 138' ' ' GLU . 47.2 t-20 -85.54 117.69 24.6 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 170.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 30.0 mp0 -46.93 -39.72 12.82 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 123.403 0.44 . . . . 0.0 111.973 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -79.76 -51.54 9.06 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.56 0.219 . . . . 0.0 111.56 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.534 ' HB2' ' HB3' ' A' ' 135' ' ' ASN . 44.9 mt-10 -66.01 -34.43 78.07 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 121.243 -0.183 . . . . 0.0 111.24 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.431 ' O ' HG21 ' A' ' 143' ' ' VAL . 81.5 t80 -67.16 -42.97 83.43 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 177.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.24 -48.54 80.08 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.187 0.518 . . . . 0.0 110.316 176.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.3 m -62.88 -35.3 79.56 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.679 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.567 ' HG ' ' HG2' ' A' ' 129' ' ' LYS . 1.4 tt -67.29 -42.54 83.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.236 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.431 HG21 ' O ' ' A' ' 139' ' ' PHE . 70.6 t -58.45 -51.73 67.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.903 178.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.463 ' HA ' ' ND2' ' A' ' 147' ' ' ASN . 47.5 tp60 -60.86 -40.61 93.55 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.122 0.487 . . . . 0.0 110.498 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -56.55 -46.69 80.57 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.618 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.558 ' O ' HD23 ' A' ' 150' ' ' LEU . 42.6 mt -64.76 -38.35 82.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.914 178.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.463 ' ND2' ' HA ' ' A' ' 144' ' ' GLN . 93.0 m-20 -53.21 -45.45 68.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.555 178.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -69.85 -36.73 75.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.079 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 84.3 mmm -63.16 -24.51 67.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.309 0.576 . . . . 0.0 110.233 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.558 HD23 ' O ' ' A' ' 146' ' ' ILE . 3.8 mm? . . . . . 0 C--N 1.324 -0.534 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.189 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.425 ' HH ' ' HB3' ' A' ' 117' ' ' ARG . 48.1 m-85 . . . . . 0 N--CA 1.453 -0.314 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 29.0 pt -115.06 1.34 8.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.187 0.518 . . . . 0.0 110.429 175.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.9 m -117.34 161.39 16.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.673 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.528 ' HB2' ' HB2' ' A' ' 11' ' ' GLU . 42.1 mtt180 -112.5 165.64 12.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.18 -176.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.456 HG12 HD21 ' A' ' 130' ' ' LEU . 67.0 mt -81.33 118.32 28.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 172.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.12 -3.96 55.4 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -172.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 8' ' ' ARG . 10.1 tp10 -90.93 153.37 20.23 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.517 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 58.2 mtp -76.37 139.41 40.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.123 0.487 . . . . 0.0 111.034 -177.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.427 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -76.64 134.38 69.38 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.918 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.581 ' HD2' ' CE1' ' A' ' 108' ' ' TYR . 24.3 Cg_exo -61.69 149.92 87.87 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.778 2.319 . . . . 0.0 111.427 177.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.0 169.41 9.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.413 -177.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.402 ' O ' ' HA ' ' A' ' 27' ' ' THR . 44.1 p90 -172.39 172.45 4.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.507 -174.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 18.1 m -125.9 100.93 6.6 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 173.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 25' ' ' GLN . 18.3 tt -99.36 143.21 13.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.954 -172.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.6 m -92.14 121.39 33.63 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.917 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.7 mt -78.9 176.6 9.45 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.756 -178.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.3 p -59.25 -28.47 66.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.889 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.713 ' OD1' ' HG2' ' A' ' 24' ' ' LYS . 0.3 OUTLIER -77.79 -28.05 50.36 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.232 178.836 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.16 -1.58 28.31 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.107 -170.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.713 ' HG2' ' OD1' ' A' ' 22' ' ' ASP . 47.4 mmtm -70.18 117.26 11.52 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.642 -0.279 . . . . 0.0 110.777 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.453 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 90.8 mt-30 -91.12 114.63 27.21 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 174.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 17' ' ' THR . 17.0 m -116.91 151.12 18.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.651 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 4.2 m -98.84 147.32 25.05 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.707 178.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.462 ' O ' HD13 ' A' ' 28' ' ' LEU . 1.1 tm? -69.96 -25.54 63.68 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.499 ' HA ' ' HG2' ' A' ' 32' ' ' ARG . 48.8 m -58.45 -24.86 61.36 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.447 175.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.9 m -75.1 -18.39 60.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.836 0.351 . . . . 0.0 111.435 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.2 mt -105.28 3.55 30.09 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.161 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.499 ' HG2' ' HA ' ' A' ' 29' ' ' SER . 29.0 mmt180 -66.7 116.18 7.34 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 127.81 -21.02 5.66 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -175.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 123' ' ' ARG . 42.9 mtmt -116.55 164.75 14.13 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 176.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.496 HG21 ' O ' ' A' ' 68' ' ' ASP . 17.4 m -76.69 124.07 34.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 174.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.557 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 6.6 t -115.06 108.71 26.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.084 0.469 . . . . 0.0 110.935 -172.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.426 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 27.4 ttt -93.29 115.32 27.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.618 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.459 ' CD1' HG13 ' A' ' 36' ' ' VAL . 6.2 mp -115.26 115.39 26.6 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.356 178.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.429 ' O ' ' HG3' ' A' ' 39' ' ' GLN . 1.4 pt20 -105.82 117.62 34.49 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.047 0.451 . . . . 0.0 110.432 176.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.649 ' O ' ' HA ' ' A' ' 116' ' ' THR . 97.9 m-85 -85.09 109.64 18.39 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 172.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.0 t -127.77 -175.39 3.46 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.247 -170.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.55 ' HB2' ' SG ' ' A' ' 45' ' ' CYS . . . -149.15 136.57 20.17 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.191 0.52 . . . . 0.0 111.686 -178.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.458 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 3.5 p -70.57 -6.26 35.16 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.445 175.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.437 ' HD1' ' HG3' ' A' ' 78' ' ' GLU . 43.5 p-90 -113.83 14.21 18.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.449 -177.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.55 ' SG ' ' HB2' ' A' ' 42' ' ' ALA . 94.8 m -112.81 138.13 50.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.901 0.382 . . . . 0.0 110.922 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -86.23 -33.33 14.67 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.218 -178.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.0 t -58.51 -36.11 57.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 121.362 0.601 . . . . 0.0 110.103 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.591 ' O ' ' HG2' ' A' ' 52' ' ' MET . 71.6 m -65.92 -16.55 63.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.714 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -77.6 -3.28 40.0 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 122.045 -0.409 . . . . 0.0 110.756 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -87.96 -53.77 4.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.103 0.478 . . . . 0.0 110.05 166.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.648 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 8.9 pt-20 -60.58 -46.28 90.83 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.912 -172.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.826 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 88.8 mmm -54.82 -59.57 10.27 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -174.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.826 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 31.8 Cg_exo -61.1 -39.76 56.85 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 122.025 1.817 . . . . 0.0 112.735 177.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.526 ' HB3' ' CZ ' ' A' ' 139' ' ' PHE . 11.6 m-85 -65.39 -46.71 79.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.58 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.51 HG12 ' HE1' ' A' ' 139' ' ' PHE . 77.3 mt -60.83 -46.15 96.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.439 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.5 tp10 -57.74 -49.12 77.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.886 0.374 . . . . 0.0 110.652 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.424 ' O ' ' HE3' ' A' ' 62' ' ' LYS . 28.6 ttpp -66.27 -52.38 48.06 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -174.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.443 ' HA ' ' NZ ' ' A' ' 62' ' ' LYS . 73.6 m-20 -105.28 -15.55 15.02 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -169.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 58.1 mt -105.43 -60.54 2.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.997 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.536 ' CD2' ' HB3' ' A' ' 94' ' ' TYR . 76.7 t-105 -63.42 -65.44 0.68 Allowed 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.158 -177.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.49 HD12 ' HE3' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -46.36 -32.63 3.3 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -174.909 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.443 ' NZ ' ' HA ' ' A' ' 58' ' ' ASP . 31.6 mmtp -81.54 -28.42 33.93 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -174.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -128.81 -43.42 1.37 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.807 -174.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.49 ' HE3' HD12 ' A' ' 61' ' ' LEU . 31.2 mttp 56.65 -92.38 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.934 0.893 . . . . 0.0 111.263 -176.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -108.35 -39.16 5.52 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 173.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 69.31 -72.62 0.1 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.217 176.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 164.8 -30.62 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.06 -173.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.496 ' O ' HG21 ' A' ' 35' ' ' VAL . 36.3 t70 -131.73 15.74 4.83 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 114.909 -1.042 . . . . 0.0 110.92 -177.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.477 ' HA ' HG21 ' A' ' 35' ' ' VAL . 69.6 t80 -121.71 145.08 48.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.115 0.483 . . . . 0.0 110.979 -177.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.39 143.88 29.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.811 174.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.426 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 3.2 tt -143.46 123.03 13.24 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -177.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 65.6 mt -125.06 119.49 55.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.723 0.297 . . . . 0.0 110.405 176.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.52 123.38 6.74 Favored Glycine 0 C--O 1.219 -0.831 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 174.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 55.9 mt -117.82 122.89 70.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 117.706 0.753 . . . . 0.0 111.097 -174.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -80.42 118.34 21.97 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 170.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.538 ' HB3' ' CD1' ' A' ' 115' ' ' ILE . 0.0 OUTLIER -74.63 -6.34 48.07 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.846 -166.854 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -153.18 -30.58 0.13 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 118.759 -1.176 . . . . 0.0 113.144 -176.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.499 ' HB3' ' HG3' ' A' ' 82' ' ' LYS . 24.2 mm-40 -85.57 152.37 57.22 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.009 0.433 . . . . 0.0 112.079 -174.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.496 ' HD2' ' HG3' ' A' ' 82' ' ' LYS . 74.4 Cg_endo -79.31 -171.61 1.3 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.324 2.682 . . . . 0.0 115.243 -176.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.498 HD12 HD21 ' A' ' 84' ' ' LEU . 2.9 tm? -52.07 -55.66 19.27 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 113.528 -1.669 . . . . 0.0 111.423 -175.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -52.41 -42.13 63.79 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.762 -0.653 . . . . 0.0 112.178 -175.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.499 ' HG3' ' HB3' ' A' ' 78' ' ' GLU . 34.8 mmtp -66.24 -47.94 72.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.641 -176.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 79' ' ' PRO . 41.1 t -58.22 -45.02 89.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.517 -178.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.498 HD21 HD12 ' A' ' 80' ' ' LEU . 4.5 mm? -68.79 -24.64 64.44 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -175.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.47 -44.33 12.81 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.819 0.343 . . . . 0.0 110.791 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.458 ' CD1' ' HA ' ' A' ' 43' ' ' SER . 85.7 t80 -67.13 -45.34 77.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.766 -174.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.79 -32.19 70.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.998 0.904 . . . . 0.0 109.815 -177.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -69.31 -34.26 74.41 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.242 -1.344 . . . . 0.0 111.023 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.6 t -87.81 -8.16 56.31 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.239 -178.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 16.5 p -108.77 -2.16 18.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.667 0.27 . . . . 0.0 111.208 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.2 36.53 39.85 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.696 177.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.575 HG21 ' HE2' ' A' ' 52' ' ' MET . 32.6 t -90.37 130.06 40.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.847 0.356 . . . . 0.0 111.706 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 25.4 m -101.67 -35.68 9.01 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.673 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.536 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 43.9 p90 -62.06 140.52 95.92 Favored Pre-proline 0 N--CA 1.463 0.201 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.247 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.27 147.65 91.04 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.66 2.24 . . . . 0.0 112.854 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.477 HD23 ' HE3' ' A' ' 52' ' ' MET . 4.8 mp -123.6 154.66 38.99 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.522 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -122.74 162.01 16.72 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.938 178.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.6 mp -96.73 142.23 29.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.593 0.235 . . . . 0.0 110.904 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -133.4 79.71 59.86 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-O 121.212 0.529 . . . . 0.0 109.783 169.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.71 106.09 0.71 Allowed 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.603 2.202 . . . . 0.0 112.859 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.42 19.64 44.54 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.145 176.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 55.77 47.56 20.12 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.477 ' HA ' HH21 ' A' ' 111' ' ' ARG . 24.8 t70 -79.85 -51.55 9.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.159 0.504 . . . . 0.0 110.315 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 35.1 mm -67.43 -33.0 59.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -63.24 -34.9 78.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.281 173.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.422 ' HB3' ' HE ' ' A' ' 111' ' ' ARG . . . -73.26 -19.76 60.99 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.92 0.39 . . . . 0.0 111.19 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.464 ' O ' ' HG2' ' A' ' 14' ' ' PRO . 55.3 mttp -77.44 -17.41 58.11 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.179 176.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.581 ' CE1' ' HD2' ' A' ' 14' ' ' PRO . 81.1 m-85 -110.19 -36.91 5.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.071 0.462 . . . . 0.0 111.006 178.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -130.68 173.23 11.11 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.154 -176.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.493 ' O ' ' HB2' ' A' ' 111' ' ' ARG . 12.1 mt -86.69 3.41 44.91 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -176.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.493 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 98.8 mtt180 78.87 -36.65 0.18 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.839 -177.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -74.58 15.94 0.32 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.149 0.5 . . . . 0.0 111.05 176.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.454 ' H ' ' C ' ' A' ' 111' ' ' ARG . . . -93.98 -3.61 51.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.394 177.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.36 -152.09 16.91 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.193 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.538 ' CD1' ' HB3' ' A' ' 76' ' ' ARG . 1.9 tp -109.04 -61.66 2.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.927 ' HB ' ' HG ' ' A' ' 133' ' ' LEU . 2.7 m -86.33 110.66 19.82 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.037 0.446 . . . . 0.0 112.059 -170.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.425 ' HB3' ' HH ' ' A' ' 5' ' ' TYR . 40.0 mmt180 -142.13 131.7 23.92 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.444 176.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 1.111 ' HB3' ' HB ' ' A' ' 131' ' ' THR . 9.6 t30 -105.64 119.99 40.54 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.135 0.493 . . . . 0.0 110.672 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.3 t -107.2 110.39 31.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.792 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.657 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 56.7 tp -92.69 111.39 22.97 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.016 0.436 . . . . 0.0 110.37 178.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.557 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 48.6 mt -95.74 133.57 36.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.143 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -83.59 166.23 18.37 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.249 178.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.419 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 7.1 mtm180 -51.96 -37.73 54.0 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 123.476 0.71 . . . . 0.0 112.081 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -70.84 -5.74 32.72 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.871 0.367 . . . . 0.0 111.672 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.444 ' HA3' HH11 ' A' ' 32' ' ' ARG . . . 89.91 12.66 61.85 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.618 -177.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 87.2 mttt -98.59 144.32 28.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.504 0.192 . . . . 0.0 110.749 -177.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 63.1 mt -84.88 115.66 27.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 176.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.1 m -106.29 -23.61 4.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.657 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 44.7 tptt -142.09 115.84 9.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.238 0.542 . . . . 0.0 112.07 -176.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.456 HD21 HG12 ' A' ' 9' ' ' ILE . 3.2 mm? -97.46 128.91 44.62 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 170.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 1.111 ' HB ' ' HB3' ' A' ' 118' ' ' ASN . 14.2 m -115.98 135.71 53.71 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.043 0.449 . . . . 0.0 110.952 -175.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.673 HH21 ' HB2' ' A' ' 138' ' ' GLU . 38.7 mtm180 -88.03 106.91 18.46 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.379 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.927 ' HG ' ' HB ' ' A' ' 116' ' ' THR . 6.5 mp 49.66 -137.34 1.05 Allowed 'General case' 0 CA--C 1.532 0.27 0 O-C-N 123.233 0.333 . . . . 0.0 110.15 -178.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.648 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 27.4 t80 -80.64 -55.94 4.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.798 171.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 56.46 109.63 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.907 0.755 . . . . 0.0 112.163 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -44.59 -54.38 6.16 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 114.99 -1.005 . . . . 0.0 112.205 -174.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.28 -34.66 28.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.081 -0.508 . . . . 0.0 112.356 -176.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.673 ' HB2' HH21 ' A' ' 132' ' ' ARG . 15.6 tt0 -70.33 -37.64 74.73 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.645 -176.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.526 ' CZ ' ' HB3' ' A' ' 54' ' ' PHE . 84.7 t80 -63.23 -43.48 97.93 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 174.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.36 -53.73 54.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.209 176.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.1 m -54.37 -45.12 72.73 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.418 174.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.533 ' O ' HG12 ' A' ' 146' ' ' ILE . 45.0 tp -57.55 -48.99 77.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.607 -178.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 139' ' ' PHE . 87.8 t -60.04 -44.06 94.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.102 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -59.07 -44.15 91.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.275 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.55 ' O ' ' HG3' ' A' ' 149' ' ' MET . 7.8 tt0 -65.74 -39.69 91.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.543 178.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 142' ' ' LEU . 35.1 mm -56.07 -47.2 80.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.202 0.525 . . . . 0.0 110.238 175.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -62.29 -31.23 71.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.341 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -71.54 -44.66 64.18 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.527 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.55 ' HG3' ' O ' ' A' ' 145' ' ' GLN . 80.0 mtp -66.88 -26.3 66.82 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.465 0.65 . . . . 0.0 109.926 -176.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.525 HD21 ' O ' ' A' ' 146' ' ' ILE . 4.4 mm? . . . . . 0 C--N 1.325 -0.475 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.161 175.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.525 ' CE2' ' HD2' ' A' ' 117' ' ' ARG . 92.9 m-85 . . . . . 0 C--O 1.235 0.292 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.18 -5.3 10.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.149 164.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.2 p -94.92 160.37 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.092 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.6 ppt_? -128.38 166.58 18.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.906 0.384 . . . . 0.0 111.998 -173.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.4 mt -68.85 131.88 33.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.592 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.98 -3.86 70.79 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.066 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -82.17 152.1 26.63 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.429 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 31.8 mtp -81.83 124.67 29.88 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.089 178.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.47 126.87 87.54 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.681 -176.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.12 121.77 10.48 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.949 2.433 . . . . 0.0 111.493 177.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.441 ' HA ' HD13 ' A' ' 28' ' ' LEU . 1.0 OUTLIER -70.77 141.86 51.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.532 -175.649 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.472 ' HE2' ' HH ' ' A' ' 108' ' ' TYR . 39.8 p90 -153.08 163.75 39.28 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.329 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 27.4 m -123.29 107.56 11.8 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 174.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.7 tt -106.8 147.83 11.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.827 0.346 . . . . 0.0 110.8 -175.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 24' ' ' LYS . 3.9 m -81.94 133.47 35.31 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.173 178.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.782 ' HB2' ' HB2' ' A' ' 24' ' ' LYS . 75.7 mt -91.19 -178.7 5.23 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.609 -0.268 . . . . 0.0 110.742 177.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.9 p -55.5 -41.72 73.47 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -172.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.404 ' OD1' ' HG2' ' A' ' 24' ' ' LYS . 4.5 p-10 -97.29 8.0 45.44 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.221 -176.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.88 8.94 44.18 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.289 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.782 ' HB2' ' HB2' ' A' ' 20' ' ' LEU . 40.5 mmtm -62.02 151.89 33.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.035 0.445 . . . . 0.0 110.718 177.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.408 HE21 ' HA ' ' A' ' 19' ' ' THR . 17.4 mm-40 -118.21 116.85 27.65 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.644 174.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 17' ' ' THR . 5.2 p -120.45 125.75 74.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.4 0.619 . . . . 0.0 110.998 -179.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 9.3 m -106.4 141.0 38.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.944 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.441 HD13 ' HA ' ' A' ' 15' ' ' ASP . 17.6 mt -62.83 -31.07 72.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.412 0.149 . . . . 0.0 111.183 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.8 m -53.43 -34.32 57.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.459 176.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.9 m -78.69 -18.13 54.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.213 0.53 . . . . 0.0 111.082 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.494 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 67.0 mt -101.65 0.78 36.77 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.856 -177.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 28' ' ' LEU . 38.2 mmt180 -66.82 127.94 34.4 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.15 -27.83 8.33 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.486 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.803 ' HB3' ' HZ3' ' A' ' 34' ' ' LYS . 0.7 OUTLIER -116.48 167.4 11.09 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.514 -0.18 . . . . 0.0 110.514 -178.532 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.432 ' HB ' ' HE1' ' A' ' 149' ' ' MET . 2.4 p -80.06 127.63 39.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.019 0.438 . . . . 0.0 110.664 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.553 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 28.1 t -119.39 121.59 66.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.855 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.636 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 28.3 ttt -107.12 120.04 41.01 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.3 mt -126.22 102.01 7.0 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.104 -177.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.9 pm0 -107.38 133.18 52.28 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.615 175.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.441 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 94.9 m-85 -89.72 132.52 35.14 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.024 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.536 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 6.6 t -140.79 169.88 16.8 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.312 -177.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.479 ' HB3' ' CD1' ' A' ' 115' ' ' ILE . . . -135.54 151.65 50.53 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.8 169.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.1 m -73.18 28.03 0.06 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -174.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.438 ' H ' ' C ' ' A' ' 42' ' ' ALA . 41.1 p-90 -147.24 7.71 0.9 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.599 0.238 . . . . 0.0 111.238 176.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.443 ' SG ' ' HB1' ' A' ' 42' ' ' ALA . 79.7 m -86.57 130.43 34.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.858 0.361 . . . . 0.0 110.891 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -83.92 -31.25 26.8 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.196 -177.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.664 HG12 ' HB2' ' A' ' 133' ' ' LEU . 38.4 t -62.86 -37.95 80.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.301 0.572 . . . . 0.0 109.835 177.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.937 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 63.2 m -70.44 -20.21 62.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.065 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -75.05 -7.57 54.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.072 0.463 . . . . 0.0 110.255 175.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -102.07 -51.55 3.36 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.5 174.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.97 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 12.2 pt-20 -65.17 -44.58 88.04 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.03 -175.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.48 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 38.3 mtm -64.79 -48.95 71.65 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -173.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.48 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 72.6 Cg_exo -54.94 -39.95 88.02 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.737 1.624 . . . . 0.0 112.161 171.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.417 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 7.6 m-85 -66.9 -40.4 87.69 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.078 176.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 51' ' ' GLU . 78.5 mt -57.65 -50.0 78.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.315 175.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.628 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 22.0 tp10 -57.52 -51.05 71.02 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 176.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -54.6 -61.7 2.14 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -175.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.843 ' HA ' ' HZ2' ' A' ' 62' ' ' LYS . 64.5 m-20 -107.56 -13.61 15.02 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -169.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.509 HG23 HG23 ' A' ' 146' ' ' ILE . 61.5 mt -101.99 -62.33 2.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.788 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.548 ' HB3' ' HA ' ' A' ' 56' ' ' GLU . 62.8 t-105 -69.79 -48.29 59.74 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.498 -173.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.628 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -54.83 -28.75 51.91 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -176.256 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.843 ' HZ2' ' HA ' ' A' ' 58' ' ' ASP . 39.3 mmtm -87.47 -25.62 23.64 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -172.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 61.8 m-70 -122.05 -40.27 2.53 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -172.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.544 ' HE2' ' HA ' ' A' ' 61' ' ' LEU . 45.8 mmtt 49.57 -102.5 0.1 Allowed 'General case' 0 C--O 1.224 -0.25 0 O-C-N 123.566 0.541 . . . . 0.0 111.526 -175.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.572 ' C ' ' H ' ' A' ' 67' ' ' ALA . 17.2 t70 -87.37 -63.58 1.28 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.809 -175.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 64.9 -25.97 0.09 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -175.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.572 ' H ' ' C ' ' A' ' 65' ' ' ASP . . . 89.09 -15.94 0.3 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.505 1.522 . . . . 0.0 109.618 -177.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.601 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 2.0 m-20 -134.06 20.43 3.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.083 178.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.478 ' CD1' HD22 ' A' ' 150' ' ' LEU . 86.7 t80 -121.92 108.46 13.46 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.297 0.57 . . . . 0.0 109.786 172.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' A' ' 36' ' ' VAL . . . -111.75 104.37 12.71 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.756 -176.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.636 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 3.9 tt -113.78 114.66 26.63 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.6 mp -125.01 123.96 66.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.004 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.443 ' HA3' HD23 ' A' ' 96' ' ' LEU . . . -89.16 119.52 5.47 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.075 176.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 65.3 mt -102.29 102.14 13.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 117.134 0.467 . . . . 0.0 111.266 -174.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.536 ' HA ' ' O ' ' A' ' 41' ' ' THR . 8.0 t0 -80.76 144.53 32.08 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 170.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.471 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 8.2 ttp180 -85.46 -105.32 0.05 Allowed 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 120.305 -0.558 . . . . 0.0 112.186 -167.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.471 ' H ' ' HB3' ' A' ' 76' ' ' ARG . 31.8 m-20 -87.7 17.14 4.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.499 -168.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -91.09 138.86 25.7 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.579 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.434 ' HD2' ' HG3' ' A' ' 82' ' ' LYS . 48.5 Cg_endo -70.22 178.63 4.66 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.773 2.316 . . . . 0.0 113.07 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.1 mt -57.95 -56.46 21.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.926 -175.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.436 ' H ' ' CD ' ' A' ' 81' ' ' GLU . 1.9 pm0 -52.99 -36.0 59.83 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.638 -177.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.434 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 25.5 mmtp -63.51 -58.06 8.21 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.71 0.291 . . . . 0.0 110.487 175.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 55.0 t -54.18 -49.68 60.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.5 -177.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.41 -42.36 98.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.66 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.546 ' HA ' ' HE3' ' A' ' 88' ' ' LYS . . . -74.26 -29.52 61.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.648 -176.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -79.86 -44.91 19.63 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.57 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.64 -54.03 49.19 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.665 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.546 ' HE3' ' HA ' ' A' ' 85' ' ' ALA . 18.1 pttp -55.44 -30.54 60.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.746 -176.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.5 m -79.73 -14.59 58.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.103 -174.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.7 p -115.07 9.02 15.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.207 0.527 . . . . 0.0 110.637 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.67 -72.46 0.91 Allowed Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.293 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.0 t 28.07 88.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.622 1.169 . . . . 0.0 113.593 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.2 m -96.59 15.81 20.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.757 0.789 . . . . 0.0 110.086 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.535 ' HB3' ' CE2' ' A' ' 60' ' ' TRP . 25.9 p90 -115.43 146.85 37.45 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.114 176.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.76 136.84 69.09 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.635 2.224 . . . . 0.0 112.874 -177.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.443 HD23 ' HA3' ' A' ' 73' ' ' GLY . 63.7 mt -110.56 151.71 27.28 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.831 176.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -121.07 162.05 14.92 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 175.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.611 ' H ' HD22 ' A' ' 98' ' ' LEU . 2.0 pt? -121.6 138.61 54.25 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 117.005 0.403 . . . . 0.0 110.559 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -122.46 72.85 39.98 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.808 -178.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 13.9 Cg_exo -69.44 111.66 2.81 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.765 2.31 . . . . 0.0 111.761 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 117.74 -1.74 17.76 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -176.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 49.66 40.21 19.26 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -177.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -82.94 -53.96 5.44 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.122 0.486 . . . . 0.0 111.077 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.8 mm -63.85 -33.55 62.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.486 ' HE2' ' O ' ' A' ' 110' ' ' LEU . 80.2 t80 -64.63 -44.3 90.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.312 174.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.645 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -65.02 -19.81 66.18 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.852 -177.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -73.71 -6.7 48.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.858 0.361 . . . . 0.0 111.31 177.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.472 ' HH ' ' HE2' ' A' ' 16' ' ' PHE . 96.1 m-85 -128.95 -42.19 1.41 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.994 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.645 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -139.07 157.14 46.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.65 -178.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.486 ' O ' ' HE2' ' A' ' 105' ' ' PHE . 7.5 mp -61.41 138.35 58.26 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 178.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -55.96 -36.66 68.06 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 122.237 1.018 . . . . 0.0 109.245 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.22 13.49 15.08 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.647 -1.615 . . . . 0.0 110.444 -172.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.428 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . . . -108.1 -171.77 1.93 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.877 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.86 119.68 19.71 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.664 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.479 ' CD1' ' HB3' ' A' ' 42' ' ' ALA . 2.3 tt -67.94 -39.09 81.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -175.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.48 HG21 ' HA ' ' A' ' 133' ' ' LEU . 12.2 m -75.99 98.88 4.4 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.1 0.476 . . . . 0.0 110.987 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.525 ' HD2' ' CE2' ' A' ' 5' ' ' TYR . 37.8 mmt-85 -136.31 133.14 36.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.487 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.47 ' HB2' HG21 ' A' ' 131' ' ' THR . 7.4 m120 -111.0 118.56 36.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.789 0.328 . . . . 0.0 110.43 -176.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.7 t -112.3 128.98 68.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.452 -178.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 46.3 tp -115.16 116.26 28.09 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.028 0.442 . . . . 0.0 110.469 175.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.553 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 55.1 mt -99.59 132.64 44.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.474 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.49 174.09 8.71 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.942 0.401 . . . . 0.0 110.438 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.6 ptp85 -53.82 -34.54 59.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.725 -177.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -81.98 -0.55 44.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.559 -174.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.08 4.5 66.77 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.563 176.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.532 ' HZ3' ' HB2' ' A' ' 126' ' ' LYS . 9.2 mtmp? -97.45 149.52 22.06 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.941 0.401 . . . . 0.0 111.107 -177.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 55.1 mt -85.31 109.88 18.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.805 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 19.4 m -98.75 -17.0 6.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.899 -175.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.684 ' HE3' ' HB ' ' A' ' 131' ' ' THR . 6.9 tmtm? -149.45 108.24 3.86 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.766 -177.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.93 109.36 15.44 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 172.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.684 ' HB ' ' HE3' ' A' ' 129' ' ' LYS . 11.8 t -117.25 164.08 15.35 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.439 -176.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.483 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -103.23 108.0 19.04 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.352 -176.492 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.664 ' HB2' HG12 ' A' ' 47' ' ' VAL . 4.4 pp 51.16 -176.55 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.315 1.046 . . . . 0.0 113.438 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.97 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 93.3 t80 -68.74 91.75 0.45 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.777 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.55 ' HB3' ' HB2' ' A' ' 138' ' ' GLU . 0.2 OUTLIER -107.15 121.15 43.93 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 173.314 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.481 ' N ' HD21 ' A' ' 135' ' ' ASN . 1.3 mp0 -38.26 -64.87 0.38 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.77 0.828 . . . . 0.0 112.772 -175.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -56.82 -51.5 68.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.347 0.594 . . . . 0.0 111.357 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.55 ' HB2' ' HB3' ' A' ' 135' ' ' ASN . 5.5 mm-40 -62.61 -43.91 97.63 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.011 -176.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.534 ' O ' HG21 ' A' ' 143' ' ' VAL . 69.1 t80 -66.07 -42.86 88.84 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.476 ' O ' ' HG2' ' A' ' 144' ' ' GLN . . . -57.22 -50.0 74.24 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.532 177.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 17.4 m -62.96 -37.8 88.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.819 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.441 ' O ' HG12 ' A' ' 146' ' ' ILE . 2.6 tt -62.85 -48.31 79.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.794 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.534 HG21 ' O ' ' A' ' 139' ' ' PHE . 99.7 t -59.05 -45.1 92.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.154 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 140' ' ' ALA . 29.8 mm-40 -62.33 -43.33 99.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.339 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.432 ' O ' ' HG2' ' A' ' 149' ' ' MET . 9.4 tt0 -63.69 -40.85 97.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.424 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.55 ' O ' HD21 ' A' ' 150' ' ' LEU . 24.5 mm -51.83 -50.08 34.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 121.176 0.512 . . . . 0.0 110.517 175.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -58.02 -43.25 86.6 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.45 -178.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -70.95 -32.95 69.98 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.009 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.432 ' HE1' ' HB ' ' A' ' 35' ' ' VAL . 83.1 mmm -60.06 -29.43 68.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.179 0.514 . . . . 0.0 110.167 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.55 HD21 ' O ' ' A' ' 146' ' ' ILE . 3.6 mm? . . . . . 0 C--N 1.324 -0.542 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.378 177.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 . . . . . 0 CA--C 1.522 -0.124 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.5 pt -115.58 -6.15 11.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.252 0.549 . . . . 0.0 109.881 172.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.1 m -100.8 166.23 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.493 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.531 ' HB2' ' HG2' ' A' ' 11' ' ' GLU . 25.2 mtt180 -126.09 167.63 15.1 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -176.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 72.8 mt -78.99 119.47 28.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 174.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.64 -25.93 9.32 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.683 -176.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.531 ' HG2' ' HB2' ' A' ' 8' ' ' ARG . 72.2 mm-40 -66.76 150.37 49.21 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.634 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 56.7 mtp -80.32 123.54 28.08 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 174.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.421 ' HA ' ' HD2' ' A' ' 14' ' ' PRO . . . -56.16 124.58 60.63 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.603 -174.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 13' ' ' ALA . 7.1 Cg_endo -52.75 132.01 44.37 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.761 2.308 . . . . 0.0 111.338 175.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -82.82 161.54 21.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.458 -175.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.533 ' HB2' HD11 ' A' ' 104' ' ' ILE . 53.9 p90 -166.65 163.48 16.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.227 -175.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.6 m -125.26 100.5 6.56 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 174.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.5 tt -96.14 149.89 4.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.704 -174.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.482 ' O ' HD21 ' A' ' 98' ' ' LEU . 19.0 m -90.75 127.06 36.2 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.051 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.402 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 71.4 mt -79.69 175.9 10.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.933 178.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.491 HG22 ' O ' ' A' ' 96' ' ' LEU . 37.0 p -59.34 -25.9 64.59 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -177.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.797 ' OD1' ' HG2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -90.28 -19.32 24.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.146 0.498 . . . . 0.0 110.634 -178.519 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 113.13 -2.71 25.45 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.467 -174.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.797 ' HG2' ' OD1' ' A' ' 22' ' ' ASP . 39.3 mmtm -65.91 126.79 29.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.83 0.348 . . . . 0.0 111.149 178.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -91.3 116.4 28.8 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.868 176.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.9 p -119.05 128.4 75.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.315 0.578 . . . . 0.0 111.089 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 6.2 m -97.88 147.9 23.97 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.281 -178.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.71 -28.31 67.56 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.473 ' HA ' ' HG2' ' A' ' 32' ' ' ARG . 44.7 m -56.27 -29.31 60.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.389 177.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.6 m -75.24 -17.13 60.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.112 0.482 . . . . 0.0 111.243 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.3 mt -104.69 1.31 29.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.432 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.473 ' HG2' ' HA ' ' A' ' 29' ' ' SER . 36.3 mmt180 -66.76 122.5 17.79 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 120.54 -19.99 8.97 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -176.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.452 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 45.1 mtmt -116.52 155.24 29.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.547 -0.326 . . . . 0.0 110.323 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.426 HG12 ' HA ' ' A' ' 69' ' ' PHE . 1.4 p -71.27 117.73 14.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.012 0.434 . . . . 0.0 109.854 174.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.532 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 43.1 t -107.68 129.76 61.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.423 -173.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 27.6 ttt -107.46 120.12 41.3 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.174 175.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.7 mt -123.66 94.78 4.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.129 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.645 HE22 HD23 ' A' ' 71' ' ' LEU . 20.2 pm0 -93.81 131.1 39.52 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.107 0.48 . . . . 0.0 110.447 177.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -96.14 110.28 22.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.421 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.6 t -115.63 -171.9 2.05 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.88 -176.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.69 ' HB2' ' SG ' ' A' ' 45' ' ' CYS . . . -163.13 143.46 9.16 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.494 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 54.8 m -62.68 -13.9 37.54 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -174.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 68.2 p-90 -101.07 -4.72 26.87 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.154 -0.341 . . . . 0.0 111.663 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.69 ' SG ' ' HB2' ' A' ' 42' ' ' ALA . 83.8 m -78.21 124.58 28.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.977 0.418 . . . . 0.0 111.732 -175.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -88.66 -18.11 55.39 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 176.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.446 ' HB ' HG22 ' A' ' 116' ' ' THR . 61.8 t -72.02 -46.52 59.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.931 0.396 . . . . 0.0 110.027 176.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.72 ' SG ' HG23 ' A' ' 116' ' ' THR . 69.2 m -66.91 -17.61 64.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.7 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.555 ' HE ' ' HE1' ' A' ' 86' ' ' PHE . 75.0 mtt180 -72.77 -6.46 44.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.154 0.502 . . . . 0.0 110.694 176.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -105.3 -44.98 4.6 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 169.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.636 ' HB2' ' HB2' ' A' ' 134' ' ' TYR . 40.6 tt0 -56.18 -57.12 13.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.369 -177.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.672 ' SD ' ' HE2' ' A' ' 86' ' ' PHE . 74.8 mtp -62.52 -50.64 77.76 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -172.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.596 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 54.7 Cg_exo -55.66 -36.22 94.42 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.959 1.773 . . . . 0.0 112.435 175.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -69.74 -41.32 75.43 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.638 175.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.533 HG13 ' O ' ' A' ' 51' ' ' GLU . 81.5 mt -56.32 -53.18 42.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.057 177.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.571 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 17.1 pt-20 -67.34 -32.09 72.8 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.525 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -62.04 -60.3 3.82 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.725 ' HA ' ' HZ3' ' A' ' 62' ' ' LYS . 52.1 m-20 -107.19 -8.48 16.43 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -171.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.506 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 70.6 mt -104.76 -57.98 4.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.612 176.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.571 ' HB3' ' HA ' ' A' ' 56' ' ' GLU . 76.5 t-105 -66.55 -67.42 0.45 Allowed 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.177 -178.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.0 mp -47.45 -32.1 4.8 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -174.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.725 ' HZ3' ' HA ' ' A' ' 58' ' ' ASP . 46.5 mmtm -77.28 -36.48 54.2 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -177.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -126.68 -43.16 1.74 Allowed 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.937 -0.477 . . . . 0.0 112.099 -173.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.2 mttp 62.03 -83.05 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.918 0.887 . . . . 0.0 111.451 -178.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -123.37 -38.85 2.51 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 174.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 70.74 -75.06 0.08 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.022 175.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 171.86 -33.83 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.898 -176.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.452 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 5.7 t70 -126.83 19.55 7.17 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.273 -177.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.426 ' HA ' HG12 ' A' ' 35' ' ' VAL . 87.7 t80 -129.11 155.17 45.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.39 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -150.24 132.46 15.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.43 176.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.645 HD23 HE22 ' A' ' 39' ' ' GLN . 5.5 tt -129.41 119.77 24.38 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.5 mm -129.89 120.29 49.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.088 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.88 128.79 9.31 Favored Glycine 0 C--O 1.224 -0.509 0 C-N-CA 120.234 -0.984 . . . . 0.0 111.457 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.3 mt -115.5 120.1 63.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 117.23 0.515 . . . . 0.0 111.174 -176.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.512 ' OD1' ' HA ' ' A' ' 42' ' ' ALA . 16.7 t0 -92.09 127.89 37.73 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 174.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.49 111.33 22.57 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.169 -171.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.7 t0 81.43 -26.09 0.15 Allowed 'General case' 0 N--CA 1.47 0.557 0 O-C-N 124.147 0.904 . . . . 0.0 112.367 169.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.483 ' HB2' ' OD1' ' A' ' 75' ' ' ASP . 5.5 mm-40 -69.49 131.98 89.68 Favored Pre-proline 0 C--O 1.235 0.295 0 CA-C-O 121.148 0.499 . . . . 0.0 110.713 177.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.564 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 36.8 Cg_endo -71.96 -168.71 0.39 Allowed 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.088 2.526 . . . . 0.0 114.624 -176.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -62.69 -52.71 62.2 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.367 -168.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.564 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -62.98 -34.1 76.8 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.502 0.191 . . . . 0.0 111.419 -175.76 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.537 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 33.6 mmtp -58.93 -58.87 6.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.828 176.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.507 HG21 ' HB3' ' A' ' 98' ' ' LEU . 45.2 t -55.27 -44.88 77.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.452 -177.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.8 mp -67.37 -31.71 72.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.698 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.777 ' HA ' ' HE2' ' A' ' 88' ' ' LYS . . . -82.86 -37.35 24.45 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.102 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.672 ' HE2' ' SD ' ' A' ' 52' ' ' MET . 83.2 t80 -67.57 -47.0 71.03 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.914 -178.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.494 ' HB3' HD11 ' A' ' 96' ' ' LEU . . . -55.15 -51.53 66.2 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.59 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.777 ' HE2' ' HA ' ' A' ' 85' ' ' ALA . 64.7 pttt -65.94 -23.2 66.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.829 0.347 . . . . 0.0 111.688 -174.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.8 m -80.42 -28.22 37.82 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.108 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.6 p -96.95 -20.53 18.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.078 0.466 . . . . 0.0 111.01 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 112.58 -74.77 0.22 Allowed Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -175.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 97.8 t 43.43 88.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 124.31 1.044 . . . . 0.0 113.322 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.2 m -79.8 6.26 11.43 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 114.704 -1.135 . . . . 0.0 111.333 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.535 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 50.7 p90 -118.71 153.55 52.35 Favored Pre-proline 0 C--N 1.329 -0.306 0 O-C-N 122.172 -0.33 . . . . 0.0 110.882 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -66.71 137.97 47.56 Favored 'Trans proline' 0 C--O 1.24 0.593 0 C-N-CA 122.175 1.916 . . . . 0.0 113.236 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.494 HD11 ' HB3' ' A' ' 87' ' ' ALA . 77.9 mt -109.61 148.28 31.57 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.738 174.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -117.59 147.8 18.74 Favored Glycine 0 N--CA 1.438 -1.221 0 N-CA-C 110.389 -1.085 . . . . 0.0 110.389 173.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.66 HD21 ' H ' ' A' ' 98' ' ' LEU . 1.5 pt? -101.6 136.63 41.13 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -178.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -116.38 73.95 5.71 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.261 178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.483 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 15.4 Cg_exo -68.09 117.25 4.79 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.655 2.237 . . . . 0.0 111.524 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.414 ' O ' ' HD2' ' A' ' 111' ' ' ARG . . . 102.41 -7.32 53.87 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.275 -175.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.548 ' HB2' ' HG2' ' A' ' 111' ' ' ARG . . . 55.68 38.73 30.5 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 122.896 0.479 . . . . 0.0 111.402 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -72.46 -46.11 56.42 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.607 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.533 HD11 ' HB2' ' A' ' 16' ' ' PHE . 21.2 mm -65.22 -38.94 83.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.687 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -65.2 -38.71 91.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.097 175.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -68.92 -15.3 63.45 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.296 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 52.2 mttp -80.16 -16.75 54.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.627 175.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -113.82 -20.97 10.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.803 0.335 . . . . 0.0 111.328 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -159.79 -179.81 8.17 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.244 -178.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.919 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 88.6 mt -65.27 138.31 58.12 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.548 ' HG2' ' HB2' ' A' ' 102' ' ' ALA . 1.3 ttp85 -42.61 -48.1 5.36 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -173.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -118.58 37.79 3.95 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.138 0.494 . . . . 0.0 110.667 -176.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.919 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . . . -81.41 34.8 0.38 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.938 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.5 -162.92 17.7 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 121.022 -0.608 . . . . 0.0 112.282 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.529 HG13 ' H ' ' A' ' 116' ' ' THR . 4.7 tp -151.78 -174.2 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -178.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.72 HG23 ' SG ' ' A' ' 48' ' ' CYS . 53.0 p 58.37 88.86 0.06 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.869 0.867 . . . . 0.0 111.692 176.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -171.09 141.86 1.72 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.223 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.682 ' HB3' ' HB ' ' A' ' 131' ' ' THR . 5.6 t30 -119.97 129.67 54.41 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.095 0.474 . . . . 0.0 111.51 -176.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 39.1 t -101.81 113.1 37.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.781 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.906 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 27.2 tp -97.64 115.7 28.43 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.33 0.586 . . . . 0.0 110.035 177.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.532 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 60.5 mt -98.85 135.68 32.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 114.988 -1.006 . . . . 0.0 109.77 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.601 ' OD2' ' HB2' ' A' ' 126' ' ' LYS . 4.4 p30 -75.87 170.23 16.62 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.919 0.39 . . . . 0.0 110.0 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -75.39 1.31 14.2 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.471 -175.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.429 ' HB2' ' OD1' ' A' ' 122' ' ' ASP . 38.7 mt-10 -91.62 -30.5 16.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.373 0.606 . . . . 0.0 109.645 175.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.82 5.56 10.84 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.214 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.635 ' HZ1' ' HB2' ' A' ' 126' ' ' LYS . 9.3 mtmp? -100.74 157.97 16.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.973 0.416 . . . . 0.0 111.263 -177.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 54.5 mt -92.06 119.08 38.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.155 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 17.0 m -114.91 -23.28 4.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.906 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 59.2 tptt -134.46 113.9 12.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.14 0.495 . . . . 0.0 111.799 -174.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -101.76 113.44 26.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.398 173.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.682 ' HB ' ' HB3' ' A' ' 118' ' ' ASN . 25.4 m -95.57 137.42 34.66 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.496 -177.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.433 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 0.4 OUTLIER -108.42 105.7 15.49 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.72 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 132' ' ' ARG . 3.4 pp 41.72 -163.1 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.093 0.871 . . . . 0.0 113.011 -177.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.636 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 84.5 t80 -94.14 107.48 19.41 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.127 0.489 . . . . 0.0 111.451 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.451 ' HB2' ' CB ' ' A' ' 138' ' ' GLU . 54.0 m-80 -119.42 149.77 41.3 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 170.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -58.58 -56.16 25.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.121 0.486 . . . . 0.0 110.752 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.05 -40.78 95.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.216 -178.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.451 ' CB ' ' HB2' ' A' ' 135' ' ' ASN . 6.1 tp10 -61.93 -49.78 74.8 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.629 -178.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -66.96 -37.92 85.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.487 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.16 -42.06 97.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.337 176.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 43.2 m -64.5 -30.3 71.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.143 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.444 HD11 HG22 ' A' ' 131' ' ' THR . 29.2 mt -72.8 -55.26 6.96 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.294 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.3 p -59.42 -38.54 75.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 O-C-N 123.166 0.291 . . . . 0.0 110.897 -175.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -67.54 -46.9 71.44 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 176.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -58.86 -46.58 87.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.605 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.539 ' O ' HD22 ' A' ' 150' ' ' LEU . 81.7 mt -65.47 -40.01 86.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.041 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -58.91 -38.63 79.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.688 0.28 . . . . 0.0 110.819 176.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -77.9 -30.41 50.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.941 178.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 87.0 mmm -67.19 -27.79 67.56 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.316 0.579 . . . . 0.0 110.143 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.539 HD22 ' O ' ' A' ' 146' ' ' ILE . 3.9 mm? . . . . . 0 C--N 1.325 -0.487 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.556 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.45 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 62.1 m-85 . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.409 ' H ' ' HA ' ' A' ' 109' ' ' ALA . 39.8 pt -92.07 -13.37 8.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.556 0.693 . . . . 0.0 109.248 173.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 p -110.57 164.16 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.298 178.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.5 mtm105 -133.68 165.85 23.97 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.902 0.382 . . . . 0.0 111.01 -174.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.4 mt -72.02 122.96 25.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.193 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.99 -22.21 19.03 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.94 -178.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -74.11 159.25 32.87 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.741 0.305 . . . . 0.0 110.722 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.565 ' SD ' ' HG2' ' A' ' 126' ' ' LYS . 56.3 mmm -79.76 133.28 36.32 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.99 129.7 90.61 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.623 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.494 ' HD2' ' CE1' ' A' ' 108' ' ' TYR . 32.9 Cg_exo -61.92 137.44 67.47 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.882 2.388 . . . . 0.0 111.744 175.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.42 ' HB2' HH22 ' A' ' 32' ' ' ARG . 23.4 t70 -80.61 153.03 28.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.888 -177.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -161.88 165.44 27.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.779 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 73.5 m -124.7 107.12 10.64 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 174.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.5 tt -105.92 144.86 14.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.94 -173.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.446 ' O ' HD23 ' A' ' 98' ' ' LEU . 5.5 m -88.52 131.69 34.81 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.077 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.466 HD11 ' HB2' ' A' ' 24' ' ' LYS . 79.0 mt -82.43 -179.43 7.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.845 0.355 . . . . 0.0 110.951 177.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.425 ' HB ' HD11 ' A' ' 84' ' ' LEU . 35.6 p -57.85 -31.65 66.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.894 -175.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.47 ' OD2' ' HG2' ' A' ' 24' ' ' LYS . 5.4 p-10 -99.45 -6.19 28.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.818 0.342 . . . . 0.0 110.835 -175.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.94 1.82 34.12 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.333 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.585 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -69.22 110.78 4.76 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 117.663 0.732 . . . . 0.0 110.297 175.623 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -92.69 115.08 27.78 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.086 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 17' ' ' THR . 12.8 m -112.66 146.03 17.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.156 0.503 . . . . 0.0 110.804 -177.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.6 m -103.2 147.06 27.5 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.712 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.17 -45.81 93.08 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.702 0.287 . . . . 0.0 110.408 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.9 m -64.95 -15.79 62.59 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.2 t -82.48 -15.38 52.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.577 0.703 . . . . 0.0 109.555 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.2 mt -112.12 -3.9 14.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.539 177.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.42 HH22 ' HB2' ' A' ' 15' ' ' ASP . 7.8 mtm180 -75.81 156.36 34.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.058 0.456 . . . . 0.0 111.024 -178.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.48 -15.71 62.68 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 -166.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.579 ' HB3' ' O ' ' A' ' 68' ' ' ASP . 36.7 mtmt -116.44 160.21 20.9 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.058 -1.071 . . . . 0.0 109.381 175.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.421 HG12 HD21 ' A' ' 150' ' ' LEU . 2.3 p -80.19 118.27 27.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.359 0.6 . . . . 0.0 109.716 174.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.8 t -112.51 122.2 66.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.967 -173.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.64 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 26.7 ttt -99.34 114.96 28.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.08 175.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 69.6 mt -110.31 97.55 6.99 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.584 178.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.536 ' HG3' ' HA2' ' A' ' 73' ' ' GLY . 1.5 pp0? -91.1 130.97 36.94 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 177.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -107.02 122.34 46.25 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.43 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 13.9 t -151.49 -171.4 3.92 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.9 -177.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.403 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . . . -150.95 163.41 38.78 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 174.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.487 ' HB2' ' HG3' ' A' ' 78' ' ' GLU . 44.1 m -67.54 -5.71 16.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.055 -0.521 . . . . 0.0 112.168 -176.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 37.0 p-90 -109.9 12.21 23.91 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.464 ' SG ' HD12 ' A' ' 115' ' ' ILE . 73.8 m -92.85 100.95 13.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.118 0.485 . . . . 0.0 111.266 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.98 -32.38 73.29 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.889 -0.596 . . . . 0.0 113.082 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.6 t -64.12 -41.29 91.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.159 0.504 . . . . 0.0 110.446 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.717 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 83.6 m -67.62 -16.94 64.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.73 -177.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -71.3 -2.6 16.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.863 0.363 . . . . 0.0 110.994 176.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -98.85 -51.87 3.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.056 0.455 . . . . 0.0 110.026 170.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.717 ' HG2' ' HA ' ' A' ' 48' ' ' CYS . 11.7 pt-20 -69.58 -39.33 77.4 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.046 -173.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.555 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 91.7 mtp -60.36 -51.03 83.02 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -177.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.555 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 35.8 Cg_exo -59.68 -35.74 94.01 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.854 1.703 . . . . 0.0 112.208 172.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.57 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 3.1 m-85 -64.32 -43.73 93.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.724 174.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 51' ' ' GLU . 97.4 mt -58.16 -48.98 83.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.853 173.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.468 ' OE1' ' HA ' ' A' ' 92' ' ' VAL . 30.2 tp10 -50.22 -53.97 24.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.934 178.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -72.53 -50.45 25.65 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -173.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -105.8 -12.96 15.68 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -168.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.429 HD11 HG12 ' A' ' 55' ' ' ILE . 73.4 mt -106.37 -61.93 2.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.024 176.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.617 ' CE2' ' HG2' ' A' ' 64' ' ' LYS . 67.5 t-105 -62.94 -67.41 0.42 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.481 -174.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.4 ' HA ' HD13 ' A' ' 61' ' ' LEU . 0.6 OUTLIER -49.02 -33.52 11.35 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -175.366 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -68.41 -30.11 68.94 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.78 -175.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.449 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 90.7 m-70 -128.98 -47.08 1.23 Allowed 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 119.678 -0.809 . . . . 0.0 112.621 -176.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.617 ' HG2' ' CE2' ' A' ' 60' ' ' TRP . 9.2 mtmp? 40.57 -93.98 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.568 0.699 . . . . 0.0 112.149 -174.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.59 -70.59 0.29 Allowed 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.045 173.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.573 ' ND2' HD11 ' A' ' 150' ' ' LEU . 5.7 t30 70.18 -68.77 0.19 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.769 0.828 . . . . 0.0 111.078 174.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 175.87 -46.3 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.363 -178.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.579 ' O ' ' HB3' ' A' ' 34' ' ' LYS . 7.9 p-10 -142.85 35.25 1.4 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.066 -177.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.555 ' HB2' HD13 ' A' ' 150' ' ' LEU . 74.5 t80 -104.13 145.72 29.78 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.657 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.76 130.33 17.89 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.934 174.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.64 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 3.4 tt -135.35 114.61 12.37 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.5 mp -125.9 126.12 69.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.825 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.536 ' HA2' ' HG3' ' A' ' 39' ' ' GLN . . . -91.16 120.4 5.95 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.608 -0.805 . . . . 0.0 111.376 176.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 65.8 mt -103.92 122.99 57.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 116.861 0.33 . . . . 0.0 111.051 -175.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.555 ' HA ' ' O ' ' A' ' 41' ' ' THR . 9.3 t70 -85.84 137.74 32.55 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 176.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 54.5 ttt-85 -74.87 -28.23 60.57 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -172.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -161.92 -18.3 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -171.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.487 ' HG3' ' HB2' ' A' ' 43' ' ' SER . 5.3 mm-40 -78.59 132.25 65.73 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-O 121.294 0.569 . . . . 0.0 111.198 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.593 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 28.4 Cg_endo -71.89 -169.94 0.49 Allowed 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 123.307 2.671 . . . . 0.0 114.366 -178.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.402 ' O ' HD21 ' A' ' 84' ' ' LEU . 79.4 mt -53.5 -59.01 5.13 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 114.958 -1.019 . . . . 0.0 113.106 -173.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.593 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -59.53 -33.43 71.38 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.479 -172.111 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.48 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 34.1 mmtp -64.35 -55.89 18.14 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.014 0.435 . . . . 0.0 110.325 174.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.403 HG21 ' O ' ' A' ' 79' ' ' PRO . 92.7 t -57.95 -44.39 86.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.43 -177.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.425 HD11 ' HB ' ' A' ' 21' ' ' THR . 4.4 mm? -69.01 -13.11 62.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.729 -178.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.485 ' HA ' ' HD2' ' A' ' 88' ' ' LYS . . . -99.84 -42.05 6.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.925 0.393 . . . . 0.0 110.789 176.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.553 ' HE2' ' SD ' ' A' ' 52' ' ' MET . 71.7 t80 -64.63 -38.08 89.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.841 -177.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -54.63 -56.01 23.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.338 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.485 ' HD2' ' HA ' ' A' ' 85' ' ' ALA . 0.3 OUTLIER -66.98 -19.05 65.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.171 0.51 . . . . 0.0 110.838 -175.519 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.4 m -81.55 -1.89 47.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.333 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.5 p -138.43 11.03 2.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.224 0.535 . . . . 0.0 110.491 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.68 -74.2 1.17 Allowed Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.468 ' HA ' ' OE1' ' A' ' 56' ' ' GLU . 54.6 t 29.65 93.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.108 1.363 . . . . 0.0 114.408 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 71.9 p -97.17 -11.91 23.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.038 0.447 . . . . 0.0 110.186 174.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.514 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 37.6 p90 -81.52 144.33 52.85 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.472 176.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.2 138.37 81.0 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.714 2.276 . . . . 0.0 113.044 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.8 mt -110.9 142.07 43.46 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.938 177.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 74' ' ' ILE . . . -115.0 142.7 17.79 Favored Glycine 0 N--CA 1.441 -1.009 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 177.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.731 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.8 pt? -103.11 129.62 50.02 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.938 0.399 . . . . 0.0 110.815 -177.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -119.33 72.07 13.23 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.818 177.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.455 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 20.1 Cg_exo -65.28 108.48 1.17 Allowed 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.504 2.136 . . . . 0.0 112.312 -176.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 118.9 -6.23 13.58 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.6 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 59.35 44.99 14.51 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.897 0.479 . . . . 0.0 111.784 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -80.8 -55.52 4.76 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 120.973 0.416 . . . . 0.0 110.499 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 38.4 mm -62.02 -35.28 67.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 176.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.658 ' HZ ' ' HA ' ' A' ' 115' ' ' ILE . 38.9 t80 -60.48 -40.61 91.89 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.264 174.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.556 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -76.89 -14.72 59.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.184 -177.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 50.0 mttp -72.75 -11.16 60.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.953 0.406 . . . . 0.0 111.353 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.494 ' CE1' ' HD2' ' A' ' 14' ' ' PRO . 98.9 m-85 -116.72 -30.03 5.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.413 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.556 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -162.89 -177.23 5.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.62 0.248 . . . . 0.0 110.714 -175.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.502 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . 95.6 mt -72.69 135.49 45.41 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.549 ' HA ' ' CD1' ' A' ' 105' ' ' PHE . 17.6 mtm180 -58.59 -34.51 71.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.936 -175.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -105.42 7.58 33.23 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.015 -170.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.502 ' CB ' ' HB2' ' A' ' 110' ' ' LEU . . . -96.24 49.76 1.14 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.136 0.493 . . . . 0.0 111.234 -177.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.67 104.52 0.9 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.059 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.658 ' HA ' ' HZ ' ' A' ' 105' ' ' PHE . 5.1 tt -72.07 -52.51 24.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -176.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.586 HG23 ' HG ' ' A' ' 48' ' ' CYS . 77.0 m -59.34 109.48 0.88 Allowed 'General case' 0 C--O 1.238 0.465 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -175.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.569 ' HB3' HH21 ' A' ' 132' ' ' ARG . 13.6 ptt180 -161.16 140.59 10.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.584 178.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -107.2 118.11 35.83 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 174.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 51.0 t -101.54 106.27 19.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.092 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 43.1 tp -93.49 119.19 32.27 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.278 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 68.5 mt -103.83 131.11 53.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.657 177.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.96 166.04 24.29 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -66.93 -13.38 61.7 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -174.102 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.562 ' HB2' ' NZ ' ' A' ' 126' ' ' LYS . 48.4 mt-10 -84.43 -27.58 27.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.014 0.435 . . . . 0.0 110.564 175.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.67 10.07 7.99 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.376 -0.916 . . . . 0.0 113.04 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.565 ' HG2' ' SD ' ' A' ' 12' ' ' MET . 31.6 mtmm -93.09 146.06 23.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.129 0.49 . . . . 0.0 111.729 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 56.0 mt -87.28 115.09 27.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.763 177.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 31.1 m -109.87 -16.72 8.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -172.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.52 ' HG2' HD12 ' A' ' 142' ' ' LEU . 51.2 tptt -137.5 122.68 19.24 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 119.896 -0.722 . . . . 0.0 112.107 -176.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 9.8 mp -121.91 105.18 10.11 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.212 174.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.429 HG21 ' HE3' ' A' ' 129' ' ' LYS . 67.9 p -96.67 162.05 13.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.137 0.494 . . . . 0.0 111.486 -177.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.599 ' HA ' ' HE ' ' A' ' 132' ' ' ARG . 2.1 mmp_? -127.27 106.93 9.56 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 173.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.547 ' HA ' HG21 ' A' ' 116' ' ' THR . 88.5 mt 63.24 176.43 0.16 Allowed 'General case' 0 N--CA 1.469 0.508 0 O-C-N 123.761 0.663 . . . . 0.0 111.382 -177.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.507 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 76.3 t80 -83.73 87.88 7.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.464 0.649 . . . . 0.0 109.684 175.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -104.15 135.66 45.22 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 176.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -55.44 -61.21 2.49 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 123.375 0.422 . . . . 0.0 112.03 -168.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.45 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.4 mp0 -55.74 -44.84 77.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.784 0.326 . . . . 0.0 110.885 -177.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -62.93 -46.03 89.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.509 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.57 ' CE2' ' HB3' ' A' ' 54' ' ' PHE . 63.6 t80 -69.99 -41.46 74.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.245 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.19 -40.15 89.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.575 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 48.1 m -67.12 -37.43 83.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.345 176.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.52 HD12 ' HG2' ' A' ' 129' ' ' LYS . 63.0 tp -62.47 -50.75 70.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.777 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.434 HG21 ' O ' ' A' ' 139' ' ' PHE . 94.6 t -56.45 -54.26 30.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.181 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -60.54 -42.85 97.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.629 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -56.28 -49.32 74.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.327 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.621 ' O ' HD22 ' A' ' 150' ' ' LEU . 28.9 mt -60.19 -50.94 78.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.1 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -55.08 -42.31 72.67 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.253 -0.179 . . . . 0.0 111.352 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -77.86 -24.51 48.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.686 0.279 . . . . 0.0 110.761 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.42 ' HE3' ' HB3' ' A' ' 149' ' ' MET . 45.3 mmm -63.26 -31.31 72.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.403 0.621 . . . . 0.0 110.011 175.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.621 HD22 ' O ' ' A' ' 146' ' ' ILE . 4.0 mm? . . . . . 0 C--N 1.323 -0.556 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.304 177.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 . . . . . 0 CA--C 1.517 -0.293 0 N-CA-C 110.568 -0.16 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.1 pt -87.78 -18.86 8.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.218 0.533 . . . . 0.0 109.667 174.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.5 m -93.84 -179.39 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.657 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.2 ppt_? -144.34 165.7 27.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.847 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 69.4 mt -67.4 128.4 30.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.138 0.494 . . . . 0.0 110.745 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.52 3.22 66.96 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.096 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -85.68 151.75 23.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.58 0.229 . . . . 0.0 110.582 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.567 ' HE2' ' HG2' ' A' ' 126' ' ' LYS . 1.2 mmt -69.49 116.79 10.31 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 175.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.401 ' HB1' HG12 ' A' ' 121' ' ' ILE . . . -54.49 126.07 54.45 Favored Pre-proline 0 C--O 1.237 0.401 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.489 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.473 ' HG2' ' O ' ' A' ' 107' ' ' LYS . 27.3 Cg_exo -60.42 115.54 2.73 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.802 2.335 . . . . 0.0 111.028 178.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -70.64 133.01 46.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.828 -173.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.571 ' HB2' HD13 ' A' ' 104' ' ' ILE . 36.1 p90 -136.49 158.87 43.41 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.035 -178.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 49.0 m -117.31 99.51 7.06 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.4 tt -97.87 152.32 4.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.609 -173.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.481 ' O ' HD22 ' A' ' 98' ' ' LEU . 27.3 m -99.35 129.41 45.55 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.944 178.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.3 mt -85.01 -178.07 6.73 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.823 0.344 . . . . 0.0 111.13 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 96' ' ' LEU . 30.9 p -62.55 -26.43 68.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.081 -176.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.407 ' OD1' ' HB2' ' A' ' 24' ' ' LYS . 13.1 p-10 -92.79 -5.11 51.83 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.526 -178.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.51 2.4 56.52 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.135 -176.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.407 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 6.2 tmtt? -62.87 112.34 2.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.79 0.328 . . . . 0.0 111.829 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -87.52 117.63 26.45 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 172.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 17' ' ' THR . 7.1 p -126.5 133.25 69.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.298 0.571 . . . . 0.0 110.97 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.2 m -93.92 144.75 25.17 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.209 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.62 -29.49 70.65 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.77 0.319 . . . . 0.0 110.53 -178.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.6 m -56.13 -30.53 62.26 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.365 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.2 m -74.79 -24.97 58.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.398 0.618 . . . . 0.0 110.809 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 89.4 mt -90.74 -10.87 41.39 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.532 -176.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.4 HH11 ' HA3' ' A' ' 125' ' ' GLY . 35.3 mmt180 -57.68 154.52 11.49 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.62 -19.53 36.3 Favored Glycine 0 C--O 1.226 -0.38 0 C-N-CA 121.088 -0.577 . . . . 0.0 111.885 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.563 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 32.5 mtmm -116.59 170.47 8.55 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 68' ' ' ASP . 35.4 m -81.75 123.34 37.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 176.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.8 t -115.78 120.6 65.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.875 0.369 . . . . 0.0 110.873 -174.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 27.2 ttt -112.42 118.27 34.73 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.01 0.433 . . . . 0.0 110.485 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.73 HD22 HD12 ' A' ' 121' ' ' ILE . 2.8 mm? -111.17 107.98 17.49 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.08 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.46 HE21 ' HB2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -109.47 127.18 54.23 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.89 175.504 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -95.39 121.12 36.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.272 0.558 . . . . 0.0 110.436 -176.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.536 ' HA ' ' SG ' ' A' ' 48' ' ' CYS . 1.9 t -122.54 171.77 8.87 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.479 -175.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.511 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -150.65 130.53 13.31 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.678 177.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.515 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 47.8 m -57.96 -28.93 64.8 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.958 -177.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 38.7 p-90 -90.56 2.4 55.82 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 52.8 t -107.59 120.31 41.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.976 0.417 . . . . 0.0 111.223 -177.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -83.41 -17.64 66.06 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.702 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.503 HG12 HG23 ' A' ' 116' ' ' THR . 42.7 t -66.37 -43.45 91.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 176.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.548 ' O ' ' HG2' ' A' ' 52' ' ' MET . 72.3 m -64.23 -27.49 69.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.318 176.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 55.4 ttt180 -69.05 -6.11 26.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.155 0.502 . . . . 0.0 110.809 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.505 ' HE3' ' CD2' ' A' ' 134' ' ' TYR . 22.9 mtpp -83.31 -55.19 4.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.476 172.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 10.6 pt-20 -70.05 -31.73 69.49 Favored 'General case' 0 C--O 1.219 -0.553 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.729 -176.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.583 ' HG3' ' HE2' ' A' ' 86' ' ' PHE . 91.7 mmm -50.6 -60.01 6.23 Favored Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.457 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 53.2 Cg_endo -69.86 -31.43 20.08 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 121.611 1.541 . . . . 0.0 112.66 177.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -68.64 -50.25 52.73 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.323 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.577 ' O ' ' HB ' ' A' ' 59' ' ' ILE . 83.8 mt -57.13 -45.38 84.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.376 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.509 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 25.5 tt0 -58.77 -48.99 79.31 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.86 175.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.405 ' NZ ' ' OD2' ' A' ' 58' ' ' ASP . 25.9 ttpp -56.49 -56.65 18.63 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -174.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.825 ' HA ' ' HZ2' ' A' ' 62' ' ' LYS . 73.5 m-20 -105.06 -9.88 17.54 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -171.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.577 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 50.4 mm -105.26 -57.35 4.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.646 176.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.54 ' CD2' ' HB3' ' A' ' 94' ' ' TYR . 74.9 t-105 -69.69 -51.6 33.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.134 -173.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.576 HD12 ' CE ' ' A' ' 64' ' ' LYS . 3.1 mm? -61.06 -16.57 45.31 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.825 ' HZ2' ' HA ' ' A' ' 58' ' ' ASP . 48.5 mmtm -86.51 -27.93 23.72 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.615 -176.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -127.48 -41.31 1.72 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -173.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.576 ' CE ' HD12 ' A' ' 61' ' ' LEU . 34.4 mmtt 55.4 -91.34 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 O-C-N 123.493 0.496 . . . . 0.0 111.094 -174.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -96.24 -63.3 1.16 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.019 0.438 . . . . 0.0 110.065 178.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.444 ' ND2' HD12 ' A' ' 150' ' ' LEU . 1.1 t30 66.15 3.92 2.9 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.083 174.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 62.2 4.17 1.18 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.467 0.707 . . . . 0.0 112.655 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.563 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 20.2 t70 -152.21 5.48 0.41 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.429 0.633 . . . . 0.0 111.086 -175.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.561 ' CE2' ' HB2' ' A' ' 71' ' ' LEU . 85.3 t80 -117.95 120.8 38.94 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 121.706 -0.621 . . . . 0.0 110.888 -174.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -122.03 104.62 9.64 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.931 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.561 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 3.7 tt -108.48 114.75 28.83 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.0 mm -117.81 115.84 49.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.132 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.7 116.66 4.68 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.105 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 55.8 mt -105.8 100.91 11.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 117.155 0.478 . . . . 0.0 111.336 -173.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.519 ' HA ' ' O ' ' A' ' 41' ' ' THR . 1.9 t70 -85.43 136.16 33.56 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 172.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.429 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 16.8 ttp180 -72.59 -112.13 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -165.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.429 ' H ' ' HB3' ' A' ' 76' ' ' ARG . 17.3 m-20 -78.55 5.91 9.84 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -169.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -76.92 131.23 73.67 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-O 121.027 0.441 . . . . 0.0 110.987 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.476 ' HG2' ' OE2' ' A' ' 81' ' ' GLU . 29.1 Cg_endo -68.65 176.76 5.5 Favored 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 122.663 2.242 . . . . 0.0 112.7 177.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 97.2 mt -53.0 -58.22 7.71 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -173.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.476 ' OE2' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -64.5 -21.39 66.66 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -173.372 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 28.7 mmtm -74.03 -54.8 7.08 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 172.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 60.1 t -56.48 -47.37 81.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.233 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.78 -33.17 75.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.283 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.72 -35.63 62.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.744 0.306 . . . . 0.0 110.882 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.583 ' HE2' ' HG3' ' A' ' 52' ' ' MET . 60.3 t80 -69.39 -40.15 77.55 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.95 -55.08 39.51 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.164 176.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -62.9 -24.19 67.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.653 -175.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.7 m -84.49 2.37 41.3 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.522 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 p -130.4 -25.65 2.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.245 175.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 124.71 -81.24 0.36 Allowed Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -176.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.5 t 45.69 85.28 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 124.366 1.066 . . . . 0.0 113.547 173.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 40.5 p -93.25 15.81 14.63 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.545 173.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.54 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 42.0 p90 -111.39 148.15 38.19 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.133 175.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -63.16 130.53 29.14 Favored 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 122.436 2.091 . . . . 0.0 113.116 -177.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.402 ' O ' HG23 ' A' ' 21' ' ' THR . 94.8 mt -103.77 146.42 28.64 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.514 174.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -119.4 149.25 18.05 Favored Glycine 0 N--CA 1.438 -1.182 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 175.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.687 ' H ' HD22 ' A' ' 98' ' ' LEU . 2.1 pt? -107.02 142.08 37.21 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.854 0.359 . . . . 0.0 110.294 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -124.12 72.98 56.68 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.006 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.402 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 16.8 Cg_exo -67.71 109.81 1.96 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.718 2.279 . . . . 0.0 111.628 177.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 116.32 -3.62 20.26 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -176.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.441 ' O ' ' HG2' ' A' ' 111' ' ' ARG . . . 51.45 36.37 16.55 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.095 0.558 . . . . 0.0 112.184 -178.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -88.04 -39.55 14.56 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.115 -175.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.571 HD13 ' HB2' ' A' ' 16' ' ' PHE . 17.6 mm -66.9 -34.56 70.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 176.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -65.1 -39.03 92.57 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.728 171.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.637 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -69.0 -16.91 63.84 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.803 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.503 ' HG2' ' HA ' ' A' ' 104' ' ' ILE . 20.7 mmtt -66.35 -25.28 66.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.16 0.505 . . . . 0.0 109.903 177.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.434 ' HH ' ' HE2' ' A' ' 16' ' ' PHE . 86.7 m-85 -112.69 -37.07 5.0 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.825 -174.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.637 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -147.39 168.36 22.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.668 0.27 . . . . 0.0 111.403 -174.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.537 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 9.0 mp -62.23 138.14 58.37 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 174.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 102' ' ' ALA . 97.4 mtt180 -58.25 -26.75 63.28 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 -170.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -113.41 12.42 18.74 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.474 0.654 . . . . 0.0 111.049 -178.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.537 ' HB3' ' HB2' ' A' ' 110' ' ' LEU . . . -83.64 46.98 1.22 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.114 0.483 . . . . 0.0 110.876 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 93.39 -159.23 24.04 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.708 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.511 HG12 ' HB1' ' A' ' 42' ' ' ALA . 5.3 tp -152.89 -54.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 122.773 -0.251 . . . . 0.0 111.248 176.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.503 HG23 HG12 ' A' ' 47' ' ' VAL . 3.0 m -64.57 123.82 20.25 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 122.469 0.308 . . . . 0.0 111.341 -174.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -176.68 152.8 1.03 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.79 0.329 . . . . 0.0 110.834 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.555 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 7.8 m120 -116.65 118.41 32.5 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 177.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 41.2 t -109.79 126.85 66.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.645 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.646 HD22 ' SD ' ' A' ' 149' ' ' MET . 40.7 tp -119.7 127.02 52.48 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.068 0.461 . . . . 0.0 111.327 -178.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.73 HD12 HD22 ' A' ' 38' ' ' LEU . 1.9 mp -113.18 137.38 46.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.175 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.67 179.44 7.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.537 -178.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -62.86 -28.06 69.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.128 -176.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.607 ' HB2' ' NZ ' ' A' ' 126' ' ' LYS . 69.4 mt-10 -79.78 -12.16 59.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.108 0.48 . . . . 0.0 110.559 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.4 ' HA3' HH11 ' A' ' 32' ' ' ARG . . . 99.67 12.06 42.08 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.804 176.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.607 ' NZ ' ' HB2' ' A' ' 124' ' ' GLU . 31.5 mtmm -93.23 143.74 25.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.896 0.379 . . . . 0.0 111.093 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 47.2 mt -78.35 108.06 11.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.1 m -104.7 -20.74 5.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -171.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.57 ' HE3' ' OG1' ' A' ' 131' ' ' THR . 8.3 tmtm? -145.18 126.73 15.08 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.429 -172.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -125.54 107.24 10.42 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.542 178.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.57 ' OG1' ' HE3' ' A' ' 129' ' ' LYS . 97.7 m -95.76 139.46 31.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.799 0.333 . . . . 0.0 110.366 174.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.511 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 89.1 mtt180 -97.05 123.11 40.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.049 -178.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 132' ' ' ARG . 4.4 pp 50.89 21.54 0.98 Allowed 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 172.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.505 ' CD2' ' HE3' ' A' ' 50' ' ' LYS . 23.0 t80 58.95 112.27 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 122.284 1.04 . . . . 0.0 112.221 -176.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -119.19 139.71 51.39 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.85 174.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -53.68 -54.14 42.06 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -175.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -58.31 -47.04 84.98 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.173 0.511 . . . . 0.0 110.806 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -57.3 -45.48 84.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.19 177.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.586 ' O ' HG23 ' A' ' 143' ' ' VAL . 70.0 t80 -61.72 -46.78 88.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.592 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.43 -45.68 80.61 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.084 0.468 . . . . 0.0 110.633 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.9 m -65.62 -39.02 91.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.329 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.76 -41.17 98.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.391 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 139' ' ' PHE . 96.0 t -56.05 -55.72 16.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.654 177.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -60.4 -44.44 95.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.337 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.594 ' O ' ' HG3' ' A' ' 149' ' ' MET . 5.7 tt0 -53.98 -52.13 61.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.009 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.59 ' O ' HD22 ' A' ' 150' ' ' LEU . 22.5 mt -62.36 -44.26 99.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.725 -0.216 . . . . 0.0 110.996 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -57.54 -39.42 76.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.144 0.497 . . . . 0.0 110.324 176.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -68.47 -36.06 78.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.195 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.646 ' SD ' HD22 ' A' ' 120' ' ' LEU . 90.1 mtp -64.74 -31.82 73.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.212 0.529 . . . . 0.0 110.435 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.59 HD22 ' O ' ' A' ' 146' ' ' ILE . 4.0 mm? . . . . . 0 C--N 1.324 -0.53 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.424 177.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 . . . . . 0 CA--C 1.517 -0.299 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.1 pt -92.75 -26.01 4.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.797 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.6 p -94.83 152.84 3.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.445 ' HE ' ' CD ' ' A' ' 11' ' ' GLU . 0.6 OUTLIER -118.03 156.6 28.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.315 0.578 . . . . 0.0 112.453 -171.087 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.4 mt -73.2 132.66 33.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.459 170.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.59 -9.15 77.76 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -175.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.445 ' CD ' ' HE ' ' A' ' 8' ' ' ARG . 36.2 tt0 -99.66 156.98 16.79 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 91.5 mmm -72.69 125.72 28.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.91 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -66.13 126.36 91.8 Favored Pre-proline 0 C--O 1.237 0.427 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.053 178.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.468 ' HG2' ' O ' ' A' ' 107' ' ' LYS . 45.9 Cg_exo -57.29 122.7 12.25 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.127 2.551 . . . . 0.0 112.125 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.481 ' HA ' HD13 ' A' ' 28' ' ' LEU . 1.4 t70 -71.16 134.69 47.14 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.63 -175.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.53 ' HB2' HD13 ' A' ' 104' ' ' ILE . 42.4 p90 -141.33 174.36 10.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.826 0.346 . . . . 0.0 110.793 -178.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 55.3 m -134.87 114.32 12.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.38 174.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 25' ' ' GLN . 14.4 tt -112.25 141.85 26.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.16 -174.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.3 m -88.38 120.34 29.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.68 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.624 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 85.7 mt -79.51 -179.09 6.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.3 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.473 ' HB ' HD13 ' A' ' 84' ' ' LEU . 36.6 p -51.07 -43.96 61.08 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -174.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -100.87 12.34 37.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.845 0.355 . . . . 0.0 111.493 -174.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.16 17.2 41.08 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.984 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.503 ' HE2' ' HA ' ' A' ' 24' ' ' LYS . 7.8 mmpt? -80.22 112.16 17.28 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 175.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.501 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 23.0 mt-30 -100.08 113.53 26.21 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.997 0.427 . . . . 0.0 110.49 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 17' ' ' THR . 14.1 m -105.84 147.05 11.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.723 -177.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.8 m -116.75 142.23 47.18 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.943 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.481 HD13 ' HA ' ' A' ' 15' ' ' ASP . 13.3 mt -60.99 -32.97 72.53 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 -178.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.2 m -56.68 -31.26 64.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.032 0.444 . . . . 0.0 111.062 177.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.8 m -79.32 -20.16 48.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.979 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.4 ' C ' ' HD3' ' A' ' 34' ' ' LYS . 86.5 mt -107.35 11.62 28.9 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.899 -178.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.418 ' HG2' ' O ' ' A' ' 28' ' ' LEU . 37.3 mmt180 -70.9 137.17 49.07 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 171.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.76 -7.65 57.66 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.499 -174.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.559 ' HG3' ' HA ' ' A' ' 68' ' ' ASP . 9.6 mptt -113.15 157.47 21.63 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 175.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.465 HG13 ' O ' ' A' ' 68' ' ' ASP . 2.1 p -84.17 103.91 11.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 170.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.432 ' HA ' ' HB2' ' A' ' 70' ' ' ALA . 22.3 t -95.86 111.62 26.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.202 -171.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 24.8 ttt -96.86 125.97 41.68 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.011 0.434 . . . . 0.0 110.277 175.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.484 HD12 HD11 ' A' ' 121' ' ' ILE . 6.5 mp -108.64 130.51 55.32 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.941 176.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.872 HE21 HD12 ' A' ' 55' ' ' ILE . 6.8 tt0 -117.66 114.5 23.45 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.441 178.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.533 ' O ' ' HA ' ' A' ' 116' ' ' THR . 94.2 m-85 -93.2 106.18 18.17 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.061 0.457 . . . . 0.0 110.152 178.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.433 ' HA ' ' SG ' ' A' ' 48' ' ' CYS . 11.7 t -117.41 175.37 5.65 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.563 -174.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.416 ' HB3' HG12 ' A' ' 115' ' ' ILE . . . -154.3 136.59 14.88 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.641 ' HG ' ' HG3' ' A' ' 78' ' ' GLU . 28.3 p -62.17 -11.07 12.48 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -173.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 2.8 p-90 -117.03 19.8 14.11 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 122.087 -0.383 . . . . 0.0 111.724 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 43.3 t -108.14 114.17 27.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.847 0.356 . . . . 0.0 110.765 178.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.18 -17.48 79.97 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.364 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.417 HG12 ' HB3' ' A' ' 133' ' ' LEU . 58.6 t -64.56 -40.1 87.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 175.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.443 ' HA ' ' HB3' ' A' ' 51' ' ' GLU . 81.1 m -68.82 -16.9 63.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.796 176.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 27.4 ttt85 -78.52 -11.98 59.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.956 0.408 . . . . 0.0 110.174 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -84.54 -50.38 7.76 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 122.128 0.966 . . . . 0.0 108.443 162.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.672 ' HB2' ' HB2' ' A' ' 134' ' ' TYR . 40.0 tt0 -57.25 -59.79 4.59 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 113.631 -1.622 . . . . 0.0 112.094 -171.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.653 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 85.7 mtp -57.37 -53.03 69.73 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -173.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.653 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 45.9 Cg_exo -60.04 -41.8 49.51 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.242 1.961 . . . . 0.0 113.053 177.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -65.16 -44.84 87.25 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.765 0.317 . . . . 0.0 110.802 177.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.872 HD12 HE21 ' A' ' 39' ' ' GLN . 64.0 mt -60.34 -42.95 92.58 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.314 176.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.57 ' OE1' ' HA ' ' A' ' 92' ' ' VAL . 37.5 tp10 -52.62 -58.81 5.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.451 0.643 . . . . 0.0 109.943 174.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -60.68 -59.09 5.94 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.36 -173.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.662 ' HA ' ' HZ3' ' A' ' 62' ' ' LYS . 72.2 m-20 -106.52 -5.26 18.94 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -168.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.597 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 22.8 mm -104.98 -57.95 4.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.061 0.458 . . . . 0.0 110.428 173.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.528 ' CD2' ' HB3' ' A' ' 94' ' ' TYR . 68.9 t-105 -66.11 -73.47 0.13 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.823 -173.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -50.98 -27.36 7.54 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -173.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.662 ' HZ3' ' HA ' ' A' ' 58' ' ' ASP . 47.9 mmtm -67.47 -33.96 76.18 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.44 ' CG ' HD11 ' A' ' 150' ' ' LEU . 67.7 m-70 -131.57 -44.5 0.99 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.236 -0.586 . . . . 0.0 112.044 -176.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.474 ' O ' ' HD2' ' A' ' 69' ' ' PHE . 9.5 mtmp? 42.93 -95.62 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.662 0.785 . . . . 0.0 112.662 -176.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.04 -72.39 0.45 Allowed 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.557 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.421 ' O ' ' HB1' ' A' ' 67' ' ' ALA . 30.5 t30 66.75 -70.55 0.11 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.472 -177.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' A' ' 66' ' ' ASN . . . 164.32 -30.33 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 124.605 1.162 . . . . 0.0 108.36 -178.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.559 ' HA ' ' HG3' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -143.27 40.18 1.46 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.965 -1.016 . . . . 0.0 112.23 -178.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.474 ' HD2' ' O ' ' A' ' 64' ' ' LYS . 80.8 t80 -119.34 138.07 53.29 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 169.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.432 ' HB2' ' HA ' ' A' ' 36' ' ' VAL . . . -134.43 139.75 45.76 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.218 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.9 tt -143.13 115.76 8.65 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -117.0 118.39 58.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.708 0.289 . . . . 0.0 110.256 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.52 ' HA3' HD11 ' A' ' 96' ' ' LEU . . . -88.38 108.67 3.45 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 175.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 59.6 mt -101.66 107.43 21.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 O-C-N 122.588 -0.36 . . . . 0.0 111.323 -173.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.496 ' HB3' HG22 ' A' ' 83' ' ' VAL . 10.7 t0 -85.58 128.47 34.77 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 174.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.4 ttp180 -91.6 126.93 36.86 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.854 -168.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 100' ' ' PRO . 53.4 m-20 71.39 -43.9 0.57 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.999 0.919 . . . . 0.0 113.054 173.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.641 ' HG3' ' HG ' ' A' ' 43' ' ' SER . 78.2 mm-40 -60.63 136.22 92.46 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 121.365 0.603 . . . . 0.0 112.141 -176.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.635 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 35.5 Cg_endo -71.16 -173.15 0.85 Allowed 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 123.301 2.667 . . . . 0.0 114.109 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.438 ' O ' HD23 ' A' ' 84' ' ' LEU . 91.6 mt -53.75 -57.08 12.15 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 114.745 -1.116 . . . . 0.0 113.308 -173.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.635 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -61.06 -29.81 69.96 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -171.66 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.564 ' HG3' ' OE1' ' A' ' 78' ' ' GLU . 40.5 mmtm -64.89 -58.28 6.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.237 0.541 . . . . 0.0 110.182 173.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.496 HG22 ' HB3' ' A' ' 75' ' ' ASP . 38.7 t -56.24 -49.62 75.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.476 -176.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.473 HD13 ' HB ' ' A' ' 21' ' ' THR . 4.4 mm? -63.24 -47.13 83.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.657 -176.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.21 -39.54 78.54 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -176.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.539 ' HE2' ' SD ' ' A' ' 52' ' ' MET . 79.6 t80 -68.81 -44.25 73.91 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 121.131 -0.228 . . . . 0.0 111.181 -176.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.1 -41.96 94.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.311 0.577 . . . . 0.0 109.72 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -59.07 -29.56 67.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.043 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 18.5 t -82.09 -7.21 59.61 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.946 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 43.6 p -123.49 7.78 8.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.763 0.316 . . . . 0.0 111.434 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.73 -53.2 4.28 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.942 -0.647 . . . . 0.0 113.092 176.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.57 ' HA ' ' OE1' ' A' ' 56' ' ' GLU . 77.1 t -2.06 113.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 125.843 1.657 . . . . 0.0 115.392 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 58.9 p -100.45 -17.73 17.03 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.61 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.528 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 29.7 p90 -72.76 145.37 86.86 Favored Pre-proline 0 N--CA 1.462 0.145 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.322 176.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.98 134.25 45.39 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.887 2.391 . . . . 0.0 113.865 -174.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.52 HD11 ' HA3' ' A' ' 73' ' ' GLY . 4.1 mm? -99.5 149.85 22.8 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.453 175.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.624 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -130.87 158.88 22.8 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.589 -0.605 . . . . 0.0 111.589 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.409 ' N ' HD12 ' A' ' 98' ' ' LEU . 6.2 mp -99.52 139.56 35.0 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.647 0.261 . . . . 0.0 110.613 -177.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -125.73 75.33 70.54 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.174 173.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 77' ' ' ASP . 61.4 Cg_endo -73.94 115.67 4.4 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.569 2.179 . . . . 0.0 112.335 -176.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 102.18 -0.66 50.82 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 56.92 36.8 28.25 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 115.189 -0.505 . . . . 0.0 111.468 -177.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -73.63 -48.05 35.41 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.389 -176.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.53 HD13 ' HB2' ' A' ' 16' ' ' PHE . 18.0 mm -67.41 -36.43 76.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.405 ' HD1' ' CD1' ' A' ' 40' ' ' PHE . 79.3 t80 -65.1 -41.14 95.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.085 174.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.621 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -66.16 -20.75 66.24 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.608 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.468 ' O ' ' HG2' ' A' ' 14' ' ' PRO . 53.0 mttp -74.14 -13.34 60.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.807 0.337 . . . . 0.0 111.164 177.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.403 ' HH ' ' HE2' ' A' ' 16' ' ' PHE . 71.4 m-85 -115.73 -40.41 3.36 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.012 0.434 . . . . 0.0 111.145 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.621 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -149.74 168.17 24.4 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.584 -177.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.407 ' HB2' ' HB1' ' A' ' 113' ' ' ALA . 90.9 mt -68.36 130.92 44.32 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.5 mtm180 -53.38 -47.11 69.75 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 122.2 1.0 . . . . 0.0 109.995 -177.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -82.48 10.46 7.19 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.767 -171.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.407 ' HB1' ' HB2' ' A' ' 110' ' ' LEU . . . -98.68 -2.61 37.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.989 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 145.27 -167.15 27.47 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.57 177.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.433 HG22 ' H ' ' A' ' 116' ' ' THR . 2.0 tp -136.19 -67.87 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 40' ' ' PHE . 24.3 m -67.07 109.67 3.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.761 0.315 . . . . 0.0 111.37 -174.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -151.7 141.77 22.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.928 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.58 ' HB2' ' OG1' ' A' ' 131' ' ' THR . 51.8 m-80 -111.18 121.63 45.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.165 0.507 . . . . 0.0 110.276 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 49.9 t -115.99 118.32 58.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.803 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.571 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 43.0 tp -106.84 127.09 53.11 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.577 0.227 . . . . 0.0 111.211 -177.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.484 HD11 HD12 ' A' ' 38' ' ' LEU . 2.5 mp -113.73 137.63 46.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.377 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.481 ' OD2' ' HB2' ' A' ' 126' ' ' LYS . 3.7 p30 -82.34 -179.42 7.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.871 0.367 . . . . 0.0 111.217 177.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.486 ' NH2' ' HA ' ' A' ' 150' ' ' LEU . 7.0 mpt_? -59.22 -32.51 70.02 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.017 -177.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -76.88 -22.59 53.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.151 0.5 . . . . 0.0 110.856 -173.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 111.64 6.8 24.74 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.175 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.6 ' HB2' ' HZ2' ' A' ' 126' ' ' LYS . 9.1 mtmp? -93.95 149.85 20.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.818 0.342 . . . . 0.0 110.914 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.444 HG22 HD22 ' A' ' 130' ' ' LEU . 62.5 mt -84.4 130.5 35.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.273 177.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 18.1 m -121.89 4.04 6.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -177.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.692 ' HE2' ' HB3' ' A' ' 142' ' ' LEU . 53.3 tptt -160.58 128.72 4.57 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.314 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.444 HD22 HG22 ' A' ' 127' ' ' ILE . 90.0 mt -132.0 104.39 6.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.478 174.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.58 ' OG1' ' HB2' ' A' ' 118' ' ' ASN . 22.9 p -107.88 156.45 19.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.017 0.437 . . . . 0.0 111.638 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.923 HH12 ' HG3' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -104.72 118.94 37.82 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.262 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.5 ' HA ' HG23 ' A' ' 116' ' ' THR . 50.0 mt 65.49 -173.47 0.18 Allowed 'General case' 0 C--O 1.236 0.389 0 O-C-N 123.883 0.739 . . . . 0.0 109.831 -175.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.672 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 9.4 t80 -58.91 -44.89 91.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.017 173.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.503 ' HB3' ' HB2' ' A' ' 138' ' ' GLU . 0.2 OUTLIER 55.82 95.34 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.851 0.72 . . . . 0.0 110.684 174.771 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -40.97 -59.34 1.48 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.226 -172.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.472 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 0.7 OUTLIER -68.45 -47.06 68.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.568 -176.56 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.923 ' HG3' HH12 ' A' ' 132' ' ' ARG . 2.5 mm-40 -64.97 -34.54 78.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.092 -175.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.471 ' HE1' HG12 ' A' ' 55' ' ' ILE . 82.2 t80 -63.51 -44.21 94.97 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.812 175.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.461 ' O ' HG11 ' A' ' 143' ' ' VAL . . . -62.07 -42.39 99.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.382 0.61 . . . . 0.0 110.361 177.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.4 m -61.49 -46.0 91.84 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.318 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.692 ' HB3' ' HE2' ' A' ' 129' ' ' LYS . 4.3 pp -80.19 -28.91 38.6 Favored 'General case' 0 C--O 1.217 -0.65 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.262 -176.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.461 HG11 ' O ' ' A' ' 140' ' ' ALA . 12.6 p -60.57 -42.09 90.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.356 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -66.41 -45.59 79.42 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.416 174.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.606 ' O ' ' HG3' ' A' ' 149' ' ' MET . 44.3 tt0 -55.78 -53.4 57.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.731 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.653 HG13 ' O ' ' A' ' 142' ' ' LEU . 38.0 mt -57.41 -47.01 85.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.929 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -48.92 -58.81 4.26 Favored 'General case' 0 CA--C 1.517 -0.327 0 O-C-N 123.134 0.271 . . . . 0.0 110.883 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -68.18 -26.15 65.6 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 123.43 0.456 . . . . 0.0 111.233 -175.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.606 ' HG3' ' O ' ' A' ' 145' ' ' GLN . 51.1 mtp -57.86 -48.88 78.51 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.022 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.608 HD21 ' O ' ' A' ' 146' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.321 -0.642 0 C-N-CA 119.253 -0.979 . . . . 0.0 112.097 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 . . . . . 0 C--O 1.236 0.358 0 CA-C-O 120.814 0.34 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.2 pt -89.38 -11.2 10.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.2 0.524 . . . . 0.0 109.749 175.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.418 HG23 HG13 ' A' ' 127' ' ' ILE . 4.8 p -94.2 162.97 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.297 177.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.561 ' HB2' ' HB2' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -128.65 151.17 49.81 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.32 -169.564 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.489 HG12 HD21 ' A' ' 130' ' ' LEU . 57.6 mt -75.24 132.91 32.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.165 177.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.69 5.01 90.23 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.615 -177.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.561 ' HB2' ' HB2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -115.02 161.48 18.28 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -176.211 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 85.3 mmm -68.15 133.47 48.96 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.093 0.473 . . . . 0.0 111.916 -173.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.73 134.58 50.27 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.585 173.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.544 ' HG2' ' O ' ' A' ' 107' ' ' LYS . 33.2 Cg_exo -62.2 121.09 8.96 Favored 'Trans proline' 0 N--CA 1.464 -0.225 0 C-N-CA 122.822 2.348 . . . . 0.0 111.759 175.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.45 ' CG ' ' HG ' ' A' ' 29' ' ' SER . 1.3 t70 -73.74 134.58 43.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.505 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.554 ' HB2' HD12 ' A' ' 104' ' ' ILE . 51.3 p90 -136.88 165.78 25.15 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.057 -173.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 58.5 m -119.74 115.48 23.98 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.439 172.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.7 tt -111.99 150.68 14.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.86 -174.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.2 m -98.77 125.11 44.03 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.263 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.51 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 85.8 mt -84.65 -177.81 6.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.791 -176.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.475 ' HB ' HD12 ' A' ' 84' ' ' LEU . 28.3 p -56.07 -40.51 73.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.837 -175.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -98.75 12.07 36.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.915 0.388 . . . . 0.0 111.042 -177.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.8 3.03 60.98 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.388 -0.91 . . . . 0.0 113.617 176.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.45 ' HB2' HD11 ' A' ' 20' ' ' LEU . 60.7 mttp -64.83 124.89 23.17 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 117.357 0.578 . . . . 0.0 111.012 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -104.83 113.79 27.6 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 17' ' ' THR . 16.4 m -122.5 148.78 26.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.858 -176.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.448 HG21 ' OD1' ' A' ' 15' ' ' ASP . 4.9 m -106.65 148.08 28.77 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.438 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.491 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 0.6 OUTLIER -61.03 -32.94 72.53 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -177.515 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.505 ' HA ' ' CG ' ' A' ' 32' ' ' ARG . 60.9 m -54.56 -25.26 24.99 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.144 177.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.6 t -77.35 -11.07 59.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.942 0.401 . . . . 0.0 110.766 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.467 HD11 ' HB3' ' A' ' 70' ' ' ALA . 76.5 mt -119.56 0.44 11.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.381 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.505 ' CG ' ' HA ' ' A' ' 29' ' ' SER . 52.1 mmm-85 -68.24 131.57 45.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.877 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.7 -27.27 7.63 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -172.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.69 ' HB2' ' C ' ' A' ' 68' ' ' ASP . 12.9 ptpt -116.09 165.63 12.92 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 174.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 68' ' ' ASP . 4.0 p -80.7 123.41 37.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.197 0.522 . . . . 0.0 110.574 -177.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.402 HG22 ' HB2' ' A' ' 70' ' ' ALA . 23.5 t -110.95 123.87 67.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.372 -176.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.553 ' SD ' HG21 ' A' ' 59' ' ' ILE . 26.1 ttt -103.03 131.51 49.96 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.233 176.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.555 HD13 HD12 ' A' ' 121' ' ' ILE . 5.5 mp -126.03 148.3 49.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.477 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.5 148.54 42.81 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 169.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -112.81 113.15 25.11 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.054 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.4 t -129.41 -168.77 1.99 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.406 -174.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.684 ' HB3' ' HG ' ' A' ' 45' ' ' CYS . . . -163.87 165.52 22.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.548 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.514 ' HB2' ' HB3' ' A' ' 82' ' ' LYS . 7.6 t -73.45 -25.04 60.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.177 0.513 . . . . 0.0 111.132 -172.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 68.2 p-90 -88.81 0.3 56.65 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 122.233 -0.292 . . . . 0.0 111.684 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.684 ' HG ' ' HB3' ' A' ' 42' ' ' ALA . 73.7 m -78.99 99.63 6.94 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.183 0.516 . . . . 0.0 111.218 -178.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.49 -37.49 89.97 Favored Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.89 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.488 HG11 ' HG ' ' A' ' 133' ' ' LEU . 38.1 t -63.19 -32.48 56.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.057 0.456 . . . . 0.0 110.617 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.633 ' SG ' HG23 ' A' ' 116' ' ' THR . 84.8 m -70.37 -15.51 62.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.277 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.726 ' HE ' ' HE1' ' A' ' 86' ' ' PHE . 98.9 mtt180 -77.81 -6.75 55.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.246 0.546 . . . . 0.0 110.084 176.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.469 ' HE2' ' CE2' ' A' ' 134' ' ' TYR . 54.6 mtpt -100.64 -43.29 6.21 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 164.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.559 ' HB3' ' HA ' ' A' ' 48' ' ' CYS . 23.0 tt0 -52.43 -64.12 0.92 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.328 -1.305 . . . . 0.0 112.218 -177.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.546 ' HE2' ' CE2' ' A' ' 86' ' ' PHE . 39.7 mtm -65.25 -46.27 71.63 Favored Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -171.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.434 ' HG2' ' O ' ' A' ' 49' ' ' ARG . 72.4 Cg_exo -53.9 -38.37 85.95 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.709 1.606 . . . . 0.0 111.885 174.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 139' ' ' PHE . 4.9 m-85 -69.11 -42.79 75.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.781 176.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 51' ' ' GLU . 76.4 mt -57.12 -48.52 81.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.173 175.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.621 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 13.9 tp10 -55.78 -48.84 74.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.097 175.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -55.08 -57.08 13.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.775 -176.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.652 ' HA ' ' HZ3' ' A' ' 62' ' ' LYS . 44.8 m-20 -106.42 -43.14 4.84 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -170.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.553 HG21 ' SD ' ' A' ' 37' ' ' MET . 1.9 mp -75.62 -56.72 7.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.982 0.42 . . . . 0.0 110.801 -176.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.781 ' CE2' ' HG2' ' A' ' 64' ' ' LYS . 22.4 t-105 -72.02 -58.82 3.11 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.338 -173.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.621 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.8 OUTLIER -44.68 -43.66 8.52 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.674 0.79 . . . . 0.0 113.027 -173.621 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.652 ' HZ3' ' HA ' ' A' ' 58' ' ' ASP . 30.0 mmtm -84.2 -23.93 30.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.206 0.526 . . . . 0.0 111.484 -174.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 68.3 m-70 -125.53 24.76 7.17 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -166.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.781 ' HG2' ' CE2' ' A' ' 60' ' ' TRP . 28.7 mttt -53.81 93.93 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 123.079 1.418 . . . . 0.0 112.528 -177.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.636 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 13.4 t70 64.4 -42.96 0.29 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 110.538 -3.028 . . . . 0.0 110.508 -168.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.535 ' H ' ' C ' ' A' ' 64' ' ' LYS . 13.0 t30 66.31 -57.08 0.38 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.094 0.958 . . . . 0.0 111.001 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 167.18 -31.35 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 125.271 1.428 . . . . 0.0 107.355 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.69 ' C ' ' HB2' ' A' ' 34' ' ' LYS . 21.7 p-10 -147.91 32.92 0.84 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.185 -1.37 . . . . 0.0 111.292 -173.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.636 ' O ' ' HA ' ' A' ' 65' ' ' ASP . 88.1 t80 -127.29 133.26 50.17 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.977 0.418 . . . . 0.0 110.014 172.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.551 ' HB1' ' HD2' ' A' ' 34' ' ' LYS . . . -124.76 142.13 51.63 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.342 175.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.5 tt -135.46 117.74 15.6 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 68.1 mt -123.87 119.42 56.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.382 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.43 ' HA3' HD22 ' A' ' 96' ' ' LEU . . . -89.69 131.35 10.68 Favored Glycine 0 C--O 1.222 -0.598 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 174.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.424 HD11 HD23 ' A' ' 38' ' ' LEU . 48.5 mt -119.78 141.64 38.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 117.548 0.674 . . . . 0.0 111.017 -173.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.52 ' OD2' ' HA ' ' A' ' 42' ' ' ALA . 10.2 t0 -114.42 120.5 40.52 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 176.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.636 ' HG2' HD12 ' A' ' 115' ' ' ILE . 4.4 ptm180 -73.84 -2.84 25.38 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -165.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 100' ' ' PRO . 0.4 OUTLIER -169.44 -32.26 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 118.448 -1.301 . . . . 0.0 113.713 -175.135 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.426 ' HB3' ' HG3' ' A' ' 82' ' ' LYS . 35.8 mt-10 -78.7 142.0 60.76 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 121.324 0.583 . . . . 0.0 111.658 -173.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.606 ' HG2' ' OE2' ' A' ' 81' ' ' GLU . 38.5 Cg_endo -71.2 -173.81 1.02 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.185 2.59 . . . . 0.0 114.437 -174.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 89.1 mt -51.43 -57.43 9.0 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.756 -174.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.609 ' OE2' ' HG2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -61.11 -28.57 69.19 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -172.326 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.609 ' HG2' ' OE2' ' A' ' 81' ' ' GLU . 44.0 mmtm -67.38 -52.75 36.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.794 0.33 . . . . 0.0 110.445 173.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 62.0 t -59.55 -51.1 76.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.241 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.475 HD12 ' HB ' ' A' ' 21' ' ' THR . 4.3 mm? -65.27 -36.5 84.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.488 -176.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.5 -32.19 60.44 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 121.061 -0.256 . . . . 0.0 111.232 -179.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.726 ' HE1' ' HE ' ' A' ' 49' ' ' ARG . 79.5 t80 -74.83 -41.27 60.22 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.492 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.53 -53.27 59.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.7 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.7 pttm -55.92 -31.75 63.16 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.762 -174.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 68.5 m -87.13 2.19 50.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.386 -175.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 33.3 p -130.57 10.1 5.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.344 0.592 . . . . 0.0 110.342 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.5 -73.11 1.68 Allowed Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.507 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.4 t 29.85 90.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.808 1.243 . . . . 0.0 114.092 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 76.0 p -98.93 17.97 18.31 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.133 0.492 . . . . 0.0 110.726 175.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.598 ' HB3' ' CE2' ' A' ' 60' ' ' TRP . 31.1 p90 -114.52 147.66 38.56 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.885 175.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.4 135.89 60.38 Favored 'Trans proline' 0 C--O 1.239 0.537 0 C-N-CA 122.44 2.093 . . . . 0.0 113.453 -176.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.43 HD22 ' HA3' ' A' ' 73' ' ' GLY . 72.7 mt -111.6 144.99 39.96 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.491 175.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.51 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -122.52 150.55 16.91 Favored Glycine 0 N--CA 1.441 -1.025 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 176.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.592 HD21 ' H ' ' A' ' 98' ' ' LEU . 1.7 pt? -117.11 132.11 56.74 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -177.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.458 ' OD1' ' HA ' ' A' ' 76' ' ' ARG . 5.0 p-10 -125.12 83.38 60.65 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-O 121.945 0.879 . . . . 0.0 110.635 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 77' ' ' ASP . 18.5 Cg_endo -57.03 130.31 39.05 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.882 2.388 . . . . 0.0 112.545 -176.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.56 11.13 69.19 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.646 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.436 ' HB3' ' CZ ' ' A' ' 76' ' ' ARG . . . 53.03 51.73 15.2 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 122.891 0.476 . . . . 0.0 111.998 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.455 ' HB2' HH22 ' A' ' 111' ' ' ARG . 28.6 t70 -82.29 -53.86 5.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.953 0.406 . . . . 0.0 111.076 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.554 HD12 ' HB2' ' A' ' 16' ' ' PHE . 17.1 mm -68.36 -30.62 48.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.417 ' HB3' ' HB2' ' A' ' 102' ' ' ALA . 74.7 t80 -60.65 -37.92 83.14 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.627 170.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.843 ' HB1' ' HG2' ' A' ' 111' ' ' ARG . . . -72.68 -15.09 61.7 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.034 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.544 ' O ' ' HG2' ' A' ' 14' ' ' PRO . 14.1 mptt -69.3 -15.97 63.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.908 0.385 . . . . 0.0 110.798 173.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -126.0 -32.94 2.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.026 0.441 . . . . 0.0 111.524 -177.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.628 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -133.68 -172.78 3.06 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.276 -178.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.8 mt -85.06 153.18 22.88 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.843 ' HG2' ' HB1' ' A' ' 106' ' ' ALA . 20.2 mtp180 -71.48 -14.11 62.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.403 0.62 . . . . 0.0 110.344 -176.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -101.09 -1.89 32.92 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.907 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.28 155.38 40.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.227 0.536 . . . . 0.0 111.916 -174.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.8 155.22 42.05 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.131 -0.941 . . . . 0.0 113.662 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.636 HD12 ' HG2' ' A' ' 76' ' ' ARG . 3.3 tp -84.15 -175.25 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 123.211 0.604 . . . . 0.0 110.366 -176.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.633 HG23 ' SG ' ' A' ' 48' ' ' CYS . 77.0 p 61.52 79.5 0.25 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.461 1.104 . . . . 0.0 111.524 177.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 117' ' ' ARG . 9.0 mtp180 -140.59 132.49 27.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.09 -177.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.626 ' HB3' ' HB ' ' A' ' 131' ' ' THR . 0.2 OUTLIER -107.73 126.18 52.3 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.559 ' N ' HD21 ' A' ' 118' ' ' ASN . 16.7 t -122.88 138.4 53.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.157 -178.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.543 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 46.3 tp -126.49 122.82 36.28 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.911 -0.315 . . . . 0.0 110.5 177.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.555 HD12 HD13 ' A' ' 38' ' ' LEU . 1.9 mp -106.34 134.59 47.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.152 177.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.68 174.79 10.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.963 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -72.23 -15.59 61.93 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -172.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.509 ' CD ' ' HZ1' ' A' ' 126' ' ' LYS . 47.1 mt-10 -80.33 -28.3 38.16 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.25 0.547 . . . . 0.0 109.863 175.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 116.85 10.36 10.12 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.316 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.509 ' HZ1' ' CD ' ' A' ' 124' ' ' GLU . 42.5 mtmt -100.44 153.17 19.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.097 0.475 . . . . 0.0 111.744 -178.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.418 HG13 HG23 ' A' ' 7' ' ' VAL . 4.4 mm -76.53 133.24 31.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.294 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 28.0 m -126.07 3.07 4.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.543 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 53.1 tptt -166.57 127.35 1.67 Allowed 'General case' 0 C--O 1.232 0.16 0 C-N-CA 120.481 -0.488 . . . . 0.0 112.027 -177.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.489 HD21 HG12 ' A' ' 9' ' ' ILE . 3.1 mm? -126.99 115.51 19.35 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.471 172.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.626 ' HB ' ' HB3' ' A' ' 118' ' ' ASN . 95.2 m -123.85 134.99 53.48 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.538 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.403 ' NH1' HD11 ' A' ' 133' ' ' LEU . 0.4 OUTLIER -106.5 122.37 46.16 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.488 ' HG ' HG11 ' A' ' 47' ' ' VAL . 10.6 tp 71.78 156.22 0.16 Allowed 'General case' 0 C--O 1.232 0.155 0 O-C-N 124.191 0.932 . . . . 0.0 110.388 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.501 ' CE2' ' HG2' ' A' ' 136' ' ' GLU . 51.1 t80 -72.52 89.04 1.26 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.362 0.601 . . . . 0.0 109.935 174.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.542 ' HB3' ' HB3' ' A' ' 138' ' ' GLU . 41.4 t30 -85.52 116.42 23.81 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 171.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.501 ' HG2' ' CE2' ' A' ' 134' ' ' TYR . 33.8 mt-10 -58.3 -52.75 64.26 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.28 -168.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -59.75 -39.59 85.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.204 0.526 . . . . 0.0 111.317 176.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.542 ' HB3' ' HB3' ' A' ' 135' ' ' ASN . 5.3 tp10 -61.99 -46.69 88.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.117 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.6 ' O ' HG22 ' A' ' 143' ' ' VAL . 82.1 t80 -59.72 -42.44 93.09 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.699 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.26 -46.44 85.99 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.121 0.486 . . . . 0.0 110.553 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.2 m -62.13 -38.81 90.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.505 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.02 -37.88 89.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.492 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 139' ' ' PHE . 97.2 t -55.39 -57.11 8.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.314 175.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -61.48 -38.23 86.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.797 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -57.43 -48.66 78.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.98 177.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.569 ' O ' HD22 ' A' ' 150' ' ' LEU . 59.6 mt -67.87 -38.95 80.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.955 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -55.42 -39.94 70.85 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.826 -0.17 . . . . 0.0 111.302 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -73.39 -35.42 65.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.762 178.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 82.1 mmm -62.83 -25.79 68.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.351 0.596 . . . . 0.0 110.119 178.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.569 HD22 ' O ' ' A' ' 146' ' ' ILE . 4.0 mm? . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.229 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 . . . . . 0 N--CA 1.456 -0.164 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.7 pt -94.9 -27.57 4.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.946 0.403 . . . . 0.0 110.431 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.56 HG11 HD12 ' A' ' 127' ' ' ILE . 15.0 t -94.3 155.07 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 174.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.3 mtt180 -125.47 165.41 18.49 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.838 -0.165 . . . . 0.0 110.594 -169.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.644 HG12 HD13 ' A' ' 130' ' ' LEU . 77.0 mt -67.81 118.43 11.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.854 0.359 . . . . 0.0 110.196 175.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.98 -7.58 62.75 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.893 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -86.37 153.24 22.07 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 -177.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.648 ' SD ' ' HG2' ' A' ' 126' ' ' LYS . 91.2 mmm -67.49 130.07 41.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.675 -178.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.3 129.93 70.59 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.664 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.402 ' HD2' ' CE1' ' A' ' 108' ' ' TYR . 31.4 Cg_exo -59.16 143.45 99.76 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.703 2.269 . . . . 0.0 111.329 174.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.96 162.55 14.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.243 -177.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.601 ' O ' ' HA ' ' A' ' 27' ' ' THR . 55.3 p90 -169.73 164.28 9.99 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.389 -173.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.9 m -123.0 100.7 7.02 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 176.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.2 tt -103.26 146.65 10.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.821 0.343 . . . . 0.0 111.159 -174.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.9 m -94.27 118.38 31.5 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.586 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.428 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 93.7 mt -81.52 169.7 16.79 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.696 -177.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 31.4 p -57.34 -26.58 61.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.219 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -83.31 -7.79 59.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.203 0.525 . . . . 0.0 110.432 -178.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.52 15.4 56.98 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.23 -175.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -90.67 116.69 28.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.384 -0.408 . . . . 0.0 110.47 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -89.62 113.11 24.52 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 174.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.81 128.59 71.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.572 0.701 . . . . 0.0 111.582 -174.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 17.9 m -94.2 137.97 32.76 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.518 175.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.549 HD22 ' HD3' ' A' ' 32' ' ' ARG . 0.6 OUTLIER -60.59 -33.27 72.48 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -177.075 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.443 ' HA ' ' CG ' ' A' ' 32' ' ' ARG . 37.6 t -56.88 -23.08 41.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.824 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.9 t -81.78 -8.81 59.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.972 0.415 . . . . 0.0 110.548 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 67.4 mt -119.57 -1.16 10.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.539 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.549 ' HD3' HD22 ' A' ' 28' ' ' LEU . 8.7 mmm-85 -66.79 103.09 1.04 Allowed 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.515 ' O ' ' HG3' ' A' ' 123' ' ' ARG . . . 139.42 -20.59 2.96 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 -172.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.525 ' HD2' ' HA ' ' A' ' 68' ' ' ASP . 37.1 mtmt -114.48 168.2 10.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.415 -0.393 . . . . 0.0 109.945 175.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 68' ' ' ASP . 34.2 m -80.1 122.52 35.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 174.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.5 t -122.93 113.93 40.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.108 0.48 . . . . 0.0 111.081 -174.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.53 ' SD ' HG23 ' A' ' 59' ' ' ILE . 26.9 ttt -97.19 126.55 42.45 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.447 177.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.511 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 7.3 mp -118.92 152.89 35.5 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.03 176.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.4 HE21 ' HA3' ' A' ' 73' ' ' GLY . 5.1 pp0? -139.29 145.93 39.73 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 169.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 89.3 m-85 -110.35 123.29 49.58 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 177.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.8 t -134.72 173.49 11.63 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.123 -174.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.496 ' HB2' ' SG ' ' A' ' 45' ' ' CYS . . . -149.93 160.02 43.92 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.476 -0.784 . . . . 0.0 108.933 175.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.573 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 28.8 t -70.74 -20.87 62.6 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -171.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 58.8 p-90 -97.11 3.12 51.83 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.855 0.316 . . . . 0.0 111.855 -177.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.496 ' SG ' ' HB2' ' A' ' 42' ' ' ALA . 84.0 m -87.86 108.18 19.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.155 0.502 . . . . 0.0 111.293 -178.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -79.01 -17.85 76.1 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.39 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.586 HG12 ' HB2' ' A' ' 133' ' ' LEU . 40.6 t -74.83 -45.97 42.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 177.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.433 ' SG ' HG22 ' A' ' 116' ' ' THR . 73.7 m -54.75 -32.59 60.08 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.819 177.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.495 ' HE ' ' HE1' ' A' ' 86' ' ' PHE . 98.0 mtt180 -65.5 -2.66 3.52 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.264 -0.426 . . . . 0.0 112.029 -178.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -96.81 -55.85 2.76 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.783 0.801 . . . . 0.0 109.734 173.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.662 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 5.1 pt-20 -71.45 -32.47 68.36 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.93 -175.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.462 ' HE1' HG22 ' A' ' 92' ' ' VAL . 63.9 mmm -52.09 -57.32 15.55 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 117.817 0.281 . . . . 0.0 111.605 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -64.27 -37.18 42.01 Favored 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 121.75 1.633 . . . . 0.0 112.447 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -62.31 -44.15 97.18 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.536 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.551 ' O ' ' HB ' ' A' ' 59' ' ' ILE . 94.0 mt -57.95 -53.53 44.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.675 178.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.549 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 14.9 pt-20 -64.95 -38.11 89.87 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.874 -176.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -63.06 -54.39 38.82 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -174.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.435 ' HA ' ' HZ1' ' A' ' 62' ' ' LYS . 27.8 m-20 -107.22 -18.12 13.97 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -172.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.551 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 2.2 mp -95.21 -55.3 6.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.971 176.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.549 ' HB3' ' HA ' ' A' ' 56' ' ' GLU . 75.0 t-105 -65.48 -70.69 0.22 Allowed 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.418 -177.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -54.05 -23.29 13.11 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -173.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.435 ' HZ1' ' HA ' ' A' ' 58' ' ' ASP . 36.7 mmtm -91.6 -37.4 13.1 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -177.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -118.9 -10.96 9.79 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -169.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.499 ' HG3' ' OD1' ' A' ' 65' ' ' ASP . 19.2 pttp -36.21 -54.13 0.81 Allowed 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -168.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.499 ' OD1' ' HG3' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -87.45 -77.99 0.32 Allowed 'General case' 0 C--O 1.254 1.311 0 CA-C-O 121.299 0.571 . . . . 0.0 109.583 -178.432 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 63.36 -74.83 0.04 OUTLIER 'General case' 0 C--N 1.34 0.153 0 CA-C-N 114.471 -1.24 . . . . 0.0 110.374 -174.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 159.26 -40.43 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -177.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.525 ' HA ' ' HD2' ' A' ' 34' ' ' LYS . 30.9 t70 -114.66 11.1 16.84 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 113.904 -1.498 . . . . 0.0 111.258 -175.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -106.36 142.9 35.26 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.128 -177.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.69 143.56 33.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.377 173.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.525 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 2.8 tt -142.53 118.67 10.73 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 3.0 mp -131.1 126.99 60.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.324 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.4 ' HA3' HE21 ' A' ' 39' ' ' GLN . . . -97.85 140.74 15.21 Favored Glycine 0 C--O 1.224 -0.529 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.353 176.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 62.0 mt -120.28 123.62 70.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 117.304 0.552 . . . . 0.0 111.396 -177.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.401 ' HB3' ' HB2' ' A' ' 78' ' ' GLU . 2.5 m-20 -88.1 122.02 31.19 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 172.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 59.7 ttp180 -50.61 -46.41 58.07 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -167.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.466 ' HA ' ' O ' ' A' ' 99' ' ' ASP . 7.8 p-10 -152.64 13.1 0.54 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.04 0.448 . . . . 0.0 111.134 -174.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.401 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 33.1 mm-40 -80.68 130.05 65.88 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.478 -177.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.456 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 36.7 Cg_endo -71.73 179.81 4.42 Favored 'Trans proline' 0 CA--C 1.531 0.341 0 C-N-CA 122.408 2.072 . . . . 0.0 112.687 174.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -50.69 -57.98 6.99 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.096 -171.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.462 ' OE1' ' HG2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -67.42 -30.79 70.64 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -172.427 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.462 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 41.7 mmtm -63.86 -52.66 58.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.753 0.311 . . . . 0.0 110.397 175.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 79' ' ' PRO . 88.0 t -54.21 -52.75 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.244 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.37 -38.83 92.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.35 -177.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.29 -42.13 79.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.673 0.273 . . . . 0.0 111.081 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.573 ' CD1' ' HA ' ' A' ' 43' ' ' SER . 86.8 t80 -64.83 -43.9 91.56 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 178.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.54 -54.31 48.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.189 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -65.65 -20.71 66.4 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -174.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.5 m -78.74 -24.3 44.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.741 0.305 . . . . 0.0 111.288 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.5 p -104.8 -22.11 13.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.083 0.468 . . . . 0.0 110.98 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 121.1 -79.32 0.33 Allowed Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -177.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.462 HG22 ' HE1' ' A' ' 52' ' ' MET . 54.1 t 46.45 86.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 124.463 1.105 . . . . 0.0 113.265 177.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.8 m -82.09 2.5 30.97 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.039 177.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.489 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 46.7 p90 -113.32 152.7 45.41 Favored Pre-proline 0 C--N 1.331 -0.235 0 O-C-N 122.203 -0.311 . . . . 0.0 110.759 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.13 133.81 29.82 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.484 2.123 . . . . 0.0 113.437 -176.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 94.1 mt -104.48 161.62 13.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.081 172.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -130.12 148.3 18.48 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.168 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.4 ' C ' ' HD3' ' A' ' 100' ' ' PRO . 5.4 mp -86.74 133.55 33.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.544 0.211 . . . . 0.0 110.54 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.466 ' O ' ' HA ' ' A' ' 77' ' ' ASP . 40.2 t0 -121.05 73.86 26.67 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-O 121.317 0.579 . . . . 0.0 109.86 169.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.4 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 22.1 Cg_exo -64.1 103.53 0.43 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.079 1.853 . . . . 0.0 112.237 -177.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 112.0 -0.18 27.05 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.483 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.428 ' HB3' ' HG2' ' A' ' 111' ' ' ARG . . . 59.02 40.64 22.01 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.092 0.472 . . . . 0.0 111.155 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -78.82 -48.76 14.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.557 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.445 HD13 ' HB2' ' A' ' 16' ' ' PHE . 34.4 mm -66.75 -37.39 79.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -59.51 -44.68 93.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.874 175.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -67.58 -21.23 65.44 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.813 -178.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -72.96 -17.69 61.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.798 0.332 . . . . 0.0 110.921 177.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.502 ' HB2' HH22 ' A' ' 117' ' ' ARG . 79.3 m-85 -111.88 -34.26 6.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.863 -178.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.566 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -161.13 172.93 15.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.768 0.318 . . . . 0.0 110.731 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.687 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 91.4 mt -71.97 131.38 42.86 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.091 178.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.428 ' HG2' ' HB3' ' A' ' 102' ' ' ALA . 11.4 mtm180 -65.4 -31.3 72.33 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.268 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -84.38 -7.36 59.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.748 -178.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.687 ' HB3' ' HB2' ' A' ' 110' ' ' LEU . . . -75.4 -56.77 4.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.718 -178.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -163.07 -149.12 5.6 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.96 -177.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.8 tp -161.35 -59.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.373 0.087 . . . . 0.0 111.125 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.66 HG21 ' HA ' ' A' ' 133' ' ' LEU . 24.0 m -67.61 109.08 3.12 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.861 0.362 . . . . 0.0 111.414 -176.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.502 HH22 ' HB2' ' A' ' 108' ' ' TYR . 19.3 ptt180 -165.97 146.44 6.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.166 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.603 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 45.9 m-80 -108.95 136.53 48.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.725 175.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 80.6 t -120.35 102.76 13.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.101 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.582 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 48.8 tp -88.75 108.14 19.33 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.707 -0.397 . . . . 0.0 109.996 178.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 56.6 mt -93.74 121.98 44.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.771 0.796 . . . . 0.0 110.523 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.69 162.66 29.2 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.485 -1.234 . . . . 0.0 111.341 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.515 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 33.8 ttm180 -52.0 -34.21 41.73 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.483 0.713 . . . . 0.0 112.742 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.505 ' O ' ' HE1' ' A' ' 12' ' ' MET . 11.8 tt0 -83.57 -7.59 59.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.33 0.586 . . . . 0.0 109.969 -175.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 96.54 31.36 7.15 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.468 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.648 ' HG2' ' SD ' ' A' ' 12' ' ' MET . 44.2 mttm -113.04 146.49 39.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.798 0.299 . . . . 0.0 110.314 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.56 HD12 HG11 ' A' ' 7' ' ' VAL . 55.7 mt -88.94 100.98 11.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.093 177.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 29.0 m -94.17 -4.54 10.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -174.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.582 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 51.8 tptt -143.95 108.76 4.92 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.687 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.644 HD13 HG12 ' A' ' 9' ' ' ILE . 10.9 mp -98.28 104.7 16.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.962 170.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.603 ' HB ' ' HB2' ' A' ' 118' ' ' ASN . 86.0 m -103.23 125.33 49.84 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.724 -0.217 . . . . 0.0 110.703 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.548 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -96.85 108.19 20.82 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 176.788 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.66 ' HA ' HG21 ' A' ' 116' ' ' THR . 4.6 pp 51.4 -177.65 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 O-C-N 124.503 1.127 . . . . 0.0 113.259 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.662 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 75.6 t80 -87.57 117.68 26.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.912 -177.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -135.89 137.69 41.67 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.949 172.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -47.79 -62.56 1.4 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -177.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -56.99 -46.75 82.01 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.316 0.579 . . . . 0.0 110.849 -178.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.44 ' HG3' HG21 ' A' ' 131' ' ' THR . 7.0 tp10 -61.72 -48.59 80.06 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.187 -177.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.464 ' O ' HG22 ' A' ' 143' ' ' VAL . 69.2 t80 -67.38 -39.16 85.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.048 -178.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.79 -43.52 97.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.662 175.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 45.8 m -63.04 -38.1 89.82 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.547 177.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.54 ' O ' HG13 ' A' ' 146' ' ' ILE . 67.7 tp -59.75 -51.61 69.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.154 177.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.475 HG21 HD12 ' A' ' 59' ' ' ILE . 61.3 t -60.19 -45.81 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.222 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -57.72 -45.05 86.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.722 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.549 ' O ' ' HG2' ' A' ' 149' ' ' MET . 9.9 tt0 -67.01 -37.34 83.98 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.391 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.54 HG13 ' O ' ' A' ' 142' ' ' LEU . 34.7 mt -59.61 -38.16 74.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.895 0.378 . . . . 0.0 109.999 175.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -59.63 -41.03 89.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.803 177.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -66.05 -36.98 84.7 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.328 0.392 . . . . 0.0 110.856 174.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.549 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 94.7 mmm -62.93 -32.1 73.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.525 0.679 . . . . 0.0 109.429 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.519 HD21 ' O ' ' A' ' 146' ' ' ILE . 3.9 mm? . . . . . 0 C--N 1.321 -0.671 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.746 176.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.521 ' CZ ' ' HD2' ' A' ' 117' ' ' ARG . 69.0 m-85 . . . . . 0 CA--C 1.52 -0.204 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.2 pt -110.23 -7.79 11.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.168 0.509 . . . . 0.0 110.144 171.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.5 m -101.47 168.8 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.733 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.577 ' HB2' ' HB2' ' A' ' 11' ' ' GLU . 38.4 mtt180 -114.83 163.25 15.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.197 -177.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.757 HG12 HD13 ' A' ' 130' ' ' LEU . 73.3 mt -79.5 121.23 32.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 174.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.48 1.34 62.31 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -175.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.577 ' HB2' ' HB2' ' A' ' 8' ' ' ARG . 10.4 tp10 -83.42 155.83 23.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.36 -0.42 . . . . 0.0 110.551 -176.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.547 ' HA ' ' HE1' ' A' ' 12' ' ' MET . 4.9 mmt -65.76 127.74 33.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.452 177.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.412 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -67.48 129.94 93.45 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.663 178.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.448 ' HD2' ' CZ ' ' A' ' 108' ' ' TYR . 15.3 Cg_exo -65.98 113.54 2.63 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.668 2.245 . . . . 0.0 111.2 178.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.68 147.19 50.92 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.604 -175.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.466 ' HE2' ' HH ' ' A' ' 108' ' ' TYR . 44.7 p90 -155.7 164.33 38.73 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.376 -176.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.8 m -116.68 102.8 9.76 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 174.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 25' ' ' GLN . 13.1 tt -97.87 138.72 21.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.937 0.399 . . . . 0.0 111.023 -174.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.2 m -94.15 118.91 32.23 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.071 177.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.459 HD13 ' HB2' ' A' ' 24' ' ' LYS . 94.3 mt -74.54 175.99 7.28 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.944 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.457 HG21 ' O ' ' A' ' 96' ' ' LEU . 31.8 p -57.88 -32.2 67.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.623 -175.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -102.13 16.97 24.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.956 0.408 . . . . 0.0 111.123 -176.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.43 7.36 69.55 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.404 173.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.459 ' HB2' HD13 ' A' ' 20' ' ' LEU . 27.3 mmtp -78.76 110.01 13.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.882 0.373 . . . . 0.0 110.72 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.481 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 94.1 mt-30 -92.0 114.48 27.03 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.481 178.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.5 m -118.03 151.5 20.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.477 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.415 ' HB ' ' OG ' ' A' ' 29' ' ' SER . 1.2 p -101.91 154.2 19.16 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.879 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.8 -34.77 77.43 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 174.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.484 ' HA ' ' HG2' ' A' ' 32' ' ' ARG . 0.5 OUTLIER -59.69 -23.7 63.34 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.676 175.516 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.8 t -78.73 -12.36 60.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.041 0.448 . . . . 0.0 110.408 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 83.0 mt -112.73 -0.82 14.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.931 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.516 ' NE ' ' HA3' ' A' ' 125' ' ' GLY . 40.5 mmm-85 -66.19 102.41 0.83 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.079 0.466 . . . . 0.0 109.76 178.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 143.64 -23.47 2.16 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -174.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.405 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 43.9 mtmt -117.08 160.07 21.57 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 174.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.527 HG22 ' O ' ' A' ' 68' ' ' ASP . 10.6 m -70.45 128.38 33.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 175.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.57 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 40.6 t -111.69 114.73 47.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 120.832 0.349 . . . . 0.0 111.153 -174.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.473 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 27.0 ttt -97.15 120.6 37.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.004 0.43 . . . . 0.0 110.067 174.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.493 HD22 HD13 ' A' ' 74' ' ' ILE . 88.3 mt -112.38 123.43 50.26 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.678 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -113.11 111.05 21.45 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.13 177.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.492 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 96.8 m-85 -88.64 115.82 26.44 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.7 t -132.7 -172.85 3.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.172 -171.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.558 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . . . -172.16 143.23 1.48 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.76 ' H ' ' HG3' ' A' ' 78' ' ' GLU . 54.7 p -70.72 -15.68 62.72 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.776 -172.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.415 ' HD1' ' OE2' ' A' ' 78' ' ' GLU . 66.6 p-90 -87.28 -0.65 57.06 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.097 0.475 . . . . 0.0 110.915 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.563 ' SG ' HG12 ' A' ' 115' ' ' ILE . 74.5 m -93.12 112.57 24.55 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.996 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -75.95 -34.29 48.09 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.63 178.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 56.2 t -61.42 -45.02 99.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.677 0.238 . . . . 0.0 110.833 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.682 ' HA ' ' CD ' ' A' ' 51' ' ' GLU . 12.5 t -61.85 -15.78 44.9 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 121.421 0.629 . . . . 0.0 111.456 -174.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -72.52 -1.91 17.7 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.862 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.474 ' HE2' ' CD2' ' A' ' 134' ' ' TYR . 56.4 mtpt -90.16 -56.87 3.05 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.214 172.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.779 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 3.8 pm0 -64.34 -30.95 71.98 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.565 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.599 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 5.9 mmt -52.29 -63.61 2.08 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.629 178.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.599 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 52.6 Cg_exo -56.63 -39.47 91.15 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 122.171 1.914 . . . . 0.0 112.912 175.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.407 ' HD1' ' O ' ' A' ' 50' ' ' LYS . 21.3 m-85 -66.99 -45.69 76.85 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 93.9 mt -61.93 -42.77 96.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.78 0.324 . . . . 0.0 110.146 177.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.473 ' OE1' ' HA ' ' A' ' 92' ' ' VAL . 26.0 tp10 -57.11 -52.36 65.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.602 178.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.487 ' HA ' HD23 ' A' ' 61' ' ' LEU . 27.6 ttpp -72.66 -54.06 10.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.522 -175.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -87.13 -26.74 23.47 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -168.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.7 mt -105.64 -61.72 2.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.817 -177.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.565 ' CD2' ' HB3' ' A' ' 94' ' ' TYR . 76.7 t-105 -61.22 -64.46 0.94 Allowed 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.499 -173.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.487 HD23 ' HA ' ' A' ' 57' ' ' LYS . 1.5 mp -47.78 -32.5 6.05 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -175.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -71.51 -38.3 71.15 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -176.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.642 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 87.2 m-70 -126.18 -43.78 1.78 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.897 -174.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.7 mttp 59.01 -82.22 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.655 0.782 . . . . 0.0 111.014 -175.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -110.8 -42.32 4.05 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 171.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.642 ' HB2' ' HB3' ' A' ' 63' ' ' HIS . 3.5 t30 71.03 -68.18 0.23 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.011 175.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 66' ' ' ASN . . . 162.93 -27.02 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 124.327 1.051 . . . . 0.0 108.759 -175.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.527 ' O ' HG22 ' A' ' 35' ' ' VAL . 25.5 t0 -140.74 26.74 2.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.614 -174.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.509 ' HB2' HD13 ' A' ' 150' ' ' LEU . 87.8 t80 -135.17 144.41 47.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.824 -177.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.67 138.02 28.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.963 173.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.473 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 1.8 tt -138.51 115.37 10.78 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -178.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.4 mp -126.79 130.69 71.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.141 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.435 ' HA3' HD22 ' A' ' 96' ' ' LEU . . . -92.69 117.22 5.3 Favored Glycine 0 C--O 1.221 -0.681 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.531 177.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.493 HD13 HD22 ' A' ' 38' ' ' LEU . 41.7 mt -104.44 118.62 52.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.938 0.369 . . . . 0.0 110.556 -175.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.558 ' OD2' ' HA ' ' A' ' 42' ' ' ALA . 9.7 t70 -84.52 142.55 29.95 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 176.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.1 ttp180 -80.03 -40.83 26.97 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -172.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -155.16 5.88 0.23 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -168.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.76 ' HG3' ' H ' ' A' ' 43' ' ' SER . 13.4 mm-40 -88.52 133.33 36.53 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 120.908 0.385 . . . . 0.0 110.373 177.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.456 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 29.3 Cg_endo -68.17 -173.11 0.48 Allowed 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 122.875 2.383 . . . . 0.0 113.63 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.434 ' O ' HD21 ' A' ' 84' ' ' LEU . 3.1 tm? -59.07 -55.82 30.15 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.084 -169.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.456 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -66.01 -34.13 77.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.497 0.189 . . . . 0.0 111.501 -173.832 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.416 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 2.7 mmmp? -60.24 -50.1 74.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.019 177.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 66.1 t -62.55 -44.85 99.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.921 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.434 HD21 ' O ' ' A' ' 80' ' ' LEU . 4.2 mm? -61.03 -47.37 86.75 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.831 0.348 . . . . 0.0 111.579 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.96 -30.93 68.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.232 -178.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -73.2 -47.75 40.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.553 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.513 ' HB1' HD13 ' A' ' 96' ' ' LEU . . . -52.34 -55.16 23.39 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.142 -177.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.82 -11.29 60.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.658 -174.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.6 m -94.81 -22.08 18.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.011 178.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.7 p -91.49 -4.51 55.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.594 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.66 0.91 90.42 Favored Glycine 0 C--O 1.228 -0.229 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.356 178.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.476 HG11 ' CE1' ' A' ' 94' ' ' TYR . 72.5 t -66.7 123.08 18.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 122.798 0.439 . . . . 0.0 111.386 -179.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.3 p -101.63 -18.83 15.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.652 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.565 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 52.7 p90 -77.52 141.76 65.79 Favored Pre-proline 0 N--CA 1.454 -0.26 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.513 177.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.423 ' HB2' HD23 ' A' ' 20' ' ' LEU . 18.5 Cg_endo -60.06 131.88 41.53 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 122.688 2.259 . . . . 0.0 113.409 -175.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.513 HD13 ' HB1' ' A' ' 87' ' ' ALA . 66.5 mt -102.39 147.49 26.64 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.002 173.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.46 ' HA3' HD12 ' A' ' 18' ' ' ILE . . . -122.3 143.84 15.76 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 177.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.716 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.0 OUTLIER -98.15 132.34 43.76 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.788 0.328 . . . . 0.0 110.551 -177.995 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' A' ' 75' ' ' ASP . 14.2 t0 -115.23 74.79 4.07 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.521 176.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.467 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 23.5 Cg_exo -63.17 104.7 0.42 Allowed 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.573 2.182 . . . . 0.0 112.364 -176.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 115.36 -4.54 21.72 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.772 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 57.52 47.42 16.2 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 122.731 0.412 . . . . 0.0 111.476 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.408 ' HA ' HH21 ' A' ' 111' ' ' ARG . 15.0 t70 -80.59 -50.62 9.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.98 0.419 . . . . 0.0 110.173 178.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 96.9 mt -61.93 -40.09 85.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 176.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -62.5 -40.39 96.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.541 176.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -67.4 -23.65 65.59 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.223 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -73.25 -13.5 61.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.257 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.466 ' HH ' ' HE2' ' A' ' 16' ' ' PHE . 45.3 m-85 -113.49 -34.38 5.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.832 0.349 . . . . 0.0 111.563 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -158.92 168.28 27.2 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.899 0.38 . . . . 0.0 111.209 -177.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.49 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 90.1 mt -67.29 138.63 56.98 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 175.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.408 HH21 ' HA ' ' A' ' 103' ' ' ASP . 94.5 mtt180 -63.16 -27.04 69.1 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.577 -174.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -92.82 -16.75 24.95 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.315 -178.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.49 ' HB3' ' HB2' ' A' ' 110' ' ' LEU . . . -80.85 47.92 1.03 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -172.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.58 143.14 9.74 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.328 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.563 HG12 ' SG ' ' A' ' 45' ' ' CYS . 1.8 tp -87.41 -64.07 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -176.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.5 m -64.78 128.03 34.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.857 0.361 . . . . 0.0 111.315 -173.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.521 ' HD2' ' CZ ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -145.43 132.13 19.97 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.432 178.28 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.642 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 3.8 m-20 -107.91 117.66 34.7 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 176.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 38' ' ' LEU . 73.2 t -120.57 118.97 58.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.426 -177.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.873 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 25.4 tp -109.77 120.13 41.53 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.261 0.553 . . . . 0.0 110.486 176.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.57 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 74.2 mt -104.23 142.02 18.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.948 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.86 172.25 13.75 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -78.01 20.96 0.34 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -175.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -110.88 -35.72 5.88 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 169.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.516 ' HA3' ' NE ' ' A' ' 32' ' ' ARG . . . 122.51 20.54 2.9 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.667 -172.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 29.3 mtmm -103.42 135.71 44.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.621 0.248 . . . . 0.0 110.493 177.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 56.4 mt -78.62 101.74 4.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 177.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.4 m -100.61 -21.63 5.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -170.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.873 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 61.0 tptt -132.03 117.05 17.87 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.131 0.491 . . . . 0.0 111.439 -176.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.757 HD13 HG12 ' A' ' 9' ' ' ILE . 10.3 mp -104.24 104.86 14.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.739 176.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.642 ' HB ' ' HB2' ' A' ' 118' ' ' ASN . 54.6 m -109.45 132.34 54.22 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.111 0.481 . . . . 0.0 110.746 -178.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.458 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 0.1 OUTLIER -91.92 107.9 19.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.825 -177.819 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 132' ' ' ARG . 0.6 OUTLIER 43.9 -160.89 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.28 0.987 . . . . 0.0 112.359 -179.008 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.779 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 94.4 t80 -85.39 84.9 7.5 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.643 0.735 . . . . 0.0 111.283 176.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.485 ' HB3' ' HB3' ' A' ' 138' ' ' GLU . 27.0 t-20 -89.09 120.07 30.16 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 165.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.404 ' HG2' ' CE2' ' A' ' 134' ' ' TYR . 46.4 mt-10 -56.38 -48.22 77.32 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -170.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.2 mp0 -68.04 -40.5 82.86 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.047 0.451 . . . . 0.0 110.511 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.485 ' HB3' ' HB3' ' A' ' 135' ' ' ASN . 8.5 tp10 -64.7 -41.05 96.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.374 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.42 ' O ' HG21 ' A' ' 143' ' ' VAL . 86.8 t80 -64.16 -40.39 96.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.381 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -59.12 -47.92 83.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.285 177.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 21.2 m -62.88 -39.87 95.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.636 176.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.459 ' O ' HG13 ' A' ' 146' ' ' ILE . 49.8 tp -60.9 -49.34 77.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.174 -178.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 139' ' ' PHE . 95.1 t -59.38 -47.96 88.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.827 0.346 . . . . 0.0 110.77 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.67 -43.1 98.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.956 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.504 ' O ' ' HG2' ' A' ' 149' ' ' MET . 7.8 tt0 -59.97 -46.99 87.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.53 177.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.483 ' O ' HD21 ' A' ' 150' ' ' LEU . 81.2 mt -56.41 -47.71 81.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.721 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -55.15 -44.76 75.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.859 176.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -76.55 -10.79 59.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.771 0.32 . . . . 0.0 111.443 -178.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.504 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 88.3 mmm -78.39 -38.96 40.46 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 171.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.509 HD13 ' HB2' ' A' ' 69' ' ' PHE . 4.4 mm? . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 114.9 -1.046 . . . . 0.0 110.294 176.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 . . . . . 0 CA--C 1.516 -0.345 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.6 pt -96.42 -15.63 7.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.771 0.32 . . . . 0.0 110.677 173.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.2 m -94.11 152.14 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.825 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.519 ' HB2' ' HB2' ' A' ' 11' ' ' GLU . 42.2 mtt85 -103.27 163.5 12.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.84 -177.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.464 HG12 HD11 ' A' ' 130' ' ' LEU . 72.5 mt -82.13 126.43 39.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 172.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.73 -10.7 64.56 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -173.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 8' ' ' ARG . 0.4 OUTLIER -77.04 150.1 35.78 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.163 -0.519 . . . . 0.0 109.809 -179.221 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.729 ' HG2' ' HG2' ' A' ' 126' ' ' LYS . 24.7 mtp -78.88 120.92 24.18 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.435 ' HA ' ' HD2' ' A' ' 14' ' ' PRO . . . -56.87 125.24 68.4 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.9 -175.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 13' ' ' ALA . 10.0 Cg_endo -54.17 115.95 2.72 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.215 2.61 . . . . 0.0 111.736 177.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.506 ' HA ' HD12 ' A' ' 28' ' ' LEU . 1.2 t70 -68.32 138.2 55.26 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.541 -174.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.574 ' HE2' ' HH ' ' A' ' 108' ' ' TYR . 36.2 p90 -146.48 161.65 39.99 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.699 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 30.6 m -123.25 112.9 18.2 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 175.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.2 tt -117.63 144.51 25.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.017 0.437 . . . . 0.0 110.934 -175.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.0 m -84.59 127.19 33.93 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.406 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.3 mt -81.55 176.94 9.24 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.972 0.415 . . . . 0.0 110.906 177.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.3 p -56.16 -34.89 66.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.881 -176.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -103.14 21.06 16.48 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.091 0.472 . . . . 0.0 110.71 -175.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.63 36.22 34.03 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.754 174.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -104.11 122.9 46.26 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.846 0.355 . . . . 0.0 110.649 177.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -88.48 115.91 26.34 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.956 177.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 17' ' ' THR . 14.3 m -114.91 143.77 23.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.017 0.437 . . . . 0.0 110.263 178.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 12.0 m -120.81 144.65 48.22 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.565 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.506 HD12 ' HA ' ' A' ' 15' ' ' ASP . 15.9 mt -61.7 -34.21 75.37 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.941 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.421 ' HA ' ' HG2' ' A' ' 32' ' ' ARG . 49.9 m -54.47 -38.21 66.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.927 0.394 . . . . 0.0 110.845 175.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.3 m -73.08 -23.23 60.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.24 0.543 . . . . 0.0 110.926 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 31' ' ' LEU . 66.6 mt -99.54 0.44 42.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.431 ' HG2' ' O ' ' A' ' 28' ' ' LEU . 38.1 mmt180 -62.37 147.47 48.3 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 175.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 102.89 -26.53 23.72 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.771 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.567 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 3.2 mppt? -110.47 165.26 11.94 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 68' ' ' ASP . 2.7 p -83.01 120.27 34.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 173.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.438 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 17.3 t -108.6 131.94 57.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.79 -172.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 26.3 ttt -113.15 117.77 32.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.812 0.339 . . . . 0.0 110.471 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -109.08 112.7 25.02 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.336 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.501 HE22 ' HB ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -107.18 125.72 51.47 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 174.142 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.474 ' O ' ' HA ' ' A' ' 116' ' ' THR . 96.8 m-85 -94.29 114.59 26.69 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.242 0.544 . . . . 0.0 109.558 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.501 ' HB ' HE22 ' A' ' 39' ' ' GLN . 14.5 t -116.9 174.47 6.08 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.039 -173.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -150.6 131.28 14.0 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.597 177.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.67 ' HB2' ' HG3' ' A' ' 78' ' ' GLU . 43.9 m -65.27 -9.48 24.34 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.794 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 26.8 p-90 -110.0 11.39 24.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.837 0.351 . . . . 0.0 111.316 177.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 51.2 t -106.5 115.32 29.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.188 0.518 . . . . 0.0 111.033 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -77.75 -3.16 83.31 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.73 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.4 t -82.53 -37.98 14.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.131 0.491 . . . . 0.0 109.748 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 81.9 m -61.96 -27.79 69.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.134 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -71.51 -3.55 21.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.531 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.418 ' O ' ' HD1' ' A' ' 54' ' ' PHE . 58.2 mttp -104.03 -46.69 4.39 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 170.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.434 ' OE1' ' HA ' ' A' ' 133' ' ' LEU . 29.5 tt0 -58.19 -57.06 14.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.406 -177.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.66 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 80.1 mtp -58.51 -53.0 70.61 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.721 -172.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.66 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 50.3 Cg_exo -56.83 -40.39 84.56 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 122.101 1.868 . . . . 0.0 112.655 176.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.418 ' HD1' ' O ' ' A' ' 50' ' ' LYS . 17.1 m-85 -67.76 -44.03 78.43 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.789 177.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.435 ' O ' ' HB ' ' A' ' 59' ' ' ILE . 37.5 mt -54.5 -54.05 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.898 177.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.581 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 16.8 pt-20 -64.83 -41.49 95.71 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.579 -176.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -58.29 -49.13 78.24 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -175.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.752 ' HA ' ' HZ1' ' A' ' 62' ' ' LYS . 77.8 m-20 -106.08 -18.09 14.13 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -172.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.435 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 67.2 mt -102.75 -60.56 2.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.79 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.614 ' CE2' ' HG2' ' A' ' 64' ' ' LYS . 70.6 t-105 -65.73 -54.06 32.42 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -175.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.568 ' HA ' ' HE3' ' A' ' 64' ' ' LYS . 3.2 mm? -54.17 -29.67 46.53 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -176.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.752 ' HZ1' ' HA ' ' A' ' 58' ' ' ASP . 34.2 mmtm -88.05 -29.97 20.28 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.923 0.392 . . . . 0.0 111.219 -176.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -122.73 23.54 9.45 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -168.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.614 ' HG2' ' CE2' ' A' ' 60' ' ' TRP . 6.2 mtmp? -41.99 96.58 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.4 t70 68.25 -54.14 0.53 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 111.611 -2.54 . . . . 0.0 111.009 178.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.2 t30 50.97 11.38 0.09 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.662 -179.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 60.1 13.64 3.94 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.115 0.566 . . . . 0.0 111.758 -173.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.55 ' HA ' ' HG3' ' A' ' 34' ' ' LYS . 44.7 t0 -153.71 6.0 0.32 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.966 0.412 . . . . 0.0 111.642 -176.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.526 ' HB2' HD13 ' A' ' 150' ' ' LEU . 84.2 t80 -136.72 119.61 16.33 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 121.668 -0.645 . . . . 0.0 110.687 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -116.37 108.24 15.81 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.892 -177.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.437 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 2.6 tt -106.73 121.1 43.69 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -178.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 40.2 mm -130.33 126.62 61.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.154 178.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.449 ' HA2' ' HG3' ' A' ' 39' ' ' GLN . . . -97.91 130.21 10.16 Favored Glycine 0 C--O 1.221 -0.686 0 C-N-CA 120.228 -0.986 . . . . 0.0 111.443 176.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 72.5 mt -119.31 125.31 74.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 117.55 0.675 . . . . 0.0 111.415 -174.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -86.3 142.41 28.54 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 174.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -74.47 -30.83 62.01 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -172.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -161.14 -22.2 0.05 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -170.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.67 ' HG3' ' HB2' ' A' ' 43' ' ' SER . 4.5 mm-40 -72.91 129.5 86.49 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-O 121.218 0.532 . . . . 0.0 111.01 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.605 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 28.1 Cg_endo -66.62 -167.05 0.12 Allowed 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.713 2.942 . . . . 0.0 115.017 -175.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.41 HD13 HD21 ' A' ' 84' ' ' LEU . 2.8 tm? -58.14 -53.51 57.41 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 114.532 -1.213 . . . . 0.0 112.329 -170.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.605 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -63.15 -29.71 71.01 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 -173.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.519 ' HG3' ' CD ' ' A' ' 78' ' ' GLU . 30.7 mmtm -66.72 -54.36 23.75 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.95 177.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.498 HG21 ' HB3' ' A' ' 98' ' ' LEU . 41.2 t -55.33 -43.97 73.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.34 -177.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.41 HD21 HD13 ' A' ' 80' ' ' LEU . 4.4 mm? -69.28 -27.28 65.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.796 0.331 . . . . 0.0 111.608 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.74 ' HA ' ' HE2' ' A' ' 88' ' ' LYS . . . -85.96 -37.65 18.81 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.272 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.535 ' HE2' ' SD ' ' A' ' 52' ' ' MET . 49.0 t80 -68.67 -42.53 77.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.809 -178.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.444 ' HB3' HD12 ' A' ' 96' ' ' LEU . . . -56.3 -53.39 57.78 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.097 178.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.74 ' HE2' ' HA ' ' A' ' 85' ' ' ALA . 63.4 pttt -65.92 -20.89 66.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.966 0.412 . . . . 0.0 111.4 -176.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.8 m -82.36 -3.53 55.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.266 178.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.459 ' HB ' ' HG3' ' A' ' 53' ' ' PRO . 15.8 p -127.1 -24.91 3.35 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.997 0.427 . . . . 0.0 111.153 177.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 122.56 -79.25 0.34 Allowed Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 -176.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.511 HG21 ' HE2' ' A' ' 52' ' ' MET . 90.6 t 45.37 89.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 124.526 1.13 . . . . 0.0 113.495 176.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.5 p -87.24 12.42 11.83 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.637 176.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.426 ' CE1' ' HB3' ' A' ' 56' ' ' GLU . 51.1 p90 -123.17 154.1 64.98 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.304 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -67.55 140.59 52.55 Favored 'Trans proline' 0 C--O 1.238 0.499 0 C-N-CA 122.201 1.934 . . . . 0.0 113.731 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.444 HD12 ' HB3' ' A' ' 87' ' ' ALA . 93.0 mt -113.95 151.43 32.31 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.661 175.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -122.53 149.82 16.94 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 175.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.662 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.0 OUTLIER -106.34 126.69 52.55 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.763 0.316 . . . . 0.0 110.827 -177.185 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -115.65 78.95 7.11 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.07 177.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.05 99.82 0.92 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.388 2.059 . . . . 0.0 112.744 -176.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 125.56 -7.05 7.95 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.899 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 63.19 44.29 5.8 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 122.853 0.461 . . . . 0.0 111.102 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -81.88 -50.91 8.64 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.196 0.522 . . . . 0.0 110.306 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.491 HD11 ' HB2' ' A' ' 16' ' ' PHE . 29.8 mm -65.23 -36.02 76.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.478 ' CD2' ' HA ' ' A' ' 111' ' ' ARG . 70.8 t80 -63.29 -42.96 99.13 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.207 175.019 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.601 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -67.45 -21.88 65.52 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.79 -178.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -72.63 -12.32 61.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.834 0.35 . . . . 0.0 111.16 178.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.574 ' HH ' ' HE2' ' A' ' 16' ' ' PHE . 54.9 m-85 -116.23 -42.8 3.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.08 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.601 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -146.37 161.4 40.44 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.221 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.59 ' HB2' ' HB1' ' A' ' 113' ' ' ALA . 97.9 mt -62.26 129.92 42.96 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.478 ' HA ' ' CD2' ' A' ' 105' ' ' PHE . 21.5 mtm180 -50.43 -43.61 55.0 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.295 0.569 . . . . 0.0 111.258 -175.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -101.47 17.64 22.21 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.705 -170.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.59 ' HB1' ' HB2' ' A' ' 110' ' ' LEU . . . -97.7 15.1 24.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.237 177.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 131.17 -179.04 17.34 Favored Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -178.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.41 HG21 ' H ' ' A' ' 116' ' ' THR . 1.0 OUTLIER -125.88 -73.2 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 117.525 0.662 . . . . 0.0 112.751 -179.689 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.692 ' HB ' ' HB3' ' A' ' 133' ' ' LEU . 5.1 m -73.68 117.42 15.42 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.092 0.472 . . . . 0.0 111.985 -167.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 75.5 mtt-85 -143.04 154.44 43.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.169 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.466 ' HB2' HG23 ' A' ' 131' ' ' THR . 0.9 OUTLIER -121.79 119.78 32.69 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 174.132 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.4 t -116.02 123.58 71.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.146 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.528 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 25.8 tp -107.65 121.84 45.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.027 0.442 . . . . 0.0 110.704 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.438 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 62.5 mt -102.77 132.5 48.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.077 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.464 ' OD2' ' HB2' ' A' ' 124' ' ' GLU . 18.4 t70 -79.43 164.96 23.56 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.679 178.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.467 ' HB3' HH11 ' A' ' 123' ' ' ARG . 0.0 OUTLIER -57.33 -29.55 64.05 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.552 179.34 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.531 ' HB3' ' NZ ' ' A' ' 126' ' ' LYS . 18.0 mm-40 -75.4 7.05 3.86 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.0 0.429 . . . . 0.0 111.096 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 76.15 14.13 82.58 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.168 176.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.729 ' HG2' ' HG2' ' A' ' 12' ' ' MET . 25.0 mtmm -113.68 139.19 49.27 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.831 0.348 . . . . 0.0 110.926 -175.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.3 mt -76.14 130.63 36.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.781 -175.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 31.0 m -116.07 -21.0 5.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -176.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.528 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 53.1 tptt -135.5 116.44 14.18 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.552 -0.459 . . . . 0.0 112.092 -174.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.464 HD11 HG12 ' A' ' 9' ' ' ILE . 10.6 mp -109.09 119.34 39.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.332 172.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.519 HG21 HD11 ' A' ' 142' ' ' LEU . 14.7 t -147.15 162.91 37.9 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.98 178.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.436 ' C ' ' HG ' ' A' ' 133' ' ' LEU . 37.2 mtm180 -115.83 116.91 28.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.112 -173.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.692 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 3.9 pp 48.62 -169.09 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 O-C-N 124.67 1.231 . . . . 0.0 114.001 174.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.431 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 60.9 t80 -80.59 114.74 19.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.449 -178.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.539 ' HB3' ' HB2' ' A' ' 138' ' ' GLU . 3.0 t-20 -130.87 133.78 46.2 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.948 -1.023 . . . . 0.0 108.429 173.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -44.87 -61.26 1.67 Allowed 'General case' 0 C--O 1.236 0.367 0 O-C-N 123.441 0.463 . . . . 0.0 112.189 -178.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -60.74 -50.71 72.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.822 0.344 . . . . 0.0 111.317 -177.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 135' ' ' ASN . 4.0 mm-40 -63.13 -39.49 94.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.981 -177.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -66.08 -41.45 90.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.807 0.337 . . . . 0.0 110.102 177.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.82 -42.02 98.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.157 176.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.4 m -67.31 -35.21 78.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.239 177.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.519 HD11 HG21 ' A' ' 131' ' ' THR . 24.7 mt -66.67 -53.4 34.29 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.836 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.6 p -60.69 -42.17 90.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.025 -175.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -67.29 -41.52 85.3 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.812 0.339 . . . . 0.0 110.547 177.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.519 ' O ' ' HG2' ' A' ' 149' ' ' MET . 8.6 tt0 -58.5 -51.39 70.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.657 176.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.592 ' O ' HD23 ' A' ' 150' ' ' LEU . 99.0 mt -62.48 -40.51 88.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.85 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -54.35 -37.47 64.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.25 177.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -88.14 -26.62 22.36 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.625 -178.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.519 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 97.5 mmm -63.8 -26.25 68.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.408 0.623 . . . . 0.0 109.704 175.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.592 HD23 ' O ' ' A' ' 146' ' ' ILE . 3.9 mm? . . . . . 0 C--N 1.325 -0.486 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.072 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.48 ' CE1' HD12 ' A' ' 130' ' ' LEU . 69.0 m-85 . . . . . 0 CA--C 1.519 -0.226 0 CA-C-O 120.674 0.273 . . . . 0.0 111.346 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.493 HG13 HG22 ' A' ' 7' ' ' VAL . 46.8 pt -101.65 -17.13 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 170.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.493 HG22 HG13 ' A' ' 6' ' ' ILE . 23.1 t -110.3 139.27 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.067 177.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.416 ' HE ' ' CD ' ' A' ' 11' ' ' GLU . 73.6 mtm180 -122.47 -178.7 3.97 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.084 0.469 . . . . 0.0 112.186 -169.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.416 ' CG1' HD21 ' A' ' 130' ' ' LEU . 67.5 mt -71.32 123.07 24.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.294 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.16 -19.82 44.91 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.166 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.416 ' CD ' ' HE ' ' A' ' 8' ' ' ARG . 7.1 mt-10 -80.87 151.32 28.71 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.632 ' HG2' ' HG2' ' A' ' 126' ' ' LYS . 45.1 mtp -77.92 137.54 38.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.844 0.354 . . . . 0.0 110.362 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.24 130.83 67.79 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.404 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -61.23 125.95 18.19 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.493 2.129 . . . . 0.0 111.427 177.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -63.01 138.64 58.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.224 0.535 . . . . 0.0 110.196 -176.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.572 ' HB2' HD13 ' A' ' 104' ' ' ILE . 47.1 p90 -131.76 149.69 52.39 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.052 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.5 m -109.17 98.79 8.17 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 170.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 25' ' ' GLN . 16.9 tt -95.6 144.8 9.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.516 -174.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.8 m -101.55 118.3 36.68 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.103 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.8 mt -73.57 172.83 10.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.959 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 96' ' ' LEU . 41.5 p -58.1 -28.84 64.98 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -175.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -102.6 18.74 20.54 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.143 0.497 . . . . 0.0 110.859 -175.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.86 40.43 17.41 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.795 174.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -108.73 117.18 33.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.887 0.375 . . . . 0.0 110.928 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 49.7 mt-30 -94.75 118.47 31.79 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.003 178.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.8 p -128.88 132.28 67.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.217 0.532 . . . . 0.0 111.123 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.41 154.81 25.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.089 177.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 40.4 tp -65.48 -40.28 92.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.844 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.562 ' HA ' ' HG3' ' A' ' 32' ' ' ARG . 75.3 m -62.92 -19.14 63.94 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 177.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 51.8 m -75.2 -18.15 60.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.511 0.672 . . . . 0.0 110.395 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.3 mt -100.81 -14.11 18.13 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.732 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.623 ' NH1' ' HA ' ' A' ' 124' ' ' GLU . 6.3 mmm180 -55.48 153.57 7.4 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 123.539 0.525 . . . . 0.0 110.917 177.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.09 -22.64 35.43 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -172.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.52 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 35.7 mtmm -117.31 170.93 8.31 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 174.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.5 m -80.9 134.03 28.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 172.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.566 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 44.3 t -111.22 109.6 29.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 121.006 0.431 . . . . 0.0 111.076 -177.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.572 ' HE3' ' HB3' ' A' ' 118' ' ' ASN . 13.9 tpt -91.81 136.25 33.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.211 175.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 78.9 mt -133.74 143.29 48.37 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.077 -178.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.55 ' OE1' ' HB ' ' A' ' 41' ' ' THR . 21.8 tm0? -138.45 131.44 29.77 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 177.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 96.7 m-85 -104.56 120.04 40.38 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.55 ' HB ' ' OE1' ' A' ' 39' ' ' GLN . 6.8 t -136.47 -175.67 4.08 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.059 0.456 . . . . 0.0 111.602 -173.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.497 ' HB1' ' HG ' ' A' ' 45' ' ' CYS . . . -169.41 164.04 10.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.463 178.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.445 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 86.3 p -67.19 -30.25 70.14 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.892 0.377 . . . . 0.0 111.739 -173.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 37.7 p-90 -89.0 4.36 48.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.668 -175.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.497 ' HG ' ' HB1' ' A' ' 42' ' ' ALA . 80.0 m -85.69 90.05 7.91 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.072 0.463 . . . . 0.0 110.796 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.84 -35.7 90.01 Favored Glycine 0 C--O 1.228 -0.265 0 C-N-CA 121.08 -0.581 . . . . 0.0 113.004 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.5 t -64.46 -35.44 74.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.012 0.434 . . . . 0.0 110.057 178.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.695 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 99.4 m -65.24 -16.84 63.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.395 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -68.99 -7.32 34.25 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 120.849 0.357 . . . . 0.0 110.604 177.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.614 ' HD3' ' CD2' ' A' ' 134' ' ' TYR . 62.1 mttt -88.24 -57.25 2.99 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.351 0.596 . . . . 0.0 110.257 168.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.735 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 5.0 pt-20 -65.65 -40.06 92.07 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.287 -172.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.586 ' HG2' ' O ' ' A' ' 48' ' ' CYS . 98.9 mmm -54.69 -58.39 14.52 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 117.999 0.363 . . . . 0.0 111.862 -177.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.418 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 29.6 Cg_endo -64.48 -38.53 32.84 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 122.018 1.812 . . . . 0.0 112.501 178.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -64.46 -42.07 96.16 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.314 178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.554 ' O ' ' HB ' ' A' ' 59' ' ' ILE . 75.0 mt -60.25 -37.49 73.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.863 0.363 . . . . 0.0 110.404 177.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.666 ' HG3' ' H ' ' A' ' 93' ' ' THR . 0.2 OUTLIER -68.42 -62.66 1.3 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 175.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.411 ' O ' ' HE2' ' A' ' 62' ' ' LYS . 29.3 ttpp -55.58 -43.1 75.64 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -174.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.568 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 8.3 m-20 -100.65 -24.82 14.34 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -171.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.554 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 53.9 mt -106.5 -60.99 2.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.458 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.507 ' CD2' ' HB3' ' A' ' 94' ' ' TYR . 76.6 t-105 -62.8 -62.65 1.58 Allowed 'General case' 0 C--O 1.226 -0.18 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.614 -175.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -46.68 -31.98 3.25 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.655 0.782 . . . . 0.0 112.497 -174.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.568 ' HE2' ' HA ' ' A' ' 58' ' ' ASP . 64.7 mmtt -72.75 -54.24 9.45 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.923 -178.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.774 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 85.8 m-70 -105.83 -45.29 4.42 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -169.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.5 mttp 55.06 -78.42 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.77 0.828 . . . . 0.0 111.495 -172.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -101.36 -63.25 1.16 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 174.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.774 ' HB2' ' HB3' ' A' ' 63' ' ' HIS . 3.9 t30 68.21 5.97 4.99 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.842 172.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 71.68 -19.44 0.26 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.769 0.828 . . . . 0.0 112.513 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.52 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 19.9 p30 -136.92 17.31 3.04 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.474 ' CE2' ' HB2' ' A' ' 71' ' ' LEU . 93.7 t80 -125.63 143.3 51.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.087 0.47 . . . . 0.0 111.112 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.81 140.59 38.61 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.744 172.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.474 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 2.2 tt -139.12 114.73 9.9 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -179.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.9 mm -124.3 120.83 60.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.133 178.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.457 ' HA3' ' CD2' ' A' ' 96' ' ' LEU . . . -88.72 130.44 10.15 Favored Glycine 0 C--O 1.223 -0.57 0 C-N-CA 120.223 -0.989 . . . . 0.0 110.809 175.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 48.6 mt -116.67 121.6 68.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 117.28 0.54 . . . . 0.0 110.759 -174.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -82.59 139.8 33.59 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 173.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.41 ' HB2' HD11 ' A' ' 115' ' ' ILE . 57.7 ttt-85 -57.37 -51.78 68.03 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.668 0.605 . . . . 0.0 112.58 -172.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.596 ' HA ' ' O ' ' A' ' 99' ' ' ASP . 11.3 p-10 -170.05 15.48 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -175.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.533 ' HB3' ' HG3' ' A' ' 82' ' ' LYS . 29.0 mt-10 -91.52 148.53 37.62 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-O 121.088 0.471 . . . . 0.0 110.599 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.632 ' HG2' ' OE2' ' A' ' 81' ' ' GLU . 38.1 Cg_endo -71.34 -174.48 1.23 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.935 2.423 . . . . 0.0 114.257 -176.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 85.2 mt -54.25 -52.5 61.16 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.618 -1.173 . . . . 0.0 112.826 -174.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.632 ' OE2' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -61.22 -24.54 66.42 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -172.819 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.623 ' HG2' ' OE2' ' A' ' 81' ' ' GLU . 42.5 mmtm -73.23 -59.87 2.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.717 0.294 . . . . 0.0 110.367 172.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.6 t -54.59 -49.24 68.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.725 -176.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.8 mp -64.69 -40.43 95.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.413 -176.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.67 -34.55 58.24 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.316 -177.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.445 ' CD1' ' HA ' ' A' ' 43' ' ' SER . 78.9 t80 -67.09 -48.94 66.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.791 -178.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.433 ' HB3' HD11 ' A' ' 96' ' ' LEU . . . -53.34 -52.05 60.46 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.042 -176.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -63.19 -28.45 70.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.043 -176.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.5 m -100.73 9.86 41.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.724 -174.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.2 p -129.46 10.87 5.75 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.108 175.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.67 43.65 91.46 Favored Glycine 0 C--O 1.227 -0.281 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.275 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.7 t -100.36 100.65 10.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.028 0.442 . . . . 0.0 110.944 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.666 ' H ' ' HG3' ' A' ' 56' ' ' GLU . 30.1 m -85.94 -20.52 28.85 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.848 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.507 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 23.6 p90 -82.48 144.12 48.97 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.816 178.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -61.5 140.67 88.53 Favored 'Trans proline' 0 C--O 1.238 0.495 0 C-N-CA 122.572 2.181 . . . . 0.0 113.175 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.457 ' CD2' ' HA3' ' A' ' 73' ' ' GLY . 76.3 mt -111.06 151.2 28.32 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.852 176.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -123.59 149.16 16.85 Favored Glycine 0 N--CA 1.438 -1.214 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 175.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.671 ' H ' HD22 ' A' ' 98' ' ' LEU . 0.8 OUTLIER -99.81 132.56 45.08 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.591 0.234 . . . . 0.0 110.561 -177.456 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.596 ' O ' ' HA ' ' A' ' 77' ' ' ASP . 26.6 t0 -109.58 83.31 2.57 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.925 176.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -60.92 101.67 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.417 2.078 . . . . 0.0 113.177 -175.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 101.51 11.76 37.5 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.852 -0.689 . . . . 0.0 113.359 175.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 61.32 43.46 10.66 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.082 0.467 . . . . 0.0 110.872 178.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.636 ' HA ' HH21 ' A' ' 111' ' ' ARG . 18.1 t70 -79.89 -50.2 10.82 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.537 0.684 . . . . 0.0 110.374 -178.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.572 HD13 ' HB2' ' A' ' 16' ' ' PHE . 31.7 mm -67.41 -39.45 82.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 175.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -56.69 -39.14 73.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.363 175.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.17 -32.32 72.49 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.77 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.428 ' HZ1' HD11 ' A' ' 104' ' ' ILE . 30.5 mtmm -74.83 -4.79 39.86 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 178.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.429 ' HH ' ' HE2' ' A' ' 16' ' ' PHE . 47.9 m-85 -116.61 -19.24 10.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 179.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.658 ' HB2' HH12 ' A' ' 117' ' ' ARG . . . -171.9 -179.99 2.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.572 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 80.2 mt -66.11 149.62 50.0 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 174.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.636 HH21 ' HA ' ' A' ' 103' ' ' ASP . 93.5 mtt180 -73.58 -15.22 61.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.121 0.486 . . . . 0.0 110.024 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -100.51 15.9 26.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.346 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.07 -179.26 5.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.475 -177.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.88 142.03 42.79 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.679 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.59 ' O ' ' HG2' ' A' ' 117' ' ' ARG . 6.6 tp -91.66 -39.77 11.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 111.36 0.133 . . . . 0.0 111.36 -178.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.562 HG21 ' SG ' ' A' ' 48' ' ' CYS . 18.0 p -68.86 105.33 2.32 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 120.484 0.183 . . . . 0.0 110.878 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.658 HH12 ' HB2' ' A' ' 109' ' ' ALA . 8.9 ptm180 -167.65 133.06 1.96 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.171 0.51 . . . . 0.0 112.127 -173.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.579 ' HB2' ' CB ' ' A' ' 131' ' ' THR . 91.2 m-20 -104.41 129.59 52.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.231 172.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.6 t -120.95 116.93 51.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 120.619 0.247 . . . . 0.0 110.394 -176.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 37.5 tp -106.38 115.12 29.66 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.113 0.482 . . . . 0.0 110.645 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.566 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 60.7 mt -95.51 135.05 30.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.366 176.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.505 ' HB2' ' HE3' ' A' ' 149' ' ' MET . 0.0 OUTLIER -79.49 177.01 9.18 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.206 0.526 . . . . 0.0 110.734 -177.213 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -62.57 -27.1 68.95 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.561 -177.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.623 ' HA ' ' NH1' ' A' ' 32' ' ' ARG . 2.1 mm-40 -91.42 6.28 46.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.066 -178.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.16 16.68 62.33 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.544 -0.836 . . . . 0.0 113.017 172.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.632 ' HG2' ' HG2' ' A' ' 12' ' ' MET . 33.3 mttt -112.18 142.77 44.24 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.829 0.347 . . . . 0.0 110.292 -177.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.462 HD13 ' CG1' ' A' ' 7' ' ' VAL . 58.3 mt -80.21 119.96 30.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 120.776 0.322 . . . . 0.0 110.613 -177.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.5 m -109.88 -8.07 11.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.419 ' CG ' HE22 ' A' ' 145' ' ' GLN . 5.2 tmtm? -149.34 111.21 4.57 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.296 -175.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.48 HD12 ' CE1' ' A' ' 5' ' ' TYR . 3.2 mm? -104.79 105.78 16.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.224 172.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.579 ' CB ' ' HB2' ' A' ' 118' ' ' ASN . 10.4 m -88.98 138.69 31.17 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.367 -177.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.507 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 2.3 mpt_? -99.78 107.08 19.04 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 176.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 132' ' ' ARG . 0.5 OUTLIER 43.44 -162.89 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 O-C-N 124.212 0.945 . . . . 0.0 111.788 -174.201 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.735 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 90.5 t80 -88.63 92.81 9.34 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.168 0.509 . . . . 0.0 110.08 173.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.539 ' HB3' ' HB3' ' A' ' 138' ' ' GLU . 10.7 t30 -95.02 131.57 40.85 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 170.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.433 ' HB2' ' OE2' ' A' ' 137' ' ' GLU . 24.9 mm-40 -50.16 -63.81 1.0 Allowed 'General case' 0 CA--C 1.536 0.424 0 O-C-N 123.687 0.617 . . . . 0.0 112.178 -168.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.513 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.2 mp0 -66.62 -32.52 73.9 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.108 0.48 . . . . 0.0 110.945 -177.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.539 ' HB3' ' HB3' ' A' ' 135' ' ' ASN . 6.0 tp10 -62.68 -46.18 89.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.606 -176.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.491 ' O ' HG23 ' A' ' 143' ' ' VAL . 91.9 t80 -63.57 -42.03 98.34 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.511 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.4 -44.06 96.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.805 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.3 m -63.68 -39.6 94.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.414 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.5 ' O ' HG13 ' A' ' 146' ' ' ILE . 58.4 tp -62.46 -44.31 96.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.942 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 139' ' ' PHE . 99.0 t -57.66 -52.94 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.15 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -60.96 -41.29 96.06 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-O 121.281 0.562 . . . . 0.0 110.872 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.419 HE22 ' CG ' ' A' ' 129' ' ' LYS . 28.6 tt0 -57.71 -48.52 79.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.575 178.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.597 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 78.0 mt -58.96 -41.92 84.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.879 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -55.2 -46.68 75.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.561 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -83.88 -25.22 30.41 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.092 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.505 ' HE3' ' HB2' ' A' ' 122' ' ' ASP . 28.8 mmm -58.92 -33.88 71.08 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.413 0.625 . . . . 0.0 110.371 178.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' A' ' 146' ' ' ILE . 52.2 mt . . . . . 0 C--N 1.319 -0.739 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.611 176.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.425 ' OH ' ' HD2' ' A' ' 117' ' ' ARG . 1.3 m-85 . . . . . 0 CA--C 1.52 -0.199 0 CA-C-O 120.771 0.319 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.412 HG13 HG13 ' A' ' 7' ' ' VAL . 38.6 pt -92.38 -24.01 5.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.437 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.412 HG13 HG13 ' A' ' 6' ' ' ILE . 27.4 m -104.51 157.16 5.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.389 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.464 ' H ' ' HG3' ' A' ' 11' ' ' GLU . 19.7 mtt180 -126.25 177.39 6.45 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.082 -174.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.606 HG12 HD11 ' A' ' 130' ' ' LEU . 79.9 mt -74.27 110.7 8.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 173.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.02 -23.45 8.2 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.092 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.464 ' HG3' ' H ' ' A' ' 8' ' ' ARG . 69.1 mm-40 -68.13 154.67 41.21 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.555 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 55.5 mtp -86.08 139.83 30.79 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.949 0.404 . . . . 0.0 110.482 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.469 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -67.44 130.06 93.46 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.561 -178.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 8.3 Cg_exo -70.7 120.98 7.5 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.926 2.418 . . . . 0.0 111.477 176.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -63.43 146.93 52.6 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.451 -176.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 1.026 ' HB3' ' HE2' ' A' ' 107' ' ' LYS . 54.0 p90 -156.7 158.54 37.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.69 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.8 m -116.33 107.27 14.62 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.748 175.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.1 tt -107.81 146.81 13.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.005 0.431 . . . . 0.0 111.003 -176.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.3 m -95.37 130.22 42.24 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.053 177.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.47 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 90.6 mt -83.89 179.01 7.66 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.005 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.449 HG23 ' O ' ' A' ' 96' ' ' LEU . 27.4 p -59.56 -31.21 69.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.714 -175.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -101.88 10.91 39.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.983 0.42 . . . . 0.0 110.917 -176.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.07 8.7 62.94 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.522 176.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.414 ' HB2' HD12 ' A' ' 20' ' ' LEU . 46.0 mmtm -77.44 120.59 22.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.362 0.581 . . . . 0.0 110.593 177.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -98.63 115.46 28.71 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.962 0.41 . . . . 0.0 110.393 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.3 m -113.78 153.07 15.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.008 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 9.1 m -122.49 142.96 50.03 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.335 -0.393 . . . . 0.0 109.961 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.67 -39.88 94.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.847 0.356 . . . . 0.0 110.841 -175.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 32' ' ' ARG . 5.3 p -61.18 -21.57 63.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.546 178.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.1 m -79.86 -25.99 40.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.068 0.461 . . . . 0.0 110.403 177.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 77.2 mt -96.5 1.88 51.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.392 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 29' ' ' SER . 0.2 OUTLIER -55.74 126.39 25.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.081 179.339 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.606 ' O ' ' HG3' ' A' ' 123' ' ' ARG . . . 106.37 -0.11 37.6 Favored Glycine 0 C--O 1.222 -0.635 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.724 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -116.51 159.54 21.93 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 174.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 p -78.29 107.3 10.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.585 0.707 . . . . 0.0 109.172 171.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.471 HG21 ' HB3' ' A' ' 70' ' ' ALA . 48.0 t -106.89 120.93 59.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.095 -173.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 26.7 ttt -98.81 120.2 38.84 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.331 176.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 94.0 mt -107.88 110.87 22.75 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.022 177.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.425 ' OE1' ' HB ' ' A' ' 41' ' ' THR . 0.6 OUTLIER -103.37 106.14 16.58 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.874 -176.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.461 ' O ' ' HA ' ' A' ' 116' ' ' THR . 95.1 m-85 -93.76 127.29 39.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.572 -177.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.429 ' HG1' ' CB ' ' A' ' 48' ' ' CYS . 15.0 t -158.26 -166.47 1.94 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.366 -176.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.486 ' HB3' HD12 ' A' ' 115' ' ' ILE . . . -151.03 156.44 41.12 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 176.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.627 ' HB2' ' HG3' ' A' ' 78' ' ' GLU . 49.7 m -66.26 -9.49 33.0 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -176.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 41.0 p-90 -105.4 4.86 31.22 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 122.201 -0.312 . . . . 0.0 111.566 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 74.9 m -83.17 113.47 20.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.023 0.439 . . . . 0.0 111.158 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -78.31 -33.21 40.45 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.863 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.3 t -66.48 -37.46 79.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.08 0.467 . . . . 0.0 110.797 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.66 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 29.1 t -67.03 -16.95 64.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.374 0.607 . . . . 0.0 110.793 -178.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.502 ' HE ' ' HE1' ' A' ' 86' ' ' PHE . 79.6 mtt180 -74.83 -2.15 25.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.681 177.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.411 ' O ' ' HD1' ' A' ' 54' ' ' PHE . 74.2 mmtt -94.02 -55.61 3.15 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.702 0.763 . . . . 0.0 109.278 169.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.983 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 10.0 pt-20 -62.68 -44.27 96.69 Favored 'General case' 0 C--O 1.213 -0.827 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.861 -173.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.651 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 33.3 mtm -56.06 -55.23 43.8 Favored Pre-proline 0 N--CA 1.466 0.362 0 CA-C-N 118.338 0.517 . . . . 0.0 112.36 -176.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.651 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 65.0 Cg_exo -53.93 -38.7 86.37 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 121.976 1.784 . . . . 0.0 111.968 175.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.465 ' HB3' ' CZ ' ' A' ' 139' ' ' PHE . 23.1 m-85 -68.26 -45.04 74.25 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.081 175.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 51' ' ' GLU . 88.1 mt -58.86 -55.68 21.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 123.065 0.546 . . . . 0.0 111.08 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.503 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 16.0 pt-20 -62.69 -35.71 80.58 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.635 -177.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.0 ttpm? -72.37 -51.4 20.69 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -176.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.768 ' HA ' ' HZ1' ' A' ' 62' ' ' LYS . 53.5 m-20 -106.99 -10.8 15.83 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -170.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.434 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 65.0 mt -104.57 -55.44 5.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.158 173.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.503 ' HB3' ' HA ' ' A' ' 56' ' ' GLU . 72.1 t-105 -69.97 -65.84 0.67 Allowed 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.575 -177.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.495 HD11 ' HE3' ' A' ' 64' ' ' LYS . 1.9 mm? -46.78 -33.88 4.78 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -175.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.768 ' HZ1' ' HA ' ' A' ' 58' ' ' ASP . 45.8 mmtm -75.72 -34.12 60.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.29 -0.414 . . . . 0.0 112.057 -176.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.405 ' ND1' ' HG ' ' A' ' 150' ' ' LEU . 79.9 m-70 -125.28 -43.73 1.91 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 120.347 -0.541 . . . . 0.0 112.351 -173.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.495 ' HE3' HD11 ' A' ' 61' ' ' LEU . 34.5 mttp 54.87 -90.6 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.944 0.898 . . . . 0.0 111.936 -177.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -108.01 -49.41 3.21 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 174.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 70.94 -71.22 0.14 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.83 178.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 169.78 -23.67 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.287 -175.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -148.3 24.93 1.01 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.79 -174.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.402 ' HB2' HD11 ' A' ' 150' ' ' LEU . 87.5 t80 -129.12 140.13 51.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.745 0.307 . . . . 0.0 110.571 -178.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.471 ' HB3' HG21 ' A' ' 36' ' ' VAL . . . -139.16 135.83 34.45 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.323 177.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 tt -133.79 117.2 16.62 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.6 mp -128.15 126.98 67.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.766 0.317 . . . . 0.0 110.332 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.81 129.46 9.91 Favored Glycine 0 C--O 1.219 -0.784 0 N-CA-C 110.799 -0.921 . . . . 0.0 110.799 174.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.0 mt -119.21 122.53 69.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 117.489 0.644 . . . . 0.0 111.338 -173.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -86.11 133.26 33.89 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 173.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.875 ' HD3' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -88.35 -22.78 23.63 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -169.271 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.875 ' HB3' ' HD3' ' A' ' 76' ' ' ARG . 3.9 p30 -151.25 -14.04 0.21 Allowed 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 118.721 -1.192 . . . . 0.0 114.131 -172.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.627 ' HG3' ' HB2' ' A' ' 43' ' ' SER . 4.9 mm-40 -88.46 133.31 36.69 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-O 121.065 0.46 . . . . 0.0 110.746 177.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.531 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 29.0 Cg_endo -69.19 -168.82 0.27 Allowed 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 123.175 2.583 . . . . 0.0 114.624 -177.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.2 -53.97 52.19 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.414 -168.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.531 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -64.23 -33.59 76.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.657 0.265 . . . . 0.0 111.305 -173.941 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.466 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 33.7 mmtp -61.06 -53.93 51.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.85 177.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.5 HG21 ' O ' ' A' ' 79' ' ' PRO . 41.1 t -57.53 -41.52 79.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.352 -177.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -66.07 -44.19 85.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.854 0.359 . . . . 0.0 111.26 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.82 -27.93 62.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.175 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.502 ' HE1' ' HE ' ' A' ' 49' ' ' ARG . 91.7 t80 -74.14 -48.08 31.73 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.19 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.455 ' HB2' HD13 ' A' ' 96' ' ' LEU . . . -58.39 -55.09 39.54 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.334 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.7 ptmm? -58.84 -24.95 62.75 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -174.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.0 m -84.15 -17.29 40.53 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -175.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.5 p -111.08 -23.39 10.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.098 0.475 . . . . 0.0 110.653 176.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 123.36 -79.78 0.35 Allowed Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -177.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 94.4 t 46.19 82.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 122.101 0.953 . . . . 0.0 112.691 178.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.3 m -71.55 -18.66 62.24 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.446 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -93.98 139.92 22.77 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.45 140.12 85.88 Favored 'Trans proline' 0 C--O 1.238 0.499 0 C-N-CA 122.46 2.107 . . . . 0.0 113.437 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.455 HD13 ' HB2' ' A' ' 87' ' ' ALA . 88.6 mt -106.23 152.21 23.79 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.868 175.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -124.33 154.41 17.86 Favored Glycine 0 N--CA 1.441 -1.025 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 175.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.657 HD21 ' H ' ' A' ' 98' ' ' LEU . 1.2 pt? -107.43 130.45 54.82 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.945 0.402 . . . . 0.0 111.126 -177.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -119.13 75.15 14.73 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.868 175.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.416 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 17.4 Cg_exo -66.23 105.16 0.82 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.6 2.2 . . . . 0.0 112.421 -177.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 119.47 -1.79 14.04 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.127 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 57.91 43.4 21.5 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 122.658 0.383 . . . . 0.0 111.931 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.404 ' O ' ' HG3' ' A' ' 107' ' ' LYS . 13.7 t70 -87.1 -50.67 6.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.06 0.457 . . . . 0.0 109.903 -177.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.542 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 34.3 mm -62.54 -34.92 67.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 174.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -61.5 -41.67 97.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.248 173.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.728 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -68.32 -21.81 64.74 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.893 -177.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 1.026 ' HE2' ' HB3' ' A' ' 16' ' ' PHE . 26.5 mtpp -70.9 -6.84 41.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.002 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -124.64 -32.75 3.07 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.158 -179.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.728 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -156.89 162.58 39.66 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 84.2 mt -56.76 149.01 18.94 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.759 0.314 . . . . 0.0 110.381 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.567 ' HG2' ' HB1' ' A' ' 106' ' ' ALA . 38.1 mtt180 -69.66 -13.46 62.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.139 0.495 . . . . 0.0 110.542 -174.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -100.96 -7.33 23.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.126 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -78.91 75.77 5.41 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.203 0.525 . . . . 0.0 111.719 -174.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.93 -140.33 29.91 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.094 178.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.487 HD11 ' HD2' ' A' ' 76' ' ' ARG . 4.6 tp -161.93 -57.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.481 0.182 . . . . 0.0 111.351 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 40' ' ' PHE . 4.8 m -87.86 111.68 21.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.073 0.464 . . . . 0.0 110.951 -175.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.425 ' HD2' ' OH ' ' A' ' 5' ' ' TYR . 46.0 mtm105 -141.61 133.17 26.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.074 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.585 ' HB2' ' CG2' ' A' ' 131' ' ' THR . 6.0 m120 -102.39 119.01 38.09 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 176.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.9 t -113.8 123.76 69.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.078 -177.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.447 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 34.4 tp -110.58 121.76 46.1 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.11 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.3 mp -102.13 139.02 24.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.67 177.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.457 ' HA ' ' HE1' ' A' ' 149' ' ' MET . 0.3 OUTLIER -90.59 -174.17 4.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.055 0.455 . . . . 0.0 111.02 -177.642 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.606 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 32.4 ttt180 -69.84 -26.26 64.14 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.604 -175.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -80.17 -15.05 57.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.703 0.287 . . . . 0.0 111.254 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.2 16.38 30.19 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.08 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 81.2 mttt -101.24 154.87 18.39 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.907 0.384 . . . . 0.0 110.414 -178.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 53.9 mt -92.62 116.44 33.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.172 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.53 -31.32 2.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -173.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.867 ' HG2' ' HG ' ' A' ' 142' ' ' LEU . 50.5 tptt -124.66 114.27 19.11 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.908 -0.495 . . . . 0.0 111.194 -176.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.606 HD11 HG12 ' A' ' 9' ' ' ILE . 8.5 mp -110.99 105.13 13.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.746 176.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.589 ' HA ' ' NH1' ' A' ' 132' ' ' ARG . 10.0 t -125.43 158.69 33.75 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.074 0.464 . . . . 0.0 110.721 177.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.589 ' NH1' ' HA ' ' A' ' 131' ' ' THR . 0.0 OUTLIER -116.24 116.47 27.85 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.144 -178.199 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 132' ' ' ARG . 4.6 pp 51.11 -175.01 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.526 1.141 . . . . 0.0 112.968 -178.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.983 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 90.5 t80 -69.75 84.13 0.46 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.647 0.737 . . . . 0.0 111.56 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.549 ' HB3' ' HB2' ' A' ' 138' ' ' GLU . 57.8 t-20 -86.7 133.57 33.67 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 171.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -52.04 -68.07 0.2 Allowed 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.36 0.413 . . . . 0.0 110.843 -176.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -55.99 -59.1 5.39 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.544 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.615 ' O ' ' HB2' ' A' ' 142' ' ' LEU . 29.0 mt-10 -63.02 -23.38 67.43 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -170.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.487 ' O ' HG23 ' A' ' 143' ' ' VAL . 82.0 t80 -75.21 -44.9 43.79 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 172.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.32 -48.88 79.83 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.99 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.415 ' OG ' ' HA ' ' A' ' 138' ' ' GLU . 2.5 p -62.69 -38.0 88.67 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.64 0.257 . . . . 0.0 111.141 177.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.867 ' HG ' ' HG2' ' A' ' 129' ' ' LYS . 1.5 tt -64.75 -50.41 66.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.244 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 139' ' ' PHE . 86.1 t -58.69 -49.51 82.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.083 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -63.81 -39.15 93.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.371 -177.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.614 ' O ' ' HG3' ' A' ' 149' ' ' MET . 8.0 tt0 -61.02 -45.79 93.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.018 176.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.51 ' O ' HD21 ' A' ' 150' ' ' LEU . 57.7 mt -55.61 -46.27 79.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.799 177.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -54.71 -42.49 71.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.609 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -69.27 -35.65 76.28 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.172 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.614 ' HG3' ' O ' ' A' ' 145' ' ' GLN . 80.5 mtp -70.46 -19.3 62.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.299 0.571 . . . . 0.0 110.088 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.51 HD21 ' O ' ' A' ' 146' ' ' ILE . 4.3 mm? . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.109 174.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.411 ' H ' HD12 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -105.96 -9.79 10.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 169.662 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.2 p -94.89 158.78 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.872 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.531 ' HB2' ' HG2' ' A' ' 11' ' ' GLU . 24.8 mtt180 -127.65 168.91 14.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.782 0.325 . . . . 0.0 111.038 -171.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.466 HG12 HD22 ' A' ' 130' ' ' LEU . 75.2 mt -78.25 117.83 24.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.75 174.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.95 -25.58 9.37 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.706 -177.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.531 ' HG2' ' HB2' ' A' ' 8' ' ' ARG . 71.6 mm-40 -66.73 152.92 44.53 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.697 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 59.7 mtp -81.48 134.6 35.55 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 175.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.473 ' HB2' HH12 ' A' ' 32' ' ' ARG . . . -59.53 133.82 88.75 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.293 -176.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -67.15 174.35 7.14 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.884 2.39 . . . . 0.0 112.18 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.546 ' O ' ' HE2' ' A' ' 107' ' ' LYS . 5.1 p-10 -76.54 163.69 26.67 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.32 177.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.545 ' HB2' HD13 ' A' ' 104' ' ' ILE . 23.0 p90 -174.11 148.91 1.39 Allowed 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 166.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.613 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 52.1 m -131.33 99.55 4.88 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 173.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.644 ' O ' ' HA ' ' A' ' 25' ' ' GLN . 16.6 tt -99.35 148.62 6.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.238 -171.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.7 m -98.16 114.84 27.19 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.059 177.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.4 mt -74.1 172.81 11.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.457 -178.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 96' ' ' LEU . 52.3 p -55.42 -27.07 45.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.997 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -96.61 14.54 24.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.351 -174.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.13 29.64 66.39 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.947 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -108.88 120.58 42.93 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.735 0.303 . . . . 0.0 110.658 -176.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.644 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 25.1 mt-30 -98.23 128.11 44.52 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.749 -178.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.613 ' O ' ' HA ' ' A' ' 17' ' ' THR . 12.2 m -125.59 150.74 31.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.591 178.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 22.9 m -113.11 142.47 45.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.383 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.505 HD12 ' CD1' ' A' ' 121' ' ' ILE . 0.6 OUTLIER -62.37 -36.78 83.35 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.673 0.273 . . . . 0.0 111.101 -177.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.7 m -58.04 -27.13 63.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.711 -177.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.9 m -78.53 -20.61 50.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.06 0.457 . . . . 0.0 111.21 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.3 mt -102.21 17.73 22.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.632 -176.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.473 HH12 ' HB2' ' A' ' 13' ' ' ALA . 22.8 mmt180 -68.74 147.06 52.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.772 0.32 . . . . 0.0 110.689 178.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.401 ' O ' ' HG3' ' A' ' 123' ' ' ARG . . . 101.77 -25.69 27.06 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.255 178.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.908 ' HB3' ' HZ3' ' A' ' 34' ' ' LYS . 0.7 OUTLIER -115.02 160.76 19.21 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.094 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 p -74.78 115.88 16.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.541 0.686 . . . . 0.0 110.41 -177.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.437 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 21.7 t -106.14 122.39 59.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.195 -177.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.534 ' SD ' ' HG ' ' A' ' 71' ' ' LEU . 2.1 tmt? -108.97 135.47 50.1 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.052 0.453 . . . . 0.0 110.125 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.47 HD23 ' CE2' ' A' ' 16' ' ' PHE . 7.0 mp -130.28 144.06 51.15 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.414 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.6 133.14 32.09 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 172.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.46 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 95.9 m-85 -99.49 105.36 17.27 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.91 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.2 t -115.52 -176.42 2.92 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.076 -172.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -169.16 139.91 2.32 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.528 ' H ' ' HG3' ' A' ' 78' ' ' GLU . 19.0 p -66.97 -23.38 65.94 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.882 0.372 . . . . 0.0 111.372 -174.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 65.4 p-90 -84.49 -2.31 57.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.66 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.4 t -90.07 139.26 30.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.269 0.557 . . . . 0.0 111.366 -178.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -93.56 -27.67 12.65 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.349 176.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 42.9 t -67.86 -39.51 81.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.87 0.367 . . . . 0.0 110.707 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.615 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 61.0 m -61.54 -15.9 42.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.761 178.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -78.41 -3.06 41.37 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.764 0.316 . . . . 0.0 110.913 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -85.93 -47.0 10.05 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.293 0.568 . . . . 0.0 109.832 165.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.615 ' HG2' ' HA ' ' A' ' 48' ' ' CYS . 14.2 pt-20 -75.0 -32.87 61.75 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.698 -172.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.543 ' CB ' ' HD3' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -48.96 -65.03 0.89 Allowed Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 175.28 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.543 ' HD3' ' CB ' ' A' ' 52' ' ' MET . 35.8 Cg_exo -60.88 -39.18 63.83 Favored 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 121.745 1.63 . . . . 0.0 112.844 177.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.639 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 8.2 m-85 -67.42 -46.73 72.32 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -176.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.13 -49.37 84.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 178.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.588 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 29.7 mm-40 -56.33 -44.52 80.09 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 123.399 0.437 . . . . 0.0 111.026 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -67.46 -49.17 64.8 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.705 -0.679 . . . . 0.0 112.276 -176.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.706 ' HA ' ' HZ1' ' A' ' 62' ' ' LYS . 42.3 m-20 -107.68 -51.2 2.94 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -170.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.4 mt -73.68 -49.05 37.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.867 -173.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.443 ' CD2' ' HB3' ' A' ' 94' ' ' TYR . 63.4 t-105 -71.63 -69.93 0.35 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.76 -178.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.588 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.4 OUTLIER -41.27 -40.27 1.59 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -171.729 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.706 ' HZ1' ' HA ' ' A' ' 58' ' ' ASP . 36.9 mmtm -75.97 -31.56 59.08 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -172.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -122.78 -43.06 2.27 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.876 -174.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.41 ' O ' ' HD2' ' A' ' 69' ' ' PHE . 53.6 mttt 51.64 -92.98 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 123.852 0.861 . . . . 0.0 111.504 -175.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -90.21 -61.04 1.77 Allowed 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 120.761 0.315 . . . . 0.0 110.471 176.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.496 ' ND2' HD12 ' A' ' 150' ' ' LEU . 0.9 OUTLIER 61.09 9.46 2.41 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.185 0.594 . . . . 0.0 111.408 175.928 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 68.27 -22.18 0.13 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.833 0.853 . . . . 0.0 112.869 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.573 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 3.2 t70 -138.81 22.76 2.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.369 0.604 . . . . 0.0 110.289 -174.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.541 ' HB2' HD11 ' A' ' 150' ' ' LEU . 86.4 t80 -127.28 116.18 20.16 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.198 173.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -114.65 104.42 11.97 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.727 -178.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.534 ' HG ' ' SD ' ' A' ' 37' ' ' MET . 5.6 tt -104.29 114.95 29.53 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.9 mp -120.83 117.26 52.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.118 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.514 ' HA3' HD21 ' A' ' 96' ' ' LEU . . . -90.33 131.8 10.94 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.315 -0.945 . . . . 0.0 110.938 175.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 45.9 mt -119.27 119.59 61.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 117.046 0.423 . . . . 0.0 110.679 -175.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -85.72 136.04 33.51 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 173.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.521 ' HD3' HD13 ' A' ' 115' ' ' ILE . 21.6 ttp180 -68.71 -45.25 72.09 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.408 -0.814 . . . . 0.0 112.689 -170.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -158.87 8.73 0.13 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -169.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.528 ' HG3' ' H ' ' A' ' 43' ' ' SER . 14.1 mm-40 -86.65 138.11 33.68 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-O 120.951 0.405 . . . . 0.0 110.678 176.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.423 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 34.5 Cg_endo -69.24 -173.6 0.67 Allowed 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.901 2.401 . . . . 0.0 113.651 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.43 ' O ' HD21 ' A' ' 84' ' ' LEU . 2.8 tm? -59.27 -56.66 19.33 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.062 -169.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.423 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -67.02 -34.31 77.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.473 -173.099 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.417 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 14.4 mmmm -60.26 -50.4 73.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.925 177.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 95.7 t -61.28 -48.26 89.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.104 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.43 HD21 ' O ' ' A' ' 80' ' ' LEU . 4.4 mm? -61.28 -52.66 63.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.623 -177.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.12 -37.27 86.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.511 -178.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -68.84 -41.34 78.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.719 -0.218 . . . . 0.0 110.918 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.478 ' HB2' HD13 ' A' ' 96' ' ' LEU . . . -66.16 -41.7 89.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.737 0.78 . . . . 0.0 109.549 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -58.99 -30.25 67.82 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.218 -1.355 . . . . 0.0 111.437 176.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.3 m -99.85 -1.38 37.61 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -176.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.1 p -113.53 -5.12 13.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.845 0.355 . . . . 0.0 111.494 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.09 -5.32 83.12 Favored Glycine 0 C--O 1.228 -0.277 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.368 177.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.501 ' CG2' ' HG3' ' A' ' 52' ' ' MET . 69.2 t -57.27 121.92 5.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.099 0.476 . . . . 0.0 111.551 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.409 ' H ' ' CD ' ' A' ' 56' ' ' GLU . 75.3 p -114.53 -15.56 12.0 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.383 176.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.443 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 36.8 p90 -71.57 144.73 89.15 Favored Pre-proline 0 C--O 1.233 0.236 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 173.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.34 124.71 13.79 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.415 2.076 . . . . 0.0 113.132 -176.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.514 HD21 ' HA3' ' A' ' 73' ' ' GLY . 84.8 mt -99.17 153.29 19.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.476 173.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -122.83 156.13 17.24 Favored Glycine 0 N--CA 1.437 -1.24 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 174.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.512 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.4 pt? -116.11 119.88 37.26 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.734 0.267 . . . . 0.0 110.349 -178.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -117.25 76.1 8.79 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.402 178.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.11 107.46 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.481 2.12 . . . . 0.0 111.936 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 131.59 -27.31 3.74 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -176.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.457 ' HB1' ' HG2' ' A' ' 76' ' ' ARG . . . 66.98 24.61 9.52 Favored 'General case' 0 CA--C 1.522 -0.097 0 C-N-CA 122.992 0.517 . . . . 0.0 111.373 176.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -70.94 -41.43 71.14 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.173 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.545 HD13 ' HB2' ' A' ' 16' ' ' PHE . 48.3 mm -62.05 -33.77 60.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.379 0.609 . . . . 0.0 109.62 174.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -70.21 -39.21 75.29 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.427 175.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -66.15 -28.92 69.15 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -174.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.546 ' HE2' ' O ' ' A' ' 15' ' ' ASP . 13.6 ptmt -79.46 -1.96 39.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.994 0.426 . . . . 0.0 111.276 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -112.09 -50.92 2.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.21 172.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -141.05 152.81 45.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.408 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.407 ' HB3' ' OD1' ' A' ' 112' ' ' ASP . 97.3 mt -62.38 139.26 58.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.849 0.357 . . . . 0.0 111.041 -178.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.406 ' HD3' ' HB2' ' A' ' 102' ' ' ALA . 12.3 mtm180 -66.01 -25.62 67.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.209 0.528 . . . . 0.0 110.837 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.407 ' OD1' ' HB3' ' A' ' 110' ' ' LEU . 4.2 p-10 -83.99 -8.49 59.14 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.171 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.83 -8.02 57.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.373 -178.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.27 -128.19 8.25 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.444 174.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.521 HD13 ' HD3' ' A' ' 76' ' ' ARG . 8.1 tp -154.25 173.65 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -174.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.444 ' N ' HG13 ' A' ' 115' ' ' ILE . 28.2 m 71.0 81.54 0.16 Allowed 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.476 0.655 . . . . 0.0 111.279 175.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.6 mmt85 -133.8 131.9 39.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.111 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.556 ' O ' ' HA ' ' A' ' 130' ' ' LEU . 0.2 OUTLIER -116.1 119.67 36.57 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.179 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.483 ' N ' HD21 ' A' ' 118' ' ' ASN . 63.2 t -113.76 131.81 64.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.996 -177.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.694 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 36.7 tp -119.36 122.04 40.91 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.316 0.579 . . . . 0.0 110.875 177.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.505 ' CD1' HD12 ' A' ' 28' ' ' LEU . 53.6 mt -100.7 135.08 38.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.778 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.86 -176.91 5.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.212 0.53 . . . . 0.0 111.09 -176.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 28.6 ttm180 -68.41 -23.32 64.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.001 -175.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.426 ' CD ' ' HZ1' ' A' ' 126' ' ' LYS . 41.1 mt-10 -80.78 -26.62 37.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.979 0.418 . . . . 0.0 110.769 175.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 112.4 12.22 13.82 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.352 -0.928 . . . . 0.0 112.311 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.697 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 77.5 mttt -97.13 160.62 14.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.822 0.344 . . . . 0.0 110.66 -178.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 47.0 mt -95.79 109.59 22.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 175.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.7 m -110.59 1.13 9.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.918 -174.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.789 ' HG2' ' HG ' ' A' ' 142' ' ' LEU . 51.7 tptt -160.94 114.05 1.98 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 -175.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.556 ' HA ' ' O ' ' A' ' 118' ' ' ASN . 0.4 OUTLIER -138.4 105.98 5.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.171 0.51 . . . . 0.0 110.449 176.35 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.567 ' HB ' ' HG2' ' A' ' 138' ' ' GLU . 10.1 t -99.46 155.89 17.32 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.095 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.425 HH21 ' CG ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -122.49 132.74 54.48 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.538 -179.807 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.429 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 3.1 mp 66.45 36.03 5.31 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 123.71 0.631 . . . . 0.0 110.614 176.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.429 ' HB3' ' O ' ' A' ' 133' ' ' LEU . 45.8 t80 71.2 -66.38 0.3 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.518 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.548 ' HB3' ' HB3' ' A' ' 138' ' ' GLU . 0.8 OUTLIER 64.54 113.18 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.046 0.45 . . . . 0.0 110.954 -175.882 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -49.95 -56.4 10.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.785 -174.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.09 -36.24 27.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.343 -174.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.567 ' HG2' ' HB ' ' A' ' 131' ' ' THR . 3.4 tp10 -63.54 -38.72 92.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.962 0.41 . . . . 0.0 110.128 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.639 ' CE2' ' HB3' ' A' ' 54' ' ' PHE . 76.6 t80 -70.65 -41.48 72.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.994 176.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.56 -49.6 75.84 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.827 0.346 . . . . 0.0 110.894 177.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.3 p -61.5 -34.11 74.93 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.69 177.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.789 ' HG ' ' HG2' ' A' ' 129' ' ' LYS . 4.6 tt -66.83 -42.94 84.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.255 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.461 ' O ' ' HB ' ' A' ' 146' ' ' ILE . 95.0 t -59.09 -51.47 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 120.782 0.325 . . . . 0.0 111.345 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.429 ' HA ' ' OE1' ' A' ' 144' ' ' GLN . 6.4 tp60 -62.0 -38.38 88.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.304 0.573 . . . . 0.0 110.168 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.401 HE22 ' HB2' ' A' ' 129' ' ' LYS . 29.0 tt0 -63.03 -36.88 85.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.724 177.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.573 ' O ' HD21 ' A' ' 150' ' ' LEU . 30.2 mm -55.09 -53.03 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 120.929 0.395 . . . . 0.0 110.259 174.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -53.06 -45.15 67.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.265 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -65.05 -37.37 87.36 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.128 0.268 . . . . 0.0 111.251 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 84.2 mmm -60.98 -29.97 69.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.65 0.738 . . . . 0.0 109.723 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.573 HD21 ' O ' ' A' ' 146' ' ' ILE . 4.0 mm? . . . . . 0 C--N 1.32 -0.713 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.62 178.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 . . . . . 0 CA--C 1.521 -0.155 0 CA-C-O 120.684 0.278 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.498 HG12 ' HA ' ' A' ' 109' ' ' ALA . 47.3 pt -92.84 -22.07 5.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.147 175.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.5 ' CG1' HD12 ' A' ' 127' ' ' ILE . 36.3 t -102.39 147.37 9.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.416 177.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 57.2 mtt85 -120.26 168.54 11.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.047 0.451 . . . . 0.0 111.893 -168.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.592 HG12 HD13 ' A' ' 130' ' ' LEU . 77.0 mt -75.18 127.19 36.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.071 176.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.6 -9.26 77.49 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -175.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -92.03 151.38 20.49 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.655 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 56.7 mtp -80.95 144.76 31.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.096 0.474 . . . . 0.0 111.346 -172.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.37 134.01 39.19 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.275 -177.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.412 ' HG2' ' O ' ' A' ' 107' ' ' LYS . 13.3 Cg_exo -70.88 139.67 36.83 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.033 2.489 . . . . 0.0 112.033 177.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -75.78 164.81 25.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.277 -178.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.5 ' HE2' ' HH ' ' A' ' 108' ' ' TYR . 54.1 p90 -165.2 162.17 19.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.872 -176.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 37.3 m -124.72 110.59 14.54 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 175.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.4 tt -112.78 151.97 14.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.453 -171.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.499 ' HB ' ' CD2' ' A' ' 98' ' ' LEU . 2.8 m -89.34 126.32 35.48 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.142 177.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.0 mt -82.01 178.36 8.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.733 0.302 . . . . 0.0 111.082 177.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.457 ' HB ' HD13 ' A' ' 84' ' ' LEU . 16.5 p -59.37 -26.26 64.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.791 -176.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.599 ' OD2' ' HG2' ' A' ' 24' ' ' LYS . 7.4 p-10 -94.2 -18.23 21.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.185 0.517 . . . . 0.0 110.418 -178.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.56 0.52 21.76 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.412 -177.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.697 ' HZ3' ' HB3' ' A' ' 24' ' ' LYS . 4.8 mmmp? -66.44 126.87 30.21 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-O 121.088 0.471 . . . . 0.0 111.696 178.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -88.67 120.92 30.51 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.445 172.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 17' ' ' THR . 11.3 m -123.66 151.83 28.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.826 0.346 . . . . 0.0 110.324 177.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.2 m -110.11 151.72 26.89 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.414 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.07 -35.35 80.45 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.525 ' HA ' ' CG ' ' A' ' 32' ' ' ARG . 37.7 t -56.88 -23.45 44.63 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.96 177.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.1 m -69.57 -24.0 63.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.27 0.557 . . . . 0.0 110.675 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.44 HD12 ' HB3' ' A' ' 70' ' ' ALA . 67.3 mt -116.1 11.57 15.32 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.932 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.525 ' CG ' ' HA ' ' A' ' 29' ' ' SER . 9.2 mmm180 -74.75 104.18 5.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.975 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 147.79 -24.75 1.48 Allowed Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.739 ' HB3' ' HZ1' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -115.45 174.74 5.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.161 -0.519 . . . . 0.0 110.466 177.883 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 68' ' ' ASP . 26.8 m -74.72 128.59 36.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.0 t -123.68 112.17 32.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 120.959 0.409 . . . . 0.0 110.575 -176.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.434 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 27.3 ttt -95.98 127.12 41.72 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.734 178.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.6 mp -122.05 137.15 54.92 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.771 176.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.4 pm0 -126.91 129.3 47.92 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 171.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.475 ' O ' ' HA ' ' A' ' 116' ' ' THR . 96.8 m-85 -90.73 110.39 21.58 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.007 -179.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.61 HG23 ' SG ' ' A' ' 48' ' ' CYS . 28.5 m -119.49 165.21 14.68 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.438 -166.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.574 ' HB1' ' SG ' ' A' ' 45' ' ' CYS . . . -145.11 147.12 32.18 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 171.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.442 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 81.0 p -60.56 -21.52 62.65 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -174.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 8.5 p-90 -103.06 3.68 36.32 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -175.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.629 ' SG ' HD12 ' A' ' 115' ' ' ILE . 89.9 m -79.59 102.12 8.69 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.97 0.414 . . . . 0.0 111.082 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.98 -40.48 97.17 Favored Glycine 0 C--O 1.228 -0.271 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.874 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 56.9 t -61.4 -37.25 77.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.222 0.534 . . . . 0.0 110.614 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.61 ' SG ' HG23 ' A' ' 41' ' ' THR . 22.8 t -72.32 -14.85 61.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.762 -178.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -75.2 -7.28 53.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.971 0.415 . . . . 0.0 110.781 177.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.458 ' HD3' ' CD2' ' A' ' 134' ' ' TYR . 70.4 mttt -83.42 -47.84 10.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 122.343 1.068 . . . . 0.0 108.376 163.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.769 ' HB2' ' HB2' ' A' ' 134' ' ' TYR . 40.3 tt0 -58.24 -58.34 8.91 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 113.263 -1.789 . . . . 0.0 112.108 -173.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.78 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 96.1 mmm -50.3 -57.43 12.96 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -175.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.78 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 32.7 Cg_exo -61.49 -38.9 59.61 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 122.3 2.0 . . . . 0.0 112.823 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.501 ' HB3' ' CZ ' ' A' ' 139' ' ' PHE . 6.4 m-85 -65.41 -43.76 89.54 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.496 0.189 . . . . 0.0 111.305 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 51' ' ' GLU . 77.0 mt -58.03 -47.86 85.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 175.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -54.75 -54.18 45.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.633 176.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -62.33 -59.31 5.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.181 -0.918 . . . . 0.0 113.226 -173.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.906 ' HA ' ' HZ1' ' A' ' 62' ' ' LYS . 67.9 m-20 -107.13 -13.53 15.14 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -166.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.2 mt -104.59 -57.24 4.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.476 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.529 ' CE2' ' HB3' ' A' ' 94' ' ' TYR . 71.3 t-105 -60.97 -68.32 0.32 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.868 -177.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.01 -23.49 2.07 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -175.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.906 ' HZ1' ' HA ' ' A' ' 58' ' ' ASP . 38.9 mmtm -87.42 -37.44 17.02 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -175.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -130.51 0.16 4.46 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -171.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.464 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 16.5 pttp -39.34 -51.91 2.04 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 -169.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.02 -83.66 0.16 Allowed 'General case' 0 C--O 1.251 1.163 0 CA-C-O 121.458 0.647 . . . . 0.0 110.117 -173.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 56.57 -153.46 0.36 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.366 -174.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -111.41 -14.21 13.78 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 168.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.504 ' OD1' ' HB3' ' A' ' 34' ' ' LYS . 5.6 m-20 -144.12 39.78 1.34 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.581 -1.19 . . . . 0.0 112.374 -172.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -121.24 128.63 52.58 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 119.134 -1.026 . . . . 0.0 110.266 168.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.44 ' HB3' HD12 ' A' ' 31' ' ' LEU . . . -130.22 142.48 50.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.841 177.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.434 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 5.6 tt -146.91 123.82 11.32 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 31.8 mt -130.6 129.88 64.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.475 ' HA3' HD21 ' A' ' 96' ' ' LEU . . . -88.05 131.83 10.87 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 175.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.0 mm -119.85 107.77 21.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 117.034 0.417 . . . . 0.0 110.842 -170.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.531 ' HA ' ' O ' ' A' ' 41' ' ' THR . 11.6 t70 -77.82 143.46 37.85 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.727 178.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 51.9 ttt-85 -71.01 -30.43 66.66 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -171.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -154.86 -32.67 0.1 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -174.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.562 ' CD ' ' HZ2' ' A' ' 82' ' ' LYS . 11.9 mm-40 -61.96 141.72 95.46 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.101 0.477 . . . . 0.0 112.258 -166.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -74.51 179.83 5.53 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 123.018 2.479 . . . . 0.0 112.793 178.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.526 HD21 HD12 ' A' ' 98' ' ' LEU . 88.1 mt -49.37 -55.57 12.52 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.846 -178.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -50.52 -36.62 34.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.638 -173.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.562 ' HZ2' ' CD ' ' A' ' 78' ' ' GLU . 41.8 mtpt -82.61 -45.61 14.35 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.77 0.319 . . . . 0.0 110.779 -178.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.555 HG21 ' HB3' ' A' ' 98' ' ' LEU . 91.0 t -56.53 -46.71 82.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.434 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.457 HD13 ' HB ' ' A' ' 21' ' ' THR . 4.1 mm? -58.52 -52.9 63.7 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.765 0.317 . . . . 0.0 111.361 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.49 -37.76 84.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.553 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.442 ' CD1' ' HA ' ' A' ' 43' ' ' SER . 91.8 t80 -65.88 -42.85 89.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.073 -179.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.448 ' HB3' HD13 ' A' ' 96' ' ' LEU . . . -66.43 -43.48 85.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.731 0.777 . . . . 0.0 109.897 178.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -59.6 -27.82 66.63 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.205 -1.361 . . . . 0.0 111.801 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.5 m -100.83 -0.47 36.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.837 -176.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.7 p -117.77 2.34 12.23 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.355 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.53 15.29 80.01 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.837 175.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.478 HG21 ' HE3' ' A' ' 52' ' ' MET . 72.6 t -73.62 127.03 35.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -177.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 61.3 p -106.31 -24.16 12.35 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.526 174.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.529 ' HB3' ' CE2' ' A' ' 60' ' ' TRP . 34.8 p90 -71.2 145.03 90.49 Favored Pre-proline 0 C--O 1.232 0.136 0 CA-C-O 120.884 0.374 . . . . 0.0 111.118 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.76 134.83 56.21 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.826 2.351 . . . . 0.0 112.893 -177.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.475 HD21 ' HA3' ' A' ' 73' ' ' GLY . 53.8 mt -109.72 139.06 45.2 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.734 174.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -113.28 145.29 18.29 Favored Glycine 0 N--CA 1.439 -1.139 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 174.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.599 HD11 ' H ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -103.54 139.02 39.43 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.188 0.518 . . . . 0.0 110.937 -179.903 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -118.83 82.0 19.99 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.12 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.74 105.07 0.6 Allowed 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.409 2.073 . . . . 0.0 112.79 -176.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.96 8.64 27.47 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.581 178.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 52.31 42.14 30.81 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -81.04 -49.78 10.48 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.123 0.487 . . . . 0.0 110.692 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 98.7 mt -66.72 -31.38 53.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 176.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -60.15 -41.13 92.08 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.177 171.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.664 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -67.23 -24.49 65.82 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.811 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.412 ' O ' ' HG2' ' A' ' 14' ' ' PRO . 14.7 mptt -64.56 -23.69 67.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.963 0.411 . . . . 0.0 111.025 176.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.5 ' HH ' ' HE2' ' A' ' 16' ' ' PHE . 57.2 m-85 -113.71 -11.74 12.9 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -173.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.664 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . 179.58 178.31 0.55 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.758 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 94.6 mt -67.87 133.93 50.01 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 175.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.456 ' HE ' ' HB2' ' A' ' 111' ' ' ARG . 1.5 mtm180 -52.39 -51.6 58.13 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 122.058 0.933 . . . . 0.0 110.578 -176.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.08 21.75 6.49 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.229 -1.35 . . . . 0.0 111.457 -172.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.758 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . . . -93.78 6.06 49.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.172 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 139.34 -164.5 25.91 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.464 178.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.749 HD13 ' N ' ' A' ' 116' ' ' THR . 0.0 OUTLIER -168.12 155.61 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.803 HG22 ' HA ' ' A' ' 133' ' ' LEU . 55.8 m 75.54 95.85 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.791 0.805 . . . . 0.0 110.386 -178.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -160.17 145.56 15.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.99 -177.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.55 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 31.1 m-80 -102.3 119.18 38.38 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.148 -178.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.1 t -118.3 109.97 28.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.843 -178.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 49.2 tp -100.31 117.06 33.74 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.699 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 53.8 mt -97.19 134.24 35.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.46 177.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.586 ' OD2' ' HB2' ' A' ' 126' ' ' LYS . 3.1 p30 -86.04 177.26 7.63 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.267 0.556 . . . . 0.0 111.261 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -66.15 -24.7 66.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.341 -177.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -80.41 -19.02 47.17 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.725 0.298 . . . . 0.0 110.557 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 106.85 12.02 25.15 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.12 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.655 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 8.3 mtmp? -102.58 158.31 16.32 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.5 HD12 ' CG1' ' A' ' 7' ' ' VAL . 54.0 mt -94.5 125.67 47.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 174.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.7 m -105.47 -22.04 5.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.901 0.382 . . . . 0.0 111.764 -174.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.412 ' HA ' ' HD2' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -142.28 125.9 16.87 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.139 -0.624 . . . . 0.0 112.35 -172.081 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.592 HD13 HG12 ' A' ' 9' ' ' ILE . 10.5 mp -114.74 117.67 31.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.405 172.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.55 ' HB ' ' HB2' ' A' ' 118' ' ' ASN . 4.2 m -122.69 131.78 53.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.801 0.334 . . . . 0.0 110.651 171.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.624 ' O ' ' HD2' ' A' ' 132' ' ' ARG . 0.1 OUTLIER -93.09 120.6 33.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.745 178.932 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.803 ' HA ' HG22 ' A' ' 116' ' ' THR . 16.9 mt 61.93 179.96 0.12 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.557 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.769 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 84.6 t80 -83.95 97.96 9.54 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 171.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -107.63 120.52 42.45 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 173.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -43.7 -56.4 3.8 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 123.841 0.713 . . . . 0.0 112.803 -173.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -56.65 -46.13 81.21 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -178.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -71.54 -35.2 70.58 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.602 -175.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.501 ' CZ ' ' HB3' ' A' ' 54' ' ' PHE . 81.4 t80 -66.06 -41.06 91.31 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 175.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.84 -41.97 98.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.42 175.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.1 m -63.27 -39.18 93.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.052 177.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.722 ' O ' HG12 ' A' ' 146' ' ' ILE . 35.6 mt -59.38 -52.46 65.52 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.575 177.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 139' ' ' PHE . 91.6 t -52.48 -50.27 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 O-C-N 123.376 0.422 . . . . 0.0 111.433 -178.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -60.41 -41.72 94.49 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.075 0.464 . . . . 0.0 110.339 178.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -63.49 -42.24 98.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.687 178.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.722 HG12 ' O ' ' A' ' 142' ' ' LEU . 35.4 mm -56.73 -46.88 83.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -56.26 -43.38 78.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.692 177.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -72.89 -33.7 66.2 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.209 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 92.1 mmm -65.41 -24.88 67.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.162 0.506 . . . . 0.0 110.378 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.619 HD23 ' O ' ' A' ' 146' ' ' ILE . 4.0 mm? . . . . . 0 C--N 1.323 -0.55 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.205 176.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 . . . . . 0 CA--C 1.518 -0.28 0 CA-C-O 120.86 0.362 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.7 pt -101.8 -7.42 9.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.01 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.3 p -110.98 159.15 11.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.48 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 24.1 mtm-85 -120.71 165.66 14.78 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -168.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.518 HG12 HD23 ' A' ' 130' ' ' LEU . 62.1 mt -76.05 137.23 23.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.414 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.51 -26.09 23.25 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.083 178.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -67.75 150.88 48.09 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.699 ' SD ' ' HG2' ' A' ' 126' ' ' LYS . 63.3 mmm -71.79 124.03 23.92 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.463 ' HB3' HD13 ' A' ' 121' ' ' ILE . . . -54.89 140.72 60.05 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.08 -178.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.68 174.58 6.33 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.613 2.209 . . . . 0.0 112.254 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.527 ' O ' ' HB3' ' A' ' 16' ' ' PHE . 3.0 p-10 -78.69 174.4 11.45 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.999 177.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.703 ' CE2' ' HG ' ' A' ' 28' ' ' LEU . 16.5 p90 176.36 144.96 0.08 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.428 163.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.642 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 56.2 m -127.93 99.88 5.69 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.444 -0.798 . . . . 0.0 108.866 175.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 25' ' ' GLN . 20.3 tt -106.0 146.91 12.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.22 -171.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 24' ' ' LYS . 24.4 m -83.19 127.87 33.99 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.027 177.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.7 mt -84.46 177.62 8.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.144 0.497 . . . . 0.0 111.462 -178.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.422 ' HB ' HD23 ' A' ' 84' ' ' LEU . 21.8 p -62.74 -23.5 67.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.988 -175.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.518 ' OD2' ' HG2' ' A' ' 24' ' ' LYS . 7.5 p-10 -105.47 9.07 33.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.167 0.508 . . . . 0.0 110.527 -176.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.3 14.17 59.15 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.247 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.518 ' HG2' ' OD2' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -85.52 171.21 11.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.207 0.503 . . . . 0.0 109.865 175.6 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 50.7 mt-30 -136.09 129.12 31.39 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 176.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 17' ' ' THR . 21.7 m -119.52 150.49 21.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.673 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 9.4 m -117.86 142.7 47.03 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.996 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.703 ' HG ' ' CE2' ' A' ' 16' ' ' PHE . 0.6 OUTLIER -64.04 -22.68 67.03 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.623 0.249 . . . . 0.0 111.358 -179.033 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.0 m -61.25 -38.43 86.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.967 0.413 . . . . 0.0 110.645 177.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.5 m -73.09 -23.66 60.56 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.52 0.676 . . . . 0.0 110.784 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.421 ' HB2' HD22 ' A' ' 28' ' ' LEU . 91.7 mt -88.1 -9.19 54.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.761 -177.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.435 HH21 HD11 ' A' ' 28' ' ' LEU . 5.8 mmt180 -60.63 150.57 31.5 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.741 0.305 . . . . 0.0 110.422 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.8 -23.75 31.38 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.602 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 31.2 mtmm -117.45 157.3 26.47 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.842 -0.679 . . . . 0.0 109.985 -178.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 68' ' ' ASP . 18.3 m -71.43 131.42 34.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.183 0.516 . . . . 0.0 109.896 177.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.501 HG13 HD23 ' A' ' 28' ' ' LEU . 20.8 t -120.01 123.56 71.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.904 0.383 . . . . 0.0 110.824 -177.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.538 ' SD ' HG22 ' A' ' 59' ' ' ILE . 28.1 ttt -108.29 117.05 33.13 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.9 0.381 . . . . 0.0 110.525 177.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -104.66 103.79 13.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.205 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.59 ' OE1' ' HG2' ' A' ' 52' ' ' MET . 0.0 OUTLIER -103.38 112.59 25.56 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.707 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 97.3 m-85 -91.86 120.06 32.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.78 -176.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.524 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 15.2 t -140.41 -178.43 5.49 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.756 -173.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.484 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . . . -162.76 157.07 21.09 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 122.721 0.408 . . . . 0.0 110.073 172.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.427 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 12.3 t -64.24 -32.54 74.17 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.672 -175.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 51.0 p-90 -83.85 8.17 15.72 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -174.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 43.4 t -99.62 130.87 45.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.964 0.411 . . . . 0.0 111.338 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -89.07 -28.48 20.52 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.624 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.4 t -67.32 -35.74 74.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.157 0.503 . . . . 0.0 110.269 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.557 ' HA ' ' HB3' ' A' ' 51' ' ' GLU . 59.4 m -65.78 -15.15 62.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.517 177.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.43 ' O ' ' HG2' ' A' ' 53' ' ' PRO . 84.4 mtt180 -78.74 -3.72 45.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.331 0.586 . . . . 0.0 110.148 177.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.466 ' NZ ' ' HE2' ' A' ' 134' ' ' TYR . 1.4 mmmp? -95.2 -52.39 4.21 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 162.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.716 ' O ' HG12 ' A' ' 55' ' ' ILE . 41.1 tt0 -56.36 -65.25 0.64 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 113.478 -1.692 . . . . 0.0 112.153 -173.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.59 ' HG2' ' OE1' ' A' ' 39' ' ' GLN . 1.7 mmm -56.29 -50.04 89.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -173.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.617 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 53.3 Cg_exo -55.34 -37.96 94.19 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 121.868 1.712 . . . . 0.0 112.097 176.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -72.69 -37.5 67.85 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.426 177.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.716 HG12 ' O ' ' A' ' 51' ' ' GLU . 28.9 mm -55.04 -57.48 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 121.025 0.441 . . . . 0.0 110.147 177.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.728 ' HG2' ' HA ' ' A' ' 92' ' ' VAL . 0.5 OUTLIER -66.18 -43.66 86.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.359 -177.617 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.617 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 3.7 ttmm -62.46 -41.52 98.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.775 -172.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.62 ' O ' ' HG2' ' A' ' 62' ' ' LYS . 6.1 t70 -104.61 -65.09 1.06 Allowed 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.877 178.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.538 HG22 ' SD ' ' A' ' 37' ' ' MET . 25.1 mm -54.01 -46.77 65.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-O 120.97 0.414 . . . . 0.0 111.113 -171.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.511 ' HB3' ' O ' ' A' ' 56' ' ' GLU . 73.5 t-105 -73.92 -60.65 2.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.17 -178.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.55 HD13 ' CE ' ' A' ' 64' ' ' LYS . 3.8 mm? -50.72 -35.09 29.61 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -173.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.62 ' HG2' ' O ' ' A' ' 58' ' ' ASP . 33.7 mmtp -73.93 -27.98 61.29 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -175.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 -126.38 -43.85 1.74 Allowed 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.191 -0.604 . . . . 0.0 112.626 -172.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.55 ' CE ' HD13 ' A' ' 61' ' ' LEU . 55.2 mttt 45.75 -89.82 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.011 0.924 . . . . 0.0 112.679 -176.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.413 ' C ' ' H ' ' A' ' 67' ' ' ALA . 15.7 t70 -87.31 -71.03 0.58 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 65.03 -4.07 0.53 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.206 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.413 ' H ' ' C ' ' A' ' 65' ' ' ASP . . . 68.48 -6.65 0.78 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.961 0.904 . . . . 0.0 112.125 -176.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.602 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 3.9 t70 -137.89 8.35 2.77 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.951 0.405 . . . . 0.0 110.692 -177.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.542 ' CE2' ' HB2' ' A' ' 71' ' ' LEU . 72.3 t80 -116.01 119.07 34.68 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.096 -0.642 . . . . 0.0 111.283 -174.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.75 107.9 12.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.669 178.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.542 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 1.7 tt -117.46 120.55 38.47 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 52.6 mt -129.89 131.31 66.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.759 0.314 . . . . 0.0 110.288 179.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.58 116.94 4.62 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 176.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 25.6 mm -103.92 111.36 33.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 116.615 0.208 . . . . 0.0 110.6 -173.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.524 ' HA ' ' O ' ' A' ' 41' ' ' THR . 8.9 t70 -80.79 140.06 35.68 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 44.4 ttt-85 -78.26 -30.92 48.82 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -172.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -163.45 -16.01 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -170.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.477 ' CD ' ' HD2' ' A' ' 82' ' ' LYS . 6.0 mm-40 -77.33 137.06 64.4 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.141 0.496 . . . . 0.0 110.793 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.494 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 30.7 Cg_endo -68.39 -174.59 0.7 Allowed 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.098 2.532 . . . . 0.0 114.576 -177.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.645 HD23 HD22 ' A' ' 84' ' ' LEU . 5.2 tt -54.26 -59.04 5.2 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.299 -1.319 . . . . 0.0 112.393 -170.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.494 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -61.31 -36.31 79.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.914 -171.883 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.477 ' HD2' ' CD ' ' A' ' 78' ' ' GLU . 42.2 mttt -64.36 -48.23 76.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.033 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.459 HG21 ' O ' ' A' ' 79' ' ' PRO . 57.9 t -53.84 -46.47 63.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.554 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.645 HD22 HD23 ' A' ' 80' ' ' LEU . 4.4 mm? -62.4 -50.37 71.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.042 178.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.48 97.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.712 -177.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.427 ' CD1' ' HA ' ' A' ' 43' ' ' SER . 62.4 t80 -66.93 -43.47 83.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.916 -178.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.19 -39.77 86.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.441 0.638 . . . . 0.0 110.212 178.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -59.12 -39.72 83.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.315 176.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.8 m -86.02 -19.31 30.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.162 -174.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.5 p -93.57 -29.81 15.3 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.426 -179.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 112.64 -3.02 26.17 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.161 178.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.728 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 60.6 t -50.88 115.89 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 122.794 0.438 . . . . 0.0 111.866 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.7 m -100.43 0.32 39.56 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.454 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.471 ' CE2' HG13 ' A' ' 92' ' ' VAL . 54.3 p90 -102.12 152.9 38.31 Favored Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.142 178.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.93 148.75 76.9 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.568 2.179 . . . . 0.0 113.107 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.454 HD12 HG11 ' A' ' 92' ' ' VAL . 5.2 mp -124.78 159.51 30.8 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.412 179.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -125.76 147.93 16.8 Favored Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 174.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.505 HD21 ' H ' ' A' ' 98' ' ' LEU . 0.6 OUTLIER -105.09 132.23 51.59 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.82 0.31 . . . . 0.0 110.737 -177.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -120.39 75.91 24.85 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.47 178.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -65.29 101.08 0.4 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.476 2.117 . . . . 0.0 112.09 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 126.5 -7.5 7.47 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.862 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.406 ' O ' ' HB1' ' A' ' 106' ' ' ALA . . . 58.18 44.01 19.64 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.691 0.396 . . . . 0.0 111.486 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -89.99 -46.54 8.44 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.129 0.49 . . . . 0.0 110.086 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.58 HD12 ' HB2' ' A' ' 16' ' ' PHE . 33.4 mm -61.76 -36.1 71.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 172.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -63.65 -39.15 93.62 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 113.624 -1.626 . . . . 0.0 110.467 174.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.596 ' HB1' ' HG2' ' A' ' 111' ' ' ARG . . . -71.72 -30.61 65.83 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -174.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.516 ' HE2' ' O ' ' A' ' 15' ' ' ASP . 13.1 ptmt -79.11 -1.78 37.53 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.857 -175.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -108.14 -37.69 5.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.223 0.535 . . . . 0.0 110.807 171.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -152.74 166.0 33.56 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.9 pp -60.42 163.98 4.77 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.85 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.596 ' HG2' ' HB1' ' A' ' 106' ' ' ALA . 50.5 mtt-85 -75.94 58.21 1.14 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -164.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 19.2 t70 169.68 -75.1 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.034 -1.439 . . . . 0.0 107.783 173.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.554 ' HB3' ' NH2' ' A' ' 117' ' ' ARG . . . 47.91 27.06 1.07 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.986 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.474 ' HA3' ' NH2' ' A' ' 132' ' ' ARG . . . 72.32 106.81 0.06 OUTLIER Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -170.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.444 ' O ' ' HB ' ' A' ' 116' ' ' THR . 19.2 tt -64.77 167.29 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.879 HG23 ' HA ' ' A' ' 133' ' ' LEU . 32.9 m 75.31 88.57 0.09 Allowed 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -174.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.952 ' HG2' ' HA ' ' A' ' 132' ' ' ARG . 41.0 mtm105 -157.61 145.76 19.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.451 -177.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -112.61 119.39 37.96 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.844 -177.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 72.2 t -110.01 107.32 22.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.838 177.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.628 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 55.0 tp -98.4 133.74 42.37 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.939 0.4 . . . . 0.0 110.337 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.463 HD13 ' HB3' ' A' ' 13' ' ' ALA . 38.2 mm -114.52 134.49 57.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.002 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.33 160.7 30.78 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 176.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.447 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 6.8 ptm180 -68.0 -22.03 65.01 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -173.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.585 ' HB2' ' HZ2' ' A' ' 126' ' ' LYS . 46.2 mt-10 -76.28 -18.52 58.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.293 0.568 . . . . 0.0 110.087 175.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 109.79 9.67 24.31 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.687 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.699 ' HG2' ' SD ' ' A' ' 12' ' ' MET . 35.3 mtmm -91.02 139.36 30.84 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.165 0.483 . . . . 0.0 110.725 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.445 HG12 HD13 ' A' ' 121' ' ' ILE . 35.3 mt -70.53 121.64 20.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 120' ' ' LEU . 8.7 p -114.19 -31.54 2.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -164.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.628 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 7.1 tmtm? -145.36 112.28 5.98 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.316 -0.553 . . . . 0.0 111.154 -174.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.518 HD23 HG12 ' A' ' 9' ' ' ILE . 2.8 mm? -112.2 111.74 22.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.888 175.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.2 t -129.32 162.46 27.9 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.689 175.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.952 ' HA ' ' HG2' ' A' ' 117' ' ' ARG . 28.8 mtp-105 -112.53 132.62 55.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.059 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.879 ' HA ' HG23 ' A' ' 116' ' ' THR . 4.6 pp 53.84 172.27 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.93 1.292 . . . . 0.0 113.687 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.466 ' HE2' ' NZ ' ' A' ' 50' ' ' LYS . 54.3 t80 -84.17 94.93 8.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.109 177.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.501 ' HB3' ' HB3' ' A' ' 138' ' ' GLU . 11.6 t30 -95.39 133.45 39.33 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 172.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -55.53 -56.94 14.39 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 123.163 0.289 . . . . 0.0 111.667 -169.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.47 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.5 mp0 -63.95 -33.13 75.02 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.178 0.513 . . . . 0.0 110.677 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.501 ' HB3' ' HB3' ' A' ' 135' ' ' ASN . 7.2 tp10 -65.63 -44.95 84.89 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.088 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.609 ' O ' HG23 ' A' ' 143' ' ' VAL . 90.5 t80 -60.96 -43.52 98.6 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.167 178.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.73 -44.9 86.32 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.007 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.7 m -63.33 -43.59 97.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.629 177.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.62 -44.3 96.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.597 -178.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 139' ' ' PHE . 95.7 t -56.75 -59.41 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.994 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -57.59 -36.91 72.35 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.534 -177.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.638 ' O ' ' HG3' ' A' ' 149' ' ' MET . 6.7 tt0 -62.62 -53.56 52.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.414 177.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 64.3 mt -56.74 -42.2 76.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 120.962 0.41 . . . . 0.0 110.835 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -51.16 -55.05 19.86 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.275 178.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -64.18 -29.01 70.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.321 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.638 ' HG3' ' O ' ' A' ' 145' ' ' GLN . 92.8 mtp -61.4 -36.7 81.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.574 0.226 . . . . 0.0 110.842 -176.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.407 0 C-N-CA 120.293 -0.563 . . . . 0.0 112.424 178.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 . . . . . 0 N--CA 1.453 -0.304 0 CA-C-O 121.168 0.509 . . . . 0.0 110.688 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.454 HG12 ' HA ' ' A' ' 109' ' ' ALA . 27.3 pt -95.22 9.53 5.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.769 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.663 HG12 HD11 ' A' ' 127' ' ' ILE . 23.2 t -118.45 153.77 20.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.135 -177.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.429 ' HB2' ' HB2' ' A' ' 11' ' ' GLU . 41.0 mtt180 -104.42 163.63 12.31 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.915 0.388 . . . . 0.0 110.924 -174.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.52 HG12 HD21 ' A' ' 130' ' ' LEU . 71.3 mt -83.16 117.78 29.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 170.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.88 0.39 56.29 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 -173.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.429 ' HB2' ' HB2' ' A' ' 8' ' ' ARG . 4.1 tp10 -69.47 144.14 53.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.289 -0.456 . . . . 0.0 110.501 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.52 ' HE2' ' HA ' ' A' ' 12' ' ' MET . 1.4 mmt -68.58 111.9 5.04 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 174.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.446 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -58.25 133.96 84.69 Favored Pre-proline 0 C--O 1.237 0.396 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.604 -176.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 6.4 Cg_exo -73.12 174.45 12.01 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.105 2.536 . . . . 0.0 112.245 178.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -81.7 168.74 17.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.663 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.556 ' HB2' HD11 ' A' ' 104' ' ' ILE . 33.5 p90 -177.57 143.56 0.36 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.316 165.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 62.7 m -117.72 106.43 13.05 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 173.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.1 tt -111.75 138.92 38.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.085 -169.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.2 m -88.2 117.95 27.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.399 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.3 mt -80.92 167.82 19.42 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.153 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.419 ' HB ' HD13 ' A' ' 84' ' ' LEU . 17.4 p -54.45 -28.08 41.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.512 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -93.6 15.32 16.44 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.166 -174.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.85 27.41 68.99 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.674 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 49.8 mmtm -108.48 119.26 38.99 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.624 0.25 . . . . 0.0 110.45 -176.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -94.95 115.23 27.19 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.189 178.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 17' ' ' THR . 20.2 m -114.96 150.59 16.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.428 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 20.7 m -110.87 142.67 42.6 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.911 177.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -60.06 -34.62 73.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.951 0.405 . . . . 0.0 110.56 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.4 m -62.86 -25.8 68.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.646 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.2 m -75.36 -21.29 58.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.218 0.532 . . . . 0.0 111.405 -176.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.8 mt -103.47 4.35 35.92 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.48 -178.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.533 ' CZ ' ' HA3' ' A' ' 125' ' ' GLY . 23.7 mmm-85 -65.83 109.67 2.56 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.113 0.482 . . . . 0.0 110.14 178.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.28 -29.44 2.61 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -173.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.413 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 27.2 mttt -96.06 173.08 7.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.237 -0.481 . . . . 0.0 109.985 176.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.445 ' O ' HG23 ' A' ' 35' ' ' VAL . 30.6 m -84.64 108.74 17.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 169.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.447 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 21.2 t -102.6 113.28 38.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.336 -172.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.42 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 27.1 ttt -98.41 124.31 43.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.451 177.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.406 ' HB2' ' HB ' ' A' ' 119' ' ' VAL . 3.2 mm? -109.86 112.99 25.36 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.857 177.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.478 HE22 ' HB ' ' A' ' 41' ' ' THR . 26.2 tm0? -107.28 107.1 17.87 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -82.22 127.31 33.05 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.518 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 12.4 t -140.44 176.19 8.98 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.136 0.493 . . . . 0.0 111.141 -172.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.466 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -152.36 133.5 14.28 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.494 177.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.487 ' HG ' ' HG3' ' A' ' 78' ' ' GLU . 12.4 p -63.59 -9.21 12.36 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -177.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 12.4 p-90 -108.79 12.82 25.38 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.84 0.352 . . . . 0.0 111.496 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 49.4 t -108.09 111.8 24.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.923 0.392 . . . . 0.0 110.695 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.1 -22.88 77.41 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.675 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.2 t -63.66 -34.58 68.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.204 0.526 . . . . 0.0 110.214 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.547 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 64.1 m -67.34 -22.33 65.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.705 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.489 ' O ' ' HG2' ' A' ' 53' ' ' PRO . 26.5 mtp-105 -73.69 -3.16 26.57 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.086 0.47 . . . . 0.0 110.583 178.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -97.74 -58.01 2.1 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.059 171.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.938 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 11.3 pt-20 -64.23 -47.96 77.67 Favored 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -175.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.649 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 94.3 mtp -59.87 -51.78 78.34 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -173.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.649 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 52.4 Cg_exo -59.06 -37.96 89.97 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.3 2.0 . . . . 0.0 112.649 174.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 139' ' ' PHE . 10.8 m-85 -67.39 -42.29 83.55 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.796 176.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 51' ' ' GLU . 94.6 mt -59.23 -48.79 85.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.173 177.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.533 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 2.0 pp20? -67.86 -35.25 78.21 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.633 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.55 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 7.9 ttmm -64.04 -44.32 92.86 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.522 -176.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.706 ' O ' ' HG2' ' A' ' 62' ' ' LYS . 3.9 t0 -106.15 -65.65 1.06 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.177 -0.609 . . . . 0.0 111.326 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.478 HG12 HG21 ' A' ' 143' ' ' VAL . 58.2 mt -56.84 -45.05 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 120.858 0.361 . . . . 0.0 111.609 -169.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.561 ' CD2' ' HB3' ' A' ' 94' ' ' TYR . 76.4 t-105 -75.37 -59.47 2.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.472 -177.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.516 HD12 ' O ' ' A' ' 56' ' ' GLU . 1.6 mp -53.83 -30.57 45.83 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -171.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.706 ' HG2' ' O ' ' A' ' 58' ' ' ASP . 31.8 mmtp -76.95 -24.88 52.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.868 0.366 . . . . 0.0 111.667 -177.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.443 ' CE1' ' HG ' ' A' ' 150' ' ' LEU . 73.8 m-70 -121.67 -41.37 2.48 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -172.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp 56.42 -95.38 0.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 122.917 0.487 . . . . 0.0 110.128 -167.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.432 ' O ' ' HB3' ' A' ' 66' ' ' ASN . 15.6 t70 -110.8 -32.07 6.97 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 171.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.432 ' HB3' ' O ' ' A' ' 65' ' ' ASP . 20.2 t-20 67.93 -68.82 0.15 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.038 -176.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 158.71 -33.91 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.627 1.571 . . . . 0.0 106.868 -175.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.413 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 15.1 t70 -125.55 18.66 8.1 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.258 -174.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -124.44 142.59 51.19 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.84 -0.537 . . . . 0.0 110.585 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.63 130.36 20.3 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.541 176.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.42 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 2.0 tt -132.92 114.67 14.31 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.1 mp -122.74 124.08 69.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.121 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.437 ' HA3' ' CD2' ' A' ' 96' ' ' LEU . . . -91.92 136.3 13.19 Favored Glycine 0 C--O 1.222 -0.64 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 173.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 59.9 mt -119.93 103.53 14.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 117.742 0.771 . . . . 0.0 111.388 -175.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.518 ' HA ' ' O ' ' A' ' 41' ' ' THR . 34.4 t0 -80.66 133.1 35.67 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 171.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.507 ' HA ' ' HB3' ' A' ' 99' ' ' ASP . 5.7 ttp180 -71.28 -105.8 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -170.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.486 ' H ' ' HB3' ' A' ' 76' ' ' ARG . 10.1 m-20 -87.33 21.19 2.52 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -168.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.487 ' HG3' ' HG ' ' A' ' 43' ' ' SER . 68.2 mm-40 -98.56 142.86 25.29 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-O 120.981 0.419 . . . . 0.0 111.449 -178.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.44 ' O ' HG23 ' A' ' 83' ' ' VAL . 64.9 Cg_endo -75.54 174.9 12.03 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.936 2.424 . . . . 0.0 112.86 178.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.439 HD23 HD11 ' A' ' 98' ' ' LEU . 32.5 mt -50.93 -50.32 57.96 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.441 -176.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -52.0 -39.82 60.04 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -176.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.479 ' HB3' ' OG ' ' A' ' 43' ' ' SER . 31.7 mmtp -66.84 -53.32 33.75 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.393 178.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 79' ' ' PRO . 15.3 t -60.7 -47.16 94.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.361 -175.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.419 HD13 ' HB ' ' A' ' 21' ' ' THR . 4.0 mm? -60.49 -48.6 81.07 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.902 0.382 . . . . 0.0 111.435 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.892 ' HA ' ' HE2' ' A' ' 88' ' ' LYS . . . -67.24 -35.8 80.31 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.307 -176.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.609 ' HE2' ' SD ' ' A' ' 52' ' ' MET . 56.1 t80 -72.51 -37.34 68.41 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.711 -178.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.46 -49.61 74.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.294 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.892 ' HE2' ' HA ' ' A' ' 85' ' ' ALA . 63.8 pttt -68.54 -29.93 68.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.29 -176.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.2 m -83.75 -2.04 55.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.725 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.458 ' HB ' ' HG3' ' A' ' 53' ' ' PRO . 11.1 p -115.64 -8.12 12.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.895 0.379 . . . . 0.0 110.902 175.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.69 4.14 87.68 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.273 178.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.56 HG23 ' HE1' ' A' ' 52' ' ' MET . 42.6 t -59.98 114.86 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.171 0.51 . . . . 0.0 111.267 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 p -100.68 7.69 43.77 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.632 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.561 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 33.4 p90 -104.25 145.63 31.03 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.228 173.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -63.07 140.6 79.47 Favored 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 122.615 2.21 . . . . 0.0 112.925 -178.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.437 ' CD2' ' HA3' ' A' ' 73' ' ' GLY . 62.5 mt -113.02 144.63 42.25 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.173 176.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -112.22 164.56 12.08 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.886 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.439 HD11 HD23 ' A' ' 80' ' ' LEU . 7.0 mp -102.95 147.49 26.86 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.507 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 36.4 t0 -130.38 70.54 82.33 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-O 121.057 0.456 . . . . 0.0 110.803 174.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.15 110.25 1.72 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.673 2.248 . . . . 0.0 112.211 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.86 -1.21 31.84 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.72 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 54.74 40.01 31.67 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.883 0.373 . . . . 0.0 111.016 -175.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.578 ' O ' ' HG3' ' A' ' 107' ' ' LYS . 15.4 t70 -84.13 -45.71 12.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.511 -174.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.556 HD11 ' HB2' ' A' ' 16' ' ' PHE . 35.3 mm -66.11 -35.55 75.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 177.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.471 ' CE1' ' HD3' ' A' ' 117' ' ' ARG . 56.6 t80 -63.51 -37.18 86.33 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.808 174.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.753 ' HB2' ' HG2' ' A' ' 111' ' ' ARG . . . -69.83 -22.92 63.24 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.566 178.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.578 ' HG3' ' O ' ' A' ' 103' ' ' ASP . 44.5 mtpt -79.46 -3.13 45.16 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.254 178.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -130.99 -3.04 4.02 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.899 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.614 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -178.16 -176.24 0.52 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 122.887 0.475 . . . . 0.0 110.448 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.3 mt -72.92 157.95 36.44 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 172.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.753 ' HG2' ' HB2' ' A' ' 106' ' ' ALA . 48.6 mtt180 -78.2 -10.31 59.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.974 0.416 . . . . 0.0 111.063 -175.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -88.0 -68.77 0.74 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 171.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 21.2 -89.26 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.775 0 O-C-N 125.177 1.548 . . . . 0.0 113.885 -178.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -164.1 -138.42 2.41 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.466 HG12 ' HB1' ' A' ' 42' ' ' ALA . 7.4 tp -150.86 -50.33 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.674 177.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.715 ' HB ' ' HB3' ' A' ' 133' ' ' LEU . 1.0 OUTLIER -77.03 107.48 9.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.002 0.429 . . . . 0.0 111.681 -178.974 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.471 ' HD3' ' CE1' ' A' ' 105' ' ' PHE . 6.1 ptm180 -159.7 135.62 8.66 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.062 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.524 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 9.0 m120 -108.68 119.02 38.31 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.406 ' HB ' ' HB2' ' A' ' 38' ' ' LEU . 57.7 t -112.49 138.23 42.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.592 -177.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.55 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 34.2 tp -123.69 123.89 41.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.017 0.437 . . . . 0.0 110.765 175.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.447 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 79.7 mt -101.09 132.51 46.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.274 175.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.05 -179.97 6.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.768 0.318 . . . . 0.0 110.553 -178.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 6.0 ptm85 -69.93 -24.09 63.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.262 -174.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -77.06 -26.98 54.17 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.51 0.671 . . . . 0.0 109.898 174.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.533 ' HA3' ' CZ ' ' A' ' 32' ' ' ARG . . . 109.93 18.77 8.58 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.854 -177.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 11' ' ' GLU . 80.9 mttt -94.63 136.42 34.95 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.954 0.407 . . . . 0.0 110.501 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.663 HD11 HG12 ' A' ' 7' ' ' VAL . 55.4 mt -79.7 99.2 3.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 28.0 m -101.33 -4.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -171.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.55 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 48.3 tptt -146.27 111.53 5.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.14 0.495 . . . . 0.0 111.597 -176.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.52 HD21 HG12 ' A' ' 9' ' ' ILE . 3.3 mm? -109.28 105.85 15.44 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.646 172.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.524 ' HB ' ' HB2' ' A' ' 118' ' ' ASN . 0.4 OUTLIER -109.64 155.86 20.94 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.999 0.428 . . . . 0.0 111.137 -174.479 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -89.85 174.35 7.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.996 178.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.715 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 2.9 pp -45.34 162.07 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 O-C-N 123.608 0.568 . . . . 0.0 112.106 175.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.938 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 91.9 t80 -43.98 97.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -174.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -114.4 129.62 56.66 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 164.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.485 ' HG2' ' HH ' ' A' ' 134' ' ' TYR . 45.2 mt-10 -55.07 -43.49 73.93 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -171.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -60.95 -49.54 77.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.99 0.424 . . . . 0.0 111.445 176.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.437 ' HB3' ' CG2' ' A' ' 131' ' ' THR . 6.6 mt-10 -65.0 -39.96 94.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.263 -178.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 54' ' ' PHE . 70.6 t80 -64.03 -42.05 97.23 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.917 0.389 . . . . 0.0 110.408 175.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.46 -40.62 97.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.725 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 60.7 p -65.64 -29.26 69.81 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.299 -0.409 . . . . 0.0 109.926 178.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.4 mt -73.15 -57.68 3.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.313 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.478 HG21 HG12 ' A' ' 59' ' ' ILE . 7.4 p -59.39 -38.34 74.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 O-C-N 123.11 0.256 . . . . 0.0 110.966 -175.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -67.41 -48.73 66.48 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 177.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.446 ' O ' ' HG2' ' A' ' 149' ' ' MET . 7.1 tt0 -55.98 -48.89 75.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.853 177.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.454 ' O ' HD23 ' A' ' 150' ' ' LEU . 93.1 mt -64.16 -44.44 97.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.189 -178.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -58.93 -40.75 85.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.201 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -73.55 -25.95 60.62 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.126 -0.229 . . . . 0.0 110.951 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.446 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 61.1 mmm -66.7 -28.44 68.44 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 175.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.454 HD23 ' O ' ' A' ' 146' ' ' ILE . 4.2 mm? . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.83 175.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.607 ' CD2' HD13 ' A' ' 130' ' ' LEU . 93.5 m-85 . . . . . 0 CA--C 1.52 -0.203 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.7 pp -109.99 -0.12 9.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.576 0.703 . . . . 0.0 109.898 171.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.2 p -114.53 163.01 12.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.612 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 28.3 mtm105 -129.88 166.4 20.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.833 0.349 . . . . 0.0 111.916 -171.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.48 HG12 ' CD2' ' A' ' 130' ' ' LEU . 53.2 mt -77.88 140.13 17.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.848 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.96 -16.56 55.0 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.128 -0.558 . . . . 0.0 111.882 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.45 ' HA ' ' OE1' ' A' ' 11' ' ' GLU . 8.0 mm-40 -82.65 158.38 23.01 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.073 0.463 . . . . 0.0 111.086 -178.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 84.9 mmm -77.15 132.33 38.75 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.373 -176.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.493 ' HB2' HD11 ' A' ' 121' ' ' ILE . . . -68.72 130.04 92.08 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.036 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.74 125.63 13.5 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.611 2.207 . . . . 0.0 111.93 177.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -64.77 145.7 55.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.039 -178.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.57 ' HB2' HD13 ' A' ' 104' ' ' ILE . 47.1 p90 -149.54 154.2 38.36 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.471 178.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 34.6 m -118.13 106.18 12.59 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.547 173.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.6 tt -110.72 145.81 16.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.599 -175.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.497 ' O ' HD22 ' A' ' 98' ' ' LEU . 16.5 m -85.99 128.2 34.8 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.309 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.1 mt -80.57 179.54 7.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.092 0.472 . . . . 0.0 111.392 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.469 HG22 ' O ' ' A' ' 96' ' ' LEU . 30.0 p -64.66 -20.03 66.06 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.329 -0.851 . . . . 0.0 112.439 -177.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.502 ' CG ' ' HZ1' ' A' ' 24' ' ' LYS . 10.9 p-10 -106.07 10.74 32.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.919 0.39 . . . . 0.0 110.647 -178.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.14 3.37 67.69 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.665 -0.779 . . . . 0.0 113.398 175.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.502 ' HZ1' ' CG ' ' A' ' 22' ' ' ASP . 32.0 mtmm -84.51 122.93 29.69 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.043 0.421 . . . . 0.0 111.353 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.468 ' HB3' HG23 ' A' ' 17' ' ' THR . 93.6 mt-30 -88.23 116.44 26.43 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 175.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 17' ' ' THR . 17.0 m -107.59 147.15 12.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.217 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.8 m -111.42 144.45 40.61 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.072 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.02 -43.4 91.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.965 0.412 . . . . 0.0 110.328 -178.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.499 ' HA ' ' CG ' ' A' ' 32' ' ' ARG . 49.4 m -62.02 -21.22 64.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.974 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.5 t -76.75 -17.29 59.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.818 0.342 . . . . 0.0 110.433 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.4 mt -118.45 19.55 13.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.136 0.494 . . . . 0.0 110.271 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.505 ' NH1' ' H ' ' A' ' 33' ' ' GLY . 10.6 mmm180 -73.71 155.89 38.48 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.966 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.505 ' H ' ' NH1' ' A' ' 32' ' ' ARG . . . 102.94 -30.97 9.31 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 -177.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.739 ' HB3' ' HZ3' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -114.31 173.55 6.4 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.515 -0.343 . . . . 0.0 110.5 -177.879 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 68' ' ' ASP . 33.2 m -79.35 130.65 35.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.944 0.402 . . . . 0.0 110.055 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.448 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 55.3 t -119.93 113.85 42.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.662 -178.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.785 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 1.6 tmt? -91.68 138.1 31.83 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 176.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.5 mt -127.9 122.51 32.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.509 -175.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -116.81 107.16 14.29 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.547 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.783 ' HB2' ' HB2' ' A' ' 117' ' ' ARG . 92.6 m-85 -90.92 112.54 24.44 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 9.2 t -141.34 -171.43 3.29 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.47 -172.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.413 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . . . -151.14 172.55 15.61 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.681 ' HG ' ' HB2' ' A' ' 86' ' ' PHE . 26.9 t -82.88 -14.04 55.0 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.835 0.35 . . . . 0.0 110.766 -178.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -102.3 -4.37 25.75 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.6 p -88.56 107.4 18.88 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 121.657 -0.652 . . . . 0.0 111.181 -178.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.83 -8.7 82.58 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 115.836 -0.62 . . . . 0.0 113.175 -177.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.4 t -77.34 -45.54 29.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 176.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.645 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 98.0 m -62.93 -22.69 66.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.475 -178.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.537 ' HE ' ' HE1' ' A' ' 86' ' ' PHE . 89.1 mtt180 -69.93 -2.12 11.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.607 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.426 ' O ' ' HD1' ' A' ' 54' ' ' PHE . 58.9 mttp -100.3 -48.28 4.65 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.346 0.593 . . . . 0.0 109.676 171.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 1.092 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 6.5 pt-20 -67.2 -44.36 79.8 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.798 -176.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.763 ' CG ' ' HD3' ' A' ' 53' ' ' PRO . 16.2 ptm -64.18 -39.77 46.66 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-O 118.576 -0.726 . . . . 0.0 112.923 -174.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.763 ' HD3' ' CG ' ' A' ' 52' ' ' MET . 46.6 Cg_exo -61.23 -41.73 40.44 Favored 'Trans proline' 0 C--N 1.362 1.254 0 C-N-CA 121.345 1.363 . . . . 0.0 112.307 169.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.426 ' HD1' ' O ' ' A' ' 50' ' ' LYS . 18.4 m-85 -64.98 -41.88 95.03 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.906 176.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 51' ' ' GLU . 70.2 mt -59.43 -50.52 79.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.094 175.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.56 ' OE1' ' HA ' ' A' ' 92' ' ' VAL . 25.2 tp10 -49.05 -49.67 40.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.232 0.539 . . . . 0.0 110.819 175.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.7 tmmt? -69.29 -47.02 65.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.915 -174.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -106.33 -50.16 3.2 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -173.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.528 HD12 HG12 ' A' ' 55' ' ' ILE . 38.4 mt -71.08 -43.48 75.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.597 -176.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.424 ' CE2' ' HB3' ' A' ' 94' ' ' TYR . 66.8 t-105 -81.66 -77.43 0.22 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.997 -178.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -44.5 -34.99 2.28 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -172.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -84.37 -26.44 28.39 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -173.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -127.15 -9.66 5.89 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -173.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.488 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 18.0 pttp -41.89 -48.84 4.51 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -165.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.52 -83.95 0.11 Allowed 'General case' 0 C--O 1.25 1.094 0 CA-C-O 121.471 0.653 . . . . 0.0 110.197 -172.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.485 ' CG ' ' H ' ' A' ' 67' ' ' ALA . 63.5 t30 49.23 -155.75 0.09 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.631 -169.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.485 ' H ' ' CG ' ' A' ' 66' ' ' ASN . . . -105.99 -10.41 16.6 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 166.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 12.8 m-20 -145.05 39.76 1.22 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.739 -170.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.488 ' CD2' ' HA ' ' A' ' 64' ' ' LYS . 62.1 t80 -118.45 129.3 55.31 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 118.976 -1.089 . . . . 0.0 110.605 169.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.24 143.75 50.97 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.533 175.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.785 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 5.4 tt -143.77 121.56 11.94 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.1 mp -125.67 127.19 71.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.378 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.428 ' HA3' HD21 ' A' ' 96' ' ' LEU . . . -95.53 133.08 11.35 Favored Glycine 0 C--O 1.223 -0.579 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.034 175.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 74.7 mt -119.74 127.38 75.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 117.203 0.501 . . . . 0.0 111.128 -174.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.438 ' O ' ' HB3' ' A' ' 99' ' ' ASP . 11.6 t70 -89.34 144.85 25.76 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.513 HH21 ' HA ' ' A' ' 112' ' ' ASP . 19.8 ttt-85 -69.71 -32.71 71.44 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -172.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -158.38 -34.26 0.07 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -173.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -71.62 138.4 83.27 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 121.262 0.553 . . . . 0.0 111.896 -165.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.561 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 37.4 Cg_endo -72.17 -170.75 0.6 Allowed 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.676 2.917 . . . . 0.0 115.411 -171.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.424 ' O ' HD22 ' A' ' 84' ' ' LEU . 87.7 mt -54.63 -60.35 3.47 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 114.422 -1.263 . . . . 0.0 113.021 -171.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.561 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -59.43 -35.39 73.91 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.032 0.444 . . . . 0.0 110.821 -173.072 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.555 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 19.4 mmmt -61.42 -53.27 58.7 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.237 174.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.405 HG21 ' O ' ' A' ' 79' ' ' PRO . 70.6 t -65.9 -43.57 92.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.341 -178.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.424 HD22 ' O ' ' A' ' 80' ' ' LEU . 4.4 mm? -61.79 -47.37 85.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.399 -178.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.86 -35.19 79.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.752 0.31 . . . . 0.0 110.725 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.681 ' HB2' ' HG ' ' A' ' 43' ' ' SER . 91.3 t80 -67.02 -52.49 41.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.125 178.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.455 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -55.47 -49.54 72.22 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.915 0.388 . . . . 0.0 110.691 177.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.4 tttm -50.69 -36.21 34.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.978 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.9 m -89.78 6.55 41.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.446 -174.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 16.5 p -132.63 8.51 4.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.191 0.519 . . . . 0.0 110.739 176.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.62 -72.12 2.17 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.56 ' HA ' ' OE1' ' A' ' 56' ' ' GLU . 58.1 t 29.37 96.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.148 1.379 . . . . 0.0 114.579 178.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.5 p -94.88 -10.83 30.04 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.639 -0.425 . . . . 0.0 110.553 176.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.424 ' HB3' ' CE2' ' A' ' 60' ' ' TRP . 37.4 p90 -85.49 141.07 36.29 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.381 175.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -62.43 137.71 66.64 Favored 'Trans proline' 0 C--O 1.239 0.546 0 C-N-CA 122.514 2.143 . . . . 0.0 113.359 -177.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.469 ' O ' HG22 ' A' ' 21' ' ' THR . 71.4 mt -109.89 149.46 29.86 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.513 174.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -120.8 148.59 17.57 Favored Glycine 0 N--CA 1.438 -1.213 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 175.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.703 ' H ' HD22 ' A' ' 98' ' ' LEU . 2.3 pt? -103.24 131.79 50.01 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.438 ' HB3' ' O ' ' A' ' 75' ' ' ASP . 12.7 t0 -115.95 79.45 8.15 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.45 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.49 105.09 1.2 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.198 1.932 . . . . 0.0 112.373 -177.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 117.47 1.92 17.79 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.149 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 55.24 39.92 31.49 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 122.638 0.375 . . . . 0.0 111.854 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -79.83 -51.13 9.54 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.283 0.563 . . . . 0.0 110.784 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.57 HD13 ' HB2' ' A' ' 16' ' ' PHE . 30.5 mm -64.82 -34.65 71.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.587 ' CD1' ' HA ' ' A' ' 111' ' ' ARG . 18.1 t80 -65.75 -34.41 78.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.032 175.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -71.88 -23.62 61.54 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.357 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -74.14 -3.9 32.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.255 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -131.0 -35.69 1.38 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.912 0.387 . . . . 0.0 111.269 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -134.52 174.89 10.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.916 0.388 . . . . 0.0 111.109 -177.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.6 mt -78.91 6.22 9.71 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.587 ' HA ' ' CD1' ' A' ' 105' ' ' PHE . 7.3 mtm180 73.98 -68.94 0.2 Allowed 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.981 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.513 ' HA ' HH21 ' A' ' 76' ' ' ARG . 20.6 m-20 -84.77 6.75 23.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.729 -172.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -85.07 41.13 0.86 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.591 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.24 151.94 19.27 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.628 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.48 HG13 ' N ' ' A' ' 116' ' ' THR . 9.5 tp -88.03 171.18 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.48 ' N ' HG13 ' A' ' 115' ' ' ILE . 25.0 m 79.79 108.52 0.07 Allowed 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.298 0.639 . . . . 0.0 111.875 174.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.783 ' HB2' ' HB2' ' A' ' 40' ' ' PHE . 77.5 mmt-85 -138.78 131.15 28.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.151 173.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.443 ' O ' ' HA ' ' A' ' 130' ' ' LEU . 7.6 m120 -114.99 117.14 29.76 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 176.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 39.4 t -129.28 141.4 46.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.879 0.371 . . . . 0.0 111.212 -172.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 46.7 tp -121.61 118.34 28.96 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.092 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.493 HD11 ' HB2' ' A' ' 13' ' ' ALA . 39.4 mm -91.44 121.35 41.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.849 177.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.554 ' OD2' ' HB2' ' A' ' 124' ' ' GLU . 13.6 t0 -67.83 158.35 32.75 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.375 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.7 ptt85 -67.57 -14.56 63.04 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.971 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.554 ' HB2' ' OD2' ' A' ' 122' ' ' ASP . 0.7 OUTLIER -77.63 -16.64 58.43 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 173.052 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.01 24.72 10.21 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.836 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -117.45 156.09 28.56 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.75 0.31 . . . . 0.0 111.359 -175.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.404 HG12 ' CD1' ' A' ' 121' ' ' ILE . 49.8 mt -86.72 113.88 25.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 174.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.1 m -104.2 -17.23 7.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.98 0.419 . . . . 0.0 111.502 -178.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -152.49 119.11 5.67 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.353 -176.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.607 HD13 ' CD2' ' A' ' 5' ' ' TYR . 1.7 pt? -141.28 105.85 4.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.537 0.684 . . . . 0.0 109.741 176.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.9 t -127.59 164.03 22.89 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.575 -175.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.784 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 62.5 mtp180 -114.71 133.12 56.13 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.54 -178.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.784 ' HG ' ' O ' ' A' ' 132' ' ' ARG . 3.9 pp 65.39 154.57 0.07 Allowed 'General case' 0 N--CA 1.471 0.578 0 O-C-N 124.988 1.43 . . . . 0.0 112.982 172.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 1.092 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 58.3 t80 -64.71 102.05 0.54 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.974 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.965 ' HB2' ' HB2' ' A' ' 138' ' ' GLU . 46.1 m-80 -98.93 167.11 10.95 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.948 171.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.14 -68.13 0.69 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.297 0.57 . . . . 0.0 110.03 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -67.83 -31.29 71.03 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.326 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.965 ' HB2' ' HB2' ' A' ' 135' ' ' ASN . 3.1 mm-40 -63.74 -40.13 95.99 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.186 177.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.467 ' HA ' HD11 ' A' ' 142' ' ' LEU . 87.2 t80 -71.1 -41.26 70.83 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.3 -39.15 89.41 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.769 177.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.0 m -65.35 -39.56 92.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.496 178.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.467 HD11 ' HA ' ' A' ' 139' ' ' PHE . 35.9 mt -58.66 -47.97 82.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.763 177.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 94.4 t -56.53 -49.25 78.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.186 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -66.22 -43.25 87.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.048 0.452 . . . . 0.0 110.589 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.506 ' O ' ' HG2' ' A' ' 149' ' ' MET . 12.7 tt0 -58.82 -50.95 72.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.031 179.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.619 ' O ' HD23 ' A' ' 150' ' ' LEU . 77.0 mt -66.83 -30.26 49.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.263 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -57.68 -43.51 85.14 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.849 176.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -67.26 -39.03 86.07 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.687 0.617 . . . . 0.0 111.089 177.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' MET . . . . . 0.543 ' HE1' ' OD1' ' A' ' 122' ' ' ASP . 88.1 mmm -59.68 -27.86 66.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.635 0.731 . . . . 0.0 110.084 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.619 HD23 ' O ' ' A' ' 146' ' ' ILE . 3.4 mm? . . . . . 0 C--N 1.324 -0.522 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.403 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.564 ' O ' ' HA ' ' A' ' 113' ' ' ALA . 16.4 ptp . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.6 p -78.04 -79.89 0.12 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.68 0.276 . . . . 0.0 111.142 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.4 mt -97.76 73.43 2.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.174 0.512 . . . . 0.0 110.234 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.67 82.9 1.4 Allowed Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.838 -176.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.553 ' HH ' ' HB2' ' A' ' 117' ' ' ARG . 47.7 m-85 -93.83 131.84 38.84 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 175.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.417 HG13 HG22 ' A' ' 7' ' ' VAL . 46.1 pt -96.78 -14.03 7.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.418 0.627 . . . . 0.0 109.42 173.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.58 HG11 HD11 ' A' ' 127' ' ' ILE . 20.5 t -110.36 151.78 12.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.181 177.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.421 ' CD ' ' HB2' ' A' ' 11' ' ' GLU . 5.0 ppt_? -126.25 168.74 13.68 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.699 0.285 . . . . 0.0 111.55 -173.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.731 HG12 HD13 ' A' ' 130' ' ' LEU . 72.7 mt -65.92 128.26 28.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 120.955 0.407 . . . . 0.0 110.509 178.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.06 -4.35 65.2 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.79 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.421 ' HB2' ' CD ' ' A' ' 8' ' ' ARG . 7.3 tp10 -89.25 151.63 22.03 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.538 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 41.7 mtp -80.29 143.89 33.28 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.126 0.489 . . . . 0.0 110.657 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.22 132.24 56.77 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.646 -175.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -63.24 156.44 55.54 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.058 2.505 . . . . 0.0 112.071 176.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -97.9 165.6 11.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.818 -177.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.509 ' HE2' ' HH ' ' A' ' 108' ' ' TYR . 47.9 p90 -177.41 166.0 2.24 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.64 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 45.7 m -131.17 106.29 8.24 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 174.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.3 tt -107.97 143.27 18.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.008 -171.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.0 m -85.39 125.32 32.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.282 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.403 HD23 ' HB2' ' A' ' 95' ' ' PRO . 97.6 mt -83.45 173.74 11.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.33 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.449 HG23 ' O ' ' A' ' 96' ' ' LEU . 3.5 p -58.69 -31.19 67.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.696 -175.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -100.69 18.37 19.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.234 0.54 . . . . 0.0 110.355 -176.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.52 39.07 23.0 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.783 173.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -108.45 136.48 48.0 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.736 0.303 . . . . 0.0 111.064 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -99.45 116.07 30.74 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 17' ' ' THR . 3.1 p -120.23 126.12 74.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.382 0.61 . . . . 0.0 111.158 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.7 m -93.44 143.3 26.42 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.115 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.46 HD22 ' HA ' ' A' ' 28' ' ' LEU . 0.7 OUTLIER -66.59 -30.69 71.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.721 0.296 . . . . 0.0 110.295 -176.312 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.9 m -53.2 -43.01 66.85 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.191 176.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.9 m -67.54 -24.75 65.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.561 -175.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.1 mt -88.45 -22.06 23.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.787 -176.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 83.5 mtm-85 -60.2 159.41 9.81 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.894 0.378 . . . . 0.0 111.585 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.544 ' O ' ' HG3' ' A' ' 123' ' ' ARG . . . 85.25 -23.42 8.26 Favored Glycine 0 N--CA 1.452 -0.265 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -172.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.44 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 31.4 mtmm -109.21 167.93 9.75 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 176.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.414 HG22 HD21 ' A' ' 150' ' ' LEU . 26.1 m -81.87 114.19 22.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 121.208 0.528 . . . . 0.0 110.233 177.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.558 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 29.9 t -110.25 115.32 49.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.137 -173.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.475 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 27.6 ttt -101.16 114.73 28.96 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.119 175.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 69.7 mt -110.11 108.58 18.81 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.891 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.403 ' CG ' ' HA2' ' A' ' 73' ' ' GLY . 9.9 pt20 -94.7 130.01 41.37 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.463 ' HB2' ' HG2' ' A' ' 117' ' ' ARG . 77.2 m-85 -101.45 107.14 18.37 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 12.6 t -130.83 -174.92 3.51 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.252 -171.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.523 ' HB2' ' SG ' ' A' ' 45' ' ' CYS . . . -164.75 143.85 6.99 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.578 177.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 57.1 p -58.64 -25.3 62.59 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -177.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 36.4 p-90 -90.83 7.85 37.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.782 0.325 . . . . 0.0 111.741 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.523 ' SG ' ' HB2' ' A' ' 42' ' ' ALA . 71.8 m -93.25 127.03 38.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.053 0.454 . . . . 0.0 110.905 177.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -85.02 -33.06 19.18 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.457 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.63 HG13 ' HB2' ' A' ' 133' ' ' LEU . 40.3 t -65.11 -34.15 68.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 121.143 0.497 . . . . 0.0 110.629 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.679 ' SG ' HG21 ' A' ' 116' ' ' THR . 92.3 m -66.26 -15.89 63.57 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.461 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -78.33 -3.32 42.43 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.478 0.656 . . . . 0.0 110.298 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.407 ' O ' ' HD1' ' A' ' 54' ' ' PHE . 18.8 mtpp -101.77 -45.54 5.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.908 163.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.601 ' HB3' ' HA ' ' A' ' 48' ' ' CYS . 37.4 tt0 -54.87 -63.32 1.19 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.178 -1.374 . . . . 0.0 111.719 -176.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.64 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 79.8 mtp -59.33 -52.19 76.15 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.994 -173.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.64 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 50.5 Cg_exo -56.4 -40.8 82.21 Favored 'Trans proline' 0 C--N 1.358 1.034 0 C-N-CA 122.165 1.91 . . . . 0.0 112.752 179.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.407 ' HD1' ' O ' ' A' ' 50' ' ' LYS . 17.0 m-85 -67.21 -44.81 78.64 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.443 177.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.567 ' O ' ' HB ' ' A' ' 59' ' ' ILE . 81.8 mt -56.44 -45.34 81.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.531 176.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.571 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 38.6 tt0 -62.55 -48.69 78.4 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.415 178.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.496 ' HA ' HD22 ' A' ' 61' ' ' LEU . 29.1 ttpp -63.4 -54.07 42.54 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -173.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -104.29 -13.0 16.31 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -170.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.567 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 71.6 mt -105.16 -63.67 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.725 177.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.573 ' CD2' ' HB3' ' A' ' 94' ' ' TYR . 74.0 t-105 -59.89 -62.09 2.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.548 -175.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.496 HD22 ' HA ' ' A' ' 57' ' ' LYS . 2.6 mp -53.47 -23.06 9.08 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -175.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -89.75 -53.15 4.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.816 0.341 . . . . 0.0 111.418 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -113.18 2.63 15.68 Favored 'General case' 0 C--O 1.221 -0.437 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -167.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.476 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 12.0 pttp -39.07 -44.07 1.09 Allowed 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -172.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -96.8 -75.99 0.52 Allowed 'General case' 0 C--O 1.251 1.146 0 CA-C-O 121.334 0.588 . . . . 0.0 109.855 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.412 ' O ' ' HB1' ' A' ' 67' ' ' ALA . 24.8 t-20 66.56 -72.19 0.09 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 114.449 -1.251 . . . . 0.0 110.667 -177.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 66' ' ' ASN . . . 155.32 -26.17 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.323 0 O-C-N 125.044 1.465 . . . . 0.0 107.704 -175.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.44 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 14.9 t70 -140.04 22.38 2.43 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.991 -172.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.536 ' CE2' ' HB2' ' A' ' 71' ' ' LEU . 68.6 t80 -113.4 139.35 48.97 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.328 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.07 128.94 29.08 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.773 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.536 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 3.6 tt -134.23 117.36 16.39 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.449 HD11 ' C ' ' A' ' 71' ' ' LEU . 3.1 mp -128.66 130.72 68.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.788 0.327 . . . . 0.0 110.141 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.403 ' HA2' ' CG ' ' A' ' 39' ' ' GLN . . . -99.23 133.73 11.41 Favored Glycine 0 C--O 1.219 -0.797 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.526 176.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.0 mt -116.52 127.76 74.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 117.29 0.545 . . . . 0.0 110.905 -176.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.471 ' OD2' ' HA ' ' A' ' 42' ' ' ALA . 10.2 t70 -90.91 135.09 33.96 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 174.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.499 ' HB2' HD11 ' A' ' 115' ' ' ILE . 58.9 ttt-85 -68.69 -28.57 66.97 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -170.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -160.1 -26.87 0.06 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -170.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -74.49 130.83 81.14 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-O 121.292 0.568 . . . . 0.0 111.314 -176.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.522 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 25.4 Cg_endo -68.75 -166.64 0.16 Allowed 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 123.337 2.692 . . . . 0.0 114.831 -176.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -58.98 -55.27 37.25 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 114.315 -1.312 . . . . 0.0 112.248 -169.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.522 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -64.16 -36.29 83.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.542 -173.813 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.461 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 33.9 mmtp -59.79 -54.26 48.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.156 0.503 . . . . 0.0 110.885 177.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.0 t -61.92 -41.87 92.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.294 -177.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.1 mp -62.91 -44.27 96.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.648 0.261 . . . . 0.0 111.254 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.529 ' HA ' ' HE3' ' A' ' 88' ' ' LYS . . . -68.42 -27.62 66.36 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.317 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.438 ' HE2' ' SD ' ' A' ' 52' ' ' MET . 93.3 t80 -80.43 -53.26 6.76 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.911 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.69 -44.35 77.28 Favored 'General case' 0 C--O 1.226 -0.163 0 O-C-N 123.39 0.431 . . . . 0.0 111.787 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.529 ' HE3' ' HA ' ' A' ' 85' ' ' ALA . 18.4 pttp -62.92 -26.46 68.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.026 0.441 . . . . 0.0 111.352 -177.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.9 m -88.73 -22.56 23.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.885 -175.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.0 p -97.08 -13.88 21.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.13 0.491 . . . . 0.0 110.631 177.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 106.54 -74.99 0.22 Allowed Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -177.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.509 HG21 ' HE1' ' A' ' 52' ' ' MET . 51.0 t 28.66 85.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.056 1.343 . . . . 0.0 114.07 175.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.1 p -83.53 -0.95 52.54 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.697 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.573 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 50.6 p90 -96.59 139.48 21.67 Favored Pre-proline 0 C--N 1.332 -0.194 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.755 176.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.403 ' HB2' HD23 ' A' ' 20' ' ' LEU . 19.6 Cg_endo -60.47 133.82 51.21 Favored 'Trans proline' 0 C--O 1.238 0.508 0 C-N-CA 122.935 2.423 . . . . 0.0 113.333 -175.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.449 ' O ' HG23 ' A' ' 21' ' ' THR . 91.3 mt -109.31 139.19 44.58 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.435 176.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -105.55 148.55 16.53 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.75 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.444 HD23 ' H ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -92.1 127.09 37.44 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.282 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.427 ' HB3' ' O ' ' A' ' 75' ' ' ASP . 21.6 t0 -120.18 74.35 21.37 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 121.135 0.493 . . . . 0.0 109.881 173.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.98 98.4 0.71 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.419 2.08 . . . . 0.0 112.534 -175.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 123.94 -5.18 9.05 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.045 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 62.66 45.17 6.17 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 122.645 0.378 . . . . 0.0 111.127 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -84.04 -50.18 8.22 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.048 0.451 . . . . 0.0 110.398 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 34.2 mm -66.0 -34.01 67.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -64.22 -41.05 97.19 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.276 173.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.599 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -69.94 -18.37 63.36 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.623 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -77.15 -7.82 56.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.486 178.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.509 ' HH ' ' HE2' ' A' ' 16' ' ' PHE . 56.0 m-85 -125.34 -32.05 2.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.836 0.35 . . . . 0.0 111.365 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.599 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -149.6 169.3 21.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.736 0.303 . . . . 0.0 111.155 -177.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.461 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . 96.6 mt -72.61 133.94 44.92 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 177.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.71 -31.71 68.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.421 0.629 . . . . 0.0 110.48 -178.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -99.43 19.53 15.43 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.121 -176.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' A' ' 1' ' ' MET . . . -119.57 56.9 0.92 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.426 -177.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 81.35 -157.68 38.87 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.409 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.499 HD11 ' HB2' ' A' ' 76' ' ' ARG . 2.5 tp -152.54 -60.48 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.679 HG21 ' SG ' ' A' ' 48' ' ' CYS . 16.5 p -56.65 111.86 1.12 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -172.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.553 ' HB2' ' HH ' ' A' ' 5' ' ' TYR . 13.5 ptp180 -169.72 154.2 5.31 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.665 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.488 ' HB2' HG21 ' A' ' 131' ' ' THR . 34.4 m-80 -124.8 131.08 53.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.457 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.7 t -108.83 109.63 29.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.981 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 30.6 tp -96.57 111.64 23.69 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.491 -0.483 . . . . 0.0 110.271 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.558 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 54.0 mt -93.21 137.49 22.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.996 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.521 ' HA ' ' HE1' ' A' ' 149' ' ' MET . 0.0 OUTLIER -90.02 179.27 5.99 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.008 0.433 . . . . 0.0 111.104 -177.259 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 32.5 ttm180 -62.95 -28.67 70.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.128 -175.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.473 ' CD ' ' HZ3' ' A' ' 126' ' ' LYS . 44.8 mt-10 -76.61 -30.37 56.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.119 0.485 . . . . 0.0 110.515 177.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.16 17.38 7.27 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.584 -176.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 80.4 mttt -103.1 148.26 25.96 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.887 0.375 . . . . 0.0 110.484 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.58 HD11 HG11 ' A' ' 7' ' ' VAL . 60.8 mt -84.7 112.43 21.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.149 178.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 28.5 m -102.3 -29.2 3.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -175.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -124.95 112.94 17.18 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.156 -173.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.731 HD13 HG12 ' A' ' 9' ' ' ILE . 11.1 mp -100.93 121.79 42.36 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.434 -0.803 . . . . 0.0 108.868 169.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.527 ' OG1' ' HB3' ' A' ' 138' ' ' GLU . 0.4 OUTLIER -122.43 145.16 48.55 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 177.565 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.416 ' N ' ' HD2' ' A' ' 132' ' ' ARG . 3.6 mpt_? -105.23 124.15 49.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.313 -177.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.675 ' HA ' ' HB ' ' A' ' 116' ' ' THR . 1.7 pp 39.86 50.07 2.29 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 124.091 0.869 . . . . 0.0 112.983 175.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.529 ' HB2' ' HG3' ' A' ' 51' ' ' GLU . 9.1 t80 68.97 -74.17 0.08 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.151 -177.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 41.6 t30 59.39 120.15 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.421 0.688 . . . . 0.0 111.814 -177.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -47.56 -62.54 1.39 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.984 -173.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -61.81 -41.66 98.04 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.833 -175.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.527 ' HB3' ' OG1' ' A' ' 131' ' ' THR . 17.7 mt-10 -64.85 -36.26 83.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.108 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.467 ' O ' HG21 ' A' ' 143' ' ' VAL . 82.1 t80 -64.42 -44.99 89.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.365 176.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.66 -50.19 70.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.906 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.2 m -66.18 -37.23 85.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.835 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.481 ' O ' HG13 ' A' ' 146' ' ' ILE . 2.6 tt -60.73 -49.16 78.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.813 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.467 HG21 ' O ' ' A' ' 139' ' ' PHE . 90.8 t -59.7 -46.56 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.258 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -58.42 -45.73 87.85 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.176 0.512 . . . . 0.0 110.266 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -61.4 -39.74 91.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.314 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.647 ' O ' HD22 ' A' ' 150' ' ' LEU . 66.6 mt -55.25 -47.95 77.08 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.196 0 CA-C-N 116.738 -0.21 . . . . 0.0 110.702 177.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -51.25 -43.64 61.56 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.72 -0.218 . . . . 0.0 110.543 176.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -67.61 -42.83 81.75 Favored 'General case' 0 C--O 1.217 -0.652 0 C-N-CA 120.646 -0.421 . . . . 0.0 111.12 175.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.521 ' HE1' ' HA ' ' A' ' 122' ' ' ASP . 38.6 mmm -57.31 -35.64 70.1 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 122.98 0.512 . . . . 0.0 111.136 -172.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.647 HD22 ' O ' ' A' ' 146' ' ' ILE . 4.4 mm? -62.02 -28.16 69.39 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.796 178.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -96.55 -51.61 4.26 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 81.77 94.87 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 114.068 -1.424 . . . . 0.0 110.724 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -129.01 2.66 6.32 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.542 175.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -78.91 -16.15 57.39 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.861 -177.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -65.99 -42.65 89.5 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 169.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 58.0 m80 70.7 -46.5 0.63 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.796 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.444 ' C ' ' H ' ' A' ' 159' ' ' HIS . 27.9 t-80 -80.14 1.83 26.52 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.913 0.387 . . . . 0.0 110.239 177.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 72.5 -37.75 0.4 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.952 0.901 . . . . 0.0 110.504 -175.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.444 ' H ' ' C ' ' A' ' 157' ' ' HIS . 73.9 t60 . . . . . 0 C--O 1.242 0.704 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 169.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.731 ' HE2' ' HA ' ' A' ' 113' ' ' ALA . 26.0 ptt? . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 110.224 -0.288 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.1 m -84.11 -85.89 0.13 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.356 -178.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 45.2 tp -124.81 -31.4 3.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.89 0.376 . . . . 0.0 111.372 -176.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.469 ' HA2' HD11 ' A' ' 110' ' ' LEU . . . 108.25 -20.1 31.06 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.949 176.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -78.13 127.02 31.66 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.913 0.387 . . . . 0.0 110.858 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.563 HG12 ' HA ' ' A' ' 109' ' ' ALA . 21.5 pt -109.58 -11.97 11.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.781 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.425 HG11 HD11 ' A' ' 127' ' ' ILE . 20.0 t -101.44 156.32 4.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.508 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 37.3 mtt85 -121.85 162.88 20.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.097 0.475 . . . . 0.0 111.342 -173.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.48 HG23 ' HA ' ' A' ' 128' ' ' VAL . 80.1 mt -75.93 126.36 36.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.153 177.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.59 -24.92 12.7 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.839 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -75.03 156.66 35.95 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.639 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 59.2 mtp -84.32 138.54 32.84 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.649 -178.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.492 ' HB2' HD12 ' A' ' 121' ' ' ILE . . . -62.65 123.01 77.62 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.432 -178.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 24.7 Cg_exo -62.44 114.62 2.44 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.615 2.21 . . . . 0.0 111.299 177.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.53 ' HA ' HD11 ' A' ' 28' ' ' LEU . 1.0 OUTLIER -63.4 151.9 39.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.418 -171.823 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.962 ' HB3' ' HE2' ' A' ' 107' ' ' LYS . 37.0 p90 -159.23 166.52 31.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.511 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 56.0 m -129.35 108.26 10.16 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.273 175.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.5 tt -106.7 145.02 14.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.991 0.424 . . . . 0.0 110.831 -174.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 24' ' ' LYS . 9.6 m -85.33 131.84 34.34 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.299 178.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.432 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 86.3 mt -87.15 172.52 9.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.311 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.451 HG21 ' O ' ' A' ' 96' ' ' LEU . 33.2 p -55.85 -34.01 65.05 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.889 -176.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -101.84 18.38 20.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.104 0.478 . . . . 0.0 110.772 -173.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.5 37.0 25.01 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.626 174.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 19' ' ' THR . 41.0 mmtm -108.16 167.04 10.29 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.1 -0.334 . . . . 0.0 110.1 176.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.33 120.37 24.23 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 -177.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 17' ' ' THR . 11.7 m -113.98 144.2 22.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.939 0.399 . . . . 0.0 110.017 175.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 18.0 m -122.61 143.42 49.77 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.645 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.53 HD11 ' HA ' ' A' ' 15' ' ' ASP . 17.5 mt -62.67 -35.98 81.41 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.715 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.481 ' HA ' ' HG2' ' A' ' 32' ' ' ARG . 59.2 m -55.83 -34.62 65.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.987 0.422 . . . . 0.0 110.937 175.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.0 t -75.25 -26.24 58.69 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.101 0.477 . . . . 0.0 110.227 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 85.8 mt -96.27 0.2 50.6 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.481 ' HG2' ' HA ' ' A' ' 29' ' ' SER . 37.8 mmt180 -60.3 138.24 57.99 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 102.99 -20.79 42.27 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -178.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.564 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 3.5 mppt? -109.72 157.79 18.76 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.203 -0.499 . . . . 0.0 110.432 178.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 p -82.2 116.52 26.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.355 0.598 . . . . 0.0 109.839 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 25.8 t -106.26 131.2 56.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.213 -173.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.529 ' SD ' HG23 ' A' ' 59' ' ' ILE . 27.7 ttt -111.64 123.6 50.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.392 175.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.432 ' HB2' ' HB ' ' A' ' 119' ' ' VAL . 3.3 mm? -103.78 116.87 33.1 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.642 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.06 114.94 29.21 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.67 176.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.494 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 92.3 m-85 -99.7 111.85 24.15 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.1 t -127.52 -174.62 3.23 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.193 -174.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -168.03 160.55 12.1 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.327 0.651 . . . . 0.0 109.736 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.45 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 78.3 p -75.91 -18.56 59.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.051 0.453 . . . . 0.0 111.353 -176.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 21.1 p-90 -103.35 12.08 35.84 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -175.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.402 ' HB3' HG22 ' A' ' 115' ' ' ILE . 23.0 p -110.12 114.58 28.2 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.074 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.93 -26.56 68.71 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.916 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.428 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 28.3 t -63.21 -36.82 77.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.959 0.409 . . . . 0.0 110.638 -178.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 52.1 m -68.32 -16.15 63.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.724 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -75.56 -7.96 55.53 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.154 0.502 . . . . 0.0 110.287 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.507 ' HD3' ' CD2' ' A' ' 134' ' ' TYR . 57.6 mttt -88.54 -54.26 4.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 122.488 1.137 . . . . 0.0 108.494 162.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.467 ' O ' HG13 ' A' ' 55' ' ' ILE . 24.3 tt0 -57.03 -62.75 1.53 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 113.001 -1.909 . . . . 0.0 112.55 -171.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.588 ' SD ' ' HE2' ' A' ' 86' ' ' PHE . 83.1 mtp -53.93 -54.77 43.14 Favored Pre-proline 0 CA--C 1.538 0.481 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -172.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.409 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 25.5 Cg_endo -62.61 -35.61 69.12 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 121.961 1.774 . . . . 0.0 112.591 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -67.04 -42.58 84.61 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.389 175.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 51' ' ' GLU . 70.4 mt -60.06 -52.93 55.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.985 178.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.57 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 16.4 pt-20 -64.75 -31.11 72.19 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.312 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -71.85 -56.03 6.47 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -176.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -108.15 -18.35 13.8 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -171.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.529 HG23 ' SD ' ' A' ' 37' ' ' MET . 48.4 mm -93.57 -53.95 7.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.721 176.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.57 ' HB3' ' HA ' ' A' ' 56' ' ' GLU . 74.9 t-105 -69.86 -73.06 0.17 Allowed 'General case' 0 C--O 1.215 -0.744 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.894 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -48.13 -29.17 3.4 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -174.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -91.38 -33.2 15.37 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.305 0.484 . . . . 0.0 112.305 -175.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -124.84 -4.55 7.57 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -171.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 17.4 pttp -43.71 -51.79 6.93 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -170.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.18 -81.18 0.18 Allowed 'General case' 0 C--O 1.247 0.959 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.499 ' CG ' HD12 ' A' ' 150' ' ' LEU . 12.1 t30 61.41 -71.7 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.347 -177.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 173.06 -26.88 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 123.573 0.749 . . . . 0.0 109.423 -177.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.496 ' HB2' ' HG3' ' A' ' 34' ' ' LYS . 6.3 p-10 -154.62 28.29 0.44 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.416 -172.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.577 ' HB2' HD11 ' A' ' 150' ' ' LEU . 79.4 t80 -100.5 125.55 46.84 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 118.548 -1.261 . . . . 0.0 110.422 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 36' ' ' VAL . . . -124.97 105.62 9.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.811 -176.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.49 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 3.9 tt -110.77 119.36 38.84 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.8 mm -124.34 126.11 71.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.444 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.469 ' HA3' HD23 ' A' ' 96' ' ' LEU . . . -89.17 133.83 12.04 Favored Glycine 0 C--O 1.221 -0.696 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.204 175.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 68.0 mt -120.8 114.74 44.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.867 0.334 . . . . 0.0 110.733 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -78.32 129.53 35.12 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 172.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.435 HH21 ' HA ' ' A' ' 112' ' ' ASP . 49.5 ttt-85 -45.67 -67.05 0.32 Allowed 'General case' 0 N--CA 1.469 0.478 0 O-C-N 123.97 0.794 . . . . 0.0 112.828 -170.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.639 ' HA ' ' O ' ' A' ' 99' ' ' ASP . 12.0 p-10 -145.61 21.05 1.5 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.58 0.705 . . . . 0.0 109.7 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -69.9 129.74 90.7 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.848 -177.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.552 ' HG2' ' HG2' ' A' ' 82' ' ' LYS . 16.5 Cg_endo -63.58 168.19 11.99 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 122.404 2.07 . . . . 0.0 112.204 173.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -52.55 -52.77 53.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.071 -172.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.542 ' OE2' ' HG2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -67.61 -28.08 67.44 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -173.602 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.552 ' HG2' ' HG2' ' A' ' 79' ' ' PRO . 44.0 mmtm -64.45 -51.07 64.97 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.831 0.348 . . . . 0.0 110.468 175.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.432 HG22 ' HB3' ' A' ' 98' ' ' LEU . 61.1 t -53.81 -52.2 37.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.106 -178.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.23 -39.22 92.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.577 -177.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.451 ' HA ' ' HE3' ' A' ' 88' ' ' LYS . . . -73.05 -26.59 61.35 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.787 -177.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.588 ' HE2' ' SD ' ' A' ' 52' ' ' MET . 71.8 t80 -84.85 -47.42 10.37 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.886 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.456 ' HB1' HD11 ' A' ' 96' ' ' LEU . . . -53.08 -47.48 68.49 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.289 0.368 . . . . 0.0 111.455 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.451 ' HE3' ' HA ' ' A' ' 85' ' ' ALA . 18.4 pttp -62.31 -23.98 67.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.033 0.444 . . . . 0.0 111.241 -178.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.9 m -92.62 -0.62 57.28 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.048 -175.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.1 p -122.97 -20.97 5.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.602 175.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 114.64 -76.29 0.25 Allowed Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -177.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.472 HG23 ' HE1' ' A' ' 52' ' ' MET . 86.7 t 43.93 87.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 124.494 1.118 . . . . 0.0 113.344 178.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.4 m -78.67 -5.4 52.94 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.493 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.447 ' CE1' ' HB3' ' A' ' 56' ' ' GLU . 49.0 p90 -107.29 145.58 31.49 Favored Pre-proline 0 C--N 1.33 -0.254 0 O-C-N 122.127 -0.358 . . . . 0.0 110.451 179.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -63.05 136.45 56.57 Favored 'Trans proline' 0 C--O 1.238 0.485 0 C-N-CA 122.371 2.047 . . . . 0.0 113.222 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.469 HD23 ' HA3' ' A' ' 73' ' ' GLY . 92.8 mt -105.14 151.51 23.94 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.871 175.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.432 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -125.13 145.51 15.73 Favored Glycine 0 N--CA 1.437 -1.297 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 175.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.729 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.2 pt? -100.09 132.71 45.3 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 120.744 0.306 . . . . 0.0 110.68 -176.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.639 ' O ' ' HA ' ' A' ' 77' ' ' ASP . 22.2 t0 -109.84 82.54 2.42 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.71 176.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.24 87.07 0.49 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.138 1.892 . . . . 0.0 112.264 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.04 -21.65 1.59 Allowed Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.131 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' A' ' 77' ' ' ASP . . . 70.15 24.25 5.0 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 122.866 0.466 . . . . 0.0 110.714 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -91.08 -29.08 17.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.583 -176.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.573 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 32.4 mm -70.04 -35.85 65.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 171.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -60.8 -40.14 91.54 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.741 172.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.665 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -68.28 -25.53 65.2 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.951 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.962 ' HE2' ' HB3' ' A' ' 16' ' ' PHE . 26.8 mtpp -70.72 -3.99 21.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.393 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.696 ' HB3' HH22 ' A' ' 117' ' ' ARG . 65.1 m-85 -129.37 -11.82 4.53 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.91 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.665 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -176.36 176.4 1.65 Allowed 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.861 ' HB2' ' HB1' ' A' ' 113' ' ' ALA . 95.4 mt -60.34 136.05 57.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.634 0.254 . . . . 0.0 110.505 177.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.56 ' HG2' ' HB1' ' A' ' 106' ' ' ALA . 53.8 mtp85 -49.57 -51.85 34.11 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.988 -177.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.435 ' HA ' HH21 ' A' ' 76' ' ' ARG . 6.8 m-20 -105.08 34.38 3.24 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.654 -173.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.861 ' HB1' ' HB2' ' A' ' 110' ' ' LEU . . . -85.02 9.88 13.44 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.1 178.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 118.1 -151.94 17.73 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.348 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.404 HG13 ' H ' ' A' ' 116' ' ' THR . 8.6 tp -151.1 170.74 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -177.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.576 HG23 ' HA ' ' A' ' 133' ' ' LEU . 30.7 m 71.77 93.97 0.08 Allowed 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.532 0.52 . . . . 0.0 110.314 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.696 HH22 ' HB3' ' A' ' 108' ' ' TYR . 54.8 mtp180 -146.58 149.13 32.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.66 -174.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.553 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 33.0 m-80 -127.6 119.83 26.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.75 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.432 ' HB ' ' HB2' ' A' ' 38' ' ' LEU . 73.1 t -124.58 122.91 64.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.619 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 34.5 tp -108.88 130.72 55.43 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.898 0.38 . . . . 0.0 110.917 -178.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.509 ' CD1' HG12 ' A' ' 127' ' ' ILE . 27.8 mm -111.07 139.11 36.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.695 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.511 ' OD2' ' HB2' ' A' ' 126' ' ' LYS . 3.4 p30 -84.47 171.82 12.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.808 0.337 . . . . 0.0 110.844 177.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -60.7 -25.52 66.46 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.427 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -82.13 -12.57 58.12 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.777 -174.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 103.86 3.92 45.61 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.607 176.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.639 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 9.0 mtmp? -96.72 160.26 14.47 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.142 0.496 . . . . 0.0 111.64 -177.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.509 HG12 ' CD1' ' A' ' 121' ' ' ILE . 43.5 mt -95.37 127.79 47.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.399 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.48 ' HA ' HG23 ' A' ' 9' ' ' ILE . 29.4 m -117.74 -23.19 3.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -176.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.619 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 50.1 tptt -128.66 115.98 18.88 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.558 -174.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.424 HD12 HG12 ' A' ' 9' ' ' ILE . 11.0 mp -110.74 109.77 20.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.975 175.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.553 ' HB ' ' HB2' ' A' ' 118' ' ' ASN . 89.3 m -135.71 141.8 44.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.878 0.371 . . . . 0.0 111.278 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 132' ' ' ARG . 1.3 ptp180 -124.42 150.61 45.43 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 171.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.576 ' HA ' HG23 ' A' ' 116' ' ' THR . 0.8 OUTLIER 46.32 104.95 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 O-C-N 124.703 1.252 . . . . 0.0 113.992 179.503 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.507 ' CD2' ' HD3' ' A' ' 50' ' ' LYS . 39.9 t80 -39.26 112.61 0.26 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.944 -1.026 . . . . 0.0 112.205 176.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -110.84 141.03 44.76 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 173.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.62 -58.45 6.75 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -173.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.405 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.7 mp0 -60.33 -32.19 71.02 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.893 0.378 . . . . 0.0 111.238 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -65.42 -47.5 76.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.571 -177.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.535 ' O ' HG22 ' A' ' 143' ' ' VAL . 88.8 t80 -61.77 -39.46 91.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.736 -178.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -59.96 -46.39 89.56 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.109 0.48 . . . . 0.0 110.375 176.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.3 m -62.69 -38.97 92.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.227 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.596 ' O ' HG12 ' A' ' 146' ' ' ILE . 1.1 mt -61.57 -46.62 89.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.953 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 139' ' ' PHE . 97.6 t -55.96 -49.19 76.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-O 120.688 0.28 . . . . 0.0 111.16 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.43 ' HA ' ' OE1' ' A' ' 144' ' ' GLN . 6.7 tp60 -66.46 -40.96 89.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.955 0.407 . . . . 0.0 110.48 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -57.96 -46.12 85.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.065 176.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.637 ' O ' HD21 ' A' ' 150' ' ' LEU . 38.4 mm -56.48 -44.69 81.08 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.279 177.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.451 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 4.8 t-20 -53.68 -52.0 61.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.848 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -76.29 -20.82 56.97 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.932 -177.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.467 ' HE2' ' HA ' ' A' ' 122' ' ' ASP . 56.1 mmm -73.0 -28.52 62.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.131 0.491 . . . . 0.0 110.608 175.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.637 HD21 ' O ' ' A' ' 146' ' ' ILE . 4.3 mm? -75.89 -11.75 60.03 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.234 175.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.602 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 42.3 mmtm -102.01 -51.46 3.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.549 176.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.602 ' HG3' ' O ' ' A' ' 151' ' ' LYS . 0.0 OUTLIER 45.86 -175.16 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.693 1.597 . . . . 0.0 112.304 -173.443 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.608 ' HA3' ' HB2' ' A' ' 156' ' ' HIS . . . -175.49 82.92 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 119.297 -1.43 . . . . 0.0 113.436 -177.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -56.94 -29.38 63.07 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 166.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 18.3 m80 -144.82 79.89 1.61 Allowed 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.53 164.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.608 ' HB2' ' HA3' ' A' ' 153' ' ' GLY . 31.0 t60 -70.15 -22.98 62.92 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.129 -176.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -73.59 114.51 11.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.896 177.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -122.04 9.12 9.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.86 0.362 . . . . 0.0 111.037 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 40.8 t-80 . . . . . 0 C--O 1.243 0.744 0 CA-C-O 118.441 -0.79 . . . . 0.0 109.553 177.857 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ppp? . . . . . 0 N--CA 1.484 1.262 0 CA-C-O 120.622 0.249 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.6 m -70.64 -14.42 62.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.792 -172.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 92.3 mt -80.02 -18.06 51.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.948 0.404 . . . . 0.0 110.615 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.32 -25.97 3.59 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.173 -0.536 . . . . 0.0 113.688 176.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.565 ' CE1' HD21 ' A' ' 130' ' ' LEU . 61.2 m-85 -65.34 130.38 43.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.994 0.426 . . . . 0.0 112.101 -175.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.9 pt -101.46 -11.64 8.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.317 169.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.8 m -110.95 150.33 13.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.005 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.434 ' HE ' ' CD ' ' A' ' 11' ' ' GLU . 77.6 mtm180 -118.82 163.78 16.37 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.339 0.59 . . . . 0.0 111.638 -175.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 77.3 mt -70.42 131.37 34.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.443 -0.798 . . . . 0.0 109.531 174.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.63 -27.27 15.5 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -176.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.434 ' CD ' ' HE ' ' A' ' 8' ' ' ARG . 14.3 mt-10 -80.19 174.94 11.1 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.65 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 55.6 mtp -98.8 146.43 25.94 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.875 0.369 . . . . 0.0 110.417 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.426 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -79.92 135.91 54.94 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.842 -177.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 21.2 Cg_exo -64.89 117.28 4.39 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.759 2.306 . . . . 0.0 111.915 177.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.41 ' CG ' ' HG ' ' A' ' 29' ' ' SER . 0.6 OUTLIER -68.21 141.85 55.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.949 -179.325 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.482 ' HB2' HD11 ' A' ' 104' ' ' ILE . 52.4 p90 -154.28 161.18 41.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.847 0.356 . . . . 0.0 111.224 -174.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.2 m -110.35 116.28 31.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.448 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.5 tt -114.64 142.14 28.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.936 0.398 . . . . 0.0 110.829 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.457 ' O ' HD22 ' A' ' 98' ' ' LEU . 14.8 m -93.41 123.03 36.42 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.126 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.428 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 92.7 mt -79.52 173.96 12.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.919 0.39 . . . . 0.0 111.393 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.456 HG21 ' O ' ' A' ' 96' ' ' LEU . 19.5 p -57.15 -34.63 68.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.283 -0.871 . . . . 0.0 113.159 -175.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -100.56 19.35 17.06 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.177 0.513 . . . . 0.0 110.535 -174.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.09 36.1 25.53 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.601 174.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -108.4 109.42 20.71 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.09 0.472 . . . . 0.0 110.337 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -89.7 113.94 25.52 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.275 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.7 m -119.12 153.94 21.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.049 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.2 m -112.88 150.96 31.02 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.529 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 0.5 OUTLIER -59.96 -38.46 82.55 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.166 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.503 ' HA ' ' CG ' ' A' ' 32' ' ' ARG . 64.9 m -54.59 -26.88 35.24 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.106 176.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.6 m -72.75 -20.2 61.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.045 0.45 . . . . 0.0 110.97 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.484 HD13 ' HB1' ' A' ' 70' ' ' ALA . 96.3 mt -114.87 3.04 14.49 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.305 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.529 ' HG2' ' O ' ' A' ' 28' ' ' LEU . 47.9 mmm-85 -66.25 139.13 58.06 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.09 -20.48 28.54 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -172.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.503 ' HB3' ' O ' ' A' ' 68' ' ' ASP . 42.5 mtmt -116.14 165.13 13.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.263 -0.468 . . . . 0.0 110.15 177.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 p -79.59 120.03 30.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.178 0.513 . . . . 0.0 110.031 174.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.496 HG23 ' HB3' ' A' ' 70' ' ' ALA . 43.5 t -115.37 125.18 72.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.863 -175.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.453 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 25.6 ttt -103.13 124.76 49.17 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.854 177.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.3 mt -117.57 141.19 48.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.183 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.447 ' N ' HE21 ' A' ' 39' ' ' GLN . 0.0 OUTLIER -139.05 136.67 35.51 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 174.791 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.422 ' HD2' ' HG3' ' A' ' 117' ' ' ARG . 98.0 m-85 -97.56 119.53 36.3 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.063 0.458 . . . . 0.0 110.675 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.4 t -127.82 -177.08 3.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.342 -175.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.632 ' HB1' ' SG ' ' A' ' 45' ' ' CYS . . . -165.77 155.52 12.45 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 176.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.475 ' H ' ' HG3' ' A' ' 78' ' ' GLU . 99.5 p -63.26 -24.28 67.8 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.93 0.395 . . . . 0.0 112.025 -175.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.5 p-90 -100.92 7.59 43.53 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.751 0.31 . . . . 0.0 111.786 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.632 ' SG ' ' HB1' ' A' ' 42' ' ' ALA . 88.8 m -88.41 99.79 12.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.037 0.446 . . . . 0.0 111.078 178.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.84 -20.44 77.59 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.203 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 34.6 t -76.29 -41.31 36.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.836 0.351 . . . . 0.0 110.197 177.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.755 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 72.2 m -68.72 -16.61 63.87 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.475 0.655 . . . . 0.0 110.376 177.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.485 HH21 ' HE1' ' A' ' 86' ' ' PHE . 25.3 ttm180 -71.19 -11.13 60.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.7 176.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.559 ' HD3' ' CD2' ' A' ' 134' ' ' TYR . 80.1 mttt -87.15 -57.66 2.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.609 0.719 . . . . 0.0 110.046 169.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.929 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 12.4 pt-20 -63.76 -44.84 92.26 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-N 115.065 -0.971 . . . . 0.0 112.495 -168.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.542 ' HE1' ' CE2' ' A' ' 86' ' ' PHE . 15.3 mtm -57.41 -55.51 43.67 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.045 -174.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.56 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 19.7 Cg_endo -60.73 -33.22 93.38 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 121.771 1.647 . . . . 0.0 112.481 177.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.418 ' HD1' ' O ' ' A' ' 50' ' ' LYS . 12.3 m-85 -70.35 -46.24 64.52 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.499 176.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 51' ' ' GLU . 96.9 mt -58.03 -51.43 70.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.612 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.61 ' HB3' ' CD1' ' A' ' 94' ' ' TYR . 0.4 OUTLIER -65.47 -34.93 79.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.403 -177.289 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.56 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 10.4 ttmm -68.5 -43.35 77.04 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.564 -174.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -106.12 -65.18 1.09 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.473 178.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 65.7 mt -55.7 -39.9 57.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.843 0.354 . . . . 0.0 110.966 -170.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.56 ' HB3' ' O ' ' A' ' 56' ' ' GLU . 75.5 t-105 -75.33 -71.32 0.37 Allowed 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.552 177.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.489 HD22 ' HD1' ' A' ' 60' ' ' TRP . 1.8 mm? -50.45 -34.91 26.43 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -173.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -84.01 -30.46 26.14 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -175.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.503 ' HB3' ' HG ' ' A' ' 150' ' ' LEU . 72.9 m-70 -129.56 -8.51 4.6 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -168.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -38.79 -48.73 1.55 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -171.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.47 -84.19 0.28 Allowed 'General case' 0 C--O 1.253 1.258 0 CA-C-O 121.246 0.546 . . . . 0.0 110.492 -175.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.427 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 44.5 t-20 59.24 -77.6 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.939 -169.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 66' ' ' ASN . . . 156.31 -23.01 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 125.327 1.451 . . . . 0.0 107.154 -173.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 34' ' ' LYS . 9.7 t70 -119.93 1.25 10.94 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.197 -173.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.507 ' HB2' HD11 ' A' ' 150' ' ' LEU . 84.9 t80 -110.67 151.04 28.17 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 119.09 -1.044 . . . . 0.0 112.297 -176.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.496 ' HB3' HG23 ' A' ' 36' ' ' VAL . . . -148.5 141.51 24.85 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.221 173.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.473 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 3.6 tt -139.02 127.25 22.66 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -177.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.404 ' N ' HD22 ' A' ' 71' ' ' LEU . 63.4 mt -135.79 130.91 49.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 120.73 0.3 . . . . 0.0 110.562 178.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.441 ' HA3' HD23 ' A' ' 96' ' ' LEU . . . -95.12 138.88 14.21 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.291 -0.956 . . . . 0.0 111.01 173.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 55.3 mt -119.66 118.21 56.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 117.395 0.598 . . . . 0.0 110.686 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.526 ' OD1' ' HA ' ' A' ' 42' ' ' ALA . 6.7 t0 -95.41 132.32 40.59 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.495 ' HD2' HD12 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -97.22 121.02 38.65 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.968 0.413 . . . . 0.0 111.942 -170.577 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 73.08 -35.81 0.34 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.347 1.059 . . . . 0.0 113.044 175.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.475 ' HG3' ' H ' ' A' ' 43' ' ' SER . 60.0 mm-40 -62.54 140.31 96.79 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-O 121.147 0.499 . . . . 0.0 111.241 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.525 ' O ' HG21 ' A' ' 83' ' ' VAL . 18.3 Cg_endo -84.25 -168.42 0.54 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.043 2.495 . . . . 0.0 113.64 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.52 HD23 HD13 ' A' ' 84' ' ' LEU . 1.7 tt -56.25 -57.49 12.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.801 -1.091 . . . . 0.0 112.138 -170.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -37.53 87.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.864 -173.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.493 ' CG ' ' HD2' ' A' ' 79' ' ' PRO . 27.1 mmtp -58.86 -50.43 74.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.585 0.231 . . . . 0.0 111.336 178.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.525 HG21 ' O ' ' A' ' 79' ' ' PRO . 46.9 t -58.4 -46.04 89.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.754 -178.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.52 HD13 HD23 ' A' ' 80' ' ' LEU . 10.9 mp -64.2 -47.63 79.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.335 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.02 -32.95 74.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.687 -176.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.542 ' CE2' ' HE1' ' A' ' 52' ' ' MET . 72.0 t80 -77.8 -43.72 29.71 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.502 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.464 ' HB3' HD12 ' A' ' 96' ' ' LEU . . . -59.22 -54.38 47.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.447 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.9 ptmm? -57.12 -26.59 60.74 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.971 -175.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 27.3 m -85.74 -4.06 59.06 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.382 -174.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 19.1 p -128.14 6.12 5.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.313 0.578 . . . . 0.0 110.321 175.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.55 -73.27 1.23 Allowed Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.294 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.449 HG13 ' O ' ' A' ' 94' ' ' TYR . 42.9 t 40.95 83.91 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.963 0.905 . . . . 0.0 112.695 -177.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.8 m -75.76 -3.8 36.91 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.541 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.61 ' CD1' ' HB3' ' A' ' 56' ' ' GLU . 50.0 p90 -107.72 153.07 41.71 Favored Pre-proline 0 C--N 1.33 -0.273 0 O-C-N 121.813 -0.554 . . . . 0.0 110.621 178.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.5 137.0 32.38 Favored 'Trans proline' 0 C--O 1.239 0.561 0 C-N-CA 122.253 1.969 . . . . 0.0 113.38 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.464 HD12 ' HB3' ' A' ' 87' ' ' ALA . 97.6 mt -104.84 153.67 21.04 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.342 173.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -121.6 147.37 17.29 Favored Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 174.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.701 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.7 pt? -100.27 131.8 46.01 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.88 0.371 . . . . 0.0 110.617 -177.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.419 ' OD2' ' HA ' ' A' ' 102' ' ' ALA . 14.8 t0 -119.35 75.46 16.6 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.491 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.439 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 15.7 Cg_exo -68.01 120.57 7.56 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.895 2.396 . . . . 0.0 111.766 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 102.42 -8.75 55.38 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -175.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.739 ' HB1' ' HE ' ' A' ' 111' ' ' ARG . . . 54.6 45.88 25.95 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 123.09 0.556 . . . . 0.0 111.547 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -76.09 -49.71 16.69 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.253 0.549 . . . . 0.0 110.062 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.482 HD11 ' HB2' ' A' ' 16' ' ' PHE . 27.9 mm -65.83 -36.28 77.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.276 178.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.445 ' HB3' ' HB2' ' A' ' 102' ' ' ALA . 71.5 t80 -62.56 -45.28 93.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.289 174.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.595 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -65.74 -21.01 66.48 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.769 -178.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -73.48 -12.06 60.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.824 0.345 . . . . 0.0 111.245 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.422 ' CZ ' ' HD2' ' A' ' 14' ' ' PRO . 65.8 m-85 -119.93 -34.57 3.69 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.351 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.595 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -154.72 160.37 41.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.783 0.325 . . . . 0.0 111.004 -177.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.454 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . 90.3 mt -67.09 136.29 54.94 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.739 ' HE ' ' HB1' ' A' ' 102' ' ' ALA . 67.5 mtp180 -49.46 -40.05 35.65 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -171.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -98.76 -8.98 25.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.12 0.486 . . . . 0.0 111.475 -175.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.454 ' CB ' ' HB2' ' A' ' 110' ' ' LEU . . . -81.45 40.88 0.59 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -171.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 97.79 114.62 3.31 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.262 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.495 HD12 ' HD2' ' A' ' 76' ' ' ARG . 2.6 tp -76.19 -49.77 24.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.642 0.258 . . . . 0.0 111.531 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.949 ' HB ' ' HB3' ' A' ' 133' ' ' LEU . 22.2 p -66.3 114.2 5.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.17 -173.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.422 ' HG3' ' HD2' ' A' ' 40' ' ' PHE . 10.8 ptp180 -169.33 145.52 3.31 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.952 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.625 ' HB2' ' OG1' ' A' ' 131' ' ' THR . 6.6 m120 -122.98 142.69 50.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.526 -177.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 29.1 t -128.51 120.7 53.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.301 -177.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.656 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 41.9 tp -105.17 116.83 32.62 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.964 174.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 57.0 mt -98.6 134.33 37.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.132 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.38 177.58 8.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.047 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.415 ' HD3' ' OD1' ' A' ' 68' ' ' ASP . 70.9 mtm180 -66.64 -27.26 67.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.967 -174.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -75.17 -29.67 60.48 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.082 0.468 . . . . 0.0 110.419 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.45 15.73 8.06 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.777 -176.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.65 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 82.4 mttt -97.62 157.62 15.94 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.827 0.346 . . . . 0.0 110.583 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.473 HG23 HD23 ' A' ' 130' ' ' LEU . 53.9 mt -91.04 120.67 40.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.576 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.6 m -114.97 1.77 8.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.83 ' HD2' HG22 ' A' ' 131' ' ' THR . 0.3 OUTLIER -163.71 124.61 2.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.779 0.323 . . . . 0.0 111.582 -178.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.565 HD21 ' CE1' ' A' ' 5' ' ' TYR . 96.5 mt -127.58 106.73 9.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.615 174.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.83 HG22 ' HD2' ' A' ' 129' ' ' LYS . 16.6 p -107.39 148.89 28.51 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.925 0.393 . . . . 0.0 111.062 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.503 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 23.5 mtm180 -92.84 107.8 19.5 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 174.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.949 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 4.0 pp 49.28 -172.18 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 O-C-N 124.239 0.962 . . . . 0.0 112.979 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.929 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 87.6 t80 -73.65 85.64 1.61 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.321 175.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.534 ' HB3' ' HB2' ' A' ' 138' ' ' GLU . 47.2 t-20 -85.54 117.69 24.6 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 170.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 30.0 mp0 -46.93 -39.72 12.82 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 123.403 0.44 . . . . 0.0 111.973 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -79.76 -51.54 9.06 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.56 0.219 . . . . 0.0 111.56 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.534 ' HB2' ' HB3' ' A' ' 135' ' ' ASN . 44.9 mt-10 -66.01 -34.43 78.07 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 121.243 -0.183 . . . . 0.0 111.24 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.431 ' O ' HG21 ' A' ' 143' ' ' VAL . 81.5 t80 -67.16 -42.97 83.43 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 177.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.24 -48.54 80.08 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.187 0.518 . . . . 0.0 110.316 176.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.3 m -62.88 -35.3 79.56 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.679 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.567 ' HG ' ' HG2' ' A' ' 129' ' ' LYS . 1.4 tt -67.29 -42.54 83.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.236 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.431 HG21 ' O ' ' A' ' 139' ' ' PHE . 70.6 t -58.45 -51.73 67.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.903 178.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.463 ' HA ' ' ND2' ' A' ' 147' ' ' ASN . 47.5 tp60 -60.86 -40.61 93.55 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.122 0.487 . . . . 0.0 110.498 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -56.55 -46.69 80.57 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.618 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.558 ' O ' HD23 ' A' ' 150' ' ' LEU . 42.6 mt -64.76 -38.35 82.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.914 178.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.505 ' O ' ' HG3' ' A' ' 151' ' ' LYS . 93.0 m-20 -53.21 -45.45 68.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.555 178.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -69.85 -36.73 75.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.079 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 84.3 mmm -63.16 -24.51 67.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.309 0.576 . . . . 0.0 110.233 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.558 HD23 ' O ' ' A' ' 146' ' ' ILE . 3.8 mm? -86.47 -22.3 26.54 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.189 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.505 ' HG3' ' O ' ' A' ' 147' ' ' ASN . 6.9 mtmp? -85.43 -47.35 10.04 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 177.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.565 ' OE1' ' HA ' ' A' ' 155' ' ' HIS . 0.6 OUTLIER 62.33 7.08 2.12 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.983 0.802 . . . . 0.0 111.142 177.022 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 60.0 35.35 86.95 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 -169.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.466 ' HE2' ' C ' ' A' ' 159' ' ' HIS . 4.8 p-80 62.51 138.61 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.666 1.586 . . . . 0.0 111.673 -173.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.565 ' HA ' ' OE1' ' A' ' 152' ' ' GLU . 21.1 m80 -49.0 113.17 0.74 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.175 -178.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -79.69 87.38 5.22 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.931 -173.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -149.74 29.0 0.76 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.499 0.666 . . . . 0.0 109.301 173.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.409 ' O ' ' HB2' ' A' ' 159' ' ' HIS . 48.3 t60 -152.71 -57.36 0.13 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.106 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.466 ' C ' ' HE2' ' A' ' 154' ' ' HIS . 65.1 t-80 . . . . . 0 C--O 1.244 0.811 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.727 175.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.4 ttp . . . . . 0 N--CA 1.48 1.053 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.1 m -84.21 107.37 16.49 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.507 ' HB3' ' HD1' ' A' ' 5' ' ' TYR . 85.6 mt -75.8 121.37 22.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.239 -178.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.99 61.41 3.39 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.433 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.507 ' HD1' ' HB3' ' A' ' 3' ' ' LEU . 48.1 m-85 -113.72 153.29 29.24 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 177.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 29.0 pt -115.06 1.34 8.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.187 0.518 . . . . 0.0 110.429 175.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.9 m -117.34 161.39 16.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.673 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.528 ' HB2' ' HB2' ' A' ' 11' ' ' GLU . 42.1 mtt180 -112.5 165.64 12.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.18 -176.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.456 HG12 HD21 ' A' ' 130' ' ' LEU . 67.0 mt -81.33 118.32 28.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 172.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.12 -3.96 55.4 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -172.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 8' ' ' ARG . 10.1 tp10 -90.93 153.37 20.23 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.517 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 58.2 mtp -76.37 139.41 40.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.123 0.487 . . . . 0.0 111.034 -177.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.427 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -76.64 134.38 69.38 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.918 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.581 ' HD2' ' CE1' ' A' ' 108' ' ' TYR . 24.3 Cg_exo -61.69 149.92 87.87 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.778 2.319 . . . . 0.0 111.427 177.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.0 169.41 9.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.413 -177.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.402 ' O ' ' HA ' ' A' ' 27' ' ' THR . 44.1 p90 -172.39 172.45 4.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.507 -174.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 18.1 m -125.9 100.93 6.6 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 173.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 25' ' ' GLN . 18.3 tt -99.36 143.21 13.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.954 -172.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.6 m -92.14 121.39 33.63 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.917 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.7 mt -78.9 176.6 9.45 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.756 -178.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.3 p -59.25 -28.47 66.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.889 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.713 ' OD1' ' HG2' ' A' ' 24' ' ' LYS . 0.3 OUTLIER -77.79 -28.05 50.36 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.232 178.836 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.16 -1.58 28.31 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.107 -170.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.713 ' HG2' ' OD1' ' A' ' 22' ' ' ASP . 47.4 mmtm -70.18 117.26 11.52 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.642 -0.279 . . . . 0.0 110.777 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.453 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 90.8 mt-30 -91.12 114.63 27.21 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 174.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 17' ' ' THR . 17.0 m -116.91 151.12 18.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.651 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 4.2 m -98.84 147.32 25.05 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.707 178.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.462 ' O ' HD13 ' A' ' 28' ' ' LEU . 1.1 tm? -69.96 -25.54 63.68 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.499 ' HA ' ' HG2' ' A' ' 32' ' ' ARG . 48.8 m -58.45 -24.86 61.36 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.447 175.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.9 m -75.1 -18.39 60.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.836 0.351 . . . . 0.0 111.435 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.2 mt -105.28 3.55 30.09 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.161 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.499 ' HG2' ' HA ' ' A' ' 29' ' ' SER . 29.0 mmt180 -66.7 116.18 7.34 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 127.81 -21.02 5.66 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -175.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 123' ' ' ARG . 42.9 mtmt -116.55 164.75 14.13 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 176.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.496 HG21 ' O ' ' A' ' 68' ' ' ASP . 17.4 m -76.69 124.07 34.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 174.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.557 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 6.6 t -115.06 108.71 26.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.084 0.469 . . . . 0.0 110.935 -172.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.426 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 27.4 ttt -93.29 115.32 27.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.618 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.459 ' CD1' HG13 ' A' ' 36' ' ' VAL . 6.2 mp -115.26 115.39 26.6 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.356 178.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.429 ' O ' ' HG3' ' A' ' 39' ' ' GLN . 1.4 pt20 -105.82 117.62 34.49 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.047 0.451 . . . . 0.0 110.432 176.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.649 ' O ' ' HA ' ' A' ' 116' ' ' THR . 97.9 m-85 -85.09 109.64 18.39 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 172.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.0 t -127.77 -175.39 3.46 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.247 -170.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.55 ' HB2' ' SG ' ' A' ' 45' ' ' CYS . . . -149.15 136.57 20.17 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.191 0.52 . . . . 0.0 111.686 -178.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.458 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 3.5 p -70.57 -6.26 35.16 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.445 175.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.437 ' HD1' ' HG3' ' A' ' 78' ' ' GLU . 43.5 p-90 -113.83 14.21 18.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.449 -177.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.55 ' SG ' ' HB2' ' A' ' 42' ' ' ALA . 94.8 m -112.81 138.13 50.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.901 0.382 . . . . 0.0 110.922 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -86.23 -33.33 14.67 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.218 -178.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.0 t -58.51 -36.11 57.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 121.362 0.601 . . . . 0.0 110.103 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.591 ' O ' ' HG2' ' A' ' 52' ' ' MET . 71.6 m -65.92 -16.55 63.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.714 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -77.6 -3.28 40.0 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 122.045 -0.409 . . . . 0.0 110.756 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -87.96 -53.77 4.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.103 0.478 . . . . 0.0 110.05 166.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.648 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 8.9 pt-20 -60.58 -46.28 90.83 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.912 -172.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.826 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 88.8 mmm -54.82 -59.57 10.27 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -174.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.826 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 31.8 Cg_exo -61.1 -39.76 56.85 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 122.025 1.817 . . . . 0.0 112.735 177.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.526 ' HB3' ' CZ ' ' A' ' 139' ' ' PHE . 11.6 m-85 -65.39 -46.71 79.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.58 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.51 HG12 ' HE1' ' A' ' 139' ' ' PHE . 77.3 mt -60.83 -46.15 96.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.439 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.5 tp10 -57.74 -49.12 77.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.886 0.374 . . . . 0.0 110.652 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.424 ' O ' ' HE3' ' A' ' 62' ' ' LYS . 28.6 ttpp -66.27 -52.38 48.06 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -174.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.443 ' HA ' ' NZ ' ' A' ' 62' ' ' LYS . 73.6 m-20 -105.28 -15.55 15.02 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -169.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 58.1 mt -105.43 -60.54 2.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.997 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.536 ' CD2' ' HB3' ' A' ' 94' ' ' TYR . 76.7 t-105 -63.42 -65.44 0.68 Allowed 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.158 -177.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.49 HD12 ' HE3' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -46.36 -32.63 3.3 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -174.909 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.443 ' NZ ' ' HA ' ' A' ' 58' ' ' ASP . 31.6 mmtp -81.54 -28.42 33.93 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -174.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -128.81 -43.42 1.37 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.807 -174.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.49 ' HE3' HD12 ' A' ' 61' ' ' LEU . 31.2 mttp 56.65 -92.38 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.934 0.893 . . . . 0.0 111.263 -176.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -108.35 -39.16 5.52 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 173.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 69.31 -72.62 0.1 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.217 176.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 164.8 -30.62 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.06 -173.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.496 ' O ' HG21 ' A' ' 35' ' ' VAL . 36.3 t70 -131.73 15.74 4.83 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 114.909 -1.042 . . . . 0.0 110.92 -177.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.477 ' HA ' HG21 ' A' ' 35' ' ' VAL . 69.6 t80 -121.71 145.08 48.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.115 0.483 . . . . 0.0 110.979 -177.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.39 143.88 29.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.811 174.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.426 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 3.2 tt -143.46 123.03 13.24 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -177.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 65.6 mt -125.06 119.49 55.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.723 0.297 . . . . 0.0 110.405 176.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.52 123.38 6.74 Favored Glycine 0 C--O 1.219 -0.831 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 174.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 55.9 mt -117.82 122.89 70.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 117.706 0.753 . . . . 0.0 111.097 -174.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -80.42 118.34 21.97 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 170.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.538 ' HB3' ' CD1' ' A' ' 115' ' ' ILE . 0.0 OUTLIER -74.63 -6.34 48.07 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.846 -166.854 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -153.18 -30.58 0.13 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 118.759 -1.176 . . . . 0.0 113.144 -176.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.499 ' HB3' ' HG3' ' A' ' 82' ' ' LYS . 24.2 mm-40 -85.57 152.37 57.22 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.009 0.433 . . . . 0.0 112.079 -174.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.496 ' HD2' ' HG3' ' A' ' 82' ' ' LYS . 74.4 Cg_endo -79.31 -171.61 1.3 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.324 2.682 . . . . 0.0 115.243 -176.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.498 HD12 HD21 ' A' ' 84' ' ' LEU . 2.9 tm? -52.07 -55.66 19.27 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 113.528 -1.669 . . . . 0.0 111.423 -175.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -52.41 -42.13 63.79 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.762 -0.653 . . . . 0.0 112.178 -175.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.499 ' HG3' ' HB3' ' A' ' 78' ' ' GLU . 34.8 mmtp -66.24 -47.94 72.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.641 -176.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 79' ' ' PRO . 41.1 t -58.22 -45.02 89.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.517 -178.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.498 HD21 HD12 ' A' ' 80' ' ' LEU . 4.5 mm? -68.79 -24.64 64.44 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -175.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.47 -44.33 12.81 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.819 0.343 . . . . 0.0 110.791 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.458 ' CD1' ' HA ' ' A' ' 43' ' ' SER . 85.7 t80 -67.13 -45.34 77.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.766 -174.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.79 -32.19 70.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.998 0.904 . . . . 0.0 109.815 -177.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -69.31 -34.26 74.41 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.242 -1.344 . . . . 0.0 111.023 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.6 t -87.81 -8.16 56.31 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.239 -178.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 16.5 p -108.77 -2.16 18.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.667 0.27 . . . . 0.0 111.208 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.2 36.53 39.85 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.696 177.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.575 HG21 ' HE2' ' A' ' 52' ' ' MET . 32.6 t -90.37 130.06 40.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.847 0.356 . . . . 0.0 111.706 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 25.4 m -101.67 -35.68 9.01 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.673 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.536 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 43.9 p90 -62.06 140.52 95.92 Favored Pre-proline 0 N--CA 1.463 0.201 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.247 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.27 147.65 91.04 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.66 2.24 . . . . 0.0 112.854 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.477 HD23 ' HE3' ' A' ' 52' ' ' MET . 4.8 mp -123.6 154.66 38.99 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.522 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -122.74 162.01 16.72 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.938 178.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.6 mp -96.73 142.23 29.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.593 0.235 . . . . 0.0 110.904 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -133.4 79.71 59.86 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-O 121.212 0.529 . . . . 0.0 109.783 169.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.71 106.09 0.71 Allowed 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.603 2.202 . . . . 0.0 112.859 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.42 19.64 44.54 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.145 176.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 55.77 47.56 20.12 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.477 ' HA ' HH21 ' A' ' 111' ' ' ARG . 24.8 t70 -79.85 -51.55 9.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.159 0.504 . . . . 0.0 110.315 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 35.1 mm -67.43 -33.0 59.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -63.24 -34.9 78.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.281 173.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.422 ' HB3' ' HE ' ' A' ' 111' ' ' ARG . . . -73.26 -19.76 60.99 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.92 0.39 . . . . 0.0 111.19 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.464 ' O ' ' HG2' ' A' ' 14' ' ' PRO . 55.3 mttp -77.44 -17.41 58.11 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.179 176.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.581 ' CE1' ' HD2' ' A' ' 14' ' ' PRO . 81.1 m-85 -110.19 -36.91 5.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.071 0.462 . . . . 0.0 111.006 178.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -130.68 173.23 11.11 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.154 -176.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.493 ' O ' ' HB2' ' A' ' 111' ' ' ARG . 12.1 mt -86.69 3.41 44.91 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -176.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.493 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 98.8 mtt180 78.87 -36.65 0.18 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.839 -177.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -74.58 15.94 0.32 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.149 0.5 . . . . 0.0 111.05 176.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.454 ' H ' ' C ' ' A' ' 111' ' ' ARG . . . -93.98 -3.61 51.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.394 177.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.36 -152.09 16.91 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.193 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.538 ' CD1' ' HB3' ' A' ' 76' ' ' ARG . 1.9 tp -109.04 -61.66 2.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.927 ' HB ' ' HG ' ' A' ' 133' ' ' LEU . 2.7 m -86.33 110.66 19.82 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.037 0.446 . . . . 0.0 112.059 -170.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.425 ' HB3' ' HH ' ' A' ' 5' ' ' TYR . 40.0 mmt180 -142.13 131.7 23.92 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.444 176.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 1.111 ' HB3' ' HB ' ' A' ' 131' ' ' THR . 9.6 t30 -105.64 119.99 40.54 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.135 0.493 . . . . 0.0 110.672 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.3 t -107.2 110.39 31.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.792 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.657 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 56.7 tp -92.69 111.39 22.97 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.016 0.436 . . . . 0.0 110.37 178.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.557 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 48.6 mt -95.74 133.57 36.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.143 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -83.59 166.23 18.37 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.249 178.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.419 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 7.1 mtm180 -51.96 -37.73 54.0 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 123.476 0.71 . . . . 0.0 112.081 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -70.84 -5.74 32.72 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.871 0.367 . . . . 0.0 111.672 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.444 ' HA3' HH11 ' A' ' 32' ' ' ARG . . . 89.91 12.66 61.85 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.618 -177.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 87.2 mttt -98.59 144.32 28.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.504 0.192 . . . . 0.0 110.749 -177.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 63.1 mt -84.88 115.66 27.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 176.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.1 m -106.29 -23.61 4.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.657 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 44.7 tptt -142.09 115.84 9.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.238 0.542 . . . . 0.0 112.07 -176.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.456 HD21 HG12 ' A' ' 9' ' ' ILE . 3.2 mm? -97.46 128.91 44.62 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 170.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 1.111 ' HB ' ' HB3' ' A' ' 118' ' ' ASN . 14.2 m -115.98 135.71 53.71 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.043 0.449 . . . . 0.0 110.952 -175.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.673 HH21 ' HB2' ' A' ' 138' ' ' GLU . 38.7 mtm180 -88.03 106.91 18.46 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.379 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.927 ' HG ' ' HB ' ' A' ' 116' ' ' THR . 6.5 mp 49.66 -137.34 1.05 Allowed 'General case' 0 CA--C 1.532 0.27 0 O-C-N 123.233 0.333 . . . . 0.0 110.15 -178.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.648 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 27.4 t80 -80.64 -55.94 4.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.798 171.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 56.46 109.63 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.907 0.755 . . . . 0.0 112.163 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -44.59 -54.38 6.16 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 114.99 -1.005 . . . . 0.0 112.205 -174.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.28 -34.66 28.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.081 -0.508 . . . . 0.0 112.356 -176.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.673 ' HB2' HH21 ' A' ' 132' ' ' ARG . 15.6 tt0 -70.33 -37.64 74.73 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.645 -176.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.526 ' CZ ' ' HB3' ' A' ' 54' ' ' PHE . 84.7 t80 -63.23 -43.48 97.93 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 174.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.36 -53.73 54.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.209 176.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.1 m -54.37 -45.12 72.73 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.418 174.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.533 ' O ' HG12 ' A' ' 146' ' ' ILE . 45.0 tp -57.55 -48.99 77.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.607 -178.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 139' ' ' PHE . 87.8 t -60.04 -44.06 94.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.102 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -59.07 -44.15 91.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.275 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.55 ' O ' ' HG3' ' A' ' 149' ' ' MET . 7.8 tt0 -65.74 -39.69 91.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.543 178.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 142' ' ' LEU . 35.1 mm -56.07 -47.2 80.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.202 0.525 . . . . 0.0 110.238 175.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -62.29 -31.23 71.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.341 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -71.54 -44.66 64.18 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.527 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.55 ' HG3' ' O ' ' A' ' 145' ' ' GLN . 80.0 mtp -66.88 -26.3 66.82 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.465 0.65 . . . . 0.0 109.926 -176.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.525 HD21 ' O ' ' A' ' 146' ' ' ILE . 4.4 mm? -76.73 -2.38 32.7 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.161 175.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -101.38 -66.69 0.9 Allowed 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 173.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 44.1 -94.92 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 O-C-N 124.574 1.171 . . . . 0.0 112.134 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 150.19 -62.13 0.41 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.402 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 44.3 p-80 -92.16 5.32 50.79 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.377 -0.484 . . . . 0.0 112.268 -170.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.91 81.78 1.19 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.605 0.717 . . . . 0.0 111.272 176.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 9.0 m170 -96.87 -26.02 15.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.734 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 39.1 m80 69.88 8.35 6.66 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.905 0.482 . . . . 0.0 110.491 -176.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 178.35 -166.88 0.06 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 43.9 t-80 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.82 172.862 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.484 1.235 0 CA-C-O 120.484 0.183 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 p -53.98 -53.05 58.2 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.333 -176.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.0 mt -77.65 11.19 2.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.936 0.398 . . . . 0.0 111.43 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.432 ' HA2' ' HB1' ' A' ' 113' ' ' ALA . . . 96.23 -56.63 1.48 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.407 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.525 ' CE2' ' HD2' ' A' ' 117' ' ' ARG . 92.9 m-85 -66.17 140.31 58.19 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -176.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.18 -5.3 10.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.149 164.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.2 p -94.92 160.37 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.092 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.6 ppt_? -128.38 166.58 18.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.906 0.384 . . . . 0.0 111.998 -173.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.4 mt -68.85 131.88 33.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.592 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.98 -3.86 70.79 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.066 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -82.17 152.1 26.63 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.429 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 31.8 mtp -81.83 124.67 29.88 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.089 178.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.47 126.87 87.54 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.681 -176.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.12 121.77 10.48 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.949 2.433 . . . . 0.0 111.493 177.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.441 ' HA ' HD13 ' A' ' 28' ' ' LEU . 1.0 OUTLIER -70.77 141.86 51.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.532 -175.649 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.472 ' HE2' ' HH ' ' A' ' 108' ' ' TYR . 39.8 p90 -153.08 163.75 39.28 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.329 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 27.4 m -123.29 107.56 11.8 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 174.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.7 tt -106.8 147.83 11.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.827 0.346 . . . . 0.0 110.8 -175.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 24' ' ' LYS . 3.9 m -81.94 133.47 35.31 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.173 178.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.782 ' HB2' ' HB2' ' A' ' 24' ' ' LYS . 75.7 mt -91.19 -178.7 5.23 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.609 -0.268 . . . . 0.0 110.742 177.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.9 p -55.5 -41.72 73.47 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -172.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.404 ' OD1' ' HG2' ' A' ' 24' ' ' LYS . 4.5 p-10 -97.29 8.0 45.44 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.221 -176.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.88 8.94 44.18 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.289 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.782 ' HB2' ' HB2' ' A' ' 20' ' ' LEU . 40.5 mmtm -62.02 151.89 33.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.035 0.445 . . . . 0.0 110.718 177.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.408 HE21 ' HA ' ' A' ' 19' ' ' THR . 17.4 mm-40 -118.21 116.85 27.65 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.644 174.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 17' ' ' THR . 5.2 p -120.45 125.75 74.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.4 0.619 . . . . 0.0 110.998 -179.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 9.3 m -106.4 141.0 38.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.944 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.441 HD13 ' HA ' ' A' ' 15' ' ' ASP . 17.6 mt -62.83 -31.07 72.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.412 0.149 . . . . 0.0 111.183 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.8 m -53.43 -34.32 57.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.459 176.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.9 m -78.69 -18.13 54.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.213 0.53 . . . . 0.0 111.082 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.494 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 67.0 mt -101.65 0.78 36.77 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.856 -177.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 28' ' ' LEU . 38.2 mmt180 -66.82 127.94 34.4 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.15 -27.83 8.33 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.486 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.803 ' HB3' ' HZ3' ' A' ' 34' ' ' LYS . 0.7 OUTLIER -116.48 167.4 11.09 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.514 -0.18 . . . . 0.0 110.514 -178.532 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.432 ' HB ' ' HE1' ' A' ' 149' ' ' MET . 2.4 p -80.06 127.63 39.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.019 0.438 . . . . 0.0 110.664 -178.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.553 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 28.1 t -119.39 121.59 66.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.855 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.636 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 28.3 ttt -107.12 120.04 41.01 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.3 mt -126.22 102.01 7.0 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.104 -177.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.9 pm0 -107.38 133.18 52.28 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.615 175.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.441 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 94.9 m-85 -89.72 132.52 35.14 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.024 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.536 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 6.6 t -140.79 169.88 16.8 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.312 -177.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.479 ' HB3' ' CD1' ' A' ' 115' ' ' ILE . . . -135.54 151.65 50.53 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.8 169.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.1 m -73.18 28.03 0.06 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -174.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.438 ' H ' ' C ' ' A' ' 42' ' ' ALA . 41.1 p-90 -147.24 7.71 0.9 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.599 0.238 . . . . 0.0 111.238 176.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.443 ' SG ' ' HB1' ' A' ' 42' ' ' ALA . 79.7 m -86.57 130.43 34.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.858 0.361 . . . . 0.0 110.891 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -83.92 -31.25 26.8 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.196 -177.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.664 HG12 ' HB2' ' A' ' 133' ' ' LEU . 38.4 t -62.86 -37.95 80.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.301 0.572 . . . . 0.0 109.835 177.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.937 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 63.2 m -70.44 -20.21 62.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.065 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -75.05 -7.57 54.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.072 0.463 . . . . 0.0 110.255 175.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -102.07 -51.55 3.36 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.5 174.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.97 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 12.2 pt-20 -65.17 -44.58 88.04 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.03 -175.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.48 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 38.3 mtm -64.79 -48.95 71.65 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -173.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.48 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 72.6 Cg_exo -54.94 -39.95 88.02 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.737 1.624 . . . . 0.0 112.161 171.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.417 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 7.6 m-85 -66.9 -40.4 87.69 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.078 176.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 51' ' ' GLU . 78.5 mt -57.65 -50.0 78.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.315 175.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.628 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 22.0 tp10 -57.52 -51.05 71.02 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 176.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -54.6 -61.7 2.14 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -175.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.843 ' HA ' ' HZ2' ' A' ' 62' ' ' LYS . 64.5 m-20 -107.56 -13.61 15.02 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -169.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.509 HG23 HG23 ' A' ' 146' ' ' ILE . 61.5 mt -101.99 -62.33 2.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.788 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.548 ' HB3' ' HA ' ' A' ' 56' ' ' GLU . 62.8 t-105 -69.79 -48.29 59.74 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.498 -173.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.628 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -54.83 -28.75 51.91 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -176.256 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.843 ' HZ2' ' HA ' ' A' ' 58' ' ' ASP . 39.3 mmtm -87.47 -25.62 23.64 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -172.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 61.8 m-70 -122.05 -40.27 2.53 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -172.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.544 ' HE2' ' HA ' ' A' ' 61' ' ' LEU . 45.8 mmtt 49.57 -102.5 0.1 Allowed 'General case' 0 C--O 1.224 -0.25 0 O-C-N 123.566 0.541 . . . . 0.0 111.526 -175.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.572 ' C ' ' H ' ' A' ' 67' ' ' ALA . 17.2 t70 -87.37 -63.58 1.28 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.809 -175.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 64.9 -25.97 0.09 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -175.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.572 ' H ' ' C ' ' A' ' 65' ' ' ASP . . . 89.09 -15.94 0.3 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.505 1.522 . . . . 0.0 109.618 -177.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.601 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 2.0 m-20 -134.06 20.43 3.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.083 178.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.478 ' CD1' HD22 ' A' ' 150' ' ' LEU . 86.7 t80 -121.92 108.46 13.46 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.297 0.57 . . . . 0.0 109.786 172.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' A' ' 36' ' ' VAL . . . -111.75 104.37 12.71 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.756 -176.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.636 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 3.9 tt -113.78 114.66 26.63 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.6 mp -125.01 123.96 66.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.004 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.443 ' HA3' HD23 ' A' ' 96' ' ' LEU . . . -89.16 119.52 5.47 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.075 176.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 65.3 mt -102.29 102.14 13.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 117.134 0.467 . . . . 0.0 111.266 -174.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.536 ' HA ' ' O ' ' A' ' 41' ' ' THR . 8.0 t0 -80.76 144.53 32.08 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 170.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.471 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 8.2 ttp180 -85.46 -105.32 0.05 Allowed 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 120.305 -0.558 . . . . 0.0 112.186 -167.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.471 ' H ' ' HB3' ' A' ' 76' ' ' ARG . 31.8 m-20 -87.7 17.14 4.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.499 -168.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -91.09 138.86 25.7 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.579 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.434 ' HD2' ' HG3' ' A' ' 82' ' ' LYS . 48.5 Cg_endo -70.22 178.63 4.66 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.773 2.316 . . . . 0.0 113.07 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.1 mt -57.95 -56.46 21.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.926 -175.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.436 ' H ' ' CD ' ' A' ' 81' ' ' GLU . 1.9 pm0 -52.99 -36.0 59.83 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.638 -177.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.434 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 25.5 mmtp -63.51 -58.06 8.21 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.71 0.291 . . . . 0.0 110.487 175.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 55.0 t -54.18 -49.68 60.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.5 -177.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.41 -42.36 98.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.66 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.546 ' HA ' ' HE3' ' A' ' 88' ' ' LYS . . . -74.26 -29.52 61.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.648 -176.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -79.86 -44.91 19.63 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.57 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.64 -54.03 49.19 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.665 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.546 ' HE3' ' HA ' ' A' ' 85' ' ' ALA . 18.1 pttp -55.44 -30.54 60.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.746 -176.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.5 m -79.73 -14.59 58.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.103 -174.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.7 p -115.07 9.02 15.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.207 0.527 . . . . 0.0 110.637 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.67 -72.46 0.91 Allowed Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.293 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.0 t 28.07 88.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.622 1.169 . . . . 0.0 113.593 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.2 m -96.59 15.81 20.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.757 0.789 . . . . 0.0 110.086 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.535 ' HB3' ' CE2' ' A' ' 60' ' ' TRP . 25.9 p90 -115.43 146.85 37.45 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.114 176.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.76 136.84 69.09 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.635 2.224 . . . . 0.0 112.874 -177.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.443 HD23 ' HA3' ' A' ' 73' ' ' GLY . 63.7 mt -110.56 151.71 27.28 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.831 176.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -121.07 162.05 14.92 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 175.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.611 ' H ' HD22 ' A' ' 98' ' ' LEU . 2.0 pt? -121.6 138.61 54.25 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 117.005 0.403 . . . . 0.0 110.559 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -122.46 72.85 39.98 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.808 -178.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 13.9 Cg_exo -69.44 111.66 2.81 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.765 2.31 . . . . 0.0 111.761 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 117.74 -1.74 17.76 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -176.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 49.66 40.21 19.26 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -177.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -82.94 -53.96 5.44 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.122 0.486 . . . . 0.0 111.077 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.8 mm -63.85 -33.55 62.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.486 ' HE2' ' O ' ' A' ' 110' ' ' LEU . 80.2 t80 -64.63 -44.3 90.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.312 174.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.645 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -65.02 -19.81 66.18 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.852 -177.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -73.71 -6.7 48.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.858 0.361 . . . . 0.0 111.31 177.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.472 ' HH ' ' HE2' ' A' ' 16' ' ' PHE . 96.1 m-85 -128.95 -42.19 1.41 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.994 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.645 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -139.07 157.14 46.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.65 -178.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.486 ' O ' ' HE2' ' A' ' 105' ' ' PHE . 7.5 mp -61.41 138.35 58.26 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 178.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -55.96 -36.66 68.06 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 122.237 1.018 . . . . 0.0 109.245 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.22 13.49 15.08 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.647 -1.615 . . . . 0.0 110.444 -172.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.432 ' HB1' ' HA2' ' A' ' 4' ' ' GLY . . . -108.1 -171.77 1.93 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.877 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.86 119.68 19.71 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.664 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.479 ' CD1' ' HB3' ' A' ' 42' ' ' ALA . 2.3 tt -67.94 -39.09 81.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -175.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.48 HG21 ' HA ' ' A' ' 133' ' ' LEU . 12.2 m -75.99 98.88 4.4 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.1 0.476 . . . . 0.0 110.987 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.525 ' HD2' ' CE2' ' A' ' 5' ' ' TYR . 37.8 mmt-85 -136.31 133.14 36.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.487 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.47 ' HB2' HG21 ' A' ' 131' ' ' THR . 7.4 m120 -111.0 118.56 36.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.789 0.328 . . . . 0.0 110.43 -176.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.7 t -112.3 128.98 68.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.452 -178.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 46.3 tp -115.16 116.26 28.09 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.028 0.442 . . . . 0.0 110.469 175.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.553 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 55.1 mt -99.59 132.64 44.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.474 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.49 174.09 8.71 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.942 0.401 . . . . 0.0 110.438 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.6 ptp85 -53.82 -34.54 59.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.725 -177.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -81.98 -0.55 44.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.559 -174.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.08 4.5 66.77 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.563 176.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.532 ' HZ3' ' HB2' ' A' ' 126' ' ' LYS . 9.2 mtmp? -97.45 149.52 22.06 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.941 0.401 . . . . 0.0 111.107 -177.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 55.1 mt -85.31 109.88 18.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.805 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 19.4 m -98.75 -17.0 6.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.899 -175.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.684 ' HE3' ' HB ' ' A' ' 131' ' ' THR . 6.9 tmtm? -149.45 108.24 3.86 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.766 -177.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.93 109.36 15.44 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 172.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.684 ' HB ' ' HE3' ' A' ' 129' ' ' LYS . 11.8 t -117.25 164.08 15.35 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.439 -176.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.483 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -103.23 108.0 19.04 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.352 -176.492 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.664 ' HB2' HG12 ' A' ' 47' ' ' VAL . 4.4 pp 51.16 -176.55 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.315 1.046 . . . . 0.0 113.438 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.97 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 93.3 t80 -68.74 91.75 0.45 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.777 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.55 ' HB3' ' HB2' ' A' ' 138' ' ' GLU . 0.2 OUTLIER -107.15 121.15 43.93 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 173.314 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.481 ' N ' HD21 ' A' ' 135' ' ' ASN . 1.3 mp0 -38.26 -64.87 0.38 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.77 0.828 . . . . 0.0 112.772 -175.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -56.82 -51.5 68.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.347 0.594 . . . . 0.0 111.357 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.55 ' HB2' ' HB3' ' A' ' 135' ' ' ASN . 5.5 mm-40 -62.61 -43.91 97.63 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.011 -176.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.534 ' O ' HG21 ' A' ' 143' ' ' VAL . 69.1 t80 -66.07 -42.86 88.84 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.476 ' O ' ' HG2' ' A' ' 144' ' ' GLN . . . -57.22 -50.0 74.24 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.532 177.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 17.4 m -62.96 -37.8 88.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.819 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.441 ' O ' HG12 ' A' ' 146' ' ' ILE . 2.6 tt -62.85 -48.31 79.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.794 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.534 HG21 ' O ' ' A' ' 139' ' ' PHE . 99.7 t -59.05 -45.1 92.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.154 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 140' ' ' ALA . 29.8 mm-40 -62.33 -43.33 99.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.339 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.432 ' O ' ' HG2' ' A' ' 149' ' ' MET . 9.4 tt0 -63.69 -40.85 97.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.424 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.55 ' O ' HD21 ' A' ' 150' ' ' LEU . 24.5 mm -51.83 -50.08 34.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 121.176 0.512 . . . . 0.0 110.517 175.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.591 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 94.4 m-20 -58.02 -43.25 86.6 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.45 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -70.95 -32.95 69.98 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.009 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.432 ' HE1' ' HB ' ' A' ' 35' ' ' VAL . 83.1 mmm -60.06 -29.43 68.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.179 0.514 . . . . 0.0 110.167 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.55 HD21 ' O ' ' A' ' 146' ' ' ILE . 3.6 mm? -78.68 -16.46 57.26 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.378 177.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.591 ' HG2' ' O ' ' A' ' 147' ' ' ASN . 0.1 OUTLIER -103.33 -51.13 3.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.266 -177.825 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 157' ' ' HIS . 0.9 OUTLIER 55.92 94.9 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.214 -172.377 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -125.35 32.23 3.99 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 175.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 2.9 m80 -116.74 -36.45 3.89 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -176.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 13.8 t60 -173.82 -33.52 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -90.52 6.15 44.77 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.622 -169.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.457 ' HB2' ' O ' ' A' ' 152' ' ' GLU . 13.6 t60 -72.68 -29.3 63.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.9 0.381 . . . . 0.0 110.359 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -92.01 141.92 28.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.23 177.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.297 -0.859 . . . . 0.0 108.762 172.49 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.8 ttp . . . . . 0 N--CA 1.483 1.197 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.8 m 60.64 80.81 0.2 Allowed 'General case' 0 CA--C 1.53 0.187 0 O-C-N 123.811 0.695 . . . . 0.0 111.511 176.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.2 mt -129.16 142.92 50.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.927 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.34 69.46 3.33 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.43 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -146.58 147.21 30.87 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 177.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.5 pt -115.58 -6.15 11.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.252 0.549 . . . . 0.0 109.881 172.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.1 m -100.8 166.23 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.493 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.531 ' HB2' ' HG2' ' A' ' 11' ' ' GLU . 25.2 mtt180 -126.09 167.63 15.1 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -176.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 72.8 mt -78.99 119.47 28.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 174.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.64 -25.93 9.32 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.683 -176.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.531 ' HG2' ' HB2' ' A' ' 8' ' ' ARG . 72.2 mm-40 -66.76 150.37 49.21 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.634 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 56.7 mtp -80.32 123.54 28.08 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 174.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.421 ' HA ' ' HD2' ' A' ' 14' ' ' PRO . . . -56.16 124.58 60.63 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.603 -174.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 13' ' ' ALA . 7.1 Cg_endo -52.75 132.01 44.37 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.761 2.308 . . . . 0.0 111.338 175.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -82.82 161.54 21.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.458 -175.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.533 ' HB2' HD11 ' A' ' 104' ' ' ILE . 53.9 p90 -166.65 163.48 16.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.227 -175.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.6 m -125.26 100.5 6.56 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 174.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.5 tt -96.14 149.89 4.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.704 -174.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.482 ' O ' HD21 ' A' ' 98' ' ' LEU . 19.0 m -90.75 127.06 36.2 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.051 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.402 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 71.4 mt -79.69 175.9 10.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.933 178.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.491 HG22 ' O ' ' A' ' 96' ' ' LEU . 37.0 p -59.34 -25.9 64.59 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -177.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.797 ' OD1' ' HG2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -90.28 -19.32 24.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.146 0.498 . . . . 0.0 110.634 -178.519 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 113.13 -2.71 25.45 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.467 -174.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.797 ' HG2' ' OD1' ' A' ' 22' ' ' ASP . 39.3 mmtm -65.91 126.79 29.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.83 0.348 . . . . 0.0 111.149 178.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -91.3 116.4 28.8 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.868 176.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.9 p -119.05 128.4 75.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.315 0.578 . . . . 0.0 111.089 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 6.2 m -97.88 147.9 23.97 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.281 -178.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.71 -28.31 67.56 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.473 ' HA ' ' HG2' ' A' ' 32' ' ' ARG . 44.7 m -56.27 -29.31 60.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.389 177.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.6 m -75.24 -17.13 60.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.112 0.482 . . . . 0.0 111.243 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.3 mt -104.69 1.31 29.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.432 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.473 ' HG2' ' HA ' ' A' ' 29' ' ' SER . 36.3 mmt180 -66.76 122.5 17.79 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 120.54 -19.99 8.97 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -176.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.452 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 45.1 mtmt -116.52 155.24 29.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.547 -0.326 . . . . 0.0 110.323 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.426 HG12 ' HA ' ' A' ' 69' ' ' PHE . 1.4 p -71.27 117.73 14.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.012 0.434 . . . . 0.0 109.854 174.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.532 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 43.1 t -107.68 129.76 61.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.423 -173.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 27.6 ttt -107.46 120.12 41.3 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.174 175.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.7 mt -123.66 94.78 4.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.129 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.645 HE22 HD23 ' A' ' 71' ' ' LEU . 20.2 pm0 -93.81 131.1 39.52 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.107 0.48 . . . . 0.0 110.447 177.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -96.14 110.28 22.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.421 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.6 t -115.63 -171.9 2.05 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.88 -176.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.69 ' HB2' ' SG ' ' A' ' 45' ' ' CYS . . . -163.13 143.46 9.16 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.494 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 54.8 m -62.68 -13.9 37.54 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -174.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 68.2 p-90 -101.07 -4.72 26.87 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.154 -0.341 . . . . 0.0 111.663 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.69 ' SG ' ' HB2' ' A' ' 42' ' ' ALA . 83.8 m -78.21 124.58 28.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.977 0.418 . . . . 0.0 111.732 -175.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -88.66 -18.11 55.39 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 176.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.446 ' HB ' HG22 ' A' ' 116' ' ' THR . 61.8 t -72.02 -46.52 59.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.931 0.396 . . . . 0.0 110.027 176.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.72 ' SG ' HG23 ' A' ' 116' ' ' THR . 69.2 m -66.91 -17.61 64.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.7 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.555 ' HE ' ' HE1' ' A' ' 86' ' ' PHE . 75.0 mtt180 -72.77 -6.46 44.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.154 0.502 . . . . 0.0 110.694 176.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -105.3 -44.98 4.6 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 169.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.636 ' HB2' ' HB2' ' A' ' 134' ' ' TYR . 40.6 tt0 -56.18 -57.12 13.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.369 -177.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.672 ' SD ' ' HE2' ' A' ' 86' ' ' PHE . 74.8 mtp -62.52 -50.64 77.76 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -172.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.596 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 54.7 Cg_exo -55.66 -36.22 94.42 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.959 1.773 . . . . 0.0 112.435 175.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -69.74 -41.32 75.43 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.638 175.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.533 HG13 ' O ' ' A' ' 51' ' ' GLU . 81.5 mt -56.32 -53.18 42.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.057 177.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.571 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 17.1 pt-20 -67.34 -32.09 72.8 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.525 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -62.04 -60.3 3.82 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.725 ' HA ' ' HZ3' ' A' ' 62' ' ' LYS . 52.1 m-20 -107.19 -8.48 16.43 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -171.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.506 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 70.6 mt -104.76 -57.98 4.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.612 176.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.571 ' HB3' ' HA ' ' A' ' 56' ' ' GLU . 76.5 t-105 -66.55 -67.42 0.45 Allowed 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.177 -178.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.0 mp -47.45 -32.1 4.8 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -174.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.725 ' HZ3' ' HA ' ' A' ' 58' ' ' ASP . 46.5 mmtm -77.28 -36.48 54.2 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -177.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -126.68 -43.16 1.74 Allowed 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.937 -0.477 . . . . 0.0 112.099 -173.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.2 mttp 62.03 -83.05 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.918 0.887 . . . . 0.0 111.451 -178.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -123.37 -38.85 2.51 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 174.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 70.74 -75.06 0.08 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.022 175.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 171.86 -33.83 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.898 -176.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.452 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 5.7 t70 -126.83 19.55 7.17 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.273 -177.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.426 ' HA ' HG12 ' A' ' 35' ' ' VAL . 87.7 t80 -129.11 155.17 45.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.39 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -150.24 132.46 15.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.43 176.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.645 HD23 HE22 ' A' ' 39' ' ' GLN . 5.5 tt -129.41 119.77 24.38 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.5 mm -129.89 120.29 49.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.088 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.88 128.79 9.31 Favored Glycine 0 C--O 1.224 -0.509 0 C-N-CA 120.234 -0.984 . . . . 0.0 111.457 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.3 mt -115.5 120.1 63.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 117.23 0.515 . . . . 0.0 111.174 -176.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.512 ' OD1' ' HA ' ' A' ' 42' ' ' ALA . 16.7 t0 -92.09 127.89 37.73 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 174.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.49 111.33 22.57 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.169 -171.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.7 t0 81.43 -26.09 0.15 Allowed 'General case' 0 N--CA 1.47 0.557 0 O-C-N 124.147 0.904 . . . . 0.0 112.367 169.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.483 ' HB2' ' OD1' ' A' ' 75' ' ' ASP . 5.5 mm-40 -69.49 131.98 89.68 Favored Pre-proline 0 C--O 1.235 0.295 0 CA-C-O 121.148 0.499 . . . . 0.0 110.713 177.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.564 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 36.8 Cg_endo -71.96 -168.71 0.39 Allowed 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.088 2.526 . . . . 0.0 114.624 -176.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -62.69 -52.71 62.2 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.367 -168.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.564 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -62.98 -34.1 76.8 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.502 0.191 . . . . 0.0 111.419 -175.76 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.537 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 33.6 mmtp -58.93 -58.87 6.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.828 176.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.507 HG21 ' HB3' ' A' ' 98' ' ' LEU . 45.2 t -55.27 -44.88 77.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.452 -177.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.8 mp -67.37 -31.71 72.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.698 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.777 ' HA ' ' HE2' ' A' ' 88' ' ' LYS . . . -82.86 -37.35 24.45 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.102 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.672 ' HE2' ' SD ' ' A' ' 52' ' ' MET . 83.2 t80 -67.57 -47.0 71.03 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.914 -178.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.494 ' HB3' HD11 ' A' ' 96' ' ' LEU . . . -55.15 -51.53 66.2 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.59 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.777 ' HE2' ' HA ' ' A' ' 85' ' ' ALA . 64.7 pttt -65.94 -23.2 66.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.829 0.347 . . . . 0.0 111.688 -174.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.8 m -80.42 -28.22 37.82 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.108 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.6 p -96.95 -20.53 18.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.078 0.466 . . . . 0.0 111.01 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 112.58 -74.77 0.22 Allowed Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -175.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 97.8 t 43.43 88.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 124.31 1.044 . . . . 0.0 113.322 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.2 m -79.8 6.26 11.43 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 114.704 -1.135 . . . . 0.0 111.333 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.535 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 50.7 p90 -118.71 153.55 52.35 Favored Pre-proline 0 C--N 1.329 -0.306 0 O-C-N 122.172 -0.33 . . . . 0.0 110.882 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -66.71 137.97 47.56 Favored 'Trans proline' 0 C--O 1.24 0.593 0 C-N-CA 122.175 1.916 . . . . 0.0 113.236 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.494 HD11 ' HB3' ' A' ' 87' ' ' ALA . 77.9 mt -109.61 148.28 31.57 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.738 174.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -117.59 147.8 18.74 Favored Glycine 0 N--CA 1.438 -1.221 0 N-CA-C 110.389 -1.085 . . . . 0.0 110.389 173.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.66 HD21 ' H ' ' A' ' 98' ' ' LEU . 1.5 pt? -101.6 136.63 41.13 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -178.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -116.38 73.95 5.71 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.261 178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.483 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 15.4 Cg_exo -68.09 117.25 4.79 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.655 2.237 . . . . 0.0 111.524 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.414 ' O ' ' HD2' ' A' ' 111' ' ' ARG . . . 102.41 -7.32 53.87 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.275 -175.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.548 ' HB2' ' HG2' ' A' ' 111' ' ' ARG . . . 55.68 38.73 30.5 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 122.896 0.479 . . . . 0.0 111.402 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -72.46 -46.11 56.42 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.607 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.533 HD11 ' HB2' ' A' ' 16' ' ' PHE . 21.2 mm -65.22 -38.94 83.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.687 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -65.2 -38.71 91.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.097 175.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -68.92 -15.3 63.45 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.296 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 52.2 mttp -80.16 -16.75 54.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.627 175.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -113.82 -20.97 10.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.803 0.335 . . . . 0.0 111.328 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -159.79 -179.81 8.17 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.244 -178.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.919 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 88.6 mt -65.27 138.31 58.12 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.548 ' HG2' ' HB2' ' A' ' 102' ' ' ALA . 1.3 ttp85 -42.61 -48.1 5.36 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -173.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -118.58 37.79 3.95 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.138 0.494 . . . . 0.0 110.667 -176.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.919 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . . . -81.41 34.8 0.38 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.938 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.5 -162.92 17.7 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 121.022 -0.608 . . . . 0.0 112.282 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.529 HG13 ' H ' ' A' ' 116' ' ' THR . 4.7 tp -151.78 -174.2 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -178.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.72 HG23 ' SG ' ' A' ' 48' ' ' CYS . 53.0 p 58.37 88.86 0.06 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.869 0.867 . . . . 0.0 111.692 176.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -171.09 141.86 1.72 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.223 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.682 ' HB3' ' HB ' ' A' ' 131' ' ' THR . 5.6 t30 -119.97 129.67 54.41 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.095 0.474 . . . . 0.0 111.51 -176.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 39.1 t -101.81 113.1 37.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.781 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.906 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 27.2 tp -97.64 115.7 28.43 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.33 0.586 . . . . 0.0 110.035 177.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.532 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 60.5 mt -98.85 135.68 32.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 114.988 -1.006 . . . . 0.0 109.77 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.601 ' OD2' ' HB2' ' A' ' 126' ' ' LYS . 4.4 p30 -75.87 170.23 16.62 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.919 0.39 . . . . 0.0 110.0 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.548 ' HD3' ' OE1' ' A' ' 152' ' ' GLU . 6.9 ptm180 -75.39 1.31 14.2 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.471 -175.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.429 ' HB2' ' OD1' ' A' ' 122' ' ' ASP . 38.7 mt-10 -91.62 -30.5 16.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.373 0.606 . . . . 0.0 109.645 175.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.82 5.56 10.84 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.214 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.635 ' HZ1' ' HB2' ' A' ' 126' ' ' LYS . 9.3 mtmp? -100.74 157.97 16.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.973 0.416 . . . . 0.0 111.263 -177.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 54.5 mt -92.06 119.08 38.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.155 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 17.0 m -114.91 -23.28 4.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.906 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 59.2 tptt -134.46 113.9 12.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.14 0.495 . . . . 0.0 111.799 -174.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -101.76 113.44 26.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.398 173.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.682 ' HB ' ' HB3' ' A' ' 118' ' ' ASN . 25.4 m -95.57 137.42 34.66 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.496 -177.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.433 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 0.4 OUTLIER -108.42 105.7 15.49 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.72 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 132' ' ' ARG . 3.4 pp 41.72 -163.1 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.093 0.871 . . . . 0.0 113.011 -177.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.636 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 84.5 t80 -94.14 107.48 19.41 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.127 0.489 . . . . 0.0 111.451 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.451 ' HB2' ' CB ' ' A' ' 138' ' ' GLU . 54.0 m-80 -119.42 149.77 41.3 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 170.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -58.58 -56.16 25.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.121 0.486 . . . . 0.0 110.752 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.05 -40.78 95.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.216 -178.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.451 ' CB ' ' HB2' ' A' ' 135' ' ' ASN . 6.1 tp10 -61.93 -49.78 74.8 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.629 -178.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -66.96 -37.92 85.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.487 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.16 -42.06 97.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.337 176.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 43.2 m -64.5 -30.3 71.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.143 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.444 HD11 HG22 ' A' ' 131' ' ' THR . 29.2 mt -72.8 -55.26 6.96 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.294 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.3 p -59.42 -38.54 75.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 O-C-N 123.166 0.291 . . . . 0.0 110.897 -175.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -67.54 -46.9 71.44 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 176.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -58.86 -46.58 87.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.605 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.539 ' O ' HD22 ' A' ' 150' ' ' LEU . 81.7 mt -65.47 -40.01 86.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.041 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -58.91 -38.63 79.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.688 0.28 . . . . 0.0 110.819 176.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -77.9 -30.41 50.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.941 178.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 87.0 mmm -67.19 -27.79 67.56 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.316 0.579 . . . . 0.0 110.143 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.539 HD22 ' O ' ' A' ' 146' ' ' ILE . 3.9 mm? -76.51 -7.08 54.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.556 175.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.627 ' HB3' ' HZ3' ' A' ' 151' ' ' LYS . 1.9 mmmp? -101.45 -64.27 1.07 Allowed 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.548 ' OE1' ' HD3' ' A' ' 123' ' ' ARG . 0.8 OUTLIER 59.94 -179.9 0.09 Allowed 'General case' 0 CA--C 1.537 0.477 0 O-C-N 124.332 1.02 . . . . 0.0 111.038 176.623 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 155' ' ' HIS . . . -119.33 31.81 5.3 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.251 -178.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -80.92 33.85 0.34 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.199 0.523 . . . . 0.0 111.174 177.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.419 ' H ' ' C ' ' A' ' 153' ' ' GLY . 56.5 t-80 -145.3 102.53 3.74 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 174.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 28.7 m170 -105.42 161.86 13.96 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.526 -174.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -106.03 156.4 18.43 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -77.29 148.83 35.5 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.063 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 76.7 t60 . . . . . 0 C--O 1.244 0.793 0 CA-C-O 118.257 -0.878 . . . . 0.0 109.184 172.594 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.6 tpt . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.461 ' HB3' ' HB2' ' A' ' 5' ' ' TYR . 50.1 m -86.84 88.7 7.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.853 0.358 . . . . 0.0 110.62 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.7 pp -104.87 -6.11 20.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.278 0.561 . . . . 0.0 110.69 177.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -154.33 25.23 0.68 Allowed Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.461 ' HB2' ' HB3' ' A' ' 2' ' ' SER . 62.1 m-85 -110.17 143.02 40.88 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.042 -0.579 . . . . 0.0 110.086 -175.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.409 ' H ' ' HA ' ' A' ' 109' ' ' ALA . 39.8 pt -92.07 -13.37 8.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.556 0.693 . . . . 0.0 109.248 173.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 p -110.57 164.16 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.298 178.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.5 mtm105 -133.68 165.85 23.97 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.902 0.382 . . . . 0.0 111.01 -174.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.4 mt -72.02 122.96 25.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.193 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.99 -22.21 19.03 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.94 -178.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -74.11 159.25 32.87 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.741 0.305 . . . . 0.0 110.722 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.565 ' SD ' ' HG2' ' A' ' 126' ' ' LYS . 56.3 mmm -79.76 133.28 36.32 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.99 129.7 90.61 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.623 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.494 ' HD2' ' CE1' ' A' ' 108' ' ' TYR . 32.9 Cg_exo -61.92 137.44 67.47 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.882 2.388 . . . . 0.0 111.744 175.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.42 ' HB2' HH22 ' A' ' 32' ' ' ARG . 23.4 t70 -80.61 153.03 28.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.888 -177.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -161.88 165.44 27.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.779 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 73.5 m -124.7 107.12 10.64 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 174.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.5 tt -105.92 144.86 14.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.94 -173.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.446 ' O ' HD23 ' A' ' 98' ' ' LEU . 5.5 m -88.52 131.69 34.81 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.077 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.466 HD11 ' HB2' ' A' ' 24' ' ' LYS . 79.0 mt -82.43 -179.43 7.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.845 0.355 . . . . 0.0 110.951 177.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.425 ' HB ' HD11 ' A' ' 84' ' ' LEU . 35.6 p -57.85 -31.65 66.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.894 -175.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.47 ' OD2' ' HG2' ' A' ' 24' ' ' LYS . 5.4 p-10 -99.45 -6.19 28.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.818 0.342 . . . . 0.0 110.835 -175.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.94 1.82 34.12 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.333 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.585 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -69.22 110.78 4.76 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 117.663 0.732 . . . . 0.0 110.297 175.623 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -92.69 115.08 27.78 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.086 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 17' ' ' THR . 12.8 m -112.66 146.03 17.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.156 0.503 . . . . 0.0 110.804 -177.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.6 m -103.2 147.06 27.5 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.712 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.17 -45.81 93.08 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.702 0.287 . . . . 0.0 110.408 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.9 m -64.95 -15.79 62.59 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.2 t -82.48 -15.38 52.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.577 0.703 . . . . 0.0 109.555 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.2 mt -112.12 -3.9 14.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.539 177.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.42 HH22 ' HB2' ' A' ' 15' ' ' ASP . 7.8 mtm180 -75.81 156.36 34.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.058 0.456 . . . . 0.0 111.024 -178.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.48 -15.71 62.68 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 -166.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.579 ' HB3' ' O ' ' A' ' 68' ' ' ASP . 36.7 mtmt -116.44 160.21 20.9 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.058 -1.071 . . . . 0.0 109.381 175.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.421 HG12 HD21 ' A' ' 150' ' ' LEU . 2.3 p -80.19 118.27 27.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.359 0.6 . . . . 0.0 109.716 174.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.8 t -112.51 122.2 66.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.967 -173.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.64 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 26.7 ttt -99.34 114.96 28.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.08 175.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 69.6 mt -110.31 97.55 6.99 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.584 178.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.536 ' HG3' ' HA2' ' A' ' 73' ' ' GLY . 1.5 pp0? -91.1 130.97 36.94 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 177.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -107.02 122.34 46.25 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.43 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 13.9 t -151.49 -171.4 3.92 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.9 -177.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.403 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . . . -150.95 163.41 38.78 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 174.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.487 ' HB2' ' HG3' ' A' ' 78' ' ' GLU . 44.1 m -67.54 -5.71 16.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.055 -0.521 . . . . 0.0 112.168 -176.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 37.0 p-90 -109.9 12.21 23.91 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.464 ' SG ' HD12 ' A' ' 115' ' ' ILE . 73.8 m -92.85 100.95 13.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.118 0.485 . . . . 0.0 111.266 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.98 -32.38 73.29 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.889 -0.596 . . . . 0.0 113.082 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.6 t -64.12 -41.29 91.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.159 0.504 . . . . 0.0 110.446 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.717 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 83.6 m -67.62 -16.94 64.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.73 -177.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -71.3 -2.6 16.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.863 0.363 . . . . 0.0 110.994 176.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -98.85 -51.87 3.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.056 0.455 . . . . 0.0 110.026 170.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.717 ' HG2' ' HA ' ' A' ' 48' ' ' CYS . 11.7 pt-20 -69.58 -39.33 77.4 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.046 -173.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.555 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 91.7 mtp -60.36 -51.03 83.02 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -177.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.555 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 35.8 Cg_exo -59.68 -35.74 94.01 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.854 1.703 . . . . 0.0 112.208 172.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.57 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 3.1 m-85 -64.32 -43.73 93.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.724 174.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 51' ' ' GLU . 97.4 mt -58.16 -48.98 83.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.853 173.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.468 ' OE1' ' HA ' ' A' ' 92' ' ' VAL . 30.2 tp10 -50.22 -53.97 24.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.934 178.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -72.53 -50.45 25.65 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -173.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -105.8 -12.96 15.68 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -168.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.429 HD11 HG12 ' A' ' 55' ' ' ILE . 73.4 mt -106.37 -61.93 2.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.024 176.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.617 ' CE2' ' HG2' ' A' ' 64' ' ' LYS . 67.5 t-105 -62.94 -67.41 0.42 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.481 -174.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.4 ' HA ' HD13 ' A' ' 61' ' ' LEU . 0.6 OUTLIER -49.02 -33.52 11.35 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -175.366 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -68.41 -30.11 68.94 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.78 -175.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.449 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 90.7 m-70 -128.98 -47.08 1.23 Allowed 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 119.678 -0.809 . . . . 0.0 112.621 -176.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.617 ' HG2' ' CE2' ' A' ' 60' ' ' TRP . 9.2 mtmp? 40.57 -93.98 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.568 0.699 . . . . 0.0 112.149 -174.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.59 -70.59 0.29 Allowed 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.045 173.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.573 ' ND2' HD11 ' A' ' 150' ' ' LEU . 5.7 t30 70.18 -68.77 0.19 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.769 0.828 . . . . 0.0 111.078 174.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 175.87 -46.3 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.363 -178.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.579 ' O ' ' HB3' ' A' ' 34' ' ' LYS . 7.9 p-10 -142.85 35.25 1.4 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.066 -177.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.555 ' HB2' HD13 ' A' ' 150' ' ' LEU . 74.5 t80 -104.13 145.72 29.78 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.657 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.76 130.33 17.89 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.934 174.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.64 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 3.4 tt -135.35 114.61 12.37 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.5 mp -125.9 126.12 69.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.825 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.536 ' HA2' ' HG3' ' A' ' 39' ' ' GLN . . . -91.16 120.4 5.95 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.608 -0.805 . . . . 0.0 111.376 176.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 65.8 mt -103.92 122.99 57.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 116.861 0.33 . . . . 0.0 111.051 -175.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.555 ' HA ' ' O ' ' A' ' 41' ' ' THR . 9.3 t70 -85.84 137.74 32.55 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 176.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 54.5 ttt-85 -74.87 -28.23 60.57 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -172.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -161.92 -18.3 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -171.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.487 ' HG3' ' HB2' ' A' ' 43' ' ' SER . 5.3 mm-40 -78.59 132.25 65.73 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-O 121.294 0.569 . . . . 0.0 111.198 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.593 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 28.4 Cg_endo -71.89 -169.94 0.49 Allowed 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 123.307 2.671 . . . . 0.0 114.366 -178.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.402 ' O ' HD21 ' A' ' 84' ' ' LEU . 79.4 mt -53.5 -59.01 5.13 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 114.958 -1.019 . . . . 0.0 113.106 -173.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.593 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -59.53 -33.43 71.38 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.479 -172.111 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.48 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 34.1 mmtp -64.35 -55.89 18.14 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.014 0.435 . . . . 0.0 110.325 174.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.403 HG21 ' O ' ' A' ' 79' ' ' PRO . 92.7 t -57.95 -44.39 86.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.43 -177.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.425 HD11 ' HB ' ' A' ' 21' ' ' THR . 4.4 mm? -69.01 -13.11 62.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.729 -178.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.485 ' HA ' ' HD2' ' A' ' 88' ' ' LYS . . . -99.84 -42.05 6.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.925 0.393 . . . . 0.0 110.789 176.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.553 ' HE2' ' SD ' ' A' ' 52' ' ' MET . 71.7 t80 -64.63 -38.08 89.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.841 -177.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -54.63 -56.01 23.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.338 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.485 ' HD2' ' HA ' ' A' ' 85' ' ' ALA . 0.3 OUTLIER -66.98 -19.05 65.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.171 0.51 . . . . 0.0 110.838 -175.519 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.4 m -81.55 -1.89 47.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.333 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.5 p -138.43 11.03 2.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.224 0.535 . . . . 0.0 110.491 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.68 -74.2 1.17 Allowed Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.468 ' HA ' ' OE1' ' A' ' 56' ' ' GLU . 54.6 t 29.65 93.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.108 1.363 . . . . 0.0 114.408 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 71.9 p -97.17 -11.91 23.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.038 0.447 . . . . 0.0 110.186 174.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.514 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 37.6 p90 -81.52 144.33 52.85 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.472 176.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.2 138.37 81.0 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.714 2.276 . . . . 0.0 113.044 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.8 mt -110.9 142.07 43.46 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.938 177.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 74' ' ' ILE . . . -115.0 142.7 17.79 Favored Glycine 0 N--CA 1.441 -1.009 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 177.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.731 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.8 pt? -103.11 129.62 50.02 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.938 0.399 . . . . 0.0 110.815 -177.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -119.33 72.07 13.23 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.818 177.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.455 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 20.1 Cg_exo -65.28 108.48 1.17 Allowed 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.504 2.136 . . . . 0.0 112.312 -176.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 118.9 -6.23 13.58 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.6 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 59.35 44.99 14.51 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.897 0.479 . . . . 0.0 111.784 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -80.8 -55.52 4.76 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 120.973 0.416 . . . . 0.0 110.499 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 38.4 mm -62.02 -35.28 67.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 176.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.658 ' HZ ' ' HA ' ' A' ' 115' ' ' ILE . 38.9 t80 -60.48 -40.61 91.89 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.264 174.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.556 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -76.89 -14.72 59.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.184 -177.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 50.0 mttp -72.75 -11.16 60.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.953 0.406 . . . . 0.0 111.353 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.494 ' CE1' ' HD2' ' A' ' 14' ' ' PRO . 98.9 m-85 -116.72 -30.03 5.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.413 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.556 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -162.89 -177.23 5.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.62 0.248 . . . . 0.0 110.714 -175.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.502 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . 95.6 mt -72.69 135.49 45.41 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.549 ' HA ' ' CD1' ' A' ' 105' ' ' PHE . 17.6 mtm180 -58.59 -34.51 71.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.936 -175.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -105.42 7.58 33.23 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.015 -170.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.502 ' CB ' ' HB2' ' A' ' 110' ' ' LEU . . . -96.24 49.76 1.14 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.136 0.493 . . . . 0.0 111.234 -177.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.67 104.52 0.9 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.059 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.658 ' HA ' ' HZ ' ' A' ' 105' ' ' PHE . 5.1 tt -72.07 -52.51 24.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -176.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.586 HG23 ' HG ' ' A' ' 48' ' ' CYS . 77.0 m -59.34 109.48 0.88 Allowed 'General case' 0 C--O 1.238 0.465 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -175.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.569 ' HB3' HH21 ' A' ' 132' ' ' ARG . 13.6 ptt180 -161.16 140.59 10.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.584 178.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -107.2 118.11 35.83 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 174.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 51.0 t -101.54 106.27 19.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.092 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 43.1 tp -93.49 119.19 32.27 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.278 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 68.5 mt -103.83 131.11 53.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.657 177.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.96 166.04 24.29 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -66.93 -13.38 61.7 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -174.102 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.562 ' HB2' ' NZ ' ' A' ' 126' ' ' LYS . 48.4 mt-10 -84.43 -27.58 27.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.014 0.435 . . . . 0.0 110.564 175.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.67 10.07 7.99 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.376 -0.916 . . . . 0.0 113.04 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.565 ' HG2' ' SD ' ' A' ' 12' ' ' MET . 31.6 mtmm -93.09 146.06 23.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.129 0.49 . . . . 0.0 111.729 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 56.0 mt -87.28 115.09 27.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.763 177.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 31.1 m -109.87 -16.72 8.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -172.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.52 ' HG2' HD12 ' A' ' 142' ' ' LEU . 51.2 tptt -137.5 122.68 19.24 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 119.896 -0.722 . . . . 0.0 112.107 -176.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 9.8 mp -121.91 105.18 10.11 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.212 174.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.429 HG21 ' HE3' ' A' ' 129' ' ' LYS . 67.9 p -96.67 162.05 13.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.137 0.494 . . . . 0.0 111.486 -177.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.599 ' HA ' ' HE ' ' A' ' 132' ' ' ARG . 2.1 mmp_? -127.27 106.93 9.56 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 173.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.547 ' HA ' HG21 ' A' ' 116' ' ' THR . 88.5 mt 63.24 176.43 0.16 Allowed 'General case' 0 N--CA 1.469 0.508 0 O-C-N 123.761 0.663 . . . . 0.0 111.382 -177.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.507 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 76.3 t80 -83.73 87.88 7.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.464 0.649 . . . . 0.0 109.684 175.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -104.15 135.66 45.22 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 176.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -55.44 -61.21 2.49 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 123.375 0.422 . . . . 0.0 112.03 -168.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.45 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.4 mp0 -55.74 -44.84 77.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.784 0.326 . . . . 0.0 110.885 -177.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -62.93 -46.03 89.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.509 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.57 ' CE2' ' HB3' ' A' ' 54' ' ' PHE . 63.6 t80 -69.99 -41.46 74.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.245 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.19 -40.15 89.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.575 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 48.1 m -67.12 -37.43 83.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.345 176.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.52 HD12 ' HG2' ' A' ' 129' ' ' LYS . 63.0 tp -62.47 -50.75 70.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.777 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.434 HG21 ' O ' ' A' ' 139' ' ' PHE . 94.6 t -56.45 -54.26 30.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.181 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -60.54 -42.85 97.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.629 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -56.28 -49.32 74.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.327 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.621 ' O ' HD22 ' A' ' 150' ' ' LEU . 28.9 mt -60.19 -50.94 78.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.1 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -55.08 -42.31 72.67 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.253 -0.179 . . . . 0.0 111.352 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -77.86 -24.51 48.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.686 0.279 . . . . 0.0 110.761 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.42 ' HE3' ' HB3' ' A' ' 149' ' ' MET . 45.3 mmm -63.26 -31.31 72.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.403 0.621 . . . . 0.0 110.011 175.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.621 HD22 ' O ' ' A' ' 146' ' ' ILE . 4.0 mm? -80.67 -11.77 59.58 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.304 177.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -102.01 -27.42 12.95 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.266 -177.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -69.28 160.5 31.11 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.166 0.508 . . . . 0.0 110.601 -174.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -143.02 104.43 0.36 Allowed Glycine 0 N--CA 1.437 -1.237 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.384 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 11.9 m80 -53.85 108.58 0.37 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.092 0.472 . . . . 0.0 110.393 176.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -104.71 115.45 30.34 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.156 -173.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.437 ' O ' ' HB3' ' A' ' 157' ' ' HIS . 20.5 t-160 -72.36 132.24 43.71 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 164.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.437 ' HB3' ' O ' ' A' ' 156' ' ' HIS . 15.3 t60 72.15 89.32 0.1 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -165.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 70.9 m80 -78.4 -36.52 45.69 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.78 -174.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 30.1 m80 . . . . . 0 C--O 1.247 0.956 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.566 177.479 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptm . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 120.515 0.198 . . . . 0.0 111.31 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.7 p -156.68 161.91 39.84 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 110.51 -0.181 . . . . 0.0 110.51 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.502 HD11 ' HD3' ' A' ' 132' ' ' ARG . 3.7 tt 63.69 -84.68 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 O-C-N 124.022 0.826 . . . . 0.0 110.06 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.424 ' H ' ' HB3' ' A' ' 3' ' ' LEU . . . -154.49 16.39 0.57 Allowed Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -81.76 133.59 35.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.873 -0.163 . . . . 0.0 110.568 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.1 pt -87.78 -18.86 8.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.218 0.533 . . . . 0.0 109.667 174.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.5 m -93.84 -179.39 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.657 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.2 ppt_? -144.34 165.7 27.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.847 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 69.4 mt -67.4 128.4 30.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.138 0.494 . . . . 0.0 110.745 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.52 3.22 66.96 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.096 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -85.68 151.75 23.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.58 0.229 . . . . 0.0 110.582 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.567 ' HE2' ' HG2' ' A' ' 126' ' ' LYS . 1.2 mmt -69.49 116.79 10.31 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 175.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.401 ' HB1' HG12 ' A' ' 121' ' ' ILE . . . -54.49 126.07 54.45 Favored Pre-proline 0 C--O 1.237 0.401 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.489 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.473 ' HG2' ' O ' ' A' ' 107' ' ' LYS . 27.3 Cg_exo -60.42 115.54 2.73 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.802 2.335 . . . . 0.0 111.028 178.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -70.64 133.01 46.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.828 -173.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.571 ' HB2' HD13 ' A' ' 104' ' ' ILE . 36.1 p90 -136.49 158.87 43.41 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.035 -178.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 49.0 m -117.31 99.51 7.06 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.4 tt -97.87 152.32 4.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.609 -173.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.481 ' O ' HD22 ' A' ' 98' ' ' LEU . 27.3 m -99.35 129.41 45.55 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.944 178.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.3 mt -85.01 -178.07 6.73 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.823 0.344 . . . . 0.0 111.13 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 96' ' ' LEU . 30.9 p -62.55 -26.43 68.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.081 -176.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.407 ' OD1' ' HB2' ' A' ' 24' ' ' LYS . 13.1 p-10 -92.79 -5.11 51.83 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.526 -178.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.51 2.4 56.52 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.135 -176.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.407 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 6.2 tmtt? -62.87 112.34 2.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.79 0.328 . . . . 0.0 111.829 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -87.52 117.63 26.45 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 172.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 17' ' ' THR . 7.1 p -126.5 133.25 69.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.298 0.571 . . . . 0.0 110.97 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.2 m -93.92 144.75 25.17 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.209 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.62 -29.49 70.65 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.77 0.319 . . . . 0.0 110.53 -178.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.6 m -56.13 -30.53 62.26 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.365 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.2 m -74.79 -24.97 58.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.398 0.618 . . . . 0.0 110.809 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 89.4 mt -90.74 -10.87 41.39 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.532 -176.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.4 HH11 ' HA3' ' A' ' 125' ' ' GLY . 35.3 mmt180 -57.68 154.52 11.49 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.62 -19.53 36.3 Favored Glycine 0 C--O 1.226 -0.38 0 C-N-CA 121.088 -0.577 . . . . 0.0 111.885 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.563 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 32.5 mtmm -116.59 170.47 8.55 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 68' ' ' ASP . 35.4 m -81.75 123.34 37.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 176.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.8 t -115.78 120.6 65.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.875 0.369 . . . . 0.0 110.873 -174.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 27.2 ttt -112.42 118.27 34.73 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.01 0.433 . . . . 0.0 110.485 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.73 HD22 HD12 ' A' ' 121' ' ' ILE . 2.8 mm? -111.17 107.98 17.49 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.08 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.46 HE21 ' HB2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -109.47 127.18 54.23 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.89 175.504 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -95.39 121.12 36.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.272 0.558 . . . . 0.0 110.436 -176.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.536 ' HA ' ' SG ' ' A' ' 48' ' ' CYS . 1.9 t -122.54 171.77 8.87 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.479 -175.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.511 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -150.65 130.53 13.31 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.678 177.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.515 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 47.8 m -57.96 -28.93 64.8 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.958 -177.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 38.7 p-90 -90.56 2.4 55.82 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 52.8 t -107.59 120.31 41.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.976 0.417 . . . . 0.0 111.223 -177.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -83.41 -17.64 66.06 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.702 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.503 HG12 HG23 ' A' ' 116' ' ' THR . 42.7 t -66.37 -43.45 91.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 176.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.548 ' O ' ' HG2' ' A' ' 52' ' ' MET . 72.3 m -64.23 -27.49 69.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.318 176.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 55.4 ttt180 -69.05 -6.11 26.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.155 0.502 . . . . 0.0 110.809 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.505 ' HE3' ' CD2' ' A' ' 134' ' ' TYR . 22.9 mtpp -83.31 -55.19 4.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.476 172.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 10.6 pt-20 -70.05 -31.73 69.49 Favored 'General case' 0 C--O 1.219 -0.553 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.729 -176.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.583 ' HG3' ' HE2' ' A' ' 86' ' ' PHE . 91.7 mmm -50.6 -60.01 6.23 Favored Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.457 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 53.2 Cg_endo -69.86 -31.43 20.08 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 121.611 1.541 . . . . 0.0 112.66 177.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -68.64 -50.25 52.73 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.323 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.577 ' O ' ' HB ' ' A' ' 59' ' ' ILE . 83.8 mt -57.13 -45.38 84.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.376 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.509 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 25.5 tt0 -58.77 -48.99 79.31 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.86 175.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.405 ' NZ ' ' OD2' ' A' ' 58' ' ' ASP . 25.9 ttpp -56.49 -56.65 18.63 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -174.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.825 ' HA ' ' HZ2' ' A' ' 62' ' ' LYS . 73.5 m-20 -105.06 -9.88 17.54 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -171.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.577 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 50.4 mm -105.26 -57.35 4.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.646 176.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.54 ' CD2' ' HB3' ' A' ' 94' ' ' TYR . 74.9 t-105 -69.69 -51.6 33.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.134 -173.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.576 HD12 ' CE ' ' A' ' 64' ' ' LYS . 3.1 mm? -61.06 -16.57 45.31 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.825 ' HZ2' ' HA ' ' A' ' 58' ' ' ASP . 48.5 mmtm -86.51 -27.93 23.72 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.615 -176.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -127.48 -41.31 1.72 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -173.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.576 ' CE ' HD12 ' A' ' 61' ' ' LEU . 34.4 mmtt 55.4 -91.34 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 O-C-N 123.493 0.496 . . . . 0.0 111.094 -174.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -96.24 -63.3 1.16 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.019 0.438 . . . . 0.0 110.065 178.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.444 ' ND2' HD12 ' A' ' 150' ' ' LEU . 1.1 t30 66.15 3.92 2.9 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.083 174.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 62.2 4.17 1.18 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.467 0.707 . . . . 0.0 112.655 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.563 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 20.2 t70 -152.21 5.48 0.41 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.429 0.633 . . . . 0.0 111.086 -175.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.561 ' CE2' ' HB2' ' A' ' 71' ' ' LEU . 85.3 t80 -117.95 120.8 38.94 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 121.706 -0.621 . . . . 0.0 110.888 -174.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -122.03 104.62 9.64 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.931 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.561 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 3.7 tt -108.48 114.75 28.83 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.0 mm -117.81 115.84 49.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.132 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.7 116.66 4.68 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.105 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 55.8 mt -105.8 100.91 11.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 117.155 0.478 . . . . 0.0 111.336 -173.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.519 ' HA ' ' O ' ' A' ' 41' ' ' THR . 1.9 t70 -85.43 136.16 33.56 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 172.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.429 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 16.8 ttp180 -72.59 -112.13 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -165.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.429 ' H ' ' HB3' ' A' ' 76' ' ' ARG . 17.3 m-20 -78.55 5.91 9.84 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -169.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -76.92 131.23 73.67 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-O 121.027 0.441 . . . . 0.0 110.987 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.476 ' HG2' ' OE2' ' A' ' 81' ' ' GLU . 29.1 Cg_endo -68.65 176.76 5.5 Favored 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 122.663 2.242 . . . . 0.0 112.7 177.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 97.2 mt -53.0 -58.22 7.71 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -173.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.476 ' OE2' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -64.5 -21.39 66.66 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -173.372 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 28.7 mmtm -74.03 -54.8 7.08 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 172.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 60.1 t -56.48 -47.37 81.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.233 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.78 -33.17 75.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.283 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.72 -35.63 62.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.744 0.306 . . . . 0.0 110.882 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.583 ' HE2' ' HG3' ' A' ' 52' ' ' MET . 60.3 t80 -69.39 -40.15 77.55 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.95 -55.08 39.51 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.164 176.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -62.9 -24.19 67.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.653 -175.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.7 m -84.49 2.37 41.3 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.522 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 p -130.4 -25.65 2.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.245 175.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 124.71 -81.24 0.36 Allowed Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -176.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.5 t 45.69 85.28 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 124.366 1.066 . . . . 0.0 113.547 173.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 40.5 p -93.25 15.81 14.63 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.545 173.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.54 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 42.0 p90 -111.39 148.15 38.19 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.133 175.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -63.16 130.53 29.14 Favored 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 122.436 2.091 . . . . 0.0 113.116 -177.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.402 ' O ' HG23 ' A' ' 21' ' ' THR . 94.8 mt -103.77 146.42 28.64 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.514 174.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -119.4 149.25 18.05 Favored Glycine 0 N--CA 1.438 -1.182 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 175.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.687 ' H ' HD22 ' A' ' 98' ' ' LEU . 2.1 pt? -107.02 142.08 37.21 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.854 0.359 . . . . 0.0 110.294 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -124.12 72.98 56.68 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.006 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.402 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 16.8 Cg_exo -67.71 109.81 1.96 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.718 2.279 . . . . 0.0 111.628 177.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 116.32 -3.62 20.26 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -176.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.441 ' O ' ' HG2' ' A' ' 111' ' ' ARG . . . 51.45 36.37 16.55 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.095 0.558 . . . . 0.0 112.184 -178.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -88.04 -39.55 14.56 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.115 -175.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.571 HD13 ' HB2' ' A' ' 16' ' ' PHE . 17.6 mm -66.9 -34.56 70.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 176.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -65.1 -39.03 92.57 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.728 171.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.637 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -69.0 -16.91 63.84 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.803 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.503 ' HG2' ' HA ' ' A' ' 104' ' ' ILE . 20.7 mmtt -66.35 -25.28 66.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.16 0.505 . . . . 0.0 109.903 177.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.434 ' HH ' ' HE2' ' A' ' 16' ' ' PHE . 86.7 m-85 -112.69 -37.07 5.0 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.825 -174.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.637 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -147.39 168.36 22.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.668 0.27 . . . . 0.0 111.403 -174.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.537 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 9.0 mp -62.23 138.14 58.37 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 174.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 102' ' ' ALA . 97.4 mtt180 -58.25 -26.75 63.28 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 -170.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -113.41 12.42 18.74 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.474 0.654 . . . . 0.0 111.049 -178.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.537 ' HB3' ' HB2' ' A' ' 110' ' ' LEU . . . -83.64 46.98 1.22 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.114 0.483 . . . . 0.0 110.876 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 93.39 -159.23 24.04 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.708 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.511 HG12 ' HB1' ' A' ' 42' ' ' ALA . 5.3 tp -152.89 -54.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 122.773 -0.251 . . . . 0.0 111.248 176.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.503 HG23 HG12 ' A' ' 47' ' ' VAL . 3.0 m -64.57 123.82 20.25 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 122.469 0.308 . . . . 0.0 111.341 -174.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -176.68 152.8 1.03 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.79 0.329 . . . . 0.0 110.834 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.555 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 7.8 m120 -116.65 118.41 32.5 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 177.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 41.2 t -109.79 126.85 66.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.645 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.646 HD22 ' SD ' ' A' ' 149' ' ' MET . 40.7 tp -119.7 127.02 52.48 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.068 0.461 . . . . 0.0 111.327 -178.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.73 HD12 HD22 ' A' ' 38' ' ' LEU . 1.9 mp -113.18 137.38 46.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.175 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.67 179.44 7.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.537 -178.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -62.86 -28.06 69.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.128 -176.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.607 ' HB2' ' NZ ' ' A' ' 126' ' ' LYS . 69.4 mt-10 -79.78 -12.16 59.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.108 0.48 . . . . 0.0 110.559 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.4 ' HA3' HH11 ' A' ' 32' ' ' ARG . . . 99.67 12.06 42.08 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.804 176.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.607 ' NZ ' ' HB2' ' A' ' 124' ' ' GLU . 31.5 mtmm -93.23 143.74 25.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.896 0.379 . . . . 0.0 111.093 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 47.2 mt -78.35 108.06 11.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.1 m -104.7 -20.74 5.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -171.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.57 ' HE3' ' OG1' ' A' ' 131' ' ' THR . 8.3 tmtm? -145.18 126.73 15.08 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.429 -172.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -125.54 107.24 10.42 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.542 178.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.57 ' OG1' ' HE3' ' A' ' 129' ' ' LYS . 97.7 m -95.76 139.46 31.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.799 0.333 . . . . 0.0 110.366 174.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.511 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 89.1 mtt180 -97.05 123.11 40.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.049 -178.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 132' ' ' ARG . 4.4 pp 50.89 21.54 0.98 Allowed 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 172.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.505 ' CD2' ' HE3' ' A' ' 50' ' ' LYS . 23.0 t80 58.95 112.27 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 122.284 1.04 . . . . 0.0 112.221 -176.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -119.19 139.71 51.39 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.85 174.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -53.68 -54.14 42.06 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -175.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -58.31 -47.04 84.98 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.173 0.511 . . . . 0.0 110.806 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -57.3 -45.48 84.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.19 177.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.586 ' O ' HG23 ' A' ' 143' ' ' VAL . 70.0 t80 -61.72 -46.78 88.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.592 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.43 -45.68 80.61 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.084 0.468 . . . . 0.0 110.633 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.9 m -65.62 -39.02 91.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.329 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.76 -41.17 98.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.391 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 139' ' ' PHE . 96.0 t -56.05 -55.72 16.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.654 177.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -60.4 -44.44 95.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.337 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.594 ' O ' ' HG3' ' A' ' 149' ' ' MET . 5.7 tt0 -53.98 -52.13 61.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.009 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.59 ' O ' HD22 ' A' ' 150' ' ' LEU . 22.5 mt -62.36 -44.26 99.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.725 -0.216 . . . . 0.0 110.996 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -57.54 -39.42 76.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.144 0.497 . . . . 0.0 110.324 176.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -68.47 -36.06 78.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.195 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.646 ' SD ' HD22 ' A' ' 120' ' ' LEU . 90.1 mtp -64.74 -31.82 73.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.212 0.529 . . . . 0.0 110.435 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.59 HD22 ' O ' ' A' ' 146' ' ' ILE . 4.0 mm? -71.33 -12.27 61.35 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.424 177.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.714 ' HZ1' ' HA ' ' A' ' 151' ' ' LYS . 0.4 OUTLIER -96.74 -46.6 6.21 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 170.751 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 74.9 117.54 0.05 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-N 114.219 -1.355 . . . . 0.0 112.161 173.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -65.82 86.2 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 165.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 13.4 m80 -49.38 112.58 0.66 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 122.03 0.919 . . . . 0.0 113.114 -166.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.468 ' H ' ' CD2' ' A' ' 155' ' ' HIS . 3.0 p80 -75.82 68.13 2.32 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.014 -1.448 . . . . 0.0 110.976 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -155.14 97.05 1.88 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.445 176.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.484 ' HB3' ' H ' ' A' ' 159' ' ' HIS . 61.2 m170 -120.67 -174.13 2.74 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.989 0.424 . . . . 0.0 110.331 -178.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -109.3 1.35 20.07 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 163.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.484 ' H ' ' HB3' ' A' ' 157' ' ' HIS . 51.4 t-80 . . . . . 0 C--O 1.247 0.955 0 CA-C-N 113.557 -1.656 . . . . 0.0 108.06 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.8 mmm . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.4 t -151.41 133.27 15.0 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.651 ' H ' HD21 ' A' ' 3' ' ' LEU . 1.1 pt? -99.15 69.01 1.7 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.597 0.713 . . . . 0.0 110.143 177.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.09 24.0 76.61 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.395 -0.82 . . . . 0.0 113.476 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -87.3 116.0 25.09 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 117.199 0.499 . . . . 0.0 109.955 174.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.1 pt -92.75 -26.01 4.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.797 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.6 p -94.83 152.84 3.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.445 ' HE ' ' CD ' ' A' ' 11' ' ' GLU . 0.6 OUTLIER -118.03 156.6 28.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.315 0.578 . . . . 0.0 112.453 -171.087 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.4 mt -73.2 132.66 33.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.459 170.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.59 -9.15 77.76 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -175.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.445 ' CD ' ' HE ' ' A' ' 8' ' ' ARG . 36.2 tt0 -99.66 156.98 16.79 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 91.5 mmm -72.69 125.72 28.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.91 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -66.13 126.36 91.8 Favored Pre-proline 0 C--O 1.237 0.427 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.053 178.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.468 ' HG2' ' O ' ' A' ' 107' ' ' LYS . 45.9 Cg_exo -57.29 122.7 12.25 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.127 2.551 . . . . 0.0 112.125 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.481 ' HA ' HD13 ' A' ' 28' ' ' LEU . 1.4 t70 -71.16 134.69 47.14 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.63 -175.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.53 ' HB2' HD13 ' A' ' 104' ' ' ILE . 42.4 p90 -141.33 174.36 10.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.826 0.346 . . . . 0.0 110.793 -178.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 55.3 m -134.87 114.32 12.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.38 174.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 25' ' ' GLN . 14.4 tt -112.25 141.85 26.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.16 -174.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.3 m -88.38 120.34 29.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.68 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.624 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 85.7 mt -79.51 -179.09 6.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.3 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.473 ' HB ' HD13 ' A' ' 84' ' ' LEU . 36.6 p -51.07 -43.96 61.08 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -174.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -100.87 12.34 37.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.845 0.355 . . . . 0.0 111.493 -174.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.16 17.2 41.08 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.984 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.503 ' HE2' ' HA ' ' A' ' 24' ' ' LYS . 7.8 mmpt? -80.22 112.16 17.28 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 175.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.501 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 23.0 mt-30 -100.08 113.53 26.21 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.997 0.427 . . . . 0.0 110.49 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 17' ' ' THR . 14.1 m -105.84 147.05 11.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.723 -177.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.8 m -116.75 142.23 47.18 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.943 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.481 HD13 ' HA ' ' A' ' 15' ' ' ASP . 13.3 mt -60.99 -32.97 72.53 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 -178.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.2 m -56.68 -31.26 64.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.032 0.444 . . . . 0.0 111.062 177.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.8 m -79.32 -20.16 48.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.979 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.4 ' C ' ' HD3' ' A' ' 34' ' ' LYS . 86.5 mt -107.35 11.62 28.9 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.899 -178.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.418 ' HG2' ' O ' ' A' ' 28' ' ' LEU . 37.3 mmt180 -70.9 137.17 49.07 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 171.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.76 -7.65 57.66 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.499 -174.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.559 ' HG3' ' HA ' ' A' ' 68' ' ' ASP . 9.6 mptt -113.15 157.47 21.63 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 175.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.465 HG13 ' O ' ' A' ' 68' ' ' ASP . 2.1 p -84.17 103.91 11.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 170.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.432 ' HA ' ' HB2' ' A' ' 70' ' ' ALA . 22.3 t -95.86 111.62 26.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.202 -171.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 24.8 ttt -96.86 125.97 41.68 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.011 0.434 . . . . 0.0 110.277 175.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.484 HD12 HD11 ' A' ' 121' ' ' ILE . 6.5 mp -108.64 130.51 55.32 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.941 176.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.872 HE21 HD12 ' A' ' 55' ' ' ILE . 6.8 tt0 -117.66 114.5 23.45 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.441 178.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.533 ' O ' ' HA ' ' A' ' 116' ' ' THR . 94.2 m-85 -93.2 106.18 18.17 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.061 0.457 . . . . 0.0 110.152 178.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.433 ' HA ' ' SG ' ' A' ' 48' ' ' CYS . 11.7 t -117.41 175.37 5.65 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.563 -174.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.416 ' HB3' HG12 ' A' ' 115' ' ' ILE . . . -154.3 136.59 14.88 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.641 ' HG ' ' HG3' ' A' ' 78' ' ' GLU . 28.3 p -62.17 -11.07 12.48 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -173.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 2.8 p-90 -117.03 19.8 14.11 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 122.087 -0.383 . . . . 0.0 111.724 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 43.3 t -108.14 114.17 27.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.847 0.356 . . . . 0.0 110.765 178.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.18 -17.48 79.97 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.364 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.417 HG12 ' HB3' ' A' ' 133' ' ' LEU . 58.6 t -64.56 -40.1 87.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 175.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.443 ' HA ' ' HB3' ' A' ' 51' ' ' GLU . 81.1 m -68.82 -16.9 63.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.796 176.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 27.4 ttt85 -78.52 -11.98 59.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.956 0.408 . . . . 0.0 110.174 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -84.54 -50.38 7.76 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 122.128 0.966 . . . . 0.0 108.443 162.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.672 ' HB2' ' HB2' ' A' ' 134' ' ' TYR . 40.0 tt0 -57.25 -59.79 4.59 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 113.631 -1.622 . . . . 0.0 112.094 -171.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.653 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 85.7 mtp -57.37 -53.03 69.73 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -173.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.653 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 45.9 Cg_exo -60.04 -41.8 49.51 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.242 1.961 . . . . 0.0 113.053 177.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -65.16 -44.84 87.25 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.765 0.317 . . . . 0.0 110.802 177.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.872 HD12 HE21 ' A' ' 39' ' ' GLN . 64.0 mt -60.34 -42.95 92.58 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.314 176.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.57 ' OE1' ' HA ' ' A' ' 92' ' ' VAL . 37.5 tp10 -52.62 -58.81 5.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.451 0.643 . . . . 0.0 109.943 174.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -60.68 -59.09 5.94 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.36 -173.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.662 ' HA ' ' HZ3' ' A' ' 62' ' ' LYS . 72.2 m-20 -106.52 -5.26 18.94 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -168.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.597 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 22.8 mm -104.98 -57.95 4.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.061 0.458 . . . . 0.0 110.428 173.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.528 ' CD2' ' HB3' ' A' ' 94' ' ' TYR . 68.9 t-105 -66.11 -73.47 0.13 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.823 -173.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -50.98 -27.36 7.54 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -173.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.662 ' HZ3' ' HA ' ' A' ' 58' ' ' ASP . 47.9 mmtm -67.47 -33.96 76.18 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.44 ' CG ' HD11 ' A' ' 150' ' ' LEU . 67.7 m-70 -131.57 -44.5 0.99 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.236 -0.586 . . . . 0.0 112.044 -176.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.474 ' O ' ' HD2' ' A' ' 69' ' ' PHE . 9.5 mtmp? 42.93 -95.62 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.662 0.785 . . . . 0.0 112.662 -176.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.04 -72.39 0.45 Allowed 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.557 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.421 ' O ' ' HB1' ' A' ' 67' ' ' ALA . 30.5 t30 66.75 -70.55 0.11 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.472 -177.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.79 ' HB2' ' HD2' ' A' ' 159' ' ' HIS . . . 164.32 -30.33 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 124.605 1.162 . . . . 0.0 108.36 -178.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.559 ' HA ' ' HG3' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -143.27 40.18 1.46 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.965 -1.016 . . . . 0.0 112.23 -178.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.474 ' HD2' ' O ' ' A' ' 64' ' ' LYS . 80.8 t80 -119.34 138.07 53.29 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 169.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.432 ' HB2' ' HA ' ' A' ' 36' ' ' VAL . . . -134.43 139.75 45.76 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.218 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.9 tt -143.13 115.76 8.65 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -117.0 118.39 58.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.708 0.289 . . . . 0.0 110.256 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.52 ' HA3' HD11 ' A' ' 96' ' ' LEU . . . -88.38 108.67 3.45 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 175.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 59.6 mt -101.66 107.43 21.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 O-C-N 122.588 -0.36 . . . . 0.0 111.323 -173.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.496 ' HB3' HG22 ' A' ' 83' ' ' VAL . 10.7 t0 -85.58 128.47 34.77 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 174.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.4 ttp180 -91.6 126.93 36.86 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.854 -168.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 100' ' ' PRO . 53.4 m-20 71.39 -43.9 0.57 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.999 0.919 . . . . 0.0 113.054 173.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.641 ' HG3' ' HG ' ' A' ' 43' ' ' SER . 78.2 mm-40 -60.63 136.22 92.46 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 121.365 0.603 . . . . 0.0 112.141 -176.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.635 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 35.5 Cg_endo -71.16 -173.15 0.85 Allowed 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 123.301 2.667 . . . . 0.0 114.109 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.438 ' O ' HD23 ' A' ' 84' ' ' LEU . 91.6 mt -53.75 -57.08 12.15 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 114.745 -1.116 . . . . 0.0 113.308 -173.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.635 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -61.06 -29.81 69.96 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -171.66 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.564 ' HG3' ' OE1' ' A' ' 78' ' ' GLU . 40.5 mmtm -64.89 -58.28 6.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.237 0.541 . . . . 0.0 110.182 173.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.496 HG22 ' HB3' ' A' ' 75' ' ' ASP . 38.7 t -56.24 -49.62 75.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.476 -176.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.473 HD13 ' HB ' ' A' ' 21' ' ' THR . 4.4 mm? -63.24 -47.13 83.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.657 -176.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.21 -39.54 78.54 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -176.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.539 ' HE2' ' SD ' ' A' ' 52' ' ' MET . 79.6 t80 -68.81 -44.25 73.91 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 121.131 -0.228 . . . . 0.0 111.181 -176.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.1 -41.96 94.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.311 0.577 . . . . 0.0 109.72 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -59.07 -29.56 67.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.043 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 18.5 t -82.09 -7.21 59.61 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.946 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 43.6 p -123.49 7.78 8.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.763 0.316 . . . . 0.0 111.434 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.73 -53.2 4.28 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.942 -0.647 . . . . 0.0 113.092 176.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.57 ' HA ' ' OE1' ' A' ' 56' ' ' GLU . 77.1 t -2.06 113.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 125.843 1.657 . . . . 0.0 115.392 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 58.9 p -100.45 -17.73 17.03 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.61 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.528 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 29.7 p90 -72.76 145.37 86.86 Favored Pre-proline 0 N--CA 1.462 0.145 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.322 176.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.98 134.25 45.39 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.887 2.391 . . . . 0.0 113.865 -174.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.52 HD11 ' HA3' ' A' ' 73' ' ' GLY . 4.1 mm? -99.5 149.85 22.8 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.453 175.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.624 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -130.87 158.88 22.8 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.589 -0.605 . . . . 0.0 111.589 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.409 ' N ' HD12 ' A' ' 98' ' ' LEU . 6.2 mp -99.52 139.56 35.0 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.647 0.261 . . . . 0.0 110.613 -177.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -125.73 75.33 70.54 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.174 173.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 77' ' ' ASP . 61.4 Cg_endo -73.94 115.67 4.4 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.569 2.179 . . . . 0.0 112.335 -176.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 102.18 -0.66 50.82 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 56.92 36.8 28.25 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 115.189 -0.505 . . . . 0.0 111.468 -177.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -73.63 -48.05 35.41 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.389 -176.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.53 HD13 ' HB2' ' A' ' 16' ' ' PHE . 18.0 mm -67.41 -36.43 76.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.405 ' HD1' ' CD1' ' A' ' 40' ' ' PHE . 79.3 t80 -65.1 -41.14 95.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.085 174.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.621 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -66.16 -20.75 66.24 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.608 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.468 ' O ' ' HG2' ' A' ' 14' ' ' PRO . 53.0 mttp -74.14 -13.34 60.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.807 0.337 . . . . 0.0 111.164 177.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.403 ' HH ' ' HE2' ' A' ' 16' ' ' PHE . 71.4 m-85 -115.73 -40.41 3.36 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.012 0.434 . . . . 0.0 111.145 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.621 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -149.74 168.17 24.4 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.584 -177.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.407 ' HB2' ' HB1' ' A' ' 113' ' ' ALA . 90.9 mt -68.36 130.92 44.32 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.5 mtm180 -53.38 -47.11 69.75 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 122.2 1.0 . . . . 0.0 109.995 -177.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -82.48 10.46 7.19 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.767 -171.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.407 ' HB1' ' HB2' ' A' ' 110' ' ' LEU . . . -98.68 -2.61 37.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.989 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 145.27 -167.15 27.47 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.57 177.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.433 HG22 ' H ' ' A' ' 116' ' ' THR . 2.0 tp -136.19 -67.87 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 40' ' ' PHE . 24.3 m -67.07 109.67 3.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.761 0.315 . . . . 0.0 111.37 -174.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -151.7 141.77 22.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.928 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.58 ' HB2' ' OG1' ' A' ' 131' ' ' THR . 51.8 m-80 -111.18 121.63 45.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.165 0.507 . . . . 0.0 110.276 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 49.9 t -115.99 118.32 58.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.803 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.571 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 43.0 tp -106.84 127.09 53.11 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.577 0.227 . . . . 0.0 111.211 -177.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.484 HD11 HD12 ' A' ' 38' ' ' LEU . 2.5 mp -113.73 137.63 46.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.377 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.481 ' OD2' ' HB2' ' A' ' 126' ' ' LYS . 3.7 p30 -82.34 -179.42 7.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.871 0.367 . . . . 0.0 111.217 177.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.486 ' NH2' ' HA ' ' A' ' 150' ' ' LEU . 7.0 mpt_? -59.22 -32.51 70.02 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.017 -177.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -76.88 -22.59 53.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.151 0.5 . . . . 0.0 110.856 -173.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 111.64 6.8 24.74 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.175 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.6 ' HB2' ' HZ2' ' A' ' 126' ' ' LYS . 9.1 mtmp? -93.95 149.85 20.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.818 0.342 . . . . 0.0 110.914 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.444 HG22 HD22 ' A' ' 130' ' ' LEU . 62.5 mt -84.4 130.5 35.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.273 177.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 18.1 m -121.89 4.04 6.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -177.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.692 ' HE2' ' HB3' ' A' ' 142' ' ' LEU . 53.3 tptt -160.58 128.72 4.57 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.314 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.444 HD22 HG22 ' A' ' 127' ' ' ILE . 90.0 mt -132.0 104.39 6.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.478 174.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.58 ' OG1' ' HB2' ' A' ' 118' ' ' ASN . 22.9 p -107.88 156.45 19.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.017 0.437 . . . . 0.0 111.638 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.923 HH12 ' HG3' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -104.72 118.94 37.82 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.262 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.5 ' HA ' HG23 ' A' ' 116' ' ' THR . 50.0 mt 65.49 -173.47 0.18 Allowed 'General case' 0 C--O 1.236 0.389 0 O-C-N 123.883 0.739 . . . . 0.0 109.831 -175.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.672 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 9.4 t80 -58.91 -44.89 91.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.017 173.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.503 ' HB3' ' HB2' ' A' ' 138' ' ' GLU . 0.2 OUTLIER 55.82 95.34 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.851 0.72 . . . . 0.0 110.684 174.771 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -40.97 -59.34 1.48 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.226 -172.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.472 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 0.7 OUTLIER -68.45 -47.06 68.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.568 -176.56 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.923 ' HG3' HH12 ' A' ' 132' ' ' ARG . 2.5 mm-40 -64.97 -34.54 78.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.092 -175.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.471 ' HE1' HG12 ' A' ' 55' ' ' ILE . 82.2 t80 -63.51 -44.21 94.97 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.812 175.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.461 ' O ' HG11 ' A' ' 143' ' ' VAL . . . -62.07 -42.39 99.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.382 0.61 . . . . 0.0 110.361 177.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.4 m -61.49 -46.0 91.84 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.318 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.692 ' HB3' ' HE2' ' A' ' 129' ' ' LYS . 4.3 pp -80.19 -28.91 38.6 Favored 'General case' 0 C--O 1.217 -0.65 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.262 -176.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.461 HG11 ' O ' ' A' ' 140' ' ' ALA . 12.6 p -60.57 -42.09 90.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.356 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -66.41 -45.59 79.42 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.416 174.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.606 ' O ' ' HG3' ' A' ' 149' ' ' MET . 44.3 tt0 -55.78 -53.4 57.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.731 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.653 HG13 ' O ' ' A' ' 142' ' ' LEU . 38.0 mt -57.41 -47.01 85.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.929 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.722 ' O ' ' HG3' ' A' ' 151' ' ' LYS . 95.4 m-20 -48.92 -58.81 4.26 Favored 'General case' 0 CA--C 1.517 -0.327 0 O-C-N 123.134 0.271 . . . . 0.0 110.883 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 151' ' ' LYS . 15.8 tp10 -68.18 -26.15 65.6 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 123.43 0.456 . . . . 0.0 111.233 -175.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.606 ' HG3' ' O ' ' A' ' 145' ' ' GLN . 51.1 mtp -57.86 -48.88 78.51 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.022 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.608 HD21 ' O ' ' A' ' 146' ' ' ILE . 0.8 OUTLIER -90.76 2.95 55.59 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.253 -0.979 . . . . 0.0 112.097 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.722 ' HG3' ' O ' ' A' ' 147' ' ' ASN . 3.6 mtpm? -76.1 -45.6 33.08 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 164.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.417 ' HB2' ' HD1' ' A' ' 154' ' ' HIS . 0.9 OUTLIER 45.14 -7.31 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 117.316 2.339 . . . . 0.0 117.316 175.496 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 151' ' ' LYS . . . 69.91 15.52 71.68 Favored Glycine 0 CA--C 1.522 0.49 0 CA-C-N 118.733 0.697 . . . . 0.0 113.975 173.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.417 ' HD1' ' HB2' ' A' ' 152' ' ' GLU . 32.4 m80 -108.98 -66.9 1.02 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.573 0.687 . . . . 0.0 109.92 177.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 51.04 74.62 0.23 Allowed 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.862 0.726 . . . . 0.0 111.402 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -132.1 103.77 6.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.258 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 33.2 m170 75.91 -40.63 0.41 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 172.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -75.39 -29.26 59.76 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.79 ' HD2' ' HB2' ' A' ' 67' ' ' ALA . 13.5 p80 . . . . . 0 C--O 1.247 0.962 0 CA-C-O 117.467 -1.254 . . . . 0.0 108.156 173.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.444 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.118 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.0 m 47.16 -141.35 0.47 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.345 0.258 . . . . 0.0 110.785 176.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.679 ' H ' HD21 ' A' ' 3' ' ' LEU . 2.3 pt? -97.44 43.74 1.06 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.387 0.613 . . . . 0.0 110.218 174.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.31 22.31 5.57 Favored Glycine 0 C--O 1.224 -0.469 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.093 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -108.81 118.44 36.78 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.814 0.34 . . . . 0.0 110.905 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.2 pt -89.38 -11.2 10.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.2 0.524 . . . . 0.0 109.749 175.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.418 HG23 HG13 ' A' ' 127' ' ' ILE . 4.8 p -94.2 162.97 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.297 177.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.561 ' HB2' ' HB2' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -128.65 151.17 49.81 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.32 -169.564 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.489 HG12 HD21 ' A' ' 130' ' ' LEU . 57.6 mt -75.24 132.91 32.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.165 177.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.69 5.01 90.23 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.615 -177.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.561 ' HB2' ' HB2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -115.02 161.48 18.28 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -176.211 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 85.3 mmm -68.15 133.47 48.96 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.093 0.473 . . . . 0.0 111.916 -173.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.73 134.58 50.27 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.585 173.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.544 ' HG2' ' O ' ' A' ' 107' ' ' LYS . 33.2 Cg_exo -62.2 121.09 8.96 Favored 'Trans proline' 0 N--CA 1.464 -0.225 0 C-N-CA 122.822 2.348 . . . . 0.0 111.759 175.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.45 ' CG ' ' HG ' ' A' ' 29' ' ' SER . 1.3 t70 -73.74 134.58 43.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.505 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.554 ' HB2' HD12 ' A' ' 104' ' ' ILE . 51.3 p90 -136.88 165.78 25.15 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.057 -173.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 58.5 m -119.74 115.48 23.98 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.439 172.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.7 tt -111.99 150.68 14.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.86 -174.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.2 m -98.77 125.11 44.03 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.263 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.51 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 85.8 mt -84.65 -177.81 6.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.791 -176.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.475 ' HB ' HD12 ' A' ' 84' ' ' LEU . 28.3 p -56.07 -40.51 73.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.837 -175.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -98.75 12.07 36.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.915 0.388 . . . . 0.0 111.042 -177.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.8 3.03 60.98 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.388 -0.91 . . . . 0.0 113.617 176.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.45 ' HB2' HD11 ' A' ' 20' ' ' LEU . 60.7 mttp -64.83 124.89 23.17 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 117.357 0.578 . . . . 0.0 111.012 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -104.83 113.79 27.6 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 17' ' ' THR . 16.4 m -122.5 148.78 26.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.858 -176.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.448 HG21 ' OD1' ' A' ' 15' ' ' ASP . 4.9 m -106.65 148.08 28.77 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.438 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.491 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 0.6 OUTLIER -61.03 -32.94 72.53 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -177.515 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.505 ' HA ' ' CG ' ' A' ' 32' ' ' ARG . 60.9 m -54.56 -25.26 24.99 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.144 177.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.6 t -77.35 -11.07 59.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.942 0.401 . . . . 0.0 110.766 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.467 HD11 ' HB3' ' A' ' 70' ' ' ALA . 76.5 mt -119.56 0.44 11.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.381 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.505 ' CG ' ' HA ' ' A' ' 29' ' ' SER . 52.1 mmm-85 -68.24 131.57 45.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.877 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.7 -27.27 7.63 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -172.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.69 ' HB2' ' C ' ' A' ' 68' ' ' ASP . 12.9 ptpt -116.09 165.63 12.92 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 174.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 68' ' ' ASP . 4.0 p -80.7 123.41 37.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.197 0.522 . . . . 0.0 110.574 -177.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.402 HG22 ' HB2' ' A' ' 70' ' ' ALA . 23.5 t -110.95 123.87 67.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.372 -176.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.553 ' SD ' HG21 ' A' ' 59' ' ' ILE . 26.1 ttt -103.03 131.51 49.96 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.233 176.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.555 HD13 HD12 ' A' ' 121' ' ' ILE . 5.5 mp -126.03 148.3 49.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.477 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.5 148.54 42.81 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 169.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -112.81 113.15 25.11 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.054 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.4 t -129.41 -168.77 1.99 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.406 -174.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.684 ' HB3' ' HG ' ' A' ' 45' ' ' CYS . . . -163.87 165.52 22.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.548 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.514 ' HB2' ' HB3' ' A' ' 82' ' ' LYS . 7.6 t -73.45 -25.04 60.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.177 0.513 . . . . 0.0 111.132 -172.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 68.2 p-90 -88.81 0.3 56.65 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 122.233 -0.292 . . . . 0.0 111.684 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.684 ' HG ' ' HB3' ' A' ' 42' ' ' ALA . 73.7 m -78.99 99.63 6.94 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.183 0.516 . . . . 0.0 111.218 -178.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.49 -37.49 89.97 Favored Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.89 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.488 HG11 ' HG ' ' A' ' 133' ' ' LEU . 38.1 t -63.19 -32.48 56.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.057 0.456 . . . . 0.0 110.617 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.633 ' SG ' HG23 ' A' ' 116' ' ' THR . 84.8 m -70.37 -15.51 62.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.277 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.726 ' HE ' ' HE1' ' A' ' 86' ' ' PHE . 98.9 mtt180 -77.81 -6.75 55.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.246 0.546 . . . . 0.0 110.084 176.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.469 ' HE2' ' CE2' ' A' ' 134' ' ' TYR . 54.6 mtpt -100.64 -43.29 6.21 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 164.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.559 ' HB3' ' HA ' ' A' ' 48' ' ' CYS . 23.0 tt0 -52.43 -64.12 0.92 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.328 -1.305 . . . . 0.0 112.218 -177.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.546 ' HE2' ' CE2' ' A' ' 86' ' ' PHE . 39.7 mtm -65.25 -46.27 71.63 Favored Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -171.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.434 ' HG2' ' O ' ' A' ' 49' ' ' ARG . 72.4 Cg_exo -53.9 -38.37 85.95 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.709 1.606 . . . . 0.0 111.885 174.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 139' ' ' PHE . 4.9 m-85 -69.11 -42.79 75.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.781 176.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 51' ' ' GLU . 76.4 mt -57.12 -48.52 81.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.173 175.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.621 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 13.9 tp10 -55.78 -48.84 74.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.097 175.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -55.08 -57.08 13.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.775 -176.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.652 ' HA ' ' HZ3' ' A' ' 62' ' ' LYS . 44.8 m-20 -106.42 -43.14 4.84 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -170.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.553 HG21 ' SD ' ' A' ' 37' ' ' MET . 1.9 mp -75.62 -56.72 7.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.982 0.42 . . . . 0.0 110.801 -176.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.781 ' CE2' ' HG2' ' A' ' 64' ' ' LYS . 22.4 t-105 -72.02 -58.82 3.11 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.338 -173.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.621 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.8 OUTLIER -44.68 -43.66 8.52 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.674 0.79 . . . . 0.0 113.027 -173.621 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.652 ' HZ3' ' HA ' ' A' ' 58' ' ' ASP . 30.0 mmtm -84.2 -23.93 30.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.206 0.526 . . . . 0.0 111.484 -174.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 68.3 m-70 -125.53 24.76 7.17 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -166.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.781 ' HG2' ' CE2' ' A' ' 60' ' ' TRP . 28.7 mttt -53.81 93.93 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 123.079 1.418 . . . . 0.0 112.528 -177.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.636 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 13.4 t70 64.4 -42.96 0.29 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 110.538 -3.028 . . . . 0.0 110.508 -168.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.535 ' H ' ' C ' ' A' ' 64' ' ' LYS . 13.0 t30 66.31 -57.08 0.38 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.094 0.958 . . . . 0.0 111.001 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 167.18 -31.35 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 125.271 1.428 . . . . 0.0 107.355 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.69 ' C ' ' HB2' ' A' ' 34' ' ' LYS . 21.7 p-10 -147.91 32.92 0.84 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.185 -1.37 . . . . 0.0 111.292 -173.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.636 ' O ' ' HA ' ' A' ' 65' ' ' ASP . 88.1 t80 -127.29 133.26 50.17 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.977 0.418 . . . . 0.0 110.014 172.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.551 ' HB1' ' HD2' ' A' ' 34' ' ' LYS . . . -124.76 142.13 51.63 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.342 175.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.5 tt -135.46 117.74 15.6 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 68.1 mt -123.87 119.42 56.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.382 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.43 ' HA3' HD22 ' A' ' 96' ' ' LEU . . . -89.69 131.35 10.68 Favored Glycine 0 C--O 1.222 -0.598 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 174.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.424 HD11 HD23 ' A' ' 38' ' ' LEU . 48.5 mt -119.78 141.64 38.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 117.548 0.674 . . . . 0.0 111.017 -173.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.52 ' OD2' ' HA ' ' A' ' 42' ' ' ALA . 10.2 t0 -114.42 120.5 40.52 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 176.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.636 ' HG2' HD12 ' A' ' 115' ' ' ILE . 4.4 ptm180 -73.84 -2.84 25.38 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -165.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 100' ' ' PRO . 0.4 OUTLIER -169.44 -32.26 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 118.448 -1.301 . . . . 0.0 113.713 -175.135 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.426 ' HB3' ' HG3' ' A' ' 82' ' ' LYS . 35.8 mt-10 -78.7 142.0 60.76 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 121.324 0.583 . . . . 0.0 111.658 -173.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.606 ' HG2' ' OE2' ' A' ' 81' ' ' GLU . 38.5 Cg_endo -71.2 -173.81 1.02 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.185 2.59 . . . . 0.0 114.437 -174.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 89.1 mt -51.43 -57.43 9.0 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.756 -174.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.609 ' OE2' ' HG2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -61.11 -28.57 69.19 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -172.326 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.609 ' HG2' ' OE2' ' A' ' 81' ' ' GLU . 44.0 mmtm -67.38 -52.75 36.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.794 0.33 . . . . 0.0 110.445 173.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 62.0 t -59.55 -51.1 76.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.241 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.475 HD12 ' HB ' ' A' ' 21' ' ' THR . 4.3 mm? -65.27 -36.5 84.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.488 -176.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -75.5 -32.19 60.44 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 121.061 -0.256 . . . . 0.0 111.232 -179.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.726 ' HE1' ' HE ' ' A' ' 49' ' ' ARG . 79.5 t80 -74.83 -41.27 60.22 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.492 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.53 -53.27 59.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.7 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.7 pttm -55.92 -31.75 63.16 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.762 -174.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 68.5 m -87.13 2.19 50.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.386 -175.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 33.3 p -130.57 10.1 5.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.344 0.592 . . . . 0.0 110.342 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.5 -73.11 1.68 Allowed Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.507 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.4 t 29.85 90.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.808 1.243 . . . . 0.0 114.092 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 76.0 p -98.93 17.97 18.31 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.133 0.492 . . . . 0.0 110.726 175.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.598 ' HB3' ' CE2' ' A' ' 60' ' ' TRP . 31.1 p90 -114.52 147.66 38.56 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.885 175.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.4 135.89 60.38 Favored 'Trans proline' 0 C--O 1.239 0.537 0 C-N-CA 122.44 2.093 . . . . 0.0 113.453 -176.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.43 HD22 ' HA3' ' A' ' 73' ' ' GLY . 72.7 mt -111.6 144.99 39.96 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.491 175.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.51 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -122.52 150.55 16.91 Favored Glycine 0 N--CA 1.441 -1.025 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 176.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.592 HD21 ' H ' ' A' ' 98' ' ' LEU . 1.7 pt? -117.11 132.11 56.74 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -177.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.458 ' OD1' ' HA ' ' A' ' 76' ' ' ARG . 5.0 p-10 -125.12 83.38 60.65 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-O 121.945 0.879 . . . . 0.0 110.635 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 77' ' ' ASP . 18.5 Cg_endo -57.03 130.31 39.05 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.882 2.388 . . . . 0.0 112.545 -176.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.56 11.13 69.19 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.646 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.436 ' HB3' ' CZ ' ' A' ' 76' ' ' ARG . . . 53.03 51.73 15.2 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 122.891 0.476 . . . . 0.0 111.998 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.455 ' HB2' HH22 ' A' ' 111' ' ' ARG . 28.6 t70 -82.29 -53.86 5.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.953 0.406 . . . . 0.0 111.076 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.554 HD12 ' HB2' ' A' ' 16' ' ' PHE . 17.1 mm -68.36 -30.62 48.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.417 ' HB3' ' HB2' ' A' ' 102' ' ' ALA . 74.7 t80 -60.65 -37.92 83.14 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.627 170.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.843 ' HB1' ' HG2' ' A' ' 111' ' ' ARG . . . -72.68 -15.09 61.7 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.034 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.544 ' O ' ' HG2' ' A' ' 14' ' ' PRO . 14.1 mptt -69.3 -15.97 63.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.908 0.385 . . . . 0.0 110.798 173.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -126.0 -32.94 2.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.026 0.441 . . . . 0.0 111.524 -177.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.628 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -133.68 -172.78 3.06 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.276 -178.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.8 mt -85.06 153.18 22.88 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.843 ' HG2' ' HB1' ' A' ' 106' ' ' ALA . 20.2 mtp180 -71.48 -14.11 62.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.403 0.62 . . . . 0.0 110.344 -176.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -101.09 -1.89 32.92 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.907 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.28 155.38 40.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.227 0.536 . . . . 0.0 111.916 -174.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.8 155.22 42.05 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.131 -0.941 . . . . 0.0 113.662 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.636 HD12 ' HG2' ' A' ' 76' ' ' ARG . 3.3 tp -84.15 -175.25 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 123.211 0.604 . . . . 0.0 110.366 -176.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.633 HG23 ' SG ' ' A' ' 48' ' ' CYS . 77.0 p 61.52 79.5 0.25 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.461 1.104 . . . . 0.0 111.524 177.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 117' ' ' ARG . 9.0 mtp180 -140.59 132.49 27.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.09 -177.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.626 ' HB3' ' HB ' ' A' ' 131' ' ' THR . 0.2 OUTLIER -107.73 126.18 52.3 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.559 ' N ' HD21 ' A' ' 118' ' ' ASN . 16.7 t -122.88 138.4 53.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.157 -178.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.543 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 46.3 tp -126.49 122.82 36.28 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.911 -0.315 . . . . 0.0 110.5 177.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.555 HD12 HD13 ' A' ' 38' ' ' LEU . 1.9 mp -106.34 134.59 47.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.152 177.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.68 174.79 10.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.963 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.44 ' HD2' ' OE1' ' A' ' 152' ' ' GLU . 5.8 ptm180 -72.23 -15.59 61.93 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -172.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.509 ' CD ' ' HZ1' ' A' ' 126' ' ' LYS . 47.1 mt-10 -80.33 -28.3 38.16 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.25 0.547 . . . . 0.0 109.863 175.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 116.85 10.36 10.12 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.316 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.509 ' HZ1' ' CD ' ' A' ' 124' ' ' GLU . 42.5 mtmt -100.44 153.17 19.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.097 0.475 . . . . 0.0 111.744 -178.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.418 HG13 HG23 ' A' ' 7' ' ' VAL . 4.4 mm -76.53 133.24 31.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.294 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 28.0 m -126.07 3.07 4.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.543 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 53.1 tptt -166.57 127.35 1.67 Allowed 'General case' 0 C--O 1.232 0.16 0 C-N-CA 120.481 -0.488 . . . . 0.0 112.027 -177.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.489 HD21 HG12 ' A' ' 9' ' ' ILE . 3.1 mm? -126.99 115.51 19.35 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.471 172.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.626 ' HB ' ' HB3' ' A' ' 118' ' ' ASN . 95.2 m -123.85 134.99 53.48 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.538 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.403 ' NH1' HD11 ' A' ' 133' ' ' LEU . 0.4 OUTLIER -106.5 122.37 46.16 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.488 ' HG ' HG11 ' A' ' 47' ' ' VAL . 10.6 tp 71.78 156.22 0.16 Allowed 'General case' 0 C--O 1.232 0.155 0 O-C-N 124.191 0.932 . . . . 0.0 110.388 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.501 ' CE2' ' HG2' ' A' ' 136' ' ' GLU . 51.1 t80 -72.52 89.04 1.26 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.362 0.601 . . . . 0.0 109.935 174.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.542 ' HB3' ' HB3' ' A' ' 138' ' ' GLU . 41.4 t30 -85.52 116.42 23.81 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 171.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.501 ' HG2' ' CE2' ' A' ' 134' ' ' TYR . 33.8 mt-10 -58.3 -52.75 64.26 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.28 -168.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -59.75 -39.59 85.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.204 0.526 . . . . 0.0 111.317 176.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.542 ' HB3' ' HB3' ' A' ' 135' ' ' ASN . 5.3 tp10 -61.99 -46.69 88.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.117 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.6 ' O ' HG22 ' A' ' 143' ' ' VAL . 82.1 t80 -59.72 -42.44 93.09 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.699 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.26 -46.44 85.99 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.121 0.486 . . . . 0.0 110.553 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.2 m -62.13 -38.81 90.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.505 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.02 -37.88 89.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.492 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 139' ' ' PHE . 97.2 t -55.39 -57.11 8.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.314 175.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -61.48 -38.23 86.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.797 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -57.43 -48.66 78.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.98 177.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.569 ' O ' HD22 ' A' ' 150' ' ' LEU . 59.6 mt -67.87 -38.95 80.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.955 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -55.42 -39.94 70.85 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.826 -0.17 . . . . 0.0 111.302 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.423 ' OE1' ' HB2' ' A' ' 151' ' ' LYS . 9.6 tp10 -73.39 -35.42 65.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.762 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 82.1 mmm -62.83 -25.79 68.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.351 0.596 . . . . 0.0 110.119 178.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.569 HD22 ' O ' ' A' ' 146' ' ' ILE . 4.0 mm? -90.86 2.08 56.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.229 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.461 ' HA ' ' HD3' ' A' ' 151' ' ' LYS . 12.9 mmtm -103.5 -66.45 0.94 Allowed 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 173.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.44 ' OE1' ' HD2' ' A' ' 123' ' ' ARG . 31.3 tt0 51.9 -83.06 0.01 OUTLIER 'General case' 0 C--O 1.237 0.435 0 O-C-N 124.632 1.207 . . . . 0.0 113.181 175.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 86.94 -54.97 4.62 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -173.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.47 ' HB2' ' O ' ' A' ' 157' ' ' HIS . 60.2 m80 -149.23 121.36 8.31 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 172.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 12.4 t60 -66.17 -0.6 2.59 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 123.325 0.391 . . . . 0.0 112.049 -173.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -137.89 21.94 2.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.608 0.242 . . . . 0.0 110.809 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.47 ' O ' ' HB2' ' A' ' 154' ' ' HIS . 5.4 t60 -168.81 98.12 0.38 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.812 0.339 . . . . 0.0 110.137 177.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -128.4 147.79 50.67 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.243 0.724 0 CA-C-O 118.659 -0.686 . . . . 0.0 109.602 177.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 120.679 0.276 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.4 p -91.29 173.68 7.79 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.738 0.304 . . . . 0.0 110.692 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.5 tt -80.69 88.84 5.74 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -103.61 69.65 0.29 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.613 -177.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -97.44 126.68 42.84 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 176.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.7 pt -94.9 -27.57 4.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.946 0.403 . . . . 0.0 110.431 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.56 HG11 HD12 ' A' ' 127' ' ' ILE . 15.0 t -94.3 155.07 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 174.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.3 mtt180 -125.47 165.41 18.49 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.838 -0.165 . . . . 0.0 110.594 -169.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.644 HG12 HD13 ' A' ' 130' ' ' LEU . 77.0 mt -67.81 118.43 11.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.854 0.359 . . . . 0.0 110.196 175.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.98 -7.58 62.75 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.893 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -86.37 153.24 22.07 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 -177.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.648 ' SD ' ' HG2' ' A' ' 126' ' ' LYS . 91.2 mmm -67.49 130.07 41.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.675 -178.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.3 129.93 70.59 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.664 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.402 ' HD2' ' CE1' ' A' ' 108' ' ' TYR . 31.4 Cg_exo -59.16 143.45 99.76 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.703 2.269 . . . . 0.0 111.329 174.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.96 162.55 14.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.243 -177.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.601 ' O ' ' HA ' ' A' ' 27' ' ' THR . 55.3 p90 -169.73 164.28 9.99 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.389 -173.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.9 m -123.0 100.7 7.02 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 176.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.2 tt -103.26 146.65 10.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.821 0.343 . . . . 0.0 111.159 -174.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.9 m -94.27 118.38 31.5 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.586 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.428 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 93.7 mt -81.52 169.7 16.79 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.696 -177.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 31.4 p -57.34 -26.58 61.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.219 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -83.31 -7.79 59.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.203 0.525 . . . . 0.0 110.432 -178.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.52 15.4 56.98 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.23 -175.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -90.67 116.69 28.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.384 -0.408 . . . . 0.0 110.47 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -89.62 113.11 24.52 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 174.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.81 128.59 71.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.572 0.701 . . . . 0.0 111.582 -174.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 17.9 m -94.2 137.97 32.76 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.518 175.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.549 HD22 ' HD3' ' A' ' 32' ' ' ARG . 0.6 OUTLIER -60.59 -33.27 72.48 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -177.075 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.443 ' HA ' ' CG ' ' A' ' 32' ' ' ARG . 37.6 t -56.88 -23.08 41.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.824 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.9 t -81.78 -8.81 59.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.972 0.415 . . . . 0.0 110.548 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 67.4 mt -119.57 -1.16 10.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.539 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.549 ' HD3' HD22 ' A' ' 28' ' ' LEU . 8.7 mmm-85 -66.79 103.09 1.04 Allowed 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.515 ' O ' ' HG3' ' A' ' 123' ' ' ARG . . . 139.42 -20.59 2.96 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 -172.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.525 ' HD2' ' HA ' ' A' ' 68' ' ' ASP . 37.1 mtmt -114.48 168.2 10.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.415 -0.393 . . . . 0.0 109.945 175.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 68' ' ' ASP . 34.2 m -80.1 122.52 35.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 174.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.5 t -122.93 113.93 40.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.108 0.48 . . . . 0.0 111.081 -174.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.53 ' SD ' HG23 ' A' ' 59' ' ' ILE . 26.9 ttt -97.19 126.55 42.45 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.447 177.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.511 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 7.3 mp -118.92 152.89 35.5 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.03 176.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.4 HE21 ' HA3' ' A' ' 73' ' ' GLY . 5.1 pp0? -139.29 145.93 39.73 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 169.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 89.3 m-85 -110.35 123.29 49.58 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 177.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.8 t -134.72 173.49 11.63 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.123 -174.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.496 ' HB2' ' SG ' ' A' ' 45' ' ' CYS . . . -149.93 160.02 43.92 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.476 -0.784 . . . . 0.0 108.933 175.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.573 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 28.8 t -70.74 -20.87 62.6 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -171.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 58.8 p-90 -97.11 3.12 51.83 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.855 0.316 . . . . 0.0 111.855 -177.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.496 ' SG ' ' HB2' ' A' ' 42' ' ' ALA . 84.0 m -87.86 108.18 19.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.155 0.502 . . . . 0.0 111.293 -178.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -79.01 -17.85 76.1 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.39 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.586 HG12 ' HB2' ' A' ' 133' ' ' LEU . 40.6 t -74.83 -45.97 42.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 177.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.433 ' SG ' HG22 ' A' ' 116' ' ' THR . 73.7 m -54.75 -32.59 60.08 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.819 177.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.495 ' HE ' ' HE1' ' A' ' 86' ' ' PHE . 98.0 mtt180 -65.5 -2.66 3.52 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.264 -0.426 . . . . 0.0 112.029 -178.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -96.81 -55.85 2.76 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.783 0.801 . . . . 0.0 109.734 173.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.662 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 5.1 pt-20 -71.45 -32.47 68.36 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.93 -175.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.462 ' HE1' HG22 ' A' ' 92' ' ' VAL . 63.9 mmm -52.09 -57.32 15.55 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 117.817 0.281 . . . . 0.0 111.605 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -64.27 -37.18 42.01 Favored 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 121.75 1.633 . . . . 0.0 112.447 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -62.31 -44.15 97.18 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.536 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.551 ' O ' ' HB ' ' A' ' 59' ' ' ILE . 94.0 mt -57.95 -53.53 44.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.675 178.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.549 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 14.9 pt-20 -64.95 -38.11 89.87 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.874 -176.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -63.06 -54.39 38.82 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -174.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.435 ' HA ' ' HZ1' ' A' ' 62' ' ' LYS . 27.8 m-20 -107.22 -18.12 13.97 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -172.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.551 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 2.2 mp -95.21 -55.3 6.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.971 176.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.549 ' HB3' ' HA ' ' A' ' 56' ' ' GLU . 75.0 t-105 -65.48 -70.69 0.22 Allowed 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.418 -177.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -54.05 -23.29 13.11 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -173.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.435 ' HZ1' ' HA ' ' A' ' 58' ' ' ASP . 36.7 mmtm -91.6 -37.4 13.1 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -177.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -118.9 -10.96 9.79 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -169.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.499 ' HG3' ' OD1' ' A' ' 65' ' ' ASP . 19.2 pttp -36.21 -54.13 0.81 Allowed 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -168.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.499 ' OD1' ' HG3' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -87.45 -77.99 0.32 Allowed 'General case' 0 C--O 1.254 1.311 0 CA-C-O 121.299 0.571 . . . . 0.0 109.583 -178.432 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 63.36 -74.83 0.04 OUTLIER 'General case' 0 C--N 1.34 0.153 0 CA-C-N 114.471 -1.24 . . . . 0.0 110.374 -174.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 159.26 -40.43 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -177.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.525 ' HA ' ' HD2' ' A' ' 34' ' ' LYS . 30.9 t70 -114.66 11.1 16.84 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 113.904 -1.498 . . . . 0.0 111.258 -175.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -106.36 142.9 35.26 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.128 -177.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.69 143.56 33.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.377 173.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.525 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 2.8 tt -142.53 118.67 10.73 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 3.0 mp -131.1 126.99 60.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.324 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.4 ' HA3' HE21 ' A' ' 39' ' ' GLN . . . -97.85 140.74 15.21 Favored Glycine 0 C--O 1.224 -0.529 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.353 176.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 62.0 mt -120.28 123.62 70.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 117.304 0.552 . . . . 0.0 111.396 -177.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.401 ' HB3' ' HB2' ' A' ' 78' ' ' GLU . 2.5 m-20 -88.1 122.02 31.19 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 172.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 59.7 ttp180 -50.61 -46.41 58.07 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -167.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.466 ' HA ' ' O ' ' A' ' 99' ' ' ASP . 7.8 p-10 -152.64 13.1 0.54 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.04 0.448 . . . . 0.0 111.134 -174.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.401 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 33.1 mm-40 -80.68 130.05 65.88 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.478 -177.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.456 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 36.7 Cg_endo -71.73 179.81 4.42 Favored 'Trans proline' 0 CA--C 1.531 0.341 0 C-N-CA 122.408 2.072 . . . . 0.0 112.687 174.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -50.69 -57.98 6.99 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.096 -171.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.462 ' OE1' ' HG2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -67.42 -30.79 70.64 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -172.427 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.462 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 41.7 mmtm -63.86 -52.66 58.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.753 0.311 . . . . 0.0 110.397 175.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 79' ' ' PRO . 88.0 t -54.21 -52.75 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.244 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.37 -38.83 92.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.35 -177.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.29 -42.13 79.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.673 0.273 . . . . 0.0 111.081 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.573 ' CD1' ' HA ' ' A' ' 43' ' ' SER . 86.8 t80 -64.83 -43.9 91.56 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 178.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.54 -54.31 48.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.189 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -65.65 -20.71 66.4 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -174.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.5 m -78.74 -24.3 44.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.741 0.305 . . . . 0.0 111.288 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.5 p -104.8 -22.11 13.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.083 0.468 . . . . 0.0 110.98 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 121.1 -79.32 0.33 Allowed Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -177.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.462 HG22 ' HE1' ' A' ' 52' ' ' MET . 54.1 t 46.45 86.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 124.463 1.105 . . . . 0.0 113.265 177.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.8 m -82.09 2.5 30.97 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.039 177.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.489 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 46.7 p90 -113.32 152.7 45.41 Favored Pre-proline 0 C--N 1.331 -0.235 0 O-C-N 122.203 -0.311 . . . . 0.0 110.759 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.13 133.81 29.82 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.484 2.123 . . . . 0.0 113.437 -176.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 94.1 mt -104.48 161.62 13.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.081 172.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -130.12 148.3 18.48 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.168 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.4 ' C ' ' HD3' ' A' ' 100' ' ' PRO . 5.4 mp -86.74 133.55 33.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.544 0.211 . . . . 0.0 110.54 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.466 ' O ' ' HA ' ' A' ' 77' ' ' ASP . 40.2 t0 -121.05 73.86 26.67 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-O 121.317 0.579 . . . . 0.0 109.86 169.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.4 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 22.1 Cg_exo -64.1 103.53 0.43 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.079 1.853 . . . . 0.0 112.237 -177.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 112.0 -0.18 27.05 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.483 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.428 ' HB3' ' HG2' ' A' ' 111' ' ' ARG . . . 59.02 40.64 22.01 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.092 0.472 . . . . 0.0 111.155 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -78.82 -48.76 14.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.557 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.445 HD13 ' HB2' ' A' ' 16' ' ' PHE . 34.4 mm -66.75 -37.39 79.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -59.51 -44.68 93.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.874 175.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -67.58 -21.23 65.44 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.813 -178.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -72.96 -17.69 61.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.798 0.332 . . . . 0.0 110.921 177.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.502 ' HB2' HH22 ' A' ' 117' ' ' ARG . 79.3 m-85 -111.88 -34.26 6.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.863 -178.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.566 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -161.13 172.93 15.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.768 0.318 . . . . 0.0 110.731 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.687 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 91.4 mt -71.97 131.38 42.86 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.091 178.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.428 ' HG2' ' HB3' ' A' ' 102' ' ' ALA . 11.4 mtm180 -65.4 -31.3 72.33 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.268 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -84.38 -7.36 59.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.748 -178.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.687 ' HB3' ' HB2' ' A' ' 110' ' ' LEU . . . -75.4 -56.77 4.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.718 -178.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -163.07 -149.12 5.6 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.96 -177.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.8 tp -161.35 -59.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.373 0.087 . . . . 0.0 111.125 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.66 HG21 ' HA ' ' A' ' 133' ' ' LEU . 24.0 m -67.61 109.08 3.12 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.861 0.362 . . . . 0.0 111.414 -176.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.502 HH22 ' HB2' ' A' ' 108' ' ' TYR . 19.3 ptt180 -165.97 146.44 6.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.166 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.603 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 45.9 m-80 -108.95 136.53 48.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.725 175.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 80.6 t -120.35 102.76 13.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.101 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.582 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 48.8 tp -88.75 108.14 19.33 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.707 -0.397 . . . . 0.0 109.996 178.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 56.6 mt -93.74 121.98 44.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.771 0.796 . . . . 0.0 110.523 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.69 162.66 29.2 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.485 -1.234 . . . . 0.0 111.341 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.515 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 33.8 ttm180 -52.0 -34.21 41.73 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.483 0.713 . . . . 0.0 112.742 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.525 ' HB2' ' CE1' ' A' ' 156' ' ' HIS . 11.8 tt0 -83.57 -7.59 59.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.33 0.586 . . . . 0.0 109.969 -175.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 96.54 31.36 7.15 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.468 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.648 ' HG2' ' SD ' ' A' ' 12' ' ' MET . 44.2 mttm -113.04 146.49 39.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.798 0.299 . . . . 0.0 110.314 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.56 HD12 HG11 ' A' ' 7' ' ' VAL . 55.7 mt -88.94 100.98 11.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.093 177.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 29.0 m -94.17 -4.54 10.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -174.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.582 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 51.8 tptt -143.95 108.76 4.92 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.687 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.644 HD13 HG12 ' A' ' 9' ' ' ILE . 10.9 mp -98.28 104.7 16.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.962 170.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.603 ' HB ' ' HB2' ' A' ' 118' ' ' ASN . 86.0 m -103.23 125.33 49.84 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.724 -0.217 . . . . 0.0 110.703 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.548 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -96.85 108.19 20.82 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 176.788 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.66 ' HA ' HG21 ' A' ' 116' ' ' THR . 4.6 pp 51.4 -177.65 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 O-C-N 124.503 1.127 . . . . 0.0 113.259 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.662 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 75.6 t80 -87.57 117.68 26.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.912 -177.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -135.89 137.69 41.67 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.949 172.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -47.79 -62.56 1.4 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -177.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -56.99 -46.75 82.01 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.316 0.579 . . . . 0.0 110.849 -178.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.44 ' HG3' HG21 ' A' ' 131' ' ' THR . 7.0 tp10 -61.72 -48.59 80.06 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.187 -177.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.464 ' O ' HG22 ' A' ' 143' ' ' VAL . 69.2 t80 -67.38 -39.16 85.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.048 -178.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.79 -43.52 97.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.662 175.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 45.8 m -63.04 -38.1 89.82 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.547 177.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.54 ' O ' HG13 ' A' ' 146' ' ' ILE . 67.7 tp -59.75 -51.61 69.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.154 177.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.475 HG21 HD12 ' A' ' 59' ' ' ILE . 61.3 t -60.19 -45.81 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.222 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -57.72 -45.05 86.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.722 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.549 ' O ' ' HG2' ' A' ' 149' ' ' MET . 9.9 tt0 -67.01 -37.34 83.98 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.391 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.54 HG13 ' O ' ' A' ' 142' ' ' LEU . 34.7 mt -59.61 -38.16 74.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.895 0.378 . . . . 0.0 109.999 175.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.566 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 87.9 m-20 -59.63 -41.03 89.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.803 177.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -66.05 -36.98 84.7 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.328 0.392 . . . . 0.0 110.856 174.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.549 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 94.7 mmm -62.93 -32.1 73.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.525 0.679 . . . . 0.0 109.429 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.519 HD21 ' O ' ' A' ' 146' ' ' ILE . 3.9 mm? -82.17 -5.83 58.76 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.746 176.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.577 ' HA ' ' HE3' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -102.22 -17.69 15.84 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 173.834 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.522 ' HA ' ' OE1' ' A' ' 152' ' ' GLU . 10.6 tp10 -51.13 108.53 0.25 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-O 122.832 1.301 . . . . 0.0 113.638 -171.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -163.69 29.94 0.25 Allowed Glycine 0 N--CA 1.437 -1.266 0 CA-C-N 112.369 -2.196 . . . . 0.0 107.709 170.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -158.85 -26.09 0.07 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 114.47 -0.865 . . . . 0.0 111.86 -168.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -83.38 -35.23 25.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.16 -169.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.525 ' CE1' ' HB2' ' A' ' 124' ' ' GLU . 19.2 m-70 -80.12 79.65 6.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.363 0.602 . . . . 0.0 111.49 178.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -99.35 99.98 10.99 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.753 175.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 59.9 m170 -75.22 -13.02 60.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.162 0.506 . . . . 0.0 109.991 177.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 . . . . . 0 C--O 1.244 0.804 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.002 176.928 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.7 ttp . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.635 0.255 . . . . 0.0 110.342 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.5 m -115.8 132.1 56.74 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.092 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 71.0 mt -141.31 162.02 36.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.221 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -100.22 88.37 0.77 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.835 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.521 ' CZ ' ' HD2' ' A' ' 117' ' ' ARG . 69.0 m-85 -147.01 135.42 21.83 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 175.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.2 pt -110.23 -7.79 11.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.168 0.509 . . . . 0.0 110.144 171.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.5 m -101.47 168.8 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.733 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.577 ' HB2' ' HB2' ' A' ' 11' ' ' GLU . 38.4 mtt180 -114.83 163.25 15.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.197 -177.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.757 HG12 HD13 ' A' ' 130' ' ' LEU . 73.3 mt -79.5 121.23 32.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 174.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.48 1.34 62.31 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -175.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.577 ' HB2' ' HB2' ' A' ' 8' ' ' ARG . 10.4 tp10 -83.42 155.83 23.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.36 -0.42 . . . . 0.0 110.551 -176.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.547 ' HA ' ' HE1' ' A' ' 12' ' ' MET . 4.9 mmt -65.76 127.74 33.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.452 177.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.412 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -67.48 129.94 93.45 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.663 178.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.448 ' HD2' ' CZ ' ' A' ' 108' ' ' TYR . 15.3 Cg_exo -65.98 113.54 2.63 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.668 2.245 . . . . 0.0 111.2 178.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.68 147.19 50.92 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.604 -175.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.466 ' HE2' ' HH ' ' A' ' 108' ' ' TYR . 44.7 p90 -155.7 164.33 38.73 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.376 -176.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.8 m -116.68 102.8 9.76 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 174.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 25' ' ' GLN . 13.1 tt -97.87 138.72 21.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.937 0.399 . . . . 0.0 111.023 -174.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.2 m -94.15 118.91 32.23 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.071 177.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.459 HD13 ' HB2' ' A' ' 24' ' ' LYS . 94.3 mt -74.54 175.99 7.28 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.944 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.457 HG21 ' O ' ' A' ' 96' ' ' LEU . 31.8 p -57.88 -32.2 67.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.623 -175.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -102.13 16.97 24.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.956 0.408 . . . . 0.0 111.123 -176.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.43 7.36 69.55 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.404 173.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.459 ' HB2' HD13 ' A' ' 20' ' ' LEU . 27.3 mmtp -78.76 110.01 13.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.882 0.373 . . . . 0.0 110.72 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.481 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 94.1 mt-30 -92.0 114.48 27.03 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.481 178.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.5 m -118.03 151.5 20.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.477 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.415 ' HB ' ' OG ' ' A' ' 29' ' ' SER . 1.2 p -101.91 154.2 19.16 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.879 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.8 -34.77 77.43 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 174.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.484 ' HA ' ' HG2' ' A' ' 32' ' ' ARG . 0.5 OUTLIER -59.69 -23.7 63.34 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.676 175.516 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.8 t -78.73 -12.36 60.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.041 0.448 . . . . 0.0 110.408 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 83.0 mt -112.73 -0.82 14.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.931 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.516 ' NE ' ' HA3' ' A' ' 125' ' ' GLY . 40.5 mmm-85 -66.19 102.41 0.83 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.079 0.466 . . . . 0.0 109.76 178.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 143.64 -23.47 2.16 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -174.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.405 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 43.9 mtmt -117.08 160.07 21.57 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 174.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.527 HG22 ' O ' ' A' ' 68' ' ' ASP . 10.6 m -70.45 128.38 33.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 175.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.57 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 40.6 t -111.69 114.73 47.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 120.832 0.349 . . . . 0.0 111.153 -174.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.473 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 27.0 ttt -97.15 120.6 37.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.004 0.43 . . . . 0.0 110.067 174.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.493 HD22 HD13 ' A' ' 74' ' ' ILE . 88.3 mt -112.38 123.43 50.26 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.678 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -113.11 111.05 21.45 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.13 177.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.492 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 96.8 m-85 -88.64 115.82 26.44 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.7 t -132.7 -172.85 3.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.172 -171.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.558 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . . . -172.16 143.23 1.48 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.76 ' H ' ' HG3' ' A' ' 78' ' ' GLU . 54.7 p -70.72 -15.68 62.72 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.776 -172.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.415 ' HD1' ' OE2' ' A' ' 78' ' ' GLU . 66.6 p-90 -87.28 -0.65 57.06 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.097 0.475 . . . . 0.0 110.915 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.563 ' SG ' HG12 ' A' ' 115' ' ' ILE . 74.5 m -93.12 112.57 24.55 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.996 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -75.95 -34.29 48.09 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.63 178.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 56.2 t -61.42 -45.02 99.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.677 0.238 . . . . 0.0 110.833 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.682 ' HA ' ' CD ' ' A' ' 51' ' ' GLU . 12.5 t -61.85 -15.78 44.9 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 121.421 0.629 . . . . 0.0 111.456 -174.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -72.52 -1.91 17.7 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.862 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.474 ' HE2' ' CD2' ' A' ' 134' ' ' TYR . 56.4 mtpt -90.16 -56.87 3.05 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.214 172.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.779 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 3.8 pm0 -64.34 -30.95 71.98 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.565 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.599 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 5.9 mmt -52.29 -63.61 2.08 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.629 178.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.599 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 52.6 Cg_exo -56.63 -39.47 91.15 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 122.171 1.914 . . . . 0.0 112.912 175.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.407 ' HD1' ' O ' ' A' ' 50' ' ' LYS . 21.3 m-85 -66.99 -45.69 76.85 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 93.9 mt -61.93 -42.77 96.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.78 0.324 . . . . 0.0 110.146 177.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.473 ' OE1' ' HA ' ' A' ' 92' ' ' VAL . 26.0 tp10 -57.11 -52.36 65.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.602 178.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.487 ' HA ' HD23 ' A' ' 61' ' ' LEU . 27.6 ttpp -72.66 -54.06 10.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.522 -175.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -87.13 -26.74 23.47 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -168.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.7 mt -105.64 -61.72 2.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.817 -177.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.565 ' CD2' ' HB3' ' A' ' 94' ' ' TYR . 76.7 t-105 -61.22 -64.46 0.94 Allowed 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.499 -173.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.487 HD23 ' HA ' ' A' ' 57' ' ' LYS . 1.5 mp -47.78 -32.5 6.05 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -175.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -71.51 -38.3 71.15 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -176.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.642 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 87.2 m-70 -126.18 -43.78 1.78 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.897 -174.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.7 mttp 59.01 -82.22 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.655 0.782 . . . . 0.0 111.014 -175.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -110.8 -42.32 4.05 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 171.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.642 ' HB2' ' HB3' ' A' ' 63' ' ' HIS . 3.5 t30 71.03 -68.18 0.23 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.011 175.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 66' ' ' ASN . . . 162.93 -27.02 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 124.327 1.051 . . . . 0.0 108.759 -175.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.527 ' O ' HG22 ' A' ' 35' ' ' VAL . 25.5 t0 -140.74 26.74 2.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.614 -174.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.509 ' HB2' HD13 ' A' ' 150' ' ' LEU . 87.8 t80 -135.17 144.41 47.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.824 -177.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.67 138.02 28.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.963 173.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.473 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 1.8 tt -138.51 115.37 10.78 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -178.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.4 mp -126.79 130.69 71.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.141 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.435 ' HA3' HD22 ' A' ' 96' ' ' LEU . . . -92.69 117.22 5.3 Favored Glycine 0 C--O 1.221 -0.681 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.531 177.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.493 HD13 HD22 ' A' ' 38' ' ' LEU . 41.7 mt -104.44 118.62 52.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.938 0.369 . . . . 0.0 110.556 -175.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.558 ' OD2' ' HA ' ' A' ' 42' ' ' ALA . 9.7 t70 -84.52 142.55 29.95 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 176.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.1 ttp180 -80.03 -40.83 26.97 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -172.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -155.16 5.88 0.23 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -168.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.76 ' HG3' ' H ' ' A' ' 43' ' ' SER . 13.4 mm-40 -88.52 133.33 36.53 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 120.908 0.385 . . . . 0.0 110.373 177.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.456 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 29.3 Cg_endo -68.17 -173.11 0.48 Allowed 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 122.875 2.383 . . . . 0.0 113.63 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.434 ' O ' HD21 ' A' ' 84' ' ' LEU . 3.1 tm? -59.07 -55.82 30.15 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.084 -169.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.456 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -66.01 -34.13 77.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.497 0.189 . . . . 0.0 111.501 -173.832 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.416 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 2.7 mmmp? -60.24 -50.1 74.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.019 177.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 66.1 t -62.55 -44.85 99.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.921 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.434 HD21 ' O ' ' A' ' 80' ' ' LEU . 4.2 mm? -61.03 -47.37 86.75 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.831 0.348 . . . . 0.0 111.579 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.96 -30.93 68.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.232 -178.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -73.2 -47.75 40.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.553 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.513 ' HB1' HD13 ' A' ' 96' ' ' LEU . . . -52.34 -55.16 23.39 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.142 -177.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.82 -11.29 60.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.658 -174.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.6 m -94.81 -22.08 18.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.011 178.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.7 p -91.49 -4.51 55.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.594 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.66 0.91 90.42 Favored Glycine 0 C--O 1.228 -0.229 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.356 178.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.476 HG11 ' CE1' ' A' ' 94' ' ' TYR . 72.5 t -66.7 123.08 18.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 122.798 0.439 . . . . 0.0 111.386 -179.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.3 p -101.63 -18.83 15.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.652 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.565 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 52.7 p90 -77.52 141.76 65.79 Favored Pre-proline 0 N--CA 1.454 -0.26 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.513 177.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.423 ' HB2' HD23 ' A' ' 20' ' ' LEU . 18.5 Cg_endo -60.06 131.88 41.53 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 122.688 2.259 . . . . 0.0 113.409 -175.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.513 HD13 ' HB1' ' A' ' 87' ' ' ALA . 66.5 mt -102.39 147.49 26.64 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.002 173.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.46 ' HA3' HD12 ' A' ' 18' ' ' ILE . . . -122.3 143.84 15.76 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 177.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.716 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.0 OUTLIER -98.15 132.34 43.76 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.788 0.328 . . . . 0.0 110.551 -177.995 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' A' ' 75' ' ' ASP . 14.2 t0 -115.23 74.79 4.07 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.521 176.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.467 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 23.5 Cg_exo -63.17 104.7 0.42 Allowed 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.573 2.182 . . . . 0.0 112.364 -176.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 115.36 -4.54 21.72 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.772 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 57.52 47.42 16.2 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 122.731 0.412 . . . . 0.0 111.476 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.408 ' HA ' HH21 ' A' ' 111' ' ' ARG . 15.0 t70 -80.59 -50.62 9.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.98 0.419 . . . . 0.0 110.173 178.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 96.9 mt -61.93 -40.09 85.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 176.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -62.5 -40.39 96.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.541 176.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -67.4 -23.65 65.59 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.223 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -73.25 -13.5 61.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.257 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.466 ' HH ' ' HE2' ' A' ' 16' ' ' PHE . 45.3 m-85 -113.49 -34.38 5.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.832 0.349 . . . . 0.0 111.563 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -158.92 168.28 27.2 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.899 0.38 . . . . 0.0 111.209 -177.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.49 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 90.1 mt -67.29 138.63 56.98 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 175.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.408 HH21 ' HA ' ' A' ' 103' ' ' ASP . 94.5 mtt180 -63.16 -27.04 69.1 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.577 -174.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -92.82 -16.75 24.95 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.315 -178.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.49 ' HB3' ' HB2' ' A' ' 110' ' ' LEU . . . -80.85 47.92 1.03 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -172.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.58 143.14 9.74 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.328 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.563 HG12 ' SG ' ' A' ' 45' ' ' CYS . 1.8 tp -87.41 -64.07 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -176.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.5 m -64.78 128.03 34.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.857 0.361 . . . . 0.0 111.315 -173.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.521 ' HD2' ' CZ ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -145.43 132.13 19.97 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.432 178.28 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.642 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 3.8 m-20 -107.91 117.66 34.7 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 176.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 38' ' ' LEU . 73.2 t -120.57 118.97 58.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.426 -177.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.873 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 25.4 tp -109.77 120.13 41.53 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.261 0.553 . . . . 0.0 110.486 176.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.57 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 74.2 mt -104.23 142.02 18.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.948 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.86 172.25 13.75 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.569 ' NH2' ' HG3' ' A' ' 152' ' ' GLU . 26.8 ptt180 -78.01 20.96 0.34 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -175.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -110.88 -35.72 5.88 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 169.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.516 ' HA3' ' NE ' ' A' ' 32' ' ' ARG . . . 122.51 20.54 2.9 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.667 -172.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 29.3 mtmm -103.42 135.71 44.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.621 0.248 . . . . 0.0 110.493 177.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 56.4 mt -78.62 101.74 4.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 177.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.4 m -100.61 -21.63 5.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -170.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.873 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 61.0 tptt -132.03 117.05 17.87 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.131 0.491 . . . . 0.0 111.439 -176.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.757 HD13 HG12 ' A' ' 9' ' ' ILE . 10.3 mp -104.24 104.86 14.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.739 176.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.642 ' HB ' ' HB2' ' A' ' 118' ' ' ASN . 54.6 m -109.45 132.34 54.22 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.111 0.481 . . . . 0.0 110.746 -178.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.458 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 0.1 OUTLIER -91.92 107.9 19.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.825 -177.819 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 132' ' ' ARG . 0.6 OUTLIER 43.9 -160.89 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.28 0.987 . . . . 0.0 112.359 -179.008 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.779 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 94.4 t80 -85.39 84.9 7.5 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.643 0.735 . . . . 0.0 111.283 176.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.485 ' HB3' ' HB3' ' A' ' 138' ' ' GLU . 27.0 t-20 -89.09 120.07 30.16 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 165.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.404 ' HG2' ' CE2' ' A' ' 134' ' ' TYR . 46.4 mt-10 -56.38 -48.22 77.32 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -170.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.2 mp0 -68.04 -40.5 82.86 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.047 0.451 . . . . 0.0 110.511 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.485 ' HB3' ' HB3' ' A' ' 135' ' ' ASN . 8.5 tp10 -64.7 -41.05 96.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.374 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.42 ' O ' HG21 ' A' ' 143' ' ' VAL . 86.8 t80 -64.16 -40.39 96.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.381 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -59.12 -47.92 83.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.285 177.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 21.2 m -62.88 -39.87 95.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.636 176.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.459 ' O ' HG13 ' A' ' 146' ' ' ILE . 49.8 tp -60.9 -49.34 77.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.174 -178.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 139' ' ' PHE . 95.1 t -59.38 -47.96 88.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.827 0.346 . . . . 0.0 110.77 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.67 -43.1 98.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.956 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.504 ' O ' ' HG2' ' A' ' 149' ' ' MET . 7.8 tt0 -59.97 -46.99 87.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.53 177.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.483 ' O ' HD21 ' A' ' 150' ' ' LEU . 81.2 mt -56.41 -47.71 81.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.721 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -55.15 -44.76 75.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.859 176.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -76.55 -10.79 59.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.771 0.32 . . . . 0.0 111.443 -178.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.504 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 88.3 mmm -78.39 -38.96 40.46 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 171.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.509 HD13 ' HB2' ' A' ' 69' ' ' PHE . 4.4 mm? -72.11 -38.38 69.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.9 -1.046 . . . . 0.0 110.294 176.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.452 ' HE2' ' HB3' ' A' ' 151' ' ' LYS . 13.5 mmmm -84.21 -33.5 24.12 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.314 -178.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.569 ' HG3' ' NH2' ' A' ' 123' ' ' ARG . 2.1 mm-40 53.15 89.81 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.536 -177.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -105.25 14.01 47.96 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.561 176.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -87.36 -41.24 13.76 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -177.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 48.0 m80 69.38 -74.44 0.08 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.372 172.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -148.32 92.95 2.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.401 0.62 . . . . 0.0 111.866 -176.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 39.2 t60 -107.01 108.29 19.73 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 174.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -62.83 132.75 53.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.934 0.397 . . . . 0.0 111.21 -178.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 . . . . . 0 C--O 1.243 0.712 0 CA-C-O 118.194 -0.908 . . . . 0.0 108.958 170.507 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.552 ' HE2' ' HB2' ' A' ' 3' ' ' LEU . 22.3 ptm . . . . . 0 N--CA 1.48 1.025 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.9 t -81.46 -26.87 34.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.199 0.523 . . . . 0.0 110.887 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.552 ' HB2' ' HE2' ' A' ' 1' ' ' MET . 3.7 mm? -95.21 172.53 8.06 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.475 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 148.87 44.62 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.816 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -88.49 134.12 33.94 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.6 pt -96.42 -15.63 7.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.771 0.32 . . . . 0.0 110.677 173.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.2 m -94.11 152.14 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.825 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.519 ' HB2' ' HB2' ' A' ' 11' ' ' GLU . 42.2 mtt85 -103.27 163.5 12.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.84 -177.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.464 HG12 HD11 ' A' ' 130' ' ' LEU . 72.5 mt -82.13 126.43 39.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 172.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.73 -10.7 64.56 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -173.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 8' ' ' ARG . 0.4 OUTLIER -77.04 150.1 35.78 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.163 -0.519 . . . . 0.0 109.809 -179.221 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.729 ' HG2' ' HG2' ' A' ' 126' ' ' LYS . 24.7 mtp -78.88 120.92 24.18 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.435 ' HA ' ' HD2' ' A' ' 14' ' ' PRO . . . -56.87 125.24 68.4 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.9 -175.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 13' ' ' ALA . 10.0 Cg_endo -54.17 115.95 2.72 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.215 2.61 . . . . 0.0 111.736 177.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.506 ' HA ' HD12 ' A' ' 28' ' ' LEU . 1.2 t70 -68.32 138.2 55.26 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.541 -174.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.574 ' HE2' ' HH ' ' A' ' 108' ' ' TYR . 36.2 p90 -146.48 161.65 39.99 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.699 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 30.6 m -123.25 112.9 18.2 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 175.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.2 tt -117.63 144.51 25.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.017 0.437 . . . . 0.0 110.934 -175.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.0 m -84.59 127.19 33.93 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.406 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.3 mt -81.55 176.94 9.24 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.972 0.415 . . . . 0.0 110.906 177.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.3 p -56.16 -34.89 66.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.881 -176.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -103.14 21.06 16.48 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.091 0.472 . . . . 0.0 110.71 -175.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.63 36.22 34.03 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.754 174.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -104.11 122.9 46.26 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.846 0.355 . . . . 0.0 110.649 177.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -88.48 115.91 26.34 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.956 177.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 17' ' ' THR . 14.3 m -114.91 143.77 23.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.017 0.437 . . . . 0.0 110.263 178.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 12.0 m -120.81 144.65 48.22 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.565 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.506 HD12 ' HA ' ' A' ' 15' ' ' ASP . 15.9 mt -61.7 -34.21 75.37 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.941 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.421 ' HA ' ' HG2' ' A' ' 32' ' ' ARG . 49.9 m -54.47 -38.21 66.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.927 0.394 . . . . 0.0 110.845 175.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.3 m -73.08 -23.23 60.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.24 0.543 . . . . 0.0 110.926 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 31' ' ' LEU . 66.6 mt -99.54 0.44 42.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.431 ' HG2' ' O ' ' A' ' 28' ' ' LEU . 38.1 mmt180 -62.37 147.47 48.3 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 175.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 102.89 -26.53 23.72 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.771 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.567 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 3.2 mppt? -110.47 165.26 11.94 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 68' ' ' ASP . 2.7 p -83.01 120.27 34.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 173.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.438 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 17.3 t -108.6 131.94 57.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.79 -172.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 26.3 ttt -113.15 117.77 32.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.812 0.339 . . . . 0.0 110.471 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -109.08 112.7 25.02 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.336 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.501 HE22 ' HB ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -107.18 125.72 51.47 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 174.142 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.474 ' O ' ' HA ' ' A' ' 116' ' ' THR . 96.8 m-85 -94.29 114.59 26.69 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.242 0.544 . . . . 0.0 109.558 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.501 ' HB ' HE22 ' A' ' 39' ' ' GLN . 14.5 t -116.9 174.47 6.08 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.039 -173.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -150.6 131.28 14.0 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.597 177.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.67 ' HB2' ' HG3' ' A' ' 78' ' ' GLU . 43.9 m -65.27 -9.48 24.34 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.794 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 26.8 p-90 -110.0 11.39 24.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.837 0.351 . . . . 0.0 111.316 177.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 51.2 t -106.5 115.32 29.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.188 0.518 . . . . 0.0 111.033 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -77.75 -3.16 83.31 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.73 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.4 t -82.53 -37.98 14.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.131 0.491 . . . . 0.0 109.748 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 81.9 m -61.96 -27.79 69.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.134 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -71.51 -3.55 21.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.531 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.418 ' O ' ' HD1' ' A' ' 54' ' ' PHE . 58.2 mttp -104.03 -46.69 4.39 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 170.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.434 ' OE1' ' HA ' ' A' ' 133' ' ' LEU . 29.5 tt0 -58.19 -57.06 14.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.406 -177.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.66 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 80.1 mtp -58.51 -53.0 70.61 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.721 -172.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.66 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 50.3 Cg_exo -56.83 -40.39 84.56 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 122.101 1.868 . . . . 0.0 112.655 176.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.418 ' HD1' ' O ' ' A' ' 50' ' ' LYS . 17.1 m-85 -67.76 -44.03 78.43 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.789 177.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.435 ' O ' ' HB ' ' A' ' 59' ' ' ILE . 37.5 mt -54.5 -54.05 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.898 177.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.581 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 16.8 pt-20 -64.83 -41.49 95.71 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.579 -176.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -58.29 -49.13 78.24 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -175.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.752 ' HA ' ' HZ1' ' A' ' 62' ' ' LYS . 77.8 m-20 -106.08 -18.09 14.13 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -172.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.435 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 67.2 mt -102.75 -60.56 2.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.79 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.614 ' CE2' ' HG2' ' A' ' 64' ' ' LYS . 70.6 t-105 -65.73 -54.06 32.42 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -175.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.568 ' HA ' ' HE3' ' A' ' 64' ' ' LYS . 3.2 mm? -54.17 -29.67 46.53 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -176.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.752 ' HZ1' ' HA ' ' A' ' 58' ' ' ASP . 34.2 mmtm -88.05 -29.97 20.28 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.923 0.392 . . . . 0.0 111.219 -176.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -122.73 23.54 9.45 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -168.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.614 ' HG2' ' CE2' ' A' ' 60' ' ' TRP . 6.2 mtmp? -41.99 96.58 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.4 t70 68.25 -54.14 0.53 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 111.611 -2.54 . . . . 0.0 111.009 178.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.2 t30 50.97 11.38 0.09 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.662 -179.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 60.1 13.64 3.94 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.115 0.566 . . . . 0.0 111.758 -173.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.55 ' HA ' ' HG3' ' A' ' 34' ' ' LYS . 44.7 t0 -153.71 6.0 0.32 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.966 0.412 . . . . 0.0 111.642 -176.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.526 ' HB2' HD13 ' A' ' 150' ' ' LEU . 84.2 t80 -136.72 119.61 16.33 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 121.668 -0.645 . . . . 0.0 110.687 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -116.37 108.24 15.81 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.892 -177.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.437 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 2.6 tt -106.73 121.1 43.69 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -178.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 40.2 mm -130.33 126.62 61.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.154 178.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.449 ' HA2' ' HG3' ' A' ' 39' ' ' GLN . . . -97.91 130.21 10.16 Favored Glycine 0 C--O 1.221 -0.686 0 C-N-CA 120.228 -0.986 . . . . 0.0 111.443 176.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 72.5 mt -119.31 125.31 74.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 117.55 0.675 . . . . 0.0 111.415 -174.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -86.3 142.41 28.54 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 174.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -74.47 -30.83 62.01 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -172.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -161.14 -22.2 0.05 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -170.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.67 ' HG3' ' HB2' ' A' ' 43' ' ' SER . 4.5 mm-40 -72.91 129.5 86.49 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-O 121.218 0.532 . . . . 0.0 111.01 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.605 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 28.1 Cg_endo -66.62 -167.05 0.12 Allowed 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.713 2.942 . . . . 0.0 115.017 -175.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.41 HD13 HD21 ' A' ' 84' ' ' LEU . 2.8 tm? -58.14 -53.51 57.41 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 114.532 -1.213 . . . . 0.0 112.329 -170.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.605 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -63.15 -29.71 71.01 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 -173.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.519 ' HG3' ' CD ' ' A' ' 78' ' ' GLU . 30.7 mmtm -66.72 -54.36 23.75 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.95 177.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.498 HG21 ' HB3' ' A' ' 98' ' ' LEU . 41.2 t -55.33 -43.97 73.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.34 -177.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.41 HD21 HD13 ' A' ' 80' ' ' LEU . 4.4 mm? -69.28 -27.28 65.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.796 0.331 . . . . 0.0 111.608 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.74 ' HA ' ' HE2' ' A' ' 88' ' ' LYS . . . -85.96 -37.65 18.81 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.272 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.535 ' HE2' ' SD ' ' A' ' 52' ' ' MET . 49.0 t80 -68.67 -42.53 77.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.809 -178.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.444 ' HB3' HD12 ' A' ' 96' ' ' LEU . . . -56.3 -53.39 57.78 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.097 178.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.74 ' HE2' ' HA ' ' A' ' 85' ' ' ALA . 63.4 pttt -65.92 -20.89 66.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.966 0.412 . . . . 0.0 111.4 -176.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.8 m -82.36 -3.53 55.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.266 178.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.459 ' HB ' ' HG3' ' A' ' 53' ' ' PRO . 15.8 p -127.1 -24.91 3.35 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.997 0.427 . . . . 0.0 111.153 177.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 122.56 -79.25 0.34 Allowed Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 -176.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.511 HG21 ' HE2' ' A' ' 52' ' ' MET . 90.6 t 45.37 89.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 124.526 1.13 . . . . 0.0 113.495 176.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.5 p -87.24 12.42 11.83 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.637 176.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.426 ' CE1' ' HB3' ' A' ' 56' ' ' GLU . 51.1 p90 -123.17 154.1 64.98 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.304 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -67.55 140.59 52.55 Favored 'Trans proline' 0 C--O 1.238 0.499 0 C-N-CA 122.201 1.934 . . . . 0.0 113.731 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.444 HD12 ' HB3' ' A' ' 87' ' ' ALA . 93.0 mt -113.95 151.43 32.31 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.661 175.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -122.53 149.82 16.94 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 175.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.662 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.0 OUTLIER -106.34 126.69 52.55 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.763 0.316 . . . . 0.0 110.827 -177.185 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -115.65 78.95 7.11 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.07 177.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.05 99.82 0.92 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.388 2.059 . . . . 0.0 112.744 -176.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 125.56 -7.05 7.95 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.899 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 63.19 44.29 5.8 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 122.853 0.461 . . . . 0.0 111.102 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -81.88 -50.91 8.64 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.196 0.522 . . . . 0.0 110.306 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.491 HD11 ' HB2' ' A' ' 16' ' ' PHE . 29.8 mm -65.23 -36.02 76.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.478 ' CD2' ' HA ' ' A' ' 111' ' ' ARG . 70.8 t80 -63.29 -42.96 99.13 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.207 175.019 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.601 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -67.45 -21.88 65.52 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.79 -178.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -72.63 -12.32 61.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.834 0.35 . . . . 0.0 111.16 178.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.574 ' HH ' ' HE2' ' A' ' 16' ' ' PHE . 54.9 m-85 -116.23 -42.8 3.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.08 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.601 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -146.37 161.4 40.44 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.221 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.59 ' HB2' ' HB1' ' A' ' 113' ' ' ALA . 97.9 mt -62.26 129.92 42.96 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.478 ' HA ' ' CD2' ' A' ' 105' ' ' PHE . 21.5 mtm180 -50.43 -43.61 55.0 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.295 0.569 . . . . 0.0 111.258 -175.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -101.47 17.64 22.21 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.705 -170.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.59 ' HB1' ' HB2' ' A' ' 110' ' ' LEU . . . -97.7 15.1 24.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.237 177.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 131.17 -179.04 17.34 Favored Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -178.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.41 HG21 ' H ' ' A' ' 116' ' ' THR . 1.0 OUTLIER -125.88 -73.2 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 117.525 0.662 . . . . 0.0 112.751 -179.689 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.692 ' HB ' ' HB3' ' A' ' 133' ' ' LEU . 5.1 m -73.68 117.42 15.42 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.092 0.472 . . . . 0.0 111.985 -167.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 75.5 mtt-85 -143.04 154.44 43.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.169 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.466 ' HB2' HG23 ' A' ' 131' ' ' THR . 0.9 OUTLIER -121.79 119.78 32.69 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 174.132 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.4 t -116.02 123.58 71.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.146 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.528 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 25.8 tp -107.65 121.84 45.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.027 0.442 . . . . 0.0 110.704 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.438 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 62.5 mt -102.77 132.5 48.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.077 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.464 ' OD2' ' HB2' ' A' ' 124' ' ' GLU . 18.4 t70 -79.43 164.96 23.56 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.679 178.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.467 ' HB3' HH11 ' A' ' 123' ' ' ARG . 0.0 OUTLIER -57.33 -29.55 64.05 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.552 179.34 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.531 ' HB3' ' NZ ' ' A' ' 126' ' ' LYS . 18.0 mm-40 -75.4 7.05 3.86 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.0 0.429 . . . . 0.0 111.096 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 76.15 14.13 82.58 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.168 176.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.729 ' HG2' ' HG2' ' A' ' 12' ' ' MET . 25.0 mtmm -113.68 139.19 49.27 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.831 0.348 . . . . 0.0 110.926 -175.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.3 mt -76.14 130.63 36.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.781 -175.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 31.0 m -116.07 -21.0 5.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -176.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.528 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 53.1 tptt -135.5 116.44 14.18 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.552 -0.459 . . . . 0.0 112.092 -174.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.464 HD11 HG12 ' A' ' 9' ' ' ILE . 10.6 mp -109.09 119.34 39.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.332 172.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.519 HG21 HD11 ' A' ' 142' ' ' LEU . 14.7 t -147.15 162.91 37.9 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.98 178.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.436 ' C ' ' HG ' ' A' ' 133' ' ' LEU . 37.2 mtm180 -115.83 116.91 28.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.112 -173.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.692 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 3.9 pp 48.62 -169.09 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 O-C-N 124.67 1.231 . . . . 0.0 114.001 174.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.431 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 60.9 t80 -80.59 114.74 19.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.449 -178.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.539 ' HB3' ' HB2' ' A' ' 138' ' ' GLU . 3.0 t-20 -130.87 133.78 46.2 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.948 -1.023 . . . . 0.0 108.429 173.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -44.87 -61.26 1.67 Allowed 'General case' 0 C--O 1.236 0.367 0 O-C-N 123.441 0.463 . . . . 0.0 112.189 -178.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -60.74 -50.71 72.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.822 0.344 . . . . 0.0 111.317 -177.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 135' ' ' ASN . 4.0 mm-40 -63.13 -39.49 94.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.981 -177.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -66.08 -41.45 90.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.807 0.337 . . . . 0.0 110.102 177.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.82 -42.02 98.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.157 176.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.4 m -67.31 -35.21 78.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.239 177.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.519 HD11 HG21 ' A' ' 131' ' ' THR . 24.7 mt -66.67 -53.4 34.29 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.836 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.6 p -60.69 -42.17 90.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.025 -175.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -67.29 -41.52 85.3 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.812 0.339 . . . . 0.0 110.547 177.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.519 ' O ' ' HG2' ' A' ' 149' ' ' MET . 8.6 tt0 -58.5 -51.39 70.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.657 176.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.592 ' O ' HD23 ' A' ' 150' ' ' LEU . 99.0 mt -62.48 -40.51 88.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.85 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -54.35 -37.47 64.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.25 177.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.51 ' HA ' ' HG2' ' A' ' 151' ' ' LYS . 1.3 tp10 -88.14 -26.62 22.36 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.625 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.519 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 97.5 mmm -63.8 -26.25 68.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.408 0.623 . . . . 0.0 109.704 175.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.592 HD23 ' O ' ' A' ' 146' ' ' ILE . 3.9 mm? -81.45 -7.61 59.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.072 177.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.51 ' HG2' ' HA ' ' A' ' 148' ' ' GLU . 18.8 mmtm -96.93 -67.2 0.86 Allowed 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 174.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.46 ' CD ' ' HD1' ' A' ' 154' ' ' HIS . 2.1 tt0 46.92 -90.74 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.545 -175.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -177.68 -29.1 0.04 OUTLIER Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.304 178.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.46 ' HD1' ' CD ' ' A' ' 152' ' ' GLU . 49.8 m80 -77.44 0.15 23.7 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -173.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -77.29 83.9 3.74 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 122.243 1.02 . . . . 0.0 110.886 -177.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -138.99 167.08 22.84 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.47 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 12.1 t60 -147.82 88.22 1.67 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 171.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 39.9 t60 -148.91 104.7 3.47 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.93 178.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 . . . . . 0 C--O 1.246 0.909 0 CA-C-O 118.205 -0.902 . . . . 0.0 109.349 179.324 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 mpp? . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.8 t 67.97 174.78 0.27 Allowed 'General case' 0 CA--C 1.532 0.27 0 O-C-N 123.971 0.794 . . . . 0.0 110.633 -177.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.419 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 21.1 tp -131.21 22.21 4.83 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.434 ' O ' ' HB3' ' A' ' 109' ' ' ALA . . . 102.1 8.15 45.26 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.218 -174.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.48 ' CE1' HD12 ' A' ' 130' ' ' LEU . 69.0 m-85 -72.95 135.58 45.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.454 -0.373 . . . . 0.0 111.346 -178.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.493 HG13 HG22 ' A' ' 7' ' ' VAL . 46.8 pt -101.65 -17.13 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 170.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.493 HG22 HG13 ' A' ' 6' ' ' ILE . 23.1 t -110.3 139.27 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.067 177.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.416 ' HE ' ' CD ' ' A' ' 11' ' ' GLU . 73.6 mtm180 -122.47 -178.7 3.97 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.084 0.469 . . . . 0.0 112.186 -169.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.416 ' CG1' HD21 ' A' ' 130' ' ' LEU . 67.5 mt -71.32 123.07 24.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.294 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.16 -19.82 44.91 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.166 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.416 ' CD ' ' HE ' ' A' ' 8' ' ' ARG . 7.1 mt-10 -80.87 151.32 28.71 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.632 ' HG2' ' HG2' ' A' ' 126' ' ' LYS . 45.1 mtp -77.92 137.54 38.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.844 0.354 . . . . 0.0 110.362 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.24 130.83 67.79 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.404 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -61.23 125.95 18.19 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.493 2.129 . . . . 0.0 111.427 177.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -63.01 138.64 58.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.224 0.535 . . . . 0.0 110.196 -176.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.572 ' HB2' HD13 ' A' ' 104' ' ' ILE . 47.1 p90 -131.76 149.69 52.39 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.052 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.5 m -109.17 98.79 8.17 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 170.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 25' ' ' GLN . 16.9 tt -95.6 144.8 9.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.516 -174.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.8 m -101.55 118.3 36.68 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.103 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.8 mt -73.57 172.83 10.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.959 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 96' ' ' LEU . 41.5 p -58.1 -28.84 64.98 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -175.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -102.6 18.74 20.54 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.143 0.497 . . . . 0.0 110.859 -175.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.86 40.43 17.41 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.795 174.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -108.73 117.18 33.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.887 0.375 . . . . 0.0 110.928 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 49.7 mt-30 -94.75 118.47 31.79 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.003 178.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.8 p -128.88 132.28 67.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.217 0.532 . . . . 0.0 111.123 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.41 154.81 25.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.089 177.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 40.4 tp -65.48 -40.28 92.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.844 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.562 ' HA ' ' HG3' ' A' ' 32' ' ' ARG . 75.3 m -62.92 -19.14 63.94 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 177.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 51.8 m -75.2 -18.15 60.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.511 0.672 . . . . 0.0 110.395 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.3 mt -100.81 -14.11 18.13 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.732 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.623 ' NH1' ' HA ' ' A' ' 124' ' ' GLU . 6.3 mmm180 -55.48 153.57 7.4 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 123.539 0.525 . . . . 0.0 110.917 177.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.09 -22.64 35.43 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -172.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.52 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 35.7 mtmm -117.31 170.93 8.31 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 174.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.5 m -80.9 134.03 28.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 172.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.566 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 44.3 t -111.22 109.6 29.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 121.006 0.431 . . . . 0.0 111.076 -177.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.572 ' HE3' ' HB3' ' A' ' 118' ' ' ASN . 13.9 tpt -91.81 136.25 33.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.211 175.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 78.9 mt -133.74 143.29 48.37 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.077 -178.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.55 ' OE1' ' HB ' ' A' ' 41' ' ' THR . 21.8 tm0? -138.45 131.44 29.77 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 177.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 96.7 m-85 -104.56 120.04 40.38 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.55 ' HB ' ' OE1' ' A' ' 39' ' ' GLN . 6.8 t -136.47 -175.67 4.08 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.059 0.456 . . . . 0.0 111.602 -173.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.497 ' HB1' ' HG ' ' A' ' 45' ' ' CYS . . . -169.41 164.04 10.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.463 178.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.445 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 86.3 p -67.19 -30.25 70.14 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.892 0.377 . . . . 0.0 111.739 -173.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 37.7 p-90 -89.0 4.36 48.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.668 -175.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.497 ' HG ' ' HB1' ' A' ' 42' ' ' ALA . 80.0 m -85.69 90.05 7.91 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.072 0.463 . . . . 0.0 110.796 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.84 -35.7 90.01 Favored Glycine 0 C--O 1.228 -0.265 0 C-N-CA 121.08 -0.581 . . . . 0.0 113.004 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.5 t -64.46 -35.44 74.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.012 0.434 . . . . 0.0 110.057 178.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.695 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 99.4 m -65.24 -16.84 63.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.395 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -68.99 -7.32 34.25 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 120.849 0.357 . . . . 0.0 110.604 177.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.614 ' HD3' ' CD2' ' A' ' 134' ' ' TYR . 62.1 mttt -88.24 -57.25 2.99 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.351 0.596 . . . . 0.0 110.257 168.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.735 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 5.0 pt-20 -65.65 -40.06 92.07 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.287 -172.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.586 ' HG2' ' O ' ' A' ' 48' ' ' CYS . 98.9 mmm -54.69 -58.39 14.52 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 117.999 0.363 . . . . 0.0 111.862 -177.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.418 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 29.6 Cg_endo -64.48 -38.53 32.84 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 122.018 1.812 . . . . 0.0 112.501 178.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -64.46 -42.07 96.16 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.314 178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.554 ' O ' ' HB ' ' A' ' 59' ' ' ILE . 75.0 mt -60.25 -37.49 73.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.863 0.363 . . . . 0.0 110.404 177.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.666 ' HG3' ' H ' ' A' ' 93' ' ' THR . 0.2 OUTLIER -68.42 -62.66 1.3 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 175.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.411 ' O ' ' HE2' ' A' ' 62' ' ' LYS . 29.3 ttpp -55.58 -43.1 75.64 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -174.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.568 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 8.3 m-20 -100.65 -24.82 14.34 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -171.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.554 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 53.9 mt -106.5 -60.99 2.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.458 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.507 ' CD2' ' HB3' ' A' ' 94' ' ' TYR . 76.6 t-105 -62.8 -62.65 1.58 Allowed 'General case' 0 C--O 1.226 -0.18 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.614 -175.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -46.68 -31.98 3.25 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.655 0.782 . . . . 0.0 112.497 -174.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.568 ' HE2' ' HA ' ' A' ' 58' ' ' ASP . 64.7 mmtt -72.75 -54.24 9.45 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.923 -178.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.774 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 85.8 m-70 -105.83 -45.29 4.42 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -169.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.5 mttp 55.06 -78.42 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.77 0.828 . . . . 0.0 111.495 -172.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -101.36 -63.25 1.16 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 174.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.774 ' HB2' ' HB3' ' A' ' 63' ' ' HIS . 3.9 t30 68.21 5.97 4.99 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.842 172.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 71.68 -19.44 0.26 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.769 0.828 . . . . 0.0 112.513 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.52 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 19.9 p30 -136.92 17.31 3.04 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.474 ' CE2' ' HB2' ' A' ' 71' ' ' LEU . 93.7 t80 -125.63 143.3 51.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.087 0.47 . . . . 0.0 111.112 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.81 140.59 38.61 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.744 172.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.474 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 2.2 tt -139.12 114.73 9.9 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -179.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.9 mm -124.3 120.83 60.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.133 178.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.457 ' HA3' ' CD2' ' A' ' 96' ' ' LEU . . . -88.72 130.44 10.15 Favored Glycine 0 C--O 1.223 -0.57 0 C-N-CA 120.223 -0.989 . . . . 0.0 110.809 175.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 48.6 mt -116.67 121.6 68.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 117.28 0.54 . . . . 0.0 110.759 -174.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -82.59 139.8 33.59 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 173.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.41 ' HB2' HD11 ' A' ' 115' ' ' ILE . 57.7 ttt-85 -57.37 -51.78 68.03 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.668 0.605 . . . . 0.0 112.58 -172.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.596 ' HA ' ' O ' ' A' ' 99' ' ' ASP . 11.3 p-10 -170.05 15.48 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -175.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.533 ' HB3' ' HG3' ' A' ' 82' ' ' LYS . 29.0 mt-10 -91.52 148.53 37.62 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-O 121.088 0.471 . . . . 0.0 110.599 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.632 ' HG2' ' OE2' ' A' ' 81' ' ' GLU . 38.1 Cg_endo -71.34 -174.48 1.23 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.935 2.423 . . . . 0.0 114.257 -176.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 85.2 mt -54.25 -52.5 61.16 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.618 -1.173 . . . . 0.0 112.826 -174.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.632 ' OE2' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -61.22 -24.54 66.42 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -172.819 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.623 ' HG2' ' OE2' ' A' ' 81' ' ' GLU . 42.5 mmtm -73.23 -59.87 2.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.717 0.294 . . . . 0.0 110.367 172.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.6 t -54.59 -49.24 68.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.725 -176.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.8 mp -64.69 -40.43 95.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.413 -176.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.67 -34.55 58.24 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.316 -177.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.445 ' CD1' ' HA ' ' A' ' 43' ' ' SER . 78.9 t80 -67.09 -48.94 66.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.791 -178.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.433 ' HB3' HD11 ' A' ' 96' ' ' LEU . . . -53.34 -52.05 60.46 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.042 -176.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -63.19 -28.45 70.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.043 -176.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.5 m -100.73 9.86 41.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.724 -174.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.2 p -129.46 10.87 5.75 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.108 175.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.67 43.65 91.46 Favored Glycine 0 C--O 1.227 -0.281 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.275 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.7 t -100.36 100.65 10.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.028 0.442 . . . . 0.0 110.944 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.666 ' H ' ' HG3' ' A' ' 56' ' ' GLU . 30.1 m -85.94 -20.52 28.85 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.848 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.507 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 23.6 p90 -82.48 144.12 48.97 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.816 178.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -61.5 140.67 88.53 Favored 'Trans proline' 0 C--O 1.238 0.495 0 C-N-CA 122.572 2.181 . . . . 0.0 113.175 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.457 ' CD2' ' HA3' ' A' ' 73' ' ' GLY . 76.3 mt -111.06 151.2 28.32 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.852 176.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -123.59 149.16 16.85 Favored Glycine 0 N--CA 1.438 -1.214 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 175.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.671 ' H ' HD22 ' A' ' 98' ' ' LEU . 0.8 OUTLIER -99.81 132.56 45.08 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.591 0.234 . . . . 0.0 110.561 -177.456 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.596 ' O ' ' HA ' ' A' ' 77' ' ' ASP . 26.6 t0 -109.58 83.31 2.57 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.925 176.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -60.92 101.67 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.417 2.078 . . . . 0.0 113.177 -175.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 101.51 11.76 37.5 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.852 -0.689 . . . . 0.0 113.359 175.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 61.32 43.46 10.66 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.082 0.467 . . . . 0.0 110.872 178.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.636 ' HA ' HH21 ' A' ' 111' ' ' ARG . 18.1 t70 -79.89 -50.2 10.82 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.537 0.684 . . . . 0.0 110.374 -178.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.572 HD13 ' HB2' ' A' ' 16' ' ' PHE . 31.7 mm -67.41 -39.45 82.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 175.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -56.69 -39.14 73.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.363 175.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.17 -32.32 72.49 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.77 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.428 ' HZ1' HD11 ' A' ' 104' ' ' ILE . 30.5 mtmm -74.83 -4.79 39.86 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 178.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.429 ' HH ' ' HE2' ' A' ' 16' ' ' PHE . 47.9 m-85 -116.61 -19.24 10.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 179.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.658 ' HB2' HH12 ' A' ' 117' ' ' ARG . . . -171.9 -179.99 2.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.572 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 80.2 mt -66.11 149.62 50.0 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 174.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.636 HH21 ' HA ' ' A' ' 103' ' ' ASP . 93.5 mtt180 -73.58 -15.22 61.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.121 0.486 . . . . 0.0 110.024 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -100.51 15.9 26.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.346 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.07 -179.26 5.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.475 -177.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.88 142.03 42.79 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.679 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.59 ' O ' ' HG2' ' A' ' 117' ' ' ARG . 6.6 tp -91.66 -39.77 11.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 111.36 0.133 . . . . 0.0 111.36 -178.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.562 HG21 ' SG ' ' A' ' 48' ' ' CYS . 18.0 p -68.86 105.33 2.32 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 120.484 0.183 . . . . 0.0 110.878 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.658 HH12 ' HB2' ' A' ' 109' ' ' ALA . 8.9 ptm180 -167.65 133.06 1.96 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.171 0.51 . . . . 0.0 112.127 -173.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.579 ' HB2' ' CB ' ' A' ' 131' ' ' THR . 91.2 m-20 -104.41 129.59 52.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.231 172.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.6 t -120.95 116.93 51.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 120.619 0.247 . . . . 0.0 110.394 -176.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 37.5 tp -106.38 115.12 29.66 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.113 0.482 . . . . 0.0 110.645 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.566 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 60.7 mt -95.51 135.05 30.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.366 176.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.505 ' HB2' ' HE3' ' A' ' 149' ' ' MET . 0.0 OUTLIER -79.49 177.01 9.18 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.206 0.526 . . . . 0.0 110.734 -177.213 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.628 ' HD2' ' OE2' ' A' ' 152' ' ' GLU . 31.6 ttm180 -62.57 -27.1 68.95 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.561 -177.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.623 ' HA ' ' NH1' ' A' ' 32' ' ' ARG . 2.1 mm-40 -91.42 6.28 46.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.066 -178.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.16 16.68 62.33 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.544 -0.836 . . . . 0.0 113.017 172.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.632 ' HG2' ' HG2' ' A' ' 12' ' ' MET . 33.3 mttt -112.18 142.77 44.24 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.829 0.347 . . . . 0.0 110.292 -177.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.462 HD13 ' CG1' ' A' ' 7' ' ' VAL . 58.3 mt -80.21 119.96 30.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 120.776 0.322 . . . . 0.0 110.613 -177.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.5 m -109.88 -8.07 11.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.419 ' CG ' HE22 ' A' ' 145' ' ' GLN . 5.2 tmtm? -149.34 111.21 4.57 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.296 -175.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.48 HD12 ' CE1' ' A' ' 5' ' ' TYR . 3.2 mm? -104.79 105.78 16.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.224 172.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.579 ' CB ' ' HB2' ' A' ' 118' ' ' ASN . 10.4 m -88.98 138.69 31.17 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.367 -177.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.507 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 2.3 mpt_? -99.78 107.08 19.04 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 176.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 132' ' ' ARG . 0.5 OUTLIER 43.44 -162.89 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 O-C-N 124.212 0.945 . . . . 0.0 111.788 -174.201 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.735 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 90.5 t80 -88.63 92.81 9.34 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.168 0.509 . . . . 0.0 110.08 173.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.539 ' HB3' ' HB3' ' A' ' 138' ' ' GLU . 10.7 t30 -95.02 131.57 40.85 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 170.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.433 ' HB2' ' OE2' ' A' ' 137' ' ' GLU . 24.9 mm-40 -50.16 -63.81 1.0 Allowed 'General case' 0 CA--C 1.536 0.424 0 O-C-N 123.687 0.617 . . . . 0.0 112.178 -168.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.513 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.2 mp0 -66.62 -32.52 73.9 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.108 0.48 . . . . 0.0 110.945 -177.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.539 ' HB3' ' HB3' ' A' ' 135' ' ' ASN . 6.0 tp10 -62.68 -46.18 89.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.606 -176.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.491 ' O ' HG23 ' A' ' 143' ' ' VAL . 91.9 t80 -63.57 -42.03 98.34 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.511 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.4 -44.06 96.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.805 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.3 m -63.68 -39.6 94.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.414 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.5 ' O ' HG13 ' A' ' 146' ' ' ILE . 58.4 tp -62.46 -44.31 96.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.942 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 139' ' ' PHE . 99.0 t -57.66 -52.94 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.15 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -60.96 -41.29 96.06 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-O 121.281 0.562 . . . . 0.0 110.872 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.419 HE22 ' CG ' ' A' ' 129' ' ' LYS . 28.6 tt0 -57.71 -48.52 79.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.575 178.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.597 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 78.0 mt -58.96 -41.92 84.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.879 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -55.2 -46.68 75.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.561 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -83.88 -25.22 30.41 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.092 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.505 ' HE3' ' HB2' ' A' ' 122' ' ' ASP . 28.8 mmm -58.92 -33.88 71.08 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.413 0.625 . . . . 0.0 110.371 178.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.629 ' HB2' ' HD2' ' A' ' 151' ' ' LYS . 52.2 mt -60.8 -39.1 87.65 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.611 176.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.629 ' HD2' ' HB2' ' A' ' 150' ' ' LEU . 11.1 mmmt -89.21 -30.16 18.74 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.629 -168.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.628 ' OE2' ' HD2' ' A' ' 123' ' ' ARG . 7.2 tt0 63.42 -121.18 0.55 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.932 167.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -74.35 -11.46 82.28 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 121.462 -0.399 . . . . 0.0 112.744 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 79.1 m80 66.29 77.84 0.28 Allowed 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 122.907 0.483 . . . . 0.0 111.555 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -78.78 97.38 5.9 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 170.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.498 ' O ' ' HB2' ' A' ' 157' ' ' HIS . 0.0 OUTLIER 71.08 153.17 0.12 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.4 -165.845 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.498 ' HB2' ' O ' ' A' ' 156' ' ' HIS . 71.5 m80 72.12 39.78 0.76 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -161.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -170.21 -32.53 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 112.775 -2.012 . . . . 0.0 105.695 -173.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.246 0.872 0 CA-C-N 113.2 -1.818 . . . . 0.0 107.503 167.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.2 ptp . . . . . 0 N--CA 1.483 1.213 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.7 m -53.4 122.85 10.48 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 123.371 0.419 . . . . 0.0 110.273 175.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 91.7 mt 71.39 143.54 0.06 Allowed 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.963 0.79 . . . . 0.0 110.798 -174.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.53 57.6 4.9 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.825 -0.703 . . . . 0.0 113.414 -174.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.425 ' OH ' ' HD2' ' A' ' 117' ' ' ARG . 1.3 m-85 -91.71 121.06 33.01 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.771 0.319 . . . . 0.0 110.247 175.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.412 HG13 HG13 ' A' ' 7' ' ' VAL . 38.6 pt -92.38 -24.01 5.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.437 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.412 HG13 HG13 ' A' ' 6' ' ' ILE . 27.4 m -104.51 157.16 5.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.389 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.464 ' H ' ' HG3' ' A' ' 11' ' ' GLU . 19.7 mtt180 -126.25 177.39 6.45 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.082 -174.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.606 HG12 HD11 ' A' ' 130' ' ' LEU . 79.9 mt -74.27 110.7 8.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 173.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.02 -23.45 8.2 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.092 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.464 ' HG3' ' H ' ' A' ' 8' ' ' ARG . 69.1 mm-40 -68.13 154.67 41.21 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.555 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 55.5 mtp -86.08 139.83 30.79 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.949 0.404 . . . . 0.0 110.482 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.469 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -67.44 130.06 93.46 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.561 -178.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 8.3 Cg_exo -70.7 120.98 7.5 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.926 2.418 . . . . 0.0 111.477 176.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -63.43 146.93 52.6 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.451 -176.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 1.026 ' HB3' ' HE2' ' A' ' 107' ' ' LYS . 54.0 p90 -156.7 158.54 37.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.69 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.8 m -116.33 107.27 14.62 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.748 175.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.1 tt -107.81 146.81 13.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.005 0.431 . . . . 0.0 111.003 -176.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.3 m -95.37 130.22 42.24 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.053 177.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.47 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 90.6 mt -83.89 179.01 7.66 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.005 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.449 HG23 ' O ' ' A' ' 96' ' ' LEU . 27.4 p -59.56 -31.21 69.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.714 -175.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -101.88 10.91 39.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.983 0.42 . . . . 0.0 110.917 -176.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.07 8.7 62.94 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.522 176.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.414 ' HB2' HD12 ' A' ' 20' ' ' LEU . 46.0 mmtm -77.44 120.59 22.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.362 0.581 . . . . 0.0 110.593 177.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -98.63 115.46 28.71 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.962 0.41 . . . . 0.0 110.393 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.3 m -113.78 153.07 15.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.008 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 9.1 m -122.49 142.96 50.03 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.335 -0.393 . . . . 0.0 109.961 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.67 -39.88 94.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.847 0.356 . . . . 0.0 110.841 -175.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 32' ' ' ARG . 5.3 p -61.18 -21.57 63.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.546 178.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.1 m -79.86 -25.99 40.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.068 0.461 . . . . 0.0 110.403 177.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 77.2 mt -96.5 1.88 51.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.392 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 29' ' ' SER . 0.2 OUTLIER -55.74 126.39 25.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.081 179.339 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.606 ' O ' ' HG3' ' A' ' 123' ' ' ARG . . . 106.37 -0.11 37.6 Favored Glycine 0 C--O 1.222 -0.635 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.724 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -116.51 159.54 21.93 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 174.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 p -78.29 107.3 10.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.585 0.707 . . . . 0.0 109.172 171.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.471 HG21 ' HB3' ' A' ' 70' ' ' ALA . 48.0 t -106.89 120.93 59.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.095 -173.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 26.7 ttt -98.81 120.2 38.84 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.331 176.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 94.0 mt -107.88 110.87 22.75 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.022 177.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.425 ' OE1' ' HB ' ' A' ' 41' ' ' THR . 0.6 OUTLIER -103.37 106.14 16.58 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.874 -176.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.461 ' O ' ' HA ' ' A' ' 116' ' ' THR . 95.1 m-85 -93.76 127.29 39.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.572 -177.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.429 ' HG1' ' CB ' ' A' ' 48' ' ' CYS . 15.0 t -158.26 -166.47 1.94 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.366 -176.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.486 ' HB3' HD12 ' A' ' 115' ' ' ILE . . . -151.03 156.44 41.12 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 176.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.627 ' HB2' ' HG3' ' A' ' 78' ' ' GLU . 49.7 m -66.26 -9.49 33.0 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -176.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 41.0 p-90 -105.4 4.86 31.22 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 122.201 -0.312 . . . . 0.0 111.566 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 74.9 m -83.17 113.47 20.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.023 0.439 . . . . 0.0 111.158 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -78.31 -33.21 40.45 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.863 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.3 t -66.48 -37.46 79.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.08 0.467 . . . . 0.0 110.797 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.66 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 29.1 t -67.03 -16.95 64.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.374 0.607 . . . . 0.0 110.793 -178.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.502 ' HE ' ' HE1' ' A' ' 86' ' ' PHE . 79.6 mtt180 -74.83 -2.15 25.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.681 177.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.411 ' O ' ' HD1' ' A' ' 54' ' ' PHE . 74.2 mmtt -94.02 -55.61 3.15 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.702 0.763 . . . . 0.0 109.278 169.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.983 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 10.0 pt-20 -62.68 -44.27 96.69 Favored 'General case' 0 C--O 1.213 -0.827 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.861 -173.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.651 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 33.3 mtm -56.06 -55.23 43.8 Favored Pre-proline 0 N--CA 1.466 0.362 0 CA-C-N 118.338 0.517 . . . . 0.0 112.36 -176.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.651 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 65.0 Cg_exo -53.93 -38.7 86.37 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 121.976 1.784 . . . . 0.0 111.968 175.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.465 ' HB3' ' CZ ' ' A' ' 139' ' ' PHE . 23.1 m-85 -68.26 -45.04 74.25 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.081 175.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 51' ' ' GLU . 88.1 mt -58.86 -55.68 21.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 123.065 0.546 . . . . 0.0 111.08 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.503 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 16.0 pt-20 -62.69 -35.71 80.58 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.635 -177.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.0 ttpm? -72.37 -51.4 20.69 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -176.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.768 ' HA ' ' HZ1' ' A' ' 62' ' ' LYS . 53.5 m-20 -106.99 -10.8 15.83 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -170.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.434 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 65.0 mt -104.57 -55.44 5.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.158 173.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.503 ' HB3' ' HA ' ' A' ' 56' ' ' GLU . 72.1 t-105 -69.97 -65.84 0.67 Allowed 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.575 -177.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.495 HD11 ' HE3' ' A' ' 64' ' ' LYS . 1.9 mm? -46.78 -33.88 4.78 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -175.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.768 ' HZ1' ' HA ' ' A' ' 58' ' ' ASP . 45.8 mmtm -75.72 -34.12 60.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.29 -0.414 . . . . 0.0 112.057 -176.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.405 ' ND1' ' HG ' ' A' ' 150' ' ' LEU . 79.9 m-70 -125.28 -43.73 1.91 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 120.347 -0.541 . . . . 0.0 112.351 -173.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.495 ' HE3' HD11 ' A' ' 61' ' ' LEU . 34.5 mttp 54.87 -90.6 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.944 0.898 . . . . 0.0 111.936 -177.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -108.01 -49.41 3.21 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 174.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 70.94 -71.22 0.14 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.83 178.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 169.78 -23.67 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.287 -175.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -148.3 24.93 1.01 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.79 -174.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.402 ' HB2' HD11 ' A' ' 150' ' ' LEU . 87.5 t80 -129.12 140.13 51.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.745 0.307 . . . . 0.0 110.571 -178.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.471 ' HB3' HG21 ' A' ' 36' ' ' VAL . . . -139.16 135.83 34.45 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.323 177.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 tt -133.79 117.2 16.62 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.6 mp -128.15 126.98 67.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.766 0.317 . . . . 0.0 110.332 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.81 129.46 9.91 Favored Glycine 0 C--O 1.219 -0.784 0 N-CA-C 110.799 -0.921 . . . . 0.0 110.799 174.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.0 mt -119.21 122.53 69.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 117.489 0.644 . . . . 0.0 111.338 -173.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -86.11 133.26 33.89 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 173.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.875 ' HD3' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -88.35 -22.78 23.63 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -169.271 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.875 ' HB3' ' HD3' ' A' ' 76' ' ' ARG . 3.9 p30 -151.25 -14.04 0.21 Allowed 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 118.721 -1.192 . . . . 0.0 114.131 -172.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.627 ' HG3' ' HB2' ' A' ' 43' ' ' SER . 4.9 mm-40 -88.46 133.31 36.69 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-O 121.065 0.46 . . . . 0.0 110.746 177.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.531 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 29.0 Cg_endo -69.19 -168.82 0.27 Allowed 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 123.175 2.583 . . . . 0.0 114.624 -177.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.2 -53.97 52.19 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.414 -168.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.531 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -64.23 -33.59 76.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.657 0.265 . . . . 0.0 111.305 -173.941 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.466 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 33.7 mmtp -61.06 -53.93 51.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.85 177.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.5 HG21 ' O ' ' A' ' 79' ' ' PRO . 41.1 t -57.53 -41.52 79.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.352 -177.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -66.07 -44.19 85.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.854 0.359 . . . . 0.0 111.26 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.82 -27.93 62.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.175 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.502 ' HE1' ' HE ' ' A' ' 49' ' ' ARG . 91.7 t80 -74.14 -48.08 31.73 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.19 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.455 ' HB2' HD13 ' A' ' 96' ' ' LEU . . . -58.39 -55.09 39.54 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.334 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.7 ptmm? -58.84 -24.95 62.75 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -174.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.0 m -84.15 -17.29 40.53 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -175.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.5 p -111.08 -23.39 10.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.098 0.475 . . . . 0.0 110.653 176.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 123.36 -79.78 0.35 Allowed Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -177.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 94.4 t 46.19 82.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 122.101 0.953 . . . . 0.0 112.691 178.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.3 m -71.55 -18.66 62.24 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.446 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -93.98 139.92 22.77 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.45 140.12 85.88 Favored 'Trans proline' 0 C--O 1.238 0.499 0 C-N-CA 122.46 2.107 . . . . 0.0 113.437 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.455 HD13 ' HB2' ' A' ' 87' ' ' ALA . 88.6 mt -106.23 152.21 23.79 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.868 175.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -124.33 154.41 17.86 Favored Glycine 0 N--CA 1.441 -1.025 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 175.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.657 HD21 ' H ' ' A' ' 98' ' ' LEU . 1.2 pt? -107.43 130.45 54.82 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.945 0.402 . . . . 0.0 111.126 -177.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -119.13 75.15 14.73 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.868 175.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.416 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 17.4 Cg_exo -66.23 105.16 0.82 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.6 2.2 . . . . 0.0 112.421 -177.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 119.47 -1.79 14.04 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.127 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 57.91 43.4 21.5 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 122.658 0.383 . . . . 0.0 111.931 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.404 ' O ' ' HG3' ' A' ' 107' ' ' LYS . 13.7 t70 -87.1 -50.67 6.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.06 0.457 . . . . 0.0 109.903 -177.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.542 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 34.3 mm -62.54 -34.92 67.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 174.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -61.5 -41.67 97.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.248 173.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.728 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -68.32 -21.81 64.74 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.893 -177.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 1.026 ' HE2' ' HB3' ' A' ' 16' ' ' PHE . 26.5 mtpp -70.9 -6.84 41.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.002 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -124.64 -32.75 3.07 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.158 -179.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.728 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -156.89 162.58 39.66 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 84.2 mt -56.76 149.01 18.94 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.759 0.314 . . . . 0.0 110.381 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.567 ' HG2' ' HB1' ' A' ' 106' ' ' ALA . 38.1 mtt180 -69.66 -13.46 62.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.139 0.495 . . . . 0.0 110.542 -174.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -100.96 -7.33 23.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.126 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -78.91 75.77 5.41 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.203 0.525 . . . . 0.0 111.719 -174.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.93 -140.33 29.91 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.094 178.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.487 HD11 ' HD2' ' A' ' 76' ' ' ARG . 4.6 tp -161.93 -57.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.481 0.182 . . . . 0.0 111.351 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 40' ' ' PHE . 4.8 m -87.86 111.68 21.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.073 0.464 . . . . 0.0 110.951 -175.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.425 ' HD2' ' OH ' ' A' ' 5' ' ' TYR . 46.0 mtm105 -141.61 133.17 26.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.074 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.585 ' HB2' ' CG2' ' A' ' 131' ' ' THR . 6.0 m120 -102.39 119.01 38.09 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 176.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.9 t -113.8 123.76 69.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.078 -177.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.447 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 34.4 tp -110.58 121.76 46.1 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.11 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.3 mp -102.13 139.02 24.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.67 177.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.457 ' HA ' ' HE1' ' A' ' 149' ' ' MET . 0.3 OUTLIER -90.59 -174.17 4.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.055 0.455 . . . . 0.0 111.02 -177.642 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.606 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 32.4 ttt180 -69.84 -26.26 64.14 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.604 -175.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -80.17 -15.05 57.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.703 0.287 . . . . 0.0 111.254 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.2 16.38 30.19 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.08 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 81.2 mttt -101.24 154.87 18.39 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.907 0.384 . . . . 0.0 110.414 -178.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 53.9 mt -92.62 116.44 33.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.172 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.53 -31.32 2.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -173.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.867 ' HG2' ' HG ' ' A' ' 142' ' ' LEU . 50.5 tptt -124.66 114.27 19.11 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.908 -0.495 . . . . 0.0 111.194 -176.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.606 HD11 HG12 ' A' ' 9' ' ' ILE . 8.5 mp -110.99 105.13 13.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.746 176.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.589 ' HA ' ' NH1' ' A' ' 132' ' ' ARG . 10.0 t -125.43 158.69 33.75 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.074 0.464 . . . . 0.0 110.721 177.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.589 ' NH1' ' HA ' ' A' ' 131' ' ' THR . 0.0 OUTLIER -116.24 116.47 27.85 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.144 -178.199 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 132' ' ' ARG . 4.6 pp 51.11 -175.01 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.526 1.141 . . . . 0.0 112.968 -178.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.983 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 90.5 t80 -69.75 84.13 0.46 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.647 0.737 . . . . 0.0 111.56 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.549 ' HB3' ' HB2' ' A' ' 138' ' ' GLU . 57.8 t-20 -86.7 133.57 33.67 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 171.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -52.04 -68.07 0.2 Allowed 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.36 0.413 . . . . 0.0 110.843 -176.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -55.99 -59.1 5.39 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.544 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.615 ' O ' ' HB2' ' A' ' 142' ' ' LEU . 29.0 mt-10 -63.02 -23.38 67.43 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -170.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.487 ' O ' HG23 ' A' ' 143' ' ' VAL . 82.0 t80 -75.21 -44.9 43.79 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 172.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.32 -48.88 79.83 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.99 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.415 ' OG ' ' HA ' ' A' ' 138' ' ' GLU . 2.5 p -62.69 -38.0 88.67 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.64 0.257 . . . . 0.0 111.141 177.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.867 ' HG ' ' HG2' ' A' ' 129' ' ' LYS . 1.5 tt -64.75 -50.41 66.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.244 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 139' ' ' PHE . 86.1 t -58.69 -49.51 82.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.083 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -63.81 -39.15 93.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.371 -177.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.614 ' O ' ' HG3' ' A' ' 149' ' ' MET . 8.0 tt0 -61.02 -45.79 93.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.018 176.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.51 ' O ' HD21 ' A' ' 150' ' ' LEU . 57.7 mt -55.61 -46.27 79.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.799 177.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -54.71 -42.49 71.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.609 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.416 ' CD ' ' HZ3' ' A' ' 151' ' ' LYS . 9.4 tp10 -69.27 -35.65 76.28 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.172 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.614 ' HG3' ' O ' ' A' ' 145' ' ' GLN . 80.5 mtp -70.46 -19.3 62.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.299 0.571 . . . . 0.0 110.088 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.51 HD21 ' O ' ' A' ' 146' ' ' ILE . 4.3 mm? -83.11 -14.6 53.3 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.109 174.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.416 ' HZ3' ' CD ' ' A' ' 148' ' ' GLU . 17.5 mtmm -97.57 -42.37 7.71 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 61.56 -155.35 0.35 Allowed 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.926 176.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 156' ' ' HIS . . . 102.19 97.29 2.35 Favored Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -178.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -74.46 -1.16 19.96 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.132 0.491 . . . . 0.0 111.392 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -104.72 31.25 4.86 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 172.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.507 ' HB2' ' O ' ' A' ' 153' ' ' GLY . 58.0 t-80 -74.26 52.99 0.49 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.58 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -145.92 154.78 42.32 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -83.88 61.5 6.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.209 0.528 . . . . 0.0 109.592 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 . . . . . 0 C--O 1.24 0.573 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.272 -179.048 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 mpp? . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 120.614 0.245 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.3 m -70.25 102.53 2.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.794 0.331 . . . . 0.0 110.899 -178.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.9 mt -107.79 4.46 25.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.159 0.504 . . . . 0.0 110.548 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.41 -3.03 78.91 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.254 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -89.2 145.56 25.34 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 177.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.411 ' H ' HD12 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -105.96 -9.79 10.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 169.662 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.2 p -94.89 158.78 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.872 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.531 ' HB2' ' HG2' ' A' ' 11' ' ' GLU . 24.8 mtt180 -127.65 168.91 14.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.782 0.325 . . . . 0.0 111.038 -171.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.466 HG12 HD22 ' A' ' 130' ' ' LEU . 75.2 mt -78.25 117.83 24.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.75 174.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.95 -25.58 9.37 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.706 -177.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.531 ' HG2' ' HB2' ' A' ' 8' ' ' ARG . 71.6 mm-40 -66.73 152.92 44.53 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.697 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 59.7 mtp -81.48 134.6 35.55 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 175.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.473 ' HB2' HH12 ' A' ' 32' ' ' ARG . . . -59.53 133.82 88.75 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.293 -176.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -67.15 174.35 7.14 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.884 2.39 . . . . 0.0 112.18 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.546 ' O ' ' HE2' ' A' ' 107' ' ' LYS . 5.1 p-10 -76.54 163.69 26.67 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.32 177.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.545 ' HB2' HD13 ' A' ' 104' ' ' ILE . 23.0 p90 -174.11 148.91 1.39 Allowed 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 166.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.613 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 52.1 m -131.33 99.55 4.88 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 173.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.644 ' O ' ' HA ' ' A' ' 25' ' ' GLN . 16.6 tt -99.35 148.62 6.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.238 -171.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.7 m -98.16 114.84 27.19 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.059 177.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.4 mt -74.1 172.81 11.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.457 -178.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 96' ' ' LEU . 52.3 p -55.42 -27.07 45.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.997 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -96.61 14.54 24.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.351 -174.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.13 29.64 66.39 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.947 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -108.88 120.58 42.93 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.735 0.303 . . . . 0.0 110.658 -176.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.644 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 25.1 mt-30 -98.23 128.11 44.52 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.749 -178.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.613 ' O ' ' HA ' ' A' ' 17' ' ' THR . 12.2 m -125.59 150.74 31.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.591 178.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 22.9 m -113.11 142.47 45.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.383 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.505 HD12 ' CD1' ' A' ' 121' ' ' ILE . 0.6 OUTLIER -62.37 -36.78 83.35 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.673 0.273 . . . . 0.0 111.101 -177.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.7 m -58.04 -27.13 63.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.711 -177.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.9 m -78.53 -20.61 50.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.06 0.457 . . . . 0.0 111.21 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.3 mt -102.21 17.73 22.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.632 -176.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.473 HH12 ' HB2' ' A' ' 13' ' ' ALA . 22.8 mmt180 -68.74 147.06 52.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.772 0.32 . . . . 0.0 110.689 178.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.401 ' O ' ' HG3' ' A' ' 123' ' ' ARG . . . 101.77 -25.69 27.06 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.255 178.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.908 ' HB3' ' HZ3' ' A' ' 34' ' ' LYS . 0.7 OUTLIER -115.02 160.76 19.21 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.094 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 p -74.78 115.88 16.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.541 0.686 . . . . 0.0 110.41 -177.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.437 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 21.7 t -106.14 122.39 59.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.195 -177.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.534 ' SD ' ' HG ' ' A' ' 71' ' ' LEU . 2.1 tmt? -108.97 135.47 50.1 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.052 0.453 . . . . 0.0 110.125 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.47 HD23 ' CE2' ' A' ' 16' ' ' PHE . 7.0 mp -130.28 144.06 51.15 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.414 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.6 133.14 32.09 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 172.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.46 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 95.9 m-85 -99.49 105.36 17.27 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.91 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.2 t -115.52 -176.42 2.92 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.076 -172.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -169.16 139.91 2.32 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.528 ' H ' ' HG3' ' A' ' 78' ' ' GLU . 19.0 p -66.97 -23.38 65.94 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.882 0.372 . . . . 0.0 111.372 -174.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 65.4 p-90 -84.49 -2.31 57.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.66 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.4 t -90.07 139.26 30.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.269 0.557 . . . . 0.0 111.366 -178.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -93.56 -27.67 12.65 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.349 176.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 42.9 t -67.86 -39.51 81.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.87 0.367 . . . . 0.0 110.707 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.615 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 61.0 m -61.54 -15.9 42.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.761 178.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -78.41 -3.06 41.37 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.764 0.316 . . . . 0.0 110.913 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -85.93 -47.0 10.05 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.293 0.568 . . . . 0.0 109.832 165.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.615 ' HG2' ' HA ' ' A' ' 48' ' ' CYS . 14.2 pt-20 -75.0 -32.87 61.75 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.698 -172.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.543 ' CB ' ' HD3' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -48.96 -65.03 0.89 Allowed Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 175.28 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.543 ' HD3' ' CB ' ' A' ' 52' ' ' MET . 35.8 Cg_exo -60.88 -39.18 63.83 Favored 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 121.745 1.63 . . . . 0.0 112.844 177.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.639 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 8.2 m-85 -67.42 -46.73 72.32 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -176.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.13 -49.37 84.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 178.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.588 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 29.7 mm-40 -56.33 -44.52 80.09 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 123.399 0.437 . . . . 0.0 111.026 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -67.46 -49.17 64.8 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.705 -0.679 . . . . 0.0 112.276 -176.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.706 ' HA ' ' HZ1' ' A' ' 62' ' ' LYS . 42.3 m-20 -107.68 -51.2 2.94 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -170.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.4 mt -73.68 -49.05 37.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.867 -173.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.443 ' CD2' ' HB3' ' A' ' 94' ' ' TYR . 63.4 t-105 -71.63 -69.93 0.35 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.76 -178.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.588 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.4 OUTLIER -41.27 -40.27 1.59 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -171.729 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.706 ' HZ1' ' HA ' ' A' ' 58' ' ' ASP . 36.9 mmtm -75.97 -31.56 59.08 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -172.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -122.78 -43.06 2.27 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.876 -174.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.41 ' O ' ' HD2' ' A' ' 69' ' ' PHE . 53.6 mttt 51.64 -92.98 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 123.852 0.861 . . . . 0.0 111.504 -175.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -90.21 -61.04 1.77 Allowed 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 120.761 0.315 . . . . 0.0 110.471 176.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.496 ' ND2' HD12 ' A' ' 150' ' ' LEU . 0.9 OUTLIER 61.09 9.46 2.41 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.185 0.594 . . . . 0.0 111.408 175.928 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 68.27 -22.18 0.13 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.833 0.853 . . . . 0.0 112.869 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.573 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 3.2 t70 -138.81 22.76 2.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.369 0.604 . . . . 0.0 110.289 -174.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.541 ' HB2' HD11 ' A' ' 150' ' ' LEU . 86.4 t80 -127.28 116.18 20.16 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.198 173.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -114.65 104.42 11.97 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.727 -178.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.534 ' HG ' ' SD ' ' A' ' 37' ' ' MET . 5.6 tt -104.29 114.95 29.53 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.9 mp -120.83 117.26 52.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.118 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.514 ' HA3' HD21 ' A' ' 96' ' ' LEU . . . -90.33 131.8 10.94 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.315 -0.945 . . . . 0.0 110.938 175.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 45.9 mt -119.27 119.59 61.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 117.046 0.423 . . . . 0.0 110.679 -175.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -85.72 136.04 33.51 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 173.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.521 ' HD3' HD13 ' A' ' 115' ' ' ILE . 21.6 ttp180 -68.71 -45.25 72.09 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.408 -0.814 . . . . 0.0 112.689 -170.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -158.87 8.73 0.13 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -169.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.528 ' HG3' ' H ' ' A' ' 43' ' ' SER . 14.1 mm-40 -86.65 138.11 33.68 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-O 120.951 0.405 . . . . 0.0 110.678 176.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.423 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 34.5 Cg_endo -69.24 -173.6 0.67 Allowed 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.901 2.401 . . . . 0.0 113.651 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.43 ' O ' HD21 ' A' ' 84' ' ' LEU . 2.8 tm? -59.27 -56.66 19.33 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.062 -169.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.423 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -67.02 -34.31 77.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.473 -173.099 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.417 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 14.4 mmmm -60.26 -50.4 73.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.925 177.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 95.7 t -61.28 -48.26 89.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.104 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.43 HD21 ' O ' ' A' ' 80' ' ' LEU . 4.4 mm? -61.28 -52.66 63.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.623 -177.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.12 -37.27 86.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.511 -178.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -68.84 -41.34 78.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.719 -0.218 . . . . 0.0 110.918 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.478 ' HB2' HD13 ' A' ' 96' ' ' LEU . . . -66.16 -41.7 89.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.737 0.78 . . . . 0.0 109.549 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -58.99 -30.25 67.82 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.218 -1.355 . . . . 0.0 111.437 176.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.3 m -99.85 -1.38 37.61 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -176.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.1 p -113.53 -5.12 13.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.845 0.355 . . . . 0.0 111.494 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.09 -5.32 83.12 Favored Glycine 0 C--O 1.228 -0.277 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.368 177.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.501 ' CG2' ' HG3' ' A' ' 52' ' ' MET . 69.2 t -57.27 121.92 5.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.099 0.476 . . . . 0.0 111.551 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.409 ' H ' ' CD ' ' A' ' 56' ' ' GLU . 75.3 p -114.53 -15.56 12.0 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.383 176.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.443 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 36.8 p90 -71.57 144.73 89.15 Favored Pre-proline 0 C--O 1.233 0.236 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 173.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.34 124.71 13.79 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.415 2.076 . . . . 0.0 113.132 -176.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.514 HD21 ' HA3' ' A' ' 73' ' ' GLY . 84.8 mt -99.17 153.29 19.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.476 173.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -122.83 156.13 17.24 Favored Glycine 0 N--CA 1.437 -1.24 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 174.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.512 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.4 pt? -116.11 119.88 37.26 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.734 0.267 . . . . 0.0 110.349 -178.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -117.25 76.1 8.79 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.402 178.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.11 107.46 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.481 2.12 . . . . 0.0 111.936 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 131.59 -27.31 3.74 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -176.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.457 ' HB1' ' HG2' ' A' ' 76' ' ' ARG . . . 66.98 24.61 9.52 Favored 'General case' 0 CA--C 1.522 -0.097 0 C-N-CA 122.992 0.517 . . . . 0.0 111.373 176.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -70.94 -41.43 71.14 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.173 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.545 HD13 ' HB2' ' A' ' 16' ' ' PHE . 48.3 mm -62.05 -33.77 60.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.379 0.609 . . . . 0.0 109.62 174.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -70.21 -39.21 75.29 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.427 175.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -66.15 -28.92 69.15 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -174.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.546 ' HE2' ' O ' ' A' ' 15' ' ' ASP . 13.6 ptmt -79.46 -1.96 39.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.994 0.426 . . . . 0.0 111.276 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -112.09 -50.92 2.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.21 172.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -141.05 152.81 45.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.408 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.407 ' HB3' ' OD1' ' A' ' 112' ' ' ASP . 97.3 mt -62.38 139.26 58.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.849 0.357 . . . . 0.0 111.041 -178.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.406 ' HD3' ' HB2' ' A' ' 102' ' ' ALA . 12.3 mtm180 -66.01 -25.62 67.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.209 0.528 . . . . 0.0 110.837 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.407 ' OD1' ' HB3' ' A' ' 110' ' ' LEU . 4.2 p-10 -83.99 -8.49 59.14 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.171 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.83 -8.02 57.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.373 -178.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.27 -128.19 8.25 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.444 174.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.521 HD13 ' HD3' ' A' ' 76' ' ' ARG . 8.1 tp -154.25 173.65 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -174.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.444 ' N ' HG13 ' A' ' 115' ' ' ILE . 28.2 m 71.0 81.54 0.16 Allowed 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.476 0.655 . . . . 0.0 111.279 175.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.6 mmt85 -133.8 131.9 39.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.111 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.556 ' O ' ' HA ' ' A' ' 130' ' ' LEU . 0.2 OUTLIER -116.1 119.67 36.57 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.179 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.483 ' N ' HD21 ' A' ' 118' ' ' ASN . 63.2 t -113.76 131.81 64.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.996 -177.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.694 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 36.7 tp -119.36 122.04 40.91 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.316 0.579 . . . . 0.0 110.875 177.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.505 ' CD1' HD12 ' A' ' 28' ' ' LEU . 53.6 mt -100.7 135.08 38.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.778 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.86 -176.91 5.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.212 0.53 . . . . 0.0 111.09 -176.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 28.6 ttm180 -68.41 -23.32 64.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.001 -175.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.426 ' CD ' ' HZ1' ' A' ' 126' ' ' LYS . 41.1 mt-10 -80.78 -26.62 37.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.979 0.418 . . . . 0.0 110.769 175.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 112.4 12.22 13.82 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.352 -0.928 . . . . 0.0 112.311 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.697 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 77.5 mttt -97.13 160.62 14.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.822 0.344 . . . . 0.0 110.66 -178.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 47.0 mt -95.79 109.59 22.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 175.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.7 m -110.59 1.13 9.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.918 -174.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.789 ' HG2' ' HG ' ' A' ' 142' ' ' LEU . 51.7 tptt -160.94 114.05 1.98 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 -175.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.556 ' HA ' ' O ' ' A' ' 118' ' ' ASN . 0.4 OUTLIER -138.4 105.98 5.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.171 0.51 . . . . 0.0 110.449 176.35 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.567 ' HB ' ' HG2' ' A' ' 138' ' ' GLU . 10.1 t -99.46 155.89 17.32 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.095 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.425 HH21 ' CG ' ' A' ' 135' ' ' ASN . 0.0 OUTLIER -122.49 132.74 54.48 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.538 -179.807 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.429 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 3.1 mp 66.45 36.03 5.31 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 123.71 0.631 . . . . 0.0 110.614 176.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.429 ' HB3' ' O ' ' A' ' 133' ' ' LEU . 45.8 t80 71.2 -66.38 0.3 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.518 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.548 ' HB3' ' HB3' ' A' ' 138' ' ' GLU . 0.8 OUTLIER 64.54 113.18 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.046 0.45 . . . . 0.0 110.954 -175.882 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -49.95 -56.4 10.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.785 -174.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.09 -36.24 27.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.343 -174.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.567 ' HG2' ' HB ' ' A' ' 131' ' ' THR . 3.4 tp10 -63.54 -38.72 92.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.962 0.41 . . . . 0.0 110.128 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.639 ' CE2' ' HB3' ' A' ' 54' ' ' PHE . 76.6 t80 -70.65 -41.48 72.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.994 176.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.56 -49.6 75.84 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.827 0.346 . . . . 0.0 110.894 177.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.3 p -61.5 -34.11 74.93 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.69 177.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.789 ' HG ' ' HG2' ' A' ' 129' ' ' LYS . 4.6 tt -66.83 -42.94 84.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.255 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.461 ' O ' ' HB ' ' A' ' 146' ' ' ILE . 95.0 t -59.09 -51.47 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 120.782 0.325 . . . . 0.0 111.345 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.429 ' HA ' ' OE1' ' A' ' 144' ' ' GLN . 6.4 tp60 -62.0 -38.38 88.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.304 0.573 . . . . 0.0 110.168 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.401 HE22 ' HB2' ' A' ' 129' ' ' LYS . 29.0 tt0 -63.03 -36.88 85.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.724 177.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.573 ' O ' HD21 ' A' ' 150' ' ' LEU . 30.2 mm -55.09 -53.03 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 120.929 0.395 . . . . 0.0 110.259 174.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.511 ' O ' ' HB3' ' A' ' 151' ' ' LYS . 85.7 m-20 -53.06 -45.15 67.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.265 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -65.05 -37.37 87.36 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.128 0.268 . . . . 0.0 111.251 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 84.2 mmm -60.98 -29.97 69.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.65 0.738 . . . . 0.0 109.723 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.573 HD21 ' O ' ' A' ' 146' ' ' ILE . 4.0 mm? -89.35 -16.72 30.38 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.62 178.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 147' ' ' ASN . 0.0 OUTLIER -101.55 -4.46 26.67 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.935 -173.264 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -27.31 -69.56 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.685 1.194 . . . . 0.0 111.948 174.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 41.05 53.92 3.8 Favored Glycine 0 C--N 1.335 0.516 0 O-C-N 123.904 0.752 . . . . 0.0 114.09 174.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 2.9 m80 -46.75 -80.1 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 55.33 -152.06 0.37 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -175.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 24.7 p80 -120.77 23.85 10.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.682 0.753 . . . . 0.0 109.054 171.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -165.37 91.8 0.53 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.424 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -102.33 3.06 37.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.442 0.639 . . . . 0.0 109.713 178.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 16.8 p80 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 117.751 -1.119 . . . . 0.0 108.132 174.644 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.402 ' SD ' ' N ' ' A' ' 1' ' ' MET . 4.3 mpp? . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.1 m -80.46 91.5 5.74 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 177.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 87.7 mt -142.83 100.93 3.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.127 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.755 ' H ' ' HB1' ' A' ' 113' ' ' ALA . . . -89.61 71.49 2.25 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.576 -177.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -81.43 120.52 25.09 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.684 0.278 . . . . 0.0 110.9 178.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.498 HG12 ' HA ' ' A' ' 109' ' ' ALA . 47.3 pt -92.84 -22.07 5.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.147 175.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.5 ' CG1' HD12 ' A' ' 127' ' ' ILE . 36.3 t -102.39 147.37 9.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.416 177.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 57.2 mtt85 -120.26 168.54 11.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.047 0.451 . . . . 0.0 111.893 -168.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.592 HG12 HD13 ' A' ' 130' ' ' LEU . 77.0 mt -75.18 127.19 36.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.071 176.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.6 -9.26 77.49 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -175.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -92.03 151.38 20.49 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.655 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 56.7 mtp -80.95 144.76 31.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.096 0.474 . . . . 0.0 111.346 -172.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.37 134.01 39.19 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.275 -177.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.412 ' HG2' ' O ' ' A' ' 107' ' ' LYS . 13.3 Cg_exo -70.88 139.67 36.83 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.033 2.489 . . . . 0.0 112.033 177.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -75.78 164.81 25.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.277 -178.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.5 ' HE2' ' HH ' ' A' ' 108' ' ' TYR . 54.1 p90 -165.2 162.17 19.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.872 -176.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 37.3 m -124.72 110.59 14.54 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 175.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.4 tt -112.78 151.97 14.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.453 -171.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.499 ' HB ' ' CD2' ' A' ' 98' ' ' LEU . 2.8 m -89.34 126.32 35.48 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.142 177.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.0 mt -82.01 178.36 8.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.733 0.302 . . . . 0.0 111.082 177.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.457 ' HB ' HD13 ' A' ' 84' ' ' LEU . 16.5 p -59.37 -26.26 64.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.791 -176.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.599 ' OD2' ' HG2' ' A' ' 24' ' ' LYS . 7.4 p-10 -94.2 -18.23 21.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.185 0.517 . . . . 0.0 110.418 -178.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.56 0.52 21.76 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.412 -177.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.697 ' HZ3' ' HB3' ' A' ' 24' ' ' LYS . 4.8 mmmp? -66.44 126.87 30.21 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-O 121.088 0.471 . . . . 0.0 111.696 178.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -88.67 120.92 30.51 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.445 172.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 17' ' ' THR . 11.3 m -123.66 151.83 28.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.826 0.346 . . . . 0.0 110.324 177.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.2 m -110.11 151.72 26.89 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.414 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.07 -35.35 80.45 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.525 ' HA ' ' CG ' ' A' ' 32' ' ' ARG . 37.7 t -56.88 -23.45 44.63 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.96 177.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.1 m -69.57 -24.0 63.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.27 0.557 . . . . 0.0 110.675 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.44 HD12 ' HB3' ' A' ' 70' ' ' ALA . 67.3 mt -116.1 11.57 15.32 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.932 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.525 ' CG ' ' HA ' ' A' ' 29' ' ' SER . 9.2 mmm180 -74.75 104.18 5.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.975 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 147.79 -24.75 1.48 Allowed Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.739 ' HB3' ' HZ1' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -115.45 174.74 5.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.161 -0.519 . . . . 0.0 110.466 177.883 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 68' ' ' ASP . 26.8 m -74.72 128.59 36.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.0 t -123.68 112.17 32.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 120.959 0.409 . . . . 0.0 110.575 -176.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.434 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 27.3 ttt -95.98 127.12 41.72 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.734 178.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.6 mp -122.05 137.15 54.92 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.771 176.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.4 pm0 -126.91 129.3 47.92 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 171.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.475 ' O ' ' HA ' ' A' ' 116' ' ' THR . 96.8 m-85 -90.73 110.39 21.58 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.007 -179.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.61 HG23 ' SG ' ' A' ' 48' ' ' CYS . 28.5 m -119.49 165.21 14.68 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.438 -166.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.574 ' HB1' ' SG ' ' A' ' 45' ' ' CYS . . . -145.11 147.12 32.18 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 171.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.442 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 81.0 p -60.56 -21.52 62.65 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -174.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 8.5 p-90 -103.06 3.68 36.32 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -175.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.629 ' SG ' HD12 ' A' ' 115' ' ' ILE . 89.9 m -79.59 102.12 8.69 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.97 0.414 . . . . 0.0 111.082 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.98 -40.48 97.17 Favored Glycine 0 C--O 1.228 -0.271 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.874 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 56.9 t -61.4 -37.25 77.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.222 0.534 . . . . 0.0 110.614 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.61 ' SG ' HG23 ' A' ' 41' ' ' THR . 22.8 t -72.32 -14.85 61.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.762 -178.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -75.2 -7.28 53.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.971 0.415 . . . . 0.0 110.781 177.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.458 ' HD3' ' CD2' ' A' ' 134' ' ' TYR . 70.4 mttt -83.42 -47.84 10.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 122.343 1.068 . . . . 0.0 108.376 163.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.769 ' HB2' ' HB2' ' A' ' 134' ' ' TYR . 40.3 tt0 -58.24 -58.34 8.91 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 113.263 -1.789 . . . . 0.0 112.108 -173.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.78 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 96.1 mmm -50.3 -57.43 12.96 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -175.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.78 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 32.7 Cg_exo -61.49 -38.9 59.61 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 122.3 2.0 . . . . 0.0 112.823 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.501 ' HB3' ' CZ ' ' A' ' 139' ' ' PHE . 6.4 m-85 -65.41 -43.76 89.54 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.496 0.189 . . . . 0.0 111.305 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 51' ' ' GLU . 77.0 mt -58.03 -47.86 85.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 175.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -54.75 -54.18 45.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.633 176.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -62.33 -59.31 5.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.181 -0.918 . . . . 0.0 113.226 -173.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.906 ' HA ' ' HZ1' ' A' ' 62' ' ' LYS . 67.9 m-20 -107.13 -13.53 15.14 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -166.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.2 mt -104.59 -57.24 4.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.476 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.529 ' CE2' ' HB3' ' A' ' 94' ' ' TYR . 71.3 t-105 -60.97 -68.32 0.32 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.868 -177.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.01 -23.49 2.07 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -175.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.906 ' HZ1' ' HA ' ' A' ' 58' ' ' ASP . 38.9 mmtm -87.42 -37.44 17.02 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -175.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -130.51 0.16 4.46 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -171.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.464 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 16.5 pttp -39.34 -51.91 2.04 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 -169.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.02 -83.66 0.16 Allowed 'General case' 0 C--O 1.251 1.163 0 CA-C-O 121.458 0.647 . . . . 0.0 110.117 -173.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 56.57 -153.46 0.36 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.366 -174.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -111.41 -14.21 13.78 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 168.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.504 ' OD1' ' HB3' ' A' ' 34' ' ' LYS . 5.6 m-20 -144.12 39.78 1.34 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.581 -1.19 . . . . 0.0 112.374 -172.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -121.24 128.63 52.58 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 119.134 -1.026 . . . . 0.0 110.266 168.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.44 ' HB3' HD12 ' A' ' 31' ' ' LEU . . . -130.22 142.48 50.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.841 177.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.434 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 5.6 tt -146.91 123.82 11.32 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 31.8 mt -130.6 129.88 64.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.475 ' HA3' HD21 ' A' ' 96' ' ' LEU . . . -88.05 131.83 10.87 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 175.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.0 mm -119.85 107.77 21.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 117.034 0.417 . . . . 0.0 110.842 -170.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.531 ' HA ' ' O ' ' A' ' 41' ' ' THR . 11.6 t70 -77.82 143.46 37.85 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.727 178.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 51.9 ttt-85 -71.01 -30.43 66.66 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -171.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -154.86 -32.67 0.1 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -174.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.562 ' CD ' ' HZ2' ' A' ' 82' ' ' LYS . 11.9 mm-40 -61.96 141.72 95.46 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.101 0.477 . . . . 0.0 112.258 -166.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -74.51 179.83 5.53 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 123.018 2.479 . . . . 0.0 112.793 178.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.526 HD21 HD12 ' A' ' 98' ' ' LEU . 88.1 mt -49.37 -55.57 12.52 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.846 -178.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -50.52 -36.62 34.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.638 -173.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.562 ' HZ2' ' CD ' ' A' ' 78' ' ' GLU . 41.8 mtpt -82.61 -45.61 14.35 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.77 0.319 . . . . 0.0 110.779 -178.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.555 HG21 ' HB3' ' A' ' 98' ' ' LEU . 91.0 t -56.53 -46.71 82.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.434 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.457 HD13 ' HB ' ' A' ' 21' ' ' THR . 4.1 mm? -58.52 -52.9 63.7 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.765 0.317 . . . . 0.0 111.361 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.49 -37.76 84.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.553 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.442 ' CD1' ' HA ' ' A' ' 43' ' ' SER . 91.8 t80 -65.88 -42.85 89.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.073 -179.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.448 ' HB3' HD13 ' A' ' 96' ' ' LEU . . . -66.43 -43.48 85.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.731 0.777 . . . . 0.0 109.897 178.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -59.6 -27.82 66.63 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.205 -1.361 . . . . 0.0 111.801 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.5 m -100.83 -0.47 36.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.837 -176.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.7 p -117.77 2.34 12.23 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.355 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.53 15.29 80.01 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.837 175.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.478 HG21 ' HE3' ' A' ' 52' ' ' MET . 72.6 t -73.62 127.03 35.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -177.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 61.3 p -106.31 -24.16 12.35 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.526 174.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.529 ' HB3' ' CE2' ' A' ' 60' ' ' TRP . 34.8 p90 -71.2 145.03 90.49 Favored Pre-proline 0 C--O 1.232 0.136 0 CA-C-O 120.884 0.374 . . . . 0.0 111.118 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.76 134.83 56.21 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.826 2.351 . . . . 0.0 112.893 -177.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.475 HD21 ' HA3' ' A' ' 73' ' ' GLY . 53.8 mt -109.72 139.06 45.2 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.734 174.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -113.28 145.29 18.29 Favored Glycine 0 N--CA 1.439 -1.139 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 174.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.599 HD11 ' H ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -103.54 139.02 39.43 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.188 0.518 . . . . 0.0 110.937 -179.903 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -118.83 82.0 19.99 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.12 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.74 105.07 0.6 Allowed 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.409 2.073 . . . . 0.0 112.79 -176.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.96 8.64 27.47 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.581 178.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 52.31 42.14 30.81 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -81.04 -49.78 10.48 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.123 0.487 . . . . 0.0 110.692 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 98.7 mt -66.72 -31.38 53.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 176.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -60.15 -41.13 92.08 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.177 171.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.664 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -67.23 -24.49 65.82 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.811 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.412 ' O ' ' HG2' ' A' ' 14' ' ' PRO . 14.7 mptt -64.56 -23.69 67.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.963 0.411 . . . . 0.0 111.025 176.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.5 ' HH ' ' HE2' ' A' ' 16' ' ' PHE . 57.2 m-85 -113.71 -11.74 12.9 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -173.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.664 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . 179.58 178.31 0.55 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.758 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 94.6 mt -67.87 133.93 50.01 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 175.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.456 ' HE ' ' HB2' ' A' ' 111' ' ' ARG . 1.5 mtm180 -52.39 -51.6 58.13 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 122.058 0.933 . . . . 0.0 110.578 -176.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.08 21.75 6.49 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.229 -1.35 . . . . 0.0 111.457 -172.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.758 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . . . -93.78 6.06 49.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.172 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 139.34 -164.5 25.91 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.464 178.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.749 HD13 ' N ' ' A' ' 116' ' ' THR . 0.0 OUTLIER -168.12 155.61 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.803 HG22 ' HA ' ' A' ' 133' ' ' LEU . 55.8 m 75.54 95.85 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.791 0.805 . . . . 0.0 110.386 -178.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -160.17 145.56 15.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.99 -177.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.55 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 31.1 m-80 -102.3 119.18 38.38 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.148 -178.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.1 t -118.3 109.97 28.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.843 -178.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 49.2 tp -100.31 117.06 33.74 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.699 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 53.8 mt -97.19 134.24 35.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.46 177.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.586 ' OD2' ' HB2' ' A' ' 126' ' ' LYS . 3.1 p30 -86.04 177.26 7.63 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.267 0.556 . . . . 0.0 111.261 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -66.15 -24.7 66.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.341 -177.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -80.41 -19.02 47.17 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.725 0.298 . . . . 0.0 110.557 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 106.85 12.02 25.15 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.12 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.655 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 8.3 mtmp? -102.58 158.31 16.32 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.5 HD12 ' CG1' ' A' ' 7' ' ' VAL . 54.0 mt -94.5 125.67 47.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 174.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.7 m -105.47 -22.04 5.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.901 0.382 . . . . 0.0 111.764 -174.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.412 ' HA ' ' HD2' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -142.28 125.9 16.87 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.139 -0.624 . . . . 0.0 112.35 -172.081 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.592 HD13 HG12 ' A' ' 9' ' ' ILE . 10.5 mp -114.74 117.67 31.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.405 172.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.55 ' HB ' ' HB2' ' A' ' 118' ' ' ASN . 4.2 m -122.69 131.78 53.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.801 0.334 . . . . 0.0 110.651 171.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.624 ' O ' ' HD2' ' A' ' 132' ' ' ARG . 0.1 OUTLIER -93.09 120.6 33.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.745 178.932 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.803 ' HA ' HG22 ' A' ' 116' ' ' THR . 16.9 mt 61.93 179.96 0.12 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.557 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.769 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 84.6 t80 -83.95 97.96 9.54 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 171.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -107.63 120.52 42.45 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 173.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -43.7 -56.4 3.8 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 123.841 0.713 . . . . 0.0 112.803 -173.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -56.65 -46.13 81.21 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -178.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -71.54 -35.2 70.58 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.602 -175.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.501 ' CZ ' ' HB3' ' A' ' 54' ' ' PHE . 81.4 t80 -66.06 -41.06 91.31 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 175.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.84 -41.97 98.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.42 175.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.1 m -63.27 -39.18 93.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.052 177.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.722 ' O ' HG12 ' A' ' 146' ' ' ILE . 35.6 mt -59.38 -52.46 65.52 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.575 177.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 139' ' ' PHE . 91.6 t -52.48 -50.27 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 O-C-N 123.376 0.422 . . . . 0.0 111.433 -178.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -60.41 -41.72 94.49 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.075 0.464 . . . . 0.0 110.339 178.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -63.49 -42.24 98.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.687 178.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.722 HG12 ' O ' ' A' ' 142' ' ' LEU . 35.4 mm -56.73 -46.88 83.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -56.26 -43.38 78.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.692 177.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.433 ' CD ' ' HZ3' ' A' ' 151' ' ' LYS . 8.7 tp10 -72.89 -33.7 66.2 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.209 -178.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 92.1 mmm -65.41 -24.88 67.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.162 0.506 . . . . 0.0 110.378 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.619 HD23 ' O ' ' A' ' 146' ' ' ILE . 4.0 mm? -79.16 -19.35 51.2 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.205 176.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.433 ' HZ3' ' CD ' ' A' ' 148' ' ' GLU . 2.8 mtmm -103.03 -19.01 14.73 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 121.088 -0.245 . . . . 0.0 110.635 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.54 ' CD ' ' H ' ' A' ' 153' ' ' GLY . 1.2 pp20? 36.86 -105.72 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.54 ' H ' ' CD ' ' A' ' 152' ' ' GLU . . . -85.08 30.09 4.07 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.662 -173.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -101.41 1.49 38.43 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.151 0.475 . . . . 0.0 110.062 177.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -97.31 9.45 42.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.427 0.632 . . . . 0.0 109.715 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.413 ' C ' ' H ' ' A' ' 158' ' ' HIS . 0.2 OUTLIER -140.71 164.21 30.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.218 177.692 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 40.4 t60 -79.89 31.89 0.26 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.493 -177.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.413 ' H ' ' C ' ' A' ' 156' ' ' HIS . 37.3 m80 65.9 16.52 10.51 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.362 0.601 . . . . 0.0 109.884 -171.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 . . . . . 0 C--O 1.248 0.976 0 CA-C-N 114.761 -1.108 . . . . 0.0 108.649 179.963 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.734 ' HG3' HD12 ' A' ' 3' ' ' LEU . 20.2 ptt? . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.414 ' O ' ' HB2' ' A' ' 3' ' ' LEU . 5.4 m -83.59 -21.06 32.7 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 123.322 0.389 . . . . 0.0 111.755 -175.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.913 ' HA ' ' HD2' ' A' ' 132' ' ' ARG . 9.9 mp 70.54 -57.28 0.59 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.182 0.593 . . . . 0.0 111.65 -177.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.486 ' HA3' ' HB1' ' A' ' 113' ' ' ALA . . . 98.25 3.96 57.57 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.102 -0.571 . . . . 0.0 112.239 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.668 ' HD2' ' HB3' ' A' ' 3' ' ' LEU . 71.4 m-85 -80.18 133.22 36.02 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.86 0.362 . . . . 0.0 110.822 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.7 pt -101.8 -7.42 9.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.01 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.3 p -110.98 159.15 11.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.48 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 24.1 mtm-85 -120.71 165.66 14.78 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -168.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.518 HG12 HD23 ' A' ' 130' ' ' LEU . 62.1 mt -76.05 137.23 23.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.414 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.51 -26.09 23.25 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.083 178.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -67.75 150.88 48.09 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.699 ' SD ' ' HG2' ' A' ' 126' ' ' LYS . 63.3 mmm -71.79 124.03 23.92 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.463 ' HB3' HD13 ' A' ' 121' ' ' ILE . . . -54.89 140.72 60.05 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.08 -178.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.68 174.58 6.33 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.613 2.209 . . . . 0.0 112.254 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.527 ' O ' ' HB3' ' A' ' 16' ' ' PHE . 3.0 p-10 -78.69 174.4 11.45 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.999 177.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.703 ' CE2' ' HG ' ' A' ' 28' ' ' LEU . 16.5 p90 176.36 144.96 0.08 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.428 163.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.642 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 56.2 m -127.93 99.88 5.69 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.444 -0.798 . . . . 0.0 108.866 175.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 25' ' ' GLN . 20.3 tt -106.0 146.91 12.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.22 -171.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 24' ' ' LYS . 24.4 m -83.19 127.87 33.99 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.027 177.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.7 mt -84.46 177.62 8.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.144 0.497 . . . . 0.0 111.462 -178.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.422 ' HB ' HD23 ' A' ' 84' ' ' LEU . 21.8 p -62.74 -23.5 67.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.988 -175.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.518 ' OD2' ' HG2' ' A' ' 24' ' ' LYS . 7.5 p-10 -105.47 9.07 33.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.167 0.508 . . . . 0.0 110.527 -176.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.3 14.17 59.15 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.247 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.518 ' HG2' ' OD2' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -85.52 171.21 11.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.207 0.503 . . . . 0.0 109.865 175.6 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 50.7 mt-30 -136.09 129.12 31.39 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 176.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 17' ' ' THR . 21.7 m -119.52 150.49 21.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.673 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 9.4 m -117.86 142.7 47.03 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.996 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.703 ' HG ' ' CE2' ' A' ' 16' ' ' PHE . 0.6 OUTLIER -64.04 -22.68 67.03 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.623 0.249 . . . . 0.0 111.358 -179.033 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.0 m -61.25 -38.43 86.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.967 0.413 . . . . 0.0 110.645 177.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.5 m -73.09 -23.66 60.56 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.52 0.676 . . . . 0.0 110.784 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.421 ' HB2' HD22 ' A' ' 28' ' ' LEU . 91.7 mt -88.1 -9.19 54.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.761 -177.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.435 HH21 HD11 ' A' ' 28' ' ' LEU . 5.8 mmt180 -60.63 150.57 31.5 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.741 0.305 . . . . 0.0 110.422 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.8 -23.75 31.38 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.602 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 31.2 mtmm -117.45 157.3 26.47 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.842 -0.679 . . . . 0.0 109.985 -178.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 68' ' ' ASP . 18.3 m -71.43 131.42 34.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.183 0.516 . . . . 0.0 109.896 177.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.501 HG13 HD23 ' A' ' 28' ' ' LEU . 20.8 t -120.01 123.56 71.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.904 0.383 . . . . 0.0 110.824 -177.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.538 ' SD ' HG22 ' A' ' 59' ' ' ILE . 28.1 ttt -108.29 117.05 33.13 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.9 0.381 . . . . 0.0 110.525 177.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -104.66 103.79 13.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.205 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.59 ' OE1' ' HG2' ' A' ' 52' ' ' MET . 0.0 OUTLIER -103.38 112.59 25.56 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.707 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 97.3 m-85 -91.86 120.06 32.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.78 -176.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.524 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 15.2 t -140.41 -178.43 5.49 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.756 -173.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.484 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . . . -162.76 157.07 21.09 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 122.721 0.408 . . . . 0.0 110.073 172.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.427 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 12.3 t -64.24 -32.54 74.17 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.672 -175.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 51.0 p-90 -83.85 8.17 15.72 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -174.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 43.4 t -99.62 130.87 45.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.964 0.411 . . . . 0.0 111.338 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -89.07 -28.48 20.52 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.624 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.4 t -67.32 -35.74 74.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.157 0.503 . . . . 0.0 110.269 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.557 ' HA ' ' HB3' ' A' ' 51' ' ' GLU . 59.4 m -65.78 -15.15 62.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.517 177.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.43 ' O ' ' HG2' ' A' ' 53' ' ' PRO . 84.4 mtt180 -78.74 -3.72 45.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.331 0.586 . . . . 0.0 110.148 177.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.466 ' NZ ' ' HE2' ' A' ' 134' ' ' TYR . 1.4 mmmp? -95.2 -52.39 4.21 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 162.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.716 ' O ' HG12 ' A' ' 55' ' ' ILE . 41.1 tt0 -56.36 -65.25 0.64 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 113.478 -1.692 . . . . 0.0 112.153 -173.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.59 ' HG2' ' OE1' ' A' ' 39' ' ' GLN . 1.7 mmm -56.29 -50.04 89.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -173.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.617 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 53.3 Cg_exo -55.34 -37.96 94.19 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 121.868 1.712 . . . . 0.0 112.097 176.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -72.69 -37.5 67.85 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.426 177.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.716 HG12 ' O ' ' A' ' 51' ' ' GLU . 28.9 mm -55.04 -57.48 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 121.025 0.441 . . . . 0.0 110.147 177.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.728 ' HG2' ' HA ' ' A' ' 92' ' ' VAL . 0.5 OUTLIER -66.18 -43.66 86.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.359 -177.617 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.617 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 3.7 ttmm -62.46 -41.52 98.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.775 -172.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.62 ' O ' ' HG2' ' A' ' 62' ' ' LYS . 6.1 t70 -104.61 -65.09 1.06 Allowed 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.877 178.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.538 HG22 ' SD ' ' A' ' 37' ' ' MET . 25.1 mm -54.01 -46.77 65.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-O 120.97 0.414 . . . . 0.0 111.113 -171.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.511 ' HB3' ' O ' ' A' ' 56' ' ' GLU . 73.5 t-105 -73.92 -60.65 2.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.17 -178.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.55 HD13 ' CE ' ' A' ' 64' ' ' LYS . 3.8 mm? -50.72 -35.09 29.61 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -173.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.62 ' HG2' ' O ' ' A' ' 58' ' ' ASP . 33.7 mmtp -73.93 -27.98 61.29 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -175.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 -126.38 -43.85 1.74 Allowed 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.191 -0.604 . . . . 0.0 112.626 -172.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.55 ' CE ' HD13 ' A' ' 61' ' ' LEU . 55.2 mttt 45.75 -89.82 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.011 0.924 . . . . 0.0 112.679 -176.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.413 ' C ' ' H ' ' A' ' 67' ' ' ALA . 15.7 t70 -87.31 -71.03 0.58 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 65.03 -4.07 0.53 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.206 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.413 ' H ' ' C ' ' A' ' 65' ' ' ASP . . . 68.48 -6.65 0.78 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.961 0.904 . . . . 0.0 112.125 -176.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.602 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 3.9 t70 -137.89 8.35 2.77 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.951 0.405 . . . . 0.0 110.692 -177.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.542 ' CE2' ' HB2' ' A' ' 71' ' ' LEU . 72.3 t80 -116.01 119.07 34.68 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.096 -0.642 . . . . 0.0 111.283 -174.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.75 107.9 12.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.669 178.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.542 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 1.7 tt -117.46 120.55 38.47 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 52.6 mt -129.89 131.31 66.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.759 0.314 . . . . 0.0 110.288 179.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.58 116.94 4.62 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 176.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 25.6 mm -103.92 111.36 33.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 116.615 0.208 . . . . 0.0 110.6 -173.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.524 ' HA ' ' O ' ' A' ' 41' ' ' THR . 8.9 t70 -80.79 140.06 35.68 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 44.4 ttt-85 -78.26 -30.92 48.82 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -172.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -163.45 -16.01 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -170.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.477 ' CD ' ' HD2' ' A' ' 82' ' ' LYS . 6.0 mm-40 -77.33 137.06 64.4 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.141 0.496 . . . . 0.0 110.793 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.494 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 30.7 Cg_endo -68.39 -174.59 0.7 Allowed 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.098 2.532 . . . . 0.0 114.576 -177.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.645 HD23 HD22 ' A' ' 84' ' ' LEU . 5.2 tt -54.26 -59.04 5.2 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.299 -1.319 . . . . 0.0 112.393 -170.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.494 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -61.31 -36.31 79.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.914 -171.883 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.477 ' HD2' ' CD ' ' A' ' 78' ' ' GLU . 42.2 mttt -64.36 -48.23 76.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.033 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.459 HG21 ' O ' ' A' ' 79' ' ' PRO . 57.9 t -53.84 -46.47 63.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.554 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.645 HD22 HD23 ' A' ' 80' ' ' LEU . 4.4 mm? -62.4 -50.37 71.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.042 178.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.48 97.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.712 -177.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.427 ' CD1' ' HA ' ' A' ' 43' ' ' SER . 62.4 t80 -66.93 -43.47 83.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.916 -178.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.19 -39.77 86.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.441 0.638 . . . . 0.0 110.212 178.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -59.12 -39.72 83.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.315 176.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.8 m -86.02 -19.31 30.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.162 -174.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.5 p -93.57 -29.81 15.3 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.426 -179.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 112.64 -3.02 26.17 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.161 178.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.728 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 60.6 t -50.88 115.89 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 122.794 0.438 . . . . 0.0 111.866 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.7 m -100.43 0.32 39.56 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.454 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.471 ' CE2' HG13 ' A' ' 92' ' ' VAL . 54.3 p90 -102.12 152.9 38.31 Favored Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.142 178.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.93 148.75 76.9 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.568 2.179 . . . . 0.0 113.107 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.454 HD12 HG11 ' A' ' 92' ' ' VAL . 5.2 mp -124.78 159.51 30.8 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.412 179.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -125.76 147.93 16.8 Favored Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 174.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.505 HD21 ' H ' ' A' ' 98' ' ' LEU . 0.6 OUTLIER -105.09 132.23 51.59 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.82 0.31 . . . . 0.0 110.737 -177.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -120.39 75.91 24.85 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.47 178.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -65.29 101.08 0.4 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.476 2.117 . . . . 0.0 112.09 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 126.5 -7.5 7.47 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.862 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.406 ' O ' ' HB1' ' A' ' 106' ' ' ALA . . . 58.18 44.01 19.64 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.691 0.396 . . . . 0.0 111.486 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -89.99 -46.54 8.44 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.129 0.49 . . . . 0.0 110.086 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.58 HD12 ' HB2' ' A' ' 16' ' ' PHE . 33.4 mm -61.76 -36.1 71.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 172.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -63.65 -39.15 93.62 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 113.624 -1.626 . . . . 0.0 110.467 174.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.596 ' HB1' ' HG2' ' A' ' 111' ' ' ARG . . . -71.72 -30.61 65.83 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -174.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.516 ' HE2' ' O ' ' A' ' 15' ' ' ASP . 13.1 ptmt -79.11 -1.78 37.53 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.857 -175.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -108.14 -37.69 5.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.223 0.535 . . . . 0.0 110.807 171.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -152.74 166.0 33.56 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.9 pp -60.42 163.98 4.77 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.85 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.596 ' HG2' ' HB1' ' A' ' 106' ' ' ALA . 50.5 mtt-85 -75.94 58.21 1.14 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -164.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 19.2 t70 169.68 -75.1 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.034 -1.439 . . . . 0.0 107.783 173.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.554 ' HB3' ' NH2' ' A' ' 117' ' ' ARG . . . 47.91 27.06 1.07 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.986 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.474 ' HA3' ' NH2' ' A' ' 132' ' ' ARG . . . 72.32 106.81 0.06 OUTLIER Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -170.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.444 ' O ' ' HB ' ' A' ' 116' ' ' THR . 19.2 tt -64.77 167.29 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.879 HG23 ' HA ' ' A' ' 133' ' ' LEU . 32.9 m 75.31 88.57 0.09 Allowed 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -174.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.952 ' HG2' ' HA ' ' A' ' 132' ' ' ARG . 41.0 mtm105 -157.61 145.76 19.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.451 -177.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -112.61 119.39 37.96 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.844 -177.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 72.2 t -110.01 107.32 22.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.838 177.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.628 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 55.0 tp -98.4 133.74 42.37 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.939 0.4 . . . . 0.0 110.337 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.463 HD13 ' HB3' ' A' ' 13' ' ' ALA . 38.2 mm -114.52 134.49 57.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.002 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.33 160.7 30.78 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 176.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.447 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 6.8 ptm180 -68.0 -22.03 65.01 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -173.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.585 ' HB2' ' HZ2' ' A' ' 126' ' ' LYS . 46.2 mt-10 -76.28 -18.52 58.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.293 0.568 . . . . 0.0 110.087 175.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 109.79 9.67 24.31 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.687 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.699 ' HG2' ' SD ' ' A' ' 12' ' ' MET . 35.3 mtmm -91.02 139.36 30.84 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.165 0.483 . . . . 0.0 110.725 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.445 HG12 HD13 ' A' ' 121' ' ' ILE . 35.3 mt -70.53 121.64 20.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 120' ' ' LEU . 8.7 p -114.19 -31.54 2.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -164.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.628 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 7.1 tmtm? -145.36 112.28 5.98 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.316 -0.553 . . . . 0.0 111.154 -174.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.518 HD23 HG12 ' A' ' 9' ' ' ILE . 2.8 mm? -112.2 111.74 22.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.888 175.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.2 t -129.32 162.46 27.9 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.689 175.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.952 ' HA ' ' HG2' ' A' ' 117' ' ' ARG . 28.8 mtp-105 -112.53 132.62 55.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.059 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.879 ' HA ' HG23 ' A' ' 116' ' ' THR . 4.6 pp 53.84 172.27 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.93 1.292 . . . . 0.0 113.687 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.466 ' HE2' ' NZ ' ' A' ' 50' ' ' LYS . 54.3 t80 -84.17 94.93 8.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.109 177.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.501 ' HB3' ' HB3' ' A' ' 138' ' ' GLU . 11.6 t30 -95.39 133.45 39.33 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 172.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -55.53 -56.94 14.39 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 123.163 0.289 . . . . 0.0 111.667 -169.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.47 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.5 mp0 -63.95 -33.13 75.02 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.178 0.513 . . . . 0.0 110.677 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.501 ' HB3' ' HB3' ' A' ' 135' ' ' ASN . 7.2 tp10 -65.63 -44.95 84.89 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.088 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.609 ' O ' HG23 ' A' ' 143' ' ' VAL . 90.5 t80 -60.96 -43.52 98.6 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.167 178.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.73 -44.9 86.32 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.007 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.7 m -63.33 -43.59 97.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.629 177.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.62 -44.3 96.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.597 -178.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 139' ' ' PHE . 95.7 t -56.75 -59.41 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.994 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -57.59 -36.91 72.35 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.534 -177.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.638 ' O ' ' HG3' ' A' ' 149' ' ' MET . 6.7 tt0 -62.62 -53.56 52.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.414 177.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 64.3 mt -56.74 -42.2 76.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 120.962 0.41 . . . . 0.0 110.835 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.761 ' O ' ' HG3' ' A' ' 151' ' ' LYS . 93.5 m-20 -51.16 -55.05 19.86 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.275 178.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -64.18 -29.01 70.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.321 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.638 ' HG3' ' O ' ' A' ' 145' ' ' GLN . 92.8 mtp -61.4 -36.7 81.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.574 0.226 . . . . 0.0 110.842 -176.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.71 -10.11 30.12 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.293 -0.563 . . . . 0.0 112.424 178.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.761 ' HG3' ' O ' ' A' ' 147' ' ' ASN . 8.7 mtmp? -85.91 -64.19 1.2 Allowed 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.687 174.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.469 ' CD ' ' H ' ' A' ' 153' ' ' GLY . 1.5 pp20? 34.44 -81.11 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.404 0 O-C-N 125.173 1.546 . . . . 0.0 114.452 -174.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.469 ' H ' ' CD ' ' A' ' 152' ' ' GLU . . . 70.68 23.9 77.38 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.364 -1.095 . . . . 0.0 110.364 -172.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 42.9 m-70 -100.13 -10.16 21.76 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.089 0.471 . . . . 0.0 110.113 -174.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.7 93.52 3.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.332 0.587 . . . . 0.0 110.706 175.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -55.88 134.98 52.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.544 175.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -80.65 -36.9 31.85 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -171.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 24.2 t-80 -157.12 10.2 0.2 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.124 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 . . . . . 0 C--O 1.242 0.672 0 CA-C-O 118.322 -0.846 . . . . 0.0 109.86 -179.458 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.8 mmm . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.745 ' O ' ' HA ' ' A' ' 113' ' ' ALA . 19.6 m -96.01 121.01 37.3 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.678 ' H ' HD22 ' A' ' 3' ' ' LEU . 1.6 pt? -63.06 91.43 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.701 0.762 . . . . 0.0 111.172 -177.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.59 78.21 1.94 Allowed Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.657 -177.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -81.62 102.84 10.92 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.168 0.509 . . . . 0.0 110.688 177.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.454 HG12 ' HA ' ' A' ' 109' ' ' ALA . 27.3 pt -95.22 9.53 5.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.769 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.663 HG12 HD11 ' A' ' 127' ' ' ILE . 23.2 t -118.45 153.77 20.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.135 -177.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.429 ' HB2' ' HB2' ' A' ' 11' ' ' GLU . 41.0 mtt180 -104.42 163.63 12.31 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.915 0.388 . . . . 0.0 110.924 -174.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.52 HG12 HD21 ' A' ' 130' ' ' LEU . 71.3 mt -83.16 117.78 29.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 170.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.88 0.39 56.29 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 -173.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.429 ' HB2' ' HB2' ' A' ' 8' ' ' ARG . 4.1 tp10 -69.47 144.14 53.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.289 -0.456 . . . . 0.0 110.501 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.52 ' HE2' ' HA ' ' A' ' 12' ' ' MET . 1.4 mmt -68.58 111.9 5.04 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 174.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.446 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -58.25 133.96 84.69 Favored Pre-proline 0 C--O 1.237 0.396 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.604 -176.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 6.4 Cg_exo -73.12 174.45 12.01 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.105 2.536 . . . . 0.0 112.245 178.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -81.7 168.74 17.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.663 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.556 ' HB2' HD11 ' A' ' 104' ' ' ILE . 33.5 p90 -177.57 143.56 0.36 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.316 165.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 62.7 m -117.72 106.43 13.05 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 173.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.1 tt -111.75 138.92 38.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.085 -169.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.2 m -88.2 117.95 27.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.399 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.3 mt -80.92 167.82 19.42 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.153 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.419 ' HB ' HD13 ' A' ' 84' ' ' LEU . 17.4 p -54.45 -28.08 41.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.512 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -93.6 15.32 16.44 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.166 -174.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.85 27.41 68.99 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.674 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 49.8 mmtm -108.48 119.26 38.99 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.624 0.25 . . . . 0.0 110.45 -176.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -94.95 115.23 27.19 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.189 178.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 17' ' ' THR . 20.2 m -114.96 150.59 16.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.428 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 20.7 m -110.87 142.67 42.6 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.911 177.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -60.06 -34.62 73.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.951 0.405 . . . . 0.0 110.56 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.4 m -62.86 -25.8 68.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.646 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.2 m -75.36 -21.29 58.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.218 0.532 . . . . 0.0 111.405 -176.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.8 mt -103.47 4.35 35.92 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.48 -178.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.533 ' CZ ' ' HA3' ' A' ' 125' ' ' GLY . 23.7 mmm-85 -65.83 109.67 2.56 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.113 0.482 . . . . 0.0 110.14 178.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.28 -29.44 2.61 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -173.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.413 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 27.2 mttt -96.06 173.08 7.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.237 -0.481 . . . . 0.0 109.985 176.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.445 ' O ' HG23 ' A' ' 35' ' ' VAL . 30.6 m -84.64 108.74 17.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 169.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.447 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 21.2 t -102.6 113.28 38.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.336 -172.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.42 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 27.1 ttt -98.41 124.31 43.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.451 177.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.406 ' HB2' ' HB ' ' A' ' 119' ' ' VAL . 3.2 mm? -109.86 112.99 25.36 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.857 177.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.478 HE22 ' HB ' ' A' ' 41' ' ' THR . 26.2 tm0? -107.28 107.1 17.87 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -82.22 127.31 33.05 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.518 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 12.4 t -140.44 176.19 8.98 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.136 0.493 . . . . 0.0 111.141 -172.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.466 ' HB1' HG12 ' A' ' 115' ' ' ILE . . . -152.36 133.5 14.28 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.494 177.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.487 ' HG ' ' HG3' ' A' ' 78' ' ' GLU . 12.4 p -63.59 -9.21 12.36 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -177.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 12.4 p-90 -108.79 12.82 25.38 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.84 0.352 . . . . 0.0 111.496 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 49.4 t -108.09 111.8 24.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.923 0.392 . . . . 0.0 110.695 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.1 -22.88 77.41 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.675 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.2 t -63.66 -34.58 68.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.204 0.526 . . . . 0.0 110.214 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.547 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 64.1 m -67.34 -22.33 65.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.705 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.489 ' O ' ' HG2' ' A' ' 53' ' ' PRO . 26.5 mtp-105 -73.69 -3.16 26.57 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.086 0.47 . . . . 0.0 110.583 178.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -97.74 -58.01 2.1 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.059 171.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.938 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 11.3 pt-20 -64.23 -47.96 77.67 Favored 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -175.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.649 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 94.3 mtp -59.87 -51.78 78.34 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -173.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.649 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 52.4 Cg_exo -59.06 -37.96 89.97 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.3 2.0 . . . . 0.0 112.649 174.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 139' ' ' PHE . 10.8 m-85 -67.39 -42.29 83.55 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.796 176.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 51' ' ' GLU . 94.6 mt -59.23 -48.79 85.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.173 177.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.533 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 2.0 pp20? -67.86 -35.25 78.21 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.633 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.55 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 7.9 ttmm -64.04 -44.32 92.86 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.522 -176.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.706 ' O ' ' HG2' ' A' ' 62' ' ' LYS . 3.9 t0 -106.15 -65.65 1.06 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.177 -0.609 . . . . 0.0 111.326 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.478 HG12 HG21 ' A' ' 143' ' ' VAL . 58.2 mt -56.84 -45.05 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 120.858 0.361 . . . . 0.0 111.609 -169.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.561 ' CD2' ' HB3' ' A' ' 94' ' ' TYR . 76.4 t-105 -75.37 -59.47 2.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.472 -177.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.516 HD12 ' O ' ' A' ' 56' ' ' GLU . 1.6 mp -53.83 -30.57 45.83 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -171.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.706 ' HG2' ' O ' ' A' ' 58' ' ' ASP . 31.8 mmtp -76.95 -24.88 52.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.868 0.366 . . . . 0.0 111.667 -177.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.443 ' CE1' ' HG ' ' A' ' 150' ' ' LEU . 73.8 m-70 -121.67 -41.37 2.48 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -172.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp 56.42 -95.38 0.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 122.917 0.487 . . . . 0.0 110.128 -167.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.432 ' O ' ' HB3' ' A' ' 66' ' ' ASN . 15.6 t70 -110.8 -32.07 6.97 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 171.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.432 ' HB3' ' O ' ' A' ' 65' ' ' ASP . 20.2 t-20 67.93 -68.82 0.15 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.038 -176.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 158.71 -33.91 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.627 1.571 . . . . 0.0 106.868 -175.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.413 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 15.1 t70 -125.55 18.66 8.1 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.258 -174.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -124.44 142.59 51.19 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.84 -0.537 . . . . 0.0 110.585 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.63 130.36 20.3 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.541 176.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.42 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 2.0 tt -132.92 114.67 14.31 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.1 mp -122.74 124.08 69.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.121 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.437 ' HA3' ' CD2' ' A' ' 96' ' ' LEU . . . -91.92 136.3 13.19 Favored Glycine 0 C--O 1.222 -0.64 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 173.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 59.9 mt -119.93 103.53 14.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 117.742 0.771 . . . . 0.0 111.388 -175.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.518 ' HA ' ' O ' ' A' ' 41' ' ' THR . 34.4 t0 -80.66 133.1 35.67 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 171.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.507 ' HA ' ' HB3' ' A' ' 99' ' ' ASP . 5.7 ttp180 -71.28 -105.8 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -170.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.486 ' H ' ' HB3' ' A' ' 76' ' ' ARG . 10.1 m-20 -87.33 21.19 2.52 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -168.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.487 ' HG3' ' HG ' ' A' ' 43' ' ' SER . 68.2 mm-40 -98.56 142.86 25.29 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-O 120.981 0.419 . . . . 0.0 111.449 -178.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.44 ' O ' HG23 ' A' ' 83' ' ' VAL . 64.9 Cg_endo -75.54 174.9 12.03 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.936 2.424 . . . . 0.0 112.86 178.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.439 HD23 HD11 ' A' ' 98' ' ' LEU . 32.5 mt -50.93 -50.32 57.96 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.441 -176.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -52.0 -39.82 60.04 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -176.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.479 ' HB3' ' OG ' ' A' ' 43' ' ' SER . 31.7 mmtp -66.84 -53.32 33.75 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.393 178.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 79' ' ' PRO . 15.3 t -60.7 -47.16 94.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.361 -175.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.419 HD13 ' HB ' ' A' ' 21' ' ' THR . 4.0 mm? -60.49 -48.6 81.07 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.902 0.382 . . . . 0.0 111.435 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.892 ' HA ' ' HE2' ' A' ' 88' ' ' LYS . . . -67.24 -35.8 80.31 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.307 -176.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.609 ' HE2' ' SD ' ' A' ' 52' ' ' MET . 56.1 t80 -72.51 -37.34 68.41 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.711 -178.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.46 -49.61 74.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.294 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.892 ' HE2' ' HA ' ' A' ' 85' ' ' ALA . 63.8 pttt -68.54 -29.93 68.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.29 -176.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.2 m -83.75 -2.04 55.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.725 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.458 ' HB ' ' HG3' ' A' ' 53' ' ' PRO . 11.1 p -115.64 -8.12 12.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.895 0.379 . . . . 0.0 110.902 175.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.69 4.14 87.68 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.273 178.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.56 HG23 ' HE1' ' A' ' 52' ' ' MET . 42.6 t -59.98 114.86 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.171 0.51 . . . . 0.0 111.267 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 p -100.68 7.69 43.77 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.632 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.561 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 33.4 p90 -104.25 145.63 31.03 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.228 173.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -63.07 140.6 79.47 Favored 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 122.615 2.21 . . . . 0.0 112.925 -178.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.437 ' CD2' ' HA3' ' A' ' 73' ' ' GLY . 62.5 mt -113.02 144.63 42.25 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.173 176.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -112.22 164.56 12.08 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.886 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.439 HD11 HD23 ' A' ' 80' ' ' LEU . 7.0 mp -102.95 147.49 26.86 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.507 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 36.4 t0 -130.38 70.54 82.33 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-O 121.057 0.456 . . . . 0.0 110.803 174.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.15 110.25 1.72 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.673 2.248 . . . . 0.0 112.211 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.86 -1.21 31.84 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.72 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 54.74 40.01 31.67 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.883 0.373 . . . . 0.0 111.016 -175.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.578 ' O ' ' HG3' ' A' ' 107' ' ' LYS . 15.4 t70 -84.13 -45.71 12.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.511 -174.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.556 HD11 ' HB2' ' A' ' 16' ' ' PHE . 35.3 mm -66.11 -35.55 75.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 177.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.471 ' CE1' ' HD3' ' A' ' 117' ' ' ARG . 56.6 t80 -63.51 -37.18 86.33 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.808 174.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.753 ' HB2' ' HG2' ' A' ' 111' ' ' ARG . . . -69.83 -22.92 63.24 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.566 178.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.578 ' HG3' ' O ' ' A' ' 103' ' ' ASP . 44.5 mtpt -79.46 -3.13 45.16 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.254 178.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -130.99 -3.04 4.02 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.899 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.614 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -178.16 -176.24 0.52 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 122.887 0.475 . . . . 0.0 110.448 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.3 mt -72.92 157.95 36.44 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 172.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.753 ' HG2' ' HB2' ' A' ' 106' ' ' ALA . 48.6 mtt180 -78.2 -10.31 59.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.974 0.416 . . . . 0.0 111.063 -175.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -88.0 -68.77 0.74 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 171.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.745 ' HA ' ' O ' ' A' ' 2' ' ' SER . . . 21.2 -89.26 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.775 0 O-C-N 125.177 1.548 . . . . 0.0 113.885 -178.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -164.1 -138.42 2.41 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.466 HG12 ' HB1' ' A' ' 42' ' ' ALA . 7.4 tp -150.86 -50.33 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.674 177.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.715 ' HB ' ' HB3' ' A' ' 133' ' ' LEU . 1.0 OUTLIER -77.03 107.48 9.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.002 0.429 . . . . 0.0 111.681 -178.974 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.471 ' HD3' ' CE1' ' A' ' 105' ' ' PHE . 6.1 ptm180 -159.7 135.62 8.66 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.062 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.524 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 9.0 m120 -108.68 119.02 38.31 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.406 ' HB ' ' HB2' ' A' ' 38' ' ' LEU . 57.7 t -112.49 138.23 42.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.592 -177.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.55 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 34.2 tp -123.69 123.89 41.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.017 0.437 . . . . 0.0 110.765 175.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.447 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 79.7 mt -101.09 132.51 46.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.274 175.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.05 -179.97 6.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.768 0.318 . . . . 0.0 110.553 -178.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 6.0 ptm85 -69.93 -24.09 63.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.262 -174.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -77.06 -26.98 54.17 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.51 0.671 . . . . 0.0 109.898 174.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.533 ' HA3' ' CZ ' ' A' ' 32' ' ' ARG . . . 109.93 18.77 8.58 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.854 -177.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 11' ' ' GLU . 80.9 mttt -94.63 136.42 34.95 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.954 0.407 . . . . 0.0 110.501 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.663 HD11 HG12 ' A' ' 7' ' ' VAL . 55.4 mt -79.7 99.2 3.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 28.0 m -101.33 -4.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -171.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.55 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 48.3 tptt -146.27 111.53 5.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.14 0.495 . . . . 0.0 111.597 -176.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.52 HD21 HG12 ' A' ' 9' ' ' ILE . 3.3 mm? -109.28 105.85 15.44 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.646 172.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.524 ' HB ' ' HB2' ' A' ' 118' ' ' ASN . 0.4 OUTLIER -109.64 155.86 20.94 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.999 0.428 . . . . 0.0 111.137 -174.479 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -89.85 174.35 7.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.996 178.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.715 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 2.9 pp -45.34 162.07 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 O-C-N 123.608 0.568 . . . . 0.0 112.106 175.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.938 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 91.9 t80 -43.98 97.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -174.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -114.4 129.62 56.66 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 164.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.485 ' HG2' ' HH ' ' A' ' 134' ' ' TYR . 45.2 mt-10 -55.07 -43.49 73.93 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -171.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -60.95 -49.54 77.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.99 0.424 . . . . 0.0 111.445 176.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.437 ' HB3' ' CG2' ' A' ' 131' ' ' THR . 6.6 mt-10 -65.0 -39.96 94.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.263 -178.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 54' ' ' PHE . 70.6 t80 -64.03 -42.05 97.23 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.917 0.389 . . . . 0.0 110.408 175.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.46 -40.62 97.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.725 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 60.7 p -65.64 -29.26 69.81 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.299 -0.409 . . . . 0.0 109.926 178.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.4 mt -73.15 -57.68 3.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.313 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.478 HG21 HG12 ' A' ' 59' ' ' ILE . 7.4 p -59.39 -38.34 74.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 O-C-N 123.11 0.256 . . . . 0.0 110.966 -175.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -67.41 -48.73 66.48 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 177.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.446 ' O ' ' HG2' ' A' ' 149' ' ' MET . 7.1 tt0 -55.98 -48.89 75.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.853 177.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.454 ' O ' HD23 ' A' ' 150' ' ' LEU . 93.1 mt -64.16 -44.44 97.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.189 -178.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -58.93 -40.75 85.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.201 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.491 ' OE1' ' HB2' ' A' ' 151' ' ' LYS . 6.1 tp10 -73.55 -25.95 60.62 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.126 -0.229 . . . . 0.0 110.951 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.446 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 61.1 mmm -66.7 -28.44 68.44 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 175.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.454 HD23 ' O ' ' A' ' 146' ' ' ILE . 4.2 mm? -81.75 -20.63 38.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.83 175.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.657 ' HA ' ' HE2' ' A' ' 151' ' ' LYS . 10.0 mmpt? -102.27 -3.62 26.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.678 -178.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.51 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . 7.0 tp10 -68.67 75.91 0.29 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 122.422 1.106 . . . . 0.0 111.517 178.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -118.6 14.66 11.7 Favored Glycine 0 N--CA 1.436 -1.353 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 164.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.51 ' CE1' ' HA ' ' A' ' 152' ' ' GLU . 2.3 m80 -69.12 -33.03 72.83 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 114.505 -0.847 . . . . 0.0 109.172 -176.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.404 ' HD1' ' CD ' ' A' ' 152' ' ' GLU . 68.2 m80 -106.12 27.88 8.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.308 -177.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -75.91 75.01 2.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.231 0.538 . . . . 0.0 110.857 -177.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 56.4 t60 -138.21 9.75 2.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.358 175.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -99.78 -28.03 13.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.245 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 . . . . . 0 C--O 1.243 0.72 0 CA-C-O 118.585 -0.721 . . . . 0.0 109.806 179.647 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptm . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.704 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . 3.7 p -154.37 127.32 8.25 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 123.386 0.429 . . . . 0.0 109.94 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.7 mp -82.0 80.67 8.2 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.899 0.38 . . . . 0.0 110.714 -177.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 70.82 41.57 62.66 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.548 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.704 ' HB2' ' HB2' ' A' ' 2' ' ' SER . 93.5 m-85 -113.1 152.59 29.4 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 178.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.7 pp -109.99 -0.12 9.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.576 0.703 . . . . 0.0 109.898 171.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.2 p -114.53 163.01 12.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.612 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 28.3 mtm105 -129.88 166.4 20.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.833 0.349 . . . . 0.0 111.916 -171.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.48 HG12 ' CD2' ' A' ' 130' ' ' LEU . 53.2 mt -77.88 140.13 17.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.848 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.96 -16.56 55.0 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.128 -0.558 . . . . 0.0 111.882 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.45 ' HA ' ' OE1' ' A' ' 11' ' ' GLU . 8.0 mm-40 -82.65 158.38 23.01 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.073 0.463 . . . . 0.0 111.086 -178.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 84.9 mmm -77.15 132.33 38.75 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.373 -176.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.493 ' HB2' HD11 ' A' ' 121' ' ' ILE . . . -68.72 130.04 92.08 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.036 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.74 125.63 13.5 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.611 2.207 . . . . 0.0 111.93 177.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -64.77 145.7 55.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.039 -178.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.57 ' HB2' HD13 ' A' ' 104' ' ' ILE . 47.1 p90 -149.54 154.2 38.36 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.471 178.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 34.6 m -118.13 106.18 12.59 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.547 173.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.6 tt -110.72 145.81 16.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.599 -175.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.497 ' O ' HD22 ' A' ' 98' ' ' LEU . 16.5 m -85.99 128.2 34.8 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.309 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.1 mt -80.57 179.54 7.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.092 0.472 . . . . 0.0 111.392 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.469 HG22 ' O ' ' A' ' 96' ' ' LEU . 30.0 p -64.66 -20.03 66.06 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.329 -0.851 . . . . 0.0 112.439 -177.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.502 ' CG ' ' HZ1' ' A' ' 24' ' ' LYS . 10.9 p-10 -106.07 10.74 32.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.919 0.39 . . . . 0.0 110.647 -178.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.14 3.37 67.69 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.665 -0.779 . . . . 0.0 113.398 175.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.502 ' HZ1' ' CG ' ' A' ' 22' ' ' ASP . 32.0 mtmm -84.51 122.93 29.69 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.043 0.421 . . . . 0.0 111.353 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.468 ' HB3' HG23 ' A' ' 17' ' ' THR . 93.6 mt-30 -88.23 116.44 26.43 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 175.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 17' ' ' THR . 17.0 m -107.59 147.15 12.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.217 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.8 m -111.42 144.45 40.61 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.072 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.02 -43.4 91.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.965 0.412 . . . . 0.0 110.328 -178.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.499 ' HA ' ' CG ' ' A' ' 32' ' ' ARG . 49.4 m -62.02 -21.22 64.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.974 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.5 t -76.75 -17.29 59.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.818 0.342 . . . . 0.0 110.433 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.4 mt -118.45 19.55 13.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.136 0.494 . . . . 0.0 110.271 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.505 ' NH1' ' H ' ' A' ' 33' ' ' GLY . 10.6 mmm180 -73.71 155.89 38.48 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.966 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.505 ' H ' ' NH1' ' A' ' 32' ' ' ARG . . . 102.94 -30.97 9.31 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 -177.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.739 ' HB3' ' HZ3' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -114.31 173.55 6.4 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.515 -0.343 . . . . 0.0 110.5 -177.879 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 68' ' ' ASP . 33.2 m -79.35 130.65 35.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.944 0.402 . . . . 0.0 110.055 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.448 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 55.3 t -119.93 113.85 42.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.662 -178.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.785 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 1.6 tmt? -91.68 138.1 31.83 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 176.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.5 mt -127.9 122.51 32.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.509 -175.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -116.81 107.16 14.29 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.547 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.783 ' HB2' ' HB2' ' A' ' 117' ' ' ARG . 92.6 m-85 -90.92 112.54 24.44 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 9.2 t -141.34 -171.43 3.29 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.47 -172.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.413 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . . . -151.14 172.55 15.61 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.681 ' HG ' ' HB2' ' A' ' 86' ' ' PHE . 26.9 t -82.88 -14.04 55.0 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.835 0.35 . . . . 0.0 110.766 -178.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -102.3 -4.37 25.75 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.6 p -88.56 107.4 18.88 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 121.657 -0.652 . . . . 0.0 111.181 -178.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.83 -8.7 82.58 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 115.836 -0.62 . . . . 0.0 113.175 -177.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.4 t -77.34 -45.54 29.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 176.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.645 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 98.0 m -62.93 -22.69 66.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.475 -178.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.537 ' HE ' ' HE1' ' A' ' 86' ' ' PHE . 89.1 mtt180 -69.93 -2.12 11.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.607 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.426 ' O ' ' HD1' ' A' ' 54' ' ' PHE . 58.9 mttp -100.3 -48.28 4.65 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.346 0.593 . . . . 0.0 109.676 171.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 1.092 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 6.5 pt-20 -67.2 -44.36 79.8 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.798 -176.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.763 ' CG ' ' HD3' ' A' ' 53' ' ' PRO . 16.2 ptm -64.18 -39.77 46.66 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-O 118.576 -0.726 . . . . 0.0 112.923 -174.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.763 ' HD3' ' CG ' ' A' ' 52' ' ' MET . 46.6 Cg_exo -61.23 -41.73 40.44 Favored 'Trans proline' 0 C--N 1.362 1.254 0 C-N-CA 121.345 1.363 . . . . 0.0 112.307 169.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.426 ' HD1' ' O ' ' A' ' 50' ' ' LYS . 18.4 m-85 -64.98 -41.88 95.03 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.906 176.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 51' ' ' GLU . 70.2 mt -59.43 -50.52 79.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.094 175.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.56 ' OE1' ' HA ' ' A' ' 92' ' ' VAL . 25.2 tp10 -49.05 -49.67 40.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.232 0.539 . . . . 0.0 110.819 175.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.7 tmmt? -69.29 -47.02 65.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.915 -174.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -106.33 -50.16 3.2 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -173.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.528 HD12 HG12 ' A' ' 55' ' ' ILE . 38.4 mt -71.08 -43.48 75.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.597 -176.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.424 ' CE2' ' HB3' ' A' ' 94' ' ' TYR . 66.8 t-105 -81.66 -77.43 0.22 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.997 -178.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -44.5 -34.99 2.28 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -172.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -84.37 -26.44 28.39 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -173.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -127.15 -9.66 5.89 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -173.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.488 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 18.0 pttp -41.89 -48.84 4.51 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -165.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.52 -83.95 0.11 Allowed 'General case' 0 C--O 1.25 1.094 0 CA-C-O 121.471 0.653 . . . . 0.0 110.197 -172.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.485 ' CG ' ' H ' ' A' ' 67' ' ' ALA . 63.5 t30 49.23 -155.75 0.09 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.631 -169.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.485 ' H ' ' CG ' ' A' ' 66' ' ' ASN . . . -105.99 -10.41 16.6 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 166.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 12.8 m-20 -145.05 39.76 1.22 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.739 -170.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.488 ' CD2' ' HA ' ' A' ' 64' ' ' LYS . 62.1 t80 -118.45 129.3 55.31 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 118.976 -1.089 . . . . 0.0 110.605 169.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.24 143.75 50.97 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.533 175.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.785 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 5.4 tt -143.77 121.56 11.94 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.1 mp -125.67 127.19 71.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.378 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.428 ' HA3' HD21 ' A' ' 96' ' ' LEU . . . -95.53 133.08 11.35 Favored Glycine 0 C--O 1.223 -0.579 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.034 175.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 74.7 mt -119.74 127.38 75.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 117.203 0.501 . . . . 0.0 111.128 -174.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.438 ' O ' ' HB3' ' A' ' 99' ' ' ASP . 11.6 t70 -89.34 144.85 25.76 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.513 HH21 ' HA ' ' A' ' 112' ' ' ASP . 19.8 ttt-85 -69.71 -32.71 71.44 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -172.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -158.38 -34.26 0.07 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -173.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -71.62 138.4 83.27 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 121.262 0.553 . . . . 0.0 111.896 -165.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.561 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 37.4 Cg_endo -72.17 -170.75 0.6 Allowed 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.676 2.917 . . . . 0.0 115.411 -171.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.424 ' O ' HD22 ' A' ' 84' ' ' LEU . 87.7 mt -54.63 -60.35 3.47 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 114.422 -1.263 . . . . 0.0 113.021 -171.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.561 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -59.43 -35.39 73.91 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.032 0.444 . . . . 0.0 110.821 -173.072 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.555 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 19.4 mmmt -61.42 -53.27 58.7 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.237 174.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.405 HG21 ' O ' ' A' ' 79' ' ' PRO . 70.6 t -65.9 -43.57 92.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.341 -178.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.424 HD22 ' O ' ' A' ' 80' ' ' LEU . 4.4 mm? -61.79 -47.37 85.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.399 -178.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.86 -35.19 79.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.752 0.31 . . . . 0.0 110.725 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.681 ' HB2' ' HG ' ' A' ' 43' ' ' SER . 91.3 t80 -67.02 -52.49 41.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.125 178.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.455 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -55.47 -49.54 72.22 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.915 0.388 . . . . 0.0 110.691 177.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.4 tttm -50.69 -36.21 34.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.978 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.9 m -89.78 6.55 41.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.446 -174.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 16.5 p -132.63 8.51 4.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.191 0.519 . . . . 0.0 110.739 176.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.62 -72.12 2.17 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.56 ' HA ' ' OE1' ' A' ' 56' ' ' GLU . 58.1 t 29.37 96.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.148 1.379 . . . . 0.0 114.579 178.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.5 p -94.88 -10.83 30.04 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.639 -0.425 . . . . 0.0 110.553 176.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.424 ' HB3' ' CE2' ' A' ' 60' ' ' TRP . 37.4 p90 -85.49 141.07 36.29 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.381 175.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -62.43 137.71 66.64 Favored 'Trans proline' 0 C--O 1.239 0.546 0 C-N-CA 122.514 2.143 . . . . 0.0 113.359 -177.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.469 ' O ' HG22 ' A' ' 21' ' ' THR . 71.4 mt -109.89 149.46 29.86 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.513 174.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -120.8 148.59 17.57 Favored Glycine 0 N--CA 1.438 -1.213 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 175.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.703 ' H ' HD22 ' A' ' 98' ' ' LEU . 2.3 pt? -103.24 131.79 50.01 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.438 ' HB3' ' O ' ' A' ' 75' ' ' ASP . 12.7 t0 -115.95 79.45 8.15 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.45 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.49 105.09 1.2 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.198 1.932 . . . . 0.0 112.373 -177.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 117.47 1.92 17.79 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.149 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 55.24 39.92 31.49 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 122.638 0.375 . . . . 0.0 111.854 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -79.83 -51.13 9.54 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.283 0.563 . . . . 0.0 110.784 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.57 HD13 ' HB2' ' A' ' 16' ' ' PHE . 30.5 mm -64.82 -34.65 71.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.587 ' CD1' ' HA ' ' A' ' 111' ' ' ARG . 18.1 t80 -65.75 -34.41 78.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.032 175.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -71.88 -23.62 61.54 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.357 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -74.14 -3.9 32.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.255 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -131.0 -35.69 1.38 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.912 0.387 . . . . 0.0 111.269 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -134.52 174.89 10.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.916 0.388 . . . . 0.0 111.109 -177.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.6 mt -78.91 6.22 9.71 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.587 ' HA ' ' CD1' ' A' ' 105' ' ' PHE . 7.3 mtm180 73.98 -68.94 0.2 Allowed 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.981 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.513 ' HA ' HH21 ' A' ' 76' ' ' ARG . 20.6 m-20 -84.77 6.75 23.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.729 -172.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -85.07 41.13 0.86 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.591 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.24 151.94 19.27 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.628 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.48 HG13 ' N ' ' A' ' 116' ' ' THR . 9.5 tp -88.03 171.18 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.48 ' N ' HG13 ' A' ' 115' ' ' ILE . 25.0 m 79.79 108.52 0.07 Allowed 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.298 0.639 . . . . 0.0 111.875 174.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.783 ' HB2' ' HB2' ' A' ' 40' ' ' PHE . 77.5 mmt-85 -138.78 131.15 28.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.151 173.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.443 ' O ' ' HA ' ' A' ' 130' ' ' LEU . 7.6 m120 -114.99 117.14 29.76 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 176.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 39.4 t -129.28 141.4 46.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.879 0.371 . . . . 0.0 111.212 -172.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 46.7 tp -121.61 118.34 28.96 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.092 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.493 HD11 ' HB2' ' A' ' 13' ' ' ALA . 39.4 mm -91.44 121.35 41.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.849 177.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.554 ' OD2' ' HB2' ' A' ' 124' ' ' GLU . 13.6 t0 -67.83 158.35 32.75 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.375 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.7 ptt85 -67.57 -14.56 63.04 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.971 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.554 ' HB2' ' OD2' ' A' ' 122' ' ' ASP . 0.7 OUTLIER -77.63 -16.64 58.43 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 173.052 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.01 24.72 10.21 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.836 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -117.45 156.09 28.56 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.75 0.31 . . . . 0.0 111.359 -175.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.404 HG12 ' CD1' ' A' ' 121' ' ' ILE . 49.8 mt -86.72 113.88 25.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 174.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.1 m -104.2 -17.23 7.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.98 0.419 . . . . 0.0 111.502 -178.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -152.49 119.11 5.67 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.353 -176.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.607 HD13 ' CD2' ' A' ' 5' ' ' TYR . 1.7 pt? -141.28 105.85 4.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.537 0.684 . . . . 0.0 109.741 176.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.9 t -127.59 164.03 22.89 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.575 -175.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.784 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 62.5 mtp180 -114.71 133.12 56.13 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.54 -178.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.784 ' HG ' ' O ' ' A' ' 132' ' ' ARG . 3.9 pp 65.39 154.57 0.07 Allowed 'General case' 0 N--CA 1.471 0.578 0 O-C-N 124.988 1.43 . . . . 0.0 112.982 172.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 1.092 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 58.3 t80 -64.71 102.05 0.54 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.974 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.965 ' HB2' ' HB2' ' A' ' 138' ' ' GLU . 46.1 m-80 -98.93 167.11 10.95 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.948 171.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.14 -68.13 0.69 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.297 0.57 . . . . 0.0 110.03 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -67.83 -31.29 71.03 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.326 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.965 ' HB2' ' HB2' ' A' ' 135' ' ' ASN . 3.1 mm-40 -63.74 -40.13 95.99 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.186 177.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.467 ' HA ' HD11 ' A' ' 142' ' ' LEU . 87.2 t80 -71.1 -41.26 70.83 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.3 -39.15 89.41 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.769 177.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.0 m -65.35 -39.56 92.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.496 178.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.467 HD11 ' HA ' ' A' ' 139' ' ' PHE . 35.9 mt -58.66 -47.97 82.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.763 177.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 94.4 t -56.53 -49.25 78.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.186 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -66.22 -43.25 87.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.048 0.452 . . . . 0.0 110.589 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.506 ' O ' ' HG2' ' A' ' 149' ' ' MET . 12.7 tt0 -58.82 -50.95 72.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.031 179.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.619 ' O ' HD23 ' A' ' 150' ' ' LEU . 77.0 mt -66.83 -30.26 49.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.263 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.597 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 9.2 t-20 -57.68 -43.51 85.14 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.849 176.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.441 ' CD ' ' HE2' ' A' ' 156' ' ' HIS . 4.6 tp10 -67.26 -39.03 86.07 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.687 0.617 . . . . 0.0 111.089 177.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' MET . . . . . 0.543 ' HE1' ' OD1' ' A' ' 122' ' ' ASP . 88.1 mmm -59.68 -27.86 66.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.635 0.731 . . . . 0.0 110.084 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.619 HD23 ' O ' ' A' ' 146' ' ' ILE . 3.4 mm? -88.27 -6.62 57.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.403 179.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.597 ' HG2' ' O ' ' A' ' 147' ' ' ASN . 38.5 mmtm -103.16 -47.36 4.35 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.846 0.355 . . . . 0.0 111.919 -178.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.558 ' HA ' ' HD2' ' A' ' 156' ' ' HIS . 5.9 pt-20 -58.96 -46.43 88.07 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -165.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.484 ' N ' ' HG3' ' A' ' 152' ' ' GLU . . . 74.89 -58.57 2.64 Favored Glycine 0 C--O 1.227 -0.344 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -170.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.453 ' O ' ' HB2' ' A' ' 152' ' ' GLU . 14.7 p-80 -125.53 148.65 48.82 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 106.12 -1.808 . . . . 0.0 106.12 166.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.519 ' HA ' ' OE1' ' A' ' 152' ' ' GLU . 45.5 m-70 -53.4 96.91 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.105 0.411 . . . . 0.0 110.783 -173.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.558 ' HD2' ' HA ' ' A' ' 152' ' ' GLU . 15.3 p80 -87.8 10.81 17.24 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -168.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 24.7 p80 -81.22 46.28 0.92 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 163.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.477 ' H ' ' C ' ' A' ' 156' ' ' HIS . 30.2 t-80 171.14 140.32 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 113.131 -1.85 . . . . 0.0 106.951 -171.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.504 -0.76 . . . . 0.0 109.799 176.694 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 . . . . . 0 N--CA 1.455 -0.186 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.418 HG13 HG23 ' A' ' 7' ' ' VAL . 46.1 pt -96.78 -14.03 7.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.418 0.627 . . . . 0.0 109.42 173.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.616 HG11 HD12 ' A' ' 127' ' ' ILE . 20.5 t -110.36 151.78 12.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.181 177.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.428 ' CD ' ' HB2' ' A' ' 11' ' ' GLU . 5.0 ppt_? -126.25 168.74 13.68 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.699 0.285 . . . . 0.0 111.55 -173.043 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.788 HG12 HD13 ' A' ' 130' ' ' LEU . 72.7 mt -65.92 128.26 28.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 120.955 0.407 . . . . 0.0 110.509 178.049 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.06 -4.35 65.2 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.79 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.428 ' HB2' ' CD ' ' A' ' 8' ' ' ARG . 7.3 tp10 -89.25 151.63 22.03 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.55 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 41.7 mtp -80.29 143.89 33.28 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.126 0.489 . . . . 0.0 110.657 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -81.22 132.24 56.77 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.646 -175.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 27.5 Cg_exo -63.24 156.44 55.54 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.058 2.505 . . . . 0.0 112.071 176.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -97.9 165.6 11.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.818 -177.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.401 ' O ' ' HA ' ' A' ' 27' ' ' THR . 47.9 p90 -177.41 166.0 2.24 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.64 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 45.7 m -131.17 106.29 8.24 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 174.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.3 tt -107.97 143.27 18.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.008 -171.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.0 m -85.39 125.32 32.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.282 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.427 HD22 ' HB2' ' A' ' 95' ' ' PRO . 97.6 mt -83.45 173.74 11.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.33 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 96' ' ' LEU . 3.5 p -58.69 -31.19 67.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.696 -175.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -100.69 18.37 19.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.234 0.54 . . . . 0.0 110.355 -176.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.52 39.07 23.0 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.783 173.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -108.45 136.48 48.0 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.736 0.303 . . . . 0.0 111.064 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -99.45 116.07 30.74 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 17' ' ' THR . 3.1 p -120.23 126.12 74.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.382 0.61 . . . . 0.0 111.158 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 15.7 m -93.44 143.3 26.42 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.115 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.487 HD22 ' HA ' ' A' ' 28' ' ' LEU . 0.7 OUTLIER -66.59 -30.69 71.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.721 0.296 . . . . 0.0 110.295 -176.312 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.9 m -53.2 -43.01 66.85 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.191 176.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.9 m -67.54 -24.75 65.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.561 -175.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.1 mt -88.45 -22.06 23.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.787 -176.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 83.5 mtm-85 -60.2 159.41 9.81 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.894 0.378 . . . . 0.0 111.585 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.544 ' O ' ' HG3' ' A' ' 123' ' ' ARG . . . 85.25 -23.42 8.26 Favored Glycine 0 N--CA 1.452 -0.265 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -172.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.452 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 31.4 mtmm -109.21 167.93 9.75 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 176.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.41 HG21 HD22 ' A' ' 150' ' ' LEU . 26.1 m -81.87 114.19 22.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 121.208 0.528 . . . . 0.0 110.233 177.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.58 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 29.9 t -110.25 115.32 49.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.137 -173.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.489 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 27.6 ttt -101.16 114.73 28.96 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.119 175.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 69.7 mt -110.11 108.58 18.81 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.891 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.445 ' HG2' ' HA2' ' A' ' 73' ' ' GLY . 9.9 pt20 -94.7 130.01 41.37 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.496 ' HB2' ' HG2' ' A' ' 117' ' ' ARG . 77.2 m-85 -101.45 107.14 18.37 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.038 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 12.6 t -130.83 -174.92 3.51 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.252 -171.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.539 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . . . -164.75 143.85 6.99 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.578 177.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 57.1 p -58.64 -25.3 62.59 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -177.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 36.4 p-90 -90.83 7.85 37.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.782 0.325 . . . . 0.0 111.741 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.539 ' SG ' ' HB3' ' A' ' 42' ' ' ALA . 71.8 m -93.25 127.03 38.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.053 0.454 . . . . 0.0 110.905 177.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -85.02 -33.06 19.18 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.457 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.651 HG11 ' HB2' ' A' ' 133' ' ' LEU . 40.3 t -65.11 -34.15 68.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 121.143 0.497 . . . . 0.0 110.629 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.685 ' SG ' HG22 ' A' ' 116' ' ' THR . 92.3 m -66.26 -15.89 63.57 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.461 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.401 ' O ' ' HG2' ' A' ' 53' ' ' PRO . 78.1 mtt180 -78.33 -3.32 42.43 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.478 0.656 . . . . 0.0 110.298 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.407 ' O ' ' HD1' ' A' ' 54' ' ' PHE . 18.8 mtpp -101.77 -45.54 5.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.908 163.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.645 ' HB3' ' HA ' ' A' ' 48' ' ' CYS . 37.4 tt0 -54.87 -63.32 1.19 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.178 -1.374 . . . . 0.0 111.719 -176.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.641 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 79.8 mtp -59.33 -52.19 76.15 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.994 -173.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.641 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 50.5 Cg_exo -56.4 -40.8 82.21 Favored 'Trans proline' 0 C--N 1.358 1.034 0 C-N-CA 122.165 1.91 . . . . 0.0 112.752 179.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.407 ' HD1' ' O ' ' A' ' 50' ' ' LYS . 17.0 m-85 -67.21 -44.81 78.64 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.443 177.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.57 ' O ' ' HB ' ' A' ' 59' ' ' ILE . 81.8 mt -56.44 -45.34 81.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.531 176.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.618 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 38.6 tt0 -62.55 -48.69 78.4 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.415 178.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.517 ' HA ' HD22 ' A' ' 61' ' ' LEU . 29.1 ttpp -63.4 -54.07 42.54 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -173.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -104.29 -13.0 16.31 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -170.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.57 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 71.6 mt -105.16 -63.67 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.725 177.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.618 ' HB3' ' HA ' ' A' ' 56' ' ' GLU . 74.0 t-105 -59.89 -62.09 2.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.548 -175.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.517 HD22 ' HA ' ' A' ' 57' ' ' LYS . 2.6 mp -53.47 -23.06 9.08 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -175.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -89.75 -53.15 4.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.816 0.341 . . . . 0.0 111.418 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -113.18 2.63 15.68 Favored 'General case' 0 C--O 1.221 -0.437 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -167.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.491 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 12.0 pttp -39.07 -44.07 1.09 Allowed 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -172.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -96.8 -75.99 0.52 Allowed 'General case' 0 C--O 1.251 1.146 0 CA-C-O 121.334 0.588 . . . . 0.0 109.855 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.421 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 24.8 t-20 66.56 -72.19 0.09 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 114.449 -1.251 . . . . 0.0 110.667 -177.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 66' ' ' ASN . . . 155.32 -26.17 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.323 0 O-C-N 125.044 1.465 . . . . 0.0 107.704 -175.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.452 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 14.9 t70 -140.04 22.38 2.43 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.991 -172.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.548 ' CE2' ' HB2' ' A' ' 71' ' ' LEU . 68.6 t80 -113.4 139.35 48.97 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.328 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.07 128.94 29.08 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.773 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.548 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 3.6 tt -134.23 117.36 16.39 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.458 HD12 ' C ' ' A' ' 71' ' ' LEU . 3.1 mp -128.66 130.72 68.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.788 0.327 . . . . 0.0 110.141 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.445 ' HA2' ' HG2' ' A' ' 39' ' ' GLN . . . -99.23 133.73 11.41 Favored Glycine 0 C--O 1.219 -0.797 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.526 176.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.0 mt -116.52 127.76 74.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 117.29 0.545 . . . . 0.0 110.905 -176.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.48 ' OD2' ' HA ' ' A' ' 42' ' ' ALA . 10.2 t70 -90.91 135.09 33.96 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 174.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.612 ' HB2' HD13 ' A' ' 115' ' ' ILE . 58.9 ttt-85 -68.69 -28.57 66.97 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -170.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -160.1 -26.87 0.06 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -170.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -74.49 130.83 81.14 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-O 121.292 0.568 . . . . 0.0 111.314 -176.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.515 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 25.4 Cg_endo -68.75 -166.64 0.16 Allowed 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 123.337 2.692 . . . . 0.0 114.831 -176.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -58.98 -55.27 37.25 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 114.315 -1.312 . . . . 0.0 112.248 -169.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.515 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -64.16 -36.29 83.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.542 -173.813 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.481 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 33.9 mmtp -59.79 -54.26 48.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.156 0.503 . . . . 0.0 110.885 177.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.0 t -61.92 -41.87 92.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.294 -177.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.1 mp -62.91 -44.27 96.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.648 0.261 . . . . 0.0 111.254 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.531 ' HA ' ' HE3' ' A' ' 88' ' ' LYS . . . -68.42 -27.62 66.36 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.317 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.437 ' HE2' ' SD ' ' A' ' 52' ' ' MET . 93.3 t80 -80.43 -53.26 6.76 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.911 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.69 -44.35 77.28 Favored 'General case' 0 C--O 1.226 -0.163 0 O-C-N 123.39 0.431 . . . . 0.0 111.787 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.531 ' HE3' ' HA ' ' A' ' 85' ' ' ALA . 18.4 pttp -62.92 -26.46 68.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.026 0.441 . . . . 0.0 111.352 -177.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.9 m -88.73 -22.56 23.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.885 -175.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.0 p -97.08 -13.88 21.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.13 0.491 . . . . 0.0 110.631 177.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 106.54 -74.99 0.22 Allowed Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -177.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.0 t 28.66 85.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.056 1.343 . . . . 0.0 114.07 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.1 p -83.53 -0.95 52.54 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.697 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.586 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 50.6 p90 -96.59 139.48 21.67 Favored Pre-proline 0 C--N 1.332 -0.194 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.755 176.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.427 ' HB2' HD22 ' A' ' 20' ' ' LEU . 19.6 Cg_endo -60.47 133.82 51.21 Favored 'Trans proline' 0 C--O 1.238 0.508 0 C-N-CA 122.935 2.423 . . . . 0.0 113.333 -175.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.459 ' O ' HG23 ' A' ' 21' ' ' THR . 91.3 mt -109.31 139.19 44.58 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.435 176.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -105.55 148.55 16.53 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.75 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.493 ' H ' HD22 ' A' ' 98' ' ' LEU . 0.4 OUTLIER -92.1 127.09 37.44 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.282 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.438 ' HB3' ' O ' ' A' ' 75' ' ' ASP . 21.6 t0 -120.18 74.35 21.37 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 121.135 0.493 . . . . 0.0 109.881 173.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.98 98.4 0.71 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.419 2.08 . . . . 0.0 112.534 -175.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 123.94 -5.18 9.05 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.045 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 62.66 45.17 6.17 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 122.645 0.378 . . . . 0.0 111.127 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -84.04 -50.18 8.22 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.048 0.451 . . . . 0.0 110.398 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 34.2 mm -66.0 -34.01 67.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -64.22 -41.05 97.19 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.276 173.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.616 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -69.94 -18.37 63.36 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.623 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -77.15 -7.82 56.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.486 178.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -125.34 -32.05 2.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.836 0.35 . . . . 0.0 111.365 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.616 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -149.6 169.3 21.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.736 0.303 . . . . 0.0 111.155 -177.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.473 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . 96.6 mt -72.61 133.94 44.92 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 177.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.71 -31.71 68.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.421 0.629 . . . . 0.0 110.48 -178.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -99.43 19.53 15.43 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.121 -176.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.473 ' CB ' ' HB2' ' A' ' 110' ' ' LEU . . . -119.57 56.9 0.92 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.426 -177.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 81.35 -157.68 38.87 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.409 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.612 HD13 ' HB2' ' A' ' 76' ' ' ARG . 2.5 tp -152.54 -60.48 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.685 HG22 ' SG ' ' A' ' 48' ' ' CYS . 16.5 p -56.65 111.86 1.12 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -172.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.496 ' HG2' ' HB2' ' A' ' 40' ' ' PHE . 13.5 ptp180 -169.72 154.2 5.31 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.665 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.555 ' HB2' HG22 ' A' ' 131' ' ' THR . 34.4 m-80 -124.8 131.08 53.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.457 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.7 t -108.83 109.63 29.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.981 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 30.6 tp -96.57 111.64 23.69 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.491 -0.483 . . . . 0.0 110.271 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.58 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 54.0 mt -93.21 137.49 22.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.996 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.02 179.27 5.99 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.008 0.433 . . . . 0.0 111.104 -177.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 32.5 ttm180 -62.95 -28.67 70.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.128 -175.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -76.61 -30.37 56.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.119 0.485 . . . . 0.0 110.515 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.16 17.38 7.27 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.584 -176.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 80.4 mttt -103.1 148.26 25.96 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.887 0.375 . . . . 0.0 110.484 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.616 HD12 HG11 ' A' ' 7' ' ' VAL . 60.8 mt -84.7 112.43 21.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.149 178.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 28.5 m -102.3 -29.2 3.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -175.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -124.95 112.94 17.18 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.156 -173.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.788 HD13 HG12 ' A' ' 9' ' ' ILE . 11.1 mp -100.93 121.79 42.36 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.434 -0.803 . . . . 0.0 108.868 169.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.555 HG22 ' HB2' ' A' ' 118' ' ' ASN . 0.4 OUTLIER -122.43 145.16 48.55 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 177.565 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.419 ' N ' ' HD2' ' A' ' 132' ' ' ARG . 3.6 mpt_? -105.23 124.15 49.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.313 -177.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.673 ' HA ' ' HB ' ' A' ' 116' ' ' THR . 1.7 pp 39.86 50.07 2.29 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 124.091 0.869 . . . . 0.0 112.983 175.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.535 ' HB2' ' HG3' ' A' ' 51' ' ' GLU . 9.1 t80 68.97 -74.17 0.08 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.151 -177.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 41.6 t30 59.39 120.15 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.421 0.688 . . . . 0.0 111.814 -177.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -47.56 -62.54 1.39 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.984 -173.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -61.81 -41.66 98.04 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.833 -175.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.535 ' HB3' ' OG1' ' A' ' 131' ' ' THR . 17.7 mt-10 -64.85 -36.26 83.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.108 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.47 ' O ' HG23 ' A' ' 143' ' ' VAL . 82.1 t80 -64.42 -44.99 89.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.365 176.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.66 -50.19 70.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.906 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.2 m -66.18 -37.23 85.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.835 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.484 ' O ' HG13 ' A' ' 146' ' ' ILE . 2.6 tt -60.73 -49.16 78.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.813 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 139' ' ' PHE . 90.8 t -59.7 -46.56 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.258 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -58.42 -45.73 87.85 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.176 0.512 . . . . 0.0 110.266 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -61.4 -39.74 91.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.314 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.654 ' O ' HD23 ' A' ' 150' ' ' LEU . 66.6 mt -55.25 -47.95 77.08 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.196 0 CA-C-N 116.738 -0.21 . . . . 0.0 110.702 177.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -51.25 -43.64 61.56 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.72 -0.218 . . . . 0.0 110.543 176.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -67.61 -42.83 81.75 Favored 'General case' 0 C--O 1.217 -0.652 0 C-N-CA 120.646 -0.421 . . . . 0.0 111.12 175.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 38.6 mmm -57.31 -35.64 70.1 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 122.98 0.512 . . . . 0.0 111.136 -172.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.654 HD23 ' O ' ' A' ' 146' ' ' ILE . 4.4 mm? . . . . . 0 C--N 1.322 -0.592 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.796 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 . . . . . 0 CA--C 1.519 -0.215 0 CA-C-O 120.913 0.387 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.581 HG12 ' HA ' ' A' ' 109' ' ' ALA . 21.5 pt -109.58 -11.97 11.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.781 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.434 HG11 HD12 ' A' ' 127' ' ' ILE . 20.0 t -101.44 156.32 4.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.508 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 37.3 mtt85 -121.85 162.88 20.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.097 0.475 . . . . 0.0 111.342 -173.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.508 HG23 ' HA ' ' A' ' 128' ' ' VAL . 80.1 mt -75.93 126.36 36.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.153 177.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.59 -24.92 12.7 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.839 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -75.03 156.66 35.95 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.661 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 59.2 mtp -84.32 138.54 32.84 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.649 -178.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.569 ' HB2' HD12 ' A' ' 121' ' ' ILE . . . -62.65 123.01 77.62 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.432 -178.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 24.7 Cg_exo -62.44 114.62 2.44 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.615 2.21 . . . . 0.0 111.299 177.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.561 ' HA ' HD12 ' A' ' 28' ' ' LEU . 1.0 OUTLIER -63.4 151.9 39.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.418 -171.823 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.999 ' HB3' ' HE2' ' A' ' 107' ' ' LYS . 37.0 p90 -159.23 166.52 31.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.511 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 56.0 m -129.35 108.26 10.16 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.273 175.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.5 tt -106.7 145.02 14.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.991 0.424 . . . . 0.0 110.831 -174.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 24' ' ' LYS . 9.6 m -85.33 131.84 34.34 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.299 178.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.46 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 86.3 mt -87.15 172.52 9.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.311 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 96' ' ' LEU . 33.2 p -55.85 -34.01 65.05 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.889 -176.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -101.84 18.38 20.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.104 0.478 . . . . 0.0 110.772 -173.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.5 37.0 25.01 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.626 174.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 19' ' ' THR . 41.0 mmtm -108.16 167.04 10.29 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.1 -0.334 . . . . 0.0 110.1 176.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -130.33 120.37 24.23 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 17' ' ' THR . 11.7 m -113.98 144.2 22.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.939 0.399 . . . . 0.0 110.017 175.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.416 HG22 ' H ' ' A' ' 29' ' ' SER . 18.0 m -122.61 143.42 49.77 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.645 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.561 HD12 ' HA ' ' A' ' 15' ' ' ASP . 17.5 mt -62.67 -35.98 81.41 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.715 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.514 ' HA ' ' HG2' ' A' ' 32' ' ' ARG . 59.2 m -55.83 -34.62 65.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.987 0.422 . . . . 0.0 110.937 175.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.0 t -75.25 -26.24 58.69 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.101 0.477 . . . . 0.0 110.227 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 85.8 mt -96.27 0.2 50.6 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.514 ' HG2' ' HA ' ' A' ' 29' ' ' SER . 37.8 mmt180 -60.3 138.24 57.99 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 102.99 -20.79 42.27 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -178.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.552 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 3.5 mppt? -109.72 157.79 18.76 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.203 -0.499 . . . . 0.0 110.432 178.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 p -82.2 116.52 26.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.355 0.598 . . . . 0.0 109.839 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 25.8 t -106.26 131.2 56.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.213 -173.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.539 ' SD ' HG21 ' A' ' 59' ' ' ILE . 27.7 ttt -111.64 123.6 50.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.392 175.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.455 ' HB2' ' HB ' ' A' ' 119' ' ' VAL . 3.3 mm? -103.78 116.87 33.1 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.642 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.444 HE21 ' HA ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -108.06 114.94 29.21 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.67 176.941 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.499 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 92.3 m-85 -99.7 111.85 24.15 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.1 t -127.52 -174.62 3.23 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.193 -174.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -168.03 160.55 12.1 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.327 0.651 . . . . 0.0 109.736 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.463 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 78.3 p -75.91 -18.56 59.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.051 0.453 . . . . 0.0 111.353 -176.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 21.1 p-90 -103.35 12.08 35.84 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -175.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.461 ' HB3' HG21 ' A' ' 115' ' ' ILE . 23.0 p -110.12 114.58 28.2 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.074 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.93 -26.56 68.71 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.916 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.439 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 28.3 t -63.21 -36.82 77.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.959 0.409 . . . . 0.0 110.638 -178.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.419 ' HA ' ' HB3' ' A' ' 51' ' ' GLU . 52.1 m -68.32 -16.15 63.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.724 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -75.56 -7.96 55.53 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.154 0.502 . . . . 0.0 110.287 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.519 ' HD3' ' CD2' ' A' ' 134' ' ' TYR . 57.6 mttt -88.54 -54.26 4.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 122.488 1.137 . . . . 0.0 108.494 162.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.466 ' O ' HG13 ' A' ' 55' ' ' ILE . 24.3 tt0 -57.03 -62.75 1.53 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 113.001 -1.909 . . . . 0.0 112.55 -171.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.587 ' SD ' ' HE2' ' A' ' 86' ' ' PHE . 83.1 mtp -53.93 -54.77 43.14 Favored Pre-proline 0 CA--C 1.538 0.481 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -172.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.485 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 25.5 Cg_endo -62.61 -35.61 69.12 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 121.961 1.774 . . . . 0.0 112.591 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -67.04 -42.58 84.61 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.389 175.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 51' ' ' GLU . 70.4 mt -60.06 -52.93 55.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.985 178.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.606 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 16.4 pt-20 -64.75 -31.11 72.19 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.312 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -71.85 -56.03 6.47 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -176.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.414 ' HA ' ' HG2' ' A' ' 62' ' ' LYS . 62.8 m-20 -108.15 -18.35 13.8 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -171.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.539 HG21 ' SD ' ' A' ' 37' ' ' MET . 48.4 mm -93.57 -53.95 7.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.721 176.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.606 ' HB3' ' HA ' ' A' ' 56' ' ' GLU . 74.9 t-105 -69.86 -73.06 0.17 Allowed 'General case' 0 C--O 1.215 -0.744 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.894 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -48.13 -29.17 3.4 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -174.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.414 ' HG2' ' HA ' ' A' ' 58' ' ' ASP . 39.6 mmtm -91.38 -33.2 15.37 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.305 0.484 . . . . 0.0 112.305 -175.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -124.84 -4.55 7.57 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -171.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.439 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 17.4 pttp -43.71 -51.79 6.93 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -170.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.18 -81.18 0.18 Allowed 'General case' 0 C--O 1.247 0.959 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.524 ' CG ' HD12 ' A' ' 150' ' ' LEU . 12.1 t30 61.41 -71.7 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.347 -177.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 173.06 -26.88 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 123.573 0.749 . . . . 0.0 109.423 -177.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.515 ' HB2' ' HG3' ' A' ' 34' ' ' LYS . 6.3 p-10 -154.62 28.29 0.44 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.416 -172.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.604 ' HB2' HD11 ' A' ' 150' ' ' LEU . 79.4 t80 -100.5 125.55 46.84 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 118.548 -1.261 . . . . 0.0 110.422 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 36' ' ' VAL . . . -124.97 105.62 9.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.811 -176.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.499 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 3.9 tt -110.77 119.36 38.84 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.8 mm -124.34 126.11 71.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.444 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.472 ' HA3' HD23 ' A' ' 96' ' ' LEU . . . -89.17 133.83 12.04 Favored Glycine 0 C--O 1.221 -0.696 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.204 175.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.499 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 68.0 mt -120.8 114.74 44.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.867 0.334 . . . . 0.0 110.733 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -78.32 129.53 35.12 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 172.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.434 HH21 ' HA ' ' A' ' 112' ' ' ASP . 49.5 ttt-85 -45.67 -67.05 0.32 Allowed 'General case' 0 N--CA 1.469 0.478 0 O-C-N 123.97 0.794 . . . . 0.0 112.828 -170.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.647 ' HA ' ' O ' ' A' ' 99' ' ' ASP . 12.0 p-10 -145.61 21.05 1.5 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.58 0.705 . . . . 0.0 109.7 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -69.9 129.74 90.7 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.848 -177.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.588 ' HG2' ' HG2' ' A' ' 82' ' ' LYS . 16.5 Cg_endo -63.58 168.19 11.99 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 122.404 2.07 . . . . 0.0 112.204 173.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -52.55 -52.77 53.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.071 -172.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.546 ' OE2' ' HG2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -67.61 -28.08 67.44 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -173.602 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.588 ' HG2' ' HG2' ' A' ' 79' ' ' PRO . 44.0 mmtm -64.45 -51.07 64.97 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.831 0.348 . . . . 0.0 110.468 175.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.448 HG21 ' HB3' ' A' ' 98' ' ' LEU . 61.1 t -53.81 -52.2 37.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.106 -178.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.23 -39.22 92.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.577 -177.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.448 ' HA ' ' HE3' ' A' ' 88' ' ' LYS . . . -73.05 -26.59 61.35 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.787 -177.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.587 ' HE2' ' SD ' ' A' ' 52' ' ' MET . 71.8 t80 -84.85 -47.42 10.37 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.886 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.485 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -53.08 -47.48 68.49 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.289 0.368 . . . . 0.0 111.455 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.448 ' HE3' ' HA ' ' A' ' 85' ' ' ALA . 18.4 pttp -62.31 -23.98 67.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.033 0.444 . . . . 0.0 111.241 -178.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.9 m -92.62 -0.62 57.28 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.048 -175.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.1 p -122.97 -20.97 5.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.602 175.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 114.64 -76.29 0.25 Allowed Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -177.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.421 HG21 ' HE1' ' A' ' 52' ' ' MET . 86.7 t 43.93 87.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 124.494 1.118 . . . . 0.0 113.344 178.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.4 m -78.67 -5.4 52.94 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.493 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.46 ' CE1' ' HB3' ' A' ' 56' ' ' GLU . 49.0 p90 -107.29 145.58 31.49 Favored Pre-proline 0 C--N 1.33 -0.254 0 O-C-N 122.127 -0.358 . . . . 0.0 110.451 179.172 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -63.05 136.45 56.57 Favored 'Trans proline' 0 C--O 1.238 0.485 0 C-N-CA 122.371 2.047 . . . . 0.0 113.222 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.485 HD12 ' HB2' ' A' ' 87' ' ' ALA . 92.8 mt -105.14 151.51 23.94 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.871 175.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -125.13 145.51 15.73 Favored Glycine 0 N--CA 1.437 -1.297 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 175.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.789 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.2 pt? -100.09 132.71 45.3 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 120.744 0.306 . . . . 0.0 110.68 -176.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.647 ' O ' ' HA ' ' A' ' 77' ' ' ASP . 22.2 t0 -109.84 82.54 2.42 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.71 176.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.24 87.07 0.49 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.138 1.892 . . . . 0.0 112.264 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.04 -21.65 1.59 Allowed Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.131 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . . . 70.15 24.25 5.0 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 122.866 0.466 . . . . 0.0 110.714 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -91.08 -29.08 17.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.583 -176.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.605 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 32.4 mm -70.04 -35.85 65.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 171.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -60.8 -40.14 91.54 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.741 172.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.682 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -68.28 -25.53 65.2 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.951 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.999 ' HE2' ' HB3' ' A' ' 16' ' ' PHE . 26.8 mtpp -70.72 -3.99 21.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.393 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.732 ' HB3' HH22 ' A' ' 117' ' ' ARG . 65.1 m-85 -129.37 -11.82 4.53 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.91 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.682 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -176.36 176.4 1.65 Allowed 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.847 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 95.4 mt -60.34 136.05 57.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.634 0.254 . . . . 0.0 110.505 177.186 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.599 ' HG2' ' HB2' ' A' ' 106' ' ' ALA . 53.8 mtp85 -49.57 -51.85 34.11 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.988 -177.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.434 ' HA ' HH21 ' A' ' 76' ' ' ARG . 6.8 m-20 -105.08 34.38 3.24 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.654 -173.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.847 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . . . -85.02 9.88 13.44 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.1 178.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 118.1 -151.94 17.73 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.348 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.461 HG21 ' HB3' ' A' ' 45' ' ' CYS . 8.6 tp -151.1 170.74 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -177.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.603 HG22 ' HA ' ' A' ' 133' ' ' LEU . 30.7 m 71.77 93.97 0.08 Allowed 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.532 0.52 . . . . 0.0 110.314 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.732 HH22 ' HB3' ' A' ' 108' ' ' TYR . 54.8 mtp180 -146.58 149.13 32.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.66 -174.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.573 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 33.0 m-80 -127.6 119.83 26.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.75 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 38' ' ' LEU . 73.1 t -124.58 122.91 64.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.655 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 34.5 tp -108.88 130.72 55.43 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.898 0.38 . . . . 0.0 110.917 -178.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.569 HD12 ' HB2' ' A' ' 13' ' ' ALA . 27.8 mm -111.07 139.11 36.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.695 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.525 ' OD2' ' HB2' ' A' ' 126' ' ' LYS . 3.4 p30 -84.47 171.82 12.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.808 0.337 . . . . 0.0 110.844 177.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -60.7 -25.52 66.46 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.427 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -82.13 -12.57 58.12 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.777 -174.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 103.86 3.92 45.61 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.607 176.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.661 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 9.0 mtmp? -96.72 160.26 14.47 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.142 0.496 . . . . 0.0 111.64 -177.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.52 HG12 ' CD1' ' A' ' 121' ' ' ILE . 43.5 mt -95.37 127.79 47.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.399 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.508 ' HA ' HG23 ' A' ' 9' ' ' ILE . 29.4 m -117.74 -23.19 3.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -176.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.655 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 50.1 tptt -128.66 115.98 18.88 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.558 -174.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.458 HD13 HG12 ' A' ' 9' ' ' ILE . 11.0 mp -110.74 109.77 20.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.975 175.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.573 ' HB ' ' HB2' ' A' ' 118' ' ' ASN . 89.3 m -135.71 141.8 44.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.878 0.371 . . . . 0.0 111.278 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 132' ' ' ARG . 1.3 ptp180 -124.42 150.61 45.43 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 171.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.603 ' HA ' HG22 ' A' ' 116' ' ' THR . 0.8 OUTLIER 46.32 104.95 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 O-C-N 124.703 1.252 . . . . 0.0 113.992 179.503 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.519 ' CD2' ' HD3' ' A' ' 50' ' ' LYS . 39.9 t80 -39.26 112.61 0.26 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.944 -1.026 . . . . 0.0 112.205 176.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -110.84 141.03 44.76 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 173.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.62 -58.45 6.75 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -173.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.464 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.7 mp0 -60.33 -32.19 71.02 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.893 0.378 . . . . 0.0 111.238 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -65.42 -47.5 76.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.571 -177.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.543 ' O ' HG23 ' A' ' 143' ' ' VAL . 88.8 t80 -61.77 -39.46 91.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.736 -178.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -59.96 -46.39 89.56 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.109 0.48 . . . . 0.0 110.375 176.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.3 m -62.69 -38.97 92.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.227 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.615 ' O ' HG12 ' A' ' 146' ' ' ILE . 1.1 mt -61.57 -46.62 89.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.953 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 139' ' ' PHE . 97.6 t -55.96 -49.19 76.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-O 120.688 0.28 . . . . 0.0 111.16 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.445 ' HA ' ' OE1' ' A' ' 144' ' ' GLN . 6.7 tp60 -66.46 -40.96 89.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.955 0.407 . . . . 0.0 110.48 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -57.96 -46.12 85.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.065 176.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.656 ' O ' HD23 ' A' ' 150' ' ' LEU . 38.4 mm -56.48 -44.69 81.08 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.279 177.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -53.68 -52.0 61.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.848 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -76.29 -20.82 56.97 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.932 -177.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.439 ' HG3' HD21 ' A' ' 120' ' ' LEU . 56.1 mmm -73.0 -28.52 62.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.131 0.491 . . . . 0.0 110.608 175.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.656 HD23 ' O ' ' A' ' 146' ' ' ILE . 4.3 mm? . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.234 175.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.573 ' CE1' HD22 ' A' ' 130' ' ' LEU . 61.2 m-85 . . . . . 0 CA--C 1.519 -0.229 0 CA-C-O 120.994 0.426 . . . . 0.0 112.101 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.9 pt -101.46 -11.64 8.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.317 169.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.8 m -110.95 150.33 13.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.005 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.465 ' HE ' ' CD ' ' A' ' 11' ' ' GLU . 77.6 mtm180 -118.82 163.78 16.37 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.339 0.59 . . . . 0.0 111.638 -175.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 77.3 mt -70.42 131.37 34.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.443 -0.798 . . . . 0.0 109.531 174.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.63 -27.27 15.5 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -176.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.465 ' CD ' ' HE ' ' A' ' 8' ' ' ARG . 14.3 mt-10 -80.19 174.94 11.1 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.671 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 55.6 mtp -98.8 146.43 25.94 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.875 0.369 . . . . 0.0 110.417 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.451 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -79.92 135.91 54.94 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.842 -177.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 21.2 Cg_exo -64.89 117.28 4.39 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.759 2.306 . . . . 0.0 111.915 177.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.21 141.85 55.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.949 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.508 ' HB2' HD12 ' A' ' 104' ' ' ILE . 52.4 p90 -154.28 161.18 41.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.847 0.356 . . . . 0.0 111.224 -174.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.2 m -110.35 116.28 31.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.448 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.5 tt -114.64 142.14 28.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.936 0.398 . . . . 0.0 110.829 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.47 ' O ' HD23 ' A' ' 98' ' ' LEU . 14.8 m -93.41 123.03 36.42 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.126 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.455 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 92.7 mt -79.52 173.96 12.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.919 0.39 . . . . 0.0 111.393 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 96' ' ' LEU . 19.5 p -57.15 -34.63 68.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.283 -0.871 . . . . 0.0 113.159 -175.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -100.56 19.35 17.06 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.177 0.513 . . . . 0.0 110.535 -174.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.09 36.1 25.53 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.601 174.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -108.4 109.42 20.71 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.09 0.472 . . . . 0.0 110.337 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -89.7 113.94 25.52 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.275 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.7 m -119.12 153.94 21.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.049 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.2 m -112.88 150.96 31.02 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.54 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 0.5 OUTLIER -59.96 -38.46 82.55 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.166 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.523 ' HA ' ' CG ' ' A' ' 32' ' ' ARG . 64.9 m -54.59 -26.88 35.24 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.106 176.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.6 m -72.75 -20.2 61.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.045 0.45 . . . . 0.0 110.97 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.509 HD13 ' HB1' ' A' ' 70' ' ' ALA . 96.3 mt -114.87 3.04 14.49 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.305 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.54 ' HG2' ' O ' ' A' ' 28' ' ' LEU . 47.9 mmm-85 -66.25 139.13 58.06 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.09 -20.48 28.54 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -172.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.499 ' HB3' ' O ' ' A' ' 68' ' ' ASP . 42.5 mtmt -116.14 165.13 13.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.263 -0.468 . . . . 0.0 110.15 177.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 p -79.59 120.03 30.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.178 0.513 . . . . 0.0 110.031 174.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.513 HG22 ' HB3' ' A' ' 70' ' ' ALA . 43.5 t -115.37 125.18 72.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.863 -175.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.473 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 25.6 ttt -103.13 124.76 49.17 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.854 177.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.3 mt -117.57 141.19 48.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.183 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.541 HE22 HD21 ' A' ' 71' ' ' LEU . 15.1 pm0 -139.05 136.67 35.51 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 174.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.437 ' HD2' ' HG3' ' A' ' 117' ' ' ARG . 98.0 m-85 -97.56 119.53 36.3 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.063 0.458 . . . . 0.0 110.675 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.4 t -127.82 -177.08 3.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.342 -175.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.647 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . . . -165.77 155.52 12.45 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 176.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.512 ' H ' ' HG3' ' A' ' 78' ' ' GLU . 99.5 p -63.26 -24.28 67.8 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.93 0.395 . . . . 0.0 112.025 -175.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.5 p-90 -100.92 7.59 43.53 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.751 0.31 . . . . 0.0 111.786 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.647 ' SG ' ' HB3' ' A' ' 42' ' ' ALA . 88.8 m -88.41 99.79 12.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.037 0.446 . . . . 0.0 111.078 178.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.84 -20.44 77.59 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.203 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 34.6 t -76.29 -41.31 36.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.836 0.351 . . . . 0.0 110.197 177.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.777 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 72.2 m -68.72 -16.61 63.87 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.475 0.655 . . . . 0.0 110.376 177.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.503 HH21 ' HE1' ' A' ' 86' ' ' PHE . 25.3 ttm180 -71.19 -11.13 60.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.7 176.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.573 ' HD3' ' CD2' ' A' ' 134' ' ' TYR . 80.1 mttt -87.15 -57.66 2.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.609 0.719 . . . . 0.0 110.046 169.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.947 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 12.4 pt-20 -63.76 -44.84 92.26 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-N 115.065 -0.971 . . . . 0.0 112.495 -168.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.498 ' HE3' HG21 ' A' ' 92' ' ' VAL . 15.3 mtm -57.41 -55.51 43.67 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.045 -174.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.577 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 19.7 Cg_endo -60.73 -33.22 93.38 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 121.771 1.647 . . . . 0.0 112.481 177.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.416 ' HD1' ' O ' ' A' ' 50' ' ' LYS . 12.3 m-85 -70.35 -46.24 64.52 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.499 176.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 51' ' ' GLU . 96.9 mt -58.03 -51.43 70.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.612 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.626 ' HB3' ' CD1' ' A' ' 94' ' ' TYR . 0.4 OUTLIER -65.47 -34.93 79.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.403 -177.289 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.577 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 10.4 ttmm -68.5 -43.35 77.04 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.564 -174.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -106.12 -65.18 1.09 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.473 178.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 65.7 mt -55.7 -39.9 57.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.843 0.354 . . . . 0.0 110.966 -170.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.566 ' HB3' ' O ' ' A' ' 56' ' ' GLU . 75.5 t-105 -75.33 -71.32 0.37 Allowed 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.552 177.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.503 HD22 ' HD1' ' A' ' 60' ' ' TRP . 1.8 mm? -50.45 -34.91 26.43 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -173.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -84.01 -30.46 26.14 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -175.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.478 ' HB3' ' HG ' ' A' ' 150' ' ' LEU . 72.9 m-70 -129.56 -8.51 4.6 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -168.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.419 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 16.0 pttp -38.79 -48.73 1.55 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -171.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.47 -84.19 0.28 Allowed 'General case' 0 C--O 1.253 1.258 0 CA-C-O 121.246 0.546 . . . . 0.0 110.492 -175.057 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 44.5 t-20 59.24 -77.6 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.939 -169.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 66' ' ' ASN . . . 156.31 -23.01 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 125.327 1.451 . . . . 0.0 107.154 -173.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.499 ' O ' ' HB3' ' A' ' 34' ' ' LYS . 9.7 t70 -119.93 1.25 10.94 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.197 -173.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.516 ' HB2' HD11 ' A' ' 150' ' ' LEU . 84.9 t80 -110.67 151.04 28.17 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 119.09 -1.044 . . . . 0.0 112.297 -176.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.513 ' HB3' HG22 ' A' ' 36' ' ' VAL . . . -148.5 141.51 24.85 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.221 173.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.541 HD21 HE22 ' A' ' 39' ' ' GLN . 3.6 tt -139.02 127.25 22.66 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -177.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.414 ' N ' HD23 ' A' ' 71' ' ' LEU . 63.4 mt -135.79 130.91 49.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 120.73 0.3 . . . . 0.0 110.562 178.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.442 ' HA3' HD23 ' A' ' 96' ' ' LEU . . . -95.12 138.88 14.21 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.291 -0.956 . . . . 0.0 111.01 173.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 55.3 mt -119.66 118.21 56.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 117.395 0.598 . . . . 0.0 110.686 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.536 ' OD1' ' HA ' ' A' ' 42' ' ' ALA . 6.7 t0 -95.41 132.32 40.59 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.488 ' HD2' HD13 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -97.22 121.02 38.65 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.968 0.413 . . . . 0.0 111.942 -170.577 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 73.08 -35.81 0.34 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.347 1.059 . . . . 0.0 113.044 175.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.512 ' HG3' ' H ' ' A' ' 43' ' ' SER . 60.0 mm-40 -62.54 140.31 96.79 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-O 121.147 0.499 . . . . 0.0 111.241 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.539 ' O ' HG23 ' A' ' 83' ' ' VAL . 18.3 Cg_endo -84.25 -168.42 0.54 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.043 2.495 . . . . 0.0 113.64 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.542 HD23 HD13 ' A' ' 84' ' ' LEU . 1.7 tt -56.25 -57.49 12.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.801 -1.091 . . . . 0.0 112.138 -170.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -37.53 87.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.864 -173.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.504 ' CG ' ' HD2' ' A' ' 79' ' ' PRO . 27.1 mmtp -58.86 -50.43 74.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.585 0.231 . . . . 0.0 111.336 178.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 79' ' ' PRO . 46.9 t -58.4 -46.04 89.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.754 -178.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.542 HD13 HD23 ' A' ' 80' ' ' LEU . 10.9 mp -64.2 -47.63 79.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.335 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.02 -32.95 74.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.687 -176.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.503 ' HE1' HH21 ' A' ' 49' ' ' ARG . 72.0 t80 -77.8 -43.72 29.71 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.502 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.531 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -59.22 -54.38 47.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.447 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.9 ptmm? -57.12 -26.59 60.74 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.971 -175.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 27.3 m -85.74 -4.06 59.06 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.382 -174.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 19.1 p -128.14 6.12 5.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.313 0.578 . . . . 0.0 110.321 175.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.55 -73.27 1.23 Allowed Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.294 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.498 HG21 ' HE3' ' A' ' 52' ' ' MET . 42.9 t 40.95 83.91 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.963 0.905 . . . . 0.0 112.695 -177.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.8 m -75.76 -3.8 36.91 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.541 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.626 ' CD1' ' HB3' ' A' ' 56' ' ' GLU . 50.0 p90 -107.72 153.07 41.71 Favored Pre-proline 0 C--N 1.33 -0.273 0 O-C-N 121.813 -0.554 . . . . 0.0 110.621 178.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.5 137.0 32.38 Favored 'Trans proline' 0 C--O 1.239 0.561 0 C-N-CA 122.253 1.969 . . . . 0.0 113.38 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.531 HD12 ' HB2' ' A' ' 87' ' ' ALA . 97.6 mt -104.84 153.67 21.04 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.342 173.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -121.6 147.37 17.29 Favored Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 174.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.781 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.7 pt? -100.27 131.8 46.01 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.88 0.371 . . . . 0.0 110.617 -177.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.439 ' OD2' ' HA ' ' A' ' 102' ' ' ALA . 14.8 t0 -119.35 75.46 16.6 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.491 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.454 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 15.7 Cg_exo -68.01 120.57 7.56 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.895 2.396 . . . . 0.0 111.766 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 102.42 -8.75 55.38 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -175.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.793 ' HB3' ' HE ' ' A' ' 111' ' ' ARG . . . 54.6 45.88 25.95 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 123.09 0.556 . . . . 0.0 111.547 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -76.09 -49.71 16.69 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.253 0.549 . . . . 0.0 110.062 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.508 HD12 ' HB2' ' A' ' 16' ' ' PHE . 27.9 mm -65.83 -36.28 77.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.276 178.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.44 ' HB3' ' HB1' ' A' ' 102' ' ' ALA . 71.5 t80 -62.56 -45.28 93.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.289 174.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.611 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -65.74 -21.01 66.48 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.769 -178.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -73.48 -12.06 60.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.824 0.345 . . . . 0.0 111.245 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.431 ' CZ ' ' HD2' ' A' ' 14' ' ' PRO . 65.8 m-85 -119.93 -34.57 3.69 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.351 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.611 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -154.72 160.37 41.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.783 0.325 . . . . 0.0 111.004 -177.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.464 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . 90.3 mt -67.09 136.29 54.94 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.793 ' HE ' ' HB3' ' A' ' 102' ' ' ALA . 67.5 mtp180 -49.46 -40.05 35.65 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -171.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -98.76 -8.98 25.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.12 0.486 . . . . 0.0 111.475 -175.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.464 ' CB ' ' HB2' ' A' ' 110' ' ' LEU . . . -81.45 40.88 0.59 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -171.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 97.79 114.62 3.31 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.262 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.488 HD13 ' HD2' ' A' ' 76' ' ' ARG . 2.6 tp -76.19 -49.77 24.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.642 0.258 . . . . 0.0 111.531 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.95 ' HB ' ' HB3' ' A' ' 133' ' ' LEU . 22.2 p -66.3 114.2 5.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.17 -173.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.437 ' HG3' ' HD2' ' A' ' 40' ' ' PHE . 10.8 ptp180 -169.33 145.52 3.31 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.952 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.62 ' HB2' ' OG1' ' A' ' 131' ' ' THR . 6.6 m120 -122.98 142.69 50.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.526 -177.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 29.1 t -128.51 120.7 53.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.301 -177.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.682 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 41.9 tp -105.17 116.83 32.62 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.964 174.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 57.0 mt -98.6 134.33 37.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.132 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.38 177.58 8.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.047 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.434 ' HD3' ' OD1' ' A' ' 68' ' ' ASP . 70.9 mtm180 -66.64 -27.26 67.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.967 -174.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -75.17 -29.67 60.48 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.082 0.468 . . . . 0.0 110.419 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.45 15.73 8.06 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.777 -176.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.671 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 82.4 mttt -97.62 157.62 15.94 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.827 0.346 . . . . 0.0 110.583 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.472 HG21 HD21 ' A' ' 130' ' ' LEU . 53.9 mt -91.04 120.67 40.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.576 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.6 m -114.97 1.77 8.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.851 ' HD2' HG23 ' A' ' 131' ' ' THR . 0.3 OUTLIER -163.71 124.61 2.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.779 0.323 . . . . 0.0 111.582 -178.956 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.573 HD22 ' CE1' ' A' ' 5' ' ' TYR . 96.5 mt -127.58 106.73 9.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.615 174.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.851 HG23 ' HD2' ' A' ' 129' ' ' LYS . 16.6 p -107.39 148.89 28.51 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.925 0.393 . . . . 0.0 111.062 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.527 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 23.5 mtm180 -92.84 107.8 19.5 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 174.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.95 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 4.0 pp 49.28 -172.18 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 O-C-N 124.239 0.962 . . . . 0.0 112.979 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.947 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 87.6 t80 -73.65 85.64 1.61 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.321 175.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.55 ' HB3' ' HB2' ' A' ' 138' ' ' GLU . 47.2 t-20 -85.54 117.69 24.6 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 170.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 30.0 mp0 -46.93 -39.72 12.82 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 123.403 0.44 . . . . 0.0 111.973 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -79.76 -51.54 9.06 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.56 0.219 . . . . 0.0 111.56 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.55 ' HB2' ' HB3' ' A' ' 135' ' ' ASN . 44.9 mt-10 -66.01 -34.43 78.07 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 121.243 -0.183 . . . . 0.0 111.24 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.441 ' O ' HG23 ' A' ' 143' ' ' VAL . 81.5 t80 -67.16 -42.97 83.43 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 177.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.24 -48.54 80.08 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.187 0.518 . . . . 0.0 110.316 176.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.3 m -62.88 -35.3 79.56 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.679 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.564 ' HG ' ' HG2' ' A' ' 129' ' ' LYS . 1.4 tt -67.29 -42.54 83.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.236 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 139' ' ' PHE . 70.6 t -58.45 -51.73 67.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.903 178.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.467 ' HA ' ' ND2' ' A' ' 147' ' ' ASN . 47.5 tp60 -60.86 -40.61 93.55 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.122 0.487 . . . . 0.0 110.498 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -56.55 -46.69 80.57 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.618 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.566 ' O ' HD23 ' A' ' 150' ' ' LEU . 42.6 mt -64.76 -38.35 82.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.914 178.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.467 ' ND2' ' HA ' ' A' ' 144' ' ' GLN . 93.0 m-20 -53.21 -45.45 68.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.555 178.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -69.85 -36.73 75.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.079 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 84.3 mmm -63.16 -24.51 67.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.309 0.576 . . . . 0.0 110.233 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.566 HD23 ' O ' ' A' ' 146' ' ' ILE . 3.8 mm? . . . . . 0 C--N 1.324 -0.534 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.189 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 . . . . . 0 N--CA 1.453 -0.314 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 29.0 pt -115.06 1.34 8.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.187 0.518 . . . . 0.0 110.429 175.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.9 m -117.34 161.39 16.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.673 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.554 ' HB2' ' HB2' ' A' ' 11' ' ' GLU . 42.1 mtt180 -112.5 165.64 12.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.18 -176.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.47 HG12 HD23 ' A' ' 130' ' ' LEU . 67.0 mt -81.33 118.32 28.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 172.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.12 -3.96 55.4 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -172.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.554 ' HB2' ' HB2' ' A' ' 8' ' ' ARG . 10.1 tp10 -90.93 153.37 20.23 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.534 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 58.2 mtp -76.37 139.41 40.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.123 0.487 . . . . 0.0 111.034 -177.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.452 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -76.64 134.38 69.38 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.918 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.594 ' HD2' ' CE1' ' A' ' 108' ' ' TYR . 24.3 Cg_exo -61.69 149.92 87.87 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.778 2.319 . . . . 0.0 111.427 177.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.0 169.41 9.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.413 -177.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' A' ' 27' ' ' THR . 44.1 p90 -172.39 172.45 4.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.507 -174.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 18.1 m -125.9 100.93 6.6 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 173.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 25' ' ' GLN . 18.3 tt -99.36 143.21 13.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.954 -172.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.6 m -92.14 121.39 33.63 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.917 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.7 mt -78.9 176.6 9.45 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.756 -178.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.3 p -59.25 -28.47 66.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.889 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.72 ' OD1' ' HG2' ' A' ' 24' ' ' LYS . 0.3 OUTLIER -77.79 -28.05 50.36 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.232 178.836 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.16 -1.58 28.31 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.107 -170.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.72 ' HG2' ' OD1' ' A' ' 22' ' ' ASP . 47.4 mmtm -70.18 117.26 11.52 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.642 -0.279 . . . . 0.0 110.777 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.458 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 90.8 mt-30 -91.12 114.63 27.21 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 174.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 17' ' ' THR . 17.0 m -116.91 151.12 18.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.651 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 29' ' ' SER . 4.2 m -98.84 147.32 25.05 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.707 178.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.475 ' O ' HD13 ' A' ' 28' ' ' LEU . 1.1 tm? -69.96 -25.54 63.68 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.548 ' HA ' ' HG2' ' A' ' 32' ' ' ARG . 48.8 m -58.45 -24.86 61.36 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.447 175.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.9 m -75.1 -18.39 60.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.836 0.351 . . . . 0.0 111.435 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.2 mt -105.28 3.55 30.09 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.161 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.548 ' HG2' ' HA ' ' A' ' 29' ' ' SER . 29.0 mmt180 -66.7 116.18 7.34 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 127.81 -21.02 5.66 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -175.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 123' ' ' ARG . 42.9 mtmt -116.55 164.75 14.13 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 176.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 68' ' ' ASP . 17.4 m -76.69 124.07 34.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 174.189 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.585 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 6.6 t -115.06 108.71 26.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.084 0.469 . . . . 0.0 110.935 -172.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.439 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 27.4 ttt -93.29 115.32 27.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.618 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.473 ' CD1' HG12 ' A' ' 36' ' ' VAL . 6.2 mp -115.26 115.39 26.6 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.356 178.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.427 ' O ' ' HG3' ' A' ' 39' ' ' GLN . 1.4 pt20 -105.82 117.62 34.49 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.047 0.451 . . . . 0.0 110.432 176.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.664 ' O ' ' HA ' ' A' ' 116' ' ' THR . 97.9 m-85 -85.09 109.64 18.39 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 172.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.0 t -127.77 -175.39 3.46 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.247 -170.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.558 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . . . -149.15 136.57 20.17 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.191 0.52 . . . . 0.0 111.686 -178.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.48 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 3.5 p -70.57 -6.26 35.16 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.445 175.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.462 ' HD1' ' HG3' ' A' ' 78' ' ' GLU . 43.5 p-90 -113.83 14.21 18.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.449 -177.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.558 ' SG ' ' HB3' ' A' ' 42' ' ' ALA . 94.8 m -112.81 138.13 50.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.901 0.382 . . . . 0.0 110.922 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -86.23 -33.33 14.67 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.218 -178.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.0 t -58.51 -36.11 57.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 121.362 0.601 . . . . 0.0 110.103 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.606 ' O ' ' HG2' ' A' ' 52' ' ' MET . 71.6 m -65.92 -16.55 63.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.714 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -77.6 -3.28 40.0 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 122.045 -0.409 . . . . 0.0 110.756 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -87.96 -53.77 4.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.103 0.478 . . . . 0.0 110.05 166.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.656 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 8.9 pt-20 -60.58 -46.28 90.83 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.912 -172.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.834 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 88.8 mmm -54.82 -59.57 10.27 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -174.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.834 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 31.8 Cg_exo -61.1 -39.76 56.85 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 122.025 1.817 . . . . 0.0 112.735 177.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.542 ' HB3' ' CZ ' ' A' ' 139' ' ' PHE . 11.6 m-85 -65.39 -46.71 79.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.58 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.534 HG12 ' HE1' ' A' ' 139' ' ' PHE . 77.3 mt -60.83 -46.15 96.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.439 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.46 ' OE2' HD13 ' A' ' 61' ' ' LEU . 33.5 tp10 -57.74 -49.12 77.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.886 0.374 . . . . 0.0 110.652 176.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.428 ' O ' ' HE3' ' A' ' 62' ' ' LYS . 28.6 ttpp -66.27 -52.38 48.06 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -174.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.438 ' HA ' ' NZ ' ' A' ' 62' ' ' LYS . 73.6 m-20 -105.28 -15.55 15.02 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -169.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 58.1 mt -105.43 -60.54 2.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.997 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.55 ' CD2' ' HB3' ' A' ' 94' ' ' TYR . 76.7 t-105 -63.42 -65.44 0.68 Allowed 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.158 -177.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.553 HD12 ' HE3' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -46.36 -32.63 3.3 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -174.909 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.438 ' NZ ' ' HA ' ' A' ' 58' ' ' ASP . 31.6 mmtp -81.54 -28.42 33.93 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -174.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -128.81 -43.42 1.37 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.807 -174.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.553 ' HE3' HD12 ' A' ' 61' ' ' LEU . 31.2 mttp 56.65 -92.38 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.934 0.893 . . . . 0.0 111.263 -176.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 66' ' ' ASN . 11.4 t70 -108.35 -39.16 5.52 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 173.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.4 ' HB3' ' O ' ' A' ' 65' ' ' ASP . 22.9 t-20 69.31 -72.62 0.1 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.217 176.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 164.8 -30.62 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.06 -173.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.507 ' O ' HG22 ' A' ' 35' ' ' VAL . 36.3 t70 -131.73 15.74 4.83 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 114.909 -1.042 . . . . 0.0 110.92 -177.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.454 ' HD2' ' O ' ' A' ' 64' ' ' LYS . 69.6 t80 -121.71 145.08 48.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.115 0.483 . . . . 0.0 110.979 -177.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.39 143.88 29.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.811 174.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.439 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 3.2 tt -143.46 123.03 13.24 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -177.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 65.6 mt -125.06 119.49 55.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.723 0.297 . . . . 0.0 110.405 176.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.416 ' HA2' ' HG3' ' A' ' 39' ' ' GLN . . . -88.52 123.38 6.74 Favored Glycine 0 C--O 1.219 -0.831 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 174.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 55.9 mt -117.82 122.89 70.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 117.706 0.753 . . . . 0.0 111.097 -174.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -80.42 118.34 21.97 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 170.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.551 ' HB3' ' CD1' ' A' ' 115' ' ' ILE . 0.0 OUTLIER -74.63 -6.34 48.07 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.846 -166.854 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -153.18 -30.58 0.13 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 118.759 -1.176 . . . . 0.0 113.144 -176.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.501 ' HB3' ' HG3' ' A' ' 82' ' ' LYS . 24.2 mm-40 -85.57 152.37 57.22 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.009 0.433 . . . . 0.0 112.079 -174.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.526 ' HD2' ' HG3' ' A' ' 82' ' ' LYS . 74.4 Cg_endo -79.31 -171.61 1.3 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.324 2.682 . . . . 0.0 115.243 -176.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.551 HD13 HD23 ' A' ' 84' ' ' LEU . 2.9 tm? -52.07 -55.66 19.27 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 113.528 -1.669 . . . . 0.0 111.423 -175.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -52.41 -42.13 63.79 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.762 -0.653 . . . . 0.0 112.178 -175.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.526 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 34.8 mmtp -66.24 -47.94 72.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.641 -176.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 79' ' ' PRO . 41.1 t -58.22 -45.02 89.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.517 -178.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.551 HD23 HD13 ' A' ' 80' ' ' LEU . 4.5 mm? -68.79 -24.64 64.44 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -175.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.47 -44.33 12.81 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.819 0.343 . . . . 0.0 110.791 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.48 ' CD1' ' HA ' ' A' ' 43' ' ' SER . 85.7 t80 -67.13 -45.34 77.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.766 -174.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.79 -32.19 70.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.998 0.904 . . . . 0.0 109.815 -177.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -69.31 -34.26 74.41 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.242 -1.344 . . . . 0.0 111.023 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.6 t -87.81 -8.16 56.31 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.239 -178.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 16.5 p -108.77 -2.16 18.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.667 0.27 . . . . 0.0 111.208 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.2 36.53 39.85 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.696 177.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.477 HG13 ' CE1' ' A' ' 94' ' ' TYR . 32.6 t -90.37 130.06 40.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.847 0.356 . . . . 0.0 111.706 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 25.4 m -101.67 -35.68 9.01 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.673 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.55 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 43.9 p90 -62.06 140.52 95.92 Favored Pre-proline 0 N--CA 1.463 0.201 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.247 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.27 147.65 91.04 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.66 2.24 . . . . 0.0 112.854 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.8 mp -123.6 154.66 38.99 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.522 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -122.74 162.01 16.72 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.938 178.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.6 mp -96.73 142.23 29.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.593 0.235 . . . . 0.0 110.904 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -133.4 79.71 59.86 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-O 121.212 0.529 . . . . 0.0 109.783 169.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.71 106.09 0.71 Allowed 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.603 2.202 . . . . 0.0 112.859 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.42 19.64 44.54 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.145 176.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 55.77 47.56 20.12 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.507 ' HA ' HH21 ' A' ' 111' ' ' ARG . 24.8 t70 -79.85 -51.55 9.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.159 0.504 . . . . 0.0 110.315 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 35.1 mm -67.43 -33.0 59.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -63.24 -34.9 78.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.281 173.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -73.26 -19.76 60.99 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.92 0.39 . . . . 0.0 111.19 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 14' ' ' PRO . 55.3 mttp -77.44 -17.41 58.11 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.179 176.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.594 ' CE1' ' HD2' ' A' ' 14' ' ' PRO . 81.1 m-85 -110.19 -36.91 5.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.071 0.462 . . . . 0.0 111.006 178.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -130.68 173.23 11.11 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.154 -176.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.492 ' O ' ' HB2' ' A' ' 111' ' ' ARG . 12.1 mt -86.69 3.41 44.91 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -176.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.507 HH21 ' HA ' ' A' ' 103' ' ' ASP . 98.8 mtt180 78.87 -36.65 0.18 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.839 -177.096 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -74.58 15.94 0.32 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.149 0.5 . . . . 0.0 111.05 176.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.416 ' H ' ' C ' ' A' ' 111' ' ' ARG . . . -93.98 -3.61 51.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.394 177.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.36 -152.09 16.91 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.193 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.551 ' CD1' ' HB3' ' A' ' 76' ' ' ARG . 1.9 tp -109.04 -61.66 2.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.956 ' HB ' ' HG ' ' A' ' 133' ' ' LEU . 2.7 m -86.33 110.66 19.82 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.037 0.446 . . . . 0.0 112.059 -170.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -142.13 131.7 23.92 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.444 176.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 1.119 ' HB3' ' HB ' ' A' ' 131' ' ' THR . 9.6 t30 -105.64 119.99 40.54 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.135 0.493 . . . . 0.0 110.672 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.3 t -107.2 110.39 31.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.792 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.686 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 56.7 tp -92.69 111.39 22.97 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.016 0.436 . . . . 0.0 110.37 178.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.585 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 48.6 mt -95.74 133.57 36.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.143 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -83.59 166.23 18.37 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.249 178.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.426 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 7.1 mtm180 -51.96 -37.73 54.0 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 123.476 0.71 . . . . 0.0 112.081 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -70.84 -5.74 32.72 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.871 0.367 . . . . 0.0 111.672 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.482 ' HA3' HH11 ' A' ' 32' ' ' ARG . . . 89.91 12.66 61.85 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.618 -177.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 87.2 mttt -98.59 144.32 28.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.504 0.192 . . . . 0.0 110.749 -177.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 63.1 mt -84.88 115.66 27.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 176.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.1 m -106.29 -23.61 4.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.686 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 44.7 tptt -142.09 115.84 9.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.238 0.542 . . . . 0.0 112.07 -176.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.47 HD23 HG12 ' A' ' 9' ' ' ILE . 3.2 mm? -97.46 128.91 44.62 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 170.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' THR . . . . . 1.119 ' HB ' ' HB3' ' A' ' 118' ' ' ASN . 14.2 m -115.98 135.71 53.71 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.043 0.449 . . . . 0.0 110.952 -175.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.697 HH21 ' HB2' ' A' ' 138' ' ' GLU . 38.7 mtm180 -88.03 106.91 18.46 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.379 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.956 ' HG ' ' HB ' ' A' ' 116' ' ' THR . 6.5 mp 49.66 -137.34 1.05 Allowed 'General case' 0 CA--C 1.532 0.27 0 O-C-N 123.233 0.333 . . . . 0.0 110.15 -178.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.656 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 27.4 t80 -80.64 -55.94 4.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.798 171.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 56.46 109.63 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.907 0.755 . . . . 0.0 112.163 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -44.59 -54.38 6.16 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 114.99 -1.005 . . . . 0.0 112.205 -174.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.28 -34.66 28.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.081 -0.508 . . . . 0.0 112.356 -176.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.697 ' HB2' HH21 ' A' ' 132' ' ' ARG . 15.6 tt0 -70.33 -37.64 74.73 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.645 -176.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.542 ' CZ ' ' HB3' ' A' ' 54' ' ' PHE . 84.7 t80 -63.23 -43.48 97.93 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 174.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.36 -53.73 54.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.209 176.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.1 m -54.37 -45.12 72.73 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.418 174.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.544 ' O ' HG12 ' A' ' 146' ' ' ILE . 45.0 tp -57.55 -48.99 77.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.607 -178.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 139' ' ' PHE . 87.8 t -60.04 -44.06 94.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.102 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -59.07 -44.15 91.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.275 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.559 ' O ' ' HG3' ' A' ' 149' ' ' MET . 56.4 tt0 -65.74 -39.69 91.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.543 178.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 142' ' ' LEU . 35.1 mm -56.07 -47.2 80.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.202 0.525 . . . . 0.0 110.238 175.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -62.29 -31.23 71.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.341 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -71.54 -44.66 64.18 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.527 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.559 ' HG3' ' O ' ' A' ' 145' ' ' GLN . 80.0 mtp -66.88 -26.3 66.82 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.465 0.65 . . . . 0.0 109.926 -176.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.544 HD23 ' O ' ' A' ' 146' ' ' ILE . 4.4 mm? . . . . . 0 C--N 1.325 -0.475 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.161 175.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.526 ' CE2' ' HD2' ' A' ' 117' ' ' ARG . 92.9 m-85 . . . . . 0 C--O 1.235 0.292 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.43 HD13 ' H ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -109.18 -5.3 10.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.149 164.421 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.2 p -94.92 160.37 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.092 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.6 ppt_? -128.38 166.58 18.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.906 0.384 . . . . 0.0 111.998 -173.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.4 mt -68.85 131.88 33.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.592 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.98 -3.86 70.79 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.066 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -82.17 152.1 26.63 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.439 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 31.8 mtp -81.83 124.67 29.88 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.089 178.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.43 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -61.47 126.87 87.54 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.681 -176.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 31.3 Cg_exo -59.12 121.77 10.48 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.949 2.433 . . . . 0.0 111.493 177.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.452 ' HA ' HD12 ' A' ' 28' ' ' LEU . 1.0 OUTLIER -70.77 141.86 51.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.532 -175.649 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.425 ' O ' ' HA ' ' A' ' 27' ' ' THR . 39.8 p90 -153.08 163.75 39.28 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.329 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 27.4 m -123.29 107.56 11.8 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 174.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.7 tt -106.8 147.83 11.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.827 0.346 . . . . 0.0 110.8 -175.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 24' ' ' LYS . 3.9 m -81.94 133.47 35.31 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.173 178.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.793 ' HB2' ' HB2' ' A' ' 24' ' ' LYS . 75.7 mt -91.19 -178.7 5.23 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.609 -0.268 . . . . 0.0 110.742 177.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.9 p -55.5 -41.72 73.47 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -172.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.425 ' OD1' ' HG2' ' A' ' 24' ' ' LYS . 4.5 p-10 -97.29 8.0 45.44 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.221 -176.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.88 8.94 44.18 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.289 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.793 ' HB2' ' HB2' ' A' ' 20' ' ' LEU . 40.5 mmtm -62.02 151.89 33.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.035 0.445 . . . . 0.0 110.718 177.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -118.21 116.85 27.65 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.644 174.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 17' ' ' THR . 5.2 p -120.45 125.75 74.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.4 0.619 . . . . 0.0 110.998 -179.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.437 HG22 ' H ' ' A' ' 29' ' ' SER . 9.3 m -106.4 141.0 38.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.944 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.452 HD12 ' HA ' ' A' ' 15' ' ' ASP . 17.6 mt -62.83 -31.07 72.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.412 0.149 . . . . 0.0 111.183 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.437 ' H ' HG22 ' A' ' 27' ' ' THR . 45.8 m -53.43 -34.32 57.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.459 176.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.9 m -78.69 -18.13 54.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.213 0.53 . . . . 0.0 111.082 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.517 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 67.0 mt -101.65 0.78 36.77 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.856 -177.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 28' ' ' LEU . 38.2 mmt180 -66.82 127.94 34.4 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.15 -27.83 8.33 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.486 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.719 ' HB3' ' HZ3' ' A' ' 34' ' ' LYS . 0.7 OUTLIER -116.48 167.4 11.09 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.514 -0.18 . . . . 0.0 110.514 -178.532 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.4 p -80.06 127.63 39.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.019 0.438 . . . . 0.0 110.664 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.577 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 28.1 t -119.39 121.59 66.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.855 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.657 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 28.3 ttt -107.12 120.04 41.01 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.3 mt -126.22 102.01 7.0 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.104 -177.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.9 pm0 -107.38 133.18 52.28 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.615 175.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 94.9 m-85 -89.72 132.52 35.14 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.024 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.536 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 6.6 t -140.79 169.88 16.8 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.312 -177.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.48 ' HB2' ' CD1' ' A' ' 115' ' ' ILE . . . -135.54 151.65 50.53 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.8 169.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.456 ' H ' ' HG3' ' A' ' 78' ' ' GLU . 46.1 m -73.18 28.03 0.06 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -174.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.401 ' H ' ' C ' ' A' ' 42' ' ' ALA . 41.1 p-90 -147.24 7.71 0.9 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.599 0.238 . . . . 0.0 111.238 176.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.461 ' SG ' ' HB3' ' A' ' 42' ' ' ALA . 79.7 m -86.57 130.43 34.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.858 0.361 . . . . 0.0 110.891 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -83.92 -31.25 26.8 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.196 -177.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.691 HG11 ' HB2' ' A' ' 133' ' ' LEU . 38.4 t -62.86 -37.95 80.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.301 0.572 . . . . 0.0 109.835 177.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.959 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 63.2 m -70.44 -20.21 62.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.065 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -75.05 -7.57 54.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.072 0.463 . . . . 0.0 110.255 175.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -102.07 -51.55 3.36 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.5 174.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 1.007 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 12.2 pt-20 -65.17 -44.58 88.04 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.03 -175.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.504 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 38.3 mtm -64.79 -48.95 71.65 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -173.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.504 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 72.6 Cg_exo -54.94 -39.95 88.02 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.737 1.624 . . . . 0.0 112.161 171.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.43 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 7.6 m-85 -66.9 -40.4 87.69 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.078 176.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.574 HG13 ' O ' ' A' ' 51' ' ' GLU . 78.5 mt -57.65 -50.0 78.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.315 175.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.634 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 22.0 tp10 -57.52 -51.05 71.02 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 176.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -54.6 -61.7 2.14 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -175.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.865 ' HA ' ' HZ3' ' A' ' 62' ' ' LYS . 64.5 m-20 -107.56 -13.61 15.02 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -169.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.535 HG23 HG21 ' A' ' 146' ' ' ILE . 61.5 mt -101.99 -62.33 2.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.788 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.583 ' HB3' ' HA ' ' A' ' 56' ' ' GLU . 62.8 t-105 -69.79 -48.29 59.74 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.498 -173.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.634 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -54.83 -28.75 51.91 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -176.256 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.865 ' HZ3' ' HA ' ' A' ' 58' ' ' ASP . 39.3 mmtm -87.47 -25.62 23.64 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -172.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 61.8 m-70 -122.05 -40.27 2.53 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -172.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.617 ' HE2' ' HA ' ' A' ' 61' ' ' LEU . 45.8 mmtt 49.57 -102.5 0.1 Allowed 'General case' 0 C--O 1.224 -0.25 0 O-C-N 123.566 0.541 . . . . 0.0 111.526 -175.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.557 ' C ' ' H ' ' A' ' 67' ' ' ALA . 17.2 t70 -87.37 -63.58 1.28 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.809 -175.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.433 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 18.4 t-20 64.9 -25.97 0.09 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -175.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.557 ' H ' ' C ' ' A' ' 65' ' ' ASP . . . 89.09 -15.94 0.3 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.505 1.522 . . . . 0.0 109.618 -177.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.613 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 2.0 m-20 -134.06 20.43 3.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.083 178.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.481 ' CD1' HD21 ' A' ' 150' ' ' LEU . 86.7 t80 -121.92 108.46 13.46 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.297 0.57 . . . . 0.0 109.786 172.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 36' ' ' VAL . . . -111.75 104.37 12.71 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.756 -176.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.657 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 3.9 tt -113.78 114.66 26.63 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.6 mp -125.01 123.96 66.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.004 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.431 ' HA3' HD22 ' A' ' 96' ' ' LEU . . . -89.16 119.52 5.47 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.075 176.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 65.3 mt -102.29 102.14 13.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 117.134 0.467 . . . . 0.0 111.266 -174.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.536 ' HA ' ' O ' ' A' ' 41' ' ' THR . 8.0 t0 -80.76 144.53 32.08 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 170.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.436 ' HD2' ' CG ' ' A' ' 105' ' ' PHE . 8.2 ttp180 -85.46 -105.32 0.05 Allowed 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 120.305 -0.558 . . . . 0.0 112.186 -167.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.413 ' H ' ' HB3' ' A' ' 76' ' ' ARG . 31.8 m-20 -87.7 17.14 4.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.499 -168.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.456 ' HG3' ' H ' ' A' ' 43' ' ' SER . 5.8 mm-40 -91.09 138.86 25.7 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.579 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.447 ' HD2' ' HG3' ' A' ' 82' ' ' LYS . 48.5 Cg_endo -70.22 178.63 4.66 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.773 2.316 . . . . 0.0 113.07 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.1 mt -57.95 -56.46 21.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.926 -175.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.508 ' CD ' ' H ' ' A' ' 81' ' ' GLU . 1.9 pm0 -52.99 -36.0 59.83 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.638 -177.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.447 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 25.5 mmtp -63.51 -58.06 8.21 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.71 0.291 . . . . 0.0 110.487 175.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 55.0 t -54.18 -49.68 60.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.5 -177.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.41 -42.36 98.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.66 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.546 ' HA ' ' HE3' ' A' ' 88' ' ' LYS . . . -74.26 -29.52 61.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.648 -176.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -79.86 -44.91 19.63 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.57 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.422 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . . . -55.64 -54.03 49.19 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.665 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.546 ' HE3' ' HA ' ' A' ' 85' ' ' ALA . 18.1 pttp -55.44 -30.54 60.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.746 -176.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.5 m -79.73 -14.59 58.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.103 -174.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.7 p -115.07 9.02 15.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.207 0.527 . . . . 0.0 110.637 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.67 -72.46 0.91 Allowed Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.293 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.0 t 28.07 88.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.622 1.169 . . . . 0.0 113.593 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.2 m -96.59 15.81 20.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.757 0.789 . . . . 0.0 110.086 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.551 ' HB3' ' CE2' ' A' ' 60' ' ' TRP . 25.9 p90 -115.43 146.85 37.45 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.114 176.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.76 136.84 69.09 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.635 2.224 . . . . 0.0 112.874 -177.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.431 HD22 ' HA3' ' A' ' 73' ' ' GLY . 63.7 mt -110.56 151.71 27.28 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.831 176.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -121.07 162.05 14.92 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 175.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.659 HD23 ' H ' ' A' ' 98' ' ' LEU . 2.0 pt? -121.6 138.61 54.25 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 117.005 0.403 . . . . 0.0 110.559 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -122.46 72.85 39.98 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.808 -178.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.448 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 13.9 Cg_exo -69.44 111.66 2.81 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.765 2.31 . . . . 0.0 111.761 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 117.74 -1.74 17.76 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -176.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 49.66 40.21 19.26 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -177.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -82.94 -53.96 5.44 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.122 0.486 . . . . 0.0 111.077 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.8 mm -63.85 -33.55 62.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.485 ' HE2' ' O ' ' A' ' 110' ' ' LEU . 80.2 t80 -64.63 -44.3 90.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.312 174.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.659 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -65.02 -19.81 66.18 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.852 -177.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -73.71 -6.7 48.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.858 0.361 . . . . 0.0 111.31 177.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -128.95 -42.19 1.41 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.994 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.659 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -139.07 157.14 46.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.65 -178.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.485 ' O ' ' HE2' ' A' ' 105' ' ' PHE . 7.5 mp -61.41 138.35 58.26 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 178.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.431 ' H ' ' HG3' ' A' ' 111' ' ' ARG . 10.0 mtm180 -55.96 -36.66 68.06 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 122.237 1.018 . . . . 0.0 109.245 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.22 13.49 15.08 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.647 -1.615 . . . . 0.0 110.444 -172.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.421 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . . . -108.1 -171.77 1.93 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.877 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.86 119.68 19.71 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.664 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.48 ' CD1' ' HB2' ' A' ' 42' ' ' ALA . 2.3 tt -67.94 -39.09 81.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -175.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.462 HG22 ' HA ' ' A' ' 133' ' ' LEU . 12.2 m -75.99 98.88 4.4 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.1 0.476 . . . . 0.0 110.987 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.526 ' HD2' ' CE2' ' A' ' 5' ' ' TYR . 37.8 mmt-85 -136.31 133.14 36.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.487 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.516 ' HB2' HG22 ' A' ' 131' ' ' THR . 7.4 m120 -111.0 118.56 36.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.789 0.328 . . . . 0.0 110.43 -176.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.7 t -112.3 128.98 68.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.452 -178.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 46.3 tp -115.16 116.26 28.09 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.028 0.442 . . . . 0.0 110.469 175.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.577 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 55.1 mt -99.59 132.64 44.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.474 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.49 174.09 8.71 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.942 0.401 . . . . 0.0 110.438 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.6 ptp85 -53.82 -34.54 59.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.725 -177.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -81.98 -0.55 44.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.559 -174.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.08 4.5 66.77 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.563 176.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 9.2 mtmp? -97.45 149.52 22.06 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.941 0.401 . . . . 0.0 111.107 -177.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 55.1 mt -85.31 109.88 18.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.805 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 19.4 m -98.75 -17.0 6.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.899 -175.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.676 ' HE3' ' HB ' ' A' ' 131' ' ' THR . 6.9 tmtm? -149.45 108.24 3.86 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.766 -177.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.93 109.36 15.44 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 172.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.676 ' HB ' ' HE3' ' A' ' 129' ' ' LYS . 11.8 t -117.25 164.08 15.35 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.439 -176.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.504 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -103.23 108.0 19.04 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.352 -176.492 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.691 ' HB2' HG11 ' A' ' 47' ' ' VAL . 4.4 pp 51.16 -176.55 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.315 1.046 . . . . 0.0 113.438 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 1.007 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 93.3 t80 -68.74 91.75 0.45 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.777 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.564 ' HB3' ' HB2' ' A' ' 138' ' ' GLU . 48.0 t-20 -107.15 121.15 43.93 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 173.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.509 ' H ' ' CD ' ' A' ' 136' ' ' GLU . 1.3 mp0 -38.26 -64.87 0.38 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.77 0.828 . . . . 0.0 112.772 -175.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -56.82 -51.5 68.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.347 0.594 . . . . 0.0 111.357 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.564 ' HB2' ' HB3' ' A' ' 135' ' ' ASN . 5.5 mm-40 -62.61 -43.91 97.63 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.011 -176.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.539 ' O ' HG23 ' A' ' 143' ' ' VAL . 69.1 t80 -66.07 -42.86 88.84 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.486 ' O ' ' HG2' ' A' ' 144' ' ' GLN . . . -57.22 -50.0 74.24 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.532 177.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 17.4 m -62.96 -37.8 88.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.819 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.459 ' O ' HG12 ' A' ' 146' ' ' ILE . 2.6 tt -62.85 -48.31 79.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.794 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 139' ' ' PHE . 99.7 t -59.05 -45.1 92.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.154 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 140' ' ' ALA . 29.8 mm-40 -62.33 -43.33 99.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.339 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.448 ' O ' ' HG2' ' A' ' 149' ' ' MET . 63.7 tt0 -63.69 -40.85 97.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.424 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.573 ' O ' HD23 ' A' ' 150' ' ' LEU . 24.5 mm -51.83 -50.08 34.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 121.176 0.512 . . . . 0.0 110.517 175.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -58.02 -43.25 86.6 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.45 -178.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -70.95 -32.95 69.98 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.009 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 83.1 mmm -60.06 -29.43 68.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.179 0.514 . . . . 0.0 110.167 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.573 HD23 ' O ' ' A' ' 146' ' ' ILE . 3.6 mm? . . . . . 0 C--N 1.324 -0.542 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.378 177.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 . . . . . 0 CA--C 1.522 -0.124 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.5 pt -115.58 -6.15 11.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.252 0.549 . . . . 0.0 109.881 172.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.1 m -100.8 166.23 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.493 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.55 ' HB2' ' HG2' ' A' ' 11' ' ' GLU . 25.2 mtt180 -126.09 167.63 15.1 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -176.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 72.8 mt -78.99 119.47 28.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 174.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.64 -25.93 9.32 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.683 -176.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.55 ' HG2' ' HB2' ' A' ' 8' ' ' ARG . 72.2 mm-40 -66.76 150.37 49.21 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.627 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 56.7 mtp -80.32 123.54 28.08 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 174.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.439 ' HA ' ' HD2' ' A' ' 14' ' ' PRO . . . -56.16 124.58 60.63 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.603 -174.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 13' ' ' ALA . 7.1 Cg_endo -52.75 132.01 44.37 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.761 2.308 . . . . 0.0 111.338 175.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -82.82 161.54 21.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.458 -175.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.594 ' HB2' HD12 ' A' ' 104' ' ' ILE . 53.9 p90 -166.65 163.48 16.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.227 -175.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.6 m -125.26 100.5 6.56 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 174.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.5 tt -96.14 149.89 4.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.704 -174.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.477 ' O ' HD23 ' A' ' 98' ' ' LEU . 19.0 m -90.75 127.06 36.2 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.051 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.429 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 71.4 mt -79.69 175.9 10.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.933 178.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 96' ' ' LEU . 37.0 p -59.34 -25.9 64.59 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -177.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.802 ' OD1' ' HG2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -90.28 -19.32 24.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.146 0.498 . . . . 0.0 110.634 -178.519 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 113.13 -2.71 25.45 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.467 -174.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.802 ' HG2' ' OD1' ' A' ' 22' ' ' ASP . 39.3 mmtm -65.91 126.79 29.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.83 0.348 . . . . 0.0 111.149 178.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -91.3 116.4 28.8 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.868 176.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.9 p -119.05 128.4 75.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.315 0.578 . . . . 0.0 111.089 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 6.2 m -97.88 147.9 23.97 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.281 -178.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.71 -28.31 67.56 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.517 ' HA ' ' HG2' ' A' ' 32' ' ' ARG . 44.7 m -56.27 -29.31 60.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.389 177.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.6 m -75.24 -17.13 60.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.112 0.482 . . . . 0.0 111.243 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.3 mt -104.69 1.31 29.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.432 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.517 ' HG2' ' HA ' ' A' ' 29' ' ' SER . 36.3 mmt180 -66.76 122.5 17.79 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 120.54 -19.99 8.97 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -176.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.462 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 45.1 mtmt -116.52 155.24 29.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.547 -0.326 . . . . 0.0 110.323 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.512 HG13 ' HD1' ' A' ' 69' ' ' PHE . 1.4 p -71.27 117.73 14.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.012 0.434 . . . . 0.0 109.854 174.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.551 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 43.1 t -107.68 129.76 61.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.423 -173.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 27.6 ttt -107.46 120.12 41.3 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.174 175.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.7 mt -123.66 94.78 4.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.129 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.679 HE22 HD21 ' A' ' 71' ' ' LEU . 20.2 pm0 -93.81 131.1 39.52 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.107 0.48 . . . . 0.0 110.447 177.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -96.14 110.28 22.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.421 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.6 t -115.63 -171.9 2.05 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.88 -176.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.718 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . . . -163.13 143.46 9.16 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.514 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 54.8 m -62.68 -13.9 37.54 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -174.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 68.2 p-90 -101.07 -4.72 26.87 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.154 -0.341 . . . . 0.0 111.663 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.718 ' SG ' ' HB3' ' A' ' 42' ' ' ALA . 83.8 m -78.21 124.58 28.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.977 0.418 . . . . 0.0 111.732 -175.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -88.66 -18.11 55.39 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 176.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.479 ' HB ' HG21 ' A' ' 116' ' ' THR . 61.8 t -72.02 -46.52 59.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.931 0.396 . . . . 0.0 110.027 176.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.736 ' SG ' HG22 ' A' ' 116' ' ' THR . 69.2 m -66.91 -17.61 64.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.7 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.558 ' HE ' ' HE1' ' A' ' 86' ' ' PHE . 75.0 mtt180 -72.77 -6.46 44.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.154 0.502 . . . . 0.0 110.694 176.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -105.3 -44.98 4.6 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 169.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.649 ' HB2' ' HB2' ' A' ' 134' ' ' TYR . 40.6 tt0 -56.18 -57.12 13.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.369 -177.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.671 ' SD ' ' HE2' ' A' ' 86' ' ' PHE . 74.8 mtp -62.52 -50.64 77.76 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -172.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.615 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 54.7 Cg_exo -55.66 -36.22 94.42 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.959 1.773 . . . . 0.0 112.435 175.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -69.74 -41.32 75.43 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.638 175.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.534 HG13 ' O ' ' A' ' 51' ' ' GLU . 81.5 mt -56.32 -53.18 42.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.057 177.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.625 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 17.1 pt-20 -67.34 -32.09 72.8 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.525 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -62.04 -60.3 3.82 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.47 ' HA ' ' NZ ' ' A' ' 62' ' ' LYS . 52.1 m-20 -107.19 -8.48 16.43 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -171.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.508 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 70.6 mt -104.76 -57.98 4.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.612 176.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.625 ' HB3' ' HA ' ' A' ' 56' ' ' GLU . 76.5 t-105 -66.55 -67.42 0.45 Allowed 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.177 -178.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.0 mp -47.45 -32.1 4.8 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -174.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.47 ' NZ ' ' HA ' ' A' ' 58' ' ' ASP . 46.5 mmtm -77.28 -36.48 54.2 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -177.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -126.68 -43.16 1.74 Allowed 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.937 -0.477 . . . . 0.0 112.099 -173.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 60' ' ' TRP . 33.2 mttp 62.03 -83.05 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.918 0.887 . . . . 0.0 111.451 -178.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -123.37 -38.85 2.51 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 174.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 70.74 -75.06 0.08 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.022 175.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 171.86 -33.83 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.898 -176.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.462 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 5.7 t70 -126.83 19.55 7.17 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.273 -177.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.512 ' HD1' HG13 ' A' ' 35' ' ' VAL . 87.7 t80 -129.11 155.17 45.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.39 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -150.24 132.46 15.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.43 176.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.679 HD21 HE22 ' A' ' 39' ' ' GLN . 5.5 tt -129.41 119.77 24.38 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.5 mm -129.89 120.29 49.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.088 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.88 128.79 9.31 Favored Glycine 0 C--O 1.224 -0.509 0 C-N-CA 120.234 -0.984 . . . . 0.0 111.457 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.3 mt -115.5 120.1 63.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 117.23 0.515 . . . . 0.0 111.174 -176.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.521 ' OD1' ' HA ' ' A' ' 42' ' ' ALA . 16.7 t0 -92.09 127.89 37.73 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 174.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.49 111.33 22.57 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.169 -171.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.7 t0 81.43 -26.09 0.15 Allowed 'General case' 0 N--CA 1.47 0.557 0 O-C-N 124.147 0.904 . . . . 0.0 112.367 169.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.488 ' HB2' ' OD1' ' A' ' 75' ' ' ASP . 5.5 mm-40 -69.49 131.98 89.68 Favored Pre-proline 0 C--O 1.235 0.295 0 CA-C-O 121.148 0.499 . . . . 0.0 110.713 177.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.561 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 36.8 Cg_endo -71.96 -168.71 0.39 Allowed 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.088 2.526 . . . . 0.0 114.624 -176.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -62.69 -52.71 62.2 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.367 -168.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.561 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -62.98 -34.1 76.8 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.502 0.191 . . . . 0.0 111.419 -175.76 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.554 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 33.6 mmtp -58.93 -58.87 6.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.828 176.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.529 HG21 ' HB3' ' A' ' 98' ' ' LEU . 45.2 t -55.27 -44.88 77.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.452 -177.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.8 mp -67.37 -31.71 72.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.698 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.791 ' HA ' ' HE2' ' A' ' 88' ' ' LYS . . . -82.86 -37.35 24.45 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.102 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.671 ' HE2' ' SD ' ' A' ' 52' ' ' MET . 83.2 t80 -67.57 -47.0 71.03 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.914 -178.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.582 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -55.15 -51.53 66.2 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.59 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.791 ' HE2' ' HA ' ' A' ' 85' ' ' ALA . 64.7 pttt -65.94 -23.2 66.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.829 0.347 . . . . 0.0 111.688 -174.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.8 m -80.42 -28.22 37.82 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.108 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.6 p -96.95 -20.53 18.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.078 0.466 . . . . 0.0 111.01 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 112.58 -74.77 0.22 Allowed Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -175.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 97.8 t 43.43 88.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 124.31 1.044 . . . . 0.0 113.322 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.2 m -79.8 6.26 11.43 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 114.704 -1.135 . . . . 0.0 111.333 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.553 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 50.7 p90 -118.71 153.55 52.35 Favored Pre-proline 0 C--N 1.329 -0.306 0 O-C-N 122.172 -0.33 . . . . 0.0 110.882 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -66.71 137.97 47.56 Favored 'Trans proline' 0 C--O 1.24 0.593 0 C-N-CA 122.175 1.916 . . . . 0.0 113.236 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.582 HD12 ' HB2' ' A' ' 87' ' ' ALA . 77.9 mt -109.61 148.28 31.57 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.738 174.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -117.59 147.8 18.74 Favored Glycine 0 N--CA 1.438 -1.221 0 N-CA-C 110.389 -1.085 . . . . 0.0 110.389 173.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.733 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.5 pt? -101.6 136.63 41.13 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -178.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.41 ' OD2' ' HA ' ' A' ' 102' ' ' ALA . 27.5 t0 -116.38 73.95 5.71 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.261 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.494 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 15.4 Cg_exo -68.09 117.25 4.79 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.655 2.237 . . . . 0.0 111.524 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.407 ' O ' ' HD2' ' A' ' 111' ' ' ARG . . . 102.41 -7.32 53.87 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.275 -175.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.518 ' HB3' ' HG2' ' A' ' 111' ' ' ARG . . . 55.68 38.73 30.5 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 122.896 0.479 . . . . 0.0 111.402 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -72.46 -46.11 56.42 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.607 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.594 HD12 ' HB2' ' A' ' 16' ' ' PHE . 21.2 mm -65.22 -38.94 83.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.687 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -65.2 -38.71 91.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.097 175.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.57 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -68.92 -15.3 63.45 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.296 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 52.2 mttp -80.16 -16.75 54.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.627 175.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -113.82 -20.97 10.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.803 0.335 . . . . 0.0 111.328 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.57 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -159.79 -179.81 8.17 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.244 -178.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.94 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 88.6 mt -65.27 138.31 58.12 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.518 ' HG2' ' HB3' ' A' ' 102' ' ' ALA . 1.3 ttp85 -42.61 -48.1 5.36 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -173.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -118.58 37.79 3.95 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.138 0.494 . . . . 0.0 110.667 -176.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.94 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . . . -81.41 34.8 0.38 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.938 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.5 -162.92 17.7 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 121.022 -0.608 . . . . 0.0 112.282 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.562 HG13 ' H ' ' A' ' 116' ' ' THR . 4.7 tp -151.78 -174.2 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -178.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.736 HG22 ' SG ' ' A' ' 48' ' ' CYS . 53.0 p 58.37 88.86 0.06 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.869 0.867 . . . . 0.0 111.692 176.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -171.09 141.86 1.72 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.223 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.686 ' HB3' ' HB ' ' A' ' 131' ' ' THR . 5.6 t30 -119.97 129.67 54.41 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.095 0.474 . . . . 0.0 111.51 -176.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 39.1 t -101.81 113.1 37.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.781 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.939 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 27.2 tp -97.64 115.7 28.43 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.33 0.586 . . . . 0.0 110.035 177.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.551 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 60.5 mt -98.85 135.68 32.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 114.988 -1.006 . . . . 0.0 109.77 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.614 ' OD2' ' HB2' ' A' ' 126' ' ' LYS . 4.4 p30 -75.87 170.23 16.62 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.919 0.39 . . . . 0.0 110.0 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -75.39 1.31 14.2 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.471 -175.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.424 ' HB2' ' OD1' ' A' ' 122' ' ' ASP . 38.7 mt-10 -91.62 -30.5 16.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.373 0.606 . . . . 0.0 109.645 175.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.82 5.56 10.84 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.214 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.627 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 9.3 mtmp? -100.74 157.97 16.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.973 0.416 . . . . 0.0 111.263 -177.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 54.5 mt -92.06 119.08 38.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.155 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 17.0 m -114.91 -23.28 4.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.939 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 59.2 tptt -134.46 113.9 12.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.14 0.495 . . . . 0.0 111.799 -174.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -101.76 113.44 26.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.398 173.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.686 ' HB ' ' HB3' ' A' ' 118' ' ' ASN . 25.4 m -95.57 137.42 34.66 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.496 -177.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.451 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 0.4 OUTLIER -108.42 105.7 15.49 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.72 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 132' ' ' ARG . 3.4 pp 41.72 -163.1 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.093 0.871 . . . . 0.0 113.011 -177.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.649 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 84.5 t80 -94.14 107.48 19.41 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.127 0.489 . . . . 0.0 111.451 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.465 ' HB2' ' CB ' ' A' ' 138' ' ' GLU . 54.0 m-80 -119.42 149.77 41.3 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 170.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -58.58 -56.16 25.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.121 0.486 . . . . 0.0 110.752 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.456 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 0.9 OUTLIER -65.05 -40.78 95.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.216 -178.567 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.465 ' CB ' ' HB2' ' A' ' 135' ' ' ASN . 6.1 tp10 -61.93 -49.78 74.8 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.629 -178.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -66.96 -37.92 85.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.487 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.16 -42.06 97.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.337 176.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 43.2 m -64.5 -30.3 71.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.143 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.493 HD11 HG21 ' A' ' 131' ' ' THR . 29.2 mt -72.8 -55.26 6.96 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.294 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.3 p -59.42 -38.54 75.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 O-C-N 123.166 0.291 . . . . 0.0 110.897 -175.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -67.54 -46.9 71.44 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 176.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.407 ' O ' ' HG2' ' A' ' 149' ' ' MET . 65.1 tt0 -58.86 -46.58 87.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.605 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.553 ' O ' HD23 ' A' ' 150' ' ' LEU . 81.7 mt -65.47 -40.01 86.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.041 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -58.91 -38.63 79.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.688 0.28 . . . . 0.0 110.819 176.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -77.9 -30.41 50.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.941 178.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.407 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 87.0 mmm -67.19 -27.79 67.56 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.316 0.579 . . . . 0.0 110.143 178.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.553 HD23 ' O ' ' A' ' 146' ' ' ILE . 3.9 mm? . . . . . 0 C--N 1.325 -0.487 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.556 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.462 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 62.1 m-85 . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.417 ' H ' ' HA ' ' A' ' 109' ' ' ALA . 39.8 pt -92.07 -13.37 8.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.556 0.693 . . . . 0.0 109.248 173.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 p -110.57 164.16 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.298 178.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.5 mtm105 -133.68 165.85 23.97 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.902 0.382 . . . . 0.0 111.01 -174.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.422 HG12 HD13 ' A' ' 130' ' ' LEU . 85.4 mt -72.02 122.96 25.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.193 178.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.99 -22.21 19.03 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.94 -178.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -74.11 159.25 32.87 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.741 0.305 . . . . 0.0 110.722 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.588 ' SD ' ' HG2' ' A' ' 126' ' ' LYS . 56.3 mmm -79.76 133.28 36.32 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.435 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -69.99 129.7 90.61 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.623 -177.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.512 ' HD2' ' CE1' ' A' ' 108' ' ' TYR . 32.9 Cg_exo -61.92 137.44 67.47 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.882 2.388 . . . . 0.0 111.744 175.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.426 ' HB2' HH22 ' A' ' 32' ' ' ARG . 23.4 t70 -80.61 153.03 28.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.888 -177.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -161.88 165.44 27.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.779 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 73.5 m -124.7 107.12 10.64 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 174.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.5 tt -105.92 144.86 14.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.94 -173.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.465 ' O ' HD23 ' A' ' 98' ' ' LEU . 5.5 m -88.52 131.69 34.81 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.077 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.491 HD12 ' HB2' ' A' ' 24' ' ' LYS . 79.0 mt -82.43 -179.43 7.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.845 0.355 . . . . 0.0 110.951 177.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.453 ' HB ' HD11 ' A' ' 84' ' ' LEU . 35.6 p -57.85 -31.65 66.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.894 -175.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.493 ' OD2' ' HG2' ' A' ' 24' ' ' LYS . 5.4 p-10 -99.45 -6.19 28.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.818 0.342 . . . . 0.0 110.835 -175.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.94 1.82 34.12 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.333 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.614 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -69.22 110.78 4.76 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 117.663 0.732 . . . . 0.0 110.297 175.623 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -92.69 115.08 27.78 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.086 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 17' ' ' THR . 12.8 m -112.66 146.03 17.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.156 0.503 . . . . 0.0 110.804 -177.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.6 m -103.2 147.06 27.5 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.712 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.17 -45.81 93.08 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.702 0.287 . . . . 0.0 110.408 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.9 m -64.95 -15.79 62.59 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.2 t -82.48 -15.38 52.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.577 0.703 . . . . 0.0 109.555 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.2 mt -112.12 -3.9 14.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.539 177.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.426 HH22 ' HB2' ' A' ' 15' ' ' ASP . 7.8 mtm180 -75.81 156.36 34.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.058 0.456 . . . . 0.0 111.024 -178.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.48 -15.71 62.68 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 -166.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.582 ' HB3' ' O ' ' A' ' 68' ' ' ASP . 36.7 mtmt -116.44 160.21 20.9 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.058 -1.071 . . . . 0.0 109.381 175.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.431 HG11 HD22 ' A' ' 150' ' ' LEU . 2.3 p -80.19 118.27 27.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.359 0.6 . . . . 0.0 109.716 174.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.8 t -112.51 122.2 66.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.967 -173.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.652 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 26.7 ttt -99.34 114.96 28.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.08 175.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 69.6 mt -110.31 97.55 6.99 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.584 178.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.552 ' HG3' ' HA2' ' A' ' 73' ' ' GLY . 1.5 pp0? -91.1 130.97 36.94 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 177.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -107.02 122.34 46.25 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.43 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 13.9 t -151.49 -171.4 3.92 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.9 -177.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.409 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . . . -150.95 163.41 38.78 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 174.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.47 ' HB2' ' HG3' ' A' ' 78' ' ' GLU . 44.1 m -67.54 -5.71 16.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.055 -0.521 . . . . 0.0 112.168 -176.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 37.0 p-90 -109.9 12.21 23.91 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.482 ' SG ' HD13 ' A' ' 115' ' ' ILE . 73.8 m -92.85 100.95 13.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.118 0.485 . . . . 0.0 111.266 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.98 -32.38 73.29 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.889 -0.596 . . . . 0.0 113.082 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.6 t -64.12 -41.29 91.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.159 0.504 . . . . 0.0 110.446 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.75 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 83.6 m -67.62 -16.94 64.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.73 -177.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -71.3 -2.6 16.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.863 0.363 . . . . 0.0 110.994 176.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -98.85 -51.87 3.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.056 0.455 . . . . 0.0 110.026 170.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.75 ' HG2' ' HA ' ' A' ' 48' ' ' CYS . 11.7 pt-20 -69.58 -39.33 77.4 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.046 -173.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.575 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 91.7 mtp -60.36 -51.03 83.02 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -177.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.575 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 35.8 Cg_exo -59.68 -35.74 94.01 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.854 1.703 . . . . 0.0 112.208 172.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.579 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 3.1 m-85 -64.32 -43.73 93.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.724 174.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 51' ' ' GLU . 97.4 mt -58.16 -48.98 83.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.853 173.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.514 ' OE1' ' HA ' ' A' ' 92' ' ' VAL . 30.2 tp10 -50.22 -53.97 24.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.934 178.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -72.53 -50.45 25.65 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -173.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -105.8 -12.96 15.68 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -168.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.454 HD12 HG12 ' A' ' 55' ' ' ILE . 73.4 mt -106.37 -61.93 2.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.024 176.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.623 ' CE2' ' HG2' ' A' ' 64' ' ' LYS . 67.5 t-105 -62.94 -67.41 0.42 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.481 -174.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.02 -33.52 11.35 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -175.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -68.41 -30.11 68.94 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.78 -175.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.461 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 90.7 m-70 -128.98 -47.08 1.23 Allowed 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 119.678 -0.809 . . . . 0.0 112.621 -176.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.623 ' HG2' ' CE2' ' A' ' 60' ' ' TRP . 9.2 mtmp? 40.57 -93.98 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.568 0.699 . . . . 0.0 112.149 -174.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.59 -70.59 0.29 Allowed 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.045 173.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.586 ' ND2' HD12 ' A' ' 150' ' ' LEU . 5.7 t30 70.18 -68.77 0.19 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.769 0.828 . . . . 0.0 111.078 174.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 175.87 -46.3 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.363 -178.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.582 ' O ' ' HB3' ' A' ' 34' ' ' LYS . 7.9 p-10 -142.85 35.25 1.4 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.066 -177.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.609 ' HB2' HD11 ' A' ' 150' ' ' LEU . 74.5 t80 -104.13 145.72 29.78 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.657 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.76 130.33 17.89 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.934 174.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.652 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 3.4 tt -135.35 114.61 12.37 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.5 mp -125.9 126.12 69.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.825 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.552 ' HA2' ' HG3' ' A' ' 39' ' ' GLN . . . -91.16 120.4 5.95 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.608 -0.805 . . . . 0.0 111.376 176.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 65.8 mt -103.92 122.99 57.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 116.861 0.33 . . . . 0.0 111.051 -175.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.555 ' HA ' ' O ' ' A' ' 41' ' ' THR . 9.3 t70 -85.84 137.74 32.55 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 176.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 54.5 ttt-85 -74.87 -28.23 60.57 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -172.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -161.92 -18.3 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -171.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.47 ' HG3' ' HB2' ' A' ' 43' ' ' SER . 5.3 mm-40 -78.59 132.25 65.73 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-O 121.294 0.569 . . . . 0.0 111.198 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.58 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 28.4 Cg_endo -71.89 -169.94 0.49 Allowed 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 123.307 2.671 . . . . 0.0 114.366 -178.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.414 ' O ' HD23 ' A' ' 84' ' ' LEU . 79.4 mt -53.5 -59.01 5.13 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 114.958 -1.019 . . . . 0.0 113.106 -173.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.58 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -59.53 -33.43 71.38 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.479 -172.111 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.487 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 34.1 mmtp -64.35 -55.89 18.14 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.014 0.435 . . . . 0.0 110.325 174.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 79' ' ' PRO . 92.7 t -57.95 -44.39 86.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.43 -177.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.453 HD11 ' HB ' ' A' ' 21' ' ' THR . 4.4 mm? -69.01 -13.11 62.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.729 -178.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.523 ' HA ' ' HD2' ' A' ' 88' ' ' LYS . . . -99.84 -42.05 6.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.925 0.393 . . . . 0.0 110.789 176.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.553 ' HE2' ' SD ' ' A' ' 52' ' ' MET . 71.7 t80 -64.63 -38.08 89.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.841 -177.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -54.63 -56.01 23.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.338 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.523 ' HD2' ' HA ' ' A' ' 85' ' ' ALA . 0.3 OUTLIER -66.98 -19.05 65.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.171 0.51 . . . . 0.0 110.838 -175.519 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.4 m -81.55 -1.89 47.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.333 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.5 p -138.43 11.03 2.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.224 0.535 . . . . 0.0 110.491 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.68 -74.2 1.17 Allowed Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.514 ' HA ' ' OE1' ' A' ' 56' ' ' GLU . 54.6 t 29.65 93.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.108 1.363 . . . . 0.0 114.408 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 71.9 p -97.17 -11.91 23.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.038 0.447 . . . . 0.0 110.186 174.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.522 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 37.6 p90 -81.52 144.33 52.85 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.472 176.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.2 138.37 81.0 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.714 2.276 . . . . 0.0 113.044 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.408 HD11 HG11 ' A' ' 92' ' ' VAL . 83.8 mt -110.9 142.07 43.46 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.938 177.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 74' ' ' ILE . . . -115.0 142.7 17.79 Favored Glycine 0 N--CA 1.441 -1.009 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 177.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.785 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.8 pt? -103.11 129.62 50.02 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.938 0.399 . . . . 0.0 110.815 -177.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -119.33 72.07 13.23 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.818 177.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.458 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 20.1 Cg_exo -65.28 108.48 1.17 Allowed 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.504 2.136 . . . . 0.0 112.312 -176.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 118.9 -6.23 13.58 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.6 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 59.35 44.99 14.51 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.897 0.479 . . . . 0.0 111.784 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -80.8 -55.52 4.76 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 120.973 0.416 . . . . 0.0 110.499 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 38.4 mm -62.02 -35.28 67.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 176.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.672 ' HZ ' ' HA ' ' A' ' 115' ' ' ILE . 38.9 t80 -60.48 -40.61 91.89 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.264 174.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -76.89 -14.72 59.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.184 -177.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 50.0 mttp -72.75 -11.16 60.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.953 0.406 . . . . 0.0 111.353 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.512 ' CE1' ' HD2' ' A' ' 14' ' ' PRO . 98.9 m-85 -116.72 -30.03 5.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.413 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.571 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -162.89 -177.23 5.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.62 0.248 . . . . 0.0 110.714 -175.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.515 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . 95.6 mt -72.69 135.49 45.41 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.563 ' HA ' ' CD1' ' A' ' 105' ' ' PHE . 17.6 mtm180 -58.59 -34.51 71.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.936 -175.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -105.42 7.58 33.23 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.015 -170.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.515 ' CB ' ' HB2' ' A' ' 110' ' ' LEU . . . -96.24 49.76 1.14 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.136 0.493 . . . . 0.0 111.234 -177.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.67 104.52 0.9 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.059 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.672 ' HA ' ' HZ ' ' A' ' 105' ' ' PHE . 5.1 tt -72.07 -52.51 24.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -176.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.538 HG21 ' HA ' ' A' ' 133' ' ' LEU . 77.0 m -59.34 109.48 0.88 Allowed 'General case' 0 C--O 1.238 0.465 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -175.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.588 ' HB3' HH21 ' A' ' 132' ' ' ARG . 13.6 ptt180 -161.16 140.59 10.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.584 178.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -107.2 118.11 35.83 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 174.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 51.0 t -101.54 106.27 19.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.092 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 43.1 tp -93.49 119.19 32.27 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.278 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 68.5 mt -103.83 131.11 53.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.657 177.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.408 ' CG ' ' H ' ' A' ' 124' ' ' GLU . 0.0 OUTLIER -74.96 166.04 24.29 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.564 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -66.93 -13.38 61.7 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -174.102 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.576 ' HB2' ' NZ ' ' A' ' 126' ' ' LYS . 48.4 mt-10 -84.43 -27.58 27.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.014 0.435 . . . . 0.0 110.564 175.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.67 10.07 7.99 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.376 -0.916 . . . . 0.0 113.04 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.588 ' HG2' ' SD ' ' A' ' 12' ' ' MET . 31.6 mtmm -93.09 146.06 23.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.129 0.49 . . . . 0.0 111.729 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 56.0 mt -87.28 115.09 27.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.763 177.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 31.1 m -109.87 -16.72 8.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -172.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.587 ' HG2' HD13 ' A' ' 142' ' ' LEU . 51.2 tptt -137.5 122.68 19.24 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 119.896 -0.722 . . . . 0.0 112.107 -176.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.422 HD13 HG12 ' A' ' 9' ' ' ILE . 9.8 mp -121.91 105.18 10.11 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.212 174.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.456 HG22 ' HE3' ' A' ' 129' ' ' LYS . 67.9 p -96.67 162.05 13.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.137 0.494 . . . . 0.0 111.486 -177.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.623 ' HA ' ' HE ' ' A' ' 132' ' ' ARG . 2.1 mmp_? -127.27 106.93 9.56 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 173.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.538 ' HA ' HG21 ' A' ' 116' ' ' THR . 88.5 mt 63.24 176.43 0.16 Allowed 'General case' 0 N--CA 1.469 0.508 0 O-C-N 123.761 0.663 . . . . 0.0 111.382 -177.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.502 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 76.3 t80 -83.73 87.88 7.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.464 0.649 . . . . 0.0 109.684 175.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -104.15 135.66 45.22 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 176.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -55.44 -61.21 2.49 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 123.375 0.422 . . . . 0.0 112.03 -168.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.523 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.4 mp0 -55.74 -44.84 77.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.784 0.326 . . . . 0.0 110.885 -177.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -62.93 -46.03 89.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.509 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.579 ' CE2' ' HB3' ' A' ' 54' ' ' PHE . 63.6 t80 -69.99 -41.46 74.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.245 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.19 -40.15 89.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.575 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 48.1 m -67.12 -37.43 83.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.345 176.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.587 HD13 ' HG2' ' A' ' 129' ' ' LYS . 63.0 tp -62.47 -50.75 70.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.777 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 139' ' ' PHE . 94.6 t -56.45 -54.26 30.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.181 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -60.54 -42.85 97.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.629 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -56.28 -49.32 74.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.327 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.629 ' O ' HD23 ' A' ' 150' ' ' LEU . 28.9 mt -60.19 -50.94 78.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.1 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -55.08 -42.31 72.67 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.253 -0.179 . . . . 0.0 111.352 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -77.86 -24.51 48.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.686 0.279 . . . . 0.0 110.761 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 45.3 mmm -63.26 -31.31 72.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.403 0.621 . . . . 0.0 110.011 175.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.629 HD23 ' O ' ' A' ' 146' ' ' ILE . 4.0 mm? . . . . . 0 C--N 1.323 -0.556 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.304 177.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 . . . . . 0 CA--C 1.517 -0.293 0 N-CA-C 110.568 -0.16 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.1 pt -87.78 -18.86 8.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.218 0.533 . . . . 0.0 109.667 174.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.5 m -93.84 -179.39 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.657 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.4 ' CD ' ' HB2' ' A' ' 11' ' ' GLU . 6.2 ppt_? -144.34 165.7 27.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.847 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 69.4 mt -67.4 128.4 30.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.138 0.494 . . . . 0.0 110.745 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.52 3.22 66.96 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.096 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.4 ' HB2' ' CD ' ' A' ' 8' ' ' ARG . 8.0 tp10 -85.68 151.75 23.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.58 0.229 . . . . 0.0 110.582 -178.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.45 ' HE2' ' HA ' ' A' ' 12' ' ' MET . 1.2 mmt -69.49 116.79 10.31 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 175.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.423 ' HB2' HG12 ' A' ' 121' ' ' ILE . . . -54.49 126.07 54.45 Favored Pre-proline 0 C--O 1.237 0.401 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.489 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.487 ' HG2' ' O ' ' A' ' 107' ' ' LYS . 27.3 Cg_exo -60.42 115.54 2.73 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.802 2.335 . . . . 0.0 111.028 178.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -70.64 133.01 46.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.828 -173.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.66 ' HB2' HD12 ' A' ' 104' ' ' ILE . 36.1 p90 -136.49 158.87 43.41 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.035 -178.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 49.0 m -117.31 99.51 7.06 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.4 tt -97.87 152.32 4.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.609 -173.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.49 ' O ' HD23 ' A' ' 98' ' ' LEU . 27.3 m -99.35 129.41 45.55 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.944 178.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.42 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 82.3 mt -85.01 -178.07 6.73 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.823 0.344 . . . . 0.0 111.13 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.442 HG23 ' O ' ' A' ' 96' ' ' LEU . 30.9 p -62.55 -26.43 68.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.081 -176.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.418 ' OD1' ' HB2' ' A' ' 24' ' ' LYS . 13.1 p-10 -92.79 -5.11 51.83 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.526 -178.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.51 2.4 56.52 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.135 -176.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.418 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 6.2 tmtt? -62.87 112.34 2.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.79 0.328 . . . . 0.0 111.829 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -87.52 117.63 26.45 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 172.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 17' ' ' THR . 7.1 p -126.5 133.25 69.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.298 0.571 . . . . 0.0 110.97 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 29' ' ' SER . 11.2 m -93.92 144.75 25.17 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.209 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.62 -29.49 70.65 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.77 0.319 . . . . 0.0 110.53 -178.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.413 ' H ' HG22 ' A' ' 27' ' ' THR . 36.6 m -56.13 -30.53 62.26 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.365 176.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.2 m -74.79 -24.97 58.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.398 0.618 . . . . 0.0 110.809 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 89.4 mt -90.74 -10.87 41.39 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.532 -176.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.437 HH11 ' HA3' ' A' ' 125' ' ' GLY . 35.3 mmt180 -57.68 154.52 11.49 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.62 -19.53 36.3 Favored Glycine 0 C--O 1.226 -0.38 0 C-N-CA 121.088 -0.577 . . . . 0.0 111.885 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.579 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 32.5 mtmm -116.59 170.47 8.55 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 68' ' ' ASP . 35.4 m -81.75 123.34 37.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 176.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.417 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 12.8 t -115.78 120.6 65.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.875 0.369 . . . . 0.0 110.873 -174.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 27.2 ttt -112.42 118.27 34.73 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.01 0.433 . . . . 0.0 110.485 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.741 HD23 HD13 ' A' ' 121' ' ' ILE . 2.8 mm? -111.17 107.98 17.49 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.08 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.447 HE21 ' HB2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -109.47 127.18 54.23 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.89 175.504 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -95.39 121.12 36.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.272 0.558 . . . . 0.0 110.436 -176.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.553 ' HA ' ' SG ' ' A' ' 48' ' ' CYS . 1.9 t -122.54 171.77 8.87 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.479 -175.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.527 ' HB2' HG12 ' A' ' 115' ' ' ILE . . . -150.65 130.53 13.31 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.678 177.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.532 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 47.8 m -57.96 -28.93 64.8 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.958 -177.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 38.7 p-90 -90.56 2.4 55.82 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 52.8 t -107.59 120.31 41.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.976 0.417 . . . . 0.0 111.223 -177.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -83.41 -17.64 66.06 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.702 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.546 HG12 HG21 ' A' ' 116' ' ' THR . 42.7 t -66.37 -43.45 91.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 176.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.566 ' O ' ' HG2' ' A' ' 52' ' ' MET . 72.3 m -64.23 -27.49 69.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.318 176.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 55.4 ttt180 -69.05 -6.11 26.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.155 0.502 . . . . 0.0 110.809 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.517 ' HE3' ' CD2' ' A' ' 134' ' ' TYR . 22.9 mtpp -83.31 -55.19 4.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.476 172.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 10.6 pt-20 -70.05 -31.73 69.49 Favored 'General case' 0 C--O 1.219 -0.553 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.729 -176.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.598 ' HG3' ' HE2' ' A' ' 86' ' ' PHE . 91.7 mmm -50.6 -60.01 6.23 Favored Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.501 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 53.2 Cg_endo -69.86 -31.43 20.08 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 121.611 1.541 . . . . 0.0 112.66 177.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -68.64 -50.25 52.73 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.323 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.589 ' O ' ' HB ' ' A' ' 59' ' ' ILE . 83.8 mt -57.13 -45.38 84.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.376 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.537 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 25.5 tt0 -58.77 -48.99 79.31 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.86 175.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -56.49 -56.65 18.63 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -174.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.69 ' HA ' ' NZ ' ' A' ' 62' ' ' LYS . 73.5 m-20 -105.06 -9.88 17.54 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -171.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.589 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 50.4 mm -105.26 -57.35 4.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.646 176.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.551 ' CD2' ' HB3' ' A' ' 94' ' ' TYR . 74.9 t-105 -69.69 -51.6 33.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.134 -173.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.572 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 3.1 mm? -61.06 -16.57 45.31 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.69 ' NZ ' ' HA ' ' A' ' 58' ' ' ASP . 48.5 mmtm -86.51 -27.93 23.72 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.615 -176.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -127.48 -41.31 1.72 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -173.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.572 ' HE2' ' HA ' ' A' ' 61' ' ' LEU . 34.4 mmtt 55.4 -91.34 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 O-C-N 123.493 0.496 . . . . 0.0 111.094 -174.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -96.24 -63.3 1.16 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.019 0.438 . . . . 0.0 110.065 178.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.449 ' ND2' HD12 ' A' ' 150' ' ' LEU . 1.1 t30 66.15 3.92 2.9 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.083 174.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 62.2 4.17 1.18 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.467 0.707 . . . . 0.0 112.655 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.579 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 20.2 t70 -152.21 5.48 0.41 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.429 0.633 . . . . 0.0 111.086 -175.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.571 ' CE2' ' HB2' ' A' ' 71' ' ' LEU . 85.3 t80 -117.95 120.8 38.94 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 121.706 -0.621 . . . . 0.0 110.888 -174.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -122.03 104.62 9.64 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.931 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.571 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 3.7 tt -108.48 114.75 28.83 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.0 mm -117.81 115.84 49.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.132 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.7 116.66 4.68 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.105 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 55.8 mt -105.8 100.91 11.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 117.155 0.478 . . . . 0.0 111.336 -173.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.526 ' HA ' ' O ' ' A' ' 41' ' ' THR . 1.9 t70 -85.43 136.16 33.56 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 172.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.468 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 16.8 ttp180 -72.59 -112.13 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -165.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.468 ' H ' ' HB3' ' A' ' 76' ' ' ARG . 17.3 m-20 -78.55 5.91 9.84 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -169.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.441 ' HG3' ' H ' ' A' ' 43' ' ' SER . 28.2 mm-40 -76.92 131.23 73.67 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-O 121.027 0.441 . . . . 0.0 110.987 -176.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.478 ' HG2' ' OE2' ' A' ' 81' ' ' GLU . 29.1 Cg_endo -68.65 176.76 5.5 Favored 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 122.663 2.242 . . . . 0.0 112.7 177.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 97.2 mt -53.0 -58.22 7.71 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -173.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.478 ' OE2' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -64.5 -21.39 66.66 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -173.372 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 28.7 mmtm -74.03 -54.8 7.08 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 172.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 60.1 t -56.48 -47.37 81.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.233 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.78 -33.17 75.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.283 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.72 -35.63 62.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.744 0.306 . . . . 0.0 110.882 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.598 ' HE2' ' HG3' ' A' ' 52' ' ' MET . 60.3 t80 -69.39 -40.15 77.55 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.424 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -57.95 -55.08 39.51 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.164 176.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -62.9 -24.19 67.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.653 -175.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.7 m -84.49 2.37 41.3 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.522 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 p -130.4 -25.65 2.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.245 175.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 124.71 -81.24 0.36 Allowed Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -176.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.5 t 45.69 85.28 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 124.366 1.066 . . . . 0.0 113.547 173.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 40.5 p -93.25 15.81 14.63 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.545 173.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.551 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 42.0 p90 -111.39 148.15 38.19 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.133 175.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -63.16 130.53 29.14 Favored 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 122.436 2.091 . . . . 0.0 113.116 -177.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.442 ' O ' HG23 ' A' ' 21' ' ' THR . 94.8 mt -103.77 146.42 28.64 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.514 174.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -119.4 149.25 18.05 Favored Glycine 0 N--CA 1.438 -1.182 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 175.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.784 HD23 ' H ' ' A' ' 98' ' ' LEU . 2.1 pt? -107.02 142.08 37.21 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.854 0.359 . . . . 0.0 110.294 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -124.12 72.98 56.68 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.006 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.416 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 16.8 Cg_exo -67.71 109.81 1.96 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.718 2.279 . . . . 0.0 111.628 177.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 116.32 -3.62 20.26 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -176.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.442 ' O ' ' HG2' ' A' ' 111' ' ' ARG . . . 51.45 36.37 16.55 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.095 0.558 . . . . 0.0 112.184 -178.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -88.04 -39.55 14.56 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.115 -175.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.66 HD12 ' HB2' ' A' ' 16' ' ' PHE . 17.6 mm -66.9 -34.56 70.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 176.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.401 ' HD2' ' HA ' ' A' ' 111' ' ' ARG . 70.8 t80 -65.1 -39.03 92.57 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.728 171.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.652 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -69.0 -16.91 63.84 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.803 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.507 ' HG2' ' HA ' ' A' ' 104' ' ' ILE . 20.7 mmtt -66.35 -25.28 66.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.16 0.505 . . . . 0.0 109.903 177.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -112.69 -37.07 5.0 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.825 -174.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.652 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -147.39 168.36 22.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.668 0.27 . . . . 0.0 111.403 -174.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 9.0 mp -62.23 138.14 58.37 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 174.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 102' ' ' ALA . 97.4 mtt180 -58.25 -26.75 63.28 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 -170.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -113.41 12.42 18.74 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.474 0.654 . . . . 0.0 111.049 -178.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.506 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . . . -83.64 46.98 1.22 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.114 0.483 . . . . 0.0 110.876 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 93.39 -159.23 24.04 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.708 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.527 HG12 ' HB2' ' A' ' 42' ' ' ALA . 5.3 tp -152.89 -54.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 122.773 -0.251 . . . . 0.0 111.248 176.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.546 HG21 HG12 ' A' ' 47' ' ' VAL . 3.0 m -64.57 123.82 20.25 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 122.469 0.308 . . . . 0.0 111.341 -174.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -176.68 152.8 1.03 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.79 0.329 . . . . 0.0 110.834 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.561 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 36.1 m-20 -116.65 118.41 32.5 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 177.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 41.2 t -109.79 126.85 66.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.645 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.642 HD21 ' SD ' ' A' ' 149' ' ' MET . 40.7 tp -119.7 127.02 52.48 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.068 0.461 . . . . 0.0 111.327 -178.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.741 HD13 HD23 ' A' ' 38' ' ' LEU . 1.9 mp -113.18 137.38 46.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.175 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.67 179.44 7.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.537 -178.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -62.86 -28.06 69.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.128 -176.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.615 ' HB2' ' NZ ' ' A' ' 126' ' ' LYS . 69.4 mt-10 -79.78 -12.16 59.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.108 0.48 . . . . 0.0 110.559 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.437 ' HA3' HH11 ' A' ' 32' ' ' ARG . . . 99.67 12.06 42.08 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.804 176.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.615 ' NZ ' ' HB2' ' A' ' 124' ' ' GLU . 31.5 mtmm -93.23 143.74 25.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.896 0.379 . . . . 0.0 111.093 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 47.2 mt -78.35 108.06 11.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.1 m -104.7 -20.74 5.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -171.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.568 ' HE3' ' OG1' ' A' ' 131' ' ' THR . 8.3 tmtm? -145.18 126.73 15.08 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.429 -172.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -125.54 107.24 10.42 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.542 178.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.568 ' OG1' ' HE3' ' A' ' 129' ' ' LYS . 97.7 m -95.76 139.46 31.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.799 0.333 . . . . 0.0 110.366 174.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.528 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 89.1 mtt180 -97.05 123.11 40.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.049 -178.071 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 132' ' ' ARG . 4.4 pp 50.89 21.54 0.98 Allowed 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 172.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.517 ' CD2' ' HE3' ' A' ' 50' ' ' LYS . 23.0 t80 58.95 112.27 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 122.284 1.04 . . . . 0.0 112.221 -176.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -119.19 139.71 51.39 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.85 174.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -53.68 -54.14 42.06 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -175.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.462 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.6 mp0 -58.31 -47.04 84.98 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.173 0.511 . . . . 0.0 110.806 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -57.3 -45.48 84.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.19 177.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.598 ' O ' HG23 ' A' ' 143' ' ' VAL . 70.0 t80 -61.72 -46.78 88.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.592 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.43 -45.68 80.61 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.084 0.468 . . . . 0.0 110.633 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.9 m -65.62 -39.02 91.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.329 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.76 -41.17 98.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.391 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 139' ' ' PHE . 96.0 t -56.05 -55.72 16.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.654 177.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -60.4 -44.44 95.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.337 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.599 ' O ' ' HG3' ' A' ' 149' ' ' MET . 42.4 tt0 -53.98 -52.13 61.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.009 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.598 ' O ' HD23 ' A' ' 150' ' ' LEU . 22.5 mt -62.36 -44.26 99.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.725 -0.216 . . . . 0.0 110.996 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -57.54 -39.42 76.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.144 0.497 . . . . 0.0 110.324 176.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -68.47 -36.06 78.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.195 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.642 ' SD ' HD21 ' A' ' 120' ' ' LEU . 90.1 mtp -64.74 -31.82 73.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.212 0.529 . . . . 0.0 110.435 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.598 HD23 ' O ' ' A' ' 146' ' ' ILE . 4.0 mm? . . . . . 0 C--N 1.324 -0.53 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.424 177.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 . . . . . 0 CA--C 1.517 -0.299 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.1 pt -92.75 -26.01 4.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.797 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.6 p -94.83 152.84 3.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.454 ' HE ' ' CD ' ' A' ' 11' ' ' GLU . 0.6 OUTLIER -118.03 156.6 28.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.315 0.578 . . . . 0.0 112.453 -171.087 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.4 mt -73.2 132.66 33.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.459 170.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.59 -9.15 77.76 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -175.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.454 ' CD ' ' HE ' ' A' ' 8' ' ' ARG . 36.2 tt0 -99.66 156.98 16.79 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 91.5 mmm -72.69 125.72 28.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.91 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.433 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -66.13 126.36 91.8 Favored Pre-proline 0 C--O 1.237 0.427 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.053 178.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.473 ' HG2' ' O ' ' A' ' 107' ' ' LYS . 45.9 Cg_exo -57.29 122.7 12.25 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.127 2.551 . . . . 0.0 112.125 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.511 ' HA ' HD12 ' A' ' 28' ' ' LEU . 1.4 t70 -71.16 134.69 47.14 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.63 -175.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.58 ' HB2' HD12 ' A' ' 104' ' ' ILE . 42.4 p90 -141.33 174.36 10.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.826 0.346 . . . . 0.0 110.793 -178.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 55.3 m -134.87 114.32 12.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.38 174.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.513 ' O ' ' HA ' ' A' ' 25' ' ' GLN . 14.4 tt -112.25 141.85 26.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.16 -174.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.3 m -88.38 120.34 29.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.68 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.654 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 85.7 mt -79.51 -179.09 6.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.3 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.475 ' HB ' HD11 ' A' ' 84' ' ' LEU . 36.6 p -51.07 -43.96 61.08 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -174.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -100.87 12.34 37.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.845 0.355 . . . . 0.0 111.493 -174.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.16 17.2 41.08 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.984 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.532 ' HE2' ' HA ' ' A' ' 24' ' ' LYS . 7.8 mmpt? -80.22 112.16 17.28 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 175.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.513 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 90.5 mt-30 -100.08 113.53 26.21 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.997 0.427 . . . . 0.0 110.49 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 17' ' ' THR . 14.1 m -105.84 147.05 11.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.723 -177.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.8 m -116.75 142.23 47.18 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.943 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.511 HD12 ' HA ' ' A' ' 15' ' ' ASP . 13.3 mt -60.99 -32.97 72.53 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 -178.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.2 m -56.68 -31.26 64.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.032 0.444 . . . . 0.0 111.062 177.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.8 m -79.32 -20.16 48.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.979 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.417 ' C ' ' HD3' ' A' ' 34' ' ' LYS . 86.5 mt -107.35 11.62 28.9 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.899 -178.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 28' ' ' LEU . 37.3 mmt180 -70.9 137.17 49.07 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 171.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.76 -7.65 57.66 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.499 -174.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.572 ' HG3' ' HA ' ' A' ' 68' ' ' ASP . 9.6 mptt -113.15 157.47 21.63 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 175.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 68' ' ' ASP . 2.1 p -84.17 103.91 11.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 170.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.435 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 22.3 t -95.86 111.62 26.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.202 -171.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 24.8 ttt -96.86 125.97 41.68 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.011 0.434 . . . . 0.0 110.277 175.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.492 HD13 HD13 ' A' ' 121' ' ' ILE . 6.5 mp -108.64 130.51 55.32 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.941 176.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.4 ' OE1' HD12 ' A' ' 55' ' ' ILE . 5.6 tt0 -117.66 114.5 23.45 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.441 178.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.544 ' O ' ' HA ' ' A' ' 116' ' ' THR . 94.2 m-85 -93.2 106.18 18.17 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.061 0.457 . . . . 0.0 110.152 178.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.441 ' HA ' ' SG ' ' A' ' 48' ' ' CYS . 11.7 t -117.41 175.37 5.65 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.563 -174.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.411 ' HB2' HG12 ' A' ' 115' ' ' ILE . . . -154.3 136.59 14.88 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.412 ' OG ' ' HG3' ' A' ' 78' ' ' GLU . 28.3 p -62.17 -11.07 12.48 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -173.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 2.8 p-90 -117.03 19.8 14.11 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 122.087 -0.383 . . . . 0.0 111.724 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.408 ' SG ' ' HB ' ' A' ' 47' ' ' VAL . 43.3 t -108.14 114.17 27.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.847 0.356 . . . . 0.0 110.765 178.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.18 -17.48 79.97 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.364 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.433 HG11 ' HB3' ' A' ' 133' ' ' LEU . 58.6 t -64.56 -40.1 87.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 175.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.468 ' HA ' ' HB3' ' A' ' 51' ' ' GLU . 81.1 m -68.82 -16.9 63.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.796 176.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 27.4 ttt85 -78.52 -11.98 59.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.956 0.408 . . . . 0.0 110.174 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -84.54 -50.38 7.76 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 122.128 0.966 . . . . 0.0 108.443 162.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.681 ' HB2' ' HB2' ' A' ' 134' ' ' TYR . 40.0 tt0 -57.25 -59.79 4.59 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 113.631 -1.622 . . . . 0.0 112.094 -171.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.664 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 85.7 mtp -57.37 -53.03 69.73 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -173.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.664 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 45.9 Cg_exo -60.04 -41.8 49.51 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.242 1.961 . . . . 0.0 113.053 177.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -65.16 -44.84 87.25 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.765 0.317 . . . . 0.0 110.802 177.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.608 ' O ' ' HB ' ' A' ' 59' ' ' ILE . 64.0 mt -60.34 -42.95 92.58 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.314 176.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.578 ' OE1' ' HA ' ' A' ' 92' ' ' VAL . 37.5 tp10 -52.62 -58.81 5.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.451 0.643 . . . . 0.0 109.943 174.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -60.68 -59.09 5.94 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.36 -173.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.496 ' HA ' ' NZ ' ' A' ' 62' ' ' LYS . 72.2 m-20 -106.52 -5.26 18.94 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -168.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.608 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 22.8 mm -104.98 -57.95 4.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.061 0.458 . . . . 0.0 110.428 173.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.538 ' CD2' ' HB3' ' A' ' 94' ' ' TYR . 68.9 t-105 -66.11 -73.47 0.13 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.823 -173.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -50.98 -27.36 7.54 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -173.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.496 ' NZ ' ' HA ' ' A' ' 58' ' ' ASP . 47.9 mmtm -67.47 -33.96 76.18 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.421 ' CG ' HD11 ' A' ' 150' ' ' LEU . 67.7 m-70 -131.57 -44.5 0.99 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.236 -0.586 . . . . 0.0 112.044 -176.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.472 ' O ' ' HD2' ' A' ' 69' ' ' PHE . 9.5 mtmp? 42.93 -95.62 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.662 0.785 . . . . 0.0 112.662 -176.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.04 -72.39 0.45 Allowed 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.557 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 30.5 t30 66.75 -70.55 0.11 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.472 -177.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.402 ' HB2' ' O ' ' A' ' 66' ' ' ASN . . . 164.32 -30.33 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 124.605 1.162 . . . . 0.0 108.36 -178.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.572 ' HA ' ' HG3' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -143.27 40.18 1.46 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.965 -1.016 . . . . 0.0 112.23 -178.94 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.472 ' HD2' ' O ' ' A' ' 64' ' ' LYS . 80.8 t80 -119.34 138.07 53.29 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 169.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.435 ' HB3' ' HA ' ' A' ' 36' ' ' VAL . . . -134.43 139.75 45.76 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.218 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.9 tt -143.13 115.76 8.65 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -117.0 118.39 58.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.708 0.289 . . . . 0.0 110.256 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.525 ' HA3' HD13 ' A' ' 96' ' ' LEU . . . -88.38 108.67 3.45 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 175.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 59.6 mt -101.66 107.43 21.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 O-C-N 122.588 -0.36 . . . . 0.0 111.323 -173.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.52 ' HB3' HG22 ' A' ' 83' ' ' VAL . 10.7 t0 -85.58 128.47 34.77 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 174.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.405 ' HD3' HD13 ' A' ' 115' ' ' ILE . 8.4 ttp180 -91.6 126.93 36.86 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.854 -168.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.527 ' HA ' ' HA ' ' A' ' 100' ' ' PRO . 53.4 m-20 71.39 -43.9 0.57 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.999 0.919 . . . . 0.0 113.054 173.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.571 ' OE1' ' HG3' ' A' ' 82' ' ' LYS . 78.2 mm-40 -60.63 136.22 92.46 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 121.365 0.603 . . . . 0.0 112.141 -176.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.636 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 35.5 Cg_endo -71.16 -173.15 0.85 Allowed 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 123.301 2.667 . . . . 0.0 114.109 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.403 ' O ' HD23 ' A' ' 84' ' ' LEU . 91.6 mt -53.75 -57.08 12.15 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 114.745 -1.116 . . . . 0.0 113.308 -173.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.636 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -61.06 -29.81 69.96 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -171.66 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.571 ' HG3' ' OE1' ' A' ' 78' ' ' GLU . 40.5 mmtm -64.89 -58.28 6.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.237 0.541 . . . . 0.0 110.182 173.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.52 HG22 ' HB3' ' A' ' 75' ' ' ASP . 38.7 t -56.24 -49.62 75.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.476 -176.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.475 HD11 ' HB ' ' A' ' 21' ' ' THR . 4.4 mm? -63.24 -47.13 83.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.657 -176.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.21 -39.54 78.54 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -176.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.537 ' HE2' ' SD ' ' A' ' 52' ' ' MET . 79.6 t80 -68.81 -44.25 73.91 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 121.131 -0.228 . . . . 0.0 111.181 -176.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.1 -41.96 94.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.311 0.577 . . . . 0.0 109.72 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -59.07 -29.56 67.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.043 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 18.5 t -82.09 -7.21 59.61 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.946 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 43.6 p -123.49 7.78 8.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.763 0.316 . . . . 0.0 111.434 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.73 -53.2 4.28 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.942 -0.647 . . . . 0.0 113.092 176.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.578 ' HA ' ' OE1' ' A' ' 56' ' ' GLU . 77.1 t -2.06 113.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 125.843 1.657 . . . . 0.0 115.392 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 58.9 p -100.45 -17.73 17.03 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.61 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.538 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 29.7 p90 -72.76 145.37 86.86 Favored Pre-proline 0 N--CA 1.462 0.145 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.322 176.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.98 134.25 45.39 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.887 2.391 . . . . 0.0 113.865 -174.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.525 HD13 ' HA3' ' A' ' 73' ' ' GLY . 4.1 mm? -99.5 149.85 22.8 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.453 175.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.654 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -130.87 158.88 22.8 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.589 -0.605 . . . . 0.0 111.589 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 98' ' ' LEU . 6.2 mp -99.52 139.56 35.0 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.647 0.261 . . . . 0.0 110.613 -177.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -125.73 75.33 70.54 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.174 173.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.527 ' HA ' ' HA ' ' A' ' 77' ' ' ASP . 61.4 Cg_endo -73.94 115.67 4.4 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.569 2.179 . . . . 0.0 112.335 -176.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 102.18 -0.66 50.82 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 56.92 36.8 28.25 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 115.189 -0.505 . . . . 0.0 111.468 -177.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -73.63 -48.05 35.41 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.389 -176.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.58 HD12 ' HB2' ' A' ' 16' ' ' PHE . 18.0 mm -67.41 -36.43 76.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.421 ' CD2' ' HA ' ' A' ' 111' ' ' ARG . 79.3 t80 -65.1 -41.14 95.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.085 174.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.638 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -66.16 -20.75 66.24 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.608 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.473 ' O ' ' HG2' ' A' ' 14' ' ' PRO . 53.0 mttp -74.14 -13.34 60.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.807 0.337 . . . . 0.0 111.164 177.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -115.73 -40.41 3.36 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.012 0.434 . . . . 0.0 111.145 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.638 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -149.74 168.17 24.4 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.584 -177.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 90.9 mt -68.36 130.92 44.32 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.487 ' HG3' ' H ' ' A' ' 111' ' ' ARG . 11.5 mtm180 -53.38 -47.11 69.75 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 122.2 1.0 . . . . 0.0 109.995 -177.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -82.48 10.46 7.19 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.767 -171.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.421 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . . . -98.68 -2.61 37.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.989 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 145.27 -167.15 27.47 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.57 177.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.52 HG23 ' H ' ' A' ' 116' ' ' THR . 2.0 tp -136.19 -67.87 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.591 ' HB ' HD23 ' A' ' 133' ' ' LEU . 24.3 m -67.07 109.67 3.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.761 0.315 . . . . 0.0 111.37 -174.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -151.7 141.77 22.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.928 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.584 ' HB2' ' OG1' ' A' ' 131' ' ' THR . 51.8 m-80 -111.18 121.63 45.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.165 0.507 . . . . 0.0 110.276 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 49.9 t -115.99 118.32 58.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.803 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.61 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 43.0 tp -106.84 127.09 53.11 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.577 0.227 . . . . 0.0 111.211 -177.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.492 HD13 HD13 ' A' ' 38' ' ' LEU . 2.5 mp -113.73 137.63 46.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.377 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.496 ' OD2' ' HB2' ' A' ' 126' ' ' LYS . 3.7 p30 -82.34 -179.42 7.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.871 0.367 . . . . 0.0 111.217 177.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.5 ' NH2' ' HA ' ' A' ' 150' ' ' LEU . 7.0 mpt_? -59.22 -32.51 70.02 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.017 -177.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -76.88 -22.59 53.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.151 0.5 . . . . 0.0 110.856 -173.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 111.64 6.8 24.74 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.175 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.496 ' HB2' ' OD2' ' A' ' 122' ' ' ASP . 9.1 mtmp? -93.95 149.85 20.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.818 0.342 . . . . 0.0 110.914 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.445 HG21 HD21 ' A' ' 130' ' ' LEU . 62.5 mt -84.4 130.5 35.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.273 177.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 18.1 m -121.89 4.04 6.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -177.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.722 ' HE2' ' HB3' ' A' ' 142' ' ' LEU . 53.3 tptt -160.58 128.72 4.57 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.314 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.445 HD21 HG21 ' A' ' 127' ' ' ILE . 90.0 mt -132.0 104.39 6.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.478 174.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.584 ' OG1' ' HB2' ' A' ' 118' ' ' ASN . 22.9 p -107.88 156.45 19.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.017 0.437 . . . . 0.0 111.638 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.948 HH12 ' HG3' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -104.72 118.94 37.82 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.262 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.591 HD23 ' HB ' ' A' ' 116' ' ' THR . 50.0 mt 65.49 -173.47 0.18 Allowed 'General case' 0 C--O 1.236 0.389 0 O-C-N 123.883 0.739 . . . . 0.0 109.831 -175.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.681 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 9.4 t80 -58.91 -44.89 91.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.017 173.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.515 ' HB3' ' HB2' ' A' ' 138' ' ' GLU . 0.2 OUTLIER 55.82 95.34 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.851 0.72 . . . . 0.0 110.684 174.771 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -40.97 -59.34 1.48 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.226 -172.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.551 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 0.7 OUTLIER -68.45 -47.06 68.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.568 -176.56 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.948 ' HG3' HH12 ' A' ' 132' ' ' ARG . 2.5 mm-40 -64.97 -34.54 78.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.092 -175.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.494 ' HE1' HG12 ' A' ' 55' ' ' ILE . 82.2 t80 -63.51 -44.21 94.97 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.812 175.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.497 ' O ' HG12 ' A' ' 143' ' ' VAL . . . -62.07 -42.39 99.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.382 0.61 . . . . 0.0 110.361 177.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.4 m -61.49 -46.0 91.84 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.318 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.722 ' HB3' ' HE2' ' A' ' 129' ' ' LYS . 4.3 pp -80.19 -28.91 38.6 Favored 'General case' 0 C--O 1.217 -0.65 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.262 -176.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 140' ' ' ALA . 12.6 p -60.57 -42.09 90.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.356 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -66.41 -45.59 79.42 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.416 174.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.605 ' O ' ' HG3' ' A' ' 149' ' ' MET . 44.3 tt0 -55.78 -53.4 57.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.731 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.657 HG13 ' O ' ' A' ' 142' ' ' LEU . 38.0 mt -57.41 -47.01 85.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.929 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -48.92 -58.81 4.26 Favored 'General case' 0 CA--C 1.517 -0.327 0 O-C-N 123.134 0.271 . . . . 0.0 110.883 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -68.18 -26.15 65.6 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 123.43 0.456 . . . . 0.0 111.233 -175.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.605 ' HG3' ' O ' ' A' ' 145' ' ' GLN . 51.1 mtp -57.86 -48.88 78.51 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.022 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.609 HD23 ' O ' ' A' ' 146' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.321 -0.642 0 C-N-CA 119.253 -0.979 . . . . 0.0 112.097 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 . . . . . 0 C--O 1.236 0.358 0 CA-C-O 120.814 0.34 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.2 pt -89.38 -11.2 10.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.2 0.524 . . . . 0.0 109.749 175.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.8 p -94.2 162.97 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.297 177.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.593 ' HB2' ' HB2' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -128.65 151.17 49.81 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.32 -169.564 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.499 HG12 HD23 ' A' ' 130' ' ' LEU . 57.6 mt -75.24 132.91 32.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.165 177.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.69 5.01 90.23 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.615 -177.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.593 ' HB2' ' HB2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -115.02 161.48 18.28 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -176.211 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 85.3 mmm -68.15 133.47 48.96 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.093 0.473 . . . . 0.0 111.916 -173.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -81.73 134.58 50.27 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.585 173.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.542 ' HG2' ' O ' ' A' ' 107' ' ' LYS . 33.2 Cg_exo -62.2 121.09 8.96 Favored 'Trans proline' 0 N--CA 1.464 -0.225 0 C-N-CA 122.822 2.348 . . . . 0.0 111.759 175.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.46 ' OD1' HG22 ' A' ' 27' ' ' THR . 1.3 t70 -73.74 134.58 43.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.505 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.62 ' HB2' HD12 ' A' ' 104' ' ' ILE . 51.3 p90 -136.88 165.78 25.15 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.057 -173.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 58.5 m -119.74 115.48 23.98 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.439 172.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.7 tt -111.99 150.68 14.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.86 -174.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.2 m -98.77 125.11 44.03 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.263 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.542 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 85.8 mt -84.65 -177.81 6.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.791 -176.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.488 ' HB ' HD11 ' A' ' 84' ' ' LEU . 28.3 p -56.07 -40.51 73.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.837 -175.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.405 ' OD2' ' HG3' ' A' ' 24' ' ' LYS . 7.5 p-10 -98.75 12.07 36.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.915 0.388 . . . . 0.0 111.042 -177.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.8 3.03 60.98 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.388 -0.91 . . . . 0.0 113.617 176.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.479 ' HB2' HD12 ' A' ' 20' ' ' LEU . 60.7 mttp -64.83 124.89 23.17 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 117.357 0.578 . . . . 0.0 111.012 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -104.83 113.79 27.6 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 17' ' ' THR . 16.4 m -122.5 148.78 26.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.858 -176.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.46 HG22 ' OD1' ' A' ' 15' ' ' ASP . 4.9 m -106.65 148.08 28.77 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.438 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.502 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 0.6 OUTLIER -61.03 -32.94 72.53 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -177.515 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.526 ' HA ' ' CG ' ' A' ' 32' ' ' ARG . 60.9 m -54.56 -25.26 24.99 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.144 177.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.6 t -77.35 -11.07 59.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.942 0.401 . . . . 0.0 110.766 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.485 HD13 ' HB1' ' A' ' 70' ' ' ALA . 76.5 mt -119.56 0.44 11.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.381 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.526 ' CG ' ' HA ' ' A' ' 29' ' ' SER . 52.1 mmm-85 -68.24 131.57 45.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.877 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.7 -27.27 7.63 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -172.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.702 ' HB2' ' C ' ' A' ' 68' ' ' ASP . 12.9 ptpt -116.09 165.63 12.92 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 174.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 68' ' ' ASP . 4.0 p -80.7 123.41 37.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.197 0.522 . . . . 0.0 110.574 -177.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.432 HG22 ' HB3' ' A' ' 70' ' ' ALA . 23.5 t -110.95 123.87 67.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.372 -176.032 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.558 ' SD ' HG21 ' A' ' 59' ' ' ILE . 26.1 ttt -103.03 131.51 49.96 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.233 176.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.553 HD13 HD13 ' A' ' 121' ' ' ILE . 5.5 mp -126.03 148.3 49.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.477 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.5 148.54 42.81 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 169.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -112.81 113.15 25.11 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.054 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.4 t -129.41 -168.77 1.99 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.406 -174.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.521 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . . . -163.87 165.52 22.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.548 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.541 ' HB2' ' HB3' ' A' ' 82' ' ' LYS . 7.6 t -73.45 -25.04 60.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.177 0.513 . . . . 0.0 111.132 -172.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 68.2 p-90 -88.81 0.3 56.65 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 122.233 -0.292 . . . . 0.0 111.684 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 42' ' ' ALA . 73.7 m -78.99 99.63 6.94 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.183 0.516 . . . . 0.0 111.218 -178.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.49 -37.49 89.97 Favored Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.89 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.521 HG21 HD11 ' A' ' 133' ' ' LEU . 38.1 t -63.19 -32.48 56.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.057 0.456 . . . . 0.0 110.617 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.644 ' SG ' HG22 ' A' ' 116' ' ' THR . 84.8 m -70.37 -15.51 62.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.277 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.748 ' HE ' ' HE1' ' A' ' 86' ' ' PHE . 98.9 mtt180 -77.81 -6.75 55.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.246 0.546 . . . . 0.0 110.084 176.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.483 ' HE2' ' CE2' ' A' ' 134' ' ' TYR . 54.6 mtpt -100.64 -43.29 6.21 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 164.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.61 ' HB3' ' HA ' ' A' ' 48' ' ' CYS . 23.0 tt0 -52.43 -64.12 0.92 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.328 -1.305 . . . . 0.0 112.218 -177.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.434 ' HE2' ' CE2' ' A' ' 86' ' ' PHE . 39.7 mtm -65.25 -46.27 71.63 Favored Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -171.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.445 ' HG2' ' O ' ' A' ' 49' ' ' ARG . 72.4 Cg_exo -53.9 -38.37 85.95 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.709 1.606 . . . . 0.0 111.885 174.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.49 ' HB3' ' CZ ' ' A' ' 139' ' ' PHE . 4.9 m-85 -69.11 -42.79 75.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.781 176.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 51' ' ' GLU . 76.4 mt -57.12 -48.52 81.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.173 175.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.627 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 13.9 tp10 -55.78 -48.84 74.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.097 175.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -55.08 -57.08 13.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.775 -176.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.637 ' HA ' ' NZ ' ' A' ' 62' ' ' LYS . 44.8 m-20 -106.42 -43.14 4.84 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -170.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.558 HG21 ' SD ' ' A' ' 37' ' ' MET . 1.9 mp -75.62 -56.72 7.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.982 0.42 . . . . 0.0 110.801 -176.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.784 ' CE2' ' HG2' ' A' ' 64' ' ' LYS . 22.4 t-105 -72.02 -58.82 3.11 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.338 -173.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.627 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.8 OUTLIER -44.68 -43.66 8.52 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.674 0.79 . . . . 0.0 113.027 -173.621 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.637 ' NZ ' ' HA ' ' A' ' 58' ' ' ASP . 30.0 mmtm -84.2 -23.93 30.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.206 0.526 . . . . 0.0 111.484 -174.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 68.3 m-70 -125.53 24.76 7.17 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -166.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.784 ' HG2' ' CE2' ' A' ' 60' ' ' TRP . 28.7 mttt -53.81 93.93 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 123.079 1.418 . . . . 0.0 112.528 -177.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.636 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 13.4 t70 64.4 -42.96 0.29 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 110.538 -3.028 . . . . 0.0 110.508 -168.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.49 ' H ' ' C ' ' A' ' 64' ' ' LYS . 13.0 t30 66.31 -57.08 0.38 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.094 0.958 . . . . 0.0 111.001 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 167.18 -31.35 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 125.271 1.428 . . . . 0.0 107.355 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.702 ' C ' ' HB2' ' A' ' 34' ' ' LYS . 21.7 p-10 -147.91 32.92 0.84 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.185 -1.37 . . . . 0.0 111.292 -173.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.636 ' O ' ' HA ' ' A' ' 65' ' ' ASP . 88.1 t80 -127.29 133.26 50.17 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.977 0.418 . . . . 0.0 110.014 172.155 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.558 ' HB2' ' HD2' ' A' ' 34' ' ' LYS . . . -124.76 142.13 51.63 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.342 175.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.5 tt -135.46 117.74 15.6 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 68.1 mt -123.87 119.42 56.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.382 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.426 ' HA3' HD22 ' A' ' 96' ' ' LEU . . . -89.69 131.35 10.68 Favored Glycine 0 C--O 1.222 -0.598 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 174.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 48.5 mt -119.78 141.64 38.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 117.548 0.674 . . . . 0.0 111.017 -173.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.521 ' OD2' ' HA ' ' A' ' 42' ' ' ALA . 10.2 t0 -114.42 120.5 40.52 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 176.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.651 ' HG2' HD13 ' A' ' 115' ' ' ILE . 4.4 ptm180 -73.84 -2.84 25.38 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -165.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.586 ' HA ' ' HA ' ' A' ' 100' ' ' PRO . 0.4 OUTLIER -169.44 -32.26 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 118.448 -1.301 . . . . 0.0 113.713 -175.135 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.424 ' HB3' ' HG3' ' A' ' 82' ' ' LYS . 35.8 mt-10 -78.7 142.0 60.76 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 121.324 0.583 . . . . 0.0 111.658 -173.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.615 ' HG2' ' OE2' ' A' ' 81' ' ' GLU . 38.5 Cg_endo -71.2 -173.81 1.02 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.185 2.59 . . . . 0.0 114.437 -174.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 89.1 mt -51.43 -57.43 9.0 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.756 -174.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.615 ' OE2' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -61.11 -28.57 69.19 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -172.326 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.612 ' HG2' ' OE2' ' A' ' 81' ' ' GLU . 44.0 mmtm -67.38 -52.75 36.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.794 0.33 . . . . 0.0 110.445 173.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 62.0 t -59.55 -51.1 76.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.241 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.488 HD11 ' HB ' ' A' ' 21' ' ' THR . 4.3 mm? -65.27 -36.5 84.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.488 -176.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.403 ' O ' ' HG2' ' A' ' 88' ' ' LYS . . . -75.5 -32.19 60.44 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 121.061 -0.256 . . . . 0.0 111.232 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.748 ' HE1' ' HE ' ' A' ' 49' ' ' ARG . 79.5 t80 -74.83 -41.27 60.22 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.492 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.42 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -59.53 -53.27 59.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.7 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 85' ' ' ALA . 19.7 pttm -55.92 -31.75 63.16 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.762 -174.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 68.5 m -87.13 2.19 50.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.386 -175.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 33.3 p -130.57 10.1 5.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.344 0.592 . . . . 0.0 110.342 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.5 -73.11 1.68 Allowed Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.507 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.4 t 29.85 90.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.808 1.243 . . . . 0.0 114.092 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 76.0 p -98.93 17.97 18.31 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.133 0.492 . . . . 0.0 110.726 175.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.611 ' HB3' ' CE2' ' A' ' 60' ' ' TRP . 31.1 p90 -114.52 147.66 38.56 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.885 175.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.4 135.89 60.38 Favored 'Trans proline' 0 C--O 1.239 0.537 0 C-N-CA 122.44 2.093 . . . . 0.0 113.453 -176.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.434 ' O ' HG23 ' A' ' 21' ' ' THR . 72.7 mt -111.6 144.99 39.96 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.491 175.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.542 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -122.52 150.55 16.91 Favored Glycine 0 N--CA 1.441 -1.025 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 176.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.669 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.7 pt? -117.11 132.11 56.74 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -177.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.489 ' OD1' ' HA ' ' A' ' 76' ' ' ARG . 5.0 p-10 -125.12 83.38 60.65 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-O 121.945 0.879 . . . . 0.0 110.635 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.586 ' HA ' ' HA ' ' A' ' 77' ' ' ASP . 18.5 Cg_endo -57.03 130.31 39.05 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.882 2.388 . . . . 0.0 112.545 -176.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.56 11.13 69.19 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.646 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 76' ' ' ARG . . . 53.03 51.73 15.2 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 122.891 0.476 . . . . 0.0 111.998 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.456 ' HB2' HH22 ' A' ' 111' ' ' ARG . 28.6 t70 -82.29 -53.86 5.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.953 0.406 . . . . 0.0 111.076 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.62 HD12 ' HB2' ' A' ' 16' ' ' PHE . 17.1 mm -68.36 -30.62 48.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.407 ' HB3' ' HB1' ' A' ' 102' ' ' ALA . 74.7 t80 -60.65 -37.92 83.14 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.627 170.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.893 ' HB2' ' HG2' ' A' ' 111' ' ' ARG . . . -72.68 -15.09 61.7 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.034 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.542 ' O ' ' HG2' ' A' ' 14' ' ' PRO . 14.1 mptt -69.3 -15.97 63.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.908 0.385 . . . . 0.0 110.798 173.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -126.0 -32.94 2.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.026 0.441 . . . . 0.0 111.524 -177.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.636 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -133.68 -172.78 3.06 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.276 -178.032 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.8 mt -85.06 153.18 22.88 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.893 ' HG2' ' HB2' ' A' ' 106' ' ' ALA . 20.2 mtp180 -71.48 -14.11 62.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.403 0.62 . . . . 0.0 110.344 -176.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -101.09 -1.89 32.92 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.907 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.28 155.38 40.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.227 0.536 . . . . 0.0 111.916 -174.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.8 155.22 42.05 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.131 -0.941 . . . . 0.0 113.662 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.651 HD13 ' HG2' ' A' ' 76' ' ' ARG . 3.3 tp -84.15 -175.25 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 123.211 0.604 . . . . 0.0 110.366 -176.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.644 HG22 ' SG ' ' A' ' 48' ' ' CYS . 77.0 p 61.52 79.5 0.25 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.461 1.104 . . . . 0.0 111.524 177.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' A' ' 117' ' ' ARG . 9.0 mtp180 -140.59 132.49 27.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.09 -177.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.647 ' HB3' ' HB ' ' A' ' 131' ' ' THR . 38.9 t-20 -107.73 126.18 52.3 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.7 t -122.88 138.4 53.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.157 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 46.3 tp -126.49 122.82 36.28 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.911 -0.315 . . . . 0.0 110.5 177.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.553 HD13 HD13 ' A' ' 38' ' ' LEU . 1.9 mp -106.34 134.59 47.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.152 177.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.68 174.79 10.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.963 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -72.23 -15.59 61.93 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -172.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -80.33 -28.3 38.16 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.25 0.547 . . . . 0.0 109.863 175.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 116.85 10.36 10.12 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.316 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -100.44 153.17 19.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.097 0.475 . . . . 0.0 111.744 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.508 HG21 HD21 ' A' ' 130' ' ' LEU . 4.4 mm -76.53 133.24 31.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.294 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 28.0 m -126.07 3.07 4.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.577 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 53.1 tptt -166.57 127.35 1.67 Allowed 'General case' 0 C--O 1.232 0.16 0 C-N-CA 120.481 -0.488 . . . . 0.0 112.027 -177.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.508 HD21 HG21 ' A' ' 127' ' ' ILE . 3.1 mm? -126.99 115.51 19.35 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.471 172.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.647 ' HB ' ' HB3' ' A' ' 118' ' ' ASN . 95.2 m -123.85 134.99 53.48 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.538 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -106.5 122.37 46.16 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.521 HD11 HG21 ' A' ' 47' ' ' VAL . 10.6 tp 71.78 156.22 0.16 Allowed 'General case' 0 C--O 1.232 0.155 0 O-C-N 124.191 0.932 . . . . 0.0 110.388 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.516 ' CE2' ' HG2' ' A' ' 136' ' ' GLU . 51.1 t80 -72.52 89.04 1.26 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.362 0.601 . . . . 0.0 109.935 174.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.557 ' HB3' ' HB3' ' A' ' 138' ' ' GLU . 2.0 t-20 -85.52 116.42 23.81 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 171.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.516 ' HG2' ' CE2' ' A' ' 134' ' ' TYR . 33.8 mt-10 -58.3 -52.75 64.26 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.28 -168.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -59.75 -39.59 85.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.204 0.526 . . . . 0.0 111.317 176.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.557 ' HB3' ' HB3' ' A' ' 135' ' ' ASN . 5.3 tp10 -61.99 -46.69 88.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.117 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.614 ' O ' HG23 ' A' ' 143' ' ' VAL . 82.1 t80 -59.72 -42.44 93.09 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.699 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.26 -46.44 85.99 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.121 0.486 . . . . 0.0 110.553 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.2 m -62.13 -38.81 90.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.505 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.02 -37.88 89.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.492 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 139' ' ' PHE . 97.2 t -55.39 -57.11 8.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.314 175.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -61.48 -38.23 86.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.797 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -57.43 -48.66 78.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.98 177.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.576 ' O ' HD23 ' A' ' 150' ' ' LEU . 59.6 mt -67.87 -38.95 80.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.955 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -55.42 -39.94 70.85 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.826 -0.17 . . . . 0.0 111.302 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -73.39 -35.42 65.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.762 178.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 82.1 mmm -62.83 -25.79 68.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.351 0.596 . . . . 0.0 110.119 178.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.628 HD11 ' HB2' ' A' ' 69' ' ' PHE . 4.0 mm? . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.229 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 . . . . . 0 N--CA 1.456 -0.164 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.7 pt -94.9 -27.57 4.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.946 0.403 . . . . 0.0 110.431 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.636 HG11 HD12 ' A' ' 127' ' ' ILE . 15.0 t -94.3 155.07 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 174.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 8' ' ' ARG . 16.3 mtt180 -125.47 165.41 18.49 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.838 -0.165 . . . . 0.0 110.594 -169.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.666 HG12 HD13 ' A' ' 130' ' ' LEU . 77.0 mt -67.81 118.43 11.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.854 0.359 . . . . 0.0 110.196 175.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.98 -7.58 62.75 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.893 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -86.37 153.24 22.07 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 -177.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.666 ' SD ' ' HG2' ' A' ' 126' ' ' LYS . 91.2 mmm -67.49 130.07 41.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.675 -178.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.41 ' HB2' HG13 ' A' ' 127' ' ' ILE . . . -79.3 129.93 70.59 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.664 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.408 ' HD2' ' CE1' ' A' ' 108' ' ' TYR . 31.4 Cg_exo -59.16 143.45 99.76 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.703 2.269 . . . . 0.0 111.329 174.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.96 162.55 14.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.243 -177.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.613 ' O ' ' HA ' ' A' ' 27' ' ' THR . 55.3 p90 -169.73 164.28 9.99 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.389 -173.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.9 m -123.0 100.7 7.02 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 176.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.2 tt -103.26 146.65 10.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.821 0.343 . . . . 0.0 111.159 -174.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.9 m -94.27 118.38 31.5 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.586 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.458 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 93.7 mt -81.52 169.7 16.79 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.696 -177.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 31.4 p -57.34 -26.58 61.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.219 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -83.31 -7.79 59.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.203 0.525 . . . . 0.0 110.432 -178.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.52 15.4 56.98 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.23 -175.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -90.67 116.69 28.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.384 -0.408 . . . . 0.0 110.47 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -89.62 113.11 24.52 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 174.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.81 128.59 71.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.572 0.701 . . . . 0.0 111.582 -174.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.613 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 17.9 m -94.2 137.97 32.76 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.518 175.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.579 HD22 ' HD3' ' A' ' 32' ' ' ARG . 0.6 OUTLIER -60.59 -33.27 72.48 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -177.075 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.459 ' HA ' ' CG ' ' A' ' 32' ' ' ARG . 37.6 t -56.88 -23.08 41.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.824 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.9 t -81.78 -8.81 59.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.972 0.415 . . . . 0.0 110.548 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 67.4 mt -119.57 -1.16 10.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.539 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.579 ' HD3' HD22 ' A' ' 28' ' ' LEU . 8.7 mmm-85 -66.79 103.09 1.04 Allowed 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.055 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.516 ' O ' ' HG3' ' A' ' 123' ' ' ARG . . . 139.42 -20.59 2.96 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 -172.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.574 ' HD2' ' HA ' ' A' ' 68' ' ' ASP . 37.1 mtmt -114.48 168.2 10.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.415 -0.393 . . . . 0.0 109.945 175.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.484 HG11 ' HB3' ' A' ' 149' ' ' MET . 34.2 m -80.1 122.52 35.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 174.111 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.5 t -122.93 113.93 40.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.108 0.48 . . . . 0.0 111.081 -174.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.541 ' SD ' HG21 ' A' ' 59' ' ' ILE . 26.9 ttt -97.19 126.55 42.45 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.447 177.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.516 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 7.3 mp -118.92 152.89 35.5 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.03 176.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.473 HE21 ' HA3' ' A' ' 73' ' ' GLY . 5.1 pp0? -139.29 145.93 39.73 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 169.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 89.3 m-85 -110.35 123.29 49.58 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 177.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.8 t -134.72 173.49 11.63 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.123 -174.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.506 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . . . -149.93 160.02 43.92 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.476 -0.784 . . . . 0.0 108.933 175.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.588 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 28.8 t -70.74 -20.87 62.6 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -171.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 58.8 p-90 -97.11 3.12 51.83 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.855 0.316 . . . . 0.0 111.855 -177.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.506 ' SG ' ' HB3' ' A' ' 42' ' ' ALA . 84.0 m -87.86 108.18 19.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.155 0.502 . . . . 0.0 111.293 -178.197 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -79.01 -17.85 76.1 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.39 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.606 HG11 ' HB2' ' A' ' 133' ' ' LEU . 40.6 t -74.83 -45.97 42.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 177.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.453 ' SG ' HG23 ' A' ' 116' ' ' THR . 73.7 m -54.75 -32.59 60.08 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.819 177.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.528 ' HE ' ' HE1' ' A' ' 86' ' ' PHE . 98.0 mtt180 -65.5 -2.66 3.52 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.264 -0.426 . . . . 0.0 112.029 -178.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -96.81 -55.85 2.76 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.783 0.801 . . . . 0.0 109.734 173.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.657 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 5.1 pt-20 -71.45 -32.47 68.36 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.93 -175.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 63.9 mmm -52.09 -57.32 15.55 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 117.817 0.281 . . . . 0.0 111.605 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.409 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 24.7 Cg_endo -64.27 -37.18 42.01 Favored 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 121.75 1.633 . . . . 0.0 112.447 175.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -62.31 -44.15 97.18 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.536 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.568 ' O ' ' HB ' ' A' ' 59' ' ' ILE . 94.0 mt -57.95 -53.53 44.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.675 178.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.587 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 14.9 pt-20 -64.95 -38.11 89.87 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.874 -176.399 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -63.06 -54.39 38.82 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -174.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -107.22 -18.12 13.97 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -172.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.568 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 2.2 mp -95.21 -55.3 6.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.971 176.01 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.587 ' HB3' ' HA ' ' A' ' 56' ' ' GLU . 75.0 t-105 -65.48 -70.69 0.22 Allowed 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.418 -177.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.433 ' HA ' HD13 ' A' ' 61' ' ' LEU . 1.6 mm? -54.05 -23.29 13.11 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -173.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -91.6 -37.4 13.1 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -177.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -118.9 -10.96 9.79 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -169.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.51 ' HG3' ' OD1' ' A' ' 65' ' ' ASP . 19.2 pttp -36.21 -54.13 0.81 Allowed 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -168.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.51 ' OD1' ' HG3' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -87.45 -77.99 0.32 Allowed 'General case' 0 C--O 1.254 1.311 0 CA-C-O 121.299 0.571 . . . . 0.0 109.583 -178.432 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.407 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 22.4 t-20 63.36 -74.83 0.04 OUTLIER 'General case' 0 C--N 1.34 0.153 0 CA-C-N 114.471 -1.24 . . . . 0.0 110.374 -174.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 66' ' ' ASN . . . 159.26 -40.43 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -177.244 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.574 ' HA ' ' HD2' ' A' ' 34' ' ' LYS . 30.9 t70 -114.66 11.1 16.84 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 113.904 -1.498 . . . . 0.0 111.258 -175.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -106.36 142.9 35.26 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.128 -177.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.69 143.56 33.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.377 173.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.533 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 2.8 tt -142.53 118.67 10.73 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 3.0 mp -131.1 126.99 60.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.324 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.473 ' HA3' HE21 ' A' ' 39' ' ' GLN . . . -97.85 140.74 15.21 Favored Glycine 0 C--O 1.224 -0.529 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.353 176.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 62.0 mt -120.28 123.62 70.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 117.304 0.552 . . . . 0.0 111.396 -177.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 78' ' ' GLU . 2.5 m-20 -88.1 122.02 31.19 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 172.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 59.7 ttp180 -50.61 -46.41 58.07 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -167.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 99' ' ' ASP . 7.8 p-10 -152.64 13.1 0.54 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.04 0.448 . . . . 0.0 111.134 -174.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 33.1 mm-40 -80.68 130.05 65.88 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.478 -177.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.459 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 36.7 Cg_endo -71.73 179.81 4.42 Favored 'Trans proline' 0 CA--C 1.531 0.341 0 C-N-CA 122.408 2.072 . . . . 0.0 112.687 174.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -50.69 -57.98 6.99 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.096 -171.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.462 ' OE1' ' HG2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -67.42 -30.79 70.64 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -172.427 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.462 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 41.7 mmtm -63.86 -52.66 58.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.753 0.311 . . . . 0.0 110.397 175.07 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 79' ' ' PRO . 88.0 t -54.21 -52.75 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.244 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.37 -38.83 92.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.35 -177.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.29 -42.13 79.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.673 0.273 . . . . 0.0 111.081 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.588 ' CD1' ' HA ' ' A' ' 43' ' ' SER . 86.8 t80 -64.83 -43.9 91.56 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 178.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.447 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -58.54 -54.31 48.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.189 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -65.65 -20.71 66.4 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -174.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.5 m -78.74 -24.3 44.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.741 0.305 . . . . 0.0 111.288 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.5 p -104.8 -22.11 13.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.083 0.468 . . . . 0.0 110.98 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 121.1 -79.32 0.33 Allowed Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -177.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.1 t 46.45 86.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 124.463 1.105 . . . . 0.0 113.265 177.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.8 m -82.09 2.5 30.97 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.039 177.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.506 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 46.7 p90 -113.32 152.7 45.41 Favored Pre-proline 0 C--N 1.331 -0.235 0 O-C-N 122.203 -0.311 . . . . 0.0 110.759 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.13 133.81 29.82 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.484 2.123 . . . . 0.0 113.437 -176.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.447 HD12 ' HB2' ' A' ' 87' ' ' ALA . 94.1 mt -104.48 161.62 13.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.081 172.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -130.12 148.3 18.48 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.168 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.417 ' N ' HD12 ' A' ' 98' ' ' LEU . 5.4 mp -86.74 133.55 33.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.544 0.211 . . . . 0.0 110.54 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.471 ' O ' ' HA ' ' A' ' 77' ' ' ASP . 40.2 t0 -121.05 73.86 26.67 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-O 121.317 0.579 . . . . 0.0 109.86 169.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.412 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 22.1 Cg_exo -64.1 103.53 0.43 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.079 1.853 . . . . 0.0 112.237 -177.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 112.0 -0.18 27.05 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.483 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.477 ' HB1' ' HG2' ' A' ' 111' ' ' ARG . . . 59.02 40.64 22.01 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.092 0.472 . . . . 0.0 111.155 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -78.82 -48.76 14.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.557 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.452 HD12 ' HB2' ' A' ' 16' ' ' PHE . 34.4 mm -66.75 -37.39 79.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -59.51 -44.68 93.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.874 175.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.587 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -67.58 -21.23 65.44 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.813 -178.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -72.96 -17.69 61.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.798 0.332 . . . . 0.0 110.921 177.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.547 ' HB2' HH22 ' A' ' 117' ' ' ARG . 79.3 m-85 -111.88 -34.26 6.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.863 -178.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.587 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -161.13 172.93 15.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.768 0.318 . . . . 0.0 110.731 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.664 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 91.4 mt -71.97 131.38 42.86 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.091 178.31 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.477 ' HG2' ' HB1' ' A' ' 102' ' ' ALA . 11.4 mtm180 -65.4 -31.3 72.33 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.268 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -84.38 -7.36 59.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.748 -178.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.664 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . . . -75.4 -56.77 4.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.718 -178.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -163.07 -149.12 5.6 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.96 -177.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.456 HG23 ' H ' ' A' ' 116' ' ' THR . 2.8 tp -161.35 -59.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.373 0.087 . . . . 0.0 111.125 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.648 HG22 ' HA ' ' A' ' 133' ' ' LEU . 24.0 m -67.61 109.08 3.12 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.861 0.362 . . . . 0.0 111.414 -176.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.547 HH22 ' HB2' ' A' ' 108' ' ' TYR . 19.3 ptt180 -165.97 146.44 6.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.166 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.605 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 45.9 m-80 -108.95 136.53 48.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.725 175.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.4 HG21 ' HE1' ' A' ' 40' ' ' PHE . 80.6 t -120.35 102.76 13.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.101 -177.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.623 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 48.8 tp -88.75 108.14 19.33 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.707 -0.397 . . . . 0.0 109.996 178.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.403 HD13 HD11 ' A' ' 28' ' ' LEU . 56.6 mt -93.74 121.98 44.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.771 0.796 . . . . 0.0 110.523 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.69 162.66 29.2 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.485 -1.234 . . . . 0.0 111.341 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.516 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 33.8 ttm180 -52.0 -34.21 41.73 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.483 0.713 . . . . 0.0 112.742 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -83.57 -7.59 59.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.33 0.586 . . . . 0.0 109.969 -175.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 96.54 31.36 7.15 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.468 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.666 ' HG2' ' SD ' ' A' ' 12' ' ' MET . 44.2 mttm -113.04 146.49 39.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.798 0.299 . . . . 0.0 110.314 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.636 HD12 HG11 ' A' ' 7' ' ' VAL . 55.7 mt -88.94 100.98 11.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.093 177.375 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 29.0 m -94.17 -4.54 10.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -174.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.623 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 51.8 tptt -143.95 108.76 4.92 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.687 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.666 HD13 HG12 ' A' ' 9' ' ' ILE . 10.9 mp -98.28 104.7 16.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.962 170.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.605 ' HB ' ' HB2' ' A' ' 118' ' ' ASN . 86.0 m -103.23 125.33 49.84 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.724 -0.217 . . . . 0.0 110.703 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.57 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -96.85 108.19 20.82 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 176.788 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.648 ' HA ' HG22 ' A' ' 116' ' ' THR . 4.6 pp 51.4 -177.65 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 O-C-N 124.503 1.127 . . . . 0.0 113.259 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.657 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 75.6 t80 -87.57 117.68 26.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.912 -177.23 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -135.89 137.69 41.67 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.949 172.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -47.79 -62.56 1.4 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -177.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.428 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.5 mp0 -56.99 -46.75 82.01 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.316 0.579 . . . . 0.0 110.849 -178.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.487 ' HG3' HG23 ' A' ' 131' ' ' THR . 7.0 tp10 -61.72 -48.59 80.06 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.187 -177.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.469 ' O ' HG23 ' A' ' 143' ' ' VAL . 69.2 t80 -67.38 -39.16 85.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.048 -178.278 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.79 -43.52 97.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.662 175.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 45.8 m -63.04 -38.1 89.82 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.547 177.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.548 ' O ' HG13 ' A' ' 146' ' ' ILE . 67.7 tp -59.75 -51.61 69.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.154 177.004 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.493 HG22 HD11 ' A' ' 59' ' ' ILE . 61.3 t -60.19 -45.81 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.222 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -57.72 -45.05 86.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.722 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.556 ' O ' ' HG2' ' A' ' 149' ' ' MET . 64.3 tt0 -67.01 -37.34 83.98 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.391 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.548 HG13 ' O ' ' A' ' 142' ' ' LEU . 34.7 mt -59.61 -38.16 74.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.895 0.378 . . . . 0.0 109.999 175.115 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -59.63 -41.03 89.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.803 177.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -66.05 -36.98 84.7 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.328 0.392 . . . . 0.0 110.856 174.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.556 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 94.7 mmm -62.93 -32.1 73.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.525 0.679 . . . . 0.0 109.429 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.545 HD23 ' O ' ' A' ' 146' ' ' ILE . 3.9 mm? . . . . . 0 C--N 1.321 -0.671 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.746 176.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.52 ' CZ ' ' HD2' ' A' ' 117' ' ' ARG . 69.0 m-85 . . . . . 0 CA--C 1.52 -0.204 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.2 pt -110.23 -7.79 11.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.168 0.509 . . . . 0.0 110.144 171.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.5 m -101.47 168.8 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.733 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.603 ' HB2' ' HB2' ' A' ' 11' ' ' GLU . 38.4 mtt180 -114.83 163.25 15.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.197 -177.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.781 HG12 HD13 ' A' ' 130' ' ' LEU . 73.3 mt -79.5 121.23 32.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 174.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.48 1.34 62.31 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -175.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 8' ' ' ARG . 10.4 tp10 -83.42 155.83 23.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.36 -0.42 . . . . 0.0 110.551 -176.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.518 ' HE2' ' HA ' ' A' ' 12' ' ' MET . 4.9 mmt -65.76 127.74 33.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.452 177.064 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.436 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -67.48 129.94 93.45 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.663 178.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.454 ' HD2' ' CZ ' ' A' ' 108' ' ' TYR . 15.3 Cg_exo -65.98 113.54 2.63 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.668 2.245 . . . . 0.0 111.2 178.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.68 147.19 50.92 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.604 -175.033 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.401 ' O ' ' HA ' ' A' ' 27' ' ' THR . 44.7 p90 -155.7 164.33 38.73 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.376 -176.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.8 m -116.68 102.8 9.76 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 174.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.49 ' O ' ' HA ' ' A' ' 25' ' ' GLN . 13.1 tt -97.87 138.72 21.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.937 0.399 . . . . 0.0 111.023 -174.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.2 m -94.15 118.91 32.23 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.071 177.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.486 HD12 ' HB2' ' A' ' 24' ' ' LYS . 94.3 mt -74.54 175.99 7.28 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.944 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 96' ' ' LEU . 31.8 p -57.88 -32.2 67.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.623 -175.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -102.13 16.97 24.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.956 0.408 . . . . 0.0 111.123 -176.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.43 7.36 69.55 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.404 173.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.486 ' HB2' HD12 ' A' ' 20' ' ' LEU . 27.3 mmtp -78.76 110.01 13.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.882 0.373 . . . . 0.0 110.72 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.49 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 94.1 mt-30 -92.0 114.48 27.03 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.481 178.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.5 m -118.03 151.5 20.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.477 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.418 ' HB ' ' OG ' ' A' ' 29' ' ' SER . 1.2 p -101.91 154.2 19.16 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.879 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.8 -34.77 77.43 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 174.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.532 ' HA ' ' HG2' ' A' ' 32' ' ' ARG . 0.5 OUTLIER -59.69 -23.7 63.34 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.676 175.516 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.8 t -78.73 -12.36 60.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.041 0.448 . . . . 0.0 110.408 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 83.0 mt -112.73 -0.82 14.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.931 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.533 ' NE ' ' HA3' ' A' ' 125' ' ' GLY . 40.5 mmm-85 -66.19 102.41 0.83 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.079 0.466 . . . . 0.0 109.76 178.33 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 143.64 -23.47 2.16 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -174.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.412 ' HA ' ' OD1' ' A' ' 68' ' ' ASP . 43.9 mtmt -117.08 160.07 21.57 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 174.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.534 HG22 ' O ' ' A' ' 68' ' ' ASP . 10.6 m -70.45 128.38 33.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 175.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.595 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 40.6 t -111.69 114.73 47.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 120.832 0.349 . . . . 0.0 111.153 -174.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.496 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 27.0 ttt -97.15 120.6 37.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.004 0.43 . . . . 0.0 110.067 174.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.498 ' HB2' ' HB ' ' A' ' 119' ' ' VAL . 88.3 mt -112.38 123.43 50.26 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.678 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -113.11 111.05 21.45 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.13 177.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.502 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 96.8 m-85 -88.64 115.82 26.44 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.7 t -132.7 -172.85 3.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.172 -171.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.559 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . . . -172.16 143.23 1.48 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.776 ' H ' ' HG3' ' A' ' 78' ' ' GLU . 54.7 p -70.72 -15.68 62.72 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.776 -172.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.408 ' HD1' ' OE2' ' A' ' 78' ' ' GLU . 66.6 p-90 -87.28 -0.65 57.06 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.097 0.475 . . . . 0.0 110.915 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.588 ' SG ' HG12 ' A' ' 115' ' ' ILE . 74.5 m -93.12 112.57 24.55 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.996 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -75.95 -34.29 48.09 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.63 178.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 56.2 t -61.42 -45.02 99.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.677 0.238 . . . . 0.0 110.833 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.696 ' HA ' ' CD ' ' A' ' 51' ' ' GLU . 12.5 t -61.85 -15.78 44.9 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 121.421 0.629 . . . . 0.0 111.456 -174.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -72.52 -1.91 17.7 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.862 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.481 ' HE2' ' CD2' ' A' ' 134' ' ' TYR . 56.4 mtpt -90.16 -56.87 3.05 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.214 172.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.773 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 3.8 pm0 -64.34 -30.95 71.98 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.565 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.64 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 5.9 mmt -52.29 -63.61 2.08 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.629 178.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.64 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 52.6 Cg_exo -56.63 -39.47 91.15 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 122.171 1.914 . . . . 0.0 112.912 175.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.407 ' HD1' ' O ' ' A' ' 50' ' ' LYS . 21.3 m-85 -66.99 -45.69 76.85 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 93.9 mt -61.93 -42.77 96.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.78 0.324 . . . . 0.0 110.146 177.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.489 ' OE1' ' HA ' ' A' ' 92' ' ' VAL . 26.0 tp10 -57.11 -52.36 65.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.602 178.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.519 ' HA ' HD22 ' A' ' 61' ' ' LEU . 27.6 ttpp -72.66 -54.06 10.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.522 -175.025 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -87.13 -26.74 23.47 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -168.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.7 mt -105.64 -61.72 2.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.817 -177.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.575 ' CD2' ' HB3' ' A' ' 94' ' ' TYR . 76.7 t-105 -61.22 -64.46 0.94 Allowed 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.499 -173.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.519 HD22 ' HA ' ' A' ' 57' ' ' LYS . 1.5 mp -47.78 -32.5 6.05 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -175.11 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -71.51 -38.3 71.15 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -176.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.658 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 87.2 m-70 -126.18 -43.78 1.78 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.897 -174.022 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.7 mttp 59.01 -82.22 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.655 0.782 . . . . 0.0 111.014 -175.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -110.8 -42.32 4.05 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 171.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.658 ' HB2' ' HB3' ' A' ' 63' ' ' HIS . 3.5 t30 71.03 -68.18 0.23 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.011 175.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 66' ' ' ASN . . . 162.93 -27.02 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 124.327 1.051 . . . . 0.0 108.759 -175.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.534 ' O ' HG22 ' A' ' 35' ' ' VAL . 25.5 t0 -140.74 26.74 2.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.614 -174.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.544 ' HB2' HD11 ' A' ' 150' ' ' LEU . 87.8 t80 -135.17 144.41 47.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.824 -177.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.67 138.02 28.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.963 173.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.496 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 1.8 tt -138.51 115.37 10.78 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -178.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.4 mp -126.79 130.69 71.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.141 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.429 ' HA3' HD22 ' A' ' 96' ' ' LEU . . . -92.69 117.22 5.3 Favored Glycine 0 C--O 1.221 -0.681 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.531 177.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 41.7 mt -104.44 118.62 52.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.938 0.369 . . . . 0.0 110.556 -175.251 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.559 ' OD2' ' HA ' ' A' ' 42' ' ' ALA . 9.7 t70 -84.52 142.55 29.95 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 176.461 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.441 ' HG2' ' HB2' ' A' ' 102' ' ' ALA . 18.1 ttp180 -80.03 -40.83 26.97 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -172.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -155.16 5.88 0.23 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -168.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.776 ' HG3' ' H ' ' A' ' 43' ' ' SER . 13.4 mm-40 -88.52 133.33 36.53 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 120.908 0.385 . . . . 0.0 110.373 177.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.454 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 29.3 Cg_endo -68.17 -173.11 0.48 Allowed 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 122.875 2.383 . . . . 0.0 113.63 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.42 ' O ' HD23 ' A' ' 84' ' ' LEU . 3.1 tm? -59.07 -55.82 30.15 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.084 -169.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.454 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -66.01 -34.13 77.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.497 0.189 . . . . 0.0 111.501 -173.832 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.433 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 2.7 mmmp? -60.24 -50.1 74.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.019 177.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 66.1 t -62.55 -44.85 99.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.921 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.42 HD23 ' O ' ' A' ' 80' ' ' LEU . 4.2 mm? -61.03 -47.37 86.75 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.831 0.348 . . . . 0.0 111.579 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.96 -30.93 68.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.232 -178.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -73.2 -47.75 40.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.553 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.59 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -52.34 -55.16 23.39 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.142 -177.228 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.82 -11.29 60.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.658 -174.074 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.6 m -94.81 -22.08 18.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.011 178.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.7 p -91.49 -4.51 55.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.594 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.66 0.91 90.42 Favored Glycine 0 C--O 1.228 -0.229 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.356 178.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.489 ' HA ' ' OE1' ' A' ' 56' ' ' GLU . 72.5 t -66.7 123.08 18.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 122.798 0.439 . . . . 0.0 111.386 -179.289 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.3 p -101.63 -18.83 15.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.652 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.575 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 52.7 p90 -77.52 141.76 65.79 Favored Pre-proline 0 N--CA 1.454 -0.26 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.513 177.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.404 ' HB2' HD22 ' A' ' 20' ' ' LEU . 18.5 Cg_endo -60.06 131.88 41.53 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 122.688 2.259 . . . . 0.0 113.409 -175.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.59 HD12 ' HB2' ' A' ' 87' ' ' ALA . 66.5 mt -102.39 147.49 26.64 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.002 173.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.462 ' HA3' HD11 ' A' ' 18' ' ' ILE . . . -122.3 143.84 15.76 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 177.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.787 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.0 OUTLIER -98.15 132.34 43.76 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.788 0.328 . . . . 0.0 110.551 -177.995 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.418 ' HB3' ' O ' ' A' ' 75' ' ' ASP . 14.2 t0 -115.23 74.79 4.07 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.521 176.037 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.473 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 23.5 Cg_exo -63.17 104.7 0.42 Allowed 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.573 2.182 . . . . 0.0 112.364 -176.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 115.36 -4.54 21.72 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.772 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.441 ' HB2' ' HG2' ' A' ' 76' ' ' ARG . . . 57.52 47.42 16.2 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 122.731 0.412 . . . . 0.0 111.476 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.435 ' HA ' HH21 ' A' ' 111' ' ' ARG . 15.0 t70 -80.59 -50.62 9.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.98 0.419 . . . . 0.0 110.173 178.11 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 96.9 mt -61.93 -40.09 85.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 176.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -62.5 -40.39 96.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.541 176.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -67.4 -23.65 65.59 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.223 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -73.25 -13.5 61.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.257 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.454 ' CZ ' ' HD2' ' A' ' 14' ' ' PRO . 45.3 m-85 -113.49 -34.38 5.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.832 0.349 . . . . 0.0 111.563 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -158.92 168.28 27.2 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.899 0.38 . . . . 0.0 111.209 -177.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.445 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 90.1 mt -67.29 138.63 56.98 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 175.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.435 HH21 ' HA ' ' A' ' 103' ' ' ASP . 94.5 mtt180 -63.16 -27.04 69.1 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.577 -174.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -92.82 -16.75 24.95 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.315 -178.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.445 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . . . -80.85 47.92 1.03 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -172.019 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.58 143.14 9.74 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.328 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.588 HG12 ' SG ' ' A' ' 45' ' ' CYS . 1.8 tp -87.41 -64.07 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -176.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.42 ' H ' HG23 ' A' ' 115' ' ' ILE . 6.5 m -64.78 128.03 34.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.857 0.361 . . . . 0.0 111.315 -173.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.52 ' HD2' ' CZ ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -145.43 132.13 19.97 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.432 178.28 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.705 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 3.8 m-20 -107.91 117.66 34.7 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 176.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.498 ' HB ' ' HB2' ' A' ' 38' ' ' LEU . 73.2 t -120.57 118.97 58.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.426 -177.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.898 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 25.4 tp -109.77 120.13 41.53 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.261 0.553 . . . . 0.0 110.486 176.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.595 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 74.2 mt -104.23 142.02 18.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.948 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.86 172.25 13.75 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.408 ' HD3' ' OD2' ' A' ' 68' ' ' ASP . 26.8 ptt180 -78.01 20.96 0.34 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -175.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.443 ' OE1' ' HE3' ' A' ' 12' ' ' MET . 1.7 tm-20 -110.88 -35.72 5.88 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 169.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.533 ' HA3' ' NE ' ' A' ' 32' ' ' ARG . . . 122.51 20.54 2.9 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.667 -172.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 29.3 mtmm -103.42 135.71 44.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.621 0.248 . . . . 0.0 110.493 177.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.4 HG23 HG13 ' A' ' 119' ' ' VAL . 56.4 mt -78.62 101.74 4.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 177.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.4 m -100.61 -21.63 5.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -170.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.898 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 61.0 tptt -132.03 117.05 17.87 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.131 0.491 . . . . 0.0 111.439 -176.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.781 HD13 HG12 ' A' ' 9' ' ' ILE . 10.3 mp -104.24 104.86 14.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.739 176.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.705 ' HB ' ' HB2' ' A' ' 118' ' ' ASN . 54.6 m -109.45 132.34 54.22 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.111 0.481 . . . . 0.0 110.746 -178.204 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.472 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 0.1 OUTLIER -91.92 107.9 19.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.825 -177.819 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 132' ' ' ARG . 0.6 OUTLIER 43.9 -160.89 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.28 0.987 . . . . 0.0 112.359 -179.008 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.773 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 94.4 t80 -85.39 84.9 7.5 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.643 0.735 . . . . 0.0 111.283 176.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.505 ' HB3' ' HB3' ' A' ' 138' ' ' GLU . 27.0 t-20 -89.09 120.07 30.16 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 165.461 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.428 ' HG2' ' CE2' ' A' ' 134' ' ' TYR . 46.4 mt-10 -56.38 -48.22 77.32 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -170.047 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.2 mp0 -68.04 -40.5 82.86 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.047 0.451 . . . . 0.0 110.511 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.505 ' HB3' ' HB3' ' A' ' 135' ' ' ASN . 8.5 tp10 -64.7 -41.05 96.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.374 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.44 ' O ' HG23 ' A' ' 143' ' ' VAL . 86.8 t80 -64.16 -40.39 96.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.381 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -59.12 -47.92 83.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.285 177.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 21.2 m -62.88 -39.87 95.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.636 176.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.459 ' O ' HG13 ' A' ' 146' ' ' ILE . 49.8 tp -60.9 -49.34 77.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.174 -178.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 139' ' ' PHE . 95.1 t -59.38 -47.96 88.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.827 0.346 . . . . 0.0 110.77 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 21.8 tm0? -60.67 -43.1 98.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.956 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.515 ' O ' ' HG2' ' A' ' 149' ' ' MET . 57.0 tt0 -59.97 -46.99 87.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.53 177.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.488 ' O ' HD23 ' A' ' 150' ' ' LEU . 81.2 mt -56.41 -47.71 81.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.721 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -55.15 -44.76 75.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.859 176.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -76.55 -10.79 59.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.771 0.32 . . . . 0.0 111.443 -178.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.515 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 88.3 mmm -78.39 -38.96 40.46 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 171.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.544 HD11 ' HB2' ' A' ' 69' ' ' PHE . 4.4 mm? . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 114.9 -1.046 . . . . 0.0 110.294 176.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.404 ' CZ ' ' HD3' ' A' ' 117' ' ' ARG . 62.6 m-85 . . . . . 0 CA--C 1.516 -0.345 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.6 pt -96.42 -15.63 7.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.771 0.32 . . . . 0.0 110.677 173.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.2 m -94.11 152.14 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.825 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.527 ' HB2' ' HB2' ' A' ' 11' ' ' GLU . 42.2 mtt85 -103.27 163.5 12.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.84 -177.112 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.493 HG12 HD13 ' A' ' 130' ' ' LEU . 72.5 mt -82.13 126.43 39.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 172.206 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.73 -10.7 64.56 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -173.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 8' ' ' ARG . 0.4 OUTLIER -77.04 150.1 35.78 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.163 -0.519 . . . . 0.0 109.809 -179.221 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.76 ' HG2' ' HG2' ' A' ' 126' ' ' LYS . 24.7 mtp -78.88 120.92 24.18 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.456 ' HA ' ' HD2' ' A' ' 14' ' ' PRO . . . -56.87 125.24 68.4 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.9 -175.404 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.456 ' HD2' ' HA ' ' A' ' 13' ' ' ALA . 10.0 Cg_endo -54.17 115.95 2.72 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.215 2.61 . . . . 0.0 111.736 177.089 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.517 ' HA ' HD12 ' A' ' 28' ' ' LEU . 1.2 t70 -68.32 138.2 55.26 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.541 -174.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.507 ' HB2' HD12 ' A' ' 104' ' ' ILE . 36.2 p90 -146.48 161.65 39.99 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.699 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 30.6 m -123.25 112.9 18.2 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 175.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.2 tt -117.63 144.51 25.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.017 0.437 . . . . 0.0 110.934 -175.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.0 m -84.59 127.19 33.93 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.406 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.411 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 85.3 mt -81.55 176.94 9.24 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.972 0.415 . . . . 0.0 110.906 177.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 96' ' ' LEU . 33.3 p -56.16 -34.89 66.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.881 -176.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -103.14 21.06 16.48 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.091 0.472 . . . . 0.0 110.71 -175.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.63 36.22 34.03 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.754 174.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 24' ' ' LYS . 43.3 mmtm -104.11 122.9 46.26 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.846 0.355 . . . . 0.0 110.649 177.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -88.48 115.91 26.34 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.956 177.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 17' ' ' THR . 14.3 m -114.91 143.77 23.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.017 0.437 . . . . 0.0 110.263 178.032 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 12.0 m -120.81 144.65 48.22 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.565 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.517 HD12 ' HA ' ' A' ' 15' ' ' ASP . 15.9 mt -61.7 -34.21 75.37 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.941 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.45 ' HA ' ' HG2' ' A' ' 32' ' ' ARG . 49.9 m -54.47 -38.21 66.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.927 0.394 . . . . 0.0 110.845 175.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.3 m -73.08 -23.23 60.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.24 0.543 . . . . 0.0 110.926 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.6 mt -99.54 0.44 42.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.45 ' HG2' ' HA ' ' A' ' 29' ' ' SER . 38.1 mmt180 -62.37 147.47 48.3 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 175.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 102.89 -26.53 23.72 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.771 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.581 ' HG3' ' HA ' ' A' ' 68' ' ' ASP . 3.2 mppt? -110.47 165.26 11.94 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.311 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.49 HG12 ' O ' ' A' ' 68' ' ' ASP . 2.7 p -83.01 120.27 34.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 173.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.459 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 17.3 t -108.6 131.94 57.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.79 -172.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 26.3 ttt -113.15 117.77 32.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.812 0.339 . . . . 0.0 110.471 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -109.08 112.7 25.02 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.336 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.516 HE22 ' HB ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -107.18 125.72 51.47 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 174.142 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.482 ' O ' ' HA ' ' A' ' 116' ' ' THR . 96.8 m-85 -94.29 114.59 26.69 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.242 0.544 . . . . 0.0 109.558 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.516 ' HB ' HE22 ' A' ' 39' ' ' GLN . 14.5 t -116.9 174.47 6.08 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.039 -173.452 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -150.6 131.28 14.0 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.597 177.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.655 ' HB2' ' HG3' ' A' ' 78' ' ' GLU . 43.9 m -65.27 -9.48 24.34 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.794 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 26.8 p-90 -110.0 11.39 24.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.837 0.351 . . . . 0.0 111.316 177.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 51.2 t -106.5 115.32 29.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.188 0.518 . . . . 0.0 111.033 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -77.75 -3.16 83.31 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.73 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.4 t -82.53 -37.98 14.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.131 0.491 . . . . 0.0 109.748 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 81.9 m -61.96 -27.79 69.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.134 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -71.51 -3.55 21.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.531 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.417 ' O ' ' HD1' ' A' ' 54' ' ' PHE . 58.2 mttp -104.03 -46.69 4.39 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 170.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.453 ' OE1' ' HA ' ' A' ' 133' ' ' LEU . 29.5 tt0 -58.19 -57.06 14.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.406 -177.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.671 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 80.1 mtp -58.51 -53.0 70.61 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.721 -172.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.671 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 50.3 Cg_exo -56.83 -40.39 84.56 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 122.101 1.868 . . . . 0.0 112.655 176.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.417 ' HD1' ' O ' ' A' ' 50' ' ' LYS . 17.1 m-85 -67.76 -44.03 78.43 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.789 177.197 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.443 ' O ' ' HB ' ' A' ' 59' ' ' ILE . 37.5 mt -54.5 -54.05 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.898 177.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.634 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 16.8 pt-20 -64.83 -41.49 95.71 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.579 -176.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -58.29 -49.13 78.24 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -175.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.705 ' HA ' ' NZ ' ' A' ' 62' ' ' LYS . 77.8 m-20 -106.08 -18.09 14.13 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -172.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.443 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 67.2 mt -102.75 -60.56 2.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.79 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.643 ' CE2' ' HG2' ' A' ' 64' ' ' LYS . 70.6 t-105 -65.73 -54.06 32.42 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -175.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.605 ' HA ' ' HE3' ' A' ' 64' ' ' LYS . 3.2 mm? -54.17 -29.67 46.53 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -176.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.705 ' NZ ' ' HA ' ' A' ' 58' ' ' ASP . 34.2 mmtm -88.05 -29.97 20.28 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.923 0.392 . . . . 0.0 111.219 -176.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -122.73 23.54 9.45 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -168.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.643 ' HG2' ' CE2' ' A' ' 60' ' ' TRP . 6.2 mtmp? -41.99 96.58 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.4 t70 68.25 -54.14 0.53 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 111.611 -2.54 . . . . 0.0 111.009 178.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 50.97 11.38 0.09 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.662 -179.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 60.1 13.64 3.94 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.115 0.566 . . . . 0.0 111.758 -173.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.581 ' HA ' ' HG3' ' A' ' 34' ' ' LYS . 44.7 t0 -153.71 6.0 0.32 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.966 0.412 . . . . 0.0 111.642 -176.342 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.58 ' HB2' HD11 ' A' ' 150' ' ' LEU . 84.2 t80 -136.72 119.61 16.33 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 121.668 -0.645 . . . . 0.0 110.687 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -116.37 108.24 15.81 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.892 -177.048 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.444 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 2.6 tt -106.73 121.1 43.69 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -178.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 40.2 mm -130.33 126.62 61.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.154 178.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.476 ' HA2' ' HG3' ' A' ' 39' ' ' GLN . . . -97.91 130.21 10.16 Favored Glycine 0 C--O 1.221 -0.686 0 C-N-CA 120.228 -0.986 . . . . 0.0 111.443 176.181 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 72.5 mt -119.31 125.31 74.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 117.55 0.675 . . . . 0.0 111.415 -174.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -86.3 142.41 28.54 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 174.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.407 ' CB ' HD13 ' A' ' 115' ' ' ILE . 58.6 ttt-85 -74.47 -30.83 62.01 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -172.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -161.14 -22.2 0.05 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -170.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.655 ' HG3' ' HB2' ' A' ' 43' ' ' SER . 4.5 mm-40 -72.91 129.5 86.49 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-O 121.218 0.532 . . . . 0.0 111.01 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.595 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 28.1 Cg_endo -66.62 -167.05 0.12 Allowed 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.713 2.942 . . . . 0.0 115.017 -175.525 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.424 HD13 HD23 ' A' ' 84' ' ' LEU . 2.8 tm? -58.14 -53.51 57.41 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 114.532 -1.213 . . . . 0.0 112.329 -170.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.595 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -63.15 -29.71 71.01 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 -173.962 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.52 ' HG3' ' CD ' ' A' ' 78' ' ' GLU . 30.7 mmtm -66.72 -54.36 23.75 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.95 177.001 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.513 HG21 ' HB3' ' A' ' 98' ' ' LEU . 41.2 t -55.33 -43.97 73.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.34 -177.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.424 HD23 HD13 ' A' ' 80' ' ' LEU . 4.4 mm? -69.28 -27.28 65.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.796 0.331 . . . . 0.0 111.608 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.749 ' HA ' ' HE2' ' A' ' 88' ' ' LYS . . . -85.96 -37.65 18.81 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.272 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.536 ' HE2' ' SD ' ' A' ' 52' ' ' MET . 49.0 t80 -68.67 -42.53 77.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.809 -178.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.485 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -56.3 -53.39 57.78 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.097 178.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.749 ' HE2' ' HA ' ' A' ' 85' ' ' ALA . 63.4 pttt -65.92 -20.89 66.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.966 0.412 . . . . 0.0 111.4 -176.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.8 m -82.36 -3.53 55.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.266 178.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.48 ' HB ' ' HG3' ' A' ' 53' ' ' PRO . 15.8 p -127.1 -24.91 3.35 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.997 0.427 . . . . 0.0 111.153 177.027 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 122.56 -79.25 0.34 Allowed Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 -176.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 90.6 t 45.37 89.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 124.526 1.13 . . . . 0.0 113.495 176.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.498 ' HG1' ' HD1' ' A' ' 60' ' ' TRP . 3.5 p -87.24 12.42 11.83 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.637 176.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.442 ' CE1' ' HB3' ' A' ' 56' ' ' GLU . 51.1 p90 -123.17 154.1 64.98 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.304 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -67.55 140.59 52.55 Favored 'Trans proline' 0 C--O 1.238 0.499 0 C-N-CA 122.201 1.934 . . . . 0.0 113.731 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.485 HD12 ' HB2' ' A' ' 87' ' ' ALA . 93.0 mt -113.95 151.43 32.31 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.661 175.075 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -122.53 149.82 16.94 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 175.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.707 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.0 OUTLIER -106.34 126.69 52.55 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.763 0.316 . . . . 0.0 110.827 -177.185 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -115.65 78.95 7.11 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.07 177.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.05 99.82 0.92 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.388 2.059 . . . . 0.0 112.744 -176.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 125.56 -7.05 7.95 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.899 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 63.19 44.29 5.8 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 122.853 0.461 . . . . 0.0 111.102 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -81.88 -50.91 8.64 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.196 0.522 . . . . 0.0 110.306 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.507 HD12 ' HB2' ' A' ' 16' ' ' PHE . 29.8 mm -65.23 -36.02 76.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.504 ' CD2' ' HA ' ' A' ' 111' ' ' ARG . 70.8 t80 -63.29 -42.96 99.13 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.207 175.019 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.62 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -67.45 -21.88 65.52 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.79 -178.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -72.63 -12.32 61.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.834 0.35 . . . . 0.0 111.16 178.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -116.23 -42.8 3.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.08 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.62 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -146.37 161.4 40.44 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.221 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.569 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 97.9 mt -62.26 129.92 42.96 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.504 ' HA ' ' CD2' ' A' ' 105' ' ' PHE . 21.5 mtm180 -50.43 -43.61 55.0 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.295 0.569 . . . . 0.0 111.258 -175.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -101.47 17.64 22.21 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.705 -170.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.569 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . . . -97.7 15.1 24.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.237 177.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 131.17 -179.04 17.34 Favored Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -178.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.444 HG23 ' H ' ' A' ' 116' ' ' THR . 1.0 OUTLIER -125.88 -73.2 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 117.525 0.662 . . . . 0.0 112.751 -179.689 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.713 ' HB ' ' HB3' ' A' ' 133' ' ' LEU . 5.1 m -73.68 117.42 15.42 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.092 0.472 . . . . 0.0 111.985 -167.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.421 ' C ' HD22 ' A' ' 118' ' ' ASN . 75.5 mtt-85 -143.04 154.44 43.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.169 -179.245 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.496 ' HB2' HG23 ' A' ' 131' ' ' THR . 0.9 OUTLIER -121.79 119.78 32.69 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 174.132 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.4 t -116.02 123.58 71.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.146 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.566 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 25.8 tp -107.65 121.84 45.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.027 0.442 . . . . 0.0 110.704 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.459 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 62.5 mt -102.77 132.5 48.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.077 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.462 ' OD2' ' HB2' ' A' ' 124' ' ' GLU . 18.4 t70 -79.43 164.96 23.56 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.679 178.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.489 ' HB3' HH11 ' A' ' 123' ' ' ARG . 0.0 OUTLIER -57.33 -29.55 64.05 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.552 179.34 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.536 ' HB3' ' NZ ' ' A' ' 126' ' ' LYS . 18.0 mm-40 -75.4 7.05 3.86 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.0 0.429 . . . . 0.0 111.096 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 76.15 14.13 82.58 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.168 176.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.76 ' HG2' ' HG2' ' A' ' 12' ' ' MET . 25.0 mtmm -113.68 139.19 49.27 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.831 0.348 . . . . 0.0 110.926 -175.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.3 mt -76.14 130.63 36.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.781 -175.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 31.0 m -116.07 -21.0 5.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -176.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.566 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 53.1 tptt -135.5 116.44 14.18 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.552 -0.459 . . . . 0.0 112.092 -174.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.493 HD13 HG12 ' A' ' 9' ' ' ILE . 10.6 mp -109.09 119.34 39.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.332 172.424 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.555 HG21 HD11 ' A' ' 142' ' ' LEU . 14.7 t -147.15 162.91 37.9 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.98 178.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.458 ' C ' ' HG ' ' A' ' 133' ' ' LEU . 37.2 mtm180 -115.83 116.91 28.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.112 -173.055 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.713 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 3.9 pp 48.62 -169.09 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 O-C-N 124.67 1.231 . . . . 0.0 114.001 174.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.446 ' HB2' ' CB ' ' A' ' 51' ' ' GLU . 60.9 t80 -80.59 114.74 19.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.449 -178.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.544 ' HB3' ' HB2' ' A' ' 138' ' ' GLU . 3.0 t-20 -130.87 133.78 46.2 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.948 -1.023 . . . . 0.0 108.429 173.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -44.87 -61.26 1.67 Allowed 'General case' 0 C--O 1.236 0.367 0 O-C-N 123.441 0.463 . . . . 0.0 112.189 -178.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -60.74 -50.71 72.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.822 0.344 . . . . 0.0 111.317 -177.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.544 ' HB2' ' HB3' ' A' ' 135' ' ' ASN . 4.0 mm-40 -63.13 -39.49 94.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.981 -177.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -66.08 -41.45 90.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.807 0.337 . . . . 0.0 110.102 177.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.82 -42.02 98.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.157 176.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.4 m -67.31 -35.21 78.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.239 177.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.555 HD11 HG21 ' A' ' 131' ' ' THR . 24.7 mt -66.67 -53.4 34.29 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.836 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.6 p -60.69 -42.17 90.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.025 -175.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -67.29 -41.52 85.3 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.812 0.339 . . . . 0.0 110.547 177.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.531 ' O ' ' HG2' ' A' ' 149' ' ' MET . 60.9 tt0 -58.5 -51.39 70.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.657 176.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.615 ' O ' HD23 ' A' ' 150' ' ' LEU . 99.0 mt -62.48 -40.51 88.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.85 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -54.35 -37.47 64.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.25 177.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -88.14 -26.62 22.36 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.625 -178.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.531 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 97.5 mmm -63.8 -26.25 68.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.408 0.623 . . . . 0.0 109.704 175.078 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.615 HD23 ' O ' ' A' ' 146' ' ' ILE . 3.9 mm? . . . . . 0 C--N 1.325 -0.486 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.072 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.491 ' CE1' HD12 ' A' ' 130' ' ' LEU . 69.0 m-85 . . . . . 0 CA--C 1.519 -0.226 0 CA-C-O 120.674 0.273 . . . . 0.0 111.346 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.52 HG13 HG23 ' A' ' 7' ' ' VAL . 46.8 pt -101.65 -17.13 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 170.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.52 HG23 HG13 ' A' ' 6' ' ' ILE . 23.1 t -110.3 139.27 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.067 177.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.439 ' HE ' ' CD ' ' A' ' 11' ' ' GLU . 73.6 mtm180 -122.47 -178.7 3.97 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.084 0.469 . . . . 0.0 112.186 -169.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.426 ' CG1' HD23 ' A' ' 130' ' ' LEU . 67.5 mt -71.32 123.07 24.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.294 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.16 -19.82 44.91 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.166 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.439 ' CD ' ' HE ' ' A' ' 8' ' ' ARG . 7.1 mt-10 -80.87 151.32 28.71 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.68 ' HG2' ' HG2' ' A' ' 126' ' ' LYS . 45.1 mtp -77.92 137.54 38.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.844 0.354 . . . . 0.0 110.362 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.24 130.83 67.79 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.404 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.402 ' HG2' ' O ' ' A' ' 107' ' ' LYS . 37.6 Cg_exo -61.23 125.95 18.19 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.493 2.129 . . . . 0.0 111.427 177.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -63.01 138.64 58.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.224 0.535 . . . . 0.0 110.196 -176.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.686 ' HB2' HD12 ' A' ' 104' ' ' ILE . 47.1 p90 -131.76 149.69 52.39 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.052 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.5 m -109.17 98.79 8.17 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 170.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 25' ' ' GLN . 16.9 tt -95.6 144.8 9.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.516 -174.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.8 m -101.55 118.3 36.68 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.103 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.8 mt -73.57 172.83 10.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.959 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 96' ' ' LEU . 41.5 p -58.1 -28.84 64.98 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -175.106 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -102.6 18.74 20.54 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.143 0.497 . . . . 0.0 110.859 -175.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.86 40.43 17.41 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.795 174.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -108.73 117.18 33.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.887 0.375 . . . . 0.0 110.928 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 49.7 mt-30 -94.75 118.47 31.79 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.003 178.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.8 p -128.88 132.28 67.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.217 0.532 . . . . 0.0 111.123 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.41 154.81 25.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.089 177.447 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 40.4 tp -65.48 -40.28 92.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.844 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.59 ' HA ' ' HG3' ' A' ' 32' ' ' ARG . 75.3 m -62.92 -19.14 63.94 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 177.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 51.8 m -75.2 -18.15 60.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.511 0.672 . . . . 0.0 110.395 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.3 mt -100.81 -14.11 18.13 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.732 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.646 ' NH1' ' HA ' ' A' ' 124' ' ' GLU . 6.3 mmm180 -55.48 153.57 7.4 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 123.539 0.525 . . . . 0.0 110.917 177.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.09 -22.64 35.43 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -172.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.524 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 35.7 mtmm -117.31 170.93 8.31 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 174.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.5 m -80.9 134.03 28.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 172.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.592 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 44.3 t -111.22 109.6 29.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 121.006 0.431 . . . . 0.0 111.076 -177.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 13.9 tpt -91.81 136.25 33.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.211 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 78.9 mt -133.74 143.29 48.37 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.077 -178.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.56 ' OE1' ' HB ' ' A' ' 41' ' ' THR . 21.8 tm0? -138.45 131.44 29.77 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 177.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.449 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 96.7 m-85 -104.56 120.04 40.38 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.56 ' HB ' ' OE1' ' A' ' 39' ' ' GLN . 6.8 t -136.47 -175.67 4.08 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.059 0.456 . . . . 0.0 111.602 -173.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.501 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . . . -169.41 164.04 10.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.463 178.248 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.454 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 86.3 p -67.19 -30.25 70.14 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.892 0.377 . . . . 0.0 111.739 -173.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 37.7 p-90 -89.0 4.36 48.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.668 -175.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.501 ' SG ' ' HB3' ' A' ' 42' ' ' ALA . 80.0 m -85.69 90.05 7.91 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.072 0.463 . . . . 0.0 110.796 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.84 -35.7 90.01 Favored Glycine 0 C--O 1.228 -0.265 0 C-N-CA 121.08 -0.581 . . . . 0.0 113.004 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.5 t -64.46 -35.44 74.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.012 0.434 . . . . 0.0 110.057 178.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.708 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 99.4 m -65.24 -16.84 63.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.395 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -68.99 -7.32 34.25 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 120.849 0.357 . . . . 0.0 110.604 177.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.629 ' HD3' ' CD2' ' A' ' 134' ' ' TYR . 62.1 mttt -88.24 -57.25 2.99 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.351 0.596 . . . . 0.0 110.257 168.149 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.736 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 5.0 pt-20 -65.65 -40.06 92.07 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.287 -172.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.596 ' HG2' ' O ' ' A' ' 48' ' ' CYS . 98.9 mmm -54.69 -58.39 14.52 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 117.999 0.363 . . . . 0.0 111.862 -177.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.459 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 29.6 Cg_endo -64.48 -38.53 32.84 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 122.018 1.812 . . . . 0.0 112.501 178.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -64.46 -42.07 96.16 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.314 178.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.562 ' O ' ' HB ' ' A' ' 59' ' ' ILE . 75.0 mt -60.25 -37.49 73.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.863 0.363 . . . . 0.0 110.404 177.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.728 ' HG3' ' H ' ' A' ' 93' ' ' THR . 0.2 OUTLIER -68.42 -62.66 1.3 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 175.921 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.403 ' O ' ' HE2' ' A' ' 62' ' ' LYS . 29.3 ttpp -55.58 -43.1 75.64 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -174.069 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.624 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 8.3 m-20 -100.65 -24.82 14.34 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -171.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.562 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 53.9 mt -106.5 -60.99 2.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.458 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.523 ' HB3' ' HA ' ' A' ' 56' ' ' GLU . 76.6 t-105 -62.8 -62.65 1.58 Allowed 'General case' 0 C--O 1.226 -0.18 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.614 -175.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.483 HD12 ' HA ' ' A' ' 61' ' ' LEU . 0.5 OUTLIER -46.68 -31.98 3.25 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.655 0.782 . . . . 0.0 112.497 -174.013 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.624 ' HE2' ' HA ' ' A' ' 58' ' ' ASP . 64.7 mmtt -72.75 -54.24 9.45 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.923 -178.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.791 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 85.8 m-70 -105.83 -45.29 4.42 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -169.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.469 ' HE3' HD12 ' A' ' 61' ' ' LEU . 32.5 mttp 55.06 -78.42 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.77 0.828 . . . . 0.0 111.495 -172.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -101.36 -63.25 1.16 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 174.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.791 ' HB2' ' HB3' ' A' ' 63' ' ' HIS . 3.9 t30 68.21 5.97 4.99 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.842 172.328 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 71.68 -19.44 0.26 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.769 0.828 . . . . 0.0 112.513 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.524 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 19.9 p30 -136.92 17.31 3.04 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.484 ' CE2' ' HB2' ' A' ' 71' ' ' LEU . 93.7 t80 -125.63 143.3 51.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.087 0.47 . . . . 0.0 111.112 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.81 140.59 38.61 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.744 172.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.484 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 2.2 tt -139.12 114.73 9.9 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -179.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.9 mm -124.3 120.83 60.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.133 178.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.455 ' HA3' ' CD2' ' A' ' 96' ' ' LEU . . . -88.72 130.44 10.15 Favored Glycine 0 C--O 1.223 -0.57 0 C-N-CA 120.223 -0.989 . . . . 0.0 110.809 175.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 48.6 mt -116.67 121.6 68.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 117.28 0.54 . . . . 0.0 110.759 -174.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -82.59 139.8 33.59 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 173.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.444 ' HB2' HD13 ' A' ' 115' ' ' ILE . 57.7 ttt-85 -57.37 -51.78 68.03 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.668 0.605 . . . . 0.0 112.58 -172.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.597 ' HA ' ' O ' ' A' ' 99' ' ' ASP . 11.3 p-10 -170.05 15.48 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -175.238 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.54 ' HB3' ' HG3' ' A' ' 82' ' ' LYS . 29.0 mt-10 -91.52 148.53 37.62 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-O 121.088 0.471 . . . . 0.0 110.599 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.642 ' HG2' ' OE2' ' A' ' 81' ' ' GLU . 38.1 Cg_endo -71.34 -174.48 1.23 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.935 2.423 . . . . 0.0 114.257 -176.249 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 85.2 mt -54.25 -52.5 61.16 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.618 -1.173 . . . . 0.0 112.826 -174.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.642 ' OE2' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -61.22 -24.54 66.42 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -172.819 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.628 ' HG2' ' OE2' ' A' ' 81' ' ' GLU . 42.5 mmtm -73.23 -59.87 2.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.717 0.294 . . . . 0.0 110.367 172.084 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.6 t -54.59 -49.24 68.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.725 -176.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.8 mp -64.69 -40.43 95.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.413 -176.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.408 ' O ' ' HG2' ' A' ' 88' ' ' LYS . . . -76.67 -34.55 58.24 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.316 -177.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.454 ' CD1' ' HA ' ' A' ' 43' ' ' SER . 78.9 t80 -67.09 -48.94 66.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.791 -178.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.467 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -53.34 -52.05 60.46 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.042 -176.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 85' ' ' ALA . 17.9 pttm -63.19 -28.45 70.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.043 -176.447 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.5 m -100.73 9.86 41.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.724 -174.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.2 p -129.46 10.87 5.75 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.108 175.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.67 43.65 91.46 Favored Glycine 0 C--O 1.227 -0.281 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.275 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.7 t -100.36 100.65 10.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.028 0.442 . . . . 0.0 110.944 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.728 ' H ' ' HG3' ' A' ' 56' ' ' GLU . 30.1 m -85.94 -20.52 28.85 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.848 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.522 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 23.6 p90 -82.48 144.12 48.97 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.816 178.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -61.5 140.67 88.53 Favored 'Trans proline' 0 C--O 1.238 0.495 0 C-N-CA 122.572 2.181 . . . . 0.0 113.175 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.475 ' O ' HG23 ' A' ' 21' ' ' THR . 76.3 mt -111.06 151.2 28.32 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.852 176.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -123.59 149.16 16.85 Favored Glycine 0 N--CA 1.438 -1.214 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 175.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.735 HD23 ' H ' ' A' ' 98' ' ' LEU . 0.8 OUTLIER -99.81 132.56 45.08 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.591 0.234 . . . . 0.0 110.561 -177.456 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.597 ' O ' ' HA ' ' A' ' 77' ' ' ASP . 26.6 t0 -109.58 83.31 2.57 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.925 176.004 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -60.92 101.67 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.417 2.078 . . . . 0.0 113.177 -175.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.442 ' H ' ' HB2' ' A' ' 77' ' ' ASP . . . 101.51 11.76 37.5 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.852 -0.689 . . . . 0.0 113.359 175.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 61.32 43.46 10.66 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.082 0.467 . . . . 0.0 110.872 178.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.645 ' HA ' HH21 ' A' ' 111' ' ' ARG . 18.1 t70 -79.89 -50.2 10.82 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.537 0.684 . . . . 0.0 110.374 -178.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.686 HD12 ' HB2' ' A' ' 16' ' ' PHE . 31.7 mm -67.41 -39.45 82.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 175.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -56.69 -39.14 73.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.363 175.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.17 -32.32 72.49 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.77 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.402 ' O ' ' HG2' ' A' ' 14' ' ' PRO . 30.5 mtmm -74.83 -4.79 39.86 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 178.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -116.61 -19.24 10.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 179.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.689 ' HB3' HH12 ' A' ' 117' ' ' ARG . . . -171.9 -179.99 2.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.572 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 80.2 mt -66.11 149.62 50.0 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 174.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.645 HH21 ' HA ' ' A' ' 103' ' ' ASP . 93.5 mtt180 -73.58 -15.22 61.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.121 0.486 . . . . 0.0 110.024 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -100.51 15.9 26.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.346 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.07 -179.26 5.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.475 -177.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.88 142.03 42.79 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.679 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.595 ' O ' ' HG2' ' A' ' 117' ' ' ARG . 6.6 tp -91.66 -39.77 11.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 111.36 0.133 . . . . 0.0 111.36 -178.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.577 HG22 ' SG ' ' A' ' 48' ' ' CYS . 18.0 p -68.86 105.33 2.32 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 120.484 0.183 . . . . 0.0 110.878 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.689 HH12 ' HB3' ' A' ' 109' ' ' ALA . 8.9 ptm180 -167.65 133.06 1.96 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.171 0.51 . . . . 0.0 112.127 -173.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.59 ' HB2' ' CB ' ' A' ' 131' ' ' THR . 91.2 m-20 -104.41 129.59 52.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.231 172.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.6 t -120.95 116.93 51.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 120.619 0.247 . . . . 0.0 110.394 -176.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 37.5 tp -106.38 115.12 29.66 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.113 0.482 . . . . 0.0 110.645 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.592 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 60.7 mt -95.51 135.05 30.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.366 176.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' A' ' 124' ' ' GLU . 0.0 OUTLIER -79.49 177.01 9.18 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.206 0.526 . . . . 0.0 110.734 -177.213 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 123' ' ' ARG . 31.6 ttm180 -62.57 -27.1 68.95 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.561 -177.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.646 ' HA ' ' NH1' ' A' ' 32' ' ' ARG . 2.1 mm-40 -91.42 6.28 46.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.066 -178.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.16 16.68 62.33 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.544 -0.836 . . . . 0.0 113.017 172.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.68 ' HG2' ' HG2' ' A' ' 12' ' ' MET . 33.3 mttt -112.18 142.77 44.24 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.829 0.347 . . . . 0.0 110.292 -177.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.474 HD12 ' CG1' ' A' ' 7' ' ' VAL . 58.3 mt -80.21 119.96 30.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 120.776 0.322 . . . . 0.0 110.613 -177.344 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.5 m -109.88 -8.07 11.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -149.34 111.21 4.57 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.296 -175.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.491 HD12 ' CE1' ' A' ' 5' ' ' TYR . 3.2 mm? -104.79 105.78 16.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.224 172.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.59 ' CB ' ' HB2' ' A' ' 118' ' ' ASN . 10.4 m -88.98 138.69 31.17 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.367 -177.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.521 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 2.3 mpt_? -99.78 107.08 19.04 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 176.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 132' ' ' ARG . 0.5 OUTLIER 43.44 -162.89 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 O-C-N 124.212 0.945 . . . . 0.0 111.788 -174.201 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.736 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 90.5 t80 -88.63 92.81 9.34 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.168 0.509 . . . . 0.0 110.08 173.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.562 ' HB3' ' HB3' ' A' ' 138' ' ' GLU . 10.7 t30 -95.02 131.57 40.85 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 170.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.432 ' HB2' ' OE2' ' A' ' 137' ' ' GLU . 24.9 mm-40 -50.16 -63.81 1.0 Allowed 'General case' 0 CA--C 1.536 0.424 0 O-C-N 123.687 0.617 . . . . 0.0 112.178 -168.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.566 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.2 mp0 -66.62 -32.52 73.9 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.108 0.48 . . . . 0.0 110.945 -177.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.562 ' HB3' ' HB3' ' A' ' 135' ' ' ASN . 6.0 tp10 -62.68 -46.18 89.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.606 -176.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.499 ' O ' HG23 ' A' ' 143' ' ' VAL . 91.9 t80 -63.57 -42.03 98.34 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.511 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.4 -44.06 96.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.805 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.3 m -63.68 -39.6 94.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.414 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.501 ' O ' HG13 ' A' ' 146' ' ' ILE . 58.4 tp -62.46 -44.31 96.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.942 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 139' ' ' PHE . 99.0 t -57.66 -52.94 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.15 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -60.96 -41.29 96.06 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-O 121.281 0.562 . . . . 0.0 110.872 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -57.71 -48.52 79.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.575 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.608 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 78.0 mt -58.96 -41.92 84.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.879 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -55.2 -46.68 75.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.561 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -83.88 -25.22 30.41 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.092 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.442 ' HB3' ' HE3' ' A' ' 149' ' ' MET . 28.8 mmm -58.92 -33.88 71.08 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.413 0.625 . . . . 0.0 110.371 178.188 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 146' ' ' ILE . 52.2 mt . . . . . 0 C--N 1.319 -0.739 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.611 176.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.429 ' OH ' ' HD2' ' A' ' 117' ' ' ARG . 1.3 m-85 . . . . . 0 CA--C 1.52 -0.199 0 CA-C-O 120.771 0.319 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.431 HG13 HG13 ' A' ' 7' ' ' VAL . 38.6 pt -92.38 -24.01 5.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.437 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.431 HG13 HG13 ' A' ' 6' ' ' ILE . 27.4 m -104.51 157.16 5.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.389 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.528 ' H ' ' HG3' ' A' ' 11' ' ' GLU . 19.7 mtt180 -126.25 177.39 6.45 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.082 -174.119 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.646 HG12 HD13 ' A' ' 130' ' ' LEU . 79.9 mt -74.27 110.7 8.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 173.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.02 -23.45 8.2 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.092 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.528 ' HG3' ' H ' ' A' ' 8' ' ' ARG . 69.1 mm-40 -68.13 154.67 41.21 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.572 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 55.5 mtp -86.08 139.83 30.79 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.949 0.404 . . . . 0.0 110.482 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.494 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -67.44 130.06 93.46 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.561 -178.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 8.3 Cg_exo -70.7 120.98 7.5 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.926 2.418 . . . . 0.0 111.477 176.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -63.43 146.93 52.6 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.451 -176.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 1.027 ' HB3' ' HE2' ' A' ' 107' ' ' LYS . 54.0 p90 -156.7 158.54 37.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.69 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.8 m -116.33 107.27 14.62 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.748 175.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.1 tt -107.81 146.81 13.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.005 0.431 . . . . 0.0 111.003 -176.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.402 ' O ' HD23 ' A' ' 98' ' ' LEU . 20.3 m -95.37 130.22 42.24 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.053 177.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.497 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 90.6 mt -83.89 179.01 7.66 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.005 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 96' ' ' LEU . 27.4 p -59.56 -31.21 69.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.714 -175.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -101.88 10.91 39.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.983 0.42 . . . . 0.0 110.917 -176.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.07 8.7 62.94 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.522 176.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.44 ' HB2' HD12 ' A' ' 20' ' ' LEU . 46.0 mmtm -77.44 120.59 22.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.362 0.581 . . . . 0.0 110.593 177.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -98.63 115.46 28.71 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.962 0.41 . . . . 0.0 110.393 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.3 m -113.78 153.07 15.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.008 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 9.1 m -122.49 142.96 50.03 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.335 -0.393 . . . . 0.0 109.961 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.67 -39.88 94.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.847 0.356 . . . . 0.0 110.841 -175.35 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 32' ' ' ARG . 5.3 p -61.18 -21.57 63.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.546 178.397 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.1 m -79.86 -25.99 40.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.068 0.461 . . . . 0.0 110.403 177.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 77.2 mt -96.5 1.88 51.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.392 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 29' ' ' SER . 0.2 OUTLIER -55.74 126.39 25.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.081 179.339 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.626 ' O ' ' HG3' ' A' ' 123' ' ' ARG . . . 106.37 -0.11 37.6 Favored Glycine 0 C--O 1.222 -0.635 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.724 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.4 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 58.1 mttm -116.51 159.54 21.93 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 174.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.475 HG13 ' HD1' ' A' ' 69' ' ' PHE . 2.1 p -78.29 107.3 10.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.585 0.707 . . . . 0.0 109.172 171.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.512 HG22 ' HB3' ' A' ' 70' ' ' ALA . 48.0 t -106.89 120.93 59.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.095 -173.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.409 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 26.7 ttt -98.81 120.2 38.84 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.331 176.178 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 94.0 mt -107.88 110.87 22.75 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.022 177.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.433 ' OE1' ' HB ' ' A' ' 41' ' ' THR . 0.6 OUTLIER -103.37 106.14 16.58 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.874 -176.983 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 116' ' ' THR . 95.1 m-85 -93.76 127.29 39.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.572 -177.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.433 ' HB ' ' OE1' ' A' ' 39' ' ' GLN . 15.0 t -158.26 -166.47 1.94 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.366 -176.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.531 ' HB2' HD11 ' A' ' 115' ' ' ILE . . . -151.03 156.44 41.12 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 176.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.616 ' HB2' ' HG3' ' A' ' 78' ' ' GLU . 49.7 m -66.26 -9.49 33.0 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -176.208 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 41.0 p-90 -105.4 4.86 31.22 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 122.201 -0.312 . . . . 0.0 111.566 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 74.9 m -83.17 113.47 20.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.023 0.439 . . . . 0.0 111.158 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -78.31 -33.21 40.45 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.863 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.3 t -66.48 -37.46 79.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.08 0.467 . . . . 0.0 110.797 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.681 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 29.1 t -67.03 -16.95 64.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.374 0.607 . . . . 0.0 110.793 -178.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.526 ' HE ' ' HE1' ' A' ' 86' ' ' PHE . 79.6 mtt180 -74.83 -2.15 25.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.681 177.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.409 ' O ' ' HD1' ' A' ' 54' ' ' PHE . 74.2 mmtt -94.02 -55.61 3.15 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.702 0.763 . . . . 0.0 109.278 169.198 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.996 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 10.0 pt-20 -62.68 -44.27 96.69 Favored 'General case' 0 C--O 1.213 -0.827 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.861 -173.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.683 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 33.3 mtm -56.06 -55.23 43.8 Favored Pre-proline 0 N--CA 1.466 0.362 0 CA-C-N 118.338 0.517 . . . . 0.0 112.36 -176.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.683 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 65.0 Cg_exo -53.93 -38.7 86.37 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 121.976 1.784 . . . . 0.0 111.968 175.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.489 ' HB3' ' CZ ' ' A' ' 139' ' ' PHE . 23.1 m-85 -68.26 -45.04 74.25 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.081 175.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 51' ' ' GLU . 88.1 mt -58.86 -55.68 21.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 123.065 0.546 . . . . 0.0 111.08 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.536 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 16.0 pt-20 -62.69 -35.71 80.58 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.635 -177.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.0 ttpm? -72.37 -51.4 20.69 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -176.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.493 ' HA ' ' NZ ' ' A' ' 62' ' ' LYS . 53.5 m-20 -106.99 -10.8 15.83 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -170.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 65.0 mt -104.57 -55.44 5.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.158 173.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.536 ' HB3' ' HA ' ' A' ' 56' ' ' GLU . 72.1 t-105 -69.97 -65.84 0.67 Allowed 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.575 -177.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.519 HD13 ' HE3' ' A' ' 64' ' ' LYS . 1.9 mm? -46.78 -33.88 4.78 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -175.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.493 ' NZ ' ' HA ' ' A' ' 58' ' ' ASP . 45.8 mmtm -75.72 -34.12 60.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.29 -0.414 . . . . 0.0 112.057 -176.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.418 ' ND1' ' HG ' ' A' ' 150' ' ' LEU . 79.9 m-70 -125.28 -43.73 1.91 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 120.347 -0.541 . . . . 0.0 112.351 -173.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.519 ' HE3' HD13 ' A' ' 61' ' ' LEU . 34.5 mttp 54.87 -90.6 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.944 0.898 . . . . 0.0 111.936 -177.278 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -108.01 -49.41 3.21 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 174.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 70.94 -71.22 0.14 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.83 178.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 169.78 -23.67 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.287 -175.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.4 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 6.9 t70 -148.3 24.93 1.01 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.79 -174.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.475 ' HD1' HG13 ' A' ' 35' ' ' VAL . 87.5 t80 -129.12 140.13 51.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.745 0.307 . . . . 0.0 110.571 -178.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.512 ' HB3' HG22 ' A' ' 36' ' ' VAL . . . -139.16 135.83 34.45 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.323 177.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.409 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 1.7 tt -133.79 117.2 16.62 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.6 mp -128.15 126.98 67.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.766 0.317 . . . . 0.0 110.332 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.81 129.46 9.91 Favored Glycine 0 C--O 1.219 -0.784 0 N-CA-C 110.799 -0.921 . . . . 0.0 110.799 174.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.0 mt -119.21 122.53 69.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 117.489 0.644 . . . . 0.0 111.338 -173.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -86.11 133.26 33.89 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 173.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.879 ' HD3' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -88.35 -22.78 23.63 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -169.271 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.879 ' HB3' ' HD3' ' A' ' 76' ' ' ARG . 3.9 p30 -151.25 -14.04 0.21 Allowed 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 118.721 -1.192 . . . . 0.0 114.131 -172.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.616 ' HG3' ' HB2' ' A' ' 43' ' ' SER . 4.9 mm-40 -88.46 133.31 36.69 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-O 121.065 0.46 . . . . 0.0 110.746 177.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.525 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 29.0 Cg_endo -69.19 -168.82 0.27 Allowed 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 123.175 2.583 . . . . 0.0 114.624 -177.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.2 -53.97 52.19 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.414 -168.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.525 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -64.23 -33.59 76.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.657 0.265 . . . . 0.0 111.305 -173.941 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.489 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 33.7 mmtp -61.06 -53.93 51.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.85 177.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 79' ' ' PRO . 41.1 t -57.53 -41.52 79.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.352 -177.052 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -66.07 -44.19 85.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.854 0.359 . . . . 0.0 111.26 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.82 -27.93 62.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.175 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.526 ' HE1' ' HE ' ' A' ' 49' ' ' ARG . 91.7 t80 -74.14 -48.08 31.73 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.19 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.53 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -58.39 -55.09 39.54 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.334 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.7 ptmm? -58.84 -24.95 62.75 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -174.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.0 m -84.15 -17.29 40.53 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -175.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.5 p -111.08 -23.39 10.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.098 0.475 . . . . 0.0 110.653 176.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 123.36 -79.78 0.35 Allowed Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -177.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 94.4 t 46.19 82.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 122.101 0.953 . . . . 0.0 112.691 178.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.3 m -71.55 -18.66 62.24 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.446 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -93.98 139.92 22.77 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.45 140.12 85.88 Favored 'Trans proline' 0 C--O 1.238 0.499 0 C-N-CA 122.46 2.107 . . . . 0.0 113.437 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.53 HD12 ' HB2' ' A' ' 87' ' ' ALA . 88.6 mt -106.23 152.21 23.79 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.868 175.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -124.33 154.41 17.86 Favored Glycine 0 N--CA 1.441 -1.025 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 175.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.715 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.2 pt? -107.43 130.45 54.82 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.945 0.402 . . . . 0.0 111.126 -177.027 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -119.13 75.15 14.73 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.868 175.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.425 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 17.4 Cg_exo -66.23 105.16 0.82 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.6 2.2 . . . . 0.0 112.421 -177.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 119.47 -1.79 14.04 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.127 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 57.91 43.4 21.5 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 122.658 0.383 . . . . 0.0 111.931 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.407 ' O ' ' HG3' ' A' ' 107' ' ' LYS . 13.7 t70 -87.1 -50.67 6.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.06 0.457 . . . . 0.0 109.903 -177.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.571 HD12 ' HB2' ' A' ' 16' ' ' PHE . 34.3 mm -62.54 -34.92 67.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 174.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -61.5 -41.67 97.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.248 173.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.749 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -68.32 -21.81 64.74 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.893 -177.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 1.027 ' HE2' ' HB3' ' A' ' 16' ' ' PHE . 26.5 mtpp -70.9 -6.84 41.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.002 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -124.64 -32.75 3.07 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.158 -179.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.749 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -156.89 162.58 39.66 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 84.2 mt -56.76 149.01 18.94 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.759 0.314 . . . . 0.0 110.381 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.61 ' HG2' ' HB2' ' A' ' 106' ' ' ALA . 38.1 mtt180 -69.66 -13.46 62.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.139 0.495 . . . . 0.0 110.542 -174.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -100.96 -7.33 23.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.126 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -78.91 75.77 5.41 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.203 0.525 . . . . 0.0 111.719 -174.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.93 -140.33 29.91 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.094 178.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.531 HD11 ' HB2' ' A' ' 42' ' ' ALA . 4.6 tp -161.93 -57.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.481 0.182 . . . . 0.0 111.351 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 40' ' ' PHE . 4.8 m -87.86 111.68 21.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.073 0.464 . . . . 0.0 110.951 -175.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.429 ' HD2' ' OH ' ' A' ' 5' ' ' TYR . 46.0 mtm105 -141.61 133.17 26.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.074 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.589 ' HB2' ' CG2' ' A' ' 131' ' ' THR . 6.0 m120 -102.39 119.01 38.09 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 176.021 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.9 t -113.8 123.76 69.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.078 -177.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 34.4 tp -110.58 121.76 46.1 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.11 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.3 mp -102.13 139.02 24.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.67 177.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.59 -174.17 4.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.055 0.455 . . . . 0.0 111.02 -177.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.626 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 32.4 ttt180 -69.84 -26.26 64.14 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.604 -175.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -80.17 -15.05 57.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.703 0.287 . . . . 0.0 111.254 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.2 16.38 30.19 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.08 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 81.2 mttt -101.24 154.87 18.39 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.907 0.384 . . . . 0.0 110.414 -178.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 53.9 mt -92.62 116.44 33.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.172 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.53 -31.32 2.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -173.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.859 ' HG2' ' HG ' ' A' ' 142' ' ' LEU . 50.5 tptt -124.66 114.27 19.11 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.908 -0.495 . . . . 0.0 111.194 -176.092 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.646 HD13 HG12 ' A' ' 9' ' ' ILE . 8.5 mp -110.99 105.13 13.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.746 176.037 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.593 ' HA ' ' NH1' ' A' ' 132' ' ' ARG . 10.0 t -125.43 158.69 33.75 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.074 0.464 . . . . 0.0 110.721 177.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.593 ' NH1' ' HA ' ' A' ' 131' ' ' THR . 0.0 OUTLIER -116.24 116.47 27.85 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.144 -178.199 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 132' ' ' ARG . 4.6 pp 51.11 -175.01 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.526 1.141 . . . . 0.0 112.968 -178.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.996 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 90.5 t80 -69.75 84.13 0.46 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.647 0.737 . . . . 0.0 111.56 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.562 ' HB3' ' HB2' ' A' ' 138' ' ' GLU . 57.8 t-20 -86.7 133.57 33.67 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 171.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -52.04 -68.07 0.2 Allowed 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.36 0.413 . . . . 0.0 110.843 -176.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -55.99 -59.1 5.39 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.544 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.629 ' O ' ' HB2' ' A' ' 142' ' ' LEU . 29.0 mt-10 -63.02 -23.38 67.43 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -170.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.52 ' O ' HG23 ' A' ' 143' ' ' VAL . 82.0 t80 -75.21 -44.9 43.79 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 172.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.32 -48.88 79.83 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.99 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.431 ' OG ' ' HA ' ' A' ' 138' ' ' GLU . 2.5 p -62.69 -38.0 88.67 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.64 0.257 . . . . 0.0 111.141 177.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.859 ' HG ' ' HG2' ' A' ' 129' ' ' LYS . 1.5 tt -64.75 -50.41 66.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.244 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 139' ' ' PHE . 86.1 t -58.69 -49.51 82.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.083 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -63.81 -39.15 93.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.371 -177.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.623 ' O ' ' HG3' ' A' ' 149' ' ' MET . 57.6 tt0 -61.02 -45.79 93.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.018 176.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.533 ' O ' HD23 ' A' ' 150' ' ' LEU . 57.7 mt -55.61 -46.27 79.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.799 177.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -54.71 -42.49 71.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.609 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -69.27 -35.65 76.28 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.172 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.623 ' HG3' ' O ' ' A' ' 145' ' ' GLN . 80.5 mtp -70.46 -19.3 62.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.299 0.571 . . . . 0.0 110.088 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.533 HD23 ' O ' ' A' ' 146' ' ' ILE . 4.3 mm? . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.109 174.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.474 HD13 ' H ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -105.96 -9.79 10.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 169.662 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.2 p -94.89 158.78 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.872 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.554 ' HB2' ' HG2' ' A' ' 11' ' ' GLU . 24.8 mtt180 -127.65 168.91 14.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.782 0.325 . . . . 0.0 111.038 -171.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.53 HG12 HD21 ' A' ' 130' ' ' LEU . 75.2 mt -78.25 117.83 24.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.75 174.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.95 -25.58 9.37 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.706 -177.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.554 ' HG2' ' HB2' ' A' ' 8' ' ' ARG . 71.6 mm-40 -66.73 152.92 44.53 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.711 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 59.7 mtp -81.48 134.6 35.55 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 175.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.495 ' HB3' HH12 ' A' ' 32' ' ' ARG . . . -59.53 133.82 88.75 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.293 -176.516 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 15.6 Cg_exo -67.15 174.35 7.14 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.884 2.39 . . . . 0.0 112.18 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.53 ' O ' ' HE2' ' A' ' 107' ' ' LYS . 5.1 p-10 -76.54 163.69 26.67 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.32 177.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.576 ' HB2' HD12 ' A' ' 104' ' ' ILE . 23.0 p90 -174.11 148.91 1.39 Allowed 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 166.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.614 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 52.1 m -131.33 99.55 4.88 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 173.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.655 ' O ' ' HA ' ' A' ' 25' ' ' GLN . 16.6 tt -99.35 148.62 6.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.238 -171.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.7 m -98.16 114.84 27.19 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.059 177.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.423 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 96.4 mt -74.1 172.81 11.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.457 -178.301 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 96' ' ' LEU . 52.3 p -55.42 -27.07 45.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.997 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -96.61 14.54 24.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.351 -174.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.13 29.64 66.39 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.947 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -108.88 120.58 42.93 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.735 0.303 . . . . 0.0 110.658 -176.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.655 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 97.4 mt-30 -98.23 128.11 44.52 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.749 -178.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.614 ' O ' ' HA ' ' A' ' 17' ' ' THR . 12.2 m -125.59 150.74 31.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.591 178.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 22.9 m -113.11 142.47 45.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.383 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.515 HD11 ' CD1' ' A' ' 121' ' ' ILE . 0.6 OUTLIER -62.37 -36.78 83.35 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.673 0.273 . . . . 0.0 111.101 -177.897 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.402 ' H ' HG22 ' A' ' 27' ' ' THR . 9.7 m -58.04 -27.13 63.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.711 -177.294 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.9 m -78.53 -20.61 50.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.06 0.457 . . . . 0.0 111.21 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.3 mt -102.21 17.73 22.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.632 -176.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.495 HH12 ' HB3' ' A' ' 13' ' ' ALA . 22.8 mmt180 -68.74 147.06 52.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.772 0.32 . . . . 0.0 110.689 178.153 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.77 -25.69 27.06 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.255 178.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.92 ' HB3' ' HZ3' ' A' ' 34' ' ' LYS . 0.7 OUTLIER -115.02 160.76 19.21 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.094 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 p -74.78 115.88 16.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.541 0.686 . . . . 0.0 110.41 -177.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.462 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 21.7 t -106.14 122.39 59.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.195 -177.028 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.547 ' HE1' HD13 ' A' ' 55' ' ' ILE . 2.1 tmt? -108.97 135.47 50.1 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.052 0.453 . . . . 0.0 110.125 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.483 HD21 ' CE2' ' A' ' 16' ' ' PHE . 7.0 mp -130.28 144.06 51.15 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.414 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.6 133.14 32.09 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 172.294 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.465 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 95.9 m-85 -99.49 105.36 17.27 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.91 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.2 t -115.52 -176.42 2.92 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.076 -172.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -169.16 139.91 2.32 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.577 ' H ' ' HG3' ' A' ' 78' ' ' GLU . 19.0 p -66.97 -23.38 65.94 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.882 0.372 . . . . 0.0 111.372 -174.332 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 65.4 p-90 -84.49 -2.31 57.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.66 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.4 t -90.07 139.26 30.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.269 0.557 . . . . 0.0 111.366 -178.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -93.56 -27.67 12.65 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.349 176.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 42.9 t -67.86 -39.51 81.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.87 0.367 . . . . 0.0 110.707 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.638 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 61.0 m -61.54 -15.9 42.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.761 178.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -78.41 -3.06 41.37 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.764 0.316 . . . . 0.0 110.913 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -85.93 -47.0 10.05 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.293 0.568 . . . . 0.0 109.832 165.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.638 ' HG2' ' HA ' ' A' ' 48' ' ' CYS . 14.2 pt-20 -75.0 -32.87 61.75 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.698 -172.028 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.554 ' CB ' ' HD3' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -48.96 -65.03 0.89 Allowed Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 175.28 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.554 ' HD3' ' CB ' ' A' ' 52' ' ' MET . 35.8 Cg_exo -60.88 -39.18 63.83 Favored 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 121.745 1.63 . . . . 0.0 112.844 177.036 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.646 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 8.2 m-85 -67.42 -46.73 72.32 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -176.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.547 HD13 ' HE1' ' A' ' 37' ' ' MET . 97.0 mt -62.13 -49.37 84.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 178.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.601 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 29.7 mm-40 -56.33 -44.52 80.09 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 123.399 0.437 . . . . 0.0 111.026 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -67.46 -49.17 64.8 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.705 -0.679 . . . . 0.0 112.276 -176.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.686 ' HA ' ' NZ ' ' A' ' 62' ' ' LYS . 42.3 m-20 -107.68 -51.2 2.94 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -170.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.4 mt -73.68 -49.05 37.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.867 -173.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.458 ' CD2' ' HB3' ' A' ' 94' ' ' TYR . 63.4 t-105 -71.63 -69.93 0.35 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.76 -178.147 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.601 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.4 OUTLIER -41.27 -40.27 1.59 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -171.729 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.686 ' NZ ' ' HA ' ' A' ' 58' ' ' ASP . 36.9 mmtm -75.97 -31.56 59.08 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -172.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -122.78 -43.06 2.27 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.876 -174.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.411 ' O ' ' HD2' ' A' ' 69' ' ' PHE . 53.6 mttt 51.64 -92.98 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 123.852 0.861 . . . . 0.0 111.504 -175.268 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -90.21 -61.04 1.77 Allowed 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 120.761 0.315 . . . . 0.0 110.471 176.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.5 ' ND2' HD12 ' A' ' 150' ' ' LEU . 0.9 OUTLIER 61.09 9.46 2.41 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.185 0.594 . . . . 0.0 111.408 175.928 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 68.27 -22.18 0.13 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.833 0.853 . . . . 0.0 112.869 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.586 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 3.2 t70 -138.81 22.76 2.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.369 0.604 . . . . 0.0 110.289 -174.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.57 ' HB2' HD11 ' A' ' 150' ' ' LEU . 86.4 t80 -127.28 116.18 20.16 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.198 173.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -114.65 104.42 11.97 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.727 -178.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.531 ' HG ' ' SD ' ' A' ' 37' ' ' MET . 5.6 tt -104.29 114.95 29.53 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.9 mp -120.83 117.26 52.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.118 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.523 ' HA3' HD23 ' A' ' 96' ' ' LEU . . . -90.33 131.8 10.94 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.315 -0.945 . . . . 0.0 110.938 175.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 45.9 mt -119.27 119.59 61.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 117.046 0.423 . . . . 0.0 110.679 -175.097 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -85.72 136.04 33.51 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 173.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.527 ' HG2' ' HB2' ' A' ' 102' ' ' ALA . 21.6 ttp180 -68.71 -45.25 72.09 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.408 -0.814 . . . . 0.0 112.689 -170.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -158.87 8.73 0.13 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -169.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.577 ' HG3' ' H ' ' A' ' 43' ' ' SER . 14.1 mm-40 -86.65 138.11 33.68 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-O 120.951 0.405 . . . . 0.0 110.678 176.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.426 ' HD2' ' HG3' ' A' ' 82' ' ' LYS . 34.5 Cg_endo -69.24 -173.6 0.67 Allowed 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.901 2.401 . . . . 0.0 113.651 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.436 ' O ' HD23 ' A' ' 84' ' ' LEU . 2.8 tm? -59.27 -56.66 19.33 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.062 -169.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.423 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -67.02 -34.31 77.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.473 -173.099 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.426 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 14.4 mmmm -60.26 -50.4 73.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.925 177.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 95.7 t -61.28 -48.26 89.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.104 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.436 HD23 ' O ' ' A' ' 80' ' ' LEU . 4.4 mm? -61.28 -52.66 63.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.623 -177.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.12 -37.27 86.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.511 -178.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -68.84 -41.34 78.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.719 -0.218 . . . . 0.0 110.918 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.546 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -66.16 -41.7 89.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.737 0.78 . . . . 0.0 109.549 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -58.99 -30.25 67.82 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.218 -1.355 . . . . 0.0 111.437 176.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.3 m -99.85 -1.38 37.61 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -176.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.1 p -113.53 -5.12 13.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.845 0.355 . . . . 0.0 111.494 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.09 -5.32 83.12 Favored Glycine 0 C--O 1.228 -0.277 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.368 177.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.517 ' CG2' ' HG3' ' A' ' 52' ' ' MET . 69.2 t -57.27 121.92 5.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.099 0.476 . . . . 0.0 111.551 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.422 ' H ' ' CD ' ' A' ' 56' ' ' GLU . 75.3 p -114.53 -15.56 12.0 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.383 176.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.458 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 36.8 p90 -71.57 144.73 89.15 Favored Pre-proline 0 C--O 1.233 0.236 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 173.373 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.34 124.71 13.79 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.415 2.076 . . . . 0.0 113.132 -176.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.546 HD12 ' HB2' ' A' ' 87' ' ' ALA . 84.8 mt -99.17 153.29 19.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.476 173.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -122.83 156.13 17.24 Favored Glycine 0 N--CA 1.437 -1.24 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 174.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.58 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.4 pt? -116.11 119.88 37.26 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.734 0.267 . . . . 0.0 110.349 -178.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -117.25 76.1 8.79 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.402 178.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.11 107.46 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.481 2.12 . . . . 0.0 111.936 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 131.59 -27.31 3.74 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -176.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.527 ' HB2' ' HG2' ' A' ' 76' ' ' ARG . . . 66.98 24.61 9.52 Favored 'General case' 0 CA--C 1.522 -0.097 0 C-N-CA 122.992 0.517 . . . . 0.0 111.373 176.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -70.94 -41.43 71.14 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.173 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.576 HD12 ' HB2' ' A' ' 16' ' ' PHE . 48.3 mm -62.05 -33.77 60.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.379 0.609 . . . . 0.0 109.62 174.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -70.21 -39.21 75.29 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.427 175.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.552 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -66.15 -28.92 69.15 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -174.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.53 ' HE2' ' O ' ' A' ' 15' ' ' ASP . 13.6 ptmt -79.46 -1.96 39.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.994 0.426 . . . . 0.0 111.276 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -112.09 -50.92 2.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.21 172.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.552 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -141.05 152.81 45.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.408 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.418 ' HB3' ' OD1' ' A' ' 112' ' ' ASP . 97.3 mt -62.38 139.26 58.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.849 0.357 . . . . 0.0 111.041 -178.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -66.01 -25.62 67.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.209 0.528 . . . . 0.0 110.837 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.418 ' OD1' ' HB3' ' A' ' 110' ' ' LEU . 4.2 p-10 -83.99 -8.49 59.14 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.171 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.83 -8.02 57.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.373 -178.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.27 -128.19 8.25 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.444 174.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.527 HD13 ' HD3' ' A' ' 76' ' ' ARG . 8.1 tp -154.25 173.65 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -174.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.437 ' N ' HG13 ' A' ' 115' ' ' ILE . 28.2 m 71.0 81.54 0.16 Allowed 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.476 0.655 . . . . 0.0 111.279 175.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.6 mmt85 -133.8 131.9 39.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.111 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.623 ' HB3' HG22 ' A' ' 131' ' ' THR . 46.3 t-20 -116.1 119.67 36.57 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.179 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 63.2 t -113.76 131.81 64.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.996 -177.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.722 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 36.7 tp -119.36 122.04 40.91 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.316 0.579 . . . . 0.0 110.875 177.358 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.515 ' CD1' HD11 ' A' ' 28' ' ' LEU . 53.6 mt -100.7 135.08 38.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.778 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.86 -176.91 5.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.212 0.53 . . . . 0.0 111.09 -176.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -68.41 -23.32 64.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.001 -175.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -80.78 -26.62 37.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.979 0.418 . . . . 0.0 110.769 175.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 112.4 12.22 13.82 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.352 -0.928 . . . . 0.0 112.311 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.711 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 77.5 mttt -97.13 160.62 14.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.822 0.344 . . . . 0.0 110.66 -178.11 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 47.0 mt -95.79 109.59 22.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 175.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.7 m -110.59 1.13 9.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.918 -174.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.799 ' HG2' ' HG ' ' A' ' 142' ' ' LEU . 51.7 tptt -160.94 114.05 1.98 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 -175.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.558 ' HA ' ' O ' ' A' ' 118' ' ' ASN . 0.4 OUTLIER -138.4 105.98 5.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.171 0.51 . . . . 0.0 110.449 176.35 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.623 HG22 ' HB3' ' A' ' 118' ' ' ASN . 10.1 t -99.46 155.89 17.32 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.095 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.446 ' NE ' ' H ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -122.49 132.74 54.48 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.538 -179.807 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.437 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 3.1 mp 66.45 36.03 5.31 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 123.71 0.631 . . . . 0.0 110.614 176.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.437 ' HB3' ' O ' ' A' ' 133' ' ' LEU . 45.8 t80 71.2 -66.38 0.3 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.518 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.596 ' HB3' ' HB3' ' A' ' 138' ' ' GLU . 0.8 OUTLIER 64.54 113.18 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.046 0.45 . . . . 0.0 110.954 -175.882 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -49.95 -56.4 10.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.785 -174.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.09 -36.24 27.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.343 -174.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.596 ' HB3' ' HB3' ' A' ' 135' ' ' ASN . 3.4 tp10 -63.54 -38.72 92.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.962 0.41 . . . . 0.0 110.128 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.646 ' CE2' ' HB3' ' A' ' 54' ' ' PHE . 76.6 t80 -70.65 -41.48 72.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.994 176.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.56 -49.6 75.84 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.827 0.346 . . . . 0.0 110.894 177.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.3 p -61.5 -34.11 74.93 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.69 177.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.799 ' HG ' ' HG2' ' A' ' 129' ' ' LYS . 4.6 tt -66.83 -42.94 84.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.255 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.473 ' O ' ' HB ' ' A' ' 146' ' ' ILE . 95.0 t -59.09 -51.47 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 120.782 0.325 . . . . 0.0 111.345 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.449 ' HA ' ' OE1' ' A' ' 144' ' ' GLN . 6.4 tp60 -62.0 -38.38 88.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.304 0.573 . . . . 0.0 110.168 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.4 ' O ' ' HG2' ' A' ' 149' ' ' MET . 36.3 tt0 -63.03 -36.88 85.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.724 177.022 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.588 ' O ' HD23 ' A' ' 150' ' ' LEU . 30.2 mm -55.09 -53.03 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 120.929 0.395 . . . . 0.0 110.259 174.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -53.06 -45.15 67.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.265 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -65.05 -37.37 87.36 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.128 0.268 . . . . 0.0 111.251 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.4 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 84.2 mmm -60.98 -29.97 69.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.65 0.738 . . . . 0.0 109.723 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.588 HD23 ' O ' ' A' ' 146' ' ' ILE . 4.0 mm? . . . . . 0 C--N 1.32 -0.713 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.62 178.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 . . . . . 0 CA--C 1.521 -0.155 0 CA-C-O 120.684 0.278 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.516 HG12 ' HA ' ' A' ' 109' ' ' ALA . 47.3 pt -92.84 -22.07 5.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.147 175.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.492 ' CG1' HD12 ' A' ' 127' ' ' ILE . 36.3 t -102.39 147.37 9.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.416 177.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 57.2 mtt85 -120.26 168.54 11.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.047 0.451 . . . . 0.0 111.893 -168.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.633 HG12 HD13 ' A' ' 130' ' ' LEU . 77.0 mt -75.18 127.19 36.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.071 176.213 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.6 -9.26 77.49 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -175.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -92.03 151.38 20.49 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.675 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 56.7 mtp -80.95 144.76 31.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.096 0.474 . . . . 0.0 111.346 -172.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.435 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -86.37 134.01 39.19 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.275 -177.461 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 13.3 Cg_exo -70.88 139.67 36.83 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.033 2.489 . . . . 0.0 112.033 177.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -75.78 164.81 25.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.277 -178.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -165.2 162.17 19.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.872 -176.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 37.3 m -124.72 110.59 14.54 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 175.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.4 tt -112.78 151.97 14.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.453 -171.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.509 ' HB ' ' CD2' ' A' ' 98' ' ' LEU . 2.8 m -89.34 126.32 35.48 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.142 177.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.0 mt -82.01 178.36 8.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.733 0.302 . . . . 0.0 111.082 177.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.48 ' HB ' HD11 ' A' ' 84' ' ' LEU . 16.5 p -59.37 -26.26 64.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.791 -176.293 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.618 ' OD2' ' HG2' ' A' ' 24' ' ' LYS . 7.4 p-10 -94.2 -18.23 21.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.185 0.517 . . . . 0.0 110.418 -178.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.56 0.52 21.76 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.412 -177.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.618 ' HG2' ' OD2' ' A' ' 22' ' ' ASP . 4.8 mmmp? -66.44 126.87 30.21 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-O 121.088 0.471 . . . . 0.0 111.696 178.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -88.67 120.92 30.51 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.445 172.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 17' ' ' THR . 11.3 m -123.66 151.83 28.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.826 0.346 . . . . 0.0 110.324 177.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.2 m -110.11 151.72 26.89 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.414 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.07 -35.35 80.45 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.249 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.538 ' HA ' ' CG ' ' A' ' 32' ' ' ARG . 37.7 t -56.88 -23.45 44.63 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.96 177.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.1 m -69.57 -24.0 63.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.27 0.557 . . . . 0.0 110.675 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.445 HD13 ' HB1' ' A' ' 70' ' ' ALA . 67.3 mt -116.1 11.57 15.32 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.932 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.538 ' CG ' ' HA ' ' A' ' 29' ' ' SER . 9.2 mmm180 -74.75 104.18 5.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.975 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 147.79 -24.75 1.48 Allowed Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.515 ' HB3' ' OD1' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -115.45 174.74 5.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.161 -0.519 . . . . 0.0 110.466 177.883 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 68' ' ' ASP . 26.8 m -74.72 128.59 36.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.0 t -123.68 112.17 32.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 120.959 0.409 . . . . 0.0 110.575 -176.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.442 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 27.3 ttt -95.98 127.12 41.72 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.734 178.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.6 mp -122.05 137.15 54.92 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.771 176.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.4 pm0 -126.91 129.3 47.92 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 171.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' A' ' 116' ' ' THR . 96.8 m-85 -90.73 110.39 21.58 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.007 -179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.631 HG23 ' SG ' ' A' ' 48' ' ' CYS . 28.5 m -119.49 165.21 14.68 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.438 -166.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.586 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . . . -145.11 147.12 32.18 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 171.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.453 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 81.0 p -60.56 -21.52 62.65 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -174.107 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 8.5 p-90 -103.06 3.68 36.32 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -175.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.639 ' SG ' HD12 ' A' ' 115' ' ' ILE . 89.9 m -79.59 102.12 8.69 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.97 0.414 . . . . 0.0 111.082 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.98 -40.48 97.17 Favored Glycine 0 C--O 1.228 -0.271 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.874 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 56.9 t -61.4 -37.25 77.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.222 0.534 . . . . 0.0 110.614 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.631 ' SG ' HG23 ' A' ' 41' ' ' THR . 22.8 t -72.32 -14.85 61.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.762 -178.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -75.2 -7.28 53.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.971 0.415 . . . . 0.0 110.781 177.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.472 ' HD3' ' CD2' ' A' ' 134' ' ' TYR . 70.4 mttt -83.42 -47.84 10.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 122.343 1.068 . . . . 0.0 108.376 163.023 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.782 ' HB2' ' HB2' ' A' ' 134' ' ' TYR . 40.3 tt0 -58.24 -58.34 8.91 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 113.263 -1.789 . . . . 0.0 112.108 -173.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.795 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 96.1 mmm -50.3 -57.43 12.96 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -175.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.795 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 32.7 Cg_exo -61.49 -38.9 59.61 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 122.3 2.0 . . . . 0.0 112.823 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.508 ' HB3' ' CZ ' ' A' ' 139' ' ' PHE . 6.4 m-85 -65.41 -43.76 89.54 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.496 0.189 . . . . 0.0 111.305 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 51' ' ' GLU . 77.0 mt -58.03 -47.86 85.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 175.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.417 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 26.1 tp10 -54.75 -54.18 45.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.633 176.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -62.33 -59.31 5.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.181 -0.918 . . . . 0.0 113.226 -173.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.698 ' HA ' ' NZ ' ' A' ' 62' ' ' LYS . 67.9 m-20 -107.13 -13.53 15.14 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -166.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.2 mt -104.59 -57.24 4.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.476 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.542 ' CE2' ' HB3' ' A' ' 94' ' ' TYR . 71.3 t-105 -60.97 -68.32 0.32 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.868 -177.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.01 -23.49 2.07 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -175.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.698 ' NZ ' ' HA ' ' A' ' 58' ' ' ASP . 38.9 mmtm -87.42 -37.44 17.02 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -175.443 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -130.51 0.16 4.46 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -171.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.482 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 16.5 pttp -39.34 -51.91 2.04 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 -169.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.02 -83.66 0.16 Allowed 'General case' 0 C--O 1.251 1.163 0 CA-C-O 121.458 0.647 . . . . 0.0 110.117 -173.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 56.57 -153.46 0.36 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.366 -174.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -111.41 -14.21 13.78 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 168.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.515 ' OD1' ' HB3' ' A' ' 34' ' ' LYS . 5.6 m-20 -144.12 39.78 1.34 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.581 -1.19 . . . . 0.0 112.374 -172.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -121.24 128.63 52.58 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 119.134 -1.026 . . . . 0.0 110.266 168.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.445 ' HB1' HD13 ' A' ' 31' ' ' LEU . . . -130.22 142.48 50.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.841 177.039 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.442 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 5.6 tt -146.91 123.82 11.32 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 31.8 mt -130.6 129.88 64.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.487 ' HA3' HD22 ' A' ' 96' ' ' LEU . . . -88.05 131.83 10.87 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 175.342 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.0 mm -119.85 107.77 21.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 117.034 0.417 . . . . 0.0 110.842 -170.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.526 ' HA ' ' O ' ' A' ' 41' ' ' THR . 11.6 t70 -77.82 143.46 37.85 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.727 178.351 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 51.9 ttt-85 -71.01 -30.43 66.66 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -171.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -154.86 -32.67 0.1 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -174.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.408 ' OE1' ' HD3' ' A' ' 82' ' ' LYS . 11.9 mm-40 -61.96 141.72 95.46 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.101 0.477 . . . . 0.0 112.258 -166.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -74.51 179.83 5.53 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 123.018 2.479 . . . . 0.0 112.793 178.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.533 HD23 HD11 ' A' ' 98' ' ' LEU . 88.1 mt -49.37 -55.57 12.52 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.846 -178.255 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -50.52 -36.62 34.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.638 -173.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.408 ' HD3' ' OE1' ' A' ' 78' ' ' GLU . 41.8 mtpt -82.61 -45.61 14.35 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.77 0.319 . . . . 0.0 110.779 -178.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.576 HG21 ' HB3' ' A' ' 98' ' ' LEU . 91.0 t -56.53 -46.71 82.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.434 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.48 HD11 ' HB ' ' A' ' 21' ' ' THR . 4.1 mm? -58.52 -52.9 63.7 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.765 0.317 . . . . 0.0 111.361 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.49 -37.76 84.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.553 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.453 ' CD1' ' HA ' ' A' ' 43' ' ' SER . 91.8 t80 -65.88 -42.85 89.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.073 -179.076 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.507 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -66.43 -43.48 85.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.731 0.777 . . . . 0.0 109.897 178.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -59.6 -27.82 66.63 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.205 -1.361 . . . . 0.0 111.801 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.5 m -100.83 -0.47 36.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.837 -176.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.7 p -117.77 2.34 12.23 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.355 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.53 15.29 80.01 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.837 175.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 72.6 t -73.62 127.03 35.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -177.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 61.3 p -106.31 -24.16 12.35 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.526 174.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.542 ' HB3' ' CE2' ' A' ' 60' ' ' TRP . 34.8 p90 -71.2 145.03 90.49 Favored Pre-proline 0 C--O 1.232 0.136 0 CA-C-O 120.884 0.374 . . . . 0.0 111.118 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.76 134.83 56.21 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.826 2.351 . . . . 0.0 112.893 -177.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.507 HD12 ' HB2' ' A' ' 87' ' ' ALA . 53.8 mt -109.72 139.06 45.2 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.734 174.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -113.28 145.29 18.29 Favored Glycine 0 N--CA 1.439 -1.139 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 174.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.625 HD13 ' H ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -103.54 139.02 39.43 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.188 0.518 . . . . 0.0 110.937 -179.903 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -118.83 82.0 19.99 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.12 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.74 105.07 0.6 Allowed 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.409 2.073 . . . . 0.0 112.79 -176.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.96 8.64 27.47 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.581 178.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 52.31 42.14 30.81 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -81.04 -49.78 10.48 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.123 0.487 . . . . 0.0 110.692 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 98.7 mt -66.72 -31.38 53.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 176.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -60.15 -41.13 92.08 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.177 171.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.682 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -67.23 -24.49 65.82 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.811 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.423 ' O ' ' HG2' ' A' ' 14' ' ' PRO . 14.7 mptt -64.56 -23.69 67.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.963 0.411 . . . . 0.0 111.025 176.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -113.71 -11.74 12.9 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -173.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.682 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . 179.58 178.31 0.55 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.785 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 94.6 mt -67.87 133.93 50.01 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 175.246 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.452 ' HE ' ' HB2' ' A' ' 111' ' ' ARG . 1.5 mtm180 -52.39 -51.6 58.13 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 122.058 0.933 . . . . 0.0 110.578 -176.177 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.08 21.75 6.49 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.229 -1.35 . . . . 0.0 111.457 -172.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.785 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . . . -93.78 6.06 49.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.172 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 139.34 -164.5 25.91 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.464 178.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.759 HD13 ' N ' ' A' ' 116' ' ' THR . 0.0 OUTLIER -168.12 155.61 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.813 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.812 HG22 ' HA ' ' A' ' 133' ' ' LEU . 55.8 m 75.54 95.85 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.791 0.805 . . . . 0.0 110.386 -178.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -160.17 145.56 15.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.99 -177.111 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.591 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 31.1 m-80 -102.3 119.18 38.38 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.148 -178.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.1 t -118.3 109.97 28.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.843 -178.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 49.2 tp -100.31 117.06 33.74 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.699 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 53.8 mt -97.19 134.24 35.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.46 177.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.598 ' OD2' ' HB2' ' A' ' 126' ' ' LYS . 3.1 p30 -86.04 177.26 7.63 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.267 0.556 . . . . 0.0 111.261 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -66.15 -24.7 66.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.341 -177.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -80.41 -19.02 47.17 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.725 0.298 . . . . 0.0 110.557 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 106.85 12.02 25.15 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.12 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.675 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 8.3 mtmp? -102.58 158.31 16.32 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.492 HD12 ' CG1' ' A' ' 7' ' ' VAL . 54.0 mt -94.5 125.67 47.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 174.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.7 m -105.47 -22.04 5.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.901 0.382 . . . . 0.0 111.764 -174.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.477 ' HA ' ' HD2' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -142.28 125.9 16.87 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.139 -0.624 . . . . 0.0 112.35 -172.081 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.633 HD13 HG12 ' A' ' 9' ' ' ILE . 10.5 mp -114.74 117.67 31.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.405 172.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.591 ' HB ' ' HB2' ' A' ' 118' ' ' ASN . 4.2 m -122.69 131.78 53.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.801 0.334 . . . . 0.0 110.651 171.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.622 ' O ' ' HD2' ' A' ' 132' ' ' ARG . 0.1 OUTLIER -93.09 120.6 33.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.745 178.932 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.812 ' HA ' HG22 ' A' ' 116' ' ' THR . 16.9 mt 61.93 179.96 0.12 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.557 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.782 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 84.6 t80 -83.95 97.96 9.54 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 171.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -107.63 120.52 42.45 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 173.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -43.7 -56.4 3.8 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 123.841 0.713 . . . . 0.0 112.803 -173.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.9 mp0 -56.65 -46.13 81.21 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -178.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -71.54 -35.2 70.58 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.602 -175.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.508 ' CZ ' ' HB3' ' A' ' 54' ' ' PHE . 81.4 t80 -66.06 -41.06 91.31 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 175.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.84 -41.97 98.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.42 175.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.1 m -63.27 -39.18 93.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.052 177.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.722 ' O ' HG12 ' A' ' 146' ' ' ILE . 35.6 mt -59.38 -52.46 65.52 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.575 177.107 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 139' ' ' PHE . 91.6 t -52.48 -50.27 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 O-C-N 123.376 0.422 . . . . 0.0 111.433 -178.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -60.41 -41.72 94.49 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.075 0.464 . . . . 0.0 110.339 178.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -63.49 -42.24 98.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.687 178.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.722 HG12 ' O ' ' A' ' 142' ' ' LEU . 35.4 mm -56.73 -46.88 83.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -56.26 -43.38 78.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.692 177.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -72.89 -33.7 66.2 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.209 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 92.1 mmm -65.41 -24.88 67.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.162 0.506 . . . . 0.0 110.378 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.614 HD23 ' O ' ' A' ' 146' ' ' ILE . 4.0 mm? . . . . . 0 C--N 1.323 -0.55 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.205 176.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 . . . . . 0 CA--C 1.518 -0.28 0 CA-C-O 120.86 0.362 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.7 pt -101.8 -7.42 9.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.01 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.3 p -110.98 159.15 11.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.48 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 24.1 mtm-85 -120.71 165.66 14.78 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -168.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.543 HG12 HD23 ' A' ' 130' ' ' LEU . 62.1 mt -76.05 137.23 23.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.414 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.51 -26.09 23.25 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.083 178.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -67.75 150.88 48.09 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.723 ' SD ' ' HG2' ' A' ' 126' ' ' LYS . 63.3 mmm -71.79 124.03 23.92 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.168 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.51 ' HB2' HD12 ' A' ' 121' ' ' ILE . . . -54.89 140.72 60.05 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.08 -178.185 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.68 174.58 6.33 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.613 2.209 . . . . 0.0 112.254 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.53 ' O ' ' HB3' ' A' ' 16' ' ' PHE . 3.0 p-10 -78.69 174.4 11.45 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.999 177.405 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.702 ' CE2' ' HG ' ' A' ' 28' ' ' LEU . 16.5 p90 176.36 144.96 0.08 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.428 163.043 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.643 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 56.2 m -127.93 99.88 5.69 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.444 -0.798 . . . . 0.0 108.866 175.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 25' ' ' GLN . 20.3 tt -106.0 146.91 12.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.22 -171.36 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 24' ' ' LYS . 24.4 m -83.19 127.87 33.99 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.027 177.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.414 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 79.7 mt -84.46 177.62 8.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.144 0.497 . . . . 0.0 111.462 -178.414 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.406 ' HB ' HD21 ' A' ' 84' ' ' LEU . 21.8 p -62.74 -23.5 67.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.988 -175.268 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.537 ' OD2' ' HG2' ' A' ' 24' ' ' LYS . 7.5 p-10 -105.47 9.07 33.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.167 0.508 . . . . 0.0 110.527 -176.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.3 14.17 59.15 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.247 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.537 ' HG2' ' OD2' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -85.52 171.21 11.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.207 0.503 . . . . 0.0 109.865 175.6 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.407 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 50.7 mt-30 -136.09 129.12 31.39 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 176.02 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.643 ' O ' ' HA ' ' A' ' 17' ' ' THR . 21.7 m -119.52 150.49 21.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.673 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 9.4 m -117.86 142.7 47.03 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.996 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.702 ' HG ' ' CE2' ' A' ' 16' ' ' PHE . 0.6 OUTLIER -64.04 -22.68 67.03 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.623 0.249 . . . . 0.0 111.358 -179.033 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.442 ' H ' HG22 ' A' ' 27' ' ' THR . 11.0 m -61.25 -38.43 86.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.967 0.413 . . . . 0.0 110.645 177.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.5 m -73.09 -23.66 60.56 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.52 0.676 . . . . 0.0 110.784 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.408 ' HB2' HD23 ' A' ' 28' ' ' LEU . 91.7 mt -88.1 -9.19 54.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.761 -177.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.448 HH21 HD13 ' A' ' 28' ' ' LEU . 5.8 mmt180 -60.63 150.57 31.5 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.741 0.305 . . . . 0.0 110.422 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.8 -23.75 31.38 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.61 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 31.2 mtmm -117.45 157.3 26.47 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.842 -0.679 . . . . 0.0 109.985 -178.253 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 68' ' ' ASP . 18.3 m -71.43 131.42 34.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.183 0.516 . . . . 0.0 109.896 177.144 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.469 HG11 HD21 ' A' ' 28' ' ' LEU . 20.8 t -120.01 123.56 71.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.904 0.383 . . . . 0.0 110.824 -177.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.552 ' SD ' HG21 ' A' ' 59' ' ' ILE . 28.1 ttt -108.29 117.05 33.13 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.9 0.381 . . . . 0.0 110.525 177.54 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -104.66 103.79 13.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.205 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.595 ' OE1' ' HG2' ' A' ' 52' ' ' MET . 0.0 OUTLIER -103.38 112.59 25.56 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.707 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 97.3 m-85 -91.86 120.06 32.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.78 -176.035 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 15.2 t -140.41 -178.43 5.49 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.756 -173.147 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.491 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . . . -162.76 157.07 21.09 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 122.721 0.408 . . . . 0.0 110.073 172.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.441 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 12.3 t -64.24 -32.54 74.17 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.672 -175.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 51.0 p-90 -83.85 8.17 15.72 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -174.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 43.4 t -99.62 130.87 45.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.964 0.411 . . . . 0.0 111.338 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -89.07 -28.48 20.52 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.624 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.4 t -67.32 -35.74 74.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.157 0.503 . . . . 0.0 110.269 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.59 ' HA ' ' HB3' ' A' ' 51' ' ' GLU . 59.4 m -65.78 -15.15 62.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.517 177.171 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.437 ' O ' ' HG2' ' A' ' 53' ' ' PRO . 84.4 mtt180 -78.74 -3.72 45.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.331 0.586 . . . . 0.0 110.148 177.149 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.465 ' NZ ' ' HE2' ' A' ' 134' ' ' TYR . 1.4 mmmp? -95.2 -52.39 4.21 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 162.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.728 ' O ' HG12 ' A' ' 55' ' ' ILE . 41.1 tt0 -56.36 -65.25 0.64 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 113.478 -1.692 . . . . 0.0 112.153 -173.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.595 ' HG2' ' OE1' ' A' ' 39' ' ' GLN . 1.7 mmm -56.29 -50.04 89.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -173.113 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.635 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 53.3 Cg_exo -55.34 -37.96 94.19 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 121.868 1.712 . . . . 0.0 112.097 176.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -72.69 -37.5 67.85 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.426 177.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.728 HG12 ' O ' ' A' ' 51' ' ' GLU . 28.9 mm -55.04 -57.48 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 121.025 0.441 . . . . 0.0 110.147 177.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.705 ' HG2' ' HA ' ' A' ' 92' ' ' VAL . 0.5 OUTLIER -66.18 -43.66 86.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.359 -177.617 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.635 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 3.7 ttmm -62.46 -41.52 98.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.775 -172.029 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.639 ' O ' ' HG2' ' A' ' 62' ' ' LYS . 6.1 t70 -104.61 -65.09 1.06 Allowed 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.877 178.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.552 HG21 ' SD ' ' A' ' 37' ' ' MET . 25.1 mm -54.01 -46.77 65.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-O 120.97 0.414 . . . . 0.0 111.113 -171.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.522 ' HB3' ' O ' ' A' ' 56' ' ' GLU . 73.5 t-105 -73.92 -60.65 2.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.17 -178.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.564 HD13 ' CE ' ' A' ' 64' ' ' LYS . 3.8 mm? -50.72 -35.09 29.61 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -173.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.639 ' HG2' ' O ' ' A' ' 58' ' ' ASP . 33.7 mmtp -73.93 -27.98 61.29 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -175.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 -126.38 -43.85 1.74 Allowed 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.191 -0.604 . . . . 0.0 112.626 -172.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.564 ' CE ' HD13 ' A' ' 61' ' ' LEU . 55.2 mttt 45.75 -89.82 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.011 0.924 . . . . 0.0 112.679 -176.052 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -87.31 -71.03 0.58 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 65.03 -4.07 0.53 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.206 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 68.48 -6.65 0.78 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.961 0.904 . . . . 0.0 112.125 -176.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.61 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 3.9 t70 -137.89 8.35 2.77 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.951 0.405 . . . . 0.0 110.692 -177.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.552 ' CE2' ' HB2' ' A' ' 71' ' ' LEU . 72.3 t80 -116.01 119.07 34.68 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.096 -0.642 . . . . 0.0 111.283 -174.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.75 107.9 12.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.669 178.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.552 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 1.7 tt -117.46 120.55 38.47 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 52.6 mt -129.89 131.31 66.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.759 0.314 . . . . 0.0 110.288 179.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.58 116.94 4.62 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 176.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 25.6 mm -103.92 111.36 33.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 116.615 0.208 . . . . 0.0 110.6 -173.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.522 ' HA ' ' O ' ' A' ' 41' ' ' THR . 8.9 t70 -80.79 140.06 35.68 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 44.4 ttt-85 -78.26 -30.92 48.82 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -172.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -163.45 -16.01 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -170.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.493 ' CD ' ' HD2' ' A' ' 82' ' ' LYS . 6.0 mm-40 -77.33 137.06 64.4 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.141 0.496 . . . . 0.0 110.793 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.489 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 30.7 Cg_endo -68.39 -174.59 0.7 Allowed 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.098 2.532 . . . . 0.0 114.576 -177.101 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.652 HD23 HD23 ' A' ' 84' ' ' LEU . 5.2 tt -54.26 -59.04 5.2 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.299 -1.319 . . . . 0.0 112.393 -170.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.489 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -61.31 -36.31 79.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.914 -171.883 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.493 ' HD2' ' CD ' ' A' ' 78' ' ' GLU . 42.2 mttt -64.36 -48.23 76.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.033 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 79' ' ' PRO . 57.9 t -53.84 -46.47 63.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.554 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.652 HD23 HD23 ' A' ' 80' ' ' LEU . 4.4 mm? -62.4 -50.37 71.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.042 178.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.48 97.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.712 -177.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.441 ' CD1' ' HA ' ' A' ' 43' ' ' SER . 62.4 t80 -66.93 -43.47 83.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.916 -178.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.19 -39.77 86.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.441 0.638 . . . . 0.0 110.212 178.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -59.12 -39.72 83.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.315 176.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.8 m -86.02 -19.31 30.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.162 -174.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.5 p -93.57 -29.81 15.3 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.426 -179.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 112.64 -3.02 26.17 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.161 178.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.705 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 60.6 t -50.88 115.89 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 122.794 0.438 . . . . 0.0 111.866 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.7 m -100.43 0.32 39.56 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.454 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.487 ' CE2' HG13 ' A' ' 92' ' ' VAL . 54.3 p90 -102.12 152.9 38.31 Favored Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.142 178.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.93 148.75 76.9 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.568 2.179 . . . . 0.0 113.107 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.482 HD11 HG11 ' A' ' 92' ' ' VAL . 5.2 mp -124.78 159.51 30.8 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.412 179.405 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -125.76 147.93 16.8 Favored Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 174.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.572 HD23 ' H ' ' A' ' 98' ' ' LEU . 0.6 OUTLIER -105.09 132.23 51.59 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.82 0.31 . . . . 0.0 110.737 -177.938 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -120.39 75.91 24.85 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.47 178.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -65.29 101.08 0.4 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.476 2.117 . . . . 0.0 112.09 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 126.5 -7.5 7.47 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.862 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 58.18 44.01 19.64 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.691 0.396 . . . . 0.0 111.486 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -89.99 -46.54 8.44 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.129 0.49 . . . . 0.0 110.086 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.659 HD12 ' HB2' ' A' ' 16' ' ' PHE . 33.4 mm -61.76 -36.1 71.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 172.414 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -63.65 -39.15 93.62 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 113.624 -1.626 . . . . 0.0 110.467 174.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.701 ' HB2' ' HG2' ' A' ' 111' ' ' ARG . . . -71.72 -30.61 65.83 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -174.366 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.5 ' HE2' ' O ' ' A' ' 15' ' ' ASP . 13.1 ptmt -79.11 -1.78 37.53 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.857 -175.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -108.14 -37.69 5.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.223 0.535 . . . . 0.0 110.807 171.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.581 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -152.74 166.0 33.56 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.9 pp -60.42 163.98 4.77 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.85 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.701 ' HG2' ' HB2' ' A' ' 106' ' ' ALA . 50.5 mtt-85 -75.94 58.21 1.14 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -164.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 19.2 t70 169.68 -75.1 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.034 -1.439 . . . . 0.0 107.783 173.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.559 ' HB3' ' NH2' ' A' ' 117' ' ' ARG . . . 47.91 27.06 1.07 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.986 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.476 ' HA3' ' NH2' ' A' ' 132' ' ' ARG . . . 72.32 106.81 0.06 OUTLIER Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -170.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.441 ' O ' ' HB ' ' A' ' 116' ' ' THR . 19.2 tt -64.77 167.29 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.889 HG22 ' HA ' ' A' ' 133' ' ' LEU . 32.9 m 75.31 88.57 0.09 Allowed 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -174.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.974 ' HG2' ' HA ' ' A' ' 132' ' ' ARG . 41.0 mtm105 -157.61 145.76 19.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.451 -177.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -112.61 119.39 37.96 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.844 -177.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 72.2 t -110.01 107.32 22.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.838 177.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.659 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 55.0 tp -98.4 133.74 42.37 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.939 0.4 . . . . 0.0 110.337 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.51 HD12 ' HB2' ' A' ' 13' ' ' ALA . 38.2 mm -114.52 134.49 57.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.002 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.33 160.7 30.78 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 176.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 6.8 ptm180 -68.0 -22.03 65.01 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -173.134 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.583 ' HB2' ' HZ3' ' A' ' 126' ' ' LYS . 46.2 mt-10 -76.28 -18.52 58.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.293 0.568 . . . . 0.0 110.087 175.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 109.79 9.67 24.31 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.687 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.723 ' HG2' ' SD ' ' A' ' 12' ' ' MET . 35.3 mtmm -91.02 139.36 30.84 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.165 0.483 . . . . 0.0 110.725 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.47 HG12 HD12 ' A' ' 121' ' ' ILE . 35.3 mt -70.53 121.64 20.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.44 HG12 ' O ' ' A' ' 120' ' ' LEU . 8.7 p -114.19 -31.54 2.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -164.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.659 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 7.1 tmtm? -145.36 112.28 5.98 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.316 -0.553 . . . . 0.0 111.154 -174.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.543 HD23 HG12 ' A' ' 9' ' ' ILE . 2.8 mm? -112.2 111.74 22.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.888 175.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.2 t -129.32 162.46 27.9 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.689 175.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.974 ' HA ' ' HG2' ' A' ' 117' ' ' ARG . 28.8 mtp-105 -112.53 132.62 55.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.059 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.889 ' HA ' HG22 ' A' ' 116' ' ' THR . 4.6 pp 53.84 172.27 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.93 1.292 . . . . 0.0 113.687 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.465 ' HE2' ' NZ ' ' A' ' 50' ' ' LYS . 54.3 t80 -84.17 94.93 8.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.109 177.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.532 ' HB3' ' HB3' ' A' ' 138' ' ' GLU . 11.6 t30 -95.39 133.45 39.33 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 172.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -55.53 -56.94 14.39 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 123.163 0.289 . . . . 0.0 111.667 -169.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.512 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.5 mp0 -63.95 -33.13 75.02 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.178 0.513 . . . . 0.0 110.677 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.532 ' HB3' ' HB3' ' A' ' 135' ' ' ASN . 7.2 tp10 -65.63 -44.95 84.89 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.088 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.622 ' O ' HG23 ' A' ' 143' ' ' VAL . 90.5 t80 -60.96 -43.52 98.6 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.167 178.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.73 -44.9 86.32 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.007 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.7 m -63.33 -43.59 97.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.629 177.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.62 -44.3 96.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.597 -178.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 139' ' ' PHE . 95.7 t -56.75 -59.41 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.994 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -57.59 -36.91 72.35 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.534 -177.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.643 ' O ' ' HG3' ' A' ' 149' ' ' MET . 50.3 tt0 -62.62 -53.56 52.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.414 177.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 64.3 mt -56.74 -42.2 76.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 120.962 0.41 . . . . 0.0 110.835 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -51.16 -55.05 19.86 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.275 178.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -64.18 -29.01 70.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.321 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.643 ' HG3' ' O ' ' A' ' 145' ' ' GLN . 92.8 mtp -61.4 -36.7 81.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.574 0.226 . . . . 0.0 110.842 -176.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.407 0 C-N-CA 120.293 -0.563 . . . . 0.0 112.424 178.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 . . . . . 0 N--CA 1.453 -0.304 0 CA-C-O 121.168 0.509 . . . . 0.0 110.688 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.476 HG12 ' HA ' ' A' ' 109' ' ' ALA . 27.3 pt -95.22 9.53 5.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.769 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.657 HG11 HD12 ' A' ' 127' ' ' ILE . 23.2 t -118.45 153.77 20.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.135 -177.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.428 ' HB2' ' HB2' ' A' ' 11' ' ' GLU . 41.0 mtt180 -104.42 163.63 12.31 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.915 0.388 . . . . 0.0 110.924 -174.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.567 HG12 HD23 ' A' ' 130' ' ' LEU . 71.3 mt -83.16 117.78 29.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 170.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.88 0.39 56.29 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 -173.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 8' ' ' ARG . 4.1 tp10 -69.47 144.14 53.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.289 -0.456 . . . . 0.0 110.501 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.4 mmt -68.58 111.9 5.04 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 174.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.46 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -58.25 133.96 84.69 Favored Pre-proline 0 C--O 1.237 0.396 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.604 -176.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 6.4 Cg_exo -73.12 174.45 12.01 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.105 2.536 . . . . 0.0 112.245 178.307 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -81.7 168.74 17.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.663 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.62 ' HB2' HD12 ' A' ' 104' ' ' ILE . 33.5 p90 -177.57 143.56 0.36 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.316 165.006 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 62.7 m -117.72 106.43 13.05 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 173.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.1 tt -111.75 138.92 38.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.085 -169.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.2 m -88.2 117.95 27.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.399 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.3 mt -80.92 167.82 19.42 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.153 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.416 ' HB ' ' CD1' ' A' ' 84' ' ' LEU . 17.4 p -54.45 -28.08 41.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.512 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -93.6 15.32 16.44 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.166 -174.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.85 27.41 68.99 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.674 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 49.8 mmtm -108.48 119.26 38.99 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.624 0.25 . . . . 0.0 110.45 -176.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -94.95 115.23 27.19 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.189 178.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 17' ' ' THR . 20.2 m -114.96 150.59 16.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.428 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 20.7 m -110.87 142.67 42.6 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.911 177.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -60.06 -34.62 73.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.951 0.405 . . . . 0.0 110.56 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.42 ' H ' HG22 ' A' ' 27' ' ' THR . 9.4 m -62.86 -25.8 68.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.646 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.2 m -75.36 -21.29 58.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.218 0.532 . . . . 0.0 111.405 -176.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.8 mt -103.47 4.35 35.92 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.48 -178.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.548 ' CZ ' ' HA3' ' A' ' 125' ' ' GLY . 23.7 mmm-85 -65.83 109.67 2.56 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.113 0.482 . . . . 0.0 110.14 178.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.28 -29.44 2.61 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -173.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.416 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 27.2 mttt -96.06 173.08 7.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.237 -0.481 . . . . 0.0 109.985 176.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.455 HG11 ' HB3' ' A' ' 149' ' ' MET . 30.6 m -84.64 108.74 17.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 169.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.467 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 21.2 t -102.6 113.28 38.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.336 -172.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.446 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 27.1 ttt -98.41 124.31 43.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.451 177.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.431 ' HB2' ' HB ' ' A' ' 119' ' ' VAL . 3.2 mm? -109.86 112.99 25.36 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.857 177.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.478 HE22 ' HB ' ' A' ' 41' ' ' THR . 26.2 tm0? -107.28 107.1 17.87 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -82.22 127.31 33.05 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.52 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 12.4 t -140.44 176.19 8.98 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.136 0.493 . . . . 0.0 111.141 -172.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.464 ' HB2' HG12 ' A' ' 115' ' ' ILE . . . -152.36 133.5 14.28 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.494 177.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.487 ' OG ' ' HB3' ' A' ' 82' ' ' LYS . 12.4 p -63.59 -9.21 12.36 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -177.095 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 12.4 p-90 -108.79 12.82 25.38 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.84 0.352 . . . . 0.0 111.496 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 49.4 t -108.09 111.8 24.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.923 0.392 . . . . 0.0 110.695 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.1 -22.88 77.41 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.675 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.2 t -63.66 -34.58 68.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.204 0.526 . . . . 0.0 110.214 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.575 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 64.1 m -67.34 -22.33 65.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.705 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.489 ' O ' ' HG2' ' A' ' 53' ' ' PRO . 26.5 mtp-105 -73.69 -3.16 26.57 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.086 0.47 . . . . 0.0 110.583 178.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -97.74 -58.01 2.1 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.059 171.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.954 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 11.3 pt-20 -64.23 -47.96 77.67 Favored 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -175.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.664 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 94.3 mtp -59.87 -51.78 78.34 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -173.359 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.664 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 52.4 Cg_exo -59.06 -37.96 89.97 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.3 2.0 . . . . 0.0 112.649 174.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.439 ' HB3' ' CZ ' ' A' ' 139' ' ' PHE . 10.8 m-85 -67.39 -42.29 83.55 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.796 176.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 51' ' ' GLU . 94.6 mt -59.23 -48.79 85.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.173 177.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.57 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 2.0 pp20? -67.86 -35.25 78.21 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.633 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.565 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 7.9 ttmm -64.04 -44.32 92.86 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.522 -176.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.725 ' O ' ' HG2' ' A' ' 62' ' ' LYS . 3.9 t0 -106.15 -65.65 1.06 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.177 -0.609 . . . . 0.0 111.326 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.509 HG12 HG23 ' A' ' 143' ' ' VAL . 58.2 mt -56.84 -45.05 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 120.858 0.361 . . . . 0.0 111.609 -169.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.571 ' CD2' ' HB3' ' A' ' 94' ' ' TYR . 76.4 t-105 -75.37 -59.47 2.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.472 -177.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.526 HD13 ' O ' ' A' ' 56' ' ' GLU . 1.6 mp -53.83 -30.57 45.83 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -171.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.725 ' HG2' ' O ' ' A' ' 58' ' ' ASP . 31.8 mmtp -76.95 -24.88 52.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.868 0.366 . . . . 0.0 111.667 -177.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.462 ' CE1' ' HG ' ' A' ' 150' ' ' LEU . 73.8 m-70 -121.67 -41.37 2.48 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -172.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.403 ' HE3' ' HA ' ' A' ' 61' ' ' LEU . 33.1 mmtp 56.42 -95.38 0.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 122.917 0.487 . . . . 0.0 110.128 -167.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.44 ' O ' ' HB3' ' A' ' 66' ' ' ASN . 15.6 t70 -110.8 -32.07 6.97 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 171.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.44 ' HB3' ' O ' ' A' ' 65' ' ' ASP . 20.2 t-20 67.93 -68.82 0.15 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.038 -176.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 158.71 -33.91 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.627 1.571 . . . . 0.0 106.868 -175.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.416 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 15.1 t70 -125.55 18.66 8.1 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.258 -174.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -124.44 142.59 51.19 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.84 -0.537 . . . . 0.0 110.585 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.63 130.36 20.3 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.541 176.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.446 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 2.0 tt -132.92 114.67 14.31 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.1 mp -122.74 124.08 69.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.121 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 96' ' ' LEU . . . -91.92 136.3 13.19 Favored Glycine 0 C--O 1.222 -0.64 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 173.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 59.9 mt -119.93 103.53 14.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 117.742 0.771 . . . . 0.0 111.388 -175.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.52 ' HA ' ' O ' ' A' ' 41' ' ' THR . 34.4 t0 -80.66 133.1 35.67 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 171.233 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.536 ' HA ' ' HB3' ' A' ' 99' ' ' ASP . 5.7 ttp180 -71.28 -105.8 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -170.147 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.452 ' H ' ' HB3' ' A' ' 76' ' ' ARG . 10.1 m-20 -87.33 21.19 2.52 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -168.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -98.56 142.86 25.29 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-O 120.981 0.419 . . . . 0.0 111.449 -178.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.446 ' O ' HG23 ' A' ' 83' ' ' VAL . 64.9 Cg_endo -75.54 174.9 12.03 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.936 2.424 . . . . 0.0 112.86 178.195 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.443 HD23 HD11 ' A' ' 98' ' ' LEU . 32.5 mt -50.93 -50.32 57.96 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.441 -176.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -52.0 -39.82 60.04 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -176.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.487 ' HB3' ' OG ' ' A' ' 43' ' ' SER . 31.7 mmtp -66.84 -53.32 33.75 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.393 178.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 79' ' ' PRO . 15.3 t -60.7 -47.16 94.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.361 -175.012 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.416 ' CD1' ' HB ' ' A' ' 21' ' ' THR . 4.0 mm? -60.49 -48.6 81.07 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.902 0.382 . . . . 0.0 111.435 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.898 ' HA ' ' HE2' ' A' ' 88' ' ' LYS . . . -67.24 -35.8 80.31 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.307 -176.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.608 ' HE2' ' SD ' ' A' ' 52' ' ' MET . 56.1 t80 -72.51 -37.34 68.41 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.711 -178.521 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.433 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -62.46 -49.61 74.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.294 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.898 ' HE2' ' HA ' ' A' ' 85' ' ' ALA . 63.8 pttt -68.54 -29.93 68.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.29 -176.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.2 m -83.75 -2.04 55.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.725 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.473 ' HB ' ' HG3' ' A' ' 53' ' ' PRO . 11.1 p -115.64 -8.12 12.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.895 0.379 . . . . 0.0 110.902 175.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.69 4.14 87.68 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.273 178.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.401 HG13 ' CE1' ' A' ' 94' ' ' TYR . 42.6 t -59.98 114.86 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.171 0.51 . . . . 0.0 111.267 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 p -100.68 7.69 43.77 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.632 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.571 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 33.4 p90 -104.25 145.63 31.03 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.228 173.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -63.07 140.6 79.47 Favored 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 122.615 2.21 . . . . 0.0 112.925 -178.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' A' ' 73' ' ' GLY . 62.5 mt -113.02 144.63 42.25 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.173 176.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -112.22 164.56 12.08 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.886 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.443 HD11 HD23 ' A' ' 80' ' ' LEU . 7.0 mp -102.95 147.49 26.86 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.536 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 36.4 t0 -130.38 70.54 82.33 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-O 121.057 0.456 . . . . 0.0 110.803 174.107 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.15 110.25 1.72 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.673 2.248 . . . . 0.0 112.211 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.86 -1.21 31.84 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.72 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 54.74 40.01 31.67 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.883 0.373 . . . . 0.0 111.016 -175.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.587 ' O ' ' HG3' ' A' ' 107' ' ' LYS . 15.4 t70 -84.13 -45.71 12.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.511 -174.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.62 HD12 ' HB2' ' A' ' 16' ' ' PHE . 35.3 mm -66.11 -35.55 75.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 177.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.491 ' CE1' ' HD3' ' A' ' 117' ' ' ARG . 56.6 t80 -63.51 -37.18 86.33 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.808 174.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.783 ' HB2' ' HG2' ' A' ' 111' ' ' ARG . . . -69.83 -22.92 63.24 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.566 178.197 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.587 ' HG3' ' O ' ' A' ' 103' ' ' ASP . 44.5 mtpt -79.46 -3.13 45.16 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.254 178.168 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -130.99 -3.04 4.02 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.899 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.63 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -178.16 -176.24 0.52 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 122.887 0.475 . . . . 0.0 110.448 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.3 mt -72.92 157.95 36.44 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 172.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.783 ' HG2' ' HB2' ' A' ' 106' ' ' ALA . 48.6 mtt180 -78.2 -10.31 59.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.974 0.416 . . . . 0.0 111.063 -175.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -88.0 -68.77 0.74 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 171.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 21.2 -89.26 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.775 0 O-C-N 125.177 1.548 . . . . 0.0 113.885 -178.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -164.1 -138.42 2.41 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.464 HG12 ' HB2' ' A' ' 42' ' ' ALA . 7.4 tp -150.86 -50.33 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.674 177.323 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.709 ' HB ' ' HB3' ' A' ' 133' ' ' LEU . 1.0 OUTLIER -77.03 107.48 9.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.002 0.429 . . . . 0.0 111.681 -178.974 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.491 ' HD3' ' CE1' ' A' ' 105' ' ' PHE . 6.1 ptm180 -159.7 135.62 8.66 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.062 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.521 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 49.8 m-20 -108.68 119.02 38.31 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' A' ' 38' ' ' LEU . 57.7 t -112.49 138.23 42.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.592 -177.04 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.589 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 34.2 tp -123.69 123.89 41.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.017 0.437 . . . . 0.0 110.765 175.208 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.467 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 79.7 mt -101.09 132.51 46.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.274 175.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.05 -179.97 6.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.768 0.318 . . . . 0.0 110.553 -178.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 6.0 ptm85 -69.93 -24.09 63.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.262 -174.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -77.06 -26.98 54.17 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.51 0.671 . . . . 0.0 109.898 174.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.548 ' HA3' ' CZ ' ' A' ' 32' ' ' ARG . . . 109.93 18.77 8.58 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.854 -177.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 11' ' ' GLU . 80.9 mttt -94.63 136.42 34.95 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.954 0.407 . . . . 0.0 110.501 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.657 HD12 HG11 ' A' ' 7' ' ' VAL . 55.4 mt -79.7 99.2 3.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 28.0 m -101.33 -4.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -171.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.589 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 48.3 tptt -146.27 111.53 5.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.14 0.495 . . . . 0.0 111.597 -176.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.567 HD23 HG12 ' A' ' 9' ' ' ILE . 3.3 mm? -109.28 105.85 15.44 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.646 172.27 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.521 ' HB ' ' HB2' ' A' ' 118' ' ' ASN . 0.4 OUTLIER -109.64 155.86 20.94 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.999 0.428 . . . . 0.0 111.137 -174.479 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -89.85 174.35 7.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.996 178.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.709 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 2.9 pp -45.34 162.07 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 O-C-N 123.608 0.568 . . . . 0.0 112.106 175.064 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.954 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 91.9 t80 -43.98 97.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -174.08 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -114.4 129.62 56.66 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 164.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -55.07 -43.49 73.93 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -171.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -60.95 -49.54 77.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.99 0.424 . . . . 0.0 111.445 176.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.438 ' HB3' ' CG2' ' A' ' 131' ' ' THR . 6.6 mt-10 -65.0 -39.96 94.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.263 -178.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.439 ' CZ ' ' HB3' ' A' ' 54' ' ' PHE . 70.6 t80 -64.03 -42.05 97.23 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.917 0.389 . . . . 0.0 110.408 175.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.46 -40.62 97.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.725 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.402 ' O ' ' HB3' ' A' ' 145' ' ' GLN . 60.7 p -65.64 -29.26 69.81 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.299 -0.409 . . . . 0.0 109.926 178.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.4 mt -73.15 -57.68 3.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.313 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.509 HG23 HG12 ' A' ' 59' ' ' ILE . 7.4 p -59.39 -38.34 74.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 O-C-N 123.11 0.256 . . . . 0.0 110.966 -175.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -67.41 -48.73 66.48 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 177.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.468 ' O ' ' HG2' ' A' ' 149' ' ' MET . 8.7 tt0 -55.98 -48.89 75.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.853 177.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.455 ' O ' HD23 ' A' ' 150' ' ' LEU . 93.1 mt -64.16 -44.44 97.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.189 -178.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -58.93 -40.75 85.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.201 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -73.55 -25.95 60.62 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.126 -0.229 . . . . 0.0 110.951 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.468 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 61.1 mmm -66.7 -28.44 68.44 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 175.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.462 ' HG ' ' CE1' ' A' ' 63' ' ' HIS . 4.2 mm? . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.83 175.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.618 ' CD2' HD12 ' A' ' 130' ' ' LEU . 93.5 m-85 . . . . . 0 CA--C 1.52 -0.203 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.7 pp -109.99 -0.12 9.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.576 0.703 . . . . 0.0 109.898 171.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.2 p -114.53 163.01 12.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.612 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 28.3 mtm105 -129.88 166.4 20.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.833 0.349 . . . . 0.0 111.916 -171.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.496 HG12 ' CD2' ' A' ' 130' ' ' LEU . 53.2 mt -77.88 140.13 17.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.848 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.96 -16.56 55.0 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.128 -0.558 . . . . 0.0 111.882 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.454 ' HA ' ' OE1' ' A' ' 11' ' ' GLU . 8.0 mm-40 -82.65 158.38 23.01 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.073 0.463 . . . . 0.0 111.086 -178.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 84.9 mmm -77.15 132.33 38.75 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.373 -176.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.535 ' HB2' HD12 ' A' ' 121' ' ' ILE . . . -68.72 130.04 92.08 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.036 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.74 125.63 13.5 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.611 2.207 . . . . 0.0 111.93 177.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -64.77 145.7 55.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.039 -178.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.692 ' HB2' HD12 ' A' ' 104' ' ' ILE . 47.1 p90 -149.54 154.2 38.36 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.471 178.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 34.6 m -118.13 106.18 12.59 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.547 173.43 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.6 tt -110.72 145.81 16.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.599 -175.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.508 ' O ' HD23 ' A' ' 98' ' ' LEU . 16.5 m -85.99 128.2 34.8 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.309 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.1 mt -80.57 179.54 7.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.092 0.472 . . . . 0.0 111.392 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 96' ' ' LEU . 30.0 p -64.66 -20.03 66.06 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.329 -0.851 . . . . 0.0 112.439 -177.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.496 ' OD2' ' HG3' ' A' ' 24' ' ' LYS . 10.9 p-10 -106.07 10.74 32.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.919 0.39 . . . . 0.0 110.647 -178.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.14 3.37 67.69 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.665 -0.779 . . . . 0.0 113.398 175.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.496 ' HG3' ' OD2' ' A' ' 22' ' ' ASP . 32.0 mtmm -84.51 122.93 29.69 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.043 0.421 . . . . 0.0 111.353 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.49 ' HB3' HG22 ' A' ' 17' ' ' THR . 93.6 mt-30 -88.23 116.44 26.43 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 175.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 17' ' ' THR . 17.0 m -107.59 147.15 12.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.217 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.8 m -111.42 144.45 40.61 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.072 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.02 -43.4 91.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.965 0.412 . . . . 0.0 110.328 -178.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.515 ' HA ' ' CG ' ' A' ' 32' ' ' ARG . 49.4 m -62.02 -21.22 64.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.974 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.5 t -76.75 -17.29 59.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.818 0.342 . . . . 0.0 110.433 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.4 mt -118.45 19.55 13.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.136 0.494 . . . . 0.0 110.271 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.534 ' NH1' ' H ' ' A' ' 33' ' ' GLY . 10.6 mmm180 -73.71 155.89 38.48 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.966 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.534 ' H ' ' NH1' ' A' ' 32' ' ' ARG . . . 102.94 -30.97 9.31 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 -177.044 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.689 ' HB3' ' HZ3' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -114.31 173.55 6.4 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.515 -0.343 . . . . 0.0 110.5 -177.879 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 68' ' ' ASP . 33.2 m -79.35 130.65 35.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.944 0.402 . . . . 0.0 110.055 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.47 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 55.3 t -119.93 113.85 42.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.662 -178.178 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.807 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 1.6 tmt? -91.68 138.1 31.83 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 176.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.415 ' HB2' ' HB ' ' A' ' 119' ' ' VAL . 93.5 mt -127.9 122.51 32.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.509 -175.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -116.81 107.16 14.29 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.547 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.779 ' HB2' ' HB2' ' A' ' 117' ' ' ARG . 92.6 m-85 -90.92 112.54 24.44 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 9.2 t -141.34 -171.43 3.29 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.47 -172.204 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.418 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . . . -151.14 172.55 15.61 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.147 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.528 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 26.9 t -82.88 -14.04 55.0 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.835 0.35 . . . . 0.0 110.766 -178.212 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -102.3 -4.37 25.75 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.6 p -88.56 107.4 18.88 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 121.657 -0.652 . . . . 0.0 111.181 -178.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.83 -8.7 82.58 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 115.836 -0.62 . . . . 0.0 113.175 -177.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.4 t -77.34 -45.54 29.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 176.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.68 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 98.0 m -62.93 -22.69 66.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.475 -178.41 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.567 ' HE ' ' HE1' ' A' ' 86' ' ' PHE . 89.1 mtt180 -69.93 -2.12 11.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.607 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.425 ' O ' ' HD1' ' A' ' 54' ' ' PHE . 58.9 mttp -100.3 -48.28 4.65 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.346 0.593 . . . . 0.0 109.676 171.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 1.098 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 6.5 pt-20 -67.2 -44.36 79.8 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.798 -176.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.805 ' HG2' ' HD3' ' A' ' 53' ' ' PRO . 16.2 ptm -64.18 -39.77 46.66 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-O 118.576 -0.726 . . . . 0.0 112.923 -174.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.805 ' HD3' ' HG2' ' A' ' 52' ' ' MET . 46.6 Cg_exo -61.23 -41.73 40.44 Favored 'Trans proline' 0 C--N 1.362 1.254 0 C-N-CA 121.345 1.363 . . . . 0.0 112.307 169.402 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 139' ' ' PHE . 18.4 m-85 -64.98 -41.88 95.03 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.906 176.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.558 HG12 HD12 ' A' ' 59' ' ' ILE . 70.2 mt -59.43 -50.52 79.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.094 175.066 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.601 ' OE1' ' HA ' ' A' ' 92' ' ' VAL . 25.2 tp10 -49.05 -49.67 40.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.232 0.539 . . . . 0.0 110.819 175.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.7 tmmt? -69.29 -47.02 65.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.915 -174.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -106.33 -50.16 3.2 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -173.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.558 HD12 HG12 ' A' ' 55' ' ' ILE . 38.4 mt -71.08 -43.48 75.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.597 -176.074 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.435 ' CE2' ' HB3' ' A' ' 94' ' ' TYR . 66.8 t-105 -81.66 -77.43 0.22 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.997 -178.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -44.5 -34.99 2.28 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -172.546 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -84.37 -26.44 28.39 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -173.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -127.15 -9.66 5.89 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -173.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.542 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 18.0 pttp -41.89 -48.84 4.51 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -165.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.52 -83.95 0.11 Allowed 'General case' 0 C--O 1.25 1.094 0 CA-C-O 121.471 0.653 . . . . 0.0 110.197 -172.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.459 ' CG ' ' H ' ' A' ' 67' ' ' ALA . 63.5 t30 49.23 -155.75 0.09 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.631 -169.012 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.459 ' H ' ' CG ' ' A' ' 66' ' ' ASN . . . -105.99 -10.41 16.6 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 166.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.489 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 12.8 m-20 -145.05 39.76 1.22 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.739 -170.25 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.542 ' CD2' ' HA ' ' A' ' 64' ' ' LYS . 62.1 t80 -118.45 129.3 55.31 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 118.976 -1.089 . . . . 0.0 110.605 169.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.24 143.75 50.97 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.533 175.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.807 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 5.4 tt -143.77 121.56 11.94 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.097 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.1 mp -125.67 127.19 71.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.378 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.428 ' HA3' HD22 ' A' ' 96' ' ' LEU . . . -95.53 133.08 11.35 Favored Glycine 0 C--O 1.223 -0.579 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.034 175.054 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 74.7 mt -119.74 127.38 75.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 117.203 0.501 . . . . 0.0 111.128 -174.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.45 ' O ' ' HB3' ' A' ' 99' ' ' ASP . 11.6 t70 -89.34 144.85 25.76 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.21 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.508 HH21 ' HA ' ' A' ' 112' ' ' ASP . 19.8 ttt-85 -69.71 -32.71 71.44 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -172.558 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -158.38 -34.26 0.07 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -173.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -71.62 138.4 83.27 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 121.262 0.553 . . . . 0.0 111.896 -165.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.563 ' HD2' ' HG3' ' A' ' 82' ' ' LYS . 37.4 Cg_endo -72.17 -170.75 0.6 Allowed 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.676 2.917 . . . . 0.0 115.411 -171.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.423 ' O ' HD23 ' A' ' 84' ' ' LEU . 87.7 mt -54.63 -60.35 3.47 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 114.422 -1.263 . . . . 0.0 113.021 -171.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.552 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -59.43 -35.39 73.91 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.032 0.444 . . . . 0.0 110.821 -173.072 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.563 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 19.4 mmmt -61.42 -53.27 58.7 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.237 174.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 79' ' ' PRO . 70.6 t -65.9 -43.57 92.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.341 -178.408 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 80' ' ' LEU . 4.4 mm? -61.79 -47.37 85.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.399 -178.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.86 -35.19 79.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.752 0.31 . . . . 0.0 110.725 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.567 ' HE1' ' HE ' ' A' ' 49' ' ' ARG . 91.3 t80 -67.02 -52.49 41.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.125 178.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.523 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -55.47 -49.54 72.22 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.915 0.388 . . . . 0.0 110.691 177.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.4 tttm -50.69 -36.21 34.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.978 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.9 m -89.78 6.55 41.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.446 -174.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 16.5 p -132.63 8.51 4.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.191 0.519 . . . . 0.0 110.739 176.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.62 -72.12 2.17 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.601 ' HA ' ' OE1' ' A' ' 56' ' ' GLU . 58.1 t 29.37 96.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.148 1.379 . . . . 0.0 114.579 178.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.5 p -94.88 -10.83 30.04 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.639 -0.425 . . . . 0.0 110.553 176.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.435 ' HB3' ' CE2' ' A' ' 60' ' ' TRP . 37.4 p90 -85.49 141.07 36.29 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.381 175.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -62.43 137.71 66.64 Favored 'Trans proline' 0 C--O 1.239 0.546 0 C-N-CA 122.514 2.143 . . . . 0.0 113.359 -177.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.523 HD12 ' HB2' ' A' ' 87' ' ' ALA . 71.4 mt -109.89 149.46 29.86 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.513 174.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -120.8 148.59 17.57 Favored Glycine 0 N--CA 1.438 -1.213 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 175.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.791 HD23 ' H ' ' A' ' 98' ' ' LEU . 2.3 pt? -103.24 131.79 50.01 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.095 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.45 ' HB3' ' O ' ' A' ' 75' ' ' ASP . 12.7 t0 -115.95 79.45 8.15 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.45 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.49 105.09 1.2 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.198 1.932 . . . . 0.0 112.373 -177.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 117.47 1.92 17.79 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.149 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 55.24 39.92 31.49 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 122.638 0.375 . . . . 0.0 111.854 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -79.83 -51.13 9.54 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.283 0.563 . . . . 0.0 110.784 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.692 HD12 ' HB2' ' A' ' 16' ' ' PHE . 30.5 mm -64.82 -34.65 71.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.615 ' CD1' ' HA ' ' A' ' 111' ' ' ARG . 18.1 t80 -65.75 -34.41 78.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.032 175.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -71.88 -23.62 61.54 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.357 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -74.14 -3.9 32.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.255 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -131.0 -35.69 1.38 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.912 0.387 . . . . 0.0 111.269 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -134.52 174.89 10.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.916 0.388 . . . . 0.0 111.109 -177.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.6 mt -78.91 6.22 9.71 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.615 ' HA ' ' CD1' ' A' ' 105' ' ' PHE . 7.3 mtm180 73.98 -68.94 0.2 Allowed 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.981 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.508 ' HA ' HH21 ' A' ' 76' ' ' ARG . 20.6 m-20 -84.77 6.75 23.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.729 -172.191 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -85.07 41.13 0.86 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.591 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.24 151.94 19.27 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.628 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.47 HG13 ' N ' ' A' ' 116' ' ' THR . 9.5 tp -88.03 171.18 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.47 ' N ' HG13 ' A' ' 115' ' ' ILE . 25.0 m 79.79 108.52 0.07 Allowed 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.298 0.639 . . . . 0.0 111.875 174.031 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.779 ' HB2' ' HB2' ' A' ' 40' ' ' PHE . 77.5 mmt-85 -138.78 131.15 28.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.151 173.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' A' ' 130' ' ' LEU . 7.6 m120 -114.99 117.14 29.76 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 176.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.415 ' HB ' ' HB2' ' A' ' 38' ' ' LEU . 39.4 t -129.28 141.4 46.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.879 0.371 . . . . 0.0 111.212 -172.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 46.7 tp -121.61 118.34 28.96 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.092 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.535 HD12 ' HB2' ' A' ' 13' ' ' ALA . 39.4 mm -91.44 121.35 41.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.849 177.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.57 ' OD2' ' HB2' ' A' ' 124' ' ' GLU . 13.6 t0 -67.83 158.35 32.75 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.375 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.7 ptt85 -67.57 -14.56 63.04 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.971 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.57 ' HB2' ' OD2' ' A' ' 122' ' ' ASP . 0.7 OUTLIER -77.63 -16.64 58.43 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 173.052 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.01 24.72 10.21 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.836 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -117.45 156.09 28.56 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.75 0.31 . . . . 0.0 111.359 -175.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.42 HG12 ' CD1' ' A' ' 121' ' ' ILE . 49.8 mt -86.72 113.88 25.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 174.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.1 m -104.2 -17.23 7.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.98 0.419 . . . . 0.0 111.502 -178.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.536 ' HB2' HE22 ' A' ' 145' ' ' GLN . 51.9 tptt -152.49 119.11 5.67 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.353 -176.081 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.618 HD12 ' CD2' ' A' ' 5' ' ' TYR . 1.7 pt? -141.28 105.85 4.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.537 0.684 . . . . 0.0 109.741 176.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.9 t -127.59 164.03 22.89 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.575 -175.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.805 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 62.5 mtp180 -114.71 133.12 56.13 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.54 -178.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.805 ' HG ' ' O ' ' A' ' 132' ' ' ARG . 3.9 pp 65.39 154.57 0.07 Allowed 'General case' 0 N--CA 1.471 0.578 0 O-C-N 124.988 1.43 . . . . 0.0 112.982 172.313 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 1.098 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 58.3 t80 -64.71 102.05 0.54 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.974 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 1.005 ' HB2' ' HB2' ' A' ' 138' ' ' GLU . 46.1 m-80 -98.93 167.11 10.95 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.948 171.177 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.14 -68.13 0.69 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.297 0.57 . . . . 0.0 110.03 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -67.83 -31.29 71.03 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.326 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 1.005 ' HB2' ' HB2' ' A' ' 135' ' ' ASN . 3.1 mm-40 -63.74 -40.13 95.99 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.186 177.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.484 ' HA ' HD12 ' A' ' 142' ' ' LEU . 87.2 t80 -71.1 -41.26 70.83 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.3 -39.15 89.41 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.769 177.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.0 m -65.35 -39.56 92.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.496 178.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.484 HD12 ' HA ' ' A' ' 139' ' ' PHE . 35.9 mt -58.66 -47.97 82.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.763 177.168 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 94.4 t -56.53 -49.25 78.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.186 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -66.22 -43.25 87.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.048 0.452 . . . . 0.0 110.589 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.536 HE22 ' HB2' ' A' ' 129' ' ' LYS . 21.5 tt0 -58.82 -50.95 72.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.031 179.062 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.626 ' O ' HD23 ' A' ' 150' ' ' LEU . 77.0 mt -66.83 -30.26 49.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.263 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -57.68 -43.51 85.14 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.849 176.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -67.26 -39.03 86.07 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.687 0.617 . . . . 0.0 111.089 177.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' MET . . . . . 0.52 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 88.1 mmm -59.68 -27.86 66.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.635 0.731 . . . . 0.0 110.084 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.626 HD23 ' O ' ' A' ' 146' ' ' ILE . 3.4 mm? . . . . . 0 C--N 1.324 -0.522 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.403 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.575 ' O ' ' HA ' ' A' ' 113' ' ' ALA . 16.4 ptp . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.6 p -78.04 -79.89 0.12 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.68 0.276 . . . . 0.0 111.142 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.4 mt -97.76 73.43 2.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.174 0.512 . . . . 0.0 110.234 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.429 ' H ' ' HB1' ' A' ' 113' ' ' ALA . . . -89.67 82.9 1.4 Allowed Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.838 -176.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -93.83 131.84 38.84 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 175.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.418 HG13 HG23 ' A' ' 7' ' ' VAL . 46.1 pt -96.78 -14.03 7.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.418 0.627 . . . . 0.0 109.42 173.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.616 HG11 HD12 ' A' ' 127' ' ' ILE . 20.5 t -110.36 151.78 12.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.181 177.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.428 ' CD ' ' HB2' ' A' ' 11' ' ' GLU . 5.0 ppt_? -126.25 168.74 13.68 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.699 0.285 . . . . 0.0 111.55 -173.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.788 HG12 HD13 ' A' ' 130' ' ' LEU . 72.7 mt -65.92 128.26 28.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 120.955 0.407 . . . . 0.0 110.509 178.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.06 -4.35 65.2 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.79 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.428 ' HB2' ' CD ' ' A' ' 8' ' ' ARG . 7.3 tp10 -89.25 151.63 22.03 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.55 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 41.7 mtp -80.29 143.89 33.28 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.126 0.489 . . . . 0.0 110.657 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -81.22 132.24 56.77 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.646 -175.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 27.5 Cg_exo -63.24 156.44 55.54 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.058 2.505 . . . . 0.0 112.071 176.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -97.9 165.6 11.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.818 -177.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.401 ' O ' ' HA ' ' A' ' 27' ' ' THR . 47.9 p90 -177.41 166.0 2.24 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.64 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 45.7 m -131.17 106.29 8.24 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 174.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.3 tt -107.97 143.27 18.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.008 -171.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.0 m -85.39 125.32 32.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.282 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.427 HD22 ' HB2' ' A' ' 95' ' ' PRO . 97.6 mt -83.45 173.74 11.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.33 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 96' ' ' LEU . 3.5 p -58.69 -31.19 67.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.696 -175.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -100.69 18.37 19.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.234 0.54 . . . . 0.0 110.355 -176.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.52 39.07 23.0 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.783 173.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -108.45 136.48 48.0 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.736 0.303 . . . . 0.0 111.064 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -99.45 116.07 30.74 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 17' ' ' THR . 3.1 p -120.23 126.12 74.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.382 0.61 . . . . 0.0 111.158 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 15.7 m -93.44 143.3 26.42 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.115 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.487 HD22 ' HA ' ' A' ' 28' ' ' LEU . 0.7 OUTLIER -66.59 -30.69 71.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.721 0.296 . . . . 0.0 110.295 -176.312 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.9 m -53.2 -43.01 66.85 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.191 176.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.9 m -67.54 -24.75 65.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.561 -175.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.1 mt -88.45 -22.06 23.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.787 -176.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 83.5 mtm-85 -60.2 159.41 9.81 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.894 0.378 . . . . 0.0 111.585 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.544 ' O ' ' HG3' ' A' ' 123' ' ' ARG . . . 85.25 -23.42 8.26 Favored Glycine 0 N--CA 1.452 -0.265 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -172.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.452 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 31.4 mtmm -109.21 167.93 9.75 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 176.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.41 HG21 HD22 ' A' ' 150' ' ' LEU . 26.1 m -81.87 114.19 22.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 121.208 0.528 . . . . 0.0 110.233 177.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.58 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 29.9 t -110.25 115.32 49.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.137 -173.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.489 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 27.6 ttt -101.16 114.73 28.96 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.119 175.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 69.7 mt -110.11 108.58 18.81 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.891 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.445 ' HG2' ' HA2' ' A' ' 73' ' ' GLY . 9.9 pt20 -94.7 130.01 41.37 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.496 ' HB2' ' HG2' ' A' ' 117' ' ' ARG . 77.2 m-85 -101.45 107.14 18.37 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 12.6 t -130.83 -174.92 3.51 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.252 -171.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.539 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . . . -164.75 143.85 6.99 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.578 177.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 57.1 p -58.64 -25.3 62.59 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -177.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 36.4 p-90 -90.83 7.85 37.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.782 0.325 . . . . 0.0 111.741 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.539 ' SG ' ' HB3' ' A' ' 42' ' ' ALA . 71.8 m -93.25 127.03 38.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.053 0.454 . . . . 0.0 110.905 177.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -85.02 -33.06 19.18 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.457 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.651 HG11 ' HB2' ' A' ' 133' ' ' LEU . 40.3 t -65.11 -34.15 68.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 121.143 0.497 . . . . 0.0 110.629 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.685 ' SG ' HG22 ' A' ' 116' ' ' THR . 92.3 m -66.26 -15.89 63.57 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.461 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.401 ' O ' ' HG2' ' A' ' 53' ' ' PRO . 78.1 mtt180 -78.33 -3.32 42.43 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.478 0.656 . . . . 0.0 110.298 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.407 ' O ' ' HD1' ' A' ' 54' ' ' PHE . 18.8 mtpp -101.77 -45.54 5.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.908 163.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.645 ' HB3' ' HA ' ' A' ' 48' ' ' CYS . 37.4 tt0 -54.87 -63.32 1.19 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.178 -1.374 . . . . 0.0 111.719 -176.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.641 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 79.8 mtp -59.33 -52.19 76.15 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.994 -173.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.641 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 50.5 Cg_exo -56.4 -40.8 82.21 Favored 'Trans proline' 0 C--N 1.358 1.034 0 C-N-CA 122.165 1.91 . . . . 0.0 112.752 179.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.407 ' HD1' ' O ' ' A' ' 50' ' ' LYS . 17.0 m-85 -67.21 -44.81 78.64 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.443 177.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.57 ' O ' ' HB ' ' A' ' 59' ' ' ILE . 81.8 mt -56.44 -45.34 81.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.531 176.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.618 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 38.6 tt0 -62.55 -48.69 78.4 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.415 178.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.517 ' HA ' HD22 ' A' ' 61' ' ' LEU . 29.1 ttpp -63.4 -54.07 42.54 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -173.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -104.29 -13.0 16.31 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -170.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.57 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 71.6 mt -105.16 -63.67 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.725 177.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.618 ' HB3' ' HA ' ' A' ' 56' ' ' GLU . 74.0 t-105 -59.89 -62.09 2.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.548 -175.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.517 HD22 ' HA ' ' A' ' 57' ' ' LYS . 2.6 mp -53.47 -23.06 9.08 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -175.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -89.75 -53.15 4.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.816 0.341 . . . . 0.0 111.418 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -113.18 2.63 15.68 Favored 'General case' 0 C--O 1.221 -0.437 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -167.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.491 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 12.0 pttp -39.07 -44.07 1.09 Allowed 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -172.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -96.8 -75.99 0.52 Allowed 'General case' 0 C--O 1.251 1.146 0 CA-C-O 121.334 0.588 . . . . 0.0 109.855 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.421 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 24.8 t-20 66.56 -72.19 0.09 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 114.449 -1.251 . . . . 0.0 110.667 -177.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 66' ' ' ASN . . . 155.32 -26.17 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.323 0 O-C-N 125.044 1.465 . . . . 0.0 107.704 -175.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.452 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 14.9 t70 -140.04 22.38 2.43 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.991 -172.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.548 ' CE2' ' HB2' ' A' ' 71' ' ' LEU . 68.6 t80 -113.4 139.35 48.97 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.328 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.07 128.94 29.08 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.773 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.548 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 3.6 tt -134.23 117.36 16.39 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.458 HD12 ' C ' ' A' ' 71' ' ' LEU . 3.1 mp -128.66 130.72 68.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.788 0.327 . . . . 0.0 110.141 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.445 ' HA2' ' HG2' ' A' ' 39' ' ' GLN . . . -99.23 133.73 11.41 Favored Glycine 0 C--O 1.219 -0.797 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.526 176.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.0 mt -116.52 127.76 74.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 117.29 0.545 . . . . 0.0 110.905 -176.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.48 ' OD2' ' HA ' ' A' ' 42' ' ' ALA . 10.2 t70 -90.91 135.09 33.96 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 174.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.612 ' HB2' HD13 ' A' ' 115' ' ' ILE . 58.9 ttt-85 -68.69 -28.57 66.97 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -170.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -160.1 -26.87 0.06 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -170.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -74.49 130.83 81.14 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-O 121.292 0.568 . . . . 0.0 111.314 -176.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.515 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 25.4 Cg_endo -68.75 -166.64 0.16 Allowed 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 123.337 2.692 . . . . 0.0 114.831 -176.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -58.98 -55.27 37.25 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 114.315 -1.312 . . . . 0.0 112.248 -169.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.515 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -64.16 -36.29 83.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.542 -173.813 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.481 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 33.9 mmtp -59.79 -54.26 48.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.156 0.503 . . . . 0.0 110.885 177.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.0 t -61.92 -41.87 92.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.294 -177.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.1 mp -62.91 -44.27 96.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.648 0.261 . . . . 0.0 111.254 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.531 ' HA ' ' HE3' ' A' ' 88' ' ' LYS . . . -68.42 -27.62 66.36 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.317 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.437 ' HE2' ' SD ' ' A' ' 52' ' ' MET . 93.3 t80 -80.43 -53.26 6.76 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.911 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.69 -44.35 77.28 Favored 'General case' 0 C--O 1.226 -0.163 0 O-C-N 123.39 0.431 . . . . 0.0 111.787 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.531 ' HE3' ' HA ' ' A' ' 85' ' ' ALA . 18.4 pttp -62.92 -26.46 68.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.026 0.441 . . . . 0.0 111.352 -177.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.9 m -88.73 -22.56 23.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.885 -175.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.0 p -97.08 -13.88 21.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.13 0.491 . . . . 0.0 110.631 177.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 106.54 -74.99 0.22 Allowed Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -177.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.0 t 28.66 85.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.056 1.343 . . . . 0.0 114.07 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.1 p -83.53 -0.95 52.54 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.697 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.586 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 50.6 p90 -96.59 139.48 21.67 Favored Pre-proline 0 C--N 1.332 -0.194 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.755 176.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.427 ' HB2' HD22 ' A' ' 20' ' ' LEU . 19.6 Cg_endo -60.47 133.82 51.21 Favored 'Trans proline' 0 C--O 1.238 0.508 0 C-N-CA 122.935 2.423 . . . . 0.0 113.333 -175.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.459 ' O ' HG23 ' A' ' 21' ' ' THR . 91.3 mt -109.31 139.19 44.58 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.435 176.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -105.55 148.55 16.53 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.75 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.493 ' H ' HD22 ' A' ' 98' ' ' LEU . 0.4 OUTLIER -92.1 127.09 37.44 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.282 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.438 ' HB3' ' O ' ' A' ' 75' ' ' ASP . 21.6 t0 -120.18 74.35 21.37 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 121.135 0.493 . . . . 0.0 109.881 173.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.98 98.4 0.71 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.419 2.08 . . . . 0.0 112.534 -175.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 123.94 -5.18 9.05 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.045 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 62.66 45.17 6.17 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 122.645 0.378 . . . . 0.0 111.127 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -84.04 -50.18 8.22 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.048 0.451 . . . . 0.0 110.398 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 34.2 mm -66.0 -34.01 67.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -64.22 -41.05 97.19 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.276 173.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.616 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -69.94 -18.37 63.36 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.623 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -77.15 -7.82 56.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.486 178.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -125.34 -32.05 2.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.836 0.35 . . . . 0.0 111.365 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.616 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -149.6 169.3 21.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.736 0.303 . . . . 0.0 111.155 -177.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.473 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . 96.6 mt -72.61 133.94 44.92 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 177.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.71 -31.71 68.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.421 0.629 . . . . 0.0 110.48 -178.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -99.43 19.53 15.43 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.121 -176.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.575 ' HA ' ' O ' ' A' ' 1' ' ' MET . . . -119.57 56.9 0.92 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.426 -177.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 81.35 -157.68 38.87 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.409 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.612 HD13 ' HB2' ' A' ' 76' ' ' ARG . 2.5 tp -152.54 -60.48 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.685 HG22 ' SG ' ' A' ' 48' ' ' CYS . 16.5 p -56.65 111.86 1.12 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -172.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.496 ' HG2' ' HB2' ' A' ' 40' ' ' PHE . 13.5 ptp180 -169.72 154.2 5.31 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.665 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.555 ' HB2' HG22 ' A' ' 131' ' ' THR . 34.4 m-80 -124.8 131.08 53.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.457 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.7 t -108.83 109.63 29.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.981 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 30.6 tp -96.57 111.64 23.69 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.491 -0.483 . . . . 0.0 110.271 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.58 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 54.0 mt -93.21 137.49 22.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.996 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.02 179.27 5.99 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.008 0.433 . . . . 0.0 111.104 -177.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 32.5 ttm180 -62.95 -28.67 70.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.128 -175.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -76.61 -30.37 56.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.119 0.485 . . . . 0.0 110.515 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.16 17.38 7.27 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.584 -176.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 80.4 mttt -103.1 148.26 25.96 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.887 0.375 . . . . 0.0 110.484 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.616 HD12 HG11 ' A' ' 7' ' ' VAL . 60.8 mt -84.7 112.43 21.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.149 178.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 28.5 m -102.3 -29.2 3.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -175.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -124.95 112.94 17.18 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.156 -173.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.788 HD13 HG12 ' A' ' 9' ' ' ILE . 11.1 mp -100.93 121.79 42.36 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.434 -0.803 . . . . 0.0 108.868 169.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.555 HG22 ' HB2' ' A' ' 118' ' ' ASN . 0.4 OUTLIER -122.43 145.16 48.55 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 177.565 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.419 ' N ' ' HD2' ' A' ' 132' ' ' ARG . 3.6 mpt_? -105.23 124.15 49.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.313 -177.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.673 ' HA ' ' HB ' ' A' ' 116' ' ' THR . 1.7 pp 39.86 50.07 2.29 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 124.091 0.869 . . . . 0.0 112.983 175.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.535 ' HB2' ' HG3' ' A' ' 51' ' ' GLU . 9.1 t80 68.97 -74.17 0.08 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.151 -177.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 41.6 t30 59.39 120.15 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.421 0.688 . . . . 0.0 111.814 -177.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -47.56 -62.54 1.39 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.984 -173.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -61.81 -41.66 98.04 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.833 -175.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.535 ' HB3' ' OG1' ' A' ' 131' ' ' THR . 17.7 mt-10 -64.85 -36.26 83.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.108 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.47 ' O ' HG23 ' A' ' 143' ' ' VAL . 82.1 t80 -64.42 -44.99 89.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.365 176.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.66 -50.19 70.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.906 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.2 m -66.18 -37.23 85.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.835 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.484 ' O ' HG13 ' A' ' 146' ' ' ILE . 2.6 tt -60.73 -49.16 78.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.813 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 139' ' ' PHE . 90.8 t -59.7 -46.56 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.258 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -58.42 -45.73 87.85 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.176 0.512 . . . . 0.0 110.266 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -61.4 -39.74 91.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.314 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.654 ' O ' HD23 ' A' ' 150' ' ' LEU . 66.6 mt -55.25 -47.95 77.08 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.196 0 CA-C-N 116.738 -0.21 . . . . 0.0 110.702 177.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -51.25 -43.64 61.56 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.72 -0.218 . . . . 0.0 110.543 176.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -67.61 -42.83 81.75 Favored 'General case' 0 C--O 1.217 -0.652 0 C-N-CA 120.646 -0.421 . . . . 0.0 111.12 175.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 38.6 mmm -57.31 -35.64 70.1 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 122.98 0.512 . . . . 0.0 111.136 -172.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.654 HD23 ' O ' ' A' ' 146' ' ' ILE . 4.4 mm? -62.02 -28.16 69.39 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.796 178.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -96.55 -51.61 4.26 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 81.77 94.87 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 114.068 -1.424 . . . . 0.0 110.724 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -129.01 2.66 6.32 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.542 175.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -78.91 -16.15 57.39 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.861 -177.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -65.99 -42.65 89.5 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 169.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 58.0 m80 70.7 -46.5 0.63 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.796 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' HIS . . . . . 0.404 ' C ' ' H ' ' A' ' 159' ' ' HIS . 27.9 t-80 -80.14 1.83 26.52 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.913 0.387 . . . . 0.0 110.239 177.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 72.5 -37.75 0.4 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.952 0.901 . . . . 0.0 110.504 -175.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.404 ' H ' ' C ' ' A' ' 157' ' ' HIS . 73.9 t60 . . . . . 0 C--O 1.242 0.704 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 169.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 110.224 -0.288 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.1 m -84.11 -85.89 0.13 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.356 -178.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 45.2 tp -124.81 -31.4 3.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.89 0.376 . . . . 0.0 111.372 -176.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.484 ' HA2' HD12 ' A' ' 110' ' ' LEU . . . 108.25 -20.1 31.06 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.949 176.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -78.13 127.02 31.66 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.913 0.387 . . . . 0.0 110.858 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.581 HG12 ' HA ' ' A' ' 109' ' ' ALA . 21.5 pt -109.58 -11.97 11.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.781 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.434 HG11 HD12 ' A' ' 127' ' ' ILE . 20.0 t -101.44 156.32 4.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.508 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 37.3 mtt85 -121.85 162.88 20.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.097 0.475 . . . . 0.0 111.342 -173.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.508 HG23 ' HA ' ' A' ' 128' ' ' VAL . 80.1 mt -75.93 126.36 36.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.153 177.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.59 -24.92 12.7 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.839 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -75.03 156.66 35.95 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.661 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 59.2 mtp -84.32 138.54 32.84 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.649 -178.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.569 ' HB2' HD12 ' A' ' 121' ' ' ILE . . . -62.65 123.01 77.62 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.432 -178.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 24.7 Cg_exo -62.44 114.62 2.44 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.615 2.21 . . . . 0.0 111.299 177.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.561 ' HA ' HD12 ' A' ' 28' ' ' LEU . 1.0 OUTLIER -63.4 151.9 39.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.418 -171.823 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.999 ' HB3' ' HE2' ' A' ' 107' ' ' LYS . 37.0 p90 -159.23 166.52 31.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.511 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 56.0 m -129.35 108.26 10.16 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.273 175.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.5 tt -106.7 145.02 14.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.991 0.424 . . . . 0.0 110.831 -174.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 24' ' ' LYS . 9.6 m -85.33 131.84 34.34 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.299 178.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.46 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 86.3 mt -87.15 172.52 9.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.311 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 96' ' ' LEU . 33.2 p -55.85 -34.01 65.05 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.889 -176.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -101.84 18.38 20.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.104 0.478 . . . . 0.0 110.772 -173.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.5 37.0 25.01 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.626 174.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 19' ' ' THR . 41.0 mmtm -108.16 167.04 10.29 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.1 -0.334 . . . . 0.0 110.1 176.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -130.33 120.37 24.23 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 17' ' ' THR . 11.7 m -113.98 144.2 22.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.939 0.399 . . . . 0.0 110.017 175.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.416 HG22 ' H ' ' A' ' 29' ' ' SER . 18.0 m -122.61 143.42 49.77 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.645 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.561 HD12 ' HA ' ' A' ' 15' ' ' ASP . 17.5 mt -62.67 -35.98 81.41 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.715 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.514 ' HA ' ' HG2' ' A' ' 32' ' ' ARG . 59.2 m -55.83 -34.62 65.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.987 0.422 . . . . 0.0 110.937 175.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.0 t -75.25 -26.24 58.69 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.101 0.477 . . . . 0.0 110.227 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 85.8 mt -96.27 0.2 50.6 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.514 ' HG2' ' HA ' ' A' ' 29' ' ' SER . 37.8 mmt180 -60.3 138.24 57.99 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 102.99 -20.79 42.27 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -178.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.552 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 3.5 mppt? -109.72 157.79 18.76 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.203 -0.499 . . . . 0.0 110.432 178.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 p -82.2 116.52 26.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.355 0.598 . . . . 0.0 109.839 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 25.8 t -106.26 131.2 56.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.213 -173.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.539 ' SD ' HG21 ' A' ' 59' ' ' ILE . 27.7 ttt -111.64 123.6 50.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.392 175.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.455 ' HB2' ' HB ' ' A' ' 119' ' ' VAL . 3.3 mm? -103.78 116.87 33.1 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.642 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.444 HE21 ' HA ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -108.06 114.94 29.21 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.67 176.941 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.499 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 92.3 m-85 -99.7 111.85 24.15 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.1 t -127.52 -174.62 3.23 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.193 -174.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -168.03 160.55 12.1 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.327 0.651 . . . . 0.0 109.736 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.463 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 78.3 p -75.91 -18.56 59.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.051 0.453 . . . . 0.0 111.353 -176.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 21.1 p-90 -103.35 12.08 35.84 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -175.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.461 ' HB3' HG21 ' A' ' 115' ' ' ILE . 23.0 p -110.12 114.58 28.2 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.074 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.93 -26.56 68.71 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.916 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.439 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 28.3 t -63.21 -36.82 77.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.959 0.409 . . . . 0.0 110.638 -178.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.419 ' HA ' ' HB3' ' A' ' 51' ' ' GLU . 52.1 m -68.32 -16.15 63.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.724 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -75.56 -7.96 55.53 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.154 0.502 . . . . 0.0 110.287 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.519 ' HD3' ' CD2' ' A' ' 134' ' ' TYR . 57.6 mttt -88.54 -54.26 4.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 122.488 1.137 . . . . 0.0 108.494 162.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.466 ' O ' HG13 ' A' ' 55' ' ' ILE . 24.3 tt0 -57.03 -62.75 1.53 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 113.001 -1.909 . . . . 0.0 112.55 -171.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.587 ' SD ' ' HE2' ' A' ' 86' ' ' PHE . 83.1 mtp -53.93 -54.77 43.14 Favored Pre-proline 0 CA--C 1.538 0.481 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -172.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.485 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 25.5 Cg_endo -62.61 -35.61 69.12 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 121.961 1.774 . . . . 0.0 112.591 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -67.04 -42.58 84.61 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.389 175.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 51' ' ' GLU . 70.4 mt -60.06 -52.93 55.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.985 178.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.606 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 16.4 pt-20 -64.75 -31.11 72.19 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.312 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -71.85 -56.03 6.47 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -176.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.414 ' HA ' ' HG2' ' A' ' 62' ' ' LYS . 62.8 m-20 -108.15 -18.35 13.8 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -171.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.539 HG21 ' SD ' ' A' ' 37' ' ' MET . 48.4 mm -93.57 -53.95 7.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.721 176.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.606 ' HB3' ' HA ' ' A' ' 56' ' ' GLU . 74.9 t-105 -69.86 -73.06 0.17 Allowed 'General case' 0 C--O 1.215 -0.744 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.894 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -48.13 -29.17 3.4 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -174.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.414 ' HG2' ' HA ' ' A' ' 58' ' ' ASP . 39.6 mmtm -91.38 -33.2 15.37 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.305 0.484 . . . . 0.0 112.305 -175.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -124.84 -4.55 7.57 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -171.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.439 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 17.4 pttp -43.71 -51.79 6.93 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -170.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.18 -81.18 0.18 Allowed 'General case' 0 C--O 1.247 0.959 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.524 ' CG ' HD12 ' A' ' 150' ' ' LEU . 12.1 t30 61.41 -71.7 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.347 -177.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 173.06 -26.88 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 123.573 0.749 . . . . 0.0 109.423 -177.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.515 ' HB2' ' HG3' ' A' ' 34' ' ' LYS . 6.3 p-10 -154.62 28.29 0.44 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.416 -172.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.604 ' HB2' HD11 ' A' ' 150' ' ' LEU . 79.4 t80 -100.5 125.55 46.84 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 118.548 -1.261 . . . . 0.0 110.422 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 36' ' ' VAL . . . -124.97 105.62 9.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.811 -176.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.499 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 3.9 tt -110.77 119.36 38.84 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.8 mm -124.34 126.11 71.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.444 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.472 ' HA3' HD23 ' A' ' 96' ' ' LEU . . . -89.17 133.83 12.04 Favored Glycine 0 C--O 1.221 -0.696 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.204 175.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.499 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 68.0 mt -120.8 114.74 44.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.867 0.334 . . . . 0.0 110.733 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -78.32 129.53 35.12 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 172.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.434 HH21 ' HA ' ' A' ' 112' ' ' ASP . 49.5 ttt-85 -45.67 -67.05 0.32 Allowed 'General case' 0 N--CA 1.469 0.478 0 O-C-N 123.97 0.794 . . . . 0.0 112.828 -170.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.647 ' HA ' ' O ' ' A' ' 99' ' ' ASP . 12.0 p-10 -145.61 21.05 1.5 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.58 0.705 . . . . 0.0 109.7 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -69.9 129.74 90.7 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.848 -177.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.588 ' HG2' ' HG2' ' A' ' 82' ' ' LYS . 16.5 Cg_endo -63.58 168.19 11.99 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 122.404 2.07 . . . . 0.0 112.204 173.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -52.55 -52.77 53.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.071 -172.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.546 ' OE2' ' HG2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -67.61 -28.08 67.44 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -173.602 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.588 ' HG2' ' HG2' ' A' ' 79' ' ' PRO . 44.0 mmtm -64.45 -51.07 64.97 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.831 0.348 . . . . 0.0 110.468 175.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.448 HG21 ' HB3' ' A' ' 98' ' ' LEU . 61.1 t -53.81 -52.2 37.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.106 -178.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.23 -39.22 92.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.577 -177.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.448 ' HA ' ' HE3' ' A' ' 88' ' ' LYS . . . -73.05 -26.59 61.35 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.787 -177.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.587 ' HE2' ' SD ' ' A' ' 52' ' ' MET . 71.8 t80 -84.85 -47.42 10.37 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.886 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.485 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -53.08 -47.48 68.49 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.289 0.368 . . . . 0.0 111.455 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.448 ' HE3' ' HA ' ' A' ' 85' ' ' ALA . 18.4 pttp -62.31 -23.98 67.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.033 0.444 . . . . 0.0 111.241 -178.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.9 m -92.62 -0.62 57.28 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.048 -175.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.1 p -122.97 -20.97 5.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.602 175.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 114.64 -76.29 0.25 Allowed Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -177.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.421 HG21 ' HE1' ' A' ' 52' ' ' MET . 86.7 t 43.93 87.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 124.494 1.118 . . . . 0.0 113.344 178.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.4 m -78.67 -5.4 52.94 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.493 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.46 ' CE1' ' HB3' ' A' ' 56' ' ' GLU . 49.0 p90 -107.29 145.58 31.49 Favored Pre-proline 0 C--N 1.33 -0.254 0 O-C-N 122.127 -0.358 . . . . 0.0 110.451 179.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -63.05 136.45 56.57 Favored 'Trans proline' 0 C--O 1.238 0.485 0 C-N-CA 122.371 2.047 . . . . 0.0 113.222 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.485 HD12 ' HB2' ' A' ' 87' ' ' ALA . 92.8 mt -105.14 151.51 23.94 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.871 175.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -125.13 145.51 15.73 Favored Glycine 0 N--CA 1.437 -1.297 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 175.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.789 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.2 pt? -100.09 132.71 45.3 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 120.744 0.306 . . . . 0.0 110.68 -176.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.647 ' O ' ' HA ' ' A' ' 77' ' ' ASP . 22.2 t0 -109.84 82.54 2.42 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.71 176.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.24 87.07 0.49 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.138 1.892 . . . . 0.0 112.264 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.04 -21.65 1.59 Allowed Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.131 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . . . 70.15 24.25 5.0 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 122.866 0.466 . . . . 0.0 110.714 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -91.08 -29.08 17.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.583 -176.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.605 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 32.4 mm -70.04 -35.85 65.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 171.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -60.8 -40.14 91.54 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.741 172.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.682 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -68.28 -25.53 65.2 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.951 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.999 ' HE2' ' HB3' ' A' ' 16' ' ' PHE . 26.8 mtpp -70.72 -3.99 21.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.393 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.732 ' HB3' HH22 ' A' ' 117' ' ' ARG . 65.1 m-85 -129.37 -11.82 4.53 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.91 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.682 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -176.36 176.4 1.65 Allowed 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.847 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 95.4 mt -60.34 136.05 57.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.634 0.254 . . . . 0.0 110.505 177.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.599 ' HG2' ' HB2' ' A' ' 106' ' ' ALA . 53.8 mtp85 -49.57 -51.85 34.11 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.988 -177.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.434 ' HA ' HH21 ' A' ' 76' ' ' ARG . 6.8 m-20 -105.08 34.38 3.24 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.654 -173.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.847 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . . . -85.02 9.88 13.44 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.1 178.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 118.1 -151.94 17.73 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.348 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.461 HG21 ' HB3' ' A' ' 45' ' ' CYS . 8.6 tp -151.1 170.74 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -177.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.603 HG22 ' HA ' ' A' ' 133' ' ' LEU . 30.7 m 71.77 93.97 0.08 Allowed 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.532 0.52 . . . . 0.0 110.314 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.732 HH22 ' HB3' ' A' ' 108' ' ' TYR . 54.8 mtp180 -146.58 149.13 32.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.66 -174.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.573 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 33.0 m-80 -127.6 119.83 26.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.75 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 38' ' ' LEU . 73.1 t -124.58 122.91 64.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.655 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 34.5 tp -108.88 130.72 55.43 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.898 0.38 . . . . 0.0 110.917 -178.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.569 HD12 ' HB2' ' A' ' 13' ' ' ALA . 27.8 mm -111.07 139.11 36.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.695 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.525 ' OD2' ' HB2' ' A' ' 126' ' ' LYS . 3.4 p30 -84.47 171.82 12.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.808 0.337 . . . . 0.0 110.844 177.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.406 ' HD2' ' OE2' ' A' ' 152' ' ' GLU . 94.4 mtt180 -60.7 -25.52 66.46 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.427 -178.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -82.13 -12.57 58.12 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.777 -174.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 103.86 3.92 45.61 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.607 176.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.661 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 9.0 mtmp? -96.72 160.26 14.47 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.142 0.496 . . . . 0.0 111.64 -177.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.52 HG12 ' CD1' ' A' ' 121' ' ' ILE . 43.5 mt -95.37 127.79 47.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.399 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.508 ' HA ' HG23 ' A' ' 9' ' ' ILE . 29.4 m -117.74 -23.19 3.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -176.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.655 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 50.1 tptt -128.66 115.98 18.88 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.558 -174.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.458 HD13 HG12 ' A' ' 9' ' ' ILE . 11.0 mp -110.74 109.77 20.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.975 175.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.573 ' HB ' ' HB2' ' A' ' 118' ' ' ASN . 89.3 m -135.71 141.8 44.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.878 0.371 . . . . 0.0 111.278 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 132' ' ' ARG . 1.3 ptp180 -124.42 150.61 45.43 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 171.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.603 ' HA ' HG22 ' A' ' 116' ' ' THR . 0.8 OUTLIER 46.32 104.95 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 O-C-N 124.703 1.252 . . . . 0.0 113.992 179.503 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.519 ' CD2' ' HD3' ' A' ' 50' ' ' LYS . 39.9 t80 -39.26 112.61 0.26 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.944 -1.026 . . . . 0.0 112.205 176.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -110.84 141.03 44.76 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 173.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.62 -58.45 6.75 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -173.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.464 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.7 mp0 -60.33 -32.19 71.02 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.893 0.378 . . . . 0.0 111.238 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -65.42 -47.5 76.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.571 -177.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.543 ' O ' HG23 ' A' ' 143' ' ' VAL . 88.8 t80 -61.77 -39.46 91.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.736 -178.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -59.96 -46.39 89.56 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.109 0.48 . . . . 0.0 110.375 176.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.3 m -62.69 -38.97 92.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.227 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.615 ' O ' HG12 ' A' ' 146' ' ' ILE . 1.1 mt -61.57 -46.62 89.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.953 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 139' ' ' PHE . 97.6 t -55.96 -49.19 76.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-O 120.688 0.28 . . . . 0.0 111.16 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.445 ' HA ' ' OE1' ' A' ' 144' ' ' GLN . 6.7 tp60 -66.46 -40.96 89.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.955 0.407 . . . . 0.0 110.48 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -57.96 -46.12 85.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.065 176.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.656 ' O ' HD23 ' A' ' 150' ' ' LEU . 38.4 mm -56.48 -44.69 81.08 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.279 177.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.46 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 4.8 t-20 -53.68 -52.0 61.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.848 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -76.29 -20.82 56.97 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.932 -177.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.439 ' HG3' HD21 ' A' ' 120' ' ' LEU . 56.1 mmm -73.0 -28.52 62.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.131 0.491 . . . . 0.0 110.608 175.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.656 HD23 ' O ' ' A' ' 146' ' ' ILE . 4.3 mm? -75.89 -11.75 60.03 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.234 175.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.609 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 42.3 mmtm -102.01 -51.46 3.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.549 176.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.609 ' HG3' ' O ' ' A' ' 151' ' ' LYS . 0.0 OUTLIER 45.86 -175.16 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.693 1.597 . . . . 0.0 112.304 -173.443 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.609 ' HA3' ' HB2' ' A' ' 156' ' ' HIS . . . -175.49 82.92 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 119.297 -1.43 . . . . 0.0 113.436 -177.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -56.94 -29.38 63.07 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 166.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 18.3 m80 -144.82 79.89 1.61 Allowed 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.53 164.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.609 ' HB2' ' HA3' ' A' ' 153' ' ' GLY . 31.0 t60 -70.15 -22.98 62.92 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.129 -176.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -73.59 114.51 11.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.896 177.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -122.04 9.12 9.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.86 0.362 . . . . 0.0 111.037 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 40.8 t-80 . . . . . 0 C--O 1.243 0.744 0 CA-C-O 118.441 -0.79 . . . . 0.0 109.553 177.857 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ppp? . . . . . 0 N--CA 1.484 1.262 0 CA-C-O 120.622 0.249 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.6 m -70.64 -14.42 62.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.792 -172.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 92.3 mt -80.02 -18.06 51.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.948 0.404 . . . . 0.0 110.615 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.426 ' HA2' ' HB1' ' A' ' 113' ' ' ALA . . . 81.32 -25.97 3.59 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.173 -0.536 . . . . 0.0 113.688 176.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.573 ' CE1' HD22 ' A' ' 130' ' ' LEU . 61.2 m-85 -65.34 130.38 43.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.994 0.426 . . . . 0.0 112.101 -175.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.9 pt -101.46 -11.64 8.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.317 169.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.8 m -110.95 150.33 13.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.005 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.465 ' HE ' ' CD ' ' A' ' 11' ' ' GLU . 77.6 mtm180 -118.82 163.78 16.37 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.339 0.59 . . . . 0.0 111.638 -175.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 77.3 mt -70.42 131.37 34.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.443 -0.798 . . . . 0.0 109.531 174.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.63 -27.27 15.5 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -176.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.465 ' CD ' ' HE ' ' A' ' 8' ' ' ARG . 14.3 mt-10 -80.19 174.94 11.1 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.671 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 55.6 mtp -98.8 146.43 25.94 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.875 0.369 . . . . 0.0 110.417 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.451 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -79.92 135.91 54.94 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.842 -177.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 21.2 Cg_exo -64.89 117.28 4.39 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.759 2.306 . . . . 0.0 111.915 177.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.21 141.85 55.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.949 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.508 ' HB2' HD12 ' A' ' 104' ' ' ILE . 52.4 p90 -154.28 161.18 41.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.847 0.356 . . . . 0.0 111.224 -174.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.2 m -110.35 116.28 31.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.448 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.5 tt -114.64 142.14 28.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.936 0.398 . . . . 0.0 110.829 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.47 ' O ' HD23 ' A' ' 98' ' ' LEU . 14.8 m -93.41 123.03 36.42 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.126 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.455 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 92.7 mt -79.52 173.96 12.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.919 0.39 . . . . 0.0 111.393 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 96' ' ' LEU . 19.5 p -57.15 -34.63 68.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.283 -0.871 . . . . 0.0 113.159 -175.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -100.56 19.35 17.06 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.177 0.513 . . . . 0.0 110.535 -174.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.09 36.1 25.53 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.601 174.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -108.4 109.42 20.71 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.09 0.472 . . . . 0.0 110.337 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -89.7 113.94 25.52 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.275 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.7 m -119.12 153.94 21.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.049 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.2 m -112.88 150.96 31.02 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.54 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 0.5 OUTLIER -59.96 -38.46 82.55 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.166 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.523 ' HA ' ' CG ' ' A' ' 32' ' ' ARG . 64.9 m -54.59 -26.88 35.24 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.106 176.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.6 m -72.75 -20.2 61.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.045 0.45 . . . . 0.0 110.97 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.509 HD13 ' HB1' ' A' ' 70' ' ' ALA . 96.3 mt -114.87 3.04 14.49 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.305 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.54 ' HG2' ' O ' ' A' ' 28' ' ' LEU . 47.9 mmm-85 -66.25 139.13 58.06 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.09 -20.48 28.54 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -172.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.499 ' HB3' ' O ' ' A' ' 68' ' ' ASP . 42.5 mtmt -116.14 165.13 13.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.263 -0.468 . . . . 0.0 110.15 177.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 p -79.59 120.03 30.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.178 0.513 . . . . 0.0 110.031 174.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.513 HG22 ' HB3' ' A' ' 70' ' ' ALA . 43.5 t -115.37 125.18 72.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.863 -175.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.473 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 25.6 ttt -103.13 124.76 49.17 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.854 177.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.3 mt -117.57 141.19 48.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.183 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.541 HE22 HD21 ' A' ' 71' ' ' LEU . 15.1 pm0 -139.05 136.67 35.51 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 174.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.437 ' HD2' ' HG3' ' A' ' 117' ' ' ARG . 98.0 m-85 -97.56 119.53 36.3 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.063 0.458 . . . . 0.0 110.675 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.4 t -127.82 -177.08 3.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.342 -175.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.647 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . . . -165.77 155.52 12.45 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 176.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.512 ' H ' ' HG3' ' A' ' 78' ' ' GLU . 99.5 p -63.26 -24.28 67.8 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.93 0.395 . . . . 0.0 112.025 -175.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.5 p-90 -100.92 7.59 43.53 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.751 0.31 . . . . 0.0 111.786 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.647 ' SG ' ' HB3' ' A' ' 42' ' ' ALA . 88.8 m -88.41 99.79 12.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.037 0.446 . . . . 0.0 111.078 178.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.84 -20.44 77.59 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.203 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 34.6 t -76.29 -41.31 36.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.836 0.351 . . . . 0.0 110.197 177.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.777 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 72.2 m -68.72 -16.61 63.87 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.475 0.655 . . . . 0.0 110.376 177.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.503 HH21 ' HE1' ' A' ' 86' ' ' PHE . 25.3 ttm180 -71.19 -11.13 60.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.7 176.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.573 ' HD3' ' CD2' ' A' ' 134' ' ' TYR . 80.1 mttt -87.15 -57.66 2.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.609 0.719 . . . . 0.0 110.046 169.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.947 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 12.4 pt-20 -63.76 -44.84 92.26 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-N 115.065 -0.971 . . . . 0.0 112.495 -168.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.498 ' HE3' HG21 ' A' ' 92' ' ' VAL . 15.3 mtm -57.41 -55.51 43.67 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.045 -174.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.577 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 19.7 Cg_endo -60.73 -33.22 93.38 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 121.771 1.647 . . . . 0.0 112.481 177.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.416 ' HD1' ' O ' ' A' ' 50' ' ' LYS . 12.3 m-85 -70.35 -46.24 64.52 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.499 176.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 51' ' ' GLU . 96.9 mt -58.03 -51.43 70.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.612 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.626 ' HB3' ' CD1' ' A' ' 94' ' ' TYR . 0.4 OUTLIER -65.47 -34.93 79.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.403 -177.289 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.577 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 10.4 ttmm -68.5 -43.35 77.04 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.564 -174.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -106.12 -65.18 1.09 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.473 178.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 65.7 mt -55.7 -39.9 57.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.843 0.354 . . . . 0.0 110.966 -170.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.566 ' HB3' ' O ' ' A' ' 56' ' ' GLU . 75.5 t-105 -75.33 -71.32 0.37 Allowed 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.552 177.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.503 HD22 ' HD1' ' A' ' 60' ' ' TRP . 1.8 mm? -50.45 -34.91 26.43 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -173.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -84.01 -30.46 26.14 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -175.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.478 ' HB3' ' HG ' ' A' ' 150' ' ' LEU . 72.9 m-70 -129.56 -8.51 4.6 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -168.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.419 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 16.0 pttp -38.79 -48.73 1.55 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -171.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.47 -84.19 0.28 Allowed 'General case' 0 C--O 1.253 1.258 0 CA-C-O 121.246 0.546 . . . . 0.0 110.492 -175.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 44.5 t-20 59.24 -77.6 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.939 -169.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 66' ' ' ASN . . . 156.31 -23.01 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 125.327 1.451 . . . . 0.0 107.154 -173.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.499 ' O ' ' HB3' ' A' ' 34' ' ' LYS . 9.7 t70 -119.93 1.25 10.94 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.197 -173.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.516 ' HB2' HD11 ' A' ' 150' ' ' LEU . 84.9 t80 -110.67 151.04 28.17 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 119.09 -1.044 . . . . 0.0 112.297 -176.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.513 ' HB3' HG22 ' A' ' 36' ' ' VAL . . . -148.5 141.51 24.85 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.221 173.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.541 HD21 HE22 ' A' ' 39' ' ' GLN . 3.6 tt -139.02 127.25 22.66 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -177.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.414 ' N ' HD23 ' A' ' 71' ' ' LEU . 63.4 mt -135.79 130.91 49.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 120.73 0.3 . . . . 0.0 110.562 178.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.442 ' HA3' HD23 ' A' ' 96' ' ' LEU . . . -95.12 138.88 14.21 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.291 -0.956 . . . . 0.0 111.01 173.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 55.3 mt -119.66 118.21 56.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 117.395 0.598 . . . . 0.0 110.686 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.536 ' OD1' ' HA ' ' A' ' 42' ' ' ALA . 6.7 t0 -95.41 132.32 40.59 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.488 ' HD2' HD13 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -97.22 121.02 38.65 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.968 0.413 . . . . 0.0 111.942 -170.577 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 73.08 -35.81 0.34 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.347 1.059 . . . . 0.0 113.044 175.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.512 ' HG3' ' H ' ' A' ' 43' ' ' SER . 60.0 mm-40 -62.54 140.31 96.79 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-O 121.147 0.499 . . . . 0.0 111.241 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.539 ' O ' HG23 ' A' ' 83' ' ' VAL . 18.3 Cg_endo -84.25 -168.42 0.54 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.043 2.495 . . . . 0.0 113.64 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.542 HD23 HD13 ' A' ' 84' ' ' LEU . 1.7 tt -56.25 -57.49 12.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.801 -1.091 . . . . 0.0 112.138 -170.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -37.53 87.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.864 -173.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.504 ' CG ' ' HD2' ' A' ' 79' ' ' PRO . 27.1 mmtp -58.86 -50.43 74.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.585 0.231 . . . . 0.0 111.336 178.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 79' ' ' PRO . 46.9 t -58.4 -46.04 89.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.754 -178.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.542 HD13 HD23 ' A' ' 80' ' ' LEU . 10.9 mp -64.2 -47.63 79.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.335 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.02 -32.95 74.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.687 -176.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.503 ' HE1' HH21 ' A' ' 49' ' ' ARG . 72.0 t80 -77.8 -43.72 29.71 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.502 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.531 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -59.22 -54.38 47.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.447 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.9 ptmm? -57.12 -26.59 60.74 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.971 -175.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 27.3 m -85.74 -4.06 59.06 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.382 -174.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 19.1 p -128.14 6.12 5.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.313 0.578 . . . . 0.0 110.321 175.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.55 -73.27 1.23 Allowed Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.294 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.498 HG21 ' HE3' ' A' ' 52' ' ' MET . 42.9 t 40.95 83.91 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.963 0.905 . . . . 0.0 112.695 -177.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.8 m -75.76 -3.8 36.91 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.541 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.626 ' CD1' ' HB3' ' A' ' 56' ' ' GLU . 50.0 p90 -107.72 153.07 41.71 Favored Pre-proline 0 C--N 1.33 -0.273 0 O-C-N 121.813 -0.554 . . . . 0.0 110.621 178.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.5 137.0 32.38 Favored 'Trans proline' 0 C--O 1.239 0.561 0 C-N-CA 122.253 1.969 . . . . 0.0 113.38 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.531 HD12 ' HB2' ' A' ' 87' ' ' ALA . 97.6 mt -104.84 153.67 21.04 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.342 173.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -121.6 147.37 17.29 Favored Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 174.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.781 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.7 pt? -100.27 131.8 46.01 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.88 0.371 . . . . 0.0 110.617 -177.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.439 ' OD2' ' HA ' ' A' ' 102' ' ' ALA . 14.8 t0 -119.35 75.46 16.6 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.491 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.454 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 15.7 Cg_exo -68.01 120.57 7.56 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.895 2.396 . . . . 0.0 111.766 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 102.42 -8.75 55.38 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -175.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.793 ' HB3' ' HE ' ' A' ' 111' ' ' ARG . . . 54.6 45.88 25.95 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 123.09 0.556 . . . . 0.0 111.547 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -76.09 -49.71 16.69 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.253 0.549 . . . . 0.0 110.062 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.508 HD12 ' HB2' ' A' ' 16' ' ' PHE . 27.9 mm -65.83 -36.28 77.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.276 178.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.44 ' HB3' ' HB1' ' A' ' 102' ' ' ALA . 71.5 t80 -62.56 -45.28 93.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.289 174.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.611 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -65.74 -21.01 66.48 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.769 -178.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -73.48 -12.06 60.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.824 0.345 . . . . 0.0 111.245 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.431 ' CZ ' ' HD2' ' A' ' 14' ' ' PRO . 65.8 m-85 -119.93 -34.57 3.69 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.351 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.611 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -154.72 160.37 41.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.783 0.325 . . . . 0.0 111.004 -177.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.464 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . 90.3 mt -67.09 136.29 54.94 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.793 ' HE ' ' HB3' ' A' ' 102' ' ' ALA . 67.5 mtp180 -49.46 -40.05 35.65 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -171.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -98.76 -8.98 25.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.12 0.486 . . . . 0.0 111.475 -175.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.464 ' CB ' ' HB2' ' A' ' 110' ' ' LEU . . . -81.45 40.88 0.59 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -171.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 97.79 114.62 3.31 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.262 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.488 HD13 ' HD2' ' A' ' 76' ' ' ARG . 2.6 tp -76.19 -49.77 24.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.642 0.258 . . . . 0.0 111.531 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.95 ' HB ' ' HB3' ' A' ' 133' ' ' LEU . 22.2 p -66.3 114.2 5.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.17 -173.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.437 ' HG3' ' HD2' ' A' ' 40' ' ' PHE . 10.8 ptp180 -169.33 145.52 3.31 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.952 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.62 ' HB2' ' OG1' ' A' ' 131' ' ' THR . 6.6 m120 -122.98 142.69 50.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.526 -177.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 29.1 t -128.51 120.7 53.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.301 -177.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.682 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 41.9 tp -105.17 116.83 32.62 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.964 174.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 57.0 mt -98.6 134.33 37.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.132 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.38 177.58 8.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.047 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.434 ' HD3' ' OD1' ' A' ' 68' ' ' ASP . 70.9 mtm180 -66.64 -27.26 67.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.967 -174.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -75.17 -29.67 60.48 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.082 0.468 . . . . 0.0 110.419 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.45 15.73 8.06 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.777 -176.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.671 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 82.4 mttt -97.62 157.62 15.94 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.827 0.346 . . . . 0.0 110.583 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.472 HG21 HD21 ' A' ' 130' ' ' LEU . 53.9 mt -91.04 120.67 40.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.576 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.6 m -114.97 1.77 8.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.851 ' HD2' HG23 ' A' ' 131' ' ' THR . 0.3 OUTLIER -163.71 124.61 2.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.779 0.323 . . . . 0.0 111.582 -178.956 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.573 HD22 ' CE1' ' A' ' 5' ' ' TYR . 96.5 mt -127.58 106.73 9.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.615 174.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.851 HG23 ' HD2' ' A' ' 129' ' ' LYS . 16.6 p -107.39 148.89 28.51 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.925 0.393 . . . . 0.0 111.062 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.527 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 23.5 mtm180 -92.84 107.8 19.5 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 174.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.95 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 4.0 pp 49.28 -172.18 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 O-C-N 124.239 0.962 . . . . 0.0 112.979 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.947 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 87.6 t80 -73.65 85.64 1.61 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.321 175.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.55 ' HB3' ' HB2' ' A' ' 138' ' ' GLU . 47.2 t-20 -85.54 117.69 24.6 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 170.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 30.0 mp0 -46.93 -39.72 12.82 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 123.403 0.44 . . . . 0.0 111.973 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -79.76 -51.54 9.06 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.56 0.219 . . . . 0.0 111.56 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.55 ' HB2' ' HB3' ' A' ' 135' ' ' ASN . 44.9 mt-10 -66.01 -34.43 78.07 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 121.243 -0.183 . . . . 0.0 111.24 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.441 ' O ' HG23 ' A' ' 143' ' ' VAL . 81.5 t80 -67.16 -42.97 83.43 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 177.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.24 -48.54 80.08 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.187 0.518 . . . . 0.0 110.316 176.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.3 m -62.88 -35.3 79.56 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.679 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.564 ' HG ' ' HG2' ' A' ' 129' ' ' LYS . 1.4 tt -67.29 -42.54 83.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.236 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 139' ' ' PHE . 70.6 t -58.45 -51.73 67.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.903 178.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.467 ' HA ' ' ND2' ' A' ' 147' ' ' ASN . 47.5 tp60 -60.86 -40.61 93.55 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.122 0.487 . . . . 0.0 110.498 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -56.55 -46.69 80.57 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.618 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.566 ' O ' HD23 ' A' ' 150' ' ' LEU . 42.6 mt -64.76 -38.35 82.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.914 178.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.528 ' O ' ' HG3' ' A' ' 151' ' ' LYS . 93.0 m-20 -53.21 -45.45 68.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.555 178.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -69.85 -36.73 75.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.079 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 84.3 mmm -63.16 -24.51 67.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.309 0.576 . . . . 0.0 110.233 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.566 HD23 ' O ' ' A' ' 146' ' ' ILE . 3.8 mm? -86.47 -22.3 26.54 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.189 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 147' ' ' ASN . 6.9 mtmp? -85.43 -47.35 10.04 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 177.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.574 ' OE1' ' HA ' ' A' ' 155' ' ' HIS . 0.6 OUTLIER 62.33 7.08 2.12 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.983 0.802 . . . . 0.0 111.142 177.022 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 60.0 35.35 86.95 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 -169.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 62.51 138.61 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.666 1.586 . . . . 0.0 111.673 -173.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.574 ' HA ' ' OE1' ' A' ' 152' ' ' GLU . 21.1 m80 -49.0 113.17 0.74 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.175 -178.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -79.69 87.38 5.22 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.931 -173.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -149.74 29.0 0.76 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.499 0.666 . . . . 0.0 109.301 173.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.42 ' O ' ' HB2' ' A' ' 159' ' ' HIS . 48.3 t60 -152.71 -57.36 0.13 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.106 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.42 ' HB2' ' O ' ' A' ' 158' ' ' HIS . 65.1 t-80 . . . . . 0 C--O 1.244 0.811 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.727 175.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.4 ttp . . . . . 0 N--CA 1.48 1.053 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.1 m -84.21 107.37 16.49 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.522 ' HB3' ' HD1' ' A' ' 5' ' ' TYR . 85.6 mt -75.8 121.37 22.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.239 -178.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.99 61.41 3.39 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.433 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.522 ' HD1' ' HB3' ' A' ' 3' ' ' LEU . 48.1 m-85 -113.72 153.29 29.24 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 177.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 29.0 pt -115.06 1.34 8.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.187 0.518 . . . . 0.0 110.429 175.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.9 m -117.34 161.39 16.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.673 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.554 ' HB2' ' HB2' ' A' ' 11' ' ' GLU . 42.1 mtt180 -112.5 165.64 12.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.18 -176.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.47 HG12 HD23 ' A' ' 130' ' ' LEU . 67.0 mt -81.33 118.32 28.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 172.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.12 -3.96 55.4 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -172.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.554 ' HB2' ' HB2' ' A' ' 8' ' ' ARG . 10.1 tp10 -90.93 153.37 20.23 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.534 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 58.2 mtp -76.37 139.41 40.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.123 0.487 . . . . 0.0 111.034 -177.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.452 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -76.64 134.38 69.38 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.918 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.594 ' HD2' ' CE1' ' A' ' 108' ' ' TYR . 24.3 Cg_exo -61.69 149.92 87.87 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.778 2.319 . . . . 0.0 111.427 177.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.0 169.41 9.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.413 -177.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' A' ' 27' ' ' THR . 44.1 p90 -172.39 172.45 4.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.507 -174.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 18.1 m -125.9 100.93 6.6 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 173.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 25' ' ' GLN . 18.3 tt -99.36 143.21 13.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.954 -172.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.6 m -92.14 121.39 33.63 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.917 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.7 mt -78.9 176.6 9.45 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.756 -178.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.3 p -59.25 -28.47 66.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.889 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.72 ' OD1' ' HG2' ' A' ' 24' ' ' LYS . 0.3 OUTLIER -77.79 -28.05 50.36 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.232 178.836 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.16 -1.58 28.31 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.107 -170.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.72 ' HG2' ' OD1' ' A' ' 22' ' ' ASP . 47.4 mmtm -70.18 117.26 11.52 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.642 -0.279 . . . . 0.0 110.777 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.458 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 90.8 mt-30 -91.12 114.63 27.21 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 174.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 17' ' ' THR . 17.0 m -116.91 151.12 18.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.651 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 29' ' ' SER . 4.2 m -98.84 147.32 25.05 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.707 178.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.475 ' O ' HD13 ' A' ' 28' ' ' LEU . 1.1 tm? -69.96 -25.54 63.68 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.548 ' HA ' ' HG2' ' A' ' 32' ' ' ARG . 48.8 m -58.45 -24.86 61.36 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.447 175.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.9 m -75.1 -18.39 60.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.836 0.351 . . . . 0.0 111.435 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.2 mt -105.28 3.55 30.09 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.161 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.548 ' HG2' ' HA ' ' A' ' 29' ' ' SER . 29.0 mmt180 -66.7 116.18 7.34 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 127.81 -21.02 5.66 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -175.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 123' ' ' ARG . 42.9 mtmt -116.55 164.75 14.13 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 176.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 68' ' ' ASP . 17.4 m -76.69 124.07 34.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 174.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.585 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 6.6 t -115.06 108.71 26.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.084 0.469 . . . . 0.0 110.935 -172.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.439 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 27.4 ttt -93.29 115.32 27.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.618 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.473 ' CD1' HG12 ' A' ' 36' ' ' VAL . 6.2 mp -115.26 115.39 26.6 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.356 178.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.427 ' O ' ' HG3' ' A' ' 39' ' ' GLN . 1.4 pt20 -105.82 117.62 34.49 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.047 0.451 . . . . 0.0 110.432 176.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.664 ' O ' ' HA ' ' A' ' 116' ' ' THR . 97.9 m-85 -85.09 109.64 18.39 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 172.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.0 t -127.77 -175.39 3.46 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.247 -170.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.558 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . . . -149.15 136.57 20.17 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.191 0.52 . . . . 0.0 111.686 -178.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.48 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 3.5 p -70.57 -6.26 35.16 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.445 175.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.462 ' HD1' ' HG3' ' A' ' 78' ' ' GLU . 43.5 p-90 -113.83 14.21 18.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.449 -177.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.558 ' SG ' ' HB3' ' A' ' 42' ' ' ALA . 94.8 m -112.81 138.13 50.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.901 0.382 . . . . 0.0 110.922 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -86.23 -33.33 14.67 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.218 -178.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.0 t -58.51 -36.11 57.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 121.362 0.601 . . . . 0.0 110.103 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.606 ' O ' ' HG2' ' A' ' 52' ' ' MET . 71.6 m -65.92 -16.55 63.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.714 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -77.6 -3.28 40.0 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 122.045 -0.409 . . . . 0.0 110.756 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -87.96 -53.77 4.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.103 0.478 . . . . 0.0 110.05 166.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.656 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 8.9 pt-20 -60.58 -46.28 90.83 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.912 -172.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.834 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 88.8 mmm -54.82 -59.57 10.27 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -174.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.834 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 31.8 Cg_exo -61.1 -39.76 56.85 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 122.025 1.817 . . . . 0.0 112.735 177.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.542 ' HB3' ' CZ ' ' A' ' 139' ' ' PHE . 11.6 m-85 -65.39 -46.71 79.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.58 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.534 HG12 ' HE1' ' A' ' 139' ' ' PHE . 77.3 mt -60.83 -46.15 96.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.439 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.46 ' OE2' HD13 ' A' ' 61' ' ' LEU . 33.5 tp10 -57.74 -49.12 77.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.886 0.374 . . . . 0.0 110.652 176.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.428 ' O ' ' HE3' ' A' ' 62' ' ' LYS . 28.6 ttpp -66.27 -52.38 48.06 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -174.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.438 ' HA ' ' NZ ' ' A' ' 62' ' ' LYS . 73.6 m-20 -105.28 -15.55 15.02 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -169.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 58.1 mt -105.43 -60.54 2.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.997 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.55 ' CD2' ' HB3' ' A' ' 94' ' ' TYR . 76.7 t-105 -63.42 -65.44 0.68 Allowed 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.158 -177.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.553 HD12 ' HE3' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -46.36 -32.63 3.3 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -174.909 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.438 ' NZ ' ' HA ' ' A' ' 58' ' ' ASP . 31.6 mmtp -81.54 -28.42 33.93 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -174.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -128.81 -43.42 1.37 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.807 -174.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.553 ' HE3' HD12 ' A' ' 61' ' ' LEU . 31.2 mttp 56.65 -92.38 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.934 0.893 . . . . 0.0 111.263 -176.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 66' ' ' ASN . 11.4 t70 -108.35 -39.16 5.52 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 173.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.4 ' HB3' ' O ' ' A' ' 65' ' ' ASP . 22.9 t-20 69.31 -72.62 0.1 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.217 176.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 164.8 -30.62 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.06 -173.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.507 ' O ' HG22 ' A' ' 35' ' ' VAL . 36.3 t70 -131.73 15.74 4.83 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 114.909 -1.042 . . . . 0.0 110.92 -177.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.454 ' HD2' ' O ' ' A' ' 64' ' ' LYS . 69.6 t80 -121.71 145.08 48.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.115 0.483 . . . . 0.0 110.979 -177.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.39 143.88 29.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.811 174.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.439 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 3.2 tt -143.46 123.03 13.24 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -177.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 65.6 mt -125.06 119.49 55.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.723 0.297 . . . . 0.0 110.405 176.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.416 ' HA2' ' HG3' ' A' ' 39' ' ' GLN . . . -88.52 123.38 6.74 Favored Glycine 0 C--O 1.219 -0.831 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 174.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 55.9 mt -117.82 122.89 70.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 117.706 0.753 . . . . 0.0 111.097 -174.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -80.42 118.34 21.97 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 170.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.551 ' HB3' ' CD1' ' A' ' 115' ' ' ILE . 0.0 OUTLIER -74.63 -6.34 48.07 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.846 -166.854 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -153.18 -30.58 0.13 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 118.759 -1.176 . . . . 0.0 113.144 -176.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.501 ' HB3' ' HG3' ' A' ' 82' ' ' LYS . 24.2 mm-40 -85.57 152.37 57.22 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.009 0.433 . . . . 0.0 112.079 -174.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.526 ' HD2' ' HG3' ' A' ' 82' ' ' LYS . 74.4 Cg_endo -79.31 -171.61 1.3 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.324 2.682 . . . . 0.0 115.243 -176.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.551 HD13 HD23 ' A' ' 84' ' ' LEU . 2.9 tm? -52.07 -55.66 19.27 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 113.528 -1.669 . . . . 0.0 111.423 -175.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -52.41 -42.13 63.79 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.762 -0.653 . . . . 0.0 112.178 -175.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.526 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 34.8 mmtp -66.24 -47.94 72.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.641 -176.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 79' ' ' PRO . 41.1 t -58.22 -45.02 89.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.517 -178.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.551 HD23 HD13 ' A' ' 80' ' ' LEU . 4.5 mm? -68.79 -24.64 64.44 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -175.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.47 -44.33 12.81 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.819 0.343 . . . . 0.0 110.791 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.48 ' CD1' ' HA ' ' A' ' 43' ' ' SER . 85.7 t80 -67.13 -45.34 77.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.766 -174.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.79 -32.19 70.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.998 0.904 . . . . 0.0 109.815 -177.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -69.31 -34.26 74.41 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.242 -1.344 . . . . 0.0 111.023 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.6 t -87.81 -8.16 56.31 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.239 -178.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 16.5 p -108.77 -2.16 18.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.667 0.27 . . . . 0.0 111.208 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.2 36.53 39.85 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.696 177.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.477 HG13 ' CE1' ' A' ' 94' ' ' TYR . 32.6 t -90.37 130.06 40.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.847 0.356 . . . . 0.0 111.706 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 25.4 m -101.67 -35.68 9.01 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.673 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.55 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 43.9 p90 -62.06 140.52 95.92 Favored Pre-proline 0 N--CA 1.463 0.201 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.247 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.27 147.65 91.04 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.66 2.24 . . . . 0.0 112.854 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.8 mp -123.6 154.66 38.99 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.522 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -122.74 162.01 16.72 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.938 178.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.6 mp -96.73 142.23 29.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.593 0.235 . . . . 0.0 110.904 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -133.4 79.71 59.86 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-O 121.212 0.529 . . . . 0.0 109.783 169.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.71 106.09 0.71 Allowed 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.603 2.202 . . . . 0.0 112.859 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.42 19.64 44.54 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.145 176.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 55.77 47.56 20.12 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.507 ' HA ' HH21 ' A' ' 111' ' ' ARG . 24.8 t70 -79.85 -51.55 9.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.159 0.504 . . . . 0.0 110.315 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 35.1 mm -67.43 -33.0 59.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -63.24 -34.9 78.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.281 173.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -73.26 -19.76 60.99 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.92 0.39 . . . . 0.0 111.19 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 14' ' ' PRO . 55.3 mttp -77.44 -17.41 58.11 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.179 176.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.594 ' CE1' ' HD2' ' A' ' 14' ' ' PRO . 81.1 m-85 -110.19 -36.91 5.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.071 0.462 . . . . 0.0 111.006 178.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -130.68 173.23 11.11 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.154 -176.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.492 ' O ' ' HB2' ' A' ' 111' ' ' ARG . 12.1 mt -86.69 3.41 44.91 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -176.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.507 HH21 ' HA ' ' A' ' 103' ' ' ASP . 98.8 mtt180 78.87 -36.65 0.18 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.839 -177.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -74.58 15.94 0.32 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.149 0.5 . . . . 0.0 111.05 176.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.416 ' H ' ' C ' ' A' ' 111' ' ' ARG . . . -93.98 -3.61 51.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.394 177.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.36 -152.09 16.91 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.193 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.551 ' CD1' ' HB3' ' A' ' 76' ' ' ARG . 1.9 tp -109.04 -61.66 2.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.956 ' HB ' ' HG ' ' A' ' 133' ' ' LEU . 2.7 m -86.33 110.66 19.82 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.037 0.446 . . . . 0.0 112.059 -170.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -142.13 131.7 23.92 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.444 176.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 1.119 ' HB3' ' HB ' ' A' ' 131' ' ' THR . 9.6 t30 -105.64 119.99 40.54 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.135 0.493 . . . . 0.0 110.672 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.3 t -107.2 110.39 31.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.792 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.686 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 56.7 tp -92.69 111.39 22.97 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.016 0.436 . . . . 0.0 110.37 178.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.585 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 48.6 mt -95.74 133.57 36.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.143 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -83.59 166.23 18.37 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.249 178.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.426 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 7.1 mtm180 -51.96 -37.73 54.0 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 123.476 0.71 . . . . 0.0 112.081 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -70.84 -5.74 32.72 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.871 0.367 . . . . 0.0 111.672 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.482 ' HA3' HH11 ' A' ' 32' ' ' ARG . . . 89.91 12.66 61.85 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.618 -177.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 87.2 mttt -98.59 144.32 28.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.504 0.192 . . . . 0.0 110.749 -177.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 63.1 mt -84.88 115.66 27.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 176.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.1 m -106.29 -23.61 4.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.686 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 44.7 tptt -142.09 115.84 9.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.238 0.542 . . . . 0.0 112.07 -176.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.47 HD23 HG12 ' A' ' 9' ' ' ILE . 3.2 mm? -97.46 128.91 44.62 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 170.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . 1.119 ' HB ' ' HB3' ' A' ' 118' ' ' ASN . 14.2 m -115.98 135.71 53.71 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.043 0.449 . . . . 0.0 110.952 -175.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.697 HH21 ' HB2' ' A' ' 138' ' ' GLU . 38.7 mtm180 -88.03 106.91 18.46 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.379 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.956 ' HG ' ' HB ' ' A' ' 116' ' ' THR . 6.5 mp 49.66 -137.34 1.05 Allowed 'General case' 0 CA--C 1.532 0.27 0 O-C-N 123.233 0.333 . . . . 0.0 110.15 -178.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.656 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 27.4 t80 -80.64 -55.94 4.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.798 171.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 56.46 109.63 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.907 0.755 . . . . 0.0 112.163 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -44.59 -54.38 6.16 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 114.99 -1.005 . . . . 0.0 112.205 -174.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.28 -34.66 28.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.081 -0.508 . . . . 0.0 112.356 -176.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.697 ' HB2' HH21 ' A' ' 132' ' ' ARG . 15.6 tt0 -70.33 -37.64 74.73 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.645 -176.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.542 ' CZ ' ' HB3' ' A' ' 54' ' ' PHE . 84.7 t80 -63.23 -43.48 97.93 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 174.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.36 -53.73 54.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.209 176.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.1 m -54.37 -45.12 72.73 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.418 174.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.544 ' O ' HG12 ' A' ' 146' ' ' ILE . 45.0 tp -57.55 -48.99 77.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.607 -178.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 139' ' ' PHE . 87.8 t -60.04 -44.06 94.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.102 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -59.07 -44.15 91.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.275 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.559 ' O ' ' HG3' ' A' ' 149' ' ' MET . 56.4 tt0 -65.74 -39.69 91.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.543 178.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 142' ' ' LEU . 35.1 mm -56.07 -47.2 80.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.202 0.525 . . . . 0.0 110.238 175.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.412 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 83.9 m-20 -62.29 -31.23 71.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.341 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -71.54 -44.66 64.18 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.527 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.559 ' HG3' ' O ' ' A' ' 145' ' ' GLN . 80.0 mtp -66.88 -26.3 66.82 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.465 0.65 . . . . 0.0 109.926 -176.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.544 HD23 ' O ' ' A' ' 146' ' ' ILE . 4.4 mm? -76.73 -2.38 32.7 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.161 175.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.412 ' HG2' ' O ' ' A' ' 147' ' ' ASN . 47.2 mmtm -101.38 -66.69 0.9 Allowed 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 173.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 44.1 -94.92 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 O-C-N 124.574 1.171 . . . . 0.0 112.134 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 150.19 -62.13 0.41 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.402 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 44.3 p-80 -92.16 5.32 50.79 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.377 -0.484 . . . . 0.0 112.268 -170.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.91 81.78 1.19 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.605 0.717 . . . . 0.0 111.272 176.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 9.0 m170 -96.87 -26.02 15.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.734 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 39.1 m80 69.88 8.35 6.66 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.905 0.482 . . . . 0.0 110.491 -176.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 178.35 -166.88 0.06 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 43.9 t-80 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.82 172.862 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.484 1.235 0 CA-C-O 120.484 0.183 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 p -53.98 -53.05 58.2 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.333 -176.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.0 mt -77.65 11.19 2.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.936 0.398 . . . . 0.0 111.43 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.453 ' HA2' ' HB1' ' A' ' 113' ' ' ALA . . . 96.23 -56.63 1.48 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.407 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.526 ' CE2' ' HD2' ' A' ' 117' ' ' ARG . 92.9 m-85 -66.17 140.31 58.19 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -176.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.43 HD13 ' H ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -109.18 -5.3 10.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.149 164.421 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.2 p -94.92 160.37 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.092 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.6 ppt_? -128.38 166.58 18.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.906 0.384 . . . . 0.0 111.998 -173.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.4 mt -68.85 131.88 33.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.592 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.98 -3.86 70.79 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.066 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -82.17 152.1 26.63 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.439 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 31.8 mtp -81.83 124.67 29.88 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.089 178.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.43 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -61.47 126.87 87.54 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.681 -176.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 31.3 Cg_exo -59.12 121.77 10.48 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.949 2.433 . . . . 0.0 111.493 177.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.452 ' HA ' HD12 ' A' ' 28' ' ' LEU . 1.0 OUTLIER -70.77 141.86 51.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.532 -175.649 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.425 ' O ' ' HA ' ' A' ' 27' ' ' THR . 39.8 p90 -153.08 163.75 39.28 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.329 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 27.4 m -123.29 107.56 11.8 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 174.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.7 tt -106.8 147.83 11.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.827 0.346 . . . . 0.0 110.8 -175.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 24' ' ' LYS . 3.9 m -81.94 133.47 35.31 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.173 178.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.793 ' HB2' ' HB2' ' A' ' 24' ' ' LYS . 75.7 mt -91.19 -178.7 5.23 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.609 -0.268 . . . . 0.0 110.742 177.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.9 p -55.5 -41.72 73.47 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -172.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.425 ' OD1' ' HG2' ' A' ' 24' ' ' LYS . 4.5 p-10 -97.29 8.0 45.44 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.221 -176.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.88 8.94 44.18 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.289 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.793 ' HB2' ' HB2' ' A' ' 20' ' ' LEU . 40.5 mmtm -62.02 151.89 33.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.035 0.445 . . . . 0.0 110.718 177.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -118.21 116.85 27.65 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.644 174.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 17' ' ' THR . 5.2 p -120.45 125.75 74.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.4 0.619 . . . . 0.0 110.998 -179.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.437 HG22 ' H ' ' A' ' 29' ' ' SER . 9.3 m -106.4 141.0 38.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.944 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.452 HD12 ' HA ' ' A' ' 15' ' ' ASP . 17.6 mt -62.83 -31.07 72.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.412 0.149 . . . . 0.0 111.183 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.437 ' H ' HG22 ' A' ' 27' ' ' THR . 45.8 m -53.43 -34.32 57.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.459 176.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.9 m -78.69 -18.13 54.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.213 0.53 . . . . 0.0 111.082 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.517 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 67.0 mt -101.65 0.78 36.77 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.856 -177.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 28' ' ' LEU . 38.2 mmt180 -66.82 127.94 34.4 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.15 -27.83 8.33 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.486 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.719 ' HB3' ' HZ3' ' A' ' 34' ' ' LYS . 0.7 OUTLIER -116.48 167.4 11.09 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.514 -0.18 . . . . 0.0 110.514 -178.532 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.4 p -80.06 127.63 39.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.019 0.438 . . . . 0.0 110.664 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.577 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 28.1 t -119.39 121.59 66.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.855 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.657 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 28.3 ttt -107.12 120.04 41.01 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.3 mt -126.22 102.01 7.0 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.104 -177.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.9 pm0 -107.38 133.18 52.28 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.615 175.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 94.9 m-85 -89.72 132.52 35.14 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.024 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.536 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 6.6 t -140.79 169.88 16.8 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.312 -177.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.48 ' HB2' ' CD1' ' A' ' 115' ' ' ILE . . . -135.54 151.65 50.53 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.8 169.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.456 ' H ' ' HG3' ' A' ' 78' ' ' GLU . 46.1 m -73.18 28.03 0.06 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -174.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.401 ' H ' ' C ' ' A' ' 42' ' ' ALA . 41.1 p-90 -147.24 7.71 0.9 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.599 0.238 . . . . 0.0 111.238 176.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.461 ' SG ' ' HB3' ' A' ' 42' ' ' ALA . 79.7 m -86.57 130.43 34.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.858 0.361 . . . . 0.0 110.891 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -83.92 -31.25 26.8 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.196 -177.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.691 HG11 ' HB2' ' A' ' 133' ' ' LEU . 38.4 t -62.86 -37.95 80.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.301 0.572 . . . . 0.0 109.835 177.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.959 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 63.2 m -70.44 -20.21 62.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.065 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -75.05 -7.57 54.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.072 0.463 . . . . 0.0 110.255 175.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -102.07 -51.55 3.36 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.5 174.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 1.007 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 12.2 pt-20 -65.17 -44.58 88.04 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.03 -175.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.504 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 38.3 mtm -64.79 -48.95 71.65 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -173.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.504 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 72.6 Cg_exo -54.94 -39.95 88.02 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.737 1.624 . . . . 0.0 112.161 171.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.43 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 7.6 m-85 -66.9 -40.4 87.69 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.078 176.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.574 HG13 ' O ' ' A' ' 51' ' ' GLU . 78.5 mt -57.65 -50.0 78.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.315 175.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.634 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 22.0 tp10 -57.52 -51.05 71.02 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 176.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -54.6 -61.7 2.14 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -175.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.865 ' HA ' ' HZ3' ' A' ' 62' ' ' LYS . 64.5 m-20 -107.56 -13.61 15.02 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -169.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.535 HG23 HG21 ' A' ' 146' ' ' ILE . 61.5 mt -101.99 -62.33 2.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.788 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.583 ' HB3' ' HA ' ' A' ' 56' ' ' GLU . 62.8 t-105 -69.79 -48.29 59.74 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.498 -173.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.634 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -54.83 -28.75 51.91 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -176.256 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.865 ' HZ3' ' HA ' ' A' ' 58' ' ' ASP . 39.3 mmtm -87.47 -25.62 23.64 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -172.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 61.8 m-70 -122.05 -40.27 2.53 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -172.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.617 ' HE2' ' HA ' ' A' ' 61' ' ' LEU . 45.8 mmtt 49.57 -102.5 0.1 Allowed 'General case' 0 C--O 1.224 -0.25 0 O-C-N 123.566 0.541 . . . . 0.0 111.526 -175.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.557 ' C ' ' H ' ' A' ' 67' ' ' ALA . 17.2 t70 -87.37 -63.58 1.28 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.809 -175.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.433 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 18.4 t-20 64.9 -25.97 0.09 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -175.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.557 ' H ' ' C ' ' A' ' 65' ' ' ASP . . . 89.09 -15.94 0.3 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.505 1.522 . . . . 0.0 109.618 -177.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.613 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 2.0 m-20 -134.06 20.43 3.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.083 178.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.481 ' CD1' HD21 ' A' ' 150' ' ' LEU . 86.7 t80 -121.92 108.46 13.46 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.297 0.57 . . . . 0.0 109.786 172.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 36' ' ' VAL . . . -111.75 104.37 12.71 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.756 -176.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.657 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 3.9 tt -113.78 114.66 26.63 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.6 mp -125.01 123.96 66.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.004 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.431 ' HA3' HD22 ' A' ' 96' ' ' LEU . . . -89.16 119.52 5.47 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.075 176.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 65.3 mt -102.29 102.14 13.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 117.134 0.467 . . . . 0.0 111.266 -174.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.536 ' HA ' ' O ' ' A' ' 41' ' ' THR . 8.0 t0 -80.76 144.53 32.08 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 170.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.436 ' HD2' ' CG ' ' A' ' 105' ' ' PHE . 8.2 ttp180 -85.46 -105.32 0.05 Allowed 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 120.305 -0.558 . . . . 0.0 112.186 -167.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.413 ' H ' ' HB3' ' A' ' 76' ' ' ARG . 31.8 m-20 -87.7 17.14 4.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.499 -168.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.456 ' HG3' ' H ' ' A' ' 43' ' ' SER . 5.8 mm-40 -91.09 138.86 25.7 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.579 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.447 ' HD2' ' HG3' ' A' ' 82' ' ' LYS . 48.5 Cg_endo -70.22 178.63 4.66 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.773 2.316 . . . . 0.0 113.07 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.1 mt -57.95 -56.46 21.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.926 -175.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.508 ' CD ' ' H ' ' A' ' 81' ' ' GLU . 1.9 pm0 -52.99 -36.0 59.83 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.638 -177.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.447 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 25.5 mmtp -63.51 -58.06 8.21 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.71 0.291 . . . . 0.0 110.487 175.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 55.0 t -54.18 -49.68 60.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.5 -177.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.41 -42.36 98.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.66 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.546 ' HA ' ' HE3' ' A' ' 88' ' ' LYS . . . -74.26 -29.52 61.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.648 -176.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -79.86 -44.91 19.63 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.57 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.422 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . . . -55.64 -54.03 49.19 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.665 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.546 ' HE3' ' HA ' ' A' ' 85' ' ' ALA . 18.1 pttp -55.44 -30.54 60.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.746 -176.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.5 m -79.73 -14.59 58.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.103 -174.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.7 p -115.07 9.02 15.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.207 0.527 . . . . 0.0 110.637 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.67 -72.46 0.91 Allowed Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.293 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.0 t 28.07 88.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.622 1.169 . . . . 0.0 113.593 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.2 m -96.59 15.81 20.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.757 0.789 . . . . 0.0 110.086 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.551 ' HB3' ' CE2' ' A' ' 60' ' ' TRP . 25.9 p90 -115.43 146.85 37.45 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.114 176.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.76 136.84 69.09 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.635 2.224 . . . . 0.0 112.874 -177.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.431 HD22 ' HA3' ' A' ' 73' ' ' GLY . 63.7 mt -110.56 151.71 27.28 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.831 176.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -121.07 162.05 14.92 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 175.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.659 HD23 ' H ' ' A' ' 98' ' ' LEU . 2.0 pt? -121.6 138.61 54.25 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 117.005 0.403 . . . . 0.0 110.559 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -122.46 72.85 39.98 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.808 -178.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.448 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 13.9 Cg_exo -69.44 111.66 2.81 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.765 2.31 . . . . 0.0 111.761 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 117.74 -1.74 17.76 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -176.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 49.66 40.21 19.26 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -177.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -82.94 -53.96 5.44 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.122 0.486 . . . . 0.0 111.077 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.8 mm -63.85 -33.55 62.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.485 ' HE2' ' O ' ' A' ' 110' ' ' LEU . 80.2 t80 -64.63 -44.3 90.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.312 174.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.659 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -65.02 -19.81 66.18 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.852 -177.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -73.71 -6.7 48.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.858 0.361 . . . . 0.0 111.31 177.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -128.95 -42.19 1.41 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.994 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.659 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -139.07 157.14 46.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.65 -178.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.485 ' O ' ' HE2' ' A' ' 105' ' ' PHE . 7.5 mp -61.41 138.35 58.26 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 178.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.431 ' H ' ' HG3' ' A' ' 111' ' ' ARG . 10.0 mtm180 -55.96 -36.66 68.06 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 122.237 1.018 . . . . 0.0 109.245 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.22 13.49 15.08 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.647 -1.615 . . . . 0.0 110.444 -172.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.453 ' HB1' ' HA2' ' A' ' 4' ' ' GLY . . . -108.1 -171.77 1.93 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.877 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.86 119.68 19.71 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.664 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.48 ' CD1' ' HB2' ' A' ' 42' ' ' ALA . 2.3 tt -67.94 -39.09 81.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -175.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.462 HG22 ' HA ' ' A' ' 133' ' ' LEU . 12.2 m -75.99 98.88 4.4 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.1 0.476 . . . . 0.0 110.987 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.526 ' HD2' ' CE2' ' A' ' 5' ' ' TYR . 37.8 mmt-85 -136.31 133.14 36.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.487 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.516 ' HB2' HG22 ' A' ' 131' ' ' THR . 7.4 m120 -111.0 118.56 36.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.789 0.328 . . . . 0.0 110.43 -176.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.7 t -112.3 128.98 68.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.452 -178.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 46.3 tp -115.16 116.26 28.09 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.028 0.442 . . . . 0.0 110.469 175.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.577 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 55.1 mt -99.59 132.64 44.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.474 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.49 174.09 8.71 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.942 0.401 . . . . 0.0 110.438 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.6 ptp85 -53.82 -34.54 59.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.725 -177.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -81.98 -0.55 44.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.559 -174.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.08 4.5 66.77 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.563 176.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 9.2 mtmp? -97.45 149.52 22.06 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.941 0.401 . . . . 0.0 111.107 -177.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 55.1 mt -85.31 109.88 18.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.805 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 19.4 m -98.75 -17.0 6.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.899 -175.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.676 ' HE3' ' HB ' ' A' ' 131' ' ' THR . 6.9 tmtm? -149.45 108.24 3.86 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.766 -177.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.93 109.36 15.44 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 172.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.676 ' HB ' ' HE3' ' A' ' 129' ' ' LYS . 11.8 t -117.25 164.08 15.35 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.439 -176.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.504 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -103.23 108.0 19.04 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.352 -176.492 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.691 ' HB2' HG11 ' A' ' 47' ' ' VAL . 4.4 pp 51.16 -176.55 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.315 1.046 . . . . 0.0 113.438 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 1.007 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 93.3 t80 -68.74 91.75 0.45 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.777 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.564 ' HB3' ' HB2' ' A' ' 138' ' ' GLU . 48.0 t-20 -107.15 121.15 43.93 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 173.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.509 ' H ' ' CD ' ' A' ' 136' ' ' GLU . 1.3 mp0 -38.26 -64.87 0.38 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.77 0.828 . . . . 0.0 112.772 -175.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -56.82 -51.5 68.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.347 0.594 . . . . 0.0 111.357 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.564 ' HB2' ' HB3' ' A' ' 135' ' ' ASN . 5.5 mm-40 -62.61 -43.91 97.63 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.011 -176.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.539 ' O ' HG23 ' A' ' 143' ' ' VAL . 69.1 t80 -66.07 -42.86 88.84 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.486 ' O ' ' HG2' ' A' ' 144' ' ' GLN . . . -57.22 -50.0 74.24 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.532 177.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 17.4 m -62.96 -37.8 88.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.819 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.459 ' O ' HG12 ' A' ' 146' ' ' ILE . 2.6 tt -62.85 -48.31 79.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.794 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 139' ' ' PHE . 99.7 t -59.05 -45.1 92.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.154 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 140' ' ' ALA . 29.8 mm-40 -62.33 -43.33 99.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.339 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.448 ' O ' ' HG2' ' A' ' 149' ' ' MET . 63.7 tt0 -63.69 -40.85 97.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.424 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.573 ' O ' HD23 ' A' ' 150' ' ' LEU . 24.5 mm -51.83 -50.08 34.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 121.176 0.512 . . . . 0.0 110.517 175.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.603 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 94.4 m-20 -58.02 -43.25 86.6 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.45 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -70.95 -32.95 69.98 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.009 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 83.1 mmm -60.06 -29.43 68.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.179 0.514 . . . . 0.0 110.167 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.573 HD23 ' O ' ' A' ' 146' ' ' ILE . 3.6 mm? -78.68 -16.46 57.26 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.378 177.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.603 ' HG2' ' O ' ' A' ' 147' ' ' ASN . 0.1 OUTLIER -103.33 -51.13 3.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.266 -177.825 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 157' ' ' HIS . 0.9 OUTLIER 55.92 94.9 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.214 -172.377 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -125.35 32.23 3.99 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 175.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 2.9 m80 -116.74 -36.45 3.89 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -176.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 13.8 t60 -173.82 -33.52 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -90.52 6.15 44.77 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.622 -169.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' HIS . . . . . 0.457 ' HB2' ' O ' ' A' ' 152' ' ' GLU . 13.6 t60 -72.68 -29.3 63.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.9 0.381 . . . . 0.0 110.359 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -92.01 141.92 28.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.23 177.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.297 -0.859 . . . . 0.0 108.762 172.49 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.8 ttp . . . . . 0 N--CA 1.483 1.197 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.8 m 60.64 80.81 0.2 Allowed 'General case' 0 CA--C 1.53 0.187 0 O-C-N 123.811 0.695 . . . . 0.0 111.511 176.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.2 mt -129.16 142.92 50.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.927 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.34 69.46 3.33 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.43 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -146.58 147.21 30.87 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 177.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.5 pt -115.58 -6.15 11.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.252 0.549 . . . . 0.0 109.881 172.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.1 m -100.8 166.23 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.493 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.55 ' HB2' ' HG2' ' A' ' 11' ' ' GLU . 25.2 mtt180 -126.09 167.63 15.1 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -176.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 72.8 mt -78.99 119.47 28.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 174.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.64 -25.93 9.32 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.683 -176.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.55 ' HG2' ' HB2' ' A' ' 8' ' ' ARG . 72.2 mm-40 -66.76 150.37 49.21 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.627 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 56.7 mtp -80.32 123.54 28.08 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 174.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.439 ' HA ' ' HD2' ' A' ' 14' ' ' PRO . . . -56.16 124.58 60.63 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.603 -174.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 13' ' ' ALA . 7.1 Cg_endo -52.75 132.01 44.37 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.761 2.308 . . . . 0.0 111.338 175.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -82.82 161.54 21.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.458 -175.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.594 ' HB2' HD12 ' A' ' 104' ' ' ILE . 53.9 p90 -166.65 163.48 16.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.227 -175.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.6 m -125.26 100.5 6.56 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 174.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.5 tt -96.14 149.89 4.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.704 -174.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.477 ' O ' HD23 ' A' ' 98' ' ' LEU . 19.0 m -90.75 127.06 36.2 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.051 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.429 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 71.4 mt -79.69 175.9 10.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.933 178.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 96' ' ' LEU . 37.0 p -59.34 -25.9 64.59 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -177.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.802 ' OD1' ' HG2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -90.28 -19.32 24.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.146 0.498 . . . . 0.0 110.634 -178.519 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 113.13 -2.71 25.45 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.467 -174.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.802 ' HG2' ' OD1' ' A' ' 22' ' ' ASP . 39.3 mmtm -65.91 126.79 29.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.83 0.348 . . . . 0.0 111.149 178.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -91.3 116.4 28.8 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.868 176.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.9 p -119.05 128.4 75.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.315 0.578 . . . . 0.0 111.089 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 6.2 m -97.88 147.9 23.97 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.281 -178.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.71 -28.31 67.56 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.517 ' HA ' ' HG2' ' A' ' 32' ' ' ARG . 44.7 m -56.27 -29.31 60.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.389 177.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.6 m -75.24 -17.13 60.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.112 0.482 . . . . 0.0 111.243 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.3 mt -104.69 1.31 29.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.432 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.517 ' HG2' ' HA ' ' A' ' 29' ' ' SER . 36.3 mmt180 -66.76 122.5 17.79 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 120.54 -19.99 8.97 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -176.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.462 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 45.1 mtmt -116.52 155.24 29.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.547 -0.326 . . . . 0.0 110.323 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.512 HG13 ' HD1' ' A' ' 69' ' ' PHE . 1.4 p -71.27 117.73 14.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.012 0.434 . . . . 0.0 109.854 174.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.551 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 43.1 t -107.68 129.76 61.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.423 -173.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 27.6 ttt -107.46 120.12 41.3 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.174 175.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.7 mt -123.66 94.78 4.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.129 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.679 HE22 HD21 ' A' ' 71' ' ' LEU . 20.2 pm0 -93.81 131.1 39.52 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.107 0.48 . . . . 0.0 110.447 177.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -96.14 110.28 22.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.421 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.6 t -115.63 -171.9 2.05 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.88 -176.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.718 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . . . -163.13 143.46 9.16 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.514 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 54.8 m -62.68 -13.9 37.54 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -174.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 68.2 p-90 -101.07 -4.72 26.87 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.154 -0.341 . . . . 0.0 111.663 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.718 ' SG ' ' HB3' ' A' ' 42' ' ' ALA . 83.8 m -78.21 124.58 28.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.977 0.418 . . . . 0.0 111.732 -175.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -88.66 -18.11 55.39 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 176.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.479 ' HB ' HG21 ' A' ' 116' ' ' THR . 61.8 t -72.02 -46.52 59.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.931 0.396 . . . . 0.0 110.027 176.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.736 ' SG ' HG22 ' A' ' 116' ' ' THR . 69.2 m -66.91 -17.61 64.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.7 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.558 ' HE ' ' HE1' ' A' ' 86' ' ' PHE . 75.0 mtt180 -72.77 -6.46 44.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.154 0.502 . . . . 0.0 110.694 176.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -105.3 -44.98 4.6 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 169.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.649 ' HB2' ' HB2' ' A' ' 134' ' ' TYR . 40.6 tt0 -56.18 -57.12 13.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.369 -177.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.671 ' SD ' ' HE2' ' A' ' 86' ' ' PHE . 74.8 mtp -62.52 -50.64 77.76 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -172.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.615 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 54.7 Cg_exo -55.66 -36.22 94.42 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.959 1.773 . . . . 0.0 112.435 175.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -69.74 -41.32 75.43 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.638 175.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.534 HG13 ' O ' ' A' ' 51' ' ' GLU . 81.5 mt -56.32 -53.18 42.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.057 177.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.625 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 17.1 pt-20 -67.34 -32.09 72.8 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.525 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -62.04 -60.3 3.82 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.47 ' HA ' ' NZ ' ' A' ' 62' ' ' LYS . 52.1 m-20 -107.19 -8.48 16.43 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -171.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.508 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 70.6 mt -104.76 -57.98 4.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.612 176.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.625 ' HB3' ' HA ' ' A' ' 56' ' ' GLU . 76.5 t-105 -66.55 -67.42 0.45 Allowed 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.177 -178.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.0 mp -47.45 -32.1 4.8 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -174.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.47 ' NZ ' ' HA ' ' A' ' 58' ' ' ASP . 46.5 mmtm -77.28 -36.48 54.2 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -177.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -126.68 -43.16 1.74 Allowed 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.937 -0.477 . . . . 0.0 112.099 -173.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 60' ' ' TRP . 33.2 mttp 62.03 -83.05 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.918 0.887 . . . . 0.0 111.451 -178.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -123.37 -38.85 2.51 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 174.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 70.74 -75.06 0.08 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.022 175.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 171.86 -33.83 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.898 -176.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.462 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 5.7 t70 -126.83 19.55 7.17 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.273 -177.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.512 ' HD1' HG13 ' A' ' 35' ' ' VAL . 87.7 t80 -129.11 155.17 45.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.39 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -150.24 132.46 15.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.43 176.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.679 HD21 HE22 ' A' ' 39' ' ' GLN . 5.5 tt -129.41 119.77 24.38 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.5 mm -129.89 120.29 49.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.088 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.88 128.79 9.31 Favored Glycine 0 C--O 1.224 -0.509 0 C-N-CA 120.234 -0.984 . . . . 0.0 111.457 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.3 mt -115.5 120.1 63.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 117.23 0.515 . . . . 0.0 111.174 -176.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.521 ' OD1' ' HA ' ' A' ' 42' ' ' ALA . 16.7 t0 -92.09 127.89 37.73 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 174.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.49 111.33 22.57 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.169 -171.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.7 t0 81.43 -26.09 0.15 Allowed 'General case' 0 N--CA 1.47 0.557 0 O-C-N 124.147 0.904 . . . . 0.0 112.367 169.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.488 ' HB2' ' OD1' ' A' ' 75' ' ' ASP . 5.5 mm-40 -69.49 131.98 89.68 Favored Pre-proline 0 C--O 1.235 0.295 0 CA-C-O 121.148 0.499 . . . . 0.0 110.713 177.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.561 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 36.8 Cg_endo -71.96 -168.71 0.39 Allowed 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.088 2.526 . . . . 0.0 114.624 -176.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -62.69 -52.71 62.2 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.367 -168.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.561 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -62.98 -34.1 76.8 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.502 0.191 . . . . 0.0 111.419 -175.76 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.554 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 33.6 mmtp -58.93 -58.87 6.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.828 176.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.529 HG21 ' HB3' ' A' ' 98' ' ' LEU . 45.2 t -55.27 -44.88 77.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.452 -177.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.8 mp -67.37 -31.71 72.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.698 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.791 ' HA ' ' HE2' ' A' ' 88' ' ' LYS . . . -82.86 -37.35 24.45 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.102 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.671 ' HE2' ' SD ' ' A' ' 52' ' ' MET . 83.2 t80 -67.57 -47.0 71.03 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.914 -178.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.582 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -55.15 -51.53 66.2 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.59 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.791 ' HE2' ' HA ' ' A' ' 85' ' ' ALA . 64.7 pttt -65.94 -23.2 66.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.829 0.347 . . . . 0.0 111.688 -174.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.8 m -80.42 -28.22 37.82 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.108 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.6 p -96.95 -20.53 18.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.078 0.466 . . . . 0.0 111.01 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 112.58 -74.77 0.22 Allowed Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -175.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 97.8 t 43.43 88.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 124.31 1.044 . . . . 0.0 113.322 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.2 m -79.8 6.26 11.43 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 114.704 -1.135 . . . . 0.0 111.333 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.553 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 50.7 p90 -118.71 153.55 52.35 Favored Pre-proline 0 C--N 1.329 -0.306 0 O-C-N 122.172 -0.33 . . . . 0.0 110.882 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -66.71 137.97 47.56 Favored 'Trans proline' 0 C--O 1.24 0.593 0 C-N-CA 122.175 1.916 . . . . 0.0 113.236 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.582 HD12 ' HB2' ' A' ' 87' ' ' ALA . 77.9 mt -109.61 148.28 31.57 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.738 174.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -117.59 147.8 18.74 Favored Glycine 0 N--CA 1.438 -1.221 0 N-CA-C 110.389 -1.085 . . . . 0.0 110.389 173.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.733 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.5 pt? -101.6 136.63 41.13 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -178.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.41 ' OD2' ' HA ' ' A' ' 102' ' ' ALA . 27.5 t0 -116.38 73.95 5.71 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.261 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.494 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 15.4 Cg_exo -68.09 117.25 4.79 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.655 2.237 . . . . 0.0 111.524 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.407 ' O ' ' HD2' ' A' ' 111' ' ' ARG . . . 102.41 -7.32 53.87 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.275 -175.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.518 ' HB3' ' HG2' ' A' ' 111' ' ' ARG . . . 55.68 38.73 30.5 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 122.896 0.479 . . . . 0.0 111.402 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -72.46 -46.11 56.42 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.607 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.594 HD12 ' HB2' ' A' ' 16' ' ' PHE . 21.2 mm -65.22 -38.94 83.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.687 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -65.2 -38.71 91.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.097 175.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.57 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -68.92 -15.3 63.45 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.296 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 52.2 mttp -80.16 -16.75 54.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.627 175.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -113.82 -20.97 10.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.803 0.335 . . . . 0.0 111.328 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.57 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -159.79 -179.81 8.17 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.244 -178.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.94 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 88.6 mt -65.27 138.31 58.12 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.518 ' HG2' ' HB3' ' A' ' 102' ' ' ALA . 1.3 ttp85 -42.61 -48.1 5.36 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -173.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -118.58 37.79 3.95 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.138 0.494 . . . . 0.0 110.667 -176.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.94 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . . . -81.41 34.8 0.38 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.938 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.5 -162.92 17.7 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 121.022 -0.608 . . . . 0.0 112.282 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.562 HG13 ' H ' ' A' ' 116' ' ' THR . 4.7 tp -151.78 -174.2 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -178.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.736 HG22 ' SG ' ' A' ' 48' ' ' CYS . 53.0 p 58.37 88.86 0.06 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.869 0.867 . . . . 0.0 111.692 176.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -171.09 141.86 1.72 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.223 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.686 ' HB3' ' HB ' ' A' ' 131' ' ' THR . 5.6 t30 -119.97 129.67 54.41 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.095 0.474 . . . . 0.0 111.51 -176.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 39.1 t -101.81 113.1 37.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.781 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.939 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 27.2 tp -97.64 115.7 28.43 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.33 0.586 . . . . 0.0 110.035 177.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.551 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 60.5 mt -98.85 135.68 32.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 114.988 -1.006 . . . . 0.0 109.77 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.614 ' OD2' ' HB2' ' A' ' 126' ' ' LYS . 4.4 p30 -75.87 170.23 16.62 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.919 0.39 . . . . 0.0 110.0 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.566 ' HD3' ' OE1' ' A' ' 152' ' ' GLU . 6.9 ptm180 -75.39 1.31 14.2 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.471 -175.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.424 ' HB2' ' OD1' ' A' ' 122' ' ' ASP . 38.7 mt-10 -91.62 -30.5 16.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.373 0.606 . . . . 0.0 109.645 175.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.82 5.56 10.84 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.214 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.627 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 9.3 mtmp? -100.74 157.97 16.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.973 0.416 . . . . 0.0 111.263 -177.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 54.5 mt -92.06 119.08 38.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.155 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 17.0 m -114.91 -23.28 4.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.939 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 59.2 tptt -134.46 113.9 12.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.14 0.495 . . . . 0.0 111.799 -174.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -101.76 113.44 26.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.398 173.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.686 ' HB ' ' HB3' ' A' ' 118' ' ' ASN . 25.4 m -95.57 137.42 34.66 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.496 -177.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.451 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 0.4 OUTLIER -108.42 105.7 15.49 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.72 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 132' ' ' ARG . 3.4 pp 41.72 -163.1 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.093 0.871 . . . . 0.0 113.011 -177.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.649 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 84.5 t80 -94.14 107.48 19.41 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.127 0.489 . . . . 0.0 111.451 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.465 ' HB2' ' CB ' ' A' ' 138' ' ' GLU . 54.0 m-80 -119.42 149.77 41.3 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 170.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -58.58 -56.16 25.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.121 0.486 . . . . 0.0 110.752 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.456 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 0.9 OUTLIER -65.05 -40.78 95.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.216 -178.567 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.465 ' CB ' ' HB2' ' A' ' 135' ' ' ASN . 6.1 tp10 -61.93 -49.78 74.8 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.629 -178.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -66.96 -37.92 85.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.487 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.16 -42.06 97.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.337 176.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 43.2 m -64.5 -30.3 71.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.143 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.493 HD11 HG21 ' A' ' 131' ' ' THR . 29.2 mt -72.8 -55.26 6.96 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.294 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.3 p -59.42 -38.54 75.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 O-C-N 123.166 0.291 . . . . 0.0 110.897 -175.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -67.54 -46.9 71.44 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 176.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.407 ' O ' ' HG2' ' A' ' 149' ' ' MET . 65.1 tt0 -58.86 -46.58 87.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.605 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.553 ' O ' HD23 ' A' ' 150' ' ' LEU . 81.7 mt -65.47 -40.01 86.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.041 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -58.91 -38.63 79.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.688 0.28 . . . . 0.0 110.819 176.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -77.9 -30.41 50.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.941 178.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.407 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 87.0 mmm -67.19 -27.79 67.56 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.316 0.579 . . . . 0.0 110.143 178.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.553 HD23 ' O ' ' A' ' 146' ' ' ILE . 3.9 mm? -76.51 -7.08 54.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.556 175.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.438 ' HZ2' ' HB3' ' A' ' 151' ' ' LYS . 1.9 mmmp? -101.45 -64.27 1.07 Allowed 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.566 ' OE1' ' HD3' ' A' ' 123' ' ' ARG . 0.8 OUTLIER 59.94 -179.9 0.09 Allowed 'General case' 0 CA--C 1.537 0.477 0 O-C-N 124.332 1.02 . . . . 0.0 111.038 176.623 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -119.33 31.81 5.3 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.251 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -80.92 33.85 0.34 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.199 0.523 . . . . 0.0 111.174 177.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -145.3 102.53 3.74 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 174.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 28.7 m170 -105.42 161.86 13.96 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.526 -174.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -106.03 156.4 18.43 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -77.29 148.83 35.5 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.063 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 76.7 t60 . . . . . 0 C--O 1.244 0.793 0 CA-C-O 118.257 -0.878 . . . . 0.0 109.184 172.594 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.6 tpt . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.46 ' HB3' ' HB2' ' A' ' 5' ' ' TYR . 50.1 m -86.84 88.7 7.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.853 0.358 . . . . 0.0 110.62 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.7 pp -104.87 -6.11 20.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.278 0.561 . . . . 0.0 110.69 177.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -154.33 25.23 0.68 Allowed Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.462 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 62.1 m-85 -110.17 143.02 40.88 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.042 -0.579 . . . . 0.0 110.086 -175.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.417 ' H ' ' HA ' ' A' ' 109' ' ' ALA . 39.8 pt -92.07 -13.37 8.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.556 0.693 . . . . 0.0 109.248 173.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 p -110.57 164.16 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.298 178.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.5 mtm105 -133.68 165.85 23.97 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.902 0.382 . . . . 0.0 111.01 -174.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.422 HG12 HD13 ' A' ' 130' ' ' LEU . 85.4 mt -72.02 122.96 25.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.193 178.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.99 -22.21 19.03 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.94 -178.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -74.11 159.25 32.87 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.741 0.305 . . . . 0.0 110.722 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.588 ' SD ' ' HG2' ' A' ' 126' ' ' LYS . 56.3 mmm -79.76 133.28 36.32 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.435 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -69.99 129.7 90.61 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.623 -177.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.512 ' HD2' ' CE1' ' A' ' 108' ' ' TYR . 32.9 Cg_exo -61.92 137.44 67.47 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.882 2.388 . . . . 0.0 111.744 175.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.426 ' HB2' HH22 ' A' ' 32' ' ' ARG . 23.4 t70 -80.61 153.03 28.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.888 -177.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -161.88 165.44 27.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.779 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 73.5 m -124.7 107.12 10.64 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 174.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.5 tt -105.92 144.86 14.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.94 -173.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.465 ' O ' HD23 ' A' ' 98' ' ' LEU . 5.5 m -88.52 131.69 34.81 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.077 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.491 HD12 ' HB2' ' A' ' 24' ' ' LYS . 79.0 mt -82.43 -179.43 7.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.845 0.355 . . . . 0.0 110.951 177.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.453 ' HB ' HD11 ' A' ' 84' ' ' LEU . 35.6 p -57.85 -31.65 66.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.894 -175.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.493 ' OD2' ' HG2' ' A' ' 24' ' ' LYS . 5.4 p-10 -99.45 -6.19 28.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.818 0.342 . . . . 0.0 110.835 -175.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.94 1.82 34.12 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.333 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.614 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -69.22 110.78 4.76 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 117.663 0.732 . . . . 0.0 110.297 175.623 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -92.69 115.08 27.78 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.086 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 17' ' ' THR . 12.8 m -112.66 146.03 17.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.156 0.503 . . . . 0.0 110.804 -177.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.6 m -103.2 147.06 27.5 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.712 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.17 -45.81 93.08 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.702 0.287 . . . . 0.0 110.408 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.9 m -64.95 -15.79 62.59 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.2 t -82.48 -15.38 52.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.577 0.703 . . . . 0.0 109.555 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.2 mt -112.12 -3.9 14.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.539 177.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.426 HH22 ' HB2' ' A' ' 15' ' ' ASP . 7.8 mtm180 -75.81 156.36 34.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.058 0.456 . . . . 0.0 111.024 -178.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.48 -15.71 62.68 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 -166.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.582 ' HB3' ' O ' ' A' ' 68' ' ' ASP . 36.7 mtmt -116.44 160.21 20.9 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.058 -1.071 . . . . 0.0 109.381 175.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.431 HG11 HD22 ' A' ' 150' ' ' LEU . 2.3 p -80.19 118.27 27.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.359 0.6 . . . . 0.0 109.716 174.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.8 t -112.51 122.2 66.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.967 -173.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.652 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 26.7 ttt -99.34 114.96 28.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.08 175.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 69.6 mt -110.31 97.55 6.99 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.584 178.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.552 ' HG3' ' HA2' ' A' ' 73' ' ' GLY . 1.5 pp0? -91.1 130.97 36.94 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 177.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -107.02 122.34 46.25 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.43 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 13.9 t -151.49 -171.4 3.92 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.9 -177.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.409 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . . . -150.95 163.41 38.78 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 174.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.47 ' HB2' ' HG3' ' A' ' 78' ' ' GLU . 44.1 m -67.54 -5.71 16.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.055 -0.521 . . . . 0.0 112.168 -176.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 37.0 p-90 -109.9 12.21 23.91 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.482 ' SG ' HD13 ' A' ' 115' ' ' ILE . 73.8 m -92.85 100.95 13.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.118 0.485 . . . . 0.0 111.266 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.98 -32.38 73.29 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.889 -0.596 . . . . 0.0 113.082 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.6 t -64.12 -41.29 91.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.159 0.504 . . . . 0.0 110.446 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.75 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 83.6 m -67.62 -16.94 64.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.73 -177.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -71.3 -2.6 16.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.863 0.363 . . . . 0.0 110.994 176.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -98.85 -51.87 3.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.056 0.455 . . . . 0.0 110.026 170.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.75 ' HG2' ' HA ' ' A' ' 48' ' ' CYS . 11.7 pt-20 -69.58 -39.33 77.4 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.046 -173.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.575 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 91.7 mtp -60.36 -51.03 83.02 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -177.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.575 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 35.8 Cg_exo -59.68 -35.74 94.01 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.854 1.703 . . . . 0.0 112.208 172.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.579 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 3.1 m-85 -64.32 -43.73 93.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.724 174.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 51' ' ' GLU . 97.4 mt -58.16 -48.98 83.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.853 173.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.514 ' OE1' ' HA ' ' A' ' 92' ' ' VAL . 30.2 tp10 -50.22 -53.97 24.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.934 178.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -72.53 -50.45 25.65 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -173.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -105.8 -12.96 15.68 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -168.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.454 HD12 HG12 ' A' ' 55' ' ' ILE . 73.4 mt -106.37 -61.93 2.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.024 176.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.623 ' CE2' ' HG2' ' A' ' 64' ' ' LYS . 67.5 t-105 -62.94 -67.41 0.42 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.481 -174.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.02 -33.52 11.35 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -175.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -68.41 -30.11 68.94 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.78 -175.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.461 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 90.7 m-70 -128.98 -47.08 1.23 Allowed 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 119.678 -0.809 . . . . 0.0 112.621 -176.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.623 ' HG2' ' CE2' ' A' ' 60' ' ' TRP . 9.2 mtmp? 40.57 -93.98 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.568 0.699 . . . . 0.0 112.149 -174.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.59 -70.59 0.29 Allowed 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.045 173.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.586 ' ND2' HD12 ' A' ' 150' ' ' LEU . 5.7 t30 70.18 -68.77 0.19 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.769 0.828 . . . . 0.0 111.078 174.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 175.87 -46.3 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.363 -178.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.582 ' O ' ' HB3' ' A' ' 34' ' ' LYS . 7.9 p-10 -142.85 35.25 1.4 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.066 -177.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.609 ' HB2' HD11 ' A' ' 150' ' ' LEU . 74.5 t80 -104.13 145.72 29.78 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.657 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.76 130.33 17.89 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.934 174.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.652 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 3.4 tt -135.35 114.61 12.37 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.5 mp -125.9 126.12 69.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.825 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.552 ' HA2' ' HG3' ' A' ' 39' ' ' GLN . . . -91.16 120.4 5.95 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.608 -0.805 . . . . 0.0 111.376 176.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 65.8 mt -103.92 122.99 57.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 116.861 0.33 . . . . 0.0 111.051 -175.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.555 ' HA ' ' O ' ' A' ' 41' ' ' THR . 9.3 t70 -85.84 137.74 32.55 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 176.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 54.5 ttt-85 -74.87 -28.23 60.57 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -172.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -161.92 -18.3 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -171.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.47 ' HG3' ' HB2' ' A' ' 43' ' ' SER . 5.3 mm-40 -78.59 132.25 65.73 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-O 121.294 0.569 . . . . 0.0 111.198 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.58 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 28.4 Cg_endo -71.89 -169.94 0.49 Allowed 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 123.307 2.671 . . . . 0.0 114.366 -178.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.414 ' O ' HD23 ' A' ' 84' ' ' LEU . 79.4 mt -53.5 -59.01 5.13 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 114.958 -1.019 . . . . 0.0 113.106 -173.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.58 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -59.53 -33.43 71.38 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.479 -172.111 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.487 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 34.1 mmtp -64.35 -55.89 18.14 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.014 0.435 . . . . 0.0 110.325 174.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 79' ' ' PRO . 92.7 t -57.95 -44.39 86.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.43 -177.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.453 HD11 ' HB ' ' A' ' 21' ' ' THR . 4.4 mm? -69.01 -13.11 62.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.729 -178.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.523 ' HA ' ' HD2' ' A' ' 88' ' ' LYS . . . -99.84 -42.05 6.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.925 0.393 . . . . 0.0 110.789 176.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.553 ' HE2' ' SD ' ' A' ' 52' ' ' MET . 71.7 t80 -64.63 -38.08 89.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.841 -177.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -54.63 -56.01 23.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.338 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.523 ' HD2' ' HA ' ' A' ' 85' ' ' ALA . 0.3 OUTLIER -66.98 -19.05 65.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.171 0.51 . . . . 0.0 110.838 -175.519 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.4 m -81.55 -1.89 47.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.333 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.5 p -138.43 11.03 2.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.224 0.535 . . . . 0.0 110.491 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.68 -74.2 1.17 Allowed Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.514 ' HA ' ' OE1' ' A' ' 56' ' ' GLU . 54.6 t 29.65 93.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.108 1.363 . . . . 0.0 114.408 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 71.9 p -97.17 -11.91 23.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.038 0.447 . . . . 0.0 110.186 174.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.522 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 37.6 p90 -81.52 144.33 52.85 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.472 176.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.2 138.37 81.0 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.714 2.276 . . . . 0.0 113.044 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.408 HD11 HG11 ' A' ' 92' ' ' VAL . 83.8 mt -110.9 142.07 43.46 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.938 177.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 74' ' ' ILE . . . -115.0 142.7 17.79 Favored Glycine 0 N--CA 1.441 -1.009 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 177.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.785 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.8 pt? -103.11 129.62 50.02 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.938 0.399 . . . . 0.0 110.815 -177.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -119.33 72.07 13.23 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.818 177.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.458 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 20.1 Cg_exo -65.28 108.48 1.17 Allowed 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.504 2.136 . . . . 0.0 112.312 -176.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 118.9 -6.23 13.58 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.6 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 59.35 44.99 14.51 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.897 0.479 . . . . 0.0 111.784 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -80.8 -55.52 4.76 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 120.973 0.416 . . . . 0.0 110.499 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 38.4 mm -62.02 -35.28 67.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 176.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.672 ' HZ ' ' HA ' ' A' ' 115' ' ' ILE . 38.9 t80 -60.48 -40.61 91.89 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.264 174.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -76.89 -14.72 59.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.184 -177.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 50.0 mttp -72.75 -11.16 60.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.953 0.406 . . . . 0.0 111.353 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.512 ' CE1' ' HD2' ' A' ' 14' ' ' PRO . 98.9 m-85 -116.72 -30.03 5.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.413 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.571 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -162.89 -177.23 5.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.62 0.248 . . . . 0.0 110.714 -175.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.515 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . 95.6 mt -72.69 135.49 45.41 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.563 ' HA ' ' CD1' ' A' ' 105' ' ' PHE . 17.6 mtm180 -58.59 -34.51 71.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.936 -175.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -105.42 7.58 33.23 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.015 -170.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.515 ' CB ' ' HB2' ' A' ' 110' ' ' LEU . . . -96.24 49.76 1.14 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.136 0.493 . . . . 0.0 111.234 -177.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.67 104.52 0.9 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.059 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.672 ' HA ' ' HZ ' ' A' ' 105' ' ' PHE . 5.1 tt -72.07 -52.51 24.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -176.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.538 HG21 ' HA ' ' A' ' 133' ' ' LEU . 77.0 m -59.34 109.48 0.88 Allowed 'General case' 0 C--O 1.238 0.465 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -175.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.588 ' HB3' HH21 ' A' ' 132' ' ' ARG . 13.6 ptt180 -161.16 140.59 10.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.584 178.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -107.2 118.11 35.83 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 174.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 51.0 t -101.54 106.27 19.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.092 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 43.1 tp -93.49 119.19 32.27 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.278 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 68.5 mt -103.83 131.11 53.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.657 177.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.408 ' CG ' ' H ' ' A' ' 124' ' ' GLU . 0.0 OUTLIER -74.96 166.04 24.29 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.564 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -66.93 -13.38 61.7 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -174.102 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.576 ' HB2' ' NZ ' ' A' ' 126' ' ' LYS . 48.4 mt-10 -84.43 -27.58 27.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.014 0.435 . . . . 0.0 110.564 175.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.67 10.07 7.99 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.376 -0.916 . . . . 0.0 113.04 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.588 ' HG2' ' SD ' ' A' ' 12' ' ' MET . 31.6 mtmm -93.09 146.06 23.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.129 0.49 . . . . 0.0 111.729 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 56.0 mt -87.28 115.09 27.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.763 177.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 31.1 m -109.87 -16.72 8.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -172.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.587 ' HG2' HD13 ' A' ' 142' ' ' LEU . 51.2 tptt -137.5 122.68 19.24 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 119.896 -0.722 . . . . 0.0 112.107 -176.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.422 HD13 HG12 ' A' ' 9' ' ' ILE . 9.8 mp -121.91 105.18 10.11 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.212 174.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.456 HG22 ' HE3' ' A' ' 129' ' ' LYS . 67.9 p -96.67 162.05 13.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.137 0.494 . . . . 0.0 111.486 -177.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.623 ' HA ' ' HE ' ' A' ' 132' ' ' ARG . 2.1 mmp_? -127.27 106.93 9.56 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 173.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.538 ' HA ' HG21 ' A' ' 116' ' ' THR . 88.5 mt 63.24 176.43 0.16 Allowed 'General case' 0 N--CA 1.469 0.508 0 O-C-N 123.761 0.663 . . . . 0.0 111.382 -177.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.502 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 76.3 t80 -83.73 87.88 7.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.464 0.649 . . . . 0.0 109.684 175.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -104.15 135.66 45.22 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 176.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -55.44 -61.21 2.49 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 123.375 0.422 . . . . 0.0 112.03 -168.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.523 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.4 mp0 -55.74 -44.84 77.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.784 0.326 . . . . 0.0 110.885 -177.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -62.93 -46.03 89.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.509 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.579 ' CE2' ' HB3' ' A' ' 54' ' ' PHE . 63.6 t80 -69.99 -41.46 74.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.245 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.19 -40.15 89.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.575 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 48.1 m -67.12 -37.43 83.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.345 176.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.587 HD13 ' HG2' ' A' ' 129' ' ' LYS . 63.0 tp -62.47 -50.75 70.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.777 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 139' ' ' PHE . 94.6 t -56.45 -54.26 30.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.181 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -60.54 -42.85 97.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.629 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -56.28 -49.32 74.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.327 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.629 ' O ' HD23 ' A' ' 150' ' ' LEU . 28.9 mt -60.19 -50.94 78.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.1 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -55.08 -42.31 72.67 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.253 -0.179 . . . . 0.0 111.352 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -77.86 -24.51 48.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.686 0.279 . . . . 0.0 110.761 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 45.3 mmm -63.26 -31.31 72.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.403 0.621 . . . . 0.0 110.011 175.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.629 HD23 ' O ' ' A' ' 146' ' ' ILE . 4.0 mm? -80.67 -11.77 59.58 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.304 177.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -102.01 -27.42 12.95 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.266 -177.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -69.28 160.5 31.11 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.166 0.508 . . . . 0.0 110.601 -174.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -143.02 104.43 0.36 Allowed Glycine 0 N--CA 1.437 -1.237 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.384 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 11.9 m80 -53.85 108.58 0.37 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.092 0.472 . . . . 0.0 110.393 176.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -104.71 115.45 30.34 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.156 -173.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.457 ' O ' ' HB3' ' A' ' 157' ' ' HIS . 20.5 t-160 -72.36 132.24 43.71 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 164.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' HIS . . . . . 0.457 ' HB3' ' O ' ' A' ' 156' ' ' HIS . 15.3 t60 72.15 89.32 0.1 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -165.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 70.9 m80 -78.4 -36.52 45.69 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.78 -174.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 30.1 m80 . . . . . 0 C--O 1.247 0.956 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.566 177.479 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptm . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 120.515 0.198 . . . . 0.0 111.31 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.7 p -156.68 161.91 39.84 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 110.51 -0.181 . . . . 0.0 110.51 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.494 HD12 ' HD3' ' A' ' 132' ' ' ARG . 3.7 tt 63.69 -84.68 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 O-C-N 124.022 0.826 . . . . 0.0 110.06 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -154.49 16.39 0.57 Allowed Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -81.76 133.59 35.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.873 -0.163 . . . . 0.0 110.568 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.1 pt -87.78 -18.86 8.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.218 0.533 . . . . 0.0 109.667 174.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.5 m -93.84 -179.39 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.657 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.4 ' CD ' ' HB2' ' A' ' 11' ' ' GLU . 6.2 ppt_? -144.34 165.7 27.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.847 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 69.4 mt -67.4 128.4 30.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.138 0.494 . . . . 0.0 110.745 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.52 3.22 66.96 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.096 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.4 ' HB2' ' CD ' ' A' ' 8' ' ' ARG . 8.0 tp10 -85.68 151.75 23.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.58 0.229 . . . . 0.0 110.582 -178.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.45 ' HE2' ' HA ' ' A' ' 12' ' ' MET . 1.2 mmt -69.49 116.79 10.31 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 175.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.423 ' HB2' HG12 ' A' ' 121' ' ' ILE . . . -54.49 126.07 54.45 Favored Pre-proline 0 C--O 1.237 0.401 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.489 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.487 ' HG2' ' O ' ' A' ' 107' ' ' LYS . 27.3 Cg_exo -60.42 115.54 2.73 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.802 2.335 . . . . 0.0 111.028 178.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -70.64 133.01 46.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.828 -173.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.66 ' HB2' HD12 ' A' ' 104' ' ' ILE . 36.1 p90 -136.49 158.87 43.41 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.035 -178.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 49.0 m -117.31 99.51 7.06 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.4 tt -97.87 152.32 4.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.609 -173.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.49 ' O ' HD23 ' A' ' 98' ' ' LEU . 27.3 m -99.35 129.41 45.55 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.944 178.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.42 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 82.3 mt -85.01 -178.07 6.73 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.823 0.344 . . . . 0.0 111.13 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.442 HG23 ' O ' ' A' ' 96' ' ' LEU . 30.9 p -62.55 -26.43 68.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.081 -176.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.418 ' OD1' ' HB2' ' A' ' 24' ' ' LYS . 13.1 p-10 -92.79 -5.11 51.83 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.526 -178.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.51 2.4 56.52 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.135 -176.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.418 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 6.2 tmtt? -62.87 112.34 2.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.79 0.328 . . . . 0.0 111.829 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -87.52 117.63 26.45 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 172.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 17' ' ' THR . 7.1 p -126.5 133.25 69.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.298 0.571 . . . . 0.0 110.97 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 29' ' ' SER . 11.2 m -93.92 144.75 25.17 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.209 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.62 -29.49 70.65 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.77 0.319 . . . . 0.0 110.53 -178.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.413 ' H ' HG22 ' A' ' 27' ' ' THR . 36.6 m -56.13 -30.53 62.26 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.365 176.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.2 m -74.79 -24.97 58.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.398 0.618 . . . . 0.0 110.809 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 89.4 mt -90.74 -10.87 41.39 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.532 -176.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.437 HH11 ' HA3' ' A' ' 125' ' ' GLY . 35.3 mmt180 -57.68 154.52 11.49 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.62 -19.53 36.3 Favored Glycine 0 C--O 1.226 -0.38 0 C-N-CA 121.088 -0.577 . . . . 0.0 111.885 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.579 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 32.5 mtmm -116.59 170.47 8.55 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 68' ' ' ASP . 35.4 m -81.75 123.34 37.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 176.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.417 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 12.8 t -115.78 120.6 65.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.875 0.369 . . . . 0.0 110.873 -174.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 27.2 ttt -112.42 118.27 34.73 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.01 0.433 . . . . 0.0 110.485 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.741 HD23 HD13 ' A' ' 121' ' ' ILE . 2.8 mm? -111.17 107.98 17.49 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.08 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.447 HE21 ' HB2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -109.47 127.18 54.23 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.89 175.504 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -95.39 121.12 36.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.272 0.558 . . . . 0.0 110.436 -176.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.553 ' HA ' ' SG ' ' A' ' 48' ' ' CYS . 1.9 t -122.54 171.77 8.87 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.479 -175.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.527 ' HB2' HG12 ' A' ' 115' ' ' ILE . . . -150.65 130.53 13.31 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.678 177.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.532 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 47.8 m -57.96 -28.93 64.8 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.958 -177.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 38.7 p-90 -90.56 2.4 55.82 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 52.8 t -107.59 120.31 41.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.976 0.417 . . . . 0.0 111.223 -177.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -83.41 -17.64 66.06 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.702 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.546 HG12 HG21 ' A' ' 116' ' ' THR . 42.7 t -66.37 -43.45 91.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 176.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.566 ' O ' ' HG2' ' A' ' 52' ' ' MET . 72.3 m -64.23 -27.49 69.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.318 176.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 55.4 ttt180 -69.05 -6.11 26.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.155 0.502 . . . . 0.0 110.809 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.517 ' HE3' ' CD2' ' A' ' 134' ' ' TYR . 22.9 mtpp -83.31 -55.19 4.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.476 172.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 10.6 pt-20 -70.05 -31.73 69.49 Favored 'General case' 0 C--O 1.219 -0.553 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.729 -176.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.598 ' HG3' ' HE2' ' A' ' 86' ' ' PHE . 91.7 mmm -50.6 -60.01 6.23 Favored Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.501 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 53.2 Cg_endo -69.86 -31.43 20.08 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 121.611 1.541 . . . . 0.0 112.66 177.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -68.64 -50.25 52.73 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.323 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.589 ' O ' ' HB ' ' A' ' 59' ' ' ILE . 83.8 mt -57.13 -45.38 84.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.376 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.537 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 25.5 tt0 -58.77 -48.99 79.31 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.86 175.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -56.49 -56.65 18.63 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -174.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.69 ' HA ' ' NZ ' ' A' ' 62' ' ' LYS . 73.5 m-20 -105.06 -9.88 17.54 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -171.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.589 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 50.4 mm -105.26 -57.35 4.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.646 176.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.551 ' CD2' ' HB3' ' A' ' 94' ' ' TYR . 74.9 t-105 -69.69 -51.6 33.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.134 -173.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.572 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 3.1 mm? -61.06 -16.57 45.31 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.69 ' NZ ' ' HA ' ' A' ' 58' ' ' ASP . 48.5 mmtm -86.51 -27.93 23.72 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.615 -176.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -127.48 -41.31 1.72 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -173.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.572 ' HE2' ' HA ' ' A' ' 61' ' ' LEU . 34.4 mmtt 55.4 -91.34 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 O-C-N 123.493 0.496 . . . . 0.0 111.094 -174.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -96.24 -63.3 1.16 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.019 0.438 . . . . 0.0 110.065 178.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.449 ' ND2' HD12 ' A' ' 150' ' ' LEU . 1.1 t30 66.15 3.92 2.9 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.083 174.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 62.2 4.17 1.18 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.467 0.707 . . . . 0.0 112.655 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.579 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 20.2 t70 -152.21 5.48 0.41 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.429 0.633 . . . . 0.0 111.086 -175.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.571 ' CE2' ' HB2' ' A' ' 71' ' ' LEU . 85.3 t80 -117.95 120.8 38.94 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 121.706 -0.621 . . . . 0.0 110.888 -174.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -122.03 104.62 9.64 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.931 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.571 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 3.7 tt -108.48 114.75 28.83 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.0 mm -117.81 115.84 49.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.132 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.7 116.66 4.68 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.105 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 55.8 mt -105.8 100.91 11.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 117.155 0.478 . . . . 0.0 111.336 -173.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.526 ' HA ' ' O ' ' A' ' 41' ' ' THR . 1.9 t70 -85.43 136.16 33.56 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 172.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.468 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 16.8 ttp180 -72.59 -112.13 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -165.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.468 ' H ' ' HB3' ' A' ' 76' ' ' ARG . 17.3 m-20 -78.55 5.91 9.84 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -169.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.441 ' HG3' ' H ' ' A' ' 43' ' ' SER . 28.2 mm-40 -76.92 131.23 73.67 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-O 121.027 0.441 . . . . 0.0 110.987 -176.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.478 ' HG2' ' OE2' ' A' ' 81' ' ' GLU . 29.1 Cg_endo -68.65 176.76 5.5 Favored 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 122.663 2.242 . . . . 0.0 112.7 177.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 97.2 mt -53.0 -58.22 7.71 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -173.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.478 ' OE2' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -64.5 -21.39 66.66 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -173.372 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 28.7 mmtm -74.03 -54.8 7.08 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 172.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 60.1 t -56.48 -47.37 81.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.233 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.78 -33.17 75.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.283 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.72 -35.63 62.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.744 0.306 . . . . 0.0 110.882 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.598 ' HE2' ' HG3' ' A' ' 52' ' ' MET . 60.3 t80 -69.39 -40.15 77.55 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.424 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -57.95 -55.08 39.51 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.164 176.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -62.9 -24.19 67.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.653 -175.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.7 m -84.49 2.37 41.3 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.522 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 p -130.4 -25.65 2.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.245 175.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 124.71 -81.24 0.36 Allowed Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -176.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.5 t 45.69 85.28 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 124.366 1.066 . . . . 0.0 113.547 173.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 40.5 p -93.25 15.81 14.63 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.545 173.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.551 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 42.0 p90 -111.39 148.15 38.19 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.133 175.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -63.16 130.53 29.14 Favored 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 122.436 2.091 . . . . 0.0 113.116 -177.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.442 ' O ' HG23 ' A' ' 21' ' ' THR . 94.8 mt -103.77 146.42 28.64 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.514 174.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -119.4 149.25 18.05 Favored Glycine 0 N--CA 1.438 -1.182 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 175.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.784 HD23 ' H ' ' A' ' 98' ' ' LEU . 2.1 pt? -107.02 142.08 37.21 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.854 0.359 . . . . 0.0 110.294 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -124.12 72.98 56.68 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.006 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.416 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 16.8 Cg_exo -67.71 109.81 1.96 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.718 2.279 . . . . 0.0 111.628 177.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 116.32 -3.62 20.26 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -176.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.442 ' O ' ' HG2' ' A' ' 111' ' ' ARG . . . 51.45 36.37 16.55 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.095 0.558 . . . . 0.0 112.184 -178.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -88.04 -39.55 14.56 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.115 -175.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.66 HD12 ' HB2' ' A' ' 16' ' ' PHE . 17.6 mm -66.9 -34.56 70.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 176.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.401 ' HD2' ' HA ' ' A' ' 111' ' ' ARG . 70.8 t80 -65.1 -39.03 92.57 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.728 171.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.652 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -69.0 -16.91 63.84 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.803 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.507 ' HG2' ' HA ' ' A' ' 104' ' ' ILE . 20.7 mmtt -66.35 -25.28 66.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.16 0.505 . . . . 0.0 109.903 177.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -112.69 -37.07 5.0 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.825 -174.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.652 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -147.39 168.36 22.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.668 0.27 . . . . 0.0 111.403 -174.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 9.0 mp -62.23 138.14 58.37 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 174.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 102' ' ' ALA . 97.4 mtt180 -58.25 -26.75 63.28 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 -170.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -113.41 12.42 18.74 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.474 0.654 . . . . 0.0 111.049 -178.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.506 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . . . -83.64 46.98 1.22 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.114 0.483 . . . . 0.0 110.876 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 93.39 -159.23 24.04 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.708 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.527 HG12 ' HB2' ' A' ' 42' ' ' ALA . 5.3 tp -152.89 -54.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 122.773 -0.251 . . . . 0.0 111.248 176.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.546 HG21 HG12 ' A' ' 47' ' ' VAL . 3.0 m -64.57 123.82 20.25 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 122.469 0.308 . . . . 0.0 111.341 -174.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -176.68 152.8 1.03 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.79 0.329 . . . . 0.0 110.834 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.561 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 36.1 m-20 -116.65 118.41 32.5 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 177.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 41.2 t -109.79 126.85 66.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.645 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.642 HD21 ' SD ' ' A' ' 149' ' ' MET . 40.7 tp -119.7 127.02 52.48 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.068 0.461 . . . . 0.0 111.327 -178.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.741 HD13 HD23 ' A' ' 38' ' ' LEU . 1.9 mp -113.18 137.38 46.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.175 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.67 179.44 7.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.537 -178.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -62.86 -28.06 69.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.128 -176.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.615 ' HB2' ' NZ ' ' A' ' 126' ' ' LYS . 69.4 mt-10 -79.78 -12.16 59.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.108 0.48 . . . . 0.0 110.559 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.437 ' HA3' HH11 ' A' ' 32' ' ' ARG . . . 99.67 12.06 42.08 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.804 176.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.615 ' NZ ' ' HB2' ' A' ' 124' ' ' GLU . 31.5 mtmm -93.23 143.74 25.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.896 0.379 . . . . 0.0 111.093 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 47.2 mt -78.35 108.06 11.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.1 m -104.7 -20.74 5.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -171.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.568 ' HE3' ' OG1' ' A' ' 131' ' ' THR . 8.3 tmtm? -145.18 126.73 15.08 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.429 -172.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -125.54 107.24 10.42 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.542 178.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.568 ' OG1' ' HE3' ' A' ' 129' ' ' LYS . 97.7 m -95.76 139.46 31.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.799 0.333 . . . . 0.0 110.366 174.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.528 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 89.1 mtt180 -97.05 123.11 40.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.049 -178.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 132' ' ' ARG . 4.4 pp 50.89 21.54 0.98 Allowed 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 172.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.517 ' CD2' ' HE3' ' A' ' 50' ' ' LYS . 23.0 t80 58.95 112.27 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 122.284 1.04 . . . . 0.0 112.221 -176.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -119.19 139.71 51.39 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.85 174.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -53.68 -54.14 42.06 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -175.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.462 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.6 mp0 -58.31 -47.04 84.98 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.173 0.511 . . . . 0.0 110.806 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -57.3 -45.48 84.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.19 177.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.598 ' O ' HG23 ' A' ' 143' ' ' VAL . 70.0 t80 -61.72 -46.78 88.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.592 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.43 -45.68 80.61 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.084 0.468 . . . . 0.0 110.633 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.9 m -65.62 -39.02 91.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.329 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.76 -41.17 98.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.391 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 139' ' ' PHE . 96.0 t -56.05 -55.72 16.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.654 177.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -60.4 -44.44 95.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.337 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.599 ' O ' ' HG3' ' A' ' 149' ' ' MET . 42.4 tt0 -53.98 -52.13 61.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.009 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.598 ' O ' HD23 ' A' ' 150' ' ' LEU . 22.5 mt -62.36 -44.26 99.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.725 -0.216 . . . . 0.0 110.996 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -57.54 -39.42 76.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.144 0.497 . . . . 0.0 110.324 176.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -68.47 -36.06 78.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.195 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.642 ' SD ' HD21 ' A' ' 120' ' ' LEU . 90.1 mtp -64.74 -31.82 73.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.212 0.529 . . . . 0.0 110.435 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.598 HD23 ' O ' ' A' ' 146' ' ' ILE . 4.0 mm? -71.33 -12.27 61.35 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.424 177.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.564 ' HA ' ' NZ ' ' A' ' 151' ' ' LYS . 0.4 OUTLIER -96.74 -46.6 6.21 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 170.751 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 74.9 117.54 0.05 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-N 114.219 -1.355 . . . . 0.0 112.161 173.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -65.82 86.2 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 165.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 13.4 m80 -49.38 112.58 0.66 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 122.03 0.919 . . . . 0.0 113.114 -166.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -75.82 68.13 2.32 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.014 -1.448 . . . . 0.0 110.976 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -155.14 97.05 1.88 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.445 176.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' HIS . . . . . 0.55 ' HB3' ' H ' ' A' ' 159' ' ' HIS . 61.2 m170 -120.67 -174.13 2.74 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.989 0.424 . . . . 0.0 110.331 -178.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -109.3 1.35 20.07 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 163.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.55 ' H ' ' HB3' ' A' ' 157' ' ' HIS . 51.4 t-80 . . . . . 0 C--O 1.247 0.955 0 CA-C-N 113.557 -1.656 . . . . 0.0 108.06 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.8 mmm . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.4 t -151.41 133.27 15.0 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.727 HD23 ' H ' ' A' ' 3' ' ' LEU . 1.1 pt? -99.15 69.01 1.7 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.597 0.713 . . . . 0.0 110.143 177.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.09 24.0 76.61 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.395 -0.82 . . . . 0.0 113.476 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -87.3 116.0 25.09 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 117.199 0.499 . . . . 0.0 109.955 174.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.1 pt -92.75 -26.01 4.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.797 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.6 p -94.83 152.84 3.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.454 ' HE ' ' CD ' ' A' ' 11' ' ' GLU . 0.6 OUTLIER -118.03 156.6 28.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.315 0.578 . . . . 0.0 112.453 -171.087 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.4 mt -73.2 132.66 33.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.459 170.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.59 -9.15 77.76 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -175.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.454 ' CD ' ' HE ' ' A' ' 8' ' ' ARG . 36.2 tt0 -99.66 156.98 16.79 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 91.5 mmm -72.69 125.72 28.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.91 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.433 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -66.13 126.36 91.8 Favored Pre-proline 0 C--O 1.237 0.427 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.053 178.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.473 ' HG2' ' O ' ' A' ' 107' ' ' LYS . 45.9 Cg_exo -57.29 122.7 12.25 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.127 2.551 . . . . 0.0 112.125 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.511 ' HA ' HD12 ' A' ' 28' ' ' LEU . 1.4 t70 -71.16 134.69 47.14 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.63 -175.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.58 ' HB2' HD12 ' A' ' 104' ' ' ILE . 42.4 p90 -141.33 174.36 10.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.826 0.346 . . . . 0.0 110.793 -178.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 55.3 m -134.87 114.32 12.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.38 174.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.513 ' O ' ' HA ' ' A' ' 25' ' ' GLN . 14.4 tt -112.25 141.85 26.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.16 -174.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.3 m -88.38 120.34 29.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.68 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.654 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 85.7 mt -79.51 -179.09 6.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.3 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.475 ' HB ' HD11 ' A' ' 84' ' ' LEU . 36.6 p -51.07 -43.96 61.08 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -174.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -100.87 12.34 37.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.845 0.355 . . . . 0.0 111.493 -174.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.16 17.2 41.08 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.984 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.532 ' HE2' ' HA ' ' A' ' 24' ' ' LYS . 7.8 mmpt? -80.22 112.16 17.28 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 175.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.513 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 90.5 mt-30 -100.08 113.53 26.21 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.997 0.427 . . . . 0.0 110.49 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 17' ' ' THR . 14.1 m -105.84 147.05 11.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.723 -177.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.8 m -116.75 142.23 47.18 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.943 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.511 HD12 ' HA ' ' A' ' 15' ' ' ASP . 13.3 mt -60.99 -32.97 72.53 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 -178.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.2 m -56.68 -31.26 64.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.032 0.444 . . . . 0.0 111.062 177.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.8 m -79.32 -20.16 48.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.979 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.417 ' C ' ' HD3' ' A' ' 34' ' ' LYS . 86.5 mt -107.35 11.62 28.9 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.899 -178.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 28' ' ' LEU . 37.3 mmt180 -70.9 137.17 49.07 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 171.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.76 -7.65 57.66 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.499 -174.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.572 ' HG3' ' HA ' ' A' ' 68' ' ' ASP . 9.6 mptt -113.15 157.47 21.63 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 175.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 68' ' ' ASP . 2.1 p -84.17 103.91 11.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 170.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.435 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 22.3 t -95.86 111.62 26.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.202 -171.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 24.8 ttt -96.86 125.97 41.68 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.011 0.434 . . . . 0.0 110.277 175.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.492 HD13 HD13 ' A' ' 121' ' ' ILE . 6.5 mp -108.64 130.51 55.32 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.941 176.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.4 ' OE1' HD12 ' A' ' 55' ' ' ILE . 5.6 tt0 -117.66 114.5 23.45 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.441 178.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.544 ' O ' ' HA ' ' A' ' 116' ' ' THR . 94.2 m-85 -93.2 106.18 18.17 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.061 0.457 . . . . 0.0 110.152 178.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.441 ' HA ' ' SG ' ' A' ' 48' ' ' CYS . 11.7 t -117.41 175.37 5.65 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.563 -174.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.411 ' HB2' HG12 ' A' ' 115' ' ' ILE . . . -154.3 136.59 14.88 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.412 ' OG ' ' HG3' ' A' ' 78' ' ' GLU . 28.3 p -62.17 -11.07 12.48 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -173.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 2.8 p-90 -117.03 19.8 14.11 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 122.087 -0.383 . . . . 0.0 111.724 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.408 ' SG ' ' HB ' ' A' ' 47' ' ' VAL . 43.3 t -108.14 114.17 27.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.847 0.356 . . . . 0.0 110.765 178.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.18 -17.48 79.97 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.364 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.433 HG11 ' HB3' ' A' ' 133' ' ' LEU . 58.6 t -64.56 -40.1 87.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 175.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.468 ' HA ' ' HB3' ' A' ' 51' ' ' GLU . 81.1 m -68.82 -16.9 63.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.796 176.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 27.4 ttt85 -78.52 -11.98 59.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.956 0.408 . . . . 0.0 110.174 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -84.54 -50.38 7.76 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 122.128 0.966 . . . . 0.0 108.443 162.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.681 ' HB2' ' HB2' ' A' ' 134' ' ' TYR . 40.0 tt0 -57.25 -59.79 4.59 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 113.631 -1.622 . . . . 0.0 112.094 -171.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.664 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 85.7 mtp -57.37 -53.03 69.73 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -173.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.664 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 45.9 Cg_exo -60.04 -41.8 49.51 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.242 1.961 . . . . 0.0 113.053 177.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -65.16 -44.84 87.25 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.765 0.317 . . . . 0.0 110.802 177.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.608 ' O ' ' HB ' ' A' ' 59' ' ' ILE . 64.0 mt -60.34 -42.95 92.58 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.314 176.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.578 ' OE1' ' HA ' ' A' ' 92' ' ' VAL . 37.5 tp10 -52.62 -58.81 5.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.451 0.643 . . . . 0.0 109.943 174.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -60.68 -59.09 5.94 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.36 -173.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.496 ' HA ' ' NZ ' ' A' ' 62' ' ' LYS . 72.2 m-20 -106.52 -5.26 18.94 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -168.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.608 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 22.8 mm -104.98 -57.95 4.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.061 0.458 . . . . 0.0 110.428 173.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.538 ' CD2' ' HB3' ' A' ' 94' ' ' TYR . 68.9 t-105 -66.11 -73.47 0.13 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.823 -173.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -50.98 -27.36 7.54 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -173.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.496 ' NZ ' ' HA ' ' A' ' 58' ' ' ASP . 47.9 mmtm -67.47 -33.96 76.18 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.421 ' CG ' HD11 ' A' ' 150' ' ' LEU . 67.7 m-70 -131.57 -44.5 0.99 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.236 -0.586 . . . . 0.0 112.044 -176.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.472 ' O ' ' HD2' ' A' ' 69' ' ' PHE . 9.5 mtmp? 42.93 -95.62 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.662 0.785 . . . . 0.0 112.662 -176.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.04 -72.39 0.45 Allowed 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.557 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 30.5 t30 66.75 -70.55 0.11 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.472 -177.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.793 ' HB3' ' HD2' ' A' ' 159' ' ' HIS . . . 164.32 -30.33 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 124.605 1.162 . . . . 0.0 108.36 -178.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.572 ' HA ' ' HG3' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -143.27 40.18 1.46 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.965 -1.016 . . . . 0.0 112.23 -178.94 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.472 ' HD2' ' O ' ' A' ' 64' ' ' LYS . 80.8 t80 -119.34 138.07 53.29 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 169.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.435 ' HB3' ' HA ' ' A' ' 36' ' ' VAL . . . -134.43 139.75 45.76 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.218 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.9 tt -143.13 115.76 8.65 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -117.0 118.39 58.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.708 0.289 . . . . 0.0 110.256 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.525 ' HA3' HD13 ' A' ' 96' ' ' LEU . . . -88.38 108.67 3.45 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 175.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 59.6 mt -101.66 107.43 21.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 O-C-N 122.588 -0.36 . . . . 0.0 111.323 -173.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.52 ' HB3' HG22 ' A' ' 83' ' ' VAL . 10.7 t0 -85.58 128.47 34.77 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 174.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.405 ' HD3' HD13 ' A' ' 115' ' ' ILE . 8.4 ttp180 -91.6 126.93 36.86 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.854 -168.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.527 ' HA ' ' HA ' ' A' ' 100' ' ' PRO . 53.4 m-20 71.39 -43.9 0.57 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.999 0.919 . . . . 0.0 113.054 173.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.571 ' OE1' ' HG3' ' A' ' 82' ' ' LYS . 78.2 mm-40 -60.63 136.22 92.46 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 121.365 0.603 . . . . 0.0 112.141 -176.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.636 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 35.5 Cg_endo -71.16 -173.15 0.85 Allowed 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 123.301 2.667 . . . . 0.0 114.109 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.403 ' O ' HD23 ' A' ' 84' ' ' LEU . 91.6 mt -53.75 -57.08 12.15 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 114.745 -1.116 . . . . 0.0 113.308 -173.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.636 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -61.06 -29.81 69.96 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -171.66 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.571 ' HG3' ' OE1' ' A' ' 78' ' ' GLU . 40.5 mmtm -64.89 -58.28 6.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.237 0.541 . . . . 0.0 110.182 173.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.52 HG22 ' HB3' ' A' ' 75' ' ' ASP . 38.7 t -56.24 -49.62 75.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.476 -176.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.475 HD11 ' HB ' ' A' ' 21' ' ' THR . 4.4 mm? -63.24 -47.13 83.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.657 -176.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.21 -39.54 78.54 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -176.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.537 ' HE2' ' SD ' ' A' ' 52' ' ' MET . 79.6 t80 -68.81 -44.25 73.91 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 121.131 -0.228 . . . . 0.0 111.181 -176.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.1 -41.96 94.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.311 0.577 . . . . 0.0 109.72 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -59.07 -29.56 67.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.043 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 18.5 t -82.09 -7.21 59.61 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.946 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 43.6 p -123.49 7.78 8.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.763 0.316 . . . . 0.0 111.434 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.73 -53.2 4.28 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.942 -0.647 . . . . 0.0 113.092 176.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.578 ' HA ' ' OE1' ' A' ' 56' ' ' GLU . 77.1 t -2.06 113.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 125.843 1.657 . . . . 0.0 115.392 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 58.9 p -100.45 -17.73 17.03 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.61 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.538 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 29.7 p90 -72.76 145.37 86.86 Favored Pre-proline 0 N--CA 1.462 0.145 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.322 176.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.98 134.25 45.39 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.887 2.391 . . . . 0.0 113.865 -174.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.525 HD13 ' HA3' ' A' ' 73' ' ' GLY . 4.1 mm? -99.5 149.85 22.8 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.453 175.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.654 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -130.87 158.88 22.8 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.589 -0.605 . . . . 0.0 111.589 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 98' ' ' LEU . 6.2 mp -99.52 139.56 35.0 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.647 0.261 . . . . 0.0 110.613 -177.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -125.73 75.33 70.54 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.174 173.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.527 ' HA ' ' HA ' ' A' ' 77' ' ' ASP . 61.4 Cg_endo -73.94 115.67 4.4 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.569 2.179 . . . . 0.0 112.335 -176.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 102.18 -0.66 50.82 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 56.92 36.8 28.25 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 115.189 -0.505 . . . . 0.0 111.468 -177.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -73.63 -48.05 35.41 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.389 -176.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.58 HD12 ' HB2' ' A' ' 16' ' ' PHE . 18.0 mm -67.41 -36.43 76.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.421 ' CD2' ' HA ' ' A' ' 111' ' ' ARG . 79.3 t80 -65.1 -41.14 95.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.085 174.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.638 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -66.16 -20.75 66.24 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.608 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.473 ' O ' ' HG2' ' A' ' 14' ' ' PRO . 53.0 mttp -74.14 -13.34 60.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.807 0.337 . . . . 0.0 111.164 177.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -115.73 -40.41 3.36 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.012 0.434 . . . . 0.0 111.145 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.638 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -149.74 168.17 24.4 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.584 -177.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 90.9 mt -68.36 130.92 44.32 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.487 ' HG3' ' H ' ' A' ' 111' ' ' ARG . 11.5 mtm180 -53.38 -47.11 69.75 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 122.2 1.0 . . . . 0.0 109.995 -177.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -82.48 10.46 7.19 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.767 -171.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.421 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . . . -98.68 -2.61 37.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.989 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 145.27 -167.15 27.47 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.57 177.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.52 HG23 ' H ' ' A' ' 116' ' ' THR . 2.0 tp -136.19 -67.87 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.591 ' HB ' HD23 ' A' ' 133' ' ' LEU . 24.3 m -67.07 109.67 3.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.761 0.315 . . . . 0.0 111.37 -174.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -151.7 141.77 22.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.928 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.584 ' HB2' ' OG1' ' A' ' 131' ' ' THR . 51.8 m-80 -111.18 121.63 45.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.165 0.507 . . . . 0.0 110.276 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 49.9 t -115.99 118.32 58.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.803 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.61 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 43.0 tp -106.84 127.09 53.11 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.577 0.227 . . . . 0.0 111.211 -177.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.492 HD13 HD13 ' A' ' 38' ' ' LEU . 2.5 mp -113.73 137.63 46.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.377 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.496 ' OD2' ' HB2' ' A' ' 126' ' ' LYS . 3.7 p30 -82.34 -179.42 7.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.871 0.367 . . . . 0.0 111.217 177.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.5 ' NH2' ' HA ' ' A' ' 150' ' ' LEU . 7.0 mpt_? -59.22 -32.51 70.02 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.017 -177.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -76.88 -22.59 53.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.151 0.5 . . . . 0.0 110.856 -173.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 111.64 6.8 24.74 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.175 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.496 ' HB2' ' OD2' ' A' ' 122' ' ' ASP . 9.1 mtmp? -93.95 149.85 20.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.818 0.342 . . . . 0.0 110.914 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.445 HG21 HD21 ' A' ' 130' ' ' LEU . 62.5 mt -84.4 130.5 35.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.273 177.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 18.1 m -121.89 4.04 6.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -177.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.722 ' HE2' ' HB3' ' A' ' 142' ' ' LEU . 53.3 tptt -160.58 128.72 4.57 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.314 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.445 HD21 HG21 ' A' ' 127' ' ' ILE . 90.0 mt -132.0 104.39 6.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.478 174.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.584 ' OG1' ' HB2' ' A' ' 118' ' ' ASN . 22.9 p -107.88 156.45 19.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.017 0.437 . . . . 0.0 111.638 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.948 HH12 ' HG3' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -104.72 118.94 37.82 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.262 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.591 HD23 ' HB ' ' A' ' 116' ' ' THR . 50.0 mt 65.49 -173.47 0.18 Allowed 'General case' 0 C--O 1.236 0.389 0 O-C-N 123.883 0.739 . . . . 0.0 109.831 -175.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.681 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 9.4 t80 -58.91 -44.89 91.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.017 173.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.515 ' HB3' ' HB2' ' A' ' 138' ' ' GLU . 0.2 OUTLIER 55.82 95.34 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.851 0.72 . . . . 0.0 110.684 174.771 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -40.97 -59.34 1.48 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.226 -172.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.551 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 0.7 OUTLIER -68.45 -47.06 68.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.568 -176.56 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.948 ' HG3' HH12 ' A' ' 132' ' ' ARG . 2.5 mm-40 -64.97 -34.54 78.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.092 -175.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.494 ' HE1' HG12 ' A' ' 55' ' ' ILE . 82.2 t80 -63.51 -44.21 94.97 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.812 175.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.497 ' O ' HG12 ' A' ' 143' ' ' VAL . . . -62.07 -42.39 99.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.382 0.61 . . . . 0.0 110.361 177.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.4 m -61.49 -46.0 91.84 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.318 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.722 ' HB3' ' HE2' ' A' ' 129' ' ' LYS . 4.3 pp -80.19 -28.91 38.6 Favored 'General case' 0 C--O 1.217 -0.65 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.262 -176.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 140' ' ' ALA . 12.6 p -60.57 -42.09 90.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.356 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -66.41 -45.59 79.42 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.416 174.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.605 ' O ' ' HG3' ' A' ' 149' ' ' MET . 44.3 tt0 -55.78 -53.4 57.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.731 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.657 HG13 ' O ' ' A' ' 142' ' ' LEU . 38.0 mt -57.41 -47.01 85.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.929 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.733 ' O ' ' HG3' ' A' ' 151' ' ' LYS . 95.4 m-20 -48.92 -58.81 4.26 Favored 'General case' 0 CA--C 1.517 -0.327 0 O-C-N 123.134 0.271 . . . . 0.0 110.883 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 151' ' ' LYS . 15.8 tp10 -68.18 -26.15 65.6 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 123.43 0.456 . . . . 0.0 111.233 -175.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.605 ' HG3' ' O ' ' A' ' 145' ' ' GLN . 51.1 mtp -57.86 -48.88 78.51 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.022 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.609 HD23 ' O ' ' A' ' 146' ' ' ILE . 0.8 OUTLIER -90.76 2.95 55.59 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.253 -0.979 . . . . 0.0 112.097 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.733 ' HG3' ' O ' ' A' ' 147' ' ' ASN . 3.6 mtpm? -76.1 -45.6 33.08 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 164.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.404 ' CG ' HH12 ' A' ' 123' ' ' ARG . 0.9 OUTLIER 45.14 -7.31 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 117.316 2.339 . . . . 0.0 117.316 175.496 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 151' ' ' LYS . . . 69.91 15.52 71.68 Favored Glycine 0 CA--C 1.522 0.49 0 CA-C-N 118.733 0.697 . . . . 0.0 113.975 173.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -108.98 -66.9 1.02 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.573 0.687 . . . . 0.0 109.92 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 51.04 74.62 0.23 Allowed 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.862 0.726 . . . . 0.0 111.402 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -132.1 103.77 6.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.258 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 33.2 m170 75.91 -40.63 0.41 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 172.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -75.39 -29.26 59.76 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.793 ' HD2' ' HB3' ' A' ' 67' ' ' ALA . 13.5 p80 . . . . . 0 C--O 1.247 0.962 0 CA-C-O 117.467 -1.254 . . . . 0.0 108.156 173.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.428 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.118 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.0 m 47.16 -141.35 0.47 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.345 0.258 . . . . 0.0 110.785 176.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.761 HD23 ' H ' ' A' ' 3' ' ' LEU . 2.3 pt? -97.44 43.74 1.06 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.387 0.613 . . . . 0.0 110.218 174.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.31 22.31 5.57 Favored Glycine 0 C--O 1.224 -0.469 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.093 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -108.81 118.44 36.78 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.814 0.34 . . . . 0.0 110.905 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.2 pt -89.38 -11.2 10.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.2 0.524 . . . . 0.0 109.749 175.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.8 p -94.2 162.97 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.297 177.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.593 ' HB2' ' HB2' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -128.65 151.17 49.81 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.32 -169.564 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.499 HG12 HD23 ' A' ' 130' ' ' LEU . 57.6 mt -75.24 132.91 32.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.165 177.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.69 5.01 90.23 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.615 -177.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.593 ' HB2' ' HB2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -115.02 161.48 18.28 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -176.211 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 85.3 mmm -68.15 133.47 48.96 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.093 0.473 . . . . 0.0 111.916 -173.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -81.73 134.58 50.27 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.585 173.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.542 ' HG2' ' O ' ' A' ' 107' ' ' LYS . 33.2 Cg_exo -62.2 121.09 8.96 Favored 'Trans proline' 0 N--CA 1.464 -0.225 0 C-N-CA 122.822 2.348 . . . . 0.0 111.759 175.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.46 ' OD1' HG22 ' A' ' 27' ' ' THR . 1.3 t70 -73.74 134.58 43.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.505 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.62 ' HB2' HD12 ' A' ' 104' ' ' ILE . 51.3 p90 -136.88 165.78 25.15 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.057 -173.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 58.5 m -119.74 115.48 23.98 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.439 172.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.7 tt -111.99 150.68 14.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.86 -174.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.2 m -98.77 125.11 44.03 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.263 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.542 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 85.8 mt -84.65 -177.81 6.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.791 -176.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.488 ' HB ' HD11 ' A' ' 84' ' ' LEU . 28.3 p -56.07 -40.51 73.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.837 -175.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.405 ' OD2' ' HG3' ' A' ' 24' ' ' LYS . 7.5 p-10 -98.75 12.07 36.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.915 0.388 . . . . 0.0 111.042 -177.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.8 3.03 60.98 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.388 -0.91 . . . . 0.0 113.617 176.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.479 ' HB2' HD12 ' A' ' 20' ' ' LEU . 60.7 mttp -64.83 124.89 23.17 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 117.357 0.578 . . . . 0.0 111.012 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -104.83 113.79 27.6 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 17' ' ' THR . 16.4 m -122.5 148.78 26.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.858 -176.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.46 HG22 ' OD1' ' A' ' 15' ' ' ASP . 4.9 m -106.65 148.08 28.77 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.438 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.502 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 0.6 OUTLIER -61.03 -32.94 72.53 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -177.515 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.526 ' HA ' ' CG ' ' A' ' 32' ' ' ARG . 60.9 m -54.56 -25.26 24.99 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.144 177.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.6 t -77.35 -11.07 59.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.942 0.401 . . . . 0.0 110.766 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.485 HD13 ' HB1' ' A' ' 70' ' ' ALA . 76.5 mt -119.56 0.44 11.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.381 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.526 ' CG ' ' HA ' ' A' ' 29' ' ' SER . 52.1 mmm-85 -68.24 131.57 45.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.877 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.7 -27.27 7.63 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -172.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.702 ' HB2' ' C ' ' A' ' 68' ' ' ASP . 12.9 ptpt -116.09 165.63 12.92 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 174.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 68' ' ' ASP . 4.0 p -80.7 123.41 37.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.197 0.522 . . . . 0.0 110.574 -177.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.432 HG22 ' HB3' ' A' ' 70' ' ' ALA . 23.5 t -110.95 123.87 67.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.372 -176.032 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.558 ' SD ' HG21 ' A' ' 59' ' ' ILE . 26.1 ttt -103.03 131.51 49.96 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.233 176.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.553 HD13 HD13 ' A' ' 121' ' ' ILE . 5.5 mp -126.03 148.3 49.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.477 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.5 148.54 42.81 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 169.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -112.81 113.15 25.11 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.054 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.4 t -129.41 -168.77 1.99 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.406 -174.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.521 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . . . -163.87 165.52 22.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.548 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.541 ' HB2' ' HB3' ' A' ' 82' ' ' LYS . 7.6 t -73.45 -25.04 60.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.177 0.513 . . . . 0.0 111.132 -172.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 68.2 p-90 -88.81 0.3 56.65 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 122.233 -0.292 . . . . 0.0 111.684 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 42' ' ' ALA . 73.7 m -78.99 99.63 6.94 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.183 0.516 . . . . 0.0 111.218 -178.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.49 -37.49 89.97 Favored Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.89 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.521 HG21 HD11 ' A' ' 133' ' ' LEU . 38.1 t -63.19 -32.48 56.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.057 0.456 . . . . 0.0 110.617 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.644 ' SG ' HG22 ' A' ' 116' ' ' THR . 84.8 m -70.37 -15.51 62.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.277 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.748 ' HE ' ' HE1' ' A' ' 86' ' ' PHE . 98.9 mtt180 -77.81 -6.75 55.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.246 0.546 . . . . 0.0 110.084 176.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.483 ' HE2' ' CE2' ' A' ' 134' ' ' TYR . 54.6 mtpt -100.64 -43.29 6.21 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 164.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.61 ' HB3' ' HA ' ' A' ' 48' ' ' CYS . 23.0 tt0 -52.43 -64.12 0.92 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.328 -1.305 . . . . 0.0 112.218 -177.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.434 ' HE2' ' CE2' ' A' ' 86' ' ' PHE . 39.7 mtm -65.25 -46.27 71.63 Favored Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -171.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.445 ' HG2' ' O ' ' A' ' 49' ' ' ARG . 72.4 Cg_exo -53.9 -38.37 85.95 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.709 1.606 . . . . 0.0 111.885 174.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.49 ' HB3' ' CZ ' ' A' ' 139' ' ' PHE . 4.9 m-85 -69.11 -42.79 75.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.781 176.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 51' ' ' GLU . 76.4 mt -57.12 -48.52 81.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.173 175.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.627 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 13.9 tp10 -55.78 -48.84 74.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.097 175.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -55.08 -57.08 13.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.775 -176.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.637 ' HA ' ' NZ ' ' A' ' 62' ' ' LYS . 44.8 m-20 -106.42 -43.14 4.84 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -170.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.558 HG21 ' SD ' ' A' ' 37' ' ' MET . 1.9 mp -75.62 -56.72 7.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.982 0.42 . . . . 0.0 110.801 -176.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.784 ' CE2' ' HG2' ' A' ' 64' ' ' LYS . 22.4 t-105 -72.02 -58.82 3.11 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.338 -173.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.627 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.8 OUTLIER -44.68 -43.66 8.52 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.674 0.79 . . . . 0.0 113.027 -173.621 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.637 ' NZ ' ' HA ' ' A' ' 58' ' ' ASP . 30.0 mmtm -84.2 -23.93 30.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.206 0.526 . . . . 0.0 111.484 -174.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 68.3 m-70 -125.53 24.76 7.17 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -166.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.784 ' HG2' ' CE2' ' A' ' 60' ' ' TRP . 28.7 mttt -53.81 93.93 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 123.079 1.418 . . . . 0.0 112.528 -177.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.636 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 13.4 t70 64.4 -42.96 0.29 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 110.538 -3.028 . . . . 0.0 110.508 -168.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.49 ' H ' ' C ' ' A' ' 64' ' ' LYS . 13.0 t30 66.31 -57.08 0.38 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.094 0.958 . . . . 0.0 111.001 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 167.18 -31.35 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 125.271 1.428 . . . . 0.0 107.355 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.702 ' C ' ' HB2' ' A' ' 34' ' ' LYS . 21.7 p-10 -147.91 32.92 0.84 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.185 -1.37 . . . . 0.0 111.292 -173.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.636 ' O ' ' HA ' ' A' ' 65' ' ' ASP . 88.1 t80 -127.29 133.26 50.17 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.977 0.418 . . . . 0.0 110.014 172.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.558 ' HB2' ' HD2' ' A' ' 34' ' ' LYS . . . -124.76 142.13 51.63 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.342 175.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.5 tt -135.46 117.74 15.6 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 68.1 mt -123.87 119.42 56.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.382 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.426 ' HA3' HD22 ' A' ' 96' ' ' LEU . . . -89.69 131.35 10.68 Favored Glycine 0 C--O 1.222 -0.598 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 174.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 48.5 mt -119.78 141.64 38.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 117.548 0.674 . . . . 0.0 111.017 -173.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.521 ' OD2' ' HA ' ' A' ' 42' ' ' ALA . 10.2 t0 -114.42 120.5 40.52 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 176.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.651 ' HG2' HD13 ' A' ' 115' ' ' ILE . 4.4 ptm180 -73.84 -2.84 25.38 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -165.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.586 ' HA ' ' HA ' ' A' ' 100' ' ' PRO . 0.4 OUTLIER -169.44 -32.26 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 118.448 -1.301 . . . . 0.0 113.713 -175.135 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.424 ' HB3' ' HG3' ' A' ' 82' ' ' LYS . 35.8 mt-10 -78.7 142.0 60.76 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 121.324 0.583 . . . . 0.0 111.658 -173.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.615 ' HG2' ' OE2' ' A' ' 81' ' ' GLU . 38.5 Cg_endo -71.2 -173.81 1.02 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.185 2.59 . . . . 0.0 114.437 -174.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 89.1 mt -51.43 -57.43 9.0 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.756 -174.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.615 ' OE2' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -61.11 -28.57 69.19 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -172.326 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.612 ' HG2' ' OE2' ' A' ' 81' ' ' GLU . 44.0 mmtm -67.38 -52.75 36.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.794 0.33 . . . . 0.0 110.445 173.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 62.0 t -59.55 -51.1 76.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.241 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.488 HD11 ' HB ' ' A' ' 21' ' ' THR . 4.3 mm? -65.27 -36.5 84.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.488 -176.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.403 ' O ' ' HG2' ' A' ' 88' ' ' LYS . . . -75.5 -32.19 60.44 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 121.061 -0.256 . . . . 0.0 111.232 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.748 ' HE1' ' HE ' ' A' ' 49' ' ' ARG . 79.5 t80 -74.83 -41.27 60.22 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.492 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.42 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -59.53 -53.27 59.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.7 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 85' ' ' ALA . 19.7 pttm -55.92 -31.75 63.16 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.762 -174.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 68.5 m -87.13 2.19 50.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.386 -175.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 33.3 p -130.57 10.1 5.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.344 0.592 . . . . 0.0 110.342 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.5 -73.11 1.68 Allowed Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.507 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.4 t 29.85 90.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.808 1.243 . . . . 0.0 114.092 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 76.0 p -98.93 17.97 18.31 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.133 0.492 . . . . 0.0 110.726 175.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.611 ' HB3' ' CE2' ' A' ' 60' ' ' TRP . 31.1 p90 -114.52 147.66 38.56 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.885 175.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.4 135.89 60.38 Favored 'Trans proline' 0 C--O 1.239 0.537 0 C-N-CA 122.44 2.093 . . . . 0.0 113.453 -176.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.434 ' O ' HG23 ' A' ' 21' ' ' THR . 72.7 mt -111.6 144.99 39.96 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.491 175.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.542 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -122.52 150.55 16.91 Favored Glycine 0 N--CA 1.441 -1.025 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 176.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.669 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.7 pt? -117.11 132.11 56.74 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -177.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.489 ' OD1' ' HA ' ' A' ' 76' ' ' ARG . 5.0 p-10 -125.12 83.38 60.65 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-O 121.945 0.879 . . . . 0.0 110.635 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.586 ' HA ' ' HA ' ' A' ' 77' ' ' ASP . 18.5 Cg_endo -57.03 130.31 39.05 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.882 2.388 . . . . 0.0 112.545 -176.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.56 11.13 69.19 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.646 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 76' ' ' ARG . . . 53.03 51.73 15.2 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 122.891 0.476 . . . . 0.0 111.998 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.456 ' HB2' HH22 ' A' ' 111' ' ' ARG . 28.6 t70 -82.29 -53.86 5.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.953 0.406 . . . . 0.0 111.076 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.62 HD12 ' HB2' ' A' ' 16' ' ' PHE . 17.1 mm -68.36 -30.62 48.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.407 ' HB3' ' HB1' ' A' ' 102' ' ' ALA . 74.7 t80 -60.65 -37.92 83.14 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.627 170.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.893 ' HB2' ' HG2' ' A' ' 111' ' ' ARG . . . -72.68 -15.09 61.7 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.034 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.542 ' O ' ' HG2' ' A' ' 14' ' ' PRO . 14.1 mptt -69.3 -15.97 63.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.908 0.385 . . . . 0.0 110.798 173.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -126.0 -32.94 2.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.026 0.441 . . . . 0.0 111.524 -177.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.636 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -133.68 -172.78 3.06 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.276 -178.032 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.8 mt -85.06 153.18 22.88 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.893 ' HG2' ' HB2' ' A' ' 106' ' ' ALA . 20.2 mtp180 -71.48 -14.11 62.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.403 0.62 . . . . 0.0 110.344 -176.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -101.09 -1.89 32.92 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.907 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.28 155.38 40.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.227 0.536 . . . . 0.0 111.916 -174.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.8 155.22 42.05 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.131 -0.941 . . . . 0.0 113.662 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.651 HD13 ' HG2' ' A' ' 76' ' ' ARG . 3.3 tp -84.15 -175.25 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 123.211 0.604 . . . . 0.0 110.366 -176.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.644 HG22 ' SG ' ' A' ' 48' ' ' CYS . 77.0 p 61.52 79.5 0.25 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.461 1.104 . . . . 0.0 111.524 177.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' A' ' 117' ' ' ARG . 9.0 mtp180 -140.59 132.49 27.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.09 -177.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.647 ' HB3' ' HB ' ' A' ' 131' ' ' THR . 38.9 t-20 -107.73 126.18 52.3 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.7 t -122.88 138.4 53.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.157 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 46.3 tp -126.49 122.82 36.28 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.911 -0.315 . . . . 0.0 110.5 177.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.553 HD13 HD13 ' A' ' 38' ' ' LEU . 1.9 mp -106.34 134.59 47.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.152 177.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.68 174.79 10.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.963 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.469 ' HD2' ' OE1' ' A' ' 152' ' ' GLU . 5.8 ptm180 -72.23 -15.59 61.93 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -172.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -80.33 -28.3 38.16 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.25 0.547 . . . . 0.0 109.863 175.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 116.85 10.36 10.12 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.316 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -100.44 153.17 19.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.097 0.475 . . . . 0.0 111.744 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.508 HG21 HD21 ' A' ' 130' ' ' LEU . 4.4 mm -76.53 133.24 31.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.294 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 28.0 m -126.07 3.07 4.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.577 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 53.1 tptt -166.57 127.35 1.67 Allowed 'General case' 0 C--O 1.232 0.16 0 C-N-CA 120.481 -0.488 . . . . 0.0 112.027 -177.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.508 HD21 HG21 ' A' ' 127' ' ' ILE . 3.1 mm? -126.99 115.51 19.35 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.471 172.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.647 ' HB ' ' HB3' ' A' ' 118' ' ' ASN . 95.2 m -123.85 134.99 53.48 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.538 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -106.5 122.37 46.16 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.521 HD11 HG21 ' A' ' 47' ' ' VAL . 10.6 tp 71.78 156.22 0.16 Allowed 'General case' 0 C--O 1.232 0.155 0 O-C-N 124.191 0.932 . . . . 0.0 110.388 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.516 ' CE2' ' HG2' ' A' ' 136' ' ' GLU . 51.1 t80 -72.52 89.04 1.26 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.362 0.601 . . . . 0.0 109.935 174.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.557 ' HB3' ' HB3' ' A' ' 138' ' ' GLU . 2.0 t-20 -85.52 116.42 23.81 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 171.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.516 ' HG2' ' CE2' ' A' ' 134' ' ' TYR . 33.8 mt-10 -58.3 -52.75 64.26 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.28 -168.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -59.75 -39.59 85.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.204 0.526 . . . . 0.0 111.317 176.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.557 ' HB3' ' HB3' ' A' ' 135' ' ' ASN . 5.3 tp10 -61.99 -46.69 88.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.117 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.614 ' O ' HG23 ' A' ' 143' ' ' VAL . 82.1 t80 -59.72 -42.44 93.09 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.699 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.26 -46.44 85.99 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.121 0.486 . . . . 0.0 110.553 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.2 m -62.13 -38.81 90.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.505 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.02 -37.88 89.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.492 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 139' ' ' PHE . 97.2 t -55.39 -57.11 8.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.314 175.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -61.48 -38.23 86.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.797 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -57.43 -48.66 78.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.98 177.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.576 ' O ' HD23 ' A' ' 150' ' ' LEU . 59.6 mt -67.87 -38.95 80.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.955 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -55.42 -39.94 70.85 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.826 -0.17 . . . . 0.0 111.302 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.438 ' OE1' ' HB2' ' A' ' 151' ' ' LYS . 9.6 tp10 -73.39 -35.42 65.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.762 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 82.1 mmm -62.83 -25.79 68.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.351 0.596 . . . . 0.0 110.119 178.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.628 HD11 ' HB2' ' A' ' 69' ' ' PHE . 4.0 mm? -90.86 2.08 56.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.229 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.439 ' HD3' ' HA ' ' A' ' 151' ' ' LYS . 12.9 mmtm -103.5 -66.45 0.94 Allowed 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 173.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.469 ' OE1' ' HD2' ' A' ' 123' ' ' ARG . 31.3 tt0 51.9 -83.06 0.01 OUTLIER 'General case' 0 C--O 1.237 0.435 0 O-C-N 124.632 1.207 . . . . 0.0 113.181 175.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 86.94 -54.97 4.62 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -173.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.481 ' HB2' ' O ' ' A' ' 157' ' ' HIS . 60.2 m80 -149.23 121.36 8.31 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 172.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 12.4 t60 -66.17 -0.6 2.59 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 123.325 0.391 . . . . 0.0 112.049 -173.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -137.89 21.94 2.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.608 0.242 . . . . 0.0 110.809 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' HIS . . . . . 0.481 ' O ' ' HB2' ' A' ' 154' ' ' HIS . 5.4 t60 -168.81 98.12 0.38 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.812 0.339 . . . . 0.0 110.137 177.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -128.4 147.79 50.67 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.243 0.724 0 CA-C-O 118.659 -0.686 . . . . 0.0 109.602 177.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 120.679 0.276 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.4 p -91.29 173.68 7.79 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.738 0.304 . . . . 0.0 110.692 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.5 tt -80.69 88.84 5.74 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.4 ' HA3' HD12 ' A' ' 110' ' ' LEU . . . -103.61 69.65 0.29 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.613 -177.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -97.44 126.68 42.84 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 176.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.7 pt -94.9 -27.57 4.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.946 0.403 . . . . 0.0 110.431 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.636 HG11 HD12 ' A' ' 127' ' ' ILE . 15.0 t -94.3 155.07 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 174.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 8' ' ' ARG . 16.3 mtt180 -125.47 165.41 18.49 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.838 -0.165 . . . . 0.0 110.594 -169.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.666 HG12 HD13 ' A' ' 130' ' ' LEU . 77.0 mt -67.81 118.43 11.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.854 0.359 . . . . 0.0 110.196 175.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.98 -7.58 62.75 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.893 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -86.37 153.24 22.07 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 -177.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.666 ' SD ' ' HG2' ' A' ' 126' ' ' LYS . 91.2 mmm -67.49 130.07 41.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.675 -178.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.41 ' HB2' HG13 ' A' ' 127' ' ' ILE . . . -79.3 129.93 70.59 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.664 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.408 ' HD2' ' CE1' ' A' ' 108' ' ' TYR . 31.4 Cg_exo -59.16 143.45 99.76 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.703 2.269 . . . . 0.0 111.329 174.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.96 162.55 14.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.243 -177.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.613 ' O ' ' HA ' ' A' ' 27' ' ' THR . 55.3 p90 -169.73 164.28 9.99 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.389 -173.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.9 m -123.0 100.7 7.02 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 176.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.2 tt -103.26 146.65 10.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.821 0.343 . . . . 0.0 111.159 -174.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.9 m -94.27 118.38 31.5 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.586 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.458 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 93.7 mt -81.52 169.7 16.79 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.696 -177.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 31.4 p -57.34 -26.58 61.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.219 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -83.31 -7.79 59.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.203 0.525 . . . . 0.0 110.432 -178.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.52 15.4 56.98 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.23 -175.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -90.67 116.69 28.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.384 -0.408 . . . . 0.0 110.47 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -89.62 113.11 24.52 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 174.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.81 128.59 71.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.572 0.701 . . . . 0.0 111.582 -174.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.613 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 17.9 m -94.2 137.97 32.76 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.518 175.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.579 HD22 ' HD3' ' A' ' 32' ' ' ARG . 0.6 OUTLIER -60.59 -33.27 72.48 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -177.075 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.459 ' HA ' ' CG ' ' A' ' 32' ' ' ARG . 37.6 t -56.88 -23.08 41.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.824 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.9 t -81.78 -8.81 59.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.972 0.415 . . . . 0.0 110.548 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 67.4 mt -119.57 -1.16 10.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.539 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.579 ' HD3' HD22 ' A' ' 28' ' ' LEU . 8.7 mmm-85 -66.79 103.09 1.04 Allowed 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.055 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.516 ' O ' ' HG3' ' A' ' 123' ' ' ARG . . . 139.42 -20.59 2.96 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 -172.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.574 ' HD2' ' HA ' ' A' ' 68' ' ' ASP . 37.1 mtmt -114.48 168.2 10.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.415 -0.393 . . . . 0.0 109.945 175.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.484 HG11 ' HB3' ' A' ' 149' ' ' MET . 34.2 m -80.1 122.52 35.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 174.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.5 t -122.93 113.93 40.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.108 0.48 . . . . 0.0 111.081 -174.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.541 ' SD ' HG21 ' A' ' 59' ' ' ILE . 26.9 ttt -97.19 126.55 42.45 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.447 177.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.516 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 7.3 mp -118.92 152.89 35.5 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.03 176.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.473 HE21 ' HA3' ' A' ' 73' ' ' GLY . 5.1 pp0? -139.29 145.93 39.73 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 169.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 89.3 m-85 -110.35 123.29 49.58 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 177.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.8 t -134.72 173.49 11.63 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.123 -174.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.506 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . . . -149.93 160.02 43.92 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.476 -0.784 . . . . 0.0 108.933 175.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.588 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 28.8 t -70.74 -20.87 62.6 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -171.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 58.8 p-90 -97.11 3.12 51.83 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.855 0.316 . . . . 0.0 111.855 -177.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.506 ' SG ' ' HB3' ' A' ' 42' ' ' ALA . 84.0 m -87.86 108.18 19.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.155 0.502 . . . . 0.0 111.293 -178.197 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -79.01 -17.85 76.1 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.39 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.606 HG11 ' HB2' ' A' ' 133' ' ' LEU . 40.6 t -74.83 -45.97 42.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 177.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.453 ' SG ' HG23 ' A' ' 116' ' ' THR . 73.7 m -54.75 -32.59 60.08 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.819 177.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.528 ' HE ' ' HE1' ' A' ' 86' ' ' PHE . 98.0 mtt180 -65.5 -2.66 3.52 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.264 -0.426 . . . . 0.0 112.029 -178.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -96.81 -55.85 2.76 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.783 0.801 . . . . 0.0 109.734 173.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.657 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 5.1 pt-20 -71.45 -32.47 68.36 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.93 -175.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 63.9 mmm -52.09 -57.32 15.55 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 117.817 0.281 . . . . 0.0 111.605 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.409 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 24.7 Cg_endo -64.27 -37.18 42.01 Favored 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 121.75 1.633 . . . . 0.0 112.447 175.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -62.31 -44.15 97.18 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.536 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.568 ' O ' ' HB ' ' A' ' 59' ' ' ILE . 94.0 mt -57.95 -53.53 44.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.675 178.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.587 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 14.9 pt-20 -64.95 -38.11 89.87 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.874 -176.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -63.06 -54.39 38.82 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -174.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -107.22 -18.12 13.97 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -172.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.568 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 2.2 mp -95.21 -55.3 6.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.971 176.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.587 ' HB3' ' HA ' ' A' ' 56' ' ' GLU . 75.0 t-105 -65.48 -70.69 0.22 Allowed 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.418 -177.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.433 ' HA ' HD13 ' A' ' 61' ' ' LEU . 1.6 mm? -54.05 -23.29 13.11 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -173.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -91.6 -37.4 13.1 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -177.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -118.9 -10.96 9.79 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -169.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.51 ' HG3' ' OD1' ' A' ' 65' ' ' ASP . 19.2 pttp -36.21 -54.13 0.81 Allowed 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -168.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.51 ' OD1' ' HG3' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -87.45 -77.99 0.32 Allowed 'General case' 0 C--O 1.254 1.311 0 CA-C-O 121.299 0.571 . . . . 0.0 109.583 -178.432 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.407 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 22.4 t-20 63.36 -74.83 0.04 OUTLIER 'General case' 0 C--N 1.34 0.153 0 CA-C-N 114.471 -1.24 . . . . 0.0 110.374 -174.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 66' ' ' ASN . . . 159.26 -40.43 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -177.244 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.574 ' HA ' ' HD2' ' A' ' 34' ' ' LYS . 30.9 t70 -114.66 11.1 16.84 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 113.904 -1.498 . . . . 0.0 111.258 -175.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -106.36 142.9 35.26 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.128 -177.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.69 143.56 33.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.377 173.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.533 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 2.8 tt -142.53 118.67 10.73 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 3.0 mp -131.1 126.99 60.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.324 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.473 ' HA3' HE21 ' A' ' 39' ' ' GLN . . . -97.85 140.74 15.21 Favored Glycine 0 C--O 1.224 -0.529 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.353 176.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 62.0 mt -120.28 123.62 70.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 117.304 0.552 . . . . 0.0 111.396 -177.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 78' ' ' GLU . 2.5 m-20 -88.1 122.02 31.19 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 172.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 59.7 ttp180 -50.61 -46.41 58.07 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -167.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 99' ' ' ASP . 7.8 p-10 -152.64 13.1 0.54 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.04 0.448 . . . . 0.0 111.134 -174.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 33.1 mm-40 -80.68 130.05 65.88 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.478 -177.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.459 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 36.7 Cg_endo -71.73 179.81 4.42 Favored 'Trans proline' 0 CA--C 1.531 0.341 0 C-N-CA 122.408 2.072 . . . . 0.0 112.687 174.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -50.69 -57.98 6.99 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.096 -171.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.462 ' OE1' ' HG2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -67.42 -30.79 70.64 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -172.427 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.462 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 41.7 mmtm -63.86 -52.66 58.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.753 0.311 . . . . 0.0 110.397 175.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 79' ' ' PRO . 88.0 t -54.21 -52.75 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.244 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.37 -38.83 92.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.35 -177.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.29 -42.13 79.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.673 0.273 . . . . 0.0 111.081 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.588 ' CD1' ' HA ' ' A' ' 43' ' ' SER . 86.8 t80 -64.83 -43.9 91.56 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 178.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.447 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -58.54 -54.31 48.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.189 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -65.65 -20.71 66.4 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -174.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.5 m -78.74 -24.3 44.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.741 0.305 . . . . 0.0 111.288 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.5 p -104.8 -22.11 13.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.083 0.468 . . . . 0.0 110.98 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 121.1 -79.32 0.33 Allowed Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -177.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.1 t 46.45 86.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 124.463 1.105 . . . . 0.0 113.265 177.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.8 m -82.09 2.5 30.97 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.039 177.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.506 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 46.7 p90 -113.32 152.7 45.41 Favored Pre-proline 0 C--N 1.331 -0.235 0 O-C-N 122.203 -0.311 . . . . 0.0 110.759 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.13 133.81 29.82 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.484 2.123 . . . . 0.0 113.437 -176.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.447 HD12 ' HB2' ' A' ' 87' ' ' ALA . 94.1 mt -104.48 161.62 13.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.081 172.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -130.12 148.3 18.48 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.168 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.417 ' N ' HD12 ' A' ' 98' ' ' LEU . 5.4 mp -86.74 133.55 33.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.544 0.211 . . . . 0.0 110.54 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.471 ' O ' ' HA ' ' A' ' 77' ' ' ASP . 40.2 t0 -121.05 73.86 26.67 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-O 121.317 0.579 . . . . 0.0 109.86 169.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.412 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 22.1 Cg_exo -64.1 103.53 0.43 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.079 1.853 . . . . 0.0 112.237 -177.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 112.0 -0.18 27.05 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.483 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.477 ' HB1' ' HG2' ' A' ' 111' ' ' ARG . . . 59.02 40.64 22.01 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.092 0.472 . . . . 0.0 111.155 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -78.82 -48.76 14.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.557 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.452 HD12 ' HB2' ' A' ' 16' ' ' PHE . 34.4 mm -66.75 -37.39 79.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -59.51 -44.68 93.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.874 175.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.587 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -67.58 -21.23 65.44 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.813 -178.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -72.96 -17.69 61.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.798 0.332 . . . . 0.0 110.921 177.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.547 ' HB2' HH22 ' A' ' 117' ' ' ARG . 79.3 m-85 -111.88 -34.26 6.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.863 -178.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.587 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -161.13 172.93 15.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.768 0.318 . . . . 0.0 110.731 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.664 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 91.4 mt -71.97 131.38 42.86 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.091 178.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.477 ' HG2' ' HB1' ' A' ' 102' ' ' ALA . 11.4 mtm180 -65.4 -31.3 72.33 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.268 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -84.38 -7.36 59.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.748 -178.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.664 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . . . -75.4 -56.77 4.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.718 -178.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -163.07 -149.12 5.6 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.96 -177.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.456 HG23 ' H ' ' A' ' 116' ' ' THR . 2.8 tp -161.35 -59.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.373 0.087 . . . . 0.0 111.125 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.648 HG22 ' HA ' ' A' ' 133' ' ' LEU . 24.0 m -67.61 109.08 3.12 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.861 0.362 . . . . 0.0 111.414 -176.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.547 HH22 ' HB2' ' A' ' 108' ' ' TYR . 19.3 ptt180 -165.97 146.44 6.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.166 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.605 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 45.9 m-80 -108.95 136.53 48.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.725 175.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.4 HG21 ' HE1' ' A' ' 40' ' ' PHE . 80.6 t -120.35 102.76 13.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.101 -177.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.623 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 48.8 tp -88.75 108.14 19.33 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.707 -0.397 . . . . 0.0 109.996 178.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.403 HD13 HD11 ' A' ' 28' ' ' LEU . 56.6 mt -93.74 121.98 44.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.771 0.796 . . . . 0.0 110.523 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.69 162.66 29.2 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.485 -1.234 . . . . 0.0 111.341 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.516 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 33.8 ttm180 -52.0 -34.21 41.73 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.483 0.713 . . . . 0.0 112.742 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.539 ' HB2' ' CE1' ' A' ' 156' ' ' HIS . 11.8 tt0 -83.57 -7.59 59.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.33 0.586 . . . . 0.0 109.969 -175.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 96.54 31.36 7.15 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.468 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.666 ' HG2' ' SD ' ' A' ' 12' ' ' MET . 44.2 mttm -113.04 146.49 39.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.798 0.299 . . . . 0.0 110.314 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.636 HD12 HG11 ' A' ' 7' ' ' VAL . 55.7 mt -88.94 100.98 11.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.093 177.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 29.0 m -94.17 -4.54 10.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -174.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.623 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 51.8 tptt -143.95 108.76 4.92 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.687 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.666 HD13 HG12 ' A' ' 9' ' ' ILE . 10.9 mp -98.28 104.7 16.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.962 170.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.605 ' HB ' ' HB2' ' A' ' 118' ' ' ASN . 86.0 m -103.23 125.33 49.84 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.724 -0.217 . . . . 0.0 110.703 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.57 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -96.85 108.19 20.82 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 176.788 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.648 ' HA ' HG22 ' A' ' 116' ' ' THR . 4.6 pp 51.4 -177.65 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 O-C-N 124.503 1.127 . . . . 0.0 113.259 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.657 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 75.6 t80 -87.57 117.68 26.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.912 -177.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -135.89 137.69 41.67 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.949 172.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -47.79 -62.56 1.4 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -177.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.428 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.5 mp0 -56.99 -46.75 82.01 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.316 0.579 . . . . 0.0 110.849 -178.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.487 ' HG3' HG23 ' A' ' 131' ' ' THR . 7.0 tp10 -61.72 -48.59 80.06 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.187 -177.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.469 ' O ' HG23 ' A' ' 143' ' ' VAL . 69.2 t80 -67.38 -39.16 85.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.048 -178.278 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.79 -43.52 97.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.662 175.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 45.8 m -63.04 -38.1 89.82 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.547 177.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.548 ' O ' HG13 ' A' ' 146' ' ' ILE . 67.7 tp -59.75 -51.61 69.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.154 177.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.493 HG22 HD11 ' A' ' 59' ' ' ILE . 61.3 t -60.19 -45.81 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.222 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -57.72 -45.05 86.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.722 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.556 ' O ' ' HG2' ' A' ' 149' ' ' MET . 64.3 tt0 -67.01 -37.34 83.98 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.391 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.548 HG13 ' O ' ' A' ' 142' ' ' LEU . 34.7 mt -59.61 -38.16 74.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.895 0.378 . . . . 0.0 109.999 175.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.579 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 87.9 m-20 -59.63 -41.03 89.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.803 177.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -66.05 -36.98 84.7 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.328 0.392 . . . . 0.0 110.856 174.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.556 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 94.7 mmm -62.93 -32.1 73.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.525 0.679 . . . . 0.0 109.429 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.545 HD23 ' O ' ' A' ' 146' ' ' ILE . 3.9 mm? -82.17 -5.83 58.76 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.746 176.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.608 ' HA ' ' HE3' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -102.22 -17.69 15.84 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 173.834 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.519 ' HA ' ' OE1' ' A' ' 152' ' ' GLU . 10.6 tp10 -51.13 108.53 0.25 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-O 122.832 1.301 . . . . 0.0 113.638 -171.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -163.69 29.94 0.25 Allowed Glycine 0 N--CA 1.437 -1.266 0 CA-C-N 112.369 -2.196 . . . . 0.0 107.709 170.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -158.85 -26.09 0.07 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 114.47 -0.865 . . . . 0.0 111.86 -168.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -83.38 -35.23 25.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.16 -169.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.539 ' CE1' ' HB2' ' A' ' 124' ' ' GLU . 19.2 m-70 -80.12 79.65 6.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.363 0.602 . . . . 0.0 111.49 178.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -99.35 99.98 10.99 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.753 175.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 59.9 m170 -75.22 -13.02 60.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.162 0.506 . . . . 0.0 109.991 177.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 . . . . . 0 C--O 1.244 0.804 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.002 176.928 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.7 ttp . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.635 0.255 . . . . 0.0 110.342 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.5 m -115.8 132.1 56.74 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.092 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 71.0 mt -141.31 162.02 36.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.221 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -100.22 88.37 0.77 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.835 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.52 ' CZ ' ' HD2' ' A' ' 117' ' ' ARG . 69.0 m-85 -147.01 135.42 21.83 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 175.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.2 pt -110.23 -7.79 11.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.168 0.509 . . . . 0.0 110.144 171.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.5 m -101.47 168.8 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.733 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.603 ' HB2' ' HB2' ' A' ' 11' ' ' GLU . 38.4 mtt180 -114.83 163.25 15.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.197 -177.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.781 HG12 HD13 ' A' ' 130' ' ' LEU . 73.3 mt -79.5 121.23 32.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 174.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.48 1.34 62.31 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -175.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 8' ' ' ARG . 10.4 tp10 -83.42 155.83 23.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.36 -0.42 . . . . 0.0 110.551 -176.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.518 ' HE2' ' HA ' ' A' ' 12' ' ' MET . 4.9 mmt -65.76 127.74 33.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.452 177.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.436 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -67.48 129.94 93.45 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.663 178.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.454 ' HD2' ' CZ ' ' A' ' 108' ' ' TYR . 15.3 Cg_exo -65.98 113.54 2.63 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.668 2.245 . . . . 0.0 111.2 178.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.68 147.19 50.92 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.604 -175.033 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.401 ' O ' ' HA ' ' A' ' 27' ' ' THR . 44.7 p90 -155.7 164.33 38.73 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.376 -176.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.8 m -116.68 102.8 9.76 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 174.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.49 ' O ' ' HA ' ' A' ' 25' ' ' GLN . 13.1 tt -97.87 138.72 21.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.937 0.399 . . . . 0.0 111.023 -174.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.2 m -94.15 118.91 32.23 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.071 177.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.486 HD12 ' HB2' ' A' ' 24' ' ' LYS . 94.3 mt -74.54 175.99 7.28 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.944 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 96' ' ' LEU . 31.8 p -57.88 -32.2 67.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.623 -175.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -102.13 16.97 24.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.956 0.408 . . . . 0.0 111.123 -176.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.43 7.36 69.55 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.404 173.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.486 ' HB2' HD12 ' A' ' 20' ' ' LEU . 27.3 mmtp -78.76 110.01 13.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.882 0.373 . . . . 0.0 110.72 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.49 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 94.1 mt-30 -92.0 114.48 27.03 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.481 178.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.5 m -118.03 151.5 20.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.477 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.418 ' HB ' ' OG ' ' A' ' 29' ' ' SER . 1.2 p -101.91 154.2 19.16 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.879 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.8 -34.77 77.43 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 174.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.532 ' HA ' ' HG2' ' A' ' 32' ' ' ARG . 0.5 OUTLIER -59.69 -23.7 63.34 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.676 175.516 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.8 t -78.73 -12.36 60.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.041 0.448 . . . . 0.0 110.408 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 83.0 mt -112.73 -0.82 14.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.931 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.533 ' NE ' ' HA3' ' A' ' 125' ' ' GLY . 40.5 mmm-85 -66.19 102.41 0.83 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.079 0.466 . . . . 0.0 109.76 178.33 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 143.64 -23.47 2.16 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -174.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.412 ' HA ' ' OD1' ' A' ' 68' ' ' ASP . 43.9 mtmt -117.08 160.07 21.57 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 174.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.534 HG22 ' O ' ' A' ' 68' ' ' ASP . 10.6 m -70.45 128.38 33.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 175.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.595 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 40.6 t -111.69 114.73 47.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 120.832 0.349 . . . . 0.0 111.153 -174.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.496 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 27.0 ttt -97.15 120.6 37.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.004 0.43 . . . . 0.0 110.067 174.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.498 ' HB2' ' HB ' ' A' ' 119' ' ' VAL . 88.3 mt -112.38 123.43 50.26 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.678 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -113.11 111.05 21.45 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.13 177.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.502 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 96.8 m-85 -88.64 115.82 26.44 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.7 t -132.7 -172.85 3.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.172 -171.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.559 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . . . -172.16 143.23 1.48 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.776 ' H ' ' HG3' ' A' ' 78' ' ' GLU . 54.7 p -70.72 -15.68 62.72 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.776 -172.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.408 ' HD1' ' OE2' ' A' ' 78' ' ' GLU . 66.6 p-90 -87.28 -0.65 57.06 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.097 0.475 . . . . 0.0 110.915 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.588 ' SG ' HG12 ' A' ' 115' ' ' ILE . 74.5 m -93.12 112.57 24.55 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.996 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -75.95 -34.29 48.09 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.63 178.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 56.2 t -61.42 -45.02 99.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.677 0.238 . . . . 0.0 110.833 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.696 ' HA ' ' CD ' ' A' ' 51' ' ' GLU . 12.5 t -61.85 -15.78 44.9 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 121.421 0.629 . . . . 0.0 111.456 -174.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -72.52 -1.91 17.7 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.862 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.481 ' HE2' ' CD2' ' A' ' 134' ' ' TYR . 56.4 mtpt -90.16 -56.87 3.05 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.214 172.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.773 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 3.8 pm0 -64.34 -30.95 71.98 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.565 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.64 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 5.9 mmt -52.29 -63.61 2.08 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.629 178.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.64 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 52.6 Cg_exo -56.63 -39.47 91.15 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 122.171 1.914 . . . . 0.0 112.912 175.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.407 ' HD1' ' O ' ' A' ' 50' ' ' LYS . 21.3 m-85 -66.99 -45.69 76.85 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 93.9 mt -61.93 -42.77 96.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.78 0.324 . . . . 0.0 110.146 177.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.489 ' OE1' ' HA ' ' A' ' 92' ' ' VAL . 26.0 tp10 -57.11 -52.36 65.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.602 178.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.519 ' HA ' HD22 ' A' ' 61' ' ' LEU . 27.6 ttpp -72.66 -54.06 10.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.522 -175.025 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -87.13 -26.74 23.47 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -168.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.7 mt -105.64 -61.72 2.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.817 -177.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.575 ' CD2' ' HB3' ' A' ' 94' ' ' TYR . 76.7 t-105 -61.22 -64.46 0.94 Allowed 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.499 -173.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.519 HD22 ' HA ' ' A' ' 57' ' ' LYS . 1.5 mp -47.78 -32.5 6.05 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -175.11 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -71.51 -38.3 71.15 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -176.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.658 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 87.2 m-70 -126.18 -43.78 1.78 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.897 -174.022 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.7 mttp 59.01 -82.22 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.655 0.782 . . . . 0.0 111.014 -175.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -110.8 -42.32 4.05 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 171.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.658 ' HB2' ' HB3' ' A' ' 63' ' ' HIS . 3.5 t30 71.03 -68.18 0.23 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.011 175.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 66' ' ' ASN . . . 162.93 -27.02 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 124.327 1.051 . . . . 0.0 108.759 -175.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.534 ' O ' HG22 ' A' ' 35' ' ' VAL . 25.5 t0 -140.74 26.74 2.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.614 -174.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.544 ' HB2' HD11 ' A' ' 150' ' ' LEU . 87.8 t80 -135.17 144.41 47.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.824 -177.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.67 138.02 28.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.963 173.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.496 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 1.8 tt -138.51 115.37 10.78 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -178.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.4 mp -126.79 130.69 71.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.141 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.429 ' HA3' HD22 ' A' ' 96' ' ' LEU . . . -92.69 117.22 5.3 Favored Glycine 0 C--O 1.221 -0.681 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.531 177.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 41.7 mt -104.44 118.62 52.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.938 0.369 . . . . 0.0 110.556 -175.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.559 ' OD2' ' HA ' ' A' ' 42' ' ' ALA . 9.7 t70 -84.52 142.55 29.95 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 176.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.441 ' HG2' ' HB2' ' A' ' 102' ' ' ALA . 18.1 ttp180 -80.03 -40.83 26.97 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -172.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -155.16 5.88 0.23 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -168.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.776 ' HG3' ' H ' ' A' ' 43' ' ' SER . 13.4 mm-40 -88.52 133.33 36.53 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 120.908 0.385 . . . . 0.0 110.373 177.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.454 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 29.3 Cg_endo -68.17 -173.11 0.48 Allowed 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 122.875 2.383 . . . . 0.0 113.63 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.42 ' O ' HD23 ' A' ' 84' ' ' LEU . 3.1 tm? -59.07 -55.82 30.15 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.084 -169.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.454 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -66.01 -34.13 77.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.497 0.189 . . . . 0.0 111.501 -173.832 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.433 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 2.7 mmmp? -60.24 -50.1 74.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.019 177.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 66.1 t -62.55 -44.85 99.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.921 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.42 HD23 ' O ' ' A' ' 80' ' ' LEU . 4.2 mm? -61.03 -47.37 86.75 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.831 0.348 . . . . 0.0 111.579 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.96 -30.93 68.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.232 -178.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -73.2 -47.75 40.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.553 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.59 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -52.34 -55.16 23.39 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.142 -177.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.82 -11.29 60.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.658 -174.074 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.6 m -94.81 -22.08 18.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.011 178.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.7 p -91.49 -4.51 55.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.594 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.66 0.91 90.42 Favored Glycine 0 C--O 1.228 -0.229 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.356 178.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.489 ' HA ' ' OE1' ' A' ' 56' ' ' GLU . 72.5 t -66.7 123.08 18.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 122.798 0.439 . . . . 0.0 111.386 -179.289 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.3 p -101.63 -18.83 15.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.652 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.575 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 52.7 p90 -77.52 141.76 65.79 Favored Pre-proline 0 N--CA 1.454 -0.26 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.513 177.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.404 ' HB2' HD22 ' A' ' 20' ' ' LEU . 18.5 Cg_endo -60.06 131.88 41.53 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 122.688 2.259 . . . . 0.0 113.409 -175.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.59 HD12 ' HB2' ' A' ' 87' ' ' ALA . 66.5 mt -102.39 147.49 26.64 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.002 173.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.462 ' HA3' HD11 ' A' ' 18' ' ' ILE . . . -122.3 143.84 15.76 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 177.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.787 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.0 OUTLIER -98.15 132.34 43.76 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.788 0.328 . . . . 0.0 110.551 -177.995 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.418 ' HB3' ' O ' ' A' ' 75' ' ' ASP . 14.2 t0 -115.23 74.79 4.07 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.521 176.037 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.473 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 23.5 Cg_exo -63.17 104.7 0.42 Allowed 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.573 2.182 . . . . 0.0 112.364 -176.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 115.36 -4.54 21.72 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.772 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.441 ' HB2' ' HG2' ' A' ' 76' ' ' ARG . . . 57.52 47.42 16.2 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 122.731 0.412 . . . . 0.0 111.476 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.435 ' HA ' HH21 ' A' ' 111' ' ' ARG . 15.0 t70 -80.59 -50.62 9.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.98 0.419 . . . . 0.0 110.173 178.11 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 96.9 mt -61.93 -40.09 85.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 176.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -62.5 -40.39 96.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.541 176.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -67.4 -23.65 65.59 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.223 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -73.25 -13.5 61.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.257 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.454 ' CZ ' ' HD2' ' A' ' 14' ' ' PRO . 45.3 m-85 -113.49 -34.38 5.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.832 0.349 . . . . 0.0 111.563 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -158.92 168.28 27.2 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.899 0.38 . . . . 0.0 111.209 -177.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.445 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 90.1 mt -67.29 138.63 56.98 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 175.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.435 HH21 ' HA ' ' A' ' 103' ' ' ASP . 94.5 mtt180 -63.16 -27.04 69.1 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.577 -174.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -92.82 -16.75 24.95 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.315 -178.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.445 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . . . -80.85 47.92 1.03 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -172.019 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.58 143.14 9.74 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.328 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.588 HG12 ' SG ' ' A' ' 45' ' ' CYS . 1.8 tp -87.41 -64.07 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -176.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.42 ' H ' HG23 ' A' ' 115' ' ' ILE . 6.5 m -64.78 128.03 34.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.857 0.361 . . . . 0.0 111.315 -173.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.52 ' HD2' ' CZ ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -145.43 132.13 19.97 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.432 178.28 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.705 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 3.8 m-20 -107.91 117.66 34.7 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 176.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.498 ' HB ' ' HB2' ' A' ' 38' ' ' LEU . 73.2 t -120.57 118.97 58.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.426 -177.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.898 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 25.4 tp -109.77 120.13 41.53 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.261 0.553 . . . . 0.0 110.486 176.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.595 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 74.2 mt -104.23 142.02 18.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.948 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.86 172.25 13.75 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.581 ' NH2' ' HG3' ' A' ' 152' ' ' GLU . 26.8 ptt180 -78.01 20.96 0.34 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -175.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.443 ' OE1' ' HE3' ' A' ' 12' ' ' MET . 1.7 tm-20 -110.88 -35.72 5.88 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 169.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.533 ' HA3' ' NE ' ' A' ' 32' ' ' ARG . . . 122.51 20.54 2.9 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.667 -172.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 29.3 mtmm -103.42 135.71 44.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.621 0.248 . . . . 0.0 110.493 177.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.4 HG23 HG13 ' A' ' 119' ' ' VAL . 56.4 mt -78.62 101.74 4.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 177.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.4 m -100.61 -21.63 5.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -170.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.898 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 61.0 tptt -132.03 117.05 17.87 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.131 0.491 . . . . 0.0 111.439 -176.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.781 HD13 HG12 ' A' ' 9' ' ' ILE . 10.3 mp -104.24 104.86 14.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.739 176.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.705 ' HB ' ' HB2' ' A' ' 118' ' ' ASN . 54.6 m -109.45 132.34 54.22 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.111 0.481 . . . . 0.0 110.746 -178.204 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.472 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 0.1 OUTLIER -91.92 107.9 19.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.825 -177.819 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 132' ' ' ARG . 0.6 OUTLIER 43.9 -160.89 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.28 0.987 . . . . 0.0 112.359 -179.008 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.773 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 94.4 t80 -85.39 84.9 7.5 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.643 0.735 . . . . 0.0 111.283 176.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.505 ' HB3' ' HB3' ' A' ' 138' ' ' GLU . 27.0 t-20 -89.09 120.07 30.16 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 165.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.428 ' HG2' ' CE2' ' A' ' 134' ' ' TYR . 46.4 mt-10 -56.38 -48.22 77.32 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -170.047 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.2 mp0 -68.04 -40.5 82.86 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.047 0.451 . . . . 0.0 110.511 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.505 ' HB3' ' HB3' ' A' ' 135' ' ' ASN . 8.5 tp10 -64.7 -41.05 96.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.374 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.44 ' O ' HG23 ' A' ' 143' ' ' VAL . 86.8 t80 -64.16 -40.39 96.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.381 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -59.12 -47.92 83.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.285 177.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 21.2 m -62.88 -39.87 95.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.636 176.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.459 ' O ' HG13 ' A' ' 146' ' ' ILE . 49.8 tp -60.9 -49.34 77.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.174 -178.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 139' ' ' PHE . 95.1 t -59.38 -47.96 88.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.827 0.346 . . . . 0.0 110.77 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 21.8 tm0? -60.67 -43.1 98.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.956 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.515 ' O ' ' HG2' ' A' ' 149' ' ' MET . 57.0 tt0 -59.97 -46.99 87.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.53 177.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.488 ' O ' HD23 ' A' ' 150' ' ' LEU . 81.2 mt -56.41 -47.71 81.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.721 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -55.15 -44.76 75.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.859 176.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -76.55 -10.79 59.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.771 0.32 . . . . 0.0 111.443 -178.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.515 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 88.3 mmm -78.39 -38.96 40.46 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 171.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.544 HD11 ' HB2' ' A' ' 69' ' ' PHE . 4.4 mm? -72.11 -38.38 69.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.9 -1.046 . . . . 0.0 110.294 176.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.416 ' HE2' ' HB3' ' A' ' 151' ' ' LYS . 13.5 mmmm -84.21 -33.5 24.12 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.314 -178.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.581 ' HG3' ' NH2' ' A' ' 123' ' ' ARG . 2.1 mm-40 53.15 89.81 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.536 -177.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -105.25 14.01 47.96 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.561 176.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -87.36 -41.24 13.76 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -177.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 48.0 m80 69.38 -74.44 0.08 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.372 172.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -148.32 92.95 2.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.401 0.62 . . . . 0.0 111.866 -176.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 39.2 t60 -107.01 108.29 19.73 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 174.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -62.83 132.75 53.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.934 0.397 . . . . 0.0 111.21 -178.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 . . . . . 0 C--O 1.243 0.712 0 CA-C-O 118.194 -0.908 . . . . 0.0 108.958 170.507 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 ptm . . . . . 0 N--CA 1.48 1.025 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.9 t -81.46 -26.87 34.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.199 0.523 . . . . 0.0 110.887 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.428 HD13 ' HD3' ' A' ' 132' ' ' ARG . 3.7 mm? -95.21 172.53 8.06 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.475 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 148.87 44.62 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.816 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.404 ' CZ ' ' HD3' ' A' ' 117' ' ' ARG . 62.6 m-85 -88.49 134.12 33.94 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.6 pt -96.42 -15.63 7.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.771 0.32 . . . . 0.0 110.677 173.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.2 m -94.11 152.14 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.825 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.527 ' HB2' ' HB2' ' A' ' 11' ' ' GLU . 42.2 mtt85 -103.27 163.5 12.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.84 -177.112 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.493 HG12 HD13 ' A' ' 130' ' ' LEU . 72.5 mt -82.13 126.43 39.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 172.206 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.73 -10.7 64.56 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -173.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 8' ' ' ARG . 0.4 OUTLIER -77.04 150.1 35.78 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.163 -0.519 . . . . 0.0 109.809 -179.221 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.76 ' HG2' ' HG2' ' A' ' 126' ' ' LYS . 24.7 mtp -78.88 120.92 24.18 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.456 ' HA ' ' HD2' ' A' ' 14' ' ' PRO . . . -56.87 125.24 68.4 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.9 -175.404 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.456 ' HD2' ' HA ' ' A' ' 13' ' ' ALA . 10.0 Cg_endo -54.17 115.95 2.72 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.215 2.61 . . . . 0.0 111.736 177.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.517 ' HA ' HD12 ' A' ' 28' ' ' LEU . 1.2 t70 -68.32 138.2 55.26 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.541 -174.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.507 ' HB2' HD12 ' A' ' 104' ' ' ILE . 36.2 p90 -146.48 161.65 39.99 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.699 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 30.6 m -123.25 112.9 18.2 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 175.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.2 tt -117.63 144.51 25.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.017 0.437 . . . . 0.0 110.934 -175.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.0 m -84.59 127.19 33.93 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.406 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.411 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 85.3 mt -81.55 176.94 9.24 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.972 0.415 . . . . 0.0 110.906 177.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 96' ' ' LEU . 33.3 p -56.16 -34.89 66.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.881 -176.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -103.14 21.06 16.48 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.091 0.472 . . . . 0.0 110.71 -175.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.63 36.22 34.03 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.754 174.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 24' ' ' LYS . 43.3 mmtm -104.11 122.9 46.26 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.846 0.355 . . . . 0.0 110.649 177.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -88.48 115.91 26.34 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.956 177.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 17' ' ' THR . 14.3 m -114.91 143.77 23.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.017 0.437 . . . . 0.0 110.263 178.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 12.0 m -120.81 144.65 48.22 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.565 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.517 HD12 ' HA ' ' A' ' 15' ' ' ASP . 15.9 mt -61.7 -34.21 75.37 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.941 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.45 ' HA ' ' HG2' ' A' ' 32' ' ' ARG . 49.9 m -54.47 -38.21 66.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.927 0.394 . . . . 0.0 110.845 175.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.3 m -73.08 -23.23 60.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.24 0.543 . . . . 0.0 110.926 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.6 mt -99.54 0.44 42.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.45 ' HG2' ' HA ' ' A' ' 29' ' ' SER . 38.1 mmt180 -62.37 147.47 48.3 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 175.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 102.89 -26.53 23.72 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.771 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.581 ' HG3' ' HA ' ' A' ' 68' ' ' ASP . 3.2 mppt? -110.47 165.26 11.94 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.49 HG12 ' O ' ' A' ' 68' ' ' ASP . 2.7 p -83.01 120.27 34.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 173.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.459 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 17.3 t -108.6 131.94 57.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.79 -172.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 26.3 ttt -113.15 117.77 32.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.812 0.339 . . . . 0.0 110.471 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -109.08 112.7 25.02 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.336 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.516 HE22 ' HB ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -107.18 125.72 51.47 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 174.142 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.482 ' O ' ' HA ' ' A' ' 116' ' ' THR . 96.8 m-85 -94.29 114.59 26.69 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.242 0.544 . . . . 0.0 109.558 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.516 ' HB ' HE22 ' A' ' 39' ' ' GLN . 14.5 t -116.9 174.47 6.08 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.039 -173.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -150.6 131.28 14.0 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.597 177.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.655 ' HB2' ' HG3' ' A' ' 78' ' ' GLU . 43.9 m -65.27 -9.48 24.34 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.794 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 26.8 p-90 -110.0 11.39 24.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.837 0.351 . . . . 0.0 111.316 177.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 51.2 t -106.5 115.32 29.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.188 0.518 . . . . 0.0 111.033 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -77.75 -3.16 83.31 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.73 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.4 t -82.53 -37.98 14.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.131 0.491 . . . . 0.0 109.748 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 81.9 m -61.96 -27.79 69.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.134 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -71.51 -3.55 21.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.531 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.417 ' O ' ' HD1' ' A' ' 54' ' ' PHE . 58.2 mttp -104.03 -46.69 4.39 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 170.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.453 ' OE1' ' HA ' ' A' ' 133' ' ' LEU . 29.5 tt0 -58.19 -57.06 14.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.406 -177.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.671 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 80.1 mtp -58.51 -53.0 70.61 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.721 -172.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.671 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 50.3 Cg_exo -56.83 -40.39 84.56 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 122.101 1.868 . . . . 0.0 112.655 176.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.417 ' HD1' ' O ' ' A' ' 50' ' ' LYS . 17.1 m-85 -67.76 -44.03 78.43 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.789 177.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.443 ' O ' ' HB ' ' A' ' 59' ' ' ILE . 37.5 mt -54.5 -54.05 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.898 177.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.634 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 16.8 pt-20 -64.83 -41.49 95.71 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.579 -176.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -58.29 -49.13 78.24 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -175.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.705 ' HA ' ' NZ ' ' A' ' 62' ' ' LYS . 77.8 m-20 -106.08 -18.09 14.13 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -172.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.443 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 67.2 mt -102.75 -60.56 2.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.79 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.643 ' CE2' ' HG2' ' A' ' 64' ' ' LYS . 70.6 t-105 -65.73 -54.06 32.42 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -175.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.605 ' HA ' ' HE3' ' A' ' 64' ' ' LYS . 3.2 mm? -54.17 -29.67 46.53 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -176.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.705 ' NZ ' ' HA ' ' A' ' 58' ' ' ASP . 34.2 mmtm -88.05 -29.97 20.28 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.923 0.392 . . . . 0.0 111.219 -176.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -122.73 23.54 9.45 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -168.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.643 ' HG2' ' CE2' ' A' ' 60' ' ' TRP . 6.2 mtmp? -41.99 96.58 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.4 t70 68.25 -54.14 0.53 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 111.611 -2.54 . . . . 0.0 111.009 178.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 50.97 11.38 0.09 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.662 -179.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 60.1 13.64 3.94 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.115 0.566 . . . . 0.0 111.758 -173.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.581 ' HA ' ' HG3' ' A' ' 34' ' ' LYS . 44.7 t0 -153.71 6.0 0.32 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.966 0.412 . . . . 0.0 111.642 -176.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.58 ' HB2' HD11 ' A' ' 150' ' ' LEU . 84.2 t80 -136.72 119.61 16.33 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 121.668 -0.645 . . . . 0.0 110.687 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -116.37 108.24 15.81 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.892 -177.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.444 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 2.6 tt -106.73 121.1 43.69 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -178.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 40.2 mm -130.33 126.62 61.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.154 178.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.476 ' HA2' ' HG3' ' A' ' 39' ' ' GLN . . . -97.91 130.21 10.16 Favored Glycine 0 C--O 1.221 -0.686 0 C-N-CA 120.228 -0.986 . . . . 0.0 111.443 176.181 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 72.5 mt -119.31 125.31 74.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 117.55 0.675 . . . . 0.0 111.415 -174.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -86.3 142.41 28.54 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 174.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.407 ' CB ' HD13 ' A' ' 115' ' ' ILE . 58.6 ttt-85 -74.47 -30.83 62.01 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -172.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -161.14 -22.2 0.05 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -170.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.655 ' HG3' ' HB2' ' A' ' 43' ' ' SER . 4.5 mm-40 -72.91 129.5 86.49 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-O 121.218 0.532 . . . . 0.0 111.01 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.595 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 28.1 Cg_endo -66.62 -167.05 0.12 Allowed 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.713 2.942 . . . . 0.0 115.017 -175.525 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.424 HD13 HD23 ' A' ' 84' ' ' LEU . 2.8 tm? -58.14 -53.51 57.41 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 114.532 -1.213 . . . . 0.0 112.329 -170.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.595 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -63.15 -29.71 71.01 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 -173.962 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.52 ' HG3' ' CD ' ' A' ' 78' ' ' GLU . 30.7 mmtm -66.72 -54.36 23.75 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.95 177.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.513 HG21 ' HB3' ' A' ' 98' ' ' LEU . 41.2 t -55.33 -43.97 73.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.34 -177.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.424 HD23 HD13 ' A' ' 80' ' ' LEU . 4.4 mm? -69.28 -27.28 65.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.796 0.331 . . . . 0.0 111.608 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.749 ' HA ' ' HE2' ' A' ' 88' ' ' LYS . . . -85.96 -37.65 18.81 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.272 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.536 ' HE2' ' SD ' ' A' ' 52' ' ' MET . 49.0 t80 -68.67 -42.53 77.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.809 -178.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.485 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -56.3 -53.39 57.78 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.097 178.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.749 ' HE2' ' HA ' ' A' ' 85' ' ' ALA . 63.4 pttt -65.92 -20.89 66.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.966 0.412 . . . . 0.0 111.4 -176.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.8 m -82.36 -3.53 55.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.266 178.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.48 ' HB ' ' HG3' ' A' ' 53' ' ' PRO . 15.8 p -127.1 -24.91 3.35 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.997 0.427 . . . . 0.0 111.153 177.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 122.56 -79.25 0.34 Allowed Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 -176.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 90.6 t 45.37 89.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 124.526 1.13 . . . . 0.0 113.495 176.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.498 ' HG1' ' HD1' ' A' ' 60' ' ' TRP . 3.5 p -87.24 12.42 11.83 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.637 176.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.442 ' CE1' ' HB3' ' A' ' 56' ' ' GLU . 51.1 p90 -123.17 154.1 64.98 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.304 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -67.55 140.59 52.55 Favored 'Trans proline' 0 C--O 1.238 0.499 0 C-N-CA 122.201 1.934 . . . . 0.0 113.731 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.485 HD12 ' HB2' ' A' ' 87' ' ' ALA . 93.0 mt -113.95 151.43 32.31 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.661 175.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -122.53 149.82 16.94 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 175.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.707 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.0 OUTLIER -106.34 126.69 52.55 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.763 0.316 . . . . 0.0 110.827 -177.185 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -115.65 78.95 7.11 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.07 177.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.05 99.82 0.92 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.388 2.059 . . . . 0.0 112.744 -176.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 125.56 -7.05 7.95 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.899 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 63.19 44.29 5.8 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 122.853 0.461 . . . . 0.0 111.102 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -81.88 -50.91 8.64 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.196 0.522 . . . . 0.0 110.306 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.507 HD12 ' HB2' ' A' ' 16' ' ' PHE . 29.8 mm -65.23 -36.02 76.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.504 ' CD2' ' HA ' ' A' ' 111' ' ' ARG . 70.8 t80 -63.29 -42.96 99.13 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.207 175.019 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.62 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -67.45 -21.88 65.52 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.79 -178.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -72.63 -12.32 61.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.834 0.35 . . . . 0.0 111.16 178.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -116.23 -42.8 3.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.08 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.62 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -146.37 161.4 40.44 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.221 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.569 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 97.9 mt -62.26 129.92 42.96 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.504 ' HA ' ' CD2' ' A' ' 105' ' ' PHE . 21.5 mtm180 -50.43 -43.61 55.0 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.295 0.569 . . . . 0.0 111.258 -175.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -101.47 17.64 22.21 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.705 -170.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.569 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . . . -97.7 15.1 24.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.237 177.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 131.17 -179.04 17.34 Favored Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -178.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.444 HG23 ' H ' ' A' ' 116' ' ' THR . 1.0 OUTLIER -125.88 -73.2 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 117.525 0.662 . . . . 0.0 112.751 -179.689 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.713 ' HB ' ' HB3' ' A' ' 133' ' ' LEU . 5.1 m -73.68 117.42 15.42 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.092 0.472 . . . . 0.0 111.985 -167.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.421 ' C ' HD22 ' A' ' 118' ' ' ASN . 75.5 mtt-85 -143.04 154.44 43.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.169 -179.245 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.496 ' HB2' HG23 ' A' ' 131' ' ' THR . 0.9 OUTLIER -121.79 119.78 32.69 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 174.132 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.4 t -116.02 123.58 71.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.146 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.566 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 25.8 tp -107.65 121.84 45.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.027 0.442 . . . . 0.0 110.704 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.459 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 62.5 mt -102.77 132.5 48.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.077 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.462 ' OD2' ' HB2' ' A' ' 124' ' ' GLU . 18.4 t70 -79.43 164.96 23.56 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.679 178.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.489 ' HB3' HH11 ' A' ' 123' ' ' ARG . 0.0 OUTLIER -57.33 -29.55 64.05 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.552 179.34 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.536 ' HB3' ' NZ ' ' A' ' 126' ' ' LYS . 18.0 mm-40 -75.4 7.05 3.86 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.0 0.429 . . . . 0.0 111.096 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 76.15 14.13 82.58 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.168 176.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.76 ' HG2' ' HG2' ' A' ' 12' ' ' MET . 25.0 mtmm -113.68 139.19 49.27 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.831 0.348 . . . . 0.0 110.926 -175.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.3 mt -76.14 130.63 36.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.781 -175.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 31.0 m -116.07 -21.0 5.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -176.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.566 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 53.1 tptt -135.5 116.44 14.18 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.552 -0.459 . . . . 0.0 112.092 -174.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.493 HD13 HG12 ' A' ' 9' ' ' ILE . 10.6 mp -109.09 119.34 39.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.332 172.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.555 HG21 HD11 ' A' ' 142' ' ' LEU . 14.7 t -147.15 162.91 37.9 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.98 178.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.458 ' C ' ' HG ' ' A' ' 133' ' ' LEU . 37.2 mtm180 -115.83 116.91 28.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.112 -173.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.713 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 3.9 pp 48.62 -169.09 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 O-C-N 124.67 1.231 . . . . 0.0 114.001 174.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.446 ' HB2' ' CB ' ' A' ' 51' ' ' GLU . 60.9 t80 -80.59 114.74 19.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.449 -178.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.544 ' HB3' ' HB2' ' A' ' 138' ' ' GLU . 3.0 t-20 -130.87 133.78 46.2 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.948 -1.023 . . . . 0.0 108.429 173.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -44.87 -61.26 1.67 Allowed 'General case' 0 C--O 1.236 0.367 0 O-C-N 123.441 0.463 . . . . 0.0 112.189 -178.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -60.74 -50.71 72.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.822 0.344 . . . . 0.0 111.317 -177.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.544 ' HB2' ' HB3' ' A' ' 135' ' ' ASN . 4.0 mm-40 -63.13 -39.49 94.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.981 -177.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -66.08 -41.45 90.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.807 0.337 . . . . 0.0 110.102 177.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.82 -42.02 98.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.157 176.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.4 m -67.31 -35.21 78.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.239 177.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.555 HD11 HG21 ' A' ' 131' ' ' THR . 24.7 mt -66.67 -53.4 34.29 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.836 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.6 p -60.69 -42.17 90.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.025 -175.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -67.29 -41.52 85.3 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.812 0.339 . . . . 0.0 110.547 177.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.531 ' O ' ' HG2' ' A' ' 149' ' ' MET . 60.9 tt0 -58.5 -51.39 70.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.657 176.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.615 ' O ' HD23 ' A' ' 150' ' ' LEU . 99.0 mt -62.48 -40.51 88.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.85 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -54.35 -37.47 64.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.25 177.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.545 ' HA ' ' HG2' ' A' ' 151' ' ' LYS . 1.3 tp10 -88.14 -26.62 22.36 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.625 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.531 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 97.5 mmm -63.8 -26.25 68.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.408 0.623 . . . . 0.0 109.704 175.078 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.615 HD23 ' O ' ' A' ' 146' ' ' ILE . 3.9 mm? -81.45 -7.61 59.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.072 177.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.545 ' HG2' ' HA ' ' A' ' 148' ' ' GLU . 18.8 mmtm -96.93 -67.2 0.86 Allowed 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 174.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.484 ' CD ' ' HD1' ' A' ' 154' ' ' HIS . 2.1 tt0 46.92 -90.74 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.545 -175.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -177.68 -29.1 0.04 OUTLIER Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.304 178.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.484 ' HD1' ' CD ' ' A' ' 152' ' ' GLU . 49.8 m80 -77.44 0.15 23.7 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -173.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -77.29 83.9 3.74 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 122.243 1.02 . . . . 0.0 110.886 -177.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -138.99 167.08 22.84 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.47 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 12.1 t60 -147.82 88.22 1.67 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 171.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 39.9 t60 -148.91 104.7 3.47 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.93 178.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 . . . . . 0 C--O 1.246 0.909 0 CA-C-O 118.205 -0.902 . . . . 0.0 109.349 179.324 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 mpp? . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.8 t 67.97 174.78 0.27 Allowed 'General case' 0 CA--C 1.532 0.27 0 O-C-N 123.971 0.794 . . . . 0.0 110.633 -177.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.435 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 21.1 tp -131.21 22.21 4.83 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.432 ' O ' ' HB1' ' A' ' 109' ' ' ALA . . . 102.1 8.15 45.26 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.218 -174.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.491 ' CE1' HD12 ' A' ' 130' ' ' LEU . 69.0 m-85 -72.95 135.58 45.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.454 -0.373 . . . . 0.0 111.346 -178.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.52 HG13 HG23 ' A' ' 7' ' ' VAL . 46.8 pt -101.65 -17.13 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 170.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.52 HG23 HG13 ' A' ' 6' ' ' ILE . 23.1 t -110.3 139.27 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.067 177.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.439 ' HE ' ' CD ' ' A' ' 11' ' ' GLU . 73.6 mtm180 -122.47 -178.7 3.97 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.084 0.469 . . . . 0.0 112.186 -169.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.426 ' CG1' HD23 ' A' ' 130' ' ' LEU . 67.5 mt -71.32 123.07 24.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.294 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.16 -19.82 44.91 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.166 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.439 ' CD ' ' HE ' ' A' ' 8' ' ' ARG . 7.1 mt-10 -80.87 151.32 28.71 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.68 ' HG2' ' HG2' ' A' ' 126' ' ' LYS . 45.1 mtp -77.92 137.54 38.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.844 0.354 . . . . 0.0 110.362 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.24 130.83 67.79 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.404 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.402 ' HG2' ' O ' ' A' ' 107' ' ' LYS . 37.6 Cg_exo -61.23 125.95 18.19 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.493 2.129 . . . . 0.0 111.427 177.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -63.01 138.64 58.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.224 0.535 . . . . 0.0 110.196 -176.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.686 ' HB2' HD12 ' A' ' 104' ' ' ILE . 47.1 p90 -131.76 149.69 52.39 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.052 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.5 m -109.17 98.79 8.17 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 170.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 25' ' ' GLN . 16.9 tt -95.6 144.8 9.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.516 -174.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.8 m -101.55 118.3 36.68 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.103 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.8 mt -73.57 172.83 10.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.959 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 96' ' ' LEU . 41.5 p -58.1 -28.84 64.98 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -175.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -102.6 18.74 20.54 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.143 0.497 . . . . 0.0 110.859 -175.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.86 40.43 17.41 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.795 174.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -108.73 117.18 33.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.887 0.375 . . . . 0.0 110.928 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 49.7 mt-30 -94.75 118.47 31.79 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.003 178.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.8 p -128.88 132.28 67.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.217 0.532 . . . . 0.0 111.123 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.41 154.81 25.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.089 177.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 40.4 tp -65.48 -40.28 92.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.844 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.59 ' HA ' ' HG3' ' A' ' 32' ' ' ARG . 75.3 m -62.92 -19.14 63.94 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 177.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 51.8 m -75.2 -18.15 60.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.511 0.672 . . . . 0.0 110.395 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.3 mt -100.81 -14.11 18.13 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.732 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.646 ' NH1' ' HA ' ' A' ' 124' ' ' GLU . 6.3 mmm180 -55.48 153.57 7.4 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 123.539 0.525 . . . . 0.0 110.917 177.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.09 -22.64 35.43 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -172.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.524 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 35.7 mtmm -117.31 170.93 8.31 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 174.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.5 m -80.9 134.03 28.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 172.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.592 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 44.3 t -111.22 109.6 29.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 121.006 0.431 . . . . 0.0 111.076 -177.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 13.9 tpt -91.81 136.25 33.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.211 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 78.9 mt -133.74 143.29 48.37 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.077 -178.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.56 ' OE1' ' HB ' ' A' ' 41' ' ' THR . 21.8 tm0? -138.45 131.44 29.77 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 177.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.449 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 96.7 m-85 -104.56 120.04 40.38 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.56 ' HB ' ' OE1' ' A' ' 39' ' ' GLN . 6.8 t -136.47 -175.67 4.08 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.059 0.456 . . . . 0.0 111.602 -173.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.501 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . . . -169.41 164.04 10.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.463 178.248 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.454 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 86.3 p -67.19 -30.25 70.14 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.892 0.377 . . . . 0.0 111.739 -173.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 37.7 p-90 -89.0 4.36 48.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.668 -175.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.501 ' SG ' ' HB3' ' A' ' 42' ' ' ALA . 80.0 m -85.69 90.05 7.91 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.072 0.463 . . . . 0.0 110.796 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.84 -35.7 90.01 Favored Glycine 0 C--O 1.228 -0.265 0 C-N-CA 121.08 -0.581 . . . . 0.0 113.004 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.5 t -64.46 -35.44 74.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.012 0.434 . . . . 0.0 110.057 178.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.708 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 99.4 m -65.24 -16.84 63.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.395 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -68.99 -7.32 34.25 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 120.849 0.357 . . . . 0.0 110.604 177.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.629 ' HD3' ' CD2' ' A' ' 134' ' ' TYR . 62.1 mttt -88.24 -57.25 2.99 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.351 0.596 . . . . 0.0 110.257 168.149 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.736 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 5.0 pt-20 -65.65 -40.06 92.07 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.287 -172.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.596 ' HG2' ' O ' ' A' ' 48' ' ' CYS . 98.9 mmm -54.69 -58.39 14.52 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 117.999 0.363 . . . . 0.0 111.862 -177.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.459 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 29.6 Cg_endo -64.48 -38.53 32.84 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 122.018 1.812 . . . . 0.0 112.501 178.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -64.46 -42.07 96.16 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.314 178.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.562 ' O ' ' HB ' ' A' ' 59' ' ' ILE . 75.0 mt -60.25 -37.49 73.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.863 0.363 . . . . 0.0 110.404 177.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.728 ' HG3' ' H ' ' A' ' 93' ' ' THR . 0.2 OUTLIER -68.42 -62.66 1.3 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 175.921 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.403 ' O ' ' HE2' ' A' ' 62' ' ' LYS . 29.3 ttpp -55.58 -43.1 75.64 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -174.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.624 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 8.3 m-20 -100.65 -24.82 14.34 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -171.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.562 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 53.9 mt -106.5 -60.99 2.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.458 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.523 ' HB3' ' HA ' ' A' ' 56' ' ' GLU . 76.6 t-105 -62.8 -62.65 1.58 Allowed 'General case' 0 C--O 1.226 -0.18 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.614 -175.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.483 HD12 ' HA ' ' A' ' 61' ' ' LEU . 0.5 OUTLIER -46.68 -31.98 3.25 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.655 0.782 . . . . 0.0 112.497 -174.013 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.624 ' HE2' ' HA ' ' A' ' 58' ' ' ASP . 64.7 mmtt -72.75 -54.24 9.45 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.923 -178.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.791 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 85.8 m-70 -105.83 -45.29 4.42 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -169.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.469 ' HE3' HD12 ' A' ' 61' ' ' LEU . 32.5 mttp 55.06 -78.42 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.77 0.828 . . . . 0.0 111.495 -172.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -101.36 -63.25 1.16 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 174.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.791 ' HB2' ' HB3' ' A' ' 63' ' ' HIS . 3.9 t30 68.21 5.97 4.99 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.842 172.328 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 71.68 -19.44 0.26 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.769 0.828 . . . . 0.0 112.513 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.524 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 19.9 p30 -136.92 17.31 3.04 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.484 ' CE2' ' HB2' ' A' ' 71' ' ' LEU . 93.7 t80 -125.63 143.3 51.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.087 0.47 . . . . 0.0 111.112 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.81 140.59 38.61 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.744 172.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.484 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 2.2 tt -139.12 114.73 9.9 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -179.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.9 mm -124.3 120.83 60.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.133 178.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.455 ' HA3' ' CD2' ' A' ' 96' ' ' LEU . . . -88.72 130.44 10.15 Favored Glycine 0 C--O 1.223 -0.57 0 C-N-CA 120.223 -0.989 . . . . 0.0 110.809 175.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 48.6 mt -116.67 121.6 68.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 117.28 0.54 . . . . 0.0 110.759 -174.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -82.59 139.8 33.59 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 173.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.444 ' HB2' HD13 ' A' ' 115' ' ' ILE . 57.7 ttt-85 -57.37 -51.78 68.03 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.668 0.605 . . . . 0.0 112.58 -172.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.597 ' HA ' ' O ' ' A' ' 99' ' ' ASP . 11.3 p-10 -170.05 15.48 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -175.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.54 ' HB3' ' HG3' ' A' ' 82' ' ' LYS . 29.0 mt-10 -91.52 148.53 37.62 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-O 121.088 0.471 . . . . 0.0 110.599 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.642 ' HG2' ' OE2' ' A' ' 81' ' ' GLU . 38.1 Cg_endo -71.34 -174.48 1.23 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.935 2.423 . . . . 0.0 114.257 -176.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 85.2 mt -54.25 -52.5 61.16 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.618 -1.173 . . . . 0.0 112.826 -174.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.642 ' OE2' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -61.22 -24.54 66.42 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -172.819 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.628 ' HG2' ' OE2' ' A' ' 81' ' ' GLU . 42.5 mmtm -73.23 -59.87 2.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.717 0.294 . . . . 0.0 110.367 172.084 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.6 t -54.59 -49.24 68.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.725 -176.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.8 mp -64.69 -40.43 95.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.413 -176.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.408 ' O ' ' HG2' ' A' ' 88' ' ' LYS . . . -76.67 -34.55 58.24 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.316 -177.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.454 ' CD1' ' HA ' ' A' ' 43' ' ' SER . 78.9 t80 -67.09 -48.94 66.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.791 -178.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.467 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -53.34 -52.05 60.46 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.042 -176.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 85' ' ' ALA . 17.9 pttm -63.19 -28.45 70.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.043 -176.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.5 m -100.73 9.86 41.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.724 -174.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.2 p -129.46 10.87 5.75 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.108 175.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.67 43.65 91.46 Favored Glycine 0 C--O 1.227 -0.281 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.275 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.7 t -100.36 100.65 10.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.028 0.442 . . . . 0.0 110.944 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.728 ' H ' ' HG3' ' A' ' 56' ' ' GLU . 30.1 m -85.94 -20.52 28.85 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.848 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.522 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 23.6 p90 -82.48 144.12 48.97 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.816 178.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -61.5 140.67 88.53 Favored 'Trans proline' 0 C--O 1.238 0.495 0 C-N-CA 122.572 2.181 . . . . 0.0 113.175 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.475 ' O ' HG23 ' A' ' 21' ' ' THR . 76.3 mt -111.06 151.2 28.32 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.852 176.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -123.59 149.16 16.85 Favored Glycine 0 N--CA 1.438 -1.214 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 175.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.735 HD23 ' H ' ' A' ' 98' ' ' LEU . 0.8 OUTLIER -99.81 132.56 45.08 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.591 0.234 . . . . 0.0 110.561 -177.456 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.597 ' O ' ' HA ' ' A' ' 77' ' ' ASP . 26.6 t0 -109.58 83.31 2.57 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.925 176.004 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -60.92 101.67 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.417 2.078 . . . . 0.0 113.177 -175.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.442 ' H ' ' HB2' ' A' ' 77' ' ' ASP . . . 101.51 11.76 37.5 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.852 -0.689 . . . . 0.0 113.359 175.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 61.32 43.46 10.66 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.082 0.467 . . . . 0.0 110.872 178.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.645 ' HA ' HH21 ' A' ' 111' ' ' ARG . 18.1 t70 -79.89 -50.2 10.82 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.537 0.684 . . . . 0.0 110.374 -178.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.686 HD12 ' HB2' ' A' ' 16' ' ' PHE . 31.7 mm -67.41 -39.45 82.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 175.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -56.69 -39.14 73.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.363 175.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.17 -32.32 72.49 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.77 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.402 ' O ' ' HG2' ' A' ' 14' ' ' PRO . 30.5 mtmm -74.83 -4.79 39.86 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 178.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -116.61 -19.24 10.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 179.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.689 ' HB3' HH12 ' A' ' 117' ' ' ARG . . . -171.9 -179.99 2.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.572 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 80.2 mt -66.11 149.62 50.0 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 174.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.645 HH21 ' HA ' ' A' ' 103' ' ' ASP . 93.5 mtt180 -73.58 -15.22 61.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.121 0.486 . . . . 0.0 110.024 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -100.51 15.9 26.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.346 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.07 -179.26 5.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.475 -177.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.88 142.03 42.79 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.679 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.595 ' O ' ' HG2' ' A' ' 117' ' ' ARG . 6.6 tp -91.66 -39.77 11.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 111.36 0.133 . . . . 0.0 111.36 -178.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.577 HG22 ' SG ' ' A' ' 48' ' ' CYS . 18.0 p -68.86 105.33 2.32 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 120.484 0.183 . . . . 0.0 110.878 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.689 HH12 ' HB3' ' A' ' 109' ' ' ALA . 8.9 ptm180 -167.65 133.06 1.96 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.171 0.51 . . . . 0.0 112.127 -173.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.59 ' HB2' ' CB ' ' A' ' 131' ' ' THR . 91.2 m-20 -104.41 129.59 52.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.231 172.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.6 t -120.95 116.93 51.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 120.619 0.247 . . . . 0.0 110.394 -176.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 37.5 tp -106.38 115.12 29.66 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.113 0.482 . . . . 0.0 110.645 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.592 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 60.7 mt -95.51 135.05 30.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.366 176.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' A' ' 124' ' ' GLU . 0.0 OUTLIER -79.49 177.01 9.18 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.206 0.526 . . . . 0.0 110.734 -177.213 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.654 ' HD2' ' OE2' ' A' ' 152' ' ' GLU . 31.6 ttm180 -62.57 -27.1 68.95 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.561 -177.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.646 ' HA ' ' NH1' ' A' ' 32' ' ' ARG . 2.1 mm-40 -91.42 6.28 46.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.066 -178.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.16 16.68 62.33 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.544 -0.836 . . . . 0.0 113.017 172.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.68 ' HG2' ' HG2' ' A' ' 12' ' ' MET . 33.3 mttt -112.18 142.77 44.24 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.829 0.347 . . . . 0.0 110.292 -177.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.474 HD12 ' CG1' ' A' ' 7' ' ' VAL . 58.3 mt -80.21 119.96 30.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 120.776 0.322 . . . . 0.0 110.613 -177.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.5 m -109.88 -8.07 11.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -149.34 111.21 4.57 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.296 -175.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.491 HD12 ' CE1' ' A' ' 5' ' ' TYR . 3.2 mm? -104.79 105.78 16.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.224 172.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.59 ' CB ' ' HB2' ' A' ' 118' ' ' ASN . 10.4 m -88.98 138.69 31.17 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.367 -177.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.521 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 2.3 mpt_? -99.78 107.08 19.04 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 176.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 132' ' ' ARG . 0.5 OUTLIER 43.44 -162.89 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 O-C-N 124.212 0.945 . . . . 0.0 111.788 -174.201 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.736 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 90.5 t80 -88.63 92.81 9.34 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.168 0.509 . . . . 0.0 110.08 173.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.562 ' HB3' ' HB3' ' A' ' 138' ' ' GLU . 10.7 t30 -95.02 131.57 40.85 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 170.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.432 ' HB2' ' OE2' ' A' ' 137' ' ' GLU . 24.9 mm-40 -50.16 -63.81 1.0 Allowed 'General case' 0 CA--C 1.536 0.424 0 O-C-N 123.687 0.617 . . . . 0.0 112.178 -168.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.566 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.2 mp0 -66.62 -32.52 73.9 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.108 0.48 . . . . 0.0 110.945 -177.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.562 ' HB3' ' HB3' ' A' ' 135' ' ' ASN . 6.0 tp10 -62.68 -46.18 89.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.606 -176.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.499 ' O ' HG23 ' A' ' 143' ' ' VAL . 91.9 t80 -63.57 -42.03 98.34 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.511 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.4 -44.06 96.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.805 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.3 m -63.68 -39.6 94.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.414 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.501 ' O ' HG13 ' A' ' 146' ' ' ILE . 58.4 tp -62.46 -44.31 96.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.942 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 139' ' ' PHE . 99.0 t -57.66 -52.94 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.15 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -60.96 -41.29 96.06 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-O 121.281 0.562 . . . . 0.0 110.872 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -57.71 -48.52 79.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.575 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.608 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 78.0 mt -58.96 -41.92 84.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.879 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -55.2 -46.68 75.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.561 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -83.88 -25.22 30.41 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.092 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.442 ' HB3' ' HE3' ' A' ' 149' ' ' MET . 28.8 mmm -58.92 -33.88 71.08 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.413 0.625 . . . . 0.0 110.371 178.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.665 ' HB2' ' HD2' ' A' ' 151' ' ' LYS . 52.2 mt -60.8 -39.1 87.65 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.611 176.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.665 ' HD2' ' HB2' ' A' ' 150' ' ' LEU . 11.1 mmmt -89.21 -30.16 18.74 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.629 -168.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.654 ' OE2' ' HD2' ' A' ' 123' ' ' ARG . 7.2 tt0 63.42 -121.18 0.55 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.932 167.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -74.35 -11.46 82.28 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 121.462 -0.399 . . . . 0.0 112.744 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 79.1 m80 66.29 77.84 0.28 Allowed 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 122.907 0.483 . . . . 0.0 111.555 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -78.78 97.38 5.9 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 170.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.489 ' O ' ' HB2' ' A' ' 157' ' ' HIS . 0.0 OUTLIER 71.08 153.17 0.12 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.4 -165.845 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 157' ' ' HIS . . . . . 0.489 ' HB2' ' O ' ' A' ' 156' ' ' HIS . 71.5 m80 72.12 39.78 0.76 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -161.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -170.21 -32.53 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 112.775 -2.012 . . . . 0.0 105.695 -173.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.246 0.872 0 CA-C-N 113.2 -1.818 . . . . 0.0 107.503 167.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.2 ptp . . . . . 0 N--CA 1.483 1.213 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.7 m -53.4 122.85 10.48 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 123.371 0.419 . . . . 0.0 110.273 175.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 91.7 mt 71.39 143.54 0.06 Allowed 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.963 0.79 . . . . 0.0 110.798 -174.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.53 57.6 4.9 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.825 -0.703 . . . . 0.0 113.414 -174.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.429 ' OH ' ' HD2' ' A' ' 117' ' ' ARG . 1.3 m-85 -91.71 121.06 33.01 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.771 0.319 . . . . 0.0 110.247 175.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.431 HG13 HG13 ' A' ' 7' ' ' VAL . 38.6 pt -92.38 -24.01 5.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.437 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.431 HG13 HG13 ' A' ' 6' ' ' ILE . 27.4 m -104.51 157.16 5.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.389 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.528 ' H ' ' HG3' ' A' ' 11' ' ' GLU . 19.7 mtt180 -126.25 177.39 6.45 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.082 -174.119 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.646 HG12 HD13 ' A' ' 130' ' ' LEU . 79.9 mt -74.27 110.7 8.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 173.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.02 -23.45 8.2 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.092 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.528 ' HG3' ' H ' ' A' ' 8' ' ' ARG . 69.1 mm-40 -68.13 154.67 41.21 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.572 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 55.5 mtp -86.08 139.83 30.79 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.949 0.404 . . . . 0.0 110.482 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.494 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -67.44 130.06 93.46 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.561 -178.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 8.3 Cg_exo -70.7 120.98 7.5 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.926 2.418 . . . . 0.0 111.477 176.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -63.43 146.93 52.6 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.451 -176.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 1.027 ' HB3' ' HE2' ' A' ' 107' ' ' LYS . 54.0 p90 -156.7 158.54 37.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.69 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.8 m -116.33 107.27 14.62 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.748 175.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.1 tt -107.81 146.81 13.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.005 0.431 . . . . 0.0 111.003 -176.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.402 ' O ' HD23 ' A' ' 98' ' ' LEU . 20.3 m -95.37 130.22 42.24 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.053 177.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.497 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 90.6 mt -83.89 179.01 7.66 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.005 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 96' ' ' LEU . 27.4 p -59.56 -31.21 69.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.714 -175.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -101.88 10.91 39.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.983 0.42 . . . . 0.0 110.917 -176.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.07 8.7 62.94 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.522 176.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.44 ' HB2' HD12 ' A' ' 20' ' ' LEU . 46.0 mmtm -77.44 120.59 22.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.362 0.581 . . . . 0.0 110.593 177.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -98.63 115.46 28.71 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.962 0.41 . . . . 0.0 110.393 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.3 m -113.78 153.07 15.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.008 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 9.1 m -122.49 142.96 50.03 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.335 -0.393 . . . . 0.0 109.961 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.67 -39.88 94.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.847 0.356 . . . . 0.0 110.841 -175.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 32' ' ' ARG . 5.3 p -61.18 -21.57 63.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.546 178.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.1 m -79.86 -25.99 40.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.068 0.461 . . . . 0.0 110.403 177.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 77.2 mt -96.5 1.88 51.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.392 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 29' ' ' SER . 0.2 OUTLIER -55.74 126.39 25.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.081 179.339 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.626 ' O ' ' HG3' ' A' ' 123' ' ' ARG . . . 106.37 -0.11 37.6 Favored Glycine 0 C--O 1.222 -0.635 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.724 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.4 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 58.1 mttm -116.51 159.54 21.93 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 174.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.475 HG13 ' HD1' ' A' ' 69' ' ' PHE . 2.1 p -78.29 107.3 10.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.585 0.707 . . . . 0.0 109.172 171.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.512 HG22 ' HB3' ' A' ' 70' ' ' ALA . 48.0 t -106.89 120.93 59.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.095 -173.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.409 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 26.7 ttt -98.81 120.2 38.84 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.331 176.178 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 94.0 mt -107.88 110.87 22.75 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.022 177.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.433 ' OE1' ' HB ' ' A' ' 41' ' ' THR . 0.6 OUTLIER -103.37 106.14 16.58 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.874 -176.983 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 116' ' ' THR . 95.1 m-85 -93.76 127.29 39.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.572 -177.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.433 ' HB ' ' OE1' ' A' ' 39' ' ' GLN . 15.0 t -158.26 -166.47 1.94 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.366 -176.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.531 ' HB2' HD11 ' A' ' 115' ' ' ILE . . . -151.03 156.44 41.12 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 176.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.616 ' HB2' ' HG3' ' A' ' 78' ' ' GLU . 49.7 m -66.26 -9.49 33.0 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -176.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 41.0 p-90 -105.4 4.86 31.22 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 122.201 -0.312 . . . . 0.0 111.566 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 74.9 m -83.17 113.47 20.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.023 0.439 . . . . 0.0 111.158 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -78.31 -33.21 40.45 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.863 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.3 t -66.48 -37.46 79.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.08 0.467 . . . . 0.0 110.797 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.681 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 29.1 t -67.03 -16.95 64.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.374 0.607 . . . . 0.0 110.793 -178.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.526 ' HE ' ' HE1' ' A' ' 86' ' ' PHE . 79.6 mtt180 -74.83 -2.15 25.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.681 177.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.409 ' O ' ' HD1' ' A' ' 54' ' ' PHE . 74.2 mmtt -94.02 -55.61 3.15 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.702 0.763 . . . . 0.0 109.278 169.198 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.996 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 10.0 pt-20 -62.68 -44.27 96.69 Favored 'General case' 0 C--O 1.213 -0.827 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.861 -173.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.683 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 33.3 mtm -56.06 -55.23 43.8 Favored Pre-proline 0 N--CA 1.466 0.362 0 CA-C-N 118.338 0.517 . . . . 0.0 112.36 -176.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.683 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 65.0 Cg_exo -53.93 -38.7 86.37 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 121.976 1.784 . . . . 0.0 111.968 175.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.489 ' HB3' ' CZ ' ' A' ' 139' ' ' PHE . 23.1 m-85 -68.26 -45.04 74.25 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.081 175.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 51' ' ' GLU . 88.1 mt -58.86 -55.68 21.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 123.065 0.546 . . . . 0.0 111.08 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.536 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 16.0 pt-20 -62.69 -35.71 80.58 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.635 -177.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.0 ttpm? -72.37 -51.4 20.69 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -176.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.493 ' HA ' ' NZ ' ' A' ' 62' ' ' LYS . 53.5 m-20 -106.99 -10.8 15.83 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -170.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 65.0 mt -104.57 -55.44 5.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.158 173.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.536 ' HB3' ' HA ' ' A' ' 56' ' ' GLU . 72.1 t-105 -69.97 -65.84 0.67 Allowed 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.575 -177.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.519 HD13 ' HE3' ' A' ' 64' ' ' LYS . 1.9 mm? -46.78 -33.88 4.78 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -175.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.493 ' NZ ' ' HA ' ' A' ' 58' ' ' ASP . 45.8 mmtm -75.72 -34.12 60.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.29 -0.414 . . . . 0.0 112.057 -176.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.418 ' ND1' ' HG ' ' A' ' 150' ' ' LEU . 79.9 m-70 -125.28 -43.73 1.91 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 120.347 -0.541 . . . . 0.0 112.351 -173.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.519 ' HE3' HD13 ' A' ' 61' ' ' LEU . 34.5 mttp 54.87 -90.6 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.944 0.898 . . . . 0.0 111.936 -177.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -108.01 -49.41 3.21 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 174.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 70.94 -71.22 0.14 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.83 178.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 169.78 -23.67 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.287 -175.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.4 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 6.9 t70 -148.3 24.93 1.01 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.79 -174.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.475 ' HD1' HG13 ' A' ' 35' ' ' VAL . 87.5 t80 -129.12 140.13 51.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.745 0.307 . . . . 0.0 110.571 -178.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.512 ' HB3' HG22 ' A' ' 36' ' ' VAL . . . -139.16 135.83 34.45 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.323 177.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.409 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 1.7 tt -133.79 117.2 16.62 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.6 mp -128.15 126.98 67.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.766 0.317 . . . . 0.0 110.332 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.81 129.46 9.91 Favored Glycine 0 C--O 1.219 -0.784 0 N-CA-C 110.799 -0.921 . . . . 0.0 110.799 174.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.0 mt -119.21 122.53 69.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 117.489 0.644 . . . . 0.0 111.338 -173.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -86.11 133.26 33.89 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 173.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.879 ' HD3' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -88.35 -22.78 23.63 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -169.271 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.879 ' HB3' ' HD3' ' A' ' 76' ' ' ARG . 3.9 p30 -151.25 -14.04 0.21 Allowed 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 118.721 -1.192 . . . . 0.0 114.131 -172.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.616 ' HG3' ' HB2' ' A' ' 43' ' ' SER . 4.9 mm-40 -88.46 133.31 36.69 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-O 121.065 0.46 . . . . 0.0 110.746 177.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.525 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 29.0 Cg_endo -69.19 -168.82 0.27 Allowed 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 123.175 2.583 . . . . 0.0 114.624 -177.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.2 -53.97 52.19 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.414 -168.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.525 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -64.23 -33.59 76.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.657 0.265 . . . . 0.0 111.305 -173.941 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.489 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 33.7 mmtp -61.06 -53.93 51.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.85 177.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 79' ' ' PRO . 41.1 t -57.53 -41.52 79.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.352 -177.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -66.07 -44.19 85.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.854 0.359 . . . . 0.0 111.26 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.82 -27.93 62.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.175 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.526 ' HE1' ' HE ' ' A' ' 49' ' ' ARG . 91.7 t80 -74.14 -48.08 31.73 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.19 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.53 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -58.39 -55.09 39.54 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.334 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.7 ptmm? -58.84 -24.95 62.75 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -174.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.0 m -84.15 -17.29 40.53 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -175.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.5 p -111.08 -23.39 10.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.098 0.475 . . . . 0.0 110.653 176.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 123.36 -79.78 0.35 Allowed Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -177.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 94.4 t 46.19 82.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 122.101 0.953 . . . . 0.0 112.691 178.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.3 m -71.55 -18.66 62.24 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.446 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -93.98 139.92 22.77 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.45 140.12 85.88 Favored 'Trans proline' 0 C--O 1.238 0.499 0 C-N-CA 122.46 2.107 . . . . 0.0 113.437 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.53 HD12 ' HB2' ' A' ' 87' ' ' ALA . 88.6 mt -106.23 152.21 23.79 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.868 175.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -124.33 154.41 17.86 Favored Glycine 0 N--CA 1.441 -1.025 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 175.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.715 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.2 pt? -107.43 130.45 54.82 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.945 0.402 . . . . 0.0 111.126 -177.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -119.13 75.15 14.73 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.868 175.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.425 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 17.4 Cg_exo -66.23 105.16 0.82 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.6 2.2 . . . . 0.0 112.421 -177.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 119.47 -1.79 14.04 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.127 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 57.91 43.4 21.5 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 122.658 0.383 . . . . 0.0 111.931 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.407 ' O ' ' HG3' ' A' ' 107' ' ' LYS . 13.7 t70 -87.1 -50.67 6.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.06 0.457 . . . . 0.0 109.903 -177.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.571 HD12 ' HB2' ' A' ' 16' ' ' PHE . 34.3 mm -62.54 -34.92 67.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 174.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -61.5 -41.67 97.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.248 173.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.749 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -68.32 -21.81 64.74 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.893 -177.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 1.027 ' HE2' ' HB3' ' A' ' 16' ' ' PHE . 26.5 mtpp -70.9 -6.84 41.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.002 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -124.64 -32.75 3.07 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.158 -179.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.749 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -156.89 162.58 39.66 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 84.2 mt -56.76 149.01 18.94 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.759 0.314 . . . . 0.0 110.381 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.61 ' HG2' ' HB2' ' A' ' 106' ' ' ALA . 38.1 mtt180 -69.66 -13.46 62.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.139 0.495 . . . . 0.0 110.542 -174.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -100.96 -7.33 23.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.126 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -78.91 75.77 5.41 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.203 0.525 . . . . 0.0 111.719 -174.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.93 -140.33 29.91 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.094 178.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.531 HD11 ' HB2' ' A' ' 42' ' ' ALA . 4.6 tp -161.93 -57.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.481 0.182 . . . . 0.0 111.351 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 40' ' ' PHE . 4.8 m -87.86 111.68 21.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.073 0.464 . . . . 0.0 110.951 -175.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.429 ' HD2' ' OH ' ' A' ' 5' ' ' TYR . 46.0 mtm105 -141.61 133.17 26.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.074 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.589 ' HB2' ' CG2' ' A' ' 131' ' ' THR . 6.0 m120 -102.39 119.01 38.09 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 176.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.9 t -113.8 123.76 69.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.078 -177.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 34.4 tp -110.58 121.76 46.1 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.11 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.3 mp -102.13 139.02 24.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.67 177.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.59 -174.17 4.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.055 0.455 . . . . 0.0 111.02 -177.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.626 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 32.4 ttt180 -69.84 -26.26 64.14 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.604 -175.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -80.17 -15.05 57.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.703 0.287 . . . . 0.0 111.254 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.2 16.38 30.19 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.08 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 81.2 mttt -101.24 154.87 18.39 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.907 0.384 . . . . 0.0 110.414 -178.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 53.9 mt -92.62 116.44 33.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.172 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.53 -31.32 2.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -173.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.859 ' HG2' ' HG ' ' A' ' 142' ' ' LEU . 50.5 tptt -124.66 114.27 19.11 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.908 -0.495 . . . . 0.0 111.194 -176.092 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.646 HD13 HG12 ' A' ' 9' ' ' ILE . 8.5 mp -110.99 105.13 13.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.746 176.037 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.593 ' HA ' ' NH1' ' A' ' 132' ' ' ARG . 10.0 t -125.43 158.69 33.75 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.074 0.464 . . . . 0.0 110.721 177.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.593 ' NH1' ' HA ' ' A' ' 131' ' ' THR . 0.0 OUTLIER -116.24 116.47 27.85 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.144 -178.199 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 132' ' ' ARG . 4.6 pp 51.11 -175.01 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.526 1.141 . . . . 0.0 112.968 -178.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.996 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 90.5 t80 -69.75 84.13 0.46 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.647 0.737 . . . . 0.0 111.56 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.562 ' HB3' ' HB2' ' A' ' 138' ' ' GLU . 57.8 t-20 -86.7 133.57 33.67 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 171.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -52.04 -68.07 0.2 Allowed 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.36 0.413 . . . . 0.0 110.843 -176.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -55.99 -59.1 5.39 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.544 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.629 ' O ' ' HB2' ' A' ' 142' ' ' LEU . 29.0 mt-10 -63.02 -23.38 67.43 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -170.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.52 ' O ' HG23 ' A' ' 143' ' ' VAL . 82.0 t80 -75.21 -44.9 43.79 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 172.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.32 -48.88 79.83 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.99 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.431 ' OG ' ' HA ' ' A' ' 138' ' ' GLU . 2.5 p -62.69 -38.0 88.67 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.64 0.257 . . . . 0.0 111.141 177.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.859 ' HG ' ' HG2' ' A' ' 129' ' ' LYS . 1.5 tt -64.75 -50.41 66.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.244 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 139' ' ' PHE . 86.1 t -58.69 -49.51 82.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.083 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -63.81 -39.15 93.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.371 -177.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.623 ' O ' ' HG3' ' A' ' 149' ' ' MET . 57.6 tt0 -61.02 -45.79 93.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.018 176.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.533 ' O ' HD23 ' A' ' 150' ' ' LEU . 57.7 mt -55.61 -46.27 79.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.799 177.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -54.71 -42.49 71.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.609 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -69.27 -35.65 76.28 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.172 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.623 ' HG3' ' O ' ' A' ' 145' ' ' GLN . 80.5 mtp -70.46 -19.3 62.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.299 0.571 . . . . 0.0 110.088 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.533 HD23 ' O ' ' A' ' 146' ' ' ILE . 4.3 mm? -83.11 -14.6 53.3 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.109 174.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 17.5 mtmm -97.57 -42.37 7.71 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 61.56 -155.35 0.35 Allowed 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.926 176.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.529 ' O ' ' HB2' ' A' ' 156' ' ' HIS . . . 102.19 97.29 2.35 Favored Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -178.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -74.46 -1.16 19.96 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.132 0.491 . . . . 0.0 111.392 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -104.72 31.25 4.86 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 172.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.529 ' HB2' ' O ' ' A' ' 153' ' ' GLY . 58.0 t-80 -74.26 52.99 0.49 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.58 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -145.92 154.78 42.32 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -83.88 61.5 6.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.209 0.528 . . . . 0.0 109.592 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 . . . . . 0 C--O 1.24 0.573 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.272 -179.048 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 mpp? . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 120.614 0.245 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.3 m -70.25 102.53 2.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.794 0.331 . . . . 0.0 110.899 -178.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.9 mt -107.79 4.46 25.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.159 0.504 . . . . 0.0 110.548 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.41 -3.03 78.91 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.254 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -89.2 145.56 25.34 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 177.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.474 HD13 ' H ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -105.96 -9.79 10.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 169.662 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.2 p -94.89 158.78 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.872 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.554 ' HB2' ' HG2' ' A' ' 11' ' ' GLU . 24.8 mtt180 -127.65 168.91 14.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.782 0.325 . . . . 0.0 111.038 -171.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.53 HG12 HD21 ' A' ' 130' ' ' LEU . 75.2 mt -78.25 117.83 24.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.75 174.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.95 -25.58 9.37 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.706 -177.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.554 ' HG2' ' HB2' ' A' ' 8' ' ' ARG . 71.6 mm-40 -66.73 152.92 44.53 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.711 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 59.7 mtp -81.48 134.6 35.55 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 175.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.495 ' HB3' HH12 ' A' ' 32' ' ' ARG . . . -59.53 133.82 88.75 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.293 -176.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 15.6 Cg_exo -67.15 174.35 7.14 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.884 2.39 . . . . 0.0 112.18 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.53 ' O ' ' HE2' ' A' ' 107' ' ' LYS . 5.1 p-10 -76.54 163.69 26.67 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.32 177.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.576 ' HB2' HD12 ' A' ' 104' ' ' ILE . 23.0 p90 -174.11 148.91 1.39 Allowed 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 166.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.614 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 52.1 m -131.33 99.55 4.88 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 173.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.655 ' O ' ' HA ' ' A' ' 25' ' ' GLN . 16.6 tt -99.35 148.62 6.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.238 -171.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.7 m -98.16 114.84 27.19 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.059 177.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.423 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 96.4 mt -74.1 172.81 11.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.457 -178.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 96' ' ' LEU . 52.3 p -55.42 -27.07 45.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.997 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -96.61 14.54 24.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.351 -174.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.13 29.64 66.39 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.947 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -108.88 120.58 42.93 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.735 0.303 . . . . 0.0 110.658 -176.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.655 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 97.4 mt-30 -98.23 128.11 44.52 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.749 -178.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.614 ' O ' ' HA ' ' A' ' 17' ' ' THR . 12.2 m -125.59 150.74 31.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.591 178.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 22.9 m -113.11 142.47 45.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.383 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.515 HD11 ' CD1' ' A' ' 121' ' ' ILE . 0.6 OUTLIER -62.37 -36.78 83.35 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.673 0.273 . . . . 0.0 111.101 -177.897 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.402 ' H ' HG22 ' A' ' 27' ' ' THR . 9.7 m -58.04 -27.13 63.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.711 -177.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.9 m -78.53 -20.61 50.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.06 0.457 . . . . 0.0 111.21 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.3 mt -102.21 17.73 22.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.632 -176.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.495 HH12 ' HB3' ' A' ' 13' ' ' ALA . 22.8 mmt180 -68.74 147.06 52.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.772 0.32 . . . . 0.0 110.689 178.153 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.77 -25.69 27.06 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.255 178.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.92 ' HB3' ' HZ3' ' A' ' 34' ' ' LYS . 0.7 OUTLIER -115.02 160.76 19.21 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.094 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 p -74.78 115.88 16.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.541 0.686 . . . . 0.0 110.41 -177.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.462 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 21.7 t -106.14 122.39 59.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.195 -177.028 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.547 ' HE1' HD13 ' A' ' 55' ' ' ILE . 2.1 tmt? -108.97 135.47 50.1 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.052 0.453 . . . . 0.0 110.125 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.483 HD21 ' CE2' ' A' ' 16' ' ' PHE . 7.0 mp -130.28 144.06 51.15 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.414 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.6 133.14 32.09 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 172.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.465 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 95.9 m-85 -99.49 105.36 17.27 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.91 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.2 t -115.52 -176.42 2.92 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.076 -172.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -169.16 139.91 2.32 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.577 ' H ' ' HG3' ' A' ' 78' ' ' GLU . 19.0 p -66.97 -23.38 65.94 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.882 0.372 . . . . 0.0 111.372 -174.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 65.4 p-90 -84.49 -2.31 57.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.66 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.4 t -90.07 139.26 30.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.269 0.557 . . . . 0.0 111.366 -178.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -93.56 -27.67 12.65 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.349 176.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 42.9 t -67.86 -39.51 81.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.87 0.367 . . . . 0.0 110.707 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.638 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 61.0 m -61.54 -15.9 42.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.761 178.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -78.41 -3.06 41.37 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.764 0.316 . . . . 0.0 110.913 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -85.93 -47.0 10.05 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.293 0.568 . . . . 0.0 109.832 165.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.638 ' HG2' ' HA ' ' A' ' 48' ' ' CYS . 14.2 pt-20 -75.0 -32.87 61.75 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.698 -172.028 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.554 ' CB ' ' HD3' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -48.96 -65.03 0.89 Allowed Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 175.28 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.554 ' HD3' ' CB ' ' A' ' 52' ' ' MET . 35.8 Cg_exo -60.88 -39.18 63.83 Favored 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 121.745 1.63 . . . . 0.0 112.844 177.036 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.646 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 8.2 m-85 -67.42 -46.73 72.32 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -176.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.547 HD13 ' HE1' ' A' ' 37' ' ' MET . 97.0 mt -62.13 -49.37 84.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 178.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.601 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 29.7 mm-40 -56.33 -44.52 80.09 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 123.399 0.437 . . . . 0.0 111.026 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -67.46 -49.17 64.8 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.705 -0.679 . . . . 0.0 112.276 -176.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.686 ' HA ' ' NZ ' ' A' ' 62' ' ' LYS . 42.3 m-20 -107.68 -51.2 2.94 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -170.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.4 mt -73.68 -49.05 37.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.867 -173.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.458 ' CD2' ' HB3' ' A' ' 94' ' ' TYR . 63.4 t-105 -71.63 -69.93 0.35 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.76 -178.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.601 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.4 OUTLIER -41.27 -40.27 1.59 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -171.729 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.686 ' NZ ' ' HA ' ' A' ' 58' ' ' ASP . 36.9 mmtm -75.97 -31.56 59.08 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -172.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -122.78 -43.06 2.27 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.876 -174.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.411 ' O ' ' HD2' ' A' ' 69' ' ' PHE . 53.6 mttt 51.64 -92.98 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 123.852 0.861 . . . . 0.0 111.504 -175.268 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -90.21 -61.04 1.77 Allowed 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 120.761 0.315 . . . . 0.0 110.471 176.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.5 ' ND2' HD12 ' A' ' 150' ' ' LEU . 0.9 OUTLIER 61.09 9.46 2.41 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.185 0.594 . . . . 0.0 111.408 175.928 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 68.27 -22.18 0.13 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.833 0.853 . . . . 0.0 112.869 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.586 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 3.2 t70 -138.81 22.76 2.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.369 0.604 . . . . 0.0 110.289 -174.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.57 ' HB2' HD11 ' A' ' 150' ' ' LEU . 86.4 t80 -127.28 116.18 20.16 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.198 173.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -114.65 104.42 11.97 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.727 -178.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.531 ' HG ' ' SD ' ' A' ' 37' ' ' MET . 5.6 tt -104.29 114.95 29.53 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.9 mp -120.83 117.26 52.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.118 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.523 ' HA3' HD23 ' A' ' 96' ' ' LEU . . . -90.33 131.8 10.94 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.315 -0.945 . . . . 0.0 110.938 175.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 45.9 mt -119.27 119.59 61.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 117.046 0.423 . . . . 0.0 110.679 -175.097 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -85.72 136.04 33.51 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 173.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.527 ' HG2' ' HB2' ' A' ' 102' ' ' ALA . 21.6 ttp180 -68.71 -45.25 72.09 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.408 -0.814 . . . . 0.0 112.689 -170.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -158.87 8.73 0.13 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -169.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.577 ' HG3' ' H ' ' A' ' 43' ' ' SER . 14.1 mm-40 -86.65 138.11 33.68 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-O 120.951 0.405 . . . . 0.0 110.678 176.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.426 ' HD2' ' HG3' ' A' ' 82' ' ' LYS . 34.5 Cg_endo -69.24 -173.6 0.67 Allowed 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.901 2.401 . . . . 0.0 113.651 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.436 ' O ' HD23 ' A' ' 84' ' ' LEU . 2.8 tm? -59.27 -56.66 19.33 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.062 -169.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.423 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -67.02 -34.31 77.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.473 -173.099 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.426 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 14.4 mmmm -60.26 -50.4 73.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.925 177.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 95.7 t -61.28 -48.26 89.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.104 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.436 HD23 ' O ' ' A' ' 80' ' ' LEU . 4.4 mm? -61.28 -52.66 63.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.623 -177.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.12 -37.27 86.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.511 -178.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -68.84 -41.34 78.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.719 -0.218 . . . . 0.0 110.918 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.546 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -66.16 -41.7 89.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.737 0.78 . . . . 0.0 109.549 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -58.99 -30.25 67.82 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.218 -1.355 . . . . 0.0 111.437 176.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.3 m -99.85 -1.38 37.61 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -176.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.1 p -113.53 -5.12 13.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.845 0.355 . . . . 0.0 111.494 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.09 -5.32 83.12 Favored Glycine 0 C--O 1.228 -0.277 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.368 177.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.517 ' CG2' ' HG3' ' A' ' 52' ' ' MET . 69.2 t -57.27 121.92 5.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.099 0.476 . . . . 0.0 111.551 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.422 ' H ' ' CD ' ' A' ' 56' ' ' GLU . 75.3 p -114.53 -15.56 12.0 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.383 176.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.458 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 36.8 p90 -71.57 144.73 89.15 Favored Pre-proline 0 C--O 1.233 0.236 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 173.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.34 124.71 13.79 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.415 2.076 . . . . 0.0 113.132 -176.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.546 HD12 ' HB2' ' A' ' 87' ' ' ALA . 84.8 mt -99.17 153.29 19.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.476 173.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -122.83 156.13 17.24 Favored Glycine 0 N--CA 1.437 -1.24 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 174.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.58 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.4 pt? -116.11 119.88 37.26 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.734 0.267 . . . . 0.0 110.349 -178.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -117.25 76.1 8.79 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.402 178.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.11 107.46 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.481 2.12 . . . . 0.0 111.936 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 131.59 -27.31 3.74 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -176.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.527 ' HB2' ' HG2' ' A' ' 76' ' ' ARG . . . 66.98 24.61 9.52 Favored 'General case' 0 CA--C 1.522 -0.097 0 C-N-CA 122.992 0.517 . . . . 0.0 111.373 176.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -70.94 -41.43 71.14 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.173 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.576 HD12 ' HB2' ' A' ' 16' ' ' PHE . 48.3 mm -62.05 -33.77 60.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.379 0.609 . . . . 0.0 109.62 174.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -70.21 -39.21 75.29 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.427 175.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.552 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -66.15 -28.92 69.15 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -174.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.53 ' HE2' ' O ' ' A' ' 15' ' ' ASP . 13.6 ptmt -79.46 -1.96 39.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.994 0.426 . . . . 0.0 111.276 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -112.09 -50.92 2.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.21 172.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.552 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -141.05 152.81 45.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.408 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.418 ' HB3' ' OD1' ' A' ' 112' ' ' ASP . 97.3 mt -62.38 139.26 58.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.849 0.357 . . . . 0.0 111.041 -178.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -66.01 -25.62 67.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.209 0.528 . . . . 0.0 110.837 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.418 ' OD1' ' HB3' ' A' ' 110' ' ' LEU . 4.2 p-10 -83.99 -8.49 59.14 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.171 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.83 -8.02 57.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.373 -178.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.27 -128.19 8.25 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.444 174.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.527 HD13 ' HD3' ' A' ' 76' ' ' ARG . 8.1 tp -154.25 173.65 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -174.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.437 ' N ' HG13 ' A' ' 115' ' ' ILE . 28.2 m 71.0 81.54 0.16 Allowed 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.476 0.655 . . . . 0.0 111.279 175.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.6 mmt85 -133.8 131.9 39.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.111 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.623 ' HB3' HG22 ' A' ' 131' ' ' THR . 46.3 t-20 -116.1 119.67 36.57 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 63.2 t -113.76 131.81 64.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.996 -177.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.722 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 36.7 tp -119.36 122.04 40.91 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.316 0.579 . . . . 0.0 110.875 177.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.515 ' CD1' HD11 ' A' ' 28' ' ' LEU . 53.6 mt -100.7 135.08 38.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.778 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.86 -176.91 5.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.212 0.53 . . . . 0.0 111.09 -176.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -68.41 -23.32 64.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.001 -175.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -80.78 -26.62 37.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.979 0.418 . . . . 0.0 110.769 175.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 112.4 12.22 13.82 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.352 -0.928 . . . . 0.0 112.311 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.711 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 77.5 mttt -97.13 160.62 14.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.822 0.344 . . . . 0.0 110.66 -178.11 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 47.0 mt -95.79 109.59 22.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 175.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.7 m -110.59 1.13 9.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.918 -174.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.799 ' HG2' ' HG ' ' A' ' 142' ' ' LEU . 51.7 tptt -160.94 114.05 1.98 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 -175.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.558 ' HA ' ' O ' ' A' ' 118' ' ' ASN . 0.4 OUTLIER -138.4 105.98 5.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.171 0.51 . . . . 0.0 110.449 176.35 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.623 HG22 ' HB3' ' A' ' 118' ' ' ASN . 10.1 t -99.46 155.89 17.32 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.095 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.446 ' NE ' ' H ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -122.49 132.74 54.48 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.538 -179.807 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.437 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 3.1 mp 66.45 36.03 5.31 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 123.71 0.631 . . . . 0.0 110.614 176.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.437 ' HB3' ' O ' ' A' ' 133' ' ' LEU . 45.8 t80 71.2 -66.38 0.3 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.518 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.596 ' HB3' ' HB3' ' A' ' 138' ' ' GLU . 0.8 OUTLIER 64.54 113.18 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.046 0.45 . . . . 0.0 110.954 -175.882 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -49.95 -56.4 10.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.785 -174.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.09 -36.24 27.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.343 -174.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.596 ' HB3' ' HB3' ' A' ' 135' ' ' ASN . 3.4 tp10 -63.54 -38.72 92.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.962 0.41 . . . . 0.0 110.128 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.646 ' CE2' ' HB3' ' A' ' 54' ' ' PHE . 76.6 t80 -70.65 -41.48 72.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.994 176.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.56 -49.6 75.84 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.827 0.346 . . . . 0.0 110.894 177.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.3 p -61.5 -34.11 74.93 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.69 177.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.799 ' HG ' ' HG2' ' A' ' 129' ' ' LYS . 4.6 tt -66.83 -42.94 84.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.255 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.473 ' O ' ' HB ' ' A' ' 146' ' ' ILE . 95.0 t -59.09 -51.47 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 120.782 0.325 . . . . 0.0 111.345 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.449 ' HA ' ' OE1' ' A' ' 144' ' ' GLN . 6.4 tp60 -62.0 -38.38 88.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.304 0.573 . . . . 0.0 110.168 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.4 ' O ' ' HG2' ' A' ' 149' ' ' MET . 36.3 tt0 -63.03 -36.88 85.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.724 177.022 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.588 ' O ' HD23 ' A' ' 150' ' ' LEU . 30.2 mm -55.09 -53.03 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 120.929 0.395 . . . . 0.0 110.259 174.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.518 ' O ' ' HB3' ' A' ' 151' ' ' LYS . 85.7 m-20 -53.06 -45.15 67.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.265 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -65.05 -37.37 87.36 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.128 0.268 . . . . 0.0 111.251 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.4 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 84.2 mmm -60.98 -29.97 69.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.65 0.738 . . . . 0.0 109.723 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.588 HD23 ' O ' ' A' ' 146' ' ' ILE . 4.0 mm? -89.35 -16.72 30.38 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.62 178.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.518 ' HB3' ' O ' ' A' ' 147' ' ' ASN . 0.0 OUTLIER -101.55 -4.46 26.67 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.935 -173.264 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -27.31 -69.56 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.685 1.194 . . . . 0.0 111.948 174.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 41.05 53.92 3.8 Favored Glycine 0 C--N 1.335 0.516 0 O-C-N 123.904 0.752 . . . . 0.0 114.09 174.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 2.9 m80 -46.75 -80.1 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 55.33 -152.06 0.37 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -175.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 24.7 p80 -120.77 23.85 10.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.682 0.753 . . . . 0.0 109.054 171.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -165.37 91.8 0.53 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.424 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -102.33 3.06 37.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.442 0.639 . . . . 0.0 109.713 178.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 16.8 p80 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 117.751 -1.119 . . . . 0.0 108.132 174.644 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.1 m -80.46 91.5 5.74 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 177.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 87.7 mt -142.83 100.93 3.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.127 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.838 ' H ' ' HB1' ' A' ' 113' ' ' ALA . . . -89.61 71.49 2.25 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.576 -177.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -81.43 120.52 25.09 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.684 0.278 . . . . 0.0 110.9 178.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.516 HG12 ' HA ' ' A' ' 109' ' ' ALA . 47.3 pt -92.84 -22.07 5.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.147 175.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.492 ' CG1' HD12 ' A' ' 127' ' ' ILE . 36.3 t -102.39 147.37 9.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.416 177.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 57.2 mtt85 -120.26 168.54 11.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.047 0.451 . . . . 0.0 111.893 -168.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.633 HG12 HD13 ' A' ' 130' ' ' LEU . 77.0 mt -75.18 127.19 36.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.071 176.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.6 -9.26 77.49 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -175.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -92.03 151.38 20.49 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.675 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 56.7 mtp -80.95 144.76 31.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.096 0.474 . . . . 0.0 111.346 -172.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.435 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -86.37 134.01 39.19 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.275 -177.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 13.3 Cg_exo -70.88 139.67 36.83 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.033 2.489 . . . . 0.0 112.033 177.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -75.78 164.81 25.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.277 -178.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -165.2 162.17 19.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.872 -176.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 37.3 m -124.72 110.59 14.54 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 175.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.4 tt -112.78 151.97 14.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.453 -171.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.509 ' HB ' ' CD2' ' A' ' 98' ' ' LEU . 2.8 m -89.34 126.32 35.48 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.142 177.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.0 mt -82.01 178.36 8.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.733 0.302 . . . . 0.0 111.082 177.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.48 ' HB ' HD11 ' A' ' 84' ' ' LEU . 16.5 p -59.37 -26.26 64.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.791 -176.293 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.618 ' OD2' ' HG2' ' A' ' 24' ' ' LYS . 7.4 p-10 -94.2 -18.23 21.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.185 0.517 . . . . 0.0 110.418 -178.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.56 0.52 21.76 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.412 -177.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.618 ' HG2' ' OD2' ' A' ' 22' ' ' ASP . 4.8 mmmp? -66.44 126.87 30.21 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-O 121.088 0.471 . . . . 0.0 111.696 178.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -88.67 120.92 30.51 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.445 172.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 17' ' ' THR . 11.3 m -123.66 151.83 28.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.826 0.346 . . . . 0.0 110.324 177.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.2 m -110.11 151.72 26.89 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.414 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.07 -35.35 80.45 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.249 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.538 ' HA ' ' CG ' ' A' ' 32' ' ' ARG . 37.7 t -56.88 -23.45 44.63 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.96 177.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.1 m -69.57 -24.0 63.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.27 0.557 . . . . 0.0 110.675 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.445 HD13 ' HB1' ' A' ' 70' ' ' ALA . 67.3 mt -116.1 11.57 15.32 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.932 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.538 ' CG ' ' HA ' ' A' ' 29' ' ' SER . 9.2 mmm180 -74.75 104.18 5.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.975 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 147.79 -24.75 1.48 Allowed Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.515 ' HB3' ' OD1' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -115.45 174.74 5.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.161 -0.519 . . . . 0.0 110.466 177.883 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 68' ' ' ASP . 26.8 m -74.72 128.59 36.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.0 t -123.68 112.17 32.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 120.959 0.409 . . . . 0.0 110.575 -176.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.442 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 27.3 ttt -95.98 127.12 41.72 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.734 178.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.6 mp -122.05 137.15 54.92 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.771 176.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.4 pm0 -126.91 129.3 47.92 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 171.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' A' ' 116' ' ' THR . 96.8 m-85 -90.73 110.39 21.58 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.007 -179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.631 HG23 ' SG ' ' A' ' 48' ' ' CYS . 28.5 m -119.49 165.21 14.68 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.438 -166.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.586 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . . . -145.11 147.12 32.18 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 171.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.453 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 81.0 p -60.56 -21.52 62.65 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -174.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 8.5 p-90 -103.06 3.68 36.32 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -175.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.639 ' SG ' HD12 ' A' ' 115' ' ' ILE . 89.9 m -79.59 102.12 8.69 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.97 0.414 . . . . 0.0 111.082 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.98 -40.48 97.17 Favored Glycine 0 C--O 1.228 -0.271 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.874 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 56.9 t -61.4 -37.25 77.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.222 0.534 . . . . 0.0 110.614 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.631 ' SG ' HG23 ' A' ' 41' ' ' THR . 22.8 t -72.32 -14.85 61.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.762 -178.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -75.2 -7.28 53.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.971 0.415 . . . . 0.0 110.781 177.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.472 ' HD3' ' CD2' ' A' ' 134' ' ' TYR . 70.4 mttt -83.42 -47.84 10.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 122.343 1.068 . . . . 0.0 108.376 163.023 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.782 ' HB2' ' HB2' ' A' ' 134' ' ' TYR . 40.3 tt0 -58.24 -58.34 8.91 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 113.263 -1.789 . . . . 0.0 112.108 -173.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.795 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 96.1 mmm -50.3 -57.43 12.96 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -175.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.795 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 32.7 Cg_exo -61.49 -38.9 59.61 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 122.3 2.0 . . . . 0.0 112.823 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.508 ' HB3' ' CZ ' ' A' ' 139' ' ' PHE . 6.4 m-85 -65.41 -43.76 89.54 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.496 0.189 . . . . 0.0 111.305 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 51' ' ' GLU . 77.0 mt -58.03 -47.86 85.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 175.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.417 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 26.1 tp10 -54.75 -54.18 45.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.633 176.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -62.33 -59.31 5.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.181 -0.918 . . . . 0.0 113.226 -173.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.698 ' HA ' ' NZ ' ' A' ' 62' ' ' LYS . 67.9 m-20 -107.13 -13.53 15.14 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -166.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.2 mt -104.59 -57.24 4.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.476 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.542 ' CE2' ' HB3' ' A' ' 94' ' ' TYR . 71.3 t-105 -60.97 -68.32 0.32 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.868 -177.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.01 -23.49 2.07 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -175.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.698 ' NZ ' ' HA ' ' A' ' 58' ' ' ASP . 38.9 mmtm -87.42 -37.44 17.02 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -175.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -130.51 0.16 4.46 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -171.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.482 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 16.5 pttp -39.34 -51.91 2.04 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 -169.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.02 -83.66 0.16 Allowed 'General case' 0 C--O 1.251 1.163 0 CA-C-O 121.458 0.647 . . . . 0.0 110.117 -173.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 56.57 -153.46 0.36 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.366 -174.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -111.41 -14.21 13.78 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 168.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.515 ' OD1' ' HB3' ' A' ' 34' ' ' LYS . 5.6 m-20 -144.12 39.78 1.34 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.581 -1.19 . . . . 0.0 112.374 -172.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -121.24 128.63 52.58 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 119.134 -1.026 . . . . 0.0 110.266 168.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.445 ' HB1' HD13 ' A' ' 31' ' ' LEU . . . -130.22 142.48 50.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.841 177.039 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.442 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 5.6 tt -146.91 123.82 11.32 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 31.8 mt -130.6 129.88 64.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.487 ' HA3' HD22 ' A' ' 96' ' ' LEU . . . -88.05 131.83 10.87 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 175.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.0 mm -119.85 107.77 21.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 117.034 0.417 . . . . 0.0 110.842 -170.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.526 ' HA ' ' O ' ' A' ' 41' ' ' THR . 11.6 t70 -77.82 143.46 37.85 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.727 178.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 51.9 ttt-85 -71.01 -30.43 66.66 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -171.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -154.86 -32.67 0.1 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -174.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.408 ' OE1' ' HD3' ' A' ' 82' ' ' LYS . 11.9 mm-40 -61.96 141.72 95.46 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.101 0.477 . . . . 0.0 112.258 -166.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -74.51 179.83 5.53 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 123.018 2.479 . . . . 0.0 112.793 178.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.533 HD23 HD11 ' A' ' 98' ' ' LEU . 88.1 mt -49.37 -55.57 12.52 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.846 -178.255 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -50.52 -36.62 34.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.638 -173.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.408 ' HD3' ' OE1' ' A' ' 78' ' ' GLU . 41.8 mtpt -82.61 -45.61 14.35 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.77 0.319 . . . . 0.0 110.779 -178.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.576 HG21 ' HB3' ' A' ' 98' ' ' LEU . 91.0 t -56.53 -46.71 82.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.434 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.48 HD11 ' HB ' ' A' ' 21' ' ' THR . 4.1 mm? -58.52 -52.9 63.7 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.765 0.317 . . . . 0.0 111.361 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.49 -37.76 84.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.553 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.453 ' CD1' ' HA ' ' A' ' 43' ' ' SER . 91.8 t80 -65.88 -42.85 89.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.073 -179.076 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.507 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -66.43 -43.48 85.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.731 0.777 . . . . 0.0 109.897 178.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -59.6 -27.82 66.63 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.205 -1.361 . . . . 0.0 111.801 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.5 m -100.83 -0.47 36.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.837 -176.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.7 p -117.77 2.34 12.23 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.355 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.53 15.29 80.01 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.837 175.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 72.6 t -73.62 127.03 35.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -177.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 61.3 p -106.31 -24.16 12.35 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.526 174.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.542 ' HB3' ' CE2' ' A' ' 60' ' ' TRP . 34.8 p90 -71.2 145.03 90.49 Favored Pre-proline 0 C--O 1.232 0.136 0 CA-C-O 120.884 0.374 . . . . 0.0 111.118 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.76 134.83 56.21 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.826 2.351 . . . . 0.0 112.893 -177.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.507 HD12 ' HB2' ' A' ' 87' ' ' ALA . 53.8 mt -109.72 139.06 45.2 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.734 174.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -113.28 145.29 18.29 Favored Glycine 0 N--CA 1.439 -1.139 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 174.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.625 HD13 ' H ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -103.54 139.02 39.43 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.188 0.518 . . . . 0.0 110.937 -179.903 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -118.83 82.0 19.99 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.12 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.74 105.07 0.6 Allowed 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.409 2.073 . . . . 0.0 112.79 -176.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.96 8.64 27.47 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.581 178.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 52.31 42.14 30.81 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -81.04 -49.78 10.48 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.123 0.487 . . . . 0.0 110.692 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 98.7 mt -66.72 -31.38 53.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 176.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -60.15 -41.13 92.08 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.177 171.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.682 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -67.23 -24.49 65.82 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.811 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.423 ' O ' ' HG2' ' A' ' 14' ' ' PRO . 14.7 mptt -64.56 -23.69 67.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.963 0.411 . . . . 0.0 111.025 176.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -113.71 -11.74 12.9 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -173.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.682 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . 179.58 178.31 0.55 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.785 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 94.6 mt -67.87 133.93 50.01 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 175.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.452 ' HE ' ' HB2' ' A' ' 111' ' ' ARG . 1.5 mtm180 -52.39 -51.6 58.13 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 122.058 0.933 . . . . 0.0 110.578 -176.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.08 21.75 6.49 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.229 -1.35 . . . . 0.0 111.457 -172.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.838 ' HB1' ' H ' ' A' ' 4' ' ' GLY . . . -93.78 6.06 49.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.172 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 139.34 -164.5 25.91 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.464 178.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.759 HD13 ' N ' ' A' ' 116' ' ' THR . 0.0 OUTLIER -168.12 155.61 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.813 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.812 HG22 ' HA ' ' A' ' 133' ' ' LEU . 55.8 m 75.54 95.85 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.791 0.805 . . . . 0.0 110.386 -178.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -160.17 145.56 15.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.99 -177.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.591 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 31.1 m-80 -102.3 119.18 38.38 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.148 -178.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.1 t -118.3 109.97 28.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.843 -178.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 49.2 tp -100.31 117.06 33.74 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.699 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 53.8 mt -97.19 134.24 35.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.46 177.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.598 ' OD2' ' HB2' ' A' ' 126' ' ' LYS . 3.1 p30 -86.04 177.26 7.63 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.267 0.556 . . . . 0.0 111.261 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -66.15 -24.7 66.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.341 -177.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -80.41 -19.02 47.17 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.725 0.298 . . . . 0.0 110.557 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 106.85 12.02 25.15 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.12 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.675 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 8.3 mtmp? -102.58 158.31 16.32 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.492 HD12 ' CG1' ' A' ' 7' ' ' VAL . 54.0 mt -94.5 125.67 47.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 174.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.7 m -105.47 -22.04 5.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.901 0.382 . . . . 0.0 111.764 -174.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.477 ' HA ' ' HD2' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -142.28 125.9 16.87 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.139 -0.624 . . . . 0.0 112.35 -172.081 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.633 HD13 HG12 ' A' ' 9' ' ' ILE . 10.5 mp -114.74 117.67 31.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.405 172.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.591 ' HB ' ' HB2' ' A' ' 118' ' ' ASN . 4.2 m -122.69 131.78 53.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.801 0.334 . . . . 0.0 110.651 171.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.622 ' O ' ' HD2' ' A' ' 132' ' ' ARG . 0.1 OUTLIER -93.09 120.6 33.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.745 178.932 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.812 ' HA ' HG22 ' A' ' 116' ' ' THR . 16.9 mt 61.93 179.96 0.12 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.557 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.782 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 84.6 t80 -83.95 97.96 9.54 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 171.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -107.63 120.52 42.45 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 173.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -43.7 -56.4 3.8 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 123.841 0.713 . . . . 0.0 112.803 -173.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.9 mp0 -56.65 -46.13 81.21 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -178.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -71.54 -35.2 70.58 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.602 -175.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.508 ' CZ ' ' HB3' ' A' ' 54' ' ' PHE . 81.4 t80 -66.06 -41.06 91.31 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 175.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.84 -41.97 98.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.42 175.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.1 m -63.27 -39.18 93.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.052 177.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.722 ' O ' HG12 ' A' ' 146' ' ' ILE . 35.6 mt -59.38 -52.46 65.52 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.575 177.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 139' ' ' PHE . 91.6 t -52.48 -50.27 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 O-C-N 123.376 0.422 . . . . 0.0 111.433 -178.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -60.41 -41.72 94.49 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.075 0.464 . . . . 0.0 110.339 178.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -63.49 -42.24 98.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.687 178.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.722 HG12 ' O ' ' A' ' 142' ' ' LEU . 35.4 mm -56.73 -46.88 83.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -56.26 -43.38 78.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.692 177.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -72.89 -33.7 66.2 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.209 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 92.1 mmm -65.41 -24.88 67.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.162 0.506 . . . . 0.0 110.378 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.614 HD23 ' O ' ' A' ' 146' ' ' ILE . 4.0 mm? -79.16 -19.35 51.2 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.205 176.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.8 mtmm -103.03 -19.01 14.73 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 121.088 -0.245 . . . . 0.0 110.635 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.545 ' CD ' ' H ' ' A' ' 153' ' ' GLY . 1.2 pp20? 36.86 -105.72 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.545 ' H ' ' CD ' ' A' ' 152' ' ' GLU . . . -85.08 30.09 4.07 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.662 -173.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -101.41 1.49 38.43 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.151 0.475 . . . . 0.0 110.062 177.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -97.31 9.45 42.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.427 0.632 . . . . 0.0 109.715 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.71 164.21 30.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.218 177.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 40.4 t60 -79.89 31.89 0.26 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.493 -177.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 37.3 m80 65.9 16.52 10.51 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.362 0.601 . . . . 0.0 109.884 -171.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 . . . . . 0 C--O 1.248 0.976 0 CA-C-N 114.761 -1.108 . . . . 0.0 108.649 179.963 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.724 ' HG3' HD12 ' A' ' 3' ' ' LEU . 20.2 ptt? . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.417 ' O ' ' HB2' ' A' ' 3' ' ' LEU . 5.4 m -83.59 -21.06 32.7 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 123.322 0.389 . . . . 0.0 111.755 -175.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.922 ' HA ' ' HD2' ' A' ' 132' ' ' ARG . 9.9 mp 70.54 -57.28 0.59 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.182 0.593 . . . . 0.0 111.65 -177.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.466 ' HA3' ' HB1' ' A' ' 113' ' ' ALA . . . 98.25 3.96 57.57 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.102 -0.571 . . . . 0.0 112.239 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.676 ' HD2' ' HB3' ' A' ' 3' ' ' LEU . 71.4 m-85 -80.18 133.22 36.02 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.86 0.362 . . . . 0.0 110.822 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.7 pt -101.8 -7.42 9.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.01 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.3 p -110.98 159.15 11.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.48 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 24.1 mtm-85 -120.71 165.66 14.78 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -168.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.543 HG12 HD23 ' A' ' 130' ' ' LEU . 62.1 mt -76.05 137.23 23.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.414 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.51 -26.09 23.25 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.083 178.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -67.75 150.88 48.09 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.723 ' SD ' ' HG2' ' A' ' 126' ' ' LYS . 63.3 mmm -71.79 124.03 23.92 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.168 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.51 ' HB2' HD12 ' A' ' 121' ' ' ILE . . . -54.89 140.72 60.05 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.08 -178.185 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.68 174.58 6.33 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.613 2.209 . . . . 0.0 112.254 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.53 ' O ' ' HB3' ' A' ' 16' ' ' PHE . 3.0 p-10 -78.69 174.4 11.45 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.999 177.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.702 ' CE2' ' HG ' ' A' ' 28' ' ' LEU . 16.5 p90 176.36 144.96 0.08 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.428 163.043 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.643 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 56.2 m -127.93 99.88 5.69 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.444 -0.798 . . . . 0.0 108.866 175.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 25' ' ' GLN . 20.3 tt -106.0 146.91 12.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.22 -171.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 24' ' ' LYS . 24.4 m -83.19 127.87 33.99 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.027 177.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.414 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 79.7 mt -84.46 177.62 8.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.144 0.497 . . . . 0.0 111.462 -178.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.406 ' HB ' HD21 ' A' ' 84' ' ' LEU . 21.8 p -62.74 -23.5 67.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.988 -175.268 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.537 ' OD2' ' HG2' ' A' ' 24' ' ' LYS . 7.5 p-10 -105.47 9.07 33.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.167 0.508 . . . . 0.0 110.527 -176.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.3 14.17 59.15 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.247 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.537 ' HG2' ' OD2' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -85.52 171.21 11.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.207 0.503 . . . . 0.0 109.865 175.6 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.407 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 50.7 mt-30 -136.09 129.12 31.39 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 176.02 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.643 ' O ' ' HA ' ' A' ' 17' ' ' THR . 21.7 m -119.52 150.49 21.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.673 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 9.4 m -117.86 142.7 47.03 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.996 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.702 ' HG ' ' CE2' ' A' ' 16' ' ' PHE . 0.6 OUTLIER -64.04 -22.68 67.03 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.623 0.249 . . . . 0.0 111.358 -179.033 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.442 ' H ' HG22 ' A' ' 27' ' ' THR . 11.0 m -61.25 -38.43 86.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.967 0.413 . . . . 0.0 110.645 177.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.5 m -73.09 -23.66 60.56 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.52 0.676 . . . . 0.0 110.784 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.408 ' HB2' HD23 ' A' ' 28' ' ' LEU . 91.7 mt -88.1 -9.19 54.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.761 -177.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.448 HH21 HD13 ' A' ' 28' ' ' LEU . 5.8 mmt180 -60.63 150.57 31.5 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.741 0.305 . . . . 0.0 110.422 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.8 -23.75 31.38 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.61 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 31.2 mtmm -117.45 157.3 26.47 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.842 -0.679 . . . . 0.0 109.985 -178.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 68' ' ' ASP . 18.3 m -71.43 131.42 34.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.183 0.516 . . . . 0.0 109.896 177.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.469 HG11 HD21 ' A' ' 28' ' ' LEU . 20.8 t -120.01 123.56 71.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.904 0.383 . . . . 0.0 110.824 -177.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.552 ' SD ' HG21 ' A' ' 59' ' ' ILE . 28.1 ttt -108.29 117.05 33.13 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.9 0.381 . . . . 0.0 110.525 177.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -104.66 103.79 13.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.205 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.595 ' OE1' ' HG2' ' A' ' 52' ' ' MET . 0.0 OUTLIER -103.38 112.59 25.56 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.707 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 97.3 m-85 -91.86 120.06 32.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.78 -176.035 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 15.2 t -140.41 -178.43 5.49 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.756 -173.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.491 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . . . -162.76 157.07 21.09 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 122.721 0.408 . . . . 0.0 110.073 172.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.441 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 12.3 t -64.24 -32.54 74.17 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.672 -175.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 51.0 p-90 -83.85 8.17 15.72 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -174.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 43.4 t -99.62 130.87 45.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.964 0.411 . . . . 0.0 111.338 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -89.07 -28.48 20.52 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.624 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.4 t -67.32 -35.74 74.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.157 0.503 . . . . 0.0 110.269 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.59 ' HA ' ' HB3' ' A' ' 51' ' ' GLU . 59.4 m -65.78 -15.15 62.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.517 177.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.437 ' O ' ' HG2' ' A' ' 53' ' ' PRO . 84.4 mtt180 -78.74 -3.72 45.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.331 0.586 . . . . 0.0 110.148 177.149 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.465 ' NZ ' ' HE2' ' A' ' 134' ' ' TYR . 1.4 mmmp? -95.2 -52.39 4.21 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 162.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.728 ' O ' HG12 ' A' ' 55' ' ' ILE . 41.1 tt0 -56.36 -65.25 0.64 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 113.478 -1.692 . . . . 0.0 112.153 -173.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.595 ' HG2' ' OE1' ' A' ' 39' ' ' GLN . 1.7 mmm -56.29 -50.04 89.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -173.113 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.635 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 53.3 Cg_exo -55.34 -37.96 94.19 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 121.868 1.712 . . . . 0.0 112.097 176.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -72.69 -37.5 67.85 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.426 177.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.728 HG12 ' O ' ' A' ' 51' ' ' GLU . 28.9 mm -55.04 -57.48 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 121.025 0.441 . . . . 0.0 110.147 177.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.705 ' HG2' ' HA ' ' A' ' 92' ' ' VAL . 0.5 OUTLIER -66.18 -43.66 86.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.359 -177.617 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.635 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 3.7 ttmm -62.46 -41.52 98.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.775 -172.029 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.639 ' O ' ' HG2' ' A' ' 62' ' ' LYS . 6.1 t70 -104.61 -65.09 1.06 Allowed 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.877 178.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.552 HG21 ' SD ' ' A' ' 37' ' ' MET . 25.1 mm -54.01 -46.77 65.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-O 120.97 0.414 . . . . 0.0 111.113 -171.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.522 ' HB3' ' O ' ' A' ' 56' ' ' GLU . 73.5 t-105 -73.92 -60.65 2.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.17 -178.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.564 HD13 ' CE ' ' A' ' 64' ' ' LYS . 3.8 mm? -50.72 -35.09 29.61 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -173.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.639 ' HG2' ' O ' ' A' ' 58' ' ' ASP . 33.7 mmtp -73.93 -27.98 61.29 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -175.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 -126.38 -43.85 1.74 Allowed 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.191 -0.604 . . . . 0.0 112.626 -172.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.564 ' CE ' HD13 ' A' ' 61' ' ' LEU . 55.2 mttt 45.75 -89.82 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.011 0.924 . . . . 0.0 112.679 -176.052 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -87.31 -71.03 0.58 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 65.03 -4.07 0.53 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.206 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 68.48 -6.65 0.78 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.961 0.904 . . . . 0.0 112.125 -176.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.61 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 3.9 t70 -137.89 8.35 2.77 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.951 0.405 . . . . 0.0 110.692 -177.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.552 ' CE2' ' HB2' ' A' ' 71' ' ' LEU . 72.3 t80 -116.01 119.07 34.68 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.096 -0.642 . . . . 0.0 111.283 -174.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.75 107.9 12.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.669 178.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.552 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 1.7 tt -117.46 120.55 38.47 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 52.6 mt -129.89 131.31 66.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.759 0.314 . . . . 0.0 110.288 179.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.58 116.94 4.62 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 176.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 25.6 mm -103.92 111.36 33.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 116.615 0.208 . . . . 0.0 110.6 -173.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.522 ' HA ' ' O ' ' A' ' 41' ' ' THR . 8.9 t70 -80.79 140.06 35.68 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 44.4 ttt-85 -78.26 -30.92 48.82 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -172.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -163.45 -16.01 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -170.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.493 ' CD ' ' HD2' ' A' ' 82' ' ' LYS . 6.0 mm-40 -77.33 137.06 64.4 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.141 0.496 . . . . 0.0 110.793 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.489 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 30.7 Cg_endo -68.39 -174.59 0.7 Allowed 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.098 2.532 . . . . 0.0 114.576 -177.101 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.652 HD23 HD23 ' A' ' 84' ' ' LEU . 5.2 tt -54.26 -59.04 5.2 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.299 -1.319 . . . . 0.0 112.393 -170.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.489 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -61.31 -36.31 79.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.914 -171.883 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.493 ' HD2' ' CD ' ' A' ' 78' ' ' GLU . 42.2 mttt -64.36 -48.23 76.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.033 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 79' ' ' PRO . 57.9 t -53.84 -46.47 63.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.554 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.652 HD23 HD23 ' A' ' 80' ' ' LEU . 4.4 mm? -62.4 -50.37 71.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.042 178.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.48 97.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.712 -177.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.441 ' CD1' ' HA ' ' A' ' 43' ' ' SER . 62.4 t80 -66.93 -43.47 83.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.916 -178.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.19 -39.77 86.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.441 0.638 . . . . 0.0 110.212 178.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -59.12 -39.72 83.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.315 176.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.8 m -86.02 -19.31 30.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.162 -174.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.5 p -93.57 -29.81 15.3 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.426 -179.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 112.64 -3.02 26.17 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.161 178.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.705 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 60.6 t -50.88 115.89 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 122.794 0.438 . . . . 0.0 111.866 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.7 m -100.43 0.32 39.56 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.454 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.487 ' CE2' HG13 ' A' ' 92' ' ' VAL . 54.3 p90 -102.12 152.9 38.31 Favored Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.142 178.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.93 148.75 76.9 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.568 2.179 . . . . 0.0 113.107 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.482 HD11 HG11 ' A' ' 92' ' ' VAL . 5.2 mp -124.78 159.51 30.8 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.412 179.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -125.76 147.93 16.8 Favored Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 174.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.572 HD23 ' H ' ' A' ' 98' ' ' LEU . 0.6 OUTLIER -105.09 132.23 51.59 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.82 0.31 . . . . 0.0 110.737 -177.938 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -120.39 75.91 24.85 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.47 178.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -65.29 101.08 0.4 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.476 2.117 . . . . 0.0 112.09 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 126.5 -7.5 7.47 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.862 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 58.18 44.01 19.64 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.691 0.396 . . . . 0.0 111.486 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -89.99 -46.54 8.44 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.129 0.49 . . . . 0.0 110.086 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.659 HD12 ' HB2' ' A' ' 16' ' ' PHE . 33.4 mm -61.76 -36.1 71.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 172.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -63.65 -39.15 93.62 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 113.624 -1.626 . . . . 0.0 110.467 174.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.701 ' HB2' ' HG2' ' A' ' 111' ' ' ARG . . . -71.72 -30.61 65.83 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -174.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.5 ' HE2' ' O ' ' A' ' 15' ' ' ASP . 13.1 ptmt -79.11 -1.78 37.53 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.857 -175.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -108.14 -37.69 5.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.223 0.535 . . . . 0.0 110.807 171.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.581 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -152.74 166.0 33.56 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.9 pp -60.42 163.98 4.77 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.85 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.701 ' HG2' ' HB2' ' A' ' 106' ' ' ALA . 50.5 mtt-85 -75.94 58.21 1.14 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -164.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 19.2 t70 169.68 -75.1 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.034 -1.439 . . . . 0.0 107.783 173.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.559 ' HB3' ' NH2' ' A' ' 117' ' ' ARG . . . 47.91 27.06 1.07 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.986 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.476 ' HA3' ' NH2' ' A' ' 132' ' ' ARG . . . 72.32 106.81 0.06 OUTLIER Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -170.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.441 ' O ' ' HB ' ' A' ' 116' ' ' THR . 19.2 tt -64.77 167.29 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.889 HG22 ' HA ' ' A' ' 133' ' ' LEU . 32.9 m 75.31 88.57 0.09 Allowed 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -174.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.974 ' HG2' ' HA ' ' A' ' 132' ' ' ARG . 41.0 mtm105 -157.61 145.76 19.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.451 -177.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -112.61 119.39 37.96 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.844 -177.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 72.2 t -110.01 107.32 22.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.838 177.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.659 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 55.0 tp -98.4 133.74 42.37 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.939 0.4 . . . . 0.0 110.337 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.51 HD12 ' HB2' ' A' ' 13' ' ' ALA . 38.2 mm -114.52 134.49 57.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.002 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.33 160.7 30.78 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 176.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 6.8 ptm180 -68.0 -22.03 65.01 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -173.134 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.583 ' HB2' ' HZ3' ' A' ' 126' ' ' LYS . 46.2 mt-10 -76.28 -18.52 58.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.293 0.568 . . . . 0.0 110.087 175.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 109.79 9.67 24.31 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.687 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.723 ' HG2' ' SD ' ' A' ' 12' ' ' MET . 35.3 mtmm -91.02 139.36 30.84 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.165 0.483 . . . . 0.0 110.725 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.47 HG12 HD12 ' A' ' 121' ' ' ILE . 35.3 mt -70.53 121.64 20.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.44 HG12 ' O ' ' A' ' 120' ' ' LEU . 8.7 p -114.19 -31.54 2.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -164.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.659 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 7.1 tmtm? -145.36 112.28 5.98 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.316 -0.553 . . . . 0.0 111.154 -174.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.543 HD23 HG12 ' A' ' 9' ' ' ILE . 2.8 mm? -112.2 111.74 22.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.888 175.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.2 t -129.32 162.46 27.9 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.689 175.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.974 ' HA ' ' HG2' ' A' ' 117' ' ' ARG . 28.8 mtp-105 -112.53 132.62 55.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.059 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.889 ' HA ' HG22 ' A' ' 116' ' ' THR . 4.6 pp 53.84 172.27 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.93 1.292 . . . . 0.0 113.687 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.465 ' HE2' ' NZ ' ' A' ' 50' ' ' LYS . 54.3 t80 -84.17 94.93 8.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.109 177.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.532 ' HB3' ' HB3' ' A' ' 138' ' ' GLU . 11.6 t30 -95.39 133.45 39.33 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 172.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -55.53 -56.94 14.39 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 123.163 0.289 . . . . 0.0 111.667 -169.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.512 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.5 mp0 -63.95 -33.13 75.02 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.178 0.513 . . . . 0.0 110.677 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.532 ' HB3' ' HB3' ' A' ' 135' ' ' ASN . 7.2 tp10 -65.63 -44.95 84.89 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.088 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.622 ' O ' HG23 ' A' ' 143' ' ' VAL . 90.5 t80 -60.96 -43.52 98.6 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.167 178.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.73 -44.9 86.32 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.007 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.7 m -63.33 -43.59 97.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.629 177.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.62 -44.3 96.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.597 -178.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 139' ' ' PHE . 95.7 t -56.75 -59.41 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.994 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -57.59 -36.91 72.35 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.534 -177.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.643 ' O ' ' HG3' ' A' ' 149' ' ' MET . 50.3 tt0 -62.62 -53.56 52.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.414 177.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 64.3 mt -56.74 -42.2 76.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 120.962 0.41 . . . . 0.0 110.835 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.779 ' O ' ' HG3' ' A' ' 151' ' ' LYS . 93.5 m-20 -51.16 -55.05 19.86 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.275 178.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -64.18 -29.01 70.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.321 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.643 ' HG3' ' O ' ' A' ' 145' ' ' GLN . 92.8 mtp -61.4 -36.7 81.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.574 0.226 . . . . 0.0 110.842 -176.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.71 -10.11 30.12 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.293 -0.563 . . . . 0.0 112.424 178.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.779 ' HG3' ' O ' ' A' ' 147' ' ' ASN . 8.7 mtmp? -85.91 -64.19 1.2 Allowed 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.687 174.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.491 ' CD ' ' H ' ' A' ' 153' ' ' GLY . 1.5 pp20? 34.44 -81.11 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.404 0 O-C-N 125.173 1.546 . . . . 0.0 114.452 -174.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.491 ' H ' ' CD ' ' A' ' 152' ' ' GLU . . . 70.68 23.9 77.38 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.364 -1.095 . . . . 0.0 110.364 -172.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 42.9 m-70 -100.13 -10.16 21.76 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.089 0.471 . . . . 0.0 110.113 -174.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.7 93.52 3.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.332 0.587 . . . . 0.0 110.706 175.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -55.88 134.98 52.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.544 175.222 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -80.65 -36.9 31.85 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -171.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 24.2 t-80 -157.12 10.2 0.2 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.124 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 . . . . . 0 C--O 1.242 0.672 0 CA-C-O 118.322 -0.846 . . . . 0.0 109.86 -179.458 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.8 mmm . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.753 ' O ' ' HA ' ' A' ' 113' ' ' ALA . 19.6 m -96.01 121.01 37.3 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.734 HD23 ' H ' ' A' ' 3' ' ' LEU . 1.6 pt? -63.06 91.43 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.701 0.762 . . . . 0.0 111.172 -177.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.59 78.21 1.94 Allowed Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.657 -177.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -81.62 102.84 10.92 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.168 0.509 . . . . 0.0 110.688 177.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.476 HG12 ' HA ' ' A' ' 109' ' ' ALA . 27.3 pt -95.22 9.53 5.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.769 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.657 HG11 HD12 ' A' ' 127' ' ' ILE . 23.2 t -118.45 153.77 20.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.135 -177.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.428 ' HB2' ' HB2' ' A' ' 11' ' ' GLU . 41.0 mtt180 -104.42 163.63 12.31 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.915 0.388 . . . . 0.0 110.924 -174.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.567 HG12 HD23 ' A' ' 130' ' ' LEU . 71.3 mt -83.16 117.78 29.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 170.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.88 0.39 56.29 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 -173.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 8' ' ' ARG . 4.1 tp10 -69.47 144.14 53.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.289 -0.456 . . . . 0.0 110.501 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.4 mmt -68.58 111.9 5.04 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 174.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.46 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -58.25 133.96 84.69 Favored Pre-proline 0 C--O 1.237 0.396 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.604 -176.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 6.4 Cg_exo -73.12 174.45 12.01 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.105 2.536 . . . . 0.0 112.245 178.307 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -81.7 168.74 17.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.663 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.62 ' HB2' HD12 ' A' ' 104' ' ' ILE . 33.5 p90 -177.57 143.56 0.36 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.316 165.006 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 62.7 m -117.72 106.43 13.05 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 173.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.1 tt -111.75 138.92 38.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.085 -169.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.2 m -88.2 117.95 27.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.399 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.3 mt -80.92 167.82 19.42 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.153 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.416 ' HB ' ' CD1' ' A' ' 84' ' ' LEU . 17.4 p -54.45 -28.08 41.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.512 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -93.6 15.32 16.44 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.166 -174.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.85 27.41 68.99 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.674 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 49.8 mmtm -108.48 119.26 38.99 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.624 0.25 . . . . 0.0 110.45 -176.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -94.95 115.23 27.19 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.189 178.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 17' ' ' THR . 20.2 m -114.96 150.59 16.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.428 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 20.7 m -110.87 142.67 42.6 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.911 177.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -60.06 -34.62 73.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.951 0.405 . . . . 0.0 110.56 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.42 ' H ' HG22 ' A' ' 27' ' ' THR . 9.4 m -62.86 -25.8 68.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.646 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.2 m -75.36 -21.29 58.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.218 0.532 . . . . 0.0 111.405 -176.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.8 mt -103.47 4.35 35.92 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.48 -178.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.548 ' CZ ' ' HA3' ' A' ' 125' ' ' GLY . 23.7 mmm-85 -65.83 109.67 2.56 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.113 0.482 . . . . 0.0 110.14 178.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.28 -29.44 2.61 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -173.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.416 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 27.2 mttt -96.06 173.08 7.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.237 -0.481 . . . . 0.0 109.985 176.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.455 HG11 ' HB3' ' A' ' 149' ' ' MET . 30.6 m -84.64 108.74 17.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 169.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.467 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 21.2 t -102.6 113.28 38.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.336 -172.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.446 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 27.1 ttt -98.41 124.31 43.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.451 177.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.431 ' HB2' ' HB ' ' A' ' 119' ' ' VAL . 3.2 mm? -109.86 112.99 25.36 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.857 177.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.478 HE22 ' HB ' ' A' ' 41' ' ' THR . 26.2 tm0? -107.28 107.1 17.87 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -82.22 127.31 33.05 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.52 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 12.4 t -140.44 176.19 8.98 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.136 0.493 . . . . 0.0 111.141 -172.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.464 ' HB2' HG12 ' A' ' 115' ' ' ILE . . . -152.36 133.5 14.28 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.494 177.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.487 ' OG ' ' HB3' ' A' ' 82' ' ' LYS . 12.4 p -63.59 -9.21 12.36 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -177.095 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 12.4 p-90 -108.79 12.82 25.38 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.84 0.352 . . . . 0.0 111.496 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 49.4 t -108.09 111.8 24.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.923 0.392 . . . . 0.0 110.695 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.1 -22.88 77.41 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.675 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.2 t -63.66 -34.58 68.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.204 0.526 . . . . 0.0 110.214 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.575 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 64.1 m -67.34 -22.33 65.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.705 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.489 ' O ' ' HG2' ' A' ' 53' ' ' PRO . 26.5 mtp-105 -73.69 -3.16 26.57 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.086 0.47 . . . . 0.0 110.583 178.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -97.74 -58.01 2.1 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.059 171.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.954 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 11.3 pt-20 -64.23 -47.96 77.67 Favored 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -175.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.664 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 94.3 mtp -59.87 -51.78 78.34 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -173.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.664 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 52.4 Cg_exo -59.06 -37.96 89.97 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.3 2.0 . . . . 0.0 112.649 174.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.439 ' HB3' ' CZ ' ' A' ' 139' ' ' PHE . 10.8 m-85 -67.39 -42.29 83.55 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.796 176.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 51' ' ' GLU . 94.6 mt -59.23 -48.79 85.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.173 177.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.57 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 2.0 pp20? -67.86 -35.25 78.21 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.633 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.565 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 7.9 ttmm -64.04 -44.32 92.86 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.522 -176.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.725 ' O ' ' HG2' ' A' ' 62' ' ' LYS . 3.9 t0 -106.15 -65.65 1.06 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.177 -0.609 . . . . 0.0 111.326 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.509 HG12 HG23 ' A' ' 143' ' ' VAL . 58.2 mt -56.84 -45.05 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 120.858 0.361 . . . . 0.0 111.609 -169.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.571 ' CD2' ' HB3' ' A' ' 94' ' ' TYR . 76.4 t-105 -75.37 -59.47 2.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.472 -177.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.526 HD13 ' O ' ' A' ' 56' ' ' GLU . 1.6 mp -53.83 -30.57 45.83 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -171.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.725 ' HG2' ' O ' ' A' ' 58' ' ' ASP . 31.8 mmtp -76.95 -24.88 52.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.868 0.366 . . . . 0.0 111.667 -177.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.462 ' CE1' ' HG ' ' A' ' 150' ' ' LEU . 73.8 m-70 -121.67 -41.37 2.48 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -172.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.403 ' HE3' ' HA ' ' A' ' 61' ' ' LEU . 33.1 mmtp 56.42 -95.38 0.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 122.917 0.487 . . . . 0.0 110.128 -167.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.44 ' O ' ' HB3' ' A' ' 66' ' ' ASN . 15.6 t70 -110.8 -32.07 6.97 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 171.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.44 ' HB3' ' O ' ' A' ' 65' ' ' ASP . 20.2 t-20 67.93 -68.82 0.15 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.038 -176.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 158.71 -33.91 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.627 1.571 . . . . 0.0 106.868 -175.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.416 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 15.1 t70 -125.55 18.66 8.1 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.258 -174.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -124.44 142.59 51.19 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.84 -0.537 . . . . 0.0 110.585 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.63 130.36 20.3 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.541 176.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.446 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 2.0 tt -132.92 114.67 14.31 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.1 mp -122.74 124.08 69.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.121 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 96' ' ' LEU . . . -91.92 136.3 13.19 Favored Glycine 0 C--O 1.222 -0.64 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 173.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 59.9 mt -119.93 103.53 14.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 117.742 0.771 . . . . 0.0 111.388 -175.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.52 ' HA ' ' O ' ' A' ' 41' ' ' THR . 34.4 t0 -80.66 133.1 35.67 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 171.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.536 ' HA ' ' HB3' ' A' ' 99' ' ' ASP . 5.7 ttp180 -71.28 -105.8 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -170.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.452 ' H ' ' HB3' ' A' ' 76' ' ' ARG . 10.1 m-20 -87.33 21.19 2.52 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -168.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -98.56 142.86 25.29 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-O 120.981 0.419 . . . . 0.0 111.449 -178.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.446 ' O ' HG23 ' A' ' 83' ' ' VAL . 64.9 Cg_endo -75.54 174.9 12.03 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.936 2.424 . . . . 0.0 112.86 178.195 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.443 HD23 HD11 ' A' ' 98' ' ' LEU . 32.5 mt -50.93 -50.32 57.96 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.441 -176.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -52.0 -39.82 60.04 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -176.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.487 ' HB3' ' OG ' ' A' ' 43' ' ' SER . 31.7 mmtp -66.84 -53.32 33.75 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.393 178.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 79' ' ' PRO . 15.3 t -60.7 -47.16 94.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.361 -175.012 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.416 ' CD1' ' HB ' ' A' ' 21' ' ' THR . 4.0 mm? -60.49 -48.6 81.07 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.902 0.382 . . . . 0.0 111.435 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.898 ' HA ' ' HE2' ' A' ' 88' ' ' LYS . . . -67.24 -35.8 80.31 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.307 -176.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.608 ' HE2' ' SD ' ' A' ' 52' ' ' MET . 56.1 t80 -72.51 -37.34 68.41 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.711 -178.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.433 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -62.46 -49.61 74.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.294 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.898 ' HE2' ' HA ' ' A' ' 85' ' ' ALA . 63.8 pttt -68.54 -29.93 68.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.29 -176.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.2 m -83.75 -2.04 55.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.725 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.473 ' HB ' ' HG3' ' A' ' 53' ' ' PRO . 11.1 p -115.64 -8.12 12.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.895 0.379 . . . . 0.0 110.902 175.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.69 4.14 87.68 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.273 178.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.401 HG13 ' CE1' ' A' ' 94' ' ' TYR . 42.6 t -59.98 114.86 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.171 0.51 . . . . 0.0 111.267 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 p -100.68 7.69 43.77 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.632 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.571 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 33.4 p90 -104.25 145.63 31.03 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.228 173.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -63.07 140.6 79.47 Favored 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 122.615 2.21 . . . . 0.0 112.925 -178.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' A' ' 73' ' ' GLY . 62.5 mt -113.02 144.63 42.25 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.173 176.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -112.22 164.56 12.08 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.886 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.443 HD11 HD23 ' A' ' 80' ' ' LEU . 7.0 mp -102.95 147.49 26.86 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.536 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 36.4 t0 -130.38 70.54 82.33 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-O 121.057 0.456 . . . . 0.0 110.803 174.107 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.15 110.25 1.72 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.673 2.248 . . . . 0.0 112.211 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.86 -1.21 31.84 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.72 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 54.74 40.01 31.67 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.883 0.373 . . . . 0.0 111.016 -175.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.587 ' O ' ' HG3' ' A' ' 107' ' ' LYS . 15.4 t70 -84.13 -45.71 12.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.511 -174.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.62 HD12 ' HB2' ' A' ' 16' ' ' PHE . 35.3 mm -66.11 -35.55 75.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 177.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.491 ' CE1' ' HD3' ' A' ' 117' ' ' ARG . 56.6 t80 -63.51 -37.18 86.33 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.808 174.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.783 ' HB2' ' HG2' ' A' ' 111' ' ' ARG . . . -69.83 -22.92 63.24 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.566 178.197 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.587 ' HG3' ' O ' ' A' ' 103' ' ' ASP . 44.5 mtpt -79.46 -3.13 45.16 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.254 178.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -130.99 -3.04 4.02 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.899 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.63 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -178.16 -176.24 0.52 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 122.887 0.475 . . . . 0.0 110.448 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.3 mt -72.92 157.95 36.44 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 172.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.783 ' HG2' ' HB2' ' A' ' 106' ' ' ALA . 48.6 mtt180 -78.2 -10.31 59.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.974 0.416 . . . . 0.0 111.063 -175.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -88.0 -68.77 0.74 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 171.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.753 ' HA ' ' O ' ' A' ' 2' ' ' SER . . . 21.2 -89.26 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.775 0 O-C-N 125.177 1.548 . . . . 0.0 113.885 -178.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -164.1 -138.42 2.41 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.464 HG12 ' HB2' ' A' ' 42' ' ' ALA . 7.4 tp -150.86 -50.33 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.674 177.323 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.709 ' HB ' ' HB3' ' A' ' 133' ' ' LEU . 1.0 OUTLIER -77.03 107.48 9.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.002 0.429 . . . . 0.0 111.681 -178.974 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.491 ' HD3' ' CE1' ' A' ' 105' ' ' PHE . 6.1 ptm180 -159.7 135.62 8.66 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.062 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.521 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 49.8 m-20 -108.68 119.02 38.31 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' A' ' 38' ' ' LEU . 57.7 t -112.49 138.23 42.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.592 -177.04 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.589 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 34.2 tp -123.69 123.89 41.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.017 0.437 . . . . 0.0 110.765 175.208 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.467 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 79.7 mt -101.09 132.51 46.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.274 175.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.05 -179.97 6.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.768 0.318 . . . . 0.0 110.553 -178.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 6.0 ptm85 -69.93 -24.09 63.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.262 -174.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -77.06 -26.98 54.17 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.51 0.671 . . . . 0.0 109.898 174.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.548 ' HA3' ' CZ ' ' A' ' 32' ' ' ARG . . . 109.93 18.77 8.58 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.854 -177.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 11' ' ' GLU . 80.9 mttt -94.63 136.42 34.95 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.954 0.407 . . . . 0.0 110.501 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.657 HD12 HG11 ' A' ' 7' ' ' VAL . 55.4 mt -79.7 99.2 3.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 28.0 m -101.33 -4.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -171.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.589 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 48.3 tptt -146.27 111.53 5.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.14 0.495 . . . . 0.0 111.597 -176.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.567 HD23 HG12 ' A' ' 9' ' ' ILE . 3.3 mm? -109.28 105.85 15.44 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.646 172.27 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.521 ' HB ' ' HB2' ' A' ' 118' ' ' ASN . 0.4 OUTLIER -109.64 155.86 20.94 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.999 0.428 . . . . 0.0 111.137 -174.479 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -89.85 174.35 7.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.996 178.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.709 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 2.9 pp -45.34 162.07 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 O-C-N 123.608 0.568 . . . . 0.0 112.106 175.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.954 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 91.9 t80 -43.98 97.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -174.08 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -114.4 129.62 56.66 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 164.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -55.07 -43.49 73.93 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -171.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -60.95 -49.54 77.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.99 0.424 . . . . 0.0 111.445 176.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.438 ' HB3' ' CG2' ' A' ' 131' ' ' THR . 6.6 mt-10 -65.0 -39.96 94.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.263 -178.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.439 ' CZ ' ' HB3' ' A' ' 54' ' ' PHE . 70.6 t80 -64.03 -42.05 97.23 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.917 0.389 . . . . 0.0 110.408 175.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.46 -40.62 97.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.725 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.402 ' O ' ' HB3' ' A' ' 145' ' ' GLN . 60.7 p -65.64 -29.26 69.81 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.299 -0.409 . . . . 0.0 109.926 178.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.4 mt -73.15 -57.68 3.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.313 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.509 HG23 HG12 ' A' ' 59' ' ' ILE . 7.4 p -59.39 -38.34 74.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 O-C-N 123.11 0.256 . . . . 0.0 110.966 -175.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -67.41 -48.73 66.48 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 177.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.468 ' O ' ' HG2' ' A' ' 149' ' ' MET . 8.7 tt0 -55.98 -48.89 75.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.853 177.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.455 ' O ' HD23 ' A' ' 150' ' ' LEU . 93.1 mt -64.16 -44.44 97.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.189 -178.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -58.93 -40.75 85.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.201 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.51 ' OE1' ' HB2' ' A' ' 151' ' ' LYS . 6.1 tp10 -73.55 -25.95 60.62 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.126 -0.229 . . . . 0.0 110.951 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.468 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 61.1 mmm -66.7 -28.44 68.44 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 175.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.462 ' HG ' ' CE1' ' A' ' 63' ' ' HIS . 4.2 mm? -81.75 -20.63 38.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.83 175.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.687 ' HA ' ' HE2' ' A' ' 151' ' ' LYS . 10.0 mmpt? -102.27 -3.62 26.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.678 -178.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.51 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . 7.0 tp10 -68.67 75.91 0.29 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 122.422 1.106 . . . . 0.0 111.517 178.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -118.6 14.66 11.7 Favored Glycine 0 N--CA 1.436 -1.353 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 164.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.51 ' CE1' ' HA ' ' A' ' 152' ' ' GLU . 2.3 m80 -69.12 -33.03 72.83 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 114.505 -0.847 . . . . 0.0 109.172 -176.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -106.12 27.88 8.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.308 -177.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -75.91 75.01 2.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.231 0.538 . . . . 0.0 110.857 -177.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 56.4 t60 -138.21 9.75 2.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.358 175.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -99.78 -28.03 13.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.245 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 . . . . . 0 C--O 1.243 0.72 0 CA-C-O 118.585 -0.721 . . . . 0.0 109.806 179.647 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptm . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.725 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . 3.7 p -154.37 127.32 8.25 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 123.386 0.429 . . . . 0.0 109.94 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.7 mp -82.0 80.67 8.2 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.899 0.38 . . . . 0.0 110.714 -177.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 70.82 41.57 62.66 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.548 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.725 ' HB2' ' HB2' ' A' ' 2' ' ' SER . 93.5 m-85 -113.1 152.59 29.4 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 178.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.7 pp -109.99 -0.12 9.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.576 0.703 . . . . 0.0 109.898 171.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.2 p -114.53 163.01 12.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.612 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 28.3 mtm105 -129.88 166.4 20.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.833 0.349 . . . . 0.0 111.916 -171.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.496 HG12 ' CD2' ' A' ' 130' ' ' LEU . 53.2 mt -77.88 140.13 17.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.848 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.96 -16.56 55.0 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.128 -0.558 . . . . 0.0 111.882 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.454 ' HA ' ' OE1' ' A' ' 11' ' ' GLU . 8.0 mm-40 -82.65 158.38 23.01 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.073 0.463 . . . . 0.0 111.086 -178.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 84.9 mmm -77.15 132.33 38.75 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.373 -176.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.535 ' HB2' HD12 ' A' ' 121' ' ' ILE . . . -68.72 130.04 92.08 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.036 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.74 125.63 13.5 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.611 2.207 . . . . 0.0 111.93 177.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -64.77 145.7 55.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.039 -178.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.692 ' HB2' HD12 ' A' ' 104' ' ' ILE . 47.1 p90 -149.54 154.2 38.36 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.471 178.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 34.6 m -118.13 106.18 12.59 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.547 173.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.6 tt -110.72 145.81 16.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.599 -175.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.508 ' O ' HD23 ' A' ' 98' ' ' LEU . 16.5 m -85.99 128.2 34.8 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.309 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.1 mt -80.57 179.54 7.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.092 0.472 . . . . 0.0 111.392 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 96' ' ' LEU . 30.0 p -64.66 -20.03 66.06 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.329 -0.851 . . . . 0.0 112.439 -177.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.496 ' OD2' ' HG3' ' A' ' 24' ' ' LYS . 10.9 p-10 -106.07 10.74 32.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.919 0.39 . . . . 0.0 110.647 -178.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.14 3.37 67.69 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.665 -0.779 . . . . 0.0 113.398 175.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.496 ' HG3' ' OD2' ' A' ' 22' ' ' ASP . 32.0 mtmm -84.51 122.93 29.69 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.043 0.421 . . . . 0.0 111.353 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.49 ' HB3' HG22 ' A' ' 17' ' ' THR . 93.6 mt-30 -88.23 116.44 26.43 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 175.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 17' ' ' THR . 17.0 m -107.59 147.15 12.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.217 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.8 m -111.42 144.45 40.61 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.072 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.02 -43.4 91.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.965 0.412 . . . . 0.0 110.328 -178.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.515 ' HA ' ' CG ' ' A' ' 32' ' ' ARG . 49.4 m -62.02 -21.22 64.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.974 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.5 t -76.75 -17.29 59.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.818 0.342 . . . . 0.0 110.433 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.4 mt -118.45 19.55 13.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.136 0.494 . . . . 0.0 110.271 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.534 ' NH1' ' H ' ' A' ' 33' ' ' GLY . 10.6 mmm180 -73.71 155.89 38.48 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.966 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.534 ' H ' ' NH1' ' A' ' 32' ' ' ARG . . . 102.94 -30.97 9.31 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 -177.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.689 ' HB3' ' HZ3' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -114.31 173.55 6.4 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.515 -0.343 . . . . 0.0 110.5 -177.879 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 68' ' ' ASP . 33.2 m -79.35 130.65 35.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.944 0.402 . . . . 0.0 110.055 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.47 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 55.3 t -119.93 113.85 42.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.662 -178.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.807 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 1.6 tmt? -91.68 138.1 31.83 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 176.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.415 ' HB2' ' HB ' ' A' ' 119' ' ' VAL . 93.5 mt -127.9 122.51 32.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.509 -175.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -116.81 107.16 14.29 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.547 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.779 ' HB2' ' HB2' ' A' ' 117' ' ' ARG . 92.6 m-85 -90.92 112.54 24.44 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 9.2 t -141.34 -171.43 3.29 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.47 -172.204 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.418 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . . . -151.14 172.55 15.61 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.147 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.528 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 26.9 t -82.88 -14.04 55.0 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.835 0.35 . . . . 0.0 110.766 -178.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -102.3 -4.37 25.75 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.6 p -88.56 107.4 18.88 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 121.657 -0.652 . . . . 0.0 111.181 -178.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.83 -8.7 82.58 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 115.836 -0.62 . . . . 0.0 113.175 -177.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.4 t -77.34 -45.54 29.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 176.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.68 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 98.0 m -62.93 -22.69 66.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.475 -178.41 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.567 ' HE ' ' HE1' ' A' ' 86' ' ' PHE . 89.1 mtt180 -69.93 -2.12 11.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.607 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.425 ' O ' ' HD1' ' A' ' 54' ' ' PHE . 58.9 mttp -100.3 -48.28 4.65 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.346 0.593 . . . . 0.0 109.676 171.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 1.098 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 6.5 pt-20 -67.2 -44.36 79.8 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.798 -176.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.805 ' HG2' ' HD3' ' A' ' 53' ' ' PRO . 16.2 ptm -64.18 -39.77 46.66 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-O 118.576 -0.726 . . . . 0.0 112.923 -174.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.805 ' HD3' ' HG2' ' A' ' 52' ' ' MET . 46.6 Cg_exo -61.23 -41.73 40.44 Favored 'Trans proline' 0 C--N 1.362 1.254 0 C-N-CA 121.345 1.363 . . . . 0.0 112.307 169.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 139' ' ' PHE . 18.4 m-85 -64.98 -41.88 95.03 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.906 176.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.558 HG12 HD12 ' A' ' 59' ' ' ILE . 70.2 mt -59.43 -50.52 79.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.094 175.066 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.601 ' OE1' ' HA ' ' A' ' 92' ' ' VAL . 25.2 tp10 -49.05 -49.67 40.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.232 0.539 . . . . 0.0 110.819 175.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.7 tmmt? -69.29 -47.02 65.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.915 -174.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -106.33 -50.16 3.2 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -173.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.558 HD12 HG12 ' A' ' 55' ' ' ILE . 38.4 mt -71.08 -43.48 75.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.597 -176.074 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.435 ' CE2' ' HB3' ' A' ' 94' ' ' TYR . 66.8 t-105 -81.66 -77.43 0.22 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.997 -178.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -44.5 -34.99 2.28 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -172.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -84.37 -26.44 28.39 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -173.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -127.15 -9.66 5.89 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -173.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.542 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 18.0 pttp -41.89 -48.84 4.51 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -165.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.52 -83.95 0.11 Allowed 'General case' 0 C--O 1.25 1.094 0 CA-C-O 121.471 0.653 . . . . 0.0 110.197 -172.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.459 ' CG ' ' H ' ' A' ' 67' ' ' ALA . 63.5 t30 49.23 -155.75 0.09 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.631 -169.012 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.459 ' H ' ' CG ' ' A' ' 66' ' ' ASN . . . -105.99 -10.41 16.6 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 166.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.489 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 12.8 m-20 -145.05 39.76 1.22 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.739 -170.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.542 ' CD2' ' HA ' ' A' ' 64' ' ' LYS . 62.1 t80 -118.45 129.3 55.31 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 118.976 -1.089 . . . . 0.0 110.605 169.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.24 143.75 50.97 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.533 175.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.807 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 5.4 tt -143.77 121.56 11.94 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.097 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.1 mp -125.67 127.19 71.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.378 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.428 ' HA3' HD22 ' A' ' 96' ' ' LEU . . . -95.53 133.08 11.35 Favored Glycine 0 C--O 1.223 -0.579 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.034 175.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 74.7 mt -119.74 127.38 75.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 117.203 0.501 . . . . 0.0 111.128 -174.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.45 ' O ' ' HB3' ' A' ' 99' ' ' ASP . 11.6 t70 -89.34 144.85 25.76 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.21 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.508 HH21 ' HA ' ' A' ' 112' ' ' ASP . 19.8 ttt-85 -69.71 -32.71 71.44 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -172.558 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -158.38 -34.26 0.07 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -173.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -71.62 138.4 83.27 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 121.262 0.553 . . . . 0.0 111.896 -165.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.563 ' HD2' ' HG3' ' A' ' 82' ' ' LYS . 37.4 Cg_endo -72.17 -170.75 0.6 Allowed 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.676 2.917 . . . . 0.0 115.411 -171.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.423 ' O ' HD23 ' A' ' 84' ' ' LEU . 87.7 mt -54.63 -60.35 3.47 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 114.422 -1.263 . . . . 0.0 113.021 -171.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.552 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -59.43 -35.39 73.91 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.032 0.444 . . . . 0.0 110.821 -173.072 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.563 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 19.4 mmmt -61.42 -53.27 58.7 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.237 174.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 79' ' ' PRO . 70.6 t -65.9 -43.57 92.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.341 -178.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 80' ' ' LEU . 4.4 mm? -61.79 -47.37 85.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.399 -178.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.86 -35.19 79.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.752 0.31 . . . . 0.0 110.725 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.567 ' HE1' ' HE ' ' A' ' 49' ' ' ARG . 91.3 t80 -67.02 -52.49 41.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.125 178.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.523 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -55.47 -49.54 72.22 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.915 0.388 . . . . 0.0 110.691 177.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.4 tttm -50.69 -36.21 34.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.978 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.9 m -89.78 6.55 41.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.446 -174.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 16.5 p -132.63 8.51 4.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.191 0.519 . . . . 0.0 110.739 176.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.62 -72.12 2.17 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.601 ' HA ' ' OE1' ' A' ' 56' ' ' GLU . 58.1 t 29.37 96.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.148 1.379 . . . . 0.0 114.579 178.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.5 p -94.88 -10.83 30.04 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.639 -0.425 . . . . 0.0 110.553 176.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.435 ' HB3' ' CE2' ' A' ' 60' ' ' TRP . 37.4 p90 -85.49 141.07 36.29 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.381 175.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -62.43 137.71 66.64 Favored 'Trans proline' 0 C--O 1.239 0.546 0 C-N-CA 122.514 2.143 . . . . 0.0 113.359 -177.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.523 HD12 ' HB2' ' A' ' 87' ' ' ALA . 71.4 mt -109.89 149.46 29.86 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.513 174.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -120.8 148.59 17.57 Favored Glycine 0 N--CA 1.438 -1.213 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 175.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.791 HD23 ' H ' ' A' ' 98' ' ' LEU . 2.3 pt? -103.24 131.79 50.01 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.45 ' HB3' ' O ' ' A' ' 75' ' ' ASP . 12.7 t0 -115.95 79.45 8.15 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.45 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.49 105.09 1.2 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.198 1.932 . . . . 0.0 112.373 -177.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 117.47 1.92 17.79 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.149 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 55.24 39.92 31.49 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 122.638 0.375 . . . . 0.0 111.854 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -79.83 -51.13 9.54 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.283 0.563 . . . . 0.0 110.784 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.692 HD12 ' HB2' ' A' ' 16' ' ' PHE . 30.5 mm -64.82 -34.65 71.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.615 ' CD1' ' HA ' ' A' ' 111' ' ' ARG . 18.1 t80 -65.75 -34.41 78.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.032 175.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -71.88 -23.62 61.54 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.357 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -74.14 -3.9 32.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.255 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -131.0 -35.69 1.38 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.912 0.387 . . . . 0.0 111.269 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -134.52 174.89 10.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.916 0.388 . . . . 0.0 111.109 -177.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.6 mt -78.91 6.22 9.71 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.615 ' HA ' ' CD1' ' A' ' 105' ' ' PHE . 7.3 mtm180 73.98 -68.94 0.2 Allowed 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.981 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.508 ' HA ' HH21 ' A' ' 76' ' ' ARG . 20.6 m-20 -84.77 6.75 23.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.729 -172.191 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -85.07 41.13 0.86 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.591 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.24 151.94 19.27 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.628 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.47 HG13 ' N ' ' A' ' 116' ' ' THR . 9.5 tp -88.03 171.18 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.47 ' N ' HG13 ' A' ' 115' ' ' ILE . 25.0 m 79.79 108.52 0.07 Allowed 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.298 0.639 . . . . 0.0 111.875 174.031 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.779 ' HB2' ' HB2' ' A' ' 40' ' ' PHE . 77.5 mmt-85 -138.78 131.15 28.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.151 173.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' A' ' 130' ' ' LEU . 7.6 m120 -114.99 117.14 29.76 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 176.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.415 ' HB ' ' HB2' ' A' ' 38' ' ' LEU . 39.4 t -129.28 141.4 46.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.879 0.371 . . . . 0.0 111.212 -172.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 46.7 tp -121.61 118.34 28.96 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.092 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.535 HD12 ' HB2' ' A' ' 13' ' ' ALA . 39.4 mm -91.44 121.35 41.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.849 177.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.57 ' OD2' ' HB2' ' A' ' 124' ' ' GLU . 13.6 t0 -67.83 158.35 32.75 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.375 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.7 ptt85 -67.57 -14.56 63.04 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.971 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.57 ' HB2' ' OD2' ' A' ' 122' ' ' ASP . 0.7 OUTLIER -77.63 -16.64 58.43 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 173.052 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.01 24.72 10.21 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.836 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -117.45 156.09 28.56 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.75 0.31 . . . . 0.0 111.359 -175.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.42 HG12 ' CD1' ' A' ' 121' ' ' ILE . 49.8 mt -86.72 113.88 25.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 174.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.1 m -104.2 -17.23 7.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.98 0.419 . . . . 0.0 111.502 -178.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.536 ' HB2' HE22 ' A' ' 145' ' ' GLN . 51.9 tptt -152.49 119.11 5.67 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.353 -176.081 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.618 HD12 ' CD2' ' A' ' 5' ' ' TYR . 1.7 pt? -141.28 105.85 4.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.537 0.684 . . . . 0.0 109.741 176.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.9 t -127.59 164.03 22.89 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.575 -175.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.805 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 62.5 mtp180 -114.71 133.12 56.13 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.54 -178.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.805 ' HG ' ' O ' ' A' ' 132' ' ' ARG . 3.9 pp 65.39 154.57 0.07 Allowed 'General case' 0 N--CA 1.471 0.578 0 O-C-N 124.988 1.43 . . . . 0.0 112.982 172.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 1.098 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 58.3 t80 -64.71 102.05 0.54 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.974 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 1.005 ' HB2' ' HB2' ' A' ' 138' ' ' GLU . 46.1 m-80 -98.93 167.11 10.95 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.948 171.177 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.14 -68.13 0.69 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.297 0.57 . . . . 0.0 110.03 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -67.83 -31.29 71.03 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.326 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 1.005 ' HB2' ' HB2' ' A' ' 135' ' ' ASN . 3.1 mm-40 -63.74 -40.13 95.99 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.186 177.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.484 ' HA ' HD12 ' A' ' 142' ' ' LEU . 87.2 t80 -71.1 -41.26 70.83 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.3 -39.15 89.41 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.769 177.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.0 m -65.35 -39.56 92.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.496 178.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.484 HD12 ' HA ' ' A' ' 139' ' ' PHE . 35.9 mt -58.66 -47.97 82.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.763 177.168 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 94.4 t -56.53 -49.25 78.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.186 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -66.22 -43.25 87.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.048 0.452 . . . . 0.0 110.589 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.536 HE22 ' HB2' ' A' ' 129' ' ' LYS . 21.5 tt0 -58.82 -50.95 72.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.031 179.062 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.626 ' O ' HD23 ' A' ' 150' ' ' LEU . 77.0 mt -66.83 -30.26 49.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.263 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.614 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 9.2 t-20 -57.68 -43.51 85.14 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.849 176.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -67.26 -39.03 86.07 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.687 0.617 . . . . 0.0 111.089 177.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' MET . . . . . 0.52 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 88.1 mmm -59.68 -27.86 66.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.635 0.731 . . . . 0.0 110.084 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.626 HD23 ' O ' ' A' ' 146' ' ' ILE . 3.4 mm? -88.27 -6.62 57.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.403 179.074 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.614 ' HG2' ' O ' ' A' ' 147' ' ' ASN . 38.5 mmtm -103.16 -47.36 4.35 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.846 0.355 . . . . 0.0 111.919 -178.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.529 ' OE1' ' HA ' ' A' ' 155' ' ' HIS . 5.9 pt-20 -58.96 -46.43 88.07 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -165.131 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.486 ' N ' ' HG3' ' A' ' 152' ' ' GLU . . . 74.89 -58.57 2.64 Favored Glycine 0 C--O 1.227 -0.344 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -170.249 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.455 ' O ' ' HB2' ' A' ' 152' ' ' GLU . 14.7 p-80 -125.53 148.65 48.82 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 106.12 -1.808 . . . . 0.0 106.12 166.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.529 ' HA ' ' OE1' ' A' ' 152' ' ' GLU . 45.5 m-70 -53.4 96.91 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.105 0.411 . . . . 0.0 110.783 -173.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.522 ' HD2' ' HA ' ' A' ' 152' ' ' GLU . 15.3 p80 -87.8 10.81 17.24 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -168.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 24.7 p80 -81.22 46.28 0.92 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 163.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.446 ' H ' ' C ' ' A' ' 156' ' ' HIS . 30.2 t-80 171.14 140.32 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 113.131 -1.85 . . . . 0.0 106.951 -171.062 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.504 -0.76 . . . . 0.0 109.799 176.694 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 . . . . . 0 N--CA 1.455 -0.186 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.418 HG13 HG23 ' A' ' 7' ' ' VAL . 46.1 pt -96.78 -14.03 7.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.418 0.627 . . . . 0.0 109.42 173.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.616 HG11 HD12 ' A' ' 127' ' ' ILE . 20.5 t -110.36 151.78 12.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.181 177.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.428 ' CD ' ' HB2' ' A' ' 11' ' ' GLU . 5.0 ppt_? -126.25 168.74 13.68 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.699 0.285 . . . . 0.0 111.55 -173.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.788 HG12 HD13 ' A' ' 130' ' ' LEU . 72.7 mt -65.92 128.26 28.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 120.955 0.407 . . . . 0.0 110.509 178.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.06 -4.35 65.2 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.79 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.428 ' HB2' ' CD ' ' A' ' 8' ' ' ARG . 7.3 tp10 -89.25 151.63 22.03 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.55 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 41.7 mtp -80.29 143.89 33.28 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.126 0.489 . . . . 0.0 110.657 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -81.22 132.24 56.77 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.646 -175.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 27.5 Cg_exo -63.24 156.44 55.54 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.058 2.505 . . . . 0.0 112.071 176.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -97.9 165.6 11.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.818 -177.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.401 ' O ' ' HA ' ' A' ' 27' ' ' THR . 47.9 p90 -177.41 166.0 2.24 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.64 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 45.7 m -131.17 106.29 8.24 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 174.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.3 tt -107.97 143.27 18.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.008 -171.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.0 m -85.39 125.32 32.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.282 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.427 HD22 ' HB2' ' A' ' 95' ' ' PRO . 97.6 mt -83.45 173.74 11.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.33 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 96' ' ' LEU . 3.5 p -58.69 -31.19 67.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.696 -175.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -100.69 18.37 19.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.234 0.54 . . . . 0.0 110.355 -176.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.52 39.07 23.0 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.783 173.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -108.45 136.48 48.0 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.736 0.303 . . . . 0.0 111.064 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -99.45 116.07 30.74 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 17' ' ' THR . 3.1 p -120.23 126.12 74.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.382 0.61 . . . . 0.0 111.158 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 15.7 m -93.44 143.3 26.42 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.115 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.487 HD22 ' HA ' ' A' ' 28' ' ' LEU . 0.7 OUTLIER -66.59 -30.69 71.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.721 0.296 . . . . 0.0 110.295 -176.312 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.9 m -53.2 -43.01 66.85 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.191 176.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.9 m -67.54 -24.75 65.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.561 -175.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.1 mt -88.45 -22.06 23.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.787 -176.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 83.5 mtm-85 -60.2 159.41 9.81 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.894 0.378 . . . . 0.0 111.585 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.544 ' O ' ' HG3' ' A' ' 123' ' ' ARG . . . 85.25 -23.42 8.26 Favored Glycine 0 N--CA 1.452 -0.265 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -172.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.452 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 31.4 mtmm -109.21 167.93 9.75 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 176.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.41 HG21 HD22 ' A' ' 150' ' ' LEU . 26.1 m -81.87 114.19 22.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 121.208 0.528 . . . . 0.0 110.233 177.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.58 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 29.9 t -110.25 115.32 49.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.137 -173.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.489 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 27.6 ttt -101.16 114.73 28.96 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.119 175.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 69.7 mt -110.11 108.58 18.81 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.891 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.445 ' HG2' ' HA2' ' A' ' 73' ' ' GLY . 9.9 pt20 -94.7 130.01 41.37 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.496 ' HB2' ' HG2' ' A' ' 117' ' ' ARG . 77.2 m-85 -101.45 107.14 18.37 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 12.6 t -130.83 -174.92 3.51 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.252 -171.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.539 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . . . -164.75 143.85 6.99 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.578 177.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 57.1 p -58.64 -25.3 62.59 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -177.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 36.4 p-90 -90.83 7.85 37.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.782 0.325 . . . . 0.0 111.741 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.539 ' SG ' ' HB3' ' A' ' 42' ' ' ALA . 71.8 m -93.25 127.03 38.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.053 0.454 . . . . 0.0 110.905 177.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -85.02 -33.06 19.18 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.457 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.651 HG11 ' HB2' ' A' ' 133' ' ' LEU . 40.3 t -65.11 -34.15 68.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 121.143 0.497 . . . . 0.0 110.629 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.685 ' SG ' HG22 ' A' ' 116' ' ' THR . 92.3 m -66.26 -15.89 63.57 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.461 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.401 ' O ' ' HG2' ' A' ' 53' ' ' PRO . 78.1 mtt180 -78.33 -3.32 42.43 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.478 0.656 . . . . 0.0 110.298 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.407 ' O ' ' HD1' ' A' ' 54' ' ' PHE . 18.8 mtpp -101.77 -45.54 5.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.908 163.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.645 ' HB3' ' HA ' ' A' ' 48' ' ' CYS . 37.4 tt0 -54.87 -63.32 1.19 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.178 -1.374 . . . . 0.0 111.719 -176.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.641 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 79.8 mtp -59.33 -52.19 76.15 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.994 -173.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.641 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 50.5 Cg_exo -56.4 -40.8 82.21 Favored 'Trans proline' 0 C--N 1.358 1.034 0 C-N-CA 122.165 1.91 . . . . 0.0 112.752 179.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.407 ' HD1' ' O ' ' A' ' 50' ' ' LYS . 17.0 m-85 -67.21 -44.81 78.64 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.443 177.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.57 ' O ' ' HB ' ' A' ' 59' ' ' ILE . 81.8 mt -56.44 -45.34 81.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.531 176.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.618 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 38.6 tt0 -62.55 -48.69 78.4 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.415 178.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.517 ' HA ' HD22 ' A' ' 61' ' ' LEU . 29.1 ttpp -63.4 -54.07 42.54 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -173.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -104.29 -13.0 16.31 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -170.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.57 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 71.6 mt -105.16 -63.67 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.725 177.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.618 ' HB3' ' HA ' ' A' ' 56' ' ' GLU . 74.0 t-105 -59.89 -62.09 2.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.548 -175.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.517 HD22 ' HA ' ' A' ' 57' ' ' LYS . 2.6 mp -53.47 -23.06 9.08 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -175.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -89.75 -53.15 4.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.816 0.341 . . . . 0.0 111.418 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -113.18 2.63 15.68 Favored 'General case' 0 C--O 1.221 -0.437 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -167.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.491 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 12.0 pttp -39.07 -44.07 1.09 Allowed 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -172.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -96.8 -75.99 0.52 Allowed 'General case' 0 C--O 1.251 1.146 0 CA-C-O 121.334 0.588 . . . . 0.0 109.855 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.421 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 24.8 t-20 66.56 -72.19 0.09 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 114.449 -1.251 . . . . 0.0 110.667 -177.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 66' ' ' ASN . . . 155.32 -26.17 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.323 0 O-C-N 125.044 1.465 . . . . 0.0 107.704 -175.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.452 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 14.9 t70 -140.04 22.38 2.43 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.991 -172.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.548 ' CE2' ' HB2' ' A' ' 71' ' ' LEU . 68.6 t80 -113.4 139.35 48.97 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.328 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.07 128.94 29.08 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.773 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.548 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 3.6 tt -134.23 117.36 16.39 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.458 HD12 ' C ' ' A' ' 71' ' ' LEU . 3.1 mp -128.66 130.72 68.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.788 0.327 . . . . 0.0 110.141 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.445 ' HA2' ' HG2' ' A' ' 39' ' ' GLN . . . -99.23 133.73 11.41 Favored Glycine 0 C--O 1.219 -0.797 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.526 176.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.0 mt -116.52 127.76 74.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 117.29 0.545 . . . . 0.0 110.905 -176.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.48 ' OD2' ' HA ' ' A' ' 42' ' ' ALA . 10.2 t70 -90.91 135.09 33.96 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 174.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.612 ' HB2' HD13 ' A' ' 115' ' ' ILE . 58.9 ttt-85 -68.69 -28.57 66.97 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -170.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -160.1 -26.87 0.06 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -170.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -74.49 130.83 81.14 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-O 121.292 0.568 . . . . 0.0 111.314 -176.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.515 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 25.4 Cg_endo -68.75 -166.64 0.16 Allowed 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 123.337 2.692 . . . . 0.0 114.831 -176.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -58.98 -55.27 37.25 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 114.315 -1.312 . . . . 0.0 112.248 -169.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.515 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -64.16 -36.29 83.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.542 -173.813 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.481 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 33.9 mmtp -59.79 -54.26 48.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.156 0.503 . . . . 0.0 110.885 177.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.0 t -61.92 -41.87 92.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.294 -177.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.1 mp -62.91 -44.27 96.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.648 0.261 . . . . 0.0 111.254 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.531 ' HA ' ' HE3' ' A' ' 88' ' ' LYS . . . -68.42 -27.62 66.36 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.317 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.437 ' HE2' ' SD ' ' A' ' 52' ' ' MET . 93.3 t80 -80.43 -53.26 6.76 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.911 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.69 -44.35 77.28 Favored 'General case' 0 C--O 1.226 -0.163 0 O-C-N 123.39 0.431 . . . . 0.0 111.787 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.531 ' HE3' ' HA ' ' A' ' 85' ' ' ALA . 18.4 pttp -62.92 -26.46 68.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.026 0.441 . . . . 0.0 111.352 -177.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.9 m -88.73 -22.56 23.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.885 -175.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.0 p -97.08 -13.88 21.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.13 0.491 . . . . 0.0 110.631 177.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 106.54 -74.99 0.22 Allowed Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -177.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.0 t 28.66 85.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.056 1.343 . . . . 0.0 114.07 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.1 p -83.53 -0.95 52.54 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.697 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.586 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 50.6 p90 -96.59 139.48 21.67 Favored Pre-proline 0 C--N 1.332 -0.194 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.755 176.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.427 ' HB2' HD22 ' A' ' 20' ' ' LEU . 19.6 Cg_endo -60.47 133.82 51.21 Favored 'Trans proline' 0 C--O 1.238 0.508 0 C-N-CA 122.935 2.423 . . . . 0.0 113.333 -175.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.459 ' O ' HG23 ' A' ' 21' ' ' THR . 91.3 mt -109.31 139.19 44.58 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.435 176.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -105.55 148.55 16.53 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.75 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.493 ' H ' HD22 ' A' ' 98' ' ' LEU . 0.4 OUTLIER -92.1 127.09 37.44 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.282 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.438 ' HB3' ' O ' ' A' ' 75' ' ' ASP . 21.6 t0 -120.18 74.35 21.37 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 121.135 0.493 . . . . 0.0 109.881 173.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.98 98.4 0.71 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.419 2.08 . . . . 0.0 112.534 -175.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 123.94 -5.18 9.05 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.045 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 62.66 45.17 6.17 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 122.645 0.378 . . . . 0.0 111.127 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -84.04 -50.18 8.22 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.048 0.451 . . . . 0.0 110.398 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 34.2 mm -66.0 -34.01 67.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -64.22 -41.05 97.19 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.276 173.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.616 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -69.94 -18.37 63.36 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.623 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -77.15 -7.82 56.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.486 178.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -125.34 -32.05 2.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.836 0.35 . . . . 0.0 111.365 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.616 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -149.6 169.3 21.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.736 0.303 . . . . 0.0 111.155 -177.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.473 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . 96.6 mt -72.61 133.94 44.92 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 177.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.71 -31.71 68.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.421 0.629 . . . . 0.0 110.48 -178.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -99.43 19.53 15.43 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.121 -176.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.473 ' CB ' ' HB2' ' A' ' 110' ' ' LEU . . . -119.57 56.9 0.92 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.426 -177.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 81.35 -157.68 38.87 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.409 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.612 HD13 ' HB2' ' A' ' 76' ' ' ARG . 2.5 tp -152.54 -60.48 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.685 HG22 ' SG ' ' A' ' 48' ' ' CYS . 16.5 p -56.65 111.86 1.12 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -172.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.496 ' HG2' ' HB2' ' A' ' 40' ' ' PHE . 13.5 ptp180 -169.72 154.2 5.31 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.665 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.555 ' HB2' HG22 ' A' ' 131' ' ' THR . 34.4 m-80 -124.8 131.08 53.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.457 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.7 t -108.83 109.63 29.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.981 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 30.6 tp -96.57 111.64 23.69 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.491 -0.483 . . . . 0.0 110.271 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.58 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 54.0 mt -93.21 137.49 22.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.996 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.02 179.27 5.99 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.008 0.433 . . . . 0.0 111.104 -177.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 32.5 ttm180 -62.95 -28.67 70.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.128 -175.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -76.61 -30.37 56.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.119 0.485 . . . . 0.0 110.515 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.16 17.38 7.27 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.584 -176.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 80.4 mttt -103.1 148.26 25.96 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.887 0.375 . . . . 0.0 110.484 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.616 HD12 HG11 ' A' ' 7' ' ' VAL . 60.8 mt -84.7 112.43 21.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.149 178.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 28.5 m -102.3 -29.2 3.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -175.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.4 ' CG ' HE22 ' A' ' 145' ' ' GLN . 4.0 tmtt? -124.95 112.94 17.18 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.156 -173.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.788 HD13 HG12 ' A' ' 9' ' ' ILE . 11.1 mp -100.93 121.79 42.36 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.434 -0.803 . . . . 0.0 108.868 169.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.555 HG22 ' HB2' ' A' ' 118' ' ' ASN . 0.4 OUTLIER -122.43 145.16 48.55 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 177.565 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.419 ' N ' ' HD2' ' A' ' 132' ' ' ARG . 3.6 mpt_? -105.23 124.15 49.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.313 -177.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.673 ' HA ' ' HB ' ' A' ' 116' ' ' THR . 1.7 pp 39.86 50.07 2.29 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 124.091 0.869 . . . . 0.0 112.983 175.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.535 ' HB2' ' HG3' ' A' ' 51' ' ' GLU . 9.1 t80 68.97 -74.17 0.08 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.151 -177.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 41.6 t30 59.39 120.15 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.421 0.688 . . . . 0.0 111.814 -177.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -47.56 -62.54 1.39 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.984 -173.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -61.81 -41.66 98.04 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.833 -175.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.535 ' HB3' ' OG1' ' A' ' 131' ' ' THR . 17.7 mt-10 -64.85 -36.26 83.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.108 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.47 ' O ' HG23 ' A' ' 143' ' ' VAL . 82.1 t80 -64.42 -44.99 89.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.365 176.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.66 -50.19 70.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.906 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.2 m -66.18 -37.23 85.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.835 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.484 ' O ' HG13 ' A' ' 146' ' ' ILE . 2.6 tt -60.73 -49.16 78.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.813 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 139' ' ' PHE . 90.8 t -59.7 -46.56 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.258 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -58.42 -45.73 87.85 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.176 0.512 . . . . 0.0 110.266 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.4 HE22 ' CG ' ' A' ' 129' ' ' LYS . 7.4 tt0 -61.4 -39.74 91.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.314 178.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.654 ' O ' HD23 ' A' ' 150' ' ' LEU . 66.6 mt -55.25 -47.95 77.08 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.196 0 CA-C-N 116.738 -0.21 . . . . 0.0 110.702 177.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -51.25 -43.64 61.56 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.72 -0.218 . . . . 0.0 110.543 176.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -67.61 -42.83 81.75 Favored 'General case' 0 C--O 1.217 -0.652 0 C-N-CA 120.646 -0.421 . . . . 0.0 111.12 175.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 38.6 mmm -57.31 -35.64 70.1 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 122.98 0.512 . . . . 0.0 111.136 -172.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.654 HD23 ' O ' ' A' ' 146' ' ' ILE . 4.4 mm? . . . . . 0 C--N 1.322 -0.592 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.796 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 . . . . . 0 CA--C 1.519 -0.215 0 CA-C-O 120.913 0.387 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.581 HG12 ' HA ' ' A' ' 109' ' ' ALA . 21.5 pt -109.58 -11.97 11.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.781 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.434 HG11 HD12 ' A' ' 127' ' ' ILE . 20.0 t -101.44 156.32 4.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.508 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 37.3 mtt85 -121.85 162.88 20.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.097 0.475 . . . . 0.0 111.342 -173.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.508 HG23 ' HA ' ' A' ' 128' ' ' VAL . 80.1 mt -75.93 126.36 36.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.153 177.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.59 -24.92 12.7 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.839 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -75.03 156.66 35.95 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.661 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 59.2 mtp -84.32 138.54 32.84 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.649 -178.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.569 ' HB2' HD12 ' A' ' 121' ' ' ILE . . . -62.65 123.01 77.62 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.432 -178.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 24.7 Cg_exo -62.44 114.62 2.44 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.615 2.21 . . . . 0.0 111.299 177.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.561 ' HA ' HD12 ' A' ' 28' ' ' LEU . 1.0 OUTLIER -63.4 151.9 39.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.418 -171.823 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.999 ' HB3' ' HE2' ' A' ' 107' ' ' LYS . 37.0 p90 -159.23 166.52 31.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.511 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 56.0 m -129.35 108.26 10.16 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.273 175.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.5 tt -106.7 145.02 14.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.991 0.424 . . . . 0.0 110.831 -174.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 24' ' ' LYS . 9.6 m -85.33 131.84 34.34 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.299 178.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.46 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 86.3 mt -87.15 172.52 9.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.311 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 96' ' ' LEU . 33.2 p -55.85 -34.01 65.05 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.889 -176.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -101.84 18.38 20.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.104 0.478 . . . . 0.0 110.772 -173.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.5 37.0 25.01 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.626 174.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 19' ' ' THR . 41.0 mmtm -108.16 167.04 10.29 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.1 -0.334 . . . . 0.0 110.1 176.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.434 HE21 ' HA ' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -130.33 120.37 24.23 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 -177.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 17' ' ' THR . 11.7 m -113.98 144.2 22.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.939 0.399 . . . . 0.0 110.017 175.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.416 HG22 ' H ' ' A' ' 29' ' ' SER . 18.0 m -122.61 143.42 49.77 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.645 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.561 HD12 ' HA ' ' A' ' 15' ' ' ASP . 17.5 mt -62.67 -35.98 81.41 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.715 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.514 ' HA ' ' HG2' ' A' ' 32' ' ' ARG . 59.2 m -55.83 -34.62 65.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.987 0.422 . . . . 0.0 110.937 175.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.0 t -75.25 -26.24 58.69 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.101 0.477 . . . . 0.0 110.227 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 85.8 mt -96.27 0.2 50.6 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.514 ' HG2' ' HA ' ' A' ' 29' ' ' SER . 37.8 mmt180 -60.3 138.24 57.99 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 102.99 -20.79 42.27 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -178.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.552 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 3.5 mppt? -109.72 157.79 18.76 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.203 -0.499 . . . . 0.0 110.432 178.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 p -82.2 116.52 26.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.355 0.598 . . . . 0.0 109.839 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 25.8 t -106.26 131.2 56.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.213 -173.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.539 ' SD ' HG21 ' A' ' 59' ' ' ILE . 27.7 ttt -111.64 123.6 50.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.392 175.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.455 ' HB2' ' HB ' ' A' ' 119' ' ' VAL . 3.3 mm? -103.78 116.87 33.1 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.642 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.444 HE21 ' HA ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -108.06 114.94 29.21 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.67 176.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.499 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 92.3 m-85 -99.7 111.85 24.15 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.1 t -127.52 -174.62 3.23 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.193 -174.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -168.03 160.55 12.1 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.327 0.651 . . . . 0.0 109.736 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.463 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 78.3 p -75.91 -18.56 59.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.051 0.453 . . . . 0.0 111.353 -176.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 21.1 p-90 -103.35 12.08 35.84 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -175.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.461 ' HB3' HG21 ' A' ' 115' ' ' ILE . 23.0 p -110.12 114.58 28.2 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.074 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.93 -26.56 68.71 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.916 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.439 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 28.3 t -63.21 -36.82 77.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.959 0.409 . . . . 0.0 110.638 -178.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.419 ' HA ' ' HB3' ' A' ' 51' ' ' GLU . 52.1 m -68.32 -16.15 63.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.724 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -75.56 -7.96 55.53 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.154 0.502 . . . . 0.0 110.287 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.519 ' HD3' ' CD2' ' A' ' 134' ' ' TYR . 57.6 mttt -88.54 -54.26 4.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 122.488 1.137 . . . . 0.0 108.494 162.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.466 ' O ' HG13 ' A' ' 55' ' ' ILE . 24.3 tt0 -57.03 -62.75 1.53 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 113.001 -1.909 . . . . 0.0 112.55 -171.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.587 ' SD ' ' HE2' ' A' ' 86' ' ' PHE . 83.1 mtp -53.93 -54.77 43.14 Favored Pre-proline 0 CA--C 1.538 0.481 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -172.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.485 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 25.5 Cg_endo -62.61 -35.61 69.12 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 121.961 1.774 . . . . 0.0 112.591 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -67.04 -42.58 84.61 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.389 175.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 51' ' ' GLU . 70.4 mt -60.06 -52.93 55.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.985 178.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.606 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 16.4 pt-20 -64.75 -31.11 72.19 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.312 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -71.85 -56.03 6.47 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -176.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.414 ' HA ' ' HG2' ' A' ' 62' ' ' LYS . 62.8 m-20 -108.15 -18.35 13.8 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -171.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.539 HG21 ' SD ' ' A' ' 37' ' ' MET . 48.4 mm -93.57 -53.95 7.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.721 176.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.606 ' HB3' ' HA ' ' A' ' 56' ' ' GLU . 74.9 t-105 -69.86 -73.06 0.17 Allowed 'General case' 0 C--O 1.215 -0.744 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.894 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -48.13 -29.17 3.4 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -174.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.414 ' HG2' ' HA ' ' A' ' 58' ' ' ASP . 39.6 mmtm -91.38 -33.2 15.37 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.305 0.484 . . . . 0.0 112.305 -175.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -124.84 -4.55 7.57 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -171.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.439 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 17.4 pttp -43.71 -51.79 6.93 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -170.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.18 -81.18 0.18 Allowed 'General case' 0 C--O 1.247 0.959 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.524 ' CG ' HD12 ' A' ' 150' ' ' LEU . 12.1 t30 61.41 -71.7 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.347 -177.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 173.06 -26.88 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 123.573 0.749 . . . . 0.0 109.423 -177.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.515 ' HB2' ' HG3' ' A' ' 34' ' ' LYS . 6.3 p-10 -154.62 28.29 0.44 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.416 -172.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.604 ' HB2' HD11 ' A' ' 150' ' ' LEU . 79.4 t80 -100.5 125.55 46.84 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 118.548 -1.261 . . . . 0.0 110.422 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 36' ' ' VAL . . . -124.97 105.62 9.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.811 -176.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.499 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 3.9 tt -110.77 119.36 38.84 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.8 mm -124.34 126.11 71.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.444 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.472 ' HA3' HD23 ' A' ' 96' ' ' LEU . . . -89.17 133.83 12.04 Favored Glycine 0 C--O 1.221 -0.696 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.204 175.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.499 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 68.0 mt -120.8 114.74 44.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.867 0.334 . . . . 0.0 110.733 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -78.32 129.53 35.12 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 172.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.434 HH21 ' HA ' ' A' ' 112' ' ' ASP . 49.5 ttt-85 -45.67 -67.05 0.32 Allowed 'General case' 0 N--CA 1.469 0.478 0 O-C-N 123.97 0.794 . . . . 0.0 112.828 -170.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.647 ' HA ' ' O ' ' A' ' 99' ' ' ASP . 12.0 p-10 -145.61 21.05 1.5 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.58 0.705 . . . . 0.0 109.7 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -69.9 129.74 90.7 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.848 -177.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.588 ' HG2' ' HG2' ' A' ' 82' ' ' LYS . 16.5 Cg_endo -63.58 168.19 11.99 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 122.404 2.07 . . . . 0.0 112.204 173.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -52.55 -52.77 53.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.071 -172.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.546 ' OE2' ' HG2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -67.61 -28.08 67.44 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -173.602 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.588 ' HG2' ' HG2' ' A' ' 79' ' ' PRO . 44.0 mmtm -64.45 -51.07 64.97 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.831 0.348 . . . . 0.0 110.468 175.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.448 HG21 ' HB3' ' A' ' 98' ' ' LEU . 61.1 t -53.81 -52.2 37.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.106 -178.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.23 -39.22 92.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.577 -177.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.448 ' HA ' ' HE3' ' A' ' 88' ' ' LYS . . . -73.05 -26.59 61.35 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.787 -177.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.587 ' HE2' ' SD ' ' A' ' 52' ' ' MET . 71.8 t80 -84.85 -47.42 10.37 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.886 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.485 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -53.08 -47.48 68.49 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.289 0.368 . . . . 0.0 111.455 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.448 ' HE3' ' HA ' ' A' ' 85' ' ' ALA . 18.4 pttp -62.31 -23.98 67.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.033 0.444 . . . . 0.0 111.241 -178.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.9 m -92.62 -0.62 57.28 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.048 -175.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.1 p -122.97 -20.97 5.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.602 175.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 114.64 -76.29 0.25 Allowed Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -177.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.421 HG21 ' HE1' ' A' ' 52' ' ' MET . 86.7 t 43.93 87.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 124.494 1.118 . . . . 0.0 113.344 178.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.4 m -78.67 -5.4 52.94 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.493 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.46 ' CE1' ' HB3' ' A' ' 56' ' ' GLU . 49.0 p90 -107.29 145.58 31.49 Favored Pre-proline 0 C--N 1.33 -0.254 0 O-C-N 122.127 -0.358 . . . . 0.0 110.451 179.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -63.05 136.45 56.57 Favored 'Trans proline' 0 C--O 1.238 0.485 0 C-N-CA 122.371 2.047 . . . . 0.0 113.222 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.485 HD12 ' HB2' ' A' ' 87' ' ' ALA . 92.8 mt -105.14 151.51 23.94 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.871 175.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -125.13 145.51 15.73 Favored Glycine 0 N--CA 1.437 -1.297 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 175.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.789 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.2 pt? -100.09 132.71 45.3 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 120.744 0.306 . . . . 0.0 110.68 -176.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.647 ' O ' ' HA ' ' A' ' 77' ' ' ASP . 22.2 t0 -109.84 82.54 2.42 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.71 176.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.24 87.07 0.49 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.138 1.892 . . . . 0.0 112.264 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.04 -21.65 1.59 Allowed Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.131 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . . . 70.15 24.25 5.0 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 122.866 0.466 . . . . 0.0 110.714 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -91.08 -29.08 17.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.583 -176.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.605 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 32.4 mm -70.04 -35.85 65.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 171.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -60.8 -40.14 91.54 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.741 172.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.682 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -68.28 -25.53 65.2 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.951 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.999 ' HE2' ' HB3' ' A' ' 16' ' ' PHE . 26.8 mtpp -70.72 -3.99 21.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.393 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.732 ' HB3' HH22 ' A' ' 117' ' ' ARG . 65.1 m-85 -129.37 -11.82 4.53 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.91 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.682 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -176.36 176.4 1.65 Allowed 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.847 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 95.4 mt -60.34 136.05 57.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.634 0.254 . . . . 0.0 110.505 177.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.599 ' HG2' ' HB2' ' A' ' 106' ' ' ALA . 53.8 mtp85 -49.57 -51.85 34.11 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.988 -177.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.434 ' HA ' HH21 ' A' ' 76' ' ' ARG . 6.8 m-20 -105.08 34.38 3.24 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.654 -173.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.847 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . . . -85.02 9.88 13.44 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.1 178.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 118.1 -151.94 17.73 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.348 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.461 HG21 ' HB3' ' A' ' 45' ' ' CYS . 8.6 tp -151.1 170.74 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -177.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.603 HG22 ' HA ' ' A' ' 133' ' ' LEU . 30.7 m 71.77 93.97 0.08 Allowed 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.532 0.52 . . . . 0.0 110.314 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.732 HH22 ' HB3' ' A' ' 108' ' ' TYR . 54.8 mtp180 -146.58 149.13 32.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.66 -174.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.573 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 33.0 m-80 -127.6 119.83 26.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.75 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 38' ' ' LEU . 73.1 t -124.58 122.91 64.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.655 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 34.5 tp -108.88 130.72 55.43 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.898 0.38 . . . . 0.0 110.917 -178.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.569 HD12 ' HB2' ' A' ' 13' ' ' ALA . 27.8 mm -111.07 139.11 36.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.695 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.525 ' OD2' ' HB2' ' A' ' 126' ' ' LYS . 3.4 p30 -84.47 171.82 12.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.808 0.337 . . . . 0.0 110.844 177.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -60.7 -25.52 66.46 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.427 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -82.13 -12.57 58.12 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.777 -174.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 103.86 3.92 45.61 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.607 176.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.661 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 9.0 mtmp? -96.72 160.26 14.47 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.142 0.496 . . . . 0.0 111.64 -177.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.52 HG12 ' CD1' ' A' ' 121' ' ' ILE . 43.5 mt -95.37 127.79 47.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.399 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.508 ' HA ' HG23 ' A' ' 9' ' ' ILE . 29.4 m -117.74 -23.19 3.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -176.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.655 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 50.1 tptt -128.66 115.98 18.88 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.558 -174.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.458 HD13 HG12 ' A' ' 9' ' ' ILE . 11.0 mp -110.74 109.77 20.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.975 175.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.573 ' HB ' ' HB2' ' A' ' 118' ' ' ASN . 89.3 m -135.71 141.8 44.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.878 0.371 . . . . 0.0 111.278 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 132' ' ' ARG . 1.3 ptp180 -124.42 150.61 45.43 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 171.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.603 ' HA ' HG22 ' A' ' 116' ' ' THR . 0.8 OUTLIER 46.32 104.95 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 O-C-N 124.703 1.252 . . . . 0.0 113.992 179.503 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.519 ' CD2' ' HD3' ' A' ' 50' ' ' LYS . 39.9 t80 -39.26 112.61 0.26 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.944 -1.026 . . . . 0.0 112.205 176.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -110.84 141.03 44.76 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 173.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.62 -58.45 6.75 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -173.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.464 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.7 mp0 -60.33 -32.19 71.02 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.893 0.378 . . . . 0.0 111.238 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -65.42 -47.5 76.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.571 -177.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.543 ' O ' HG23 ' A' ' 143' ' ' VAL . 88.8 t80 -61.77 -39.46 91.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.736 -178.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -59.96 -46.39 89.56 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.109 0.48 . . . . 0.0 110.375 176.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.3 m -62.69 -38.97 92.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.227 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.615 ' O ' HG12 ' A' ' 146' ' ' ILE . 1.1 mt -61.57 -46.62 89.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.953 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 139' ' ' PHE . 97.6 t -55.96 -49.19 76.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-O 120.688 0.28 . . . . 0.0 111.16 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.445 ' HA ' ' OE1' ' A' ' 144' ' ' GLN . 6.7 tp60 -66.46 -40.96 89.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.955 0.407 . . . . 0.0 110.48 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -57.96 -46.12 85.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.065 176.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.656 ' O ' HD23 ' A' ' 150' ' ' LEU . 38.4 mm -56.48 -44.69 81.08 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.279 177.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -53.68 -52.0 61.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.848 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -76.29 -20.82 56.97 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.932 -177.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.439 ' HG3' HD21 ' A' ' 120' ' ' LEU . 56.1 mmm -73.0 -28.52 62.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.131 0.491 . . . . 0.0 110.608 175.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.656 HD23 ' O ' ' A' ' 146' ' ' ILE . 4.3 mm? . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.234 175.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.573 ' CE1' HD22 ' A' ' 130' ' ' LEU . 61.2 m-85 . . . . . 0 CA--C 1.519 -0.229 0 CA-C-O 120.994 0.426 . . . . 0.0 112.101 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.9 pt -101.46 -11.64 8.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.317 169.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.8 m -110.95 150.33 13.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.005 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.465 ' HE ' ' CD ' ' A' ' 11' ' ' GLU . 77.6 mtm180 -118.82 163.78 16.37 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.339 0.59 . . . . 0.0 111.638 -175.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 77.3 mt -70.42 131.37 34.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.443 -0.798 . . . . 0.0 109.531 174.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.63 -27.27 15.5 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -176.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.465 ' CD ' ' HE ' ' A' ' 8' ' ' ARG . 14.3 mt-10 -80.19 174.94 11.1 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.671 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 55.6 mtp -98.8 146.43 25.94 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.875 0.369 . . . . 0.0 110.417 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.451 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -79.92 135.91 54.94 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.842 -177.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 21.2 Cg_exo -64.89 117.28 4.39 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.759 2.306 . . . . 0.0 111.915 177.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.21 141.85 55.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.949 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.508 ' HB2' HD12 ' A' ' 104' ' ' ILE . 52.4 p90 -154.28 161.18 41.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.847 0.356 . . . . 0.0 111.224 -174.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.2 m -110.35 116.28 31.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.448 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.5 tt -114.64 142.14 28.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.936 0.398 . . . . 0.0 110.829 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.47 ' O ' HD23 ' A' ' 98' ' ' LEU . 14.8 m -93.41 123.03 36.42 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.126 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.455 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 92.7 mt -79.52 173.96 12.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.919 0.39 . . . . 0.0 111.393 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 96' ' ' LEU . 19.5 p -57.15 -34.63 68.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.283 -0.871 . . . . 0.0 113.159 -175.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -100.56 19.35 17.06 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.177 0.513 . . . . 0.0 110.535 -174.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.09 36.1 25.53 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.601 174.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -108.4 109.42 20.71 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.09 0.472 . . . . 0.0 110.337 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -89.7 113.94 25.52 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.275 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.7 m -119.12 153.94 21.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.049 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.2 m -112.88 150.96 31.02 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.54 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 0.5 OUTLIER -59.96 -38.46 82.55 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.166 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.523 ' HA ' ' CG ' ' A' ' 32' ' ' ARG . 64.9 m -54.59 -26.88 35.24 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.106 176.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.6 m -72.75 -20.2 61.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.045 0.45 . . . . 0.0 110.97 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.509 HD13 ' HB1' ' A' ' 70' ' ' ALA . 96.3 mt -114.87 3.04 14.49 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.305 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.54 ' HG2' ' O ' ' A' ' 28' ' ' LEU . 47.9 mmm-85 -66.25 139.13 58.06 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.09 -20.48 28.54 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -172.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.499 ' HB3' ' O ' ' A' ' 68' ' ' ASP . 42.5 mtmt -116.14 165.13 13.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.263 -0.468 . . . . 0.0 110.15 177.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 p -79.59 120.03 30.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.178 0.513 . . . . 0.0 110.031 174.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.513 HG22 ' HB3' ' A' ' 70' ' ' ALA . 43.5 t -115.37 125.18 72.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.863 -175.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.473 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 25.6 ttt -103.13 124.76 49.17 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.854 177.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.3 mt -117.57 141.19 48.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.183 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.472 ' N ' HE21 ' A' ' 39' ' ' GLN . 0.0 OUTLIER -139.05 136.67 35.51 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 174.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.437 ' HD2' ' HG3' ' A' ' 117' ' ' ARG . 98.0 m-85 -97.56 119.53 36.3 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.063 0.458 . . . . 0.0 110.675 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.4 t -127.82 -177.08 3.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.342 -175.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.647 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . . . -165.77 155.52 12.45 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 176.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.512 ' H ' ' HG3' ' A' ' 78' ' ' GLU . 99.5 p -63.26 -24.28 67.8 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.93 0.395 . . . . 0.0 112.025 -175.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.5 p-90 -100.92 7.59 43.53 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.751 0.31 . . . . 0.0 111.786 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.647 ' SG ' ' HB3' ' A' ' 42' ' ' ALA . 88.8 m -88.41 99.79 12.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.037 0.446 . . . . 0.0 111.078 178.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.84 -20.44 77.59 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.203 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 34.6 t -76.29 -41.31 36.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.836 0.351 . . . . 0.0 110.197 177.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.777 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 72.2 m -68.72 -16.61 63.87 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.475 0.655 . . . . 0.0 110.376 177.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.503 HH21 ' HE1' ' A' ' 86' ' ' PHE . 25.3 ttm180 -71.19 -11.13 60.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.7 176.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.573 ' HD3' ' CD2' ' A' ' 134' ' ' TYR . 80.1 mttt -87.15 -57.66 2.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.609 0.719 . . . . 0.0 110.046 169.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.947 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 12.4 pt-20 -63.76 -44.84 92.26 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-N 115.065 -0.971 . . . . 0.0 112.495 -168.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.498 ' HE3' HG21 ' A' ' 92' ' ' VAL . 15.3 mtm -57.41 -55.51 43.67 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.045 -174.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.577 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 19.7 Cg_endo -60.73 -33.22 93.38 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 121.771 1.647 . . . . 0.0 112.481 177.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.416 ' HD1' ' O ' ' A' ' 50' ' ' LYS . 12.3 m-85 -70.35 -46.24 64.52 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.499 176.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 51' ' ' GLU . 96.9 mt -58.03 -51.43 70.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.612 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.626 ' HB3' ' CD1' ' A' ' 94' ' ' TYR . 0.4 OUTLIER -65.47 -34.93 79.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.403 -177.289 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.577 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 10.4 ttmm -68.5 -43.35 77.04 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.564 -174.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -106.12 -65.18 1.09 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.473 178.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 65.7 mt -55.7 -39.9 57.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.843 0.354 . . . . 0.0 110.966 -170.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.566 ' HB3' ' O ' ' A' ' 56' ' ' GLU . 75.5 t-105 -75.33 -71.32 0.37 Allowed 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.552 177.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.503 HD22 ' HD1' ' A' ' 60' ' ' TRP . 1.8 mm? -50.45 -34.91 26.43 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -173.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -84.01 -30.46 26.14 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -175.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.478 ' HB3' ' HG ' ' A' ' 150' ' ' LEU . 72.9 m-70 -129.56 -8.51 4.6 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -168.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.419 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 16.0 pttp -38.79 -48.73 1.55 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -171.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.47 -84.19 0.28 Allowed 'General case' 0 C--O 1.253 1.258 0 CA-C-O 121.246 0.546 . . . . 0.0 110.492 -175.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 44.5 t-20 59.24 -77.6 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.939 -169.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 66' ' ' ASN . . . 156.31 -23.01 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 125.327 1.451 . . . . 0.0 107.154 -173.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.499 ' O ' ' HB3' ' A' ' 34' ' ' LYS . 9.7 t70 -119.93 1.25 10.94 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.197 -173.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.516 ' HB2' HD11 ' A' ' 150' ' ' LEU . 84.9 t80 -110.67 151.04 28.17 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 119.09 -1.044 . . . . 0.0 112.297 -176.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.513 ' HB3' HG22 ' A' ' 36' ' ' VAL . . . -148.5 141.51 24.85 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.221 173.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.481 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 3.6 tt -139.02 127.25 22.66 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -177.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.414 ' N ' HD23 ' A' ' 71' ' ' LEU . 63.4 mt -135.79 130.91 49.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 120.73 0.3 . . . . 0.0 110.562 178.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.442 ' HA3' HD23 ' A' ' 96' ' ' LEU . . . -95.12 138.88 14.21 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.291 -0.956 . . . . 0.0 111.01 173.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 55.3 mt -119.66 118.21 56.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 117.395 0.598 . . . . 0.0 110.686 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.536 ' OD1' ' HA ' ' A' ' 42' ' ' ALA . 6.7 t0 -95.41 132.32 40.59 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.488 ' HD2' HD13 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -97.22 121.02 38.65 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.968 0.413 . . . . 0.0 111.942 -170.577 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 73.08 -35.81 0.34 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.347 1.059 . . . . 0.0 113.044 175.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.512 ' HG3' ' H ' ' A' ' 43' ' ' SER . 60.0 mm-40 -62.54 140.31 96.79 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-O 121.147 0.499 . . . . 0.0 111.241 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.539 ' O ' HG23 ' A' ' 83' ' ' VAL . 18.3 Cg_endo -84.25 -168.42 0.54 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.043 2.495 . . . . 0.0 113.64 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.542 HD23 HD13 ' A' ' 84' ' ' LEU . 1.7 tt -56.25 -57.49 12.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.801 -1.091 . . . . 0.0 112.138 -170.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -37.53 87.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.864 -173.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.504 ' CG ' ' HD2' ' A' ' 79' ' ' PRO . 27.1 mmtp -58.86 -50.43 74.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.585 0.231 . . . . 0.0 111.336 178.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 79' ' ' PRO . 46.9 t -58.4 -46.04 89.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.754 -178.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.542 HD13 HD23 ' A' ' 80' ' ' LEU . 10.9 mp -64.2 -47.63 79.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.335 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.02 -32.95 74.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.687 -176.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.503 ' HE1' HH21 ' A' ' 49' ' ' ARG . 72.0 t80 -77.8 -43.72 29.71 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.502 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.531 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -59.22 -54.38 47.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.447 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.9 ptmm? -57.12 -26.59 60.74 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.971 -175.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 27.3 m -85.74 -4.06 59.06 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.382 -174.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 19.1 p -128.14 6.12 5.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.313 0.578 . . . . 0.0 110.321 175.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.55 -73.27 1.23 Allowed Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.294 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.498 HG21 ' HE3' ' A' ' 52' ' ' MET . 42.9 t 40.95 83.91 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.963 0.905 . . . . 0.0 112.695 -177.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.8 m -75.76 -3.8 36.91 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.541 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.626 ' CD1' ' HB3' ' A' ' 56' ' ' GLU . 50.0 p90 -107.72 153.07 41.71 Favored Pre-proline 0 C--N 1.33 -0.273 0 O-C-N 121.813 -0.554 . . . . 0.0 110.621 178.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.5 137.0 32.38 Favored 'Trans proline' 0 C--O 1.239 0.561 0 C-N-CA 122.253 1.969 . . . . 0.0 113.38 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.531 HD12 ' HB2' ' A' ' 87' ' ' ALA . 97.6 mt -104.84 153.67 21.04 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.342 173.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -121.6 147.37 17.29 Favored Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 174.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.781 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.7 pt? -100.27 131.8 46.01 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.88 0.371 . . . . 0.0 110.617 -177.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.439 ' OD2' ' HA ' ' A' ' 102' ' ' ALA . 14.8 t0 -119.35 75.46 16.6 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.491 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.454 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 15.7 Cg_exo -68.01 120.57 7.56 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.895 2.396 . . . . 0.0 111.766 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 102.42 -8.75 55.38 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -175.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.793 ' HB3' ' HE ' ' A' ' 111' ' ' ARG . . . 54.6 45.88 25.95 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 123.09 0.556 . . . . 0.0 111.547 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -76.09 -49.71 16.69 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.253 0.549 . . . . 0.0 110.062 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.508 HD12 ' HB2' ' A' ' 16' ' ' PHE . 27.9 mm -65.83 -36.28 77.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.276 178.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.44 ' HB3' ' HB1' ' A' ' 102' ' ' ALA . 71.5 t80 -62.56 -45.28 93.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.289 174.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.611 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -65.74 -21.01 66.48 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.769 -178.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -73.48 -12.06 60.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.824 0.345 . . . . 0.0 111.245 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.431 ' CZ ' ' HD2' ' A' ' 14' ' ' PRO . 65.8 m-85 -119.93 -34.57 3.69 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.351 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.611 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -154.72 160.37 41.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.783 0.325 . . . . 0.0 111.004 -177.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.464 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . 90.3 mt -67.09 136.29 54.94 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.793 ' HE ' ' HB3' ' A' ' 102' ' ' ALA . 67.5 mtp180 -49.46 -40.05 35.65 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -171.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -98.76 -8.98 25.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.12 0.486 . . . . 0.0 111.475 -175.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.464 ' CB ' ' HB2' ' A' ' 110' ' ' LEU . . . -81.45 40.88 0.59 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -171.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 97.79 114.62 3.31 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.262 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.488 HD13 ' HD2' ' A' ' 76' ' ' ARG . 2.6 tp -76.19 -49.77 24.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.642 0.258 . . . . 0.0 111.531 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.95 ' HB ' ' HB3' ' A' ' 133' ' ' LEU . 22.2 p -66.3 114.2 5.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.17 -173.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.437 ' HG3' ' HD2' ' A' ' 40' ' ' PHE . 10.8 ptp180 -169.33 145.52 3.31 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.952 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.62 ' HB2' ' OG1' ' A' ' 131' ' ' THR . 6.6 m120 -122.98 142.69 50.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.526 -177.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 29.1 t -128.51 120.7 53.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.301 -177.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.682 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 41.9 tp -105.17 116.83 32.62 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.964 174.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 57.0 mt -98.6 134.33 37.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.132 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.38 177.58 8.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.047 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.434 ' HD3' ' OD1' ' A' ' 68' ' ' ASP . 70.9 mtm180 -66.64 -27.26 67.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.967 -174.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -75.17 -29.67 60.48 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.082 0.468 . . . . 0.0 110.419 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.45 15.73 8.06 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.777 -176.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.671 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 82.4 mttt -97.62 157.62 15.94 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.827 0.346 . . . . 0.0 110.583 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.472 HG21 HD21 ' A' ' 130' ' ' LEU . 53.9 mt -91.04 120.67 40.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.576 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.6 m -114.97 1.77 8.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.851 ' HD2' HG23 ' A' ' 131' ' ' THR . 0.3 OUTLIER -163.71 124.61 2.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.779 0.323 . . . . 0.0 111.582 -178.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.573 HD22 ' CE1' ' A' ' 5' ' ' TYR . 96.5 mt -127.58 106.73 9.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.615 174.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.851 HG23 ' HD2' ' A' ' 129' ' ' LYS . 16.6 p -107.39 148.89 28.51 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.925 0.393 . . . . 0.0 111.062 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.527 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 23.5 mtm180 -92.84 107.8 19.5 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 174.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.95 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 4.0 pp 49.28 -172.18 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 O-C-N 124.239 0.962 . . . . 0.0 112.979 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.947 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 87.6 t80 -73.65 85.64 1.61 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.321 175.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.55 ' HB3' ' HB2' ' A' ' 138' ' ' GLU . 47.2 t-20 -85.54 117.69 24.6 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 170.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 30.0 mp0 -46.93 -39.72 12.82 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 123.403 0.44 . . . . 0.0 111.973 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -79.76 -51.54 9.06 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.56 0.219 . . . . 0.0 111.56 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.55 ' HB2' ' HB3' ' A' ' 135' ' ' ASN . 44.9 mt-10 -66.01 -34.43 78.07 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 121.243 -0.183 . . . . 0.0 111.24 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.441 ' O ' HG23 ' A' ' 143' ' ' VAL . 81.5 t80 -67.16 -42.97 83.43 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 177.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.24 -48.54 80.08 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.187 0.518 . . . . 0.0 110.316 176.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.3 m -62.88 -35.3 79.56 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.679 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.564 ' HG ' ' HG2' ' A' ' 129' ' ' LYS . 1.4 tt -67.29 -42.54 83.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.236 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 139' ' ' PHE . 70.6 t -58.45 -51.73 67.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.903 178.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.467 ' HA ' ' ND2' ' A' ' 147' ' ' ASN . 47.5 tp60 -60.86 -40.61 93.55 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.122 0.487 . . . . 0.0 110.498 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -56.55 -46.69 80.57 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.618 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.566 ' O ' HD23 ' A' ' 150' ' ' LEU . 42.6 mt -64.76 -38.35 82.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.914 178.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.467 ' ND2' ' HA ' ' A' ' 144' ' ' GLN . 93.0 m-20 -53.21 -45.45 68.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.555 178.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -69.85 -36.73 75.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.079 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 84.3 mmm -63.16 -24.51 67.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.309 0.576 . . . . 0.0 110.233 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.566 HD23 ' O ' ' A' ' 146' ' ' ILE . 3.8 mm? . . . . . 0 C--N 1.324 -0.534 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.189 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 . . . . . 0 N--CA 1.453 -0.314 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 29.0 pt -115.06 1.34 8.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.187 0.518 . . . . 0.0 110.429 175.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.9 m -117.34 161.39 16.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.673 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.554 ' HB2' ' HB2' ' A' ' 11' ' ' GLU . 42.1 mtt180 -112.5 165.64 12.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.18 -176.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.47 HG12 HD23 ' A' ' 130' ' ' LEU . 67.0 mt -81.33 118.32 28.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 172.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.12 -3.96 55.4 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -172.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.554 ' HB2' ' HB2' ' A' ' 8' ' ' ARG . 10.1 tp10 -90.93 153.37 20.23 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.534 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 58.2 mtp -76.37 139.41 40.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.123 0.487 . . . . 0.0 111.034 -177.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.452 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -76.64 134.38 69.38 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.918 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.594 ' HD2' ' CE1' ' A' ' 108' ' ' TYR . 24.3 Cg_exo -61.69 149.92 87.87 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.778 2.319 . . . . 0.0 111.427 177.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.0 169.41 9.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.413 -177.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' A' ' 27' ' ' THR . 44.1 p90 -172.39 172.45 4.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.507 -174.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 18.1 m -125.9 100.93 6.6 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 173.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 25' ' ' GLN . 18.3 tt -99.36 143.21 13.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.954 -172.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.6 m -92.14 121.39 33.63 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.917 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.7 mt -78.9 176.6 9.45 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.756 -178.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.3 p -59.25 -28.47 66.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.889 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.72 ' OD1' ' HG2' ' A' ' 24' ' ' LYS . 0.3 OUTLIER -77.79 -28.05 50.36 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.232 178.836 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.16 -1.58 28.31 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.107 -170.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.72 ' HG2' ' OD1' ' A' ' 22' ' ' ASP . 47.4 mmtm -70.18 117.26 11.52 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.642 -0.279 . . . . 0.0 110.777 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.458 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 90.8 mt-30 -91.12 114.63 27.21 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 174.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 17' ' ' THR . 17.0 m -116.91 151.12 18.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.651 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 29' ' ' SER . 4.2 m -98.84 147.32 25.05 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.707 178.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.475 ' O ' HD13 ' A' ' 28' ' ' LEU . 1.1 tm? -69.96 -25.54 63.68 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.548 ' HA ' ' HG2' ' A' ' 32' ' ' ARG . 48.8 m -58.45 -24.86 61.36 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.447 175.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.9 m -75.1 -18.39 60.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.836 0.351 . . . . 0.0 111.435 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.2 mt -105.28 3.55 30.09 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.161 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.548 ' HG2' ' HA ' ' A' ' 29' ' ' SER . 29.0 mmt180 -66.7 116.18 7.34 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 127.81 -21.02 5.66 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -175.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 123' ' ' ARG . 42.9 mtmt -116.55 164.75 14.13 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 176.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 68' ' ' ASP . 17.4 m -76.69 124.07 34.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 174.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.585 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 6.6 t -115.06 108.71 26.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.084 0.469 . . . . 0.0 110.935 -172.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.439 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 27.4 ttt -93.29 115.32 27.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.618 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.473 ' CD1' HG12 ' A' ' 36' ' ' VAL . 6.2 mp -115.26 115.39 26.6 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.356 178.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.427 ' O ' ' HG3' ' A' ' 39' ' ' GLN . 1.4 pt20 -105.82 117.62 34.49 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.047 0.451 . . . . 0.0 110.432 176.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.664 ' O ' ' HA ' ' A' ' 116' ' ' THR . 97.9 m-85 -85.09 109.64 18.39 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 172.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.0 t -127.77 -175.39 3.46 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.247 -170.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.558 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . . . -149.15 136.57 20.17 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.191 0.52 . . . . 0.0 111.686 -178.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.48 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 3.5 p -70.57 -6.26 35.16 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.445 175.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.462 ' HD1' ' HG3' ' A' ' 78' ' ' GLU . 43.5 p-90 -113.83 14.21 18.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.449 -177.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.558 ' SG ' ' HB3' ' A' ' 42' ' ' ALA . 94.8 m -112.81 138.13 50.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.901 0.382 . . . . 0.0 110.922 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -86.23 -33.33 14.67 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.218 -178.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.0 t -58.51 -36.11 57.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 121.362 0.601 . . . . 0.0 110.103 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.606 ' O ' ' HG2' ' A' ' 52' ' ' MET . 71.6 m -65.92 -16.55 63.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.714 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -77.6 -3.28 40.0 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 122.045 -0.409 . . . . 0.0 110.756 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -87.96 -53.77 4.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.103 0.478 . . . . 0.0 110.05 166.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.656 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 8.9 pt-20 -60.58 -46.28 90.83 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.912 -172.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.834 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 88.8 mmm -54.82 -59.57 10.27 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -174.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.834 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 31.8 Cg_exo -61.1 -39.76 56.85 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 122.025 1.817 . . . . 0.0 112.735 177.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.542 ' HB3' ' CZ ' ' A' ' 139' ' ' PHE . 11.6 m-85 -65.39 -46.71 79.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.58 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.534 HG12 ' HE1' ' A' ' 139' ' ' PHE . 77.3 mt -60.83 -46.15 96.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.439 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.46 ' OE2' HD13 ' A' ' 61' ' ' LEU . 33.5 tp10 -57.74 -49.12 77.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.886 0.374 . . . . 0.0 110.652 176.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.428 ' O ' ' HE3' ' A' ' 62' ' ' LYS . 28.6 ttpp -66.27 -52.38 48.06 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -174.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.438 ' HA ' ' NZ ' ' A' ' 62' ' ' LYS . 73.6 m-20 -105.28 -15.55 15.02 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -169.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 58.1 mt -105.43 -60.54 2.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.997 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.55 ' CD2' ' HB3' ' A' ' 94' ' ' TYR . 76.7 t-105 -63.42 -65.44 0.68 Allowed 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.158 -177.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.553 HD12 ' HE3' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -46.36 -32.63 3.3 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -174.909 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.438 ' NZ ' ' HA ' ' A' ' 58' ' ' ASP . 31.6 mmtp -81.54 -28.42 33.93 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -174.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -128.81 -43.42 1.37 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.807 -174.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.553 ' HE3' HD12 ' A' ' 61' ' ' LEU . 31.2 mttp 56.65 -92.38 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.934 0.893 . . . . 0.0 111.263 -176.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 66' ' ' ASN . 11.4 t70 -108.35 -39.16 5.52 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 173.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.4 ' HB3' ' O ' ' A' ' 65' ' ' ASP . 22.9 t-20 69.31 -72.62 0.1 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.217 176.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 164.8 -30.62 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.06 -173.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.507 ' O ' HG22 ' A' ' 35' ' ' VAL . 36.3 t70 -131.73 15.74 4.83 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 114.909 -1.042 . . . . 0.0 110.92 -177.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.454 ' HD2' ' O ' ' A' ' 64' ' ' LYS . 69.6 t80 -121.71 145.08 48.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.115 0.483 . . . . 0.0 110.979 -177.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.39 143.88 29.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.811 174.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.439 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 3.2 tt -143.46 123.03 13.24 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -177.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 65.6 mt -125.06 119.49 55.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.723 0.297 . . . . 0.0 110.405 176.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.416 ' HA2' ' HG3' ' A' ' 39' ' ' GLN . . . -88.52 123.38 6.74 Favored Glycine 0 C--O 1.219 -0.831 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 174.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 55.9 mt -117.82 122.89 70.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 117.706 0.753 . . . . 0.0 111.097 -174.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -80.42 118.34 21.97 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 170.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.551 ' HB3' ' CD1' ' A' ' 115' ' ' ILE . 0.0 OUTLIER -74.63 -6.34 48.07 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.846 -166.854 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -153.18 -30.58 0.13 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 118.759 -1.176 . . . . 0.0 113.144 -176.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.501 ' HB3' ' HG3' ' A' ' 82' ' ' LYS . 24.2 mm-40 -85.57 152.37 57.22 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.009 0.433 . . . . 0.0 112.079 -174.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.526 ' HD2' ' HG3' ' A' ' 82' ' ' LYS . 74.4 Cg_endo -79.31 -171.61 1.3 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.324 2.682 . . . . 0.0 115.243 -176.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.551 HD13 HD23 ' A' ' 84' ' ' LEU . 2.9 tm? -52.07 -55.66 19.27 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 113.528 -1.669 . . . . 0.0 111.423 -175.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -52.41 -42.13 63.79 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.762 -0.653 . . . . 0.0 112.178 -175.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.526 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 34.8 mmtp -66.24 -47.94 72.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.641 -176.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 79' ' ' PRO . 41.1 t -58.22 -45.02 89.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.517 -178.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.551 HD23 HD13 ' A' ' 80' ' ' LEU . 4.5 mm? -68.79 -24.64 64.44 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -175.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.47 -44.33 12.81 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.819 0.343 . . . . 0.0 110.791 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.48 ' CD1' ' HA ' ' A' ' 43' ' ' SER . 85.7 t80 -67.13 -45.34 77.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.766 -174.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.79 -32.19 70.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.998 0.904 . . . . 0.0 109.815 -177.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -69.31 -34.26 74.41 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.242 -1.344 . . . . 0.0 111.023 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.6 t -87.81 -8.16 56.31 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.239 -178.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 16.5 p -108.77 -2.16 18.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.667 0.27 . . . . 0.0 111.208 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.2 36.53 39.85 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.696 177.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.477 HG13 ' CE1' ' A' ' 94' ' ' TYR . 32.6 t -90.37 130.06 40.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.847 0.356 . . . . 0.0 111.706 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 25.4 m -101.67 -35.68 9.01 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.673 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.55 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 43.9 p90 -62.06 140.52 95.92 Favored Pre-proline 0 N--CA 1.463 0.201 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.247 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.27 147.65 91.04 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.66 2.24 . . . . 0.0 112.854 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.8 mp -123.6 154.66 38.99 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.522 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -122.74 162.01 16.72 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.938 178.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.6 mp -96.73 142.23 29.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.593 0.235 . . . . 0.0 110.904 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -133.4 79.71 59.86 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-O 121.212 0.529 . . . . 0.0 109.783 169.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.71 106.09 0.71 Allowed 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.603 2.202 . . . . 0.0 112.859 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.42 19.64 44.54 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.145 176.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 55.77 47.56 20.12 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.507 ' HA ' HH21 ' A' ' 111' ' ' ARG . 24.8 t70 -79.85 -51.55 9.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.159 0.504 . . . . 0.0 110.315 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 35.1 mm -67.43 -33.0 59.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -63.24 -34.9 78.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.281 173.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -73.26 -19.76 60.99 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.92 0.39 . . . . 0.0 111.19 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 14' ' ' PRO . 55.3 mttp -77.44 -17.41 58.11 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.179 176.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.594 ' CE1' ' HD2' ' A' ' 14' ' ' PRO . 81.1 m-85 -110.19 -36.91 5.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.071 0.462 . . . . 0.0 111.006 178.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -130.68 173.23 11.11 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.154 -176.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.492 ' O ' ' HB2' ' A' ' 111' ' ' ARG . 12.1 mt -86.69 3.41 44.91 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -176.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.507 HH21 ' HA ' ' A' ' 103' ' ' ASP . 98.8 mtt180 78.87 -36.65 0.18 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.839 -177.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -74.58 15.94 0.32 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.149 0.5 . . . . 0.0 111.05 176.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.416 ' H ' ' C ' ' A' ' 111' ' ' ARG . . . -93.98 -3.61 51.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.394 177.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.36 -152.09 16.91 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.193 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.551 ' CD1' ' HB3' ' A' ' 76' ' ' ARG . 1.9 tp -109.04 -61.66 2.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.956 ' HB ' ' HG ' ' A' ' 133' ' ' LEU . 2.7 m -86.33 110.66 19.82 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.037 0.446 . . . . 0.0 112.059 -170.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -142.13 131.7 23.92 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.444 176.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 1.119 ' HB3' ' HB ' ' A' ' 131' ' ' THR . 9.6 t30 -105.64 119.99 40.54 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.135 0.493 . . . . 0.0 110.672 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.3 t -107.2 110.39 31.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.792 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.686 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 56.7 tp -92.69 111.39 22.97 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.016 0.436 . . . . 0.0 110.37 178.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.585 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 48.6 mt -95.74 133.57 36.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.143 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -83.59 166.23 18.37 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.249 178.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.426 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 7.1 mtm180 -51.96 -37.73 54.0 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 123.476 0.71 . . . . 0.0 112.081 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -70.84 -5.74 32.72 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.871 0.367 . . . . 0.0 111.672 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.482 ' HA3' HH11 ' A' ' 32' ' ' ARG . . . 89.91 12.66 61.85 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.618 -177.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 87.2 mttt -98.59 144.32 28.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.504 0.192 . . . . 0.0 110.749 -177.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 63.1 mt -84.88 115.66 27.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 176.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.1 m -106.29 -23.61 4.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.686 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 44.7 tptt -142.09 115.84 9.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.238 0.542 . . . . 0.0 112.07 -176.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.47 HD23 HG12 ' A' ' 9' ' ' ILE . 3.2 mm? -97.46 128.91 44.62 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 170.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 1.119 ' HB ' ' HB3' ' A' ' 118' ' ' ASN . 14.2 m -115.98 135.71 53.71 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.043 0.449 . . . . 0.0 110.952 -175.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.697 HH21 ' HB2' ' A' ' 138' ' ' GLU . 38.7 mtm180 -88.03 106.91 18.46 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.379 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.956 ' HG ' ' HB ' ' A' ' 116' ' ' THR . 6.5 mp 49.66 -137.34 1.05 Allowed 'General case' 0 CA--C 1.532 0.27 0 O-C-N 123.233 0.333 . . . . 0.0 110.15 -178.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.656 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 27.4 t80 -80.64 -55.94 4.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.798 171.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 56.46 109.63 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.907 0.755 . . . . 0.0 112.163 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -44.59 -54.38 6.16 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 114.99 -1.005 . . . . 0.0 112.205 -174.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.28 -34.66 28.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.081 -0.508 . . . . 0.0 112.356 -176.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.697 ' HB2' HH21 ' A' ' 132' ' ' ARG . 15.6 tt0 -70.33 -37.64 74.73 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.645 -176.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.542 ' CZ ' ' HB3' ' A' ' 54' ' ' PHE . 84.7 t80 -63.23 -43.48 97.93 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 174.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.36 -53.73 54.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.209 176.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.1 m -54.37 -45.12 72.73 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.418 174.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.544 ' O ' HG12 ' A' ' 146' ' ' ILE . 45.0 tp -57.55 -48.99 77.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.607 -178.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 139' ' ' PHE . 87.8 t -60.04 -44.06 94.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.102 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -59.07 -44.15 91.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.275 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.559 ' O ' ' HG3' ' A' ' 149' ' ' MET . 7.8 tt0 -65.74 -39.69 91.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.543 178.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 142' ' ' LEU . 35.1 mm -56.07 -47.2 80.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.202 0.525 . . . . 0.0 110.238 175.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -62.29 -31.23 71.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.341 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -71.54 -44.66 64.18 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.527 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.559 ' HG3' ' O ' ' A' ' 145' ' ' GLN . 80.0 mtp -66.88 -26.3 66.82 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.465 0.65 . . . . 0.0 109.926 -176.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.544 HD23 ' O ' ' A' ' 146' ' ' ILE . 4.4 mm? . . . . . 0 C--N 1.325 -0.475 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.161 175.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.526 ' CE2' ' HD2' ' A' ' 117' ' ' ARG . 92.9 m-85 . . . . . 0 C--O 1.235 0.292 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.43 HD13 ' H ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -109.18 -5.3 10.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.149 164.421 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.2 p -94.92 160.37 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.092 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.6 ppt_? -128.38 166.58 18.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.906 0.384 . . . . 0.0 111.998 -173.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.4 mt -68.85 131.88 33.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.592 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.98 -3.86 70.79 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.066 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -82.17 152.1 26.63 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.439 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 31.8 mtp -81.83 124.67 29.88 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.089 178.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.43 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -61.47 126.87 87.54 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.681 -176.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 31.3 Cg_exo -59.12 121.77 10.48 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.949 2.433 . . . . 0.0 111.493 177.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.452 ' HA ' HD12 ' A' ' 28' ' ' LEU . 1.0 OUTLIER -70.77 141.86 51.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.532 -175.649 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.425 ' O ' ' HA ' ' A' ' 27' ' ' THR . 39.8 p90 -153.08 163.75 39.28 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.329 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 27.4 m -123.29 107.56 11.8 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 174.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.7 tt -106.8 147.83 11.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.827 0.346 . . . . 0.0 110.8 -175.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 24' ' ' LYS . 3.9 m -81.94 133.47 35.31 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.173 178.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.793 ' HB2' ' HB2' ' A' ' 24' ' ' LYS . 75.7 mt -91.19 -178.7 5.23 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.609 -0.268 . . . . 0.0 110.742 177.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.9 p -55.5 -41.72 73.47 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -172.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.425 ' OD1' ' HG2' ' A' ' 24' ' ' LYS . 4.5 p-10 -97.29 8.0 45.44 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.221 -176.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.88 8.94 44.18 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.289 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.793 ' HB2' ' HB2' ' A' ' 20' ' ' LEU . 40.5 mmtm -62.02 151.89 33.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.035 0.445 . . . . 0.0 110.718 177.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.457 HE21 ' HA ' ' A' ' 19' ' ' THR . 17.4 mm-40 -118.21 116.85 27.65 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.644 174.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 17' ' ' THR . 5.2 p -120.45 125.75 74.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.4 0.619 . . . . 0.0 110.998 -179.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.437 HG22 ' H ' ' A' ' 29' ' ' SER . 9.3 m -106.4 141.0 38.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.944 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.452 HD12 ' HA ' ' A' ' 15' ' ' ASP . 17.6 mt -62.83 -31.07 72.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.412 0.149 . . . . 0.0 111.183 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.437 ' H ' HG22 ' A' ' 27' ' ' THR . 45.8 m -53.43 -34.32 57.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.459 176.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.9 m -78.69 -18.13 54.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.213 0.53 . . . . 0.0 111.082 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.517 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 67.0 mt -101.65 0.78 36.77 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.856 -177.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 28' ' ' LEU . 38.2 mmt180 -66.82 127.94 34.4 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.15 -27.83 8.33 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.486 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.719 ' HB3' ' HZ3' ' A' ' 34' ' ' LYS . 0.7 OUTLIER -116.48 167.4 11.09 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.514 -0.18 . . . . 0.0 110.514 -178.532 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.4 p -80.06 127.63 39.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.019 0.438 . . . . 0.0 110.664 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.577 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 28.1 t -119.39 121.59 66.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.855 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.657 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 28.3 ttt -107.12 120.04 41.01 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.3 mt -126.22 102.01 7.0 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.104 -177.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.9 pm0 -107.38 133.18 52.28 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.615 175.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 94.9 m-85 -89.72 132.52 35.14 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.024 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.536 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 6.6 t -140.79 169.88 16.8 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.312 -177.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.48 ' HB2' ' CD1' ' A' ' 115' ' ' ILE . . . -135.54 151.65 50.53 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.8 169.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.456 ' H ' ' HG3' ' A' ' 78' ' ' GLU . 46.1 m -73.18 28.03 0.06 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -174.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.401 ' H ' ' C ' ' A' ' 42' ' ' ALA . 41.1 p-90 -147.24 7.71 0.9 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.599 0.238 . . . . 0.0 111.238 176.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.461 ' SG ' ' HB3' ' A' ' 42' ' ' ALA . 79.7 m -86.57 130.43 34.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.858 0.361 . . . . 0.0 110.891 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -83.92 -31.25 26.8 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.196 -177.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.691 HG11 ' HB2' ' A' ' 133' ' ' LEU . 38.4 t -62.86 -37.95 80.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.301 0.572 . . . . 0.0 109.835 177.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.959 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 63.2 m -70.44 -20.21 62.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.065 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -75.05 -7.57 54.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.072 0.463 . . . . 0.0 110.255 175.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -102.07 -51.55 3.36 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.5 174.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 1.007 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 12.2 pt-20 -65.17 -44.58 88.04 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.03 -175.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.504 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 38.3 mtm -64.79 -48.95 71.65 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -173.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.504 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 72.6 Cg_exo -54.94 -39.95 88.02 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.737 1.624 . . . . 0.0 112.161 171.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.43 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 7.6 m-85 -66.9 -40.4 87.69 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.078 176.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.574 HG13 ' O ' ' A' ' 51' ' ' GLU . 78.5 mt -57.65 -50.0 78.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.315 175.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.634 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 22.0 tp10 -57.52 -51.05 71.02 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 176.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -54.6 -61.7 2.14 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -175.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.865 ' HA ' ' HZ3' ' A' ' 62' ' ' LYS . 64.5 m-20 -107.56 -13.61 15.02 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -169.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.535 HG23 HG21 ' A' ' 146' ' ' ILE . 61.5 mt -101.99 -62.33 2.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.788 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.583 ' HB3' ' HA ' ' A' ' 56' ' ' GLU . 62.8 t-105 -69.79 -48.29 59.74 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.498 -173.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.634 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -54.83 -28.75 51.91 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -176.256 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.865 ' HZ3' ' HA ' ' A' ' 58' ' ' ASP . 39.3 mmtm -87.47 -25.62 23.64 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -172.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 61.8 m-70 -122.05 -40.27 2.53 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -172.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.617 ' HE2' ' HA ' ' A' ' 61' ' ' LEU . 45.8 mmtt 49.57 -102.5 0.1 Allowed 'General case' 0 C--O 1.224 -0.25 0 O-C-N 123.566 0.541 . . . . 0.0 111.526 -175.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.557 ' C ' ' H ' ' A' ' 67' ' ' ALA . 17.2 t70 -87.37 -63.58 1.28 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.809 -175.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.433 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 18.4 t-20 64.9 -25.97 0.09 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -175.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.557 ' H ' ' C ' ' A' ' 65' ' ' ASP . . . 89.09 -15.94 0.3 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.505 1.522 . . . . 0.0 109.618 -177.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.613 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 2.0 m-20 -134.06 20.43 3.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.083 178.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.481 ' CD1' HD21 ' A' ' 150' ' ' LEU . 86.7 t80 -121.92 108.46 13.46 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.297 0.57 . . . . 0.0 109.786 172.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 36' ' ' VAL . . . -111.75 104.37 12.71 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.756 -176.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.657 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 3.9 tt -113.78 114.66 26.63 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.6 mp -125.01 123.96 66.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.004 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.431 ' HA3' HD22 ' A' ' 96' ' ' LEU . . . -89.16 119.52 5.47 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.075 176.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 65.3 mt -102.29 102.14 13.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 117.134 0.467 . . . . 0.0 111.266 -174.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.536 ' HA ' ' O ' ' A' ' 41' ' ' THR . 8.0 t0 -80.76 144.53 32.08 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 170.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.436 ' HD2' ' CG ' ' A' ' 105' ' ' PHE . 8.2 ttp180 -85.46 -105.32 0.05 Allowed 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 120.305 -0.558 . . . . 0.0 112.186 -167.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.413 ' H ' ' HB3' ' A' ' 76' ' ' ARG . 31.8 m-20 -87.7 17.14 4.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.499 -168.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.456 ' HG3' ' H ' ' A' ' 43' ' ' SER . 5.8 mm-40 -91.09 138.86 25.7 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.579 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.447 ' HD2' ' HG3' ' A' ' 82' ' ' LYS . 48.5 Cg_endo -70.22 178.63 4.66 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.773 2.316 . . . . 0.0 113.07 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.1 mt -57.95 -56.46 21.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.926 -175.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.508 ' CD ' ' H ' ' A' ' 81' ' ' GLU . 1.9 pm0 -52.99 -36.0 59.83 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.638 -177.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.447 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 25.5 mmtp -63.51 -58.06 8.21 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.71 0.291 . . . . 0.0 110.487 175.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 55.0 t -54.18 -49.68 60.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.5 -177.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.41 -42.36 98.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.66 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.546 ' HA ' ' HE3' ' A' ' 88' ' ' LYS . . . -74.26 -29.52 61.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.648 -176.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -79.86 -44.91 19.63 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.57 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.422 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . . . -55.64 -54.03 49.19 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.665 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.546 ' HE3' ' HA ' ' A' ' 85' ' ' ALA . 18.1 pttp -55.44 -30.54 60.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.746 -176.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.5 m -79.73 -14.59 58.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.103 -174.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.7 p -115.07 9.02 15.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.207 0.527 . . . . 0.0 110.637 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.67 -72.46 0.91 Allowed Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.293 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.0 t 28.07 88.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.622 1.169 . . . . 0.0 113.593 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.2 m -96.59 15.81 20.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.757 0.789 . . . . 0.0 110.086 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.551 ' HB3' ' CE2' ' A' ' 60' ' ' TRP . 25.9 p90 -115.43 146.85 37.45 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.114 176.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.76 136.84 69.09 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.635 2.224 . . . . 0.0 112.874 -177.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.431 HD22 ' HA3' ' A' ' 73' ' ' GLY . 63.7 mt -110.56 151.71 27.28 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.831 176.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -121.07 162.05 14.92 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 175.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.659 HD23 ' H ' ' A' ' 98' ' ' LEU . 2.0 pt? -121.6 138.61 54.25 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 117.005 0.403 . . . . 0.0 110.559 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -122.46 72.85 39.98 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.808 -178.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.448 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 13.9 Cg_exo -69.44 111.66 2.81 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.765 2.31 . . . . 0.0 111.761 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 117.74 -1.74 17.76 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -176.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 49.66 40.21 19.26 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -177.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -82.94 -53.96 5.44 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.122 0.486 . . . . 0.0 111.077 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.8 mm -63.85 -33.55 62.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.485 ' HE2' ' O ' ' A' ' 110' ' ' LEU . 80.2 t80 -64.63 -44.3 90.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.312 174.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.659 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -65.02 -19.81 66.18 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.852 -177.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -73.71 -6.7 48.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.858 0.361 . . . . 0.0 111.31 177.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -128.95 -42.19 1.41 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.994 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.659 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -139.07 157.14 46.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.65 -178.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.485 ' O ' ' HE2' ' A' ' 105' ' ' PHE . 7.5 mp -61.41 138.35 58.26 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 178.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.431 ' H ' ' HG3' ' A' ' 111' ' ' ARG . 10.0 mtm180 -55.96 -36.66 68.06 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 122.237 1.018 . . . . 0.0 109.245 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.22 13.49 15.08 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.647 -1.615 . . . . 0.0 110.444 -172.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.421 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . . . -108.1 -171.77 1.93 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.877 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.86 119.68 19.71 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.664 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.48 ' CD1' ' HB2' ' A' ' 42' ' ' ALA . 2.3 tt -67.94 -39.09 81.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -175.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.462 HG22 ' HA ' ' A' ' 133' ' ' LEU . 12.2 m -75.99 98.88 4.4 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.1 0.476 . . . . 0.0 110.987 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.526 ' HD2' ' CE2' ' A' ' 5' ' ' TYR . 37.8 mmt-85 -136.31 133.14 36.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.487 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.516 ' HB2' HG22 ' A' ' 131' ' ' THR . 7.4 m120 -111.0 118.56 36.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.789 0.328 . . . . 0.0 110.43 -176.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.7 t -112.3 128.98 68.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.452 -178.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 46.3 tp -115.16 116.26 28.09 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.028 0.442 . . . . 0.0 110.469 175.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.577 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 55.1 mt -99.59 132.64 44.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.474 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.49 174.09 8.71 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.942 0.401 . . . . 0.0 110.438 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.6 ptp85 -53.82 -34.54 59.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.725 -177.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -81.98 -0.55 44.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.559 -174.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.08 4.5 66.77 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.563 176.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 9.2 mtmp? -97.45 149.52 22.06 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.941 0.401 . . . . 0.0 111.107 -177.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 55.1 mt -85.31 109.88 18.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.805 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 19.4 m -98.75 -17.0 6.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.899 -175.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.676 ' HE3' ' HB ' ' A' ' 131' ' ' THR . 6.9 tmtm? -149.45 108.24 3.86 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.766 -177.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.93 109.36 15.44 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 172.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.676 ' HB ' ' HE3' ' A' ' 129' ' ' LYS . 11.8 t -117.25 164.08 15.35 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.439 -176.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.504 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -103.23 108.0 19.04 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.352 -176.492 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.691 ' HB2' HG11 ' A' ' 47' ' ' VAL . 4.4 pp 51.16 -176.55 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.315 1.046 . . . . 0.0 113.438 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 1.007 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 93.3 t80 -68.74 91.75 0.45 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.777 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.564 ' HB3' ' HB2' ' A' ' 138' ' ' GLU . 0.2 OUTLIER -107.15 121.15 43.93 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 173.314 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.511 ' N ' HD22 ' A' ' 135' ' ' ASN . 1.3 mp0 -38.26 -64.87 0.38 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.77 0.828 . . . . 0.0 112.772 -175.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -56.82 -51.5 68.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.347 0.594 . . . . 0.0 111.357 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.564 ' HB2' ' HB3' ' A' ' 135' ' ' ASN . 5.5 mm-40 -62.61 -43.91 97.63 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.011 -176.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.539 ' O ' HG23 ' A' ' 143' ' ' VAL . 69.1 t80 -66.07 -42.86 88.84 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.486 ' O ' ' HG2' ' A' ' 144' ' ' GLN . . . -57.22 -50.0 74.24 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.532 177.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 17.4 m -62.96 -37.8 88.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.819 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.459 ' O ' HG12 ' A' ' 146' ' ' ILE . 2.6 tt -62.85 -48.31 79.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.794 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 139' ' ' PHE . 99.7 t -59.05 -45.1 92.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.154 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 140' ' ' ALA . 29.8 mm-40 -62.33 -43.33 99.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.339 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.448 ' O ' ' HG2' ' A' ' 149' ' ' MET . 9.4 tt0 -63.69 -40.85 97.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.424 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.573 ' O ' HD23 ' A' ' 150' ' ' LEU . 24.5 mm -51.83 -50.08 34.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 121.176 0.512 . . . . 0.0 110.517 175.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -58.02 -43.25 86.6 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.45 -178.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -70.95 -32.95 69.98 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.009 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 83.1 mmm -60.06 -29.43 68.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.179 0.514 . . . . 0.0 110.167 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.573 HD23 ' O ' ' A' ' 146' ' ' ILE . 3.6 mm? . . . . . 0 C--N 1.324 -0.542 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.378 177.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 . . . . . 0 CA--C 1.522 -0.124 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.5 pt -115.58 -6.15 11.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.252 0.549 . . . . 0.0 109.881 172.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.1 m -100.8 166.23 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.493 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.55 ' HB2' ' HG2' ' A' ' 11' ' ' GLU . 25.2 mtt180 -126.09 167.63 15.1 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -176.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 72.8 mt -78.99 119.47 28.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 174.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.64 -25.93 9.32 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.683 -176.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.55 ' HG2' ' HB2' ' A' ' 8' ' ' ARG . 72.2 mm-40 -66.76 150.37 49.21 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.627 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 56.7 mtp -80.32 123.54 28.08 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 174.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.439 ' HA ' ' HD2' ' A' ' 14' ' ' PRO . . . -56.16 124.58 60.63 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.603 -174.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 13' ' ' ALA . 7.1 Cg_endo -52.75 132.01 44.37 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.761 2.308 . . . . 0.0 111.338 175.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -82.82 161.54 21.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.458 -175.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.594 ' HB2' HD12 ' A' ' 104' ' ' ILE . 53.9 p90 -166.65 163.48 16.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.227 -175.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.6 m -125.26 100.5 6.56 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 174.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.5 tt -96.14 149.89 4.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.704 -174.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.477 ' O ' HD23 ' A' ' 98' ' ' LEU . 19.0 m -90.75 127.06 36.2 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.051 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.429 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 71.4 mt -79.69 175.9 10.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.933 178.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 96' ' ' LEU . 37.0 p -59.34 -25.9 64.59 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -177.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.802 ' OD1' ' HG2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -90.28 -19.32 24.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.146 0.498 . . . . 0.0 110.634 -178.519 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 113.13 -2.71 25.45 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.467 -174.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.802 ' HG2' ' OD1' ' A' ' 22' ' ' ASP . 39.3 mmtm -65.91 126.79 29.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.83 0.348 . . . . 0.0 111.149 178.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -91.3 116.4 28.8 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.868 176.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.9 p -119.05 128.4 75.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.315 0.578 . . . . 0.0 111.089 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 6.2 m -97.88 147.9 23.97 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.281 -178.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.71 -28.31 67.56 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.517 ' HA ' ' HG2' ' A' ' 32' ' ' ARG . 44.7 m -56.27 -29.31 60.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.389 177.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.6 m -75.24 -17.13 60.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.112 0.482 . . . . 0.0 111.243 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.3 mt -104.69 1.31 29.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.432 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.517 ' HG2' ' HA ' ' A' ' 29' ' ' SER . 36.3 mmt180 -66.76 122.5 17.79 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 120.54 -19.99 8.97 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -176.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.462 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 45.1 mtmt -116.52 155.24 29.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.547 -0.326 . . . . 0.0 110.323 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.512 HG13 ' HD1' ' A' ' 69' ' ' PHE . 1.4 p -71.27 117.73 14.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.012 0.434 . . . . 0.0 109.854 174.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.551 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 43.1 t -107.68 129.76 61.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.423 -173.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 27.6 ttt -107.46 120.12 41.3 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.174 175.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.7 mt -123.66 94.78 4.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.129 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.679 HE22 HD21 ' A' ' 71' ' ' LEU . 20.2 pm0 -93.81 131.1 39.52 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.107 0.48 . . . . 0.0 110.447 177.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -96.14 110.28 22.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.421 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.6 t -115.63 -171.9 2.05 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.88 -176.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.718 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . . . -163.13 143.46 9.16 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.514 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 54.8 m -62.68 -13.9 37.54 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -174.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 68.2 p-90 -101.07 -4.72 26.87 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.154 -0.341 . . . . 0.0 111.663 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.718 ' SG ' ' HB3' ' A' ' 42' ' ' ALA . 83.8 m -78.21 124.58 28.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.977 0.418 . . . . 0.0 111.732 -175.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -88.66 -18.11 55.39 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 176.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.479 ' HB ' HG21 ' A' ' 116' ' ' THR . 61.8 t -72.02 -46.52 59.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.931 0.396 . . . . 0.0 110.027 176.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.736 ' SG ' HG22 ' A' ' 116' ' ' THR . 69.2 m -66.91 -17.61 64.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.7 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.558 ' HE ' ' HE1' ' A' ' 86' ' ' PHE . 75.0 mtt180 -72.77 -6.46 44.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.154 0.502 . . . . 0.0 110.694 176.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -105.3 -44.98 4.6 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 169.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.649 ' HB2' ' HB2' ' A' ' 134' ' ' TYR . 40.6 tt0 -56.18 -57.12 13.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.369 -177.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.671 ' SD ' ' HE2' ' A' ' 86' ' ' PHE . 74.8 mtp -62.52 -50.64 77.76 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -172.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.615 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 54.7 Cg_exo -55.66 -36.22 94.42 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.959 1.773 . . . . 0.0 112.435 175.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -69.74 -41.32 75.43 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.638 175.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.534 HG13 ' O ' ' A' ' 51' ' ' GLU . 81.5 mt -56.32 -53.18 42.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.057 177.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.625 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 17.1 pt-20 -67.34 -32.09 72.8 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.525 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -62.04 -60.3 3.82 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.47 ' HA ' ' NZ ' ' A' ' 62' ' ' LYS . 52.1 m-20 -107.19 -8.48 16.43 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -171.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.508 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 70.6 mt -104.76 -57.98 4.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.612 176.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.625 ' HB3' ' HA ' ' A' ' 56' ' ' GLU . 76.5 t-105 -66.55 -67.42 0.45 Allowed 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.177 -178.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.0 mp -47.45 -32.1 4.8 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -174.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.47 ' NZ ' ' HA ' ' A' ' 58' ' ' ASP . 46.5 mmtm -77.28 -36.48 54.2 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -177.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -126.68 -43.16 1.74 Allowed 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.937 -0.477 . . . . 0.0 112.099 -173.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 60' ' ' TRP . 33.2 mttp 62.03 -83.05 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.918 0.887 . . . . 0.0 111.451 -178.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -123.37 -38.85 2.51 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 174.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 70.74 -75.06 0.08 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.022 175.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 171.86 -33.83 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.898 -176.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.462 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 5.7 t70 -126.83 19.55 7.17 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.273 -177.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.512 ' HD1' HG13 ' A' ' 35' ' ' VAL . 87.7 t80 -129.11 155.17 45.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.39 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -150.24 132.46 15.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.43 176.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.679 HD21 HE22 ' A' ' 39' ' ' GLN . 5.5 tt -129.41 119.77 24.38 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.5 mm -129.89 120.29 49.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.088 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.88 128.79 9.31 Favored Glycine 0 C--O 1.224 -0.509 0 C-N-CA 120.234 -0.984 . . . . 0.0 111.457 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.3 mt -115.5 120.1 63.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 117.23 0.515 . . . . 0.0 111.174 -176.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.521 ' OD1' ' HA ' ' A' ' 42' ' ' ALA . 16.7 t0 -92.09 127.89 37.73 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 174.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.49 111.33 22.57 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.169 -171.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.7 t0 81.43 -26.09 0.15 Allowed 'General case' 0 N--CA 1.47 0.557 0 O-C-N 124.147 0.904 . . . . 0.0 112.367 169.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.488 ' HB2' ' OD1' ' A' ' 75' ' ' ASP . 5.5 mm-40 -69.49 131.98 89.68 Favored Pre-proline 0 C--O 1.235 0.295 0 CA-C-O 121.148 0.499 . . . . 0.0 110.713 177.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.561 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 36.8 Cg_endo -71.96 -168.71 0.39 Allowed 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.088 2.526 . . . . 0.0 114.624 -176.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -62.69 -52.71 62.2 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.367 -168.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.561 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -62.98 -34.1 76.8 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.502 0.191 . . . . 0.0 111.419 -175.76 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.554 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 33.6 mmtp -58.93 -58.87 6.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.828 176.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.529 HG21 ' HB3' ' A' ' 98' ' ' LEU . 45.2 t -55.27 -44.88 77.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.452 -177.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.8 mp -67.37 -31.71 72.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.698 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.791 ' HA ' ' HE2' ' A' ' 88' ' ' LYS . . . -82.86 -37.35 24.45 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.102 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.671 ' HE2' ' SD ' ' A' ' 52' ' ' MET . 83.2 t80 -67.57 -47.0 71.03 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.914 -178.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.582 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -55.15 -51.53 66.2 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.59 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.791 ' HE2' ' HA ' ' A' ' 85' ' ' ALA . 64.7 pttt -65.94 -23.2 66.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.829 0.347 . . . . 0.0 111.688 -174.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.8 m -80.42 -28.22 37.82 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.108 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.6 p -96.95 -20.53 18.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.078 0.466 . . . . 0.0 111.01 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 112.58 -74.77 0.22 Allowed Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -175.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 97.8 t 43.43 88.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 124.31 1.044 . . . . 0.0 113.322 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.2 m -79.8 6.26 11.43 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 114.704 -1.135 . . . . 0.0 111.333 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.553 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 50.7 p90 -118.71 153.55 52.35 Favored Pre-proline 0 C--N 1.329 -0.306 0 O-C-N 122.172 -0.33 . . . . 0.0 110.882 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -66.71 137.97 47.56 Favored 'Trans proline' 0 C--O 1.24 0.593 0 C-N-CA 122.175 1.916 . . . . 0.0 113.236 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.582 HD12 ' HB2' ' A' ' 87' ' ' ALA . 77.9 mt -109.61 148.28 31.57 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.738 174.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -117.59 147.8 18.74 Favored Glycine 0 N--CA 1.438 -1.221 0 N-CA-C 110.389 -1.085 . . . . 0.0 110.389 173.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.733 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.5 pt? -101.6 136.63 41.13 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -178.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.41 ' OD2' ' HA ' ' A' ' 102' ' ' ALA . 27.5 t0 -116.38 73.95 5.71 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.261 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.494 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 15.4 Cg_exo -68.09 117.25 4.79 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.655 2.237 . . . . 0.0 111.524 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.407 ' O ' ' HD2' ' A' ' 111' ' ' ARG . . . 102.41 -7.32 53.87 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.275 -175.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.518 ' HB3' ' HG2' ' A' ' 111' ' ' ARG . . . 55.68 38.73 30.5 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 122.896 0.479 . . . . 0.0 111.402 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -72.46 -46.11 56.42 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.607 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.594 HD12 ' HB2' ' A' ' 16' ' ' PHE . 21.2 mm -65.22 -38.94 83.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.687 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -65.2 -38.71 91.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.097 175.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.57 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -68.92 -15.3 63.45 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.296 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 52.2 mttp -80.16 -16.75 54.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.627 175.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -113.82 -20.97 10.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.803 0.335 . . . . 0.0 111.328 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.57 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -159.79 -179.81 8.17 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.244 -178.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.94 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 88.6 mt -65.27 138.31 58.12 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.518 ' HG2' ' HB3' ' A' ' 102' ' ' ALA . 1.3 ttp85 -42.61 -48.1 5.36 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -173.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -118.58 37.79 3.95 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.138 0.494 . . . . 0.0 110.667 -176.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.94 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . . . -81.41 34.8 0.38 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.938 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.5 -162.92 17.7 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 121.022 -0.608 . . . . 0.0 112.282 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.562 HG13 ' H ' ' A' ' 116' ' ' THR . 4.7 tp -151.78 -174.2 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -178.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.736 HG22 ' SG ' ' A' ' 48' ' ' CYS . 53.0 p 58.37 88.86 0.06 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.869 0.867 . . . . 0.0 111.692 176.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -171.09 141.86 1.72 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.223 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.686 ' HB3' ' HB ' ' A' ' 131' ' ' THR . 5.6 t30 -119.97 129.67 54.41 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.095 0.474 . . . . 0.0 111.51 -176.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 39.1 t -101.81 113.1 37.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.781 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.939 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 27.2 tp -97.64 115.7 28.43 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.33 0.586 . . . . 0.0 110.035 177.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.551 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 60.5 mt -98.85 135.68 32.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 114.988 -1.006 . . . . 0.0 109.77 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.614 ' OD2' ' HB2' ' A' ' 126' ' ' LYS . 4.4 p30 -75.87 170.23 16.62 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.919 0.39 . . . . 0.0 110.0 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -75.39 1.31 14.2 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.471 -175.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.424 ' HB2' ' OD1' ' A' ' 122' ' ' ASP . 38.7 mt-10 -91.62 -30.5 16.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.373 0.606 . . . . 0.0 109.645 175.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.82 5.56 10.84 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.214 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.627 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 9.3 mtmp? -100.74 157.97 16.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.973 0.416 . . . . 0.0 111.263 -177.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 54.5 mt -92.06 119.08 38.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.155 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 17.0 m -114.91 -23.28 4.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.939 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 59.2 tptt -134.46 113.9 12.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.14 0.495 . . . . 0.0 111.799 -174.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -101.76 113.44 26.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.398 173.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.686 ' HB ' ' HB3' ' A' ' 118' ' ' ASN . 25.4 m -95.57 137.42 34.66 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.496 -177.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.451 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 0.4 OUTLIER -108.42 105.7 15.49 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.72 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 132' ' ' ARG . 3.4 pp 41.72 -163.1 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.093 0.871 . . . . 0.0 113.011 -177.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.649 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 84.5 t80 -94.14 107.48 19.41 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.127 0.489 . . . . 0.0 111.451 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.465 ' HB2' ' CB ' ' A' ' 138' ' ' GLU . 54.0 m-80 -119.42 149.77 41.3 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 170.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -58.58 -56.16 25.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.121 0.486 . . . . 0.0 110.752 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.456 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 0.9 OUTLIER -65.05 -40.78 95.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.216 -178.567 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.465 ' CB ' ' HB2' ' A' ' 135' ' ' ASN . 6.1 tp10 -61.93 -49.78 74.8 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.629 -178.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -66.96 -37.92 85.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.487 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.16 -42.06 97.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.337 176.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 43.2 m -64.5 -30.3 71.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.143 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.493 HD11 HG21 ' A' ' 131' ' ' THR . 29.2 mt -72.8 -55.26 6.96 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.294 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.3 p -59.42 -38.54 75.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 O-C-N 123.166 0.291 . . . . 0.0 110.897 -175.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -67.54 -46.9 71.44 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 176.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.412 HE22 ' HG2' ' A' ' 129' ' ' LYS . 9.6 tt0 -58.86 -46.58 87.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.605 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.553 ' O ' HD23 ' A' ' 150' ' ' LEU . 81.7 mt -65.47 -40.01 86.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.041 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -58.91 -38.63 79.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.688 0.28 . . . . 0.0 110.819 176.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -77.9 -30.41 50.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.941 178.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.407 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 87.0 mmm -67.19 -27.79 67.56 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.316 0.579 . . . . 0.0 110.143 178.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.553 HD23 ' O ' ' A' ' 146' ' ' ILE . 3.9 mm? . . . . . 0 C--N 1.325 -0.487 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.556 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.462 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 62.1 m-85 . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.417 ' H ' ' HA ' ' A' ' 109' ' ' ALA . 39.8 pt -92.07 -13.37 8.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.556 0.693 . . . . 0.0 109.248 173.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 p -110.57 164.16 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.298 178.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.5 mtm105 -133.68 165.85 23.97 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.902 0.382 . . . . 0.0 111.01 -174.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.422 HG12 HD13 ' A' ' 130' ' ' LEU . 85.4 mt -72.02 122.96 25.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.193 178.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.99 -22.21 19.03 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.94 -178.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -74.11 159.25 32.87 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.741 0.305 . . . . 0.0 110.722 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.588 ' SD ' ' HG2' ' A' ' 126' ' ' LYS . 56.3 mmm -79.76 133.28 36.32 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.435 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -69.99 129.7 90.61 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.623 -177.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.512 ' HD2' ' CE1' ' A' ' 108' ' ' TYR . 32.9 Cg_exo -61.92 137.44 67.47 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.882 2.388 . . . . 0.0 111.744 175.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.426 ' HB2' HH22 ' A' ' 32' ' ' ARG . 23.4 t70 -80.61 153.03 28.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.888 -177.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -161.88 165.44 27.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.779 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 73.5 m -124.7 107.12 10.64 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 174.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.5 tt -105.92 144.86 14.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.94 -173.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.465 ' O ' HD23 ' A' ' 98' ' ' LEU . 5.5 m -88.52 131.69 34.81 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.077 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.491 HD12 ' HB2' ' A' ' 24' ' ' LYS . 79.0 mt -82.43 -179.43 7.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.845 0.355 . . . . 0.0 110.951 177.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.453 ' HB ' HD11 ' A' ' 84' ' ' LEU . 35.6 p -57.85 -31.65 66.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.894 -175.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.493 ' OD2' ' HG2' ' A' ' 24' ' ' LYS . 5.4 p-10 -99.45 -6.19 28.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.818 0.342 . . . . 0.0 110.835 -175.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.94 1.82 34.12 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.333 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.614 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -69.22 110.78 4.76 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 117.663 0.732 . . . . 0.0 110.297 175.623 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -92.69 115.08 27.78 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.086 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 17' ' ' THR . 12.8 m -112.66 146.03 17.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.156 0.503 . . . . 0.0 110.804 -177.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.6 m -103.2 147.06 27.5 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.712 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.17 -45.81 93.08 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.702 0.287 . . . . 0.0 110.408 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.9 m -64.95 -15.79 62.59 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.2 t -82.48 -15.38 52.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.577 0.703 . . . . 0.0 109.555 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.2 mt -112.12 -3.9 14.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.539 177.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.426 HH22 ' HB2' ' A' ' 15' ' ' ASP . 7.8 mtm180 -75.81 156.36 34.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.058 0.456 . . . . 0.0 111.024 -178.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.48 -15.71 62.68 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 -166.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.582 ' HB3' ' O ' ' A' ' 68' ' ' ASP . 36.7 mtmt -116.44 160.21 20.9 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.058 -1.071 . . . . 0.0 109.381 175.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.431 HG11 HD22 ' A' ' 150' ' ' LEU . 2.3 p -80.19 118.27 27.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.359 0.6 . . . . 0.0 109.716 174.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.8 t -112.51 122.2 66.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.967 -173.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.652 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 26.7 ttt -99.34 114.96 28.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.08 175.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 69.6 mt -110.31 97.55 6.99 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.584 178.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.552 ' HG3' ' HA2' ' A' ' 73' ' ' GLY . 1.5 pp0? -91.1 130.97 36.94 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 177.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -107.02 122.34 46.25 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.43 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 13.9 t -151.49 -171.4 3.92 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.9 -177.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.409 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . . . -150.95 163.41 38.78 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 174.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.47 ' HB2' ' HG3' ' A' ' 78' ' ' GLU . 44.1 m -67.54 -5.71 16.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.055 -0.521 . . . . 0.0 112.168 -176.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 37.0 p-90 -109.9 12.21 23.91 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.482 ' SG ' HD13 ' A' ' 115' ' ' ILE . 73.8 m -92.85 100.95 13.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.118 0.485 . . . . 0.0 111.266 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.98 -32.38 73.29 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.889 -0.596 . . . . 0.0 113.082 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.6 t -64.12 -41.29 91.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.159 0.504 . . . . 0.0 110.446 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.75 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 83.6 m -67.62 -16.94 64.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.73 -177.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -71.3 -2.6 16.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.863 0.363 . . . . 0.0 110.994 176.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -98.85 -51.87 3.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.056 0.455 . . . . 0.0 110.026 170.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.75 ' HG2' ' HA ' ' A' ' 48' ' ' CYS . 11.7 pt-20 -69.58 -39.33 77.4 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.046 -173.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.575 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 91.7 mtp -60.36 -51.03 83.02 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -177.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.575 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 35.8 Cg_exo -59.68 -35.74 94.01 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.854 1.703 . . . . 0.0 112.208 172.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.579 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 3.1 m-85 -64.32 -43.73 93.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.724 174.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 51' ' ' GLU . 97.4 mt -58.16 -48.98 83.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.853 173.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.514 ' OE1' ' HA ' ' A' ' 92' ' ' VAL . 30.2 tp10 -50.22 -53.97 24.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.934 178.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -72.53 -50.45 25.65 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -173.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -105.8 -12.96 15.68 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -168.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.454 HD12 HG12 ' A' ' 55' ' ' ILE . 73.4 mt -106.37 -61.93 2.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.024 176.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.623 ' CE2' ' HG2' ' A' ' 64' ' ' LYS . 67.5 t-105 -62.94 -67.41 0.42 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.481 -174.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.02 -33.52 11.35 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -175.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -68.41 -30.11 68.94 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.78 -175.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.461 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 90.7 m-70 -128.98 -47.08 1.23 Allowed 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 119.678 -0.809 . . . . 0.0 112.621 -176.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.623 ' HG2' ' CE2' ' A' ' 60' ' ' TRP . 9.2 mtmp? 40.57 -93.98 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.568 0.699 . . . . 0.0 112.149 -174.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.59 -70.59 0.29 Allowed 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.045 173.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.586 ' ND2' HD12 ' A' ' 150' ' ' LEU . 5.7 t30 70.18 -68.77 0.19 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.769 0.828 . . . . 0.0 111.078 174.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 175.87 -46.3 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.363 -178.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.582 ' O ' ' HB3' ' A' ' 34' ' ' LYS . 7.9 p-10 -142.85 35.25 1.4 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.066 -177.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.609 ' HB2' HD11 ' A' ' 150' ' ' LEU . 74.5 t80 -104.13 145.72 29.78 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.657 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.76 130.33 17.89 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.934 174.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.652 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 3.4 tt -135.35 114.61 12.37 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.5 mp -125.9 126.12 69.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.825 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.552 ' HA2' ' HG3' ' A' ' 39' ' ' GLN . . . -91.16 120.4 5.95 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.608 -0.805 . . . . 0.0 111.376 176.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 65.8 mt -103.92 122.99 57.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 116.861 0.33 . . . . 0.0 111.051 -175.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.555 ' HA ' ' O ' ' A' ' 41' ' ' THR . 9.3 t70 -85.84 137.74 32.55 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 176.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 54.5 ttt-85 -74.87 -28.23 60.57 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -172.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -161.92 -18.3 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -171.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.47 ' HG3' ' HB2' ' A' ' 43' ' ' SER . 5.3 mm-40 -78.59 132.25 65.73 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-O 121.294 0.569 . . . . 0.0 111.198 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.58 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 28.4 Cg_endo -71.89 -169.94 0.49 Allowed 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 123.307 2.671 . . . . 0.0 114.366 -178.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.414 ' O ' HD23 ' A' ' 84' ' ' LEU . 79.4 mt -53.5 -59.01 5.13 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 114.958 -1.019 . . . . 0.0 113.106 -173.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.58 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -59.53 -33.43 71.38 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.479 -172.111 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.487 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 34.1 mmtp -64.35 -55.89 18.14 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.014 0.435 . . . . 0.0 110.325 174.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 79' ' ' PRO . 92.7 t -57.95 -44.39 86.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.43 -177.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.453 HD11 ' HB ' ' A' ' 21' ' ' THR . 4.4 mm? -69.01 -13.11 62.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.729 -178.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.523 ' HA ' ' HD2' ' A' ' 88' ' ' LYS . . . -99.84 -42.05 6.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.925 0.393 . . . . 0.0 110.789 176.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.553 ' HE2' ' SD ' ' A' ' 52' ' ' MET . 71.7 t80 -64.63 -38.08 89.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.841 -177.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -54.63 -56.01 23.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.338 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.523 ' HD2' ' HA ' ' A' ' 85' ' ' ALA . 0.3 OUTLIER -66.98 -19.05 65.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.171 0.51 . . . . 0.0 110.838 -175.519 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.4 m -81.55 -1.89 47.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.333 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.5 p -138.43 11.03 2.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.224 0.535 . . . . 0.0 110.491 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.68 -74.2 1.17 Allowed Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.514 ' HA ' ' OE1' ' A' ' 56' ' ' GLU . 54.6 t 29.65 93.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.108 1.363 . . . . 0.0 114.408 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 71.9 p -97.17 -11.91 23.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.038 0.447 . . . . 0.0 110.186 174.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.522 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 37.6 p90 -81.52 144.33 52.85 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.472 176.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.2 138.37 81.0 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.714 2.276 . . . . 0.0 113.044 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.408 HD11 HG11 ' A' ' 92' ' ' VAL . 83.8 mt -110.9 142.07 43.46 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.938 177.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 74' ' ' ILE . . . -115.0 142.7 17.79 Favored Glycine 0 N--CA 1.441 -1.009 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 177.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.785 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.8 pt? -103.11 129.62 50.02 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.938 0.399 . . . . 0.0 110.815 -177.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -119.33 72.07 13.23 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.818 177.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.458 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 20.1 Cg_exo -65.28 108.48 1.17 Allowed 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.504 2.136 . . . . 0.0 112.312 -176.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 118.9 -6.23 13.58 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.6 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 59.35 44.99 14.51 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.897 0.479 . . . . 0.0 111.784 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -80.8 -55.52 4.76 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 120.973 0.416 . . . . 0.0 110.499 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 38.4 mm -62.02 -35.28 67.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 176.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.672 ' HZ ' ' HA ' ' A' ' 115' ' ' ILE . 38.9 t80 -60.48 -40.61 91.89 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.264 174.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -76.89 -14.72 59.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.184 -177.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 50.0 mttp -72.75 -11.16 60.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.953 0.406 . . . . 0.0 111.353 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.512 ' CE1' ' HD2' ' A' ' 14' ' ' PRO . 98.9 m-85 -116.72 -30.03 5.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.413 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.571 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -162.89 -177.23 5.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.62 0.248 . . . . 0.0 110.714 -175.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.515 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . 95.6 mt -72.69 135.49 45.41 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.563 ' HA ' ' CD1' ' A' ' 105' ' ' PHE . 17.6 mtm180 -58.59 -34.51 71.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.936 -175.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -105.42 7.58 33.23 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.015 -170.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.515 ' CB ' ' HB2' ' A' ' 110' ' ' LEU . . . -96.24 49.76 1.14 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.136 0.493 . . . . 0.0 111.234 -177.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.67 104.52 0.9 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.059 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.672 ' HA ' ' HZ ' ' A' ' 105' ' ' PHE . 5.1 tt -72.07 -52.51 24.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -176.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.538 HG21 ' HA ' ' A' ' 133' ' ' LEU . 77.0 m -59.34 109.48 0.88 Allowed 'General case' 0 C--O 1.238 0.465 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -175.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.588 ' HB3' HH21 ' A' ' 132' ' ' ARG . 13.6 ptt180 -161.16 140.59 10.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.584 178.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -107.2 118.11 35.83 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 174.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 51.0 t -101.54 106.27 19.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.092 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 43.1 tp -93.49 119.19 32.27 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.278 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 68.5 mt -103.83 131.11 53.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.657 177.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.408 ' CG ' ' H ' ' A' ' 124' ' ' GLU . 0.0 OUTLIER -74.96 166.04 24.29 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.564 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -66.93 -13.38 61.7 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -174.102 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.576 ' HB2' ' NZ ' ' A' ' 126' ' ' LYS . 48.4 mt-10 -84.43 -27.58 27.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.014 0.435 . . . . 0.0 110.564 175.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.67 10.07 7.99 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.376 -0.916 . . . . 0.0 113.04 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.588 ' HG2' ' SD ' ' A' ' 12' ' ' MET . 31.6 mtmm -93.09 146.06 23.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.129 0.49 . . . . 0.0 111.729 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 56.0 mt -87.28 115.09 27.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.763 177.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 31.1 m -109.87 -16.72 8.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -172.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.587 ' HG2' HD13 ' A' ' 142' ' ' LEU . 51.2 tptt -137.5 122.68 19.24 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 119.896 -0.722 . . . . 0.0 112.107 -176.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.422 HD13 HG12 ' A' ' 9' ' ' ILE . 9.8 mp -121.91 105.18 10.11 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.212 174.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.456 HG22 ' HE3' ' A' ' 129' ' ' LYS . 67.9 p -96.67 162.05 13.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.137 0.494 . . . . 0.0 111.486 -177.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.623 ' HA ' ' HE ' ' A' ' 132' ' ' ARG . 2.1 mmp_? -127.27 106.93 9.56 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 173.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.538 ' HA ' HG21 ' A' ' 116' ' ' THR . 88.5 mt 63.24 176.43 0.16 Allowed 'General case' 0 N--CA 1.469 0.508 0 O-C-N 123.761 0.663 . . . . 0.0 111.382 -177.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.502 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 76.3 t80 -83.73 87.88 7.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.464 0.649 . . . . 0.0 109.684 175.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -104.15 135.66 45.22 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 176.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -55.44 -61.21 2.49 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 123.375 0.422 . . . . 0.0 112.03 -168.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.523 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.4 mp0 -55.74 -44.84 77.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.784 0.326 . . . . 0.0 110.885 -177.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -62.93 -46.03 89.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.509 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.579 ' CE2' ' HB3' ' A' ' 54' ' ' PHE . 63.6 t80 -69.99 -41.46 74.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.245 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.19 -40.15 89.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.575 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 48.1 m -67.12 -37.43 83.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.345 176.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.587 HD13 ' HG2' ' A' ' 129' ' ' LYS . 63.0 tp -62.47 -50.75 70.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.777 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 139' ' ' PHE . 94.6 t -56.45 -54.26 30.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.181 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -60.54 -42.85 97.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.629 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -56.28 -49.32 74.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.327 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.629 ' O ' HD23 ' A' ' 150' ' ' LEU . 28.9 mt -60.19 -50.94 78.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.1 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -55.08 -42.31 72.67 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.253 -0.179 . . . . 0.0 111.352 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -77.86 -24.51 48.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.686 0.279 . . . . 0.0 110.761 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 45.3 mmm -63.26 -31.31 72.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.403 0.621 . . . . 0.0 110.011 175.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.629 HD23 ' O ' ' A' ' 146' ' ' ILE . 4.0 mm? . . . . . 0 C--N 1.323 -0.556 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.304 177.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 . . . . . 0 CA--C 1.517 -0.293 0 N-CA-C 110.568 -0.16 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.1 pt -87.78 -18.86 8.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.218 0.533 . . . . 0.0 109.667 174.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.5 m -93.84 -179.39 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.657 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.4 ' CD ' ' HB2' ' A' ' 11' ' ' GLU . 6.2 ppt_? -144.34 165.7 27.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.847 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 69.4 mt -67.4 128.4 30.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.138 0.494 . . . . 0.0 110.745 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.52 3.22 66.96 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.096 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.4 ' HB2' ' CD ' ' A' ' 8' ' ' ARG . 8.0 tp10 -85.68 151.75 23.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.58 0.229 . . . . 0.0 110.582 -178.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.45 ' HE2' ' HA ' ' A' ' 12' ' ' MET . 1.2 mmt -69.49 116.79 10.31 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 175.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.423 ' HB2' HG12 ' A' ' 121' ' ' ILE . . . -54.49 126.07 54.45 Favored Pre-proline 0 C--O 1.237 0.401 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.489 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.487 ' HG2' ' O ' ' A' ' 107' ' ' LYS . 27.3 Cg_exo -60.42 115.54 2.73 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.802 2.335 . . . . 0.0 111.028 178.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -70.64 133.01 46.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.828 -173.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.66 ' HB2' HD12 ' A' ' 104' ' ' ILE . 36.1 p90 -136.49 158.87 43.41 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.035 -178.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 49.0 m -117.31 99.51 7.06 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.4 tt -97.87 152.32 4.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.609 -173.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.49 ' O ' HD23 ' A' ' 98' ' ' LEU . 27.3 m -99.35 129.41 45.55 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.944 178.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.42 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 82.3 mt -85.01 -178.07 6.73 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.823 0.344 . . . . 0.0 111.13 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.442 HG23 ' O ' ' A' ' 96' ' ' LEU . 30.9 p -62.55 -26.43 68.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.081 -176.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.418 ' OD1' ' HB2' ' A' ' 24' ' ' LYS . 13.1 p-10 -92.79 -5.11 51.83 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.526 -178.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.51 2.4 56.52 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.135 -176.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.418 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 6.2 tmtt? -62.87 112.34 2.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.79 0.328 . . . . 0.0 111.829 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -87.52 117.63 26.45 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 172.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 17' ' ' THR . 7.1 p -126.5 133.25 69.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.298 0.571 . . . . 0.0 110.97 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 29' ' ' SER . 11.2 m -93.92 144.75 25.17 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.209 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.62 -29.49 70.65 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.77 0.319 . . . . 0.0 110.53 -178.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.413 ' H ' HG22 ' A' ' 27' ' ' THR . 36.6 m -56.13 -30.53 62.26 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.365 176.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.2 m -74.79 -24.97 58.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.398 0.618 . . . . 0.0 110.809 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 89.4 mt -90.74 -10.87 41.39 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.532 -176.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.437 HH11 ' HA3' ' A' ' 125' ' ' GLY . 35.3 mmt180 -57.68 154.52 11.49 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.62 -19.53 36.3 Favored Glycine 0 C--O 1.226 -0.38 0 C-N-CA 121.088 -0.577 . . . . 0.0 111.885 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.579 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 32.5 mtmm -116.59 170.47 8.55 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 68' ' ' ASP . 35.4 m -81.75 123.34 37.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 176.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.417 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 12.8 t -115.78 120.6 65.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.875 0.369 . . . . 0.0 110.873 -174.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 27.2 ttt -112.42 118.27 34.73 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.01 0.433 . . . . 0.0 110.485 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.741 HD23 HD13 ' A' ' 121' ' ' ILE . 2.8 mm? -111.17 107.98 17.49 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.08 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.447 HE21 ' HB2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -109.47 127.18 54.23 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.89 175.504 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -95.39 121.12 36.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.272 0.558 . . . . 0.0 110.436 -176.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.553 ' HA ' ' SG ' ' A' ' 48' ' ' CYS . 1.9 t -122.54 171.77 8.87 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.479 -175.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.527 ' HB2' HG12 ' A' ' 115' ' ' ILE . . . -150.65 130.53 13.31 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.678 177.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.532 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 47.8 m -57.96 -28.93 64.8 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.958 -177.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 38.7 p-90 -90.56 2.4 55.82 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 52.8 t -107.59 120.31 41.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.976 0.417 . . . . 0.0 111.223 -177.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -83.41 -17.64 66.06 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.702 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.546 HG12 HG21 ' A' ' 116' ' ' THR . 42.7 t -66.37 -43.45 91.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 176.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.566 ' O ' ' HG2' ' A' ' 52' ' ' MET . 72.3 m -64.23 -27.49 69.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.318 176.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 55.4 ttt180 -69.05 -6.11 26.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.155 0.502 . . . . 0.0 110.809 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.517 ' HE3' ' CD2' ' A' ' 134' ' ' TYR . 22.9 mtpp -83.31 -55.19 4.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.476 172.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 10.6 pt-20 -70.05 -31.73 69.49 Favored 'General case' 0 C--O 1.219 -0.553 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.729 -176.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.598 ' HG3' ' HE2' ' A' ' 86' ' ' PHE . 91.7 mmm -50.6 -60.01 6.23 Favored Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.501 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 53.2 Cg_endo -69.86 -31.43 20.08 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 121.611 1.541 . . . . 0.0 112.66 177.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -68.64 -50.25 52.73 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.323 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.589 ' O ' ' HB ' ' A' ' 59' ' ' ILE . 83.8 mt -57.13 -45.38 84.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.376 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.537 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 25.5 tt0 -58.77 -48.99 79.31 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.86 175.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -56.49 -56.65 18.63 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -174.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.69 ' HA ' ' NZ ' ' A' ' 62' ' ' LYS . 73.5 m-20 -105.06 -9.88 17.54 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -171.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.589 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 50.4 mm -105.26 -57.35 4.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.646 176.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.551 ' CD2' ' HB3' ' A' ' 94' ' ' TYR . 74.9 t-105 -69.69 -51.6 33.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.134 -173.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.572 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 3.1 mm? -61.06 -16.57 45.31 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.69 ' NZ ' ' HA ' ' A' ' 58' ' ' ASP . 48.5 mmtm -86.51 -27.93 23.72 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.615 -176.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -127.48 -41.31 1.72 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -173.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.572 ' HE2' ' HA ' ' A' ' 61' ' ' LEU . 34.4 mmtt 55.4 -91.34 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 O-C-N 123.493 0.496 . . . . 0.0 111.094 -174.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -96.24 -63.3 1.16 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.019 0.438 . . . . 0.0 110.065 178.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.449 ' ND2' HD12 ' A' ' 150' ' ' LEU . 1.1 t30 66.15 3.92 2.9 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.083 174.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 62.2 4.17 1.18 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.467 0.707 . . . . 0.0 112.655 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.579 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 20.2 t70 -152.21 5.48 0.41 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.429 0.633 . . . . 0.0 111.086 -175.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.571 ' CE2' ' HB2' ' A' ' 71' ' ' LEU . 85.3 t80 -117.95 120.8 38.94 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 121.706 -0.621 . . . . 0.0 110.888 -174.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -122.03 104.62 9.64 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.931 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.571 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 3.7 tt -108.48 114.75 28.83 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.0 mm -117.81 115.84 49.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.132 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.7 116.66 4.68 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.105 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 55.8 mt -105.8 100.91 11.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 117.155 0.478 . . . . 0.0 111.336 -173.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.526 ' HA ' ' O ' ' A' ' 41' ' ' THR . 1.9 t70 -85.43 136.16 33.56 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 172.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.468 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 16.8 ttp180 -72.59 -112.13 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -165.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.468 ' H ' ' HB3' ' A' ' 76' ' ' ARG . 17.3 m-20 -78.55 5.91 9.84 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -169.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.441 ' HG3' ' H ' ' A' ' 43' ' ' SER . 28.2 mm-40 -76.92 131.23 73.67 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-O 121.027 0.441 . . . . 0.0 110.987 -176.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.478 ' HG2' ' OE2' ' A' ' 81' ' ' GLU . 29.1 Cg_endo -68.65 176.76 5.5 Favored 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 122.663 2.242 . . . . 0.0 112.7 177.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 97.2 mt -53.0 -58.22 7.71 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -173.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.478 ' OE2' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -64.5 -21.39 66.66 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -173.372 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 28.7 mmtm -74.03 -54.8 7.08 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 172.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 60.1 t -56.48 -47.37 81.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.233 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.78 -33.17 75.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.283 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.72 -35.63 62.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.744 0.306 . . . . 0.0 110.882 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.598 ' HE2' ' HG3' ' A' ' 52' ' ' MET . 60.3 t80 -69.39 -40.15 77.55 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.424 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -57.95 -55.08 39.51 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.164 176.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -62.9 -24.19 67.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.653 -175.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.7 m -84.49 2.37 41.3 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.522 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 p -130.4 -25.65 2.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.245 175.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 124.71 -81.24 0.36 Allowed Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -176.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.5 t 45.69 85.28 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 124.366 1.066 . . . . 0.0 113.547 173.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 40.5 p -93.25 15.81 14.63 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.545 173.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.551 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 42.0 p90 -111.39 148.15 38.19 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.133 175.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -63.16 130.53 29.14 Favored 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 122.436 2.091 . . . . 0.0 113.116 -177.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.442 ' O ' HG23 ' A' ' 21' ' ' THR . 94.8 mt -103.77 146.42 28.64 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.514 174.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -119.4 149.25 18.05 Favored Glycine 0 N--CA 1.438 -1.182 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 175.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.784 HD23 ' H ' ' A' ' 98' ' ' LEU . 2.1 pt? -107.02 142.08 37.21 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.854 0.359 . . . . 0.0 110.294 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -124.12 72.98 56.68 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.006 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.416 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 16.8 Cg_exo -67.71 109.81 1.96 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.718 2.279 . . . . 0.0 111.628 177.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 116.32 -3.62 20.26 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -176.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.442 ' O ' ' HG2' ' A' ' 111' ' ' ARG . . . 51.45 36.37 16.55 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.095 0.558 . . . . 0.0 112.184 -178.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -88.04 -39.55 14.56 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.115 -175.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.66 HD12 ' HB2' ' A' ' 16' ' ' PHE . 17.6 mm -66.9 -34.56 70.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 176.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.401 ' HD2' ' HA ' ' A' ' 111' ' ' ARG . 70.8 t80 -65.1 -39.03 92.57 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.728 171.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.652 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -69.0 -16.91 63.84 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.803 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.507 ' HG2' ' HA ' ' A' ' 104' ' ' ILE . 20.7 mmtt -66.35 -25.28 66.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.16 0.505 . . . . 0.0 109.903 177.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -112.69 -37.07 5.0 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.825 -174.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.652 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -147.39 168.36 22.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.668 0.27 . . . . 0.0 111.403 -174.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 9.0 mp -62.23 138.14 58.37 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 174.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 102' ' ' ALA . 97.4 mtt180 -58.25 -26.75 63.28 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 -170.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -113.41 12.42 18.74 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.474 0.654 . . . . 0.0 111.049 -178.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.506 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . . . -83.64 46.98 1.22 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.114 0.483 . . . . 0.0 110.876 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 93.39 -159.23 24.04 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.708 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.527 HG12 ' HB2' ' A' ' 42' ' ' ALA . 5.3 tp -152.89 -54.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 122.773 -0.251 . . . . 0.0 111.248 176.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.546 HG21 HG12 ' A' ' 47' ' ' VAL . 3.0 m -64.57 123.82 20.25 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 122.469 0.308 . . . . 0.0 111.341 -174.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -176.68 152.8 1.03 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.79 0.329 . . . . 0.0 110.834 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.561 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 7.8 m120 -116.65 118.41 32.5 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 177.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 41.2 t -109.79 126.85 66.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.645 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.642 HD21 ' SD ' ' A' ' 149' ' ' MET . 40.7 tp -119.7 127.02 52.48 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.068 0.461 . . . . 0.0 111.327 -178.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.741 HD13 HD23 ' A' ' 38' ' ' LEU . 1.9 mp -113.18 137.38 46.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.175 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.67 179.44 7.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.537 -178.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -62.86 -28.06 69.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.128 -176.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.615 ' HB2' ' NZ ' ' A' ' 126' ' ' LYS . 69.4 mt-10 -79.78 -12.16 59.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.108 0.48 . . . . 0.0 110.559 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.437 ' HA3' HH11 ' A' ' 32' ' ' ARG . . . 99.67 12.06 42.08 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.804 176.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.615 ' NZ ' ' HB2' ' A' ' 124' ' ' GLU . 31.5 mtmm -93.23 143.74 25.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.896 0.379 . . . . 0.0 111.093 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 47.2 mt -78.35 108.06 11.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.1 m -104.7 -20.74 5.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -171.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.568 ' HE3' ' OG1' ' A' ' 131' ' ' THR . 8.3 tmtm? -145.18 126.73 15.08 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.429 -172.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -125.54 107.24 10.42 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.542 178.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.568 ' OG1' ' HE3' ' A' ' 129' ' ' LYS . 97.7 m -95.76 139.46 31.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.799 0.333 . . . . 0.0 110.366 174.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.528 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 89.1 mtt180 -97.05 123.11 40.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.049 -178.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 132' ' ' ARG . 4.4 pp 50.89 21.54 0.98 Allowed 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 172.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.517 ' CD2' ' HE3' ' A' ' 50' ' ' LYS . 23.0 t80 58.95 112.27 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 122.284 1.04 . . . . 0.0 112.221 -176.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -119.19 139.71 51.39 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.85 174.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -53.68 -54.14 42.06 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -175.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.462 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.6 mp0 -58.31 -47.04 84.98 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.173 0.511 . . . . 0.0 110.806 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -57.3 -45.48 84.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.19 177.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.598 ' O ' HG23 ' A' ' 143' ' ' VAL . 70.0 t80 -61.72 -46.78 88.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.592 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.43 -45.68 80.61 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.084 0.468 . . . . 0.0 110.633 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.9 m -65.62 -39.02 91.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.329 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.76 -41.17 98.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.391 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 139' ' ' PHE . 96.0 t -56.05 -55.72 16.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.654 177.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -60.4 -44.44 95.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.337 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.599 ' O ' ' HG3' ' A' ' 149' ' ' MET . 5.7 tt0 -53.98 -52.13 61.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.009 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.598 ' O ' HD23 ' A' ' 150' ' ' LEU . 22.5 mt -62.36 -44.26 99.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.725 -0.216 . . . . 0.0 110.996 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -57.54 -39.42 76.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.144 0.497 . . . . 0.0 110.324 176.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -68.47 -36.06 78.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.195 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.642 ' SD ' HD21 ' A' ' 120' ' ' LEU . 90.1 mtp -64.74 -31.82 73.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.212 0.529 . . . . 0.0 110.435 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.598 HD23 ' O ' ' A' ' 146' ' ' ILE . 4.0 mm? . . . . . 0 C--N 1.324 -0.53 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.424 177.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 . . . . . 0 CA--C 1.517 -0.299 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.1 pt -92.75 -26.01 4.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.797 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.6 p -94.83 152.84 3.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.454 ' HE ' ' CD ' ' A' ' 11' ' ' GLU . 0.6 OUTLIER -118.03 156.6 28.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.315 0.578 . . . . 0.0 112.453 -171.087 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.4 mt -73.2 132.66 33.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.459 170.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.59 -9.15 77.76 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -175.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.454 ' CD ' ' HE ' ' A' ' 8' ' ' ARG . 36.2 tt0 -99.66 156.98 16.79 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 91.5 mmm -72.69 125.72 28.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.91 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.433 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -66.13 126.36 91.8 Favored Pre-proline 0 C--O 1.237 0.427 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.053 178.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.473 ' HG2' ' O ' ' A' ' 107' ' ' LYS . 45.9 Cg_exo -57.29 122.7 12.25 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.127 2.551 . . . . 0.0 112.125 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.511 ' HA ' HD12 ' A' ' 28' ' ' LEU . 1.4 t70 -71.16 134.69 47.14 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.63 -175.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.58 ' HB2' HD12 ' A' ' 104' ' ' ILE . 42.4 p90 -141.33 174.36 10.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.826 0.346 . . . . 0.0 110.793 -178.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 55.3 m -134.87 114.32 12.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.38 174.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.513 ' O ' ' HA ' ' A' ' 25' ' ' GLN . 14.4 tt -112.25 141.85 26.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.16 -174.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.3 m -88.38 120.34 29.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.68 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.654 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 85.7 mt -79.51 -179.09 6.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.3 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.475 ' HB ' HD11 ' A' ' 84' ' ' LEU . 36.6 p -51.07 -43.96 61.08 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -174.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -100.87 12.34 37.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.845 0.355 . . . . 0.0 111.493 -174.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.16 17.2 41.08 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.984 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.532 ' HE2' ' HA ' ' A' ' 24' ' ' LYS . 7.8 mmpt? -80.22 112.16 17.28 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 175.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.513 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 23.0 mt-30 -100.08 113.53 26.21 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.997 0.427 . . . . 0.0 110.49 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 17' ' ' THR . 14.1 m -105.84 147.05 11.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.723 -177.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.8 m -116.75 142.23 47.18 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.943 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.511 HD12 ' HA ' ' A' ' 15' ' ' ASP . 13.3 mt -60.99 -32.97 72.53 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 -178.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.2 m -56.68 -31.26 64.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.032 0.444 . . . . 0.0 111.062 177.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.8 m -79.32 -20.16 48.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.979 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.417 ' C ' ' HD3' ' A' ' 34' ' ' LYS . 86.5 mt -107.35 11.62 28.9 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.899 -178.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 28' ' ' LEU . 37.3 mmt180 -70.9 137.17 49.07 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 171.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.76 -7.65 57.66 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.499 -174.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.572 ' HG3' ' HA ' ' A' ' 68' ' ' ASP . 9.6 mptt -113.15 157.47 21.63 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 175.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 68' ' ' ASP . 2.1 p -84.17 103.91 11.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 170.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.435 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 22.3 t -95.86 111.62 26.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.202 -171.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 24.8 ttt -96.86 125.97 41.68 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.011 0.434 . . . . 0.0 110.277 175.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.492 HD13 HD13 ' A' ' 121' ' ' ILE . 6.5 mp -108.64 130.51 55.32 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.941 176.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.92 HE21 HD12 ' A' ' 55' ' ' ILE . 6.8 tt0 -117.66 114.5 23.45 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.441 178.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.544 ' O ' ' HA ' ' A' ' 116' ' ' THR . 94.2 m-85 -93.2 106.18 18.17 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.061 0.457 . . . . 0.0 110.152 178.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.441 ' HA ' ' SG ' ' A' ' 48' ' ' CYS . 11.7 t -117.41 175.37 5.65 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.563 -174.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.411 ' HB2' HG12 ' A' ' 115' ' ' ILE . . . -154.3 136.59 14.88 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.412 ' OG ' ' HG3' ' A' ' 78' ' ' GLU . 28.3 p -62.17 -11.07 12.48 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -173.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 2.8 p-90 -117.03 19.8 14.11 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 122.087 -0.383 . . . . 0.0 111.724 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.408 ' SG ' ' HB ' ' A' ' 47' ' ' VAL . 43.3 t -108.14 114.17 27.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.847 0.356 . . . . 0.0 110.765 178.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.18 -17.48 79.97 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.364 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.433 HG11 ' HB3' ' A' ' 133' ' ' LEU . 58.6 t -64.56 -40.1 87.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 175.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.468 ' HA ' ' HB3' ' A' ' 51' ' ' GLU . 81.1 m -68.82 -16.9 63.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.796 176.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 27.4 ttt85 -78.52 -11.98 59.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.956 0.408 . . . . 0.0 110.174 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -84.54 -50.38 7.76 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 122.128 0.966 . . . . 0.0 108.443 162.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.681 ' HB2' ' HB2' ' A' ' 134' ' ' TYR . 40.0 tt0 -57.25 -59.79 4.59 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 113.631 -1.622 . . . . 0.0 112.094 -171.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.664 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 85.7 mtp -57.37 -53.03 69.73 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -173.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.664 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 45.9 Cg_exo -60.04 -41.8 49.51 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.242 1.961 . . . . 0.0 113.053 177.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -65.16 -44.84 87.25 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.765 0.317 . . . . 0.0 110.802 177.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.92 HD12 HE21 ' A' ' 39' ' ' GLN . 64.0 mt -60.34 -42.95 92.58 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.314 176.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.578 ' OE1' ' HA ' ' A' ' 92' ' ' VAL . 37.5 tp10 -52.62 -58.81 5.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.451 0.643 . . . . 0.0 109.943 174.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -60.68 -59.09 5.94 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.36 -173.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.496 ' HA ' ' NZ ' ' A' ' 62' ' ' LYS . 72.2 m-20 -106.52 -5.26 18.94 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -168.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.608 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 22.8 mm -104.98 -57.95 4.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.061 0.458 . . . . 0.0 110.428 173.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.538 ' CD2' ' HB3' ' A' ' 94' ' ' TYR . 68.9 t-105 -66.11 -73.47 0.13 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.823 -173.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -50.98 -27.36 7.54 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -173.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.496 ' NZ ' ' HA ' ' A' ' 58' ' ' ASP . 47.9 mmtm -67.47 -33.96 76.18 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.421 ' CG ' HD11 ' A' ' 150' ' ' LEU . 67.7 m-70 -131.57 -44.5 0.99 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.236 -0.586 . . . . 0.0 112.044 -176.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.472 ' O ' ' HD2' ' A' ' 69' ' ' PHE . 9.5 mtmp? 42.93 -95.62 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.662 0.785 . . . . 0.0 112.662 -176.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.04 -72.39 0.45 Allowed 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.557 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 30.5 t30 66.75 -70.55 0.11 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.472 -177.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.402 ' HB2' ' O ' ' A' ' 66' ' ' ASN . . . 164.32 -30.33 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 124.605 1.162 . . . . 0.0 108.36 -178.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.572 ' HA ' ' HG3' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -143.27 40.18 1.46 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.965 -1.016 . . . . 0.0 112.23 -178.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.472 ' HD2' ' O ' ' A' ' 64' ' ' LYS . 80.8 t80 -119.34 138.07 53.29 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 169.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.435 ' HB3' ' HA ' ' A' ' 36' ' ' VAL . . . -134.43 139.75 45.76 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.218 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.9 tt -143.13 115.76 8.65 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -117.0 118.39 58.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.708 0.289 . . . . 0.0 110.256 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.525 ' HA3' HD13 ' A' ' 96' ' ' LEU . . . -88.38 108.67 3.45 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 175.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 59.6 mt -101.66 107.43 21.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 O-C-N 122.588 -0.36 . . . . 0.0 111.323 -173.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.52 ' HB3' HG22 ' A' ' 83' ' ' VAL . 10.7 t0 -85.58 128.47 34.77 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 174.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.405 ' HD3' HD13 ' A' ' 115' ' ' ILE . 8.4 ttp180 -91.6 126.93 36.86 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.854 -168.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.527 ' HA ' ' HA ' ' A' ' 100' ' ' PRO . 53.4 m-20 71.39 -43.9 0.57 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.999 0.919 . . . . 0.0 113.054 173.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.571 ' OE1' ' HG3' ' A' ' 82' ' ' LYS . 78.2 mm-40 -60.63 136.22 92.46 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 121.365 0.603 . . . . 0.0 112.141 -176.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.636 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 35.5 Cg_endo -71.16 -173.15 0.85 Allowed 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 123.301 2.667 . . . . 0.0 114.109 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.403 ' O ' HD23 ' A' ' 84' ' ' LEU . 91.6 mt -53.75 -57.08 12.15 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 114.745 -1.116 . . . . 0.0 113.308 -173.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.636 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -61.06 -29.81 69.96 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -171.66 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.571 ' HG3' ' OE1' ' A' ' 78' ' ' GLU . 40.5 mmtm -64.89 -58.28 6.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.237 0.541 . . . . 0.0 110.182 173.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.52 HG22 ' HB3' ' A' ' 75' ' ' ASP . 38.7 t -56.24 -49.62 75.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.476 -176.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.475 HD11 ' HB ' ' A' ' 21' ' ' THR . 4.4 mm? -63.24 -47.13 83.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.657 -176.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.21 -39.54 78.54 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -176.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.537 ' HE2' ' SD ' ' A' ' 52' ' ' MET . 79.6 t80 -68.81 -44.25 73.91 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 121.131 -0.228 . . . . 0.0 111.181 -176.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.1 -41.96 94.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.311 0.577 . . . . 0.0 109.72 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -59.07 -29.56 67.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.043 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 18.5 t -82.09 -7.21 59.61 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.946 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 43.6 p -123.49 7.78 8.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.763 0.316 . . . . 0.0 111.434 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.73 -53.2 4.28 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.942 -0.647 . . . . 0.0 113.092 176.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.578 ' HA ' ' OE1' ' A' ' 56' ' ' GLU . 77.1 t -2.06 113.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 125.843 1.657 . . . . 0.0 115.392 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 58.9 p -100.45 -17.73 17.03 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.61 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.538 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 29.7 p90 -72.76 145.37 86.86 Favored Pre-proline 0 N--CA 1.462 0.145 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.322 176.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.98 134.25 45.39 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.887 2.391 . . . . 0.0 113.865 -174.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.525 HD13 ' HA3' ' A' ' 73' ' ' GLY . 4.1 mm? -99.5 149.85 22.8 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.453 175.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.654 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -130.87 158.88 22.8 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.589 -0.605 . . . . 0.0 111.589 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 98' ' ' LEU . 6.2 mp -99.52 139.56 35.0 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.647 0.261 . . . . 0.0 110.613 -177.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -125.73 75.33 70.54 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.174 173.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.527 ' HA ' ' HA ' ' A' ' 77' ' ' ASP . 61.4 Cg_endo -73.94 115.67 4.4 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.569 2.179 . . . . 0.0 112.335 -176.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 102.18 -0.66 50.82 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 56.92 36.8 28.25 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 115.189 -0.505 . . . . 0.0 111.468 -177.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -73.63 -48.05 35.41 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.389 -176.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.58 HD12 ' HB2' ' A' ' 16' ' ' PHE . 18.0 mm -67.41 -36.43 76.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.421 ' CD2' ' HA ' ' A' ' 111' ' ' ARG . 79.3 t80 -65.1 -41.14 95.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.085 174.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.638 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -66.16 -20.75 66.24 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.608 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.473 ' O ' ' HG2' ' A' ' 14' ' ' PRO . 53.0 mttp -74.14 -13.34 60.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.807 0.337 . . . . 0.0 111.164 177.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -115.73 -40.41 3.36 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.012 0.434 . . . . 0.0 111.145 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.638 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -149.74 168.17 24.4 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.584 -177.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 90.9 mt -68.36 130.92 44.32 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.487 ' HG3' ' H ' ' A' ' 111' ' ' ARG . 11.5 mtm180 -53.38 -47.11 69.75 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 122.2 1.0 . . . . 0.0 109.995 -177.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -82.48 10.46 7.19 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.767 -171.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.421 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . . . -98.68 -2.61 37.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.989 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 145.27 -167.15 27.47 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.57 177.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.52 HG23 ' H ' ' A' ' 116' ' ' THR . 2.0 tp -136.19 -67.87 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.591 ' HB ' HD23 ' A' ' 133' ' ' LEU . 24.3 m -67.07 109.67 3.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.761 0.315 . . . . 0.0 111.37 -174.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -151.7 141.77 22.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.928 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.584 ' HB2' ' OG1' ' A' ' 131' ' ' THR . 51.8 m-80 -111.18 121.63 45.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.165 0.507 . . . . 0.0 110.276 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 49.9 t -115.99 118.32 58.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.803 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.61 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 43.0 tp -106.84 127.09 53.11 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.577 0.227 . . . . 0.0 111.211 -177.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.492 HD13 HD13 ' A' ' 38' ' ' LEU . 2.5 mp -113.73 137.63 46.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.377 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.496 ' OD2' ' HB2' ' A' ' 126' ' ' LYS . 3.7 p30 -82.34 -179.42 7.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.871 0.367 . . . . 0.0 111.217 177.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.5 ' NH2' ' HA ' ' A' ' 150' ' ' LEU . 7.0 mpt_? -59.22 -32.51 70.02 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.017 -177.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -76.88 -22.59 53.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.151 0.5 . . . . 0.0 110.856 -173.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 111.64 6.8 24.74 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.175 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.496 ' HB2' ' OD2' ' A' ' 122' ' ' ASP . 9.1 mtmp? -93.95 149.85 20.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.818 0.342 . . . . 0.0 110.914 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.445 HG21 HD21 ' A' ' 130' ' ' LEU . 62.5 mt -84.4 130.5 35.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.273 177.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 18.1 m -121.89 4.04 6.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -177.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.722 ' HE2' ' HB3' ' A' ' 142' ' ' LEU . 53.3 tptt -160.58 128.72 4.57 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.314 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.445 HD21 HG21 ' A' ' 127' ' ' ILE . 90.0 mt -132.0 104.39 6.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.478 174.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.584 ' OG1' ' HB2' ' A' ' 118' ' ' ASN . 22.9 p -107.88 156.45 19.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.017 0.437 . . . . 0.0 111.638 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.948 HH12 ' HG3' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -104.72 118.94 37.82 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.262 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.591 HD23 ' HB ' ' A' ' 116' ' ' THR . 50.0 mt 65.49 -173.47 0.18 Allowed 'General case' 0 C--O 1.236 0.389 0 O-C-N 123.883 0.739 . . . . 0.0 109.831 -175.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.681 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 9.4 t80 -58.91 -44.89 91.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.017 173.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.515 ' HB3' ' HB2' ' A' ' 138' ' ' GLU . 0.2 OUTLIER 55.82 95.34 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.851 0.72 . . . . 0.0 110.684 174.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -40.97 -59.34 1.48 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.226 -172.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.551 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 0.7 OUTLIER -68.45 -47.06 68.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.568 -176.56 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.948 ' HG3' HH12 ' A' ' 132' ' ' ARG . 2.5 mm-40 -64.97 -34.54 78.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.092 -175.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.494 ' HE1' HG12 ' A' ' 55' ' ' ILE . 82.2 t80 -63.51 -44.21 94.97 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.812 175.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.497 ' O ' HG12 ' A' ' 143' ' ' VAL . . . -62.07 -42.39 99.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.382 0.61 . . . . 0.0 110.361 177.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.4 m -61.49 -46.0 91.84 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.318 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.722 ' HB3' ' HE2' ' A' ' 129' ' ' LYS . 4.3 pp -80.19 -28.91 38.6 Favored 'General case' 0 C--O 1.217 -0.65 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.262 -176.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 140' ' ' ALA . 12.6 p -60.57 -42.09 90.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.356 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -66.41 -45.59 79.42 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.416 174.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.605 ' O ' ' HG3' ' A' ' 149' ' ' MET . 44.3 tt0 -55.78 -53.4 57.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.731 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.657 HG13 ' O ' ' A' ' 142' ' ' LEU . 38.0 mt -57.41 -47.01 85.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.929 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -48.92 -58.81 4.26 Favored 'General case' 0 CA--C 1.517 -0.327 0 O-C-N 123.134 0.271 . . . . 0.0 110.883 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -68.18 -26.15 65.6 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 123.43 0.456 . . . . 0.0 111.233 -175.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.605 ' HG3' ' O ' ' A' ' 145' ' ' GLN . 51.1 mtp -57.86 -48.88 78.51 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.022 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.609 HD23 ' O ' ' A' ' 146' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.321 -0.642 0 C-N-CA 119.253 -0.979 . . . . 0.0 112.097 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 . . . . . 0 C--O 1.236 0.358 0 CA-C-O 120.814 0.34 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.2 pt -89.38 -11.2 10.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.2 0.524 . . . . 0.0 109.749 175.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.8 p -94.2 162.97 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.297 177.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.593 ' HB2' ' HB2' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -128.65 151.17 49.81 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.32 -169.564 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.499 HG12 HD23 ' A' ' 130' ' ' LEU . 57.6 mt -75.24 132.91 32.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.165 177.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.69 5.01 90.23 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.615 -177.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.593 ' HB2' ' HB2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -115.02 161.48 18.28 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -176.211 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 85.3 mmm -68.15 133.47 48.96 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.093 0.473 . . . . 0.0 111.916 -173.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -81.73 134.58 50.27 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.585 173.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.542 ' HG2' ' O ' ' A' ' 107' ' ' LYS . 33.2 Cg_exo -62.2 121.09 8.96 Favored 'Trans proline' 0 N--CA 1.464 -0.225 0 C-N-CA 122.822 2.348 . . . . 0.0 111.759 175.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.46 ' OD1' HG22 ' A' ' 27' ' ' THR . 1.3 t70 -73.74 134.58 43.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.505 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.62 ' HB2' HD12 ' A' ' 104' ' ' ILE . 51.3 p90 -136.88 165.78 25.15 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.057 -173.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 58.5 m -119.74 115.48 23.98 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.439 172.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.7 tt -111.99 150.68 14.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.86 -174.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.2 m -98.77 125.11 44.03 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.263 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.542 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 85.8 mt -84.65 -177.81 6.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.791 -176.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.488 ' HB ' HD11 ' A' ' 84' ' ' LEU . 28.3 p -56.07 -40.51 73.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.837 -175.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.405 ' OD2' ' HG3' ' A' ' 24' ' ' LYS . 7.5 p-10 -98.75 12.07 36.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.915 0.388 . . . . 0.0 111.042 -177.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.8 3.03 60.98 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.388 -0.91 . . . . 0.0 113.617 176.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.479 ' HB2' HD12 ' A' ' 20' ' ' LEU . 60.7 mttp -64.83 124.89 23.17 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 117.357 0.578 . . . . 0.0 111.012 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -104.83 113.79 27.6 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 17' ' ' THR . 16.4 m -122.5 148.78 26.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.858 -176.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.46 HG22 ' OD1' ' A' ' 15' ' ' ASP . 4.9 m -106.65 148.08 28.77 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.438 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.502 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 0.6 OUTLIER -61.03 -32.94 72.53 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -177.515 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.526 ' HA ' ' CG ' ' A' ' 32' ' ' ARG . 60.9 m -54.56 -25.26 24.99 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.144 177.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.6 t -77.35 -11.07 59.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.942 0.401 . . . . 0.0 110.766 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.485 HD13 ' HB1' ' A' ' 70' ' ' ALA . 76.5 mt -119.56 0.44 11.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.381 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.526 ' CG ' ' HA ' ' A' ' 29' ' ' SER . 52.1 mmm-85 -68.24 131.57 45.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.877 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.7 -27.27 7.63 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -172.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.702 ' HB2' ' C ' ' A' ' 68' ' ' ASP . 12.9 ptpt -116.09 165.63 12.92 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 174.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 68' ' ' ASP . 4.0 p -80.7 123.41 37.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.197 0.522 . . . . 0.0 110.574 -177.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.432 HG22 ' HB3' ' A' ' 70' ' ' ALA . 23.5 t -110.95 123.87 67.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.372 -176.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.558 ' SD ' HG21 ' A' ' 59' ' ' ILE . 26.1 ttt -103.03 131.51 49.96 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.233 176.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.553 HD13 HD13 ' A' ' 121' ' ' ILE . 5.5 mp -126.03 148.3 49.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.477 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.5 148.54 42.81 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 169.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -112.81 113.15 25.11 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.054 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.4 t -129.41 -168.77 1.99 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.406 -174.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.521 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . . . -163.87 165.52 22.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.548 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.541 ' HB2' ' HB3' ' A' ' 82' ' ' LYS . 7.6 t -73.45 -25.04 60.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.177 0.513 . . . . 0.0 111.132 -172.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 68.2 p-90 -88.81 0.3 56.65 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 122.233 -0.292 . . . . 0.0 111.684 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 42' ' ' ALA . 73.7 m -78.99 99.63 6.94 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.183 0.516 . . . . 0.0 111.218 -178.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.49 -37.49 89.97 Favored Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.89 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.521 HG21 HD11 ' A' ' 133' ' ' LEU . 38.1 t -63.19 -32.48 56.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.057 0.456 . . . . 0.0 110.617 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.644 ' SG ' HG22 ' A' ' 116' ' ' THR . 84.8 m -70.37 -15.51 62.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.277 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.748 ' HE ' ' HE1' ' A' ' 86' ' ' PHE . 98.9 mtt180 -77.81 -6.75 55.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.246 0.546 . . . . 0.0 110.084 176.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.483 ' HE2' ' CE2' ' A' ' 134' ' ' TYR . 54.6 mtpt -100.64 -43.29 6.21 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 164.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.61 ' HB3' ' HA ' ' A' ' 48' ' ' CYS . 23.0 tt0 -52.43 -64.12 0.92 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.328 -1.305 . . . . 0.0 112.218 -177.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.434 ' HE2' ' CE2' ' A' ' 86' ' ' PHE . 39.7 mtm -65.25 -46.27 71.63 Favored Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -171.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.445 ' HG2' ' O ' ' A' ' 49' ' ' ARG . 72.4 Cg_exo -53.9 -38.37 85.95 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.709 1.606 . . . . 0.0 111.885 174.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.49 ' HB3' ' CZ ' ' A' ' 139' ' ' PHE . 4.9 m-85 -69.11 -42.79 75.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.781 176.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 51' ' ' GLU . 76.4 mt -57.12 -48.52 81.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.173 175.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.627 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 13.9 tp10 -55.78 -48.84 74.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.097 175.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -55.08 -57.08 13.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.775 -176.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.637 ' HA ' ' NZ ' ' A' ' 62' ' ' LYS . 44.8 m-20 -106.42 -43.14 4.84 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -170.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.558 HG21 ' SD ' ' A' ' 37' ' ' MET . 1.9 mp -75.62 -56.72 7.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.982 0.42 . . . . 0.0 110.801 -176.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.784 ' CE2' ' HG2' ' A' ' 64' ' ' LYS . 22.4 t-105 -72.02 -58.82 3.11 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.338 -173.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.627 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.8 OUTLIER -44.68 -43.66 8.52 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.674 0.79 . . . . 0.0 113.027 -173.621 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.637 ' NZ ' ' HA ' ' A' ' 58' ' ' ASP . 30.0 mmtm -84.2 -23.93 30.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.206 0.526 . . . . 0.0 111.484 -174.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 68.3 m-70 -125.53 24.76 7.17 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -166.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.784 ' HG2' ' CE2' ' A' ' 60' ' ' TRP . 28.7 mttt -53.81 93.93 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 123.079 1.418 . . . . 0.0 112.528 -177.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.636 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 13.4 t70 64.4 -42.96 0.29 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 110.538 -3.028 . . . . 0.0 110.508 -168.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.49 ' H ' ' C ' ' A' ' 64' ' ' LYS . 13.0 t30 66.31 -57.08 0.38 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.094 0.958 . . . . 0.0 111.001 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 167.18 -31.35 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 125.271 1.428 . . . . 0.0 107.355 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.702 ' C ' ' HB2' ' A' ' 34' ' ' LYS . 21.7 p-10 -147.91 32.92 0.84 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.185 -1.37 . . . . 0.0 111.292 -173.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.636 ' O ' ' HA ' ' A' ' 65' ' ' ASP . 88.1 t80 -127.29 133.26 50.17 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.977 0.418 . . . . 0.0 110.014 172.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.558 ' HB2' ' HD2' ' A' ' 34' ' ' LYS . . . -124.76 142.13 51.63 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.342 175.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.5 tt -135.46 117.74 15.6 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 68.1 mt -123.87 119.42 56.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.382 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.426 ' HA3' HD22 ' A' ' 96' ' ' LEU . . . -89.69 131.35 10.68 Favored Glycine 0 C--O 1.222 -0.598 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 174.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 48.5 mt -119.78 141.64 38.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 117.548 0.674 . . . . 0.0 111.017 -173.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.521 ' OD2' ' HA ' ' A' ' 42' ' ' ALA . 10.2 t0 -114.42 120.5 40.52 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 176.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.651 ' HG2' HD13 ' A' ' 115' ' ' ILE . 4.4 ptm180 -73.84 -2.84 25.38 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -165.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.586 ' HA ' ' HA ' ' A' ' 100' ' ' PRO . 0.4 OUTLIER -169.44 -32.26 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 118.448 -1.301 . . . . 0.0 113.713 -175.135 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.424 ' HB3' ' HG3' ' A' ' 82' ' ' LYS . 35.8 mt-10 -78.7 142.0 60.76 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 121.324 0.583 . . . . 0.0 111.658 -173.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.615 ' HG2' ' OE2' ' A' ' 81' ' ' GLU . 38.5 Cg_endo -71.2 -173.81 1.02 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.185 2.59 . . . . 0.0 114.437 -174.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 89.1 mt -51.43 -57.43 9.0 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.756 -174.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.615 ' OE2' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -61.11 -28.57 69.19 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -172.326 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.612 ' HG2' ' OE2' ' A' ' 81' ' ' GLU . 44.0 mmtm -67.38 -52.75 36.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.794 0.33 . . . . 0.0 110.445 173.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 62.0 t -59.55 -51.1 76.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.241 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.488 HD11 ' HB ' ' A' ' 21' ' ' THR . 4.3 mm? -65.27 -36.5 84.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.488 -176.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.403 ' O ' ' HG2' ' A' ' 88' ' ' LYS . . . -75.5 -32.19 60.44 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 121.061 -0.256 . . . . 0.0 111.232 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.748 ' HE1' ' HE ' ' A' ' 49' ' ' ARG . 79.5 t80 -74.83 -41.27 60.22 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.492 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.42 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -59.53 -53.27 59.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.7 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 85' ' ' ALA . 19.7 pttm -55.92 -31.75 63.16 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.762 -174.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 68.5 m -87.13 2.19 50.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.386 -175.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 33.3 p -130.57 10.1 5.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.344 0.592 . . . . 0.0 110.342 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.5 -73.11 1.68 Allowed Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.507 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.4 t 29.85 90.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.808 1.243 . . . . 0.0 114.092 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 76.0 p -98.93 17.97 18.31 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.133 0.492 . . . . 0.0 110.726 175.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.611 ' HB3' ' CE2' ' A' ' 60' ' ' TRP . 31.1 p90 -114.52 147.66 38.56 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.885 175.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.4 135.89 60.38 Favored 'Trans proline' 0 C--O 1.239 0.537 0 C-N-CA 122.44 2.093 . . . . 0.0 113.453 -176.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.434 ' O ' HG23 ' A' ' 21' ' ' THR . 72.7 mt -111.6 144.99 39.96 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.491 175.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.542 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -122.52 150.55 16.91 Favored Glycine 0 N--CA 1.441 -1.025 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 176.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.669 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.7 pt? -117.11 132.11 56.74 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -177.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.489 ' OD1' ' HA ' ' A' ' 76' ' ' ARG . 5.0 p-10 -125.12 83.38 60.65 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-O 121.945 0.879 . . . . 0.0 110.635 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.586 ' HA ' ' HA ' ' A' ' 77' ' ' ASP . 18.5 Cg_endo -57.03 130.31 39.05 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.882 2.388 . . . . 0.0 112.545 -176.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.56 11.13 69.19 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.646 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 76' ' ' ARG . . . 53.03 51.73 15.2 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 122.891 0.476 . . . . 0.0 111.998 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.456 ' HB2' HH22 ' A' ' 111' ' ' ARG . 28.6 t70 -82.29 -53.86 5.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.953 0.406 . . . . 0.0 111.076 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.62 HD12 ' HB2' ' A' ' 16' ' ' PHE . 17.1 mm -68.36 -30.62 48.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.407 ' HB3' ' HB1' ' A' ' 102' ' ' ALA . 74.7 t80 -60.65 -37.92 83.14 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.627 170.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.893 ' HB2' ' HG2' ' A' ' 111' ' ' ARG . . . -72.68 -15.09 61.7 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.034 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.542 ' O ' ' HG2' ' A' ' 14' ' ' PRO . 14.1 mptt -69.3 -15.97 63.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.908 0.385 . . . . 0.0 110.798 173.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -126.0 -32.94 2.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.026 0.441 . . . . 0.0 111.524 -177.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.636 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -133.68 -172.78 3.06 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.276 -178.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.8 mt -85.06 153.18 22.88 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.893 ' HG2' ' HB2' ' A' ' 106' ' ' ALA . 20.2 mtp180 -71.48 -14.11 62.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.403 0.62 . . . . 0.0 110.344 -176.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -101.09 -1.89 32.92 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.907 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.28 155.38 40.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.227 0.536 . . . . 0.0 111.916 -174.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.8 155.22 42.05 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.131 -0.941 . . . . 0.0 113.662 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.651 HD13 ' HG2' ' A' ' 76' ' ' ARG . 3.3 tp -84.15 -175.25 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 123.211 0.604 . . . . 0.0 110.366 -176.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.644 HG22 ' SG ' ' A' ' 48' ' ' CYS . 77.0 p 61.52 79.5 0.25 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.461 1.104 . . . . 0.0 111.524 177.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' A' ' 117' ' ' ARG . 9.0 mtp180 -140.59 132.49 27.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.09 -177.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.647 ' HB3' ' HB ' ' A' ' 131' ' ' THR . 0.2 OUTLIER -107.73 126.18 52.3 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.595 ' N ' HD22 ' A' ' 118' ' ' ASN . 16.7 t -122.88 138.4 53.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.157 -178.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 46.3 tp -126.49 122.82 36.28 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.911 -0.315 . . . . 0.0 110.5 177.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.553 HD13 HD13 ' A' ' 38' ' ' LEU . 1.9 mp -106.34 134.59 47.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.152 177.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.68 174.79 10.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.963 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -72.23 -15.59 61.93 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -172.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -80.33 -28.3 38.16 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.25 0.547 . . . . 0.0 109.863 175.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 116.85 10.36 10.12 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.316 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -100.44 153.17 19.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.097 0.475 . . . . 0.0 111.744 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.508 HG21 HD21 ' A' ' 130' ' ' LEU . 4.4 mm -76.53 133.24 31.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.294 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 28.0 m -126.07 3.07 4.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.577 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 53.1 tptt -166.57 127.35 1.67 Allowed 'General case' 0 C--O 1.232 0.16 0 C-N-CA 120.481 -0.488 . . . . 0.0 112.027 -177.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.508 HD21 HG21 ' A' ' 127' ' ' ILE . 3.1 mm? -126.99 115.51 19.35 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.471 172.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.647 ' HB ' ' HB3' ' A' ' 118' ' ' ASN . 95.2 m -123.85 134.99 53.48 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.538 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -106.5 122.37 46.16 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.521 HD11 HG21 ' A' ' 47' ' ' VAL . 10.6 tp 71.78 156.22 0.16 Allowed 'General case' 0 C--O 1.232 0.155 0 O-C-N 124.191 0.932 . . . . 0.0 110.388 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.516 ' CE2' ' HG2' ' A' ' 136' ' ' GLU . 51.1 t80 -72.52 89.04 1.26 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.362 0.601 . . . . 0.0 109.935 174.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.557 ' HB3' ' HB3' ' A' ' 138' ' ' GLU . 41.4 t30 -85.52 116.42 23.81 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 171.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.516 ' HG2' ' CE2' ' A' ' 134' ' ' TYR . 33.8 mt-10 -58.3 -52.75 64.26 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.28 -168.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -59.75 -39.59 85.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.204 0.526 . . . . 0.0 111.317 176.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.557 ' HB3' ' HB3' ' A' ' 135' ' ' ASN . 5.3 tp10 -61.99 -46.69 88.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.117 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.614 ' O ' HG23 ' A' ' 143' ' ' VAL . 82.1 t80 -59.72 -42.44 93.09 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.699 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.26 -46.44 85.99 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.121 0.486 . . . . 0.0 110.553 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.2 m -62.13 -38.81 90.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.505 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.02 -37.88 89.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.492 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 139' ' ' PHE . 97.2 t -55.39 -57.11 8.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.314 175.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -61.48 -38.23 86.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.797 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -57.43 -48.66 78.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.98 177.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.576 ' O ' HD23 ' A' ' 150' ' ' LEU . 59.6 mt -67.87 -38.95 80.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.955 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -55.42 -39.94 70.85 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.826 -0.17 . . . . 0.0 111.302 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -73.39 -35.42 65.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.762 178.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 82.1 mmm -62.83 -25.79 68.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.351 0.596 . . . . 0.0 110.119 178.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.628 HD11 ' HB2' ' A' ' 69' ' ' PHE . 4.0 mm? . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.229 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 . . . . . 0 N--CA 1.456 -0.164 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.7 pt -94.9 -27.57 4.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.946 0.403 . . . . 0.0 110.431 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.636 HG11 HD12 ' A' ' 127' ' ' ILE . 15.0 t -94.3 155.07 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 174.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 8' ' ' ARG . 16.3 mtt180 -125.47 165.41 18.49 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.838 -0.165 . . . . 0.0 110.594 -169.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.666 HG12 HD13 ' A' ' 130' ' ' LEU . 77.0 mt -67.81 118.43 11.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.854 0.359 . . . . 0.0 110.196 175.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.98 -7.58 62.75 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.893 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -86.37 153.24 22.07 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 -177.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.666 ' SD ' ' HG2' ' A' ' 126' ' ' LYS . 91.2 mmm -67.49 130.07 41.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.675 -178.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.41 ' HB2' HG13 ' A' ' 127' ' ' ILE . . . -79.3 129.93 70.59 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.664 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.408 ' HD2' ' CE1' ' A' ' 108' ' ' TYR . 31.4 Cg_exo -59.16 143.45 99.76 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.703 2.269 . . . . 0.0 111.329 174.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.96 162.55 14.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.243 -177.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.613 ' O ' ' HA ' ' A' ' 27' ' ' THR . 55.3 p90 -169.73 164.28 9.99 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.389 -173.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.9 m -123.0 100.7 7.02 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 176.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.2 tt -103.26 146.65 10.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.821 0.343 . . . . 0.0 111.159 -174.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.9 m -94.27 118.38 31.5 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.586 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.458 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 93.7 mt -81.52 169.7 16.79 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.696 -177.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 31.4 p -57.34 -26.58 61.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.219 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -83.31 -7.79 59.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.203 0.525 . . . . 0.0 110.432 -178.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.52 15.4 56.98 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.23 -175.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -90.67 116.69 28.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.384 -0.408 . . . . 0.0 110.47 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -89.62 113.11 24.52 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 174.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.81 128.59 71.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.572 0.701 . . . . 0.0 111.582 -174.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.613 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 17.9 m -94.2 137.97 32.76 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.518 175.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.579 HD22 ' HD3' ' A' ' 32' ' ' ARG . 0.6 OUTLIER -60.59 -33.27 72.48 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -177.075 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.459 ' HA ' ' CG ' ' A' ' 32' ' ' ARG . 37.6 t -56.88 -23.08 41.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.824 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.9 t -81.78 -8.81 59.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.972 0.415 . . . . 0.0 110.548 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 67.4 mt -119.57 -1.16 10.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.539 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.579 ' HD3' HD22 ' A' ' 28' ' ' LEU . 8.7 mmm-85 -66.79 103.09 1.04 Allowed 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.516 ' O ' ' HG3' ' A' ' 123' ' ' ARG . . . 139.42 -20.59 2.96 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 -172.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.574 ' HD2' ' HA ' ' A' ' 68' ' ' ASP . 37.1 mtmt -114.48 168.2 10.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.415 -0.393 . . . . 0.0 109.945 175.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.484 HG11 ' HB3' ' A' ' 149' ' ' MET . 34.2 m -80.1 122.52 35.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 174.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.5 t -122.93 113.93 40.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.108 0.48 . . . . 0.0 111.081 -174.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.541 ' SD ' HG21 ' A' ' 59' ' ' ILE . 26.9 ttt -97.19 126.55 42.45 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.447 177.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.516 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 7.3 mp -118.92 152.89 35.5 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.03 176.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.473 HE21 ' HA3' ' A' ' 73' ' ' GLY . 5.1 pp0? -139.29 145.93 39.73 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 169.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 89.3 m-85 -110.35 123.29 49.58 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 177.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.8 t -134.72 173.49 11.63 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.123 -174.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.506 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . . . -149.93 160.02 43.92 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.476 -0.784 . . . . 0.0 108.933 175.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.588 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 28.8 t -70.74 -20.87 62.6 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -171.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 58.8 p-90 -97.11 3.12 51.83 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.855 0.316 . . . . 0.0 111.855 -177.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.506 ' SG ' ' HB3' ' A' ' 42' ' ' ALA . 84.0 m -87.86 108.18 19.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.155 0.502 . . . . 0.0 111.293 -178.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -79.01 -17.85 76.1 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.39 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.606 HG11 ' HB2' ' A' ' 133' ' ' LEU . 40.6 t -74.83 -45.97 42.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 177.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.453 ' SG ' HG23 ' A' ' 116' ' ' THR . 73.7 m -54.75 -32.59 60.08 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.819 177.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.528 ' HE ' ' HE1' ' A' ' 86' ' ' PHE . 98.0 mtt180 -65.5 -2.66 3.52 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.264 -0.426 . . . . 0.0 112.029 -178.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -96.81 -55.85 2.76 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.783 0.801 . . . . 0.0 109.734 173.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.657 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 5.1 pt-20 -71.45 -32.47 68.36 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.93 -175.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 63.9 mmm -52.09 -57.32 15.55 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 117.817 0.281 . . . . 0.0 111.605 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.409 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 24.7 Cg_endo -64.27 -37.18 42.01 Favored 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 121.75 1.633 . . . . 0.0 112.447 175.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -62.31 -44.15 97.18 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.536 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.568 ' O ' ' HB ' ' A' ' 59' ' ' ILE . 94.0 mt -57.95 -53.53 44.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.675 178.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.587 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 14.9 pt-20 -64.95 -38.11 89.87 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.874 -176.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -63.06 -54.39 38.82 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -174.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -107.22 -18.12 13.97 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -172.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.568 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 2.2 mp -95.21 -55.3 6.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.971 176.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.587 ' HB3' ' HA ' ' A' ' 56' ' ' GLU . 75.0 t-105 -65.48 -70.69 0.22 Allowed 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.418 -177.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.433 ' HA ' HD13 ' A' ' 61' ' ' LEU . 1.6 mm? -54.05 -23.29 13.11 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -173.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -91.6 -37.4 13.1 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -177.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -118.9 -10.96 9.79 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -169.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.51 ' HG3' ' OD1' ' A' ' 65' ' ' ASP . 19.2 pttp -36.21 -54.13 0.81 Allowed 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -168.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.51 ' OD1' ' HG3' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -87.45 -77.99 0.32 Allowed 'General case' 0 C--O 1.254 1.311 0 CA-C-O 121.299 0.571 . . . . 0.0 109.583 -178.432 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.407 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 22.4 t-20 63.36 -74.83 0.04 OUTLIER 'General case' 0 C--N 1.34 0.153 0 CA-C-N 114.471 -1.24 . . . . 0.0 110.374 -174.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 66' ' ' ASN . . . 159.26 -40.43 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -177.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.574 ' HA ' ' HD2' ' A' ' 34' ' ' LYS . 30.9 t70 -114.66 11.1 16.84 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 113.904 -1.498 . . . . 0.0 111.258 -175.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -106.36 142.9 35.26 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.128 -177.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.69 143.56 33.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.377 173.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.533 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 2.8 tt -142.53 118.67 10.73 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 3.0 mp -131.1 126.99 60.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.324 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.473 ' HA3' HE21 ' A' ' 39' ' ' GLN . . . -97.85 140.74 15.21 Favored Glycine 0 C--O 1.224 -0.529 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.353 176.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 62.0 mt -120.28 123.62 70.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 117.304 0.552 . . . . 0.0 111.396 -177.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 78' ' ' GLU . 2.5 m-20 -88.1 122.02 31.19 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 172.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 59.7 ttp180 -50.61 -46.41 58.07 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -167.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 99' ' ' ASP . 7.8 p-10 -152.64 13.1 0.54 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.04 0.448 . . . . 0.0 111.134 -174.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 33.1 mm-40 -80.68 130.05 65.88 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.478 -177.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.459 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 36.7 Cg_endo -71.73 179.81 4.42 Favored 'Trans proline' 0 CA--C 1.531 0.341 0 C-N-CA 122.408 2.072 . . . . 0.0 112.687 174.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -50.69 -57.98 6.99 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.096 -171.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.462 ' OE1' ' HG2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -67.42 -30.79 70.64 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -172.427 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.462 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 41.7 mmtm -63.86 -52.66 58.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.753 0.311 . . . . 0.0 110.397 175.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 79' ' ' PRO . 88.0 t -54.21 -52.75 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.244 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.37 -38.83 92.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.35 -177.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.29 -42.13 79.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.673 0.273 . . . . 0.0 111.081 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.588 ' CD1' ' HA ' ' A' ' 43' ' ' SER . 86.8 t80 -64.83 -43.9 91.56 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 178.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.447 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -58.54 -54.31 48.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.189 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -65.65 -20.71 66.4 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -174.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.5 m -78.74 -24.3 44.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.741 0.305 . . . . 0.0 111.288 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.5 p -104.8 -22.11 13.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.083 0.468 . . . . 0.0 110.98 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 121.1 -79.32 0.33 Allowed Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -177.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.1 t 46.45 86.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 124.463 1.105 . . . . 0.0 113.265 177.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.8 m -82.09 2.5 30.97 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.039 177.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.506 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 46.7 p90 -113.32 152.7 45.41 Favored Pre-proline 0 C--N 1.331 -0.235 0 O-C-N 122.203 -0.311 . . . . 0.0 110.759 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.13 133.81 29.82 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.484 2.123 . . . . 0.0 113.437 -176.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.447 HD12 ' HB2' ' A' ' 87' ' ' ALA . 94.1 mt -104.48 161.62 13.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.081 172.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -130.12 148.3 18.48 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.168 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.417 ' N ' HD12 ' A' ' 98' ' ' LEU . 5.4 mp -86.74 133.55 33.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.544 0.211 . . . . 0.0 110.54 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.471 ' O ' ' HA ' ' A' ' 77' ' ' ASP . 40.2 t0 -121.05 73.86 26.67 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-O 121.317 0.579 . . . . 0.0 109.86 169.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.412 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 22.1 Cg_exo -64.1 103.53 0.43 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.079 1.853 . . . . 0.0 112.237 -177.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 112.0 -0.18 27.05 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.483 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.477 ' HB1' ' HG2' ' A' ' 111' ' ' ARG . . . 59.02 40.64 22.01 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.092 0.472 . . . . 0.0 111.155 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -78.82 -48.76 14.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.557 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.452 HD12 ' HB2' ' A' ' 16' ' ' PHE . 34.4 mm -66.75 -37.39 79.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -59.51 -44.68 93.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.874 175.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.587 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -67.58 -21.23 65.44 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.813 -178.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -72.96 -17.69 61.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.798 0.332 . . . . 0.0 110.921 177.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.547 ' HB2' HH22 ' A' ' 117' ' ' ARG . 79.3 m-85 -111.88 -34.26 6.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.863 -178.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.587 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -161.13 172.93 15.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.768 0.318 . . . . 0.0 110.731 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.664 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 91.4 mt -71.97 131.38 42.86 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.091 178.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.477 ' HG2' ' HB1' ' A' ' 102' ' ' ALA . 11.4 mtm180 -65.4 -31.3 72.33 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.268 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -84.38 -7.36 59.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.748 -178.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.664 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . . . -75.4 -56.77 4.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.718 -178.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -163.07 -149.12 5.6 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.96 -177.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.456 HG23 ' H ' ' A' ' 116' ' ' THR . 2.8 tp -161.35 -59.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.373 0.087 . . . . 0.0 111.125 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.648 HG22 ' HA ' ' A' ' 133' ' ' LEU . 24.0 m -67.61 109.08 3.12 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.861 0.362 . . . . 0.0 111.414 -176.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.547 HH22 ' HB2' ' A' ' 108' ' ' TYR . 19.3 ptt180 -165.97 146.44 6.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.166 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.605 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 45.9 m-80 -108.95 136.53 48.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.725 175.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.4 HG21 ' HE1' ' A' ' 40' ' ' PHE . 80.6 t -120.35 102.76 13.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.101 -177.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.623 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 48.8 tp -88.75 108.14 19.33 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.707 -0.397 . . . . 0.0 109.996 178.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.403 HD13 HD11 ' A' ' 28' ' ' LEU . 56.6 mt -93.74 121.98 44.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.771 0.796 . . . . 0.0 110.523 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.69 162.66 29.2 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.485 -1.234 . . . . 0.0 111.341 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.516 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 33.8 ttm180 -52.0 -34.21 41.73 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.483 0.713 . . . . 0.0 112.742 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -83.57 -7.59 59.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.33 0.586 . . . . 0.0 109.969 -175.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 96.54 31.36 7.15 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.468 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.666 ' HG2' ' SD ' ' A' ' 12' ' ' MET . 44.2 mttm -113.04 146.49 39.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.798 0.299 . . . . 0.0 110.314 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.636 HD12 HG11 ' A' ' 7' ' ' VAL . 55.7 mt -88.94 100.98 11.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.093 177.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 29.0 m -94.17 -4.54 10.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -174.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.623 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 51.8 tptt -143.95 108.76 4.92 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.687 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.666 HD13 HG12 ' A' ' 9' ' ' ILE . 10.9 mp -98.28 104.7 16.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.962 170.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.605 ' HB ' ' HB2' ' A' ' 118' ' ' ASN . 86.0 m -103.23 125.33 49.84 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.724 -0.217 . . . . 0.0 110.703 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.57 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -96.85 108.19 20.82 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 176.788 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.648 ' HA ' HG22 ' A' ' 116' ' ' THR . 4.6 pp 51.4 -177.65 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 O-C-N 124.503 1.127 . . . . 0.0 113.259 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.657 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 75.6 t80 -87.57 117.68 26.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.912 -177.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -135.89 137.69 41.67 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.949 172.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -47.79 -62.56 1.4 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -177.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.428 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.5 mp0 -56.99 -46.75 82.01 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.316 0.579 . . . . 0.0 110.849 -178.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.487 ' HG3' HG23 ' A' ' 131' ' ' THR . 7.0 tp10 -61.72 -48.59 80.06 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.187 -177.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.469 ' O ' HG23 ' A' ' 143' ' ' VAL . 69.2 t80 -67.38 -39.16 85.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.048 -178.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.79 -43.52 97.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.662 175.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 45.8 m -63.04 -38.1 89.82 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.547 177.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.548 ' O ' HG13 ' A' ' 146' ' ' ILE . 67.7 tp -59.75 -51.61 69.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.154 177.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.493 HG22 HD11 ' A' ' 59' ' ' ILE . 61.3 t -60.19 -45.81 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.222 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -57.72 -45.05 86.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.722 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.556 ' O ' ' HG2' ' A' ' 149' ' ' MET . 9.9 tt0 -67.01 -37.34 83.98 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.391 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.548 HG13 ' O ' ' A' ' 142' ' ' LEU . 34.7 mt -59.61 -38.16 74.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.895 0.378 . . . . 0.0 109.999 175.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -59.63 -41.03 89.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.803 177.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -66.05 -36.98 84.7 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.328 0.392 . . . . 0.0 110.856 174.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.556 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 94.7 mmm -62.93 -32.1 73.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.525 0.679 . . . . 0.0 109.429 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.545 HD23 ' O ' ' A' ' 146' ' ' ILE . 3.9 mm? . . . . . 0 C--N 1.321 -0.671 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.746 176.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.52 ' CZ ' ' HD2' ' A' ' 117' ' ' ARG . 69.0 m-85 . . . . . 0 CA--C 1.52 -0.204 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.2 pt -110.23 -7.79 11.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.168 0.509 . . . . 0.0 110.144 171.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.5 m -101.47 168.8 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.733 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.603 ' HB2' ' HB2' ' A' ' 11' ' ' GLU . 38.4 mtt180 -114.83 163.25 15.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.197 -177.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.781 HG12 HD13 ' A' ' 130' ' ' LEU . 73.3 mt -79.5 121.23 32.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 174.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.48 1.34 62.31 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -175.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 8' ' ' ARG . 10.4 tp10 -83.42 155.83 23.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.36 -0.42 . . . . 0.0 110.551 -176.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.518 ' HE2' ' HA ' ' A' ' 12' ' ' MET . 4.9 mmt -65.76 127.74 33.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.452 177.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.436 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -67.48 129.94 93.45 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.663 178.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.454 ' HD2' ' CZ ' ' A' ' 108' ' ' TYR . 15.3 Cg_exo -65.98 113.54 2.63 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.668 2.245 . . . . 0.0 111.2 178.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.68 147.19 50.92 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.604 -175.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.401 ' O ' ' HA ' ' A' ' 27' ' ' THR . 44.7 p90 -155.7 164.33 38.73 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.376 -176.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.8 m -116.68 102.8 9.76 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 174.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.49 ' O ' ' HA ' ' A' ' 25' ' ' GLN . 13.1 tt -97.87 138.72 21.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.937 0.399 . . . . 0.0 111.023 -174.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.2 m -94.15 118.91 32.23 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.071 177.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.486 HD12 ' HB2' ' A' ' 24' ' ' LYS . 94.3 mt -74.54 175.99 7.28 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.944 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 96' ' ' LEU . 31.8 p -57.88 -32.2 67.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.623 -175.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -102.13 16.97 24.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.956 0.408 . . . . 0.0 111.123 -176.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.43 7.36 69.55 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.404 173.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.486 ' HB2' HD12 ' A' ' 20' ' ' LEU . 27.3 mmtp -78.76 110.01 13.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.882 0.373 . . . . 0.0 110.72 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.49 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 94.1 mt-30 -92.0 114.48 27.03 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.481 178.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.5 m -118.03 151.5 20.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.477 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.418 ' HB ' ' OG ' ' A' ' 29' ' ' SER . 1.2 p -101.91 154.2 19.16 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.879 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.8 -34.77 77.43 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 174.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.532 ' HA ' ' HG2' ' A' ' 32' ' ' ARG . 0.5 OUTLIER -59.69 -23.7 63.34 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.676 175.516 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.8 t -78.73 -12.36 60.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.041 0.448 . . . . 0.0 110.408 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 83.0 mt -112.73 -0.82 14.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.931 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.533 ' NE ' ' HA3' ' A' ' 125' ' ' GLY . 40.5 mmm-85 -66.19 102.41 0.83 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.079 0.466 . . . . 0.0 109.76 178.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 143.64 -23.47 2.16 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -174.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.412 ' HA ' ' OD1' ' A' ' 68' ' ' ASP . 43.9 mtmt -117.08 160.07 21.57 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 174.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.534 HG22 ' O ' ' A' ' 68' ' ' ASP . 10.6 m -70.45 128.38 33.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 175.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.595 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 40.6 t -111.69 114.73 47.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 120.832 0.349 . . . . 0.0 111.153 -174.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.496 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 27.0 ttt -97.15 120.6 37.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.004 0.43 . . . . 0.0 110.067 174.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.498 ' HB2' ' HB ' ' A' ' 119' ' ' VAL . 88.3 mt -112.38 123.43 50.26 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.678 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -113.11 111.05 21.45 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.13 177.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.502 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 96.8 m-85 -88.64 115.82 26.44 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.7 t -132.7 -172.85 3.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.172 -171.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.559 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . . . -172.16 143.23 1.48 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.776 ' H ' ' HG3' ' A' ' 78' ' ' GLU . 54.7 p -70.72 -15.68 62.72 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.776 -172.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.408 ' HD1' ' OE2' ' A' ' 78' ' ' GLU . 66.6 p-90 -87.28 -0.65 57.06 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.097 0.475 . . . . 0.0 110.915 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.588 ' SG ' HG12 ' A' ' 115' ' ' ILE . 74.5 m -93.12 112.57 24.55 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.996 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -75.95 -34.29 48.09 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.63 178.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 56.2 t -61.42 -45.02 99.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.677 0.238 . . . . 0.0 110.833 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.696 ' HA ' ' CD ' ' A' ' 51' ' ' GLU . 12.5 t -61.85 -15.78 44.9 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 121.421 0.629 . . . . 0.0 111.456 -174.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -72.52 -1.91 17.7 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.862 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.481 ' HE2' ' CD2' ' A' ' 134' ' ' TYR . 56.4 mtpt -90.16 -56.87 3.05 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.214 172.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.773 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 3.8 pm0 -64.34 -30.95 71.98 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.565 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.64 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 5.9 mmt -52.29 -63.61 2.08 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.629 178.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.64 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 52.6 Cg_exo -56.63 -39.47 91.15 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 122.171 1.914 . . . . 0.0 112.912 175.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.407 ' HD1' ' O ' ' A' ' 50' ' ' LYS . 21.3 m-85 -66.99 -45.69 76.85 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 93.9 mt -61.93 -42.77 96.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.78 0.324 . . . . 0.0 110.146 177.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.489 ' OE1' ' HA ' ' A' ' 92' ' ' VAL . 26.0 tp10 -57.11 -52.36 65.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.602 178.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.519 ' HA ' HD22 ' A' ' 61' ' ' LEU . 27.6 ttpp -72.66 -54.06 10.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.522 -175.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -87.13 -26.74 23.47 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -168.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.7 mt -105.64 -61.72 2.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.817 -177.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.575 ' CD2' ' HB3' ' A' ' 94' ' ' TYR . 76.7 t-105 -61.22 -64.46 0.94 Allowed 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.499 -173.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.519 HD22 ' HA ' ' A' ' 57' ' ' LYS . 1.5 mp -47.78 -32.5 6.05 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -175.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -71.51 -38.3 71.15 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -176.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.658 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 87.2 m-70 -126.18 -43.78 1.78 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.897 -174.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.7 mttp 59.01 -82.22 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.655 0.782 . . . . 0.0 111.014 -175.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -110.8 -42.32 4.05 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 171.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.658 ' HB2' ' HB3' ' A' ' 63' ' ' HIS . 3.5 t30 71.03 -68.18 0.23 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.011 175.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 66' ' ' ASN . . . 162.93 -27.02 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 124.327 1.051 . . . . 0.0 108.759 -175.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.534 ' O ' HG22 ' A' ' 35' ' ' VAL . 25.5 t0 -140.74 26.74 2.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.614 -174.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.544 ' HB2' HD11 ' A' ' 150' ' ' LEU . 87.8 t80 -135.17 144.41 47.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.824 -177.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.67 138.02 28.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.963 173.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.496 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 1.8 tt -138.51 115.37 10.78 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -178.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.4 mp -126.79 130.69 71.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.141 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.429 ' HA3' HD22 ' A' ' 96' ' ' LEU . . . -92.69 117.22 5.3 Favored Glycine 0 C--O 1.221 -0.681 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.531 177.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 41.7 mt -104.44 118.62 52.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.938 0.369 . . . . 0.0 110.556 -175.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.559 ' OD2' ' HA ' ' A' ' 42' ' ' ALA . 9.7 t70 -84.52 142.55 29.95 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 176.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.441 ' HG2' ' HB2' ' A' ' 102' ' ' ALA . 18.1 ttp180 -80.03 -40.83 26.97 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -172.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -155.16 5.88 0.23 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -168.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.776 ' HG3' ' H ' ' A' ' 43' ' ' SER . 13.4 mm-40 -88.52 133.33 36.53 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 120.908 0.385 . . . . 0.0 110.373 177.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.454 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 29.3 Cg_endo -68.17 -173.11 0.48 Allowed 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 122.875 2.383 . . . . 0.0 113.63 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.42 ' O ' HD23 ' A' ' 84' ' ' LEU . 3.1 tm? -59.07 -55.82 30.15 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.084 -169.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.454 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -66.01 -34.13 77.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.497 0.189 . . . . 0.0 111.501 -173.832 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.433 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 2.7 mmmp? -60.24 -50.1 74.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.019 177.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 66.1 t -62.55 -44.85 99.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.921 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.42 HD23 ' O ' ' A' ' 80' ' ' LEU . 4.2 mm? -61.03 -47.37 86.75 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.831 0.348 . . . . 0.0 111.579 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.96 -30.93 68.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.232 -178.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -73.2 -47.75 40.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.553 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.59 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -52.34 -55.16 23.39 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.142 -177.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.82 -11.29 60.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.658 -174.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.6 m -94.81 -22.08 18.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.011 178.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.7 p -91.49 -4.51 55.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.594 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.66 0.91 90.42 Favored Glycine 0 C--O 1.228 -0.229 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.356 178.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.489 ' HA ' ' OE1' ' A' ' 56' ' ' GLU . 72.5 t -66.7 123.08 18.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 122.798 0.439 . . . . 0.0 111.386 -179.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.3 p -101.63 -18.83 15.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.652 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.575 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 52.7 p90 -77.52 141.76 65.79 Favored Pre-proline 0 N--CA 1.454 -0.26 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.513 177.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.404 ' HB2' HD22 ' A' ' 20' ' ' LEU . 18.5 Cg_endo -60.06 131.88 41.53 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 122.688 2.259 . . . . 0.0 113.409 -175.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.59 HD12 ' HB2' ' A' ' 87' ' ' ALA . 66.5 mt -102.39 147.49 26.64 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.002 173.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.462 ' HA3' HD11 ' A' ' 18' ' ' ILE . . . -122.3 143.84 15.76 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 177.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.787 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.0 OUTLIER -98.15 132.34 43.76 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.788 0.328 . . . . 0.0 110.551 -177.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.418 ' HB3' ' O ' ' A' ' 75' ' ' ASP . 14.2 t0 -115.23 74.79 4.07 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.521 176.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.473 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 23.5 Cg_exo -63.17 104.7 0.42 Allowed 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.573 2.182 . . . . 0.0 112.364 -176.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 115.36 -4.54 21.72 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.772 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.441 ' HB2' ' HG2' ' A' ' 76' ' ' ARG . . . 57.52 47.42 16.2 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 122.731 0.412 . . . . 0.0 111.476 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.435 ' HA ' HH21 ' A' ' 111' ' ' ARG . 15.0 t70 -80.59 -50.62 9.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.98 0.419 . . . . 0.0 110.173 178.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 96.9 mt -61.93 -40.09 85.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 176.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -62.5 -40.39 96.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.541 176.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -67.4 -23.65 65.59 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.223 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -73.25 -13.5 61.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.257 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.454 ' CZ ' ' HD2' ' A' ' 14' ' ' PRO . 45.3 m-85 -113.49 -34.38 5.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.832 0.349 . . . . 0.0 111.563 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -158.92 168.28 27.2 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.899 0.38 . . . . 0.0 111.209 -177.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.445 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 90.1 mt -67.29 138.63 56.98 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 175.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.435 HH21 ' HA ' ' A' ' 103' ' ' ASP . 94.5 mtt180 -63.16 -27.04 69.1 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.577 -174.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -92.82 -16.75 24.95 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.315 -178.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.445 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . . . -80.85 47.92 1.03 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -172.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.58 143.14 9.74 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.328 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.588 HG12 ' SG ' ' A' ' 45' ' ' CYS . 1.8 tp -87.41 -64.07 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -176.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.42 ' H ' HG23 ' A' ' 115' ' ' ILE . 6.5 m -64.78 128.03 34.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.857 0.361 . . . . 0.0 111.315 -173.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.52 ' HD2' ' CZ ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -145.43 132.13 19.97 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.432 178.28 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.705 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 3.8 m-20 -107.91 117.66 34.7 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 176.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.498 ' HB ' ' HB2' ' A' ' 38' ' ' LEU . 73.2 t -120.57 118.97 58.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.426 -177.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.898 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 25.4 tp -109.77 120.13 41.53 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.261 0.553 . . . . 0.0 110.486 176.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.595 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 74.2 mt -104.23 142.02 18.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.948 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.86 172.25 13.75 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.408 ' HD3' ' OD2' ' A' ' 68' ' ' ASP . 26.8 ptt180 -78.01 20.96 0.34 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -175.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.443 ' OE1' ' HE3' ' A' ' 12' ' ' MET . 1.7 tm-20 -110.88 -35.72 5.88 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 169.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.533 ' HA3' ' NE ' ' A' ' 32' ' ' ARG . . . 122.51 20.54 2.9 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.667 -172.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 29.3 mtmm -103.42 135.71 44.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.621 0.248 . . . . 0.0 110.493 177.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.4 HG23 HG13 ' A' ' 119' ' ' VAL . 56.4 mt -78.62 101.74 4.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 177.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.4 m -100.61 -21.63 5.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -170.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.898 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 61.0 tptt -132.03 117.05 17.87 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.131 0.491 . . . . 0.0 111.439 -176.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.781 HD13 HG12 ' A' ' 9' ' ' ILE . 10.3 mp -104.24 104.86 14.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.739 176.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.705 ' HB ' ' HB2' ' A' ' 118' ' ' ASN . 54.6 m -109.45 132.34 54.22 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.111 0.481 . . . . 0.0 110.746 -178.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.472 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 0.1 OUTLIER -91.92 107.9 19.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.825 -177.819 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 132' ' ' ARG . 0.6 OUTLIER 43.9 -160.89 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.28 0.987 . . . . 0.0 112.359 -179.008 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.773 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 94.4 t80 -85.39 84.9 7.5 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.643 0.735 . . . . 0.0 111.283 176.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.505 ' HB3' ' HB3' ' A' ' 138' ' ' GLU . 27.0 t-20 -89.09 120.07 30.16 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 165.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.428 ' HG2' ' CE2' ' A' ' 134' ' ' TYR . 46.4 mt-10 -56.38 -48.22 77.32 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -170.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.2 mp0 -68.04 -40.5 82.86 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.047 0.451 . . . . 0.0 110.511 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.505 ' HB3' ' HB3' ' A' ' 135' ' ' ASN . 8.5 tp10 -64.7 -41.05 96.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.374 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.44 ' O ' HG23 ' A' ' 143' ' ' VAL . 86.8 t80 -64.16 -40.39 96.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.381 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -59.12 -47.92 83.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.285 177.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 21.2 m -62.88 -39.87 95.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.636 176.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.459 ' O ' HG13 ' A' ' 146' ' ' ILE . 49.8 tp -60.9 -49.34 77.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.174 -178.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 139' ' ' PHE . 95.1 t -59.38 -47.96 88.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.827 0.346 . . . . 0.0 110.77 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.402 HE21 ' HB3' ' A' ' 144' ' ' GLN . 0.9 OUTLIER -60.67 -43.1 98.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.956 179.389 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.515 ' O ' ' HG2' ' A' ' 149' ' ' MET . 7.8 tt0 -59.97 -46.99 87.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.53 177.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.488 ' O ' HD23 ' A' ' 150' ' ' LEU . 81.2 mt -56.41 -47.71 81.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.721 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -55.15 -44.76 75.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.859 176.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -76.55 -10.79 59.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.771 0.32 . . . . 0.0 111.443 -178.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.515 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 88.3 mmm -78.39 -38.96 40.46 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 171.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.544 HD11 ' HB2' ' A' ' 69' ' ' PHE . 4.4 mm? . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 114.9 -1.046 . . . . 0.0 110.294 176.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.404 ' CZ ' ' HD3' ' A' ' 117' ' ' ARG . 62.6 m-85 . . . . . 0 CA--C 1.516 -0.345 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.6 pt -96.42 -15.63 7.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.771 0.32 . . . . 0.0 110.677 173.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.2 m -94.11 152.14 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.825 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.527 ' HB2' ' HB2' ' A' ' 11' ' ' GLU . 42.2 mtt85 -103.27 163.5 12.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.84 -177.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.493 HG12 HD13 ' A' ' 130' ' ' LEU . 72.5 mt -82.13 126.43 39.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 172.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.73 -10.7 64.56 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -173.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 8' ' ' ARG . 0.4 OUTLIER -77.04 150.1 35.78 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.163 -0.519 . . . . 0.0 109.809 -179.221 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.76 ' HG2' ' HG2' ' A' ' 126' ' ' LYS . 24.7 mtp -78.88 120.92 24.18 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.456 ' HA ' ' HD2' ' A' ' 14' ' ' PRO . . . -56.87 125.24 68.4 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.9 -175.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.456 ' HD2' ' HA ' ' A' ' 13' ' ' ALA . 10.0 Cg_endo -54.17 115.95 2.72 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.215 2.61 . . . . 0.0 111.736 177.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.517 ' HA ' HD12 ' A' ' 28' ' ' LEU . 1.2 t70 -68.32 138.2 55.26 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.541 -174.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.507 ' HB2' HD12 ' A' ' 104' ' ' ILE . 36.2 p90 -146.48 161.65 39.99 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.699 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 30.6 m -123.25 112.9 18.2 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 175.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.2 tt -117.63 144.51 25.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.017 0.437 . . . . 0.0 110.934 -175.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.0 m -84.59 127.19 33.93 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.406 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.411 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 85.3 mt -81.55 176.94 9.24 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.972 0.415 . . . . 0.0 110.906 177.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 96' ' ' LEU . 33.3 p -56.16 -34.89 66.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.881 -176.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -103.14 21.06 16.48 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.091 0.472 . . . . 0.0 110.71 -175.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.63 36.22 34.03 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.754 174.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 24' ' ' LYS . 43.3 mmtm -104.11 122.9 46.26 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.846 0.355 . . . . 0.0 110.649 177.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -88.48 115.91 26.34 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.956 177.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 17' ' ' THR . 14.3 m -114.91 143.77 23.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.017 0.437 . . . . 0.0 110.263 178.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 12.0 m -120.81 144.65 48.22 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.565 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.517 HD12 ' HA ' ' A' ' 15' ' ' ASP . 15.9 mt -61.7 -34.21 75.37 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.941 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.45 ' HA ' ' HG2' ' A' ' 32' ' ' ARG . 49.9 m -54.47 -38.21 66.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.927 0.394 . . . . 0.0 110.845 175.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.3 m -73.08 -23.23 60.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.24 0.543 . . . . 0.0 110.926 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.6 mt -99.54 0.44 42.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.45 ' HG2' ' HA ' ' A' ' 29' ' ' SER . 38.1 mmt180 -62.37 147.47 48.3 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 175.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 102.89 -26.53 23.72 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.771 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.581 ' HG3' ' HA ' ' A' ' 68' ' ' ASP . 3.2 mppt? -110.47 165.26 11.94 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.49 HG12 ' O ' ' A' ' 68' ' ' ASP . 2.7 p -83.01 120.27 34.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 173.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.459 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 17.3 t -108.6 131.94 57.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.79 -172.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 26.3 ttt -113.15 117.77 32.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.812 0.339 . . . . 0.0 110.471 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -109.08 112.7 25.02 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.336 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.516 HE22 ' HB ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -107.18 125.72 51.47 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 174.142 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.482 ' O ' ' HA ' ' A' ' 116' ' ' THR . 96.8 m-85 -94.29 114.59 26.69 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.242 0.544 . . . . 0.0 109.558 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.516 ' HB ' HE22 ' A' ' 39' ' ' GLN . 14.5 t -116.9 174.47 6.08 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.039 -173.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -150.6 131.28 14.0 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.597 177.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.655 ' HB2' ' HG3' ' A' ' 78' ' ' GLU . 43.9 m -65.27 -9.48 24.34 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.794 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 26.8 p-90 -110.0 11.39 24.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.837 0.351 . . . . 0.0 111.316 177.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 51.2 t -106.5 115.32 29.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.188 0.518 . . . . 0.0 111.033 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -77.75 -3.16 83.31 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.73 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.4 t -82.53 -37.98 14.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.131 0.491 . . . . 0.0 109.748 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 81.9 m -61.96 -27.79 69.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.134 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -71.51 -3.55 21.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.531 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.417 ' O ' ' HD1' ' A' ' 54' ' ' PHE . 58.2 mttp -104.03 -46.69 4.39 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 170.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.453 ' OE1' ' HA ' ' A' ' 133' ' ' LEU . 29.5 tt0 -58.19 -57.06 14.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.406 -177.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.671 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 80.1 mtp -58.51 -53.0 70.61 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.721 -172.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.671 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 50.3 Cg_exo -56.83 -40.39 84.56 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 122.101 1.868 . . . . 0.0 112.655 176.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.417 ' HD1' ' O ' ' A' ' 50' ' ' LYS . 17.1 m-85 -67.76 -44.03 78.43 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.789 177.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.443 ' O ' ' HB ' ' A' ' 59' ' ' ILE . 37.5 mt -54.5 -54.05 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.898 177.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.634 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 16.8 pt-20 -64.83 -41.49 95.71 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.579 -176.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -58.29 -49.13 78.24 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -175.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.705 ' HA ' ' NZ ' ' A' ' 62' ' ' LYS . 77.8 m-20 -106.08 -18.09 14.13 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -172.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.443 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 67.2 mt -102.75 -60.56 2.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.79 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.643 ' CE2' ' HG2' ' A' ' 64' ' ' LYS . 70.6 t-105 -65.73 -54.06 32.42 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -175.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.605 ' HA ' ' HE3' ' A' ' 64' ' ' LYS . 3.2 mm? -54.17 -29.67 46.53 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -176.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.705 ' NZ ' ' HA ' ' A' ' 58' ' ' ASP . 34.2 mmtm -88.05 -29.97 20.28 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.923 0.392 . . . . 0.0 111.219 -176.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -122.73 23.54 9.45 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -168.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.643 ' HG2' ' CE2' ' A' ' 60' ' ' TRP . 6.2 mtmp? -41.99 96.58 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.4 t70 68.25 -54.14 0.53 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 111.611 -2.54 . . . . 0.0 111.009 178.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.2 t30 50.97 11.38 0.09 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.662 -179.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 60.1 13.64 3.94 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.115 0.566 . . . . 0.0 111.758 -173.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.581 ' HA ' ' HG3' ' A' ' 34' ' ' LYS . 44.7 t0 -153.71 6.0 0.32 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.966 0.412 . . . . 0.0 111.642 -176.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.58 ' HB2' HD11 ' A' ' 150' ' ' LEU . 84.2 t80 -136.72 119.61 16.33 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 121.668 -0.645 . . . . 0.0 110.687 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -116.37 108.24 15.81 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.892 -177.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.444 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 2.6 tt -106.73 121.1 43.69 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -178.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 40.2 mm -130.33 126.62 61.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.154 178.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.476 ' HA2' ' HG3' ' A' ' 39' ' ' GLN . . . -97.91 130.21 10.16 Favored Glycine 0 C--O 1.221 -0.686 0 C-N-CA 120.228 -0.986 . . . . 0.0 111.443 176.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 72.5 mt -119.31 125.31 74.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 117.55 0.675 . . . . 0.0 111.415 -174.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -86.3 142.41 28.54 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 174.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.407 ' CB ' HD13 ' A' ' 115' ' ' ILE . 58.6 ttt-85 -74.47 -30.83 62.01 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -172.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -161.14 -22.2 0.05 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -170.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.655 ' HG3' ' HB2' ' A' ' 43' ' ' SER . 4.5 mm-40 -72.91 129.5 86.49 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-O 121.218 0.532 . . . . 0.0 111.01 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.595 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 28.1 Cg_endo -66.62 -167.05 0.12 Allowed 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.713 2.942 . . . . 0.0 115.017 -175.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.424 HD13 HD23 ' A' ' 84' ' ' LEU . 2.8 tm? -58.14 -53.51 57.41 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 114.532 -1.213 . . . . 0.0 112.329 -170.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.595 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -63.15 -29.71 71.01 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 -173.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.52 ' HG3' ' CD ' ' A' ' 78' ' ' GLU . 30.7 mmtm -66.72 -54.36 23.75 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.95 177.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.513 HG21 ' HB3' ' A' ' 98' ' ' LEU . 41.2 t -55.33 -43.97 73.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.34 -177.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.424 HD23 HD13 ' A' ' 80' ' ' LEU . 4.4 mm? -69.28 -27.28 65.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.796 0.331 . . . . 0.0 111.608 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.749 ' HA ' ' HE2' ' A' ' 88' ' ' LYS . . . -85.96 -37.65 18.81 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.272 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.536 ' HE2' ' SD ' ' A' ' 52' ' ' MET . 49.0 t80 -68.67 -42.53 77.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.809 -178.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.485 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -56.3 -53.39 57.78 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.097 178.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.749 ' HE2' ' HA ' ' A' ' 85' ' ' ALA . 63.4 pttt -65.92 -20.89 66.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.966 0.412 . . . . 0.0 111.4 -176.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.8 m -82.36 -3.53 55.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.266 178.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.48 ' HB ' ' HG3' ' A' ' 53' ' ' PRO . 15.8 p -127.1 -24.91 3.35 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.997 0.427 . . . . 0.0 111.153 177.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 122.56 -79.25 0.34 Allowed Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 -176.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 90.6 t 45.37 89.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 124.526 1.13 . . . . 0.0 113.495 176.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.498 ' HG1' ' HD1' ' A' ' 60' ' ' TRP . 3.5 p -87.24 12.42 11.83 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.637 176.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.442 ' CE1' ' HB3' ' A' ' 56' ' ' GLU . 51.1 p90 -123.17 154.1 64.98 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.304 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -67.55 140.59 52.55 Favored 'Trans proline' 0 C--O 1.238 0.499 0 C-N-CA 122.201 1.934 . . . . 0.0 113.731 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.485 HD12 ' HB2' ' A' ' 87' ' ' ALA . 93.0 mt -113.95 151.43 32.31 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.661 175.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -122.53 149.82 16.94 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 175.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.707 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.0 OUTLIER -106.34 126.69 52.55 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.763 0.316 . . . . 0.0 110.827 -177.185 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -115.65 78.95 7.11 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.07 177.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.05 99.82 0.92 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.388 2.059 . . . . 0.0 112.744 -176.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 125.56 -7.05 7.95 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.899 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 63.19 44.29 5.8 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 122.853 0.461 . . . . 0.0 111.102 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -81.88 -50.91 8.64 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.196 0.522 . . . . 0.0 110.306 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.507 HD12 ' HB2' ' A' ' 16' ' ' PHE . 29.8 mm -65.23 -36.02 76.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.504 ' CD2' ' HA ' ' A' ' 111' ' ' ARG . 70.8 t80 -63.29 -42.96 99.13 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.207 175.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.62 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -67.45 -21.88 65.52 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.79 -178.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -72.63 -12.32 61.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.834 0.35 . . . . 0.0 111.16 178.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -116.23 -42.8 3.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.08 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.62 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -146.37 161.4 40.44 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.221 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.569 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 97.9 mt -62.26 129.92 42.96 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.504 ' HA ' ' CD2' ' A' ' 105' ' ' PHE . 21.5 mtm180 -50.43 -43.61 55.0 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.295 0.569 . . . . 0.0 111.258 -175.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -101.47 17.64 22.21 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.705 -170.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.569 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . . . -97.7 15.1 24.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.237 177.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 131.17 -179.04 17.34 Favored Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -178.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.444 HG23 ' H ' ' A' ' 116' ' ' THR . 1.0 OUTLIER -125.88 -73.2 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 117.525 0.662 . . . . 0.0 112.751 -179.689 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.713 ' HB ' ' HB3' ' A' ' 133' ' ' LEU . 5.1 m -73.68 117.42 15.42 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.092 0.472 . . . . 0.0 111.985 -167.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.421 ' C ' HD22 ' A' ' 118' ' ' ASN . 75.5 mtt-85 -143.04 154.44 43.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.169 -179.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.496 ' HB2' HG23 ' A' ' 131' ' ' THR . 0.9 OUTLIER -121.79 119.78 32.69 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 174.132 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.4 t -116.02 123.58 71.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.146 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.566 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 25.8 tp -107.65 121.84 45.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.027 0.442 . . . . 0.0 110.704 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.459 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 62.5 mt -102.77 132.5 48.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.077 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.462 ' OD2' ' HB2' ' A' ' 124' ' ' GLU . 18.4 t70 -79.43 164.96 23.56 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.679 178.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.489 ' HB3' HH11 ' A' ' 123' ' ' ARG . 0.0 OUTLIER -57.33 -29.55 64.05 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.552 179.34 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.536 ' HB3' ' NZ ' ' A' ' 126' ' ' LYS . 18.0 mm-40 -75.4 7.05 3.86 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.0 0.429 . . . . 0.0 111.096 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 76.15 14.13 82.58 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.168 176.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.76 ' HG2' ' HG2' ' A' ' 12' ' ' MET . 25.0 mtmm -113.68 139.19 49.27 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.831 0.348 . . . . 0.0 110.926 -175.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.3 mt -76.14 130.63 36.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.781 -175.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 31.0 m -116.07 -21.0 5.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -176.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.566 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 53.1 tptt -135.5 116.44 14.18 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.552 -0.459 . . . . 0.0 112.092 -174.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.493 HD13 HG12 ' A' ' 9' ' ' ILE . 10.6 mp -109.09 119.34 39.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.332 172.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.555 HG21 HD11 ' A' ' 142' ' ' LEU . 14.7 t -147.15 162.91 37.9 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.98 178.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.458 ' C ' ' HG ' ' A' ' 133' ' ' LEU . 37.2 mtm180 -115.83 116.91 28.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.112 -173.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.713 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 3.9 pp 48.62 -169.09 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 O-C-N 124.67 1.231 . . . . 0.0 114.001 174.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.446 ' HB2' ' CB ' ' A' ' 51' ' ' GLU . 60.9 t80 -80.59 114.74 19.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.449 -178.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.544 ' HB3' ' HB2' ' A' ' 138' ' ' GLU . 3.0 t-20 -130.87 133.78 46.2 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.948 -1.023 . . . . 0.0 108.429 173.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -44.87 -61.26 1.67 Allowed 'General case' 0 C--O 1.236 0.367 0 O-C-N 123.441 0.463 . . . . 0.0 112.189 -178.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -60.74 -50.71 72.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.822 0.344 . . . . 0.0 111.317 -177.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.544 ' HB2' ' HB3' ' A' ' 135' ' ' ASN . 4.0 mm-40 -63.13 -39.49 94.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.981 -177.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -66.08 -41.45 90.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.807 0.337 . . . . 0.0 110.102 177.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.82 -42.02 98.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.157 176.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.4 m -67.31 -35.21 78.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.239 177.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.555 HD11 HG21 ' A' ' 131' ' ' THR . 24.7 mt -66.67 -53.4 34.29 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.836 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.6 p -60.69 -42.17 90.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.025 -175.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -67.29 -41.52 85.3 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.812 0.339 . . . . 0.0 110.547 177.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.531 ' O ' ' HG2' ' A' ' 149' ' ' MET . 8.6 tt0 -58.5 -51.39 70.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.657 176.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.615 ' O ' HD23 ' A' ' 150' ' ' LEU . 99.0 mt -62.48 -40.51 88.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.85 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -54.35 -37.47 64.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.25 177.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -88.14 -26.62 22.36 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.625 -178.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.531 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 97.5 mmm -63.8 -26.25 68.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.408 0.623 . . . . 0.0 109.704 175.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.615 HD23 ' O ' ' A' ' 146' ' ' ILE . 3.9 mm? . . . . . 0 C--N 1.325 -0.486 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.072 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.491 ' CE1' HD12 ' A' ' 130' ' ' LEU . 69.0 m-85 . . . . . 0 CA--C 1.519 -0.226 0 CA-C-O 120.674 0.273 . . . . 0.0 111.346 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.52 HG13 HG23 ' A' ' 7' ' ' VAL . 46.8 pt -101.65 -17.13 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 170.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.52 HG23 HG13 ' A' ' 6' ' ' ILE . 23.1 t -110.3 139.27 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.067 177.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.439 ' HE ' ' CD ' ' A' ' 11' ' ' GLU . 73.6 mtm180 -122.47 -178.7 3.97 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.084 0.469 . . . . 0.0 112.186 -169.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.426 ' CG1' HD23 ' A' ' 130' ' ' LEU . 67.5 mt -71.32 123.07 24.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.294 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.16 -19.82 44.91 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.166 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.439 ' CD ' ' HE ' ' A' ' 8' ' ' ARG . 7.1 mt-10 -80.87 151.32 28.71 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.68 ' HG2' ' HG2' ' A' ' 126' ' ' LYS . 45.1 mtp -77.92 137.54 38.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.844 0.354 . . . . 0.0 110.362 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.24 130.83 67.79 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.404 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.402 ' HG2' ' O ' ' A' ' 107' ' ' LYS . 37.6 Cg_exo -61.23 125.95 18.19 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.493 2.129 . . . . 0.0 111.427 177.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -63.01 138.64 58.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.224 0.535 . . . . 0.0 110.196 -176.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.686 ' HB2' HD12 ' A' ' 104' ' ' ILE . 47.1 p90 -131.76 149.69 52.39 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.052 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.5 m -109.17 98.79 8.17 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 170.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 25' ' ' GLN . 16.9 tt -95.6 144.8 9.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.516 -174.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.8 m -101.55 118.3 36.68 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.103 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.8 mt -73.57 172.83 10.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.959 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 96' ' ' LEU . 41.5 p -58.1 -28.84 64.98 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -175.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -102.6 18.74 20.54 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.143 0.497 . . . . 0.0 110.859 -175.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.86 40.43 17.41 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.795 174.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -108.73 117.18 33.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.887 0.375 . . . . 0.0 110.928 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 49.7 mt-30 -94.75 118.47 31.79 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.003 178.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.8 p -128.88 132.28 67.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.217 0.532 . . . . 0.0 111.123 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.41 154.81 25.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.089 177.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 40.4 tp -65.48 -40.28 92.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.844 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.59 ' HA ' ' HG3' ' A' ' 32' ' ' ARG . 75.3 m -62.92 -19.14 63.94 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 177.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 51.8 m -75.2 -18.15 60.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.511 0.672 . . . . 0.0 110.395 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.3 mt -100.81 -14.11 18.13 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.732 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.646 ' NH1' ' HA ' ' A' ' 124' ' ' GLU . 6.3 mmm180 -55.48 153.57 7.4 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 123.539 0.525 . . . . 0.0 110.917 177.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.09 -22.64 35.43 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -172.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.524 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 35.7 mtmm -117.31 170.93 8.31 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 174.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.5 m -80.9 134.03 28.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 172.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.592 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 44.3 t -111.22 109.6 29.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 121.006 0.431 . . . . 0.0 111.076 -177.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 13.9 tpt -91.81 136.25 33.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.211 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 78.9 mt -133.74 143.29 48.37 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.077 -178.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.56 ' OE1' ' HB ' ' A' ' 41' ' ' THR . 21.8 tm0? -138.45 131.44 29.77 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 177.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.449 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 96.7 m-85 -104.56 120.04 40.38 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.56 ' HB ' ' OE1' ' A' ' 39' ' ' GLN . 6.8 t -136.47 -175.67 4.08 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.059 0.456 . . . . 0.0 111.602 -173.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.501 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . . . -169.41 164.04 10.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.463 178.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.454 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 86.3 p -67.19 -30.25 70.14 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.892 0.377 . . . . 0.0 111.739 -173.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 37.7 p-90 -89.0 4.36 48.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.668 -175.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.501 ' SG ' ' HB3' ' A' ' 42' ' ' ALA . 80.0 m -85.69 90.05 7.91 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.072 0.463 . . . . 0.0 110.796 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.84 -35.7 90.01 Favored Glycine 0 C--O 1.228 -0.265 0 C-N-CA 121.08 -0.581 . . . . 0.0 113.004 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.5 t -64.46 -35.44 74.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.012 0.434 . . . . 0.0 110.057 178.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.708 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 99.4 m -65.24 -16.84 63.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.395 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -68.99 -7.32 34.25 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 120.849 0.357 . . . . 0.0 110.604 177.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.629 ' HD3' ' CD2' ' A' ' 134' ' ' TYR . 62.1 mttt -88.24 -57.25 2.99 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.351 0.596 . . . . 0.0 110.257 168.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.736 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 5.0 pt-20 -65.65 -40.06 92.07 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.287 -172.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.596 ' HG2' ' O ' ' A' ' 48' ' ' CYS . 98.9 mmm -54.69 -58.39 14.52 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 117.999 0.363 . . . . 0.0 111.862 -177.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.459 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 29.6 Cg_endo -64.48 -38.53 32.84 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 122.018 1.812 . . . . 0.0 112.501 178.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -64.46 -42.07 96.16 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.314 178.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.562 ' O ' ' HB ' ' A' ' 59' ' ' ILE . 75.0 mt -60.25 -37.49 73.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.863 0.363 . . . . 0.0 110.404 177.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.728 ' HG3' ' H ' ' A' ' 93' ' ' THR . 0.2 OUTLIER -68.42 -62.66 1.3 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 175.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.403 ' O ' ' HE2' ' A' ' 62' ' ' LYS . 29.3 ttpp -55.58 -43.1 75.64 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -174.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.624 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 8.3 m-20 -100.65 -24.82 14.34 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -171.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.562 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 53.9 mt -106.5 -60.99 2.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.458 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.523 ' HB3' ' HA ' ' A' ' 56' ' ' GLU . 76.6 t-105 -62.8 -62.65 1.58 Allowed 'General case' 0 C--O 1.226 -0.18 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.614 -175.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.483 HD12 ' HA ' ' A' ' 61' ' ' LEU . 0.5 OUTLIER -46.68 -31.98 3.25 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.655 0.782 . . . . 0.0 112.497 -174.013 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.624 ' HE2' ' HA ' ' A' ' 58' ' ' ASP . 64.7 mmtt -72.75 -54.24 9.45 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.923 -178.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.791 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 85.8 m-70 -105.83 -45.29 4.42 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -169.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.469 ' HE3' HD12 ' A' ' 61' ' ' LEU . 32.5 mttp 55.06 -78.42 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.77 0.828 . . . . 0.0 111.495 -172.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -101.36 -63.25 1.16 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 174.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.791 ' HB2' ' HB3' ' A' ' 63' ' ' HIS . 3.9 t30 68.21 5.97 4.99 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.842 172.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 71.68 -19.44 0.26 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.769 0.828 . . . . 0.0 112.513 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.524 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 19.9 p30 -136.92 17.31 3.04 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.484 ' CE2' ' HB2' ' A' ' 71' ' ' LEU . 93.7 t80 -125.63 143.3 51.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.087 0.47 . . . . 0.0 111.112 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.81 140.59 38.61 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.744 172.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.484 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 2.2 tt -139.12 114.73 9.9 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -179.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.9 mm -124.3 120.83 60.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.133 178.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.455 ' HA3' ' CD2' ' A' ' 96' ' ' LEU . . . -88.72 130.44 10.15 Favored Glycine 0 C--O 1.223 -0.57 0 C-N-CA 120.223 -0.989 . . . . 0.0 110.809 175.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 48.6 mt -116.67 121.6 68.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 117.28 0.54 . . . . 0.0 110.759 -174.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -82.59 139.8 33.59 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 173.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.444 ' HB2' HD13 ' A' ' 115' ' ' ILE . 57.7 ttt-85 -57.37 -51.78 68.03 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.668 0.605 . . . . 0.0 112.58 -172.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.597 ' HA ' ' O ' ' A' ' 99' ' ' ASP . 11.3 p-10 -170.05 15.48 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -175.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.54 ' HB3' ' HG3' ' A' ' 82' ' ' LYS . 29.0 mt-10 -91.52 148.53 37.62 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-O 121.088 0.471 . . . . 0.0 110.599 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.642 ' HG2' ' OE2' ' A' ' 81' ' ' GLU . 38.1 Cg_endo -71.34 -174.48 1.23 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.935 2.423 . . . . 0.0 114.257 -176.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 85.2 mt -54.25 -52.5 61.16 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.618 -1.173 . . . . 0.0 112.826 -174.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.642 ' OE2' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -61.22 -24.54 66.42 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -172.819 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.628 ' HG2' ' OE2' ' A' ' 81' ' ' GLU . 42.5 mmtm -73.23 -59.87 2.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.717 0.294 . . . . 0.0 110.367 172.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.6 t -54.59 -49.24 68.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.725 -176.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.8 mp -64.69 -40.43 95.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.413 -176.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.408 ' O ' ' HG2' ' A' ' 88' ' ' LYS . . . -76.67 -34.55 58.24 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.316 -177.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.454 ' CD1' ' HA ' ' A' ' 43' ' ' SER . 78.9 t80 -67.09 -48.94 66.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.791 -178.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.467 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -53.34 -52.05 60.46 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.042 -176.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 85' ' ' ALA . 17.9 pttm -63.19 -28.45 70.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.043 -176.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.5 m -100.73 9.86 41.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.724 -174.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.2 p -129.46 10.87 5.75 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.108 175.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.67 43.65 91.46 Favored Glycine 0 C--O 1.227 -0.281 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.275 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.7 t -100.36 100.65 10.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.028 0.442 . . . . 0.0 110.944 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.728 ' H ' ' HG3' ' A' ' 56' ' ' GLU . 30.1 m -85.94 -20.52 28.85 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.848 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.522 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 23.6 p90 -82.48 144.12 48.97 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.816 178.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -61.5 140.67 88.53 Favored 'Trans proline' 0 C--O 1.238 0.495 0 C-N-CA 122.572 2.181 . . . . 0.0 113.175 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.475 ' O ' HG23 ' A' ' 21' ' ' THR . 76.3 mt -111.06 151.2 28.32 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.852 176.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -123.59 149.16 16.85 Favored Glycine 0 N--CA 1.438 -1.214 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 175.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.735 HD23 ' H ' ' A' ' 98' ' ' LEU . 0.8 OUTLIER -99.81 132.56 45.08 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.591 0.234 . . . . 0.0 110.561 -177.456 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.597 ' O ' ' HA ' ' A' ' 77' ' ' ASP . 26.6 t0 -109.58 83.31 2.57 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.925 176.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -60.92 101.67 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.417 2.078 . . . . 0.0 113.177 -175.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.442 ' H ' ' HB2' ' A' ' 77' ' ' ASP . . . 101.51 11.76 37.5 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.852 -0.689 . . . . 0.0 113.359 175.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 61.32 43.46 10.66 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.082 0.467 . . . . 0.0 110.872 178.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.645 ' HA ' HH21 ' A' ' 111' ' ' ARG . 18.1 t70 -79.89 -50.2 10.82 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.537 0.684 . . . . 0.0 110.374 -178.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.686 HD12 ' HB2' ' A' ' 16' ' ' PHE . 31.7 mm -67.41 -39.45 82.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 175.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -56.69 -39.14 73.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.363 175.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.17 -32.32 72.49 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.77 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.402 ' O ' ' HG2' ' A' ' 14' ' ' PRO . 30.5 mtmm -74.83 -4.79 39.86 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 178.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -116.61 -19.24 10.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 179.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.689 ' HB3' HH12 ' A' ' 117' ' ' ARG . . . -171.9 -179.99 2.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.572 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 80.2 mt -66.11 149.62 50.0 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 174.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.645 HH21 ' HA ' ' A' ' 103' ' ' ASP . 93.5 mtt180 -73.58 -15.22 61.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.121 0.486 . . . . 0.0 110.024 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -100.51 15.9 26.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.346 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.07 -179.26 5.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.475 -177.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.88 142.03 42.79 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.679 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.595 ' O ' ' HG2' ' A' ' 117' ' ' ARG . 6.6 tp -91.66 -39.77 11.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 111.36 0.133 . . . . 0.0 111.36 -178.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.577 HG22 ' SG ' ' A' ' 48' ' ' CYS . 18.0 p -68.86 105.33 2.32 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 120.484 0.183 . . . . 0.0 110.878 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.689 HH12 ' HB3' ' A' ' 109' ' ' ALA . 8.9 ptm180 -167.65 133.06 1.96 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.171 0.51 . . . . 0.0 112.127 -173.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.59 ' HB2' ' CB ' ' A' ' 131' ' ' THR . 91.2 m-20 -104.41 129.59 52.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.231 172.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.6 t -120.95 116.93 51.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 120.619 0.247 . . . . 0.0 110.394 -176.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 37.5 tp -106.38 115.12 29.66 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.113 0.482 . . . . 0.0 110.645 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.592 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 60.7 mt -95.51 135.05 30.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.366 176.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' A' ' 124' ' ' GLU . 0.0 OUTLIER -79.49 177.01 9.18 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.206 0.526 . . . . 0.0 110.734 -177.213 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 123' ' ' ARG . 31.6 ttm180 -62.57 -27.1 68.95 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.561 -177.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.646 ' HA ' ' NH1' ' A' ' 32' ' ' ARG . 2.1 mm-40 -91.42 6.28 46.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.066 -178.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.16 16.68 62.33 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.544 -0.836 . . . . 0.0 113.017 172.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.68 ' HG2' ' HG2' ' A' ' 12' ' ' MET . 33.3 mttt -112.18 142.77 44.24 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.829 0.347 . . . . 0.0 110.292 -177.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.474 HD12 ' CG1' ' A' ' 7' ' ' VAL . 58.3 mt -80.21 119.96 30.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 120.776 0.322 . . . . 0.0 110.613 -177.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.5 m -109.88 -8.07 11.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.483 ' CG ' HE22 ' A' ' 145' ' ' GLN . 5.2 tmtm? -149.34 111.21 4.57 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.296 -175.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.491 HD12 ' CE1' ' A' ' 5' ' ' TYR . 3.2 mm? -104.79 105.78 16.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.224 172.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.59 ' CB ' ' HB2' ' A' ' 118' ' ' ASN . 10.4 m -88.98 138.69 31.17 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.367 -177.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.521 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 2.3 mpt_? -99.78 107.08 19.04 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 176.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 132' ' ' ARG . 0.5 OUTLIER 43.44 -162.89 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 O-C-N 124.212 0.945 . . . . 0.0 111.788 -174.201 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.736 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 90.5 t80 -88.63 92.81 9.34 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.168 0.509 . . . . 0.0 110.08 173.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.562 ' HB3' ' HB3' ' A' ' 138' ' ' GLU . 10.7 t30 -95.02 131.57 40.85 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 170.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.432 ' HB2' ' OE2' ' A' ' 137' ' ' GLU . 24.9 mm-40 -50.16 -63.81 1.0 Allowed 'General case' 0 CA--C 1.536 0.424 0 O-C-N 123.687 0.617 . . . . 0.0 112.178 -168.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.566 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.2 mp0 -66.62 -32.52 73.9 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.108 0.48 . . . . 0.0 110.945 -177.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.562 ' HB3' ' HB3' ' A' ' 135' ' ' ASN . 6.0 tp10 -62.68 -46.18 89.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.606 -176.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.499 ' O ' HG23 ' A' ' 143' ' ' VAL . 91.9 t80 -63.57 -42.03 98.34 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.511 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.4 -44.06 96.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.805 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.3 m -63.68 -39.6 94.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.414 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.501 ' O ' HG13 ' A' ' 146' ' ' ILE . 58.4 tp -62.46 -44.31 96.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.942 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 139' ' ' PHE . 99.0 t -57.66 -52.94 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.15 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.409 ' HB3' HE21 ' A' ' 144' ' ' GLN . 21.8 mt-30 -60.96 -41.29 96.06 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-O 121.281 0.562 . . . . 0.0 110.872 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.483 HE22 ' CG ' ' A' ' 129' ' ' LYS . 28.6 tt0 -57.71 -48.52 79.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.575 178.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.608 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 78.0 mt -58.96 -41.92 84.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.879 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -55.2 -46.68 75.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.561 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -83.88 -25.22 30.41 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.092 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.442 ' HB3' ' HE3' ' A' ' 149' ' ' MET . 28.8 mmm -58.92 -33.88 71.08 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.413 0.625 . . . . 0.0 110.371 178.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 146' ' ' ILE . 52.2 mt . . . . . 0 C--N 1.319 -0.739 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.611 176.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.429 ' OH ' ' HD2' ' A' ' 117' ' ' ARG . 1.3 m-85 . . . . . 0 CA--C 1.52 -0.199 0 CA-C-O 120.771 0.319 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.431 HG13 HG13 ' A' ' 7' ' ' VAL . 38.6 pt -92.38 -24.01 5.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.437 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.431 HG13 HG13 ' A' ' 6' ' ' ILE . 27.4 m -104.51 157.16 5.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.389 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.528 ' H ' ' HG3' ' A' ' 11' ' ' GLU . 19.7 mtt180 -126.25 177.39 6.45 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.082 -174.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.646 HG12 HD13 ' A' ' 130' ' ' LEU . 79.9 mt -74.27 110.7 8.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 173.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.02 -23.45 8.2 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.092 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.528 ' HG3' ' H ' ' A' ' 8' ' ' ARG . 69.1 mm-40 -68.13 154.67 41.21 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.572 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 55.5 mtp -86.08 139.83 30.79 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.949 0.404 . . . . 0.0 110.482 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.494 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -67.44 130.06 93.46 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.561 -178.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 8.3 Cg_exo -70.7 120.98 7.5 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.926 2.418 . . . . 0.0 111.477 176.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -63.43 146.93 52.6 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.451 -176.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 1.027 ' HB3' ' HE2' ' A' ' 107' ' ' LYS . 54.0 p90 -156.7 158.54 37.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.69 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.8 m -116.33 107.27 14.62 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.748 175.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.1 tt -107.81 146.81 13.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.005 0.431 . . . . 0.0 111.003 -176.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.402 ' O ' HD23 ' A' ' 98' ' ' LEU . 20.3 m -95.37 130.22 42.24 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.053 177.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.497 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 90.6 mt -83.89 179.01 7.66 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.005 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 96' ' ' LEU . 27.4 p -59.56 -31.21 69.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.714 -175.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -101.88 10.91 39.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.983 0.42 . . . . 0.0 110.917 -176.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.07 8.7 62.94 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.522 176.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.44 ' HB2' HD12 ' A' ' 20' ' ' LEU . 46.0 mmtm -77.44 120.59 22.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.362 0.581 . . . . 0.0 110.593 177.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -98.63 115.46 28.71 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.962 0.41 . . . . 0.0 110.393 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.3 m -113.78 153.07 15.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.008 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 9.1 m -122.49 142.96 50.03 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.335 -0.393 . . . . 0.0 109.961 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.67 -39.88 94.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.847 0.356 . . . . 0.0 110.841 -175.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 32' ' ' ARG . 5.3 p -61.18 -21.57 63.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.546 178.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.1 m -79.86 -25.99 40.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.068 0.461 . . . . 0.0 110.403 177.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 77.2 mt -96.5 1.88 51.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.392 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 29' ' ' SER . 0.2 OUTLIER -55.74 126.39 25.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.081 179.339 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.626 ' O ' ' HG3' ' A' ' 123' ' ' ARG . . . 106.37 -0.11 37.6 Favored Glycine 0 C--O 1.222 -0.635 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.724 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.4 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 58.1 mttm -116.51 159.54 21.93 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 174.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.475 HG13 ' HD1' ' A' ' 69' ' ' PHE . 2.1 p -78.29 107.3 10.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.585 0.707 . . . . 0.0 109.172 171.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.512 HG22 ' HB3' ' A' ' 70' ' ' ALA . 48.0 t -106.89 120.93 59.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.095 -173.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.409 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 26.7 ttt -98.81 120.2 38.84 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.331 176.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 94.0 mt -107.88 110.87 22.75 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.022 177.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.433 ' OE1' ' HB ' ' A' ' 41' ' ' THR . 0.6 OUTLIER -103.37 106.14 16.58 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.874 -176.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 116' ' ' THR . 95.1 m-85 -93.76 127.29 39.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.572 -177.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.433 ' HB ' ' OE1' ' A' ' 39' ' ' GLN . 15.0 t -158.26 -166.47 1.94 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.366 -176.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.531 ' HB2' HD11 ' A' ' 115' ' ' ILE . . . -151.03 156.44 41.12 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 176.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.616 ' HB2' ' HG3' ' A' ' 78' ' ' GLU . 49.7 m -66.26 -9.49 33.0 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -176.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 41.0 p-90 -105.4 4.86 31.22 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 122.201 -0.312 . . . . 0.0 111.566 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 74.9 m -83.17 113.47 20.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.023 0.439 . . . . 0.0 111.158 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -78.31 -33.21 40.45 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.863 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.3 t -66.48 -37.46 79.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.08 0.467 . . . . 0.0 110.797 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.681 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 29.1 t -67.03 -16.95 64.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.374 0.607 . . . . 0.0 110.793 -178.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.526 ' HE ' ' HE1' ' A' ' 86' ' ' PHE . 79.6 mtt180 -74.83 -2.15 25.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.681 177.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.409 ' O ' ' HD1' ' A' ' 54' ' ' PHE . 74.2 mmtt -94.02 -55.61 3.15 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.702 0.763 . . . . 0.0 109.278 169.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.996 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 10.0 pt-20 -62.68 -44.27 96.69 Favored 'General case' 0 C--O 1.213 -0.827 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.861 -173.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.683 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 33.3 mtm -56.06 -55.23 43.8 Favored Pre-proline 0 N--CA 1.466 0.362 0 CA-C-N 118.338 0.517 . . . . 0.0 112.36 -176.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.683 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 65.0 Cg_exo -53.93 -38.7 86.37 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 121.976 1.784 . . . . 0.0 111.968 175.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.489 ' HB3' ' CZ ' ' A' ' 139' ' ' PHE . 23.1 m-85 -68.26 -45.04 74.25 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.081 175.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 51' ' ' GLU . 88.1 mt -58.86 -55.68 21.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 123.065 0.546 . . . . 0.0 111.08 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.536 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 16.0 pt-20 -62.69 -35.71 80.58 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.635 -177.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.0 ttpm? -72.37 -51.4 20.69 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -176.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.493 ' HA ' ' NZ ' ' A' ' 62' ' ' LYS . 53.5 m-20 -106.99 -10.8 15.83 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -170.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 65.0 mt -104.57 -55.44 5.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.158 173.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.536 ' HB3' ' HA ' ' A' ' 56' ' ' GLU . 72.1 t-105 -69.97 -65.84 0.67 Allowed 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.575 -177.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.519 HD13 ' HE3' ' A' ' 64' ' ' LYS . 1.9 mm? -46.78 -33.88 4.78 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -175.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.493 ' NZ ' ' HA ' ' A' ' 58' ' ' ASP . 45.8 mmtm -75.72 -34.12 60.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.29 -0.414 . . . . 0.0 112.057 -176.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.418 ' ND1' ' HG ' ' A' ' 150' ' ' LEU . 79.9 m-70 -125.28 -43.73 1.91 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 120.347 -0.541 . . . . 0.0 112.351 -173.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.519 ' HE3' HD13 ' A' ' 61' ' ' LEU . 34.5 mttp 54.87 -90.6 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.944 0.898 . . . . 0.0 111.936 -177.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -108.01 -49.41 3.21 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 174.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 70.94 -71.22 0.14 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.83 178.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 169.78 -23.67 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.287 -175.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.4 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 6.9 t70 -148.3 24.93 1.01 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.79 -174.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.475 ' HD1' HG13 ' A' ' 35' ' ' VAL . 87.5 t80 -129.12 140.13 51.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.745 0.307 . . . . 0.0 110.571 -178.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.512 ' HB3' HG22 ' A' ' 36' ' ' VAL . . . -139.16 135.83 34.45 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.323 177.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.409 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 1.7 tt -133.79 117.2 16.62 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.6 mp -128.15 126.98 67.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.766 0.317 . . . . 0.0 110.332 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.81 129.46 9.91 Favored Glycine 0 C--O 1.219 -0.784 0 N-CA-C 110.799 -0.921 . . . . 0.0 110.799 174.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.0 mt -119.21 122.53 69.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 117.489 0.644 . . . . 0.0 111.338 -173.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -86.11 133.26 33.89 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 173.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.879 ' HD3' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -88.35 -22.78 23.63 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -169.271 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.879 ' HB3' ' HD3' ' A' ' 76' ' ' ARG . 3.9 p30 -151.25 -14.04 0.21 Allowed 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 118.721 -1.192 . . . . 0.0 114.131 -172.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.616 ' HG3' ' HB2' ' A' ' 43' ' ' SER . 4.9 mm-40 -88.46 133.31 36.69 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-O 121.065 0.46 . . . . 0.0 110.746 177.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.525 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 29.0 Cg_endo -69.19 -168.82 0.27 Allowed 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 123.175 2.583 . . . . 0.0 114.624 -177.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.2 -53.97 52.19 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.414 -168.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.525 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -64.23 -33.59 76.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.657 0.265 . . . . 0.0 111.305 -173.941 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.489 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 33.7 mmtp -61.06 -53.93 51.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.85 177.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 79' ' ' PRO . 41.1 t -57.53 -41.52 79.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.352 -177.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -66.07 -44.19 85.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.854 0.359 . . . . 0.0 111.26 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.82 -27.93 62.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.175 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.526 ' HE1' ' HE ' ' A' ' 49' ' ' ARG . 91.7 t80 -74.14 -48.08 31.73 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.19 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.53 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -58.39 -55.09 39.54 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.334 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.7 ptmm? -58.84 -24.95 62.75 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -174.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.0 m -84.15 -17.29 40.53 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -175.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.5 p -111.08 -23.39 10.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.098 0.475 . . . . 0.0 110.653 176.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 123.36 -79.78 0.35 Allowed Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -177.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 94.4 t 46.19 82.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 122.101 0.953 . . . . 0.0 112.691 178.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.3 m -71.55 -18.66 62.24 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.446 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -93.98 139.92 22.77 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.45 140.12 85.88 Favored 'Trans proline' 0 C--O 1.238 0.499 0 C-N-CA 122.46 2.107 . . . . 0.0 113.437 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.53 HD12 ' HB2' ' A' ' 87' ' ' ALA . 88.6 mt -106.23 152.21 23.79 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.868 175.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -124.33 154.41 17.86 Favored Glycine 0 N--CA 1.441 -1.025 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 175.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.715 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.2 pt? -107.43 130.45 54.82 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.945 0.402 . . . . 0.0 111.126 -177.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -119.13 75.15 14.73 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.868 175.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.425 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 17.4 Cg_exo -66.23 105.16 0.82 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.6 2.2 . . . . 0.0 112.421 -177.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 119.47 -1.79 14.04 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.127 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 57.91 43.4 21.5 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 122.658 0.383 . . . . 0.0 111.931 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.407 ' O ' ' HG3' ' A' ' 107' ' ' LYS . 13.7 t70 -87.1 -50.67 6.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.06 0.457 . . . . 0.0 109.903 -177.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.571 HD12 ' HB2' ' A' ' 16' ' ' PHE . 34.3 mm -62.54 -34.92 67.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 174.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -61.5 -41.67 97.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.248 173.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.749 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -68.32 -21.81 64.74 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.893 -177.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 1.027 ' HE2' ' HB3' ' A' ' 16' ' ' PHE . 26.5 mtpp -70.9 -6.84 41.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.002 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -124.64 -32.75 3.07 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.158 -179.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.749 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -156.89 162.58 39.66 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 84.2 mt -56.76 149.01 18.94 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.759 0.314 . . . . 0.0 110.381 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.61 ' HG2' ' HB2' ' A' ' 106' ' ' ALA . 38.1 mtt180 -69.66 -13.46 62.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.139 0.495 . . . . 0.0 110.542 -174.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -100.96 -7.33 23.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.126 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -78.91 75.77 5.41 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.203 0.525 . . . . 0.0 111.719 -174.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.93 -140.33 29.91 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.094 178.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.531 HD11 ' HB2' ' A' ' 42' ' ' ALA . 4.6 tp -161.93 -57.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.481 0.182 . . . . 0.0 111.351 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 40' ' ' PHE . 4.8 m -87.86 111.68 21.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.073 0.464 . . . . 0.0 110.951 -175.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.429 ' HD2' ' OH ' ' A' ' 5' ' ' TYR . 46.0 mtm105 -141.61 133.17 26.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.074 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.589 ' HB2' ' CG2' ' A' ' 131' ' ' THR . 6.0 m120 -102.39 119.01 38.09 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 176.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.9 t -113.8 123.76 69.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.078 -177.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 34.4 tp -110.58 121.76 46.1 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.11 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.3 mp -102.13 139.02 24.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.67 177.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.59 -174.17 4.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.055 0.455 . . . . 0.0 111.02 -177.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.626 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 32.4 ttt180 -69.84 -26.26 64.14 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.604 -175.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -80.17 -15.05 57.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.703 0.287 . . . . 0.0 111.254 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.2 16.38 30.19 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.08 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 81.2 mttt -101.24 154.87 18.39 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.907 0.384 . . . . 0.0 110.414 -178.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 53.9 mt -92.62 116.44 33.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.172 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.53 -31.32 2.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -173.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.859 ' HG2' ' HG ' ' A' ' 142' ' ' LEU . 50.5 tptt -124.66 114.27 19.11 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.908 -0.495 . . . . 0.0 111.194 -176.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.646 HD13 HG12 ' A' ' 9' ' ' ILE . 8.5 mp -110.99 105.13 13.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.746 176.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.593 ' HA ' ' NH1' ' A' ' 132' ' ' ARG . 10.0 t -125.43 158.69 33.75 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.074 0.464 . . . . 0.0 110.721 177.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.593 ' NH1' ' HA ' ' A' ' 131' ' ' THR . 0.0 OUTLIER -116.24 116.47 27.85 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.144 -178.199 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 132' ' ' ARG . 4.6 pp 51.11 -175.01 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.526 1.141 . . . . 0.0 112.968 -178.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.996 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 90.5 t80 -69.75 84.13 0.46 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.647 0.737 . . . . 0.0 111.56 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.562 ' HB3' ' HB2' ' A' ' 138' ' ' GLU . 57.8 t-20 -86.7 133.57 33.67 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 171.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -52.04 -68.07 0.2 Allowed 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.36 0.413 . . . . 0.0 110.843 -176.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -55.99 -59.1 5.39 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.544 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.629 ' O ' ' HB2' ' A' ' 142' ' ' LEU . 29.0 mt-10 -63.02 -23.38 67.43 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -170.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.52 ' O ' HG23 ' A' ' 143' ' ' VAL . 82.0 t80 -75.21 -44.9 43.79 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 172.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.32 -48.88 79.83 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.99 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.431 ' OG ' ' HA ' ' A' ' 138' ' ' GLU . 2.5 p -62.69 -38.0 88.67 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.64 0.257 . . . . 0.0 111.141 177.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.859 ' HG ' ' HG2' ' A' ' 129' ' ' LYS . 1.5 tt -64.75 -50.41 66.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.244 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 139' ' ' PHE . 86.1 t -58.69 -49.51 82.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.083 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -63.81 -39.15 93.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.371 -177.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.623 ' O ' ' HG3' ' A' ' 149' ' ' MET . 8.0 tt0 -61.02 -45.79 93.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.018 176.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.533 ' O ' HD23 ' A' ' 150' ' ' LEU . 57.7 mt -55.61 -46.27 79.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.799 177.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -54.71 -42.49 71.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.609 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -69.27 -35.65 76.28 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.172 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.623 ' HG3' ' O ' ' A' ' 145' ' ' GLN . 80.5 mtp -70.46 -19.3 62.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.299 0.571 . . . . 0.0 110.088 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.533 HD23 ' O ' ' A' ' 146' ' ' ILE . 4.3 mm? . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.109 174.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.474 HD13 ' H ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -105.96 -9.79 10.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 169.662 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.2 p -94.89 158.78 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.872 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.554 ' HB2' ' HG2' ' A' ' 11' ' ' GLU . 24.8 mtt180 -127.65 168.91 14.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.782 0.325 . . . . 0.0 111.038 -171.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.53 HG12 HD21 ' A' ' 130' ' ' LEU . 75.2 mt -78.25 117.83 24.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.75 174.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.95 -25.58 9.37 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.706 -177.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.554 ' HG2' ' HB2' ' A' ' 8' ' ' ARG . 71.6 mm-40 -66.73 152.92 44.53 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.711 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 59.7 mtp -81.48 134.6 35.55 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 175.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.495 ' HB3' HH12 ' A' ' 32' ' ' ARG . . . -59.53 133.82 88.75 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.293 -176.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 15.6 Cg_exo -67.15 174.35 7.14 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.884 2.39 . . . . 0.0 112.18 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.53 ' O ' ' HE2' ' A' ' 107' ' ' LYS . 5.1 p-10 -76.54 163.69 26.67 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.32 177.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.576 ' HB2' HD12 ' A' ' 104' ' ' ILE . 23.0 p90 -174.11 148.91 1.39 Allowed 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 166.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.614 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 52.1 m -131.33 99.55 4.88 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 173.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.655 ' O ' ' HA ' ' A' ' 25' ' ' GLN . 16.6 tt -99.35 148.62 6.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.238 -171.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.7 m -98.16 114.84 27.19 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.059 177.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.423 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 96.4 mt -74.1 172.81 11.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.457 -178.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 96' ' ' LEU . 52.3 p -55.42 -27.07 45.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.997 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -96.61 14.54 24.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.351 -174.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.13 29.64 66.39 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.947 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -108.88 120.58 42.93 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.735 0.303 . . . . 0.0 110.658 -176.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.655 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 25.1 mt-30 -98.23 128.11 44.52 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.749 -178.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.614 ' O ' ' HA ' ' A' ' 17' ' ' THR . 12.2 m -125.59 150.74 31.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.591 178.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 22.9 m -113.11 142.47 45.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.383 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.515 HD11 ' CD1' ' A' ' 121' ' ' ILE . 0.6 OUTLIER -62.37 -36.78 83.35 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.673 0.273 . . . . 0.0 111.101 -177.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.402 ' H ' HG22 ' A' ' 27' ' ' THR . 9.7 m -58.04 -27.13 63.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.711 -177.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.9 m -78.53 -20.61 50.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.06 0.457 . . . . 0.0 111.21 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.3 mt -102.21 17.73 22.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.632 -176.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.495 HH12 ' HB3' ' A' ' 13' ' ' ALA . 22.8 mmt180 -68.74 147.06 52.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.772 0.32 . . . . 0.0 110.689 178.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.77 -25.69 27.06 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.255 178.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.92 ' HB3' ' HZ3' ' A' ' 34' ' ' LYS . 0.7 OUTLIER -115.02 160.76 19.21 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.094 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 p -74.78 115.88 16.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.541 0.686 . . . . 0.0 110.41 -177.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.462 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 21.7 t -106.14 122.39 59.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.195 -177.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.531 ' SD ' ' HG ' ' A' ' 71' ' ' LEU . 2.1 tmt? -108.97 135.47 50.1 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.052 0.453 . . . . 0.0 110.125 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.483 HD21 ' CE2' ' A' ' 16' ' ' PHE . 7.0 mp -130.28 144.06 51.15 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.414 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.468 ' HB3' ' HE1' ' A' ' 37' ' ' MET . 0.0 OUTLIER -138.6 133.14 32.09 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 172.294 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.465 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 95.9 m-85 -99.49 105.36 17.27 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.91 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.2 t -115.52 -176.42 2.92 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.076 -172.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -169.16 139.91 2.32 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.577 ' H ' ' HG3' ' A' ' 78' ' ' GLU . 19.0 p -66.97 -23.38 65.94 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.882 0.372 . . . . 0.0 111.372 -174.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 65.4 p-90 -84.49 -2.31 57.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.66 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.4 t -90.07 139.26 30.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.269 0.557 . . . . 0.0 111.366 -178.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -93.56 -27.67 12.65 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.349 176.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 42.9 t -67.86 -39.51 81.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.87 0.367 . . . . 0.0 110.707 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.638 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 61.0 m -61.54 -15.9 42.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.761 178.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -78.41 -3.06 41.37 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.764 0.316 . . . . 0.0 110.913 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -85.93 -47.0 10.05 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.293 0.568 . . . . 0.0 109.832 165.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.638 ' HG2' ' HA ' ' A' ' 48' ' ' CYS . 14.2 pt-20 -75.0 -32.87 61.75 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.698 -172.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.554 ' CB ' ' HD3' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -48.96 -65.03 0.89 Allowed Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 175.28 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.554 ' HD3' ' CB ' ' A' ' 52' ' ' MET . 35.8 Cg_exo -60.88 -39.18 63.83 Favored 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 121.745 1.63 . . . . 0.0 112.844 177.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.646 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 8.2 m-85 -67.42 -46.73 72.32 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -176.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.13 -49.37 84.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 178.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.601 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 29.7 mm-40 -56.33 -44.52 80.09 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 123.399 0.437 . . . . 0.0 111.026 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -67.46 -49.17 64.8 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.705 -0.679 . . . . 0.0 112.276 -176.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.686 ' HA ' ' NZ ' ' A' ' 62' ' ' LYS . 42.3 m-20 -107.68 -51.2 2.94 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -170.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.4 mt -73.68 -49.05 37.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.867 -173.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.458 ' CD2' ' HB3' ' A' ' 94' ' ' TYR . 63.4 t-105 -71.63 -69.93 0.35 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.76 -178.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.601 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.4 OUTLIER -41.27 -40.27 1.59 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -171.729 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.686 ' NZ ' ' HA ' ' A' ' 58' ' ' ASP . 36.9 mmtm -75.97 -31.56 59.08 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -172.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -122.78 -43.06 2.27 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.876 -174.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.411 ' O ' ' HD2' ' A' ' 69' ' ' PHE . 53.6 mttt 51.64 -92.98 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 123.852 0.861 . . . . 0.0 111.504 -175.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -90.21 -61.04 1.77 Allowed 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 120.761 0.315 . . . . 0.0 110.471 176.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.5 ' ND2' HD12 ' A' ' 150' ' ' LEU . 0.9 OUTLIER 61.09 9.46 2.41 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.185 0.594 . . . . 0.0 111.408 175.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 68.27 -22.18 0.13 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.833 0.853 . . . . 0.0 112.869 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.586 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 3.2 t70 -138.81 22.76 2.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.369 0.604 . . . . 0.0 110.289 -174.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.57 ' HB2' HD11 ' A' ' 150' ' ' LEU . 86.4 t80 -127.28 116.18 20.16 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.198 173.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -114.65 104.42 11.97 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.727 -178.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.531 ' HG ' ' SD ' ' A' ' 37' ' ' MET . 5.6 tt -104.29 114.95 29.53 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.9 mp -120.83 117.26 52.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.118 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.523 ' HA3' HD23 ' A' ' 96' ' ' LEU . . . -90.33 131.8 10.94 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.315 -0.945 . . . . 0.0 110.938 175.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 45.9 mt -119.27 119.59 61.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 117.046 0.423 . . . . 0.0 110.679 -175.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -85.72 136.04 33.51 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 173.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.527 ' HG2' ' HB2' ' A' ' 102' ' ' ALA . 21.6 ttp180 -68.71 -45.25 72.09 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.408 -0.814 . . . . 0.0 112.689 -170.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -158.87 8.73 0.13 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -169.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.577 ' HG3' ' H ' ' A' ' 43' ' ' SER . 14.1 mm-40 -86.65 138.11 33.68 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-O 120.951 0.405 . . . . 0.0 110.678 176.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.426 ' HD2' ' HG3' ' A' ' 82' ' ' LYS . 34.5 Cg_endo -69.24 -173.6 0.67 Allowed 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.901 2.401 . . . . 0.0 113.651 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.436 ' O ' HD23 ' A' ' 84' ' ' LEU . 2.8 tm? -59.27 -56.66 19.33 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.062 -169.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.423 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -67.02 -34.31 77.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.473 -173.099 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.426 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 14.4 mmmm -60.26 -50.4 73.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.925 177.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 95.7 t -61.28 -48.26 89.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.104 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.436 HD23 ' O ' ' A' ' 80' ' ' LEU . 4.4 mm? -61.28 -52.66 63.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.623 -177.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.12 -37.27 86.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.511 -178.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -68.84 -41.34 78.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.719 -0.218 . . . . 0.0 110.918 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.546 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -66.16 -41.7 89.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.737 0.78 . . . . 0.0 109.549 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -58.99 -30.25 67.82 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.218 -1.355 . . . . 0.0 111.437 176.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.3 m -99.85 -1.38 37.61 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -176.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.1 p -113.53 -5.12 13.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.845 0.355 . . . . 0.0 111.494 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.09 -5.32 83.12 Favored Glycine 0 C--O 1.228 -0.277 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.368 177.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.517 ' CG2' ' HG3' ' A' ' 52' ' ' MET . 69.2 t -57.27 121.92 5.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.099 0.476 . . . . 0.0 111.551 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.422 ' H ' ' CD ' ' A' ' 56' ' ' GLU . 75.3 p -114.53 -15.56 12.0 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.383 176.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.458 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 36.8 p90 -71.57 144.73 89.15 Favored Pre-proline 0 C--O 1.233 0.236 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 173.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.34 124.71 13.79 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.415 2.076 . . . . 0.0 113.132 -176.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.546 HD12 ' HB2' ' A' ' 87' ' ' ALA . 84.8 mt -99.17 153.29 19.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.476 173.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -122.83 156.13 17.24 Favored Glycine 0 N--CA 1.437 -1.24 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 174.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.58 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.4 pt? -116.11 119.88 37.26 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.734 0.267 . . . . 0.0 110.349 -178.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -117.25 76.1 8.79 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.402 178.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.11 107.46 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.481 2.12 . . . . 0.0 111.936 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 131.59 -27.31 3.74 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -176.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.527 ' HB2' ' HG2' ' A' ' 76' ' ' ARG . . . 66.98 24.61 9.52 Favored 'General case' 0 CA--C 1.522 -0.097 0 C-N-CA 122.992 0.517 . . . . 0.0 111.373 176.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -70.94 -41.43 71.14 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.173 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.576 HD12 ' HB2' ' A' ' 16' ' ' PHE . 48.3 mm -62.05 -33.77 60.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.379 0.609 . . . . 0.0 109.62 174.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -70.21 -39.21 75.29 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.427 175.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.552 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -66.15 -28.92 69.15 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -174.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.53 ' HE2' ' O ' ' A' ' 15' ' ' ASP . 13.6 ptmt -79.46 -1.96 39.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.994 0.426 . . . . 0.0 111.276 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -112.09 -50.92 2.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.21 172.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.552 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -141.05 152.81 45.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.408 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.418 ' HB3' ' OD1' ' A' ' 112' ' ' ASP . 97.3 mt -62.38 139.26 58.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.849 0.357 . . . . 0.0 111.041 -178.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -66.01 -25.62 67.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.209 0.528 . . . . 0.0 110.837 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.418 ' OD1' ' HB3' ' A' ' 110' ' ' LEU . 4.2 p-10 -83.99 -8.49 59.14 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.171 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.83 -8.02 57.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.373 -178.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.27 -128.19 8.25 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.444 174.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.527 HD13 ' HD3' ' A' ' 76' ' ' ARG . 8.1 tp -154.25 173.65 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -174.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.437 ' N ' HG13 ' A' ' 115' ' ' ILE . 28.2 m 71.0 81.54 0.16 Allowed 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.476 0.655 . . . . 0.0 111.279 175.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.6 mmt85 -133.8 131.9 39.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.111 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.623 ' HB3' HG22 ' A' ' 131' ' ' THR . 0.2 OUTLIER -116.1 119.67 36.57 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.179 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.517 ' N ' HD22 ' A' ' 118' ' ' ASN . 63.2 t -113.76 131.81 64.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.996 -177.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.722 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 36.7 tp -119.36 122.04 40.91 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.316 0.579 . . . . 0.0 110.875 177.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.515 ' CD1' HD11 ' A' ' 28' ' ' LEU . 53.6 mt -100.7 135.08 38.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.778 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.86 -176.91 5.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.212 0.53 . . . . 0.0 111.09 -176.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -68.41 -23.32 64.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.001 -175.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -80.78 -26.62 37.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.979 0.418 . . . . 0.0 110.769 175.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 112.4 12.22 13.82 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.352 -0.928 . . . . 0.0 112.311 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.711 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 77.5 mttt -97.13 160.62 14.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.822 0.344 . . . . 0.0 110.66 -178.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 47.0 mt -95.79 109.59 22.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 175.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.7 m -110.59 1.13 9.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.918 -174.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.799 ' HG2' ' HG ' ' A' ' 142' ' ' LEU . 51.7 tptt -160.94 114.05 1.98 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 -175.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.558 ' HA ' ' O ' ' A' ' 118' ' ' ASN . 0.4 OUTLIER -138.4 105.98 5.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.171 0.51 . . . . 0.0 110.449 176.35 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.623 HG22 ' HB3' ' A' ' 118' ' ' ASN . 10.1 t -99.46 155.89 17.32 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.095 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.446 ' NE ' ' H ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -122.49 132.74 54.48 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.538 -179.807 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.437 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 3.1 mp 66.45 36.03 5.31 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 123.71 0.631 . . . . 0.0 110.614 176.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.437 ' HB3' ' O ' ' A' ' 133' ' ' LEU . 45.8 t80 71.2 -66.38 0.3 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.518 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.596 ' HB3' ' HB3' ' A' ' 138' ' ' GLU . 0.8 OUTLIER 64.54 113.18 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.046 0.45 . . . . 0.0 110.954 -175.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -49.95 -56.4 10.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.785 -174.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.09 -36.24 27.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.343 -174.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.596 ' HB3' ' HB3' ' A' ' 135' ' ' ASN . 3.4 tp10 -63.54 -38.72 92.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.962 0.41 . . . . 0.0 110.128 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.646 ' CE2' ' HB3' ' A' ' 54' ' ' PHE . 76.6 t80 -70.65 -41.48 72.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.994 176.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.56 -49.6 75.84 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.827 0.346 . . . . 0.0 110.894 177.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.3 p -61.5 -34.11 74.93 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.69 177.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.799 ' HG ' ' HG2' ' A' ' 129' ' ' LYS . 4.6 tt -66.83 -42.94 84.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.255 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.473 ' O ' ' HB ' ' A' ' 146' ' ' ILE . 95.0 t -59.09 -51.47 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 120.782 0.325 . . . . 0.0 111.345 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.449 ' HA ' ' OE1' ' A' ' 144' ' ' GLN . 6.4 tp60 -62.0 -38.38 88.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.304 0.573 . . . . 0.0 110.168 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.445 HE22 ' HB2' ' A' ' 129' ' ' LYS . 29.0 tt0 -63.03 -36.88 85.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.724 177.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.588 ' O ' HD23 ' A' ' 150' ' ' LEU . 30.2 mm -55.09 -53.03 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 120.929 0.395 . . . . 0.0 110.259 174.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -53.06 -45.15 67.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.265 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -65.05 -37.37 87.36 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.128 0.268 . . . . 0.0 111.251 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.4 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 84.2 mmm -60.98 -29.97 69.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.65 0.738 . . . . 0.0 109.723 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.588 HD23 ' O ' ' A' ' 146' ' ' ILE . 4.0 mm? . . . . . 0 C--N 1.32 -0.713 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.62 178.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 . . . . . 0 CA--C 1.521 -0.155 0 CA-C-O 120.684 0.278 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.516 HG12 ' HA ' ' A' ' 109' ' ' ALA . 47.3 pt -92.84 -22.07 5.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.147 175.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.492 ' CG1' HD12 ' A' ' 127' ' ' ILE . 36.3 t -102.39 147.37 9.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.416 177.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 57.2 mtt85 -120.26 168.54 11.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.047 0.451 . . . . 0.0 111.893 -168.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.633 HG12 HD13 ' A' ' 130' ' ' LEU . 77.0 mt -75.18 127.19 36.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.071 176.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.6 -9.26 77.49 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -175.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -92.03 151.38 20.49 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.675 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 56.7 mtp -80.95 144.76 31.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.096 0.474 . . . . 0.0 111.346 -172.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.435 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -86.37 134.01 39.19 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.275 -177.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 13.3 Cg_exo -70.88 139.67 36.83 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.033 2.489 . . . . 0.0 112.033 177.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -75.78 164.81 25.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.277 -178.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -165.2 162.17 19.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.872 -176.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 37.3 m -124.72 110.59 14.54 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 175.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.4 tt -112.78 151.97 14.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.453 -171.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.509 ' HB ' ' CD2' ' A' ' 98' ' ' LEU . 2.8 m -89.34 126.32 35.48 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.142 177.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.0 mt -82.01 178.36 8.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.733 0.302 . . . . 0.0 111.082 177.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.48 ' HB ' HD11 ' A' ' 84' ' ' LEU . 16.5 p -59.37 -26.26 64.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.791 -176.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.618 ' OD2' ' HG2' ' A' ' 24' ' ' LYS . 7.4 p-10 -94.2 -18.23 21.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.185 0.517 . . . . 0.0 110.418 -178.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.56 0.52 21.76 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.412 -177.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.618 ' HG2' ' OD2' ' A' ' 22' ' ' ASP . 4.8 mmmp? -66.44 126.87 30.21 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-O 121.088 0.471 . . . . 0.0 111.696 178.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -88.67 120.92 30.51 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.445 172.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 17' ' ' THR . 11.3 m -123.66 151.83 28.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.826 0.346 . . . . 0.0 110.324 177.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.2 m -110.11 151.72 26.89 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.414 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.07 -35.35 80.45 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.538 ' HA ' ' CG ' ' A' ' 32' ' ' ARG . 37.7 t -56.88 -23.45 44.63 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.96 177.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.1 m -69.57 -24.0 63.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.27 0.557 . . . . 0.0 110.675 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.445 HD13 ' HB1' ' A' ' 70' ' ' ALA . 67.3 mt -116.1 11.57 15.32 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.932 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.538 ' CG ' ' HA ' ' A' ' 29' ' ' SER . 9.2 mmm180 -74.75 104.18 5.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.975 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 147.79 -24.75 1.48 Allowed Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.515 ' HB3' ' OD1' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -115.45 174.74 5.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.161 -0.519 . . . . 0.0 110.466 177.883 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 68' ' ' ASP . 26.8 m -74.72 128.59 36.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.0 t -123.68 112.17 32.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 120.959 0.409 . . . . 0.0 110.575 -176.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.442 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 27.3 ttt -95.98 127.12 41.72 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.734 178.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.6 mp -122.05 137.15 54.92 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.771 176.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.4 pm0 -126.91 129.3 47.92 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 171.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' A' ' 116' ' ' THR . 96.8 m-85 -90.73 110.39 21.58 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.007 -179.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.631 HG23 ' SG ' ' A' ' 48' ' ' CYS . 28.5 m -119.49 165.21 14.68 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.438 -166.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.586 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . . . -145.11 147.12 32.18 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 171.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.453 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 81.0 p -60.56 -21.52 62.65 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -174.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 8.5 p-90 -103.06 3.68 36.32 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -175.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.639 ' SG ' HD12 ' A' ' 115' ' ' ILE . 89.9 m -79.59 102.12 8.69 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.97 0.414 . . . . 0.0 111.082 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.98 -40.48 97.17 Favored Glycine 0 C--O 1.228 -0.271 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.874 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 56.9 t -61.4 -37.25 77.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.222 0.534 . . . . 0.0 110.614 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.631 ' SG ' HG23 ' A' ' 41' ' ' THR . 22.8 t -72.32 -14.85 61.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.762 -178.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -75.2 -7.28 53.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.971 0.415 . . . . 0.0 110.781 177.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.472 ' HD3' ' CD2' ' A' ' 134' ' ' TYR . 70.4 mttt -83.42 -47.84 10.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 122.343 1.068 . . . . 0.0 108.376 163.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.782 ' HB2' ' HB2' ' A' ' 134' ' ' TYR . 40.3 tt0 -58.24 -58.34 8.91 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 113.263 -1.789 . . . . 0.0 112.108 -173.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.795 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 96.1 mmm -50.3 -57.43 12.96 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -175.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.795 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 32.7 Cg_exo -61.49 -38.9 59.61 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 122.3 2.0 . . . . 0.0 112.823 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.508 ' HB3' ' CZ ' ' A' ' 139' ' ' PHE . 6.4 m-85 -65.41 -43.76 89.54 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.496 0.189 . . . . 0.0 111.305 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 51' ' ' GLU . 77.0 mt -58.03 -47.86 85.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 175.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.417 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 26.1 tp10 -54.75 -54.18 45.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.633 176.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -62.33 -59.31 5.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.181 -0.918 . . . . 0.0 113.226 -173.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.698 ' HA ' ' NZ ' ' A' ' 62' ' ' LYS . 67.9 m-20 -107.13 -13.53 15.14 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -166.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.2 mt -104.59 -57.24 4.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.476 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.542 ' CE2' ' HB3' ' A' ' 94' ' ' TYR . 71.3 t-105 -60.97 -68.32 0.32 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.868 -177.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.01 -23.49 2.07 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -175.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.698 ' NZ ' ' HA ' ' A' ' 58' ' ' ASP . 38.9 mmtm -87.42 -37.44 17.02 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -175.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -130.51 0.16 4.46 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -171.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.482 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 16.5 pttp -39.34 -51.91 2.04 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 -169.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.02 -83.66 0.16 Allowed 'General case' 0 C--O 1.251 1.163 0 CA-C-O 121.458 0.647 . . . . 0.0 110.117 -173.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 56.57 -153.46 0.36 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.366 -174.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -111.41 -14.21 13.78 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 168.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.515 ' OD1' ' HB3' ' A' ' 34' ' ' LYS . 5.6 m-20 -144.12 39.78 1.34 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.581 -1.19 . . . . 0.0 112.374 -172.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -121.24 128.63 52.58 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 119.134 -1.026 . . . . 0.0 110.266 168.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.445 ' HB1' HD13 ' A' ' 31' ' ' LEU . . . -130.22 142.48 50.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.841 177.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.442 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 5.6 tt -146.91 123.82 11.32 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 31.8 mt -130.6 129.88 64.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.487 ' HA3' HD22 ' A' ' 96' ' ' LEU . . . -88.05 131.83 10.87 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 175.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.0 mm -119.85 107.77 21.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 117.034 0.417 . . . . 0.0 110.842 -170.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.526 ' HA ' ' O ' ' A' ' 41' ' ' THR . 11.6 t70 -77.82 143.46 37.85 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.727 178.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 51.9 ttt-85 -71.01 -30.43 66.66 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -171.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -154.86 -32.67 0.1 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -174.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.408 ' OE1' ' HD3' ' A' ' 82' ' ' LYS . 11.9 mm-40 -61.96 141.72 95.46 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.101 0.477 . . . . 0.0 112.258 -166.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -74.51 179.83 5.53 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 123.018 2.479 . . . . 0.0 112.793 178.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.533 HD23 HD11 ' A' ' 98' ' ' LEU . 88.1 mt -49.37 -55.57 12.52 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.846 -178.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -50.52 -36.62 34.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.638 -173.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.408 ' HD3' ' OE1' ' A' ' 78' ' ' GLU . 41.8 mtpt -82.61 -45.61 14.35 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.77 0.319 . . . . 0.0 110.779 -178.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.576 HG21 ' HB3' ' A' ' 98' ' ' LEU . 91.0 t -56.53 -46.71 82.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.434 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.48 HD11 ' HB ' ' A' ' 21' ' ' THR . 4.1 mm? -58.52 -52.9 63.7 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.765 0.317 . . . . 0.0 111.361 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.49 -37.76 84.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.553 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.453 ' CD1' ' HA ' ' A' ' 43' ' ' SER . 91.8 t80 -65.88 -42.85 89.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.073 -179.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.507 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -66.43 -43.48 85.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.731 0.777 . . . . 0.0 109.897 178.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -59.6 -27.82 66.63 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.205 -1.361 . . . . 0.0 111.801 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.5 m -100.83 -0.47 36.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.837 -176.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.7 p -117.77 2.34 12.23 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.355 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.53 15.29 80.01 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.837 175.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 72.6 t -73.62 127.03 35.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -177.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 61.3 p -106.31 -24.16 12.35 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.526 174.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.542 ' HB3' ' CE2' ' A' ' 60' ' ' TRP . 34.8 p90 -71.2 145.03 90.49 Favored Pre-proline 0 C--O 1.232 0.136 0 CA-C-O 120.884 0.374 . . . . 0.0 111.118 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.76 134.83 56.21 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.826 2.351 . . . . 0.0 112.893 -177.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.507 HD12 ' HB2' ' A' ' 87' ' ' ALA . 53.8 mt -109.72 139.06 45.2 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.734 174.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -113.28 145.29 18.29 Favored Glycine 0 N--CA 1.439 -1.139 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 174.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.625 HD13 ' H ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -103.54 139.02 39.43 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.188 0.518 . . . . 0.0 110.937 -179.903 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -118.83 82.0 19.99 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.12 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.74 105.07 0.6 Allowed 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.409 2.073 . . . . 0.0 112.79 -176.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.96 8.64 27.47 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.581 178.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 52.31 42.14 30.81 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -81.04 -49.78 10.48 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.123 0.487 . . . . 0.0 110.692 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 98.7 mt -66.72 -31.38 53.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 176.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -60.15 -41.13 92.08 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.177 171.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.682 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -67.23 -24.49 65.82 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.811 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.423 ' O ' ' HG2' ' A' ' 14' ' ' PRO . 14.7 mptt -64.56 -23.69 67.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.963 0.411 . . . . 0.0 111.025 176.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -113.71 -11.74 12.9 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -173.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.682 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . 179.58 178.31 0.55 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.785 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 94.6 mt -67.87 133.93 50.01 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 175.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.452 ' HE ' ' HB2' ' A' ' 111' ' ' ARG . 1.5 mtm180 -52.39 -51.6 58.13 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 122.058 0.933 . . . . 0.0 110.578 -176.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.08 21.75 6.49 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.229 -1.35 . . . . 0.0 111.457 -172.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.785 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . . . -93.78 6.06 49.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.172 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 139.34 -164.5 25.91 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.464 178.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.759 HD13 ' N ' ' A' ' 116' ' ' THR . 0.0 OUTLIER -168.12 155.61 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.812 HG22 ' HA ' ' A' ' 133' ' ' LEU . 55.8 m 75.54 95.85 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.791 0.805 . . . . 0.0 110.386 -178.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -160.17 145.56 15.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.99 -177.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.591 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 31.1 m-80 -102.3 119.18 38.38 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.148 -178.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.1 t -118.3 109.97 28.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.843 -178.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 49.2 tp -100.31 117.06 33.74 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.699 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 53.8 mt -97.19 134.24 35.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.46 177.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.598 ' OD2' ' HB2' ' A' ' 126' ' ' LYS . 3.1 p30 -86.04 177.26 7.63 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.267 0.556 . . . . 0.0 111.261 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -66.15 -24.7 66.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.341 -177.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -80.41 -19.02 47.17 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.725 0.298 . . . . 0.0 110.557 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 106.85 12.02 25.15 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.12 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.675 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 8.3 mtmp? -102.58 158.31 16.32 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.492 HD12 ' CG1' ' A' ' 7' ' ' VAL . 54.0 mt -94.5 125.67 47.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 174.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.7 m -105.47 -22.04 5.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.901 0.382 . . . . 0.0 111.764 -174.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.477 ' HA ' ' HD2' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -142.28 125.9 16.87 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.139 -0.624 . . . . 0.0 112.35 -172.081 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.633 HD13 HG12 ' A' ' 9' ' ' ILE . 10.5 mp -114.74 117.67 31.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.405 172.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.591 ' HB ' ' HB2' ' A' ' 118' ' ' ASN . 4.2 m -122.69 131.78 53.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.801 0.334 . . . . 0.0 110.651 171.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.622 ' O ' ' HD2' ' A' ' 132' ' ' ARG . 0.1 OUTLIER -93.09 120.6 33.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.745 178.932 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.812 ' HA ' HG22 ' A' ' 116' ' ' THR . 16.9 mt 61.93 179.96 0.12 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.557 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.782 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 84.6 t80 -83.95 97.96 9.54 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 171.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -107.63 120.52 42.45 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 173.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -43.7 -56.4 3.8 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 123.841 0.713 . . . . 0.0 112.803 -173.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.9 mp0 -56.65 -46.13 81.21 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -178.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -71.54 -35.2 70.58 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.602 -175.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.508 ' CZ ' ' HB3' ' A' ' 54' ' ' PHE . 81.4 t80 -66.06 -41.06 91.31 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 175.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.84 -41.97 98.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.42 175.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.1 m -63.27 -39.18 93.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.052 177.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.722 ' O ' HG12 ' A' ' 146' ' ' ILE . 35.6 mt -59.38 -52.46 65.52 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.575 177.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 139' ' ' PHE . 91.6 t -52.48 -50.27 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 O-C-N 123.376 0.422 . . . . 0.0 111.433 -178.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -60.41 -41.72 94.49 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.075 0.464 . . . . 0.0 110.339 178.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.437 HE21 ' HB3' ' A' ' 145' ' ' GLN . 5.6 tt0 -63.49 -42.24 98.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.687 178.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.722 HG12 ' O ' ' A' ' 142' ' ' LEU . 35.4 mm -56.73 -46.88 83.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -56.26 -43.38 78.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.692 177.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -72.89 -33.7 66.2 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.209 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 92.1 mmm -65.41 -24.88 67.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.162 0.506 . . . . 0.0 110.378 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.614 HD23 ' O ' ' A' ' 146' ' ' ILE . 4.0 mm? . . . . . 0 C--N 1.323 -0.55 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.205 176.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 . . . . . 0 CA--C 1.518 -0.28 0 CA-C-O 120.86 0.362 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.7 pt -101.8 -7.42 9.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.01 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.3 p -110.98 159.15 11.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.48 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 24.1 mtm-85 -120.71 165.66 14.78 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -168.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.543 HG12 HD23 ' A' ' 130' ' ' LEU . 62.1 mt -76.05 137.23 23.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.414 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.51 -26.09 23.25 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.083 178.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -67.75 150.88 48.09 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.723 ' SD ' ' HG2' ' A' ' 126' ' ' LYS . 63.3 mmm -71.79 124.03 23.92 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.51 ' HB2' HD12 ' A' ' 121' ' ' ILE . . . -54.89 140.72 60.05 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.08 -178.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.68 174.58 6.33 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.613 2.209 . . . . 0.0 112.254 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.53 ' O ' ' HB3' ' A' ' 16' ' ' PHE . 3.0 p-10 -78.69 174.4 11.45 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.999 177.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.702 ' CE2' ' HG ' ' A' ' 28' ' ' LEU . 16.5 p90 176.36 144.96 0.08 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.428 163.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.643 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 56.2 m -127.93 99.88 5.69 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.444 -0.798 . . . . 0.0 108.866 175.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 25' ' ' GLN . 20.3 tt -106.0 146.91 12.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.22 -171.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 24' ' ' LYS . 24.4 m -83.19 127.87 33.99 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.027 177.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.414 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 79.7 mt -84.46 177.62 8.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.144 0.497 . . . . 0.0 111.462 -178.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.406 ' HB ' HD21 ' A' ' 84' ' ' LEU . 21.8 p -62.74 -23.5 67.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.988 -175.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.537 ' OD2' ' HG2' ' A' ' 24' ' ' LYS . 7.5 p-10 -105.47 9.07 33.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.167 0.508 . . . . 0.0 110.527 -176.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.3 14.17 59.15 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.247 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.537 ' HG2' ' OD2' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -85.52 171.21 11.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.207 0.503 . . . . 0.0 109.865 175.6 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.407 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 50.7 mt-30 -136.09 129.12 31.39 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 176.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.643 ' O ' ' HA ' ' A' ' 17' ' ' THR . 21.7 m -119.52 150.49 21.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.673 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 9.4 m -117.86 142.7 47.03 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.996 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.702 ' HG ' ' CE2' ' A' ' 16' ' ' PHE . 0.6 OUTLIER -64.04 -22.68 67.03 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.623 0.249 . . . . 0.0 111.358 -179.033 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.442 ' H ' HG22 ' A' ' 27' ' ' THR . 11.0 m -61.25 -38.43 86.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.967 0.413 . . . . 0.0 110.645 177.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.5 m -73.09 -23.66 60.56 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.52 0.676 . . . . 0.0 110.784 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.408 ' HB2' HD23 ' A' ' 28' ' ' LEU . 91.7 mt -88.1 -9.19 54.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.761 -177.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.448 HH21 HD13 ' A' ' 28' ' ' LEU . 5.8 mmt180 -60.63 150.57 31.5 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.741 0.305 . . . . 0.0 110.422 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.8 -23.75 31.38 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.61 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 31.2 mtmm -117.45 157.3 26.47 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.842 -0.679 . . . . 0.0 109.985 -178.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 68' ' ' ASP . 18.3 m -71.43 131.42 34.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.183 0.516 . . . . 0.0 109.896 177.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.469 HG11 HD21 ' A' ' 28' ' ' LEU . 20.8 t -120.01 123.56 71.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.904 0.383 . . . . 0.0 110.824 -177.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.552 ' SD ' HG21 ' A' ' 59' ' ' ILE . 28.1 ttt -108.29 117.05 33.13 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.9 0.381 . . . . 0.0 110.525 177.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -104.66 103.79 13.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.205 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.595 ' OE1' ' HG2' ' A' ' 52' ' ' MET . 0.0 OUTLIER -103.38 112.59 25.56 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.707 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 97.3 m-85 -91.86 120.06 32.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.78 -176.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 15.2 t -140.41 -178.43 5.49 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.756 -173.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.491 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . . . -162.76 157.07 21.09 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 122.721 0.408 . . . . 0.0 110.073 172.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.441 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 12.3 t -64.24 -32.54 74.17 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.672 -175.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 51.0 p-90 -83.85 8.17 15.72 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -174.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 43.4 t -99.62 130.87 45.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.964 0.411 . . . . 0.0 111.338 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -89.07 -28.48 20.52 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.624 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.4 t -67.32 -35.74 74.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.157 0.503 . . . . 0.0 110.269 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.59 ' HA ' ' HB3' ' A' ' 51' ' ' GLU . 59.4 m -65.78 -15.15 62.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.517 177.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.437 ' O ' ' HG2' ' A' ' 53' ' ' PRO . 84.4 mtt180 -78.74 -3.72 45.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.331 0.586 . . . . 0.0 110.148 177.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.465 ' NZ ' ' HE2' ' A' ' 134' ' ' TYR . 1.4 mmmp? -95.2 -52.39 4.21 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 162.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.728 ' O ' HG12 ' A' ' 55' ' ' ILE . 41.1 tt0 -56.36 -65.25 0.64 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 113.478 -1.692 . . . . 0.0 112.153 -173.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.595 ' HG2' ' OE1' ' A' ' 39' ' ' GLN . 1.7 mmm -56.29 -50.04 89.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -173.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.635 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 53.3 Cg_exo -55.34 -37.96 94.19 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 121.868 1.712 . . . . 0.0 112.097 176.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -72.69 -37.5 67.85 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.426 177.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.728 HG12 ' O ' ' A' ' 51' ' ' GLU . 28.9 mm -55.04 -57.48 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 121.025 0.441 . . . . 0.0 110.147 177.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.705 ' HG2' ' HA ' ' A' ' 92' ' ' VAL . 0.5 OUTLIER -66.18 -43.66 86.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.359 -177.617 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.635 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 3.7 ttmm -62.46 -41.52 98.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.775 -172.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.639 ' O ' ' HG2' ' A' ' 62' ' ' LYS . 6.1 t70 -104.61 -65.09 1.06 Allowed 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.877 178.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.552 HG21 ' SD ' ' A' ' 37' ' ' MET . 25.1 mm -54.01 -46.77 65.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-O 120.97 0.414 . . . . 0.0 111.113 -171.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.522 ' HB3' ' O ' ' A' ' 56' ' ' GLU . 73.5 t-105 -73.92 -60.65 2.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.17 -178.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.564 HD13 ' CE ' ' A' ' 64' ' ' LYS . 3.8 mm? -50.72 -35.09 29.61 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -173.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.639 ' HG2' ' O ' ' A' ' 58' ' ' ASP . 33.7 mmtp -73.93 -27.98 61.29 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -175.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 -126.38 -43.85 1.74 Allowed 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.191 -0.604 . . . . 0.0 112.626 -172.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.564 ' CE ' HD13 ' A' ' 61' ' ' LEU . 55.2 mttt 45.75 -89.82 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.011 0.924 . . . . 0.0 112.679 -176.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -87.31 -71.03 0.58 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 65.03 -4.07 0.53 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.206 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 68.48 -6.65 0.78 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.961 0.904 . . . . 0.0 112.125 -176.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.61 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 3.9 t70 -137.89 8.35 2.77 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.951 0.405 . . . . 0.0 110.692 -177.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.552 ' CE2' ' HB2' ' A' ' 71' ' ' LEU . 72.3 t80 -116.01 119.07 34.68 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.096 -0.642 . . . . 0.0 111.283 -174.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.75 107.9 12.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.669 178.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.552 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 1.7 tt -117.46 120.55 38.47 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 52.6 mt -129.89 131.31 66.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.759 0.314 . . . . 0.0 110.288 179.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.58 116.94 4.62 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 176.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 25.6 mm -103.92 111.36 33.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 116.615 0.208 . . . . 0.0 110.6 -173.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.522 ' HA ' ' O ' ' A' ' 41' ' ' THR . 8.9 t70 -80.79 140.06 35.68 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 44.4 ttt-85 -78.26 -30.92 48.82 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -172.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -163.45 -16.01 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -170.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.493 ' CD ' ' HD2' ' A' ' 82' ' ' LYS . 6.0 mm-40 -77.33 137.06 64.4 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.141 0.496 . . . . 0.0 110.793 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.489 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 30.7 Cg_endo -68.39 -174.59 0.7 Allowed 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.098 2.532 . . . . 0.0 114.576 -177.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.652 HD23 HD23 ' A' ' 84' ' ' LEU . 5.2 tt -54.26 -59.04 5.2 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.299 -1.319 . . . . 0.0 112.393 -170.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.489 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -61.31 -36.31 79.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.914 -171.883 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.493 ' HD2' ' CD ' ' A' ' 78' ' ' GLU . 42.2 mttt -64.36 -48.23 76.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.033 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 79' ' ' PRO . 57.9 t -53.84 -46.47 63.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.554 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.652 HD23 HD23 ' A' ' 80' ' ' LEU . 4.4 mm? -62.4 -50.37 71.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.042 178.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.48 97.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.712 -177.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.441 ' CD1' ' HA ' ' A' ' 43' ' ' SER . 62.4 t80 -66.93 -43.47 83.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.916 -178.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.19 -39.77 86.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.441 0.638 . . . . 0.0 110.212 178.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -59.12 -39.72 83.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.315 176.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.8 m -86.02 -19.31 30.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.162 -174.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.5 p -93.57 -29.81 15.3 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.426 -179.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 112.64 -3.02 26.17 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.161 178.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.705 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 60.6 t -50.88 115.89 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 122.794 0.438 . . . . 0.0 111.866 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.7 m -100.43 0.32 39.56 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.454 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.487 ' CE2' HG13 ' A' ' 92' ' ' VAL . 54.3 p90 -102.12 152.9 38.31 Favored Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.142 178.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.93 148.75 76.9 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.568 2.179 . . . . 0.0 113.107 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.482 HD11 HG11 ' A' ' 92' ' ' VAL . 5.2 mp -124.78 159.51 30.8 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.412 179.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -125.76 147.93 16.8 Favored Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 174.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.572 HD23 ' H ' ' A' ' 98' ' ' LEU . 0.6 OUTLIER -105.09 132.23 51.59 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.82 0.31 . . . . 0.0 110.737 -177.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -120.39 75.91 24.85 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.47 178.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -65.29 101.08 0.4 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.476 2.117 . . . . 0.0 112.09 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 126.5 -7.5 7.47 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.862 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 58.18 44.01 19.64 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.691 0.396 . . . . 0.0 111.486 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -89.99 -46.54 8.44 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.129 0.49 . . . . 0.0 110.086 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.659 HD12 ' HB2' ' A' ' 16' ' ' PHE . 33.4 mm -61.76 -36.1 71.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 172.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -63.65 -39.15 93.62 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 113.624 -1.626 . . . . 0.0 110.467 174.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.701 ' HB2' ' HG2' ' A' ' 111' ' ' ARG . . . -71.72 -30.61 65.83 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -174.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.5 ' HE2' ' O ' ' A' ' 15' ' ' ASP . 13.1 ptmt -79.11 -1.78 37.53 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.857 -175.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -108.14 -37.69 5.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.223 0.535 . . . . 0.0 110.807 171.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.581 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -152.74 166.0 33.56 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.9 pp -60.42 163.98 4.77 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.85 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.701 ' HG2' ' HB2' ' A' ' 106' ' ' ALA . 50.5 mtt-85 -75.94 58.21 1.14 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -164.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 19.2 t70 169.68 -75.1 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.034 -1.439 . . . . 0.0 107.783 173.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.559 ' HB3' ' NH2' ' A' ' 117' ' ' ARG . . . 47.91 27.06 1.07 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.986 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.476 ' HA3' ' NH2' ' A' ' 132' ' ' ARG . . . 72.32 106.81 0.06 OUTLIER Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -170.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.441 ' O ' ' HB ' ' A' ' 116' ' ' THR . 19.2 tt -64.77 167.29 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.889 HG22 ' HA ' ' A' ' 133' ' ' LEU . 32.9 m 75.31 88.57 0.09 Allowed 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -174.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.974 ' HG2' ' HA ' ' A' ' 132' ' ' ARG . 41.0 mtm105 -157.61 145.76 19.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.451 -177.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -112.61 119.39 37.96 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.844 -177.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 72.2 t -110.01 107.32 22.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.838 177.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.659 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 55.0 tp -98.4 133.74 42.37 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.939 0.4 . . . . 0.0 110.337 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.51 HD12 ' HB2' ' A' ' 13' ' ' ALA . 38.2 mm -114.52 134.49 57.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.002 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.33 160.7 30.78 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 176.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 6.8 ptm180 -68.0 -22.03 65.01 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -173.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.583 ' HB2' ' HZ3' ' A' ' 126' ' ' LYS . 46.2 mt-10 -76.28 -18.52 58.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.293 0.568 . . . . 0.0 110.087 175.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 109.79 9.67 24.31 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.687 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.723 ' HG2' ' SD ' ' A' ' 12' ' ' MET . 35.3 mtmm -91.02 139.36 30.84 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.165 0.483 . . . . 0.0 110.725 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.47 HG12 HD12 ' A' ' 121' ' ' ILE . 35.3 mt -70.53 121.64 20.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.44 HG12 ' O ' ' A' ' 120' ' ' LEU . 8.7 p -114.19 -31.54 2.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -164.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.659 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 7.1 tmtm? -145.36 112.28 5.98 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.316 -0.553 . . . . 0.0 111.154 -174.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.543 HD23 HG12 ' A' ' 9' ' ' ILE . 2.8 mm? -112.2 111.74 22.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.888 175.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.2 t -129.32 162.46 27.9 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.689 175.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.974 ' HA ' ' HG2' ' A' ' 117' ' ' ARG . 28.8 mtp-105 -112.53 132.62 55.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.059 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.889 ' HA ' HG22 ' A' ' 116' ' ' THR . 4.6 pp 53.84 172.27 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.93 1.292 . . . . 0.0 113.687 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.465 ' HE2' ' NZ ' ' A' ' 50' ' ' LYS . 54.3 t80 -84.17 94.93 8.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.109 177.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.532 ' HB3' ' HB3' ' A' ' 138' ' ' GLU . 11.6 t30 -95.39 133.45 39.33 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 172.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -55.53 -56.94 14.39 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 123.163 0.289 . . . . 0.0 111.667 -169.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.512 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.5 mp0 -63.95 -33.13 75.02 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.178 0.513 . . . . 0.0 110.677 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.532 ' HB3' ' HB3' ' A' ' 135' ' ' ASN . 7.2 tp10 -65.63 -44.95 84.89 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.088 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.622 ' O ' HG23 ' A' ' 143' ' ' VAL . 90.5 t80 -60.96 -43.52 98.6 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.167 178.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.73 -44.9 86.32 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.007 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.7 m -63.33 -43.59 97.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.629 177.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.62 -44.3 96.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.597 -178.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 139' ' ' PHE . 95.7 t -56.75 -59.41 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.994 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -57.59 -36.91 72.35 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.534 -177.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.643 ' O ' ' HG3' ' A' ' 149' ' ' MET . 6.7 tt0 -62.62 -53.56 52.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.414 177.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 64.3 mt -56.74 -42.2 76.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 120.962 0.41 . . . . 0.0 110.835 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -51.16 -55.05 19.86 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.275 178.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -64.18 -29.01 70.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.321 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.643 ' HG3' ' O ' ' A' ' 145' ' ' GLN . 92.8 mtp -61.4 -36.7 81.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.574 0.226 . . . . 0.0 110.842 -176.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.407 0 C-N-CA 120.293 -0.563 . . . . 0.0 112.424 178.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 . . . . . 0 N--CA 1.453 -0.304 0 CA-C-O 121.168 0.509 . . . . 0.0 110.688 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.476 HG12 ' HA ' ' A' ' 109' ' ' ALA . 27.3 pt -95.22 9.53 5.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.769 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.657 HG11 HD12 ' A' ' 127' ' ' ILE . 23.2 t -118.45 153.77 20.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.135 -177.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.428 ' HB2' ' HB2' ' A' ' 11' ' ' GLU . 41.0 mtt180 -104.42 163.63 12.31 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.915 0.388 . . . . 0.0 110.924 -174.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.567 HG12 HD23 ' A' ' 130' ' ' LEU . 71.3 mt -83.16 117.78 29.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 170.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.88 0.39 56.29 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 -173.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 8' ' ' ARG . 4.1 tp10 -69.47 144.14 53.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.289 -0.456 . . . . 0.0 110.501 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.4 mmt -68.58 111.9 5.04 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 174.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.46 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -58.25 133.96 84.69 Favored Pre-proline 0 C--O 1.237 0.396 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.604 -176.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 6.4 Cg_exo -73.12 174.45 12.01 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.105 2.536 . . . . 0.0 112.245 178.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -81.7 168.74 17.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.663 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.62 ' HB2' HD12 ' A' ' 104' ' ' ILE . 33.5 p90 -177.57 143.56 0.36 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.316 165.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 62.7 m -117.72 106.43 13.05 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 173.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.1 tt -111.75 138.92 38.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.085 -169.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.2 m -88.2 117.95 27.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.399 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.3 mt -80.92 167.82 19.42 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.153 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.416 ' HB ' ' CD1' ' A' ' 84' ' ' LEU . 17.4 p -54.45 -28.08 41.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.512 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -93.6 15.32 16.44 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.166 -174.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.85 27.41 68.99 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.674 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 49.8 mmtm -108.48 119.26 38.99 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.624 0.25 . . . . 0.0 110.45 -176.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -94.95 115.23 27.19 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.189 178.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 17' ' ' THR . 20.2 m -114.96 150.59 16.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.428 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 20.7 m -110.87 142.67 42.6 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.911 177.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -60.06 -34.62 73.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.951 0.405 . . . . 0.0 110.56 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.42 ' H ' HG22 ' A' ' 27' ' ' THR . 9.4 m -62.86 -25.8 68.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.646 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.2 m -75.36 -21.29 58.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.218 0.532 . . . . 0.0 111.405 -176.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.8 mt -103.47 4.35 35.92 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.48 -178.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.548 ' CZ ' ' HA3' ' A' ' 125' ' ' GLY . 23.7 mmm-85 -65.83 109.67 2.56 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.113 0.482 . . . . 0.0 110.14 178.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.28 -29.44 2.61 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -173.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.416 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 27.2 mttt -96.06 173.08 7.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.237 -0.481 . . . . 0.0 109.985 176.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.455 HG11 ' HB3' ' A' ' 149' ' ' MET . 30.6 m -84.64 108.74 17.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 169.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.467 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 21.2 t -102.6 113.28 38.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.336 -172.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.446 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 27.1 ttt -98.41 124.31 43.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.451 177.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.431 ' HB2' ' HB ' ' A' ' 119' ' ' VAL . 3.2 mm? -109.86 112.99 25.36 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.857 177.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.478 HE22 ' HB ' ' A' ' 41' ' ' THR . 26.2 tm0? -107.28 107.1 17.87 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -82.22 127.31 33.05 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.52 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 12.4 t -140.44 176.19 8.98 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.136 0.493 . . . . 0.0 111.141 -172.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.464 ' HB2' HG12 ' A' ' 115' ' ' ILE . . . -152.36 133.5 14.28 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.494 177.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.487 ' OG ' ' HB3' ' A' ' 82' ' ' LYS . 12.4 p -63.59 -9.21 12.36 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -177.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 12.4 p-90 -108.79 12.82 25.38 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.84 0.352 . . . . 0.0 111.496 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 49.4 t -108.09 111.8 24.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.923 0.392 . . . . 0.0 110.695 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.1 -22.88 77.41 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.675 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.2 t -63.66 -34.58 68.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.204 0.526 . . . . 0.0 110.214 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.575 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 64.1 m -67.34 -22.33 65.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.705 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.489 ' O ' ' HG2' ' A' ' 53' ' ' PRO . 26.5 mtp-105 -73.69 -3.16 26.57 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.086 0.47 . . . . 0.0 110.583 178.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -97.74 -58.01 2.1 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.059 171.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.954 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 11.3 pt-20 -64.23 -47.96 77.67 Favored 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -175.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.664 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 94.3 mtp -59.87 -51.78 78.34 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -173.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.664 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 52.4 Cg_exo -59.06 -37.96 89.97 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.3 2.0 . . . . 0.0 112.649 174.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.439 ' HB3' ' CZ ' ' A' ' 139' ' ' PHE . 10.8 m-85 -67.39 -42.29 83.55 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.796 176.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 51' ' ' GLU . 94.6 mt -59.23 -48.79 85.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.173 177.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.57 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 2.0 pp20? -67.86 -35.25 78.21 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.633 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.565 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 7.9 ttmm -64.04 -44.32 92.86 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.522 -176.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.725 ' O ' ' HG2' ' A' ' 62' ' ' LYS . 3.9 t0 -106.15 -65.65 1.06 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.177 -0.609 . . . . 0.0 111.326 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.509 HG12 HG23 ' A' ' 143' ' ' VAL . 58.2 mt -56.84 -45.05 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 120.858 0.361 . . . . 0.0 111.609 -169.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.571 ' CD2' ' HB3' ' A' ' 94' ' ' TYR . 76.4 t-105 -75.37 -59.47 2.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.472 -177.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.526 HD13 ' O ' ' A' ' 56' ' ' GLU . 1.6 mp -53.83 -30.57 45.83 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -171.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.725 ' HG2' ' O ' ' A' ' 58' ' ' ASP . 31.8 mmtp -76.95 -24.88 52.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.868 0.366 . . . . 0.0 111.667 -177.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.462 ' CE1' ' HG ' ' A' ' 150' ' ' LEU . 73.8 m-70 -121.67 -41.37 2.48 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -172.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.403 ' HE3' ' HA ' ' A' ' 61' ' ' LEU . 33.1 mmtp 56.42 -95.38 0.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 122.917 0.487 . . . . 0.0 110.128 -167.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.44 ' O ' ' HB3' ' A' ' 66' ' ' ASN . 15.6 t70 -110.8 -32.07 6.97 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 171.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.44 ' HB3' ' O ' ' A' ' 65' ' ' ASP . 20.2 t-20 67.93 -68.82 0.15 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.038 -176.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 158.71 -33.91 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.627 1.571 . . . . 0.0 106.868 -175.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.416 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 15.1 t70 -125.55 18.66 8.1 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.258 -174.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -124.44 142.59 51.19 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.84 -0.537 . . . . 0.0 110.585 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.63 130.36 20.3 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.541 176.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.446 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 2.0 tt -132.92 114.67 14.31 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.1 mp -122.74 124.08 69.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.121 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 96' ' ' LEU . . . -91.92 136.3 13.19 Favored Glycine 0 C--O 1.222 -0.64 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 173.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 59.9 mt -119.93 103.53 14.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 117.742 0.771 . . . . 0.0 111.388 -175.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.52 ' HA ' ' O ' ' A' ' 41' ' ' THR . 34.4 t0 -80.66 133.1 35.67 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 171.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.536 ' HA ' ' HB3' ' A' ' 99' ' ' ASP . 5.7 ttp180 -71.28 -105.8 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -170.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.452 ' H ' ' HB3' ' A' ' 76' ' ' ARG . 10.1 m-20 -87.33 21.19 2.52 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -168.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -98.56 142.86 25.29 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-O 120.981 0.419 . . . . 0.0 111.449 -178.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.446 ' O ' HG23 ' A' ' 83' ' ' VAL . 64.9 Cg_endo -75.54 174.9 12.03 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.936 2.424 . . . . 0.0 112.86 178.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.443 HD23 HD11 ' A' ' 98' ' ' LEU . 32.5 mt -50.93 -50.32 57.96 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.441 -176.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -52.0 -39.82 60.04 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -176.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.487 ' HB3' ' OG ' ' A' ' 43' ' ' SER . 31.7 mmtp -66.84 -53.32 33.75 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.393 178.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 79' ' ' PRO . 15.3 t -60.7 -47.16 94.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.361 -175.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.416 ' CD1' ' HB ' ' A' ' 21' ' ' THR . 4.0 mm? -60.49 -48.6 81.07 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.902 0.382 . . . . 0.0 111.435 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.898 ' HA ' ' HE2' ' A' ' 88' ' ' LYS . . . -67.24 -35.8 80.31 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.307 -176.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.608 ' HE2' ' SD ' ' A' ' 52' ' ' MET . 56.1 t80 -72.51 -37.34 68.41 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.711 -178.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.433 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -62.46 -49.61 74.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.294 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.898 ' HE2' ' HA ' ' A' ' 85' ' ' ALA . 63.8 pttt -68.54 -29.93 68.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.29 -176.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.2 m -83.75 -2.04 55.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.725 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.473 ' HB ' ' HG3' ' A' ' 53' ' ' PRO . 11.1 p -115.64 -8.12 12.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.895 0.379 . . . . 0.0 110.902 175.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.69 4.14 87.68 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.273 178.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.401 HG13 ' CE1' ' A' ' 94' ' ' TYR . 42.6 t -59.98 114.86 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.171 0.51 . . . . 0.0 111.267 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 p -100.68 7.69 43.77 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.632 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.571 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 33.4 p90 -104.25 145.63 31.03 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.228 173.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -63.07 140.6 79.47 Favored 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 122.615 2.21 . . . . 0.0 112.925 -178.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' A' ' 73' ' ' GLY . 62.5 mt -113.02 144.63 42.25 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.173 176.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -112.22 164.56 12.08 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.886 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.443 HD11 HD23 ' A' ' 80' ' ' LEU . 7.0 mp -102.95 147.49 26.86 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.536 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 36.4 t0 -130.38 70.54 82.33 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-O 121.057 0.456 . . . . 0.0 110.803 174.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.15 110.25 1.72 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.673 2.248 . . . . 0.0 112.211 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.86 -1.21 31.84 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.72 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 54.74 40.01 31.67 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.883 0.373 . . . . 0.0 111.016 -175.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.587 ' O ' ' HG3' ' A' ' 107' ' ' LYS . 15.4 t70 -84.13 -45.71 12.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.511 -174.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.62 HD12 ' HB2' ' A' ' 16' ' ' PHE . 35.3 mm -66.11 -35.55 75.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 177.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.491 ' CE1' ' HD3' ' A' ' 117' ' ' ARG . 56.6 t80 -63.51 -37.18 86.33 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.808 174.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.783 ' HB2' ' HG2' ' A' ' 111' ' ' ARG . . . -69.83 -22.92 63.24 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.566 178.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.587 ' HG3' ' O ' ' A' ' 103' ' ' ASP . 44.5 mtpt -79.46 -3.13 45.16 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.254 178.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -130.99 -3.04 4.02 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.899 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.63 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -178.16 -176.24 0.52 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 122.887 0.475 . . . . 0.0 110.448 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.3 mt -72.92 157.95 36.44 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 172.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.783 ' HG2' ' HB2' ' A' ' 106' ' ' ALA . 48.6 mtt180 -78.2 -10.31 59.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.974 0.416 . . . . 0.0 111.063 -175.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -88.0 -68.77 0.74 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 171.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 21.2 -89.26 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.775 0 O-C-N 125.177 1.548 . . . . 0.0 113.885 -178.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -164.1 -138.42 2.41 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.464 HG12 ' HB2' ' A' ' 42' ' ' ALA . 7.4 tp -150.86 -50.33 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.674 177.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.709 ' HB ' ' HB3' ' A' ' 133' ' ' LEU . 1.0 OUTLIER -77.03 107.48 9.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.002 0.429 . . . . 0.0 111.681 -178.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.491 ' HD3' ' CE1' ' A' ' 105' ' ' PHE . 6.1 ptm180 -159.7 135.62 8.66 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.062 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.521 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 9.0 m120 -108.68 119.02 38.31 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' A' ' 38' ' ' LEU . 57.7 t -112.49 138.23 42.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.592 -177.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.589 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 34.2 tp -123.69 123.89 41.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.017 0.437 . . . . 0.0 110.765 175.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.467 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 79.7 mt -101.09 132.51 46.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.274 175.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.05 -179.97 6.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.768 0.318 . . . . 0.0 110.553 -178.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 6.0 ptm85 -69.93 -24.09 63.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.262 -174.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -77.06 -26.98 54.17 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.51 0.671 . . . . 0.0 109.898 174.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.548 ' HA3' ' CZ ' ' A' ' 32' ' ' ARG . . . 109.93 18.77 8.58 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.854 -177.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 11' ' ' GLU . 80.9 mttt -94.63 136.42 34.95 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.954 0.407 . . . . 0.0 110.501 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.657 HD12 HG11 ' A' ' 7' ' ' VAL . 55.4 mt -79.7 99.2 3.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 28.0 m -101.33 -4.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -171.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.589 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 48.3 tptt -146.27 111.53 5.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.14 0.495 . . . . 0.0 111.597 -176.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.567 HD23 HG12 ' A' ' 9' ' ' ILE . 3.3 mm? -109.28 105.85 15.44 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.646 172.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.521 ' HB ' ' HB2' ' A' ' 118' ' ' ASN . 0.4 OUTLIER -109.64 155.86 20.94 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.999 0.428 . . . . 0.0 111.137 -174.479 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -89.85 174.35 7.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.996 178.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.709 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 2.9 pp -45.34 162.07 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 O-C-N 123.608 0.568 . . . . 0.0 112.106 175.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.954 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 91.9 t80 -43.98 97.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -174.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -114.4 129.62 56.66 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 164.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -55.07 -43.49 73.93 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -171.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -60.95 -49.54 77.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.99 0.424 . . . . 0.0 111.445 176.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.438 ' HB3' ' CG2' ' A' ' 131' ' ' THR . 6.6 mt-10 -65.0 -39.96 94.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.263 -178.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.439 ' CZ ' ' HB3' ' A' ' 54' ' ' PHE . 70.6 t80 -64.03 -42.05 97.23 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.917 0.389 . . . . 0.0 110.408 175.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.46 -40.62 97.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.725 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.402 ' O ' ' HB3' ' A' ' 145' ' ' GLN . 60.7 p -65.64 -29.26 69.81 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.299 -0.409 . . . . 0.0 109.926 178.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.4 mt -73.15 -57.68 3.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.313 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.509 HG23 HG12 ' A' ' 59' ' ' ILE . 7.4 p -59.39 -38.34 74.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 O-C-N 123.11 0.256 . . . . 0.0 110.966 -175.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -67.41 -48.73 66.48 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 177.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.468 ' O ' ' HG2' ' A' ' 149' ' ' MET . 7.1 tt0 -55.98 -48.89 75.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.853 177.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.455 ' O ' HD23 ' A' ' 150' ' ' LEU . 93.1 mt -64.16 -44.44 97.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.189 -178.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -58.93 -40.75 85.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.201 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -73.55 -25.95 60.62 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.126 -0.229 . . . . 0.0 110.951 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.468 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 61.1 mmm -66.7 -28.44 68.44 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 175.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.462 ' HG ' ' CE1' ' A' ' 63' ' ' HIS . 4.2 mm? . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.83 175.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.618 ' CD2' HD12 ' A' ' 130' ' ' LEU . 93.5 m-85 . . . . . 0 CA--C 1.52 -0.203 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.7 pp -109.99 -0.12 9.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.576 0.703 . . . . 0.0 109.898 171.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.2 p -114.53 163.01 12.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.612 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 28.3 mtm105 -129.88 166.4 20.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.833 0.349 . . . . 0.0 111.916 -171.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.496 HG12 ' CD2' ' A' ' 130' ' ' LEU . 53.2 mt -77.88 140.13 17.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.848 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.96 -16.56 55.0 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.128 -0.558 . . . . 0.0 111.882 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.454 ' HA ' ' OE1' ' A' ' 11' ' ' GLU . 8.0 mm-40 -82.65 158.38 23.01 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.073 0.463 . . . . 0.0 111.086 -178.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 84.9 mmm -77.15 132.33 38.75 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.373 -176.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.535 ' HB2' HD12 ' A' ' 121' ' ' ILE . . . -68.72 130.04 92.08 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.036 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.74 125.63 13.5 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.611 2.207 . . . . 0.0 111.93 177.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -64.77 145.7 55.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.039 -178.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.692 ' HB2' HD12 ' A' ' 104' ' ' ILE . 47.1 p90 -149.54 154.2 38.36 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.471 178.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 34.6 m -118.13 106.18 12.59 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.547 173.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.6 tt -110.72 145.81 16.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.599 -175.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.508 ' O ' HD23 ' A' ' 98' ' ' LEU . 16.5 m -85.99 128.2 34.8 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.309 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.1 mt -80.57 179.54 7.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.092 0.472 . . . . 0.0 111.392 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 96' ' ' LEU . 30.0 p -64.66 -20.03 66.06 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.329 -0.851 . . . . 0.0 112.439 -177.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.496 ' OD2' ' HG3' ' A' ' 24' ' ' LYS . 10.9 p-10 -106.07 10.74 32.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.919 0.39 . . . . 0.0 110.647 -178.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.14 3.37 67.69 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.665 -0.779 . . . . 0.0 113.398 175.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.496 ' HG3' ' OD2' ' A' ' 22' ' ' ASP . 32.0 mtmm -84.51 122.93 29.69 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.043 0.421 . . . . 0.0 111.353 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.49 ' HB3' HG22 ' A' ' 17' ' ' THR . 93.6 mt-30 -88.23 116.44 26.43 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 175.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 17' ' ' THR . 17.0 m -107.59 147.15 12.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.217 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.8 m -111.42 144.45 40.61 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.072 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.02 -43.4 91.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.965 0.412 . . . . 0.0 110.328 -178.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.515 ' HA ' ' CG ' ' A' ' 32' ' ' ARG . 49.4 m -62.02 -21.22 64.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.974 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.5 t -76.75 -17.29 59.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.818 0.342 . . . . 0.0 110.433 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.4 mt -118.45 19.55 13.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.136 0.494 . . . . 0.0 110.271 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.534 ' NH1' ' H ' ' A' ' 33' ' ' GLY . 10.6 mmm180 -73.71 155.89 38.48 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.966 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.534 ' H ' ' NH1' ' A' ' 32' ' ' ARG . . . 102.94 -30.97 9.31 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 -177.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.689 ' HB3' ' HZ3' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -114.31 173.55 6.4 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.515 -0.343 . . . . 0.0 110.5 -177.879 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 68' ' ' ASP . 33.2 m -79.35 130.65 35.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.944 0.402 . . . . 0.0 110.055 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.47 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 55.3 t -119.93 113.85 42.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.662 -178.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.807 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 1.6 tmt? -91.68 138.1 31.83 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 176.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.415 ' HB2' ' HB ' ' A' ' 119' ' ' VAL . 93.5 mt -127.9 122.51 32.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.509 -175.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -116.81 107.16 14.29 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.547 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.779 ' HB2' ' HB2' ' A' ' 117' ' ' ARG . 92.6 m-85 -90.92 112.54 24.44 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 9.2 t -141.34 -171.43 3.29 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.47 -172.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.418 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . . . -151.14 172.55 15.61 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.528 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 26.9 t -82.88 -14.04 55.0 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.835 0.35 . . . . 0.0 110.766 -178.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -102.3 -4.37 25.75 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.6 p -88.56 107.4 18.88 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 121.657 -0.652 . . . . 0.0 111.181 -178.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.83 -8.7 82.58 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 115.836 -0.62 . . . . 0.0 113.175 -177.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.4 t -77.34 -45.54 29.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 176.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.68 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 98.0 m -62.93 -22.69 66.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.475 -178.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.567 ' HE ' ' HE1' ' A' ' 86' ' ' PHE . 89.1 mtt180 -69.93 -2.12 11.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.607 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.425 ' O ' ' HD1' ' A' ' 54' ' ' PHE . 58.9 mttp -100.3 -48.28 4.65 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.346 0.593 . . . . 0.0 109.676 171.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 1.098 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 6.5 pt-20 -67.2 -44.36 79.8 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.798 -176.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.805 ' HG2' ' HD3' ' A' ' 53' ' ' PRO . 16.2 ptm -64.18 -39.77 46.66 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-O 118.576 -0.726 . . . . 0.0 112.923 -174.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.805 ' HD3' ' HG2' ' A' ' 52' ' ' MET . 46.6 Cg_exo -61.23 -41.73 40.44 Favored 'Trans proline' 0 C--N 1.362 1.254 0 C-N-CA 121.345 1.363 . . . . 0.0 112.307 169.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 139' ' ' PHE . 18.4 m-85 -64.98 -41.88 95.03 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.906 176.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.558 HG12 HD12 ' A' ' 59' ' ' ILE . 70.2 mt -59.43 -50.52 79.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.094 175.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.601 ' OE1' ' HA ' ' A' ' 92' ' ' VAL . 25.2 tp10 -49.05 -49.67 40.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.232 0.539 . . . . 0.0 110.819 175.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.7 tmmt? -69.29 -47.02 65.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.915 -174.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -106.33 -50.16 3.2 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -173.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.558 HD12 HG12 ' A' ' 55' ' ' ILE . 38.4 mt -71.08 -43.48 75.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.597 -176.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.435 ' CE2' ' HB3' ' A' ' 94' ' ' TYR . 66.8 t-105 -81.66 -77.43 0.22 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.997 -178.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -44.5 -34.99 2.28 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -172.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -84.37 -26.44 28.39 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -173.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -127.15 -9.66 5.89 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -173.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.542 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 18.0 pttp -41.89 -48.84 4.51 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -165.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.52 -83.95 0.11 Allowed 'General case' 0 C--O 1.25 1.094 0 CA-C-O 121.471 0.653 . . . . 0.0 110.197 -172.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.459 ' CG ' ' H ' ' A' ' 67' ' ' ALA . 63.5 t30 49.23 -155.75 0.09 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.631 -169.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.459 ' H ' ' CG ' ' A' ' 66' ' ' ASN . . . -105.99 -10.41 16.6 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 166.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.489 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 12.8 m-20 -145.05 39.76 1.22 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.739 -170.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.542 ' CD2' ' HA ' ' A' ' 64' ' ' LYS . 62.1 t80 -118.45 129.3 55.31 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 118.976 -1.089 . . . . 0.0 110.605 169.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.24 143.75 50.97 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.533 175.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.807 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 5.4 tt -143.77 121.56 11.94 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.1 mp -125.67 127.19 71.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.378 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.428 ' HA3' HD22 ' A' ' 96' ' ' LEU . . . -95.53 133.08 11.35 Favored Glycine 0 C--O 1.223 -0.579 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.034 175.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 74.7 mt -119.74 127.38 75.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 117.203 0.501 . . . . 0.0 111.128 -174.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.45 ' O ' ' HB3' ' A' ' 99' ' ' ASP . 11.6 t70 -89.34 144.85 25.76 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.508 HH21 ' HA ' ' A' ' 112' ' ' ASP . 19.8 ttt-85 -69.71 -32.71 71.44 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -172.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -158.38 -34.26 0.07 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -173.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -71.62 138.4 83.27 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 121.262 0.553 . . . . 0.0 111.896 -165.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.563 ' HD2' ' HG3' ' A' ' 82' ' ' LYS . 37.4 Cg_endo -72.17 -170.75 0.6 Allowed 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.676 2.917 . . . . 0.0 115.411 -171.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.423 ' O ' HD23 ' A' ' 84' ' ' LEU . 87.7 mt -54.63 -60.35 3.47 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 114.422 -1.263 . . . . 0.0 113.021 -171.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.552 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -59.43 -35.39 73.91 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.032 0.444 . . . . 0.0 110.821 -173.072 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.563 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 19.4 mmmt -61.42 -53.27 58.7 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.237 174.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 79' ' ' PRO . 70.6 t -65.9 -43.57 92.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.341 -178.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 80' ' ' LEU . 4.4 mm? -61.79 -47.37 85.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.399 -178.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.86 -35.19 79.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.752 0.31 . . . . 0.0 110.725 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.567 ' HE1' ' HE ' ' A' ' 49' ' ' ARG . 91.3 t80 -67.02 -52.49 41.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.125 178.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.523 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -55.47 -49.54 72.22 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.915 0.388 . . . . 0.0 110.691 177.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.4 tttm -50.69 -36.21 34.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.978 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.9 m -89.78 6.55 41.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.446 -174.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 16.5 p -132.63 8.51 4.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.191 0.519 . . . . 0.0 110.739 176.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.62 -72.12 2.17 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.601 ' HA ' ' OE1' ' A' ' 56' ' ' GLU . 58.1 t 29.37 96.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.148 1.379 . . . . 0.0 114.579 178.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.5 p -94.88 -10.83 30.04 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.639 -0.425 . . . . 0.0 110.553 176.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.435 ' HB3' ' CE2' ' A' ' 60' ' ' TRP . 37.4 p90 -85.49 141.07 36.29 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.381 175.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -62.43 137.71 66.64 Favored 'Trans proline' 0 C--O 1.239 0.546 0 C-N-CA 122.514 2.143 . . . . 0.0 113.359 -177.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.523 HD12 ' HB2' ' A' ' 87' ' ' ALA . 71.4 mt -109.89 149.46 29.86 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.513 174.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -120.8 148.59 17.57 Favored Glycine 0 N--CA 1.438 -1.213 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 175.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.791 HD23 ' H ' ' A' ' 98' ' ' LEU . 2.3 pt? -103.24 131.79 50.01 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.45 ' HB3' ' O ' ' A' ' 75' ' ' ASP . 12.7 t0 -115.95 79.45 8.15 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.45 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.49 105.09 1.2 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.198 1.932 . . . . 0.0 112.373 -177.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 117.47 1.92 17.79 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.149 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 55.24 39.92 31.49 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 122.638 0.375 . . . . 0.0 111.854 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -79.83 -51.13 9.54 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.283 0.563 . . . . 0.0 110.784 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.692 HD12 ' HB2' ' A' ' 16' ' ' PHE . 30.5 mm -64.82 -34.65 71.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.615 ' CD1' ' HA ' ' A' ' 111' ' ' ARG . 18.1 t80 -65.75 -34.41 78.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.032 175.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -71.88 -23.62 61.54 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.357 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -74.14 -3.9 32.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.255 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -131.0 -35.69 1.38 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.912 0.387 . . . . 0.0 111.269 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -134.52 174.89 10.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.916 0.388 . . . . 0.0 111.109 -177.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.6 mt -78.91 6.22 9.71 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.615 ' HA ' ' CD1' ' A' ' 105' ' ' PHE . 7.3 mtm180 73.98 -68.94 0.2 Allowed 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.981 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.508 ' HA ' HH21 ' A' ' 76' ' ' ARG . 20.6 m-20 -84.77 6.75 23.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.729 -172.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -85.07 41.13 0.86 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.591 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.24 151.94 19.27 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.628 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.47 HG13 ' N ' ' A' ' 116' ' ' THR . 9.5 tp -88.03 171.18 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.47 ' N ' HG13 ' A' ' 115' ' ' ILE . 25.0 m 79.79 108.52 0.07 Allowed 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.298 0.639 . . . . 0.0 111.875 174.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.779 ' HB2' ' HB2' ' A' ' 40' ' ' PHE . 77.5 mmt-85 -138.78 131.15 28.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.151 173.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' A' ' 130' ' ' LEU . 7.6 m120 -114.99 117.14 29.76 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 176.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.415 ' HB ' ' HB2' ' A' ' 38' ' ' LEU . 39.4 t -129.28 141.4 46.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.879 0.371 . . . . 0.0 111.212 -172.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 46.7 tp -121.61 118.34 28.96 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.092 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.535 HD12 ' HB2' ' A' ' 13' ' ' ALA . 39.4 mm -91.44 121.35 41.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.849 177.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.57 ' OD2' ' HB2' ' A' ' 124' ' ' GLU . 13.6 t0 -67.83 158.35 32.75 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.375 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.7 ptt85 -67.57 -14.56 63.04 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.971 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.57 ' HB2' ' OD2' ' A' ' 122' ' ' ASP . 0.7 OUTLIER -77.63 -16.64 58.43 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 173.052 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.01 24.72 10.21 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.836 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -117.45 156.09 28.56 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.75 0.31 . . . . 0.0 111.359 -175.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.42 HG12 ' CD1' ' A' ' 121' ' ' ILE . 49.8 mt -86.72 113.88 25.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 174.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.1 m -104.2 -17.23 7.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.98 0.419 . . . . 0.0 111.502 -178.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.431 ' HG2' HE22 ' A' ' 145' ' ' GLN . 51.9 tptt -152.49 119.11 5.67 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.353 -176.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.618 HD12 ' CD2' ' A' ' 5' ' ' TYR . 1.7 pt? -141.28 105.85 4.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.537 0.684 . . . . 0.0 109.741 176.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.9 t -127.59 164.03 22.89 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.575 -175.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.805 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 62.5 mtp180 -114.71 133.12 56.13 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.54 -178.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.805 ' HG ' ' O ' ' A' ' 132' ' ' ARG . 3.9 pp 65.39 154.57 0.07 Allowed 'General case' 0 N--CA 1.471 0.578 0 O-C-N 124.988 1.43 . . . . 0.0 112.982 172.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 1.098 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 58.3 t80 -64.71 102.05 0.54 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.974 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 1.005 ' HB2' ' HB2' ' A' ' 138' ' ' GLU . 46.1 m-80 -98.93 167.11 10.95 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.948 171.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.14 -68.13 0.69 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.297 0.57 . . . . 0.0 110.03 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -67.83 -31.29 71.03 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.326 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 1.005 ' HB2' ' HB2' ' A' ' 135' ' ' ASN . 3.1 mm-40 -63.74 -40.13 95.99 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.186 177.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.484 ' HA ' HD12 ' A' ' 142' ' ' LEU . 87.2 t80 -71.1 -41.26 70.83 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.3 -39.15 89.41 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.769 177.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.0 m -65.35 -39.56 92.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.496 178.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.484 HD12 ' HA ' ' A' ' 139' ' ' PHE . 35.9 mt -58.66 -47.97 82.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.763 177.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 94.4 t -56.53 -49.25 78.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.186 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -66.22 -43.25 87.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.048 0.452 . . . . 0.0 110.589 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.52 ' O ' ' HG2' ' A' ' 149' ' ' MET . 12.7 tt0 -58.82 -50.95 72.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.031 179.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.626 ' O ' HD23 ' A' ' 150' ' ' LEU . 77.0 mt -66.83 -30.26 49.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.263 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -57.68 -43.51 85.14 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.849 176.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -67.26 -39.03 86.07 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.687 0.617 . . . . 0.0 111.089 177.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' MET . . . . . 0.52 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 88.1 mmm -59.68 -27.86 66.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.635 0.731 . . . . 0.0 110.084 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.626 HD23 ' O ' ' A' ' 146' ' ' ILE . 3.4 mm? . . . . . 0 C--N 1.324 -0.522 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.403 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.575 ' O ' ' HA ' ' A' ' 113' ' ' ALA . 16.4 ptp . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.6 p -78.04 -79.89 0.12 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.68 0.276 . . . . 0.0 111.142 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.4 mt -97.76 73.43 2.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.174 0.512 . . . . 0.0 110.234 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.429 ' H ' ' HB1' ' A' ' 113' ' ' ALA . . . -89.67 82.9 1.4 Allowed Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.838 -176.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -93.83 131.84 38.84 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 175.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.418 HG13 HG23 ' A' ' 7' ' ' VAL . 46.1 pt -96.78 -14.03 7.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.418 0.627 . . . . 0.0 109.42 173.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.616 HG11 HD12 ' A' ' 127' ' ' ILE . 20.5 t -110.36 151.78 12.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.181 177.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.428 ' CD ' ' HB2' ' A' ' 11' ' ' GLU . 5.0 ppt_? -126.25 168.74 13.68 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.699 0.285 . . . . 0.0 111.55 -173.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.788 HG12 HD13 ' A' ' 130' ' ' LEU . 72.7 mt -65.92 128.26 28.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 120.955 0.407 . . . . 0.0 110.509 178.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.06 -4.35 65.2 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.79 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.428 ' HB2' ' CD ' ' A' ' 8' ' ' ARG . 7.3 tp10 -89.25 151.63 22.03 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.55 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 41.7 mtp -80.29 143.89 33.28 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.126 0.489 . . . . 0.0 110.657 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -81.22 132.24 56.77 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.646 -175.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 27.5 Cg_exo -63.24 156.44 55.54 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.058 2.505 . . . . 0.0 112.071 176.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -97.9 165.6 11.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.818 -177.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.401 ' O ' ' HA ' ' A' ' 27' ' ' THR . 47.9 p90 -177.41 166.0 2.24 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.64 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 45.7 m -131.17 106.29 8.24 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 174.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.3 tt -107.97 143.27 18.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.008 -171.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.0 m -85.39 125.32 32.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.282 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.427 HD22 ' HB2' ' A' ' 95' ' ' PRO . 97.6 mt -83.45 173.74 11.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.33 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 96' ' ' LEU . 3.5 p -58.69 -31.19 67.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.696 -175.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -100.69 18.37 19.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.234 0.54 . . . . 0.0 110.355 -176.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.52 39.07 23.0 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.783 173.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -108.45 136.48 48.0 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.736 0.303 . . . . 0.0 111.064 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -99.45 116.07 30.74 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 17' ' ' THR . 3.1 p -120.23 126.12 74.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.382 0.61 . . . . 0.0 111.158 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 15.7 m -93.44 143.3 26.42 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.115 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.487 HD22 ' HA ' ' A' ' 28' ' ' LEU . 0.7 OUTLIER -66.59 -30.69 71.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.721 0.296 . . . . 0.0 110.295 -176.312 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.9 m -53.2 -43.01 66.85 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.191 176.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.9 m -67.54 -24.75 65.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.561 -175.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.1 mt -88.45 -22.06 23.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.787 -176.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 83.5 mtm-85 -60.2 159.41 9.81 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.894 0.378 . . . . 0.0 111.585 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.544 ' O ' ' HG3' ' A' ' 123' ' ' ARG . . . 85.25 -23.42 8.26 Favored Glycine 0 N--CA 1.452 -0.265 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -172.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.452 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 31.4 mtmm -109.21 167.93 9.75 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 176.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.41 HG21 HD22 ' A' ' 150' ' ' LEU . 26.1 m -81.87 114.19 22.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 121.208 0.528 . . . . 0.0 110.233 177.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.58 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 29.9 t -110.25 115.32 49.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.137 -173.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.489 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 27.6 ttt -101.16 114.73 28.96 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.119 175.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 69.7 mt -110.11 108.58 18.81 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.891 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.445 ' HG2' ' HA2' ' A' ' 73' ' ' GLY . 9.9 pt20 -94.7 130.01 41.37 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.496 ' HB2' ' HG2' ' A' ' 117' ' ' ARG . 77.2 m-85 -101.45 107.14 18.37 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 12.6 t -130.83 -174.92 3.51 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.252 -171.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.539 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . . . -164.75 143.85 6.99 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.578 177.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 57.1 p -58.64 -25.3 62.59 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -177.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 36.4 p-90 -90.83 7.85 37.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.782 0.325 . . . . 0.0 111.741 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.539 ' SG ' ' HB3' ' A' ' 42' ' ' ALA . 71.8 m -93.25 127.03 38.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.053 0.454 . . . . 0.0 110.905 177.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -85.02 -33.06 19.18 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.457 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.651 HG11 ' HB2' ' A' ' 133' ' ' LEU . 40.3 t -65.11 -34.15 68.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 121.143 0.497 . . . . 0.0 110.629 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.685 ' SG ' HG22 ' A' ' 116' ' ' THR . 92.3 m -66.26 -15.89 63.57 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.461 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.401 ' O ' ' HG2' ' A' ' 53' ' ' PRO . 78.1 mtt180 -78.33 -3.32 42.43 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.478 0.656 . . . . 0.0 110.298 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.407 ' O ' ' HD1' ' A' ' 54' ' ' PHE . 18.8 mtpp -101.77 -45.54 5.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.908 163.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.645 ' HB3' ' HA ' ' A' ' 48' ' ' CYS . 37.4 tt0 -54.87 -63.32 1.19 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.178 -1.374 . . . . 0.0 111.719 -176.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.641 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 79.8 mtp -59.33 -52.19 76.15 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.994 -173.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.641 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 50.5 Cg_exo -56.4 -40.8 82.21 Favored 'Trans proline' 0 C--N 1.358 1.034 0 C-N-CA 122.165 1.91 . . . . 0.0 112.752 179.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.407 ' HD1' ' O ' ' A' ' 50' ' ' LYS . 17.0 m-85 -67.21 -44.81 78.64 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.443 177.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.57 ' O ' ' HB ' ' A' ' 59' ' ' ILE . 81.8 mt -56.44 -45.34 81.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.531 176.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.618 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 38.6 tt0 -62.55 -48.69 78.4 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.415 178.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.517 ' HA ' HD22 ' A' ' 61' ' ' LEU . 29.1 ttpp -63.4 -54.07 42.54 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -173.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -104.29 -13.0 16.31 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -170.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.57 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 71.6 mt -105.16 -63.67 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.725 177.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.618 ' HB3' ' HA ' ' A' ' 56' ' ' GLU . 74.0 t-105 -59.89 -62.09 2.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.548 -175.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.517 HD22 ' HA ' ' A' ' 57' ' ' LYS . 2.6 mp -53.47 -23.06 9.08 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -175.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -89.75 -53.15 4.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.816 0.341 . . . . 0.0 111.418 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -113.18 2.63 15.68 Favored 'General case' 0 C--O 1.221 -0.437 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -167.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.491 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 12.0 pttp -39.07 -44.07 1.09 Allowed 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -172.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -96.8 -75.99 0.52 Allowed 'General case' 0 C--O 1.251 1.146 0 CA-C-O 121.334 0.588 . . . . 0.0 109.855 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.421 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 24.8 t-20 66.56 -72.19 0.09 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 114.449 -1.251 . . . . 0.0 110.667 -177.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 66' ' ' ASN . . . 155.32 -26.17 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.323 0 O-C-N 125.044 1.465 . . . . 0.0 107.704 -175.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.452 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 14.9 t70 -140.04 22.38 2.43 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.991 -172.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.548 ' CE2' ' HB2' ' A' ' 71' ' ' LEU . 68.6 t80 -113.4 139.35 48.97 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.328 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.07 128.94 29.08 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.773 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.548 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 3.6 tt -134.23 117.36 16.39 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.458 HD12 ' C ' ' A' ' 71' ' ' LEU . 3.1 mp -128.66 130.72 68.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.788 0.327 . . . . 0.0 110.141 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.445 ' HA2' ' HG2' ' A' ' 39' ' ' GLN . . . -99.23 133.73 11.41 Favored Glycine 0 C--O 1.219 -0.797 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.526 176.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.0 mt -116.52 127.76 74.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 117.29 0.545 . . . . 0.0 110.905 -176.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.48 ' OD2' ' HA ' ' A' ' 42' ' ' ALA . 10.2 t70 -90.91 135.09 33.96 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 174.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.612 ' HB2' HD13 ' A' ' 115' ' ' ILE . 58.9 ttt-85 -68.69 -28.57 66.97 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -170.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -160.1 -26.87 0.06 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -170.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -74.49 130.83 81.14 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-O 121.292 0.568 . . . . 0.0 111.314 -176.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.515 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 25.4 Cg_endo -68.75 -166.64 0.16 Allowed 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 123.337 2.692 . . . . 0.0 114.831 -176.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -58.98 -55.27 37.25 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 114.315 -1.312 . . . . 0.0 112.248 -169.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.515 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -64.16 -36.29 83.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.542 -173.813 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.481 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 33.9 mmtp -59.79 -54.26 48.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.156 0.503 . . . . 0.0 110.885 177.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.0 t -61.92 -41.87 92.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.294 -177.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.1 mp -62.91 -44.27 96.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.648 0.261 . . . . 0.0 111.254 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.531 ' HA ' ' HE3' ' A' ' 88' ' ' LYS . . . -68.42 -27.62 66.36 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.317 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.437 ' HE2' ' SD ' ' A' ' 52' ' ' MET . 93.3 t80 -80.43 -53.26 6.76 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.911 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -55.69 -44.35 77.28 Favored 'General case' 0 C--O 1.226 -0.163 0 O-C-N 123.39 0.431 . . . . 0.0 111.787 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.531 ' HE3' ' HA ' ' A' ' 85' ' ' ALA . 18.4 pttp -62.92 -26.46 68.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.026 0.441 . . . . 0.0 111.352 -177.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.9 m -88.73 -22.56 23.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.885 -175.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.0 p -97.08 -13.88 21.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.13 0.491 . . . . 0.0 110.631 177.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 106.54 -74.99 0.22 Allowed Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -177.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.0 t 28.66 85.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.056 1.343 . . . . 0.0 114.07 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.1 p -83.53 -0.95 52.54 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.697 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.586 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 50.6 p90 -96.59 139.48 21.67 Favored Pre-proline 0 C--N 1.332 -0.194 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.755 176.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.427 ' HB2' HD22 ' A' ' 20' ' ' LEU . 19.6 Cg_endo -60.47 133.82 51.21 Favored 'Trans proline' 0 C--O 1.238 0.508 0 C-N-CA 122.935 2.423 . . . . 0.0 113.333 -175.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.459 ' O ' HG23 ' A' ' 21' ' ' THR . 91.3 mt -109.31 139.19 44.58 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.435 176.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -105.55 148.55 16.53 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.75 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.493 ' H ' HD22 ' A' ' 98' ' ' LEU . 0.4 OUTLIER -92.1 127.09 37.44 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.282 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.438 ' HB3' ' O ' ' A' ' 75' ' ' ASP . 21.6 t0 -120.18 74.35 21.37 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 121.135 0.493 . . . . 0.0 109.881 173.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.98 98.4 0.71 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.419 2.08 . . . . 0.0 112.534 -175.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 123.94 -5.18 9.05 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.045 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 62.66 45.17 6.17 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 122.645 0.378 . . . . 0.0 111.127 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -84.04 -50.18 8.22 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.048 0.451 . . . . 0.0 110.398 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 34.2 mm -66.0 -34.01 67.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -64.22 -41.05 97.19 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.276 173.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.616 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -69.94 -18.37 63.36 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.623 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -77.15 -7.82 56.47 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.486 178.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -125.34 -32.05 2.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.836 0.35 . . . . 0.0 111.365 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.616 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -149.6 169.3 21.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.736 0.303 . . . . 0.0 111.155 -177.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.473 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . 96.6 mt -72.61 133.94 44.92 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 177.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.71 -31.71 68.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.421 0.629 . . . . 0.0 110.48 -178.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -99.43 19.53 15.43 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.121 -176.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.575 ' HA ' ' O ' ' A' ' 1' ' ' MET . . . -119.57 56.9 0.92 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.426 -177.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 81.35 -157.68 38.87 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.409 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.612 HD13 ' HB2' ' A' ' 76' ' ' ARG . 2.5 tp -152.54 -60.48 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.685 HG22 ' SG ' ' A' ' 48' ' ' CYS . 16.5 p -56.65 111.86 1.12 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -172.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.496 ' HG2' ' HB2' ' A' ' 40' ' ' PHE . 13.5 ptp180 -169.72 154.2 5.31 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.665 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.555 ' HB2' HG22 ' A' ' 131' ' ' THR . 34.4 m-80 -124.8 131.08 53.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.457 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.7 t -108.83 109.63 29.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.981 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 30.6 tp -96.57 111.64 23.69 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.491 -0.483 . . . . 0.0 110.271 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.58 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 54.0 mt -93.21 137.49 22.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.996 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.02 179.27 5.99 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.008 0.433 . . . . 0.0 111.104 -177.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 32.5 ttm180 -62.95 -28.67 70.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.128 -175.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -76.61 -30.37 56.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.119 0.485 . . . . 0.0 110.515 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.16 17.38 7.27 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.584 -176.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 80.4 mttt -103.1 148.26 25.96 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.887 0.375 . . . . 0.0 110.484 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.616 HD12 HG11 ' A' ' 7' ' ' VAL . 60.8 mt -84.7 112.43 21.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.149 178.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 28.5 m -102.3 -29.2 3.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -175.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.4 ' CG ' HE22 ' A' ' 145' ' ' GLN . 4.0 tmtt? -124.95 112.94 17.18 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.156 -173.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.788 HD13 HG12 ' A' ' 9' ' ' ILE . 11.1 mp -100.93 121.79 42.36 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.434 -0.803 . . . . 0.0 108.868 169.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.555 HG22 ' HB2' ' A' ' 118' ' ' ASN . 0.4 OUTLIER -122.43 145.16 48.55 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 177.565 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.419 ' N ' ' HD2' ' A' ' 132' ' ' ARG . 3.6 mpt_? -105.23 124.15 49.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.313 -177.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.673 ' HA ' ' HB ' ' A' ' 116' ' ' THR . 1.7 pp 39.86 50.07 2.29 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 124.091 0.869 . . . . 0.0 112.983 175.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.535 ' HB2' ' HG3' ' A' ' 51' ' ' GLU . 9.1 t80 68.97 -74.17 0.08 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.151 -177.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 41.6 t30 59.39 120.15 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.421 0.688 . . . . 0.0 111.814 -177.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -47.56 -62.54 1.39 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.984 -173.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -61.81 -41.66 98.04 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.833 -175.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.535 ' HB3' ' OG1' ' A' ' 131' ' ' THR . 17.7 mt-10 -64.85 -36.26 83.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.108 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.47 ' O ' HG23 ' A' ' 143' ' ' VAL . 82.1 t80 -64.42 -44.99 89.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.365 176.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.66 -50.19 70.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.906 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.2 m -66.18 -37.23 85.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.835 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.484 ' O ' HG13 ' A' ' 146' ' ' ILE . 2.6 tt -60.73 -49.16 78.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.813 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 139' ' ' PHE . 90.8 t -59.7 -46.56 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.258 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -58.42 -45.73 87.85 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.176 0.512 . . . . 0.0 110.266 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.4 HE22 ' CG ' ' A' ' 129' ' ' LYS . 7.4 tt0 -61.4 -39.74 91.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.314 178.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.654 ' O ' HD23 ' A' ' 150' ' ' LEU . 66.6 mt -55.25 -47.95 77.08 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.196 0 CA-C-N 116.738 -0.21 . . . . 0.0 110.702 177.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -51.25 -43.64 61.56 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.72 -0.218 . . . . 0.0 110.543 176.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -67.61 -42.83 81.75 Favored 'General case' 0 C--O 1.217 -0.652 0 C-N-CA 120.646 -0.421 . . . . 0.0 111.12 175.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 38.6 mmm -57.31 -35.64 70.1 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 122.98 0.512 . . . . 0.0 111.136 -172.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.654 HD23 ' O ' ' A' ' 146' ' ' ILE . 4.4 mm? -62.02 -28.16 69.39 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.796 178.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -96.55 -51.61 4.26 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 81.77 94.87 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 114.068 -1.424 . . . . 0.0 110.724 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -129.01 2.66 6.32 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.542 175.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -78.91 -16.15 57.39 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.861 -177.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -65.99 -42.65 89.5 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 169.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 58.0 m80 70.7 -46.5 0.63 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.796 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.404 ' C ' ' H ' ' A' ' 159' ' ' HIS . 27.9 t-80 -80.14 1.83 26.52 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.913 0.387 . . . . 0.0 110.239 177.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 72.5 -37.75 0.4 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.952 0.901 . . . . 0.0 110.504 -175.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.404 ' H ' ' C ' ' A' ' 157' ' ' HIS . 73.9 t60 . . . . . 0 C--O 1.242 0.704 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 169.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 110.224 -0.288 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.1 m -84.11 -85.89 0.13 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.356 -178.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 45.2 tp -124.81 -31.4 3.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.89 0.376 . . . . 0.0 111.372 -176.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.484 ' HA2' HD12 ' A' ' 110' ' ' LEU . . . 108.25 -20.1 31.06 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.949 176.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -78.13 127.02 31.66 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.913 0.387 . . . . 0.0 110.858 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.581 HG12 ' HA ' ' A' ' 109' ' ' ALA . 21.5 pt -109.58 -11.97 11.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.781 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.434 HG11 HD12 ' A' ' 127' ' ' ILE . 20.0 t -101.44 156.32 4.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.508 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 37.3 mtt85 -121.85 162.88 20.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.097 0.475 . . . . 0.0 111.342 -173.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.508 HG23 ' HA ' ' A' ' 128' ' ' VAL . 80.1 mt -75.93 126.36 36.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.153 177.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.59 -24.92 12.7 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.839 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -75.03 156.66 35.95 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.661 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 59.2 mtp -84.32 138.54 32.84 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.649 -178.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.569 ' HB2' HD12 ' A' ' 121' ' ' ILE . . . -62.65 123.01 77.62 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.432 -178.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 24.7 Cg_exo -62.44 114.62 2.44 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.615 2.21 . . . . 0.0 111.299 177.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.561 ' HA ' HD12 ' A' ' 28' ' ' LEU . 1.0 OUTLIER -63.4 151.9 39.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.418 -171.823 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.999 ' HB3' ' HE2' ' A' ' 107' ' ' LYS . 37.0 p90 -159.23 166.52 31.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.511 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 56.0 m -129.35 108.26 10.16 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.273 175.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.5 tt -106.7 145.02 14.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.991 0.424 . . . . 0.0 110.831 -174.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 24' ' ' LYS . 9.6 m -85.33 131.84 34.34 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.299 178.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.46 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 86.3 mt -87.15 172.52 9.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.311 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 96' ' ' LEU . 33.2 p -55.85 -34.01 65.05 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.889 -176.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -101.84 18.38 20.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.104 0.478 . . . . 0.0 110.772 -173.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 79.5 37.0 25.01 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.626 174.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 19' ' ' THR . 41.0 mmtm -108.16 167.04 10.29 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.1 -0.334 . . . . 0.0 110.1 176.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.434 HE21 ' HA ' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -130.33 120.37 24.23 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 -177.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 17' ' ' THR . 11.7 m -113.98 144.2 22.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.939 0.399 . . . . 0.0 110.017 175.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.416 HG22 ' H ' ' A' ' 29' ' ' SER . 18.0 m -122.61 143.42 49.77 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.645 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.561 HD12 ' HA ' ' A' ' 15' ' ' ASP . 17.5 mt -62.67 -35.98 81.41 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.715 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.514 ' HA ' ' HG2' ' A' ' 32' ' ' ARG . 59.2 m -55.83 -34.62 65.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.987 0.422 . . . . 0.0 110.937 175.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.0 t -75.25 -26.24 58.69 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.101 0.477 . . . . 0.0 110.227 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 85.8 mt -96.27 0.2 50.6 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.514 ' HG2' ' HA ' ' A' ' 29' ' ' SER . 37.8 mmt180 -60.3 138.24 57.99 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 102.99 -20.79 42.27 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -178.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.552 ' HD3' ' N ' ' A' ' 34' ' ' LYS . 3.5 mppt? -109.72 157.79 18.76 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.203 -0.499 . . . . 0.0 110.432 178.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 p -82.2 116.52 26.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.355 0.598 . . . . 0.0 109.839 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 25.8 t -106.26 131.2 56.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.213 -173.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.539 ' SD ' HG21 ' A' ' 59' ' ' ILE . 27.7 ttt -111.64 123.6 50.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.392 175.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.455 ' HB2' ' HB ' ' A' ' 119' ' ' VAL . 3.3 mm? -103.78 116.87 33.1 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.642 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.444 HE21 ' HA ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -108.06 114.94 29.21 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.67 176.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.499 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 92.3 m-85 -99.7 111.85 24.15 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.1 t -127.52 -174.62 3.23 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.193 -174.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -168.03 160.55 12.1 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.327 0.651 . . . . 0.0 109.736 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.463 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 78.3 p -75.91 -18.56 59.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.051 0.453 . . . . 0.0 111.353 -176.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 21.1 p-90 -103.35 12.08 35.84 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -175.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.461 ' HB3' HG21 ' A' ' 115' ' ' ILE . 23.0 p -110.12 114.58 28.2 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.074 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.93 -26.56 68.71 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.916 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.439 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 28.3 t -63.21 -36.82 77.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.959 0.409 . . . . 0.0 110.638 -178.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.419 ' HA ' ' HB3' ' A' ' 51' ' ' GLU . 52.1 m -68.32 -16.15 63.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.724 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -75.56 -7.96 55.53 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.154 0.502 . . . . 0.0 110.287 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.519 ' HD3' ' CD2' ' A' ' 134' ' ' TYR . 57.6 mttt -88.54 -54.26 4.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 122.488 1.137 . . . . 0.0 108.494 162.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.466 ' O ' HG13 ' A' ' 55' ' ' ILE . 24.3 tt0 -57.03 -62.75 1.53 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 113.001 -1.909 . . . . 0.0 112.55 -171.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.587 ' SD ' ' HE2' ' A' ' 86' ' ' PHE . 83.1 mtp -53.93 -54.77 43.14 Favored Pre-proline 0 CA--C 1.538 0.481 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -172.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.485 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 25.5 Cg_endo -62.61 -35.61 69.12 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 121.961 1.774 . . . . 0.0 112.591 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -67.04 -42.58 84.61 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.389 175.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 51' ' ' GLU . 70.4 mt -60.06 -52.93 55.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.985 178.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.606 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 16.4 pt-20 -64.75 -31.11 72.19 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.312 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -71.85 -56.03 6.47 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -176.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.414 ' HA ' ' HG2' ' A' ' 62' ' ' LYS . 62.8 m-20 -108.15 -18.35 13.8 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -171.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.539 HG21 ' SD ' ' A' ' 37' ' ' MET . 48.4 mm -93.57 -53.95 7.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.721 176.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.606 ' HB3' ' HA ' ' A' ' 56' ' ' GLU . 74.9 t-105 -69.86 -73.06 0.17 Allowed 'General case' 0 C--O 1.215 -0.744 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.894 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -48.13 -29.17 3.4 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -174.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.414 ' HG2' ' HA ' ' A' ' 58' ' ' ASP . 39.6 mmtm -91.38 -33.2 15.37 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.305 0.484 . . . . 0.0 112.305 -175.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -124.84 -4.55 7.57 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -171.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.439 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 17.4 pttp -43.71 -51.79 6.93 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -170.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.18 -81.18 0.18 Allowed 'General case' 0 C--O 1.247 0.959 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.524 ' CG ' HD12 ' A' ' 150' ' ' LEU . 12.1 t30 61.41 -71.7 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.347 -177.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 173.06 -26.88 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 123.573 0.749 . . . . 0.0 109.423 -177.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.515 ' HB2' ' HG3' ' A' ' 34' ' ' LYS . 6.3 p-10 -154.62 28.29 0.44 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.416 -172.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.604 ' HB2' HD11 ' A' ' 150' ' ' LEU . 79.4 t80 -100.5 125.55 46.84 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 118.548 -1.261 . . . . 0.0 110.422 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 36' ' ' VAL . . . -124.97 105.62 9.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.811 -176.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.499 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 3.9 tt -110.77 119.36 38.84 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.8 mm -124.34 126.11 71.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.444 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.472 ' HA3' HD23 ' A' ' 96' ' ' LEU . . . -89.17 133.83 12.04 Favored Glycine 0 C--O 1.221 -0.696 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.204 175.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.499 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 68.0 mt -120.8 114.74 44.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.867 0.334 . . . . 0.0 110.733 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -78.32 129.53 35.12 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 172.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.434 HH21 ' HA ' ' A' ' 112' ' ' ASP . 49.5 ttt-85 -45.67 -67.05 0.32 Allowed 'General case' 0 N--CA 1.469 0.478 0 O-C-N 123.97 0.794 . . . . 0.0 112.828 -170.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.647 ' HA ' ' O ' ' A' ' 99' ' ' ASP . 12.0 p-10 -145.61 21.05 1.5 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.58 0.705 . . . . 0.0 109.7 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -69.9 129.74 90.7 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.848 -177.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.588 ' HG2' ' HG2' ' A' ' 82' ' ' LYS . 16.5 Cg_endo -63.58 168.19 11.99 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 122.404 2.07 . . . . 0.0 112.204 173.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -52.55 -52.77 53.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.071 -172.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.546 ' OE2' ' HG2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -67.61 -28.08 67.44 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -173.602 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.588 ' HG2' ' HG2' ' A' ' 79' ' ' PRO . 44.0 mmtm -64.45 -51.07 64.97 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.831 0.348 . . . . 0.0 110.468 175.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.448 HG21 ' HB3' ' A' ' 98' ' ' LEU . 61.1 t -53.81 -52.2 37.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.106 -178.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.23 -39.22 92.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.577 -177.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.448 ' HA ' ' HE3' ' A' ' 88' ' ' LYS . . . -73.05 -26.59 61.35 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.787 -177.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.587 ' HE2' ' SD ' ' A' ' 52' ' ' MET . 71.8 t80 -84.85 -47.42 10.37 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.886 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.485 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -53.08 -47.48 68.49 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.289 0.368 . . . . 0.0 111.455 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.448 ' HE3' ' HA ' ' A' ' 85' ' ' ALA . 18.4 pttp -62.31 -23.98 67.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.033 0.444 . . . . 0.0 111.241 -178.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.9 m -92.62 -0.62 57.28 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.048 -175.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.1 p -122.97 -20.97 5.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.602 175.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 114.64 -76.29 0.25 Allowed Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -177.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.421 HG21 ' HE1' ' A' ' 52' ' ' MET . 86.7 t 43.93 87.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 C-N-CA 124.494 1.118 . . . . 0.0 113.344 178.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.4 m -78.67 -5.4 52.94 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.493 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.46 ' CE1' ' HB3' ' A' ' 56' ' ' GLU . 49.0 p90 -107.29 145.58 31.49 Favored Pre-proline 0 C--N 1.33 -0.254 0 O-C-N 122.127 -0.358 . . . . 0.0 110.451 179.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -63.05 136.45 56.57 Favored 'Trans proline' 0 C--O 1.238 0.485 0 C-N-CA 122.371 2.047 . . . . 0.0 113.222 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.485 HD12 ' HB2' ' A' ' 87' ' ' ALA . 92.8 mt -105.14 151.51 23.94 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.871 175.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -125.13 145.51 15.73 Favored Glycine 0 N--CA 1.437 -1.297 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 175.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.789 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.2 pt? -100.09 132.71 45.3 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 120.744 0.306 . . . . 0.0 110.68 -176.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.647 ' O ' ' HA ' ' A' ' 77' ' ' ASP . 22.2 t0 -109.84 82.54 2.42 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.71 176.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.24 87.07 0.49 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.138 1.892 . . . . 0.0 112.264 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.04 -21.65 1.59 Allowed Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.131 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . . . 70.15 24.25 5.0 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 122.866 0.466 . . . . 0.0 110.714 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -91.08 -29.08 17.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.583 -176.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.605 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 32.4 mm -70.04 -35.85 65.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 171.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -60.8 -40.14 91.54 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.741 172.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.682 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -68.28 -25.53 65.2 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.951 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.999 ' HE2' ' HB3' ' A' ' 16' ' ' PHE . 26.8 mtpp -70.72 -3.99 21.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.393 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.732 ' HB3' HH22 ' A' ' 117' ' ' ARG . 65.1 m-85 -129.37 -11.82 4.53 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.91 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.682 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -176.36 176.4 1.65 Allowed 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.847 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 95.4 mt -60.34 136.05 57.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.634 0.254 . . . . 0.0 110.505 177.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.599 ' HG2' ' HB2' ' A' ' 106' ' ' ALA . 53.8 mtp85 -49.57 -51.85 34.11 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.988 -177.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.434 ' HA ' HH21 ' A' ' 76' ' ' ARG . 6.8 m-20 -105.08 34.38 3.24 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.654 -173.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.847 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . . . -85.02 9.88 13.44 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.1 178.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 118.1 -151.94 17.73 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.348 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.461 HG21 ' HB3' ' A' ' 45' ' ' CYS . 8.6 tp -151.1 170.74 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -177.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.603 HG22 ' HA ' ' A' ' 133' ' ' LEU . 30.7 m 71.77 93.97 0.08 Allowed 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.532 0.52 . . . . 0.0 110.314 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.732 HH22 ' HB3' ' A' ' 108' ' ' TYR . 54.8 mtp180 -146.58 149.13 32.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.66 -174.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.573 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 33.0 m-80 -127.6 119.83 26.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.75 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 38' ' ' LEU . 73.1 t -124.58 122.91 64.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.655 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 34.5 tp -108.88 130.72 55.43 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.898 0.38 . . . . 0.0 110.917 -178.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.569 HD12 ' HB2' ' A' ' 13' ' ' ALA . 27.8 mm -111.07 139.11 36.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.695 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.525 ' OD2' ' HB2' ' A' ' 126' ' ' LYS . 3.4 p30 -84.47 171.82 12.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.808 0.337 . . . . 0.0 110.844 177.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.406 ' HD2' ' OE2' ' A' ' 152' ' ' GLU . 94.4 mtt180 -60.7 -25.52 66.46 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.427 -178.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -82.13 -12.57 58.12 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.777 -174.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 103.86 3.92 45.61 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.607 176.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.661 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 9.0 mtmp? -96.72 160.26 14.47 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.142 0.496 . . . . 0.0 111.64 -177.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.52 HG12 ' CD1' ' A' ' 121' ' ' ILE . 43.5 mt -95.37 127.79 47.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.399 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.508 ' HA ' HG23 ' A' ' 9' ' ' ILE . 29.4 m -117.74 -23.19 3.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -176.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.655 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 50.1 tptt -128.66 115.98 18.88 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.558 -174.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.458 HD13 HG12 ' A' ' 9' ' ' ILE . 11.0 mp -110.74 109.77 20.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.975 175.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.573 ' HB ' ' HB2' ' A' ' 118' ' ' ASN . 89.3 m -135.71 141.8 44.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.878 0.371 . . . . 0.0 111.278 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 132' ' ' ARG . 1.3 ptp180 -124.42 150.61 45.43 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 171.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.603 ' HA ' HG22 ' A' ' 116' ' ' THR . 0.8 OUTLIER 46.32 104.95 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 O-C-N 124.703 1.252 . . . . 0.0 113.992 179.503 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.519 ' CD2' ' HD3' ' A' ' 50' ' ' LYS . 39.9 t80 -39.26 112.61 0.26 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 114.944 -1.026 . . . . 0.0 112.205 176.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -110.84 141.03 44.76 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 173.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.62 -58.45 6.75 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -173.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.464 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.7 mp0 -60.33 -32.19 71.02 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.893 0.378 . . . . 0.0 111.238 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -65.42 -47.5 76.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.571 -177.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.543 ' O ' HG23 ' A' ' 143' ' ' VAL . 88.8 t80 -61.77 -39.46 91.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.736 -178.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -59.96 -46.39 89.56 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.109 0.48 . . . . 0.0 110.375 176.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.3 m -62.69 -38.97 92.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.227 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.615 ' O ' HG12 ' A' ' 146' ' ' ILE . 1.1 mt -61.57 -46.62 89.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.953 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 139' ' ' PHE . 97.6 t -55.96 -49.19 76.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-O 120.688 0.28 . . . . 0.0 111.16 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.445 ' HA ' ' OE1' ' A' ' 144' ' ' GLN . 6.7 tp60 -66.46 -40.96 89.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.955 0.407 . . . . 0.0 110.48 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -57.96 -46.12 85.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.065 176.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.656 ' O ' HD23 ' A' ' 150' ' ' LEU . 38.4 mm -56.48 -44.69 81.08 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.279 177.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.46 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 4.8 t-20 -53.68 -52.0 61.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.848 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -76.29 -20.82 56.97 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.932 -177.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.439 ' HG3' HD21 ' A' ' 120' ' ' LEU . 56.1 mmm -73.0 -28.52 62.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.131 0.491 . . . . 0.0 110.608 175.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.656 HD23 ' O ' ' A' ' 146' ' ' ILE . 4.3 mm? -75.89 -11.75 60.03 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.234 175.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.609 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 42.3 mmtm -102.01 -51.46 3.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.549 176.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.609 ' HG3' ' O ' ' A' ' 151' ' ' LYS . 0.0 OUTLIER 45.86 -175.16 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.693 1.597 . . . . 0.0 112.304 -173.443 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.609 ' HA3' ' HB2' ' A' ' 156' ' ' HIS . . . -175.49 82.92 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 119.297 -1.43 . . . . 0.0 113.436 -177.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -56.94 -29.38 63.07 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 166.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 18.3 m80 -144.82 79.89 1.61 Allowed 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.53 164.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.609 ' HB2' ' HA3' ' A' ' 153' ' ' GLY . 31.0 t60 -70.15 -22.98 62.92 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.129 -176.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -73.59 114.51 11.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.896 177.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -122.04 9.12 9.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.86 0.362 . . . . 0.0 111.037 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 40.8 t-80 . . . . . 0 C--O 1.243 0.744 0 CA-C-O 118.441 -0.79 . . . . 0.0 109.553 177.857 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ppp? . . . . . 0 N--CA 1.484 1.262 0 CA-C-O 120.622 0.249 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.6 m -70.64 -14.42 62.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.792 -172.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 92.3 mt -80.02 -18.06 51.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.948 0.404 . . . . 0.0 110.615 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.426 ' HA2' ' HB1' ' A' ' 113' ' ' ALA . . . 81.32 -25.97 3.59 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.173 -0.536 . . . . 0.0 113.688 176.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.573 ' CE1' HD22 ' A' ' 130' ' ' LEU . 61.2 m-85 -65.34 130.38 43.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.994 0.426 . . . . 0.0 112.101 -175.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.9 pt -101.46 -11.64 8.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.317 169.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.8 m -110.95 150.33 13.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.005 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.465 ' HE ' ' CD ' ' A' ' 11' ' ' GLU . 77.6 mtm180 -118.82 163.78 16.37 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.339 0.59 . . . . 0.0 111.638 -175.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 77.3 mt -70.42 131.37 34.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.443 -0.798 . . . . 0.0 109.531 174.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.63 -27.27 15.5 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -176.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.465 ' CD ' ' HE ' ' A' ' 8' ' ' ARG . 14.3 mt-10 -80.19 174.94 11.1 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.671 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 55.6 mtp -98.8 146.43 25.94 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.875 0.369 . . . . 0.0 110.417 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.451 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -79.92 135.91 54.94 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.842 -177.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 21.2 Cg_exo -64.89 117.28 4.39 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.759 2.306 . . . . 0.0 111.915 177.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.21 141.85 55.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.949 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.508 ' HB2' HD12 ' A' ' 104' ' ' ILE . 52.4 p90 -154.28 161.18 41.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.847 0.356 . . . . 0.0 111.224 -174.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.2 m -110.35 116.28 31.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.448 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.5 tt -114.64 142.14 28.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.936 0.398 . . . . 0.0 110.829 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.47 ' O ' HD23 ' A' ' 98' ' ' LEU . 14.8 m -93.41 123.03 36.42 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.126 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.455 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 92.7 mt -79.52 173.96 12.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.919 0.39 . . . . 0.0 111.393 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 96' ' ' LEU . 19.5 p -57.15 -34.63 68.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.283 -0.871 . . . . 0.0 113.159 -175.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -100.56 19.35 17.06 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.177 0.513 . . . . 0.0 110.535 -174.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.09 36.1 25.53 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.601 174.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -108.4 109.42 20.71 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.09 0.472 . . . . 0.0 110.337 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -89.7 113.94 25.52 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.275 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.7 m -119.12 153.94 21.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.049 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.2 m -112.88 150.96 31.02 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.54 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 0.5 OUTLIER -59.96 -38.46 82.55 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.166 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.523 ' HA ' ' CG ' ' A' ' 32' ' ' ARG . 64.9 m -54.59 -26.88 35.24 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.106 176.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.6 m -72.75 -20.2 61.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.045 0.45 . . . . 0.0 110.97 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.509 HD13 ' HB1' ' A' ' 70' ' ' ALA . 96.3 mt -114.87 3.04 14.49 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.305 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.54 ' HG2' ' O ' ' A' ' 28' ' ' LEU . 47.9 mmm-85 -66.25 139.13 58.06 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.09 -20.48 28.54 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -172.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.499 ' HB3' ' O ' ' A' ' 68' ' ' ASP . 42.5 mtmt -116.14 165.13 13.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.263 -0.468 . . . . 0.0 110.15 177.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 p -79.59 120.03 30.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.178 0.513 . . . . 0.0 110.031 174.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.513 HG22 ' HB3' ' A' ' 70' ' ' ALA . 43.5 t -115.37 125.18 72.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.863 -175.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.473 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 25.6 ttt -103.13 124.76 49.17 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.854 177.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.3 mt -117.57 141.19 48.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.183 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.472 ' N ' HE21 ' A' ' 39' ' ' GLN . 0.0 OUTLIER -139.05 136.67 35.51 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 174.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.437 ' HD2' ' HG3' ' A' ' 117' ' ' ARG . 98.0 m-85 -97.56 119.53 36.3 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.063 0.458 . . . . 0.0 110.675 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.4 t -127.82 -177.08 3.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.342 -175.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.647 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . . . -165.77 155.52 12.45 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 176.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.512 ' H ' ' HG3' ' A' ' 78' ' ' GLU . 99.5 p -63.26 -24.28 67.8 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.93 0.395 . . . . 0.0 112.025 -175.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.5 p-90 -100.92 7.59 43.53 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.751 0.31 . . . . 0.0 111.786 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.647 ' SG ' ' HB3' ' A' ' 42' ' ' ALA . 88.8 m -88.41 99.79 12.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.037 0.446 . . . . 0.0 111.078 178.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.84 -20.44 77.59 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.203 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 50' ' ' LYS . 34.6 t -76.29 -41.31 36.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.836 0.351 . . . . 0.0 110.197 177.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.777 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 72.2 m -68.72 -16.61 63.87 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.475 0.655 . . . . 0.0 110.376 177.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.503 HH21 ' HE1' ' A' ' 86' ' ' PHE . 25.3 ttm180 -71.19 -11.13 60.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.7 176.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.573 ' HD3' ' CD2' ' A' ' 134' ' ' TYR . 80.1 mttt -87.15 -57.66 2.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.609 0.719 . . . . 0.0 110.046 169.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.947 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 12.4 pt-20 -63.76 -44.84 92.26 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-N 115.065 -0.971 . . . . 0.0 112.495 -168.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.498 ' HE3' HG21 ' A' ' 92' ' ' VAL . 15.3 mtm -57.41 -55.51 43.67 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.045 -174.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.577 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 19.7 Cg_endo -60.73 -33.22 93.38 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 121.771 1.647 . . . . 0.0 112.481 177.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.416 ' HD1' ' O ' ' A' ' 50' ' ' LYS . 12.3 m-85 -70.35 -46.24 64.52 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.499 176.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 51' ' ' GLU . 96.9 mt -58.03 -51.43 70.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.612 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.626 ' HB3' ' CD1' ' A' ' 94' ' ' TYR . 0.4 OUTLIER -65.47 -34.93 79.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.403 -177.289 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.577 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 10.4 ttmm -68.5 -43.35 77.04 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.564 -174.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -106.12 -65.18 1.09 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.473 178.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 65.7 mt -55.7 -39.9 57.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.843 0.354 . . . . 0.0 110.966 -170.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.566 ' HB3' ' O ' ' A' ' 56' ' ' GLU . 75.5 t-105 -75.33 -71.32 0.37 Allowed 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.552 177.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.503 HD22 ' HD1' ' A' ' 60' ' ' TRP . 1.8 mm? -50.45 -34.91 26.43 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -173.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -84.01 -30.46 26.14 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -175.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.478 ' HB3' ' HG ' ' A' ' 150' ' ' LEU . 72.9 m-70 -129.56 -8.51 4.6 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -168.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.419 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 16.0 pttp -38.79 -48.73 1.55 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -171.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.47 -84.19 0.28 Allowed 'General case' 0 C--O 1.253 1.258 0 CA-C-O 121.246 0.546 . . . . 0.0 110.492 -175.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 44.5 t-20 59.24 -77.6 0.02 OUTLIER 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.939 -169.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 66' ' ' ASN . . . 156.31 -23.01 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 125.327 1.451 . . . . 0.0 107.154 -173.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.499 ' O ' ' HB3' ' A' ' 34' ' ' LYS . 9.7 t70 -119.93 1.25 10.94 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.197 -173.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.516 ' HB2' HD11 ' A' ' 150' ' ' LEU . 84.9 t80 -110.67 151.04 28.17 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 119.09 -1.044 . . . . 0.0 112.297 -176.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.513 ' HB3' HG22 ' A' ' 36' ' ' VAL . . . -148.5 141.51 24.85 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.221 173.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.481 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 3.6 tt -139.02 127.25 22.66 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -177.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.414 ' N ' HD23 ' A' ' 71' ' ' LEU . 63.4 mt -135.79 130.91 49.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 120.73 0.3 . . . . 0.0 110.562 178.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.442 ' HA3' HD23 ' A' ' 96' ' ' LEU . . . -95.12 138.88 14.21 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.291 -0.956 . . . . 0.0 111.01 173.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 55.3 mt -119.66 118.21 56.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 117.395 0.598 . . . . 0.0 110.686 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.536 ' OD1' ' HA ' ' A' ' 42' ' ' ALA . 6.7 t0 -95.41 132.32 40.59 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.488 ' HD2' HD13 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -97.22 121.02 38.65 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.968 0.413 . . . . 0.0 111.942 -170.577 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 73.08 -35.81 0.34 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.347 1.059 . . . . 0.0 113.044 175.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.512 ' HG3' ' H ' ' A' ' 43' ' ' SER . 60.0 mm-40 -62.54 140.31 96.79 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-O 121.147 0.499 . . . . 0.0 111.241 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.539 ' O ' HG23 ' A' ' 83' ' ' VAL . 18.3 Cg_endo -84.25 -168.42 0.54 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.043 2.495 . . . . 0.0 113.64 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.542 HD23 HD13 ' A' ' 84' ' ' LEU . 1.7 tt -56.25 -57.49 12.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.801 -1.091 . . . . 0.0 112.138 -170.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -37.53 87.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.864 -173.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.504 ' CG ' ' HD2' ' A' ' 79' ' ' PRO . 27.1 mmtp -58.86 -50.43 74.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.585 0.231 . . . . 0.0 111.336 178.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 79' ' ' PRO . 46.9 t -58.4 -46.04 89.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.754 -178.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.542 HD13 HD23 ' A' ' 80' ' ' LEU . 10.9 mp -64.2 -47.63 79.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.335 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.02 -32.95 74.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.687 -176.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.503 ' HE1' HH21 ' A' ' 49' ' ' ARG . 72.0 t80 -77.8 -43.72 29.71 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.502 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.531 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -59.22 -54.38 47.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.447 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.9 ptmm? -57.12 -26.59 60.74 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.971 -175.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 27.3 m -85.74 -4.06 59.06 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.382 -174.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 19.1 p -128.14 6.12 5.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.313 0.578 . . . . 0.0 110.321 175.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.55 -73.27 1.23 Allowed Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.294 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.498 HG21 ' HE3' ' A' ' 52' ' ' MET . 42.9 t 40.95 83.91 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.963 0.905 . . . . 0.0 112.695 -177.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.8 m -75.76 -3.8 36.91 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.541 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.626 ' CD1' ' HB3' ' A' ' 56' ' ' GLU . 50.0 p90 -107.72 153.07 41.71 Favored Pre-proline 0 C--N 1.33 -0.273 0 O-C-N 121.813 -0.554 . . . . 0.0 110.621 178.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.5 137.0 32.38 Favored 'Trans proline' 0 C--O 1.239 0.561 0 C-N-CA 122.253 1.969 . . . . 0.0 113.38 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.531 HD12 ' HB2' ' A' ' 87' ' ' ALA . 97.6 mt -104.84 153.67 21.04 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.342 173.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -121.6 147.37 17.29 Favored Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 174.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.781 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.7 pt? -100.27 131.8 46.01 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.88 0.371 . . . . 0.0 110.617 -177.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.439 ' OD2' ' HA ' ' A' ' 102' ' ' ALA . 14.8 t0 -119.35 75.46 16.6 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.491 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.454 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 15.7 Cg_exo -68.01 120.57 7.56 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.895 2.396 . . . . 0.0 111.766 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 102.42 -8.75 55.38 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -175.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.793 ' HB3' ' HE ' ' A' ' 111' ' ' ARG . . . 54.6 45.88 25.95 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 123.09 0.556 . . . . 0.0 111.547 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -76.09 -49.71 16.69 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.253 0.549 . . . . 0.0 110.062 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.508 HD12 ' HB2' ' A' ' 16' ' ' PHE . 27.9 mm -65.83 -36.28 77.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.276 178.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.44 ' HB3' ' HB1' ' A' ' 102' ' ' ALA . 71.5 t80 -62.56 -45.28 93.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.289 174.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.611 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -65.74 -21.01 66.48 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.769 -178.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -73.48 -12.06 60.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.824 0.345 . . . . 0.0 111.245 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.431 ' CZ ' ' HD2' ' A' ' 14' ' ' PRO . 65.8 m-85 -119.93 -34.57 3.69 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.351 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.611 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -154.72 160.37 41.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.783 0.325 . . . . 0.0 111.004 -177.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.464 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . 90.3 mt -67.09 136.29 54.94 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.793 ' HE ' ' HB3' ' A' ' 102' ' ' ALA . 67.5 mtp180 -49.46 -40.05 35.65 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -171.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -98.76 -8.98 25.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.12 0.486 . . . . 0.0 111.475 -175.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.464 ' CB ' ' HB2' ' A' ' 110' ' ' LEU . . . -81.45 40.88 0.59 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -171.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 97.79 114.62 3.31 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.262 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.488 HD13 ' HD2' ' A' ' 76' ' ' ARG . 2.6 tp -76.19 -49.77 24.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.642 0.258 . . . . 0.0 111.531 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.95 ' HB ' ' HB3' ' A' ' 133' ' ' LEU . 22.2 p -66.3 114.2 5.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.17 -173.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.437 ' HG3' ' HD2' ' A' ' 40' ' ' PHE . 10.8 ptp180 -169.33 145.52 3.31 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.952 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.62 ' HB2' ' OG1' ' A' ' 131' ' ' THR . 6.6 m120 -122.98 142.69 50.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.526 -177.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 29.1 t -128.51 120.7 53.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.301 -177.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.682 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 41.9 tp -105.17 116.83 32.62 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.964 174.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 57.0 mt -98.6 134.33 37.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.132 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.38 177.58 8.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.047 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.434 ' HD3' ' OD1' ' A' ' 68' ' ' ASP . 70.9 mtm180 -66.64 -27.26 67.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.967 -174.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -75.17 -29.67 60.48 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.082 0.468 . . . . 0.0 110.419 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.45 15.73 8.06 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.777 -176.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.671 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 82.4 mttt -97.62 157.62 15.94 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.827 0.346 . . . . 0.0 110.583 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.472 HG21 HD21 ' A' ' 130' ' ' LEU . 53.9 mt -91.04 120.67 40.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.576 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.6 m -114.97 1.77 8.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.851 ' HD2' HG23 ' A' ' 131' ' ' THR . 0.3 OUTLIER -163.71 124.61 2.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.779 0.323 . . . . 0.0 111.582 -178.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.573 HD22 ' CE1' ' A' ' 5' ' ' TYR . 96.5 mt -127.58 106.73 9.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.615 174.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.851 HG23 ' HD2' ' A' ' 129' ' ' LYS . 16.6 p -107.39 148.89 28.51 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.925 0.393 . . . . 0.0 111.062 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.527 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 23.5 mtm180 -92.84 107.8 19.5 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 174.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.95 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 4.0 pp 49.28 -172.18 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 O-C-N 124.239 0.962 . . . . 0.0 112.979 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.947 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 87.6 t80 -73.65 85.64 1.61 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.321 175.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.55 ' HB3' ' HB2' ' A' ' 138' ' ' GLU . 47.2 t-20 -85.54 117.69 24.6 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 170.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 30.0 mp0 -46.93 -39.72 12.82 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 123.403 0.44 . . . . 0.0 111.973 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -79.76 -51.54 9.06 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.56 0.219 . . . . 0.0 111.56 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.55 ' HB2' ' HB3' ' A' ' 135' ' ' ASN . 44.9 mt-10 -66.01 -34.43 78.07 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 121.243 -0.183 . . . . 0.0 111.24 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.441 ' O ' HG23 ' A' ' 143' ' ' VAL . 81.5 t80 -67.16 -42.97 83.43 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 177.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.24 -48.54 80.08 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.187 0.518 . . . . 0.0 110.316 176.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.3 m -62.88 -35.3 79.56 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.679 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.564 ' HG ' ' HG2' ' A' ' 129' ' ' LYS . 1.4 tt -67.29 -42.54 83.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.236 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 139' ' ' PHE . 70.6 t -58.45 -51.73 67.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.903 178.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.467 ' HA ' ' ND2' ' A' ' 147' ' ' ASN . 47.5 tp60 -60.86 -40.61 93.55 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.122 0.487 . . . . 0.0 110.498 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -56.55 -46.69 80.57 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.618 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.566 ' O ' HD23 ' A' ' 150' ' ' LEU . 42.6 mt -64.76 -38.35 82.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.914 178.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.528 ' O ' ' HG3' ' A' ' 151' ' ' LYS . 93.0 m-20 -53.21 -45.45 68.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.555 178.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -69.85 -36.73 75.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.079 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 84.3 mmm -63.16 -24.51 67.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.309 0.576 . . . . 0.0 110.233 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.566 HD23 ' O ' ' A' ' 146' ' ' ILE . 3.8 mm? -86.47 -22.3 26.54 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.189 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 147' ' ' ASN . 6.9 mtmp? -85.43 -47.35 10.04 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 177.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.574 ' OE1' ' HA ' ' A' ' 155' ' ' HIS . 0.6 OUTLIER 62.33 7.08 2.12 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.983 0.802 . . . . 0.0 111.142 177.022 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 60.0 35.35 86.95 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 -169.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 62.51 138.61 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.666 1.586 . . . . 0.0 111.673 -173.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.574 ' HA ' ' OE1' ' A' ' 152' ' ' GLU . 21.1 m80 -49.0 113.17 0.74 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.175 -178.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -79.69 87.38 5.22 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.931 -173.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -149.74 29.0 0.76 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.499 0.666 . . . . 0.0 109.301 173.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.42 ' O ' ' HB2' ' A' ' 159' ' ' HIS . 48.3 t60 -152.71 -57.36 0.13 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.106 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.42 ' HB2' ' O ' ' A' ' 158' ' ' HIS . 65.1 t-80 . . . . . 0 C--O 1.244 0.811 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.727 175.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.4 ttp . . . . . 0 N--CA 1.48 1.053 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.1 m -84.21 107.37 16.49 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.522 ' HB3' ' HD1' ' A' ' 5' ' ' TYR . 85.6 mt -75.8 121.37 22.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.239 -178.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.99 61.41 3.39 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.433 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.522 ' HD1' ' HB3' ' A' ' 3' ' ' LEU . 48.1 m-85 -113.72 153.29 29.24 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 177.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 29.0 pt -115.06 1.34 8.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.187 0.518 . . . . 0.0 110.429 175.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.9 m -117.34 161.39 16.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.673 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.554 ' HB2' ' HB2' ' A' ' 11' ' ' GLU . 42.1 mtt180 -112.5 165.64 12.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.18 -176.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.47 HG12 HD23 ' A' ' 130' ' ' LEU . 67.0 mt -81.33 118.32 28.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 172.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.12 -3.96 55.4 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -172.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.554 ' HB2' ' HB2' ' A' ' 8' ' ' ARG . 10.1 tp10 -90.93 153.37 20.23 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.534 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 58.2 mtp -76.37 139.41 40.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.123 0.487 . . . . 0.0 111.034 -177.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.452 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -76.64 134.38 69.38 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.918 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.594 ' HD2' ' CE1' ' A' ' 108' ' ' TYR . 24.3 Cg_exo -61.69 149.92 87.87 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.778 2.319 . . . . 0.0 111.427 177.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.0 169.41 9.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.413 -177.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' A' ' 27' ' ' THR . 44.1 p90 -172.39 172.45 4.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.507 -174.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 18.1 m -125.9 100.93 6.6 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 173.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 25' ' ' GLN . 18.3 tt -99.36 143.21 13.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.954 -172.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.6 m -92.14 121.39 33.63 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.917 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.7 mt -78.9 176.6 9.45 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.756 -178.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.3 p -59.25 -28.47 66.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.889 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.72 ' OD1' ' HG2' ' A' ' 24' ' ' LYS . 0.3 OUTLIER -77.79 -28.05 50.36 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.232 178.836 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.16 -1.58 28.31 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.107 -170.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.72 ' HG2' ' OD1' ' A' ' 22' ' ' ASP . 47.4 mmtm -70.18 117.26 11.52 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.642 -0.279 . . . . 0.0 110.777 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.458 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 90.8 mt-30 -91.12 114.63 27.21 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 174.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 17' ' ' THR . 17.0 m -116.91 151.12 18.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.651 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 29' ' ' SER . 4.2 m -98.84 147.32 25.05 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.707 178.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.475 ' O ' HD13 ' A' ' 28' ' ' LEU . 1.1 tm? -69.96 -25.54 63.68 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.548 ' HA ' ' HG2' ' A' ' 32' ' ' ARG . 48.8 m -58.45 -24.86 61.36 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.447 175.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.9 m -75.1 -18.39 60.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.836 0.351 . . . . 0.0 111.435 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.2 mt -105.28 3.55 30.09 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.161 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.548 ' HG2' ' HA ' ' A' ' 29' ' ' SER . 29.0 mmt180 -66.7 116.18 7.34 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 127.81 -21.02 5.66 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -175.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 123' ' ' ARG . 42.9 mtmt -116.55 164.75 14.13 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 176.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 68' ' ' ASP . 17.4 m -76.69 124.07 34.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 174.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.585 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 6.6 t -115.06 108.71 26.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.084 0.469 . . . . 0.0 110.935 -172.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.439 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 27.4 ttt -93.29 115.32 27.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.618 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.473 ' CD1' HG12 ' A' ' 36' ' ' VAL . 6.2 mp -115.26 115.39 26.6 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.356 178.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.427 ' O ' ' HG3' ' A' ' 39' ' ' GLN . 1.4 pt20 -105.82 117.62 34.49 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.047 0.451 . . . . 0.0 110.432 176.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.664 ' O ' ' HA ' ' A' ' 116' ' ' THR . 97.9 m-85 -85.09 109.64 18.39 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 172.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.0 t -127.77 -175.39 3.46 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.247 -170.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.558 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . . . -149.15 136.57 20.17 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.191 0.52 . . . . 0.0 111.686 -178.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.48 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 3.5 p -70.57 -6.26 35.16 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.445 175.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.462 ' HD1' ' HG3' ' A' ' 78' ' ' GLU . 43.5 p-90 -113.83 14.21 18.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.449 -177.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.558 ' SG ' ' HB3' ' A' ' 42' ' ' ALA . 94.8 m -112.81 138.13 50.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.901 0.382 . . . . 0.0 110.922 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -86.23 -33.33 14.67 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.218 -178.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.0 t -58.51 -36.11 57.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 121.362 0.601 . . . . 0.0 110.103 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.606 ' O ' ' HG2' ' A' ' 52' ' ' MET . 71.6 m -65.92 -16.55 63.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.714 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -77.6 -3.28 40.0 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 122.045 -0.409 . . . . 0.0 110.756 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -87.96 -53.77 4.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.103 0.478 . . . . 0.0 110.05 166.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.656 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 8.9 pt-20 -60.58 -46.28 90.83 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.912 -172.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.834 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 88.8 mmm -54.82 -59.57 10.27 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -174.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.834 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 31.8 Cg_exo -61.1 -39.76 56.85 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 122.025 1.817 . . . . 0.0 112.735 177.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.542 ' HB3' ' CZ ' ' A' ' 139' ' ' PHE . 11.6 m-85 -65.39 -46.71 79.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.58 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.534 HG12 ' HE1' ' A' ' 139' ' ' PHE . 77.3 mt -60.83 -46.15 96.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.439 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.46 ' OE2' HD13 ' A' ' 61' ' ' LEU . 33.5 tp10 -57.74 -49.12 77.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.886 0.374 . . . . 0.0 110.652 176.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.428 ' O ' ' HE3' ' A' ' 62' ' ' LYS . 28.6 ttpp -66.27 -52.38 48.06 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -174.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.438 ' HA ' ' NZ ' ' A' ' 62' ' ' LYS . 73.6 m-20 -105.28 -15.55 15.02 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -169.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 58.1 mt -105.43 -60.54 2.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.997 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.55 ' CD2' ' HB3' ' A' ' 94' ' ' TYR . 76.7 t-105 -63.42 -65.44 0.68 Allowed 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.158 -177.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.553 HD12 ' HE3' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -46.36 -32.63 3.3 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -174.909 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.438 ' NZ ' ' HA ' ' A' ' 58' ' ' ASP . 31.6 mmtp -81.54 -28.42 33.93 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -174.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -128.81 -43.42 1.37 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.807 -174.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.553 ' HE3' HD12 ' A' ' 61' ' ' LEU . 31.2 mttp 56.65 -92.38 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.934 0.893 . . . . 0.0 111.263 -176.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 66' ' ' ASN . 11.4 t70 -108.35 -39.16 5.52 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 173.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.4 ' HB3' ' O ' ' A' ' 65' ' ' ASP . 22.9 t-20 69.31 -72.62 0.1 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.217 176.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 164.8 -30.62 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.06 -173.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.507 ' O ' HG22 ' A' ' 35' ' ' VAL . 36.3 t70 -131.73 15.74 4.83 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 114.909 -1.042 . . . . 0.0 110.92 -177.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.454 ' HD2' ' O ' ' A' ' 64' ' ' LYS . 69.6 t80 -121.71 145.08 48.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.115 0.483 . . . . 0.0 110.979 -177.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.39 143.88 29.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.811 174.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.439 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 3.2 tt -143.46 123.03 13.24 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -177.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 65.6 mt -125.06 119.49 55.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.723 0.297 . . . . 0.0 110.405 176.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.416 ' HA2' ' HG3' ' A' ' 39' ' ' GLN . . . -88.52 123.38 6.74 Favored Glycine 0 C--O 1.219 -0.831 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 174.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 55.9 mt -117.82 122.89 70.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 117.706 0.753 . . . . 0.0 111.097 -174.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -80.42 118.34 21.97 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 170.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.551 ' HB3' ' CD1' ' A' ' 115' ' ' ILE . 0.0 OUTLIER -74.63 -6.34 48.07 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.846 -166.854 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -153.18 -30.58 0.13 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 118.759 -1.176 . . . . 0.0 113.144 -176.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.501 ' HB3' ' HG3' ' A' ' 82' ' ' LYS . 24.2 mm-40 -85.57 152.37 57.22 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.009 0.433 . . . . 0.0 112.079 -174.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.526 ' HD2' ' HG3' ' A' ' 82' ' ' LYS . 74.4 Cg_endo -79.31 -171.61 1.3 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.324 2.682 . . . . 0.0 115.243 -176.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.551 HD13 HD23 ' A' ' 84' ' ' LEU . 2.9 tm? -52.07 -55.66 19.27 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 113.528 -1.669 . . . . 0.0 111.423 -175.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -52.41 -42.13 63.79 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.762 -0.653 . . . . 0.0 112.178 -175.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.526 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 34.8 mmtp -66.24 -47.94 72.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.641 -176.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 79' ' ' PRO . 41.1 t -58.22 -45.02 89.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.517 -178.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.551 HD23 HD13 ' A' ' 80' ' ' LEU . 4.5 mm? -68.79 -24.64 64.44 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -175.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.47 -44.33 12.81 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.819 0.343 . . . . 0.0 110.791 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.48 ' CD1' ' HA ' ' A' ' 43' ' ' SER . 85.7 t80 -67.13 -45.34 77.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.766 -174.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.79 -32.19 70.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.998 0.904 . . . . 0.0 109.815 -177.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -69.31 -34.26 74.41 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.242 -1.344 . . . . 0.0 111.023 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.6 t -87.81 -8.16 56.31 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.239 -178.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 16.5 p -108.77 -2.16 18.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.667 0.27 . . . . 0.0 111.208 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.2 36.53 39.85 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.696 177.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.477 HG13 ' CE1' ' A' ' 94' ' ' TYR . 32.6 t -90.37 130.06 40.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.847 0.356 . . . . 0.0 111.706 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 25.4 m -101.67 -35.68 9.01 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.673 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.55 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 43.9 p90 -62.06 140.52 95.92 Favored Pre-proline 0 N--CA 1.463 0.201 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.247 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.27 147.65 91.04 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.66 2.24 . . . . 0.0 112.854 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.8 mp -123.6 154.66 38.99 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.522 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -122.74 162.01 16.72 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.938 178.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.6 mp -96.73 142.23 29.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.593 0.235 . . . . 0.0 110.904 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -133.4 79.71 59.86 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-O 121.212 0.529 . . . . 0.0 109.783 169.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.71 106.09 0.71 Allowed 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.603 2.202 . . . . 0.0 112.859 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.42 19.64 44.54 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.145 176.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 55.77 47.56 20.12 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.507 ' HA ' HH21 ' A' ' 111' ' ' ARG . 24.8 t70 -79.85 -51.55 9.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.159 0.504 . . . . 0.0 110.315 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 35.1 mm -67.43 -33.0 59.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -63.24 -34.9 78.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.281 173.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -73.26 -19.76 60.99 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.92 0.39 . . . . 0.0 111.19 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 14' ' ' PRO . 55.3 mttp -77.44 -17.41 58.11 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.179 176.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.594 ' CE1' ' HD2' ' A' ' 14' ' ' PRO . 81.1 m-85 -110.19 -36.91 5.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.071 0.462 . . . . 0.0 111.006 178.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -130.68 173.23 11.11 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.154 -176.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.492 ' O ' ' HB2' ' A' ' 111' ' ' ARG . 12.1 mt -86.69 3.41 44.91 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -176.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.507 HH21 ' HA ' ' A' ' 103' ' ' ASP . 98.8 mtt180 78.87 -36.65 0.18 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.839 -177.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -74.58 15.94 0.32 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.149 0.5 . . . . 0.0 111.05 176.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.416 ' H ' ' C ' ' A' ' 111' ' ' ARG . . . -93.98 -3.61 51.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.394 177.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.36 -152.09 16.91 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.193 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.551 ' CD1' ' HB3' ' A' ' 76' ' ' ARG . 1.9 tp -109.04 -61.66 2.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.956 ' HB ' ' HG ' ' A' ' 133' ' ' LEU . 2.7 m -86.33 110.66 19.82 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.037 0.446 . . . . 0.0 112.059 -170.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -142.13 131.7 23.92 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.444 176.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 1.119 ' HB3' ' HB ' ' A' ' 131' ' ' THR . 9.6 t30 -105.64 119.99 40.54 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.135 0.493 . . . . 0.0 110.672 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.3 t -107.2 110.39 31.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.792 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.686 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 56.7 tp -92.69 111.39 22.97 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.016 0.436 . . . . 0.0 110.37 178.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.585 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 48.6 mt -95.74 133.57 36.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.143 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -83.59 166.23 18.37 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.249 178.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.426 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 7.1 mtm180 -51.96 -37.73 54.0 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 123.476 0.71 . . . . 0.0 112.081 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -70.84 -5.74 32.72 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.871 0.367 . . . . 0.0 111.672 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.482 ' HA3' HH11 ' A' ' 32' ' ' ARG . . . 89.91 12.66 61.85 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.618 -177.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 87.2 mttt -98.59 144.32 28.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.504 0.192 . . . . 0.0 110.749 -177.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 63.1 mt -84.88 115.66 27.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 176.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.1 m -106.29 -23.61 4.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.686 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 44.7 tptt -142.09 115.84 9.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.238 0.542 . . . . 0.0 112.07 -176.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.47 HD23 HG12 ' A' ' 9' ' ' ILE . 3.2 mm? -97.46 128.91 44.62 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 170.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 1.119 ' HB ' ' HB3' ' A' ' 118' ' ' ASN . 14.2 m -115.98 135.71 53.71 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.043 0.449 . . . . 0.0 110.952 -175.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.697 HH21 ' HB2' ' A' ' 138' ' ' GLU . 38.7 mtm180 -88.03 106.91 18.46 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.379 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.956 ' HG ' ' HB ' ' A' ' 116' ' ' THR . 6.5 mp 49.66 -137.34 1.05 Allowed 'General case' 0 CA--C 1.532 0.27 0 O-C-N 123.233 0.333 . . . . 0.0 110.15 -178.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.656 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 27.4 t80 -80.64 -55.94 4.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.798 171.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 56.46 109.63 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.907 0.755 . . . . 0.0 112.163 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -44.59 -54.38 6.16 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 114.99 -1.005 . . . . 0.0 112.205 -174.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.28 -34.66 28.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.081 -0.508 . . . . 0.0 112.356 -176.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.697 ' HB2' HH21 ' A' ' 132' ' ' ARG . 15.6 tt0 -70.33 -37.64 74.73 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.645 -176.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.542 ' CZ ' ' HB3' ' A' ' 54' ' ' PHE . 84.7 t80 -63.23 -43.48 97.93 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 174.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.36 -53.73 54.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.209 176.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.1 m -54.37 -45.12 72.73 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.418 174.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.544 ' O ' HG12 ' A' ' 146' ' ' ILE . 45.0 tp -57.55 -48.99 77.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.607 -178.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 139' ' ' PHE . 87.8 t -60.04 -44.06 94.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.102 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -59.07 -44.15 91.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.275 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.559 ' O ' ' HG3' ' A' ' 149' ' ' MET . 7.8 tt0 -65.74 -39.69 91.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.543 178.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 142' ' ' LEU . 35.1 mm -56.07 -47.2 80.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.202 0.525 . . . . 0.0 110.238 175.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.412 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 83.9 m-20 -62.29 -31.23 71.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.341 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -71.54 -44.66 64.18 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.527 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.559 ' HG3' ' O ' ' A' ' 145' ' ' GLN . 80.0 mtp -66.88 -26.3 66.82 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.465 0.65 . . . . 0.0 109.926 -176.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.544 HD23 ' O ' ' A' ' 146' ' ' ILE . 4.4 mm? -76.73 -2.38 32.7 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.161 175.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.412 ' HG2' ' O ' ' A' ' 147' ' ' ASN . 47.2 mmtm -101.38 -66.69 0.9 Allowed 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 173.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 44.1 -94.92 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 O-C-N 124.574 1.171 . . . . 0.0 112.134 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 150.19 -62.13 0.41 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.402 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 44.3 p-80 -92.16 5.32 50.79 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.377 -0.484 . . . . 0.0 112.268 -170.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.91 81.78 1.19 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.605 0.717 . . . . 0.0 111.272 176.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 9.0 m170 -96.87 -26.02 15.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.734 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 39.1 m80 69.88 8.35 6.66 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.905 0.482 . . . . 0.0 110.491 -176.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 178.35 -166.88 0.06 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 43.9 t-80 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.82 172.862 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.484 1.235 0 CA-C-O 120.484 0.183 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 p -53.98 -53.05 58.2 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.333 -176.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.0 mt -77.65 11.19 2.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.936 0.398 . . . . 0.0 111.43 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.453 ' HA2' ' HB1' ' A' ' 113' ' ' ALA . . . 96.23 -56.63 1.48 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.407 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.526 ' CE2' ' HD2' ' A' ' 117' ' ' ARG . 92.9 m-85 -66.17 140.31 58.19 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -176.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.43 HD13 ' H ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -109.18 -5.3 10.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.149 164.421 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.2 p -94.92 160.37 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.092 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.6 ppt_? -128.38 166.58 18.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.906 0.384 . . . . 0.0 111.998 -173.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.4 mt -68.85 131.88 33.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.592 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.98 -3.86 70.79 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.066 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -82.17 152.1 26.63 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.439 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 31.8 mtp -81.83 124.67 29.88 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.089 178.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.43 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -61.47 126.87 87.54 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.681 -176.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 31.3 Cg_exo -59.12 121.77 10.48 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.949 2.433 . . . . 0.0 111.493 177.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.452 ' HA ' HD12 ' A' ' 28' ' ' LEU . 1.0 OUTLIER -70.77 141.86 51.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.532 -175.649 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.425 ' O ' ' HA ' ' A' ' 27' ' ' THR . 39.8 p90 -153.08 163.75 39.28 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.329 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 27.4 m -123.29 107.56 11.8 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 174.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.7 tt -106.8 147.83 11.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.827 0.346 . . . . 0.0 110.8 -175.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 24' ' ' LYS . 3.9 m -81.94 133.47 35.31 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.173 178.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.793 ' HB2' ' HB2' ' A' ' 24' ' ' LYS . 75.7 mt -91.19 -178.7 5.23 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.609 -0.268 . . . . 0.0 110.742 177.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.9 p -55.5 -41.72 73.47 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -172.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.425 ' OD1' ' HG2' ' A' ' 24' ' ' LYS . 4.5 p-10 -97.29 8.0 45.44 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.221 -176.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.88 8.94 44.18 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.289 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.793 ' HB2' ' HB2' ' A' ' 20' ' ' LEU . 40.5 mmtm -62.02 151.89 33.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.035 0.445 . . . . 0.0 110.718 177.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.457 HE21 ' HA ' ' A' ' 19' ' ' THR . 17.4 mm-40 -118.21 116.85 27.65 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.644 174.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 17' ' ' THR . 5.2 p -120.45 125.75 74.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.4 0.619 . . . . 0.0 110.998 -179.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.437 HG22 ' H ' ' A' ' 29' ' ' SER . 9.3 m -106.4 141.0 38.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.944 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.452 HD12 ' HA ' ' A' ' 15' ' ' ASP . 17.6 mt -62.83 -31.07 72.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.412 0.149 . . . . 0.0 111.183 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.437 ' H ' HG22 ' A' ' 27' ' ' THR . 45.8 m -53.43 -34.32 57.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.459 176.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.9 m -78.69 -18.13 54.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.213 0.53 . . . . 0.0 111.082 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.517 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 67.0 mt -101.65 0.78 36.77 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.856 -177.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 28' ' ' LEU . 38.2 mmt180 -66.82 127.94 34.4 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.15 -27.83 8.33 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.486 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.719 ' HB3' ' HZ3' ' A' ' 34' ' ' LYS . 0.7 OUTLIER -116.48 167.4 11.09 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.514 -0.18 . . . . 0.0 110.514 -178.532 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.4 p -80.06 127.63 39.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.019 0.438 . . . . 0.0 110.664 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.577 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 28.1 t -119.39 121.59 66.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.855 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.657 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 28.3 ttt -107.12 120.04 41.01 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.3 mt -126.22 102.01 7.0 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.104 -177.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.9 pm0 -107.38 133.18 52.28 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.615 175.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 94.9 m-85 -89.72 132.52 35.14 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.024 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.536 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 6.6 t -140.79 169.88 16.8 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.312 -177.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.48 ' HB2' ' CD1' ' A' ' 115' ' ' ILE . . . -135.54 151.65 50.53 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.8 169.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.456 ' H ' ' HG3' ' A' ' 78' ' ' GLU . 46.1 m -73.18 28.03 0.06 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -174.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.401 ' H ' ' C ' ' A' ' 42' ' ' ALA . 41.1 p-90 -147.24 7.71 0.9 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.599 0.238 . . . . 0.0 111.238 176.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.461 ' SG ' ' HB3' ' A' ' 42' ' ' ALA . 79.7 m -86.57 130.43 34.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.858 0.361 . . . . 0.0 110.891 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -83.92 -31.25 26.8 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.196 -177.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.691 HG11 ' HB2' ' A' ' 133' ' ' LEU . 38.4 t -62.86 -37.95 80.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.301 0.572 . . . . 0.0 109.835 177.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.959 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 63.2 m -70.44 -20.21 62.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.065 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -75.05 -7.57 54.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.072 0.463 . . . . 0.0 110.255 175.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -102.07 -51.55 3.36 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.5 174.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 1.007 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 12.2 pt-20 -65.17 -44.58 88.04 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.03 -175.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.504 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 38.3 mtm -64.79 -48.95 71.65 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -173.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.504 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 72.6 Cg_exo -54.94 -39.95 88.02 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.737 1.624 . . . . 0.0 112.161 171.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.43 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 7.6 m-85 -66.9 -40.4 87.69 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.078 176.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.574 HG13 ' O ' ' A' ' 51' ' ' GLU . 78.5 mt -57.65 -50.0 78.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.315 175.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.634 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 22.0 tp10 -57.52 -51.05 71.02 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 176.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -54.6 -61.7 2.14 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -175.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.865 ' HA ' ' HZ3' ' A' ' 62' ' ' LYS . 64.5 m-20 -107.56 -13.61 15.02 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -169.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.535 HG23 HG21 ' A' ' 146' ' ' ILE . 61.5 mt -101.99 -62.33 2.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.788 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.583 ' HB3' ' HA ' ' A' ' 56' ' ' GLU . 62.8 t-105 -69.79 -48.29 59.74 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.498 -173.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.634 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -54.83 -28.75 51.91 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -176.256 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.865 ' HZ3' ' HA ' ' A' ' 58' ' ' ASP . 39.3 mmtm -87.47 -25.62 23.64 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -172.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 61.8 m-70 -122.05 -40.27 2.53 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -172.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.617 ' HE2' ' HA ' ' A' ' 61' ' ' LEU . 45.8 mmtt 49.57 -102.5 0.1 Allowed 'General case' 0 C--O 1.224 -0.25 0 O-C-N 123.566 0.541 . . . . 0.0 111.526 -175.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.557 ' C ' ' H ' ' A' ' 67' ' ' ALA . 17.2 t70 -87.37 -63.58 1.28 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.809 -175.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.433 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 18.4 t-20 64.9 -25.97 0.09 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -175.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.557 ' H ' ' C ' ' A' ' 65' ' ' ASP . . . 89.09 -15.94 0.3 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.505 1.522 . . . . 0.0 109.618 -177.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.613 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 2.0 m-20 -134.06 20.43 3.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.083 178.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.481 ' CD1' HD21 ' A' ' 150' ' ' LEU . 86.7 t80 -121.92 108.46 13.46 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.297 0.57 . . . . 0.0 109.786 172.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 36' ' ' VAL . . . -111.75 104.37 12.71 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.756 -176.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.657 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 3.9 tt -113.78 114.66 26.63 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.6 mp -125.01 123.96 66.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.004 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.431 ' HA3' HD22 ' A' ' 96' ' ' LEU . . . -89.16 119.52 5.47 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.075 176.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 65.3 mt -102.29 102.14 13.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 117.134 0.467 . . . . 0.0 111.266 -174.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.536 ' HA ' ' O ' ' A' ' 41' ' ' THR . 8.0 t0 -80.76 144.53 32.08 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 170.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.436 ' HD2' ' CG ' ' A' ' 105' ' ' PHE . 8.2 ttp180 -85.46 -105.32 0.05 Allowed 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 120.305 -0.558 . . . . 0.0 112.186 -167.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.413 ' H ' ' HB3' ' A' ' 76' ' ' ARG . 31.8 m-20 -87.7 17.14 4.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.499 -168.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.456 ' HG3' ' H ' ' A' ' 43' ' ' SER . 5.8 mm-40 -91.09 138.86 25.7 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.579 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.447 ' HD2' ' HG3' ' A' ' 82' ' ' LYS . 48.5 Cg_endo -70.22 178.63 4.66 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.773 2.316 . . . . 0.0 113.07 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.1 mt -57.95 -56.46 21.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.926 -175.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.508 ' CD ' ' H ' ' A' ' 81' ' ' GLU . 1.9 pm0 -52.99 -36.0 59.83 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.638 -177.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.447 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 25.5 mmtp -63.51 -58.06 8.21 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.71 0.291 . . . . 0.0 110.487 175.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 55.0 t -54.18 -49.68 60.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.5 -177.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.41 -42.36 98.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.66 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.546 ' HA ' ' HE3' ' A' ' 88' ' ' LYS . . . -74.26 -29.52 61.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.648 -176.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -79.86 -44.91 19.63 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.57 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.422 ' HB2' ' CD1' ' A' ' 96' ' ' LEU . . . -55.64 -54.03 49.19 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.665 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.546 ' HE3' ' HA ' ' A' ' 85' ' ' ALA . 18.1 pttp -55.44 -30.54 60.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.746 -176.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.5 m -79.73 -14.59 58.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.103 -174.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.7 p -115.07 9.02 15.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.207 0.527 . . . . 0.0 110.637 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.67 -72.46 0.91 Allowed Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.293 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.0 t 28.07 88.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.622 1.169 . . . . 0.0 113.593 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.2 m -96.59 15.81 20.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.757 0.789 . . . . 0.0 110.086 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.551 ' HB3' ' CE2' ' A' ' 60' ' ' TRP . 25.9 p90 -115.43 146.85 37.45 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.114 176.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.76 136.84 69.09 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.635 2.224 . . . . 0.0 112.874 -177.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.431 HD22 ' HA3' ' A' ' 73' ' ' GLY . 63.7 mt -110.56 151.71 27.28 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.831 176.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -121.07 162.05 14.92 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 175.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.659 HD23 ' H ' ' A' ' 98' ' ' LEU . 2.0 pt? -121.6 138.61 54.25 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 117.005 0.403 . . . . 0.0 110.559 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -122.46 72.85 39.98 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.808 -178.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.448 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 13.9 Cg_exo -69.44 111.66 2.81 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.765 2.31 . . . . 0.0 111.761 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 117.74 -1.74 17.76 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -176.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 49.66 40.21 19.26 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -177.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -82.94 -53.96 5.44 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.122 0.486 . . . . 0.0 111.077 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.8 mm -63.85 -33.55 62.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.485 ' HE2' ' O ' ' A' ' 110' ' ' LEU . 80.2 t80 -64.63 -44.3 90.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.312 174.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.659 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -65.02 -19.81 66.18 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.852 -177.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -73.71 -6.7 48.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.858 0.361 . . . . 0.0 111.31 177.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -128.95 -42.19 1.41 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.994 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.659 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -139.07 157.14 46.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.65 -178.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.485 ' O ' ' HE2' ' A' ' 105' ' ' PHE . 7.5 mp -61.41 138.35 58.26 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 178.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.431 ' H ' ' HG3' ' A' ' 111' ' ' ARG . 10.0 mtm180 -55.96 -36.66 68.06 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 122.237 1.018 . . . . 0.0 109.245 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.22 13.49 15.08 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.647 -1.615 . . . . 0.0 110.444 -172.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.453 ' HB1' ' HA2' ' A' ' 4' ' ' GLY . . . -108.1 -171.77 1.93 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.877 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.86 119.68 19.71 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.664 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.48 ' CD1' ' HB2' ' A' ' 42' ' ' ALA . 2.3 tt -67.94 -39.09 81.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -175.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.462 HG22 ' HA ' ' A' ' 133' ' ' LEU . 12.2 m -75.99 98.88 4.4 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.1 0.476 . . . . 0.0 110.987 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.526 ' HD2' ' CE2' ' A' ' 5' ' ' TYR . 37.8 mmt-85 -136.31 133.14 36.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.487 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.516 ' HB2' HG22 ' A' ' 131' ' ' THR . 7.4 m120 -111.0 118.56 36.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.789 0.328 . . . . 0.0 110.43 -176.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.7 t -112.3 128.98 68.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.452 -178.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 46.3 tp -115.16 116.26 28.09 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.028 0.442 . . . . 0.0 110.469 175.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.577 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 55.1 mt -99.59 132.64 44.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.474 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.49 174.09 8.71 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.942 0.401 . . . . 0.0 110.438 -178.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.6 ptp85 -53.82 -34.54 59.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.725 -177.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -81.98 -0.55 44.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.559 -174.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.08 4.5 66.77 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.563 176.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 9.2 mtmp? -97.45 149.52 22.06 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.941 0.401 . . . . 0.0 111.107 -177.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 55.1 mt -85.31 109.88 18.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.805 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 19.4 m -98.75 -17.0 6.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.899 -175.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.676 ' HE3' ' HB ' ' A' ' 131' ' ' THR . 6.9 tmtm? -149.45 108.24 3.86 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.766 -177.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.93 109.36 15.44 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 172.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.676 ' HB ' ' HE3' ' A' ' 129' ' ' LYS . 11.8 t -117.25 164.08 15.35 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.439 -176.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.504 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -103.23 108.0 19.04 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.352 -176.492 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.691 ' HB2' HG11 ' A' ' 47' ' ' VAL . 4.4 pp 51.16 -176.55 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.315 1.046 . . . . 0.0 113.438 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 1.007 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 93.3 t80 -68.74 91.75 0.45 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.777 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.564 ' HB3' ' HB2' ' A' ' 138' ' ' GLU . 0.2 OUTLIER -107.15 121.15 43.93 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 173.314 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.511 ' N ' HD22 ' A' ' 135' ' ' ASN . 1.3 mp0 -38.26 -64.87 0.38 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.77 0.828 . . . . 0.0 112.772 -175.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -56.82 -51.5 68.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.347 0.594 . . . . 0.0 111.357 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.564 ' HB2' ' HB3' ' A' ' 135' ' ' ASN . 5.5 mm-40 -62.61 -43.91 97.63 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.011 -176.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.539 ' O ' HG23 ' A' ' 143' ' ' VAL . 69.1 t80 -66.07 -42.86 88.84 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.486 ' O ' ' HG2' ' A' ' 144' ' ' GLN . . . -57.22 -50.0 74.24 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.532 177.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 17.4 m -62.96 -37.8 88.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.819 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.459 ' O ' HG12 ' A' ' 146' ' ' ILE . 2.6 tt -62.85 -48.31 79.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.794 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 139' ' ' PHE . 99.7 t -59.05 -45.1 92.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.154 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 140' ' ' ALA . 29.8 mm-40 -62.33 -43.33 99.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.339 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.448 ' O ' ' HG2' ' A' ' 149' ' ' MET . 9.4 tt0 -63.69 -40.85 97.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.424 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.573 ' O ' HD23 ' A' ' 150' ' ' LEU . 24.5 mm -51.83 -50.08 34.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 121.176 0.512 . . . . 0.0 110.517 175.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.603 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 94.4 m-20 -58.02 -43.25 86.6 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.45 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -70.95 -32.95 69.98 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.009 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 83.1 mmm -60.06 -29.43 68.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.179 0.514 . . . . 0.0 110.167 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.573 HD23 ' O ' ' A' ' 146' ' ' ILE . 3.6 mm? -78.68 -16.46 57.26 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.378 177.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.603 ' HG2' ' O ' ' A' ' 147' ' ' ASN . 0.1 OUTLIER -103.33 -51.13 3.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.266 -177.825 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 157' ' ' HIS . 0.9 OUTLIER 55.92 94.9 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.214 -172.377 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -125.35 32.23 3.99 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 175.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 2.9 m80 -116.74 -36.45 3.89 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -176.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 13.8 t60 -173.82 -33.52 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -90.52 6.15 44.77 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.622 -169.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.457 ' HB2' ' O ' ' A' ' 152' ' ' GLU . 13.6 t60 -72.68 -29.3 63.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.9 0.381 . . . . 0.0 110.359 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -92.01 141.92 28.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.23 177.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.297 -0.859 . . . . 0.0 108.762 172.49 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.8 ttp . . . . . 0 N--CA 1.483 1.197 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.8 m 60.64 80.81 0.2 Allowed 'General case' 0 CA--C 1.53 0.187 0 O-C-N 123.811 0.695 . . . . 0.0 111.511 176.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.2 mt -129.16 142.92 50.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.927 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.34 69.46 3.33 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.43 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -146.58 147.21 30.87 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 177.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.5 pt -115.58 -6.15 11.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.252 0.549 . . . . 0.0 109.881 172.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.1 m -100.8 166.23 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.493 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.55 ' HB2' ' HG2' ' A' ' 11' ' ' GLU . 25.2 mtt180 -126.09 167.63 15.1 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -176.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 72.8 mt -78.99 119.47 28.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 174.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.64 -25.93 9.32 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.683 -176.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.55 ' HG2' ' HB2' ' A' ' 8' ' ' ARG . 72.2 mm-40 -66.76 150.37 49.21 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.627 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 56.7 mtp -80.32 123.54 28.08 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 174.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.439 ' HA ' ' HD2' ' A' ' 14' ' ' PRO . . . -56.16 124.58 60.63 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.603 -174.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 13' ' ' ALA . 7.1 Cg_endo -52.75 132.01 44.37 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.761 2.308 . . . . 0.0 111.338 175.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -82.82 161.54 21.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.458 -175.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.594 ' HB2' HD12 ' A' ' 104' ' ' ILE . 53.9 p90 -166.65 163.48 16.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.227 -175.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.6 m -125.26 100.5 6.56 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 174.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.5 tt -96.14 149.89 4.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.704 -174.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.477 ' O ' HD23 ' A' ' 98' ' ' LEU . 19.0 m -90.75 127.06 36.2 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.051 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.429 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 71.4 mt -79.69 175.9 10.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.933 178.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 96' ' ' LEU . 37.0 p -59.34 -25.9 64.59 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -177.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.802 ' OD1' ' HG2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -90.28 -19.32 24.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.146 0.498 . . . . 0.0 110.634 -178.519 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 113.13 -2.71 25.45 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.467 -174.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.802 ' HG2' ' OD1' ' A' ' 22' ' ' ASP . 39.3 mmtm -65.91 126.79 29.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.83 0.348 . . . . 0.0 111.149 178.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -91.3 116.4 28.8 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.868 176.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.9 p -119.05 128.4 75.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.315 0.578 . . . . 0.0 111.089 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 6.2 m -97.88 147.9 23.97 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.281 -178.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.71 -28.31 67.56 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.517 ' HA ' ' HG2' ' A' ' 32' ' ' ARG . 44.7 m -56.27 -29.31 60.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.389 177.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.6 m -75.24 -17.13 60.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.112 0.482 . . . . 0.0 111.243 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.3 mt -104.69 1.31 29.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.432 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.517 ' HG2' ' HA ' ' A' ' 29' ' ' SER . 36.3 mmt180 -66.76 122.5 17.79 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 120.54 -19.99 8.97 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -176.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.462 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 45.1 mtmt -116.52 155.24 29.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.547 -0.326 . . . . 0.0 110.323 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.512 HG13 ' HD1' ' A' ' 69' ' ' PHE . 1.4 p -71.27 117.73 14.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.012 0.434 . . . . 0.0 109.854 174.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.551 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 43.1 t -107.68 129.76 61.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.423 -173.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 27.6 ttt -107.46 120.12 41.3 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.174 175.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.7 mt -123.66 94.78 4.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.129 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.679 HE22 HD21 ' A' ' 71' ' ' LEU . 20.2 pm0 -93.81 131.1 39.52 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.107 0.48 . . . . 0.0 110.447 177.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -96.14 110.28 22.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.421 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.6 t -115.63 -171.9 2.05 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.88 -176.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.718 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . . . -163.13 143.46 9.16 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.514 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 54.8 m -62.68 -13.9 37.54 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -174.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 68.2 p-90 -101.07 -4.72 26.87 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.154 -0.341 . . . . 0.0 111.663 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.718 ' SG ' ' HB3' ' A' ' 42' ' ' ALA . 83.8 m -78.21 124.58 28.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.977 0.418 . . . . 0.0 111.732 -175.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -88.66 -18.11 55.39 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 176.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.479 ' HB ' HG21 ' A' ' 116' ' ' THR . 61.8 t -72.02 -46.52 59.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.931 0.396 . . . . 0.0 110.027 176.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.736 ' SG ' HG22 ' A' ' 116' ' ' THR . 69.2 m -66.91 -17.61 64.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.7 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.558 ' HE ' ' HE1' ' A' ' 86' ' ' PHE . 75.0 mtt180 -72.77 -6.46 44.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.154 0.502 . . . . 0.0 110.694 176.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -105.3 -44.98 4.6 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 169.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.649 ' HB2' ' HB2' ' A' ' 134' ' ' TYR . 40.6 tt0 -56.18 -57.12 13.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.369 -177.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.671 ' SD ' ' HE2' ' A' ' 86' ' ' PHE . 74.8 mtp -62.52 -50.64 77.76 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -172.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.615 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 54.7 Cg_exo -55.66 -36.22 94.42 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.959 1.773 . . . . 0.0 112.435 175.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -69.74 -41.32 75.43 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.638 175.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.534 HG13 ' O ' ' A' ' 51' ' ' GLU . 81.5 mt -56.32 -53.18 42.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.057 177.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.625 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 17.1 pt-20 -67.34 -32.09 72.8 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.525 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -62.04 -60.3 3.82 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.47 ' HA ' ' NZ ' ' A' ' 62' ' ' LYS . 52.1 m-20 -107.19 -8.48 16.43 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -171.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.508 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 70.6 mt -104.76 -57.98 4.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.612 176.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.625 ' HB3' ' HA ' ' A' ' 56' ' ' GLU . 76.5 t-105 -66.55 -67.42 0.45 Allowed 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.177 -178.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.0 mp -47.45 -32.1 4.8 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -174.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.47 ' NZ ' ' HA ' ' A' ' 58' ' ' ASP . 46.5 mmtm -77.28 -36.48 54.2 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -177.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -126.68 -43.16 1.74 Allowed 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.937 -0.477 . . . . 0.0 112.099 -173.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 60' ' ' TRP . 33.2 mttp 62.03 -83.05 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.918 0.887 . . . . 0.0 111.451 -178.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -123.37 -38.85 2.51 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 174.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 70.74 -75.06 0.08 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.022 175.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 171.86 -33.83 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.898 -176.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.462 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 5.7 t70 -126.83 19.55 7.17 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.273 -177.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.512 ' HD1' HG13 ' A' ' 35' ' ' VAL . 87.7 t80 -129.11 155.17 45.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.39 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -150.24 132.46 15.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.43 176.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.679 HD21 HE22 ' A' ' 39' ' ' GLN . 5.5 tt -129.41 119.77 24.38 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.5 mm -129.89 120.29 49.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.088 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.88 128.79 9.31 Favored Glycine 0 C--O 1.224 -0.509 0 C-N-CA 120.234 -0.984 . . . . 0.0 111.457 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.3 mt -115.5 120.1 63.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 117.23 0.515 . . . . 0.0 111.174 -176.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.521 ' OD1' ' HA ' ' A' ' 42' ' ' ALA . 16.7 t0 -92.09 127.89 37.73 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 174.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.49 111.33 22.57 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.169 -171.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.7 t0 81.43 -26.09 0.15 Allowed 'General case' 0 N--CA 1.47 0.557 0 O-C-N 124.147 0.904 . . . . 0.0 112.367 169.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.488 ' HB2' ' OD1' ' A' ' 75' ' ' ASP . 5.5 mm-40 -69.49 131.98 89.68 Favored Pre-proline 0 C--O 1.235 0.295 0 CA-C-O 121.148 0.499 . . . . 0.0 110.713 177.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.561 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 36.8 Cg_endo -71.96 -168.71 0.39 Allowed 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.088 2.526 . . . . 0.0 114.624 -176.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -62.69 -52.71 62.2 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.367 -168.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.561 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -62.98 -34.1 76.8 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.502 0.191 . . . . 0.0 111.419 -175.76 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.554 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 33.6 mmtp -58.93 -58.87 6.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.828 176.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.529 HG21 ' HB3' ' A' ' 98' ' ' LEU . 45.2 t -55.27 -44.88 77.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.452 -177.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.8 mp -67.37 -31.71 72.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.698 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.791 ' HA ' ' HE2' ' A' ' 88' ' ' LYS . . . -82.86 -37.35 24.45 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.102 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.671 ' HE2' ' SD ' ' A' ' 52' ' ' MET . 83.2 t80 -67.57 -47.0 71.03 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.914 -178.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.582 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -55.15 -51.53 66.2 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.59 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.791 ' HE2' ' HA ' ' A' ' 85' ' ' ALA . 64.7 pttt -65.94 -23.2 66.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.829 0.347 . . . . 0.0 111.688 -174.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.8 m -80.42 -28.22 37.82 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.108 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.6 p -96.95 -20.53 18.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.078 0.466 . . . . 0.0 111.01 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 112.58 -74.77 0.22 Allowed Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -175.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 97.8 t 43.43 88.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 124.31 1.044 . . . . 0.0 113.322 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.2 m -79.8 6.26 11.43 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 114.704 -1.135 . . . . 0.0 111.333 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.553 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 50.7 p90 -118.71 153.55 52.35 Favored Pre-proline 0 C--N 1.329 -0.306 0 O-C-N 122.172 -0.33 . . . . 0.0 110.882 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -66.71 137.97 47.56 Favored 'Trans proline' 0 C--O 1.24 0.593 0 C-N-CA 122.175 1.916 . . . . 0.0 113.236 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.582 HD12 ' HB2' ' A' ' 87' ' ' ALA . 77.9 mt -109.61 148.28 31.57 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.738 174.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -117.59 147.8 18.74 Favored Glycine 0 N--CA 1.438 -1.221 0 N-CA-C 110.389 -1.085 . . . . 0.0 110.389 173.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.733 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.5 pt? -101.6 136.63 41.13 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -178.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.41 ' OD2' ' HA ' ' A' ' 102' ' ' ALA . 27.5 t0 -116.38 73.95 5.71 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.261 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.494 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 15.4 Cg_exo -68.09 117.25 4.79 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.655 2.237 . . . . 0.0 111.524 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.407 ' O ' ' HD2' ' A' ' 111' ' ' ARG . . . 102.41 -7.32 53.87 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.275 -175.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.518 ' HB3' ' HG2' ' A' ' 111' ' ' ARG . . . 55.68 38.73 30.5 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 122.896 0.479 . . . . 0.0 111.402 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -72.46 -46.11 56.42 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.607 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.594 HD12 ' HB2' ' A' ' 16' ' ' PHE . 21.2 mm -65.22 -38.94 83.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.687 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -65.2 -38.71 91.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.097 175.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.57 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -68.92 -15.3 63.45 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.296 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 52.2 mttp -80.16 -16.75 54.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.627 175.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -113.82 -20.97 10.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.803 0.335 . . . . 0.0 111.328 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.57 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -159.79 -179.81 8.17 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.244 -178.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.94 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 88.6 mt -65.27 138.31 58.12 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.518 ' HG2' ' HB3' ' A' ' 102' ' ' ALA . 1.3 ttp85 -42.61 -48.1 5.36 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -173.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -118.58 37.79 3.95 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.138 0.494 . . . . 0.0 110.667 -176.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.94 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . . . -81.41 34.8 0.38 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.938 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.5 -162.92 17.7 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 121.022 -0.608 . . . . 0.0 112.282 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.562 HG13 ' H ' ' A' ' 116' ' ' THR . 4.7 tp -151.78 -174.2 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -178.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.736 HG22 ' SG ' ' A' ' 48' ' ' CYS . 53.0 p 58.37 88.86 0.06 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.869 0.867 . . . . 0.0 111.692 176.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -171.09 141.86 1.72 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.223 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.686 ' HB3' ' HB ' ' A' ' 131' ' ' THR . 5.6 t30 -119.97 129.67 54.41 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.095 0.474 . . . . 0.0 111.51 -176.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 39.1 t -101.81 113.1 37.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.781 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.939 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 27.2 tp -97.64 115.7 28.43 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.33 0.586 . . . . 0.0 110.035 177.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.551 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 60.5 mt -98.85 135.68 32.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 114.988 -1.006 . . . . 0.0 109.77 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.614 ' OD2' ' HB2' ' A' ' 126' ' ' LYS . 4.4 p30 -75.87 170.23 16.62 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.919 0.39 . . . . 0.0 110.0 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.566 ' HD3' ' OE1' ' A' ' 152' ' ' GLU . 6.9 ptm180 -75.39 1.31 14.2 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.471 -175.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.424 ' HB2' ' OD1' ' A' ' 122' ' ' ASP . 38.7 mt-10 -91.62 -30.5 16.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.373 0.606 . . . . 0.0 109.645 175.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.82 5.56 10.84 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.214 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.627 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 9.3 mtmp? -100.74 157.97 16.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.973 0.416 . . . . 0.0 111.263 -177.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 54.5 mt -92.06 119.08 38.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.155 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 17.0 m -114.91 -23.28 4.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.939 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 59.2 tptt -134.46 113.9 12.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.14 0.495 . . . . 0.0 111.799 -174.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -101.76 113.44 26.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.398 173.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.686 ' HB ' ' HB3' ' A' ' 118' ' ' ASN . 25.4 m -95.57 137.42 34.66 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.496 -177.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.451 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 0.4 OUTLIER -108.42 105.7 15.49 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.72 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 132' ' ' ARG . 3.4 pp 41.72 -163.1 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.093 0.871 . . . . 0.0 113.011 -177.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.649 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 84.5 t80 -94.14 107.48 19.41 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.127 0.489 . . . . 0.0 111.451 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.465 ' HB2' ' CB ' ' A' ' 138' ' ' GLU . 54.0 m-80 -119.42 149.77 41.3 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 170.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -58.58 -56.16 25.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.121 0.486 . . . . 0.0 110.752 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.456 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 0.9 OUTLIER -65.05 -40.78 95.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.216 -178.567 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.465 ' CB ' ' HB2' ' A' ' 135' ' ' ASN . 6.1 tp10 -61.93 -49.78 74.8 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.629 -178.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -66.96 -37.92 85.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.487 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.16 -42.06 97.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.337 176.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 43.2 m -64.5 -30.3 71.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.143 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.493 HD11 HG21 ' A' ' 131' ' ' THR . 29.2 mt -72.8 -55.26 6.96 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.294 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.3 p -59.42 -38.54 75.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 O-C-N 123.166 0.291 . . . . 0.0 110.897 -175.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -67.54 -46.9 71.44 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 176.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.412 HE22 ' HG2' ' A' ' 129' ' ' LYS . 9.6 tt0 -58.86 -46.58 87.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.605 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.553 ' O ' HD23 ' A' ' 150' ' ' LEU . 81.7 mt -65.47 -40.01 86.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.041 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -58.91 -38.63 79.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.688 0.28 . . . . 0.0 110.819 176.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -77.9 -30.41 50.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.941 178.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.407 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 87.0 mmm -67.19 -27.79 67.56 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.316 0.579 . . . . 0.0 110.143 178.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.553 HD23 ' O ' ' A' ' 146' ' ' ILE . 3.9 mm? -76.51 -7.08 54.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.556 175.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.438 ' HZ2' ' HB3' ' A' ' 151' ' ' LYS . 1.9 mmmp? -101.45 -64.27 1.07 Allowed 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.566 ' OE1' ' HD3' ' A' ' 123' ' ' ARG . 0.8 OUTLIER 59.94 -179.9 0.09 Allowed 'General case' 0 CA--C 1.537 0.477 0 O-C-N 124.332 1.02 . . . . 0.0 111.038 176.623 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -119.33 31.81 5.3 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.251 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -80.92 33.85 0.34 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.199 0.523 . . . . 0.0 111.174 177.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -145.3 102.53 3.74 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 174.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 28.7 m170 -105.42 161.86 13.96 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.526 -174.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -106.03 156.4 18.43 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -77.29 148.83 35.5 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.063 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 76.7 t60 . . . . . 0 C--O 1.244 0.793 0 CA-C-O 118.257 -0.878 . . . . 0.0 109.184 172.594 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.6 tpt . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.46 ' HB3' ' HB2' ' A' ' 5' ' ' TYR . 50.1 m -86.84 88.7 7.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.853 0.358 . . . . 0.0 110.62 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.7 pp -104.87 -6.11 20.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.278 0.561 . . . . 0.0 110.69 177.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -154.33 25.23 0.68 Allowed Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.462 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 62.1 m-85 -110.17 143.02 40.88 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.042 -0.579 . . . . 0.0 110.086 -175.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.417 ' H ' ' HA ' ' A' ' 109' ' ' ALA . 39.8 pt -92.07 -13.37 8.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.556 0.693 . . . . 0.0 109.248 173.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 p -110.57 164.16 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.298 178.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.5 mtm105 -133.68 165.85 23.97 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.902 0.382 . . . . 0.0 111.01 -174.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.422 HG12 HD13 ' A' ' 130' ' ' LEU . 85.4 mt -72.02 122.96 25.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.193 178.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.99 -22.21 19.03 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.94 -178.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -74.11 159.25 32.87 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.741 0.305 . . . . 0.0 110.722 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.588 ' SD ' ' HG2' ' A' ' 126' ' ' LYS . 56.3 mmm -79.76 133.28 36.32 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.435 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -69.99 129.7 90.61 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.623 -177.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.512 ' HD2' ' CE1' ' A' ' 108' ' ' TYR . 32.9 Cg_exo -61.92 137.44 67.47 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.882 2.388 . . . . 0.0 111.744 175.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.426 ' HB2' HH22 ' A' ' 32' ' ' ARG . 23.4 t70 -80.61 153.03 28.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.888 -177.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -161.88 165.44 27.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.779 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 73.5 m -124.7 107.12 10.64 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 174.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.5 tt -105.92 144.86 14.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.94 -173.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.465 ' O ' HD23 ' A' ' 98' ' ' LEU . 5.5 m -88.52 131.69 34.81 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.077 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.491 HD12 ' HB2' ' A' ' 24' ' ' LYS . 79.0 mt -82.43 -179.43 7.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.845 0.355 . . . . 0.0 110.951 177.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.453 ' HB ' HD11 ' A' ' 84' ' ' LEU . 35.6 p -57.85 -31.65 66.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.894 -175.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.493 ' OD2' ' HG2' ' A' ' 24' ' ' LYS . 5.4 p-10 -99.45 -6.19 28.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.818 0.342 . . . . 0.0 110.835 -175.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 107.94 1.82 34.12 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.333 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.614 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -69.22 110.78 4.76 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 117.663 0.732 . . . . 0.0 110.297 175.623 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -92.69 115.08 27.78 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.086 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 17' ' ' THR . 12.8 m -112.66 146.03 17.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.156 0.503 . . . . 0.0 110.804 -177.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 14.6 m -103.2 147.06 27.5 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.712 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.17 -45.81 93.08 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.702 0.287 . . . . 0.0 110.408 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.9 m -64.95 -15.79 62.59 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.2 t -82.48 -15.38 52.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.577 0.703 . . . . 0.0 109.555 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.2 mt -112.12 -3.9 14.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.539 177.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.426 HH22 ' HB2' ' A' ' 15' ' ' ASP . 7.8 mtm180 -75.81 156.36 34.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.058 0.456 . . . . 0.0 111.024 -178.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.48 -15.71 62.68 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 -166.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.582 ' HB3' ' O ' ' A' ' 68' ' ' ASP . 36.7 mtmt -116.44 160.21 20.9 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.058 -1.071 . . . . 0.0 109.381 175.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.431 HG11 HD22 ' A' ' 150' ' ' LEU . 2.3 p -80.19 118.27 27.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.359 0.6 . . . . 0.0 109.716 174.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.8 t -112.51 122.2 66.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.967 -173.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.652 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 26.7 ttt -99.34 114.96 28.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.08 175.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 69.6 mt -110.31 97.55 6.99 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.584 178.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.552 ' HG3' ' HA2' ' A' ' 73' ' ' GLY . 1.5 pp0? -91.1 130.97 36.94 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 177.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -107.02 122.34 46.25 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.43 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 13.9 t -151.49 -171.4 3.92 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.9 -177.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.409 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . . . -150.95 163.41 38.78 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 174.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.47 ' HB2' ' HG3' ' A' ' 78' ' ' GLU . 44.1 m -67.54 -5.71 16.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.055 -0.521 . . . . 0.0 112.168 -176.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 37.0 p-90 -109.9 12.21 23.91 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.482 ' SG ' HD13 ' A' ' 115' ' ' ILE . 73.8 m -92.85 100.95 13.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.118 0.485 . . . . 0.0 111.266 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.98 -32.38 73.29 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.889 -0.596 . . . . 0.0 113.082 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.6 t -64.12 -41.29 91.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.159 0.504 . . . . 0.0 110.446 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.75 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 83.6 m -67.62 -16.94 64.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.73 -177.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -71.3 -2.6 16.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.863 0.363 . . . . 0.0 110.994 176.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -98.85 -51.87 3.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.056 0.455 . . . . 0.0 110.026 170.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.75 ' HG2' ' HA ' ' A' ' 48' ' ' CYS . 11.7 pt-20 -69.58 -39.33 77.4 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.046 -173.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.575 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 91.7 mtp -60.36 -51.03 83.02 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -177.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.575 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 35.8 Cg_exo -59.68 -35.74 94.01 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.854 1.703 . . . . 0.0 112.208 172.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.579 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 3.1 m-85 -64.32 -43.73 93.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.724 174.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 51' ' ' GLU . 97.4 mt -58.16 -48.98 83.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.853 173.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.514 ' OE1' ' HA ' ' A' ' 92' ' ' VAL . 30.2 tp10 -50.22 -53.97 24.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.934 178.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -72.53 -50.45 25.65 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -173.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -105.8 -12.96 15.68 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -168.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.454 HD12 HG12 ' A' ' 55' ' ' ILE . 73.4 mt -106.37 -61.93 2.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.024 176.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.623 ' CE2' ' HG2' ' A' ' 64' ' ' LYS . 67.5 t-105 -62.94 -67.41 0.42 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.481 -174.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.02 -33.52 11.35 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -175.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -68.41 -30.11 68.94 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.78 -175.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.461 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 90.7 m-70 -128.98 -47.08 1.23 Allowed 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 119.678 -0.809 . . . . 0.0 112.621 -176.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.623 ' HG2' ' CE2' ' A' ' 60' ' ' TRP . 9.2 mtmp? 40.57 -93.98 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.568 0.699 . . . . 0.0 112.149 -174.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.59 -70.59 0.29 Allowed 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.045 173.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.586 ' ND2' HD12 ' A' ' 150' ' ' LEU . 5.7 t30 70.18 -68.77 0.19 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.769 0.828 . . . . 0.0 111.078 174.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 175.87 -46.3 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.363 -178.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.582 ' O ' ' HB3' ' A' ' 34' ' ' LYS . 7.9 p-10 -142.85 35.25 1.4 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.066 -177.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.609 ' HB2' HD11 ' A' ' 150' ' ' LEU . 74.5 t80 -104.13 145.72 29.78 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.657 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.76 130.33 17.89 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.934 174.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.652 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 3.4 tt -135.35 114.61 12.37 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.5 mp -125.9 126.12 69.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.825 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.552 ' HA2' ' HG3' ' A' ' 39' ' ' GLN . . . -91.16 120.4 5.95 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.608 -0.805 . . . . 0.0 111.376 176.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 65.8 mt -103.92 122.99 57.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 116.861 0.33 . . . . 0.0 111.051 -175.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.555 ' HA ' ' O ' ' A' ' 41' ' ' THR . 9.3 t70 -85.84 137.74 32.55 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 176.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 54.5 ttt-85 -74.87 -28.23 60.57 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -172.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -161.92 -18.3 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -171.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.47 ' HG3' ' HB2' ' A' ' 43' ' ' SER . 5.3 mm-40 -78.59 132.25 65.73 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-O 121.294 0.569 . . . . 0.0 111.198 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.58 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 28.4 Cg_endo -71.89 -169.94 0.49 Allowed 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 123.307 2.671 . . . . 0.0 114.366 -178.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.414 ' O ' HD23 ' A' ' 84' ' ' LEU . 79.4 mt -53.5 -59.01 5.13 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 114.958 -1.019 . . . . 0.0 113.106 -173.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.58 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -59.53 -33.43 71.38 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.479 -172.111 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.487 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 34.1 mmtp -64.35 -55.89 18.14 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.014 0.435 . . . . 0.0 110.325 174.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 79' ' ' PRO . 92.7 t -57.95 -44.39 86.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.43 -177.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.453 HD11 ' HB ' ' A' ' 21' ' ' THR . 4.4 mm? -69.01 -13.11 62.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.729 -178.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.523 ' HA ' ' HD2' ' A' ' 88' ' ' LYS . . . -99.84 -42.05 6.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.925 0.393 . . . . 0.0 110.789 176.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.553 ' HE2' ' SD ' ' A' ' 52' ' ' MET . 71.7 t80 -64.63 -38.08 89.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.841 -177.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -54.63 -56.01 23.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.338 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.523 ' HD2' ' HA ' ' A' ' 85' ' ' ALA . 0.3 OUTLIER -66.98 -19.05 65.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.171 0.51 . . . . 0.0 110.838 -175.519 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.4 m -81.55 -1.89 47.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.333 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.5 p -138.43 11.03 2.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.224 0.535 . . . . 0.0 110.491 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.68 -74.2 1.17 Allowed Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.514 ' HA ' ' OE1' ' A' ' 56' ' ' GLU . 54.6 t 29.65 93.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.108 1.363 . . . . 0.0 114.408 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 71.9 p -97.17 -11.91 23.7 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.038 0.447 . . . . 0.0 110.186 174.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.522 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 37.6 p90 -81.52 144.33 52.85 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.472 176.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.2 138.37 81.0 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.714 2.276 . . . . 0.0 113.044 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.408 HD11 HG11 ' A' ' 92' ' ' VAL . 83.8 mt -110.9 142.07 43.46 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.938 177.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 74' ' ' ILE . . . -115.0 142.7 17.79 Favored Glycine 0 N--CA 1.441 -1.009 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 177.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.785 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.8 pt? -103.11 129.62 50.02 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.938 0.399 . . . . 0.0 110.815 -177.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -119.33 72.07 13.23 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.818 177.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.458 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 20.1 Cg_exo -65.28 108.48 1.17 Allowed 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.504 2.136 . . . . 0.0 112.312 -176.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 118.9 -6.23 13.58 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.6 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 59.35 44.99 14.51 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.897 0.479 . . . . 0.0 111.784 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -80.8 -55.52 4.76 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 120.973 0.416 . . . . 0.0 110.499 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 38.4 mm -62.02 -35.28 67.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 176.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.672 ' HZ ' ' HA ' ' A' ' 115' ' ' ILE . 38.9 t80 -60.48 -40.61 91.89 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.264 174.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -76.89 -14.72 59.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.184 -177.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 50.0 mttp -72.75 -11.16 60.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.953 0.406 . . . . 0.0 111.353 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.512 ' CE1' ' HD2' ' A' ' 14' ' ' PRO . 98.9 m-85 -116.72 -30.03 5.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.413 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.571 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -162.89 -177.23 5.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.62 0.248 . . . . 0.0 110.714 -175.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.515 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . 95.6 mt -72.69 135.49 45.41 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.563 ' HA ' ' CD1' ' A' ' 105' ' ' PHE . 17.6 mtm180 -58.59 -34.51 71.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.936 -175.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -105.42 7.58 33.23 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.015 -170.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.515 ' CB ' ' HB2' ' A' ' 110' ' ' LEU . . . -96.24 49.76 1.14 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.136 0.493 . . . . 0.0 111.234 -177.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.67 104.52 0.9 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.059 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.672 ' HA ' ' HZ ' ' A' ' 105' ' ' PHE . 5.1 tt -72.07 -52.51 24.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -176.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.538 HG21 ' HA ' ' A' ' 133' ' ' LEU . 77.0 m -59.34 109.48 0.88 Allowed 'General case' 0 C--O 1.238 0.465 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -175.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.588 ' HB3' HH21 ' A' ' 132' ' ' ARG . 13.6 ptt180 -161.16 140.59 10.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.584 178.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -107.2 118.11 35.83 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 174.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 51.0 t -101.54 106.27 19.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.092 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 43.1 tp -93.49 119.19 32.27 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.278 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 68.5 mt -103.83 131.11 53.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.657 177.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.408 ' CG ' ' H ' ' A' ' 124' ' ' GLU . 0.0 OUTLIER -74.96 166.04 24.29 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.564 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -66.93 -13.38 61.7 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -174.102 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.576 ' HB2' ' NZ ' ' A' ' 126' ' ' LYS . 48.4 mt-10 -84.43 -27.58 27.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.014 0.435 . . . . 0.0 110.564 175.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.67 10.07 7.99 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.376 -0.916 . . . . 0.0 113.04 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.588 ' HG2' ' SD ' ' A' ' 12' ' ' MET . 31.6 mtmm -93.09 146.06 23.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.129 0.49 . . . . 0.0 111.729 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 56.0 mt -87.28 115.09 27.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.763 177.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 31.1 m -109.87 -16.72 8.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -172.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.587 ' HG2' HD13 ' A' ' 142' ' ' LEU . 51.2 tptt -137.5 122.68 19.24 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 119.896 -0.722 . . . . 0.0 112.107 -176.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.422 HD13 HG12 ' A' ' 9' ' ' ILE . 9.8 mp -121.91 105.18 10.11 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.212 174.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.456 HG22 ' HE3' ' A' ' 129' ' ' LYS . 67.9 p -96.67 162.05 13.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.137 0.494 . . . . 0.0 111.486 -177.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.623 ' HA ' ' HE ' ' A' ' 132' ' ' ARG . 2.1 mmp_? -127.27 106.93 9.56 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 173.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.538 ' HA ' HG21 ' A' ' 116' ' ' THR . 88.5 mt 63.24 176.43 0.16 Allowed 'General case' 0 N--CA 1.469 0.508 0 O-C-N 123.761 0.663 . . . . 0.0 111.382 -177.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.502 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 76.3 t80 -83.73 87.88 7.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.464 0.649 . . . . 0.0 109.684 175.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -104.15 135.66 45.22 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 176.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -55.44 -61.21 2.49 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 123.375 0.422 . . . . 0.0 112.03 -168.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.523 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.4 mp0 -55.74 -44.84 77.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.784 0.326 . . . . 0.0 110.885 -177.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -62.93 -46.03 89.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.509 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.579 ' CE2' ' HB3' ' A' ' 54' ' ' PHE . 63.6 t80 -69.99 -41.46 74.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.245 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.19 -40.15 89.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.575 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 48.1 m -67.12 -37.43 83.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.345 176.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.587 HD13 ' HG2' ' A' ' 129' ' ' LYS . 63.0 tp -62.47 -50.75 70.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.777 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 139' ' ' PHE . 94.6 t -56.45 -54.26 30.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.181 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -60.54 -42.85 97.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.629 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -56.28 -49.32 74.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.327 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.629 ' O ' HD23 ' A' ' 150' ' ' LEU . 28.9 mt -60.19 -50.94 78.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.1 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -55.08 -42.31 72.67 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.253 -0.179 . . . . 0.0 111.352 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -77.86 -24.51 48.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.686 0.279 . . . . 0.0 110.761 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 45.3 mmm -63.26 -31.31 72.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.403 0.621 . . . . 0.0 110.011 175.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.629 HD23 ' O ' ' A' ' 146' ' ' ILE . 4.0 mm? -80.67 -11.77 59.58 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.304 177.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -102.01 -27.42 12.95 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.266 -177.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -69.28 160.5 31.11 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.166 0.508 . . . . 0.0 110.601 -174.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -143.02 104.43 0.36 Allowed Glycine 0 N--CA 1.437 -1.237 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.384 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 11.9 m80 -53.85 108.58 0.37 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.092 0.472 . . . . 0.0 110.393 176.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -104.71 115.45 30.34 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.156 -173.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.457 ' O ' ' HB3' ' A' ' 157' ' ' HIS . 20.5 t-160 -72.36 132.24 43.71 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 164.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.457 ' HB3' ' O ' ' A' ' 156' ' ' HIS . 15.3 t60 72.15 89.32 0.1 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -165.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 70.9 m80 -78.4 -36.52 45.69 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.78 -174.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 30.1 m80 . . . . . 0 C--O 1.247 0.956 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.566 177.479 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptm . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 120.515 0.198 . . . . 0.0 111.31 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.7 p -156.68 161.91 39.84 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 110.51 -0.181 . . . . 0.0 110.51 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.494 HD12 ' HD3' ' A' ' 132' ' ' ARG . 3.7 tt 63.69 -84.68 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 O-C-N 124.022 0.826 . . . . 0.0 110.06 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -154.49 16.39 0.57 Allowed Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -81.76 133.59 35.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.873 -0.163 . . . . 0.0 110.568 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.1 pt -87.78 -18.86 8.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.218 0.533 . . . . 0.0 109.667 174.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.5 m -93.84 -179.39 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.657 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.4 ' CD ' ' HB2' ' A' ' 11' ' ' GLU . 6.2 ppt_? -144.34 165.7 27.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.847 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 69.4 mt -67.4 128.4 30.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.138 0.494 . . . . 0.0 110.745 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.52 3.22 66.96 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.096 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.4 ' HB2' ' CD ' ' A' ' 8' ' ' ARG . 8.0 tp10 -85.68 151.75 23.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.58 0.229 . . . . 0.0 110.582 -178.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.45 ' HE2' ' HA ' ' A' ' 12' ' ' MET . 1.2 mmt -69.49 116.79 10.31 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 175.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.423 ' HB2' HG12 ' A' ' 121' ' ' ILE . . . -54.49 126.07 54.45 Favored Pre-proline 0 C--O 1.237 0.401 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.489 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.487 ' HG2' ' O ' ' A' ' 107' ' ' LYS . 27.3 Cg_exo -60.42 115.54 2.73 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.802 2.335 . . . . 0.0 111.028 178.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -70.64 133.01 46.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.828 -173.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.66 ' HB2' HD12 ' A' ' 104' ' ' ILE . 36.1 p90 -136.49 158.87 43.41 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.035 -178.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 49.0 m -117.31 99.51 7.06 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.4 tt -97.87 152.32 4.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.609 -173.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.49 ' O ' HD23 ' A' ' 98' ' ' LEU . 27.3 m -99.35 129.41 45.55 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.944 178.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.42 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 82.3 mt -85.01 -178.07 6.73 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.823 0.344 . . . . 0.0 111.13 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.442 HG23 ' O ' ' A' ' 96' ' ' LEU . 30.9 p -62.55 -26.43 68.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.081 -176.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.418 ' OD1' ' HB2' ' A' ' 24' ' ' LYS . 13.1 p-10 -92.79 -5.11 51.83 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.526 -178.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.51 2.4 56.52 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.135 -176.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.418 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 6.2 tmtt? -62.87 112.34 2.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.79 0.328 . . . . 0.0 111.829 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -87.52 117.63 26.45 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 172.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 17' ' ' THR . 7.1 p -126.5 133.25 69.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.298 0.571 . . . . 0.0 110.97 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 29' ' ' SER . 11.2 m -93.92 144.75 25.17 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.209 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.62 -29.49 70.65 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.77 0.319 . . . . 0.0 110.53 -178.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.413 ' H ' HG22 ' A' ' 27' ' ' THR . 36.6 m -56.13 -30.53 62.26 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.365 176.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.2 m -74.79 -24.97 58.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.398 0.618 . . . . 0.0 110.809 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 89.4 mt -90.74 -10.87 41.39 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.532 -176.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.437 HH11 ' HA3' ' A' ' 125' ' ' GLY . 35.3 mmt180 -57.68 154.52 11.49 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.62 -19.53 36.3 Favored Glycine 0 C--O 1.226 -0.38 0 C-N-CA 121.088 -0.577 . . . . 0.0 111.885 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.579 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 32.5 mtmm -116.59 170.47 8.55 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 68' ' ' ASP . 35.4 m -81.75 123.34 37.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 176.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.417 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 12.8 t -115.78 120.6 65.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.875 0.369 . . . . 0.0 110.873 -174.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 27.2 ttt -112.42 118.27 34.73 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.01 0.433 . . . . 0.0 110.485 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.741 HD23 HD13 ' A' ' 121' ' ' ILE . 2.8 mm? -111.17 107.98 17.49 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.08 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.447 HE21 ' HB2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -109.47 127.18 54.23 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.492 -0.483 . . . . 0.0 109.89 175.504 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -95.39 121.12 36.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.272 0.558 . . . . 0.0 110.436 -176.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.553 ' HA ' ' SG ' ' A' ' 48' ' ' CYS . 1.9 t -122.54 171.77 8.87 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.479 -175.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.527 ' HB2' HG12 ' A' ' 115' ' ' ILE . . . -150.65 130.53 13.31 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.678 177.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.532 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 47.8 m -57.96 -28.93 64.8 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.958 -177.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 38.7 p-90 -90.56 2.4 55.82 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 52.8 t -107.59 120.31 41.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.976 0.417 . . . . 0.0 111.223 -177.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -83.41 -17.64 66.06 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.702 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.546 HG12 HG21 ' A' ' 116' ' ' THR . 42.7 t -66.37 -43.45 91.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 176.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.566 ' O ' ' HG2' ' A' ' 52' ' ' MET . 72.3 m -64.23 -27.49 69.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.318 176.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 55.4 ttt180 -69.05 -6.11 26.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.155 0.502 . . . . 0.0 110.809 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.517 ' HE3' ' CD2' ' A' ' 134' ' ' TYR . 22.9 mtpp -83.31 -55.19 4.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.476 172.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 10.6 pt-20 -70.05 -31.73 69.49 Favored 'General case' 0 C--O 1.219 -0.553 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.729 -176.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.598 ' HG3' ' HE2' ' A' ' 86' ' ' PHE . 91.7 mmm -50.6 -60.01 6.23 Favored Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.501 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 53.2 Cg_endo -69.86 -31.43 20.08 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 121.611 1.541 . . . . 0.0 112.66 177.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -68.64 -50.25 52.73 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.323 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.589 ' O ' ' HB ' ' A' ' 59' ' ' ILE . 83.8 mt -57.13 -45.38 84.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.376 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.537 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 25.5 tt0 -58.77 -48.99 79.31 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.86 175.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -56.49 -56.65 18.63 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -174.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.69 ' HA ' ' NZ ' ' A' ' 62' ' ' LYS . 73.5 m-20 -105.06 -9.88 17.54 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -171.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.589 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 50.4 mm -105.26 -57.35 4.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.646 176.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.551 ' CD2' ' HB3' ' A' ' 94' ' ' TYR . 74.9 t-105 -69.69 -51.6 33.05 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.134 -173.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.572 ' HA ' ' HE2' ' A' ' 64' ' ' LYS . 3.1 mm? -61.06 -16.57 45.31 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.69 ' NZ ' ' HA ' ' A' ' 58' ' ' ASP . 48.5 mmtm -86.51 -27.93 23.72 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.615 -176.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -127.48 -41.31 1.72 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -173.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.572 ' HE2' ' HA ' ' A' ' 61' ' ' LEU . 34.4 mmtt 55.4 -91.34 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 O-C-N 123.493 0.496 . . . . 0.0 111.094 -174.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -96.24 -63.3 1.16 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.019 0.438 . . . . 0.0 110.065 178.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.449 ' ND2' HD12 ' A' ' 150' ' ' LEU . 1.1 t30 66.15 3.92 2.9 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.083 174.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 62.2 4.17 1.18 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.467 0.707 . . . . 0.0 112.655 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.579 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 20.2 t70 -152.21 5.48 0.41 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.429 0.633 . . . . 0.0 111.086 -175.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.571 ' CE2' ' HB2' ' A' ' 71' ' ' LEU . 85.3 t80 -117.95 120.8 38.94 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 121.706 -0.621 . . . . 0.0 110.888 -174.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -122.03 104.62 9.64 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.931 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.571 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 3.7 tt -108.48 114.75 28.83 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.0 mm -117.81 115.84 49.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.132 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.7 116.66 4.68 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.105 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 55.8 mt -105.8 100.91 11.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 117.155 0.478 . . . . 0.0 111.336 -173.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.526 ' HA ' ' O ' ' A' ' 41' ' ' THR . 1.9 t70 -85.43 136.16 33.56 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 172.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.468 ' HB3' ' H ' ' A' ' 77' ' ' ASP . 16.8 ttp180 -72.59 -112.13 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -165.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.468 ' H ' ' HB3' ' A' ' 76' ' ' ARG . 17.3 m-20 -78.55 5.91 9.84 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -169.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.441 ' HG3' ' H ' ' A' ' 43' ' ' SER . 28.2 mm-40 -76.92 131.23 73.67 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-O 121.027 0.441 . . . . 0.0 110.987 -176.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.478 ' HG2' ' OE2' ' A' ' 81' ' ' GLU . 29.1 Cg_endo -68.65 176.76 5.5 Favored 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 122.663 2.242 . . . . 0.0 112.7 177.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 97.2 mt -53.0 -58.22 7.71 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -173.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.478 ' OE2' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -64.5 -21.39 66.66 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -173.372 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 28.7 mmtm -74.03 -54.8 7.08 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 172.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 60.1 t -56.48 -47.37 81.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.233 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.78 -33.17 75.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.283 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -74.72 -35.63 62.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.744 0.306 . . . . 0.0 110.882 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.598 ' HE2' ' HG3' ' A' ' 52' ' ' MET . 60.3 t80 -69.39 -40.15 77.55 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.424 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -57.95 -55.08 39.51 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.164 176.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -62.9 -24.19 67.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.653 -175.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.7 m -84.49 2.37 41.3 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.522 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 p -130.4 -25.65 2.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.245 175.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 124.71 -81.24 0.36 Allowed Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -176.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.5 t 45.69 85.28 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 124.366 1.066 . . . . 0.0 113.547 173.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 40.5 p -93.25 15.81 14.63 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.545 173.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.551 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 42.0 p90 -111.39 148.15 38.19 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.133 175.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -63.16 130.53 29.14 Favored 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 122.436 2.091 . . . . 0.0 113.116 -177.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.442 ' O ' HG23 ' A' ' 21' ' ' THR . 94.8 mt -103.77 146.42 28.64 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.514 174.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -119.4 149.25 18.05 Favored Glycine 0 N--CA 1.438 -1.182 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 175.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.784 HD23 ' H ' ' A' ' 98' ' ' LEU . 2.1 pt? -107.02 142.08 37.21 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.854 0.359 . . . . 0.0 110.294 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -124.12 72.98 56.68 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.006 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.416 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 16.8 Cg_exo -67.71 109.81 1.96 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.718 2.279 . . . . 0.0 111.628 177.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 116.32 -3.62 20.26 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -176.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.442 ' O ' ' HG2' ' A' ' 111' ' ' ARG . . . 51.45 36.37 16.55 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.095 0.558 . . . . 0.0 112.184 -178.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -88.04 -39.55 14.56 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.115 -175.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.66 HD12 ' HB2' ' A' ' 16' ' ' PHE . 17.6 mm -66.9 -34.56 70.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 176.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.401 ' HD2' ' HA ' ' A' ' 111' ' ' ARG . 70.8 t80 -65.1 -39.03 92.57 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.728 171.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.652 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -69.0 -16.91 63.84 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.803 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.507 ' HG2' ' HA ' ' A' ' 104' ' ' ILE . 20.7 mmtt -66.35 -25.28 66.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.16 0.505 . . . . 0.0 109.903 177.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -112.69 -37.07 5.0 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.825 -174.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.652 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -147.39 168.36 22.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.668 0.27 . . . . 0.0 111.403 -174.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 9.0 mp -62.23 138.14 58.37 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 174.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 102' ' ' ALA . 97.4 mtt180 -58.25 -26.75 63.28 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 -170.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -113.41 12.42 18.74 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.474 0.654 . . . . 0.0 111.049 -178.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.506 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . . . -83.64 46.98 1.22 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.114 0.483 . . . . 0.0 110.876 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 93.39 -159.23 24.04 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.708 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.527 HG12 ' HB2' ' A' ' 42' ' ' ALA . 5.3 tp -152.89 -54.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 122.773 -0.251 . . . . 0.0 111.248 176.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.546 HG21 HG12 ' A' ' 47' ' ' VAL . 3.0 m -64.57 123.82 20.25 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 122.469 0.308 . . . . 0.0 111.341 -174.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -176.68 152.8 1.03 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.79 0.329 . . . . 0.0 110.834 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.561 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 7.8 m120 -116.65 118.41 32.5 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 177.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 41.2 t -109.79 126.85 66.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.645 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.642 HD21 ' SD ' ' A' ' 149' ' ' MET . 40.7 tp -119.7 127.02 52.48 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.068 0.461 . . . . 0.0 111.327 -178.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.741 HD13 HD23 ' A' ' 38' ' ' LEU . 1.9 mp -113.18 137.38 46.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.175 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.67 179.44 7.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.537 -178.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -62.86 -28.06 69.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.128 -176.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.615 ' HB2' ' NZ ' ' A' ' 126' ' ' LYS . 69.4 mt-10 -79.78 -12.16 59.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.108 0.48 . . . . 0.0 110.559 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.437 ' HA3' HH11 ' A' ' 32' ' ' ARG . . . 99.67 12.06 42.08 Favored Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.804 176.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.615 ' NZ ' ' HB2' ' A' ' 124' ' ' GLU . 31.5 mtmm -93.23 143.74 25.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.896 0.379 . . . . 0.0 111.093 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 47.2 mt -78.35 108.06 11.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.1 m -104.7 -20.74 5.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -171.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.568 ' HE3' ' OG1' ' A' ' 131' ' ' THR . 8.3 tmtm? -145.18 126.73 15.08 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.429 -172.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -125.54 107.24 10.42 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.542 178.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.568 ' OG1' ' HE3' ' A' ' 129' ' ' LYS . 97.7 m -95.76 139.46 31.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.799 0.333 . . . . 0.0 110.366 174.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.528 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 89.1 mtt180 -97.05 123.11 40.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.049 -178.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 132' ' ' ARG . 4.4 pp 50.89 21.54 0.98 Allowed 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 172.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.517 ' CD2' ' HE3' ' A' ' 50' ' ' LYS . 23.0 t80 58.95 112.27 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 122.284 1.04 . . . . 0.0 112.221 -176.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -119.19 139.71 51.39 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.85 174.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -53.68 -54.14 42.06 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -175.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.462 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.6 mp0 -58.31 -47.04 84.98 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.173 0.511 . . . . 0.0 110.806 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -57.3 -45.48 84.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.19 177.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.598 ' O ' HG23 ' A' ' 143' ' ' VAL . 70.0 t80 -61.72 -46.78 88.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.592 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.43 -45.68 80.61 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.084 0.468 . . . . 0.0 110.633 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.9 m -65.62 -39.02 91.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.329 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.76 -41.17 98.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.391 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 139' ' ' PHE . 96.0 t -56.05 -55.72 16.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.654 177.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -60.4 -44.44 95.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.337 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.599 ' O ' ' HG3' ' A' ' 149' ' ' MET . 5.7 tt0 -53.98 -52.13 61.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.009 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.598 ' O ' HD23 ' A' ' 150' ' ' LEU . 22.5 mt -62.36 -44.26 99.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.725 -0.216 . . . . 0.0 110.996 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -57.54 -39.42 76.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.144 0.497 . . . . 0.0 110.324 176.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -68.47 -36.06 78.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.195 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.642 ' SD ' HD21 ' A' ' 120' ' ' LEU . 90.1 mtp -64.74 -31.82 73.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.212 0.529 . . . . 0.0 110.435 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.598 HD23 ' O ' ' A' ' 146' ' ' ILE . 4.0 mm? -71.33 -12.27 61.35 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.424 177.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.564 ' HA ' ' NZ ' ' A' ' 151' ' ' LYS . 0.4 OUTLIER -96.74 -46.6 6.21 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 170.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 74.9 117.54 0.05 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-N 114.219 -1.355 . . . . 0.0 112.161 173.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -65.82 86.2 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 165.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 13.4 m80 -49.38 112.58 0.66 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 122.03 0.919 . . . . 0.0 113.114 -166.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.558 ' H ' ' CD2' ' A' ' 155' ' ' HIS . 3.0 p80 -75.82 68.13 2.32 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.014 -1.448 . . . . 0.0 110.976 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -155.14 97.05 1.88 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.445 176.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.55 ' HB3' ' H ' ' A' ' 159' ' ' HIS . 61.2 m170 -120.67 -174.13 2.74 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.989 0.424 . . . . 0.0 110.331 -178.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -109.3 1.35 20.07 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 163.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.55 ' H ' ' HB3' ' A' ' 157' ' ' HIS . 51.4 t-80 . . . . . 0 C--O 1.247 0.955 0 CA-C-N 113.557 -1.656 . . . . 0.0 108.06 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.8 mmm . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.4 t -151.41 133.27 15.0 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.727 HD23 ' H ' ' A' ' 3' ' ' LEU . 1.1 pt? -99.15 69.01 1.7 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.597 0.713 . . . . 0.0 110.143 177.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.09 24.0 76.61 Favored Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.395 -0.82 . . . . 0.0 113.476 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -87.3 116.0 25.09 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 117.199 0.499 . . . . 0.0 109.955 174.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.1 pt -92.75 -26.01 4.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.797 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.6 p -94.83 152.84 3.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.454 ' HE ' ' CD ' ' A' ' 11' ' ' GLU . 0.6 OUTLIER -118.03 156.6 28.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.315 0.578 . . . . 0.0 112.453 -171.087 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.4 mt -73.2 132.66 33.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.459 170.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.59 -9.15 77.76 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -175.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.454 ' CD ' ' HE ' ' A' ' 8' ' ' ARG . 36.2 tt0 -99.66 156.98 16.79 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 91.5 mmm -72.69 125.72 28.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.91 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.433 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -66.13 126.36 91.8 Favored Pre-proline 0 C--O 1.237 0.427 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.053 178.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.473 ' HG2' ' O ' ' A' ' 107' ' ' LYS . 45.9 Cg_exo -57.29 122.7 12.25 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.127 2.551 . . . . 0.0 112.125 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.511 ' HA ' HD12 ' A' ' 28' ' ' LEU . 1.4 t70 -71.16 134.69 47.14 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.63 -175.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.58 ' HB2' HD12 ' A' ' 104' ' ' ILE . 42.4 p90 -141.33 174.36 10.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.826 0.346 . . . . 0.0 110.793 -178.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 55.3 m -134.87 114.32 12.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.38 174.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.513 ' O ' ' HA ' ' A' ' 25' ' ' GLN . 14.4 tt -112.25 141.85 26.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.16 -174.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.3 m -88.38 120.34 29.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.68 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.654 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 85.7 mt -79.51 -179.09 6.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.3 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.475 ' HB ' HD11 ' A' ' 84' ' ' LEU . 36.6 p -51.07 -43.96 61.08 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -174.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -100.87 12.34 37.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.845 0.355 . . . . 0.0 111.493 -174.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.16 17.2 41.08 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.984 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.532 ' HE2' ' HA ' ' A' ' 24' ' ' LYS . 7.8 mmpt? -80.22 112.16 17.28 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 175.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.513 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 23.0 mt-30 -100.08 113.53 26.21 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.997 0.427 . . . . 0.0 110.49 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 17' ' ' THR . 14.1 m -105.84 147.05 11.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.723 -177.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.8 m -116.75 142.23 47.18 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.943 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.511 HD12 ' HA ' ' A' ' 15' ' ' ASP . 13.3 mt -60.99 -32.97 72.53 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 -178.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.2 m -56.68 -31.26 64.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.032 0.444 . . . . 0.0 111.062 177.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.8 m -79.32 -20.16 48.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.979 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.417 ' C ' ' HD3' ' A' ' 34' ' ' LYS . 86.5 mt -107.35 11.62 28.9 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.899 -178.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 28' ' ' LEU . 37.3 mmt180 -70.9 137.17 49.07 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 171.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.76 -7.65 57.66 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.499 -174.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.572 ' HG3' ' HA ' ' A' ' 68' ' ' ASP . 9.6 mptt -113.15 157.47 21.63 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 175.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 68' ' ' ASP . 2.1 p -84.17 103.91 11.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 170.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.435 ' HA ' ' HB3' ' A' ' 70' ' ' ALA . 22.3 t -95.86 111.62 26.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.202 -171.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 24.8 ttt -96.86 125.97 41.68 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.011 0.434 . . . . 0.0 110.277 175.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.492 HD13 HD13 ' A' ' 121' ' ' ILE . 6.5 mp -108.64 130.51 55.32 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.941 176.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.92 HE21 HD12 ' A' ' 55' ' ' ILE . 6.8 tt0 -117.66 114.5 23.45 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.441 178.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.544 ' O ' ' HA ' ' A' ' 116' ' ' THR . 94.2 m-85 -93.2 106.18 18.17 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.061 0.457 . . . . 0.0 110.152 178.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.441 ' HA ' ' SG ' ' A' ' 48' ' ' CYS . 11.7 t -117.41 175.37 5.65 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.563 -174.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.411 ' HB2' HG12 ' A' ' 115' ' ' ILE . . . -154.3 136.59 14.88 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.412 ' OG ' ' HG3' ' A' ' 78' ' ' GLU . 28.3 p -62.17 -11.07 12.48 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -173.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 2.8 p-90 -117.03 19.8 14.11 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 122.087 -0.383 . . . . 0.0 111.724 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.408 ' SG ' ' HB ' ' A' ' 47' ' ' VAL . 43.3 t -108.14 114.17 27.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.847 0.356 . . . . 0.0 110.765 178.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.18 -17.48 79.97 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.364 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.433 HG11 ' HB3' ' A' ' 133' ' ' LEU . 58.6 t -64.56 -40.1 87.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 175.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.468 ' HA ' ' HB3' ' A' ' 51' ' ' GLU . 81.1 m -68.82 -16.9 63.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.796 176.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 27.4 ttt85 -78.52 -11.98 59.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.956 0.408 . . . . 0.0 110.174 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -84.54 -50.38 7.76 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 122.128 0.966 . . . . 0.0 108.443 162.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.681 ' HB2' ' HB2' ' A' ' 134' ' ' TYR . 40.0 tt0 -57.25 -59.79 4.59 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 113.631 -1.622 . . . . 0.0 112.094 -171.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.664 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 85.7 mtp -57.37 -53.03 69.73 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -173.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.664 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 45.9 Cg_exo -60.04 -41.8 49.51 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.242 1.961 . . . . 0.0 113.053 177.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -65.16 -44.84 87.25 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.765 0.317 . . . . 0.0 110.802 177.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.92 HD12 HE21 ' A' ' 39' ' ' GLN . 64.0 mt -60.34 -42.95 92.58 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.314 176.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.578 ' OE1' ' HA ' ' A' ' 92' ' ' VAL . 37.5 tp10 -52.62 -58.81 5.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.451 0.643 . . . . 0.0 109.943 174.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -60.68 -59.09 5.94 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.36 -173.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.496 ' HA ' ' NZ ' ' A' ' 62' ' ' LYS . 72.2 m-20 -106.52 -5.26 18.94 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -168.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.608 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 22.8 mm -104.98 -57.95 4.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.061 0.458 . . . . 0.0 110.428 173.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.538 ' CD2' ' HB3' ' A' ' 94' ' ' TYR . 68.9 t-105 -66.11 -73.47 0.13 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.823 -173.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -50.98 -27.36 7.54 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -173.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.496 ' NZ ' ' HA ' ' A' ' 58' ' ' ASP . 47.9 mmtm -67.47 -33.96 76.18 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.421 ' CG ' HD11 ' A' ' 150' ' ' LEU . 67.7 m-70 -131.57 -44.5 0.99 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.236 -0.586 . . . . 0.0 112.044 -176.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.472 ' O ' ' HD2' ' A' ' 69' ' ' PHE . 9.5 mtmp? 42.93 -95.62 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.662 0.785 . . . . 0.0 112.662 -176.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.04 -72.39 0.45 Allowed 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.557 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 30.5 t30 66.75 -70.55 0.11 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.472 -177.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.793 ' HB3' ' HD2' ' A' ' 159' ' ' HIS . . . 164.32 -30.33 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 124.605 1.162 . . . . 0.0 108.36 -178.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.572 ' HA ' ' HG3' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -143.27 40.18 1.46 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.965 -1.016 . . . . 0.0 112.23 -178.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.472 ' HD2' ' O ' ' A' ' 64' ' ' LYS . 80.8 t80 -119.34 138.07 53.29 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 169.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.435 ' HB3' ' HA ' ' A' ' 36' ' ' VAL . . . -134.43 139.75 45.76 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.218 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.9 tt -143.13 115.76 8.65 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -117.0 118.39 58.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.708 0.289 . . . . 0.0 110.256 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.525 ' HA3' HD13 ' A' ' 96' ' ' LEU . . . -88.38 108.67 3.45 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 175.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 59.6 mt -101.66 107.43 21.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 O-C-N 122.588 -0.36 . . . . 0.0 111.323 -173.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.52 ' HB3' HG22 ' A' ' 83' ' ' VAL . 10.7 t0 -85.58 128.47 34.77 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 174.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.405 ' HD3' HD13 ' A' ' 115' ' ' ILE . 8.4 ttp180 -91.6 126.93 36.86 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.854 -168.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.527 ' HA ' ' HA ' ' A' ' 100' ' ' PRO . 53.4 m-20 71.39 -43.9 0.57 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.999 0.919 . . . . 0.0 113.054 173.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.571 ' OE1' ' HG3' ' A' ' 82' ' ' LYS . 78.2 mm-40 -60.63 136.22 92.46 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 121.365 0.603 . . . . 0.0 112.141 -176.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.636 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 35.5 Cg_endo -71.16 -173.15 0.85 Allowed 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 123.301 2.667 . . . . 0.0 114.109 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.403 ' O ' HD23 ' A' ' 84' ' ' LEU . 91.6 mt -53.75 -57.08 12.15 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 114.745 -1.116 . . . . 0.0 113.308 -173.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.636 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -61.06 -29.81 69.96 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -171.66 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.571 ' HG3' ' OE1' ' A' ' 78' ' ' GLU . 40.5 mmtm -64.89 -58.28 6.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.237 0.541 . . . . 0.0 110.182 173.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.52 HG22 ' HB3' ' A' ' 75' ' ' ASP . 38.7 t -56.24 -49.62 75.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.476 -176.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.475 HD11 ' HB ' ' A' ' 21' ' ' THR . 4.4 mm? -63.24 -47.13 83.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.657 -176.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.21 -39.54 78.54 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -176.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.537 ' HE2' ' SD ' ' A' ' 52' ' ' MET . 79.6 t80 -68.81 -44.25 73.91 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 121.131 -0.228 . . . . 0.0 111.181 -176.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.1 -41.96 94.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.311 0.577 . . . . 0.0 109.72 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -59.07 -29.56 67.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.043 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 18.5 t -82.09 -7.21 59.61 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.946 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 43.6 p -123.49 7.78 8.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.763 0.316 . . . . 0.0 111.434 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.73 -53.2 4.28 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.942 -0.647 . . . . 0.0 113.092 176.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.578 ' HA ' ' OE1' ' A' ' 56' ' ' GLU . 77.1 t -2.06 113.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 125.843 1.657 . . . . 0.0 115.392 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 58.9 p -100.45 -17.73 17.03 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.61 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.538 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 29.7 p90 -72.76 145.37 86.86 Favored Pre-proline 0 N--CA 1.462 0.145 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.322 176.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.98 134.25 45.39 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.887 2.391 . . . . 0.0 113.865 -174.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.525 HD13 ' HA3' ' A' ' 73' ' ' GLY . 4.1 mm? -99.5 149.85 22.8 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.453 175.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.654 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -130.87 158.88 22.8 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.589 -0.605 . . . . 0.0 111.589 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 98' ' ' LEU . 6.2 mp -99.52 139.56 35.0 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.647 0.261 . . . . 0.0 110.613 -177.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -125.73 75.33 70.54 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.174 173.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.527 ' HA ' ' HA ' ' A' ' 77' ' ' ASP . 61.4 Cg_endo -73.94 115.67 4.4 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.569 2.179 . . . . 0.0 112.335 -176.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 102.18 -0.66 50.82 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 56.92 36.8 28.25 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 115.189 -0.505 . . . . 0.0 111.468 -177.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -73.63 -48.05 35.41 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.389 -176.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.58 HD12 ' HB2' ' A' ' 16' ' ' PHE . 18.0 mm -67.41 -36.43 76.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.421 ' CD2' ' HA ' ' A' ' 111' ' ' ARG . 79.3 t80 -65.1 -41.14 95.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.085 174.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.638 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -66.16 -20.75 66.24 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.608 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.473 ' O ' ' HG2' ' A' ' 14' ' ' PRO . 53.0 mttp -74.14 -13.34 60.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.807 0.337 . . . . 0.0 111.164 177.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -115.73 -40.41 3.36 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.012 0.434 . . . . 0.0 111.145 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.638 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -149.74 168.17 24.4 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.584 -177.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 90.9 mt -68.36 130.92 44.32 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.487 ' HG3' ' H ' ' A' ' 111' ' ' ARG . 11.5 mtm180 -53.38 -47.11 69.75 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 122.2 1.0 . . . . 0.0 109.995 -177.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -82.48 10.46 7.19 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.767 -171.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.421 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . . . -98.68 -2.61 37.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.989 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 145.27 -167.15 27.47 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.57 177.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.52 HG23 ' H ' ' A' ' 116' ' ' THR . 2.0 tp -136.19 -67.87 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.591 ' HB ' HD23 ' A' ' 133' ' ' LEU . 24.3 m -67.07 109.67 3.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.761 0.315 . . . . 0.0 111.37 -174.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -151.7 141.77 22.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.928 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.584 ' HB2' ' OG1' ' A' ' 131' ' ' THR . 51.8 m-80 -111.18 121.63 45.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.165 0.507 . . . . 0.0 110.276 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 49.9 t -115.99 118.32 58.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.803 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.61 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 43.0 tp -106.84 127.09 53.11 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.577 0.227 . . . . 0.0 111.211 -177.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.492 HD13 HD13 ' A' ' 38' ' ' LEU . 2.5 mp -113.73 137.63 46.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.377 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.496 ' OD2' ' HB2' ' A' ' 126' ' ' LYS . 3.7 p30 -82.34 -179.42 7.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.871 0.367 . . . . 0.0 111.217 177.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.5 ' NH2' ' HA ' ' A' ' 150' ' ' LEU . 7.0 mpt_? -59.22 -32.51 70.02 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.017 -177.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -76.88 -22.59 53.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.151 0.5 . . . . 0.0 110.856 -173.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 111.64 6.8 24.74 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.175 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.496 ' HB2' ' OD2' ' A' ' 122' ' ' ASP . 9.1 mtmp? -93.95 149.85 20.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.818 0.342 . . . . 0.0 110.914 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.445 HG21 HD21 ' A' ' 130' ' ' LEU . 62.5 mt -84.4 130.5 35.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.273 177.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 18.1 m -121.89 4.04 6.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -177.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.722 ' HE2' ' HB3' ' A' ' 142' ' ' LEU . 53.3 tptt -160.58 128.72 4.57 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.314 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.445 HD21 HG21 ' A' ' 127' ' ' ILE . 90.0 mt -132.0 104.39 6.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.478 174.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.584 ' OG1' ' HB2' ' A' ' 118' ' ' ASN . 22.9 p -107.88 156.45 19.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.017 0.437 . . . . 0.0 111.638 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.948 HH12 ' HG3' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -104.72 118.94 37.82 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.262 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.591 HD23 ' HB ' ' A' ' 116' ' ' THR . 50.0 mt 65.49 -173.47 0.18 Allowed 'General case' 0 C--O 1.236 0.389 0 O-C-N 123.883 0.739 . . . . 0.0 109.831 -175.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.681 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 9.4 t80 -58.91 -44.89 91.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.017 173.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.515 ' HB3' ' HB2' ' A' ' 138' ' ' GLU . 0.2 OUTLIER 55.82 95.34 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.851 0.72 . . . . 0.0 110.684 174.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -40.97 -59.34 1.48 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.226 -172.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.551 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 0.7 OUTLIER -68.45 -47.06 68.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.568 -176.56 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.948 ' HG3' HH12 ' A' ' 132' ' ' ARG . 2.5 mm-40 -64.97 -34.54 78.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.092 -175.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.494 ' HE1' HG12 ' A' ' 55' ' ' ILE . 82.2 t80 -63.51 -44.21 94.97 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.812 175.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.497 ' O ' HG12 ' A' ' 143' ' ' VAL . . . -62.07 -42.39 99.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.382 0.61 . . . . 0.0 110.361 177.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.4 m -61.49 -46.0 91.84 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.318 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.722 ' HB3' ' HE2' ' A' ' 129' ' ' LYS . 4.3 pp -80.19 -28.91 38.6 Favored 'General case' 0 C--O 1.217 -0.65 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.262 -176.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 140' ' ' ALA . 12.6 p -60.57 -42.09 90.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.356 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -66.41 -45.59 79.42 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.416 174.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.605 ' O ' ' HG3' ' A' ' 149' ' ' MET . 44.3 tt0 -55.78 -53.4 57.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.731 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.657 HG13 ' O ' ' A' ' 142' ' ' LEU . 38.0 mt -57.41 -47.01 85.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.929 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.733 ' O ' ' HG3' ' A' ' 151' ' ' LYS . 95.4 m-20 -48.92 -58.81 4.26 Favored 'General case' 0 CA--C 1.517 -0.327 0 O-C-N 123.134 0.271 . . . . 0.0 110.883 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 151' ' ' LYS . 15.8 tp10 -68.18 -26.15 65.6 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 123.43 0.456 . . . . 0.0 111.233 -175.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.605 ' HG3' ' O ' ' A' ' 145' ' ' GLN . 51.1 mtp -57.86 -48.88 78.51 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.022 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.609 HD23 ' O ' ' A' ' 146' ' ' ILE . 0.8 OUTLIER -90.76 2.95 55.59 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.253 -0.979 . . . . 0.0 112.097 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.733 ' HG3' ' O ' ' A' ' 147' ' ' ASN . 3.6 mtpm? -76.1 -45.6 33.08 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 164.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.404 ' CG ' HH12 ' A' ' 123' ' ' ARG . 0.9 OUTLIER 45.14 -7.31 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 117.316 2.339 . . . . 0.0 117.316 175.496 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 151' ' ' LYS . . . 69.91 15.52 71.68 Favored Glycine 0 CA--C 1.522 0.49 0 CA-C-N 118.733 0.697 . . . . 0.0 113.975 173.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -108.98 -66.9 1.02 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.573 0.687 . . . . 0.0 109.92 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 51.04 74.62 0.23 Allowed 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.862 0.726 . . . . 0.0 111.402 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -132.1 103.77 6.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.258 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 33.2 m170 75.91 -40.63 0.41 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 172.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -75.39 -29.26 59.76 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.793 ' HD2' ' HB3' ' A' ' 67' ' ' ALA . 13.5 p80 . . . . . 0 C--O 1.247 0.962 0 CA-C-O 117.467 -1.254 . . . . 0.0 108.156 173.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.428 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.118 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.0 m 47.16 -141.35 0.47 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.345 0.258 . . . . 0.0 110.785 176.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.761 HD23 ' H ' ' A' ' 3' ' ' LEU . 2.3 pt? -97.44 43.74 1.06 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.387 0.613 . . . . 0.0 110.218 174.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.31 22.31 5.57 Favored Glycine 0 C--O 1.224 -0.469 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.093 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -108.81 118.44 36.78 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.814 0.34 . . . . 0.0 110.905 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.2 pt -89.38 -11.2 10.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.2 0.524 . . . . 0.0 109.749 175.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.8 p -94.2 162.97 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.297 177.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.593 ' HB2' ' HB2' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -128.65 151.17 49.81 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.32 -169.564 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.499 HG12 HD23 ' A' ' 130' ' ' LEU . 57.6 mt -75.24 132.91 32.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.165 177.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.69 5.01 90.23 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.615 -177.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.593 ' HB2' ' HB2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -115.02 161.48 18.28 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -176.211 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 85.3 mmm -68.15 133.47 48.96 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.093 0.473 . . . . 0.0 111.916 -173.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -81.73 134.58 50.27 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.585 173.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.542 ' HG2' ' O ' ' A' ' 107' ' ' LYS . 33.2 Cg_exo -62.2 121.09 8.96 Favored 'Trans proline' 0 N--CA 1.464 -0.225 0 C-N-CA 122.822 2.348 . . . . 0.0 111.759 175.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.46 ' OD1' HG22 ' A' ' 27' ' ' THR . 1.3 t70 -73.74 134.58 43.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.505 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.62 ' HB2' HD12 ' A' ' 104' ' ' ILE . 51.3 p90 -136.88 165.78 25.15 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.057 -173.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 58.5 m -119.74 115.48 23.98 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.439 172.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.7 tt -111.99 150.68 14.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.86 -174.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.2 m -98.77 125.11 44.03 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.263 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.542 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 85.8 mt -84.65 -177.81 6.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.791 -176.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.488 ' HB ' HD11 ' A' ' 84' ' ' LEU . 28.3 p -56.07 -40.51 73.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.837 -175.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.405 ' OD2' ' HG3' ' A' ' 24' ' ' LYS . 7.5 p-10 -98.75 12.07 36.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.915 0.388 . . . . 0.0 111.042 -177.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.8 3.03 60.98 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.388 -0.91 . . . . 0.0 113.617 176.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.479 ' HB2' HD12 ' A' ' 20' ' ' LEU . 60.7 mttp -64.83 124.89 23.17 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 117.357 0.578 . . . . 0.0 111.012 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -104.83 113.79 27.6 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 17' ' ' THR . 16.4 m -122.5 148.78 26.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.858 -176.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.46 HG22 ' OD1' ' A' ' 15' ' ' ASP . 4.9 m -106.65 148.08 28.77 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.438 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.502 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 0.6 OUTLIER -61.03 -32.94 72.53 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -177.515 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.526 ' HA ' ' CG ' ' A' ' 32' ' ' ARG . 60.9 m -54.56 -25.26 24.99 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.144 177.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.6 t -77.35 -11.07 59.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.942 0.401 . . . . 0.0 110.766 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.485 HD13 ' HB1' ' A' ' 70' ' ' ALA . 76.5 mt -119.56 0.44 11.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.381 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.526 ' CG ' ' HA ' ' A' ' 29' ' ' SER . 52.1 mmm-85 -68.24 131.57 45.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.877 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.7 -27.27 7.63 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -172.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.702 ' HB2' ' C ' ' A' ' 68' ' ' ASP . 12.9 ptpt -116.09 165.63 12.92 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 174.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 68' ' ' ASP . 4.0 p -80.7 123.41 37.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.197 0.522 . . . . 0.0 110.574 -177.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.432 HG22 ' HB3' ' A' ' 70' ' ' ALA . 23.5 t -110.95 123.87 67.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.372 -176.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.558 ' SD ' HG21 ' A' ' 59' ' ' ILE . 26.1 ttt -103.03 131.51 49.96 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.233 176.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.553 HD13 HD13 ' A' ' 121' ' ' ILE . 5.5 mp -126.03 148.3 49.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.477 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.5 148.54 42.81 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 169.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -112.81 113.15 25.11 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.054 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.4 t -129.41 -168.77 1.99 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.406 -174.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.521 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . . . -163.87 165.52 22.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.548 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.541 ' HB2' ' HB3' ' A' ' 82' ' ' LYS . 7.6 t -73.45 -25.04 60.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.177 0.513 . . . . 0.0 111.132 -172.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 68.2 p-90 -88.81 0.3 56.65 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 122.233 -0.292 . . . . 0.0 111.684 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 42' ' ' ALA . 73.7 m -78.99 99.63 6.94 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.183 0.516 . . . . 0.0 111.218 -178.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.49 -37.49 89.97 Favored Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.89 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.521 HG21 HD11 ' A' ' 133' ' ' LEU . 38.1 t -63.19 -32.48 56.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.057 0.456 . . . . 0.0 110.617 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.644 ' SG ' HG22 ' A' ' 116' ' ' THR . 84.8 m -70.37 -15.51 62.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.277 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.748 ' HE ' ' HE1' ' A' ' 86' ' ' PHE . 98.9 mtt180 -77.81 -6.75 55.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.246 0.546 . . . . 0.0 110.084 176.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.483 ' HE2' ' CE2' ' A' ' 134' ' ' TYR . 54.6 mtpt -100.64 -43.29 6.21 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 164.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.61 ' HB3' ' HA ' ' A' ' 48' ' ' CYS . 23.0 tt0 -52.43 -64.12 0.92 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.328 -1.305 . . . . 0.0 112.218 -177.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.434 ' HE2' ' CE2' ' A' ' 86' ' ' PHE . 39.7 mtm -65.25 -46.27 71.63 Favored Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -171.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.445 ' HG2' ' O ' ' A' ' 49' ' ' ARG . 72.4 Cg_exo -53.9 -38.37 85.95 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.709 1.606 . . . . 0.0 111.885 174.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.49 ' HB3' ' CZ ' ' A' ' 139' ' ' PHE . 4.9 m-85 -69.11 -42.79 75.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.781 176.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 51' ' ' GLU . 76.4 mt -57.12 -48.52 81.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.173 175.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.627 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 13.9 tp10 -55.78 -48.84 74.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.097 175.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -55.08 -57.08 13.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.775 -176.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.637 ' HA ' ' NZ ' ' A' ' 62' ' ' LYS . 44.8 m-20 -106.42 -43.14 4.84 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -170.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.558 HG21 ' SD ' ' A' ' 37' ' ' MET . 1.9 mp -75.62 -56.72 7.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.982 0.42 . . . . 0.0 110.801 -176.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.784 ' CE2' ' HG2' ' A' ' 64' ' ' LYS . 22.4 t-105 -72.02 -58.82 3.11 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.338 -173.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.627 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.8 OUTLIER -44.68 -43.66 8.52 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.674 0.79 . . . . 0.0 113.027 -173.621 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.637 ' NZ ' ' HA ' ' A' ' 58' ' ' ASP . 30.0 mmtm -84.2 -23.93 30.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.206 0.526 . . . . 0.0 111.484 -174.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 68.3 m-70 -125.53 24.76 7.17 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -166.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.784 ' HG2' ' CE2' ' A' ' 60' ' ' TRP . 28.7 mttt -53.81 93.93 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 123.079 1.418 . . . . 0.0 112.528 -177.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.636 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 13.4 t70 64.4 -42.96 0.29 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 110.538 -3.028 . . . . 0.0 110.508 -168.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.49 ' H ' ' C ' ' A' ' 64' ' ' LYS . 13.0 t30 66.31 -57.08 0.38 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.094 0.958 . . . . 0.0 111.001 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 167.18 -31.35 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 125.271 1.428 . . . . 0.0 107.355 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.702 ' C ' ' HB2' ' A' ' 34' ' ' LYS . 21.7 p-10 -147.91 32.92 0.84 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.185 -1.37 . . . . 0.0 111.292 -173.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.636 ' O ' ' HA ' ' A' ' 65' ' ' ASP . 88.1 t80 -127.29 133.26 50.17 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.977 0.418 . . . . 0.0 110.014 172.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.558 ' HB2' ' HD2' ' A' ' 34' ' ' LYS . . . -124.76 142.13 51.63 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.342 175.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.5 tt -135.46 117.74 15.6 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 68.1 mt -123.87 119.42 56.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.382 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.426 ' HA3' HD22 ' A' ' 96' ' ' LEU . . . -89.69 131.35 10.68 Favored Glycine 0 C--O 1.222 -0.598 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 174.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 48.5 mt -119.78 141.64 38.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 117.548 0.674 . . . . 0.0 111.017 -173.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.521 ' OD2' ' HA ' ' A' ' 42' ' ' ALA . 10.2 t0 -114.42 120.5 40.52 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 176.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.651 ' HG2' HD13 ' A' ' 115' ' ' ILE . 4.4 ptm180 -73.84 -2.84 25.38 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -165.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.586 ' HA ' ' HA ' ' A' ' 100' ' ' PRO . 0.4 OUTLIER -169.44 -32.26 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 118.448 -1.301 . . . . 0.0 113.713 -175.135 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.424 ' HB3' ' HG3' ' A' ' 82' ' ' LYS . 35.8 mt-10 -78.7 142.0 60.76 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 121.324 0.583 . . . . 0.0 111.658 -173.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.615 ' HG2' ' OE2' ' A' ' 81' ' ' GLU . 38.5 Cg_endo -71.2 -173.81 1.02 Allowed 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.185 2.59 . . . . 0.0 114.437 -174.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 89.1 mt -51.43 -57.43 9.0 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.756 -174.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.615 ' OE2' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -61.11 -28.57 69.19 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -172.326 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.612 ' HG2' ' OE2' ' A' ' 81' ' ' GLU . 44.0 mmtm -67.38 -52.75 36.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.794 0.33 . . . . 0.0 110.445 173.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 62.0 t -59.55 -51.1 76.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.241 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.488 HD11 ' HB ' ' A' ' 21' ' ' THR . 4.3 mm? -65.27 -36.5 84.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.488 -176.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.403 ' O ' ' HG2' ' A' ' 88' ' ' LYS . . . -75.5 -32.19 60.44 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 121.061 -0.256 . . . . 0.0 111.232 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.748 ' HE1' ' HE ' ' A' ' 49' ' ' ARG . 79.5 t80 -74.83 -41.27 60.22 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.492 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.42 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -59.53 -53.27 59.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.7 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 85' ' ' ALA . 19.7 pttm -55.92 -31.75 63.16 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.762 -174.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 68.5 m -87.13 2.19 50.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.386 -175.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 33.3 p -130.57 10.1 5.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.344 0.592 . . . . 0.0 110.342 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.5 -73.11 1.68 Allowed Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.507 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.4 t 29.85 90.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.808 1.243 . . . . 0.0 114.092 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 76.0 p -98.93 17.97 18.31 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.133 0.492 . . . . 0.0 110.726 175.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.611 ' HB3' ' CE2' ' A' ' 60' ' ' TRP . 31.1 p90 -114.52 147.66 38.56 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.885 175.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.4 135.89 60.38 Favored 'Trans proline' 0 C--O 1.239 0.537 0 C-N-CA 122.44 2.093 . . . . 0.0 113.453 -176.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.434 ' O ' HG23 ' A' ' 21' ' ' THR . 72.7 mt -111.6 144.99 39.96 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.491 175.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.542 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -122.52 150.55 16.91 Favored Glycine 0 N--CA 1.441 -1.025 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 176.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.669 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.7 pt? -117.11 132.11 56.74 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -177.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.489 ' OD1' ' HA ' ' A' ' 76' ' ' ARG . 5.0 p-10 -125.12 83.38 60.65 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-O 121.945 0.879 . . . . 0.0 110.635 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.586 ' HA ' ' HA ' ' A' ' 77' ' ' ASP . 18.5 Cg_endo -57.03 130.31 39.05 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.882 2.388 . . . . 0.0 112.545 -176.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.56 11.13 69.19 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.646 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 76' ' ' ARG . . . 53.03 51.73 15.2 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 122.891 0.476 . . . . 0.0 111.998 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.456 ' HB2' HH22 ' A' ' 111' ' ' ARG . 28.6 t70 -82.29 -53.86 5.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.953 0.406 . . . . 0.0 111.076 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.62 HD12 ' HB2' ' A' ' 16' ' ' PHE . 17.1 mm -68.36 -30.62 48.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.407 ' HB3' ' HB1' ' A' ' 102' ' ' ALA . 74.7 t80 -60.65 -37.92 83.14 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.627 170.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.893 ' HB2' ' HG2' ' A' ' 111' ' ' ARG . . . -72.68 -15.09 61.7 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.034 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.542 ' O ' ' HG2' ' A' ' 14' ' ' PRO . 14.1 mptt -69.3 -15.97 63.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.908 0.385 . . . . 0.0 110.798 173.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -126.0 -32.94 2.73 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.026 0.441 . . . . 0.0 111.524 -177.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.636 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -133.68 -172.78 3.06 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.276 -178.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.8 mt -85.06 153.18 22.88 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.893 ' HG2' ' HB2' ' A' ' 106' ' ' ALA . 20.2 mtp180 -71.48 -14.11 62.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.403 0.62 . . . . 0.0 110.344 -176.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -101.09 -1.89 32.92 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.907 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.28 155.38 40.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.227 0.536 . . . . 0.0 111.916 -174.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.8 155.22 42.05 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.131 -0.941 . . . . 0.0 113.662 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.651 HD13 ' HG2' ' A' ' 76' ' ' ARG . 3.3 tp -84.15 -175.25 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 123.211 0.604 . . . . 0.0 110.366 -176.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.644 HG22 ' SG ' ' A' ' 48' ' ' CYS . 77.0 p 61.52 79.5 0.25 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.461 1.104 . . . . 0.0 111.524 177.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' A' ' 117' ' ' ARG . 9.0 mtp180 -140.59 132.49 27.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.09 -177.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.647 ' HB3' ' HB ' ' A' ' 131' ' ' THR . 0.2 OUTLIER -107.73 126.18 52.3 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.595 ' N ' HD22 ' A' ' 118' ' ' ASN . 16.7 t -122.88 138.4 53.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.157 -178.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 46.3 tp -126.49 122.82 36.28 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.911 -0.315 . . . . 0.0 110.5 177.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.553 HD13 HD13 ' A' ' 38' ' ' LEU . 1.9 mp -106.34 134.59 47.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.152 177.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.68 174.79 10.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.963 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.469 ' HD2' ' OE1' ' A' ' 152' ' ' GLU . 5.8 ptm180 -72.23 -15.59 61.93 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -172.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -80.33 -28.3 38.16 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.25 0.547 . . . . 0.0 109.863 175.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 116.85 10.36 10.12 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.316 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -100.44 153.17 19.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.097 0.475 . . . . 0.0 111.744 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.508 HG21 HD21 ' A' ' 130' ' ' LEU . 4.4 mm -76.53 133.24 31.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.294 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 28.0 m -126.07 3.07 4.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.577 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 53.1 tptt -166.57 127.35 1.67 Allowed 'General case' 0 C--O 1.232 0.16 0 C-N-CA 120.481 -0.488 . . . . 0.0 112.027 -177.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.508 HD21 HG21 ' A' ' 127' ' ' ILE . 3.1 mm? -126.99 115.51 19.35 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.471 172.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.647 ' HB ' ' HB3' ' A' ' 118' ' ' ASN . 95.2 m -123.85 134.99 53.48 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.538 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -106.5 122.37 46.16 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.521 HD11 HG21 ' A' ' 47' ' ' VAL . 10.6 tp 71.78 156.22 0.16 Allowed 'General case' 0 C--O 1.232 0.155 0 O-C-N 124.191 0.932 . . . . 0.0 110.388 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.516 ' CE2' ' HG2' ' A' ' 136' ' ' GLU . 51.1 t80 -72.52 89.04 1.26 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.362 0.601 . . . . 0.0 109.935 174.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.557 ' HB3' ' HB3' ' A' ' 138' ' ' GLU . 41.4 t30 -85.52 116.42 23.81 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 171.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.516 ' HG2' ' CE2' ' A' ' 134' ' ' TYR . 33.8 mt-10 -58.3 -52.75 64.26 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.28 -168.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -59.75 -39.59 85.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.204 0.526 . . . . 0.0 111.317 176.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.557 ' HB3' ' HB3' ' A' ' 135' ' ' ASN . 5.3 tp10 -61.99 -46.69 88.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.117 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.614 ' O ' HG23 ' A' ' 143' ' ' VAL . 82.1 t80 -59.72 -42.44 93.09 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.699 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.26 -46.44 85.99 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.121 0.486 . . . . 0.0 110.553 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.2 m -62.13 -38.81 90.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.505 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.02 -37.88 89.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.492 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 139' ' ' PHE . 97.2 t -55.39 -57.11 8.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.314 175.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -61.48 -38.23 86.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.797 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -57.43 -48.66 78.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.98 177.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.576 ' O ' HD23 ' A' ' 150' ' ' LEU . 59.6 mt -67.87 -38.95 80.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.955 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -55.42 -39.94 70.85 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.826 -0.17 . . . . 0.0 111.302 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.438 ' OE1' ' HB2' ' A' ' 151' ' ' LYS . 9.6 tp10 -73.39 -35.42 65.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.762 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 82.1 mmm -62.83 -25.79 68.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.351 0.596 . . . . 0.0 110.119 178.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.628 HD11 ' HB2' ' A' ' 69' ' ' PHE . 4.0 mm? -90.86 2.08 56.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.229 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.439 ' HD3' ' HA ' ' A' ' 151' ' ' LYS . 12.9 mmtm -103.5 -66.45 0.94 Allowed 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 173.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.469 ' OE1' ' HD2' ' A' ' 123' ' ' ARG . 31.3 tt0 51.9 -83.06 0.01 OUTLIER 'General case' 0 C--O 1.237 0.435 0 O-C-N 124.632 1.207 . . . . 0.0 113.181 175.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 86.94 -54.97 4.62 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -173.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.481 ' HB2' ' O ' ' A' ' 157' ' ' HIS . 60.2 m80 -149.23 121.36 8.31 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 172.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 12.4 t60 -66.17 -0.6 2.59 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 123.325 0.391 . . . . 0.0 112.049 -173.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -137.89 21.94 2.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.608 0.242 . . . . 0.0 110.809 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.481 ' O ' ' HB2' ' A' ' 154' ' ' HIS . 5.4 t60 -168.81 98.12 0.38 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.812 0.339 . . . . 0.0 110.137 177.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -128.4 147.79 50.67 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.243 0.724 0 CA-C-O 118.659 -0.686 . . . . 0.0 109.602 177.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 120.679 0.276 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.4 p -91.29 173.68 7.79 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.738 0.304 . . . . 0.0 110.692 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.5 tt -80.69 88.84 5.74 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.4 ' HA3' HD12 ' A' ' 110' ' ' LEU . . . -103.61 69.65 0.29 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.613 -177.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -97.44 126.68 42.84 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 176.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.7 pt -94.9 -27.57 4.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.946 0.403 . . . . 0.0 110.431 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.636 HG11 HD12 ' A' ' 127' ' ' ILE . 15.0 t -94.3 155.07 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 174.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 8' ' ' ARG . 16.3 mtt180 -125.47 165.41 18.49 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.838 -0.165 . . . . 0.0 110.594 -169.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.666 HG12 HD13 ' A' ' 130' ' ' LEU . 77.0 mt -67.81 118.43 11.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.854 0.359 . . . . 0.0 110.196 175.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.98 -7.58 62.75 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.893 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -86.37 153.24 22.07 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 -177.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.666 ' SD ' ' HG2' ' A' ' 126' ' ' LYS . 91.2 mmm -67.49 130.07 41.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.675 -178.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.41 ' HB2' HG13 ' A' ' 127' ' ' ILE . . . -79.3 129.93 70.59 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.664 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.408 ' HD2' ' CE1' ' A' ' 108' ' ' TYR . 31.4 Cg_exo -59.16 143.45 99.76 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.703 2.269 . . . . 0.0 111.329 174.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.96 162.55 14.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.243 -177.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.613 ' O ' ' HA ' ' A' ' 27' ' ' THR . 55.3 p90 -169.73 164.28 9.99 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.389 -173.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.9 m -123.0 100.7 7.02 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 176.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.2 tt -103.26 146.65 10.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.821 0.343 . . . . 0.0 111.159 -174.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.9 m -94.27 118.38 31.5 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.586 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.458 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 93.7 mt -81.52 169.7 16.79 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.696 -177.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 31.4 p -57.34 -26.58 61.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.219 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -83.31 -7.79 59.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.203 0.525 . . . . 0.0 110.432 -178.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.52 15.4 56.98 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.23 -175.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -90.67 116.69 28.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.384 -0.408 . . . . 0.0 110.47 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -89.62 113.11 24.52 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 174.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.81 128.59 71.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.572 0.701 . . . . 0.0 111.582 -174.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.613 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 17.9 m -94.2 137.97 32.76 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.518 175.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.579 HD22 ' HD3' ' A' ' 32' ' ' ARG . 0.6 OUTLIER -60.59 -33.27 72.48 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -177.075 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.459 ' HA ' ' CG ' ' A' ' 32' ' ' ARG . 37.6 t -56.88 -23.08 41.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.824 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.9 t -81.78 -8.81 59.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.972 0.415 . . . . 0.0 110.548 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 67.4 mt -119.57 -1.16 10.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.539 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.579 ' HD3' HD22 ' A' ' 28' ' ' LEU . 8.7 mmm-85 -66.79 103.09 1.04 Allowed 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.516 ' O ' ' HG3' ' A' ' 123' ' ' ARG . . . 139.42 -20.59 2.96 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 -172.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.574 ' HD2' ' HA ' ' A' ' 68' ' ' ASP . 37.1 mtmt -114.48 168.2 10.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.415 -0.393 . . . . 0.0 109.945 175.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.484 HG11 ' HB3' ' A' ' 149' ' ' MET . 34.2 m -80.1 122.52 35.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 174.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.5 t -122.93 113.93 40.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.108 0.48 . . . . 0.0 111.081 -174.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.541 ' SD ' HG21 ' A' ' 59' ' ' ILE . 26.9 ttt -97.19 126.55 42.45 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.447 177.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.516 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 7.3 mp -118.92 152.89 35.5 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.03 176.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.473 HE21 ' HA3' ' A' ' 73' ' ' GLY . 5.1 pp0? -139.29 145.93 39.73 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 169.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 89.3 m-85 -110.35 123.29 49.58 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 177.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.8 t -134.72 173.49 11.63 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.123 -174.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.506 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . . . -149.93 160.02 43.92 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.476 -0.784 . . . . 0.0 108.933 175.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.588 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 28.8 t -70.74 -20.87 62.6 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -171.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 58.8 p-90 -97.11 3.12 51.83 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.855 0.316 . . . . 0.0 111.855 -177.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.506 ' SG ' ' HB3' ' A' ' 42' ' ' ALA . 84.0 m -87.86 108.18 19.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.155 0.502 . . . . 0.0 111.293 -178.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -79.01 -17.85 76.1 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.39 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.606 HG11 ' HB2' ' A' ' 133' ' ' LEU . 40.6 t -74.83 -45.97 42.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 177.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.453 ' SG ' HG23 ' A' ' 116' ' ' THR . 73.7 m -54.75 -32.59 60.08 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.819 177.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.528 ' HE ' ' HE1' ' A' ' 86' ' ' PHE . 98.0 mtt180 -65.5 -2.66 3.52 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.264 -0.426 . . . . 0.0 112.029 -178.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -96.81 -55.85 2.76 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.783 0.801 . . . . 0.0 109.734 173.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.657 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 5.1 pt-20 -71.45 -32.47 68.36 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.93 -175.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 63.9 mmm -52.09 -57.32 15.55 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 117.817 0.281 . . . . 0.0 111.605 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.409 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 24.7 Cg_endo -64.27 -37.18 42.01 Favored 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 121.75 1.633 . . . . 0.0 112.447 175.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -62.31 -44.15 97.18 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.536 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.568 ' O ' ' HB ' ' A' ' 59' ' ' ILE . 94.0 mt -57.95 -53.53 44.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.675 178.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.587 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 14.9 pt-20 -64.95 -38.11 89.87 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.874 -176.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -63.06 -54.39 38.82 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -174.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -107.22 -18.12 13.97 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -172.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.568 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 2.2 mp -95.21 -55.3 6.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.971 176.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.587 ' HB3' ' HA ' ' A' ' 56' ' ' GLU . 75.0 t-105 -65.48 -70.69 0.22 Allowed 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.418 -177.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.433 ' HA ' HD13 ' A' ' 61' ' ' LEU . 1.6 mm? -54.05 -23.29 13.11 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -173.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -91.6 -37.4 13.1 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -177.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -118.9 -10.96 9.79 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -169.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.51 ' HG3' ' OD1' ' A' ' 65' ' ' ASP . 19.2 pttp -36.21 -54.13 0.81 Allowed 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -168.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.51 ' OD1' ' HG3' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -87.45 -77.99 0.32 Allowed 'General case' 0 C--O 1.254 1.311 0 CA-C-O 121.299 0.571 . . . . 0.0 109.583 -178.432 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.407 ' O ' ' HB2' ' A' ' 67' ' ' ALA . 22.4 t-20 63.36 -74.83 0.04 OUTLIER 'General case' 0 C--N 1.34 0.153 0 CA-C-N 114.471 -1.24 . . . . 0.0 110.374 -174.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 66' ' ' ASN . . . 159.26 -40.43 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -177.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.574 ' HA ' ' HD2' ' A' ' 34' ' ' LYS . 30.9 t70 -114.66 11.1 16.84 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 113.904 -1.498 . . . . 0.0 111.258 -175.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -106.36 142.9 35.26 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 119.058 -1.057 . . . . 0.0 111.128 -177.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.69 143.56 33.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.377 173.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.533 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 2.8 tt -142.53 118.67 10.73 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 3.0 mp -131.1 126.99 60.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.324 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.473 ' HA3' HE21 ' A' ' 39' ' ' GLN . . . -97.85 140.74 15.21 Favored Glycine 0 C--O 1.224 -0.529 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.353 176.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 62.0 mt -120.28 123.62 70.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 117.304 0.552 . . . . 0.0 111.396 -177.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 78' ' ' GLU . 2.5 m-20 -88.1 122.02 31.19 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 172.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 59.7 ttp180 -50.61 -46.41 58.07 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -167.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 99' ' ' ASP . 7.8 p-10 -152.64 13.1 0.54 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.04 0.448 . . . . 0.0 111.134 -174.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 33.1 mm-40 -80.68 130.05 65.88 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.478 -177.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.459 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 36.7 Cg_endo -71.73 179.81 4.42 Favored 'Trans proline' 0 CA--C 1.531 0.341 0 C-N-CA 122.408 2.072 . . . . 0.0 112.687 174.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -50.69 -57.98 6.99 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.096 -171.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.462 ' OE1' ' HG2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -67.42 -30.79 70.64 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -172.427 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.462 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 41.7 mmtm -63.86 -52.66 58.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.753 0.311 . . . . 0.0 110.397 175.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 79' ' ' PRO . 88.0 t -54.21 -52.75 35.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.244 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.37 -38.83 92.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.35 -177.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.29 -42.13 79.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.673 0.273 . . . . 0.0 111.081 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.588 ' CD1' ' HA ' ' A' ' 43' ' ' SER . 86.8 t80 -64.83 -43.9 91.56 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 178.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.447 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -58.54 -54.31 48.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.189 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -65.65 -20.71 66.4 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -174.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.5 m -78.74 -24.3 44.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.741 0.305 . . . . 0.0 111.288 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.5 p -104.8 -22.11 13.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.083 0.468 . . . . 0.0 110.98 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 121.1 -79.32 0.33 Allowed Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -177.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.1 t 46.45 86.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 124.463 1.105 . . . . 0.0 113.265 177.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.8 m -82.09 2.5 30.97 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.039 177.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.506 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 46.7 p90 -113.32 152.7 45.41 Favored Pre-proline 0 C--N 1.331 -0.235 0 O-C-N 122.203 -0.311 . . . . 0.0 110.759 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.13 133.81 29.82 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.484 2.123 . . . . 0.0 113.437 -176.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.447 HD12 ' HB2' ' A' ' 87' ' ' ALA . 94.1 mt -104.48 161.62 13.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.081 172.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -130.12 148.3 18.48 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.168 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.417 ' N ' HD12 ' A' ' 98' ' ' LEU . 5.4 mp -86.74 133.55 33.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.544 0.211 . . . . 0.0 110.54 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.471 ' O ' ' HA ' ' A' ' 77' ' ' ASP . 40.2 t0 -121.05 73.86 26.67 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-O 121.317 0.579 . . . . 0.0 109.86 169.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.412 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 22.1 Cg_exo -64.1 103.53 0.43 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.079 1.853 . . . . 0.0 112.237 -177.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 112.0 -0.18 27.05 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.483 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.477 ' HB1' ' HG2' ' A' ' 111' ' ' ARG . . . 59.02 40.64 22.01 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.092 0.472 . . . . 0.0 111.155 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -78.82 -48.76 14.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.557 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.452 HD12 ' HB2' ' A' ' 16' ' ' PHE . 34.4 mm -66.75 -37.39 79.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -59.51 -44.68 93.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.874 175.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.587 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -67.58 -21.23 65.44 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.813 -178.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -72.96 -17.69 61.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.798 0.332 . . . . 0.0 110.921 177.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.547 ' HB2' HH22 ' A' ' 117' ' ' ARG . 79.3 m-85 -111.88 -34.26 6.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.863 -178.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.587 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -161.13 172.93 15.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.768 0.318 . . . . 0.0 110.731 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.664 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 91.4 mt -71.97 131.38 42.86 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.091 178.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.477 ' HG2' ' HB1' ' A' ' 102' ' ' ALA . 11.4 mtm180 -65.4 -31.3 72.33 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.268 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -84.38 -7.36 59.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.748 -178.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.664 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . . . -75.4 -56.77 4.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.718 -178.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -163.07 -149.12 5.6 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.96 -177.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.456 HG23 ' H ' ' A' ' 116' ' ' THR . 2.8 tp -161.35 -59.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.373 0.087 . . . . 0.0 111.125 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.648 HG22 ' HA ' ' A' ' 133' ' ' LEU . 24.0 m -67.61 109.08 3.12 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.861 0.362 . . . . 0.0 111.414 -176.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.547 HH22 ' HB2' ' A' ' 108' ' ' TYR . 19.3 ptt180 -165.97 146.44 6.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.166 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.605 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 45.9 m-80 -108.95 136.53 48.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.725 175.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.4 HG21 ' HE1' ' A' ' 40' ' ' PHE . 80.6 t -120.35 102.76 13.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.101 -177.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.623 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 48.8 tp -88.75 108.14 19.33 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.707 -0.397 . . . . 0.0 109.996 178.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.403 HD13 HD11 ' A' ' 28' ' ' LEU . 56.6 mt -93.74 121.98 44.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.771 0.796 . . . . 0.0 110.523 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.69 162.66 29.2 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.485 -1.234 . . . . 0.0 111.341 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.516 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 33.8 ttm180 -52.0 -34.21 41.73 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.483 0.713 . . . . 0.0 112.742 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.539 ' HB2' ' CE1' ' A' ' 156' ' ' HIS . 11.8 tt0 -83.57 -7.59 59.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.33 0.586 . . . . 0.0 109.969 -175.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 96.54 31.36 7.15 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.468 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.666 ' HG2' ' SD ' ' A' ' 12' ' ' MET . 44.2 mttm -113.04 146.49 39.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.798 0.299 . . . . 0.0 110.314 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.636 HD12 HG11 ' A' ' 7' ' ' VAL . 55.7 mt -88.94 100.98 11.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.093 177.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 29.0 m -94.17 -4.54 10.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -174.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.623 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 51.8 tptt -143.95 108.76 4.92 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.687 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.666 HD13 HG12 ' A' ' 9' ' ' ILE . 10.9 mp -98.28 104.7 16.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.962 170.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.605 ' HB ' ' HB2' ' A' ' 118' ' ' ASN . 86.0 m -103.23 125.33 49.84 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.724 -0.217 . . . . 0.0 110.703 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.57 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -96.85 108.19 20.82 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 176.788 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.648 ' HA ' HG22 ' A' ' 116' ' ' THR . 4.6 pp 51.4 -177.65 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 O-C-N 124.503 1.127 . . . . 0.0 113.259 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.657 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 75.6 t80 -87.57 117.68 26.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.912 -177.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -135.89 137.69 41.67 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.949 172.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -47.79 -62.56 1.4 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -177.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.428 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.5 mp0 -56.99 -46.75 82.01 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.316 0.579 . . . . 0.0 110.849 -178.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.487 ' HG3' HG23 ' A' ' 131' ' ' THR . 7.0 tp10 -61.72 -48.59 80.06 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.187 -177.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.469 ' O ' HG23 ' A' ' 143' ' ' VAL . 69.2 t80 -67.38 -39.16 85.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.048 -178.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.79 -43.52 97.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.662 175.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 45.8 m -63.04 -38.1 89.82 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.547 177.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.548 ' O ' HG13 ' A' ' 146' ' ' ILE . 67.7 tp -59.75 -51.61 69.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.154 177.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.493 HG22 HD11 ' A' ' 59' ' ' ILE . 61.3 t -60.19 -45.81 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.222 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -57.72 -45.05 86.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.722 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.556 ' O ' ' HG2' ' A' ' 149' ' ' MET . 9.9 tt0 -67.01 -37.34 83.98 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.391 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.548 HG13 ' O ' ' A' ' 142' ' ' LEU . 34.7 mt -59.61 -38.16 74.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.895 0.378 . . . . 0.0 109.999 175.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.579 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 87.9 m-20 -59.63 -41.03 89.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.803 177.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -66.05 -36.98 84.7 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.328 0.392 . . . . 0.0 110.856 174.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.556 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 94.7 mmm -62.93 -32.1 73.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.525 0.679 . . . . 0.0 109.429 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.545 HD23 ' O ' ' A' ' 146' ' ' ILE . 3.9 mm? -82.17 -5.83 58.76 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.746 176.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.608 ' HA ' ' HE3' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -102.22 -17.69 15.84 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 173.834 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.519 ' HA ' ' OE1' ' A' ' 152' ' ' GLU . 10.6 tp10 -51.13 108.53 0.25 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-O 122.832 1.301 . . . . 0.0 113.638 -171.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -163.69 29.94 0.25 Allowed Glycine 0 N--CA 1.437 -1.266 0 CA-C-N 112.369 -2.196 . . . . 0.0 107.709 170.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -158.85 -26.09 0.07 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 114.47 -0.865 . . . . 0.0 111.86 -168.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -83.38 -35.23 25.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.16 -169.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.539 ' CE1' ' HB2' ' A' ' 124' ' ' GLU . 19.2 m-70 -80.12 79.65 6.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.363 0.602 . . . . 0.0 111.49 178.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -99.35 99.98 10.99 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.753 175.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 59.9 m170 -75.22 -13.02 60.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.162 0.506 . . . . 0.0 109.991 177.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 . . . . . 0 C--O 1.244 0.804 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.002 176.928 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.7 ttp . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.635 0.255 . . . . 0.0 110.342 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.5 m -115.8 132.1 56.74 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.092 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 71.0 mt -141.31 162.02 36.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.221 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -100.22 88.37 0.77 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.835 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.52 ' CZ ' ' HD2' ' A' ' 117' ' ' ARG . 69.0 m-85 -147.01 135.42 21.83 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 175.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 39.2 pt -110.23 -7.79 11.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.168 0.509 . . . . 0.0 110.144 171.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.5 m -101.47 168.8 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.733 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.603 ' HB2' ' HB2' ' A' ' 11' ' ' GLU . 38.4 mtt180 -114.83 163.25 15.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.197 -177.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.781 HG12 HD13 ' A' ' 130' ' ' LEU . 73.3 mt -79.5 121.23 32.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 174.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.48 1.34 62.31 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -175.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 8' ' ' ARG . 10.4 tp10 -83.42 155.83 23.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.36 -0.42 . . . . 0.0 110.551 -176.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.518 ' HE2' ' HA ' ' A' ' 12' ' ' MET . 4.9 mmt -65.76 127.74 33.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.452 177.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.436 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -67.48 129.94 93.45 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.663 178.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.454 ' HD2' ' CZ ' ' A' ' 108' ' ' TYR . 15.3 Cg_exo -65.98 113.54 2.63 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.668 2.245 . . . . 0.0 111.2 178.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.68 147.19 50.92 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.604 -175.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.401 ' O ' ' HA ' ' A' ' 27' ' ' THR . 44.7 p90 -155.7 164.33 38.73 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.376 -176.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.8 m -116.68 102.8 9.76 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 174.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.49 ' O ' ' HA ' ' A' ' 25' ' ' GLN . 13.1 tt -97.87 138.72 21.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.937 0.399 . . . . 0.0 111.023 -174.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.2 m -94.15 118.91 32.23 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.071 177.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.486 HD12 ' HB2' ' A' ' 24' ' ' LYS . 94.3 mt -74.54 175.99 7.28 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.944 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 96' ' ' LEU . 31.8 p -57.88 -32.2 67.48 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.623 -175.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -102.13 16.97 24.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.956 0.408 . . . . 0.0 111.123 -176.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.43 7.36 69.55 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.404 173.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.486 ' HB2' HD12 ' A' ' 20' ' ' LEU . 27.3 mmtp -78.76 110.01 13.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.882 0.373 . . . . 0.0 110.72 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.49 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 94.1 mt-30 -92.0 114.48 27.03 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.481 178.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.5 m -118.03 151.5 20.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.477 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.418 ' HB ' ' OG ' ' A' ' 29' ' ' SER . 1.2 p -101.91 154.2 19.16 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.879 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.8 -34.77 77.43 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 174.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.532 ' HA ' ' HG2' ' A' ' 32' ' ' ARG . 0.5 OUTLIER -59.69 -23.7 63.34 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.676 175.516 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.8 t -78.73 -12.36 60.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.041 0.448 . . . . 0.0 110.408 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 83.0 mt -112.73 -0.82 14.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.931 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.533 ' NE ' ' HA3' ' A' ' 125' ' ' GLY . 40.5 mmm-85 -66.19 102.41 0.83 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.079 0.466 . . . . 0.0 109.76 178.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 143.64 -23.47 2.16 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -174.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.412 ' HA ' ' OD1' ' A' ' 68' ' ' ASP . 43.9 mtmt -117.08 160.07 21.57 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 174.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.534 HG22 ' O ' ' A' ' 68' ' ' ASP . 10.6 m -70.45 128.38 33.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 175.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.595 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 40.6 t -111.69 114.73 47.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 120.832 0.349 . . . . 0.0 111.153 -174.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.496 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 27.0 ttt -97.15 120.6 37.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.004 0.43 . . . . 0.0 110.067 174.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.498 ' HB2' ' HB ' ' A' ' 119' ' ' VAL . 88.3 mt -112.38 123.43 50.26 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.678 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -113.11 111.05 21.45 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.13 177.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.502 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 96.8 m-85 -88.64 115.82 26.44 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.7 t -132.7 -172.85 3.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.172 -171.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.559 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . . . -172.16 143.23 1.48 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.776 ' H ' ' HG3' ' A' ' 78' ' ' GLU . 54.7 p -70.72 -15.68 62.72 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.776 -172.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.408 ' HD1' ' OE2' ' A' ' 78' ' ' GLU . 66.6 p-90 -87.28 -0.65 57.06 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.097 0.475 . . . . 0.0 110.915 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.588 ' SG ' HG12 ' A' ' 115' ' ' ILE . 74.5 m -93.12 112.57 24.55 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.996 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -75.95 -34.29 48.09 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.63 178.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 56.2 t -61.42 -45.02 99.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.677 0.238 . . . . 0.0 110.833 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.696 ' HA ' ' CD ' ' A' ' 51' ' ' GLU . 12.5 t -61.85 -15.78 44.9 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 121.421 0.629 . . . . 0.0 111.456 -174.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -72.52 -1.91 17.7 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.862 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.481 ' HE2' ' CD2' ' A' ' 134' ' ' TYR . 56.4 mtpt -90.16 -56.87 3.05 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.214 172.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.773 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 3.8 pm0 -64.34 -30.95 71.98 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.565 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.64 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 5.9 mmt -52.29 -63.61 2.08 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.629 178.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.64 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 52.6 Cg_exo -56.63 -39.47 91.15 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 122.171 1.914 . . . . 0.0 112.912 175.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.407 ' HD1' ' O ' ' A' ' 50' ' ' LYS . 21.3 m-85 -66.99 -45.69 76.85 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 93.9 mt -61.93 -42.77 96.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.78 0.324 . . . . 0.0 110.146 177.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.489 ' OE1' ' HA ' ' A' ' 92' ' ' VAL . 26.0 tp10 -57.11 -52.36 65.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.602 178.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.519 ' HA ' HD22 ' A' ' 61' ' ' LEU . 27.6 ttpp -72.66 -54.06 10.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.522 -175.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -87.13 -26.74 23.47 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -168.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.7 mt -105.64 -61.72 2.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.817 -177.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.575 ' CD2' ' HB3' ' A' ' 94' ' ' TYR . 76.7 t-105 -61.22 -64.46 0.94 Allowed 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.499 -173.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.519 HD22 ' HA ' ' A' ' 57' ' ' LYS . 1.5 mp -47.78 -32.5 6.05 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -175.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -71.51 -38.3 71.15 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -176.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.658 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 87.2 m-70 -126.18 -43.78 1.78 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.897 -174.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.7 mttp 59.01 -82.22 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.655 0.782 . . . . 0.0 111.014 -175.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -110.8 -42.32 4.05 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 171.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.658 ' HB2' ' HB3' ' A' ' 63' ' ' HIS . 3.5 t30 71.03 -68.18 0.23 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.011 175.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 66' ' ' ASN . . . 162.93 -27.02 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 124.327 1.051 . . . . 0.0 108.759 -175.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.534 ' O ' HG22 ' A' ' 35' ' ' VAL . 25.5 t0 -140.74 26.74 2.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.614 -174.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.544 ' HB2' HD11 ' A' ' 150' ' ' LEU . 87.8 t80 -135.17 144.41 47.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.824 -177.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.67 138.02 28.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.963 173.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.496 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 1.8 tt -138.51 115.37 10.78 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -178.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.4 mp -126.79 130.69 71.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.141 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.429 ' HA3' HD22 ' A' ' 96' ' ' LEU . . . -92.69 117.22 5.3 Favored Glycine 0 C--O 1.221 -0.681 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.531 177.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 41.7 mt -104.44 118.62 52.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.938 0.369 . . . . 0.0 110.556 -175.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.559 ' OD2' ' HA ' ' A' ' 42' ' ' ALA . 9.7 t70 -84.52 142.55 29.95 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 176.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.441 ' HG2' ' HB2' ' A' ' 102' ' ' ALA . 18.1 ttp180 -80.03 -40.83 26.97 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -172.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -155.16 5.88 0.23 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -168.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.776 ' HG3' ' H ' ' A' ' 43' ' ' SER . 13.4 mm-40 -88.52 133.33 36.53 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 120.908 0.385 . . . . 0.0 110.373 177.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.454 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 29.3 Cg_endo -68.17 -173.11 0.48 Allowed 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 122.875 2.383 . . . . 0.0 113.63 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.42 ' O ' HD23 ' A' ' 84' ' ' LEU . 3.1 tm? -59.07 -55.82 30.15 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.084 -169.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.454 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -66.01 -34.13 77.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.497 0.189 . . . . 0.0 111.501 -173.832 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.433 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 2.7 mmmp? -60.24 -50.1 74.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.019 177.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 66.1 t -62.55 -44.85 99.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.921 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.42 HD23 ' O ' ' A' ' 80' ' ' LEU . 4.2 mm? -61.03 -47.37 86.75 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.831 0.348 . . . . 0.0 111.579 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.96 -30.93 68.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.232 -178.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -73.2 -47.75 40.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.553 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.59 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -52.34 -55.16 23.39 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.142 -177.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.82 -11.29 60.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.658 -174.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.6 m -94.81 -22.08 18.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.011 178.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.7 p -91.49 -4.51 55.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.594 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.66 0.91 90.42 Favored Glycine 0 C--O 1.228 -0.229 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.356 178.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.489 ' HA ' ' OE1' ' A' ' 56' ' ' GLU . 72.5 t -66.7 123.08 18.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 C-N-CA 122.798 0.439 . . . . 0.0 111.386 -179.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.3 p -101.63 -18.83 15.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.652 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.575 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 52.7 p90 -77.52 141.76 65.79 Favored Pre-proline 0 N--CA 1.454 -0.26 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.513 177.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.404 ' HB2' HD22 ' A' ' 20' ' ' LEU . 18.5 Cg_endo -60.06 131.88 41.53 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 122.688 2.259 . . . . 0.0 113.409 -175.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.59 HD12 ' HB2' ' A' ' 87' ' ' ALA . 66.5 mt -102.39 147.49 26.64 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.002 173.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.462 ' HA3' HD11 ' A' ' 18' ' ' ILE . . . -122.3 143.84 15.76 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 177.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.787 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.0 OUTLIER -98.15 132.34 43.76 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.788 0.328 . . . . 0.0 110.551 -177.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.418 ' HB3' ' O ' ' A' ' 75' ' ' ASP . 14.2 t0 -115.23 74.79 4.07 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.521 176.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.473 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 23.5 Cg_exo -63.17 104.7 0.42 Allowed 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.573 2.182 . . . . 0.0 112.364 -176.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 115.36 -4.54 21.72 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.772 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.441 ' HB2' ' HG2' ' A' ' 76' ' ' ARG . . . 57.52 47.42 16.2 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 122.731 0.412 . . . . 0.0 111.476 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.435 ' HA ' HH21 ' A' ' 111' ' ' ARG . 15.0 t70 -80.59 -50.62 9.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.98 0.419 . . . . 0.0 110.173 178.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 96.9 mt -61.93 -40.09 85.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 176.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -62.5 -40.39 96.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.541 176.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -67.4 -23.65 65.59 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.223 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -73.25 -13.5 61.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.257 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.454 ' CZ ' ' HD2' ' A' ' 14' ' ' PRO . 45.3 m-85 -113.49 -34.38 5.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.832 0.349 . . . . 0.0 111.563 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -158.92 168.28 27.2 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.899 0.38 . . . . 0.0 111.209 -177.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.445 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 90.1 mt -67.29 138.63 56.98 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 175.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.435 HH21 ' HA ' ' A' ' 103' ' ' ASP . 94.5 mtt180 -63.16 -27.04 69.1 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.577 -174.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -92.82 -16.75 24.95 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.315 -178.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.445 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . . . -80.85 47.92 1.03 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -172.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.58 143.14 9.74 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.328 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.588 HG12 ' SG ' ' A' ' 45' ' ' CYS . 1.8 tp -87.41 -64.07 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -176.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.42 ' H ' HG23 ' A' ' 115' ' ' ILE . 6.5 m -64.78 128.03 34.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.857 0.361 . . . . 0.0 111.315 -173.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.52 ' HD2' ' CZ ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -145.43 132.13 19.97 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.432 178.28 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.705 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 3.8 m-20 -107.91 117.66 34.7 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 176.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.498 ' HB ' ' HB2' ' A' ' 38' ' ' LEU . 73.2 t -120.57 118.97 58.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.426 -177.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.898 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 25.4 tp -109.77 120.13 41.53 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.261 0.553 . . . . 0.0 110.486 176.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.595 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 74.2 mt -104.23 142.02 18.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.948 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.86 172.25 13.75 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.581 ' NH2' ' HG3' ' A' ' 152' ' ' GLU . 26.8 ptt180 -78.01 20.96 0.34 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -175.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.443 ' OE1' ' HE3' ' A' ' 12' ' ' MET . 1.7 tm-20 -110.88 -35.72 5.88 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 169.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.533 ' HA3' ' NE ' ' A' ' 32' ' ' ARG . . . 122.51 20.54 2.9 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.667 -172.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 29.3 mtmm -103.42 135.71 44.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.621 0.248 . . . . 0.0 110.493 177.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.4 HG23 HG13 ' A' ' 119' ' ' VAL . 56.4 mt -78.62 101.74 4.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 177.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.4 m -100.61 -21.63 5.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -170.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.898 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 61.0 tptt -132.03 117.05 17.87 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.131 0.491 . . . . 0.0 111.439 -176.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.781 HD13 HG12 ' A' ' 9' ' ' ILE . 10.3 mp -104.24 104.86 14.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.739 176.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.705 ' HB ' ' HB2' ' A' ' 118' ' ' ASN . 54.6 m -109.45 132.34 54.22 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.111 0.481 . . . . 0.0 110.746 -178.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.472 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 0.1 OUTLIER -91.92 107.9 19.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.825 -177.819 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 132' ' ' ARG . 0.6 OUTLIER 43.9 -160.89 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.28 0.987 . . . . 0.0 112.359 -179.008 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.773 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 94.4 t80 -85.39 84.9 7.5 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.643 0.735 . . . . 0.0 111.283 176.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.505 ' HB3' ' HB3' ' A' ' 138' ' ' GLU . 27.0 t-20 -89.09 120.07 30.16 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 165.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.428 ' HG2' ' CE2' ' A' ' 134' ' ' TYR . 46.4 mt-10 -56.38 -48.22 77.32 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -170.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.2 mp0 -68.04 -40.5 82.86 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.047 0.451 . . . . 0.0 110.511 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.505 ' HB3' ' HB3' ' A' ' 135' ' ' ASN . 8.5 tp10 -64.7 -41.05 96.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.374 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.44 ' O ' HG23 ' A' ' 143' ' ' VAL . 86.8 t80 -64.16 -40.39 96.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.381 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -59.12 -47.92 83.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.285 177.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 21.2 m -62.88 -39.87 95.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.636 176.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.459 ' O ' HG13 ' A' ' 146' ' ' ILE . 49.8 tp -60.9 -49.34 77.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.174 -178.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 139' ' ' PHE . 95.1 t -59.38 -47.96 88.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.827 0.346 . . . . 0.0 110.77 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.402 HE21 ' HB3' ' A' ' 144' ' ' GLN . 0.9 OUTLIER -60.67 -43.1 98.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.956 179.389 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.515 ' O ' ' HG2' ' A' ' 149' ' ' MET . 7.8 tt0 -59.97 -46.99 87.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.53 177.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.488 ' O ' HD23 ' A' ' 150' ' ' LEU . 81.2 mt -56.41 -47.71 81.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.721 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -55.15 -44.76 75.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.859 176.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -76.55 -10.79 59.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.771 0.32 . . . . 0.0 111.443 -178.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.515 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 88.3 mmm -78.39 -38.96 40.46 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 171.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.544 HD11 ' HB2' ' A' ' 69' ' ' PHE . 4.4 mm? -72.11 -38.38 69.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.9 -1.046 . . . . 0.0 110.294 176.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.416 ' HE2' ' HB3' ' A' ' 151' ' ' LYS . 13.5 mmmm -84.21 -33.5 24.12 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.314 -178.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.581 ' HG3' ' NH2' ' A' ' 123' ' ' ARG . 2.1 mm-40 53.15 89.81 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.536 -177.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -105.25 14.01 47.96 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.561 176.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -87.36 -41.24 13.76 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -177.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 48.0 m80 69.38 -74.44 0.08 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.372 172.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -148.32 92.95 2.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.401 0.62 . . . . 0.0 111.866 -176.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 39.2 t60 -107.01 108.29 19.73 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 174.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -62.83 132.75 53.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.934 0.397 . . . . 0.0 111.21 -178.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 . . . . . 0 C--O 1.243 0.712 0 CA-C-O 118.194 -0.908 . . . . 0.0 108.958 170.507 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 ptm . . . . . 0 N--CA 1.48 1.025 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.9 t -81.46 -26.87 34.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.199 0.523 . . . . 0.0 110.887 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.428 HD13 ' HD3' ' A' ' 132' ' ' ARG . 3.7 mm? -95.21 172.53 8.06 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.475 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 148.87 44.62 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.816 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.404 ' CZ ' ' HD3' ' A' ' 117' ' ' ARG . 62.6 m-85 -88.49 134.12 33.94 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.6 pt -96.42 -15.63 7.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.771 0.32 . . . . 0.0 110.677 173.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.2 m -94.11 152.14 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.825 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.527 ' HB2' ' HB2' ' A' ' 11' ' ' GLU . 42.2 mtt85 -103.27 163.5 12.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.84 -177.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.493 HG12 HD13 ' A' ' 130' ' ' LEU . 72.5 mt -82.13 126.43 39.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 172.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.73 -10.7 64.56 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -173.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 8' ' ' ARG . 0.4 OUTLIER -77.04 150.1 35.78 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.163 -0.519 . . . . 0.0 109.809 -179.221 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.76 ' HG2' ' HG2' ' A' ' 126' ' ' LYS . 24.7 mtp -78.88 120.92 24.18 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.456 ' HA ' ' HD2' ' A' ' 14' ' ' PRO . . . -56.87 125.24 68.4 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.9 -175.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.456 ' HD2' ' HA ' ' A' ' 13' ' ' ALA . 10.0 Cg_endo -54.17 115.95 2.72 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.215 2.61 . . . . 0.0 111.736 177.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.517 ' HA ' HD12 ' A' ' 28' ' ' LEU . 1.2 t70 -68.32 138.2 55.26 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.541 -174.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.507 ' HB2' HD12 ' A' ' 104' ' ' ILE . 36.2 p90 -146.48 161.65 39.99 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.699 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 30.6 m -123.25 112.9 18.2 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 175.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.2 tt -117.63 144.51 25.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.017 0.437 . . . . 0.0 110.934 -175.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.0 m -84.59 127.19 33.93 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.406 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.411 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 85.3 mt -81.55 176.94 9.24 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.972 0.415 . . . . 0.0 110.906 177.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 96' ' ' LEU . 33.3 p -56.16 -34.89 66.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.881 -176.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -103.14 21.06 16.48 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.091 0.472 . . . . 0.0 110.71 -175.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.63 36.22 34.03 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.754 174.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 24' ' ' LYS . 43.3 mmtm -104.11 122.9 46.26 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.846 0.355 . . . . 0.0 110.649 177.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -88.48 115.91 26.34 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.956 177.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 17' ' ' THR . 14.3 m -114.91 143.77 23.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.017 0.437 . . . . 0.0 110.263 178.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 12.0 m -120.81 144.65 48.22 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.565 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.517 HD12 ' HA ' ' A' ' 15' ' ' ASP . 15.9 mt -61.7 -34.21 75.37 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.941 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.45 ' HA ' ' HG2' ' A' ' 32' ' ' ARG . 49.9 m -54.47 -38.21 66.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.927 0.394 . . . . 0.0 110.845 175.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.3 m -73.08 -23.23 60.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.24 0.543 . . . . 0.0 110.926 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.6 mt -99.54 0.44 42.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.45 ' HG2' ' HA ' ' A' ' 29' ' ' SER . 38.1 mmt180 -62.37 147.47 48.3 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 175.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 102.89 -26.53 23.72 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.771 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.581 ' HG3' ' HA ' ' A' ' 68' ' ' ASP . 3.2 mppt? -110.47 165.26 11.94 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.49 HG12 ' O ' ' A' ' 68' ' ' ASP . 2.7 p -83.01 120.27 34.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 173.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.459 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 17.3 t -108.6 131.94 57.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.79 -172.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 26.3 ttt -113.15 117.77 32.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.812 0.339 . . . . 0.0 110.471 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -109.08 112.7 25.02 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.336 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.516 HE22 ' HB ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -107.18 125.72 51.47 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 174.142 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.482 ' O ' ' HA ' ' A' ' 116' ' ' THR . 96.8 m-85 -94.29 114.59 26.69 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.242 0.544 . . . . 0.0 109.558 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.516 ' HB ' HE22 ' A' ' 39' ' ' GLN . 14.5 t -116.9 174.47 6.08 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.039 -173.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -150.6 131.28 14.0 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.597 177.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.655 ' HB2' ' HG3' ' A' ' 78' ' ' GLU . 43.9 m -65.27 -9.48 24.34 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.794 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 26.8 p-90 -110.0 11.39 24.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.837 0.351 . . . . 0.0 111.316 177.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 51.2 t -106.5 115.32 29.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.188 0.518 . . . . 0.0 111.033 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -77.75 -3.16 83.31 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.73 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.4 t -82.53 -37.98 14.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.131 0.491 . . . . 0.0 109.748 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 81.9 m -61.96 -27.79 69.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.134 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -71.51 -3.55 21.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.531 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.417 ' O ' ' HD1' ' A' ' 54' ' ' PHE . 58.2 mttp -104.03 -46.69 4.39 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 170.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.453 ' OE1' ' HA ' ' A' ' 133' ' ' LEU . 29.5 tt0 -58.19 -57.06 14.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.406 -177.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.671 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 80.1 mtp -58.51 -53.0 70.61 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.721 -172.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.671 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 50.3 Cg_exo -56.83 -40.39 84.56 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 122.101 1.868 . . . . 0.0 112.655 176.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.417 ' HD1' ' O ' ' A' ' 50' ' ' LYS . 17.1 m-85 -67.76 -44.03 78.43 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.789 177.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.443 ' O ' ' HB ' ' A' ' 59' ' ' ILE . 37.5 mt -54.5 -54.05 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.898 177.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.634 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 16.8 pt-20 -64.83 -41.49 95.71 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.579 -176.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -58.29 -49.13 78.24 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -175.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.705 ' HA ' ' NZ ' ' A' ' 62' ' ' LYS . 77.8 m-20 -106.08 -18.09 14.13 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -172.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.443 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 67.2 mt -102.75 -60.56 2.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.79 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.643 ' CE2' ' HG2' ' A' ' 64' ' ' LYS . 70.6 t-105 -65.73 -54.06 32.42 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -175.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.605 ' HA ' ' HE3' ' A' ' 64' ' ' LYS . 3.2 mm? -54.17 -29.67 46.53 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -176.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.705 ' NZ ' ' HA ' ' A' ' 58' ' ' ASP . 34.2 mmtm -88.05 -29.97 20.28 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.923 0.392 . . . . 0.0 111.219 -176.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -122.73 23.54 9.45 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -168.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.643 ' HG2' ' CE2' ' A' ' 60' ' ' TRP . 6.2 mtmp? -41.99 96.58 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.4 t70 68.25 -54.14 0.53 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 111.611 -2.54 . . . . 0.0 111.009 178.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.2 t30 50.97 11.38 0.09 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.662 -179.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 60.1 13.64 3.94 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.115 0.566 . . . . 0.0 111.758 -173.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.581 ' HA ' ' HG3' ' A' ' 34' ' ' LYS . 44.7 t0 -153.71 6.0 0.32 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.966 0.412 . . . . 0.0 111.642 -176.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.58 ' HB2' HD11 ' A' ' 150' ' ' LEU . 84.2 t80 -136.72 119.61 16.33 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 121.668 -0.645 . . . . 0.0 110.687 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -116.37 108.24 15.81 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.892 -177.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.444 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 2.6 tt -106.73 121.1 43.69 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -178.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 40.2 mm -130.33 126.62 61.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.154 178.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.476 ' HA2' ' HG3' ' A' ' 39' ' ' GLN . . . -97.91 130.21 10.16 Favored Glycine 0 C--O 1.221 -0.686 0 C-N-CA 120.228 -0.986 . . . . 0.0 111.443 176.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 72.5 mt -119.31 125.31 74.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 117.55 0.675 . . . . 0.0 111.415 -174.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -86.3 142.41 28.54 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 174.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.407 ' CB ' HD13 ' A' ' 115' ' ' ILE . 58.6 ttt-85 -74.47 -30.83 62.01 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -172.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -161.14 -22.2 0.05 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -170.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.655 ' HG3' ' HB2' ' A' ' 43' ' ' SER . 4.5 mm-40 -72.91 129.5 86.49 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-O 121.218 0.532 . . . . 0.0 111.01 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.595 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 28.1 Cg_endo -66.62 -167.05 0.12 Allowed 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.713 2.942 . . . . 0.0 115.017 -175.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.424 HD13 HD23 ' A' ' 84' ' ' LEU . 2.8 tm? -58.14 -53.51 57.41 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 114.532 -1.213 . . . . 0.0 112.329 -170.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.595 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -63.15 -29.71 71.01 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 -173.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.52 ' HG3' ' CD ' ' A' ' 78' ' ' GLU . 30.7 mmtm -66.72 -54.36 23.75 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.95 177.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.513 HG21 ' HB3' ' A' ' 98' ' ' LEU . 41.2 t -55.33 -43.97 73.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.34 -177.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.424 HD23 HD13 ' A' ' 80' ' ' LEU . 4.4 mm? -69.28 -27.28 65.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.796 0.331 . . . . 0.0 111.608 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.749 ' HA ' ' HE2' ' A' ' 88' ' ' LYS . . . -85.96 -37.65 18.81 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.272 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.536 ' HE2' ' SD ' ' A' ' 52' ' ' MET . 49.0 t80 -68.67 -42.53 77.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.809 -178.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.485 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -56.3 -53.39 57.78 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.097 178.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.749 ' HE2' ' HA ' ' A' ' 85' ' ' ALA . 63.4 pttt -65.92 -20.89 66.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.966 0.412 . . . . 0.0 111.4 -176.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.8 m -82.36 -3.53 55.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.266 178.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.48 ' HB ' ' HG3' ' A' ' 53' ' ' PRO . 15.8 p -127.1 -24.91 3.35 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.997 0.427 . . . . 0.0 111.153 177.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 122.56 -79.25 0.34 Allowed Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 -176.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 90.6 t 45.37 89.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 124.526 1.13 . . . . 0.0 113.495 176.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.498 ' HG1' ' HD1' ' A' ' 60' ' ' TRP . 3.5 p -87.24 12.42 11.83 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.637 176.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.442 ' CE1' ' HB3' ' A' ' 56' ' ' GLU . 51.1 p90 -123.17 154.1 64.98 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.304 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -67.55 140.59 52.55 Favored 'Trans proline' 0 C--O 1.238 0.499 0 C-N-CA 122.201 1.934 . . . . 0.0 113.731 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.485 HD12 ' HB2' ' A' ' 87' ' ' ALA . 93.0 mt -113.95 151.43 32.31 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.661 175.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -122.53 149.82 16.94 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 175.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.707 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.0 OUTLIER -106.34 126.69 52.55 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.763 0.316 . . . . 0.0 110.827 -177.185 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -115.65 78.95 7.11 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.07 177.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.05 99.82 0.92 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.388 2.059 . . . . 0.0 112.744 -176.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 125.56 -7.05 7.95 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.899 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 63.19 44.29 5.8 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 122.853 0.461 . . . . 0.0 111.102 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -81.88 -50.91 8.64 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.196 0.522 . . . . 0.0 110.306 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.507 HD12 ' HB2' ' A' ' 16' ' ' PHE . 29.8 mm -65.23 -36.02 76.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.504 ' CD2' ' HA ' ' A' ' 111' ' ' ARG . 70.8 t80 -63.29 -42.96 99.13 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.207 175.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.62 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -67.45 -21.88 65.52 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.79 -178.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -72.63 -12.32 61.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.834 0.35 . . . . 0.0 111.16 178.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -116.23 -42.8 3.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.08 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.62 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -146.37 161.4 40.44 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.221 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.569 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 97.9 mt -62.26 129.92 42.96 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.504 ' HA ' ' CD2' ' A' ' 105' ' ' PHE . 21.5 mtm180 -50.43 -43.61 55.0 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.295 0.569 . . . . 0.0 111.258 -175.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -101.47 17.64 22.21 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.705 -170.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.569 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . . . -97.7 15.1 24.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.237 177.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 131.17 -179.04 17.34 Favored Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -178.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.444 HG23 ' H ' ' A' ' 116' ' ' THR . 1.0 OUTLIER -125.88 -73.2 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 117.525 0.662 . . . . 0.0 112.751 -179.689 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.713 ' HB ' ' HB3' ' A' ' 133' ' ' LEU . 5.1 m -73.68 117.42 15.42 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.092 0.472 . . . . 0.0 111.985 -167.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.421 ' C ' HD22 ' A' ' 118' ' ' ASN . 75.5 mtt-85 -143.04 154.44 43.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.169 -179.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.496 ' HB2' HG23 ' A' ' 131' ' ' THR . 0.9 OUTLIER -121.79 119.78 32.69 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 174.132 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.4 t -116.02 123.58 71.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.146 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.566 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 25.8 tp -107.65 121.84 45.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.027 0.442 . . . . 0.0 110.704 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.459 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 62.5 mt -102.77 132.5 48.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.077 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.462 ' OD2' ' HB2' ' A' ' 124' ' ' GLU . 18.4 t70 -79.43 164.96 23.56 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.679 178.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.489 ' HB3' HH11 ' A' ' 123' ' ' ARG . 0.0 OUTLIER -57.33 -29.55 64.05 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.552 179.34 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.536 ' HB3' ' NZ ' ' A' ' 126' ' ' LYS . 18.0 mm-40 -75.4 7.05 3.86 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.0 0.429 . . . . 0.0 111.096 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 76.15 14.13 82.58 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.168 176.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.76 ' HG2' ' HG2' ' A' ' 12' ' ' MET . 25.0 mtmm -113.68 139.19 49.27 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.831 0.348 . . . . 0.0 110.926 -175.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.3 mt -76.14 130.63 36.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.781 -175.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 31.0 m -116.07 -21.0 5.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -176.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.566 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 53.1 tptt -135.5 116.44 14.18 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.552 -0.459 . . . . 0.0 112.092 -174.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.493 HD13 HG12 ' A' ' 9' ' ' ILE . 10.6 mp -109.09 119.34 39.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.332 172.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.555 HG21 HD11 ' A' ' 142' ' ' LEU . 14.7 t -147.15 162.91 37.9 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.98 178.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.458 ' C ' ' HG ' ' A' ' 133' ' ' LEU . 37.2 mtm180 -115.83 116.91 28.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.112 -173.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.713 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 3.9 pp 48.62 -169.09 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 O-C-N 124.67 1.231 . . . . 0.0 114.001 174.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.446 ' HB2' ' CB ' ' A' ' 51' ' ' GLU . 60.9 t80 -80.59 114.74 19.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.449 -178.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.544 ' HB3' ' HB2' ' A' ' 138' ' ' GLU . 3.0 t-20 -130.87 133.78 46.2 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.948 -1.023 . . . . 0.0 108.429 173.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -44.87 -61.26 1.67 Allowed 'General case' 0 C--O 1.236 0.367 0 O-C-N 123.441 0.463 . . . . 0.0 112.189 -178.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -60.74 -50.71 72.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.822 0.344 . . . . 0.0 111.317 -177.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.544 ' HB2' ' HB3' ' A' ' 135' ' ' ASN . 4.0 mm-40 -63.13 -39.49 94.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.981 -177.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -66.08 -41.45 90.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.807 0.337 . . . . 0.0 110.102 177.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.82 -42.02 98.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.157 176.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.4 m -67.31 -35.21 78.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.239 177.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.555 HD11 HG21 ' A' ' 131' ' ' THR . 24.7 mt -66.67 -53.4 34.29 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.836 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.6 p -60.69 -42.17 90.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.025 -175.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -67.29 -41.52 85.3 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.812 0.339 . . . . 0.0 110.547 177.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.531 ' O ' ' HG2' ' A' ' 149' ' ' MET . 8.6 tt0 -58.5 -51.39 70.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.657 176.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.615 ' O ' HD23 ' A' ' 150' ' ' LEU . 99.0 mt -62.48 -40.51 88.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.85 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -54.35 -37.47 64.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.25 177.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.545 ' HA ' ' HG2' ' A' ' 151' ' ' LYS . 1.3 tp10 -88.14 -26.62 22.36 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.625 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.531 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 97.5 mmm -63.8 -26.25 68.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.408 0.623 . . . . 0.0 109.704 175.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.615 HD23 ' O ' ' A' ' 146' ' ' ILE . 3.9 mm? -81.45 -7.61 59.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.072 177.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.545 ' HG2' ' HA ' ' A' ' 148' ' ' GLU . 18.8 mmtm -96.93 -67.2 0.86 Allowed 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 174.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.484 ' CD ' ' HD1' ' A' ' 154' ' ' HIS . 2.1 tt0 46.92 -90.74 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.545 -175.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -177.68 -29.1 0.04 OUTLIER Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.304 178.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.484 ' HD1' ' CD ' ' A' ' 152' ' ' GLU . 49.8 m80 -77.44 0.15 23.7 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -173.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -77.29 83.9 3.74 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 122.243 1.02 . . . . 0.0 110.886 -177.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -138.99 167.08 22.84 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.47 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 12.1 t60 -147.82 88.22 1.67 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 171.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 39.9 t60 -148.91 104.7 3.47 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.93 178.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 . . . . . 0 C--O 1.246 0.909 0 CA-C-O 118.205 -0.902 . . . . 0.0 109.349 179.324 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 mpp? . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.8 t 67.97 174.78 0.27 Allowed 'General case' 0 CA--C 1.532 0.27 0 O-C-N 123.971 0.794 . . . . 0.0 110.633 -177.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.435 ' HB3' ' CE2' ' A' ' 5' ' ' TYR . 21.1 tp -131.21 22.21 4.83 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.432 ' O ' ' HB1' ' A' ' 109' ' ' ALA . . . 102.1 8.15 45.26 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.218 -174.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.491 ' CE1' HD12 ' A' ' 130' ' ' LEU . 69.0 m-85 -72.95 135.58 45.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.454 -0.373 . . . . 0.0 111.346 -178.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.52 HG13 HG23 ' A' ' 7' ' ' VAL . 46.8 pt -101.65 -17.13 7.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 170.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.52 HG23 HG13 ' A' ' 6' ' ' ILE . 23.1 t -110.3 139.27 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.067 177.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.439 ' HE ' ' CD ' ' A' ' 11' ' ' GLU . 73.6 mtm180 -122.47 -178.7 3.97 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.084 0.469 . . . . 0.0 112.186 -169.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.426 ' CG1' HD23 ' A' ' 130' ' ' LEU . 67.5 mt -71.32 123.07 24.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.294 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.16 -19.82 44.91 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.166 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.439 ' CD ' ' HE ' ' A' ' 8' ' ' ARG . 7.1 mt-10 -80.87 151.32 28.71 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.68 ' HG2' ' HG2' ' A' ' 126' ' ' LYS . 45.1 mtp -77.92 137.54 38.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.844 0.354 . . . . 0.0 110.362 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.24 130.83 67.79 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.404 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.402 ' HG2' ' O ' ' A' ' 107' ' ' LYS . 37.6 Cg_exo -61.23 125.95 18.19 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.493 2.129 . . . . 0.0 111.427 177.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -63.01 138.64 58.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.224 0.535 . . . . 0.0 110.196 -176.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.686 ' HB2' HD12 ' A' ' 104' ' ' ILE . 47.1 p90 -131.76 149.69 52.39 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.052 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.5 m -109.17 98.79 8.17 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 170.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 25' ' ' GLN . 16.9 tt -95.6 144.8 9.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.516 -174.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.8 m -101.55 118.3 36.68 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.103 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.8 mt -73.57 172.83 10.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.959 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 96' ' ' LEU . 41.5 p -58.1 -28.84 64.98 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -175.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -102.6 18.74 20.54 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.143 0.497 . . . . 0.0 110.859 -175.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.86 40.43 17.41 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.795 174.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -108.73 117.18 33.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.887 0.375 . . . . 0.0 110.928 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 49.7 mt-30 -94.75 118.47 31.79 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.003 178.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.8 p -128.88 132.28 67.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.217 0.532 . . . . 0.0 111.123 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.41 154.81 25.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.089 177.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 40.4 tp -65.48 -40.28 92.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.844 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.59 ' HA ' ' HG3' ' A' ' 32' ' ' ARG . 75.3 m -62.92 -19.14 63.94 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 177.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 51.8 m -75.2 -18.15 60.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.511 0.672 . . . . 0.0 110.395 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.3 mt -100.81 -14.11 18.13 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.732 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.646 ' NH1' ' HA ' ' A' ' 124' ' ' GLU . 6.3 mmm180 -55.48 153.57 7.4 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 123.539 0.525 . . . . 0.0 110.917 177.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.09 -22.64 35.43 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -172.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.524 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 35.7 mtmm -117.31 170.93 8.31 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 174.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.5 m -80.9 134.03 28.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 172.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.592 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 44.3 t -111.22 109.6 29.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 121.006 0.431 . . . . 0.0 111.076 -177.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 13.9 tpt -91.81 136.25 33.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.211 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 78.9 mt -133.74 143.29 48.37 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.077 -178.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.56 ' OE1' ' HB ' ' A' ' 41' ' ' THR . 21.8 tm0? -138.45 131.44 29.77 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 177.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.449 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 96.7 m-85 -104.56 120.04 40.38 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.56 ' HB ' ' OE1' ' A' ' 39' ' ' GLN . 6.8 t -136.47 -175.67 4.08 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.059 0.456 . . . . 0.0 111.602 -173.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.501 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . . . -169.41 164.04 10.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.463 178.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.454 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 86.3 p -67.19 -30.25 70.14 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.892 0.377 . . . . 0.0 111.739 -173.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 37.7 p-90 -89.0 4.36 48.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.668 -175.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.501 ' SG ' ' HB3' ' A' ' 42' ' ' ALA . 80.0 m -85.69 90.05 7.91 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.072 0.463 . . . . 0.0 110.796 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.84 -35.7 90.01 Favored Glycine 0 C--O 1.228 -0.265 0 C-N-CA 121.08 -0.581 . . . . 0.0 113.004 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.5 t -64.46 -35.44 74.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.012 0.434 . . . . 0.0 110.057 178.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.708 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 99.4 m -65.24 -16.84 63.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.395 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -68.99 -7.32 34.25 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 120.849 0.357 . . . . 0.0 110.604 177.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.629 ' HD3' ' CD2' ' A' ' 134' ' ' TYR . 62.1 mttt -88.24 -57.25 2.99 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.351 0.596 . . . . 0.0 110.257 168.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.736 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 5.0 pt-20 -65.65 -40.06 92.07 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.287 -172.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.596 ' HG2' ' O ' ' A' ' 48' ' ' CYS . 98.9 mmm -54.69 -58.39 14.52 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 117.999 0.363 . . . . 0.0 111.862 -177.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.459 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 29.6 Cg_endo -64.48 -38.53 32.84 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 122.018 1.812 . . . . 0.0 112.501 178.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -64.46 -42.07 96.16 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.314 178.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.562 ' O ' ' HB ' ' A' ' 59' ' ' ILE . 75.0 mt -60.25 -37.49 73.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.863 0.363 . . . . 0.0 110.404 177.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.728 ' HG3' ' H ' ' A' ' 93' ' ' THR . 0.2 OUTLIER -68.42 -62.66 1.3 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 175.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.403 ' O ' ' HE2' ' A' ' 62' ' ' LYS . 29.3 ttpp -55.58 -43.1 75.64 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -174.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.624 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 8.3 m-20 -100.65 -24.82 14.34 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -171.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.562 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 53.9 mt -106.5 -60.99 2.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.458 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.523 ' HB3' ' HA ' ' A' ' 56' ' ' GLU . 76.6 t-105 -62.8 -62.65 1.58 Allowed 'General case' 0 C--O 1.226 -0.18 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.614 -175.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.483 HD12 ' HA ' ' A' ' 61' ' ' LEU . 0.5 OUTLIER -46.68 -31.98 3.25 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.655 0.782 . . . . 0.0 112.497 -174.013 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.624 ' HE2' ' HA ' ' A' ' 58' ' ' ASP . 64.7 mmtt -72.75 -54.24 9.45 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.923 -178.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.791 ' HB3' ' HB2' ' A' ' 66' ' ' ASN . 85.8 m-70 -105.83 -45.29 4.42 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -169.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.469 ' HE3' HD12 ' A' ' 61' ' ' LEU . 32.5 mttp 55.06 -78.42 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.77 0.828 . . . . 0.0 111.495 -172.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -101.36 -63.25 1.16 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 174.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.791 ' HB2' ' HB3' ' A' ' 63' ' ' HIS . 3.9 t30 68.21 5.97 4.99 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.842 172.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 71.68 -19.44 0.26 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.769 0.828 . . . . 0.0 112.513 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.524 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 19.9 p30 -136.92 17.31 3.04 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -178.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.484 ' CE2' ' HB2' ' A' ' 71' ' ' LEU . 93.7 t80 -125.63 143.3 51.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.087 0.47 . . . . 0.0 111.112 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -138.81 140.59 38.61 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.744 172.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.484 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 2.2 tt -139.12 114.73 9.9 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -179.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.9 mm -124.3 120.83 60.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.133 178.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.455 ' HA3' ' CD2' ' A' ' 96' ' ' LEU . . . -88.72 130.44 10.15 Favored Glycine 0 C--O 1.223 -0.57 0 C-N-CA 120.223 -0.989 . . . . 0.0 110.809 175.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 48.6 mt -116.67 121.6 68.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 117.28 0.54 . . . . 0.0 110.759 -174.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -82.59 139.8 33.59 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 173.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.444 ' HB2' HD13 ' A' ' 115' ' ' ILE . 57.7 ttt-85 -57.37 -51.78 68.03 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.668 0.605 . . . . 0.0 112.58 -172.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.597 ' HA ' ' O ' ' A' ' 99' ' ' ASP . 11.3 p-10 -170.05 15.48 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -175.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.54 ' HB3' ' HG3' ' A' ' 82' ' ' LYS . 29.0 mt-10 -91.52 148.53 37.62 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-O 121.088 0.471 . . . . 0.0 110.599 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.642 ' HG2' ' OE2' ' A' ' 81' ' ' GLU . 38.1 Cg_endo -71.34 -174.48 1.23 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.935 2.423 . . . . 0.0 114.257 -176.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 85.2 mt -54.25 -52.5 61.16 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.618 -1.173 . . . . 0.0 112.826 -174.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.642 ' OE2' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -61.22 -24.54 66.42 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -172.819 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.628 ' HG2' ' OE2' ' A' ' 81' ' ' GLU . 42.5 mmtm -73.23 -59.87 2.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.717 0.294 . . . . 0.0 110.367 172.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.6 t -54.59 -49.24 68.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.725 -176.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.8 mp -64.69 -40.43 95.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.413 -176.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.408 ' O ' ' HG2' ' A' ' 88' ' ' LYS . . . -76.67 -34.55 58.24 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.316 -177.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.454 ' CD1' ' HA ' ' A' ' 43' ' ' SER . 78.9 t80 -67.09 -48.94 66.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.791 -178.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.467 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -53.34 -52.05 60.46 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.042 -176.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 85' ' ' ALA . 17.9 pttm -63.19 -28.45 70.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.043 -176.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.5 m -100.73 9.86 41.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.724 -174.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.2 p -129.46 10.87 5.75 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.108 175.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.67 43.65 91.46 Favored Glycine 0 C--O 1.227 -0.281 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.275 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.7 t -100.36 100.65 10.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.028 0.442 . . . . 0.0 110.944 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.728 ' H ' ' HG3' ' A' ' 56' ' ' GLU . 30.1 m -85.94 -20.52 28.85 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.848 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.522 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 23.6 p90 -82.48 144.12 48.97 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.816 178.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -61.5 140.67 88.53 Favored 'Trans proline' 0 C--O 1.238 0.495 0 C-N-CA 122.572 2.181 . . . . 0.0 113.175 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.475 ' O ' HG23 ' A' ' 21' ' ' THR . 76.3 mt -111.06 151.2 28.32 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.852 176.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -123.59 149.16 16.85 Favored Glycine 0 N--CA 1.438 -1.214 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 175.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.735 HD23 ' H ' ' A' ' 98' ' ' LEU . 0.8 OUTLIER -99.81 132.56 45.08 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.591 0.234 . . . . 0.0 110.561 -177.456 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.597 ' O ' ' HA ' ' A' ' 77' ' ' ASP . 26.6 t0 -109.58 83.31 2.57 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.925 176.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -60.92 101.67 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.417 2.078 . . . . 0.0 113.177 -175.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.442 ' H ' ' HB2' ' A' ' 77' ' ' ASP . . . 101.51 11.76 37.5 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.852 -0.689 . . . . 0.0 113.359 175.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 61.32 43.46 10.66 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.082 0.467 . . . . 0.0 110.872 178.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.645 ' HA ' HH21 ' A' ' 111' ' ' ARG . 18.1 t70 -79.89 -50.2 10.82 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.537 0.684 . . . . 0.0 110.374 -178.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.686 HD12 ' HB2' ' A' ' 16' ' ' PHE . 31.7 mm -67.41 -39.45 82.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 175.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -56.69 -39.14 73.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.363 175.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.17 -32.32 72.49 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.77 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.402 ' O ' ' HG2' ' A' ' 14' ' ' PRO . 30.5 mtmm -74.83 -4.79 39.86 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 178.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -116.61 -19.24 10.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 179.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.689 ' HB3' HH12 ' A' ' 117' ' ' ARG . . . -171.9 -179.99 2.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.572 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 80.2 mt -66.11 149.62 50.0 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 174.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.645 HH21 ' HA ' ' A' ' 103' ' ' ASP . 93.5 mtt180 -73.58 -15.22 61.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.121 0.486 . . . . 0.0 110.024 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -100.51 15.9 26.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.346 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.07 -179.26 5.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.475 -177.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.88 142.03 42.79 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.679 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.595 ' O ' ' HG2' ' A' ' 117' ' ' ARG . 6.6 tp -91.66 -39.77 11.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 111.36 0.133 . . . . 0.0 111.36 -178.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.577 HG22 ' SG ' ' A' ' 48' ' ' CYS . 18.0 p -68.86 105.33 2.32 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 120.484 0.183 . . . . 0.0 110.878 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.689 HH12 ' HB3' ' A' ' 109' ' ' ALA . 8.9 ptm180 -167.65 133.06 1.96 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.171 0.51 . . . . 0.0 112.127 -173.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.59 ' HB2' ' CB ' ' A' ' 131' ' ' THR . 91.2 m-20 -104.41 129.59 52.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.231 172.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.6 t -120.95 116.93 51.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 120.619 0.247 . . . . 0.0 110.394 -176.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 37.5 tp -106.38 115.12 29.66 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.113 0.482 . . . . 0.0 110.645 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.592 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 60.7 mt -95.51 135.05 30.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.366 176.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' A' ' 124' ' ' GLU . 0.0 OUTLIER -79.49 177.01 9.18 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.206 0.526 . . . . 0.0 110.734 -177.213 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.654 ' HD2' ' OE2' ' A' ' 152' ' ' GLU . 31.6 ttm180 -62.57 -27.1 68.95 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.561 -177.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.646 ' HA ' ' NH1' ' A' ' 32' ' ' ARG . 2.1 mm-40 -91.42 6.28 46.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.066 -178.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.16 16.68 62.33 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.544 -0.836 . . . . 0.0 113.017 172.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.68 ' HG2' ' HG2' ' A' ' 12' ' ' MET . 33.3 mttt -112.18 142.77 44.24 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.829 0.347 . . . . 0.0 110.292 -177.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.474 HD12 ' CG1' ' A' ' 7' ' ' VAL . 58.3 mt -80.21 119.96 30.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 120.776 0.322 . . . . 0.0 110.613 -177.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.5 m -109.88 -8.07 11.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.483 ' CG ' HE22 ' A' ' 145' ' ' GLN . 5.2 tmtm? -149.34 111.21 4.57 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.296 -175.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.491 HD12 ' CE1' ' A' ' 5' ' ' TYR . 3.2 mm? -104.79 105.78 16.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.224 172.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.59 ' CB ' ' HB2' ' A' ' 118' ' ' ASN . 10.4 m -88.98 138.69 31.17 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.367 -177.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.521 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 2.3 mpt_? -99.78 107.08 19.04 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 176.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 132' ' ' ARG . 0.5 OUTLIER 43.44 -162.89 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 O-C-N 124.212 0.945 . . . . 0.0 111.788 -174.201 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.736 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 90.5 t80 -88.63 92.81 9.34 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.168 0.509 . . . . 0.0 110.08 173.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.562 ' HB3' ' HB3' ' A' ' 138' ' ' GLU . 10.7 t30 -95.02 131.57 40.85 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 170.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.432 ' HB2' ' OE2' ' A' ' 137' ' ' GLU . 24.9 mm-40 -50.16 -63.81 1.0 Allowed 'General case' 0 CA--C 1.536 0.424 0 O-C-N 123.687 0.617 . . . . 0.0 112.178 -168.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.566 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.2 mp0 -66.62 -32.52 73.9 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.108 0.48 . . . . 0.0 110.945 -177.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.562 ' HB3' ' HB3' ' A' ' 135' ' ' ASN . 6.0 tp10 -62.68 -46.18 89.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.606 -176.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.499 ' O ' HG23 ' A' ' 143' ' ' VAL . 91.9 t80 -63.57 -42.03 98.34 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.511 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.4 -44.06 96.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.805 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.3 m -63.68 -39.6 94.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.414 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.501 ' O ' HG13 ' A' ' 146' ' ' ILE . 58.4 tp -62.46 -44.31 96.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.942 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 139' ' ' PHE . 99.0 t -57.66 -52.94 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.15 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.409 ' HB3' HE21 ' A' ' 144' ' ' GLN . 21.8 mt-30 -60.96 -41.29 96.06 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-O 121.281 0.562 . . . . 0.0 110.872 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.483 HE22 ' CG ' ' A' ' 129' ' ' LYS . 28.6 tt0 -57.71 -48.52 79.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.575 178.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.608 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 78.0 mt -58.96 -41.92 84.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.879 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -55.2 -46.68 75.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.561 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -83.88 -25.22 30.41 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.092 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.442 ' HB3' ' HE3' ' A' ' 149' ' ' MET . 28.8 mmm -58.92 -33.88 71.08 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.413 0.625 . . . . 0.0 110.371 178.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.665 ' HB2' ' HD2' ' A' ' 151' ' ' LYS . 52.2 mt -60.8 -39.1 87.65 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.611 176.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.665 ' HD2' ' HB2' ' A' ' 150' ' ' LEU . 11.1 mmmt -89.21 -30.16 18.74 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.629 -168.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.654 ' OE2' ' HD2' ' A' ' 123' ' ' ARG . 7.2 tt0 63.42 -121.18 0.55 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.932 167.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -74.35 -11.46 82.28 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 121.462 -0.399 . . . . 0.0 112.744 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 79.1 m80 66.29 77.84 0.28 Allowed 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 122.907 0.483 . . . . 0.0 111.555 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -78.78 97.38 5.9 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 170.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.489 ' O ' ' HB2' ' A' ' 157' ' ' HIS . 0.0 OUTLIER 71.08 153.17 0.12 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.4 -165.845 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.489 ' HB2' ' O ' ' A' ' 156' ' ' HIS . 71.5 m80 72.12 39.78 0.76 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -161.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -170.21 -32.53 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 112.775 -2.012 . . . . 0.0 105.695 -173.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.246 0.872 0 CA-C-N 113.2 -1.818 . . . . 0.0 107.503 167.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.2 ptp . . . . . 0 N--CA 1.483 1.213 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.7 m -53.4 122.85 10.48 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 123.371 0.419 . . . . 0.0 110.273 175.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 91.7 mt 71.39 143.54 0.06 Allowed 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.963 0.79 . . . . 0.0 110.798 -174.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.53 57.6 4.9 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.825 -0.703 . . . . 0.0 113.414 -174.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.429 ' OH ' ' HD2' ' A' ' 117' ' ' ARG . 1.3 m-85 -91.71 121.06 33.01 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.771 0.319 . . . . 0.0 110.247 175.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.431 HG13 HG13 ' A' ' 7' ' ' VAL . 38.6 pt -92.38 -24.01 5.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.437 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.431 HG13 HG13 ' A' ' 6' ' ' ILE . 27.4 m -104.51 157.16 5.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.389 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.528 ' H ' ' HG3' ' A' ' 11' ' ' GLU . 19.7 mtt180 -126.25 177.39 6.45 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.082 -174.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.646 HG12 HD13 ' A' ' 130' ' ' LEU . 79.9 mt -74.27 110.7 8.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 173.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.02 -23.45 8.2 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.092 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.528 ' HG3' ' H ' ' A' ' 8' ' ' ARG . 69.1 mm-40 -68.13 154.67 41.21 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.572 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 55.5 mtp -86.08 139.83 30.79 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.949 0.404 . . . . 0.0 110.482 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.494 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -67.44 130.06 93.46 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.561 -178.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 8.3 Cg_exo -70.7 120.98 7.5 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.926 2.418 . . . . 0.0 111.477 176.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -63.43 146.93 52.6 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.451 -176.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 1.027 ' HB3' ' HE2' ' A' ' 107' ' ' LYS . 54.0 p90 -156.7 158.54 37.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.69 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.8 m -116.33 107.27 14.62 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.748 175.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.1 tt -107.81 146.81 13.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.005 0.431 . . . . 0.0 111.003 -176.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.402 ' O ' HD23 ' A' ' 98' ' ' LEU . 20.3 m -95.37 130.22 42.24 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.053 177.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.497 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 90.6 mt -83.89 179.01 7.66 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.005 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 96' ' ' LEU . 27.4 p -59.56 -31.21 69.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.714 -175.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -101.88 10.91 39.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.983 0.42 . . . . 0.0 110.917 -176.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.07 8.7 62.94 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.522 176.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.44 ' HB2' HD12 ' A' ' 20' ' ' LEU . 46.0 mmtm -77.44 120.59 22.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.362 0.581 . . . . 0.0 110.593 177.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -98.63 115.46 28.71 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.962 0.41 . . . . 0.0 110.393 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.3 m -113.78 153.07 15.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.008 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 9.1 m -122.49 142.96 50.03 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.335 -0.393 . . . . 0.0 109.961 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.67 -39.88 94.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.847 0.356 . . . . 0.0 110.841 -175.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 32' ' ' ARG . 5.3 p -61.18 -21.57 63.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.546 178.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.1 m -79.86 -25.99 40.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.068 0.461 . . . . 0.0 110.403 177.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 77.2 mt -96.5 1.88 51.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.392 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 29' ' ' SER . 0.2 OUTLIER -55.74 126.39 25.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.081 179.339 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.626 ' O ' ' HG3' ' A' ' 123' ' ' ARG . . . 106.37 -0.11 37.6 Favored Glycine 0 C--O 1.222 -0.635 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.724 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.4 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 58.1 mttm -116.51 159.54 21.93 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 174.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.475 HG13 ' HD1' ' A' ' 69' ' ' PHE . 2.1 p -78.29 107.3 10.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.585 0.707 . . . . 0.0 109.172 171.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.512 HG22 ' HB3' ' A' ' 70' ' ' ALA . 48.0 t -106.89 120.93 59.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.095 -173.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.409 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 26.7 ttt -98.81 120.2 38.84 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.331 176.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 94.0 mt -107.88 110.87 22.75 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.022 177.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.433 ' OE1' ' HB ' ' A' ' 41' ' ' THR . 0.6 OUTLIER -103.37 106.14 16.58 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.874 -176.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 116' ' ' THR . 95.1 m-85 -93.76 127.29 39.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.572 -177.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.433 ' HB ' ' OE1' ' A' ' 39' ' ' GLN . 15.0 t -158.26 -166.47 1.94 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.366 -176.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.531 ' HB2' HD11 ' A' ' 115' ' ' ILE . . . -151.03 156.44 41.12 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 176.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.616 ' HB2' ' HG3' ' A' ' 78' ' ' GLU . 49.7 m -66.26 -9.49 33.0 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -176.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 41.0 p-90 -105.4 4.86 31.22 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 122.201 -0.312 . . . . 0.0 111.566 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 74.9 m -83.17 113.47 20.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.023 0.439 . . . . 0.0 111.158 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -78.31 -33.21 40.45 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.863 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.3 t -66.48 -37.46 79.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.08 0.467 . . . . 0.0 110.797 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.681 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 29.1 t -67.03 -16.95 64.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.374 0.607 . . . . 0.0 110.793 -178.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.526 ' HE ' ' HE1' ' A' ' 86' ' ' PHE . 79.6 mtt180 -74.83 -2.15 25.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.681 177.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.409 ' O ' ' HD1' ' A' ' 54' ' ' PHE . 74.2 mmtt -94.02 -55.61 3.15 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.702 0.763 . . . . 0.0 109.278 169.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.996 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 10.0 pt-20 -62.68 -44.27 96.69 Favored 'General case' 0 C--O 1.213 -0.827 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.861 -173.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.683 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 33.3 mtm -56.06 -55.23 43.8 Favored Pre-proline 0 N--CA 1.466 0.362 0 CA-C-N 118.338 0.517 . . . . 0.0 112.36 -176.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.683 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 65.0 Cg_exo -53.93 -38.7 86.37 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 121.976 1.784 . . . . 0.0 111.968 175.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.489 ' HB3' ' CZ ' ' A' ' 139' ' ' PHE . 23.1 m-85 -68.26 -45.04 74.25 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.081 175.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 51' ' ' GLU . 88.1 mt -58.86 -55.68 21.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 123.065 0.546 . . . . 0.0 111.08 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.536 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 16.0 pt-20 -62.69 -35.71 80.58 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.635 -177.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.0 ttpm? -72.37 -51.4 20.69 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -176.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.493 ' HA ' ' NZ ' ' A' ' 62' ' ' LYS . 53.5 m-20 -106.99 -10.8 15.83 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -170.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 65.0 mt -104.57 -55.44 5.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.158 173.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.536 ' HB3' ' HA ' ' A' ' 56' ' ' GLU . 72.1 t-105 -69.97 -65.84 0.67 Allowed 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.575 -177.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.519 HD13 ' HE3' ' A' ' 64' ' ' LYS . 1.9 mm? -46.78 -33.88 4.78 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -175.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.493 ' NZ ' ' HA ' ' A' ' 58' ' ' ASP . 45.8 mmtm -75.72 -34.12 60.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.29 -0.414 . . . . 0.0 112.057 -176.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.418 ' ND1' ' HG ' ' A' ' 150' ' ' LEU . 79.9 m-70 -125.28 -43.73 1.91 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 120.347 -0.541 . . . . 0.0 112.351 -173.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.519 ' HE3' HD13 ' A' ' 61' ' ' LEU . 34.5 mttp 54.87 -90.6 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.944 0.898 . . . . 0.0 111.936 -177.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -108.01 -49.41 3.21 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 174.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 70.94 -71.22 0.14 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.83 178.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 169.78 -23.67 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.287 -175.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.4 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 6.9 t70 -148.3 24.93 1.01 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.79 -174.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.475 ' HD1' HG13 ' A' ' 35' ' ' VAL . 87.5 t80 -129.12 140.13 51.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.745 0.307 . . . . 0.0 110.571 -178.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.512 ' HB3' HG22 ' A' ' 36' ' ' VAL . . . -139.16 135.83 34.45 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.323 177.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.409 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 1.7 tt -133.79 117.2 16.62 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.6 mp -128.15 126.98 67.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.766 0.317 . . . . 0.0 110.332 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.81 129.46 9.91 Favored Glycine 0 C--O 1.219 -0.784 0 N-CA-C 110.799 -0.921 . . . . 0.0 110.799 174.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.0 mt -119.21 122.53 69.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 117.489 0.644 . . . . 0.0 111.338 -173.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -86.11 133.26 33.89 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 173.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.879 ' HD3' ' HB3' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -88.35 -22.78 23.63 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -169.271 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.879 ' HB3' ' HD3' ' A' ' 76' ' ' ARG . 3.9 p30 -151.25 -14.04 0.21 Allowed 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 118.721 -1.192 . . . . 0.0 114.131 -172.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.616 ' HG3' ' HB2' ' A' ' 43' ' ' SER . 4.9 mm-40 -88.46 133.31 36.69 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-O 121.065 0.46 . . . . 0.0 110.746 177.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.525 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 29.0 Cg_endo -69.19 -168.82 0.27 Allowed 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 123.175 2.583 . . . . 0.0 114.624 -177.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.2 -53.97 52.19 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.414 -168.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.525 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -64.23 -33.59 76.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.657 0.265 . . . . 0.0 111.305 -173.941 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.489 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 33.7 mmtp -61.06 -53.93 51.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.85 177.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 79' ' ' PRO . 41.1 t -57.53 -41.52 79.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.352 -177.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -66.07 -44.19 85.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.854 0.359 . . . . 0.0 111.26 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.82 -27.93 62.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.175 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.526 ' HE1' ' HE ' ' A' ' 49' ' ' ARG . 91.7 t80 -74.14 -48.08 31.73 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.19 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.53 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -58.39 -55.09 39.54 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.334 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.7 ptmm? -58.84 -24.95 62.75 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -174.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.0 m -84.15 -17.29 40.53 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -175.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.5 p -111.08 -23.39 10.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.098 0.475 . . . . 0.0 110.653 176.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 123.36 -79.78 0.35 Allowed Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -177.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 94.4 t 46.19 82.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 122.101 0.953 . . . . 0.0 112.691 178.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.3 m -71.55 -18.66 62.24 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.446 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -93.98 139.92 22.77 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.45 140.12 85.88 Favored 'Trans proline' 0 C--O 1.238 0.499 0 C-N-CA 122.46 2.107 . . . . 0.0 113.437 -177.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.53 HD12 ' HB2' ' A' ' 87' ' ' ALA . 88.6 mt -106.23 152.21 23.79 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.868 175.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -124.33 154.41 17.86 Favored Glycine 0 N--CA 1.441 -1.025 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 175.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.715 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.2 pt? -107.43 130.45 54.82 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.945 0.402 . . . . 0.0 111.126 -177.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -119.13 75.15 14.73 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.868 175.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.425 ' HD3' ' C ' ' A' ' 98' ' ' LEU . 17.4 Cg_exo -66.23 105.16 0.82 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.6 2.2 . . . . 0.0 112.421 -177.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 119.47 -1.79 14.04 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.127 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 57.91 43.4 21.5 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 122.658 0.383 . . . . 0.0 111.931 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.407 ' O ' ' HG3' ' A' ' 107' ' ' LYS . 13.7 t70 -87.1 -50.67 6.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.06 0.457 . . . . 0.0 109.903 -177.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.571 HD12 ' HB2' ' A' ' 16' ' ' PHE . 34.3 mm -62.54 -34.92 67.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 174.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -61.5 -41.67 97.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.248 173.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.749 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -68.32 -21.81 64.74 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.893 -177.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 1.027 ' HE2' ' HB3' ' A' ' 16' ' ' PHE . 26.5 mtpp -70.9 -6.84 41.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.002 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -124.64 -32.75 3.07 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.158 -179.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.749 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -156.89 162.58 39.66 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 84.2 mt -56.76 149.01 18.94 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.759 0.314 . . . . 0.0 110.381 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.61 ' HG2' ' HB2' ' A' ' 106' ' ' ALA . 38.1 mtt180 -69.66 -13.46 62.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.139 0.495 . . . . 0.0 110.542 -174.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -100.96 -7.33 23.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.126 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -78.91 75.77 5.41 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.203 0.525 . . . . 0.0 111.719 -174.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 71.93 -140.33 29.91 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.094 178.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.531 HD11 ' HB2' ' A' ' 42' ' ' ALA . 4.6 tp -161.93 -57.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.481 0.182 . . . . 0.0 111.351 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 40' ' ' PHE . 4.8 m -87.86 111.68 21.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.073 0.464 . . . . 0.0 110.951 -175.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.429 ' HD2' ' OH ' ' A' ' 5' ' ' TYR . 46.0 mtm105 -141.61 133.17 26.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.074 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.589 ' HB2' ' CG2' ' A' ' 131' ' ' THR . 6.0 m120 -102.39 119.01 38.09 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 176.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.9 t -113.8 123.76 69.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.078 -177.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 34.4 tp -110.58 121.76 46.1 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.11 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.3 mp -102.13 139.02 24.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.67 177.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.59 -174.17 4.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.055 0.455 . . . . 0.0 111.02 -177.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.626 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 32.4 ttt180 -69.84 -26.26 64.14 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.604 -175.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -80.17 -15.05 57.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.703 0.287 . . . . 0.0 111.254 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.2 16.38 30.19 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.08 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 81.2 mttt -101.24 154.87 18.39 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.907 0.384 . . . . 0.0 110.414 -178.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 53.9 mt -92.62 116.44 33.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.172 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.53 -31.32 2.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -173.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.859 ' HG2' ' HG ' ' A' ' 142' ' ' LEU . 50.5 tptt -124.66 114.27 19.11 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.908 -0.495 . . . . 0.0 111.194 -176.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.646 HD13 HG12 ' A' ' 9' ' ' ILE . 8.5 mp -110.99 105.13 13.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.746 176.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.593 ' HA ' ' NH1' ' A' ' 132' ' ' ARG . 10.0 t -125.43 158.69 33.75 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.074 0.464 . . . . 0.0 110.721 177.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.593 ' NH1' ' HA ' ' A' ' 131' ' ' THR . 0.0 OUTLIER -116.24 116.47 27.85 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.144 -178.199 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 132' ' ' ARG . 4.6 pp 51.11 -175.01 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.526 1.141 . . . . 0.0 112.968 -178.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.996 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 90.5 t80 -69.75 84.13 0.46 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.647 0.737 . . . . 0.0 111.56 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.562 ' HB3' ' HB2' ' A' ' 138' ' ' GLU . 57.8 t-20 -86.7 133.57 33.67 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 171.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -52.04 -68.07 0.2 Allowed 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.36 0.413 . . . . 0.0 110.843 -176.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -55.99 -59.1 5.39 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.544 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.629 ' O ' ' HB2' ' A' ' 142' ' ' LEU . 29.0 mt-10 -63.02 -23.38 67.43 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -170.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.52 ' O ' HG23 ' A' ' 143' ' ' VAL . 82.0 t80 -75.21 -44.9 43.79 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 172.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.32 -48.88 79.83 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.99 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.431 ' OG ' ' HA ' ' A' ' 138' ' ' GLU . 2.5 p -62.69 -38.0 88.67 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.64 0.257 . . . . 0.0 111.141 177.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.859 ' HG ' ' HG2' ' A' ' 129' ' ' LYS . 1.5 tt -64.75 -50.41 66.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.244 -179.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 139' ' ' PHE . 86.1 t -58.69 -49.51 82.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.083 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -63.81 -39.15 93.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.371 -177.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.623 ' O ' ' HG3' ' A' ' 149' ' ' MET . 8.0 tt0 -61.02 -45.79 93.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.018 176.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.533 ' O ' HD23 ' A' ' 150' ' ' LEU . 57.7 mt -55.61 -46.27 79.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.799 177.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -54.71 -42.49 71.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.609 178.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -69.27 -35.65 76.28 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.172 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.623 ' HG3' ' O ' ' A' ' 145' ' ' GLN . 80.5 mtp -70.46 -19.3 62.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.299 0.571 . . . . 0.0 110.088 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.533 HD23 ' O ' ' A' ' 146' ' ' ILE . 4.3 mm? -83.11 -14.6 53.3 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.109 174.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 17.5 mtmm -97.57 -42.37 7.71 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 61.56 -155.35 0.35 Allowed 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.926 176.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.529 ' O ' ' HB2' ' A' ' 156' ' ' HIS . . . 102.19 97.29 2.35 Favored Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -178.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -74.46 -1.16 19.96 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.132 0.491 . . . . 0.0 111.392 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -104.72 31.25 4.86 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 172.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.529 ' HB2' ' O ' ' A' ' 153' ' ' GLY . 58.0 t-80 -74.26 52.99 0.49 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.58 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -145.92 154.78 42.32 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -83.88 61.5 6.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.209 0.528 . . . . 0.0 109.592 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 . . . . . 0 C--O 1.24 0.573 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.272 -179.048 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 mpp? . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 120.614 0.245 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.3 m -70.25 102.53 2.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.794 0.331 . . . . 0.0 110.899 -178.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.9 mt -107.79 4.46 25.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.159 0.504 . . . . 0.0 110.548 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.41 -3.03 78.91 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.254 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -89.2 145.56 25.34 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 177.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.474 HD13 ' H ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -105.96 -9.79 10.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 169.662 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.2 p -94.89 158.78 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.872 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.554 ' HB2' ' HG2' ' A' ' 11' ' ' GLU . 24.8 mtt180 -127.65 168.91 14.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.782 0.325 . . . . 0.0 111.038 -171.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.53 HG12 HD21 ' A' ' 130' ' ' LEU . 75.2 mt -78.25 117.83 24.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.75 174.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.95 -25.58 9.37 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.706 -177.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.554 ' HG2' ' HB2' ' A' ' 8' ' ' ARG . 71.6 mm-40 -66.73 152.92 44.53 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.711 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 59.7 mtp -81.48 134.6 35.55 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 175.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.495 ' HB3' HH12 ' A' ' 32' ' ' ARG . . . -59.53 133.82 88.75 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.293 -176.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 15.6 Cg_exo -67.15 174.35 7.14 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.884 2.39 . . . . 0.0 112.18 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.53 ' O ' ' HE2' ' A' ' 107' ' ' LYS . 5.1 p-10 -76.54 163.69 26.67 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.32 177.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.576 ' HB2' HD12 ' A' ' 104' ' ' ILE . 23.0 p90 -174.11 148.91 1.39 Allowed 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 166.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.614 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 52.1 m -131.33 99.55 4.88 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 173.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.655 ' O ' ' HA ' ' A' ' 25' ' ' GLN . 16.6 tt -99.35 148.62 6.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.238 -171.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.7 m -98.16 114.84 27.19 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.059 177.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.423 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 96.4 mt -74.1 172.81 11.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.457 -178.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 96' ' ' LEU . 52.3 p -55.42 -27.07 45.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.997 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -96.61 14.54 24.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.351 -174.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.13 29.64 66.39 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.947 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.1 mmtp -108.88 120.58 42.93 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.735 0.303 . . . . 0.0 110.658 -176.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.655 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 25.1 mt-30 -98.23 128.11 44.52 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.749 -178.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.614 ' O ' ' HA ' ' A' ' 17' ' ' THR . 12.2 m -125.59 150.74 31.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.591 178.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 22.9 m -113.11 142.47 45.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.383 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.515 HD11 ' CD1' ' A' ' 121' ' ' ILE . 0.6 OUTLIER -62.37 -36.78 83.35 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.673 0.273 . . . . 0.0 111.101 -177.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.402 ' H ' HG22 ' A' ' 27' ' ' THR . 9.7 m -58.04 -27.13 63.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.711 -177.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.9 m -78.53 -20.61 50.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.06 0.457 . . . . 0.0 111.21 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.3 mt -102.21 17.73 22.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.632 -176.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.495 HH12 ' HB3' ' A' ' 13' ' ' ALA . 22.8 mmt180 -68.74 147.06 52.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.772 0.32 . . . . 0.0 110.689 178.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.77 -25.69 27.06 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.255 178.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.92 ' HB3' ' HZ3' ' A' ' 34' ' ' LYS . 0.7 OUTLIER -115.02 160.76 19.21 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.094 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 p -74.78 115.88 16.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.541 0.686 . . . . 0.0 110.41 -177.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.462 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 21.7 t -106.14 122.39 59.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.195 -177.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.531 ' SD ' ' HG ' ' A' ' 71' ' ' LEU . 2.1 tmt? -108.97 135.47 50.1 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.052 0.453 . . . . 0.0 110.125 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.483 HD21 ' CE2' ' A' ' 16' ' ' PHE . 7.0 mp -130.28 144.06 51.15 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.414 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.468 ' HB3' ' HE1' ' A' ' 37' ' ' MET . 0.0 OUTLIER -138.6 133.14 32.09 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 172.294 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.465 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 95.9 m-85 -99.49 105.36 17.27 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.91 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.2 t -115.52 -176.42 2.92 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.076 -172.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -169.16 139.91 2.32 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.577 ' H ' ' HG3' ' A' ' 78' ' ' GLU . 19.0 p -66.97 -23.38 65.94 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.882 0.372 . . . . 0.0 111.372 -174.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 65.4 p-90 -84.49 -2.31 57.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.66 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.4 t -90.07 139.26 30.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.269 0.557 . . . . 0.0 111.366 -178.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -93.56 -27.67 12.65 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.349 176.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 42.9 t -67.86 -39.51 81.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.87 0.367 . . . . 0.0 110.707 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.638 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 61.0 m -61.54 -15.9 42.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.761 178.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -78.41 -3.06 41.37 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.764 0.316 . . . . 0.0 110.913 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -85.93 -47.0 10.05 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.293 0.568 . . . . 0.0 109.832 165.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.638 ' HG2' ' HA ' ' A' ' 48' ' ' CYS . 14.2 pt-20 -75.0 -32.87 61.75 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.698 -172.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.554 ' CB ' ' HD3' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -48.96 -65.03 0.89 Allowed Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 175.28 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.554 ' HD3' ' CB ' ' A' ' 52' ' ' MET . 35.8 Cg_exo -60.88 -39.18 63.83 Favored 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 121.745 1.63 . . . . 0.0 112.844 177.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.646 ' HB3' ' CE2' ' A' ' 139' ' ' PHE . 8.2 m-85 -67.42 -46.73 72.32 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -176.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.13 -49.37 84.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 178.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.601 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 29.7 mm-40 -56.33 -44.52 80.09 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 123.399 0.437 . . . . 0.0 111.026 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -67.46 -49.17 64.8 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.705 -0.679 . . . . 0.0 112.276 -176.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.686 ' HA ' ' NZ ' ' A' ' 62' ' ' LYS . 42.3 m-20 -107.68 -51.2 2.94 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -170.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.4 mt -73.68 -49.05 37.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.867 -173.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.458 ' CD2' ' HB3' ' A' ' 94' ' ' TYR . 63.4 t-105 -71.63 -69.93 0.35 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.76 -178.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.601 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.4 OUTLIER -41.27 -40.27 1.59 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -171.729 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.686 ' NZ ' ' HA ' ' A' ' 58' ' ' ASP . 36.9 mmtm -75.97 -31.56 59.08 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -172.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -122.78 -43.06 2.27 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.876 -174.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.411 ' O ' ' HD2' ' A' ' 69' ' ' PHE . 53.6 mttt 51.64 -92.98 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 123.852 0.861 . . . . 0.0 111.504 -175.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -90.21 -61.04 1.77 Allowed 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 120.761 0.315 . . . . 0.0 110.471 176.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.5 ' ND2' HD12 ' A' ' 150' ' ' LEU . 0.9 OUTLIER 61.09 9.46 2.41 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.185 0.594 . . . . 0.0 111.408 175.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 68.27 -22.18 0.13 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.833 0.853 . . . . 0.0 112.869 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.586 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 3.2 t70 -138.81 22.76 2.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.369 0.604 . . . . 0.0 110.289 -174.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.57 ' HB2' HD11 ' A' ' 150' ' ' LEU . 86.4 t80 -127.28 116.18 20.16 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.198 173.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -114.65 104.42 11.97 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.727 -178.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.531 ' HG ' ' SD ' ' A' ' 37' ' ' MET . 5.6 tt -104.29 114.95 29.53 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.9 mp -120.83 117.26 52.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.118 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.523 ' HA3' HD23 ' A' ' 96' ' ' LEU . . . -90.33 131.8 10.94 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.315 -0.945 . . . . 0.0 110.938 175.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 45.9 mt -119.27 119.59 61.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 117.046 0.423 . . . . 0.0 110.679 -175.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -85.72 136.04 33.51 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 173.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.527 ' HG2' ' HB2' ' A' ' 102' ' ' ALA . 21.6 ttp180 -68.71 -45.25 72.09 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.408 -0.814 . . . . 0.0 112.689 -170.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -158.87 8.73 0.13 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -169.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.577 ' HG3' ' H ' ' A' ' 43' ' ' SER . 14.1 mm-40 -86.65 138.11 33.68 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-O 120.951 0.405 . . . . 0.0 110.678 176.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.426 ' HD2' ' HG3' ' A' ' 82' ' ' LYS . 34.5 Cg_endo -69.24 -173.6 0.67 Allowed 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.901 2.401 . . . . 0.0 113.651 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.436 ' O ' HD23 ' A' ' 84' ' ' LEU . 2.8 tm? -59.27 -56.66 19.33 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.062 -169.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.423 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -67.02 -34.31 77.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.473 -173.099 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.426 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 14.4 mmmm -60.26 -50.4 73.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.925 177.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 95.7 t -61.28 -48.26 89.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.104 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.436 HD23 ' O ' ' A' ' 80' ' ' LEU . 4.4 mm? -61.28 -52.66 63.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.623 -177.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.12 -37.27 86.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.511 -178.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -68.84 -41.34 78.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.719 -0.218 . . . . 0.0 110.918 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.546 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -66.16 -41.7 89.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.737 0.78 . . . . 0.0 109.549 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -58.99 -30.25 67.82 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.218 -1.355 . . . . 0.0 111.437 176.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.3 m -99.85 -1.38 37.61 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -176.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.1 p -113.53 -5.12 13.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.845 0.355 . . . . 0.0 111.494 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.09 -5.32 83.12 Favored Glycine 0 C--O 1.228 -0.277 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.368 177.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.517 ' CG2' ' HG3' ' A' ' 52' ' ' MET . 69.2 t -57.27 121.92 5.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.099 0.476 . . . . 0.0 111.551 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.422 ' H ' ' CD ' ' A' ' 56' ' ' GLU . 75.3 p -114.53 -15.56 12.0 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.383 176.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.458 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 36.8 p90 -71.57 144.73 89.15 Favored Pre-proline 0 C--O 1.233 0.236 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 173.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.34 124.71 13.79 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.415 2.076 . . . . 0.0 113.132 -176.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.546 HD12 ' HB2' ' A' ' 87' ' ' ALA . 84.8 mt -99.17 153.29 19.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.476 173.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -122.83 156.13 17.24 Favored Glycine 0 N--CA 1.437 -1.24 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 174.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.58 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.4 pt? -116.11 119.88 37.26 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.734 0.267 . . . . 0.0 110.349 -178.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -117.25 76.1 8.79 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.402 178.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.11 107.46 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.481 2.12 . . . . 0.0 111.936 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 131.59 -27.31 3.74 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -176.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.527 ' HB2' ' HG2' ' A' ' 76' ' ' ARG . . . 66.98 24.61 9.52 Favored 'General case' 0 CA--C 1.522 -0.097 0 C-N-CA 122.992 0.517 . . . . 0.0 111.373 176.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -70.94 -41.43 71.14 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.173 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.576 HD12 ' HB2' ' A' ' 16' ' ' PHE . 48.3 mm -62.05 -33.77 60.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.379 0.609 . . . . 0.0 109.62 174.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -70.21 -39.21 75.29 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.427 175.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.552 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -66.15 -28.92 69.15 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -174.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.53 ' HE2' ' O ' ' A' ' 15' ' ' ASP . 13.6 ptmt -79.46 -1.96 39.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.994 0.426 . . . . 0.0 111.276 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -112.09 -50.92 2.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.21 172.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.552 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -141.05 152.81 45.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.408 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.418 ' HB3' ' OD1' ' A' ' 112' ' ' ASP . 97.3 mt -62.38 139.26 58.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.849 0.357 . . . . 0.0 111.041 -178.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -66.01 -25.62 67.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.209 0.528 . . . . 0.0 110.837 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.418 ' OD1' ' HB3' ' A' ' 110' ' ' LEU . 4.2 p-10 -83.99 -8.49 59.14 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.171 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.83 -8.02 57.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.373 -178.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.27 -128.19 8.25 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.444 174.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.527 HD13 ' HD3' ' A' ' 76' ' ' ARG . 8.1 tp -154.25 173.65 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -174.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.437 ' N ' HG13 ' A' ' 115' ' ' ILE . 28.2 m 71.0 81.54 0.16 Allowed 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.476 0.655 . . . . 0.0 111.279 175.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.6 mmt85 -133.8 131.9 39.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.111 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.623 ' HB3' HG22 ' A' ' 131' ' ' THR . 0.2 OUTLIER -116.1 119.67 36.57 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.179 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.517 ' N ' HD22 ' A' ' 118' ' ' ASN . 63.2 t -113.76 131.81 64.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.996 -177.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.722 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 36.7 tp -119.36 122.04 40.91 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.316 0.579 . . . . 0.0 110.875 177.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.515 ' CD1' HD11 ' A' ' 28' ' ' LEU . 53.6 mt -100.7 135.08 38.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.778 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.86 -176.91 5.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.212 0.53 . . . . 0.0 111.09 -176.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -68.41 -23.32 64.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.001 -175.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -80.78 -26.62 37.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.979 0.418 . . . . 0.0 110.769 175.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 112.4 12.22 13.82 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.352 -0.928 . . . . 0.0 112.311 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.711 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 77.5 mttt -97.13 160.62 14.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.822 0.344 . . . . 0.0 110.66 -178.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 47.0 mt -95.79 109.59 22.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 175.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 30.7 m -110.59 1.13 9.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.918 -174.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.799 ' HG2' ' HG ' ' A' ' 142' ' ' LEU . 51.7 tptt -160.94 114.05 1.98 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 -175.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.558 ' HA ' ' O ' ' A' ' 118' ' ' ASN . 0.4 OUTLIER -138.4 105.98 5.59 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.171 0.51 . . . . 0.0 110.449 176.35 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.623 HG22 ' HB3' ' A' ' 118' ' ' ASN . 10.1 t -99.46 155.89 17.32 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.095 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.446 ' NE ' ' H ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -122.49 132.74 54.48 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.538 -179.807 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.437 ' O ' ' HB3' ' A' ' 134' ' ' TYR . 3.1 mp 66.45 36.03 5.31 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 123.71 0.631 . . . . 0.0 110.614 176.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.437 ' HB3' ' O ' ' A' ' 133' ' ' LEU . 45.8 t80 71.2 -66.38 0.3 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.518 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.596 ' HB3' ' HB3' ' A' ' 138' ' ' GLU . 0.8 OUTLIER 64.54 113.18 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.046 0.45 . . . . 0.0 110.954 -175.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -49.95 -56.4 10.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.785 -174.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.09 -36.24 27.8 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.343 -174.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.596 ' HB3' ' HB3' ' A' ' 135' ' ' ASN . 3.4 tp10 -63.54 -38.72 92.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.962 0.41 . . . . 0.0 110.128 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.646 ' CE2' ' HB3' ' A' ' 54' ' ' PHE . 76.6 t80 -70.65 -41.48 72.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.994 176.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.56 -49.6 75.84 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.827 0.346 . . . . 0.0 110.894 177.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 34.3 p -61.5 -34.11 74.93 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.69 177.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.799 ' HG ' ' HG2' ' A' ' 129' ' ' LYS . 4.6 tt -66.83 -42.94 84.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.255 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.473 ' O ' ' HB ' ' A' ' 146' ' ' ILE . 95.0 t -59.09 -51.47 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 120.782 0.325 . . . . 0.0 111.345 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.449 ' HA ' ' OE1' ' A' ' 144' ' ' GLN . 6.4 tp60 -62.0 -38.38 88.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.304 0.573 . . . . 0.0 110.168 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.445 HE22 ' HB2' ' A' ' 129' ' ' LYS . 29.0 tt0 -63.03 -36.88 85.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.724 177.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.588 ' O ' HD23 ' A' ' 150' ' ' LEU . 30.2 mm -55.09 -53.03 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 120.929 0.395 . . . . 0.0 110.259 174.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.518 ' O ' ' HB3' ' A' ' 151' ' ' LYS . 85.7 m-20 -53.06 -45.15 67.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.265 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -65.05 -37.37 87.36 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.128 0.268 . . . . 0.0 111.251 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.4 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 84.2 mmm -60.98 -29.97 69.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.65 0.738 . . . . 0.0 109.723 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.588 HD23 ' O ' ' A' ' 146' ' ' ILE . 4.0 mm? -89.35 -16.72 30.38 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.62 178.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.518 ' HB3' ' O ' ' A' ' 147' ' ' ASN . 0.0 OUTLIER -101.55 -4.46 26.67 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.935 -173.264 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -27.31 -69.56 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.685 1.194 . . . . 0.0 111.948 174.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 41.05 53.92 3.8 Favored Glycine 0 C--N 1.335 0.516 0 O-C-N 123.904 0.752 . . . . 0.0 114.09 174.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 2.9 m80 -46.75 -80.1 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 55.33 -152.06 0.37 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -175.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 24.7 p80 -120.77 23.85 10.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.682 0.753 . . . . 0.0 109.054 171.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -165.37 91.8 0.53 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.424 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -102.33 3.06 37.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.442 0.639 . . . . 0.0 109.713 178.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 16.8 p80 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 117.751 -1.119 . . . . 0.0 108.132 174.644 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.1 m -80.46 91.5 5.74 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 177.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 87.7 mt -142.83 100.93 3.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.127 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.838 ' H ' ' HB1' ' A' ' 113' ' ' ALA . . . -89.61 71.49 2.25 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.576 -177.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -81.43 120.52 25.09 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.684 0.278 . . . . 0.0 110.9 178.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.516 HG12 ' HA ' ' A' ' 109' ' ' ALA . 47.3 pt -92.84 -22.07 5.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.147 175.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.492 ' CG1' HD12 ' A' ' 127' ' ' ILE . 36.3 t -102.39 147.37 9.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.416 177.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 57.2 mtt85 -120.26 168.54 11.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.047 0.451 . . . . 0.0 111.893 -168.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.633 HG12 HD13 ' A' ' 130' ' ' LEU . 77.0 mt -75.18 127.19 36.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.071 176.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.6 -9.26 77.49 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -175.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -92.03 151.38 20.49 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.675 ' HA ' ' HA ' ' A' ' 126' ' ' LYS . 56.7 mtp -80.95 144.76 31.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.096 0.474 . . . . 0.0 111.346 -172.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.435 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -86.37 134.01 39.19 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.275 -177.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 13.3 Cg_exo -70.88 139.67 36.83 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.033 2.489 . . . . 0.0 112.033 177.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -75.78 164.81 25.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.277 -178.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -165.2 162.17 19.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.872 -176.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 37.3 m -124.72 110.59 14.54 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 175.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.4 tt -112.78 151.97 14.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.453 -171.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.509 ' HB ' ' CD2' ' A' ' 98' ' ' LEU . 2.8 m -89.34 126.32 35.48 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.142 177.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.0 mt -82.01 178.36 8.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.733 0.302 . . . . 0.0 111.082 177.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.48 ' HB ' HD11 ' A' ' 84' ' ' LEU . 16.5 p -59.37 -26.26 64.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.791 -176.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.618 ' OD2' ' HG2' ' A' ' 24' ' ' LYS . 7.4 p-10 -94.2 -18.23 21.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.185 0.517 . . . . 0.0 110.418 -178.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 115.56 0.52 21.76 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.412 -177.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.618 ' HG2' ' OD2' ' A' ' 22' ' ' ASP . 4.8 mmmp? -66.44 126.87 30.21 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-O 121.088 0.471 . . . . 0.0 111.696 178.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -88.67 120.92 30.51 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.445 172.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 17' ' ' THR . 11.3 m -123.66 151.83 28.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.826 0.346 . . . . 0.0 110.324 177.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.2 m -110.11 151.72 26.89 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.414 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.07 -35.35 80.45 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.538 ' HA ' ' CG ' ' A' ' 32' ' ' ARG . 37.7 t -56.88 -23.45 44.63 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.96 177.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.1 m -69.57 -24.0 63.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.27 0.557 . . . . 0.0 110.675 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.445 HD13 ' HB1' ' A' ' 70' ' ' ALA . 67.3 mt -116.1 11.57 15.32 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.932 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.538 ' CG ' ' HA ' ' A' ' 29' ' ' SER . 9.2 mmm180 -74.75 104.18 5.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.975 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 147.79 -24.75 1.48 Allowed Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.515 ' HB3' ' OD1' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -115.45 174.74 5.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.161 -0.519 . . . . 0.0 110.466 177.883 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 68' ' ' ASP . 26.8 m -74.72 128.59 36.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.0 t -123.68 112.17 32.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 120.959 0.409 . . . . 0.0 110.575 -176.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.442 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 27.3 ttt -95.98 127.12 41.72 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.734 178.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.6 mp -122.05 137.15 54.92 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.771 176.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.4 pm0 -126.91 129.3 47.92 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 171.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' A' ' 116' ' ' THR . 96.8 m-85 -90.73 110.39 21.58 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.007 -179.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.631 HG23 ' SG ' ' A' ' 48' ' ' CYS . 28.5 m -119.49 165.21 14.68 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.438 -166.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.586 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . . . -145.11 147.12 32.18 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 171.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.453 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 81.0 p -60.56 -21.52 62.65 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -174.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 8.5 p-90 -103.06 3.68 36.32 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -175.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.639 ' SG ' HD12 ' A' ' 115' ' ' ILE . 89.9 m -79.59 102.12 8.69 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.97 0.414 . . . . 0.0 111.082 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.98 -40.48 97.17 Favored Glycine 0 C--O 1.228 -0.271 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.874 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 56.9 t -61.4 -37.25 77.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.222 0.534 . . . . 0.0 110.614 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.631 ' SG ' HG23 ' A' ' 41' ' ' THR . 22.8 t -72.32 -14.85 61.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.762 -178.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -75.2 -7.28 53.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.971 0.415 . . . . 0.0 110.781 177.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.472 ' HD3' ' CD2' ' A' ' 134' ' ' TYR . 70.4 mttt -83.42 -47.84 10.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 122.343 1.068 . . . . 0.0 108.376 163.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.782 ' HB2' ' HB2' ' A' ' 134' ' ' TYR . 40.3 tt0 -58.24 -58.34 8.91 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 113.263 -1.789 . . . . 0.0 112.108 -173.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.795 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 96.1 mmm -50.3 -57.43 12.96 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -175.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.795 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 32.7 Cg_exo -61.49 -38.9 59.61 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 122.3 2.0 . . . . 0.0 112.823 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.508 ' HB3' ' CZ ' ' A' ' 139' ' ' PHE . 6.4 m-85 -65.41 -43.76 89.54 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.496 0.189 . . . . 0.0 111.305 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 51' ' ' GLU . 77.0 mt -58.03 -47.86 85.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 175.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.417 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 26.1 tp10 -54.75 -54.18 45.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.633 176.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -62.33 -59.31 5.19 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.181 -0.918 . . . . 0.0 113.226 -173.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.698 ' HA ' ' NZ ' ' A' ' 62' ' ' LYS . 67.9 m-20 -107.13 -13.53 15.14 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -166.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.2 mt -104.59 -57.24 4.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.476 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.542 ' CE2' ' HB3' ' A' ' 94' ' ' TYR . 71.3 t-105 -60.97 -68.32 0.32 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.868 -177.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.01 -23.49 2.07 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -175.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.698 ' NZ ' ' HA ' ' A' ' 58' ' ' ASP . 38.9 mmtm -87.42 -37.44 17.02 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -175.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -130.51 0.16 4.46 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -171.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.482 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 16.5 pttp -39.34 -51.91 2.04 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 -169.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.02 -83.66 0.16 Allowed 'General case' 0 C--O 1.251 1.163 0 CA-C-O 121.458 0.647 . . . . 0.0 110.117 -173.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 56.57 -153.46 0.36 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.366 -174.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -111.41 -14.21 13.78 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 168.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.515 ' OD1' ' HB3' ' A' ' 34' ' ' LYS . 5.6 m-20 -144.12 39.78 1.34 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.581 -1.19 . . . . 0.0 112.374 -172.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -121.24 128.63 52.58 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 119.134 -1.026 . . . . 0.0 110.266 168.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.445 ' HB1' HD13 ' A' ' 31' ' ' LEU . . . -130.22 142.48 50.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.841 177.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.442 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 5.6 tt -146.91 123.82 11.32 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 31.8 mt -130.6 129.88 64.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.487 ' HA3' HD22 ' A' ' 96' ' ' LEU . . . -88.05 131.83 10.87 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 175.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.0 mm -119.85 107.77 21.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 117.034 0.417 . . . . 0.0 110.842 -170.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.526 ' HA ' ' O ' ' A' ' 41' ' ' THR . 11.6 t70 -77.82 143.46 37.85 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.727 178.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 51.9 ttt-85 -71.01 -30.43 66.66 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -171.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -154.86 -32.67 0.1 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -174.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.408 ' OE1' ' HD3' ' A' ' 82' ' ' LYS . 11.9 mm-40 -61.96 141.72 95.46 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.101 0.477 . . . . 0.0 112.258 -166.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -74.51 179.83 5.53 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 123.018 2.479 . . . . 0.0 112.793 178.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.533 HD23 HD11 ' A' ' 98' ' ' LEU . 88.1 mt -49.37 -55.57 12.52 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.846 -178.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -50.52 -36.62 34.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.638 -173.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.408 ' HD3' ' OE1' ' A' ' 78' ' ' GLU . 41.8 mtpt -82.61 -45.61 14.35 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.77 0.319 . . . . 0.0 110.779 -178.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.576 HG21 ' HB3' ' A' ' 98' ' ' LEU . 91.0 t -56.53 -46.71 82.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.434 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.48 HD11 ' HB ' ' A' ' 21' ' ' THR . 4.1 mm? -58.52 -52.9 63.7 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.765 0.317 . . . . 0.0 111.361 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.49 -37.76 84.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.553 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.453 ' CD1' ' HA ' ' A' ' 43' ' ' SER . 91.8 t80 -65.88 -42.85 89.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.073 -179.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.507 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -66.43 -43.48 85.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.731 0.777 . . . . 0.0 109.897 178.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -59.6 -27.82 66.63 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.205 -1.361 . . . . 0.0 111.801 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.5 m -100.83 -0.47 36.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.837 -176.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.7 p -117.77 2.34 12.23 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.355 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.53 15.29 80.01 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.837 175.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 72.6 t -73.62 127.03 35.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -177.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 61.3 p -106.31 -24.16 12.35 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.526 174.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.542 ' HB3' ' CE2' ' A' ' 60' ' ' TRP . 34.8 p90 -71.2 145.03 90.49 Favored Pre-proline 0 C--O 1.232 0.136 0 CA-C-O 120.884 0.374 . . . . 0.0 111.118 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.76 134.83 56.21 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.826 2.351 . . . . 0.0 112.893 -177.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.507 HD12 ' HB2' ' A' ' 87' ' ' ALA . 53.8 mt -109.72 139.06 45.2 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.734 174.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -113.28 145.29 18.29 Favored Glycine 0 N--CA 1.439 -1.139 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 174.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.625 HD13 ' H ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -103.54 139.02 39.43 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.188 0.518 . . . . 0.0 110.937 -179.903 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -118.83 82.0 19.99 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.12 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.74 105.07 0.6 Allowed 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.409 2.073 . . . . 0.0 112.79 -176.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.96 8.64 27.47 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.581 178.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 52.31 42.14 30.81 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -81.04 -49.78 10.48 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.123 0.487 . . . . 0.0 110.692 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 98.7 mt -66.72 -31.38 53.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 176.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -60.15 -41.13 92.08 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.177 171.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.682 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -67.23 -24.49 65.82 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.811 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.423 ' O ' ' HG2' ' A' ' 14' ' ' PRO . 14.7 mptt -64.56 -23.69 67.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.963 0.411 . . . . 0.0 111.025 176.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -113.71 -11.74 12.9 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -173.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.682 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . 179.58 178.31 0.55 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.785 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 94.6 mt -67.87 133.93 50.01 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 175.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.452 ' HE ' ' HB2' ' A' ' 111' ' ' ARG . 1.5 mtm180 -52.39 -51.6 58.13 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 122.058 0.933 . . . . 0.0 110.578 -176.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.08 21.75 6.49 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.229 -1.35 . . . . 0.0 111.457 -172.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.838 ' HB1' ' H ' ' A' ' 4' ' ' GLY . . . -93.78 6.06 49.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.172 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 139.34 -164.5 25.91 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.464 178.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.759 HD13 ' N ' ' A' ' 116' ' ' THR . 0.0 OUTLIER -168.12 155.61 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.812 HG22 ' HA ' ' A' ' 133' ' ' LEU . 55.8 m 75.54 95.85 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.791 0.805 . . . . 0.0 110.386 -178.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -160.17 145.56 15.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.99 -177.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.591 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 31.1 m-80 -102.3 119.18 38.38 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.148 -178.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.1 t -118.3 109.97 28.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.843 -178.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 49.2 tp -100.31 117.06 33.74 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.699 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 53.8 mt -97.19 134.24 35.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.46 177.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.598 ' OD2' ' HB2' ' A' ' 126' ' ' LYS . 3.1 p30 -86.04 177.26 7.63 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.267 0.556 . . . . 0.0 111.261 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -66.15 -24.7 66.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.341 -177.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -80.41 -19.02 47.17 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.725 0.298 . . . . 0.0 110.557 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 106.85 12.02 25.15 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.12 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.675 ' HA ' ' HA ' ' A' ' 12' ' ' MET . 8.3 mtmp? -102.58 158.31 16.32 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.492 HD12 ' CG1' ' A' ' 7' ' ' VAL . 54.0 mt -94.5 125.67 47.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 174.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.7 m -105.47 -22.04 5.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.901 0.382 . . . . 0.0 111.764 -174.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.477 ' HA ' ' HD2' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -142.28 125.9 16.87 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.139 -0.624 . . . . 0.0 112.35 -172.081 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.633 HD13 HG12 ' A' ' 9' ' ' ILE . 10.5 mp -114.74 117.67 31.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.405 172.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.591 ' HB ' ' HB2' ' A' ' 118' ' ' ASN . 4.2 m -122.69 131.78 53.95 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.801 0.334 . . . . 0.0 110.651 171.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.622 ' O ' ' HD2' ' A' ' 132' ' ' ARG . 0.1 OUTLIER -93.09 120.6 33.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.745 178.932 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.812 ' HA ' HG22 ' A' ' 116' ' ' THR . 16.9 mt 61.93 179.96 0.12 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.557 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.782 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 84.6 t80 -83.95 97.96 9.54 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 171.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -107.63 120.52 42.45 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 173.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -43.7 -56.4 3.8 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 123.841 0.713 . . . . 0.0 112.803 -173.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.9 mp0 -56.65 -46.13 81.21 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -178.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -71.54 -35.2 70.58 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.602 -175.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.508 ' CZ ' ' HB3' ' A' ' 54' ' ' PHE . 81.4 t80 -66.06 -41.06 91.31 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 175.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.84 -41.97 98.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.42 175.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 24.1 m -63.27 -39.18 93.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.052 177.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.722 ' O ' HG12 ' A' ' 146' ' ' ILE . 35.6 mt -59.38 -52.46 65.52 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.575 177.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 139' ' ' PHE . 91.6 t -52.48 -50.27 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 O-C-N 123.376 0.422 . . . . 0.0 111.433 -178.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -60.41 -41.72 94.49 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.075 0.464 . . . . 0.0 110.339 178.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.437 HE21 ' HB3' ' A' ' 145' ' ' GLN . 5.6 tt0 -63.49 -42.24 98.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.687 178.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.722 HG12 ' O ' ' A' ' 142' ' ' LEU . 35.4 mm -56.73 -46.88 83.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -56.26 -43.38 78.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.692 177.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -72.89 -33.7 66.2 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.209 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . . . . . . . . . 92.1 mmm -65.41 -24.88 67.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.162 0.506 . . . . 0.0 110.378 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.614 HD23 ' O ' ' A' ' 146' ' ' ILE . 4.0 mm? -79.16 -19.35 51.2 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.205 176.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.8 mtmm -103.03 -19.01 14.73 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 121.088 -0.245 . . . . 0.0 110.635 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.545 ' CD ' ' H ' ' A' ' 153' ' ' GLY . 1.2 pp20? 36.86 -105.72 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.545 ' H ' ' CD ' ' A' ' 152' ' ' GLU . . . -85.08 30.09 4.07 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.662 -173.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -101.41 1.49 38.43 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.151 0.475 . . . . 0.0 110.062 177.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -97.31 9.45 42.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.427 0.632 . . . . 0.0 109.715 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.71 164.21 30.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.218 177.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 40.4 t60 -79.89 31.89 0.26 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.493 -177.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 37.3 m80 65.9 16.52 10.51 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.362 0.601 . . . . 0.0 109.884 -171.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 . . . . . 0 C--O 1.248 0.976 0 CA-C-N 114.761 -1.108 . . . . 0.0 108.649 179.963 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.724 ' HG3' HD12 ' A' ' 3' ' ' LEU . 20.2 ptt? . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.417 ' O ' ' HB2' ' A' ' 3' ' ' LEU . 5.4 m -83.59 -21.06 32.7 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 123.322 0.389 . . . . 0.0 111.755 -175.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.922 ' HA ' ' HD2' ' A' ' 132' ' ' ARG . 9.9 mp 70.54 -57.28 0.59 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.182 0.593 . . . . 0.0 111.65 -177.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.466 ' HA3' ' HB1' ' A' ' 113' ' ' ALA . . . 98.25 3.96 57.57 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.102 -0.571 . . . . 0.0 112.239 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.676 ' HD2' ' HB3' ' A' ' 3' ' ' LEU . 71.4 m-85 -80.18 133.22 36.02 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.86 0.362 . . . . 0.0 110.822 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 36.7 pt -101.8 -7.42 9.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.01 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.3 p -110.98 159.15 11.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.48 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 24.1 mtm-85 -120.71 165.66 14.78 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -168.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.543 HG12 HD23 ' A' ' 130' ' ' LEU . 62.1 mt -76.05 137.23 23.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.414 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.51 -26.09 23.25 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.083 178.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -67.75 150.88 48.09 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.723 ' SD ' ' HG2' ' A' ' 126' ' ' LYS . 63.3 mmm -71.79 124.03 23.92 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.51 ' HB2' HD12 ' A' ' 121' ' ' ILE . . . -54.89 140.72 60.05 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.08 -178.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.68 174.58 6.33 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.613 2.209 . . . . 0.0 112.254 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.53 ' O ' ' HB3' ' A' ' 16' ' ' PHE . 3.0 p-10 -78.69 174.4 11.45 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.999 177.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.702 ' CE2' ' HG ' ' A' ' 28' ' ' LEU . 16.5 p90 176.36 144.96 0.08 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.428 163.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.643 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 56.2 m -127.93 99.88 5.69 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.444 -0.798 . . . . 0.0 108.866 175.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 25' ' ' GLN . 20.3 tt -106.0 146.91 12.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.22 -171.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 24' ' ' LYS . 24.4 m -83.19 127.87 33.99 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.027 177.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.414 ' HA ' ' HA2' ' A' ' 97' ' ' GLY . 79.7 mt -84.46 177.62 8.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.144 0.497 . . . . 0.0 111.462 -178.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.406 ' HB ' HD21 ' A' ' 84' ' ' LEU . 21.8 p -62.74 -23.5 67.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.988 -175.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.537 ' OD2' ' HG2' ' A' ' 24' ' ' LYS . 7.5 p-10 -105.47 9.07 33.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.167 0.508 . . . . 0.0 110.527 -176.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.3 14.17 59.15 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.247 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.537 ' HG2' ' OD2' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -85.52 171.21 11.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.207 0.503 . . . . 0.0 109.865 175.6 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.407 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 50.7 mt-30 -136.09 129.12 31.39 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 176.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.643 ' O ' ' HA ' ' A' ' 17' ' ' THR . 21.7 m -119.52 150.49 21.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.673 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 9.4 m -117.86 142.7 47.03 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.996 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.702 ' HG ' ' CE2' ' A' ' 16' ' ' PHE . 0.6 OUTLIER -64.04 -22.68 67.03 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.623 0.249 . . . . 0.0 111.358 -179.033 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.442 ' H ' HG22 ' A' ' 27' ' ' THR . 11.0 m -61.25 -38.43 86.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.967 0.413 . . . . 0.0 110.645 177.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.5 m -73.09 -23.66 60.56 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.52 0.676 . . . . 0.0 110.784 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.408 ' HB2' HD23 ' A' ' 28' ' ' LEU . 91.7 mt -88.1 -9.19 54.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.761 -177.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.448 HH21 HD13 ' A' ' 28' ' ' LEU . 5.8 mmt180 -60.63 150.57 31.5 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.741 0.305 . . . . 0.0 110.422 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.8 -23.75 31.38 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.61 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 31.2 mtmm -117.45 157.3 26.47 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.842 -0.679 . . . . 0.0 109.985 -178.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 68' ' ' ASP . 18.3 m -71.43 131.42 34.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.183 0.516 . . . . 0.0 109.896 177.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.469 HG11 HD21 ' A' ' 28' ' ' LEU . 20.8 t -120.01 123.56 71.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.904 0.383 . . . . 0.0 110.824 -177.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.552 ' SD ' HG21 ' A' ' 59' ' ' ILE . 28.1 ttt -108.29 117.05 33.13 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.9 0.381 . . . . 0.0 110.525 177.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -104.66 103.79 13.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.205 178.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.595 ' OE1' ' HG2' ' A' ' 52' ' ' MET . 0.0 OUTLIER -103.38 112.59 25.56 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.707 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 74' ' ' ILE . 97.3 m-85 -91.86 120.06 32.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.78 -176.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 15.2 t -140.41 -178.43 5.49 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.756 -173.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.491 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . . . -162.76 157.07 21.09 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 122.721 0.408 . . . . 0.0 110.073 172.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.441 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 12.3 t -64.24 -32.54 74.17 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.672 -175.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 51.0 p-90 -83.85 8.17 15.72 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -174.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 43.4 t -99.62 130.87 45.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.964 0.411 . . . . 0.0 111.338 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -89.07 -28.48 20.52 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.624 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.4 t -67.32 -35.74 74.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.157 0.503 . . . . 0.0 110.269 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.59 ' HA ' ' HB3' ' A' ' 51' ' ' GLU . 59.4 m -65.78 -15.15 62.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.517 177.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.437 ' O ' ' HG2' ' A' ' 53' ' ' PRO . 84.4 mtt180 -78.74 -3.72 45.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.331 0.586 . . . . 0.0 110.148 177.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.465 ' NZ ' ' HE2' ' A' ' 134' ' ' TYR . 1.4 mmmp? -95.2 -52.39 4.21 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 162.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.728 ' O ' HG12 ' A' ' 55' ' ' ILE . 41.1 tt0 -56.36 -65.25 0.64 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 113.478 -1.692 . . . . 0.0 112.153 -173.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.595 ' HG2' ' OE1' ' A' ' 39' ' ' GLN . 1.7 mmm -56.29 -50.04 89.84 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -173.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.635 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 53.3 Cg_exo -55.34 -37.96 94.19 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 121.868 1.712 . . . . 0.0 112.097 176.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -72.69 -37.5 67.85 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.426 177.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.728 HG12 ' O ' ' A' ' 51' ' ' GLU . 28.9 mm -55.04 -57.48 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 121.025 0.441 . . . . 0.0 110.147 177.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.705 ' HG2' ' HA ' ' A' ' 92' ' ' VAL . 0.5 OUTLIER -66.18 -43.66 86.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.359 -177.617 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.635 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 3.7 ttmm -62.46 -41.52 98.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.775 -172.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.639 ' O ' ' HG2' ' A' ' 62' ' ' LYS . 6.1 t70 -104.61 -65.09 1.06 Allowed 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.877 178.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.552 HG21 ' SD ' ' A' ' 37' ' ' MET . 25.1 mm -54.01 -46.77 65.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-O 120.97 0.414 . . . . 0.0 111.113 -171.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.522 ' HB3' ' O ' ' A' ' 56' ' ' GLU . 73.5 t-105 -73.92 -60.65 2.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.17 -178.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.564 HD13 ' CE ' ' A' ' 64' ' ' LYS . 3.8 mm? -50.72 -35.09 29.61 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -173.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.639 ' HG2' ' O ' ' A' ' 58' ' ' ASP . 33.7 mmtp -73.93 -27.98 61.29 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -175.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 -126.38 -43.85 1.74 Allowed 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.191 -0.604 . . . . 0.0 112.626 -172.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.564 ' CE ' HD13 ' A' ' 61' ' ' LEU . 55.2 mttt 45.75 -89.82 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.011 0.924 . . . . 0.0 112.679 -176.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -87.31 -71.03 0.58 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 65.03 -4.07 0.53 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.206 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 68.48 -6.65 0.78 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.961 0.904 . . . . 0.0 112.125 -176.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.61 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 3.9 t70 -137.89 8.35 2.77 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.951 0.405 . . . . 0.0 110.692 -177.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.552 ' CE2' ' HB2' ' A' ' 71' ' ' LEU . 72.3 t80 -116.01 119.07 34.68 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.096 -0.642 . . . . 0.0 111.283 -174.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.75 107.9 12.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.669 178.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.552 ' HB2' ' CE2' ' A' ' 69' ' ' PHE . 1.7 tt -117.46 120.55 38.47 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 52.6 mt -129.89 131.31 66.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.759 0.314 . . . . 0.0 110.288 179.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.58 116.94 4.62 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 176.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 40' ' ' PHE . 25.6 mm -103.92 111.36 33.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 116.615 0.208 . . . . 0.0 110.6 -173.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.522 ' HA ' ' O ' ' A' ' 41' ' ' THR . 8.9 t70 -80.79 140.06 35.68 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 44.4 ttt-85 -78.26 -30.92 48.82 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -172.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -163.45 -16.01 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -170.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.493 ' CD ' ' HD2' ' A' ' 82' ' ' LYS . 6.0 mm-40 -77.33 137.06 64.4 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.141 0.496 . . . . 0.0 110.793 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.489 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 30.7 Cg_endo -68.39 -174.59 0.7 Allowed 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.098 2.532 . . . . 0.0 114.576 -177.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.652 HD23 HD23 ' A' ' 84' ' ' LEU . 5.2 tt -54.26 -59.04 5.2 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.299 -1.319 . . . . 0.0 112.393 -170.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.489 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -61.31 -36.31 79.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.914 -171.883 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.493 ' HD2' ' CD ' ' A' ' 78' ' ' GLU . 42.2 mttt -64.36 -48.23 76.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.033 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 79' ' ' PRO . 57.9 t -53.84 -46.47 63.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.554 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.652 HD23 HD23 ' A' ' 80' ' ' LEU . 4.4 mm? -62.4 -50.37 71.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.042 178.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.48 97.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.712 -177.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.441 ' CD1' ' HA ' ' A' ' 43' ' ' SER . 62.4 t80 -66.93 -43.47 83.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.916 -178.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.19 -39.77 86.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.441 0.638 . . . . 0.0 110.212 178.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -59.12 -39.72 83.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.315 176.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.8 m -86.02 -19.31 30.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.162 -174.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.5 p -93.57 -29.81 15.3 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.426 -179.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 112.64 -3.02 26.17 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.161 178.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.705 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 60.6 t -50.88 115.89 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 122.794 0.438 . . . . 0.0 111.866 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.7 m -100.43 0.32 39.56 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.454 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.487 ' CE2' HG13 ' A' ' 92' ' ' VAL . 54.3 p90 -102.12 152.9 38.31 Favored Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.142 178.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.93 148.75 76.9 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.568 2.179 . . . . 0.0 113.107 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.482 HD11 HG11 ' A' ' 92' ' ' VAL . 5.2 mp -124.78 159.51 30.8 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.412 179.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 20' ' ' LEU . . . -125.76 147.93 16.8 Favored Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 174.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.572 HD23 ' H ' ' A' ' 98' ' ' LEU . 0.6 OUTLIER -105.09 132.23 51.59 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.82 0.31 . . . . 0.0 110.737 -177.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -120.39 75.91 24.85 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.47 178.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -65.29 101.08 0.4 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.476 2.117 . . . . 0.0 112.09 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 126.5 -7.5 7.47 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.862 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 58.18 44.01 19.64 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.691 0.396 . . . . 0.0 111.486 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -89.99 -46.54 8.44 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.129 0.49 . . . . 0.0 110.086 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.659 HD12 ' HB2' ' A' ' 16' ' ' PHE . 33.4 mm -61.76 -36.1 71.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 172.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -63.65 -39.15 93.62 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 113.624 -1.626 . . . . 0.0 110.467 174.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.701 ' HB2' ' HG2' ' A' ' 111' ' ' ARG . . . -71.72 -30.61 65.83 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -174.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.5 ' HE2' ' O ' ' A' ' 15' ' ' ASP . 13.1 ptmt -79.11 -1.78 37.53 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.857 -175.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -108.14 -37.69 5.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.223 0.535 . . . . 0.0 110.807 171.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.581 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -152.74 166.0 33.56 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.9 pp -60.42 163.98 4.77 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.85 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.701 ' HG2' ' HB2' ' A' ' 106' ' ' ALA . 50.5 mtt-85 -75.94 58.21 1.14 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -164.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 19.2 t70 169.68 -75.1 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.034 -1.439 . . . . 0.0 107.783 173.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.559 ' HB3' ' NH2' ' A' ' 117' ' ' ARG . . . 47.91 27.06 1.07 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.986 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.476 ' HA3' ' NH2' ' A' ' 132' ' ' ARG . . . 72.32 106.81 0.06 OUTLIER Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -170.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.441 ' O ' ' HB ' ' A' ' 116' ' ' THR . 19.2 tt -64.77 167.29 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.889 HG22 ' HA ' ' A' ' 133' ' ' LEU . 32.9 m 75.31 88.57 0.09 Allowed 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -174.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.974 ' HG2' ' HA ' ' A' ' 132' ' ' ARG . 41.0 mtm105 -157.61 145.76 19.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.451 -177.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -112.61 119.39 37.96 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.844 -177.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 72.2 t -110.01 107.32 22.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.838 177.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.659 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 55.0 tp -98.4 133.74 42.37 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.939 0.4 . . . . 0.0 110.337 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.51 HD12 ' HB2' ' A' ' 13' ' ' ALA . 38.2 mm -114.52 134.49 57.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.002 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.33 160.7 30.78 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 176.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 6.8 ptm180 -68.0 -22.03 65.01 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -173.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.583 ' HB2' ' HZ3' ' A' ' 126' ' ' LYS . 46.2 mt-10 -76.28 -18.52 58.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.293 0.568 . . . . 0.0 110.087 175.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 109.79 9.67 24.31 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.687 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.723 ' HG2' ' SD ' ' A' ' 12' ' ' MET . 35.3 mtmm -91.02 139.36 30.84 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.165 0.483 . . . . 0.0 110.725 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.47 HG12 HD12 ' A' ' 121' ' ' ILE . 35.3 mt -70.53 121.64 20.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.44 HG12 ' O ' ' A' ' 120' ' ' LEU . 8.7 p -114.19 -31.54 2.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -164.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.659 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 7.1 tmtm? -145.36 112.28 5.98 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.316 -0.553 . . . . 0.0 111.154 -174.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.543 HD23 HG12 ' A' ' 9' ' ' ILE . 2.8 mm? -112.2 111.74 22.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.888 175.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.2 t -129.32 162.46 27.9 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.689 175.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.974 ' HA ' ' HG2' ' A' ' 117' ' ' ARG . 28.8 mtp-105 -112.53 132.62 55.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.059 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.889 ' HA ' HG22 ' A' ' 116' ' ' THR . 4.6 pp 53.84 172.27 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.93 1.292 . . . . 0.0 113.687 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.465 ' HE2' ' NZ ' ' A' ' 50' ' ' LYS . 54.3 t80 -84.17 94.93 8.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.109 177.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.532 ' HB3' ' HB3' ' A' ' 138' ' ' GLU . 11.6 t30 -95.39 133.45 39.33 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 172.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -55.53 -56.94 14.39 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 123.163 0.289 . . . . 0.0 111.667 -169.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.512 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.5 mp0 -63.95 -33.13 75.02 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.178 0.513 . . . . 0.0 110.677 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.532 ' HB3' ' HB3' ' A' ' 135' ' ' ASN . 7.2 tp10 -65.63 -44.95 84.89 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.088 -178.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.622 ' O ' HG23 ' A' ' 143' ' ' VAL . 90.5 t80 -60.96 -43.52 98.6 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.167 178.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.73 -44.9 86.32 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.007 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.7 m -63.33 -43.59 97.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.629 177.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.62 -44.3 96.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.597 -178.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 139' ' ' PHE . 95.7 t -56.75 -59.41 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.994 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -57.59 -36.91 72.35 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.534 -177.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.643 ' O ' ' HG3' ' A' ' 149' ' ' MET . 6.7 tt0 -62.62 -53.56 52.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.414 177.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 64.3 mt -56.74 -42.2 76.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 120.962 0.41 . . . . 0.0 110.835 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.779 ' O ' ' HG3' ' A' ' 151' ' ' LYS . 93.5 m-20 -51.16 -55.05 19.86 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.275 178.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -64.18 -29.01 70.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.321 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.643 ' HG3' ' O ' ' A' ' 145' ' ' GLN . 92.8 mtp -61.4 -36.7 81.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.574 0.226 . . . . 0.0 110.842 -176.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.71 -10.11 30.12 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.293 -0.563 . . . . 0.0 112.424 178.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.779 ' HG3' ' O ' ' A' ' 147' ' ' ASN . 8.7 mtmp? -85.91 -64.19 1.2 Allowed 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.687 174.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.491 ' CD ' ' H ' ' A' ' 153' ' ' GLY . 1.5 pp20? 34.44 -81.11 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.404 0 O-C-N 125.173 1.546 . . . . 0.0 114.452 -174.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.491 ' H ' ' CD ' ' A' ' 152' ' ' GLU . . . 70.68 23.9 77.38 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.364 -1.095 . . . . 0.0 110.364 -172.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 42.9 m-70 -100.13 -10.16 21.76 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.089 0.471 . . . . 0.0 110.113 -174.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.7 93.52 3.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.332 0.587 . . . . 0.0 110.706 175.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -55.88 134.98 52.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.544 175.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -80.65 -36.9 31.85 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -171.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 24.2 t-80 -157.12 10.2 0.2 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.124 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 . . . . . 0 C--O 1.242 0.672 0 CA-C-O 118.322 -0.846 . . . . 0.0 109.86 -179.458 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.8 mmm . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.753 ' O ' ' HA ' ' A' ' 113' ' ' ALA . 19.6 m -96.01 121.01 37.3 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.734 HD23 ' H ' ' A' ' 3' ' ' LEU . 1.6 pt? -63.06 91.43 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.701 0.762 . . . . 0.0 111.172 -177.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.59 78.21 1.94 Allowed Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.657 -177.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -81.62 102.84 10.92 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.168 0.509 . . . . 0.0 110.688 177.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.476 HG12 ' HA ' ' A' ' 109' ' ' ALA . 27.3 pt -95.22 9.53 5.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.769 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.657 HG11 HD12 ' A' ' 127' ' ' ILE . 23.2 t -118.45 153.77 20.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.135 -177.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.428 ' HB2' ' HB2' ' A' ' 11' ' ' GLU . 41.0 mtt180 -104.42 163.63 12.31 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.915 0.388 . . . . 0.0 110.924 -174.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.567 HG12 HD23 ' A' ' 130' ' ' LEU . 71.3 mt -83.16 117.78 29.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 170.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.88 0.39 56.29 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 -173.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 8' ' ' ARG . 4.1 tp10 -69.47 144.14 53.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.289 -0.456 . . . . 0.0 110.501 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.4 mmt -68.58 111.9 5.04 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 174.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.46 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . . . -58.25 133.96 84.69 Favored Pre-proline 0 C--O 1.237 0.396 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.604 -176.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 13' ' ' ALA . 6.4 Cg_exo -73.12 174.45 12.01 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.105 2.536 . . . . 0.0 112.245 178.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -81.7 168.74 17.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.663 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.62 ' HB2' HD12 ' A' ' 104' ' ' ILE . 33.5 p90 -177.57 143.56 0.36 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.316 165.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 62.7 m -117.72 106.43 13.05 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 173.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.1 tt -111.75 138.92 38.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.085 -169.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.2 m -88.2 117.95 27.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.399 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.3 mt -80.92 167.82 19.42 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.153 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.416 ' HB ' ' CD1' ' A' ' 84' ' ' LEU . 17.4 p -54.45 -28.08 41.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.512 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -93.6 15.32 16.44 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.166 -174.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.85 27.41 68.99 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.674 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 49.8 mmtm -108.48 119.26 38.99 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.624 0.25 . . . . 0.0 110.45 -176.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -94.95 115.23 27.19 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.189 178.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 17' ' ' THR . 20.2 m -114.96 150.59 16.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.428 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 20.7 m -110.87 142.67 42.6 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.911 177.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -60.06 -34.62 73.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.951 0.405 . . . . 0.0 110.56 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.42 ' H ' HG22 ' A' ' 27' ' ' THR . 9.4 m -62.86 -25.8 68.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.646 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.2 m -75.36 -21.29 58.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.218 0.532 . . . . 0.0 111.405 -176.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.8 mt -103.47 4.35 35.92 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.48 -178.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.548 ' CZ ' ' HA3' ' A' ' 125' ' ' GLY . 23.7 mmm-85 -65.83 109.67 2.56 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.113 0.482 . . . . 0.0 110.14 178.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.28 -29.44 2.61 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -173.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.416 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 27.2 mttt -96.06 173.08 7.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.237 -0.481 . . . . 0.0 109.985 176.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.455 HG11 ' HB3' ' A' ' 149' ' ' MET . 30.6 m -84.64 108.74 17.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 169.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.467 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 21.2 t -102.6 113.28 38.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.336 -172.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.446 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 27.1 ttt -98.41 124.31 43.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.451 177.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.431 ' HB2' ' HB ' ' A' ' 119' ' ' VAL . 3.2 mm? -109.86 112.99 25.36 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.857 177.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.478 HE22 ' HB ' ' A' ' 41' ' ' THR . 26.2 tm0? -107.28 107.1 17.87 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -82.22 127.31 33.05 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.52 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 12.4 t -140.44 176.19 8.98 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.136 0.493 . . . . 0.0 111.141 -172.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.464 ' HB2' HG12 ' A' ' 115' ' ' ILE . . . -152.36 133.5 14.28 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.494 177.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.487 ' OG ' ' HB3' ' A' ' 82' ' ' LYS . 12.4 p -63.59 -9.21 12.36 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -177.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 12.4 p-90 -108.79 12.82 25.38 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.84 0.352 . . . . 0.0 111.496 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 49.4 t -108.09 111.8 24.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.923 0.392 . . . . 0.0 110.695 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.1 -22.88 77.41 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.675 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.2 t -63.66 -34.58 68.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.204 0.526 . . . . 0.0 110.214 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.575 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 64.1 m -67.34 -22.33 65.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.705 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.489 ' O ' ' HG2' ' A' ' 53' ' ' PRO . 26.5 mtp-105 -73.69 -3.16 26.57 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.086 0.47 . . . . 0.0 110.583 178.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -97.74 -58.01 2.1 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.059 171.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.954 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 11.3 pt-20 -64.23 -47.96 77.67 Favored 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -175.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.664 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 94.3 mtp -59.87 -51.78 78.34 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -173.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.664 ' HD3' ' HB2' ' A' ' 52' ' ' MET . 52.4 Cg_exo -59.06 -37.96 89.97 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.3 2.0 . . . . 0.0 112.649 174.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.439 ' HB3' ' CZ ' ' A' ' 139' ' ' PHE . 10.8 m-85 -67.39 -42.29 83.55 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.796 176.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 51' ' ' GLU . 94.6 mt -59.23 -48.79 85.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.173 177.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.57 ' HA ' ' HB3' ' A' ' 60' ' ' TRP . 2.0 pp20? -67.86 -35.25 78.21 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.633 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.565 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 7.9 ttmm -64.04 -44.32 92.86 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.522 -176.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.725 ' O ' ' HG2' ' A' ' 62' ' ' LYS . 3.9 t0 -106.15 -65.65 1.06 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.177 -0.609 . . . . 0.0 111.326 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.509 HG12 HG23 ' A' ' 143' ' ' VAL . 58.2 mt -56.84 -45.05 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 120.858 0.361 . . . . 0.0 111.609 -169.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.571 ' CD2' ' HB3' ' A' ' 94' ' ' TYR . 76.4 t-105 -75.37 -59.47 2.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.472 -177.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.526 HD13 ' O ' ' A' ' 56' ' ' GLU . 1.6 mp -53.83 -30.57 45.83 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -171.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.725 ' HG2' ' O ' ' A' ' 58' ' ' ASP . 31.8 mmtp -76.95 -24.88 52.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.868 0.366 . . . . 0.0 111.667 -177.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.462 ' CE1' ' HG ' ' A' ' 150' ' ' LEU . 73.8 m-70 -121.67 -41.37 2.48 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -172.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.403 ' HE3' ' HA ' ' A' ' 61' ' ' LEU . 33.1 mmtp 56.42 -95.38 0.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 122.917 0.487 . . . . 0.0 110.128 -167.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.44 ' O ' ' HB3' ' A' ' 66' ' ' ASN . 15.6 t70 -110.8 -32.07 6.97 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 171.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.44 ' HB3' ' O ' ' A' ' 65' ' ' ASP . 20.2 t-20 67.93 -68.82 0.15 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.038 -176.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 158.71 -33.91 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.627 1.571 . . . . 0.0 106.868 -175.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.416 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 15.1 t70 -125.55 18.66 8.1 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.258 -174.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -124.44 142.59 51.19 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.84 -0.537 . . . . 0.0 110.585 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -143.63 130.36 20.3 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.541 176.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.446 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 2.0 tt -132.92 114.67 14.31 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.1 mp -122.74 124.08 69.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.121 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 96' ' ' LEU . . . -91.92 136.3 13.19 Favored Glycine 0 C--O 1.222 -0.64 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 173.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 59.9 mt -119.93 103.53 14.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 117.742 0.771 . . . . 0.0 111.388 -175.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.52 ' HA ' ' O ' ' A' ' 41' ' ' THR . 34.4 t0 -80.66 133.1 35.67 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 171.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.536 ' HA ' ' HB3' ' A' ' 99' ' ' ASP . 5.7 ttp180 -71.28 -105.8 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -170.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.452 ' H ' ' HB3' ' A' ' 76' ' ' ARG . 10.1 m-20 -87.33 21.19 2.52 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -168.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -98.56 142.86 25.29 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-O 120.981 0.419 . . . . 0.0 111.449 -178.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.446 ' O ' HG23 ' A' ' 83' ' ' VAL . 64.9 Cg_endo -75.54 174.9 12.03 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.936 2.424 . . . . 0.0 112.86 178.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.443 HD23 HD11 ' A' ' 98' ' ' LEU . 32.5 mt -50.93 -50.32 57.96 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.441 -176.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -52.0 -39.82 60.04 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -176.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.487 ' HB3' ' OG ' ' A' ' 43' ' ' SER . 31.7 mmtp -66.84 -53.32 33.75 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.393 178.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 79' ' ' PRO . 15.3 t -60.7 -47.16 94.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.361 -175.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.416 ' CD1' ' HB ' ' A' ' 21' ' ' THR . 4.0 mm? -60.49 -48.6 81.07 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.902 0.382 . . . . 0.0 111.435 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.898 ' HA ' ' HE2' ' A' ' 88' ' ' LYS . . . -67.24 -35.8 80.31 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.307 -176.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.608 ' HE2' ' SD ' ' A' ' 52' ' ' MET . 56.1 t80 -72.51 -37.34 68.41 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.711 -178.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.433 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -62.46 -49.61 74.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.294 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.898 ' HE2' ' HA ' ' A' ' 85' ' ' ALA . 63.8 pttt -68.54 -29.93 68.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.29 -176.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.2 m -83.75 -2.04 55.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.725 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.473 ' HB ' ' HG3' ' A' ' 53' ' ' PRO . 11.1 p -115.64 -8.12 12.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.895 0.379 . . . . 0.0 110.902 175.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.69 4.14 87.68 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.273 178.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.401 HG13 ' CE1' ' A' ' 94' ' ' TYR . 42.6 t -59.98 114.86 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.171 0.51 . . . . 0.0 111.267 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 p -100.68 7.69 43.77 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.632 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.571 ' HB3' ' CD2' ' A' ' 60' ' ' TRP . 33.4 p90 -104.25 145.63 31.03 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.228 173.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -63.07 140.6 79.47 Favored 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 122.615 2.21 . . . . 0.0 112.925 -178.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' A' ' 73' ' ' GLY . 62.5 mt -113.02 144.63 42.25 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.173 176.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -112.22 164.56 12.08 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.886 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.443 HD11 HD23 ' A' ' 80' ' ' LEU . 7.0 mp -102.95 147.49 26.86 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.536 ' HB3' ' HA ' ' A' ' 76' ' ' ARG . 36.4 t0 -130.38 70.54 82.33 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-O 121.057 0.456 . . . . 0.0 110.803 174.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.15 110.25 1.72 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.673 2.248 . . . . 0.0 112.211 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.86 -1.21 31.84 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.72 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 54.74 40.01 31.67 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.883 0.373 . . . . 0.0 111.016 -175.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.587 ' O ' ' HG3' ' A' ' 107' ' ' LYS . 15.4 t70 -84.13 -45.71 12.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.511 -174.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.62 HD12 ' HB2' ' A' ' 16' ' ' PHE . 35.3 mm -66.11 -35.55 75.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 177.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.491 ' CE1' ' HD3' ' A' ' 117' ' ' ARG . 56.6 t80 -63.51 -37.18 86.33 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.808 174.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.783 ' HB2' ' HG2' ' A' ' 111' ' ' ARG . . . -69.83 -22.92 63.24 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.566 178.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.587 ' HG3' ' O ' ' A' ' 103' ' ' ASP . 44.5 mtpt -79.46 -3.13 45.16 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.254 178.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -130.99 -3.04 4.02 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.899 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.63 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -178.16 -176.24 0.52 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 122.887 0.475 . . . . 0.0 110.448 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.3 mt -72.92 157.95 36.44 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 172.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.783 ' HG2' ' HB2' ' A' ' 106' ' ' ALA . 48.6 mtt180 -78.2 -10.31 59.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.974 0.416 . . . . 0.0 111.063 -175.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -88.0 -68.77 0.74 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 171.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.753 ' HA ' ' O ' ' A' ' 2' ' ' SER . . . 21.2 -89.26 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.775 0 O-C-N 125.177 1.548 . . . . 0.0 113.885 -178.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -164.1 -138.42 2.41 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.464 HG12 ' HB2' ' A' ' 42' ' ' ALA . 7.4 tp -150.86 -50.33 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.674 177.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.709 ' HB ' ' HB3' ' A' ' 133' ' ' LEU . 1.0 OUTLIER -77.03 107.48 9.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.002 0.429 . . . . 0.0 111.681 -178.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.491 ' HD3' ' CE1' ' A' ' 105' ' ' PHE . 6.1 ptm180 -159.7 135.62 8.66 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.062 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.521 ' HB2' ' HB ' ' A' ' 131' ' ' THR . 9.0 m120 -108.68 119.02 38.31 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' A' ' 38' ' ' LEU . 57.7 t -112.49 138.23 42.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.592 -177.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.589 ' HB3' ' HB3' ' A' ' 129' ' ' LYS . 34.2 tp -123.69 123.89 41.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.017 0.437 . . . . 0.0 110.765 175.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.467 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 79.7 mt -101.09 132.51 46.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.274 175.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.05 -179.97 6.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.768 0.318 . . . . 0.0 110.553 -178.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 6.0 ptm85 -69.93 -24.09 63.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.262 -174.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -77.06 -26.98 54.17 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.51 0.671 . . . . 0.0 109.898 174.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.548 ' HA3' ' CZ ' ' A' ' 32' ' ' ARG . . . 109.93 18.77 8.58 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.854 -177.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 11' ' ' GLU . 80.9 mttt -94.63 136.42 34.95 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.954 0.407 . . . . 0.0 110.501 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.657 HD12 HG11 ' A' ' 7' ' ' VAL . 55.4 mt -79.7 99.2 3.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 28.0 m -101.33 -4.85 9.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -171.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.589 ' HB3' ' HB3' ' A' ' 120' ' ' LEU . 48.3 tptt -146.27 111.53 5.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.14 0.495 . . . . 0.0 111.597 -176.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.567 HD23 HG12 ' A' ' 9' ' ' ILE . 3.3 mm? -109.28 105.85 15.44 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.646 172.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.521 ' HB ' ' HB2' ' A' ' 118' ' ' ASN . 0.4 OUTLIER -109.64 155.86 20.94 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.999 0.428 . . . . 0.0 111.137 -174.479 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -89.85 174.35 7.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.996 178.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.709 ' HB3' ' HB ' ' A' ' 116' ' ' THR . 2.9 pp -45.34 162.07 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 O-C-N 123.608 0.568 . . . . 0.0 112.106 175.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.954 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 91.9 t80 -43.98 97.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -174.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -114.4 129.62 56.66 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 164.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -55.07 -43.49 73.93 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -171.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -60.95 -49.54 77.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.99 0.424 . . . . 0.0 111.445 176.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.438 ' HB3' ' CG2' ' A' ' 131' ' ' THR . 6.6 mt-10 -65.0 -39.96 94.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.263 -178.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.439 ' CZ ' ' HB3' ' A' ' 54' ' ' PHE . 70.6 t80 -64.03 -42.05 97.23 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.917 0.389 . . . . 0.0 110.408 175.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.46 -40.62 97.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.725 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.402 ' O ' ' HB3' ' A' ' 145' ' ' GLN . 60.7 p -65.64 -29.26 69.81 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.299 -0.409 . . . . 0.0 109.926 178.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 19.4 mt -73.15 -57.68 3.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.313 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.509 HG23 HG12 ' A' ' 59' ' ' ILE . 7.4 p -59.39 -38.34 74.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 O-C-N 123.11 0.256 . . . . 0.0 110.966 -175.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -67.41 -48.73 66.48 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 177.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.468 ' O ' ' HG2' ' A' ' 149' ' ' MET . 7.1 tt0 -55.98 -48.89 75.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.853 177.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.455 ' O ' HD23 ' A' ' 150' ' ' LEU . 93.1 mt -64.16 -44.44 97.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.189 -178.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -58.93 -40.75 85.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.201 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.51 ' OE1' ' HB2' ' A' ' 151' ' ' LYS . 6.1 tp10 -73.55 -25.95 60.62 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.126 -0.229 . . . . 0.0 110.951 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.468 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 61.1 mmm -66.7 -28.44 68.44 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 175.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.462 ' HG ' ' CE1' ' A' ' 63' ' ' HIS . 4.2 mm? -81.75 -20.63 38.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.83 175.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.687 ' HA ' ' HE2' ' A' ' 151' ' ' LYS . 10.0 mmpt? -102.27 -3.62 26.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.678 -178.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.51 ' HA ' ' CE1' ' A' ' 154' ' ' HIS . 7.0 tp10 -68.67 75.91 0.29 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 122.422 1.106 . . . . 0.0 111.517 178.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -118.6 14.66 11.7 Favored Glycine 0 N--CA 1.436 -1.353 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 164.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.51 ' CE1' ' HA ' ' A' ' 152' ' ' GLU . 2.3 m80 -69.12 -33.03 72.83 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 114.505 -0.847 . . . . 0.0 109.172 -176.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -106.12 27.88 8.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.308 -177.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -75.91 75.01 2.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.231 0.538 . . . . 0.0 110.857 -177.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 56.4 t60 -138.21 9.75 2.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.358 175.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -99.78 -28.03 13.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.245 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 . . . . . 0 C--O 1.243 0.72 0 CA-C-O 118.585 -0.721 . . . . 0.0 109.806 179.647 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptm . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.725 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . 3.7 p -154.37 127.32 8.25 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 123.386 0.429 . . . . 0.0 109.94 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.7 mp -82.0 80.67 8.2 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.899 0.38 . . . . 0.0 110.714 -177.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 70.82 41.57 62.66 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.548 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.725 ' HB2' ' HB2' ' A' ' 2' ' ' SER . 93.5 m-85 -113.1 152.59 29.4 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 178.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.7 pp -109.99 -0.12 9.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.576 0.703 . . . . 0.0 109.898 171.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.2 p -114.53 163.01 12.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.612 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 28.3 mtm105 -129.88 166.4 20.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.833 0.349 . . . . 0.0 111.916 -171.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.496 HG12 ' CD2' ' A' ' 130' ' ' LEU . 53.2 mt -77.88 140.13 17.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.848 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.96 -16.56 55.0 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.128 -0.558 . . . . 0.0 111.882 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.454 ' HA ' ' OE1' ' A' ' 11' ' ' GLU . 8.0 mm-40 -82.65 158.38 23.01 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.073 0.463 . . . . 0.0 111.086 -178.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 84.9 mmm -77.15 132.33 38.75 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.373 -176.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.535 ' HB2' HD12 ' A' ' 121' ' ' ILE . . . -68.72 130.04 92.08 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.036 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -67.74 125.63 13.5 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.611 2.207 . . . . 0.0 111.93 177.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -64.77 145.7 55.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.039 -178.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.692 ' HB2' HD12 ' A' ' 104' ' ' ILE . 47.1 p90 -149.54 154.2 38.36 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.471 178.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 34.6 m -118.13 106.18 12.59 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.547 173.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.6 tt -110.72 145.81 16.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.599 -175.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.508 ' O ' HD23 ' A' ' 98' ' ' LEU . 16.5 m -85.99 128.2 34.8 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.309 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.1 mt -80.57 179.54 7.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.092 0.472 . . . . 0.0 111.392 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 96' ' ' LEU . 30.0 p -64.66 -20.03 66.06 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.329 -0.851 . . . . 0.0 112.439 -177.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.496 ' OD2' ' HG3' ' A' ' 24' ' ' LYS . 10.9 p-10 -106.07 10.74 32.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.919 0.39 . . . . 0.0 110.647 -178.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.14 3.37 67.69 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.665 -0.779 . . . . 0.0 113.398 175.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.496 ' HG3' ' OD2' ' A' ' 22' ' ' ASP . 32.0 mtmm -84.51 122.93 29.69 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.043 0.421 . . . . 0.0 111.353 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.49 ' HB3' HG22 ' A' ' 17' ' ' THR . 93.6 mt-30 -88.23 116.44 26.43 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 175.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 17' ' ' THR . 17.0 m -107.59 147.15 12.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.217 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.8 m -111.42 144.45 40.61 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.072 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.02 -43.4 91.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.965 0.412 . . . . 0.0 110.328 -178.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.515 ' HA ' ' CG ' ' A' ' 32' ' ' ARG . 49.4 m -62.02 -21.22 64.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.974 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.5 t -76.75 -17.29 59.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.818 0.342 . . . . 0.0 110.433 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.4 mt -118.45 19.55 13.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.136 0.494 . . . . 0.0 110.271 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.534 ' NH1' ' H ' ' A' ' 33' ' ' GLY . 10.6 mmm180 -73.71 155.89 38.48 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.966 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.534 ' H ' ' NH1' ' A' ' 32' ' ' ARG . . . 102.94 -30.97 9.31 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 -177.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.689 ' HB3' ' HZ3' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -114.31 173.55 6.4 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.515 -0.343 . . . . 0.0 110.5 -177.879 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 68' ' ' ASP . 33.2 m -79.35 130.65 35.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.944 0.402 . . . . 0.0 110.055 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.47 ' HB ' ' HB ' ' A' ' 121' ' ' ILE . 55.3 t -119.93 113.85 42.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.662 -178.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.807 ' HB3' ' HG ' ' A' ' 71' ' ' LEU . 1.6 tmt? -91.68 138.1 31.83 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 176.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.415 ' HB2' ' HB ' ' A' ' 119' ' ' VAL . 93.5 mt -127.9 122.51 32.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.509 -175.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -116.81 107.16 14.29 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.547 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.779 ' HB2' ' HB2' ' A' ' 117' ' ' ARG . 92.6 m-85 -90.92 112.54 24.44 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 75' ' ' ASP . 9.2 t -141.34 -171.43 3.29 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.47 -172.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.418 ' HA ' ' OD2' ' A' ' 75' ' ' ASP . . . -151.14 172.55 15.61 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.528 ' HA ' ' CD1' ' A' ' 86' ' ' PHE . 26.9 t -82.88 -14.04 55.0 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.835 0.35 . . . . 0.0 110.766 -178.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -102.3 -4.37 25.75 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.6 p -88.56 107.4 18.88 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 121.657 -0.652 . . . . 0.0 111.181 -178.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.83 -8.7 82.58 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 115.836 -0.62 . . . . 0.0 113.175 -177.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.4 t -77.34 -45.54 29.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 176.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.68 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 98.0 m -62.93 -22.69 66.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.475 -178.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.567 ' HE ' ' HE1' ' A' ' 86' ' ' PHE . 89.1 mtt180 -69.93 -2.12 11.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.607 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.425 ' O ' ' HD1' ' A' ' 54' ' ' PHE . 58.9 mttp -100.3 -48.28 4.65 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.346 0.593 . . . . 0.0 109.676 171.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 1.098 ' HB3' ' HB2' ' A' ' 134' ' ' TYR . 6.5 pt-20 -67.2 -44.36 79.8 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.798 -176.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.805 ' HG2' ' HD3' ' A' ' 53' ' ' PRO . 16.2 ptm -64.18 -39.77 46.66 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-O 118.576 -0.726 . . . . 0.0 112.923 -174.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.805 ' HD3' ' HG2' ' A' ' 52' ' ' MET . 46.6 Cg_exo -61.23 -41.73 40.44 Favored 'Trans proline' 0 C--N 1.362 1.254 0 C-N-CA 121.345 1.363 . . . . 0.0 112.307 169.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 139' ' ' PHE . 18.4 m-85 -64.98 -41.88 95.03 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.906 176.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.558 HG12 HD12 ' A' ' 59' ' ' ILE . 70.2 mt -59.43 -50.52 79.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.094 175.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.601 ' OE1' ' HA ' ' A' ' 92' ' ' VAL . 25.2 tp10 -49.05 -49.67 40.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.232 0.539 . . . . 0.0 110.819 175.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.7 tmmt? -69.29 -47.02 65.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.915 -174.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -106.33 -50.16 3.2 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -173.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.558 HD12 HG12 ' A' ' 55' ' ' ILE . 38.4 mt -71.08 -43.48 75.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.597 -176.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.435 ' CE2' ' HB3' ' A' ' 94' ' ' TYR . 66.8 t-105 -81.66 -77.43 0.22 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.997 -178.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -44.5 -34.99 2.28 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -172.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -84.37 -26.44 28.39 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -173.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -127.15 -9.66 5.89 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -173.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.542 ' HA ' ' CD2' ' A' ' 69' ' ' PHE . 18.0 pttp -41.89 -48.84 4.51 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -165.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.52 -83.95 0.11 Allowed 'General case' 0 C--O 1.25 1.094 0 CA-C-O 121.471 0.653 . . . . 0.0 110.197 -172.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.459 ' CG ' ' H ' ' A' ' 67' ' ' ALA . 63.5 t30 49.23 -155.75 0.09 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.631 -169.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.459 ' H ' ' CG ' ' A' ' 66' ' ' ASN . . . -105.99 -10.41 16.6 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 166.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.489 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 12.8 m-20 -145.05 39.76 1.22 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.739 -170.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.542 ' CD2' ' HA ' ' A' ' 64' ' ' LYS . 62.1 t80 -118.45 129.3 55.31 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 118.976 -1.089 . . . . 0.0 110.605 169.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.24 143.75 50.97 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.533 175.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.807 ' HG ' ' HB3' ' A' ' 37' ' ' MET . 5.4 tt -143.77 121.56 11.94 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.1 mp -125.67 127.19 71.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.378 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.428 ' HA3' HD22 ' A' ' 96' ' ' LEU . . . -95.53 133.08 11.35 Favored Glycine 0 C--O 1.223 -0.579 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.034 175.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 74.7 mt -119.74 127.38 75.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 117.203 0.501 . . . . 0.0 111.128 -174.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.45 ' O ' ' HB3' ' A' ' 99' ' ' ASP . 11.6 t70 -89.34 144.85 25.76 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.508 HH21 ' HA ' ' A' ' 112' ' ' ASP . 19.8 ttt-85 -69.71 -32.71 71.44 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -172.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -158.38 -34.26 0.07 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -173.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -71.62 138.4 83.27 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 121.262 0.553 . . . . 0.0 111.896 -165.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.563 ' HD2' ' HG3' ' A' ' 82' ' ' LYS . 37.4 Cg_endo -72.17 -170.75 0.6 Allowed 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.676 2.917 . . . . 0.0 115.411 -171.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.423 ' O ' HD23 ' A' ' 84' ' ' LEU . 87.7 mt -54.63 -60.35 3.47 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 114.422 -1.263 . . . . 0.0 113.021 -171.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.552 ' OE1' ' HG2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER -59.43 -35.39 73.91 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.032 0.444 . . . . 0.0 110.821 -173.072 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.563 ' HG3' ' HD2' ' A' ' 79' ' ' PRO . 19.4 mmmt -61.42 -53.27 58.7 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.237 174.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 79' ' ' PRO . 70.6 t -65.9 -43.57 92.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.341 -178.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 80' ' ' LEU . 4.4 mm? -61.79 -47.37 85.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.399 -178.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.86 -35.19 79.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.752 0.31 . . . . 0.0 110.725 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.567 ' HE1' ' HE ' ' A' ' 49' ' ' ARG . 91.3 t80 -67.02 -52.49 41.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.125 178.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.523 ' HB2' HD12 ' A' ' 96' ' ' LEU . . . -55.47 -49.54 72.22 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.915 0.388 . . . . 0.0 110.691 177.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.4 tttm -50.69 -36.21 34.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.978 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.9 m -89.78 6.55 41.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.446 -174.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 16.5 p -132.63 8.51 4.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.191 0.519 . . . . 0.0 110.739 176.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.62 -72.12 2.17 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.601 ' HA ' ' OE1' ' A' ' 56' ' ' GLU . 58.1 t 29.37 96.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.148 1.379 . . . . 0.0 114.579 178.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.5 p -94.88 -10.83 30.04 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.639 -0.425 . . . . 0.0 110.553 176.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.435 ' HB3' ' CE2' ' A' ' 60' ' ' TRP . 37.4 p90 -85.49 141.07 36.29 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.381 175.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -62.43 137.71 66.64 Favored 'Trans proline' 0 C--O 1.239 0.546 0 C-N-CA 122.514 2.143 . . . . 0.0 113.359 -177.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.523 HD12 ' HB2' ' A' ' 87' ' ' ALA . 71.4 mt -109.89 149.46 29.86 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.513 174.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -120.8 148.59 17.57 Favored Glycine 0 N--CA 1.438 -1.213 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 175.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.791 HD23 ' H ' ' A' ' 98' ' ' LEU . 2.3 pt? -103.24 131.79 50.01 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.45 ' HB3' ' O ' ' A' ' 75' ' ' ASP . 12.7 t0 -115.95 79.45 8.15 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.45 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -68.49 105.09 1.2 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.198 1.932 . . . . 0.0 112.373 -177.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 117.47 1.92 17.79 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.149 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 55.24 39.92 31.49 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 122.638 0.375 . . . . 0.0 111.854 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -79.83 -51.13 9.54 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.283 0.563 . . . . 0.0 110.784 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.692 HD12 ' HB2' ' A' ' 16' ' ' PHE . 30.5 mm -64.82 -34.65 71.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.615 ' CD1' ' HA ' ' A' ' 111' ' ' ARG . 18.1 t80 -65.75 -34.41 78.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.032 175.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 109' ' ' ALA . . . -71.88 -23.62 61.54 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.357 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -74.14 -3.9 32.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.255 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -131.0 -35.69 1.38 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.912 0.387 . . . . 0.0 111.269 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 106' ' ' ALA . . . -134.52 174.89 10.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.916 0.388 . . . . 0.0 111.109 -177.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.6 mt -78.91 6.22 9.71 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.615 ' HA ' ' CD1' ' A' ' 105' ' ' PHE . 7.3 mtm180 73.98 -68.94 0.2 Allowed 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.981 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.508 ' HA ' HH21 ' A' ' 76' ' ' ARG . 20.6 m-20 -84.77 6.75 23.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.729 -172.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -85.07 41.13 0.86 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.591 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.24 151.94 19.27 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.628 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.47 HG13 ' N ' ' A' ' 116' ' ' THR . 9.5 tp -88.03 171.18 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.47 ' N ' HG13 ' A' ' 115' ' ' ILE . 25.0 m 79.79 108.52 0.07 Allowed 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.298 0.639 . . . . 0.0 111.875 174.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.779 ' HB2' ' HB2' ' A' ' 40' ' ' PHE . 77.5 mmt-85 -138.78 131.15 28.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.151 173.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' A' ' 130' ' ' LEU . 7.6 m120 -114.99 117.14 29.76 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 176.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.415 ' HB ' ' HB2' ' A' ' 38' ' ' LEU . 39.4 t -129.28 141.4 46.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.879 0.371 . . . . 0.0 111.212 -172.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 46.7 tp -121.61 118.34 28.96 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.092 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.535 HD12 ' HB2' ' A' ' 13' ' ' ALA . 39.4 mm -91.44 121.35 41.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.849 177.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.57 ' OD2' ' HB2' ' A' ' 124' ' ' GLU . 13.6 t0 -67.83 158.35 32.75 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.375 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.7 ptt85 -67.57 -14.56 63.04 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.971 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.57 ' HB2' ' OD2' ' A' ' 122' ' ' ASP . 0.7 OUTLIER -77.63 -16.64 58.43 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 173.052 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.01 24.72 10.21 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.836 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -117.45 156.09 28.56 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.75 0.31 . . . . 0.0 111.359 -175.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.42 HG12 ' CD1' ' A' ' 121' ' ' ILE . 49.8 mt -86.72 113.88 25.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 174.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.1 m -104.2 -17.23 7.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.98 0.419 . . . . 0.0 111.502 -178.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.431 ' HG2' HE22 ' A' ' 145' ' ' GLN . 51.9 tptt -152.49 119.11 5.67 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.353 -176.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.618 HD12 ' CD2' ' A' ' 5' ' ' TYR . 1.7 pt? -141.28 105.85 4.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.537 0.684 . . . . 0.0 109.741 176.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.9 t -127.59 164.03 22.89 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.575 -175.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.805 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 62.5 mtp180 -114.71 133.12 56.13 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.54 -178.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.805 ' HG ' ' O ' ' A' ' 132' ' ' ARG . 3.9 pp 65.39 154.57 0.07 Allowed 'General case' 0 N--CA 1.471 0.578 0 O-C-N 124.988 1.43 . . . . 0.0 112.982 172.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 1.098 ' HB2' ' HB3' ' A' ' 51' ' ' GLU . 58.3 t80 -64.71 102.05 0.54 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.974 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 1.005 ' HB2' ' HB2' ' A' ' 138' ' ' GLU . 46.1 m-80 -98.93 167.11 10.95 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.948 171.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.14 -68.13 0.69 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.297 0.57 . . . . 0.0 110.03 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -67.83 -31.29 71.03 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.326 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 1.005 ' HB2' ' HB2' ' A' ' 135' ' ' ASN . 3.1 mm-40 -63.74 -40.13 95.99 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.186 177.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.484 ' HA ' HD12 ' A' ' 142' ' ' LEU . 87.2 t80 -71.1 -41.26 70.83 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.3 -39.15 89.41 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.769 177.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.0 m -65.35 -39.56 92.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.496 178.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.484 HD12 ' HA ' ' A' ' 139' ' ' PHE . 35.9 mt -58.66 -47.97 82.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.763 177.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 94.4 t -56.53 -49.25 78.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.186 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -66.22 -43.25 87.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.048 0.452 . . . . 0.0 110.589 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.52 ' O ' ' HG2' ' A' ' 149' ' ' MET . 12.7 tt0 -58.82 -50.95 72.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.031 179.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.626 ' O ' HD23 ' A' ' 150' ' ' LEU . 77.0 mt -66.83 -30.26 49.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.263 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.614 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 9.2 t-20 -57.68 -43.51 85.14 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.849 176.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -67.26 -39.03 86.07 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.687 0.617 . . . . 0.0 111.089 177.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' MET . . . . . 0.52 ' HG2' ' O ' ' A' ' 145' ' ' GLN . 88.1 mmm -59.68 -27.86 66.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.635 0.731 . . . . 0.0 110.084 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.626 HD23 ' O ' ' A' ' 146' ' ' ILE . 3.4 mm? -88.27 -6.62 57.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.403 179.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.614 ' HG2' ' O ' ' A' ' 147' ' ' ASN . 38.5 mmtm -103.16 -47.36 4.35 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.846 0.355 . . . . 0.0 111.919 -178.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.529 ' OE1' ' HA ' ' A' ' 155' ' ' HIS . 5.9 pt-20 -58.96 -46.43 88.07 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -165.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.486 ' N ' ' HG3' ' A' ' 152' ' ' GLU . . . 74.89 -58.57 2.64 Favored Glycine 0 C--O 1.227 -0.344 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -170.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.455 ' O ' ' HB2' ' A' ' 152' ' ' GLU . 14.7 p-80 -125.53 148.65 48.82 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 106.12 -1.808 . . . . 0.0 106.12 166.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.529 ' HA ' ' OE1' ' A' ' 152' ' ' GLU . 45.5 m-70 -53.4 96.91 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.105 0.411 . . . . 0.0 110.783 -173.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.522 ' HD2' ' HA ' ' A' ' 152' ' ' GLU . 15.3 p80 -87.8 10.81 17.24 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -168.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 24.7 p80 -81.22 46.28 0.92 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 163.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.446 ' H ' ' C ' ' A' ' 156' ' ' HIS . 30.2 t-80 171.14 140.32 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 113.131 -1.85 . . . . 0.0 106.951 -171.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.504 -0.76 . . . . 0.0 109.799 176.694 . . . . . . . . 0 0 . 1 stop_ save_